Gebrauchshinweis
SARSTEDT S-Monovette® Blutentnahmesystem

2 - 10
11 - 19
20 - 28
29 - 37
38 - 46
47 - 55
56 - 64
65 - 73
74 - 82
83 - 91
92 - 100
101 - 109
110 - 118
119 - 127
128 - 136
137 - 145
146 - 154
155 - 163
164 - 172173 - 181
182 - 190
191 - 199
200 - 208
209 - 117
218 - 226
227 - 235
236 - 244

gb_506_a_0722

DE Gebrauchshinweis – SARSTEDT S-Monovette® Blutentnahmesystem
EN Instructions for use – SARSTEDT S-Monovette® Blood Collection System
BG ȤɉɍɎɌɏɆɒɄɄɃȼɏɋɊɎɌɁȽȼş6$567('7ɍɄɍɎɁɈȼɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®
CS Návod k obsluze – SARSTEDT S-Monovette®V\VWÜPSURRGEÞUNUYH
DA Brugsanvisning – SARSTEDT S-Monovette® blodprøvetagningssystem
EL 2ǳǶǲǮǴǿȄǾǭȀǴȆǿşǣȊȀȁǶƑǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH® SARSTEDTES Instrucciones de uso – Sistema de extracción de sangre SARSTEDT S-Monovette®
ET Kasutusjuhend – SARSTEDTI verevõtusüsteem S-Monovette®
FR Mode d‘emploi – Système de prélèvement sanguin S-Monovette® SARSTEDT
HR Uputa za upotrebu – SARSTEDT S-Monovette® – sustav za prikupljanje krvi
HU Használati utasítás – SARSTEDT S-Monovette® vérvételi rendszer
Istruzioni d‘uso – Sistema di prelievo ematico S-Microvette® SARSTEDTIT
KO ㌂㣿G㍺ⳛ㍲ – SARSTEDT S-Monovette® 㺚䡞 㔲㓺䎲
LT Naudojimo instrukcijos – SARSTEDT „S-Monovette®“ kraujo surinkimo sistema
LV /LHWRđDQDVQRUÌGHVş6$567('760RQRYHWWH®DVLQVSDÿHPđDQDVVLVWàPD
NL Gebruiksaanwijzing – SARSTEDT S-Monovette® bloedafnamesysteem
NO Bruksanvisning – SARSTEDT S-Monovette®-blodprøvetakingssystem
PL ,QVWUXNFMDREVúXJLş6\VWHPGRSRELHUDQLDNUZL60RQRYHWWH® SARSTEDTPT Instruções de utilização – S-Monovette® Sistema de colheita de sangue SARSTEDT
RO ,QVWUXFėLXQLGHXWLOL]DUHş6LVWHPGHUHFROWDUHDVÉQJHOXL60RQRYHWWH® SARSTEDTRU ȤɉɍɎɌɏɆɒɄɛɋɊɋɌɄɈɁɉɁɉɄɚşȭɄɍɎɁɈȼȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH® SARSTEDTSK 1ÈYRGQD3RXĭLWLHş6$567('760RQRYHWWH® systém na odber krvi
SL Navodila za uporabo – Sistem za odvzem krvi S-Monovette® SARSTEDTSV Bruksanvisning – SARSTEDT S-Monovette® system för blodprovstagning
TH คําแนะนําในการใช้งาน – ระบบการเจาะเลือด S-Monovette® ของ SARSTEDT
TR .XOODQêPL×LQWDOLPDWODUş6$567('760RQRYHWWH® Kan alma sistemi
ZH ἗䓀完㖦 – SARSTEDT S-Monovette® 埘㵊慟晞䲓乷1

DE
Zur in-vitro-diagnostischen Verwendung
Verwendungszweck
S-Monovette® Blutentnahmesysteme, Kanülen und Adapter werden zusammen als System für die venöse Blutentnahme eingesetzt. S-Monovette® Blutentnahmesysteme dienen der Entnahme, dem Transport, derVerarbeitung und der Lagerung von Blutproben für in-vitro diagnostische Bestimmungen aus Serum, Plasma oder Vollblut im klinischen Labor. Das Produkt ist für den Einsatz im professionellen Umfeld und die
Anwendung durch medizinisches Fachpersonal und Laborpersonal bestimmt.

Produktbeschreibung
S-Monovette® Blutentnahmesysteme bestehen aus einem Kunststoffgefäß, einem Kolben, einer Kolbenstange und einer farbkodierten Kunststoff-Schraubkappe mit integrierter Membran, die speziell für den Anschluss
an eine S-Monovette® (Safety-) Kanüle oder (Safety-) Multifly®-Kanüle entwickelt wurde, sowie verschiedenen Additiven (Präparierungen). Es ist ebenfalls eine S-Monovette® ohne Additiv erhältlich. S-Monovette®
Blutentnahmesysteme mit den Additiven Gerinnungsaktivator, Gerinnungsaktivator mit Gel, Lithium-Heparin, Lithium-Heparin mit Gel, Natrium-Heparin, Citrat, EDTA, Fluorid EDTA, Fluorid Heparin, Fluorid Citrat, CPDA
sowie ohne Additiv, deren Additivkonzentrationen, das Volumen der flüssigen Additive und deren zulässige Toleranzen sowie das Verhältnis von Blut zu Additiv entsprechen den Anforderungen und Empfehlungen derinternationalen Norm DIN EN ISO 6710 „Single-use containers for venous blood specimen collection“ und den Clinical and Laboratory Standards Institute’s Approved Standards (CLSI). Die Wahl des Additivs hängt
von der analytischen Testmethode ab. Sie wird vom Testreagenzien- und/oder des Analysengeräteherstellers, mit dem der Test durchgeführt wird, vorgegeben. Das S-Monovette® Blutentnahmesystem gibt es in den
Ausführungen innen steril oder einzeln verpackt innen und außen steril.

Farbcodes der S-Monovette® Schraubkappen*:

Additiv

Buchstaben-Code

Kappenfarbe DIN EN ISO
6710

Kappenfarbe orientiert an
BS 4851+

Z

weiß

weiß

Gefäß ohne Präparierung
S-Monovette® Neutral Z
Serum Gefäß
S-Monovette® Serum CAT, mit Gerinnungsaktivator

CAT

rot

weiß

S-Monovette® Serum-Gel CAT, mit Gerinnungsaktivator und GelCATdunkelgelb

dunkelgelb

S-Monovette® Serum Express Gel CAT, mit Gerinnungsaktivator Thrombin und Gel

CATorange-Heparin Gefäß
S-Monovette® Lithium-Heparin LH, mit Lithium-Heparin

LH

grün

orangeS-Monovette®/LWKLXP+HSDULQĲĞVVLJ/+PLW/LWKLXP+HSDULQ

LH

grün

orangeS-Monovette® Lithium-Heparin-Gel LH, mit Lithium-Heparin und Gel

LH

grün

orangeS-Monovette® Lithium-Heparin-Gel+ LH, mit Lithium-Heparin und schnellem Gel

LH

grün

orangeS-Monovette® Natrium-Heparin NH, mit Natrium-Heparin

NH

braun

grün

S-Monovette® Ammonium-Heparin AH, mit Ammonium-Heparin

n.d.

blau

blau

S-Monovette® Citrat 9NC, Natriumcitrat 3,13%

9NC

blau

grün

S-Monovette 3)$&LWUDW1&1DWULXPFLWUDWJHSXĳHUW

9NC

hellblau-

S-Monovette® K3 EDTA K3E, mit Kalium EDTA

K3E

violett

rot

S-Monovette® K2 EDTA K2E, mit Kalium EDTA

K2E

violett

rot

S-Monovette® K2 EDTA-Gel K2E, mit Kalium EDTA und Gel

K2E

violett

rot

S-Monovette® Fluorid EDTA FE, mit Fluorid und EDTA

FE

grau

gelb

S-Monovette® Fluorid Heparin FH, mit Fluorid und Heparin

FH

-

gelb

S-Monovette® GlucoEXACT FC, mit Fluorid, Citrat und EDTA

FC

pink

grau

LH

dunkelblau

orangeS-Monovette® ThromboExact, mit Magnesium Verbindungn.d.

n.d., brombeerfarbenn.d., brombeerfarben

S-Monovette® CTADn.d.

n.d., blaun.d., grün

S-Monovette® ACD

ACD

gelb

gelb

S-Monovette® CPDA

CPDA

gelb

gelb

S-Monovette® Hirudinn.d.

n.d., olivgrünn.d., olivgrün

S-Monovette® Homocystein HCY-Z Gel, mit Gel und Stabilisatorn.d.

n.d., grau

n.d., grau

S-Monovette®+RPRF\VWHLQ+&<&PLW&LWUDW3XĳHU

n.d.

n.d., violett

n.d., violett

S-Monovette® DNA Exactn.d.

n.d., blaun.d., blau

Citrat Gefäß®

EDTA Gefäß

Gefäß mit Glykolyse-Inhibitoren

Gefäß für Metallanalytik
S-Monovette® Metallanalytik LH, mit Lithium-Heparin

Weitere Vollblut und Plasmagefäße* Weitere Schraubkappenfarben erhältlich.
n.d.: nicht definiert+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, zurückgezogen.

2

DE
SARSTEDT S-Monovette® Serum CAT / Serum-Gel CAT
Die S-Monovette® Serum CAT enthält ein mit einem Gerinnungsaktivator (Silikat) beschichtetes Kunststoffgranulat und dient der Serumgewinnung**. Das Kunststoffgranulat setzt sich durch Zentrifugation zwischen
Blutkuchen und Serum.
Die S-Monovette® Serum-Gel CAT enthält neben dem mit einem Gerinnungsaktivator (Silikat) beschichteten Kunststoffgranulat ein polymerbasiertes Gel und dient der Serumgewinnung**. Das Gel setzt sich durch
Zentrifugation zwischen Blutkuchen und Serum und bildet eine stabile Trennschicht während Transport, Lagerung und Analyse.
Serum wird als Probenmaterial in klinisch-chemischen und immunologischen Routineuntersuchungen sowie in der Serologie verwendet.
Nach der Blutentnahme soll das Blut in der S-Monovette® Serum CAT / Serum-Gel CAT für 30 Minuten in aufrechter Position gerinnen, um eine gut ausgebildete horizontale Trennschicht nach der Zentrifugation zu
gewährleisten. Die empfohlene Zeit basiert auf einem intakten Gerinnungsprozess. Blut von Patienten mit krankheitsbedingten Gerinnungsstörungen oder unter gerinnungshemmenden Therapien benötigt gegebenenfalls
mehr Zeit für die vollständige Gerinnung.

SARSTEDT S-Monovette® Serum Express Gel CAT
Die S-Monovette® Serum Express Gel CAT enthält neben dem mit dem Gerinnungsaktivator (Thrombin) beschichteten Kunststoffgranulat ein polymerbasiertes Gel und dient der Serumgewinnung**. Das Gel setzt sichdurch Zentrifugation zwischen Blutkuchen und Serum und bildet eine stabile Trennschicht während Transport, Lagerung und Analyse.
Nach der Blutentnahme soll das Blut in der S-Monovette® Serum Express Gel für 5 Minuten in aufrechter Position gerinnen, um eine gut ausgebildete horizontale Trennschicht nach der Zentrifugation zu gewährleisten.
Die empfohlene Zeit basiert auf einem intakten Gerinnungsprozess, auch für Blut von heparinisierten Patienten. Blut von Patienten mit krankheitsbedingten Gerinnungsstörungen oder unter gerinnungshemmenden
Therapien inklusive hochdosiertem Heparin benötigt mehr Zeit für die vollständige Gerinnung.
Serum wird als Probenmaterial in klinisch-chemischen und immunologischen Routineuntersuchungen sowie in der Serologie verwendet.

SARSTEDT S-Monovette® Neutral Z
Die S-Monovette® Neutral Z enthält keine Präparierung, was einer natürlichen Gerinnung der Blutprobe ohne Gerinnungsaktivator entspricht, und dient der Serumgewinnung**. Durch Zentrifugation erfolgt eine Trennung
in Blutkuchen und Serum.
Serum wird als Probenmaterial für anwenderspezifische Untersuchungen verwendet.
Darüber hinaus kann die S-Monovette® Neutral Z auch als Leergefäß wie folgt eingesetzt werden: soll die Blutentnahme mit einer S-Monovette® Citrat in Kombination mit einer (Safety-)Multifly®-Kanüle (Flügelkanüle)
begonnen werden, wird die S-Monovette® Neutral Z als erstes Gefäß (Leergefäß) zur Befüllung des Schlauches der (Safety-)Multifly®-Kanüle verwendet.

SARSTEDT S-Monovette® Lithium-Heparin LH / Lithium-Heparin-Gel LH / Lithium-Heparin-Gel+ LH, Natrium-Heparin NH, Ammonium-Heparin AH
Die S-Monovette® Lithium-Heparin LH / Natrium-Heparin NH / Ammonium-Heparin AH enthält ein mit dem Gerinnungshemmer (Antikoagulans) Lithium-Heparin / Natrium-Heparin / Ammonium-Heparin (i.d.R. 16 I.E.
Heparin / ml Blut) beschichtetes Kunststoffgranulat und dient der Vollblut- und Plasmagewinnung**. Das Kunststoffgranulat setzt sich durch Zentrifugation zwischen Blutzellen und Plasma.
Bei einer S-Monovette® Lithium-Heparin LH ohne Kunststoffgranulat liegt das Antikoagulans Lithium-Heparin in sprühdosierter Form (i.d.R. 19 I.E. Heparin / ml Blut) vor.
Die S-Monovette® Lithium-Heparin-Gel LH enthält neben dem mit dem Antikoagulans Lithium-Heparin (i.d.R. 25 I.E. Heparin / ml Blut) beschichteten Kunststoffgranulat ein polymerbasiertes Gel und dient derPlasmagewinnung**. Das Gel setzt sich durch Zentrifugation zwischen Blutzellen und Plasma und bildet eine stabile Trennschicht während Transport, Lagerung und Analyse.
Die S-Monovette® Lithium-Heparin Gel+ LH enthält ebenfalls ein polymerbasiertes Gel, welches eine um ca. 50% reduzierte Zentrifugationszeit im Vergleich zur S-Monovette® Lithium-Heparin Gel ermöglicht.
Heparin-Plasma wird als Probenmaterial in klinisch-chemischen und immunologischen Routineuntersuchungen verwendet. Heparin-Vollblut wird als Probenmaterial in immunologischen Routineuntersuchungen und in
der Serologie verwendet.
Die Gerinnungshemmung mit Heparin erfolgt durch eine Aktivierung von Antithrombin.
HINWEIS: Aus der S-Monovette® Lithium-Heparin LH, Lithium-Heparin-Gel/Gel+ LH dürfen keine Lithium-Bestimmungen, aus der S-Monovette® Natrium-Heparin NH dürfen keine NatriumBestimmungen und aus der S-Monovette® Ammonium-Heparin AH dürfen keine Ammonium-Bestimmungen durchgeführt werden. Eine mit venösem Blut befüllte S-Monovette® Lithium-Heparin/
Lithium-Heparin-Gel/Gel+ / Natrium-Heparin / Ammonium-Heparin sind nicht für die Blutgasanalyse geeignet.

SARSTEDT S-Monovette® Metallanalytik
Die S-Monovette® Metallanalytik enthält das Antikoagulans Lithium-Heparin und dient der Vollblut- und Plasmagewinnung**. Lithium-Heparin liegt in sprühdosierter Form (19 I.E. Heparin / ml Blut) vor.
Heparin-Vollblut bzw. Heparin-Plasma der S-Monovette® Metallanalytik in Kombination mit der speziellen Safety-Kanüle 21G x 1 ½“ (Art.-Nr. 85.1162.600) wird als Probenmaterial für die Untersuchungen vonSpurenelementen / Metallen verwendet. Die Spurenelemente / Metalle wurden mittels der Atomabsorptionsspektrometrie (AAS) validiert. Für das System Safety-Kanüle und S-Monovette® Metallanalytik ergeben sichfolgende maximalen Leerwerte in ng/System für diese Spurenelemente:

Element

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/System

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

®

Die maximalen Leerwerte sind für jedes Element auf dem Etikett der S-Monovette angegeben.
Spurenelementbestimmungen erfolgen abhängig vom Analysenverfahren aus Heparin-Vollblut oder Heparin-Plasma.
Die Gerinnungshemmung mit Heparin erfolgt durch eine Aktivierung von Antithrombin.

SARSTEDT S-Monovette® Citrat 9NC
Die S-Monovette® Citrat 9NC enthält das Antikoagulans Trinatriumcitrat und dient der Vollblut- und Plasmagewinnung**. Trinatriumcitrat liegt als 0,106 molare Lösung (3,13% Trinatriumcitrat-Lösung; oft zu 3,2%
aufgerundet) vor und beträgt 10% des Nennvolumens einer S-Monovette® Citrat. Das Mischungsverhältnis von Citrat zu Blut beträgt 1:9 – 1 Volumenanteil Citrat und 9 Volumenanteile Blut. Eine korrekte Befüllung ist für
die Analytik zwingend erforderlich.
Citrat-Plasma wird als Probenmaterial in hämostaseologische Routineuntersuchungen verwendet.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch Citrat.
Bitte HINWEISE unter Probenahme und Handhabung zur Kombination S-Monovette® Citrat und Flügelkanüle beachten.

SARSTEDT S-Monovette® PFA 9NC
Die S-Monovette® PFA 9NC enthält das Antikoagulans Trinatriumcitrat zur Vollblut- und Plasmagewinnung**. Trinatriumcitrat liegt als 0,129 molare gepufferte Lösung (3,8% gepuffert; pH 5,5) vor und beträgt 10% des
Nennvolumens einer S-Monovette® PFA. Das Mischungsverhältnis von Citrat zu Blut beträgt 1:9 – 1 Volumenanteil Citrat und 9 Volumenanteile Blut. Eine korrekte Befüllung ist für die Analytik zwingend erforderlich.
Das Vollblut der S-Monovette® PFA 9NC wird als Probenmaterial für die Thrombozytenfunktionsbestimmung mit dem SIEMENS Healthineers Analysengerät PFA verwendet und ist dafür validiert.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch Citrat.
Bitte HINWEISE unter Probenahme und Handhabung zur Kombination S-Monovette® PFA und Flügelkanüle beachten.

SARSTEDT S-Monovette® CTAD
Die S-Monovette® CTAD enthält das Antikoagulans Trinatriumcitrat sowie Theophyllin, Adenosin und Dipyridamol und dient der Vollblut- und Plasmagewinnung**. CTAD liegt als Lösung vor und beträgt 10% des
Nennvolumens einer S-Monovette® CTAD. Das Mischungsverhältnis von CTAD zu Blut beträgt 1:9 – 1 Volumenanteil CTAD und 9 Volumenanteile Blut. Eine korrekte Befüllung ist für die Analytik zwingend erforderlich.
CTAD-Plasma wird als Probenmaterial für die Bestimmung von Plättchenfaktor 4 (PF4), beta(ß)-Thromboglobulin (ßTG) und Plasminogenaktivator-Inhibitor (PAI-1) sowie für hämostaseologische Routineuntersuchungenverwendet.
Die Thrombozytenaktivierung wird für einen Zeitraum von mindestens 4 Stunden inhibiert und dient zur Überwachung von Heparintherapien.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch Citrat.
Bitte HINWEISE unter Probenahme und Handhabung zur Kombination S-Monovette® CTAD und Flügelkanüle beachten.
HINWEIS: CTAD ist gelb. Die S-Monovette® CTAD muss während der Lagerung vor künstlichem und natürlichem Licht geschützt werden. Eine starke Lichteinwirkung von mehr als 12 Stunden kann zu
einer Inaktivierung der Additive führen.

3

DE
SARSTEDT S-Monovette® EDTA K2E / K3E
Die S-Monovette® EDTA K2E / S-Monovette® EDTA K3E enthält das Antikoagulans K2 EDTA bzw. K3 EDTA und dient der Vollblutgewinnung**. K2 EDTA bzw. K3 EDTA liegt in sprühdosierter Form (1,6 mg EDTA / ml Blut)
vor.
EDTA-Vollblut wird als Probenmaterial für hämatologische Untersuchungen verwendet. Blutausstriche sollen innerhalb von vier Stunden nach der Blutentnahme angefertigt werden.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch EDTA.
Blut aus der S-Monovette® EDTA K2E / K3E kann ebenfalls für immunhämatologische Routineuntersuchungen und Tests von Infektionskrankheiten verwendet werden. Die Eignung des Probenmaterials für dieseUntersuchungen obliegt der Verantwortung des Anwenders mit den entsprechenden Testreagenzien / Analysengeräten inkl. Lagerbedingungen zu validieren.

SARSTEDT S-Monovette® EDTA-Gel K2E
Die S-Monovette® EDTA-Gel K2E enthält neben dem Antikoagulans K2 EDTA ein polymerbasiertes Gel und dient der Plasmagewinnung**. K2 EDTA liegt in sprühdosierter Form (1,6 mg EDTA / ml Blut) vor. Das Gel setzt
sich durch Zentrifugation zwischen Blutzellen und Plasma und bildet eine stabile Trennschicht während Transport, Lagerung und Analyse.
EDTA-Plasma wird als Probenmaterial für die molekulare Virusdiagnostik verwendet.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch EDTA.

SARSTEDT S-Monovette® Fluorid EDTA FE / Fluorid Heparin FH / Fluorid Citrat EDTA FC mit Glykolyse-Inhibitoren
Die S-Monovette® Fluorid EDTA FE enthält das Antikoagulans EDTA (1,2 mg / ml Blut) sowie Fluorid (1,0 mg / ml Blut) zur Glykolyse-Inhibierung und dient der Plasmagewinnung**. Fluorid EDTA liegt in sprühdosierter Formvor.
Die S-Monovette® Fluorid Heparin FH enthält das Antikoagulans Heparin (16 I.E. Heparin / ml Blut) sowie Fluorid (1,0 mg / ml Blut) zur Glykolyse-Inhibierung und dient der Plasmagewinnung**. Fluorid Heparin liegt in
sprühdosierter Form vor.
Die Glykolyse-Inhibierung allein durch Fluorid beginnt ca. 2 Stunden nach Befüllung des Blutentnahmegefäßes und zeigt seine volle Wirkung nach ca. 4 Stunden. Glukose baut sich daher im Mittel bis zu 6 % nachwenigen Stunden und bis zu 10-15% nach 24 Stunden im Vollblut ab.
Die S-Monovette® GlucoEXACT FC enthält das Antikoagulans EDTA sowie Citrat und Fluorid zur sofortigen Glykolyse-Inhibierung und dient der Plasmagewinnung**. EDTA, Citrat und Fluorid liegen als Lösung vor. Die
Berechnung der Glukosekonzentration erfordert auf Grund der Verdünnung die Multiplikation mit 1,16.
Die S-Monovette® GlucoEXACT FC erfüllt die Gestationsdiabetes-Leitlinie der Deutschen Diabetes Gesellschaft (DDG) und die Nationale VersorgungsLeitlinie (NVL) für Typ-2-Diabetes. Die sofortige Stabilisierung der
Glukosekonzentration wird für bis zu 96 Stunden bei Raumtemperatur im Vollblut gewährleistet, siehe auch SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
Fluorid-EDTA-(Citrat-)Plasma wird als Probenmaterial für die Glukosebestimmung verwendet.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch EDTA.
HINWEIS: Fluorid kann einen Anstieg von Hämolyse verursachen. Weitere Informationen zu Substanzen, die störend wirken können, sind dem jeweiligen Gebrauchshinweis des TestreagenzienHerstellers zu entnehmen.
Bitte HINWEISE unter Probenahme und Handhabung zur Kombination S-Monovette® GlucoEXACT und Flügelkanüle beachten.

SARSTEDT S-Monovette® CPDA
Die S-Monovette® CPDA enthält das Antikoagulans Natriumcitrat sowie Zitronensäure, Natriumphosphat, Dextrose und Adenin und dient der Vollblut- und Plasmagewinnung**. CPDA liegt als Lösung vor. Das
Mischungsverhältnis von CPDA zu Blut beträgt 1:6 - 1 Volumenteil CPDA und 6 Volumenteile Blut. Eine korrekte Befüllung ist auf Grund der Analytik zwingend erforderlich.
CPDA Vollblut / Plasma wird als Probenmaterial für die Blutgruppenserologie in der Transfusionsmedizin, für Verträglichkeitsuntersuchungen (Kreuzproben) bei Transfusionen verwendet. Konkret ist die S-Monovette®
CPDA für die Blutgruppenbestimmung (AB0) inklusive Kell und Rhesusformel, Antikörpersuchtest auf irreguläre Blutgruppenantikörper, polyspezifischer direkter Coombstest (bis Tag 10), Verträglichkeitstest (Kreuzprobe)
mit blutgruppenkompatiblem Patientenserum/-plasma (Major Test) geeignet.
Die Transportdauer bis zur Lagerung ist für maximal 4 Stunden bei 2 - 21 °C validiert. Zur Sedimentation der Zellen müssen die Proben zuvor für mind. 16 Stunden aufrecht stehend im Kühlschrank gelagert werden.
Anschließend können die o.g. Analyten bis zu 35 Tagen analog der üblichen Blutkonservenlaufzeit nach Lagerung im Kühlschrank (2 - 6 °C) bestimmt werden (ausgenommen direkter Coombstest 10 Tage). Geeignet fürSäulenagglutinationsverfahren z.B. am Vision Max von Ortho Clinical Diagnostics. Das Probenmaterial darf nicht eingefroren werden.
Die Eignung des Probenmaterials für diese Untersuchungen mit anderen Methoden / Testreagenzien / Analysengeräten inkl. Lagerbedingungen obliegt der Verantwortung des Anwenders und ist von ihm selbst zu
validieren.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch Citrat.
Bitte HINWEISE unter Probenahme und Handhabung zur Kombination S-Monovette® CPDA und Flügelkanüle beachten.

SARSTEDT S-Monovette® ThromboExact
Die S-Monovette® ThromboExact enthält als Antikoagulans ein Magnesium Salz und dient der Volblutgewinnung**. Das Magnesium Salz liegt in sprühdosierter Form vor.
Das Vollblut der S-Monovette® ThromboExact wird als Probenmaterial für den Ausschluss falsch niedriger Thrombozytenzahlen auf Grund einer Antikoagulanzien-Unverträglichkeit (wie EDTA, Citrat, Heparin), auch
Pseudothrombozytopenie bezeichnet, verwendet. Die Bildung von Thrombozytenaggregaten werden verhindert und die Bestimmung der tatsächlichen Thrombozytenzahl ist bis zu 12 Stunden nach Blutentnahmemöglich.
Die Gerinnungshemmung erfolgt über die Magnesium-Ionen, in dem die Magnesium-Ionen thrombozytäres Thromboxan A2 sowie die durch ADP und Arachidonsäure vermittelte Thrombozytenaggregation inhibiert.

SARSTEDT S-Monovette® Hirudin
Die S-Monovette® Hirudin enthält das Antikoagulans Hirudin und dient der Vollblutgewinnung**. Hirudin liegt in sprühdosierter Form vor.
Hirudin-Vollblut wird als Probenmaterial für die Bestimmung der Thrombozytenfunktion am Multiplate® Gerät (multiple platelet function analyser) von ROCHE Diagnostics verwendet und ist hierfür validiert. Eingesetzt wird
es zur Therapieüberwachung plättchenhemmender Medikamente sowie zum Nachweis oder Ausschluss von Thrombozytenfunktionsstörungen.
Die S-Monovette® Hirudin wurde speziell für die Bestimmung der Thrombozytenfunktion zusammen mit der Firma Verum Diagnostica, heute ROCHE Diagnostics, am Multiplate® Gerät entwickelt.
Die Gerinnungshemmung erfolgt über Hirudin durch direkte Thrombinhemmung und erlaubt so eine Thrombozytenfunktionsdiagnostik im nativen Zustand.

SARSTEDT S-Monovette® Homocystein HCY-Z-Gel / HCY-C
Die S-Monovette® Homocystein HCY-Z-Gel enthält neben dem mit einem Gerinnungsaktivator (Silikat) beschichteten Kunststoffgranulat einen speziellen Stabilisator sowie ein polymerbasiertes Gel und dient derSerumgewinnung**. Das Gel setzt sich durch Zentrifugation zwischen Blutkuchen und Serum und bildet eine stabile Trennschicht während Transport, Lagerung und Analyse. Die Präparierung liegt in sprühdosierter Formvor.
Homocystein wird bis zu 8 Stunden im Vollblut bei Raumtemperatur stabilisiert. Erfolgt die Zentrifugation innerhalb der ersten 8 Stunden mit korrekt ausgebildeter Trennschicht zwischen Blutkuchen und Serum wird
Homocystein bis zu 96 Stunden stabilisiert.
Das Serum der S-Monovette® Homocystein HCY-Z-Gel wird als Probenmaterial zur Homocystein Bestimmung verwendet. Die S-Monovette® Homocystein HCY-C enthält als Antikoagulans saures Citrat (pH 4,3) und
dient der Plasmagewinnung**. Citrat liegt als Lösung vor. Die Berechnung der Homocysteinkonzentration erfordert auf Grund der Verdünnung die Multiplikation mit 1,11.
Homocystein wird bei Raumtemperatur bis 6 Stunden und bei 4 °C bis zu 48 Stunden im Vollblut stabilisiert.
Das Plasma der S-Monovette® Homocystein HCY-C wird als Probenmaterial zur Homocystein Bestimmung verwendet.
Die Gerinnungshemmung in der S-Monovette® Homocystein HCY-C erfolgt durch die Komplexierung der Calcium-Ionen durch Citrat.
Bitte HINWEISE unter Probenahme und Handhabung zur Kombination S-Monovette® HCY-C und Flügelkanüle beachten.

SARSTEDT S-Monovette® DNA Exact
Die S-Monovette® DNA Exact enthält ein Antikoagulans auf EDTA-Basis und dient der Vollblutgewinnung**. EDTA liegt in sprühdosierter Form vor.
EDTA-Vollblut wird als Probenmaterial zur Stabilisierung von gDNA verwendet. Die Stabilisierungsleistung für gDNA ist validiert über 5 Tage bei 35 °C, 14 Tage bei Raumtemperatur (22 °C), 28 Tage bei Kühlung (4 °C)
und mind. 1 Jahr bei -20 °C. Zusätzlich überstehen die stabilisierten Proben 5 Einfrier- und Auftauzyklen ohne Qualitätseinbußen, siehe auch SARSTEDT White Paper https://www.sarstedt.com/en/products/diagnostic/
venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
Die Gerinnungshemmung erfolgt durch die Komplexierung der Calcium-Ionen durch EDTA.

**Die Eignung des Probenmaterials ist abhängig vom Analyt und dem Testreagenz / Analysengerät. Entsprechende Empfehlungen der Hersteller sind zu berücksichtigen.

4

DE
Sicherheitshinweise / Warnhinweise
1.

Allgemeine Vorsichtsmaßnahmen: Verwenden Sie Handschuhe und andere allgemeine persönliche Schutzausrüstung, um sich vor Blut und einer möglichen Exposition gegenüber potenziell infektiösem
Probenmaterial und übertragbaren Krankheitserregern zu schützen.

2.

Behandeln Sie alle biologischen Proben und scharfen/spitzen Blutentnahmeutensilien (Kanülen, Adapter) gemäß den Richtlinien und Verfahren Ihrer Einrichtung. Suchen Sie im Falle eines direkten Kontakts mit
ELRORJLVFKHQ3UREHQRGHUHLQHU6WLFKYHUOHW]XQJHLQHQ$U]WDXIGDKLHUGXUFK+,9+&9+%9RGHUDQGHUH,QIHNWLRQVNUDQNKHLWHQĞEHUWUDJHQZHUGHQNąQQHQ%HQXW]HQ6LH6DIHW\.DQĞOHQ6DIHW\0XOWLĲ\®-Kanülen mit
eingebautem Nadelschutz. Die Sicherheitsrichtlinien und -verfahren Ihrer Einrichtung müssen befolgt werden.

3.

Gilt für einzeln steril verpackte Produkte: Vor Benutzung jede Einzelverpackung auf Beschädigung überprüfen und im Fall einer Beschädigung nicht benutzen.

4.

'DV3URGXNWLVWIĞUGLHHLQPDOLJH9HUZHQGXQJYRUJHVHKHQ(QWVRUJHQ6LHDOOHVFKDUIHQVSLW]HQ*HJHQVWËQGH .DQĞOHQ$GDSWHU ]XU%OXWHQWQDKPHLQJHHLJQHWHQ$EZXUIEHKËOWHUQIĞUELRORJLVFKH*HIDKUVWRĳH

5.

Wird Blut über einen intravenösen (IV) Zugang entnommen, muss sichergestellt werden, dass der Zugang gemäß der Einrichtung ordnungsgemäß gespült (=von der IV-Lösung gereinigt) wird, bevor die
Blutentnahme begonnen wird. Das ordnungsgemäße Spülen des Zugangs vermeidet fehlerhafte Analysenergebnisse.

6.

Eine Unterfüllung der S-Monovette® führt zu einem falschen Verhältnis von Blut zu Präparierung/Additiv und kann zu falschen Analysenergebnissen führen.

7.

Das mit der S-Monovette® entnommene und verarbeitete Blut ist nicht zur Reinjektion in den menschlichen Körper bestimmt.

8.

Das Produkt darf nach Ablauf der Haltbarkeit nicht mehr verwendet werden. Die Haltbarkeit endet am letzten Tag des angegebenen Monats und Jahres.

Lagerung
Das Produkt ist bis zur Anwendung bei Raumtemperatur zu lagern.

Einschränkungen
1.

Lagerungsdauer und -temperatur einer befüllten S-Monovette® sind anhängig von der Haltbarkeit der zu untersuchenden Analyten. Die Beurteilung erfolgt durch das Labor bzw. Informationen werden aus dem
Gebrauchshinweis des Testreagenzien-/ Analysengeräteherstellers entnommen.

2.

Auch wenn Plasma oder Serum durch Zentrifugation einer S-Monovette®JHWUHQQWZLUGXQGRGHUHLQH%DUULHUHYRUKDQGHQLVWZHUGHQQLFKWXQEHGLQJWDOOH=HOOHQYROOVWËQGLJDEJHWUHQQW5HVWVWRĳZHFKVHORGHUQDWĞUOLFKHU$EEDXNąQQHQGLH.RQ]HQWUDWLRQHQYRQ$QDO\WHQEHHLQĲXVVHQ'LH6WDELOLWËWGHU$QDO\WHQVROOWHEH]ĞJOLFKGHU/DJHUEHKËOWHUXQGGHU%HGLQJXQJHQGHVMHZHLOLJHQ/DERUVEHXUWHLOWZHUGHQ3.

Im Fall therapeutischer Medikamente ist die Eignung des Probenmaterials im Gebrauchshinweis des Testreagenzien/Analysengeräteherstellers zu überprüfen.

4.

Analysen für Spurenelemente / Metalle sind mit dem System S-Monovette® Metallanalytik + Safety-Kanüle Metallanalytik durchzuführen.

Probenahme und Handhabung
LESEN SIE DIESES DOKUMENT VOLLSTÄNDIG DURCH, BEVOR SIE MIT DER VENÖSEN BLUTENTNAHME BEGINNEN.
Für die Probenahme benötigtes Arbeitsmaterial
1.

Alle benötigten S-Monovette® Blutentnahmesysteme.

2.

6DIHW\ .DQĞOHQRGHU 6DIHW\ 0XOWLĲ\®-Kanülen.

3.

Handschuhe, Kittel, Augenschutz oder andere geeignete Schutzkleidung zum Schutz vor durch Blut übertragene Pathogene oder potenziell infektiösen Materialien.

4.

(WLNHWWHQ]XU3DWLHQWHQLGHQWLıNDWLRQ5.

Desinfektionsmaterial zur Reinigung der Entnahmestelle (Richtlinien der Einrichtung für sterile Probenentnahme zur Vorbereitung der Entnahmestelle befolgen). Keine Reinigungsmaterialien auf Alkoholbasis
verwenden, wenn die Proben für Blutalkoholtests verwendet werden sollen.

6.

Trockene, keimarme Einwegtupfer.

7.

Venenstaubinde.

8.

3ĲDVWHURGHU9HUEDQG

9.

Abwurfbehälter für scharfe/spitze Gegenstände zur sicheren Entsorgung gebrauchten Materials.

Empfohlene Entnahmereihenfolge:
1.

Blutkultur-Flaschen

2.

Gefäße mit Citrat oder Gerinnungsaktivator (mit / ohne Gel Serum CAT / Serum-Gel CAT)3.

Gefäße mit Gerinnungsaktivator oder Citrat

4.

Gefäße mit Heparin mit / ohne Gel

5.

Gefäße mit EDTA mit / ohne Gel

6.

Gefäße mit Glykolyse-Inhibitoren

7.

Gefäße mit anderen Additiven
HINWEIS: Wird mit der Entnahme eines Citrat Gefäßes oder eines anderen Gefäßes mit einer Flüssigpräparierung wie z.B. PFA, CTAD, CPDA, HCY-C oder GlucoEXACT
LQ.RPELQDWLRQPLWHLQHU)OĞJHONDQĞOH ]% 6DIHW\ 0XOWLĲ\®-Kanüle) begonnen, wird die Entnahme eines Leergefäßes(z.B. S-Monovette® Neutral Z) vorab empfohlen, um eine Unterfüllung des Gefäßes durch die Befüllung des Schlauches der Flügelkanüle zu vermeiden.
Dadurch kann eine korrekte Befüllung des Gefäßes und damit ein korrektes Mischungsverhältnis (Flüssigkeit zu Blut) gewährleistet werden.
HINWEIS: Befolgen Sie zur Entnahmereihenfolge die Vorschriften Ihrer Einrichtung.

5ĞFNĲXVVYHUPHLGHQ
Die meisten S-Monovetten enthalten chemische Additive. Zur Verhinderung vor Rückfluss sind die folgenden Hinweise zu beachten:
1. Verwenden Sie ausschließlich die im Gebrauchshinweis empfohlenen Materialien.
2.

Patienten so lagern, dass ein einfacher Zugang zur Vene gegeben ist und den Arm oder anderen Punktionsbereich des Patienten nach unten richten.

3.

Halten Sie die S-Monovette®PLWGHU6FKUDXENDSSHQDFKREHQXQGEHL9HUZHQGXQJHLQHU 6DIHW\ 0XOWLĲ\®-Kanüle zusätzlich unterhalb des Armniveaus / Punktionsbereiches.

4.

Es muss sichergestellt werden, dass der Inhalt der S-Monovette® bei der Venenpunktion weder die Schraubkappe noch das Ende der Kanüle berührt.

5.

Die Venenstaubinde lösen, während das Blut in die S-Monovette®ĲLHĔW5

DE
Einfrieren / Auftauen
Gemäß den Empfehlungen der WHO (WHO/DIL/Lab/99.1 Rev.02) wird empfohlen, Serum/Plasma vor dem Einfrieren von Blutzellen zu trennen.
Für die S-Monovette® gelten die folgenden Empfehlungen zum Einfrieren:
Einfrieren unter 0 °C•

Der Einsatz im Minustemperaturbereich muss grundsätzlich unter realen Bedingungen getestet werden, da die Belastung der Gefäße je nach dem einzufrierenden Medium und den Routinebedingungen sehr
unterschiedlich sein kann. (siehe Kapitel Materialeigenschaften, SARSTEDT Katalog).

•*UXQGVËW]OLFKZHUGHQGLH)HVWLJNHLWVZHUWHYRQ.XQVWVWRĳHQLP7HPSHUDWXUEHUHLFKXQWHUƓ&UHGX]LHUW0HFKDQLVFKH%HODVWXQJHQVLQGGDKHUJHQHUHOO]XYHUPHLGHQ•Die Einfrierbedingungen müssen so gewählt sein, dass der Inhalt der S-Monovette® gleichmäßig bzw. von unten nach oben gefriert. Die S-Monovette® sollte in einem Ständer oder Lagerkarton genügend Spielhaben, damit sie sich ausdehnen kann. Ständer aus Styropor oder Metall sind ungeeignet, da sie zu Dehnungsrissen führen können.

Einfrieren auf -20 °C – Vor dem Einfrieren prüfen:•,QWHUIHUHQ]HQ3UĞIHQREGDV(LQIULHUHQVWąUHQGH(LQĲĞVVHDXIGLH%OXWSUREHRGHU$QDO\VHKDW ]%+ËPRO\VH6WDELOLWËWGHU$QDO\WHQ •

Zentrifugation: Abhängig von der geplanten Analyse erforderlich. Zentrifugationsbedingungen, siehe dieses Dokument unter "Zentrifugation" bzw. SARSTEDT Website https://www.sarstedt.com/en/service/centrifugation/ beachten, sowie visuelle Probenkontrolle durchführen.

•

Hämolyse: Vollblut hämolysiert beim Einfrieren: Zur Vermeidung sollte entweder die S-Monovette® Gel bzw. nach der Zentrifugation der Seraplas®9HQWLOıOWHUYHUZHQGHWRGHUGLH3UREHLQHLQ6HNXQGËUJHIËĔ
abpipettiert werden.

Einfrieren auf -20 °C – Durchführung:•

Herunterkühlen: Die S-Monovette® aufrecht stehend über einen Zeitraum von 45 – 60 min. von RT auf +4 °C abkühlen, bevor sie bei -20 °C eingefroren werden kann.

•

Auftauen: Mindestens 45 min. bei RT aufrecht stehend auftauen lassen. Auch hier sind mechanische Belastungen zu vermeiden. Zu schnelles Auftauen kann zur Beeinträchtigung der Analysenergebnisse führen.

(LQIULHUHQXQG7LHĳULHUHQXQWHUƓ&•

7LHĳULHUHQDXIXQWHUƓ&ZXUGHYRP+HUVWHOOHUQLFKWJHSUĞIW$XI*UXQGGHU9LHO]DKOPąJOLFKHU(LQĲXVVIDNWRUHQZLUGHPSIRKOHQ(LQIULHUWHVWVXQWHU/DERU5RXWLQHEHGLQJXQJHQGXUFK]XIĞKUHQ

Einfrieren der S-Monovette® Gel:•

Das Einfrieren erfolgt wie unter Punkt Einfrieren auf -20 °C – Durchführung.

•

Bekannt ist, dass sich die Gelschicht bedingt durch den Einfrierprozess verändern kann.

•$XI*UXQGGHU9LHO]DKOPąJOLFKHU(LQĲXVVIDNWRUHQZLUGHPSIRKOHQ(LQIULHUWHVWVXQWHU/DERU5RXWLQHEHGLQJXQJHQGXUFK]XIĞKUHQ

•Auftauen: Die Probe aufrecht stehend auftauen lassen. Das Probenmaterial nach dem Auftauen durch Abpipettieren (nicht Abdekantieren) bis ca. 2 mm über der Gelschicht aus dem Primärgefäß in ein
Sekundärgefäß überführen. Rest verwerfen.
HINWEIS: Für die Stabilität der Analyten sind die Gebrauchshinweise der Testreagenzien- / Analysengerätehersteller zu beachten.

6DE
Blutentnahme
Entnahmetechniken
Man unterscheidet zwei Entnahmetechniken: die Aspirationstechnik und die Vakuumtechnik.
Die Aspirationstechnik ermöglicht durch das kontrollierte Ziehen der Kolbenstange eine schonende Blutentnahme mit einem kontinuierlichen, langsamen Blutfluss. Auf diese Weise lässt sich der Blutfluss unmittelbar analle Venenverhältnisse und Gegebenheiten anpassen sowie Hämolyse reduzieren.
Die Vakuumtechnik ermöglicht durch ein vorevakuiertes Gefäß die Blutentnahme nach dem Unterdruckprinzip mit einem kontinuierlichen schnellen Blutfluss. Daher ist diese Technik ideal für gute Venenverhältnisse undeinfache Entnahmebedingungen geeignet.
Handhabung zur Blutentnahme: siehe auch Handhabungsvideo zur S-Monovette® in der Aspirationstechnik bzw. Vakuumtechnik mit der Safety-Kanüle bzw. Safety-Multifly® Kanüle:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
ZUR MINIMIERUNG DES EXPOSITIONSRISIKOS WÄHREND DER BLUTENTNAHME HANDSCHUHE TRAGEN.
1. Geeignete S-Monovette® für die erforderliche Probe auswählen.
2.

Wählen Sie die Stelle für die Venenpunktion. Für die Vorbereitung der Venenpunktionsstelle bitte Richtlinien der Einrichtung beachten.

Blutentnahme mit der Aspirationstechnik
Achtung! S-Monovette® nur zur Blutentnahme und nicht zur Injektion verwenden.
Nur mit diesen Kanülen (S-Monovette® (Safety-)Kanülen, oder (Safety-)Multifly®-Kanülen / Adapter für die S-Monovette®) verwenden.
Hier wird die Anwendung mit der Safety-Kanüle gezeigt:

klick

Unmittelbar vor der Venenpunktion die S-Monovette® in den integrierten Halter der Safety-Kanüle hineinschieben und durch leichtes Drehen im Uhrzeigersinn sichern .
Venenstaubinde nach Bedarf anlegen (max. 1 Minute). Die Punktionsstelle mit einem geeigneten Desinfektionsmittel vorbereiten. Venenpunktionsstelle nach der Desinfektion nicht mehr
berühren. Patienten so lagern, dass ein einfacher Zugang zur Vene gegeben ist und den Arm oder anderen Punktionsbereich des Patienten nach unten richten.
Nadelschutz entfernen. Vene punktieren, die Kolbenstange langsam zurückziehen und die Venenstaubinde lösen während das Blut in die S-Monovette® fließt
Warten bis der Blutfluss stoppt, um so eine korrekte Befüllung zu ermöglichen.

.

S-Monovette® durch leichtes Drehen gegen den Uhrzeigersinn
bewegen und dann aus der Safety-Kanüle ziehen (diskonnektieren) . Safety-Kanüle verbleibt in der Vene.
Bei Mehrfachentnahmen wie oben beschrieben nachfolgende S-Monovetten mit der Safety-Kanüle konnektieren und weitere Proben entnehmen.
Beendigung der Blutentnahme: Erst S-Monovette®
+diskonnektieren, dann Safety-Kanüle aus der Vene ziehen. Mit der Einhandtechnik den Nadelschutz entweder auf einer stabilen, ebenen Fläche- bis die Kanüle mit einem spür- und hörbaren „Klick“ im Nadelschutz einrastet (aktivieren) - oder durch Drücken mit dem Zeigefinger gegen das untere Ende des Nadelschutzes aktivieren, siehe auch
Gebrauchshinweis für die S-Monovette® (Safety-)Kanüle oder (Safety-)Multifly®-Kanüle.
Jede S-Monovette® direkt nach der Diskonnektion von der Safety-Kanüle 1x über Kopf schwenken und nach Beendigung der vollständigen Blutentnahme alle Proben mit Antikoagulanzien behutsam
mehrmals über Kopf schwenken!
Für Transport und Zentrifugation die Kolbenstange hörbar in die Einrastposition des Kolbens
ziehen (Kolben rastet im S-Monovette®-Boden ein) und Kolbenstangeabbrechen.
1.

Punktionsstelle mit trockenem, keimarmen Tupfer drücken, bis die Blutung aufhört.

2.

Sobald die Blutgerinnung eingetreten ist, legen Sie einen Verband an, falls gewünscht.

3.

(QWVRUJHQ6LHGLH6DIHW\.DQĞOHLQHLQHPJHHLJQHWHQ$EZXUIEHKËOWHUIĞUELRORJLVFKH*HIDKUVWRĳH

7

DE
Blutentnahme mit der Vakuumtechnik
Achtung! S-Monovette® nur zur Blutentnahme und nicht zur Injektion verwenden.
Nur mit diesen Kanülen (S-Monovette® (Safety-)Kanülen, oder (Safety-)Multifly®-Kanülen / Adapter für die S-Monovette®) verwenden.
Hier wird die Anwendung mit der Safety-Kanüle gezeigt:

klick

Um die Blutentnahme schonend zu beginnen, empfiehlt SARSTEDT, die erste S-Monovette® mit der Aspirationstechnik zu entnehmen, siehe VENENPUNKTIONSTECHNIK Aspirationstechnik
Danach mit der Vakuumtechnik fortfahren.
Vor der Blutentnahme mit der Kolbenstange den Kolben bis zum S-Monovette®-Boden ziehen und hörbar einrasten
lassen. Dann wird die Kolbenstange abgebrochen .
Diese vorbereitete S-Monovette® in den integrierten Halter der S-Monovette® Safety-Kanüle hineinschieben und durch leichtes Drehen im Uhrzeigersinn sichern

+

–

.

.

Warten bis der Blutfluss stoppt, um so eine korrekte Befüllung zu ermöglichen.

S-Monovette® durch leichtes Drehen gegen den Uhrzeigersinn
bewegen und dann aus der Safety-Kanüle ziehen (diskonnektieren) . Safety-Kanüle verbleibt in der Vene.
Bei Mehrfachentnahmen wie oben beschrieben erst nachfolgende S-Monovetten mit der Safety-Kanüle konnektieren und weitere Proben entnehmen.
Beendigung der Blutentnahme:
S-Monovette® diskonnektieren + , dann Safety-Kanüle aus der Vene ziehen. Mit der Einhandtechnik den Nadelschutz entweder auf einer stabilen, ebenen Fläche - bis die Kanüle mit einem spür- undhörbaren „Klick“ im Nadelschutz einrastet (aktivieren) - oder den Nadelschutz durch Drücken mit dem Zeigefinger gegen das untere Ende des Nadelschutzes aktivieren.
Jede S-Monovette® direkt nach der Diskonnektion von der Safety-Kanüle 1x über Kopf schwenken und nach Beendigung der vollständigen Blutentnahme alle Proben mit Antikoagulanzien behutsam
mehrmals über Kopf schwenken!
1.

Punktionsstelle mit trockenem, keimarmen Tupfer drücken, bis die Blutung aufhört.

2.

Sobald die Blutgerinnung eingetreten ist, legen Sie einen Verband an, falls gewünscht.

3.

(QWVRUJHQ6LHGLH6DIHW\.DQĞOHLQHLQHPJHHLJQHWHQ$EZXUIEHKËOWHUIĞUELRORJLVFKH*HIDKUVWRĳH

8

DE
Zentrifugation
ACHTUNG! SARSTEDT S-Monovetten sind für 4.000 x g ausgelegt. Ausgenommen sind S-Monovetten mit Ø 8 mm (S-Monovette® Pädiatrie), die aktuell bis 2.500 x g validiert sind. Nur geeignete Trägerröhren bzw.
Einsätze sind zu verwenden. Das Zentrifugieren von S-Monovetten mit Rissen bzw. das Zentrifugieren bei zu hoher Zentrifugalbeschleunigung kann zum Brechen der S-Monovetten führen, wodurch potenziell infektiöses
Material freigesetzt werden kann.
Zentrifugeneinsätze sind gemäß der Größe der verwendeten S-Monovetten auszuwählen. Die relative Zentrifugalbeschleunigung steht in folgender Beziehung zur eingestellten Umdrehung/min:
RZB = 11,2 x r x (UpM/1000)2,
RZB : „Relative Zentrifugalbeschleunigung auch „g-Kraft“ genannt“, (Englisch: RCF „relative centrifugal force“),„UpM“: „Umdrehung pro Minute“ (U/min), oder: n = „Drehzahl pro Minute“ (Englisch: RPM „revolutions per minute“),„r“: „Schleuderradius von der Mitte der Zentrifuge zum Boden der S-Monovette®“, (cm).
S-Monovetten ohne Gel können in Zentrifugen mit Festwinkel- oder mit Ausschwingrotor zentrifugiert werden.
S-Monovetten mit Gel sind ausschließlich für Zentrifugen mit Ausschwingrotor ausgelegt. Die Zentrifugation in Zentrifugen mit Festwinkelrotor ist seitens SARSTEDT nicht validiert und wird nicht empfohlen.
S-Monovetten sollten gemäß den unten aufgeführten Zentrifugationsbedingungen zentrifugiert werden. Sollten andere Bedingungen verwendet werden, sind diese vom Anwender selbst zu validieren.
Es ist sicherzustellen, dass die S-Monovetten passend in den Zentrifugeneinsätzen sitzen. S-Monovetten, die über den Einsatz hinausragen, können sich am Zentrifugenkopf verfangen und zu Bruch gehen. Eine
gleichmäßige Befüllung der Zentrifuge muss gegeben sein. Hierzu bitte den Gebrauchshinweis der Zentrifuge beachten.
VORSICHT! Zerbrochene S-Monovetten nicht von Hand entfernen.
+LQZHLVH ]XU 'HVLQIHNWLRQ GHU =HQWULIXJH ıQGHQ 6LH LQ GHP *HEUDXFKVKLQZHLV GHU =HQWULIXJH

Orientiert an
BS 4851+(EU-Code)

Relative Zentrifugalbeschleunigung (g)DIN EN ISO
6710–

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*Serum

10 min10 min

6 min

4 min

4 min

Serum-Gel

15 min10 min

4 min

4 min

4 min

Serum Express Gel

15 min10 min

4 min

n.v.

n.v.

Lithium-Heparin

10 min10 min

7 min

7 min

7 min

Lithium-Heparin-Gel

15 min15 min10 min

7 min

7 min

Lithium-Heparin-Gel+

8 min

7 min

5 min

4 min

4 min

EDTA

n.v.

n.v.

7 min

6 min

5 min

EDTA-Gel

15 min10 min10 min

7 min

7 min

Citrat

9 min

8 min

7 min

6 min

5 min

EDTA, Fluorid Heparin

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Citrat PBM 1,8 ml
Zentrifugenradius > 17 cm

9 min

8 min

7 min

6 min

5 min

Citrat PBM 1,8 ml=HQWULIXJHQUDGLXV!ELVƉFP

n.v.

n.v.

10 minn.v.

n.v.

n.v. = nicht validiert* Gilt für alle S-Monovetten mit Ausnahme Ø 8 mm (S-Monovetten Pädiatrie).

Zentrifugation bei 20 ºC+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, zurückgezogen.

Information zum Trennmaterial
Fließeigenschaften des Trennmaterials (Gel) sind temperaturabhängig. Werden S-Monovetten vor oder während der Zentrifugation gekühlt, ist eine durchgehende Schicht des Trenngels nicht mehr gewährleistet.
S-Monovetten dürfen nicht erneut zentrifugiert / rezentrifugiert werden.

Entsorgung
1.

Es sind die allgemeinen Hygienerichtlinien sowie die gesetzlichen Bestimmungen für die ordnungsgemäße Entsorgung von infektiösem Material zu beachten und einzuhalten.

2.

Einmalhandschuhe verhindern das Risiko einer Infektion.

3.

.RQWDPLQLHUWHRGHUEHIĞOOWH%OXWHQWQDKPHV\VWHPHPĞVVHQLQJHHLJQHWHQ(QWVRUJXQJVEHKËOWHUQIĞUELRORJLVFKH*HIDKUVWRĳHHQWVRUJWZHUGHQGLHDQVFKOLHĔHQGDXWRNODYLHUWXQGYHUEUDQQWZHUGHQNąQQHQ

4.

Die Entsorgung muss in einer geeigneten Verbrennungsanlage oder mittels Autoklavieren (Dampfsterilisation) erfolgen.

9DE
3URGXNWVSH]LıVFKH1RUPHQXQG5LFKWOLQLHQLQGHUMHZHLOVJĞOWLJHQ)DVVXQJCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Norm zu Gefäßen für die venöse Blutentnahme:
DIN EN ISO 6710: Gefäße zur einmaligen Verwendung für die venöse Blutentnahme beim Menschen*CLSI (Clinical and Laboratory Standards Institute)

Symbol- und Kennzeichnungsschlüssel:

Artikelnummer

Zusätzlich gilt für einzeln steril verpackte Produkte

Chargenbezeichnung

Bei beschädigter Verpackung nicht verwendet

Verwendbar bis

Einfach-Sterilbarrieresystem mit äußerer Schutzverpackung

CE-Zeichen

Sterilisation durch Bestrahlung

In-vitro-Diagnostikum

Gebrauchsanleitung beachten

Bei Wiederverwendung: Kontaminationsgefahr

Vor Sonnenlicht geschützt aufbewahren

Trocken lagern

Hersteller

Land der Herstellung

Sterile Flüssigkeitsbahn

Nicht erneut sterilisieren

Technische Änderungen vorbehalten.
Alle in Zusammenhang mit dem Produkt aufgetretenen schwerwiegenden Vorfälle sind dem Hersteller und der zuständigen nationalen Behörde zu melden.

10Instructions for use – SARSTEDT S-Monovette® Blood Collection System

EN

For in vitro diagnostic use
Intended use
S-Monovette® blood collection systems, needles and adapters are used together as a system for venous blood collection. S-Monovette® blood collection systems are used to collect, transport, process and store blood
samples for in vitro diagnostic tests on serum, plasma or whole blood in the clinical laboratory. The product is intended for use in a professional environment by qualified medical and laboratory personnel.

Product description
S-Monovette® blood collection systems consist of a plastic container, a plunger, a plunger rod and a colour-coded plastic screw cap with an integrated membrane developed especially for connecting it to an
S-Monovette® (safety) needle or (Safety-) Multifly® needle, and various additives (preparations). An S-Monovette® without additive is also available. S-Monovette® blood collection systems with the additives clotting
activator, clotting activator with gel, lithium heparin, lithium heparin with gel, sodium heparin, citrate, EDTA, fluoride EDTA, fluoride heparin, fluoride citrate, CPDA, as well as without additive, with additive concentrations,the volume of liquid additive and their permitted tolerances and the ratio of blood to additive complying with the requirements and recommendations of the international DIN EN ISO 6710 standard “Single-use containers
for venous blood specimen collection” and the Clinical and Laboratory Standards Institute’s Approved Standards (CLSI). The selection of the additive depends on the analytical test method. It is specified by the
manufacturer of the test reagents and/or analysis equipment used to carry out the test. The S-Monovette® blood collection system is available as a sterile inside version or as an individually packaged version that issterile inside and out.

Colour codes of the S-Monovette® screw caps*:

Additive

Letter code

Cap colour DIN EN ISO
6710

Cap colour based on BS
4851+

Z

white

white

Tube without additive
S-Monovette® neutral Z
Serum tube
S-Monovette® Serum CAT, with clotting activator

CAT

red

white

S-Monovette® Serum Gel CAT, with clotting activator and gelCATdark yellow

dark yellow

S-Monovette® Serum Express Gel CAT, with clotting activator thrombin and gelCATorange-S-Monovette® Lithium Heparin LH, with lithium heparin

LH

green

orangeS-Monovette® Lithium Heparin, liquid LH, with lithium heparin

LH

green

orangeS-Monovette® Lithium Heparin Gel LH, with lithium heparin and gel

LH

green

orangeS-Monovette® Lithium Heparin Gel+ LH, with lithium heparin and rapid gel

LH

green

orangeS-Monovette® Sodium Heparin NH, with sodium heparin

NH

brown

green

S-Monovette® Ammonium Heparin AH, with ammonium heparin

n.d.

blue

blue

S-Monovette® Citrate 9NC, sodium citrate 3.13%

9NC

blue

green

S-Monovette 3)$&LWUDWH1&VRGLXPFLWUDWHEXĳHUHG

9NC

light blue-

S-Monovette® K3 EDTA K3E, with potassium EDTA

K3E

violetred

S-Monovette® K2 EDTA K2E, with potassium EDTA

K2E

violetred

S-Monovette® K2 EDTA Gel K2E, with potassium EDTA and gel

K2E

violetred

S-Monovette®)OXRULGH('7$)(ZLWKĲXRULGHDQG('7$

FE

grey

yellow

S-Monovette®)OXRULGH+HSDULQ)+ZLWKĲXRULGHDQGKHSDULQ

FH-yellow

S-Monovette®*OXFR(;$&7)&ZLWKĲXRULGHFLWUDWHDQG('7$

FC

pink

grey

LH

dark blue

orangeS-Monovette® ThromboExact, with magnesium compoundn.d.

n.d., raspberryn.d., raspberry

S-Monovette® CTADn.d.

n.d., blue

n.d., green

S-Monovette® ACD

ACD

yellowyellow

S-Monovette® CPDA

CPDA

yellowyellow

S-Monovette® Hirudinn.d.

n.d., olive greenn.d., olive green

S-Monovette® Homocysteine HCY-Z Gel, with gel and stabiliser

n.d.

n.d., greyn.d., grey

S-Monovette®+RPRF\VWHLQH+&<&ZLWKFLWUDWHEXĳHU

n.d.

n.d., violet

n.d., violet

S-Monovette® DNA Exactn.d.

n.d., blue

n.d., blue

Heparin tube

Citrate tube®

EDTA tube

Tube with glycolysis inhibitors

Tube for metal analysis
S-Monovette® Metal analysis LH, with lithium heparin

Other whole blood and plasma tubes* Additional screw cap colours available.
n.d.: not defined+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, revoked.

11

EN
SARSTEDT S-Monovette® Serum CAT / Serum Gel CAT
The S-Monovette® Serum CAT contains a synthetic granulate coated with a clotting activator (silicate) and is used for serum collection**. The synthetic granulate settles between the blood clot and serum during
centrifugation.
The S-Monovette® Serum Gel CAT contains a polymer-based gel, in addition to the synthetic granulate coated with a clotting activator (silicate), and is used for serum collection**. The gel settles between the blood clot
and serum during centrifugation and forms a stable separation layer during transport, storage and analysis.
Serum is used as sample material in routine biochemical and immunological testing and in serology.
After collecting blood, let the blood coagulate in the S-Monovette® Serum CAT / Serum Gel CAT for 30 minutes in an upright position to ensure a well-formed horizontal separation layer after centrifugation. The
recommended time is based on an intact coagulation process. Blood from patients with coagulation disorders due to their illness or under anticoagulant therapy requires more time for complete coagulation.

SARSTEDT S-Monovette® Serum Express Gel CAT
The S-Monovette® Serum Express Gel CAT contains a polymer-based gel, in addition to the synthetic granulate coated with clotting activator (thrombin), and is used for serum collection**. The gel settles between the
blood clot and serum during centrifugation and forms a stable separation layer during transport, storage and analysis.
After collecting blood, let the blood coagulate in the S-Monovette® Serum Express Gel for 5 minutes in an upright position to ensure a well-formed horizontal separation layer after centrifugation. The recommended time
is based on an intact coagulation process, also for blood from heparinised patients. Blood from patients with coagulation disorders due to their illness or under anticoagulant therapy including high-dose heparin requires
more time for complete coagulation.
Serum is used as sample material in routine biochemical and immunological testing and in serology.

SARSTEDT S-Monovette® neutral Z
The S-Monovette® neutral Z contains no additive, which is equivalent to natural coagulation of the blood sample without clotting activators, and is used for serum collection**. Centrifugation results in separation of bloodclot and serum.
Serum is used as sample material for user-specific analyses.
Furthermore, the S-Monovette® neutral Z can also be used as an empty container as follows: if blood collection is to be started with a S-Monovette® Citrate in combination with a (Safety-)Multifly® needle (butterfly
needle), the S-Monovette® neutral Z is used as the first container (empty container) for filling the tubing of the (Safety-)Multifly® needle.

SARSTEDT S-Monovette® Lithium Heparin LH / Lithium Heparin Gel LH / Lithium Heparin Gel+ LH, Sodium Heparin NH, Ammonium Heparin AH
The S-Monovette® Lithium Heparin LH / Sodium Heparin NH / Ammonium Heparin AH contains a synthetic granulate coated with the anticoagulant lithium heparin / sodium heparin / ammonium heparin (generally 16 IU
heparin/ml blood) and is used for whole blood and plasma collection**. The synthetic granulate settles between the blood cells and plasma during centrifugation.
In a S-Monovette® Lithium Heparin LH without synthetic granulate, the anticoagulant lithium heparin is in a spray dose form (generally 19 IU heparin/ml blood).
The S-Monovette® Lithium Heparin Gel LH contains a polymer-based gel, in addition to the synthetic granulate coated with the anticoagulant lithium heparin (generally 25 IU heparin/ml blood), and is used for plasmacollection**. The gel settles between the blood cells and plasma during centrifugation and forms a stable separation layer during transport, storage and analysis.
The S-Monovette® Lithium Heparin Gel+ LH also contains a polymer-based gel that allows the centrifugation time to be reduced by approx. 50% compared with the S-Monovette® Lithium Heparin Gel.
Heparin plasma is used as sample material in routine biochemical and immunological testing. Heparin whole blood is used as sample material in routine immunological testing and in serology.
Anticoagulation with heparin occurs through activation of antithrombin.
NOTE: No lithium measurements may be made from the S-Monovette® Lithium Heparin LH, Lithium Heparin Gel/Gel+, no sodium measurements may be made from the S-Monovette® Sodium Heparin
NH and no ammonium measurements may be made from the S-Monovette® Ammonium Heparin AH. A S-Monovette® Lithium Heparin / Lithium Heparin Gel/Gel+ / Sodium Heparin / Ammonium HeparinıOOHGZLWKYHQRXVEORRGLVQRWVXLWDEOHIRUDEORRGJDVDQDO\VLVSARSTEDT S-Monovette® Metal analysis
The S-Monovette® Metal analysis contains the anticoagulant lithium heparin and is used for whole blood and plasma collection**. Lithium heparin is in a spray dose form (19 IU heparin/ml blood).
Heparin whole blood and heparin plasma of the S-Monovette® Metal analysis is used in combination with the special safety needle 21G x 1 ½“ (Art. no. 85.1162.600) as sample material for testing for traceelements / metals. The trace elements / metals were validated by atomic absorption spectroscopy (AAS). For the system safety needle and S-Monovette® Metal analysis, this results in the following maximum blankvalues in ng/system for these trace elements:

ElementTl

ng/system

2.5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1.5

8.0

5.0

5

50

70

70

10

40

10

10

The maximum blank values are indicated for each element on the label of the S-Monovette®.
Trace element determinations are carried out using heparin whole blood or heparin plasma, depending on the analysis method.
Anticoagulation with heparin occurs through activation of antithrombin.

SARSTEDT S-Monovette® Citrate 9NC
The S-Monovette® Citrate 9NC contains the anticoagulant trisodium citrate and is used for whole blood and plasma collection**. Trisodium citrate is in the form of a 0.106 molar solution (3.13% trisodium citrate solution;
often rounded up to 3.2%) and amounts to 10% of the nominal volume of an S-Monovette® Citrate. The mixture ratio of citrate to blood is 1:9 – 1 part by volume citrate and 9 parts by volume blood. Correct filling isabsolutely necessary for the analysis.
Citrate plasma is used as sample material in routine testing in haemostaseology.
Anticoagulation occurs through calcium ion complex formation by citrate.
Please observe the NOTES under sample collection and handling for the S-Monovette® Citrate and butterfly needle combination.

SARSTEDT S-Monovette® PFA 9NC
The S-Monovette® PFA 9NC contains the anticoagulant trisodium citrate for whole blood and plasma collection**. Trisodium citrate is in the form of a 0.129 molar buffered solution (3.8% buffered; pH 5.5) and amounts
to 10% of the nominal volume of a S-Monovette® PFA. The mixture ratio of citrate to blood is 1:9 – 1 part by volume citrate and 9 parts by volume blood. Correct filling is absolutely necessary for the analysis.
The whole blood of the S-Monovette® PFA 9NC is used as sample material for determination of platelet function with the SIEMENS Healthineers PFA analyser and is validated for this.
Anticoagulation occurs through calcium ion complex formation by citrate.
Please observe the NOTES under sample collection and handling for the S-Monovette® PFA and butterfly needle combination.

SARSTEDT S-Monovette® CTAD
The S-Monovette® CTAD contains the anticoagulant trisodium citrate as well as theophylline, adenosine and dipyridamole and is used for whole blood and plasma collection**. CTAD is in the form of a solution andamounts to 10% of the nominal volume of a S-Monovette® CTAD. The mixture ratio of CTAD to blood is 1:9 – 1 part by volume CTAD and 9 parts by volume blood. Correct filling is absolutely necessary for the analysis.
CTAD plasma is used as sample material for the determination of platelet factor 4 (PF4), beta(ß)-thromboglobulin (ßTG) and plasminogen activator inhibitor-1 (PAI-1) as well as for routine testing in haemostaseology.
Platelet activation is inhibited for a period of at least 4 hours and is used to monitor heparin therapies.
Anticoagulation occurs through calcium ion complex formation by citrate.
Please observe the NOTES under sample collection and handling for the S-Monovette® CTAD and butterfly needle combination.
NOTE: CTAD is yellow. The S-Monovette®&7$'PXVWEHSURWHFWHGIURPDUWLıFLDODQGQDWXUDOOLJKWGXULQJVWRUDJH([SRVXUHWRVWURQJOLJKWIRUPRUHWKDQKRXUVFDQGHDFWLYDWHWKHDGGLWLYHVSARSTEDT S-Monovette® EDTA K2E / K3E
The S-Monovette® EDTA K2E / S-Monovette® EDTA K3E contains the anticoagulant K2 EDTA or K3 EDTA and is used for whole blood collection**. K2 EDTA or K3 EDTA is in a spray dose form (1.6 mg EDTA /ml blood).
EDTA whole blood is used as sample material for haematological analyses. Blood smears should be made within four hours after blood collection.
Anticoagulation occurs through calcium ion complex formation by EDTA.
Blood from the S-Monovette® EDTA K2E / K3E can also be used for routine immunohaematology analyses and tests for infectious diseases. The user is responsibility for validating the suitability of the sample material forthese analyses with the appropriate test reagents / analysis equipment incl. storage conditions.

12

EN
SARSTEDT S-Monovette® EDTA Gel K2E
The S-Monovette® EDTA Gel K2E contains a polymer-based gel, in addition to the anticoagulant K2 EDTA and is used for plasma collection**. K2 EDTA is in a spray dose form (1.6 mg EDTA /ml blood). The gel settles
between the blood cells and plasma during centrifugation and forms a stable separation layer during transport, storage and analysis.
EDTA plasma is used as sample material for molecular virus diagnostics.
Anticoagulation occurs through calcium ion complex formation by EDTA.

SARSTEDT S-Monovette® Fluoride EDTA / Fluoride Heparin / Fluoride Citrate EDTA with glycolysis inhibitors
The S-Monovette® Fluoride EDTA FE contains the anticoagulant EDTA (1.2 mg /ml blood) as well as fluoride (1.0 mg/ml blood) for glycolysis inhibition and is used for plasma collection**. Fluoride EDTA is in a spray doseform.
The S-Monovette® Fluoride Heparin FH contains the anticoagulant heparin (16 IU heparin/ml blood) as well as fluoride (1.0 mg/ml blood) for glycolysis inhibition and is used for plasma collection**. Fluoride heparin is in aspray dose form.
Glycolysis inhibition through fluoride alone starts approx. 2 hours after filling the blood collection tube and shows its full effect after approx. 4 hours. On average, therefore, in whole blood up to 6% of glucose breaks
down after a few hours and up to 10-15% after 24 hours.
The S-Monovette® GlucoEXACT FC contains the anticoagulant EDTA as well as citrate and fluoride for immediate glycolysis inhibition and is used for plasma collection**. EDTA, citrate and fluoride are in the form of asolution. Because of the dilution, it is necessary to multiply by 1.16 to calculate the glucose concentration.
The S-Monovette® GlucoEXACT FC complies with the gestational diabetes guideline of the German Diabetes Association (DDG) and the national treatment guideline (NVL) for type 2 diabetes. The immediate stabilisationof the glucose concentration is maintained for up to 96 hours at room temperature in whole blood, see also SARSTEDT White Paper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / "Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours".
Fluoride EDTA (citrate) plasma is used as sample material for glucose determination.
Anticoagulation occurs through calcium ion complex formation by EDTA.
NOTE: Fluoride can cause increased haemolysis. Further information on substances that can cause interference can be found in the respective instructions for use of the test reagent manufacturer.
Please observe the NOTES under sample collection and handling for the S-Monovette® GlucoEXACT and butterfly needle combination.

SARSTEDT S-Monovette® CPDA
The S-Monovette® CPDA contains the anticoagulant sodium citrate as well as citric acid, sodium phosphate, dextrose and adenine and is used for whole blood and plasma collection**. CPDA is in the form of a solution.
The mixture ratio of CPDA to blood is 1:6 – 1 part by volume CPDA and 6 parts by volume blood. Correct filling is absolutely necessary because of the analysis.
CPDA whole blood / plasma is used as sample material for blood group serology in transfusion medicine, for tolerability investigations (cross matching) with transfusions. Specifically, the S-Monovette® CPDA is suitablefor blood group testing (AB0) including Kell and Rhesus factor, Coombs test for irregular blood group antibodies, polyspecific direct Coombs test (up to day 10), tolerability test (cross matching) with blood groupcompatible patient serum/plasma (major test).
7UDQVSRUWGXUDWLRQXQWLOVWRUDJHLVYDOLGDWHGIRUDPD[LPXPRIKRXUVDWbƓ&)RUVHGLPHQWDWLRQRIWKHFHOOVWKHVDPSOHVPXVWILUVWEHVWRUHGLQDQXSULJKWSRVLWLRQLQWKHUHIULJHUDWRUIRUDWOHDVWKRXUV7KHQ
the aforementioned analytes can be determined for up to 35 days analogous to the usual life cycle of banked blood after storage in the refrigerator (2 - 6 °C) (with the exception of 10 days for the direct Coombs test).
Suitable for the column agglutination technique e.g. on the Vision Max from Ortho Clinical Diagnostics. The sample material must not be frozen.
The suitability of the sample material for these analyses with other methods / test reagents / analysis equipment incl. storage conditions is the responsibility of the user and must be validated by the user.
Anticoagulation occurs through calcium ion complex formation by citrate.
Please observe the NOTES under sample collection and handling for the S-Monovette® CPDA and butterfly needle combination.

SARSTEDT S-Monovette® ThromboExact
The S-Monovette® ThromboExact contains a magnesium salt as anticoagulant and is used for whole blood collection**. The magnesium salt is in a spray dose form.
The whole blood of the S-Monovette® ThromboExact is used as sample material for the exclusion of false low platelet counts as a result of anticoagulant intolerability (such as EDTA, citrate, heparin), also termed
pseudothrombocytopenia. Formation of platelet aggregates is prevented and determination of the actual platelet count is possible up to 12 hours after blood collection.
Inhibition of coagulation occurs through magnesium ions, with the magnesium ions inhibiting platelet-derived thromboxane A2 as well as the platelet aggregation mediated by ADP and arachidonic acid.

SARSTEDT S-Monovette® Hirudin
The S-Monovette® Hirudin contains the anticoagulant hirudin and is used for whole blood collection**. Hirudin is in a spray dose form.
Hirudin whole blood is used as sample material for the determination of platelet function on the Multiplate® apparatus (multiple platelet function analyser) from ROCHE Diagnostics and is validated for this. It is used formonitoring therapy with platelet inhibiting medication and for the proof or exclusion of platelet function disorders.
The S-Monovette® Hirudin was developed especially for determining platelet function in cooperation with the company Verum Diagnostica, now ROCHE Diagnostics, on the Multiplate® apparatus.
Inhibition of coagulation occurs through hirudin by direct inhibition of thrombin, thus allowing platelet function diagnostics in the native condition.

SARSTEDT S-Monovette® Homocysteine HCY-Z Gel / HCY-C
The S-Monovette® Homocysteine HCY-Z Gel contains a special stabiliser and a polymer-based gel, in addition to the synthetic granulate coated with a clotting activator (silicate), and is used for serum collection**. The
gel settles between the blood clot and serum during centrifugation and forms a stable separation layer during transport, storage and analysis. The additive is in a spray dose form.
Homocysteine is stabilised for up to 8 hours in whole blood at room temperature. If centrifugation takes place within the first 8 hours with a correctly formed separation layer between the blood clot and serum,
homocysteine is stabilised for up to 96 hours.
The serum of the S-Monovette® Homocysteine HCY-Z-Gel is used as sample material for homocysteine determination. The S-Monovette® Homocysteine HCY-C contains acid citrate (pH 4.3) as anticoagulant and isused for plasma collection**. Citrate is in the form of a solution. Because of the dilution, it is necessary to multiply by 1.11 to calculate the homocysteine concentration.
Homocysteine in whole blood is stabilised for up to 6 hours at room temperature and up to 48 hours at 4°C.
The plasma of the S-Monovette® Homocysteine HCY-C is used as sample material for homocysteine determination.
Inhibition of coagulation in the S-Monovette® Homocysteine HCY-C occurs through calcium ion complex formation by citrate.
Please observe the NOTES under sample collection and handling for the S-Monovette® HCY-C and butterfly needle combination.

SARSTEDT S-Monovette® DNA Exact
The S-Monovette® DNA Exact contains an anticoagulant based on EDTA and is used for whole blood collection**. EDTA is in a spray dose form.
EDTA whole blood is used as sample material for stabilisation of gDNA. The stabilisation property for gDNA is validated for 5 days at 35 °C, 14 days at room temperature (22 °C), 28 days under refrigeration (4 °C) andat least 1 year at -20 °C. In addition, the stabilised specimens can be frozen and thawed for 5 cycles without loss of quality, see also SARSTEDT White Paper https://www.sarstedt.com/en/products/diagnostic/venousblood/s-monovetter/ Literature /”SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
Anticoagulation occurs through calcium ion complex formation by EDTA.

**Suitability of the sample material depends on the analyte and test reagent / analysis equipment. Corresponding recommendations of the manufacturer must be observed.

13

EN
Safety information / Warnings
1.

General precautions: Use gloves and other general personal protective equipment to protect yourself from blood and possible exposure to potentially infectious specimen material and transmissible pathogens.

2.

Treat all biological specimens and sharp blood collection utensils (needles, adapters) according to the guidelines and procedures in your institution. In case of direct contact with biological specimens or a
QHHGOHVWLFNLQMXU\FRQVXOWDGRFWRUGXHWRWKHULVNRIWUDQVPLVVLRQRI+,9+&9RU+%9RURWKHULQIHFWLRXVGLVHDVHV8VHVDIHW\QHHGOHV6DIHW\0XOWLĲ\® needles with integrated needle guard. Always follow thesafety guidelines and procedures of your facility.

3.

Applies to individually sterile-packed products: Check each individual package for damage before use and do not use if packaging is damaged.

4.

The product is intended for single use. Dispose of all sharp objects (needles, adapters) for blood collection in suitable containers for hazardous biological waste.

5.

,IEORRGLVFROOHFWHGIURPDQLQWUDYHQRXV ,9 OLQHLWPXVWEHHQVXUHGWKDWWKHOLQHLVSURSHUO\ĲXVKHGLQDFFRUGDQFHZLWKWKHLQVWLWXWLRQ FOHDQHGRIWKH,9VROXWLRQ EHIRUHEHJLQQLQJEORRGFROOHFWLRQ3URSHUO\ĲXVKLQJthe line prevents faulty analysis results.

6.

8QGHUıOOLQJWKH60RQRYHWWH® leads to an incorrect ratio of blood to preparation/additive and can lead to false analysis results.

7.

The blood collected with the S-Monovette® and processed is not intended to be re-injected into the human body.

8.

Do not use the product after the expiry date. The expiry date of the product is the last day of the month and year indicated.

Storage
Store the product at room temperature until use.

Limitations
1.

7KHVWRUDJHSHULRGDQGWHPSHUDWXUHRIDıOOHG60RQRYHWWH® depend on the stability of the analytes for investigation. The assessment is made by the laboratory, or information is obtained from the manufacturer's
instructions for use for the test reagents / analysis device.

2.

Even if plasma or serum is separated by centrifuging a S-Monovette®DQGRUDEDUULHULVSUHVHQWDOOFHOOVDUHQRWQHFHVVDULO\FRPSOHWHO\VHSDUDWHG5HVLGXDOPHWDEROLVPRUQDWXUDOGHJUDGDWLRQFDQDĳHFWWKH
concentrations of analytes. The stability of the analytes should be evaluated with respect to the storage container and the conditions of the respective laboratory.

3.

For therapeutic medication, the suitability of the sample material must be checked in the manufacturer's instructions for use for the test reagents / analysis device.

4.

Analyses for trace elements / metals are to be conducted with the S-Monovette® Metal Analysis + Safety Needle Metal Analysis system.

Specimen collection and handling
READ ALL OF THIS DOCUMENT BEFORE STARTING TO DRAW VENOUS BLOOD.
Equipment required for specimen collection
1.

All necessary S-Monovette® blood collection systems.

2.

6DIHW\ QHHGOHVRU 6DIHW\ 0XOWLĲ\® needles

3.

Gloves, gown, goggles or other suitable protective gear to protect from bloodborne pathogens or potentially infectious materials.

4.

/DEHOVIRUSDWLHQWLGHQWLıFDWLRQ5.

Disinfectant to clean the collection site (follow guidelines of the facility for sterile specimen collection to prepare the collection site). Do not use any alcohol-based cleaning materials if the specimens are to be used
for a blood alcohol test.

6.

Dry, clean, disposable swabs.

7.

A tourniquet.

8.

Plaster or dressing.

9.

Sharps disposal container for the safe disposal of used material.

Recommended order of collection:
1.

Blood culture vials

2.

Tubes with citrate or clotting activator (with/without gel, Serum CAT / Serum Gel CAT)

3.

Tubes with clotting activator or citrate4.

Tubes with heparin with/without gel

5.

Tubes with EDTA with/without gel

6.

Tubes with glycolysis inhibitors

7.

Tubes with other additives
127(

: KHQVWDUWLQJFROOHFWLRQZLWKDFLWUDWHWXEHRUDQRWKHUWXEHZLWKDOLTXLGDGGLWLYHVXFKDV3)$&7$'&3'$+&<&RU*OXFR(;$&7LQFRPELQDWLRQZLWKDEXWWHUĲ\QHHGOH HJ 6DIHW\0XOWLĲ\® needle), collection with an empty tube (e.g. S-Monovette®QHXWUDO= ıUVWLVUHFRPPHQGHGWRDYRLGXQGHUıOOLQJRIWKHWXEHGXHWRıOOLQJRIWKHWXELQJRIWKHEXWWHUĲ\QHHGOH
7KLVFDQHQVXUHWKHFRUUHFWıOOLQJRIWKHWXEHDQGWKXVDFRUUHFWPL[LQJUDWLR OLTXLGWREORRG 

NOTE:Follow the regulations of your institution for the order of collection.

3UHYHQWLQJUHĲX[Most S-Monovettes contain chemical additives. To prevent reflux, the following should be noted:
1. Use only the materials recommended in the instructions for use.
2.

Position the patient so that there is easy access to the vein, and the arm or other puncture site on the patient is directed downwards.

3.

Hold the S-Monovette®ZLWKWKHVFUHZFDSSRLQWLQJXSDQGZKHQXVLQJD 6DIHW\ 0XOWLĲ\® needle, also below the level of the arm / puncture site.

4.

It must be ensured that the contents of the S-Monovette® do not touch the screw cap or the end of the needle during the venous puncture.

5.

/RRVHQWKHWRXUQLTXHWZKLOHWKHEORRGLVĲRZLQJLQWRWKH60RQRYHWWH®.

14

EN
Freezing/thawing
According to the recommendations of the WHO (WHO/DIL/Lab/99.1 Rev.02), it is recommended to separate serum/plasma from blood cells before freezing.
The following recommendations for freezing apply to the S-Monovette®:
Freezing below 0 °C•

Use at temperatures below freezing must be tested under real conditions, as the stress on the containers can vary widely depending on the medium to be frozen and the routine conditions (see section on Material
characteristics in the SARSTEDT catalogue).

•

The strength values of plastics are reduced in the temperature range below 0 °C. Mechanical stress should therefore be avoided.

•

The conditions for freezing must be selected so that the contents of the S-Monovette® freeze evenly or from bottom to top. The S-Monovette® should have enough room in a holder or storage box to allow it to
expand. Holders made of polystyrene or metal are unsuitable as they can lead to expansion tears.

Freezing to -20 °C – Check before freezing:•

Interferences: Check whether freezing will interfere with the blood specimen or analysis (e.g. haemolysis, analyte stability).

•

Centrifugation: Necessary depending on the planned analysis. Take note of centrifugation conditions, see this document under "Centrifugation" / SARSTEDT website https://www.sarstedt.com/en/service/centrifugation/, and perform a visual specimen control.

•

Haemolysis: Whole blood is haemolysed when freezing: To prevent this, either the S-Monovette® Gel, or after centrifugation, the Seraplas®YDOYHıOWHUVKRXOGEHXVHGRUWKHVSHFLPHQVKRXOGEHSLSHWWHGLQWRD
secondary container.

Freezing to -20 °C – Implementation:•

Cooling down: Cool down the S-Monovette® while it is standing upright for a period of 45 – 60 min. from room temperature to +4 °C before it can be frozen at -20 °C.

•

Thawing: Allow to thaw at least 45 min. at room temperature while standing upright. Mechanical stress must also be prevented in this step. Thawing too quickly can impair the analysis results.

Freezing and deep-freezing below -20 °C•'HHSIUHH]LQJWREHORZƓ&KDVQRWEHHQWHVWHGE\WKHPDQXIDFWXUHU'XHWRWKHQXPEHURISRVVLEOHLQĲXHQFLQJIDFWRUVLWLVUHFRPPHQGHGWRFRQGXFWIUHH]LQJWHVWVXQGHUURXWLQHODERUDWRU\FRQGLWLRQV

Freezing the S-Monovette® Gel:•

Freezing is implemented as under the section – Freezing to -20 °C – Implementation.

•

It is known that the gel layer can be changed due to the freezing process.

•'XHWRWKHQXPEHURISRVVLEOHLQĲXHQFLQJIDFWRUVLWLVUHFRPPHQGHGWRFRQGXFWIUHH]LQJWHVWVXQGHUURXWLQHODERUDWRU\FRQGLWLRQV

•Thawing: Allow the specimen to thaw while standing upright. Transfer the specimen material from the primary to a secondary container after thawing by pipetting (not decanting) it up to approx. 2 mm above the gellayer. Discard the rest.
NOTE: For the stability of the analytes, follow the instructions for use of the test reagents / analysis device manufacturer.

15

EN
Blood collection
Collection techniques
A distinction is made between two collection techniques: the aspiration technique and the vacuum technique.
The aspiration technique enables gentle blood collection with a continuous, slow blood flow, by controlled pulling on the plunger rod. In this way, the blood flow can be adapted immediately to all vein conditions andcircumstances as well as reducing haemolysis.
The vacuum technique using a pre-evacuated tube allows blood to be collected according to the negative pressure principle with a continuous rapid blood flow. This technique is thus ideal for good vein status and easycollection conditions.
Handling of blood collection: see also the handling video for the S-Monovette® in the aspiration technique or vacuum technique with the safety needle or Safety-Multifly® needle:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
WEAR GLOVES TO MINIMISE THE RISK OF EXPOSURE DURING BLOOD COLLECTION.
1. Select a suitable S-Monovette® for the required specimen.
2.

Select a site for the venipuncture. Please follow the guidelines of the institution for preparing the venipuncture site.

Blood collection with the aspiration technique
Important! Use S-Monovette® only for blood collection, not for injection.
Use only with these needles (S-Monovette® (safety) needles, or (Safety-)Multifly® needles/adapters for the S-Monovette®).
Use with a safety needle is shown here:

Click

Immediately prior to the venipuncture, put the S-Monovette® into the integrated holder of the safety needle
and secure it by twisting clockwise slightly .
Apply a venous tourniquet if necessary (max. 1 minute). Prepare the puncture site with a suitable disinfectant. Do not touch the puncture site after disinfection. Position the patient so that thereis easy access to the vein, and the arm or other puncture site on the patient is directed downwards.
Remove the needle guard. Puncture the vein, slowly retract the plunger and loosen the tourniquet while the blood is flowing into the S-Monovette®
Wait until the flow of blood stops to allow correct filling.

.

Move the S-Monovette® by twisting it anticlockwise slightly and then pull (disconnect) it from the safety needle . The safety needle remains in the vein.
For multiple specimens – as described above – the subsequent S-Monovettes are connected to the safety needle and additional specimens are taken.
Completing blood collection: First disconnect the S-Monovette®
+ , then withdraw the safety needle from the vein. Using one hand, either activate the needle guard on a stable, level surface – until theneedle snaps into the needle guard with a perceptible and audible "click" – or by pressing the index finger against the lower end of the needle guard, see also instructions for use for the S-Monovette®
(safety) needle or (Safety-)Multifly® needle.
Invert each S-Monovette® once immediately after disconnecting it from the safety needle, and after completing blood collection, carefully invert all specimens with anticoagulants several times.
For transport and centrifugation, retract the plunger rod until the plunger snaps audibly into place(plunger clicks in the bottom of the S-Monovette®) and break off the plunger rod .
1.

Press a clean, dry swab against the puncture site until bleeding stops.

2.

As soon as coagulation has set in, you may apply a dressing if desired.

3.

Dispose of the safety needle in a suitable container for hazardous biological waste.

16

EN
Blood collection with the vacuum technique
Important! Use S-Monovette® only for blood collection, not for injection.
Use only with these needles (S-Monovette® (safety) needles, or (Safety-)Multifly® needles/adapters for the S-Monovette®).
Use with a safety needle is shown here:

Click

To begin blood collection gently, SARSTEDT recommends collecting the first S-Monovette® using the aspiration technique, see VENIPUNCTURE TECHNIQUE Aspiration technique
Then continue with the vacuum technique.
Before collecting blood, use the plunger rod to pull the plunger to the bottom of the S-Monovette® and allow it to snap into place audibly. Then the plunger rod is broken off .
Slide this prepared S-Monovette® into the integrated holder of the S-Monovette® safety needle and secure it by twisting it clockwise slightly

+

–

.

.

Wait until the flow of blood stops to allow correct filling.

Move the S-Monovette® by twisting it anticlockwise slightly and then pull (disconnect) it from the safety needle . The safety needle remains in the vein.
For multiple specimens – as described above – the subsequent S-Monovettes are connected to the safety needle and additional specimens are taken.
Completing blood collection:
First disconnect the S-Monovette® + , then withdraw the safety needle from the vein. Using one hand, activate the needle guard either on a stable, level surface – until the needle snaps into the needle
guard with a perceptible and audible "click"– or by pressing the index finger against the lower end of the needle guard.
Invert each S-Monovette® once immediately after disconnecting it from the safety needle, and after completing blood collection, carefully invert all specimens with anticoagulants several times.
1.

Press a clean, dry swab against the puncture site until bleeding stops.

2.

As soon as coagulation has set in, you may apply a dressing if desired.

3.

Dispose of the safety needle in a suitable container for hazardous biological waste.

17

EN
Centrifugation
IMPORTANT! SARSTEDT S-Monovettes are designed for 4,000 x g. S-Monovettes with a diameter of 8 mm (S-Monovette® Paediatrics), are an exception, and are currently validated up to 2,500 x g. Only use suitable
tube holders or inserts. Centrifuging S-Monovettes with cracks or centrifuging at an excessive centrifugal force can lead to breakage of the S-Monovettes, which can release potentially infectious material.
Centrifuge inserts are to be selected according to the size of the S-Monovettes used. The relative centrifugal force has the following ratio to the selected rpm:
RCF = 11.2 x r x (rpm/1,000)2,
RCF: “Relative centrifugal force”, also called “g-force",“rpm”: “Revolutions per minute”,”r”: "Radius of rotation from the middle of the centrifuge to the bottom” of the S-Monovette®, (cm).
S-Monovettes without gel can be centrifuged in centrifuges with a fixed-angle or swing-out rotor.
S-Monovettes with gel are designed solely for use in centrifuges with swing-out rotor. Centrifugation in centrifuges with a fixed-angle rotor is not validated by SARSTEDT and is not recommended.
S-Monovettes should be centrifuged in accordance with the centrifugation conditions listed below. If other conditions are used, they must be validated by the users themselves.
It must be ensured that the S-Monovettes fit well in the centrifuge inserts. S-Monovettes that protrude above the insert can get caught in the centrifuge head and be broken. Ensure that the centrifuge is filled evenly.
Please refer to the centrifuge instructions for use for further information.
CAUTION! Do not remove broken S-Monovettes by hand.
Refer to the centrifuge instructions for use for information on disinfecting the centrifuge.

Based on
BS 4851+ (EUcode)

Relative centrifugal force (g)S-Monovette®

DIN EN ISO 6710–

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*Serum

10 min10 min

6 min

4 min

4 min

Serum Gel

15 min10 min

4 min

4 min

4 min

Serum Express Gel

15 min10 min

4 min

n.v.

n.v.

Lithium Heparin

10 min10 min

7 min

7 min

7 min

Lithium Heparin Gel

15 min15 min10 min

7 min

7 min

Lithium Heparin Gel+

8 min

7 min

5 min

4 min

4 min

EDTA

n.v.

n.v.

7 min

6 min

5 min

EDTA Gel

15 min10 min10 min

7 min

7 min

Citrate

9 min

8 min

7 min

6 min

5 min

EDTA, Fluoride Heparin

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Citrat PBM 1.8 ml
Centrifuge radius > 17 cm

9 min

8 min

7 min

6 min

5 min

Citrate PBM 1.8 ml&HQWULIXJHUDGLXV!WRƉFP

n.v.

n.v.

10 minn.v.

n.v.

n.v. = not validated* Applies to all S-Monovettes except with 8 mm diameter (S-Monovettes Paediatrics)

Centrifugation at 20 ºC+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, revoked.

Information on separation material
The flow properties of the separation material (gel) are temperature dependent. If S-Monovettes are cooled before or during centrifugation, a continuous layer of the separation gel is no longer ensured.
S-Monovettes must not be centrifuged again / re-centrifuged.

Disposal
1.

The general hygiene guidelines and regulations for the proper disposal of infectious material must be observed and complied with.

2.

Disposable gloves prevent the risk of infection.

3.

&RQWDPLQDWHGRUıOOHGEORRGFROOHFWLRQV\VWHPVPXVWEHGLVSRVHGRILQVXLWDEOHFRQWDLQHUVIRUKD]DUGRXVELRORJLFDOZDVWHWKDWFDQEHVXEVHTXHQWO\DXWRFODYHGDQGLQFLQHUDWHG

4.

They must be disposed of in a suitable incinerator or by autoclaving (steam sterilisation).

18

EN
3URGXFWVSHFLıFVWDQGDUGVDQGJXLGHOLQHVDVDPHQGHGXSGDWHG
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 “WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Standard for containers for venous blood collection:
DIN EN ISO 6710: Single-use containers for human venous blood specimen collection*CLSI (Clinical and Laboratory Standards Institute)

Key for symbols and labels:

Article number

Additionally applies to individually sterile-packed products:

Batch number

Do not use if the packaging is damaged

Use bySingle sterile barrier system with external protective packaging

CE marking

Sterilisation by irradiation

In vitro diagnostic device

Follow the instructions for use

If reused: Risk of contamination

Store away from sunlight

Store in a dry place

Manufacturer

Country of manufacture

6WHULOHĲXLGSDWK

Do not resterilise

Technical modifications reserved.
All serious incidents relating to the product must be reported to the manufacturer and the competent national authority.

19ȤɉɍɎɌɏɆɒɄɄɃȼɏɋɊɎɌɁȽȼş6$567('7ɍɄɍɎɁɈȼɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®

BG

ȣȼɄɉȾɄɎɌɊɀɄȼȿɉɊɍɎɄɆȼ
ȫɌɄɇɊɂɁɉɄɁ
ȭɄɍɎɁɈɄɎɁɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®ɃȼɁɀɉɊɍɆȼɉɚɇɄɎɁɄȼɀȼɋɎɁɌȼɋɌɁɀɍɎȼȾɇɛȾȼɎɍɄɍɎɁɈȼɃȼȾɁɉɊɃɉɊȾɃɁɈȼɉɁɉȼɆɌɖȾɉɄɋɌɊȽɄȭɄɍɎɁɈɄɎɁɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®ɍɁɄɃɋɊɇɃȾȼɎɃȼ
ȾɃɁɈȼɉɁɎɌȼɉɍɋɊɌɎɊȽɌȼȽɊɎɆȼɄɍɖɑɌȼɉɁɉɄɁɉȼɆɌɖȾɉɄɋɌɊȽɄɃȼɀɄȼȿɉɊɍɎɄɓɉɄɄɉȾɄɎɌɊɄɃɍɇɁɀȾȼɉɄɛɉȼɍɁɌɏɈɋɇȼɃɈȼɄɇɄɆɌɖȾȾɆɇɄɉɄɓɉɄɇȼȽɊɌȼɎɊɌɄɄȫɌɊɀɏɆɎɖɎɁɋɌɁɀɉȼɃɉȼɓɁɉɃȼɏɋɊɎɌɁȽȼȾ
ɋɌɊɐɁɍɄɊɉȼɇɉȼɊȽɍɎȼɉɊȾɆȼɊɎɊȽɏɓɁɉɈɁɀɄɒɄɉɍɆɄɋɁɌɍɊɉȼɇ

ȪɋɄɍȼɉɄɁɉȼɋɌɊɀɏɆɎȼ
ȭɄɍɎɁɈɄɎɁɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®ɍɁɍɖɍɎɊɛɎɊɎɋɇȼɍɎɈȼɍɊȾȼɁɋɌɏȾɁɎɆȼɒɄɇɄɉɀɖɌɍȽɏɎȼɇɊɄɒȾɁɎɊȾɊɆɊɀɄɌȼɉȼɋɇȼɍɎɈȼɍɊȾȼɆȼɋȼɓɆȼɉȼȾɄɉɎɍȾȿɌȼɀɁɉȼɈɁɈȽɌȼɉȼɄɍȼɌȼɃɌȼȽɊɎɁɉɄɍɋɁɒɄȼɇɉɊ
ɃȼɍɖȾɈɁɍɎɄɈɊɍɎɍ60RQRYHWWH® ɊȽɁɃɊɋȼɍɁɉɄ ɆȼɉɚɇɄɄɇɄɊȽɁɃɊɋȼɍɁɉɄ0XOWLIO\®ɆȼɉɚɇɄɆȼɆɎɊɄɍɌȼɃɇɄɓɉɄɀɊȽȼȾɆɄ ɋɌɁɋȼɌȼɎɄ ȫɌɁɀɇȼȿȼɍɁɍɖɕɊɎȼɆȼɄ60RQRYHWWH®ȽɁɃɀɊȽȼȾɆɄȭɄɍɎɁɈɄɎɁɃȼ
ȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®ɍɀɊȽȼȾɁɉɄɛɐȼɆɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɍȿɁɇɇɄɎɄɁȾɑɁɋȼɌɄɉɇɄɎɄɁȾɑɁɋȼɌɄɉɍȿɁɇɉȼɎɌɄɁȾɑɁɋȼɌɄɉɒɄɎɌȼɎ('7$ɐɇɏɊɌɄɀ('7$ɐɇɏɊɌɄɀɑɁɋȼɌɄɉ
ɐɇɏɊɌɄɀɒɄɎɌȼɎ&3'$ɆȼɆɎɊɄȽɁɃɀɊȽȼȾɆɄɆɊɉɒɁɉɎɌȼɒɄɄɎɁɉȼɀɊȽȼȾɆɄɎɁɊȽɁɈɖɎɉȼɎɁɓɉɄɎɁɀɊȽȼȾɆɄɄɎɁɑɉɄɎɁɀɊɋɏɍɎɄɈɄɊɎɆɇɊɉɁɉɄɛɆȼɆɎɊɄɍɖɊɎɉɊɔɁɉɄɁɎɊɈɁɂɀɏɆɌɖȾɄɀɊȽȼȾɆȼɊɎȿɊȾȼɌɛɎɉȼ
ɄɃɄɍɆȾȼɉɄɛɎȼɄɋɌɁɋɊɌɖɆɄɎɁɉȼɈɁɂɀɏɉȼɌɊɀɉɄɛɍɎȼɉɀȼɌɎ',1(1,62ŚȡɋɌɏȾɁɎɆɄɃȼɁɀɉɊɆɌȼɎɉȼɏɋɊɎɌɁȽȼɃȼȾɃɁɈȼɉɁɉȼɋɌɊȽɄȾɁɉɊɃɉȼɆɌɖȾŗɄɊɀɊȽɌɁɉɄɎɁɍɎȼɉɀȼɌɎɄɉȼȤɉɍɎɄɎɏɎȼɃȼɆɇɄɉɄɓɉɄɄ
ɇȼȽɊɌȼɎɊɌɉɄɍɎȼɉɀȼɌɎɄ &/6, ȤɃȽɊɌɖɎɉȼɀɊȽȼȾɆȼɎȼɃȼȾɄɍɄɊɎȼɉȼɇɄɎɄɓɉɄɛɎɁɍɎɊȾɄɈɁɎɊɀȮɊɅɍɁɊɋɌɁɀɁɇɛɊɎɋɌɊɄɃȾɊɀɄɎɁɇɛɉȼɎɁɍɎɊȾɄɌɁȼȿɁɉɎɄɄɄɇɄɉȼɏɌɁɀȼɃȼȼɉȼɇɄɃɍɆɊɅɎɊɕɁɍɁɋɌɊȾɁɂɀȼ
ɎɁɍɎɖɎȭɄɍɎɁɈȼɎȼɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®ɍɁɋɌɁɀɇȼȿȼȾɖȾȾȼɌɄȼɉɎɄȾɖɎɌɁɔɉɊɍɎɁɌɄɇɉȼɄɇɄȾɖɎɌɁɔɉɊɄȾɖɉɔɉɊɍɎɁɌɄɇɉȼɁɀɄɉɄɓɉȼɊɋȼɆɊȾɆȼ

ȲȾɁɎɊȾɄɆɊɀɉȼɆȼɋȼɓɆɄɎɁɉȼȾɄɉɎ ɉȼ60RQRYHWWH®:ȠɊȽȼȾɆȼ

ȝɏɆȾɁɉɆɊɀ

ȲȾɛɎɉȼɆȼɋȼɓɆȼɎȼ',1
EN ISO 6710

ȲȾɁɎɖɎɉȼɆȼɋȼɓɆȼɎȼ
ɍɖɊɎȾɁɎɍɎȾȼɉȼ%6+

Z

Ƚɛɇ

Ƚɛɇ

ȡɋɌɏȾɁɎɆȼȽɁɃɋɌɁɋȼɌȼɎ
S-Monovette®ɉɁɏɎɌȼɇɉȼ=ȡɋɌɏȾɁɎɆȼɍɖɍɍɁɌɏɈ
S-Monovette®ɍɖɍɍɁɌɏɈ&$7ɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ

CATɓɁɌȾɁɉ

ȽɛɇS-Monovette®ɍɖɍɍɁɌɏɈȿɁɇ&$7ɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼɄȿɁɇ

CATɎɖɈɉɊɂɖɇɎ

ɎɖɈɉɊɂɖɇɎ

S-Monovette®ɍɖɍɍɁɌɏɈ([SUHVVȿɁɇ&$7ɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ

CATɊɌȼɉɂɁȾ

-S-Monovette®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ/+ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ

LH

ɃɁɇɁɉ

ɊɌȼɉɂɁȾ

S-Monovette®ɍɎɁɓɁɉɇɄɎɄɁȾɑɁɋȼɌɄɉ/+ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ

LH

ɃɁɇɁɉ

ɊɌȼɉɂɁȾ

S-Monovette®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ/+ɍɇɄɎɄɁȾɑɁɋȼɌɄɉɄȿɁɇ

LH

ɃɁɇɁɉ

ɊɌȼɉɂɁȾ

S-Monovette®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ+/+ɍɇɄɎɄɁȾɑɁɋȼɌɄɉɄȽɖɌɃȿɁɇ

LH

ɃɁɇɁɉ

ɊɌȼɉɂɁȾ

S-Monovette®ɍɉȼɎɌɄɁȾɑɁɋȼɌɄɉ1+ȾɉȼɎɌɄɁȾɑɁɋȼɌɄɉ

NH

ɆȼɐɛȾ

ɃɁɇɁɉ

S-Monovette®ɍȼɈɊɉɄɁȾɑɁɋȼɌɄɉ$+ɍȼɈɊɉɄɁȾɑɁɋȼɌɄɉ

ɉɊ

ɍɄɉ

ɍɄɉ

S-Monovette®ɍɒɄɎɌȼɎ1&ɉȼɎɌɄɁȾɒɄɎɌȼɎ

9NC

ɍɄɉ

ɃɁɇɁɉ

S-Monovette 3)$ɒɄɎɌȼɎ1&ɉȼɎɌɄɁȾɒɄɎɌȼɎȽɏɐɁɌɄɌȼɉ

9NC

ɍȾɁɎɇɊɍɄɉ

-S-Monovette®.('7$.(ɍɆȼɇɄɁȾ('7$K3EȾɄɊɇɁɎɊȾ

ɓɁɌȾɁɉ

S-Monovette®.('7$.(ɍɆȼɇɄɁȾ('7$K2EȾɄɊɇɁɎɊȾ

ɓɁɌȾɁɉ

S-Monovette®.('7$ȿɁɇ.(ɍɆȼɇɄɁȾ('7$ɄȿɁɇ

K2E

ȾɄɊɇɁɎɊȾ

ɓɁɌȾɁɉ

S-Monovette®ɍɐɇɏɊɌɄɀ('7$)(ɍɐɇɏɊɌɄɀɄ('7$

FE

ɍɄȾ

ɂɖɇɎ

S-Monovette®ɍɐɇɏɊɌɄɀɑɁɋȼɌɄɉ)+ɍɐɇɏɊɌɄɀɄɑɁɋȼɌɄɉ

FH

-

ɂɖɇɎ

S-Monovette®*OXFR(;$&7)&ɍɐɇɏɊɌɄɀɒɄɎɌȼɎɄ('7$

FC

ɌɊɃɊȾ

ɍɄȾ

LH

ɎɖɈɉɊɍɄɉ

ɊɌȼɉɂɁȾ

S-Monovette®7KURPER([DFWɍɈȼȿɉɁɃɄɁȾɊɍɖɁɀɄɉɁɉɄɁ

ɉɊɉɊɒȾɛɎɉȼɆɖɋɄɉȼ

ɉɊɒȾɛɎɉȼɆɖɋɄɉȼ

S-Monovette®ɍ&7$'ɉɊɉɊɍɄɉ

ɉɊɃɁɇɁɉ

S-Monovette®ɍ$&'

ACD

ɂɖɇɎ

ɂɖɇɎ

S-Monovette®ɍ&3'$

CPDA

ɂɖɇɎ

ɂɖɇɎ

S-Monovette®ɍɑɄɌɏɀɄɉ

ɉɊɉɊɈȼɍɇɄɉɁɉɊɃɁɇɁɉ

ɉɊɈȼɍɇɄɉɁɉɊɃɁɇɁɉ

ȡɋɌɏȾɁɎɆȼɍɑɁɋȼɌɄɉ

ȡɋɌɏȾɁɎɆȼɃȼɒɄɎɌȼɎ

®

ȡɋɌɏȾɁɎɆȼɍȡȠȮȜȡɋɌɏȾɁɎɆȼɍȿɇɚɆɊɃɉɄɄɉɑɄȽɄɎɊɌɄ

ȡɋɌɏȾɁɎɆȼɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇ
S-Monovette®ɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄ/+ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ

ȠɌɏȿɄɁɋɌɏȾɁɎɆɄɃȼɆɌɖȾɄɋɇȼɃɈȼ

S-Monovette®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɍȿɁɇɄɍɎȼȽɄɇɄɃȼɎɊɌ

ɉɊɉɊɍɄȾ

ɉɊɍɄȾ

S-Monovette®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<&ɍɒɄɎɌȼɎɁɉȽɏɐɁɌ

ɉɊɉɊȾɄɊɇɁɎɊȾ

ɉɊȾɄɊɇɁɎɊȾ

S-Monovette®ȠȩȦ([DFWɉɊɉɊɍɄɉ

ɉɊɍɄɉ

ȫɌɁɀɇȼȿȼɎɍɁɄɀɌɏȿɄɒȾɁɎɊȾɁɉȼɆȼɋȼɓɆȼɎȼɉȼȾɄɉɎ
ɉɊɉɁɁɊɋɌɁɀɁɇɁɉ
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistryɊɎɈɁɉɁɉ20

BG
SARSTEDT S-Monovette®ɍɖɍɍɁɌɏɈ&$7ɍɁɌɏɈȿɁɇ&$7
S-Monovette®ɍɖɍɍɁɌɏɈ&$7ɍɖɀɖɌɂȼɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄɋɊɆɌɄɎɄɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ ɍɄɇɄɆȼɎ ɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɍɁɌɏɈ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁɋɇȼɍɎɈȼɍɊȾɄɎɁȿɌȼɉɏɇɄɍɁɏɎȼɛȾȼɎ
ɈɁɂɀɏɆɌɖȾɉȼɎȼɏɎȼɅɆȼɄɍɁɌɏɈȼ
ȪɍȾɁɉɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄɋɊɆɌɄɎɄɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ ɍɄɇɄɆȼɎ 60RQRYHWWH®ɍɖɍɍɁɌɏɈȿɁɇ&$7ɍɖɀɖɌɂȼɄȿɁɇɉȼɋɊɇɄɈɁɌɉȼɊɍɉɊȾȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɍɁɌɏɈ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁ
ɋɇȼɍɎɈȼɍɊȾɄɎɁȿɌȼɉɏɇɄɍɁɏɎȼɛȾȼɎɈɁɂɀɏɆɌɖȾɉȼɎȼɏɎȼɅɆȼɄɍɁɌɏɈȼɄɊȽɌȼɃɏȾȼɎɍɎȼȽɄɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɋɊȾɌɁɈɁɉȼɎɌȼɉɍɋɊɌɎɍɖɑɌȼɉɁɉɄɁɄȼɉȼɇɄɃ
ȭɁɌɏɈɖɎɍɁɄɃɋɊɇɃȾȼɆȼɎɊɈȼɎɁɌɄȼɇɃȼɋɌɊȽɄɋɌɄɌɏɎɄɉɉɄɆɇɄɉɄɓɉɊɑɄɈɄɓɉɄɄɄɈɏɉɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛɄȾɍɁɌɊɇɊȿɄɛɎȼ
ȭɇɁɀȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾɍɖɍ60RQRYHWWH®ɍɖɍɍɁɌɏɈɍɁɌɏɈȿɁɇ&$7ɊɍɎȼȾɁɎɁɆɌɖȾɎȼɀȼɆɊȼȿɏɇɄɌȼȾɄɃɋɌȼȾɁɉɊɋɊɇɊɂɁɉɄɁɃȼɈɄɉɏɎɄɃȼɀȼɋɊɀɍɄȿɏɌɄɎɁɃɉȼɓɄɎɁɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɍɇɁɀ
ɒɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊȫɌɁɋɊɌɖɓɄɎɁɇɉɊɎɊȾɌɁɈɁɍɁɊɍɉɊȾȼȾȼɉȼɄɉɎȼɆɎɁɉɋɌɊɒɁɍɉȼɆɊȼȿɏɇȼɒɄɛȞɖɃɈɊɂɉɊɁɆɌɖȾɎȼɊɎɋȼɒɄɁɉɎɄɍȽɊɇɁɍɎɉɊɉȼɌɏɔɁɉȼɆɊȼȿɏɇȼɒɄɛɄɇɄɊɎɋȼɒɄɁɉɎɄɉȼȼɉɎɄɆɊȼȿɏɇȼɉɎɉɊ
ɇɁɓɁɉɄɁɀȼɍɁɉɏɂɀȼɁɊɎɋɊȾɁɓɁȾɌɁɈɁɃȼɀȼɆɊȼȿɏɇɄɌȼɉȼɋɖɇɉɊ

SARSTEDT S-Monovette®ɍɖɍɍɁɌɏɈ([SUHVVȿɁɇ&$7
ȪɍȾɁɉɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄɋɊɆɌɄɎɄɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ ɎɌɊɈȽɄɉ 60RQRYHWWH®ɍɖɍɍɁɌɏɈ([SUHVVȿɁɇ&$7ɍɖɀɖɌɂȼɄȿɁɇɉȼɋɊɇɄɈɁɌɉȼɊɍɉɊȾȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɍɁɌɏɈ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁɋɇȼɍɎɈȼɍɊȾɄɎɁȿɌȼɉɏɇɄɍɁɏɎȼɛȾȼɎɈɁɂɀɏɆɌɖȾɉȼɎȼɏɎȼɅɆȼɄɍɁɌɏɈȼɄɊȽɌȼɃɏȾȼɎɍɎȼȽɄɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɋɊȾɌɁɈɁɉȼɎɌȼɉɍɋɊɌɎɍɖɑɌȼɉɁɉɄɁɄȼɉȼɇɄɃ
ȭɇɁɀȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾɍɖɍ60RQRYHWWH®ɍɖɍɍɁɌɏɈ([SUHVVȿɁɇ&$7ɊɍɎȼȾɁɎɁɆɌɖȾɎȼɀȼɆɊȼȿɏɇɄɌȼȾɄɃɋɌȼȾɁɉɊɋɊɇɊɂɁɉɄɁɃȼɈɄɉɏɎɄɃȼɀȼɋɊɀɍɄȿɏɌɄɎɁɀɊȽɌɁɄɃȿɌȼɀɁɉɑɊɌɄɃɊɉɎȼɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉ
ɍɇɊɅɍɇɁɀɒɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊȫɌɁɋɊɌɖɓɄɎɁɇɉɊɎɊȾɌɁɈɁɍɁɊɍɉɊȾȼȾȼɉȼɄɉɎȼɆɎɁɉɋɌɊɒɁɍɉȼɆɊȼȿɏɇȼɒɄɛɀɊɌɄɄɋɌɄɑɁɋȼɌɄɉɄɃɄɌȼɉɄɋȼɒɄɁɉɎɄȦɌɖȾɎȼɊɎɋȼɒɄɁɉɎɄɍȽɊɇɁɍɎɉɊɉȼɌɏɔɁɉȼɆɊȼȿɏɇȼɒɄɛɄɇɄɊɎ
ɋȼɒɄɁɉɎɄɉȼȼɉɎɄɆɊȼȿɏɇȼɉɎɉɊɇɁɓɁɉɄɁɍȾɄɍɊɆɄɀɊɃɄɑɁɋȼɌɄɉɍɁɉɏɂɀȼɁɊɎɋɊȾɁɓɁȾɌɁɈɁɃȼɀȼɆɊȼȿɏɇɄɌȼɉȼɋɖɇɉɊ
ȭɁɌɏɈɖɎɍɁɄɃɋɊɇɃȾȼɆȼɎɊɈȼɎɁɌɄȼɇɃȼɋɌɊȽɄɋɌɄɌɏɎɄɉɉɄɆɇɄɉɄɓɉɊɑɄɈɄɓɉɄɄɄɈɏɉɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛɆȼɆɎɊɄȾɍɁɌɊɇɊȿɄɛɎȼ

SARSTEDT S-Monovette®ɉɁɏɎɌȼɇɉȼ=S-Monovette®ɉɁɏɎɌȼɇɉȼ=ɉɁɍɖɀɖɌɂȼɋɌɁɋȼɌȼɎɄɆɊɁɎɊɊɎȿɊȾȼɌɛɉȼɁɍɎɁɍɎȾɁɉɆɊȼȿɏɇȼɒɄɊɉɁɉɋɌɊɒɁɍɉȼɆɌɖȾɉȼɎȼɋɌɊȽȼȽɁɃȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɍɁɌɏɈ ȬȼɃɀɁɇɛɉɁɎɊɉȼ
ɆɌɖȾɉȼɎȼɏɎȼɅɆȼɄɍɁɌɏɈȼɍɁɊɍɖɕɁɍɎȾɛȾȼɓɌɁɃɒɁɉɎɌɊɐɏȿɄɌȼɉɁ
ȭɁɌɏɈɖɎɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɋɌɄɍɋɁɒɄɐɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛ
ȪɍȾɁɉɎɊȾȼ60RQRYHWWH®ɉɁɏɎɌȼɇɉȼ=ɈɊɂɁɀȼɍɁɄɃɋɊɇɃȾȼɄɆȼɎɊɋɌȼɃɉȼɁɋɌɏȾɁɎɆȼȾɍɇɏɓȼɅɓɁɃȼɋɊɓɉɁɎɁɍȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾɍ60RQRYHWWH®ɍɒɄɎɌȼɎȾɆɊɈȽɄɉȼɒɄɛɍ ɊȽɁɃɊɋȼɍɁɉȼ 0XOWLIO\®Ɇȼɉɚɇȼ
ɆȼɉɚɇȼɍɆɌɄɇɒȼ 60RQRYHWWH®ɉɁɏɎɌȼɇɉȼ=ɍɇɏɂɄɆȼɎɊɄɃɑɊɀɉȼɁɋɌɏȾɁɎɆȼ ɋɌȼɃɉȼɁɋɌɏȾɁɎɆȼ ɃȼɀȼɉȼɋɖɇɉɄɎɁɎɌɖȽɄɓɆȼɎȼɉȼ ɊȽɁɃɊɋȼɍɁɉȼɎȼ 0XOWLIO\®Ɇȼɉɚɇȼ

SARSTEDT S-Monovette®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ/+ɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ/+ɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ+/+ɉȼɎɌɄɁȾɑɁɋȼɌɄɉ1+ȼɈɊɉɄɁȾɑɁɋȼɌɄɉ$+S-Monovette®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ/+ɉȼɎɌɄɁȾɑɁɋȼɌɄɉ1+ȼɈɊɉɄɁȾɑɁɋȼɌɄɉ$+ɍɖɀɖɌɂȼɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄɋɊɆɌɄɎɄɍȼɉɎɄɆɊȼȿɏɇȼɉɎȼɇɄɎɄɁȾɑɁɋȼɌɄɉɉȼɎɌɄɁȾɑɁɋȼɌɄɉȼɈɊɉɄɁȾɑɁɋȼɌɄɉ ɊȽɄɆɉɊȾɁɉɊ
,8ɑɁɋȼɌɄɉPOɆɌɖȾ ɄɍɇɏɂȼɎɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾɄɋɇȼɃɈȼ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁɋɇȼɍɎɈȼɍɊȾɄɎɁȿɌȼɉɏɇɄɍɁɏɎȼɛȾȼɎɈɁɂɀɏɆɌɖȾɉɄɎɁɆɇɁɎɆɄɄɍɁɌɏɈȼ
ȫɌɄ60RQRYHWWH®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ/+ȽɁɃɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄ ɊȽɄɆɉɊȾɁɉɊ,8ɑɁɋȼɌɄɉPOɆɌɖȾ ɇɄɎɄɁȾɄɛɎɑɁɋȼɌɄɉɁɉȼɇɄɓɁɉɆȼɎɊɍɋɌɁɅ
ȪɍȾɁɉɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄɋɊɆɌɄɎɄɍȼɉɎɄɆɊȼȿɏɇȼɉɎȼɇɄɎɄɁȾɑɁɋȼɌɄɉ ɊȽɄɆɉɊȾɁɉɊ,8ɑɁɋȼɌɄɉPOɆɌɖȾ 60RQRYHWWH®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ/+ɍɖɀɖɌɂȼɄȿɁɇɉȼɋɊɇɄɈɁɌɉȼɊɍɉɊȾȼɄɍɇɏɂɄɃȼ
ɋɊɇɏɓȼȾȼɉɁɉȼɍɁɌɏɈ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁȿɁɇɖɎɍɁɏɎȼɛȾȼɈɁɂɀɏɆɌɖȾɉɄɎɁɆɇɁɎɆɄɄɋɇȼɃɈȼɎȼɄɊȽɌȼɃɏȾȼɍɎȼȽɄɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɋɊȾɌɁɈɁɉȼɎɌȼɉɍɋɊɌɎɍɖɑɌȼɉɁɉɄɁɄȼɉȼɇɄɃ
S-Monovetten®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ+/+ɍɖɕɊɍɖɀɖɌɂȼɎȿɁɇɉȼɋɊɇɄɈɁɌɉȼɊɍɉɊȾȼɆɊɅɎɊɉȼɈȼɇɛȾȼȾɌɁɈɁɎɊɉȼɒɁɉɎɌɊɐɏȿɄɌȼɉɁɍɊɆɊɇɊȾɍɌȼȾɉɁɉɄɁɍɊȽɄɆɉɊȾɁɉɄɎɁ60RQRYHWWHQ®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ
ȿɁɇȫɇȼɃɈȼɎȼɍɑɁɋȼɌɄɉɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɋɌɄɌɏɎɄɉɉɄɆɇɄɉɄɓɉɊɑɄɈɄɓɉɄɄɄɈɏɉɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛȲɛɇɊɍɎɉȼɎȼɆɌɖȾɍɑɁɋȼɌɄɉɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɋɌɄɌɏɎɄɉɄ
ɄɈɏɉɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛɄȾɍɁɌɊɇɊȿɄɛɎȼ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɑɁɋȼɌɄɉɍɁȼɆɎɄȾɄɌȼɍɋɊɈɊɕɎȼɉȼȼɉɎɄɎɌɊɈȽɄɉ
ȣȜȝȡȧȡȢȦȜ60RQRYHWWH®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉ/+ɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇȿɁɇ+/+ɉɁɎɌɛȽȾȼɀȼɍɁɄɃɋɊɇɃȾȼɃȼɊɋɌɁɀɁɇɛɉɁɉȼɇɄɎɄɅ60RQRYHWWH®ɍɉȼɎɌɄɁȾɑɁɋȼɌɄɉ1+ɉɁɎɌɛȽȾȼɀȼɍɁɄɃɋɊɇɃȾȼ
ɃȼɊɋɌɁɀɁɇɛɉɁɉȼɉȼɎɌɄɅɄ60RQRYHWWH®ɍȼɈɊɉɄɁȾɑɁɋȼɌɄɉ$+ɉɁɎɌɛȽȾȼɀȼɍɁɄɃɋɊɇɃȾȼɃȼɊɋɌɁɀɁɇɛɉɁɉȼȼɈɊɉɛɆ60RQRYHWWHQ®ɍɇɄɎɄɁȾɑɁɋȼɌɄɉɇɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇȿɁɇ+ɉȼɎɌɄɁȾ
ɑɁɋȼɌɄɉȼɈɊɉɄɁȾɑɁɋȼɌɄɉɉɁɁɋɊɀɑɊɀɛɕȼɃȼȼɉȼɇɄɃɉȼɆɌɖȾɉɄȿȼɃɊȾɁȼɆɊɁɋɖɇɉȼɍȾɁɉɊɃɉȼɆɌɖȾ

SARSTEDT S-Monovette®ɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄ
S-Monovette®ɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɇɄɎɄɁȾɑɁɋȼɌɄɉɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾɄɋɇȼɃɈȼ ȧɄɎɄɁȾɄɛɎɑɁɋȼɌɄɉɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ 8,ɑɁɋȼɌɄɉPOɆɌɖȾ ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɍɑɁɋȼɌɄɉɌɁɍɋɁɆɎɄȾɉɊɋɇȼɃɈȼɎȼɍɑɁɋȼɌɄɉɊɎ60RQRYHWWH®ɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄɃȼɁɀɉɊɍɖɍɍɋɁɒɄȼɇɉȼɎȼɊȽɁɃɊɋȼɍɁɉȼɆȼɉɚɇȼ*ɑŹŗ ȼɌɎɄɆɏɇǂ ɍɁɄɃɋɊɇɃȾȼɃȼ
ɄɃɍɇɁɀȾȼɉɁɉȼɈɄɌɆɊɁɇɁɈɁɉɎɄɈɁɎȼɇɄȨɄɆɌɊɁɇɁɈɁɉɎɄɎɁɈɁɎȼɇɄɎɁɍɁȾȼɇɄɀɄɌȼɎɓɌɁɃȼɎɊɈɉɊȼȽɍɊɌȽɒɄɊɉɉȼɍɋɁɆɎɌɊɍɆɊɋɄɛ $$6 ȣȼɍɄɍɎɁɈȼɎȼɊȽɁɃɊɋȼɍɁɉȼɆȼɉɚɇȼɄ60RQRYHWWH®ɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄ
ɍȼɄɃɓɄɍɇɁɉɄɍɇɁɀɉɄɎɁɈȼɆɍɄɈȼɇɉɄɍɎɊɅɉɊɍɎɄɉȼɋɌȼɃɉȼɋɌɊȽȼɃȼɎɁɃɄɈɄɆɌɊɁɇɁɈɁɉɎɄȾQJɍɄɍɎɁɈȼ

ȡɇɁɈɁɉɎ

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

QJȭɄɍɎɁɈȼ

2,5

1,5

8,0

5,0

5

50

70

70

10

40

Se

Hg

10

10

ȨȼɆɍɄɈȼɇɉɄɎɁɍɎɊɅɉɊɍɎɄɉȼɋɌȼɃɉȼɋɌɊȽȼɃȼȾɍɁɆɄɁɇɁɈɁɉɎɍȼɋɊɍɊɓɁɉɄɉȼɁɎɄɆɁɎȼɉȼ60RQRYHWWH .
®

ȪɋɌɁɀɁɇɛɉɁɎɊɉȼɈɄɆɌɊɁɇɁɈɁɉɎɄɃȼȾɄɍɄɊɎɈɁɎɊɀȼɃȼȼɉȼɇɄɃɉȼɒɛɇɊɍɎɉȼɆɌɖȾɍɑɁɋȼɌɄɉɄɇɄɋɇȼɃɈȼɍɑɁɋȼɌɄɉ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɑɁɋȼɌɄɉɍɁȼɆɎɄȾɄɌȼɍɋɊɈɊɕɎȼɉȼȼɉɎɄɎɌɊɈȽɄɉ

SARSTEDT S-Monovette®ɍɒɄɎɌȼɎ1&
S-Monovette®ɍɒɄɎɌȼɎ1&ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɎɌɄɉȼɎɌɄɁȾɒɄɎɌȼɎɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾɄɋɇȼɃɈȼ ȮɌɄɉȼɎɌɄɁȾɄɛɎɒɄɎɌȼɎɁɉȼɇɄɓɁɉɆȼɎɊɈɊɇȼɌɁɉɌȼɃɎȾɊɌ 
ɎɌɄɉȼɎɌɄɁȾɒɄɎɌȼɎɁɉɌȼɃɎȾɊɌɓɁɍɎɊɍɁɃȼɆɌɖȿɇɛɉȼ ɄɋɌɁɀɍɎȼȾɇɛȾȼɊɎɉɊɈɄɉȼɇɉɄɛɊȽɁɈɉȼ60RQRYHWWH®ɍɒɄɎɌȼɎȭɖɊɎɉɊɔɁɉɄɁɎɊɈɁɂɀɏɒɄɎɌȼɎɄɆɌɖȾɁşɊȽɁɈɉȼɓȼɍɎɒɄɎɌȼɎɄ
ɊȽɁɈɉɄɓȼɍɎɄɆɌɖȾȜɉȼɇɄɃɖɎɄɃɄɍɆȾȼɃȼɀɖɇɂɄɎɁɇɉɊɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁ
ȫɇȼɃɈȼɎȼɍɒɄɎɌȼɎɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɋɌɄɌɏɎɄɉɉɄɑɁɈɊɍɎȼɃɁɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼɒɄɎɌȼɎ
ȨɊɇɛɍɋȼɃȾȼɅɎɁȣȜȝȡȧȡȢȦȤȮȡɊɎɌȼɃɀɁɇȼŚ ȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼŗ ɋɌɄɆɊɈȽɄɉɄɌȼɉɁɉȼ60RQRYHWWH®ɍɒɄɎɌȼɎɄɆȼɉɚɇȼɍɆɌɄɇɒȼ

SARSTEDT S-Monovette®ɍ3)$1&
S-Monovette®ɍ3)$1&ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɎɌɄɉȼɎɌɄɁȾɒɄɎɌȼɎɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾɄɋɇȼɃɈȼ ȮɌɄɉȼɎɌɄɁȾɄɛɎɒɄɎɌȼɎɁɉȼɇɄɓɁɉɆȼɎɊɈɊɇȼɌɁɉȽɏɐɁɌɄɌȼɉɌȼɃɎȾɊɌ 
ȽɏɐɁɌɄɃȼɒɄɛɌȩ ɄɋɌɁɀɍɎȼȾɇɛȾȼɊɎɉɊɈɄɉȼɇɉɄɛɊȽɁɈɉȼ60RQRYHWWH®ɍ3)$ȭɖɊɎɉɊɔɁɉɄɁɎɊɈɁɂɀɏɒɄɎɌȼɎɄɆɌɖȾɁşɊȽɁɈɉȼɓȼɍɎɒɄɎɌȼɎɄɊȽɁɈɉɄɓȼɍɎɄɆɌɖȾȜɉȼɇɄɃɖɎɄɃɄɍɆȾȼ
ɃȼɀɖɇɂɄɎɁɇɉɊɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁ
ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɊɎ60RQRYHWWH®ɍ3)$1&ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɃȼɊɋɌɁɀɁɇɛɉɁɎɊɉȼɐɏɉɆɒɄɄɎɁɉȼɎɌɊɈȽɊɒɄɎɄɎɁɍɋɊɈɊɕɎȼɉȼɏɌɁɀɃȼȼɉȼɇɄɃ3)$ɉȼ6,(0(16+HDOWKLQHHUVɄɁȾȼɇɄɀɄɌȼɉȼ
ɃȼɎȼɃɄɒɁɇ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼɒɄɎɌȼɎ
ȨɊɇɛɍɋȼɃȾȼɅɎɁȣȜȝȡȧȡȢȦȤȮȡɊɎɌȼɃɀɁɇȼŚȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼŗɋɌɄɆɊɈȽɄɉɄɌȼɉɁɉȼ60RQRYHWWH®ɍ3)$ɄɆȼɉɚɇȼɍɆɌɄɇɒȼ

SARSTEDT S-Monovette®ɍ&7$'
S-Monovette®ɍ&7$'ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɎɌɄɉȼɎɌɄɁȾɒɄɎɌȼɎɆȼɆɎɊɄɀɊɋɖɇɉɄɎɁɇɉɄɎɁɍɖɍɎȼȾɆɄɎɁɊɐɄɇɄɉȼɀɁɉɊɃɄɉɄɀɄɋɄɌȼɈɄɀɊɇɄɁɋɌɁɀɉȼɃɉȼɓɁɉȼɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾɄɋɇȼɃɈȼ &7$'ɁɉȼɇɄɓɁɉɆȼɎɊɌȼɃɎȾɊɌɄɋɌɁɀɍɎȼȾɇɛȾȼɊɎɉɊɈɄɉȼɇɉɄɛɊȽɁɈɉȼ60RQRYHWWH®ɍ&7$'ȭɖɊɎɉɊɔɁɉɄɁɎɊɈɁɂɀɏ&7$'ɄɆɌɖȾɁşɊȽɁɈɉȼɓȼɍɎ&7$'ɄɊȽɁɈɉɄɓȼɍɎɄɒɛɇɊɍɎɉȼɆɌɖȾȜɉȼɇɄɃɖɎ
ɄɃɄɍɆȾȼɃȼɀɖɇɂɄɎɁɇɉɊɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁ
ȫɇȼɃɈȼɎȼɍ&7$'ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɃȼɊɋɌɁɀɁɇɛɉɁɉȼɎɌɊɈȽɊɒɄɎɉɄɛɐȼɆɎɊɌ 3) ȽɁɎȼ Ĕ ɎɌɊɈȽɊȿɇɊȽɏɇɄɉ Ĕ7* ɄɄɉɑɄȽɄɎɊɌȼɉȼɋɇȼɃɈɄɉɊȿɁɉɉɄɛȼɆɎɄȾȼɎɊɌ 3$, ɆȼɆɎɊɄɃȼɌɏɎɄɉɉɄ
ɑɁɈɊɍɎȼɃɁɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛ
ȜɆɎɄȾȼɒɄɛɎȼɉȼɎɌɊɈȽɊɒɄɎɄɎɁɍɁɄɉɑɄȽɄɌȼɃȼɋɁɌɄɊɀɊɎɈɄɉɄɈɏɈɓȼɍȼɄɁɋɌɁɀɉȼɃɉȼɓɁɉȼɃȼɉȼȽɇɚɀɁɉɄɁɋɌɄɑɁɋȼɌɄɉɊȾɊɇɁɓɁɉɄɁ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼɒɄɎɌȼɎ
ȨɊɇɛɍɋȼɃȾȼɅɎɁȣȜȝȡȧȡȢȦȤȮȡɊɎɌȼɃɀɁɇȼŚ ȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼŗ ɋɌɄɆɊɈȽɄɉɄɌȼɉɁɉȼ60RQRYHWWH®ɍ&7$'ɄɆȼɉɚɇȼɍɆɌɄɇɒȼ
ȣȜȝȡȧȡȢȦȜ&7$'ɁɂɖɇɎȫɌɄɍɖɑɌȼɉɁɉɄɁ60RQRYHWWH®ɍ&7$'ɎɌɛȽȾȼɀȼɍɁɋȼɃɄɊɎɄɃɆɏɍɎȾɁɉȼɄɁɍɎɁɍɎȾɁɉȼɍȾɁɎɇɄɉȼȤɃɇȼȿȼɉɁɎɊɉȼɍɄɇɉȼɍȾɁɎɇɄɉȼɃȼɋɊȾɁɓɁɊɎɓȼɍȼɈɊɂɁɀȼ
ɀɊȾɁɀɁɀɊɄɉȼɆɎɄȾȼɒɄɛɉȼɀɊȽȼȾɆɄɎɁ21

BG
SARSTEDT S-Monovette®ɍ('7$.(.(S-Monovette®ɍ('7$.(60RQRYHWWH®ɍ('7$.(ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼ.('7$ɌɁɍɋɁɆɎɄȾɉɊ.('7$ɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾ .('7$ɌɁɍɋɁɆɎɄȾɉɊ.('7$ɍɁɋɌɁɀɇȼȿȼɎɆȼɎɊ
ɍɋɌɁɅ PJ('7$POɆɌɖȾ ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɍ('7$ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɋɌɄɑɁɈȼɎɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛȦɌɖȾɉɄɎɁɒɄɎɊɉȼɈȼɃɆɄɎɌɛȽȾȼɀȼɍɁɋɌɄȿɊɎȾɛɎȾɌȼɈɆɄɎɁɉȼɓɁɎɄɌɄɓȼɍȼɍɇɁɀȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼ('7$
ȦɌɖȾɎȼɊɎ60RQRYHWWH®ɍ('7$.(.(ɈɊɂɁɀȼɍɁɄɃɋɊɇɃȾȼɄɃȼɌɏɎɄɉɉɄɄɈɏɉɊɑɁɈȼɎɊɇɊȿɄɓɉɄɄɃɍɇɁɀȾȼɉɄɛɄɎɁɍɎɊȾɁɉȼɄɉɐɁɆɒɄɊɃɉɄɃȼȽɊɇɛȾȼɉɄɛȫɊɎɌɁȽɄɎɁɇɛɎɋɊɁɈȼɊɎȿɊȾɊɌɉɊɍɎɀȼȾȼɇɄɀɄɌȼ
ɋɌɄȿɊɀɉɊɍɎɎȼɉȼɋɌɊȽɉɄɛɈȼɎɁɌɄȼɇɃȼɎɁɃɄɄɃɍɇɁɀȾȼɉɄɛɍɖɍɍɖɊɎȾɁɎɉɄɎɁɎɁɍɎɊȾɄɌɁȼȿɁɉɎɄɏɌɁɀɄɃȼȼɉȼɇɄɃɄɏɍɇɊȾɄɛɃȼɍɖɑɌȼɉɁɉɄɁ

SARSTEDT S-Monovette®ɍ('7$ȿɁɇ.(ȪɍȾɁɉȼɉɎɄɆɊȼȿɏɇȼɉɎȼȦ('7$60RQRYHWWH®ɍ('7$ȿɁɇ.(ɍɖɀɖɌɂȼɄȿɁɇɉȼɋɊɇɄɈɁɌɉȼɊɍɉɊȾȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɋɇȼɃɈȼ .('7$ɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ PJ('7$POɆɌɖȾ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁȿɁɇɖɎɍɁɏɎȼɛȾȼɈɁɂɀɏɆɌɖȾɉɄɎɁɆɇɁɎɆɄɄɋɇȼɃɈȼɎȼɄɊȽɌȼɃɏȾȼɍɎȼȽɄɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɋɊȾɌɁɈɁɉȼɎɌȼɉɍɋɊɌɎɍɖɑɌȼɉɁɉɄɁɄȼɉȼɇɄɃ
ȫɇȼɃɈȼɎȼɍ('7$ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇȾɈɊɇɁɆɏɇɛɌɉȼɎȼȾɄɌɏɍɉȼɀɄȼȿɉɊɍɎɄɆȼ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼ('7$

SARSTEDT S-Monovette®ɍɐɇɏɊɌɄɀ('7$)(ɐɇɏɊɌɄɀɑɁɋȼɌɄɉ)+ɐɇɏɊɌɄɀɒɄɎɌȼɎ('7$)&ɄȿɇɚɆɊɃɉɄɄɉɑɄȽɄɎɊɌɄ
S-Monovette®ɍɐɇɏɊɌɄɀ('7$)(ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼ('7$ PJPOɆɌɖȾ ɆȼɆɎɊɄɐɇɏɊɌɄɀ PJPOɆɌɖȾ ɃȼɄɉɑɄȽɄɌȼɉɁɉȼȿɇɚɆɊɃȼɎȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɋɇȼɃɈȼ ȰɇɏɊɌɄɀ('7$ɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ
S-Monovette®ɍɐɇɏɊɌɄɀɑɁɋȼɌɄɉ('7$)ȩɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɑɁɋȼɌɄɉ PJɑɁɋȼɌɄɉPOɆɌɖȾ ɆȼɆɎɊɄɐɇɏɊɌɄɀ PJPOɆɌɖȾ ɃȼɄɉɑɄȽɄɌȼɉɁɉȼȿɇɚɆɊɃȼɎȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɋɇȼɃɈȼ ȰɇɏɊɌɄɀɑɁɋȼɌɄɉɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼȿɇɄɆɊɇɄɃȼɎȼɍȼɈɊɍɐɇɏɊɌɄɀɃȼɋɊɓȾȼɊɆɊɇɊɓȼɍȼɍɇɁɀɉȼɋɖɇȾȼɉɁɎɊɉȼɁɋɌɏȾɁɎɆȼɎȼɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾɄɋɌɊɛȾɛȾȼɋɖɇɉɄɛɍɄɁɐɁɆɎɍɇɁɀɋɌɄȽɇɄɃɄɎɁɇɉɊɓȼɍȼȫɊɌȼɀɄɎɊȾȼȿɇɚɆɊɃȼɎȼ
ɍɁɌȼɃȿɌȼɂɀȼɍɌɁɀɉɊɀɊɍɇɁɀɉɛɆɊɇɆɊɓȼɍȼɄɀɊɍɇɁɀɓȼɍȼȾɒɛɇɊɍɎɉȼɎȼɆɌɖȾ
S-Monovette®ɍ*OXFR(;$&7)&ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼ('7$ɆȼɆɎɊɄɒɄɎɌȼɎɄɐɇɏɊɌɄɀɃȼɉɁɃȼȽȼȾɉɊɄɉɑɄȽɄɌȼɉɁɉȼȿɇɚɆɊɃȼɎȼɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɋɇȼɃɈȼ ('7$ɒɄɎɌȼɎɖɎɄɐɇɏɊɌɄɀɖɎɍɁ
ɋɌɁɀɇȼȿȼɎɆȼɎɊɌȼɃɎȾɊɌȫɊɌȼɀɄɌȼɃɌɁɂɀȼɉɁɎɊɄɃɓɄɍɇɁɉɄɁɎɊɉȼɆɊɉɒɁɉɎɌȼɒɄɛɎȼɉȼȿɇɚɆɊɃȼɎȼɄɃɄɍɆȾȼɏɈɉɊɂɁɉɄɁɋɊ
S-Monovette®ɍ*OXFR(;$&7)&ɊɎȿɊȾȼɌɛɉȼɄɃɄɍɆȾȼɉɄɛɎȼɉȼȟɁɌɈȼɉɍɆɊɎɊɊȽɕɁɍɎȾɊɃȼɀɄȼȽɁɎ ''* ɋɌɄȿɁɍɎȼɒɄɊɉɁɉɀɄȼȽɁɎɄȩȼɒɄɊɉȼɇɉɄɎɁɄɃɄɍɆȾȼɉɄɛɃȼɌȼɃɋɌɊɍɎɌȼɉɁɉɄɁ 19/ ɋɌɄɀɄȼȽɁɎɎɄɋ
ȩɁɃȼȽȼȾɉɊɎɊɍɎȼȽɄɇɄɃɄɌȼɉɁɉȼɆɊɉɒɁɉɎɌȼɒɄɛɎȼɉȼȿɇɚɆɊɃȼɍɁɃȼɋȼɃȾȼɀɊɓȼɍȼɋɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼȾɒɛɇɊɍɎɉȼɆɌɖȾȾɄɂɎɁɍɖɕɊɎȼɆȼ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/
diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
ȫɇȼɃɈȼɎȼɍɐɇɏɊɌɄɀ('7$ ɒɄɎɌȼɎ ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɃȼɊɋɌɁɀɁɇɛɉɁɉȼȿɇɚɆɊɃȼɎȼ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼ('7$
ȣȜȝȡȧȡȢȦȜȰɇɏɊɌɄɀɖɎɈɊɂɁɀȼɋɌɄɓɄɉɄɋɊȾɄɔȼȾȼɉɁɉȼɑɁɈɊɇɄɃȼɎȼȣȼɋɊȾɁɓɁɄɉɐɊɌɈȼɒɄɛɊɎɉɊɍɉɊȾɁɕɁɍɎȾȼɆɊɄɎɊɈɊȿȼɎɀȼɋɊȾɇɄɛɛɎɊɎɌɄɒȼɎɁɇɉɊɍɁɆɊɉɍɏɇɎɄɌȼɅɎɁɍɖɍɍɖɊɎȾɁɎɉɄɎɁ
ɏɆȼɃȼɉɄɛɃȼɏɋɊɎɌɁȽȼɉȼɋɌɊɄɃȾɊɀɄɎɁɇɛɉȼɎɁɍɎɊȾɄɎɁɌɁȼȿɁɉɎɄ
ȨɊɇɛɍɋȼɃȾȼɅɎɁȣȜȝȡȧȡȢȦȤȮȡɊɎɌȼɃɀɁɇȼŗȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼŗɋɌɄɆɊɈȽɄɉɄɌȼɉɁɉȼ60RQRYHWWH®*OXFR(;$&7ɄɆȼɉɚɇȼɍɆɌɄɇɒȼ

SARSTEDT S-Monovette®ɍ&3'$
S-Monovette®ɍ&3'$ɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɉȼɎɌɄɁȾɒɄɎɌȼɎɆȼɆɎɊɄɇɄɈɊɉɁɉȼɆɄɍɁɇɄɉȼɉȼɎɌɄɁȾɐɊɍɐȼɎɀɁɆɍɎɌɊɃȼɄȼɀɁɉɄɉɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾɄɋɇȼɃɈȼ &3'$ɍɁɋɌɁɀɇȼȿȼ
ɆȼɎɊɌȼɃɎȾɊɌȭɖɊɎɉɊɔɁɉɄɁɎɊɈɁɂɀɏ&3'$ɄɆɌɖȾɁşɊȽɁɈɉȼɓȼɍɎ&3'$ɄɊȽɁɈɉɄɓȼɍɎɄɒɛɇɊɍɎɉȼɆɌɖȾȜɉȼɇɄɃɖɎɄɃɄɍɆȾȼɃȼɀɖɇɂɄɎɁɇɉɊɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁ
ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɋɇȼɃɈȼɎȼɍ&3'$ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇȾɎɌȼɉɍɐɏɃɄɊɉɉȼɎȼɈɁɀɄɒɄɉȼɋɌɄɍɁɌɊɇɊȿɄɛɎȼɉȼɆɌɖȾɉɄȿɌɏɋɄɋɌɄɎɁɍɎɊȾɁɃȼɍɖȾɈɁɍɎɄɈɊɍɎ ɆɌɖɍɎɊɍȼɉɄɎɁɍɎɊȾɁ ɋɌɄ
ɎɌȼɉɍɐɏɃɄɄ60RQRYHWWH®ɍ&3'$ɁɋɌɁɀɉȼɃɉȼɓɁɉȼɆɊɉɆɌɁɎɉɊɃȼɊɋɌɁɀɁɇɛɉɁɉȼɆɌɖȾɉɄȿɌɏɋɄ ȜȞ ȾɆɇɚɓɄɎɁɇɉɊȦɁɇɄȬɁɃɏɍɐɊɌɈɏɇȼɎɁɍɎɃȼɉɁɋɌȼȾɄɇɉɄȼɉɎɄɎɁɇȼɉȼɆɌɖȾɉɄɎɁȿɌɏɋɄɋɊɇɄɍɋɁɒɄɐɄɓɁɉ
ɉɁɋɊɍɌɁɀɍɎȾɁɉɎɁɍɎɉȼȦɏɈȽɍ ɀɊɀɁɉ ɄɁɋɊɀɑɊɀɛɕȼɃȼɎɁɍɎɃȼɍɖȾɈɁɍɎɄɈɊɍɎ ɆɌɖɍɎɊɍȼɉɎɁɍɎ ɍɖɍɍɁɌɏɈɋɇȼɃɈȼɊɎɋȼɒɄɁɉɎɍɖȾɈɁɍɎɄɈɍɆɌɖȾɉȼɎȼȿɌɏɋȼ 0DMRUȮHVW ȞɌɁɈɁɎɊɃȼɎɌȼɉɍɋɊɌɎɄɌȼɉɁɄɍɖɑɌȼɉɁɉɄɁɁȾȼɇɄɀɄɌȼɉɊɃȼɈȼɆɍɄɈɏɈɓȼɍȼɋɌɄƓ&ȣȼɀȼɍɁɏɎȼɛɎɆɇɁɎɆɄɎɁɋɌɊȽɄɎɁɎɌɛȽȾȼɋɖɌȾɊɀȼɍɁɍɖɑɌȼɉɛɎȾɄɃɋɌȼȾɁɉɊɋɊɇɊɂɁɉɄɁȾɑɇȼɀɄɇɉɄɆɃȼɉȼɅɈȼɇɆɊ
ɓȼɍȼȞɋɊɍɇɁɀɍɎȾɄɁȿɊɌɁɍɋɊɈɁɉȼɎɄɎɁȼɉȼɇɄɎɄɈɊȿȼɎɀȼɍɁɊɋɌɁɀɁɇɛɎɀɊɀɉɄɆɊɁɎɊɁȼɉȼɇɊȿɄɓɉɊɉȼɊȽɄɓȼɅɉɊɎɊȾɌɁɈɁɃȼɍɖɑɌȼɉɁɉɄɁɉȼɆɌɖȾɎȼɍɇɁɀɍɖɑɌȼɉɁɉɄɁȾɑɇȼɀɄɇɉɄɆ Ɠ&  ɍɄɃɆɇɚɓɁɉɄɁ
ɉȼɀɄɌɁɆɎɉɄɛɎɁɍɎɉȼȦɏɈȽɍşɀɉɄ ȫɊɀɑɊɀɛɕȼɃȼɋɌɊɒɁɀɏɌɄɃȼȼȿɇɏɎɄɉȼɒɄɛȾɆɊɇɊɉȼɉȼɋɌɉȼ9LVLRQ0D[ɉȼ2UWKR&OLQLFDO'LDJQRVWLFVȫɌɊȽɉɄɛɎɈȼɎɁɌɄȼɇɉɁɎɌɛȽȾȼɀȼɍɁɃȼɈɌȼɃɛȾȼ
ȫɊɎɌɁȽɄɎɁɇɛɎɋɊɁɈȼɊɎȿɊȾɊɌɉɊɍɎɀȼȾȼɇɄɀɄɌȼɋɌɄȿɊɀɉɊɍɎɎȼɉȼɋɌɊȽɉɄɛɈȼɎɁɌɄȼɇɃȼɎɁɃɄɄɃɍɇɁɀȾȼɉɄɛɍɋɊɈɊɕɎȼɉȼɀɌɏȿɄɈɁɎɊɀɄɎɁɍɎɊȾɄɌɁȼȿɁɉɎɄɏɌɁɀɄɃȼȼɉȼɇɄɃɄɏɍɇɊȾɄɛɃȼɍɖɑɌȼɉɁɉɄɁ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼɒɄɎɌȼɎ
ȨɊɇɛɍɋȼɃȾȼɅɎɁȣȜȝȡȧȡȢȦȤȮȡɊɎɌȼɃɀɁɇȼŗȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼŗɋɌɄɆɊɈȽɄɉɄɌȼɉɁɉȼ60RQRYHWWH®ɍ&3'$ɄɆȼɉɚɇȼɍɆɌɄɇɒȼ

SARSTEDT S-Monovette® ThromboExact
S-Monovette®7KURPER([DFWɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɈȼȿɉɁɃɄɁȾȼɍɊɇɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾ ȨȼȿɉɁɃɄȾȼɎȼɍɊɇɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ
ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɊɎ60RQRYHWWH®7KURPER([DFWɍɇɏɂɄɃȼɄɃɆɇɚɓȾȼɉɁɉȼɋɊȿɌɁɔɉɊɉɄɍɖɆȽɌɊɅɎɌɊɈȽɊɒɄɎɄɋɊɌȼɀɄȼɉɎɄɆɊȼȿɏɇȼɉɎɉȼɉɁɋɊɉɊɍɄɈɊɍɎ ɆȼɎɊ('7$ɒɄɎɌȼɎɑɁɋȼɌɄɉ ɉȼɌɄɓȼɉɊɕɁ
ɋɍɁȾɀɊɎɌɊɈȽɊɒɄɎɊɋɁɉɄɛȮȼɆȼɍɁɋɌɁɀɊɎȾɌȼɎɛȾȼȼȿɌɁȿȼɒɄɛɎȼɉȼɎɌɊɈȽɊɒɄɎɄɄɁȾɖɃɈɊɂɉɊɊɋɌɁɀɁɇɛɉɁɎɊɉȼɀɁɅɍɎȾɄɎɁɇɉɄɛȽɌɊɅɎɌɊɈȽɊɒɄɎɄɀɊɓȼɍȼɍɇɁɀȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɊɍɖɕɁɍɎȾɛȾȼɍɋɊɈɊɕɎȼɉȼɈȼȿɉɁɃɄɁȾɄɎɁɅɊɉɄɆɊɄɎɊɄɉɑɄȽɄɌȼɎɎɌɊɈȽɊɆɍȼɉȜȾɎɌɊɈȽɊɒɄɎɄɎɁɄɎɌɊɈȽɊɒɄɎɉȼɎȼȼȿɌɁȿȼɒɄɛɈɁɀɄɄɌȼɉȼɊɎ$'3ɄȼɌȼɑɄɀɊɉɊȾȼɆɄɍɁɇɄɉȼ

SARSTEDT S-Monovette®ɍɑɄɌɏɀɄɉ
S-Monovette®ɍɑɄɌɏɀɄɉɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɑɄɌɏɀɄɉɒɄɎɌȼɎɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾ ȱɄɌɏɀɄɉɖɎɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ
ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɍɑɄɌɏɀɄɉɍɁɄɃɋɊɇɃȾȼɃȼɊɋɌɁɀɁɇɛɉɁɉȼɐɏɉɆɒɄɛɎȼɉȼɎɌɊɈȽɊɒɄɎɄɎɁɍȼɉȼɇɄɃȼɎɊɌȼ0XOWLSODWH® ȼɉȼɇɄɃȼɎɊɌɉȼɐɏɉɆɒɄɄɎɁɉȼɈɉɊɂɁɍɎȾɊɎɌɊɈȽɊɒɄɎɄ ɉȼ52&+('LDJQRVWLFVɄɁȾȼɇɄɀɄɌȼɉɊ
ɃȼɎȼɃɄɒɁɇȮɊɅɍɁɋɌɄɇȼȿȼɃȼɋɌɊɍɇɁɀɛȾȼɉɁɉȼɇɁɓɁɉɄɁɍɈɁɀɄɆȼɈɁɉɎɄɆɊɄɎɊɄɉɑɄȽɄɌȼɎɎɌɊɈȽɊɒɄɎɄɎɁɄɃȼɀɊɆȼɃȾȼɉɁɄɇɄɄɃɆɇɚɓȾȼɉɁɉȼɉȼɌɏɔɁɉɄɐɏɉɆɒɄɄɉȼɎɌɊɈȽɊɒɄɎɄɎɁ
S-Monovette®ɍɑɄɌɏɀɄɉɁɌȼɃɌȼȽɊɎɁɉȼɃȼɁɀɉɊɍɐɄɌɈȼɎȼ9HUXP'LDJQRVWLFDɋɊɉȼɍɎɊɛɕɁɈ52&+('LDJQRVLWFVɍɋɁɒɄȼɇɉɊɃȼɊɋɌɁɀɁɇɛɉɁɉȼɐɏɉɆɒɄɛɎȼɉȼɎɌɊɈȽɊɒɄɎɄɎɁɍȼɉȼɇɄɃȼɎɊɌȼ0XOWLSODWH®.
ȱɄɌɏɀɄɉɖɎɀɁɅɍɎȾȼɆȼɎɊɀɄɌɁɆɎɉɊɄɉɑɄȽɄɌȼɎɌɊɈȽɄɉȼɄɋɊɎɊɃɄɉȼɓɄɉɋɊɃȾɊɇɛȾȼɀɄȼȿɉɊɍɎɄɆȼɉȼɐɏɉɆɒɄɛɎȼɉȼɎɌɊɈȽɊɒɄɎɄɎɁȾɁɍɎɁɍɎȾɁɉɊɍɖɍɎɊɛɉɄɁ

SARSTEDT S-Monovette®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇ+&<&ȪɍȾɁɉɋɇȼɍɎɈȼɍɊȾɄȿɌȼɉɏɇɄɋɊɆɌɄɎɄɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ ɍɄɇɄɆȼɎ 60RQRYHWWH®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɍɖɀɖɌɂȼɍɋɁɒɄȼɇɁɉɍɎȼȽɄɇɄɃȼɎɊɌɆȼɆɎɊɄȿɁɇɉȼɋɊɇɄɈɁɌɉȼɊɍɉɊȾȼɄɍɇɏɂɄɃȼ
ɋɊɇɏɓȼȾȼɉɁɉȼɍɁɌɏɈ ȫɌɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁɋɇȼɍɎɈȼɍɊȾɄɎɁȿɌȼɉɏɇɄɍɁɏɎȼɛȾȼɎɈɁɂɀɏɆɌɖȾɉȼɎȼɏɎȼɅɆȼɄɍɁɌɏɈȼɄɊȽɌȼɃɏȾȼɎɍɎȼȽɄɇɁɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɋɊȾɌɁɈɁɉȼɎɌȼɉɍɋɊɌɎɍɖɑɌȼɉɁɉɄɁɄȼɉȼɇɄɃ
ȫɌɁɋȼɌȼɎɖɎɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ
ȱɊɈɊɒɄɍɎɁɄɉɖɎɍɁɍɎȼȽɄɇɄɃɄɌȼɀɊɓȼɍȼȾɒɛɇɊɍɎɉȼɎȼɆɌɖȾɋɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼȜɆɊɒɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊɍɁɋɌɊȾɁɀɁȾɌȼɈɆɄɎɁɉȼɋɖɌȾɄɎɁɓȼɍȼɋɌɄɋɌȼȾɄɇɉɊɊȽɌȼɃɏȾȼɉɌȼɃɀɁɇɄɎɁɇɁɉɍɇɊɅɈɁɂɀɏ
ɆɌɖȾɉȼɎȼɏɎȼɅɆȼɄɍɁɌɏɈȼɑɊɈɊɒɄɍɎɁɄɉɖɎɍɁɍɎȼȽɄɇɄɃɄɌȼɃȼɓȼɍȼ
ȭɁɌɏɈɖɎɊɎ60RQRYHWWH®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɃȼɊɋɌɁɀɁɇɛɉɁɉȼɑɊɈɊɒɄɍɎɁɄɉȼ60RQRYHWWH®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<ȭɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎȼɆɄɍɁɇɒɄɎɌȼɎ Ɍȩ ɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɋɇȼɃɈȼ ȲɄɎɌȼɎɖɎɍɁɋɌɁɀɇȼȿȼɆȼɎɊɌȼɃɎȾɊɌȫɊɌȼɀɄɌȼɃɌɁɂɀȼɉɁɎɊɄɃɓɄɍɇɁɉɄɁɎɊɉȼɆɊɉɒɁɉɎɌȼɒɄɛɎȼɉȼɑɊɈɊɒɄɍɎɁɄɉȼɄɃɄɍɆȾȼɏɈɉɊɂɁɉɄɁɋɊ
ȫɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼɑɊɈɊɒɄɍɎɁɄɉɖɎɍɁɍɎȼȽɄɇɄɃɄɌȼȾɒɛɇɊɍɎɉȼɎȼɆɌɖȾɀɊɓȼɍȼȼɋɌɄƓ&ɀɊɓȼɍȼ
ȫɇȼɃɈȼɎȼɊɎ60RQRYHWWH®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<ȭɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɃȼɊɋɌɁɀɁɇɛɉɁɉȼɑɊɈɊɒɄɍɎɁɄɉȼ
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼȾ60RQRYHWWH®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<ȭɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼɒɄɎɌȼɎ
ȨɊɇɛɍɋȼɃȾȼɅɎɁȣȜȝȡȧȡȢȦȤȮȡɊɎɌȼɃɀɁɇȼŗȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼŗɋɌɄɆɊɈȽɄɉɄɌȼɉɁɉȼ60RQRYHWWH®ɍɑɊɈɊɒɄɍɎɁɄɉ+&<ȭɄɆȼɉɚɇȼɍɆɌɄɇɒȼ

SARSTEDT S-Monovette®ɍȠȩȦ([DFWS-Monovette®ɍȠȩȦ([DFWɍɖɀɖɌɂȼȼɉɎɄɆɊȼȿɏɇȼɉɎɉȼȽȼɃȼɎȼɉȼ('7$ɄɍɇɏɂɄɃȼɋɊɇɏɓȼȾȼɉɁɉȼɒɛɇɊɍɎɉȼɆɌɖȾ ('7$ɍɁɋɌɁɀɇȼȿȼɆȼɎɊɍɋɌɁɅ
ȲɛɇɊɍɎɉȼɎȼɆɌɖȾɍ('7$ɍɁɄɃɋɊɇɃȾȼɆȼɎɊɋɌɊȽɁɉɈȼɎɁɌɄȼɇɃȼɍɎȼȽɄɇɄɃɄɌȼɉɁɉȼȿɁɉɊɈɉȼȠȩȦȭɎȼȽɄɇɄɃɄɌȼɉɁɎɊɉȼȿɁɉɊɈɉȼȠȩȦɁȾȼɇɄɀɄɌȼɉɊɃȼɀɉɄɋɌɄƓ&ɃȼɀɉɄɋɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼ
Ɠ& ɃȼɀɉɄɋɌɄɊɑɇȼɂɀȼɉɁ Ɠ& ɄɃȼɈɄɉɄɈɏɈȿɊɀɄɉȼɋɌɄƓ&ȪɍȾɁɉɎɊȾȼɍɎȼȽɄɇɄɃɄɌȼɉɄɎɁɋɌɊȽɄɈɊȿȼɎɀȼɏɍɎɊɛɎɉȼɒɄɆɖɇȼɉȼɃȼɈɌȼɃɛȾȼɉɁɄɌȼɃɈɌȼɃɛȾȼɉɁȽɁɃɃȼȿɏȽȼɉȼɆȼɓɁɍɎȾɊɎɊȾɂ
ɍɖɕɊ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube forCollection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
ȤɉɑɄȽɄɌȼɉɁɎɊɉȼɆɊȼȿɏɇȼɒɄɛɎȼɍɁɄɃȾɖɌɔȾȼɓɌɁɃɆɊɈɋɇɁɆɍɊɊȽɌȼɃɏȾȼɉɁɉȼɆȼɇɒɄɁȾɄɎɁɅɊɉɄɍɋɊɈɊɕɎȼɉȼ('7$ȫɌɄȿɊɀɉɊɍɎɎȼɉȼɋɌɊȽɉɄɛɈȼɎɁɌɄȼɇɃȼȾɄɍɄɊɎȼɉȼɇɄɎȼɄɎɁɍɎɊȾɄɛɌɁȼɆɎɄȾɏɌɁɀȼɃȼȼɉȼɇɄɃȭɋȼɃȾȼɅɎɁɍɖɊɎȾɁɎɉɄɎɁɋɌɁɋɊɌɖɆɄɉȼɋɌɊɄɃȾɊɀɄɎɁɇɛ

22

BG
ȤɉɍɎɌɏɆɒɄɄɃȼȽɁɃɊɋȼɍɉɊɍɎ
1.

ȪȽɕɄɋɌɁɀɋȼɃɉɄɈɁɌɆɄȤɃɋɊɇɃȾȼɅɎɁɌɖɆȼȾɄɒɄɄɀɌɏȿɄɊȽɕɄɇɄɓɉɄɋɌɁɀɋȼɃɉɄɍɌɁɀɍɎȾȼɃȼɀȼɍɁɋɌɁɀɋȼɃɄɎɁɊɎɆɌɖȾɄɇɄɁȾɁɉɎɏȼɇɉɊɄɃɇȼȿȼɉɁɉȼɋɊɎɁɉɒɄȼɇɉɊɄɉɐɁɆɒɄɊɃɉɄɋɌɊȽɉɄɈȼɎɁɌɄȼɇɄɄ
ɋȼɎɊȿɁɉɄɋɌɁɉȼɍɛɉɄɍɆɌɖȾɎȼ

2.

ȞɍɄɓɆɄȽɄɊɇɊȿɄɓɉɄɋɌɊȽɄɄɊɍɎɌɄȼɆɍɁɍɊȼɌɄɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ ɆȼɉɚɇɄȼɀȼɋɎɁɌɄ ɎɌɛȽȾȼɀȼȽɖɀȼɎɎɌɁɎɄɌȼɉɄɍɖȿɇȼɍɉɊɉȼɌɁɀȽɄɎɁɄɋɌɊɒɁɀɏɌɄɎɁɉȼɍɖɊɎȾɁɎɉɊɎɊɇɁɓɁȽɉɊɃȼȾɁɀɁɉɄɁȞɍɇɏɓȼɅɓɁ
ȽɖɀɁɎɁɀɄɌɁɆɎɉɊɄɃɇɊɂɁɉɄɉȼȽɄɊɇɊȿɄɓɉɄɋɌɊȽɄɄɇɄɍɁɉȼɌȼɉɄɎɁɍɊɍɎɖɌɋɌɁɀɈɁɎɋɊɎɖɌɍɁɎɁɇɁɆȼɌɍɆȼɋɊɈɊɕɃȼɕɊɎɊɁȾɖɃɈɊɂɉɊɃȼɌȼɃɛȾȼɉɁɍ+,9+&9+%9ɄɇɄɀɌɏȿɄɄɉɐɁɆɒɄɊɃɉɄɃȼȽɊɇɛȾȼɉɄɛ
ȤɃɋɊɇɃȾȼɅɎɁɊȽɁɃɊɋȼɍɁɉɄɆȼɉɚɇɄɊȽɁɃɊɋȼɍɁɉɄ0XOWLĲ\®ɆȼɉɚɇɄɍȾȿɌȼɀɁɉɋɌɁɀɋȼɃɄɎɁɇɉȼɄȿɇȼɎȼȭɋȼɃȾȼɅɎɁɉȼɌɁɀȽɄɎɁɄɋɌɊɒɁɀɏɌɄɎɁɃȼȽɁɃɊɋȼɍɉɊɍɎɉȼɍɖɊɎȾɁɎɉɊɎɊɇɁɓɁȽɉɊɃȼȾɁɀɁɉɄɁ

3.

ȞȼɂɄɃȼȾɍɄɓɆɄɍɎɁɌɄɇɉɄɁɀɄɉɄɓɉɊɊɋȼɆɊȾȼɉɄɋɌɊɀɏɆɎɄȫɌɁɀɄɏɋɊɎɌɁȽȼɋɌɊȾɁɌɁɎɁɀȼɇɄɁɀɄɉɄɓɉȼɎȼɊɋȼɆɊȾɆȼɁɋɊȾɌɁɀɁɉȼɄȼɆɊɁɎȼɆȼɉɁɄɃɋɊɇɃȾȼɅɎɁɋɌɊɀɏɆɎȼ

4.

ȫɌɊɀɏɆɎɖɎɁɋɌɁɀɉȼɃɉȼɓɁɉɃȼɁɀɉɊɆɌȼɎɉȼɏɋɊɎɌɁȽȼȤɃɑȾɖɌɇɛɅɎɁȾɍɄɓɆɄɊɍɎɌɄɊɍɎɌɊȾɖɌɑɄȼɆɍɁɍɊȼɌɄ ɆȼɉɚɇɄȼɀȼɋɎɁɌɄ ɃȼȾɃɁɈȼɉɁɉȼɋɌɊȽɄȾɋɊɀɑɊɀɛɕɄɆɊɉɎɁɅɉɁɌɄɃȼɊɋȼɍɉɄȽɄɊɇɊȿɄɓɉɄ
ɊɎɋȼɀɖɒɄ

5.

ȫɌɄȾɃɁɈȼɉɁɉȼɆɌɖȾɊɎȾɁɓɁɋɊɍɎȼȾɁɉɄɉɎɌȼȾɁɉɊɃɁɉ ɄȾ ɋɖɎɎɌɛȽȾȼɀȼɍɁɋɊɀɍɄȿɏɌɄɎɁɓɁɋɖɎɛɎɁɋɌɊɈɄɎ ɋɌɊɓɄɍɎɁɉɍɄȾɌȼɃɎȾɊɌ ɋɌɁɀɄɀȼɃȼɋɊɓɉɁɎɁȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾȫɌȼȾɄɇɉɊɎɊɋɌɊɈɄȾȼɉɁ
ɉȼɄɉɎɌȼȾɁɉɊɃɉɄɛɋɖɎɋɌɁɀɊɎȾɌȼɎɛȾȼɋɊȿɌɁɔɉɄɌɁɃɏɇɎȼɎɄɊɎȼɉȼɇɄɃȼ

6.

ȜɆɊ60RQRYHWWH®ɉɁɍɁɉȼɋɖɇɉɄɀɊɍɎȼɎɖɓɉɊɎɊȾȼɈɊɂɁɀȼɀɊȾɁɀɁɀɊɋɊȿɌɁɔɉɊɍɖɊɎɉɊɔɁɉɄɁɈɁɂɀɏɆɌɖȾɎȼɄɋɌɁɋȼɌȼɎȼɀɊȽȼȾɆȼɎȼɄɍɖɊɎȾɁɎɉɊɀɊɋɊȿɌɁɔɁɉɌɁɃɏɇɎȼɎɊɎȼɉȼɇɄɃȼ

7.

ȦɌɖȾɎȼȾɃɁɎȼɄɊȽɌȼȽɊɎɁɉȼɍ60RQRYHWWH®ɉɁɎɌɛȽȾȼɀȼɍɁɄɉɂɁɆɎɄɌȼɊȽɌȼɎɉɊȾɓɊȾɁɔɆɊɎɊɎɛɇɊ

8.

ȩɁɄɃɋɊɇɃȾȼɅɎɁɋɌɊɀɏɆɎȼɍɇɁɀɄɃɎɄɓȼɉɁɉȼɍɌɊɆȼɉȼȿɊɀɉɊɍɎȭɌɊɆɖɎɉȼȿɊɀɉɊɍɎɉȼɋɌɊɀɏɆɎȼɄɃɎɄɓȼɉȼɋɊɍɇɁɀɉɄɛɀɁɉɉȼɋɊɍɊɓɁɉɄɎɁɈɁɍɁɒɄȿɊɀɄɉȼ

ȭɖɑɌȼɉɁɉɄɁ
ȭɖɑɌȼɉɛȾȼɅɎɁɋɌɊɀɏɆɎȼɋɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼɀɊɏɋɊɎɌɁȽȼɎȼ

ȪȿɌȼɉɄɓɁɉɄɛ
1.

ȞɌɁɈɁɎɊɄɎɁɈɋɁɌȼɎɏɌȼɎȼɉȼɍɖɑɌȼɉɁɉɄɁɉȼɋɖɇɉȼ60RQRYHWWH®ɃȼȾɄɍɛɎɊɎɎɌȼɅɉɊɍɎɎȼɉȼɄɃɍɇɁɀȾȼɉɄɎɁɋȼɌȼɈɁɎɌɄȪɒɁɉɆȼɎȼɍɁɄɃȾɖɌɔȾȼɊɎɇȼȽɊɌȼɎɊɌɄɛɎȼɄɇɄɍɁɍɇɁɀȾȼɄɉɐɊɌɈȼɒɄɛɎȼɊɎ
ɄɉɍɎɌɏɆɒɄɄɎɁɃȼɏɋɊɎɌɁȽȼɉȼɋɌɊɄɃȾɊɀɄɎɁɇɛɉȼɎɁɍɎɊȾɄɛɌɁȼȿɁɉɎɏɌɁɀȼɃȼȼɉȼɇɄɃ

2.

ȠɊɌɄɆɊȿȼɎɊɋɇȼɃɈȼɎȼɄɇɄɍɁɌɏɈȼɍȼɌȼɃɀɁɇɁɉɄɓɌɁɃɒɁɉɎɌɊɐɏȿɄɌȼɉɁɉȼ60RQRYHWWH®ɄɄɇɄȾɁɓɁɁɏɍɎȼɉɊȾɁɉȼȽȼɌɄɁɌȼɉɁɁɃȼɀɖɇɂɄɎɁɇɉɊȾɍɄɓɆɄɆɇɁɎɆɄɀȼɍȼɍɁɊɎɀɁɇɄɇɄɉȼɋɖɇɉɊȪɍɎȼɎɖɓɁɉ
ɈɁɎȼȽɊɇɄɃɖɈɄɇɄɁɍɎɁɍɎȾɁɉɌȼɃɋȼɀɈɊȿȼɎɀȼɋɊȾɇɄɛɛɎɉȼɆɊɉɒɁɉɎɌȼɒɄɛɎȼɉȼȼɉȼɇɄɎɄɎɁȭɎȼȽɄɇɉɊɍɎɎȼɉȼȼɉȼɇɄɎɄɎɁɎɌɛȽȾȼɀȼȽɖɀɁɊɒɁɉɁɉȼȾɖɃɊɍɉɊȾȼɉȼɆɊɉɎɁɅɉɁɌȼɃȼɍɖɑɌȼɉɁɉɄɁɄɉȼɏɍɇɊȾɄɛɎȼȾ
ɍɖɊɎȾɁɎɉȼɎȼɇȼȽɊɌȼɎɊɌɄɛ

3.

ȞɍɇɏɓȼɅɓɁɁɉȼɇɄɓɁɉɋɌɄɁɈɉȼɎɁɌȼɋɁȾɎɄɓɉɄɇɁɆȼɌɍɎȾȼɎɌɛȽȾȼɀȼɍɁɆɊɉɍɏɇɎɄɌȼɎɁɍɄɉɍɎɌɏɆɒɄɄɎɁɃȼɏɋɊɎɌɁȽȼɉȼɋɌɊɄɃȾɊɀɄɎɁɇɛɉȼɎɁɍɎɊȾɄɛɌɁȼȿɁɉɎɏɌɁɀȼɃȼȼɉȼɇɄɃɊɎɉɊɍɉɊɋɌɄȿɊɀɉɊɍɎɎȼɉȼ
ɈȼɎɁɌɄȼɇȼɉȼɋɌɊȽɄɎɁ

4.

ȜɉȼɇɄɃɄɎɁɃȼɈɄɆɌɊɁɇɁɈɁɉɎɄɈɁɎȼɇɄɎɌɛȽȾȼɀȼɍɁɄɃȾɖɌɔȾȼɎɍɖɍɍɄɍɎɁɈȼɎȼ60RQRYHWWH®ɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄɊȽɁɃɊɋȼɍɁɉȼɆȼɉɚɇȼɃȼȼɉȼɇɄɃɉȼɈɁɎȼɇɄ

ȞɃɁɈȼɉɁɉȼɋɌɊȽɄɄɏɋɊɎɌɁȽȼ
ȫȬȪȳȡȮȡȮȡȮȪȣȤȠȪȦȯȨȡȩȮȤȣȲȻȧȪȫȬȡȠȤȠȜȣȜȫȪȳȩȡȮȡȭȞȣȡȨȜȩȡȮȪȩȜȞȡȩȪȣȩȜȦȬȶȞȬȼȽɊɎɉɄɈȼɎɁɌɄȼɇɄɉɁɊȽɑɊɀɄɈɄɃȼȾɃɁɈȼɉɁɎɊɉȼɋɌɊȽɄ
1.

ȞɍɄɓɆɄɉɁɊȽɑɊɀɄɈɄɍɄɍɎɁɈɄɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ60RQRYHWWH®.

2.

ȪȽɁɃɊɋȼɍɁɉɄ ɆȼɉɚɇɄɄɇɄ ɊȽɁɃɊɋȼɍɁɉɄ 0XOWLĲ\®ɆȼɉɚɇɄ

3.

ȬɖɆȼȾɄɒɄɋɌɁɍɎɄɇɆȼɊɓɄɇȼɄɇɄɀɌɏȿɊɋɊɀɑɊɀɛɕɊɃȼɕɄɎɉɊɊȽɇɁɆɇɊɃȼɃȼɕɄɎȼɊɎɋȼɎɊȿɁɉɄɋɌɁɉɊɍɄɈɄɍɆɌɖȾɎȼɄɇɄɀɌɏȿɄɋɊɎɁɉɒɄȼɇɉɊɄɉɐɁɆɒɄɊɃɉɄɈȼɎɁɌɄȼɇɄ

4.

ȡɎɄɆɁɎɄɃȼɄɀɁɉɎɄɐɄɆȼɒɄɛɉȼɋȼɒɄɁɉɎȼ

5.

ȠɁɃɄɉɐɁɆɎȼɉɎɃȼɋɊɓɄɍɎȾȼɉɁɉȼɈɛɍɎɊɎɊɉȼȾɃɁɈȼɉɁɉȼɋɌɊȽȼ ɉȼɌɁɀȽɄɉȼɍɖɊɎȾɁɎɉɊɎɊɇɁɓɁȽɉɊɃȼȾɁɀɁɉɄɁɃȼɋɊɀȿɊɎȾɛɉɁɉȼɈɛɍɎɊɎɊɉȼȾɃɁɈȼɉɁɉȼɋɌɊȽɄɃȼɍɎɁɌɄɇɉɊȾɃɁɈȼɉɁɉȼɋɌɊȽɄ ȩɁɏɋɊɎɌɁȽɛȾȼɅɎɁɋɊɓɄɍɎȾȼɕɄɈȼɎɁɌɄȼɇɄɉȼȼɇɆɊɑɊɇɉȼɊɍɉɊȾȼȼɆɊɋɌɊȽɄɎɁɍȼɉɁɊȽɑɊɀɄɈɄɃȼɏɍɎȼɉɊȾɛȾȼɉɁɉȼȼɇɆɊɑɊɇȾɆɌɖȾɎȼ

6.

ȭɏɑɄɍɎɁɌɄɇɉɄɎȼɈɋɊɉɄɃȼɁɀɉɊɆɌȼɎɉȼɏɋɊɎɌɁȽȼ

7.

ȮɏɌɉɄɆɁɎ

8.

ȧɁɅɆɊɋɇȼɍɎɄɇɄɋɌɁȾɌɖɃɆȼ

9.

ȦɊɉɎɁɅɉɁɌɃȼɊɍɎɌɄɊɎɋȼɀɖɒɄɃȼȽɁɃɊɋȼɍɉɊɄɃɑȾɖɌɇɛɉɁɉȼɏɋɊɎɌɁȽɛȾȼɉɄɈȼɎɁɌɄȼɇɄ

ȫɌɁɋɊɌɖɓɄɎɁɇɁɉɌɁɀɋɌɄȾɃɁɈȼɉɁɉȼɋɌɊȽɄ
1.

ȰɇȼɆɊɉɄɍɆɌɖȾɉɄɆɏɇɎɏɌɄ

2.

ȡɋɌɏȾɁɎɆɄɎɁɍɒɄɎɌȼɎɄɇɄȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼ ȽɁɃɍȿɁɇɍɁɌɏɈ&$7ɍɁɌɏɈȿɁɇ&$7 

3.

ȡɋɌɏȾɁɎɆɄɍȼɆɎɄȾȼɎɊɌɉȼɆɊȼȿɏɇȼɒɄɛɎȼɄɇɄɒɄɎɌȼɎ

4.

ȡɋɌɏȾɁɎɆɄɍɑɁɋȼɌɄɉɍȽɁɃȿɁɇ

5.

ȡɋɌɏȾɁɎɆɄɍ('7$ɍȽɁɃȿɁɇ

6.

ȡɋɌɏȾɁɎɆɄɍȿɇɚɆɊɃɉɄɄɉɑɄȽɄɎɊɌɄ

7.

ȡɋɌɏȾɁɎɆɄɍɀɌɏȿɄɀɊȽȼȾɆɄ
ȣȜȝȡȧȡȢȦȜȜɆɊɃȼɋɊɓɉɁɎɁɍȾɃɁɈȼɉɁɎɊɉȼɋɌɊȽɄɍɒɄɎɌȼɎɉȼɄɇɄɀɌɏȿȼɁɋɌɏȾɁɎɆȼɍɎɁɓɁɉɋɌɁɋȼɌȼɎɆȼɎɊ3)$&7$'&3'$+&<&ɄɇɄ*OXFR(;$&7ɆɊɈȽɄɉɄɌȼɉɍɆȼɉɚɇȼɍɆɌɄɇɒȼ
ɉȼɋɌ ɊȽɁɃɊɋȼɍɁɉȼɎȼ 0XOWLĲ\®Ɇȼɉɚɇȼ ɍɁɋɌɁɋɊɌɖɓȾȼɋɌɁɀȾȼɌɄɎɁɇɉɊȾɃɁɈȼɉɁɉȼɋɌɊȽȼȾɋɌȼɃɉȼɁɋɌɏȾɁɎɆȼ ɉȼɋɌ60RQRYHWWH®ɉɁɏɎɌȼɇɉȼ= ɃȼɀȼɍɁɄɃȽɁȿɉɁ
ɉɁɀɊɍɎȼɎɖɓɉɊɄɃɋɖɇȾȼɉɁɉȼɁɋɌɏȾɁɎɆȼɎȼɋɊɌȼɀɄɉȼɋɖɇȾȼɉɁɎɊɉȼɎɌɖȽɄɓɆȼɎȼɉȼɆȼɉɚɇȼɎȼɍɆɌɄɇɒȼ
ȫɊɎɊɃɄɉȼɓɄɉɍɁȿȼɌȼɉɎɄɌȼɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁɉȼɁɋɌɏȾɁɎɆȼɎȼɍɒɄɎɌȼɎɄɍɖɊɎȾɁɎɉɊɋɌȼȾɄɇɉɊɍɖɊɎɉɊɔɁɉɄɁ ɈɁɂɀɏɒɄɎɌȼɎɄɆɌɖȾ ȣȜȝȡȧȡȢȦȜȪɎɉɊɍɉɊɌɁɀȼɉȼȾɃɁɈȼɉɁɉȼɋɌɊȽɄɍɇɁɀȾȼɅɎɁɉȼɌɁɀȽɄɎɁɉȼɍɖɊɎȾɁɎɉɊɎɊɇɁɓɁȽɉɊɃȼȾɁɀɁɉɄɁ

ȫɌɁɀɊɎȾɌȼɎɛȾȼɉɁɉȼɊȽɌȼɎɁɉɋɊɎɊɆ
ȫɊȾɁɓɁɎɊ6ɈɊɉɊȾɁɎɄɍɖɀɖɌɂȼɎɑɄɈɄɓɁɍɆɄɀɊȽȼȾɆɄȣȼɀȼɄɃȽɁȿɉɁɎɁɊȽɌȼɎɁɉɋɊɎɊɆɎɌɛȽȾȼɀȼɍɋȼɃȾȼɎɁɍɇɁɀɉɄɎɁɉȼɍɊɆɄ
1. ȤɃɋɊɇɃȾȼɅɎɁɍȼɈɊɈȼɎɁɌɄȼɇɄɋɊɍɊɓɁɉɄȾɏɆȼɃȼɉɄɛɎȼɃȼɏɋɊɎɌɁȽȼ
2.

ȫɊɇɊɂɁɎɁɋȼɒɄɁɉɎȼɎȼɆȼɓɁɀȼɊɍɄȿɏɌɄɎɁɇɁɍɁɉɀɊɍɎɖɋɀɊȾɁɉȼɎȼɄɉȼɍɊɓɁɎɁɌɖɆȼɎȼɄɇɄɀɌɏȿȼɎȼɊȽɇȼɍɎɉȼɋɏɉɆɒɄɛɉȼɋȼɒɄɁɉɎȼɉȼɀɊɇɏ

3.

ȠɌɖɂɎɁ60RQRYHWWH®ɍɆȼɋȼɓɆȼɎȼɉȼȾɄɉɎɉȼȿɊɌɁȼɆɊȿȼɎɊɄɃɋɊɇɃȾȼɎɁ ɊȽɁɃɊɋȼɍɁɉȼ 0XOWLĲ\®ɆȼɉɚɇȼɛɀɌɖɂɎɁɋɊɀɉɄȾɊɎɊɉȼɌɖɆȼɎȼɈɛɍɎɊɎɊɉȼɋɏɉɆɒɄɛɎȼ

4.

ȯȾɁɌɁɎɁɍɁɓɁɋɌɄȾɁɉɊɃɉȼɋɏɉɆɒɄɛɍɖɀɖɌɂȼɉɄɁɎɊɉȼ60RQRYHWWH®ɉɁɀɊɆɊɍȾȼɉɄɎɊɆȼɋȼɓɆȼɎȼɉȼȾɄɉɎɉɄɎɊɆɌȼɛɉȼɆȼɉɚɇȼɎȼ

5.

ȪɍȾɊȽɊɀɁɎɁɎɏɌɉɄɆɁɎȼɀɊɆȼɎɊɆɌɖȾɎȼɍɁȾɎɄɓȼȾ60RQRYHWWH®.

23

BG
ȣȼɈɌȼɃɛȾȼɉɁȬȼɃɈɌȼɃɛȾȼɉɁ
ȭɖȿɇȼɍɉɊɋɌɁɋɊɌɖɆɄɎɁɉȼȭȣȪ :+2',//DE5HY ɁɋɌɁɋɊɌɖɓɄɎɁɇɉɊɋɌɁɀɄɃȼɈɌȼɃɛȾȼɉɁɍɁɌɏɈɖɎɋɇȼɃɈȼɎȼɀȼɍɁɊɎɀɁɇɄɊɎɆɌɖȾɉɄɎɁɆɇɁɎɆɄ
ȭɋȼɃȾȼɅɎɁɍɇɁɀɉɄɎɁɋɌɁɋɊɌɖɆɄɃȼɃȼɈɌȼɃɛȾȼɉɁɉȼ60RQRYHWWH®:ȣȼɈɌȼɃɛȾȼɉɁɋɊɀƓ&•ȯɋɊɎɌɁȽȼɎȼɋɌɄɈɄɉɏɍɊȾɄɎɁɈɋɁɌȼɎɏɌɄɎɌɛȽȾȼɀȼȽɖɀɁɎɁɍɎȾȼɉȼɋɌɄɀɁɅɍɎȾɄɎɁɇɉɄɏɍɇɊȾɄɛɃȼɕɊɎɊɉȼɎɊȾȼɌȾȼɉɁɎɊȾɖɌɑɏɁɋɌɏȾɁɎɆɄɎɁɈɊɂɁɀȼȾȼɌɄɌȼɃɉȼɓɄɎɁɇɉɊȾɃȼȾɄɍɄɈɊɍɎɊɎɍɌɁɀȼɎȼɉȼ
ɃȼɈɌȼɃɛȾȼɉɁɄɌɏɎɄɉɉɄɎɁɏɍɇɊȾɄɛ ȞɄɂɎɁɌȼɃɀɁɇȼŚȭȾɊɅɍɎȾȼɉȼɈȼɎɁɌɄȼɇȼŗȾɆȼɎȼɇɊȿȼɉȼ6$567('7 •ȦȼɎɊɒɛɇɊɍɎɊɅɉɊɍɎɎȼɉȼɛɆɊɍɎɉȼɋɇȼɍɎɈȼɍɄɎɁɉȼɈȼɇɛȾȼɋɌɄɎɁɈɋɁɌȼɎɏɌɄɋɊɀƓ&ȮɊȾȼɁɋɌɄɓɄɉȼɎȼɋɌɄɉɒɄɋɉɊɀȼɍɁɄɃȽɛȿȾȼɎɈɁɑȼɉɄɓɉɄɎɁɉȼɎɊȾȼɌȾȼɉɄɛ

•ȤɃȽɁɌɁɎɁɏɍɇɊȾɄɛɎȼɉȼɃȼɈɌȼɃɛȾȼɉɁɎȼɆȼɓɁɍɖɀɖɌɂȼɉɄɁɎɊɉȼ60RQRYHWWH®ɀȼɃȼɈɌɖɃȾȼɌȼȾɉɊɈɁɌɉɊɌɁɍɋɁɆɎɄȾɉɊɊɎɀɊɇɏɉȼȿɊɌɁȯȾɁɌɁɎɁɍɁɓɁ60RQRYHWWH®ɄɈȼɀɊɍɎȼɎɖɓɉɊɈɛɍɎɊɉȼɍɎɊɅɆȼɎȼɄɇɄ
ȾɆȼɌɎɊɉɁɉȼɆɏɎɄɛɃȼɍɖɑɌȼɉɁɉɄɁɃȼɀȼɈɊɂɁɀȼɍɁɌȼɃɔɄɌɛȾȼȭɎɊɅɆɄɎɁɊɎɍɎɄɌɊɋɊɌɄɇɄɈɁɎȼɇɉɁɍȼɋɊɀɑɊɀɛɕɄɃȼɕɊɎɊɈɊȿȼɎɀȼɀɊȾɁɀȼɎɀɊɋɏɆɉȼɎɄɉɄɊɎɌȼɃɔɄɌɛȾȼɉɁ

ȣȼɈɌȼɃɛȾȼɉɁɀɊƓ&şȫɌɁɀɄɃȼɈɌȼɃɛȾȼɉɁɎɊɋɌɊȾɁɌɁɎɁ
•ȤɉɎɁɌɐɁɌɁɉɒɄɄȫɌɊȾɁɌɁɎɁɀȼɇɄɃȼɈɌȼɃɛȾȼɉɁɎɊɄɈȼɊɎɌɄɒȼɎɁɇɉɊȾɇɄɛɉɄɁȾɖɌɑɏɆɌɖȾɉȼɎȼɋɌɊȽȼɄɇɄȼɉȼɇɄɃȼ ɉȼɋɌɑɁɈɊɇɄɃȼɍɎȼȽɄɇɉɊɍɎɉȼȼɉȼɇɄɎɄɎɁ •ȲɁɉɎɌɊɐɏȿɄɌȼɉɁȩɁɊȽɑɊɀɄɈɊȾɃȼȾɄɍɄɈɊɍɎɊɎɋɇȼɉɄɌȼɉɄɛȼɉȼɇɄɃȯɍɇɊȾɄɛɃȼɒɁɉɎɌɊɐɏȿɄɌȼɉɁȾɄɂɎɁŚȲɁɉɎɌɊɐɏȿɄɌȼɉɁŗȾɀɊɆɏɈɁɉɎȼɌɁɍɋɁɆɎɄȾɉɊɆɊɉɍɏɇɎɄɌȼɅɎɁɏɁȽɍȼɅɎȼɉȼ6$567('7https://www.sarstedt.com/en/service/centrifugation/ɄɉȼɋɌȼȾɁɎɁȾɄɃɏȼɇɉȼɋɌɊȾɁɌɆȼ

•ȱɁɈɊɇɄɃȼȦɌɖȾɎȼɑɁɈɊɇɄɃɄɌȼɋɌɄɃȼɈɌȼɃɛȾȼɉɁȣȼɀȼɄɃȽɁȿɉɁɎɁɎɊɃɄɁɐɁɆɎɄɃɋɊɇɃȾȼɅɎɁ60RQRYHWWH®ɍȿɁɇɌɁɍɋɁɆɎɄȾɉɊ6HUDSODV®ɍɆɇȼɋȼɉɁɉɐɄɇɎɖɌɍɇɁɀɒɁɉɎɌɊɐɏȿɄɌȼɉɁɄɇɄɊɎɋɄɋɁɎɄɌȼɅɎɁ
ɋɌɊȽȼɎȼȾɖȾȾɎɊɌɄɓɁɉɆɊɉɎɁɅɉɁɌ

ȣȼɈɌȼɃɛȾȼɉɁɀɊƓ&şȤɃɋɖɇɉɁɉɄɁ
•ȪɑɇȼɂɀȼɉɁȪɍɎȼȾɁɎɁ60RQRYHWWH®ȾɄɃɋɌȼȾɁɉɊɋɊɇɊɂɁɉɄɁɋɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼɃȼɋɁɌɄɊɀɊɎɈɄɉɀȼɍɁɊɑɇȼɀɄɀɊƓ&ɋɌɁɀɄɀȼɛɃȼɈɌȼɃɄɎɁɀɊƓ&•ȬȼɃɈɌȼɃɛȾȼɉɁȪɍɎȼȾɁɎɁɀȼɍɁɌȼɃɈɌȼɃɛȾȼɃȼɈɄɉɄɈɏɈɈɄɉɏɎɄɋɌɄɍɎȼɅɉȼɎɁɈɋɁɌȼɎɏɌȼȾɄɃɋɌȼȾɁɉɊɋɊɇɊɂɁɉɄɁȤɎɏɆɄɃȽɛȿȾȼɅɎɁɈɁɑȼɉɄɓɉɄɉȼɎɊȾȼɌȾȼɉɄɛȫɌɁɆȼɇɁɉɊȽɖɌɃɊɎɊɌȼɃɈɌȼɃɛȾȼɉɁɈɊɂɁ
ɀȼɋɊȾɇɄɛɁɉȼɌɁɃɏɇɎȼɎɄɎɁɊɎȼɉȼɇɄɃȼ

ȣȼɈɌȼɃɛȾȼɉɁɄɀɖɇȽɊɆɊɃȼɈɌȼɃɛȾȼɉɁɋɊɀƓ&•ȫɌɊɄɃȾɊɀɄɎɁɇɛɎɉɁɁȾȼɇɄɀɄɌȼɇɀɖɇȽɊɆɊɃȼɈɌȼɃɛȾȼɉɁɋɊɀƓ&ȫɊɌȼɀɄȾɄɍɊɆɄɛȽɌɊɅȾɖɃɈɊɂɉɄɐȼɆɎɊɌɄɆɊɄɎɊȽɄɑȼɈɊȿɇɄɀȼɋɊȾɇɄɛɛɎɁɋɌɁɋɊɌɖɓɄɎɁɇɉɊɎɁɍɎɊȾɁɎɁɉȼɃȼɈɌȼɃɛȾȼɉɁɀȼɍɁ
ɋɌɊȾɁɂɀȼɎɋɌɄɌɏɎɄɉɉɄɇȼȽɊɌȼɎɊɌɉɄɏɍɇɊȾɄɛ

ȣȼɈɌȼɃɛȾȼɉɁɉȼ60RQRYHWWH®ɍȿɁɇ
•ȣȼɈɌȼɃɛȾȼɉɁɎɊɋɌɊɎɄɓȼɆȼɆɎɊɁɊɋɄɍȼɉɊȾɎɊɓɆȼŚȣȼɈɌȼɃɛȾȼɉɁɀɊƓ&şȤɃɋɖɇɉɁɉɄɁŗ•ȤɃȾɁɍɎɉɊɁɓɁɁȾɖɃɈɊɂɉɊɍɇɊɛɎȿɁɇɀȼɍɁɋɌɊɈɁɉɄɋɌɄɋɌɊɒɁɍȼɉȼɃȼɈɌȼɃɛȾȼɉɁ

•ȫɊɌȼɀɄȾɄɍɊɆɄɛȽɌɊɅȾɖɃɈɊɂɉɄɐȼɆɎɊɌɄɆɊɄɎɊȽɄɑȼɈɊȿɇɄɀȼɋɊȾɇɄɛɛɎɁɋɌɁɋɊɌɖɓɄɎɁɇɉɊɎɁɍɎɊȾɁɎɁɉȼɃȼɈɌȼɃɛȾȼɉɁɀȼɍɁɋɌɊȾɁɂɀȼɎɋɌɄɌɏɎɄɉɉɄɇȼȽɊɌȼɎɊɌɉɄɏɍɇɊȾɄɛ

•ȬȼɃɈɌȼɃɛȾȼɉɁȪɍɎȼȾɁɎɁɋɌɊȽȼɎȼɀȼɍɁɌȼɃɈɌȼɃɛȾȼȾɄɃɋɌȼȾɁɉɊɋɊɇɊɂɁɉɄɁȭɇɁɀɌȼɃɈɌȼɃɛȾȼɉɁɋɌɁɑȾɖɌɇɁɎɁɈȼɎɁɌɄȼɇȼɃȼɋɌɊȽȼɊɎɄɃɑɊɀɉɄɛɆɊɉɎɁɅɉɁɌȾɖȾȾɎɊɌɄɓɁɉɆɊɉɎɁɅɉɁɌɓɌɁɃɊɎɋɄɋɁɎɄɌȼɉɁ
ɉɁɀɁɆȼɉɎɄɌȼɉɁ ɀɊɊɆɊɇɊbPPɉȼɀȿɁɇɊȾɄɛɍɇɊɅȤɃɑȾɖɌɇɁɎɁɊɍɎȼɎɖɆȼ
ȣȜȝȡȧȡȢȦȜȦɊɉɍɏɇɎɄɌȼɅɎɁɍɁɍɄɉɍɎɌɏɆɒɄɄɎɁɃȼɏɋɊɎɌɁȽȼɉȼɋɌɊɄɃȾɊɀɄɎɁɇɛɉȼɎɁɍɎɊȾɄɌɁȼȿɁɉɎɄɏɌɁɀȼɃȼȼɉȼɇɄɃɊɎɉɊɍɉɊɍɎȼȽɄɇɉɊɍɎɎȼɉȼȼɉȼɇɄɎɄɎɁ

24

BG
ȞɃɁɈȼɉɁɉȼɆɌɖȾ
ȨɁɎɊɀɄɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ
ȬȼɃɇɄɓȼȾȼɎɍɁɀȾȼɈɁɎɊɀȼɉȼȾɃɁɈȼɉɁɉȼɆɌɖȾȼɍɋɄɌȼɎɊɌɁɉɄȾȼɆɏɏɈɁɉɈɁɎɊɀ
ȜɍɋɄɌȼɎɊɌɉɄɛɎɈɁɎɊɀɋɊɃȾɊɇɛȾȼɆɊɉɎɌɊɇɄɌȼɉɊɎɊɄɃɎɁȿɇɛɉɁɉȼȽɏɎȼɇɊɎɊɄɕȼɀɛɕɊȾɃɁɈȼɉɁɉȼɆɌɖȾɋɌɄɉɁɋɌɁɆɖɍɉȼɎȽȼȾɁɉɆɌɖȾɊɎɊɆȫɊɎɊɃɄɉȼɓɄɉɁȾɖɃɈɊɂɉɊɆɌɖȾɊɎɊɆɖɎɀȼɍɁȼɀȼɋɎɄɌȼɆɖɈȾɍɄɓɆɄ
ȾɄɀɊȾɁȾɁɉɄɄɏɍɇɊȾɄɛɄɀȼɉȼɈȼɇɄɑɁɈɊɇɄɃȼɎȼ
ȞȼɆɏɏɈɉɄɛɎɈɁɎɊɀɋɊɃȾɊɇɛȾȼȾɃɁɈȼɉɁɉȼɆɌɖȾɍɉɁɋɌɁɆɖɍɉȼɎȽɖɌɃɆɌɖȾɊɎɊɆɍɋɊɈɊɕɎȼɉȼɋɌɁɀȾȼɌɄɎɁɇɉɊɁȾȼɆɏɄɌȼɉȼɁɋɌɏȾɁɎɆȼɉȼɋɌɄɉɒɄɋȼɉȼɊɎɌɄɒȼɎɁɇɉɊɎɊɉȼɇɛȿȼɉɁȫɊɌȼɀɄɎȼɃɄɋɌɄɓɄɉȼɎɊɃɄɈɁɎɊɀ
ɁɄɀɁȼɇɁɉɃȼɀɊȽɌɄȾɁɉɄɄɊɋɌɊɍɎɁɉɄɏɍɇɊȾɄɛɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾ
ȯɋɊɎɌɁȽȼɍɒɁɇȾɃɁɈȼɉɁɉȼɆɌɖȾȾɄɂɎɁɍɖɕɊɎȼɆȼȾɄɀɁɊɎɊɉȼɎɁɈȼɏɋɊɎɌɁȽȼɉȼ60RQRYHWWH®ɋɌɄɋɌɄɇȼȿȼɉɁɉȼȼɍɋɄɌȼɎɊɌɉɄɛɌɁɍɋɁɆɎɄȾɉɊȾȼɆɏɏɈɉɄɛɈɁɎɊɀɍɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɌɁɍɋɁɆɎɄȾɉɊ
ɊȽɁɃɊɋȼɍɁɉȼɎȼ0XOWLIO\®Ɇȼɉɚɇȼ
www.sarstedt.com/en/download/videos/Diagnostics/Venous bloodȩȪȭȡȮȡȬȶȦȜȞȤȲȤȣȜȠȜȩȜȨȜȧȤȮȡȬȤȭȦȜȪȮȤȣȧȜȟȜȩȡȩȜȫȜȮȪȟȡȩȤȫȪȞȬȡȨȡȩȜȞȣȡȨȜȩȡȩȜȦȬȶȞ
1. ȤɃȽɁɌɁɎɁɋɊɀɑɊɀɛɕȼ60RQRYHWWH®ɃȼɍɖɊɎȾɁɎɉȼɎȼɋɌɊȽȼ
2.

ȤɃȽɁɌɁɎɁɈɛɍɎɊɎɊɉȼȾɁɉɊɃɉȼɎȼɋɏɉɆɒɄɛȭɋȼɃȾȼɅɎɁɉȼɌɁɀȽɄɎɁɉȼɍɖɊɎȾɁɎɉɊɎɊɇɁɓɁȽɉɊɃȼȾɁɀɁɉɄɁɋɌɄɋɊɀȿɊɎɊȾɆȼɉȼɈɛɍɎɊɎɊɃȼȾɁɉɊɃɉȼɋɏɉɆɒɄɛ

ȞɃɁɈȼɉɁɉȼɆɌɖȾɍȼɍɋɄɌȼɎɊɌɉɄɛɈɁɎɊɀ
ȞɉɄɈȼɉɄɁȤɃɋɊɇɃȾȼɅɎɁ60RQRYHWWH®ɍȼɈɊɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾɉɊɉɁɄɃȼɋɊɍɎȼȾɛɉɁɉȼɄɉɂɁɆɒɄɄ
ȤɃɋɊɇɃȾȼɅɎɁɍȼɈɊɍɖɍɍɇɁɀɉɄɎɁɆȼɉɚɇɄ 60RQRYHWWH® ɊȽɁɃɊɋȼɍɁɉɄ ɆȼɉɚɇɄɄɇɄ ɊȽɁɃɊɋȼɍɁɉɄ 0XOWLIO\®ɆȼɉɚɇɄȼɀȼɋɎɁɌɃȼ60RQRYHWWH®).
ȮɏɆɁɋɊɆȼɃȼɉɊɋɌɄɇɊɂɁɉɄɁɍɊȽɁɃɊɋȼɍɁɉȼɆȼɉɚɇȼ

ɆɇɄɆȞɖȾɁɀɁɎɁ60RQRYHWWH®ȾɖȾȾȿɌȼɀɁɉɄɛɀɖɌɂȼɓɉȼɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɉɁɋɊɍɌɁɀɍɎȾɁɉɊɋɌɁɀɄȾɁɉɊɃɉȼɎȼɋɏɉɆɒɄɛ ɄɛɐɄɆɍɄɌȼɅɎɁɍɇɁɆɊɃȼȾɖɌɎȼɉɁɋɊɋɊɍɊɆȼɉȼɓȼɍɊȾɉɄɆɊȾȼɎȼɍɎɌɁɇɆȼ
.
ȫɌɄɉɁɊȽɑɊɀɄɈɊɍɎɋɊɍɎȼȾɁɎɁɎɏɌɉɄɆɁɎ ɈȼɆɍɈɄɉɏɎȼ ȫɊɓɄɍɎɁɎɁɈɛɍɎɊɎɊɉȼɋɏɉɆɒɄɛɍɋɊɀɑɊɀɛɕɀɁɃɄɉɐɁɆɎȼɉɎȩɁɀɊɆɊɍȾȼɅɎɁɈɛɍɎɊɎɊɉȼɋɏɉɆɒɄɛɍɇɁɀɀɁɃɄɉɐɁɆɒɄɛȫɊɇɊɂɁɎɁ
ɋȼɒɄɁɉɎȼɎȼɆȼɓɁɀȼɊɍɄȿɏɌɄɎɁɇɁɍɁɉɀɊɍɎɖɋɀɊȾɁɉȼɎȼɄɉȼɍɊɓɁɎɁɌɖɆȼɎȼɄɇɄɀɌɏȿȼɎȼɊȽɇȼɍɎɉȼɋɏɉɆɒɄɛɉȼɋȼɒɄɁɉɎȼɉȼɀɊɇɏ
ȪɎɍɎɌȼɉɁɎɁɋɌɁɀɋȼɃɄɎɁɇɛɉȼɄȿɇȼɎȼȫɏɉɆɎɄɌȼɅɎɁȾɁɉȼɎȼɇɁɆɊɄɃɀɖɌɋȼɅɎɁȽɏɎȼɇɊɎɊɉȼɃȼɀɄɊɍȾɊȽɊɀɁɎɁɎɏɌɉɄɆɁɎȼɀɊɆȼɎɊɆɌɖȾɎȼɍɁȾɎɄɓȼȾ60RQRYHWWH® .
ȤɃɓȼɆȼɅɎɁɆɌɖȾɊɎɊɆȼɀȼɍɋɌɁɃȼɀȼɊɍɄȿɏɌɄɎɁɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁ

ȬȼɃɀȾɄɂɁɎɁ60RQRYHWWH®ɍɇɁɆɊɃȼȾɖɌɎȼɉɁɍɌɁɕɏɓȼɍɊȾɉɄɆɊȾȼɎȼɍɎɌɁɇɆȼ ɄɍɇɁɀɎɊȾȼɛɄɃȾȼɀɁɎɁɊɎɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼ ɊɎɆȼɓȼɉɁ  ȪȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɊɍɎȼȾȼȾɖȾȾɁɉȼɎȼ
ȫɌɄɈɉɊȿɊɆɌȼɎɉɊȾɃɁɈȼɉɁɉȼɆɌɖȾɆȼɆɎɊɁɊɋɄɍȼɉɊɋɊȿɊɌɁɍȾɖɌɂɁɎɁɍɇɁɀȾȼɕɄɎɁ6ɈɊɉɊȾɁɎɄɍɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɄȾɃɁɈɁɎɁɀɊɋɖɇɉɄɎɁɇɉɄɋɌɊȽɄ
ȫɌɁɆɌȼɎɛȾȼɉɁɉȼȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾȫɖɌȾɊɊɎɆȼɓɁɎɁ60RQRYHWWH®
+ ɍɇɁɀɎɊȾȼɄɃɎɁȿɇɁɎɁɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɊɎȾɁɉȼɎȼȜɆɎɄȾɄɌȼɅɎɁɋɌɁɀɋȼɃɉɄɛɈɁɑȼɉɄɃɖɈɉȼɄȿɇȼɎȼɍɁɀɉȼɌɖɆȼȾɖɌɑɏ
ɍɎȼȽɄɇɉȼɋɇɊɍɆȼɋɊȾɖɌɑɉɊɍɎɀɊɆȼɎɊɆȼɉɚɇȼɎȼɍɁɐɄɆɍɄɌȼȾɋɌɁɀɋȼɃɄɎɁɇɛ ȼɆɎɄȾȼɒɄɛ ɍɊɍɁɃȼɁɈɊɄɛɍɉɊɀɊɇɊȾɄɈɊŚɕɌȼɆȾȼɉɁŗɄɇɄɆȼɎɊɉȼɎɄɍɉɁɎɁɄȼɆɎɄȾɄɌȼɎɁɍɋɊɆȼɃȼɇɁɒɀɊɇɉɄɛɆɌȼɅɉȼ
ɋɌɁɀɋȼɃɄɎɁɇɛɉȼɄȿɇȼɎȼȞɄɂɎɁɄɄɉɍɎɌɏɆɒɄɄɎɁɃȼɏɋɊɎɌɁȽȼɉȼ60RQRYHWWH® ɊȽɁɃɊɋȼɍɁɉɄ ɆȼɉɚɇɄɄɇɄ ɊȽɁɃɊɋȼɍɁɉɄ 0XOWLIO\®ɆȼɉɚɇɄ
ȞɁɀɉȼȿȼɍɇɁɀɆȼɎɊɊɎɀɁɇɄɎɁȾɍɛɆȼ60RQRYHWWH®ɊɎɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɛɊȽɖɌɉɁɎɁȾɁɀɉɖɂɍɀɖɉɊɎɊɉȼȿɊɌɁȼɍɇɁɀɆȼɎɊɋɌɄɆɇɚɓɄɎɁɉȼɋɖɇɉɊɍȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾȾɉɄɈȼɎɁɇɉɊɊȽɖɌɉɁɎɁ
ȾɍɄɓɆɄɋɌɊȽɄɍȼɉɎɄɆɊȼȿɏɇȼɎɄɉɛɆɊɇɆɊɋɖɎɄɍɀɖɉɊɎɊɉȼȿɊɌɁ
ȫɌɄɎɌȼɉɍɋɊɌɎɄɒɁɉɎɌɊɐɏȿɄɌȼɉɁɄɃɀɖɌɋȼɅɎɁȽɏɎȼɇɊɎɊɀɊɆȼɎɊɏɍɁɎɄɎɁɄɓɏɁɎɁɐɄɆɍɄɌȼɉɁ  ɆɌȼɛɎɉȼȽɏɎȼɇɊɎɊɍɁɐɄɆɍɄɌȼɉȼɀɖɉɊɎɊɉȼ60RQRYHWWH® Ʉ ɊɎɓɏɋɁɎɁɀɖɇȿȼɎȼɓȼɍɎ
1.

ȫɌɄɎɄɍɉɁɎɁɈɛɍɎɊɎɊɉȼɋɏɉɆɒɄɛɎȼɍɖɍɍɏɑɍɎɁɌɄɇɁɉɎȼɈɋɊɉɀɊɆȼɎɊɆɖɌȾɁɉɁɎɊɍɋɌɁ

2.

ȭɇɁɀɆȼɎɊɃȼɋɊɓɉɁɆɊȼȿɏɇȼɒɄɛɎȼɉȼɋɌȼȾɁɎɁɋɌɁȾɌɖɃɆȼȼɆɊɁɉɁɊȽɑɊɀɄɈɊ

3.

ȤɃɑȾɖɌɇɁɎɁɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼȾɋɊɀɑɊɀɛɕɆɊɉɎɁɅɉɁɌɃȼɊɋȼɍɉɄȽɄɊɇɊȿɄɓɉɄɊɎɋȼɀɖɒɄ

25

BG
ȞɃɁɈȼɉɁɉȼɆɌɖȾɍȾȼɆɏɏɈɉɄɛɈɁɎɊɀ
ȞɉɄɈȼɉɄɁȤɃɋɊɇɃȾȼɅɎɁ60RQRYHWWH®ɍȼɈɊɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾɉɊɉɁɄɃȼɋɊɍɎȼȾɛɉɁɉȼɄɉɂɁɆɒɄɄ
ȤɃɋɊɇɃȾȼɅɎɁɍȼɈɊɍɖɍɍɇɁɀɉɄɎɁɆȼɉɚɇɄ 60RQRYHWWH® ɊȽɁɃɊɋȼɍɁɉɄ ɆȼɉɚɇɄɄɇɄ ɊȽɁɃɊɋȼɍɁɉɄ 0XOWLIO\®ɆȼɉɚɇɄȼɀȼɋɎɁɌɃȼ60RQRYHWWH®).
ȮɏɆɁɋɊɆȼɃȼɉɊɋɌɄɇɊɂɁɉɄɁɍɊȽɁɃɊɋȼɍɁɉȼɆȼɉɚɇȼ

ɆɇɄɆȣȼɕȼɀɛɕɊȾɃɁɈȼɉɁɉȼɆɌɖȾ6$567('7ɋɌɁɋɊɌɖɓȾȼɀȼɃȼɋɊɓɉɁɎɁɍȼɍɋɄɌȼɎɊɌɉɄɛɈɁɎɊɀɍɋɖɌȾȼɎȼ60RQRYHWWH®ȾɄɂɎɁȨȡȮȪȠ$ȣȜȞȡȩȪȣȩȜȫȯȩȦȲȤȻȜɍɋɄɌȼɎɊɌɁɉɈɁɎɊɀ
ȭɇɁɀɎɊȾȼɋɌɊɀɖɇɂɁɎɁɄɃɋɊɇɃȾȼɅɆɄȾȼɆɏɏɈɉɄɛɈɁɎɊɀ
ȫɌɁɀɄȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾɄɃɀɖɌɋȼɅɎɁȽɏɎȼɇɊɎɊɀɊɀɖɉɊɎɊɉȼ60RQRYHWWH®ɀɊɆȼɎɊɏɍɁɎɄɎɁɄɓɏɁɎɁ ɐɄɆɍɄɌȼɉɁȭɇɁɀɎɊȾȼɊɎɓɏɋɁɎɁɀɖɇȿȼɎȼɓȼɍɎɉȼȽɏɎȼɇɊɎɊ .
ȞɖȾɁɀɁɎɁɋɊɀȿɊɎȾɁɉȼɎȼ60RQRYHWWH®ȾɖȾȾȿɌȼɀɁɉɄɛɀɖɌɂȼɓɉȼ60RQRYHWWH®ɊȽɁɃɊɋȼɍɁɉȼɆȼɉɚɇȼɄɛɐɄɆɍɄɌȼɅɎɁɍɇɁɆɊɃȼȾɖɌɎȼɉɁɋɊɋɊɍɊɆȼɉȼɓȼɍɊȾɉɄɆɊȾȼɎȼɍɎɌɁɇɆȼ

–

+

.

.

ȤɃɓȼɆȼɅɎɁɆɌɖȾɊɎɊɆɖɎɀȼɍɋɌɁɃȼɀȼɊɍɄȿɏɌɄɎɁɋɌȼȾɄɇɉɊɉȼɋɖɇȾȼɉɁ

ȬȼɃɀȾɄɂɁɎɁ60RQRYHWWH®ɍɇɁɆɊɃȼȾɖɌɎȼɉɁɍɌɁɕɏɓȼɍɊȾɉɄɆɊȾȼɎȼɍɎɌɁɇɆȼ ɄɍɇɁɀɎɊȾȼɛɄɃȾȼɀɁɎɁɊɎɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼ ɊɎɆȼɓȼɉɁ  ȪȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɊɍɎȼȾȼȾɖȾȾɁɉȼɎȼ
ȫɌɄɈɉɊȿɊɆɌȼɎɉɊȾɃɁɈȼɉɁɉȼɆɌɖȾɆȼɆɎɊɁɊɋɄɍȼɉɊɋɊȿɊɌɁɋɖɌȾɊɍȾɖɌɂɁɎɁɍɇɁɀȾȼɕȼɎȼ60RQRYHWWHQɍɖɍɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɄȾɃɁɈɁɎɁɀɊɋɖɇɉɄɎɁɇɉɄɋɌɊȽɄ
ȫɌɁɆɌȼɎɛȾȼɉɁɉȼȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾ
ȪɎɆȼɓɁɎɁ60RQRYHWWH®
+ ɍɇɁɀɎɊȾȼɄɃɎɁȿɇɁɎɁɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɊɎȾɁɉȼɎȼȜɆɎɄȾɄɌȼɅɎɁɋɌɁɀɋȼɃɉɄɛɈɁɑȼɉɄɃɖɈɉȼɄȿɇȼɎȼɍɁɀɉȼɌɖɆȼȾɖɌɑɏɍɎȼȽɄɇɉȼɋɇɊɍɆȼɋɊȾɖɌɑɉɊɍɎɀɊɆȼɎɊ
ɆȼɉɚɇȼɎȼɍɁɐɄɆɍɄɌȼȾɋɌɁɀɋȼɃɄɎɁɇɛ ɍɁȼɆɎɄȾɄɌȼ ɍɊɍɁɃȼɁɈɊɄɛɍɉɊɀɊɇɊȾɄɈɊŚɕɌȼɆȾȼɉɁŗɄɇɄȼɆɎɄȾɄɌȼɅɎɁɋɌɁɀɋȼɃɄɎɁɇɛɉȼɄȿɇȼɎȼɆȼɎɊɉȼɎɄɍɉɁɎɁɍɋɊɆȼɃȼɇɁɒɀɊɇɉɄɛɈɏɆɌȼɅ
ȞɁɀɉȼȿȼɍɇɁɀɆȼɎɊɊɎɀɁɇɄɎɁȾɍɛɆȼ60RQRYHWWH®ɊɎɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼɛɊȽɖɌɉɁɎɁȾɁɀɉɖɂɍɀɖɉɊɎɊɉȼȿɊɌɁȼɍɇɁɀɆȼɎɊɋɌɄɆɇɚɓɄɎɁɉȼɋɖɇɉɊɍȾɃɁɈȼɉɁɎɊɉȼɆɌɖȾȾɉɄɈȼɎɁɇɉɊɊȽɖɌɉɁɎɁ
ȾɍɄɓɆɄɋɌɊȽɄɍȼɉɎɄɆɊȼȿɏɇȼɎɄɉɛɆɊɇɆɊɋɖɎɄɍɀɖɉɊɎɊɉȼȿɊɌɁ
1.

ȫɌɄɎɄɍɉɁɎɁɈɛɍɎɊɎɊɉȼɋɏɉɆɒɄɛɎȼɍɖɍɍɏɑɍɎɁɌɄɇɁɉɎȼɈɋɊɉɀɊɆȼɎɊɆɖɌȾɁɉɁɎɊɍɋɌɁ

2.

ȭɇɁɀɆȼɎɊɃȼɋɊɓɉɁɆɊȼȿɏɇȼɒɄɛɎȼɉȼɋɌȼȾɁɎɁɋɌɁȾɌɖɃɆȼȼɆɊɁɉɁɊȽɑɊɀɄɈɊ

3.

ȤɃɑȾɖɌɇɁɎɁɊȽɁɃɊɋȼɍɁɉȼɎȼɆȼɉɚɇȼȾɋɊɀɑɊɀɛɕɆɊɉɎɁɅɉɁɌɃȼɊɋȼɍɉɄȽɄɊɇɊȿɄɓɉɄɊɎɋȼɀɖɒɄ

26

BG
ȲɁɉɎɌɊɐɏȿɄɌȼɉɁ
ȞȩȤȨȜȩȤȡ6$567('76ɈɊɉɊȾɁɎɄɎɁɍȼɋɌɁɀȾɄɀɁɉɄɃȼ[JȤɃɆɇɚɓɁɉɄɁɋɌȼȾɛɎ6ɈɊɉɊȾɁɎɄɎɁɍ¢PP 60RQRYHWWH®ɋɁɀɄȼɎɌɄɛ ɆɊɄɎɊɋɊɉȼɍɎɊɛɕɁɈɍȼȾȼɇɄɀɄɌȼɉɄɃȼɑJȤɃɋɊɇɃȾȼɅɎɁɍȼɈɊ
ɋɊɀɑɊɀɛɕɄɁɋɌɏȾɁɎɆɄɄɄɇɄɉȼɆɌȼɅɉɄɒɄȲɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊɉȼ6ɈɊɉɊȾɁɎɄɍɋɏɆɉȼɎɄɉɄɌɁɍɋɁɆɎɄȾɉɊɒɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊɋɌɄɋɌɁɆȼɇɁɉɊȾɄɍɊɆɊɒɁɉɎɌɊɐɏȿȼɇɉɊɏɍɆɊɌɁɉɄɁɈɊɂɁɀȼɀɊȾɁɀɁɀɊɍɓɏɋȾȼɉɁɉȼ
6ɈɊɉɊȾɁɎɄɎɁɋɌɄɆɊɁɎɊɁȾɖɃɈɊɂɉɊɊɎɀɁɇɛɉɁɉȼɋɊɎɁɉɒɄȼɇɉɊɄɉɐɁɆɒɄɊɃɉɄɈȼɎɁɌɄȼɇɄ
ȲɁɉɎɌɊɐɏȿȼɇɉɄɎɁɉȼɆɌȼɅɉɄɒɄɎɌɛȽȾȼɀȼɍɁɄɃȽɄɌȼɎɍɋɊɌɁɀɌȼɃɈɁɌȼɉȼ6ɈɊɉɊȾɁɎɄɎɁȪɎɉɊɍɄɎɁɇɉɊɎɊɒɁɉɎɌɊɐɏȿȼɇɉɊɏɍɆɊɌɁɉɄɁɁȾɍɇɁɀɉȼɎȼɃȼȾɄɍɄɈɊɍɎɊɎɃȼɀȼɀɁɉɄɎɁɊȽɊɌɊɎɄɈɄɉ
RCF = 11,2 x r x (RPM/1000)2,
5&)ŚȪɎɉɊɍɄɎɁɇɉɊɒɁɉɎɌɊɐɏȿȼɇɉɊɏɍɆɊɌɁɉɄɁŗɄɇɄJɍɄɇȼ ɉȼȼɉȿɇɄɅɍɆɄ5&)ɄɇɄŚUHODWLYHFHQWULIXJDOIRUFHŘ 
Ś530ŗŚȪȽɊɌɊɎɄȾɈɄɉɏɎȼŗ ɊɈɄɉ ɄɇɄQ ŚȪȽɊɌɊɎɄȾɈɄɉɏɎȼŗ ɉȼȼɉȿɇɄɅɍɆɄ530ɄɇɄŚUHYROXWLRQVSHUPLQXWHŗ ŚUŗŚȬȼɀɄɏɍɉȼɒɁɉɎɌɊɐɏȿȼɎȼɊɎɒɁɉɎɖɌȼɉȼɒɁɉɎɌɊɐɏȿȼɎȼɀɊɀɖɉɊɎɊɉȼ60RQRYHWWH®“, (cm).
6ɈɊɉɊȾɁɎɄɎɁȽɁɃȿɁɇɈɊȿȼɎɀȼɍɁɒɁɉɎɌɊɐɏȿɄɌȼɎɍɌɊɎɊɌɍɐɄɆɍɄɌȼɉɄɇɄɋɌɊɈɁɉɛɕɍɁɖȿɖɇɉȼȾɖɌɎɁɉɁ
6ɈɊɉɊȾɁɎɄɎɁɍȿɁɇɍȼɌȼɃɌȼȽɊɎɁɉɄɍȼɈɊɃȼɒɁɉɎɌɊɐɏȿɄɍɋɌɊɈɁɉɛɕɍɁɖȿɖɇɉȼȾɖɌɎɁɉɁȲɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊȾɒɁɉɎɌɊɐɏȿɄɍɐɄɆɍɄɌȼɉɖȿɖɇɉȼȾɖɌɎɁɉɁɉɁɁȾȼɇɄɀɄɌȼɉɊɊɎ6$567('7ɄɉɁɁ
ɋɌɁɋɊɌɖɓɄɎɁɇɉɊ
6ɈɊɉɊȾɁɎɄɎɁɎɌɛȽȾȼɀȼɍɁɒɁɉɎɌɊɐɏȿɄɌȼɎɍɖȿɇȼɍɉɊɏɍɇɊȾɄɛɎȼɃȼɒɁɉɎɌɊɐɏȿɄɌȼɉɁɋɌɁɀɍɎȼȾɁɉɄɋɊɀɊɇɏȜɆɊɍɁɋɌɄɇȼȿȼɎɀɌɏȿɄɏɍɇɊȾɄɛɎɁɎɌɛȽȾȼɀȼȽɖɀȼɎȾȼɇɄɀɄɌȼɉɄɊɎɍȼɈɄɛɋɊɎɌɁȽɄɎɁɇ
ȯȾɁɌɁɎɁɍɁɓɁ6ɈɊɉɊȾɁɎɄɎɁɍȼɋɊɍɎȼȾɁɉɄɋɌȼȾɄɇɉɊȾɍɎɊɅɆɄɎɁɉȼɒɁɉɎɌɊɐɏȿɄɎɁ6ɈɊɉɊȾɁɎɄɆɊɄɎɊɉȼɀɍɎɖɌɓȼɎȽɄɑȼɈɊȿɇɄɀȼɃȼɆȼɓȼɎɊɍɉɊȾȼɎȼɉȼɒɁɉɎɌɊɐɏȿȼɎȼɄɀȼɍɁɍɓɏɋɛɎȯȾɁɌɁɎɁɍɁɓɁ
ɒɁɉɎɌɊɐɏȿȼɎȼɁɉȼɋɖɇɉɁɉȼɌȼȾɉɊɈɁɌɉɊȣȼɎȼɃɄɒɁɇɈɊɇɛɍɋȼɃȾȼɅɎɁɏɆȼɃȼɉɄɛɎȼɃȼɏɋɊɎɌɁȽȼɉȼɒɁɉɎɌɊɐɏȿȼɎȼ
ȞȩȤȨȜȩȤȡ ȩɁ ɊɎɍɎɌȼɉɛȾȼɅɎɁ ɍɓɏɋɁɉɄɎɁ 6ɈɊɉɊȾɁɎɄ ɍ ȿɊɇɄ ɌɖɒɁ
ȩȼɍɊɆɄ Ƀȼ ɀɁɃɄɉɐɁɆɒɄɛ ɉȼ ɒɁɉɎɌɊɐɏȿȼɎȼ ɕɁ ɉȼɈɁɌɄɎɁ Ⱦ ɏɆȼɃȼɉɄɛɎȼ Ƀȼ ɏɋɊɎɌɁȽȼ ɉȼ ɒɁɉɎɌɊɐɏȿȼɎȼ

ȪɎɉɊɍɄɎɁɇɉɊɒɁɉɎɌɊȽɁɂɉɊɏɍɆɊɌɁɉɄɁ J

ȭɖɊɎȾɁɎɍɎȾȼ
ɉȼ%6+ DIN EN ISO 6710
ȡȭɆɊɀ

–S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*ȭɁɌɏɈ

10 min10 min

6 min

4 min

4 min

ȭɁɌɏɈȿɁɇ

15 min10 min

4 min

4 min

4 min

ȭɁɌɏɈ([SUHVVȿɁɇ

15 min10 min

4 min

ɉȾ

ɉȾ

ȧɄɎɄɁȾɑɁɋȼɌɄɉ

10 min10 min

7 min

7 min

7 min

ȧɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ

15 min15 min10 min

7 min

7 min

ȧɄɎɄɁȾɑɁɋȼɌɄɉȿɁɇ+

8 min

7 min

5 min

4 min

4 min

EDTA

ɉȾ

ɉȾ

7 min

6 min

5 min

('7$ȿɁɇ

15 min10 min10 min

7 min

7 min

ȲɄɎɌȼɎ

9 min

8 min

7 min

6 min

5 min

('7$ɐɇɏɊɌɄɀɑɁɋȼɌɄɉ

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

ȲɄɎɌȼɎ3%0POȬȼɀɄɏɍɉȼɒɁɉɎɌɊɐɏȿɄɌȼɉɁ!FP

9 min

8 min

7 min

6 min

5 min

ȲɄɎɌȼɎ3%0POȬȼɀɄɏɍɉȼɒɁɉɎɌɊɐɏȿɄɌȼɉɁ!ɀɊƉFP

ɉȾ

ɉȾ

10 minɉȾɉȾɉȾ ɉɁɁȾȼɇɄɀɄɌȼɉ
ȪɎɉȼɍɛɍɁɃȼȾɍɄɓɆɄ6ɈɊɉɊȾɁɎɄɍɄɃɆɇɚɓɁɉɄɁɉȼ¢bɈɈ ɋɁɀɄȼɎɌɄɓɉɄ6ɈɊɉɊȾɁɎɄ

ȲɁɉɎɌɊɐɏȿɄɌȼɉɁɋɌɄų&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry,ɊɎɈɁɉɁɉ

ȤɉɐɊɌɈȼɒɄɛɃȼɌȼɃɀɁɇɄɎɁɇɉɄɎɁɈȼɎɁɌɄȼɇɄ
ȮɁɓɉɄɎɁɍȾɊɅɍɎȾȼɉȼɌȼɃɀɁɇɄɎɁɇɉɄɛɈȼɎɁɌɄȼɇ ȿɁɇ ɃȼȾɄɍɛɎɊɎɎɁɈɋɁɌȼɎɏɌȼɎȼȜɆɊ6ɈɊɉɊȾɁɎɄɎɁɍɁɊɑɇȼɂɀȼɎɋɌɁɀɄɄɇɄɋɊȾɌɁɈɁɉȼɒɁɉɎɌɊɐɏȿɄɌȼɉɁɎɊɉɁɈɊɂɁɀȼɍɁȿȼɌȼɉɎɄɌȼɉɁɋɌɁɆɖɍɉȼɎɍɇɊɅɉȼ
ɌȼɃɀɁɇɄɎɁɇɉɄɛȿɁɇ
6ɈɊɉɊȾɁɎɄɎɁɉɁɎɌɛȽȾȼɀȼɍɁɒɁɉɎɌɊɐɏȿɄɌȼɎɋɊȾɎɊɌɉɊ

ȤɃɑȾɖɌɇɛɉɁ
1.

ȭɋȼɃȾȼɅɎɁɊȽɕɄɎɁɑɄȿɄɁɉɉɄɄɃɄɍɆȾȼɉɄɛɄɃȼɆɊɉɊȾɄɉȼɌɁɀȽɄɃȼɋɌȼȾɄɇɉɊɎɊɄɃɑȾɖɌɇɛɉɁɉȼɄɉɐɁɆɒɄɊɃɉɄɈȼɎɁɌɄȼɇɄ

2.

ȬɖɆȼȾɄɒɄɎɁɃȼɁɀɉɊɆɌȼɎɉȼɏɋɊɎɌɁȽȼɋɌɁɀɊɎȾɌȼɎɛȾȼɎɌɄɍɆȼɊɎɄɉɐɁɆɒɄɄ

3.

ȣȼɈɖɌɍɁɉɄɎɁɄɇɄɋɖɇɉɄɍɄɍɎɁɈɄɃȼȾɃɁɈȼɉɁɉȼɆɌɖȾɎɌɛȽȾȼɀȼɍɁɄɃɑȾɖɌɇɛɎȾɋɊɀɑɊɀɛɕɄɆɊɉɎɁɅɉɁɌɄɃȼɊɋȼɍɉɄȽɄɊɇɊȿɄɓɉɄɊɎɋȼɀɖɒɄɍɇɁɀɆɊɁɎɊɈɊȿȼɎɀȼȽɖɀȼɎȼȾɎɊɆɇȼȾɄɌȼɉɄɄɄɃȿɊɌɁɉɄ

4.

ȪɎɋȼɀɖɓɉɄɎɁɋɌɊɀɏɆɎɄɎɌɛȽȾȼɀȼɈɄɉȼɎɋɌɁɃɋɊɀɑɊɀɛɕɄɉɍɄɉɁɌȼɎɊɌɄɇɄɋɌɊɒɁɍɉȼȼȾɎɊɆɇȼȾɄɌȼɉɁ ɍɎɁɌɄɇɄɃȼɒɄɛɍɋȼɌȼ 27

BGȭɎȼɉɀȼɌɎɄɄɉȼɍɊɆɄɍɋɁɒɄɐɄɓɉɄɃȼɋɌɊɀɏɆɎȼȾɎɁɆɏɕȼɎȼȾɁɌɍɄɛCLSI* GP39 „Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 „Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 „Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 „Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 „WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

ȭɎȼɉɀȼɌɎɃȼɁɋɌɏȾɁɎɆɄɃȼȾɃɁɈȼɉɁɉȼȾɁɉɊɃɉȼɆɌɖȾ
',1(1,62ȡɋɌɏȾɁɎɆɄɃȼȾɃɁɈȼɉɁɉȼȾɁɉɊɃɉȼɓɊȾɁɔɆȼɆɌɖȾɃȼɁɀɉɊɆɌȼɎɉȼɏɋɊɎɌɁȽȼ*CLSI (Clinical and Laboratory Standards Institute)ȦɊɀɉȼɍɄɈȾɊɇɄɄɄɀɁɉɎɄɐɄɆȼɒɄɄ

ȩɊɈɁɌɉȼȼɌɎɄɆɏɇ

ȞɀɊɋɖɇɉɁɉɄɁɃȼɁɀɄɉɄɓɉɊɊɋȼɆɊȾȼɉɄɍɎɁɌɄɇɉɄɋɌɊɀɏɆɎɄȾȼɂɄ

ȫȼɌɎɄɀȼ

ȩɁɏɋɊɎɌɁȽɛȾȼɅɎɁȼɆɊɊɋȼɆɊȾɆȼɎȼɁɋɊȾɌɁɀɁɉȼ

ȟɊɀɁɉɀɊ

ȪɋɌɊɍɎɁɉȼɍɄɍɎɁɈȼɍɖɍɍɎɁɌɄɇɉȼȽȼɌɄɁɌȼɍȾɖɉɔɉȼɋɌɁɀɋȼɃɉȼɊɋȼɆɊȾɆȼ

ȭȡɈȼɌɆɄɌɊȾɆȼ

ȧɖɓɁȾȼɍɎɁɌɄɇɄɃȼɒɄɛ

ȤɉȾɄɎɌɊɀɄȼȿɉɊɍɎɄɆȼ

ȭɋȼɃȾȼɅɎɁɌɖɆɊȾɊɀɍɎȾɊɎɊɃȼɏɋɊɎɌɁȽȼ

ȫɌɄɋɊȾɎɊɌɉȼɏɋɊɎɌɁȽȼȪɋȼɍɉɊɍɎɊɎɆɊɉɎȼɈɄɉȼɒɄɛ

ȫȼɃɁɎɁɊɎɍɇɖɉɓɁȾȼɍȾɁɎɇɄɉȼ

ȭɖɑɌȼɉɛȾȼɅɎɁɉȼɍɏɑɊ

ȫɌɊɄɃȾɊɀɄɎɁɇ

ȠɖɌɂȼȾȼɉȼɋɌɊɄɃȾɊɀɍɎȾɊ

ȭɎɁɌɄɇɁɉɋɖɎɉȼɎɁɓɉɊɍɎɎȼ

ȩɁɍɎɁɌɄɇɄɃɄɌȼɅɎɁɋɊȾɎɊɌɉɊ

ȣȼɋȼɃɁɉɊɋɌȼȾɊɃȼɎɁɑɉɄɓɁɍɆɄɋɌɊɈɁɉɄ
ȫɌɄȾɖɃɉɄɆȾȼɉɁɉȼɄɉɒɄɀɁɉɎɄɍȾɖɌɃȼɉɄɍɏɋɊɎɌɁȽȼɎȼɉȼɋɌɊɀɏɆɎȼɄɉɐɊɌɈɄɌȼɅɎɁɋɌɊɄɃȾɊɀɄɎɁɇɛɄɊɎȿɊȾɊɌɉɄɎɁɊɌȿȼɉɄɉȼɍɖɊɎȾɁɎɉȼɎȼɀɖɌɂȼȾȼ

28

1ÈYRGNREVOX]Hş6$567('760RQRYHWWH®V\VWÜPSURRGEÞUNUYHCS.SRXĭLWìMDNRGLDJQRVWLFNĨSURVWčHGHNin vitro³ÕHOSRXĭLWì
S-Monovette®V\VWÜP\SURRGEÞUNUYHMHKO\DbDGDSWÜU\VHSRXĭìYDMìVSROHÕQÞMDNRV\VWÜPSURRGEÞUĭLOQìNUYH60RQRYHWWH®V\VWÜP\SURRGEÞUNUYHVORXĭìSURRGEÞU\WUDQVSRUW]SUDFRYÈQìDbVNODGRYÈQìNUHYQìFKY]RUNġSURGLDJQRVWLFNÜDQDOĨ]\in vitro]HVÜUDSOD]P\QHERSOQÜNUYHYbNOLQLFNÜODERUDWRčL3URGXNWMHXUÕHQNbSURIHVLRQÈOQìPXSRXĭLWìRGERUQĨPL]GUDYRWQLFNĨPLDbODERUDWRUQìPLSUDFRYQìN\Popis produktu
S-Monovette®V\VWÜP\SURRGEÞUNUYHVHVNOÈGDMì]bSODVWRYÜ]NXPDYN\SìVWXSìVWQLFHDbSODVWRYÜKRđURXERYDFìKRYìÕNDVbEDUHYQĨPNĂGRYÈQìPVbLQWHJURYDQRXPHPEUÈQRXNWHUÈE\ODY\YLQXWDVSHFLÈOQÞSURSčLSRMHQì
EH]SHÕQRVWQì MHKO\60RQRYHWWH®QHER EH]SHÕQRVWQì MHKO\0XOWLIO\®DbUġ]QĨFKSUHSDUDFì SčìSUDYNġ .GRVWÈQìMHWDNÜ60RQRYHWWH® bez aditiv. S-Monovette®V\VWÜP\SURRGEÞUNUYHVbDGLWLY\MDNRMVRXDNWLYÈWRUVUÈĭHQìDNWLYÈWRUVUÈĭHQìVbJHOHPKHSDULQOLWKQĨKHSDULQOLWKQĨVbJHOHPKHSDULQVRGQĨFLWUÈW('7$IOXRULG('7$IOXRULGKHSDULQIOXRULGFLWUÈW&3'$DbEH]DGLWLYMHMLFKNRQFHQWUDFHDGLWLYREMHPNDSDOQĨFKDGLWLYDbMHMLFKSRYROHQÜWROHUDQFHDbSRPÞUNUYHNbDGLWLYġPRGSRYìGDMìSRĭDGDYNġPDbGRSRUXÕHQìPPH]LQÈURGQìQRUP\',1(1,62=NXPDYN\QDMHGQRSRXĭLWìSURRGEÞUY]RUNġĭLOQìNUYHDbVFKYÈOHQĨPQRUPÈP,QVWLWXWXSURNOLQLFNÜDbODERUDWRUQìQRUP\ &/6, 9ĨEÞUDGLWLYD]ÈYLVìQDDQDO\WLFNÜWHVWRYDFìPHWRGÞ8UÕXMHMHMYĨUREFHWHVWRYDFìFKÕLQLGHODQHERDQDO\]ÈWRUXQDNWHUÜPVHWHVWSURYÈGì60RQRYHWWH®V\VWÜPSURRGEÞUNUYHMHNbGLVSR]LFLYbSURYHGHQìFKVHVWHULOQìPYQLWčNHPQHERMHGQRWOLYÞ]DEDOHQĨVHVWHULOQìPYQLWčNHPLbYQÞMđNHP%DUHYQÜNĂGRYÈQìđURXERYDFìFKYìÕHN0RQRYHWWH®:

Aditivum

Písmenný kód%DUYDYìÕND',1(1,62
6710%DUYDYìÕNDSRGOH%6
4851+

Z

bílá

bílá

Zkumavka bez preparace
S-Monovette® neutrální Z
Zkumavka sérum
S-Monovette®VÜUXP&$7VbDNWLYÈWRUHPVUÈĭHQì

CATÕHUYHQÈ

bílá

S-Monovette®VÜUXPJHO&$7VbDNWLYÈWRUHPVUÈĭHQìDbJHOHPCATWPDYÞĭOXWÈ

WPDYÞĭOXWÈ

S-Monovette®VÜUXPH[SUHVVJHO&$7VbDNWLYÈWRU\VUÈĭHQìWURPELQHPDbJHOHPCATRUDQĭRYÈ

-S-Monovette®KHSDULQOLWKQĨ/+VbKHSDULQHPOLWKQĨP

LH

zelená

RUDQĭRYÈ

S-Monovette®WHNXWĨKHSDULQOLWKQĨ/+VbKHSDULQHPOLWKQĨP

LH

zelená

RUDQĭRYÈ

S-Monovette®KHSDULQOLWKQĨJHO/+VbKHSDULQHPOLWKQĨPDbJHOHP

LH

zelená

RUDQĭRYÈ

S-Monovette®KHSDULQOLWKQĨJHO+/+VbKHSDULQHPOLWKQĨPDJHOHP

LH

zelená

RUDQĭRYÈ

S-Monovette®KHSDULQVRGQĨ1+VbKHSDULQHPVRGQĨP

NH

KQÞGÈ

zelená

S-Monovette®KHSDULQDPRQQĨ$+VbKHSDULQHPDPRQQĨP

ned.

modrá

modrá

S-Monovette®FLWUÈW1&FLWUÈWVRGQĨ

9NC

modrá

zelená

S-Monovette 3)$FLWUÈW1&FLWUÈWVRGQĨSXIURYDQĨ

9NC

VYÞWOHPRGUĨ

-S-Monovette®.('7$.(Vb('7$NDOLHP

K3E

ıDORYÈ

ÕHUYHQÈ

S-Monovette®.('7$.(Vb('7$NDOLHP

K2E

ıDORYÈ

ÕHUYHQÈ

S-Monovette®.('7$JHO.(Vb('7$NDOLHPDbJHOHP

K2E

ıDORYÈ

ÕHUYHQÈ

S-Monovette®ĲXRULG('7$)(VbĲXRULGHPDb('7$

FE

šedá

ĭOXWÈ

S-Monovette®ĲXRULGKHSDULQ)+VbĲXRULGHPDbKHSDULQHP

FH

-

ĭOXWÈ

S-Monovette®*OXFR(;$&7)&VbĲXRULGHPFLWUÈWHPDb('7$FCUġĭRYÈ

šedá

LHWPDYÞPRGUÈ

RUDQĭRYÈ

S-Monovette®7KURPER([DFWVHVORXÕHQLQRXKRčÕìNX

ned.

QHGRVWUXĭLQRYÈ

QHGRVWUXĭLQRYÈ

S-Monovette® CTAD

ned.

ned., modráned., zelená

S-Monovette® ACD

ACD

ĭOXWÈ

ĭOXWÈ

S-Monovette® CPDA

CPDA

ĭOXWÈ

ĭOXWÈ

S-Monovette® hirudin

ned.

QHGROLYRYÞ]HOHQÈ

QHGROLYRYÞ]HOHQÈ

S-Monovette®KRPRF\VWHLQ+&<=JHOVbJHOHPDbVWDELOL]ÈWRUHP

ned.

ned., šedáned., šedáS-Monovette®KRPRF\VWHLQ+&<&VbFLWUÈWRYĨPSXIUHP

ned.

QHGıDORYÈ

QHGıDORYÈ

S-Monovette® DNA Exactned.

ned., modráned., modrá=NXPDYNDVbKHSDULQHP=NXPDYNDVbFLWUÈWHP

®

Zkumavka EDTA

=NXPDYNDVbLQKLELWRU\JO\NROĨ]\=NXPDYN\SURDQDOĨ]XNRYġ
S-Monovette®DQDOĨ]DNRYġ/+VbKHSDULQHPOLWKQĨP

'DOđì]NXPDYN\QDSOQRXNUHYDbSOD]PX.GRVWÈQìGDOđìEDUY\YìÕHN
ned.: nedefinováno+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistryVWDĭHQR29

CS
SARSTEDT S-Monovette® sérum CAT/sérum-gel CAT
S-Monovette®VÜUXP&$7REVDKXMHSODVWRYĨJUDQXOÈWSRWDĭHQĨDNWLYÈWRUHPVUÈĭHQì VLOLNÈW DbVORXĭìNbRGEÞUXVÜUD 3ODVWRYĨJUDQXOÈWVHSčLFHQWULIXJDFLXVDGìPH]LNUHYQìVUDĭHQLQXDbVÜUXP
S-Monovette®VÜUXPJHO&$7REVDKXMHYHGOHSODVWRYÜKRJUDQXOÈWXSRWDĭHQÜKRDNWLYÈWRUHPVUÈĭHQì VLOLNÈW WDNÜJHOQDEÈ]LSRO\PHUXDbVORXĭìNbRGEÞUXVÜUD *HOVHSčLFHQWULIXJDFLXVDGìPH]LNUHYQìVUDĭHQLQXDbVÜUXP
DbYbSUġEÞKXSčHSUDY\VNODGRYÈQìDbDQDOĨ]\SDNWYRčìVWDELOQìVHSDUDÕQìYUVWYX
6ÜUXPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\SčLbNOLQLFNRELRFKHPLFNĨFKDbEÞĭQĨFKLPXQRORJLFNĨFKY\đHWčHQìFKDbYbVÜURORJLL
3RRGEÞUXNUYHQHFKWHNUHYYb60RQRYHWWH®VÜUXP&$7VÜUXPJHO&$7SRGREXbPLQXWVUÈĭHWYHVYLVOÜSROR]HDE\VHSRFHQWULIXJDFL]DUXÕHQÞY\WYRčLOD]čHWHOQÈVHSDUDÕQìYUVWYD'RSRUXÕHQÈGREDMH]DORĭHQDQD
LQWDNWQìPSURFHVXVUÈĭHQì.UHYSDFLHQWġVbSRUXFKDPLVUÈĭOLYRVWLNUYH]SġVREHQĨPLRQHPRFQÞQìPQHEROÜÕHQĨFKDQWLNRDJXODQW\PġĭHQDěSOQÜY\VUÈĭHQìSRWčHERYDWYìFHÕDVX

SARSTEDT S-Monovette® sérum express gel CAT
S-Monovette®VÜUXPH[SUHVVJHO&$7REVDKXMHYHGOHSODVWRYÜKRJUDQXOÈWXSRWDĭHQÜKRDNWLYÈWRUHPVUÈĭHQì WURPELQ WDNÜJHOQDEÈ]LSRO\PHUXDbVORXĭìNbRGEÞUXVÜUD *HOVHSčLRGVWčHØRYÈQìXVDGìPH]LNUHYQìVUDĭHQLQXDbVÜUXPDbYbSUġEÞKXWUDQVSRUWXVNODGRYÈQìDbDQDOĨ]\SDNWYRčìVWDELOQìVHSDUDÕQìYUVWYX
3RRGEÞUXNUYHQHFKWHNUHYYb60RQRYHWWH®VÜUXPH[SUHVVJHOSRGREXbPLQXWVUÈĭHWYHVYLVOÜSROR]HDE\VHSRFHQWULIXJDFL]DUXÕHQÞY\WYRčLOD]čHWHOQÈVHSDUDÕQìYUVWYD'RSRUXÕHQÈGREDMH]DORĭHQDQDLQWDNWQìP
SURFHVXVUÈĭHQìWDNÜSURNUHYKHSDULQL]RYDQĨFKSDFLHQWġ.UHYSDFLHQWġVbSRUXFKDPLVUÈĭOLYRVWLNUYH]SġVREHQĨPLRQHPRFQÞQìPQHEROÜÕHQĨFKDQWLNRDJXODQW\YÕHWQÞY\VRNĨFKGÈYHNKHSDULQXSRWčHEXMHQDěSOQÜ
Y\VUÈĭHQìYìFHÕDVX
6ÜUXPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\SčLbNOLQLFNRELRFKHPLFNĨFKDbEÞĭQĨFKLPXQRORJLFNĨFKY\đHWčHQìFKDbYbVÜURORJLLSARSTEDT S-Monovette® neutrální Z
S-Monovette®QHXWUÈOQì=QHREVDKXMHĭÈGQRXSUHSDUDFLFRĭRGSRYìGÈSčLUR]HQÜPXVUÈĭHQìNUHYQìKRY]RUNXEH]DNWLYÈWRUXVUÈĭHQìDbVORXĭìNbRGEÞUXVÜUD &HQWULIXJDFìVHSURYHGHRGGÞOHQìNUHYQìVUDĭHQLQ\DbVÜUD
6ÜUXPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\YbXĭLYDWHOVN\VSHFLILFNĨFKY\đHWčHQìFK.URPÞWRKRO]H60RQRYHWWH®QHXWUÈOQì=SRXĭìWWDNÜMDNRSUÈ]GQRX]NXPDYNXPÈOLEĨWRGEÞUNUYH]DKÈMHQSRPRFì60RQRYHWWH®FLWUÈWYbNRPELQDFLVb EH]SHÕQRVWQì MHKORX0XOWLIO\® MHKODVbNčLGÜON\ SRXĭLMHVH
S-Monovette®QHXWUÈOQì=MDNRSUYQì]NXPDYND SUÈ]GQÈ]NXPDYND SURQDSOQÞQìKDGLÕN\ EH]SHÕQRVWQì MHKO\0XOWLIO\®.

SARSTEDT S-Monovette®KHSDULQOLWKQĨ/+KHSDULQOLWKQĨJHO/+KHSDULQOLWKQĨJHO+/+KHSDULQVRGQĨ1+KHSDULQDPRQQĨ$+
S-Monovette®KHSDULQOLWKQĨ/+KHSDULQVRGQĨ1+KHSDULQDPRQQĨ$+REVDKXMHSODVWRYĨJUDQXOÈWSRWDĭHQĨDQWLNRDJXODÕQìPSčìSUDYNHP DQWLNRDJXODQV KHSDULQOLWKQĨ/+KHSDULQVRGQĨKHSDULQDPRQQĨ REY\NOH,8KHSDULQXPONUYH DbVORXĭìNbRGEÞUXSOQÜNUYHDbSOD]P\ 3ODVWRYĨJUDQXOÈWVHSčLRGVWčHØRYÈQìXVDGìPH]LNUHYQìEXýN\DbSOD]PXU S-Monovette®KHSDULQOLWKQĨ/+EH]SODVWRYÜKRJUDQXOÈWXMHNbGLVSR]LFLDQWLNRDJXODQWKHSDULQOLWKQĨYHIRUPÞGÈYNRYÈQìVSUHMHP REY\NOH,8KHSDULQXPONUYH 
S-Monovette®KHSDULQOLWKQĨJHO/+REVDKXMHYHGOHSODVWRYÜKRJUDQXOÈWXSRWDĭHQÜKRDQWLNRDJXODQWHPKHSDULQOLWKQĨ REY\NOH,8KHSDULQXPONUYH WDNÜJHOQDEÈ]LSRO\PHUXDbVORXĭìNbRGEÞUXSOD]P\ *HOVHSčLFHQWULIXJDFLXVDGìPH]LNUHYQìEXýN\DbSOD]PXDbYbSUġEÞKXWUDQVSRUWXVNODGRYÈQìDbDQDOĨ]\SDNWYRčìVWDELOQìVHSDUDÕQìYUVWYX
S-Monovette®KHSDULQOLWKQĨJHO+/+REVDKXMHURYQÞĭJHOQDEÈ]LSRO\PHUXNWHUĨXPRĭýXMHYbSRURYQÈQìVH]NXPDYNRX60RQRYHWWH®KHSDULQOLWKQĨJHOVQìĭLWÕDVFHQWULIXJDFHDVLRbb
3OD]PDVbKHSDULQHPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\YbNOLQLFNRELRFKHPLFNĨFKDbEÞĭQĨFKLPXQRORJLFNĨFKY\đHWčHQìFK3OQÈNUHYVbKHSDULQHPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\YbEÞĭQĨFKLPXQRORJLFNĨFK
Y\đHWčHQìFKDbYbVÜURORJLL$QWLNRDJXODFHKHSDULQHPSUREìKÈSURVWčHGQLFWYìPDNWLYDFHDQWLWURPELQX
832=251z1=H]NXPDYHN60RQRYHWWH® heparin lithný LH, heparin lithný gel/gel+/+VHQHVPÞMìSURYÈGÞWDQDOĨ]\OLWKLD]H]NXPDYHN60RQRYHWWH®KHSDULQVRGQĨ1+VHQHVPÞMìSURYÈGÞWDQDOĨ]\VRGìNXDb]H]NXPDYHN60RQRYHWWH®KHSDULQDPRQQĨ$+VHQHVPÞMìSURYÈGÞWDQDOĨ]\DPRQLDÅLOQìNUYìQDSOQÞQÜ]NXPDYN\60RQRYHWWH® heparin lithný, heparin lithný gel / gel+/ heparin sodný /KHSDULQDPRQQĨQHMVRXYKRGQÜSURDQDOĨ]XNUHYQìFKSO\Qġ

SARSTEDT S-Monovette®DQDOĨ]DNRYġ
S-Monovette®DQDOĨ]DNRYġREVDKXMHDQWLNRDJXODQWKHSDULQOLWKQĨDbVORXĭìNbRGEÞUXSOQÜNUYHDbSOD]P\ +HSDULQOLWKQĨMHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP REY\NOH,8KHSDULQXPONUYH 
3OQÈNUHYQHERSOD]PDVbKHSDULQHPYb60RQRYHWWH®DQDOĨ]DNRYġYbNRPELQDFLVHVSHFLÈOQìEH]SHÕQRVWQìMHKORX*[Źŗ ÕYĨU VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbY\đHWčHQìPVWRSRYĨFKSUYNġNRYġ
6WRSRYÜSUYN\NRY\E\O\RYÞčHQ\SURVWčHGQLFWYìPDWRPRYÜDEVRUSÕQìVSHNWURPHWULH $$6 3URV\VWÜPEH]SHÕQRVWQìMHKO\Db60RQRYHWWH®DQDOĨ]DNRYġY\SOĨYDMìQÈVOHGXMìFìPD[LPÈOQìSUÈ]GQÜKRGQRW\YbQJV\VWÜPXSUR
tyto stopové prvky:

Chemický prvekTlng/systém

2,5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1,5

8,0

5,0

5

50

70

70

10

40

10

10

0D[LPÈOQìSUÈ]GQÜKRGQRW\MVRXSURNDĭGĨSUYHNXYHGHQ\QDđWìWNX60RQRYHWWH®.
$QDOĨ]\VWRSRYĨFKSUYNġVHSURYÈGÞMì]bSOQÜNUYHVbKHSDULQHPQHERSOD]P\VbKHSDULQHPYb]ÈYLVORVWLQDDQDO\WLFNÜPSRVWXSX$QWLNRDJXODFHKHSDULQHPSUREìKÈSURVWčHGQLFWYìPDNWLYDFHDQWLWURPELQXSARSTEDT S-Monovette® citrát 9NC
S-Monovette®FLWUÈW1&REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDbVORXĭìNbRGEÞUXSOQÜNUYHDbSOD]P\ &LWUÈWWULVRGQĨMHSčìWRPHQMDNRPROÈUQìUR]WRN UR]WRNFLWUÈWXWULVRGQÜKRÕDVWRVH]DRNURXKOXMHQD
b DbWYRčìbMPHQRYLWÜKRREMHPX]NXPDYN\60RQRYHWWH®FLWUÈW0ìVìFìSRPÞUFLWUÈWXNHNUYLMHşREMHPRYĨSRGìOFLWUÈWXDbREMHPRYĨFKGìOġNUYH3URDQDOĨ]XMHQH]E\WQÞQXWQÜGRGUĭRYDWVSUÈYQĨREMHPQDSOQÞQì
3OD]PDVbFLWUÈWHPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\YbEÞĭQĨFKKHPRVWD]HRORJLFNĨFKY\đHWčHQìFK$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìPFLWUÈWX'RGUĭXMWHSURVìP32.<1<YbÕÈVWL2GEÞUY]RUNġDbPDQLSXODFHVbQLPLNHNRPELQDFL60RQRYHWWH®FLWUÈWDbMHKODVbNčLGÜON\

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDbVORXĭìNbRGEÞUXSOQÜNUYHDbSOD]P\ &LWUÈWWULVRGQĨMHSčìWRPHQMDNRPROÈUQìSXIURYDQĨUR]WRN SXIURYDQĨS+ DbWYRčìbMPHQRYLWÜKR
objemu zkumavky S-Monovette®3)$0ìVìFìSRPÞUFLWUÈWXNHNUYLMHşREMHPRYĨSRGìOFLWUÈWXDbREMHPRYĨFKGìOġNUYH3URDQDOĨ]XMHQH]E\WQÞQXWQÜGRGUĭRYDWVSUÈYQĨREMHPQDSOQÞQì
3OQÈNUHY]b60RQRYHWWH®3)$1&VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbDQDOĨ]HIXQNFHWURPERF\WġSRPRFìDQDO\]ÈWRUX3)$6,(0(16+HDOWKLQHHUVDbMHSURWHQWRSRVWXSRYÞčHQD$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìPFLWUÈWX'RGUĭXMWHSURVìP32.<1<YbÕÈVWL2GEÞUY]RUNġDbPDQLSXODFHVbQLPLNHNRPELQDFL60RQRYHWWH®3)$DbMHKODVbNčLGÜON\

SARSTEDT S-Monovette® CTAD
S-Monovette®&7$'REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDbWHRI\OLQDGHQRVLQDbGLS\ULGDPRODbVORXĭìNbRGEÞUXSOQÜNUYHDbSOD]P\ &7$'MHSčìWRPHQMDNRUR]WRNDbWYRčìbMPHQRYLWÜKRREMHPX60RQRYHWWH® CTAD.
0ìVìFìSRPÞU&7$'NHNUYLMHşREMHPRYĨSRGìO&7$'DbREMHPRYĨFKGìOġNUYH3URDQDOĨ]XMHQH]E\WQÞQXWQÜGRGUĭRYDWVSUÈYQĨREMHPQDSOQÞQì
3OD]PDVb&7$'VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbDQDOĨ]HGHVWLÕNRYÜKRIDNWRUX 3) EHWD Ĕ WURPERJOREXOLQX Ĕ7* bLQKLELWRUXDNWLYÈWRUXSOD]PLQRJHQX 3$, DbSUREÞĭQÈY\đHWčHQìKHPRVWÈ]\
3RGREXQHMPÜQÞKRGLQVHSRWODÕìDNWLYDFHWURPERF\WġDbSURYHGHVHNRQWURODOÜÕE\KHSDULQHP$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìPFLWUÈWX'RGUĭXMWHSURVìP32.<1<YbÕÈVWLb2GEÞUY]RUNġDbPDQLSXODFHVbQLPLNHNRPELQDFL60RQRYHWWH®&7$'DbMHKODVbNčLGÜON\
832=251z1&7$'MHĭOXWÈ60RQRYHWWH®&7$'PXVìWHSčLVNODGRYÈQìFKUÈQLWSčHGXPÞOĨPDbSčLUR]HQĨPVYÞWOHP6LOQÜY\VWDYHQìVYÞWOXSRGREXGHOđìQHĭKRGLQPġĭH]SġVRELWGHDNWLYDFLSčìVDGSARSTEDT S-Monovette® EDTA K2E/K3E
S-Monovette® EDTA K2E/S-Monovette®('7$.(REVDKXMHDQWLNRDJXODQW.('7$QHER.('7$DbVORXĭìNbRGEÞUXSOQÜNUYH .('7$QHER.('7$MHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP
(1,6 mg EDTA/ml krve).
3OQÈNUHYVb('7$VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\SčLbKHPDWRORJLFNĨFKY\đHWčHQìFK.UHYQìQÈWÞU\E\VHPÞO\SURYÜVWGRÕW\čKRGLQSRRGEÞUXNUYH$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìP('7$
.UHY]b60RQRYHWWH®('7$.(.(O]HWDNÜSRXĭìWSUREÞĭQÈLPXQRKHPDWRORJLFNÈY\đHWčHQìDbWHVW\LQIHNÕQìFKRQHPRFQÞQì8ĭLYDWHORGSRYìGÈ]DRYÞčHQìYKRGQRVWLPDWHULÈOXSURY]RUN\NbWÞPWRY\đHWčHQìPSRPRFìYKRGQĨFKWHVWRYDFìFKÕLQLGHODQDO\]ÈWRUġYÕHWQÞSRGPìQHNVNODGRYÈQì30

CS
SARSTEDT S-Monovette® EDTA gel K2E
S-Monovette®('7$JHO.(REVDKXMHYHGOHDQWLNRDJXODQWX.('7$WDNÜJHOQDEÈ]LSRO\PHUXDbVORXĭìNbRGEÞUXSOD]P\ .('7$MHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP PJ('7$PONUYH *HOVHSčLFHQWULIXJDFLXVDGìPH]LNUHYQìEXýN\DbSOD]PXDbYbSUġEÞKXWUDQVSRUWXVNODGRYÈQìDbDQDOĨ]\SDNWYRčìVWDELOQìVHSDUDÕQìYUVWYX
3OD]PDVb('7$VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbPROHNXOÈUQìGLDJQRVWLFHYLUġ$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìP('7$

SARSTEDT S-Monovette®ĲXRULG('7$)(ĲXRULGKHSDULQ)+ĲXRULGFLWUÈW('7$)&VbLQKLELWRU\JOXNĂ]\S-Monovette®IOXRULG('7$)(REVDKXMHDQWLNRDJXODQW('7$ PJPONUYH DbIOXRULG PJPONUYH NbLQKLELFLJO\NROĨ]\DbVORXĭìNbRGEÞUXSOD]P\ )OXRULG('7$MHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHPS-Monovette®IOXRULGKHSDULQ)+REVDKXMHDQWLNRDJXODQWKHSDULQ ,8KHSDULQXPONUYH DbIOXRULG PJPONUYH NbLQKLELFLJO\NROĨ]\DbVORXĭìNbRGEÞUXSOD]P\ )OXRULGKHSDULQMHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìaerosolem.
,QKLELFHJO\NROĨ]\VDPRWQĨPIOXRULGHP]DÕìQÈDVLKRGLQ\SRQRGEÞUXNUYHGR]NXPDYN\DbMHMìěÕLQHNVHSOQÞSURMHYìSRDVLKRGLQÈFK*OXNĂ]DSURWRYbSOQÜNUYLGHJUDGXMHYbSUġPÞUXDĭRbSRQÞNROLNDKRGLQÈFKDbDĭRbSRKRGLQÈFK
S-Monovette®*OXFR(;$&7)&REVDKXMHDQWLNRDJXODQW('7$DbFLWUÈWDbIOXRULGNbRNDPĭLWÜLQKLELFLJO\NROĨ]\DbVORXĭìNbRGEÞUXSOD]P\ ('7$FLWUÈWDbIOXRULGH[LVWXMìMDNRUR]WRN9ĨSRÕHWNRQFHQWUDFHJOXNĂ]\Y\ĭDGXMH]bGġYRGXčHGÞQìY\QÈVREHQìNRHILFLHQWHP
S-Monovette®*OXFR(;$&7)&VSOýXMHVPÞUQLFH1ÞPHFNÜGLDEHWRORJLFNÜDVRFLDFH ''* SURWÞKRWHQVNĨGLDEHWHVDb1ÈURGQì]GUDYRWQLFNÜVPÞUQLFH 19/ SURGLDEHWHVW\SX2NDPĭLWÈVWDELOL]DFHNRQFHQWUDFH
JOXNĂ]\YbSOQÜNUYLMHSčLSRNRMRYÜWHSORWÞ]DUXÕHQDDĭGRKRGLQYL]WDNÜ%ìOÈNQLKD6$567('7https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt S-Monovette®
GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
3OD]PDIOXRULG('7$ FLWUÈW VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbDQDOĨ]HJOXNĂ]\$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìP('7$
832=251z1)OXRULGPġĭH]SġVRELW]YĨđHQìKHPROĨ]\'DOđìLQIRUPDFHRbOÈWNÈFKNWHUÜPRKRXSġVRELWUXđLYÞQDOH]QHWHYbSčìVOXđQÜPQÈYRGXNbSRXĭLWìRGYĨUREFHWHVWRYDFìFKÕLQLGHO'RGUĭXMWHSURVìP32.<1<YbÕÈVWL2GEÞUY]RUNġDbPDQLSXODFHVbQLPLNHNRPELQDFL60RQRYHWWH®*OXFR(;$&7DbMHKODVbNčLGÜON\

SARSTEDT S-Monovette® CPDA
S-Monovette®&3'$REVDKXMHDQWLNRDJXODQWFLWUÈWVRGQĨDbN\VHOLQXFLWURQRYRXIRVIRUHÕQDQVRGQĨGH[WUĂ]XDbDGHQLQDbVORXĭìNbRGEÞUXSOQÜNUYHDbSOD]P\ &3'$MHNbGLVSR]LFLYHIRUPÞUR]WRNX0ìVìFìSRPÞU&3'$
NHNUYLMHşREMHPRYĨSRGìO&3'$DbREMHPRYĨFKGìOġNUYH3URDQDOĨ]XMHQH]E\WQÞQXWQÜVSUÈYQÜQDSOQÞQì
3OQÈNUHYSOD]PDVb&3'$VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\YbVÜURORJLLNUHYQìFKVNXSLQYbWUDQVIX]QìPOÜNDčVWYìDbSURWHVW\NRPSDWLELOLW\ NčìĭRYÜ]NRXđN\ SčLWUDQVIX]ìFK.RQNUÜWQÞMH60RQRYHWWH® CPDA vhodná pro
VWDQRYHQìNUHYQìVNXSLQ\ $% YÕHWQÞ.HOODQWLJHQXDb5KHVXVIDNWRUXSURWHVWQDQHSUDYLGHOQÜSURWLOÈWN\SURWLNUHYQìPVNXSLQÈPSURSRO\VSHFLILFNĨSčìPĨ&RRPEVġYWHVW GRGQH SURWHVWNRPSDWLELOLW\ NčìĭRYÈ]NRXđND VHVÜUHPSOD]PRXSDFLHQWDNRPSDWLELOQìPLVbNUHYQìVNXSLQRX KODYQìWHVW 'REDWUDQVSRUWXDĭGRXVNODGQÞQìMHRYÞčHQDQDPD[LPÈOQÞKRGLQ\SčLWHSORWÞşbƓ&3URVHGLPHQWDFLEXQÞNPXVìEĨWY]RUN\SčHGWìPXORĭHQ\SRGREXQHMPÜQÞKRGLQYHVYLVOÜSROR]HYbFKODGQLÕFH1ÈVOHGQÞO]HYĨđHXYHGHQÜDQDO\W\XUÕRYDWDĭGRGQìDQDORJLFN\NbREY\NOÜGREÞVNODGRYÈQìWUDQVIX]QìKRSčìSUDYNXSRXORĭHQìYbFKODGQLÕFH şbƓ&  XbSčìPÜKR&RRPEVRYDWHVWXSODWìYĨMLPNDGQì 9KRGQÜSURPHWRGXVORXSFRYÜDJOXWLQDFHQDSčQDSčìVWURML9LVLRQ0D[RGVSROHÕQRVWL2UWKR&OLQLFDO'LDJQRVWLFV0DWHULÈOSURY]RUN\VHQHVPìPUD]LW
8ĭLYDWHORGSRYìGÈ]DRYÞčHQìYKRGQRVWLPDWHULÈOXSURY]RUN\NbWÞPWRY\đHWčHQìPSRPRFìMLQĨFKPHWRGWHVWRYDFìFKÕLQLGHODQDO\]ÈWRUġYÕHWQÞSRGPìQHNVNODGRYÈQìDbPXVìMHVÈPRYÞčLW$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìPFLWUÈWX'RGUĭXMWHSURVìP32.<1<YbÕÈVWL2GEÞUY]RUNġDbPDQLSXODFHVbQLPLNHNRPELQDFL60RQRYHWWH®&3'$DbMHKODVbNčLGÜON\

SARSTEDT S-Monovette® ThromboExact
S-Monovette®7KURPER([DFWREVDKXMHMDNRDQWLNRDJXODQWKRčHÕQDWRXVġODbVORXĭìNbRGEÞUXSOQÜNUYH +RčHÕQDWÈVġOMHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP
Plná krev S-Monovette®7KURPER([DFWVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbY\ORXÕHQìFK\EQÜKRVWDQRYHQìQì]NÜKRSRÕWXWURPERF\WġYbGġVOHGNXQHVQÈđHQOLYRVWLDQWLNRDJXODQWġ QDSč('7$FLWUÈWKHSDULQ WHG\W]YIDOHđQÜWURPERF\WRSHQLH=DEUÈQìVHWYRUEÞDJUHJÈWġWURPERF\WġDbGRKRGLQSRRGEÞUXNUYHMHPRĭQÜVWDQRYLWVNXWHÕQĨSRÕHWWURPERF\Wġ$QWLNRDJXODFHSUREìKÈSURVWčHGQLFWYìPKRčHÕQDWĨFKLRQWġNWHUÜLQKLEXMìWURPERF\WÈUQìWURPER[DQ$DbDJUHJDFLWURPERF\Wġ]SURVWčHGNRYDQRXSURVWčHGQLFWYìP$'3DbN\VHOLQ\DUDFKLGRQRYÜ

SARSTEDT S-Monovette® Hirudin
S-Monovette®KLUXGLQREVDKXMHDQWLNRDJXODQWKLUXGLQDbVORXĭìNbRGEÞUXSOQÜNUYH +LUXGLQMHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP
3OQÈNUHYVbKLUXGLQHPVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbDQDOĨ]HIXQNFHWURPERF\WġQDSčìVWURML0XOWLSODWH® PXOWLSOHSODWHOHWIXQFWLRQDQDO\VHUşYìFHQÈVREQĨDQDO\]ÈWRUIXQNFHNUHYQìFKGHVWLÕHN RGVSROHÕQRVWL
52&+('LDJQRVWLFVDbMHSURQLRYÞčHQD3RXĭìYÈVHNHVOHGRYÈQìOÜÕE\DQWLDJUHJDÕQìPLOÜN\DbNbGLDJQRVWLFHÕLY\ORXÕHQìSRUXFK\WURPERF\Wġ
S-Monovette®+LUXGLQE\ODY\YLQXWDVSHFLÈOQÞSURDQDOĨ]XIXQNFHWURPERF\WġYHVSROXSUÈFLVbILUPRX9HUXP'LDJQRVWLFDGQHV52&+('LDJQRVWLFVQDSčìVWURML0XOWLSODWH®.
$QWLNRDJXODFHSUREìKÈSURVWčHGQLFWYìPKLUXGLQXSčìPRXLQKLELFìWURPELQXFRĭXPRĭýXMHGLDJQRVWLNXIXQNFHWURPERF\WġYbSġYRGQìPVWDYXSARSTEDT S-Monovette® Homocystein HCY-Z gel/HCY-C
S-Monovette®KRPRF\VWHLQ+&<=JHOREVDKXMHYHGOHSODVWRYÜKRJUDQXOÈWXSRWDĭHQÜKRDNWLYÈWRUHPVUÈĭHQì VLOLNÈW WDNÜVSHFLÈOQìVWDELOL]ÈWRUDbJHOQDEÈ]LSRO\PHUXDbVORXĭìNbRGEÞUXVÜUD *HOVHSčLFHQWULIXJDFLXVDGìPH]LNUHYQìVUDĭHQLQXDbVÜUXPDbYbSUġEÞKXWUDQVSRUWXVNODGRYÈQìDbDQDOĨ]\SDNWYRčìVWDELOQìVHSDUDÕQìYUVWYX3čìSUDYHNMHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP+RPRF\VWHLQMHYbSOQÜNUYLVWDELOL]RYÈQSčLSRNRMRYÜWHSORWÞSRGREXDĭKRGLQ3RNXGFHQWULIXJDFHSUREÞKQHYbSUġEÞKXSUYQìFKKRGLQVHVSUÈYQÞY\WYRčHQRXVHSDUDÕQìYUVWYRXPH]LNUHYQìVUDĭHQLQRXDbVÜUHPMHKRPRF\VWHLQVWDELOL]RYÈQDĭSRGREXKRGLQ
6ÜUXP]b60RQRYHWWH®KRPRF\VWHLQ+&<=JHOVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbDQDOĨ]HKRPRF\VWHLQX60RQRYHWWH®KRPRF\VWHLQ+&<&REVDKXMHMDNRDQWLNRDJXODQWFLWUÈWN\VHOLQ\ S+ DbVORXĭìNbRGEÞUXSOD]P\ &LWUÈWMHNbGLVSR]LFLYHIRUPÞUR]WRNX9ĨSRÕHWNRQFHQWUDFHKRPRF\VWHLQXY\ĭDGXMH]bGġYRGXčHGÞQìY\QÈVREHQìNRHILFLHQWHP+RPRF\VWHLQMHYbSOQÜNUYLVWDELOL]RYÈQSčLSRNRMRYÜWHSORWÞSRGREXDĭKRGLQDbSčLƓ&SRGREXDĭKRGLQ
3OD]PD]b60RQRYHWWH®KRPRF\VWHLQ+&<&JHOVHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NbDQDOĨ]HKRPRF\VWHLQX$QWLNRDJXODFHYb60RQRYHWWH®KRPRF\VWHLQ+&<&SUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìPFLWUÈWX'RGUĭXMWHSURVìP32.<1<YbÕÈVWL2GEÞUY]RUNġDbPDQLSXODFHVbQLPLNHNRPELQDFL60RQRYHWWH®+&<&DbMHKODVbNčLGÜON\

SARSTEDT S-Monovette® DNA Exact
S-Monovette®'1$([DFWREVDKXMHDQWLNRDJXODQWQDEÈ]L('7$DbVORXĭìNbRGEÞUXSOQÜNUYH ('7$MHNbGLVSR]LFLYHIRUPÞGÈYNRYÈQìDHURVROHP
3OQÈNUHYVb('7$VHSRXĭìYÈMDNRPDWHULÈOSURY]RUN\NHVWDELOL]DFLJ'1$6WDELOL]DFHJ'1$MHRYÞčHQDQDGREXGQġSčLƓ&QDGQġSčLSRNRMRYÜWHSORWÞ Ɠ& QDGQġYbFKODGX bƓ& DbQHMPÜQÞURNSčLWHSORWÞbƓ&6WDELOL]RYDQÜY]RUN\QDYìFSčHĭLMì]PUD]RYDFìFKDbUR]PUD]RYDFìFKF\NOġEH]]WUÈW\NYDOLW\YL]WDNÜ%ìOÈNQLKD6$567('7https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
$QWLNRDJXODFHSUREìKÈWYRUERXNRPSOH[XYÈSHQDWĨFKLRQWġSURVWčHGQLFWYìP('7$

9KRGQRVWPDWHULÈOXSURY]RUN\]ÈYLVìQDDQDO\WXDbWHVWRYDFìPÕLQLGOHDQDO\]ÈWRUX-HQXWQÜGRGUĭRYDWSčìVOXđQÈGRSRUXÕHQìYĨUREFġ31

CS%H]SHÕQRVWQìSRN\Q\YĨVWUDĭQÈXSR]RUQÞQì
1.

9đHREHFQÈSUHYHQWLYQìEH]SHÕQRVWQìRSDWčHQì3RXĭìYHMWHUXNDYLFHDbGDOđìREY\NOÜRVREQìRFKUDQQÜSRPġFN\QDRFKUDQXSčHGSRWčìVQÞQìPNUYìDbSčHGPRĭQĨPY\VWDYHQìPSRWHQFLÈOQìPXLQIHNÕQìPXPDWHULÈOXYHY]RUFìFKDbSġYRGFġPFKRURESčHQÈđHQĨFKNUYì

2.

6HYđHPLELRORJLFNĨPLY]RUN\DbRVWUĨPLđSLÕDWĨPLSURVWčHGN\SURRGEÞU MHKO\DGDSWÜU\ ]DFKÈ]HMWHSRGOHVPÞUQLFDbSRVWXSġYDđHKR]GUDYRWQLFNÜKR]Dčì]HQì9SčìSDGÞSčìPÜKRNRQWDNWXVbELRORJLFNĨPLY]RUN\QHERSRUDQÞQìYSLFKHPMHKO\Y\KOHGHMWHOÜNDčVNRXSRPRFSURWRĭHPġĭHGRMìWNbSčHQRVX+,9+&9+%9QHERMLQĨFKLQIHNÕQìFKRQHPRFQÞQì3RXĭìYHMWHEH]SHÕQRVWQìMHKO\EH]SHÕQRVWQìMHKO\0XOWLĲ\®VbLQVWDORYDQRXRFKUDQRXMHKO\-HQH]E\WQÜGRGUĭRYDWEH]SHÕQRVWQìVPÞUQLFHDbSRVWXS\YDđHKR]GUDYRWQLFNÜKR]Dčì]HQì3.

3ODWìSURMHGQRWOLYÞ]DEDOHQÜSURGXNW\3čHGSRXĭLWìP]NRQWUROXMWHQHSRđNR]HQRVWNDĭGÜKRMHGQRWOLYÜKRREDOXDbMHOLSRđNR]HQSURGXNWQHSRXĭìYHMWH

4.

3URGXNWMHXUÕHQNbMHGQRUÈ]RYÜPXSRXĭLWì9đHFKQ\RVWUÜđSLÕDWÜSčHGPÞW\ MHKO\DGDSWÜU\ SURRGEÞUNUYH]OLNYLGXMWHYHYKRGQĨFKRGSDGRYĨFKNRQWHMQHUHFKQDRVWUĨRGSDG

5.

3RNXGNUHYRGHEìUÈWHLQWUDYHQĂ]QìP ,9 SčìVWXSHPPXVìWH]DMLVWLWDE\E\OSčHG]DKÈMHQìPRGEÞUXNUYHčÈGQÞSURSOÈFKQXWĨ RÕLđWÞQĨRGLQWUDYHQĂ]QìKRUR]WRNX YbVRXODGXVbSRĭDGDYN\]GUDYRWQLFNÜKR]Dčì]HQì¦ÈGQÜSURSOÈFKQXWìSčìVWXSX]DEUDýXMHFK\EQĨPYĨVOHGNġPDQDOĨ]\

6.

1HGRVWDWHÕQÜQDSOQÞQì60RQRYHWWH®YHGHNbFK\EQÜPXSRPÞUXNUYHDbSčìSUDYNXDGLWLYDDbPġĭH]SġVRELWFK\EQÜYĨVOHGN\DQDOĨ]\

7.

.UHYRGHEUDQÈDb]SUDFRYDQÈSRPRFì60RQRYHWWH®QHQìXUÕHQDNH]SÞWQÜDSOLNDFLGROLGVNÜKRWÞOD

8.

3RXSO\QXWìGRE\SRXĭLWHOQRVWLMLĭQHVPìWHSURGXNWSRXĭìYDW'REDSRXĭLWHOQRVWLNRQÕìSRVOHGQìPGQHPXYHGHQÜKRPÞVìFHDbURNXSkladování
3URGXNWPXVìEĨWDĭGRGRE\SRXĭLWìVNODGRYÈQSčLSRNRMRYÜWHSORWÞOmezení1.

'REDDbWHSORWDVNODGRYÈQìQDSOQÞQÜ60RQRYHWWH®]ÈYLVìQDVWDELOLWÞY\đHWčRYDQĨFKDQDO\Wġ3RVRX]HQìSURYHGHODERUDWRčQHERVHčLØWHQÈYRGHPNbSRXĭLWìRGYĨUREFHWHVWRYDFìKRÕLQLGODDQDO\]ÈWRUX2.

,NG\ĭVHSOD]PDQHERVÜUXPFHQWULIXJDFì]NXPDYHN60RQRYHWWH®RGGÞOìDQHERVHY\WYRčìEDULÜUDQHYđHFKQ\EXýN\PXVìEĨW]FHODRGGÞOHQ\=E\WNRYĨPHWDEROLVPXVQHERSčLUR]HQÈGHJUDGDFHPRKRXRYOLYQLWNRQFHQWUDFLDQDO\Wġ6WDELOLWDDQDO\WġE\VHPÞODSRVRXGLWVbRKOHGHPQDVNODGRYDFìSURVWRU\DbSRGPìQN\SčìVOXđQÜODERUDWRčH

3.

9SčìSDGÞWHUDSHXWLFNĨFKOÜNġRYÞčWHYKRGQRVWPDWHULÈOXSURY]RUN\YbQÈYRGXNbSRXĭLWìRGYĨUREFHWHVWRYDFìKRÕLQLGODDQDO\]ÈWRUX

4.

$QDOĨ]\VWRSRYĨFKSUYNġNRYġSURYÈGÞMWHV\VWÜPHP60RQRYHWWH®DQDOĨ]DNRYġEH]SHÕQRVWQìMHKODDQDOĨ]DNRYġ2GEÞUY]RUNġDbPDQLSXODFHVbQLPL
1(Å=$q1(7(62'%z5(0Å,/1.59(3¦(q7z7(6,&(/À7(1721d92'
3UDFRYQìSRPġFN\SRWčHEQÜSURRGEÞUY]RUNX
1.

9đHFKQ\SRWčHEQÜV\VWÜP\SURRGEÞUNUYH60RQRYHWWH®.

2.

%H]SHÕQRVWQì MHKO\QHER EH]SHÕQRVWQì MHKO\0XOWLĲ\®.

3.

5XNDYLFHSUDFRYQìSOÈđĕRFKUDQDRÕìQHERMLQĨYKRGQĨRFKUDQQĨRGÞYQDRFKUDQXSčHGSDWRJHQ\SčHQÈđHQĨPLNUYìQHERSRWHQFLÈOQÞLQIHNÕQìPLPDWHULÈO\

4.

(WLNHW\NbLGHQWLıNDFLSDFLHQWġ

5.

'H]LQIHNÕQìPDWHULÈONbGH]LQIHNFLPìVWDRGEÞUX GRGUĭXMWHVPÞUQLFH]GUDYRWQLFNÜKR]Dčì]HQìSURVWHULOQìRGEÞUY]RUNġNbSčìSUDYÞPìVWDRGEÞUX 0DMìOLY]RUN\VORXĭLWNH]MLđWÞQìDONRKROXYbNUYLQHSRXĭìYHMWHGH]LQIHNÕQìSURVWčHGN\QDEÈ]LDONRKROX

6.

6WHULOQìVXFKÜWDPSRQ\EH]FKRURERSORGQĨFK]ÈURGNġ7.

Škrtidlo.

8.

Náplast nebo obvaz.

9.

2GSDGRYĨNRQWHMQHUQDRVWUÜđSLÕDWÜSčHGPÞW\SUREH]SHÕQRXOLNYLGDFLSRXĭLWÜKRPDWHULÈOX'RSRUXÕHQÜSRčDGìRGEÞUX
1.

/DKYLÕN\QDNUHYQìNXOWXU\2.

=NXPDYN\VbFLWUÈWHPQHERDNWLYÈWRUHPVUÈĭHQì VbJHOHPEH]JHOVÜUD&$7VÜUXPJHO&$7 

3.

=NXPDYN\VbDNWLYÈWRUHPVUÈĭHQìQHERFLWUÈWHP

4.

=NXPDYN\VbKHSDULQHPVbJHOHPEH]JHOX

5.

=NXPDYN\Vb('7$VbJHOHPEH]JHOX6.

=NXPDYN\VbLQKLELWRU\JO\NROĨ]\7.

=NXPDYN\VbRVWDWQìPLDGLWLY\
832=251z1.G\ĭ]DÕQHWHVbRGEÞUHPFLWUÈWRYÜ]NXPDYN\QHERMLQÜ]NXPDYN\VbWHNXWĨPSčìSUDYNHPMDNRMHQDSčìNODG3)$&7$'&3'$+&<&QHER*OXFR(;$&7YbNRPELQDFLVbMHKORXVbNčLGÜON\ QDSč EH]SHÕQRVWQì MHKOD0XOWLĲ\® GRSRUXÕXMHPHSčHGHPY\MPRXWSUÈ]GQRX]NXPDYNX QDSč60RQRYHWWH®QHXWUÈOQì= DE\VH]DEUÈQLORQHGRVWDWHÕQÜPXQDSOQÞQì]NXPDYN\QDSOQÞQìPKDGLÕN\MHKO\VbNčLGÜON\7ìPMH]DMLđWÞQRVSUÈYQÜQDSOQÞQì]NXPDYN\DbWDNÜVSUÈYQĨPìVìFìSRPÞU NDSDOLQ\DbNUYH 

832=251z1

8SRčDGìRGEÞUġGRGUĭXMWHSčHGSLV\YDđHKR]GUDYRWQLFNÜKR]Dčì]HQì=DEUDýWH]SÞWQÜPXWRNXNUYH
9ÞWđLQD]NXPDYHN60RQRYHWWHREVDKXMHFKHPLFNÜSčìVDG\3UR]DEUÈQÞQì]SÞWQÜKRWRNXMHQXWQÜGRGUĭRYDWW\WRSRN\Q\
1. 3RXĭìYHMWHYĨKUDGQÞPDWHULÈO\GRSRUXÕHQÜYbQÈYRGXNbSRXĭLWì
2.

=YROWHSRORKXSDFLHQWDWDNDE\VWHPÞOLVQDGQĨSčìVWXSNbĭìOHDbSDĭLQHERMLQRXREODVWYSLFKXXbSDFLHQWDXPìVWÞWHWDNDE\VPÞčRYDODGROġ

3.

'UĭWH60RQRYHWWH®đURXERYDFìPYìÕNHPVPÞUHPQDKRUXDbSčLSRXĭLWì EH]SHÕQRVWQì MHKO\0XOWLĲ\®QDYìFSRGěURYQìSDĭHREODVWLSXQNFH

4.

Je nutné zajistit, aby obsah zkumavky S-Monovette®SčLYSLFKXĭìO\QHE\OYbNRQWDNWXDQLVHđURXERYDFìPYìÕNHPDQLNRQFHPMHKO\5.

8YROQÞWHđNUWLGORMHđWÞNG\ĭNUHYSURXGìGR60RQRYHWWH®.

32

CS
Zmrazení/rozmrazení
3RGOHGRSRUXÕHQì:+2 :+2',//DE5HY GRSRUXÕXMHPHRGGÞOLWVÜUXPSOD]PXSčHG]PUD]HQìPNUHYQìFKEXQÞN
Pro S-Monovette®SODWìSUR]PUD]HQìWDWRGRSRUXÕHQì=PUD]HQìSRGWHSORWXbƓ&•3RXĭLWìSčLWHSORWÈFKSRGERGHPPUD]XMHWčHEDYĭG\RWHVWRYDWYbUHÈOQĨFKSRGPìQNÈFKSURWRĭH]DWìĭHQì]NXPDYHNVHPġĭH]QDÕQÞOLđLWYb]ÈYLVORVWLQD]PUD]RYDQÜPPÜGLXDbEÞĭQĨFKSRGPìQNÈFK YL]NDSLWROD
Vlastnosti materiálu, katalog SARSTEDT).

•

9b]ÈVDGÞSODWìĭHSčLWHSORWÞSRGbƓ&VHKRGQRW\SHYQRVWLSODVWġVQLĭXMì3URWRMHREHFQÞQXWQÜ]DEUÈQLWPHFKDQLFNÜPX]DWìĭHQì•3RGPìQN\]PUD]HQìMHWčHED]YROLWWDNDE\VHREVDK60RQRYHWWH®]PUD]LOURYQRPÞUQÞUHVS]GRODQDKRUX60RQRYHWWH®E\PÞODPìWYHVWRMÈQNXQHERěORĭQÜPNDUWRQRYÜPREDOXGRVWDWHNSURVWRUXDE\VHPRKODUR]SìQDW6WRMÈQN\]HVW\URSRUXQHERNRYXQHMVRXYKRGQÜSURWRĭHE\PRKO\]SġVRELWGLODWDÕQìWUKOLQ\=PUD]HQìQDWHSORWXƓ&şSčHG]PUD]HQìP]NRQWUROXMWH•,QWHUIHUHQFH2YÞčWHMHVWOL]PUD]HQìQHPÈQHJDWLYQìYOLYQDNUHYQìY]RUHNQHERQDDQDOĨ]X QDSčìNODGKHPROĨ]DVWDELOLWDDQDO\Wġ •&HQWULIXJDFH3RWčHEQÜYb]ÈYLVORVWLQDSOÈQRYDQÜDQDOĨ]H'RGUĭXMWHSRGPìQN\FHQWULIXJDFHYL]WHQWRGRNXPHQWYbÕÈVWLŚ&HQWULIXJDFHŗQHERQDZHERYÜVWUÈQFHhttps://www.sarstedt.com/en/service/centrifugation/,
DbSURYHØWHYL]XÈOQìNRQWUROXY]RUNX•+HPROĨ]D3OQÈNUHYSR]PUD]HQìKHPRO\]XMH$E\NbWRPXQHGRđORMHWčHEDSRXĭìWEXØ60RQRYHWWH®JHOSčìSDGQÞSRFHQWULIXJDFLSRXĭìWYHQWLORYĨıOWU6HUDSODV®, nebo vzorek odpipetovat do sekundární zkumavky.

Zmrazení na teplotu -20 °C – provedení:•Ochlazení: Ochlazujte S-Monovette®YHVYLVOÜSROR]HQHMSUYHSRGREXşPLQXW]bSRNRMRYÜWHSORW\QDWHSORWXƓb&WHSUYHSDNMLPġĭHWH]PUD]LWSčLWHSORWÞƓb&

•5R]PUD]HQì1HFKWHSRGREXQHMPÜQÞPLQXWUR]PUD]RYDWSčLSRNRMRYÜWHSORWÞ7DNÜYbWRPWRSčìSDGÞMHQXWQÜ]DEUÈQLWPHFKDQLFNÜPX]DWìĭHQì3čìOLđU\FKOÜUR]PUD]HQìPġĭHQHJDWLYQÞRYOLYQLWYĨVOHGN\DQDOĨ]\=PUD]HQìDbKOXERNÜ]PUD]HQìSčLWHSORWÞSRGbƓ&•+OXERNÜ]PUD]HQìSčLWHSORWÞSRGbƓ&YĨUREFHQHWHVWRYDO9]KOHGHPNbPQRKDPRĭQĨPRYOLYýXMìFìPIDNWRUġPGRSRUXÕXMHPHSURYÜVWWHVW]PUD]HQì]DEÞĭQĨFKODERUDWRUQìFKSRGPìQHN

Zmrazení zkumavky S-Monovette® gel:•

=PUD]HQìSURYHØWHMDNRYbERGÞ=PUD]HQìQDWHSORWXƓ&şSURYHGHQì•-H]QÈPRĭHYUVWYDJHOXVHPġĭHYbGġVOHGNXSURFHVX]PUD]RYÈQìPÞQLW•9]KOHGHPNbPQRKDPRĭQĨPRYOLYýXMìFìPIDNWRUġPGRSRUXÕXMHPHSURYÜVWWHVW]PUD]HQì]DEÞĭQĨFKODERUDWRUQìFKSRGPìQHN•

Rozmrazení:1HFKWHY]RUHNUR]PUD]LWYHVYLVOÜSROR]H3RUR]PUD]HQìSčHQHVWHPDWHULÈOSURY]RUN\SLSHWRX QLNROLGHNDQWDFì GRYĨđN\SčLEOLĭQÞbPPQDGJHORYRXYUVWYRX]bSULPÈUQìGRVHNXQGÈUQì]NXPDYN\=E\WHN
Y\KRØWH
832=251z13URVWDELOLWXDQDO\WġMHQXWQÜGRGUĭRYDWQÈYRG\NbSRXĭLWìRGYĨUREFġWHVWRYDFìFKÕLQLGHODQDO\]ÈWRUġ

33

CS2GEÞUNUYH
0HWRG\RGEÞUX5R]OLđXMHPHGYÞPHWRG\RGEÞUXDVSLUDÕQìPHWRGDDbYDNXRYÈPHWRGD$VSLUDÕQìPHWRGDXPRĭýXMHSURYÜVWNRQWURORYDQĨPWDĭHQìPSìVWQLFHđHWUQĨRGEÞUNUYHVbSO\QXOĨPDbSRPDOĨPWRNHPNUYH7ìPWR]SġVREHPO]HRNDPĭLWÞSčL]SġVRELWWRNNUYHYđHPSRGPìQNÈPDbRNROQRVWHPYbĭLOÈFKDbVQìĭLWKHPROĨ]X
9DNXRYÈPHWRGDXPRĭýXMHSURYÜVWRGEÞUNUYHSRPRFìSčHGHPY\WYRčHQÜKRYDNXDYH]NXPDYFHVbSO\QXOĨPDbU\FKOĨPWRNHPNUYH7DWRPHWRGDMHSURWRLGHÈOQìSčLGREUÜPVWDYXĭLODbSčLMHGQRGXFKĨFKSRGPìQNÈFKRGEÞUX
0DQLSXODFHSURRGEÞUNUYHYL]WDNÜYLGHRRbPDQLSXODFLVH]NXPDYNRX60RQRYHWWH®SčLSRXĭLWìDVSLUDÕQìPHWRG\QHERYDNXRYÜPHWRG\VbEH]SHÕQRVWQìMHKORXQHEREH]SHÕQRVWQìMHKORX0XOWLIO\®:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood3520,1,0$/,=$&,5,=,.$.217$0,1$&(1267(3¦,2'%z58.59(58.$9,&(1. Zvolte vhodnou zkumavku S-Monovette®SURSRĭDGRYDQĨY]RUHN2.

=YROWHPìVWRSURQDSìFKQXWìĭìO\3čLSčìSUDYÞPìVWDQDSìFKQXWìĭìO\GRGUĭXMWHVPÞUQLFHSčìVOXđQÜKR]GUDYRWQLFNÜKR]Dčì]HQì2GEÞUNUYHSRPRFìDVSLUDÕQìPHWRG\POZOR! S-Monovette®SRXĭìYHMWHSRX]HNbRGEÞUXNUYHDbQLNROLNbLQMHNFL
3RXĭìYHMWHSRX]HVbWÞPLWRMHKODPL EH]SHÕQRVWQì MHKO\60RQRYHWWH®QHER EH]SHÕQRVWQì MHKO\DGDSWÜU\0XOWLIO\® pro S-Monovette®).
=GHMH]REUD]HQRSRXĭLWìVbEH]SHÕQRVWQìMHKORX

kliknutí%H]SURVWčHGQÞSčHGQDSìFKQXWìPĭìO\]DVXýWH60RQRYHWWH®GRLQWHJURYDQÜKRGUĭÈNXEH]SHÕQRVWQìMHKO\ Db]DMLVWÞWHPìUQĨPRWRÕHQìPYHVPÞUXKRGLQRYĨFKUXÕLÕHN .
3RGOHSRWčHE\SčLORĭWHđNUWLGOR PD[PLQXWX 3čLSUDYWHPìVWRYSLFKXSRPRFìYKRGQÜKRGH]LQIHNÕQìKRSURVWčHGNX3RGH]LQIHNFLVHMLĭPìVWDYSLFKXĭìO\QHGRWĨNHMWH=YROWHSRORKXSDFLHQWDWDNDE\VWHPÞOLVQDGQĨSčìVWXSNbĭìOHDbSDĭLQHERMLQRXREODVWYSLFKXXbSDFLHQWDXPìVWÞWHWDNDE\VPÞčRYDODGROġ
2GVWUDýWHRFKUDQXMHKO\3URYHØWHQDSìFKQXWìĭìO\SìVWSRPDOXYWDKXMWHDbXYROQÞWHđNUWLGORMHđWÞNG\ĭNUHYSURXGìGR60RQRYHWWH® .
3RÕNHMWHGRNXGVHWRNNUYHQH]DVWDYìDE\VWHXPRĭQLOLVSUÈYQÜQDSOQÞQì

S-Monovette®RWRÕWHPìUQÞSURWLVPÞUXKRGLQRYĨFKUXÕLÕHN DbSRWRPY\WÈKQÞWH]bEH]SHÕQRVWQìMHKO\ RGSRMWH  %H]SHÕQRVWQìMHKOD]ġVWDQHYbĭìOH
3čLYìFHQÈVREQĨFKRGEÞUHFKQDSRMWHGDOđì]NXPDYN\60RQRYHWWHQDbEH]SHÕQRVWQìMHKOXDbRGHEHUWHGDOđìY]RUN\SRGOHYĨđHSRSVDQÜKRSRVWXSX
8NRQÕHQìRGEÞUXNUYH1HMSUYHRGSRMWH60RQRYHWWH®
+ SRWRPY\WÈKQÞWHEH]SHÕQRVWQìMHKOX]HĭìO\3RPRFìPHWRG\REVOXK\MHGQRXUXNRXDNWLYXMWHRFKUDQXMHKO\EXØQDVWDELOQìURYQÜSORđHşGRNXG
jehla nezacvakne (neaktivuje se) do ochrany jehly se ]QDWHOQĨPDbVO\đLWHOQĨPŚNOLNQXWìPŗşQHER]DWODÕHQìPXND]RYÈÕNHPQDVSRGQìNRQHFRFKUDQ\MHKO\YL]WDNÜQÈYRGNbSRXĭLWìSUR EH]SHÕQRVWQì MHKOXS-Monovette®QHER EH]SHÕQRVWQì MHKOX0XOWLIO\®.
.DĭGRX60RQRYHWWH®LKQHGSRRGSRMHQìRGEH]SHÕQRVWQìMHKO\RWRÕWHƅGQHPY]KġUXDbSRNRPSOHWQìPGRNRQÕHQìRGEÞUXNUYHRWRÕWHRSDWUQÞQÞNROLNUÈWGQHPY]KġUXYđHFKQ\Y]RUN\VbDQWLNRDJXODQW\
3URSčHSUDYXDbFHQWULIXJDFLY\WÈKQÞWHSìVWVO\đLWHOQÞGR]DFYDNÈYDFìSRORK\SìVWX (píst zacvakne do dna zkumavky S-Monovette® DbSìVWQLFL odlomte.
1.

0ìVWRYSLFKXVWODÕXMWHVWHULOQìPWDPSĂQHPGRNXGVHNUYÈFHQìQH]DVWDYì

2.

-DNPLOHVHNUHY]DÕQHVUÈĭHWSčLORĭWHYbSčìSDGÞSRWčHE\REYD]

3.

%H]SHÕQRVWQìMHKOX]OLNYLGXMWHYbRGSDGRYÜQÈGREÞQDRVWUĨRGSDG

34

CS2GEÞUNUYHSRPRFìYDNXRYÜPHWRG\
POZOR! S-Monovette®SRXĭìYHMWHSRX]HNbRGEÞUXNUYHDbQLNROLNbLQMHNFL
3RXĭìYHMWHSRX]HVbWÞPLWRMHKODPL EH]SHÕQRVWQì MHKO\60RQRYHWWH®QHER EH]SHÕQRVWQì MHKO\DGDSWÜU\0XOWLIO\® pro S-Monovette®).
=GHMH]REUD]HQRSRXĭLWìVbEH]SHÕQRVWQìMHKORX

kliknutí3URđHWUQÜ]DKÈMHQìRGEÞUXNUYHGRSRUXÕXMHVSROHÕQRVW6$567('7SURYÜVWSUYQìRGEÞUGR60RQRYHWWH®SRPRFìDVSLUDÕQìPHWRG\YL]7(&+1,.$1$3&+187Å/<DVSLUDÕQìPHWRGD
3RWRPSRNUDÕXMWHSRPRFìYDNXRYÜPHWRG\3čHGRGEÞUHPNUYHY\WÈKQÞWHSìVWSìVWQLFìDĭNHGQX60RQRYHWWH®DbQHFKWHMLVO\đLWHOQÞ]DFYDNQRXW . Potom píst odlomte .
7XWRSčHGHPSčLSUDYHQRX60RQRYHWWH®]DVXýWHGRLQWHJURYDQÜKRGUĭÈNXEH]SHÕQRVWQìMHKO\60RQRYHWWH®Db]DMLVWÞWHPìUQĨPRWRÕHQìPYHVPÞUXKRGLQRYĨFKUXÕLÕHN

+

–

.

.

3RÕNHMWHGRNXGVHWRNNUYHQH]DVWDYìDE\VWHXPRĭQLOLVSUÈYQÜQDSOQÞQì

S-Monovette®RWRÕWHPìUQÞSURWLVPÞUXKRGLQRYĨFKUXÕLÕHN DbSRWRPY\WÈKQÞWH]bEH]SHÕQRVWQìMHKO\ RGSRMWH  %H]SHÕQRVWQìMHKOD]ġVWDQHYbĭìOH
3čLYìFHQÈVREQĨFKRGEÞUHFKQDSRMWHQHMSUYHGDOđì]NXPDYN\60RQRYHWWHQDbEH]SHÕQRVWQìMHKOXDbSRWÜRGHEHUWHGDOđìY]RUN\SRGOHYĨđHSRSVDQÜKRSRVWXSX
8NRQÕHQìRGEÞUXNUYH
Nejprve odpojte S-Monovette® + SRWRPY\WÈKQÞWHEH]SHÕQRVWQìMHKOX]bĭìO\3RPRFìPHWRG\REVOXK\MHGQRXUXNRXDNWLYXMWHRFKUDQXMHKO\EXØQDVWDELOQìURYQÜSORđHşGRNXGMHKODQH]DFYDNQH QHDNWLYXMHse) do ochrany jehly se ]QDWHOQĨPDbVO\đLWHOQĨPŚNOLNQXWìPŗşQHER]DWODÕHQìPXND]RYÈÕNHPQDVSRGQìNRQHFRFKUDQ\MHKO\.DĭGRX60RQRYHWWH®LKQHGSRRGSRMHQìRGEH]SHÕQRVWQìMHKO\RWRÕWHƅGQHPY]KġUXDbSRNRPSOHWQìPGRNRQÕHQìRGEÞUXNUYHRWRÕWHRSDWUQÞQÞNROLNUÈWGQHPY]KġUXYđHFKQ\Y]RUN\VbDQWLNRDJXODQW\
1.

0ìVWRYSLFKXVWODÕXMWHVXFKĨPVWHULOQìPWDPSĂQHPGRNXGVHNUYÈFHQìQH]DVWDYì

2.

-DNPLOHVHNUHY]DÕQHVUÈĭHWSčLORĭWHYbSčìSDGÞSRWčHE\REYD]

3.

%H]SHÕQRVWQìMHKOX]OLNYLGXMWHYbRGSDGRYÜQÈGREÞQDRVWUĨRGSDG

35

CSCentrifugace
32=25=NXPDYN\6$567('760RQRYHWWHMVRXNRQVWUXRYÈQ\SURƅJ9ĨMLPNRXMVRX]NXPDYN\60RQRYHWWHRb¢PP 60RQRYHWWH®SHGLDWULH NWHUÜMVRXDNWXÈOQÞRYÞčHQ\GRƅJ3RXĭìYHMWHSRX]HYKRGQÜQRVLÕHUHVSYORĭN\]NXPDYHN&HQWULIXJDFH]NXPDYHN60RQRYHWWHVbWUKOLQDPLSRSčìSDGÞFHQWULIXJDFHSčLSčìOLđY\VRNÜPFHQWULIXJDÕQìP]U\FKOHQìPġĭH]SġVRELWSUDVNQXWì60RQRYHWWHSčLÕHPĭVHPRKRXXYROQLWSRWHQFLÈOQÞQHEH]SHÕQÜOÈWN\9ORĭN\FHQWULIXJ\MHWčHED]YROLWSRGOHYHOLNRVWLSRXĭLWĨFK]NXPDYHN60RQRYHWWH5HODWLYQìFHQWULIXJDÕQì]U\FKOHQìMHNbQDVWDYHQĨPRWÈÕNÈPPLQYbWRPWRSRPÞUX
5=% ƅUƅ RWPLQ 2,
5=%ŚUHODWLYQìFHQWULIXJDÕQì]U\FKOHQìWDNÜŚVìODJŗŗ DQJOLFN\5&)ŚUHODWLYHFHQWULIXJDOIRUFHŗ ŚRWPLQŗŚRWÈÕN\]DPLQXWXŗ RWPLQ QHERQ ŚSRÕHWRWÈÕHN]DPLQXWXŗ DQJOLFN\530ŚUHYROXWLRQVSHUPLQXWHŗ ŚUŗŚ3RORPÞUFHQWULIXJDFHRGVWčHGXFHQWULIXJ\NHbGQX60RQRYHWWH®“, (cm).
=NXPDYN\60RQRYHWWHEH]JHOXMHPRĭQÜFHQWULIXJRYDWYbFHQWULIXJÈFKVbURWRUHPVbSHYQĨPěKOHPQHERVbYĨN\YQĨPURWRUHP=NXPDYN\60RQRYHWWHVbJHOHPMVRXXUÕHQ\YĨKUDGQÞSURFHQWULIXJ\VbYĨN\YQĨPURWRUHP&HQWULIXJDFHYbFHQWULIXJÈFKVbURWRUHPVbSHYQĨPěKOHPQHQì]HVWUDQ\VSROHÕQRVWL6$567('7VFKYÈOHQDDbQHGRSRUXÕXMHVH
=NXPDYN\60RQRYHWWHE\PÞO\EĨWFHQWULIXJRYÈQ\]DQìĭHXYHGHQĨFKSRGPìQHNFHQWULIXJDFH3RNXGMVRXDSOLNRYÈQ\MLQÜSRGPìQN\PXVìMHYDOLGRYDWVÈPXĭLYDWHO-HQXWQÜ]DMLVWLWDE\E\O\]NXPDYN\60RQRYHWWHYHYORĭNÈFKFHQWULIXJ\SčHVQÞXVD]HQ\=NXPDYN\60RQRYHWWHNWHUÜ]bYORĭN\Y\ÕQìYDMìPRKRX]DYDGLWRbKODYLFLFHQWULIXJ\DbSUDVNQRXW1H]E\WQRXSRGPìQNRXMHURYQRPÞUQÜQDSOQÞQìFHQWULIXJ\'RGUĭXMWHSčLWRPQÈYRGNbSRXĭLWìFHQWULIXJ\
32=25 3UDVNOÜ ]NXPDYN\ 60RQRYHWWH QHY\MìPHMWH UXNRX3RN\Q\ SUR GH]LQIHNFL FHQWULIXJ\ QDMGHWH YbQÈYRGX NbSRXĭLWì FHQWULIXJ\

5HODWLYQìFHQWULIXJDÕQì]U\FKOHQì J

Podle BSDIN EN ISO 6710
4851+ (kód EU)–

S-Monovette®
bƅJ

bƅJ

bƅJ

bƅJ

bƅJ

Sérum

bPLQbPLQbPLQ

bPLQ

bPLQ

Sérum-gelbPLQbPLQ

bPLQ

bPLQ

bPLQ

Sérum express gel

bPLQbPLQ

bPLQ

neov.

neov.

Heparin lithný

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Heparin lithný gel

bPLQbPLQbPLQ

bPLQ

bPLQ

Heparin lithný gel+

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA

neov.

neov.

bPLQ

bPLQ

bPLQ

EDTA gelbPLQbPLQbPLQ

bPLQ

bPLQ

&LWUÈW

9 min

bPLQ

bPLQ

bPLQ

bPLQ

('7$ĲXRULGKHSDULQ

9 min

bPLQ

bPLQ

bPLQ

bPLQ

GlucoEXACT

9 min

bPLQ

bPLQ

bPLQ

bPLQ

&LWUÈW3%0bPO
3RORPÞURGVWčHØRYÈQì!bFP

9 min

bPLQ

bPLQ

bPLQ

bPLQ

&LWUÈW3%0bPO
3RORPÞURGVWčHØRYÈQì!DĭƉFP

neov.

neov.

bPLQ

neov.

neov.

QHRY QHRYÞčHQR
3ODWìSURYđHFKQ\]NXPDYN\VbYĨMLPNRX¢bPP 60RQRYHWWHSHGLDWULH &HQWULIXJDFHSčLbƓ&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry,VWDĭHQR,QIRUPDFHNbVHSDUDÕQìPXPDWHULÈOX
9ODVWQRVWLNRQ]LVWHQFHVHSDUDÕQìKRPDWHULÈOX JHO ]ÈYLVìQDWHSORWÞ3RNXGVH]NXPDYN\60RQRYHWWHSčHGQHERSčLFHQWULIXJDFLRFKODGìQHQìMLĭ]DUXÕHQDVRXYLVOÈYUVWYDVHSDUDÕQìKRJHOX=NXPDYN\60RQRYHWWHVHQHVPÞMì]QRYXRSDNRYDQÞFHQWULIXJRYDW

Likvidace1.

0XVìWHGRGUĭRYDWREHFQÜK\JLHQLFNÜSčHGSLV\Db]ÈNRQQÈXVWDQRYHQìXSUDYXMìFìčÈGQRXOLNYLGDFLLQIHNÕQìKRPDWHULÈOX2.

-HGQRUÈ]RYÜUXNDYLFH]DEUDýXMìUL]LNXLQIHNFH

3.

.RQWDPLQRYDQÜQHERQDSOQÞQÜV\VWÜP\SURRGEÞUNUYHMHWčHEDXORĭLWGRYKRGQĨFKRGSDGRYĨFKQÈGREQDELRORJLFN\QHEH]SHÕQĨPDWHULÈONWHUÜMHPRĭQÜQÈVOHGQÞVWHULOL]RYDWYbDXWRNOÈYXDbVSÈOLW

4.

/LNYLGDFHPXVìSUREìKDWYHYKRGQÜVSDORYQÞQHERSRPRFìDXWRNOÈYX VWHULOL]DFHSÈURX 

36

CS
1RUP\DbVPÞUQLFHVSHFLıFNÜSURGDQĨSURGXNWYbDNWXÈOQÞSODWQÜP]QÞQì
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

1RUP\SUR]NXPDYN\NbRGEÞUXĭLOQìNUYH
',1(1,62=NXPDYN\SURMHGQRUÈ]RYÜSRXĭLWìNbRGEÞUXĭLOQìNUYHXbOLGì*CLSI (Clinical and Laboratory Standards Institute).OìÕSURV\PERO\DbR]QDÕHQìqìVORYĨURENX

1DYìFSODWìSURMHGQRWOLYÞ]DEDOHQÜSURGXNW\

2]QDÕHQìđDUĭH

1HSRXĭìYHMWHSRNXGMHREDOSRđNR]HQ

3RXĭLWHOQÜGR-HGQRGXFKĨVWHULOQìEDULÜURYĨV\VWÜPVbYQÞMđìPRFKUDQQĨPREDOHP

2]QDÕHQì&(

6WHULOL]DFH]ÈčHQìP'LDJQRVWLFNĨ]GUDYRWQLFNĨSURVWčHGHN in vitro'RGUĭXMWHQÈYRGNbSRXĭLWì

3čLRSDNRYDQÜPSRXĭLWìQHEH]SHÕìNRQWDPLQDFH

8FKRYÈYHMWHPLPRGRVDKSčìPÜKRVOXQHÕQìKRVYÞWOD

6NODGXMWHYbVXFKX

9ĨUREFH=HPÞYĨURE\Sterilní dráha kapaliny

1HVWHULOL]XMWHRSDNRYDQÞ

7HFKQLFNÜ]PÞQ\Y\KUD]HQ\
9đHFKQ\]ÈYDĭQÜXGÈORVWLNHNWHUĨPGRđORYbVRXYLVORVWLVbSURGXNWHPMHWčHEDQDKOÈVLWYĨUREFLDbSčìVOXđQÜPXVWÈWQìPXRUJÈQX37

Brugsanvisning – SARSTEDT S-Monovette® blodprøvetagningssystemDA

Til diagnostisk in vitro brugPåtænkt anvendelse
S-Monovette® blodprøvetagningssystem, kanyler og adapter anvendes samlet som system til venøs blodprøvetagning. S-Monovette® blodprøvetagningssystem bruges til prøvetagning, transport, behandling og lagring
af blodprøver til diagnostisk bestemmelse in-vitro fra serum, plasma eller helblod på et klinisk laboratorium. Produktet er beregnet til anvendelse i et professionelt miljø og af medicinsk fag- og laboratoriepersonale.

Produktbeskrivelse
S-Monovette® blodprøvetagningssystem består af en plastikbeholder, et stempel, en stempelstang og en farvekodet plastikskruehætte med integreret membran, som blev udviklet specielt til tilslutning til en
S-Monovette®-(sikkerheds-)kanyle eller Multifly®-(sikkerheds-)kanyle, samt forskellige additiver (præparater). S-Monovette® fås også uden additiv. S-Monovette® blodprøvetagningssystem med additiverne
koagulationsaktivator, koagulationsaktivator med gel, lithiumheparin, lithiumheparin med gel, natriumheparin citrat, EDTA, fluourid-EDTA, flouridheparin, fluoridcitrat, CPDA samt uden additiv, hvis additivkoncentrater,
volumen af flydende additiver og deres tilladte tolerancer samt forholdet mellem blod og additiv opfylder kravene og anbefalingerne i den internationale standard DIN EN ISO 6710 "Single-use containers for venous
blood specimen collection" og Clinical and Laboratory Standards Institute’s Approved Standards (CLSI). Valget af additiv afhænger af den analytiske testmetode. De angives af producenten af testreagenser og/eller
analyseenheden med hvilken testen gennemføres. S-Monovette® blodprøvetagningssystemet fås i varianterne sterilt indvendigt eller individuelt pakket sterilt indvendigt og udvendigt.

Farvekoder for S-Monovette®-skruehætter*:

Additiv

BogstavskodeHættefarve DIN EN ISO
6710Hættefarve i henhold til BS
4851+

Z

hvid

hvid

Beholder uden præparering
S-Monovette® Neutral Z
Serumbeholder
S-Monovette® Serum CAT, med koagulationsaktivator

CAT

rød

hvid

S-Monovette® Serum-Gel CAT, med koagulationsaktivator og -gelCATmørkegulmørkegul

S-Monovette® Serum Express Gel CAT, med koagulationsaktivator trombin og gelCATorange–S-Monovette® Lithiumheparin LH, med lithiumheparin

LH

grøn

orangeS-Monovette®/LWKLXPKHSDULQĲ\GHQGH/+PHGOLWKLXPKHSDULQ

LH

grøn

orangeS-Monovette® Lithiumheparin-gel LH, med lithiumheparin og gel

LH

grøn

orangeS-Monovette® Lithiumheparingel+ LH, med lithiumheparin og hurtiggel

LH

grøn

orangeS-Monovette® Natriumheparin NH, med natriumheparin

NH

brun

grøn

S-Monovette® Ammoniakheparin AH, med ammoniakheparin

i.d.

blå

blå

S-Monovette® Citrat 9NC, natriumcitrat 3,13 %

9NC

blå

grøn

S-Monovette 3)$FLWUDW1&QDWULXPFLWUDWEXĳHUHW

9NC

lyseblå

–S-Monovette® K3 EDTA K3E, med kalium-EDTA

K3E

violetrød

S-Monovette® K2 EDTA K2E, med kalium-EDTA

K2E

violetrød

S-Monovette® K2 EDTA Gel K2E, med kalium-EDTA og gel

K2E

violetrød

S-Monovette®)OXRULG('7$)(PHGĲXRULGRJ('7$

FE

grå

gul

S-Monovette®)OXRULG+HSDULQ)+PHGĲXRULGRJKHSDULQ

FH

–

gul

S-Monovette®*OXFR(;$&7)&PHGĲXRULGFLWUDWRJ('7$FC

lyserød

grå

LH

mørkeblå

orangeS-Monovette® ThromboExact, med magnesiumforbindelse

i.d.

i.d., brombærfarveti.d., brombærfarvet

S-Monovette® CTAD

i.d.

i.d., blåi.d., grøn

S-Monovette® ACD

ACD

gul

gul

S-Monovette® CPDA

CPDA

gul

gul

S-Monovette® Hirudini.d.

i.d., olivengrøn

i.d., olivengrøn

S-Monovette® Homocystein HCY-Z Gel, med gel og stabilisatori.d.

i.d., gråi.d., gråS-Monovette®+RPRF\VWHLQ+&<&PHGFLWUDWEXĳHU

i.d.

i.d., violet

i.d., violet

S-Monovette® DNA Exacti.d.

i.d., blåi.d., blåHeparinbeholder

Citratbeholder®

EDTA-beholder

Beholder med glykolyseinhibitorer

Beholder til metalanalyse
S-Monovette® Metalanalyse LH, med lithiumheparin

Flere fuldblods- og plasmabeholdere

6NUXHOÎJHWIÎVLĲHUHIDUYHU
i.d.: ikke defineret+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry; trukket tilbage.

38

DA
SARSTEDT S-Monovette® Serum CAT/Serumgel CAT
S-Monovette® Serum CAT indeholder et plastikgranulat, der er belagt med en koagulationsaktivator (silikat), og bruges til udvinding af serum**. Plastikgranulatet sætter sig som følge af centrifugering mellem blodkage og
serum.
S-Monovette® Serum CAT indeholder ud over et plastikgranulat, der er belagt med en koagulationsaktivator (silikat), en polymerbaseret gel og bruges til udvinding af serum**. Gelen sætter sig som følge af centrifugering
mellem blodkage og serum og danner et stabilt skillelag under transport, opbevaring og analyse.
Serum anvendes som prøvemateriale i kliniske/kemiske og immunologiske rutineundersøgelser samt i serologien.
Efter blodprøvetagningen skal du lade blodet i S-Monovette® Serum CAT/Serumgel CAT koagulere i 30 minutter i opret position for at sikre et tydeligt skillelag efter centrifugeringen. Det anbefalede tidsrum er baseret på
en intakt koagulationsproces. Blod fra patienter med sygdomsbetingede koagulationsforstyrrelser eller under koagulationshæmmende behandlinger kræver i så fald mere tid, inden koagulationen er fuldstændig.

SARSTEDT S-Monovette® Serum Express Gel CAT
S-Monovette® Serum Express Gel CAT indeholder ud over det plastikgranulat, der er belagt med en koagulationsaktivator (trombin), en polymerbaseret gel og bruges til udvinding af serum**. Gelen sætter sig som følge
af centrifugering mellem blodkage og serum og danner et stabilt skillelag under transport, opbevaring og analyse.
Efter blodprøvetagningen skal du lade blodet i S-Monovette® Serum Express Gel koagulere i 5 minutter i opret position for at sikre et tydeligt skillelag efter centrifugeringen. Det anbefalede tidsrum er baseret på en intaktkoagulationsproces og gælder også for blod fra heparinbehandlede patienter. Blod fra patienter med sygdomsbetingede koagulationsforstyrrelser eller under koagulationshæmmende behandlinger, inklusive højdoseret
heparin, kræver mere tid, inden koagulationen er fuldstændig.
Serum anvendes som prøvemateriale i kliniske/kemiske og immunologiske rutineundersøgelser samt i serologien.

SARSTEDT S-Monovette® Neutral Z
S-Monovette® Neutral Z indeholder ingen præparering, hvilket giver en naturlig koagulation af blodprøven uden koagulationsaktivator og bruges til udvinding af serum**. Gennem centrifugering opnås en opdeling i
blodkage og serum.
Serum anvendes som prøvemateriale til brugerspecifikke undersøgelser.
Derudover kan S-Monovette® Neutral Z også anvendes som tombeholder på følgende måde: Hvis blodprøvetagningen skal startes med en S-Monovette® Citrat i kombination med en Multifly®-(sikkerheds-)kanyle(vingekanyle), anvendes S-Monovette® Neutral Z som første beholder (tombeholder) til fyldning af slangen på Multifly®-(sikkerheds-)kanylen.

SARSTEDT S-Monovette® Lithiumheparin LH / Lithiumheparin-Gel LH / Lithiumheparingel+ LH, Natriumheparin NH, Ammoniakheparin AH
S-Monovette® Lithiumheparin LH / Natriumheparin NH / Ammoniakheparin AH indeholder et plastikgranulat, der er belagt med koagulationshæmmeren (antikoagulant) lithiumheparin/natriumheparin/ammoniakheparin(normalt 16 I.E. heparin/ml blod) og bruges til udvinding af fuldblod og plasma**. Plastikgranulatet sætter sig som følge af centrifugering mellem blodceller og plasma.
Til en S-Monovette® Lithiumheparin LH uden plastikgranulat fås antikoagulanten lithiumheparin som sprøjtedosering (normalt 19 I.E. heparin/ml blod).
S-Monovette® Lithiumheparing LH indeholder ud over det plastikgranulat, der er belagt med antikoagulanten lithiumheparin (normalt 25 I.E. heparin/ml blod), en polymerbaseret gel og bruges til udvinding af serum**.
Gelen sætter sig som følge af centrifugering mellem blodceller og plasma og danner et stabilt skillelag under transport, opbevaring og analyse.
S-Monovette®-lithiumheparingel+ LH indeholder desuden en polymerbaseret gel, der muliggør en ca. 50 % reduceret centrifugeringstid til sammenligning med den sædvanlige S-Monovette®-lithiumheparingel.
Heparinplasma anvendes som prøvemateriale i kliniske/kemiske og immunologiske rutineundersøgelser. Heparinfuldblod anvendes som prøvemateriale i immunologiske rutineundersøgelser samt i serologien.
Koagulationshæmning med heparin sker gennem aktivering af antitrombin.
BEMÆRK: Med S-Monovette®-lithiumheparin LH, -lithiumheparingel/gel+ må der ikke udføres lithiumbestemmelser, med S-Monovette®-natriumheparin NH må der ikke udføres nogennatriumbestemmelser og med S-Monovette®-ammoniakheparin AH må der ikke udføres ammoniakbestemmelser. En S-Monovette® Lithiumheparin/Lithiumheparingel/Lithiumheparingel/Gel+/
Natriumheparin/Ammoniakheparin, der er fyldt med venøst blod, er ikke egnet til blodgasanalyse.

SARSTEDT S-Monovette® Metalanalyse
S-Monovette® Metalanalyse indeholder antikoagulanten lithiumheparin og anvendes til udvinding af fuldblod og plasma**. Litiumheparin fås i sprøjtedoseret form (19 I.E. heparin/ml blod).
Heparinfuldblod eller heparinplasma til S-Monovette® Metalanalyse i kombination med den specielle sikkerhedskanyle 21G x 1 ½" (varenr. 85.1162.600) anvendes som prøvemateriale til undersøgelse af sporelementer/
metaller. Sporelementerne/metallerne blev valideret ved hjælp af atomabsorptionsspektrometri (AAS). Til systemet med sikkerhedskanyle og S-Monovette® Metalanalyse opnås følgende maksimale tomværdier i ng/
system for følgende sporelementer:

ElementTl

ng/system

2,5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1,5

8,0

5,0

5

50

70

70

10

40

10

10

De maksimale tomværdier er angivet for hvert element på etiketten på S-Monovette®.
Bestemmelse af sporelementer sker afhængigt af analyseprocessen fra heparinfuldblod eller heparinplasma.
Koagulationshæmning med heparin sker gennem aktivering af antitrombin.

SARSTEDT S-Monovette® Citrat 9NC
S-Monovette® Citrat 9NC indeholder antikoagulanten trinatriumcitrat og anvendes til udvinding af fuldblod og plasma**. Trinatriumcitrat foreligger som 0,106 molær opløsning (3,13 % trinatriumcitratopløsning; ofte
afrundet til 3,2), og udgør 10 % af det nominelle volumen af en S-Monovette® Citrat. Blandingsforholdet mellem citrat og blod er 1:9 – 1 volumenandel citrat og 9 volumenandele blod. Korrekt fyldning er absolut
nødvendigt for analysen.
Citrat-plasma anvendes som prøvemateriale i hæmostaseologiske rutineundersøgelser.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af citrat.
Læs BEMÆRK-meddelelser under prøvetagning og håndtering ved kombinationen S-Monovette®-citrat og vingekanyle.

SARSTEDT S-Monovette® PFA 9NC
S-Monovette® PFA 9NC indeholder antikoagulanten trinatriumcitrat til udvinding af fuldblod og plasma**. Trinatriumcitrat foreligger som 0,129 molær bufferopløsning (3,8 % buffer; pH 5,5), og udgør 10 % af det
nominelle volumen af en S-Monovette® PFA. Blandingsforholdet mellem citrat og blod er 1:9 – 1 volumenandel citrat og 9 volumenandele blod. Korrekt fyldning er absolut nødvendigt for analysen.
Fuldblodet i S-Monovette® PFA 9NC anvendes som prøvemateriale til trombocytfunktionsbestemmelsen på SIEMENS Healthineers-analyseapparatet PFA og er valideret dertil.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af citrat.
Læs BEMÆRK-meddelelser under prøvetagning og håndtering ved kombinationen S-Monovette® PFA og vingekanyle.

SARSTEDT S-Monovette® CTAD
S-Monovette® CTAD indeholder antikoagulanten trinatriumcitrat samt theophyllin, adenosin og Dipyridamol og anvendes til udvinding af fuldblod og plasma**. CTAD foreligger som løsning og udgør 10 % af det nominelle
volumen af en S-Monovette® CTAD. Blandingsforholdet mellem CTAD og blod er 1:9 – 1 volumenandel citrat og 9 volumenandele blod. Korrekt fyldning er absolut nødvendigt for analysen.
CTAD-plasma anvendes som prøvemateriale til bestemmelse af blodpladefaktor 4 (PF4), beta(ß)-thromboglobulin (ßTG) og plasminogenaktivator-inhibitor (PAI-1) samt til hæmostaseologiske rutineundersøgelser.
Trombocytaktiveringen hæmmes i en periode på mindst 4 timer og anvendes til overvågning af heparainterapier.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af citrat.
Læs BEMÆRK-meddelelser under prøvetagning og håndtering ved kombinationen S-Monovette® CTAD og vingekanyle.
BEMÆRK: CTAD er gul. S-Monovette® CTAD skal beskyttes mod kunstig og naturligt lys under opbevaringen. Stærk lyspåvirkning i mere end 12 timer kan føre til inaktivering af additiverne.

39

DA
SARSTEDT S-Monovette® EDTA K2E / K3E
S-Monovette® EDTA K2E / S-Monovette® EDTA K3E indeholder antikoagulanten K2 EDTA eller K3 EDTA og anvendes til udvinding af fuldblod**.
K2 EDTA eller K3 EDTA foreligger i sprøjtedoseret form (1,6 mg EDTA/mg blod).
EDTA-fuldblod anvendes som prøvemateriale til hæmatologiske undersøgelser. Blodudstrygninger skal foretages inden for fire timer fra blodprøvetagningen.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af EDTA.
Blod fra S-Monovette® EDTA K2E/K3E kan også anvendes til immunhæmatologiske rutineundersøgelser og test af infektionssygdomme. Det er brugerens ansvar at validere egnetheden af prøvematerialet til disse
undersøgelser ved hjælp af de relevante testreagenser/analyseapparater inkl. opbevaringsbetingelser.

SARSTEDT S-Monovette® EDTA-Gel K2E
S-Monovette® EDTA-Gel K2E indeholder ud over antikoagulanten K2 EDTA en polymerbaseret gel og anvendes til udvinding af plasma**. K2 EDTA foreligger i sprøjtedoseret form (1,6 mg EDTA/mg blod). Gelen sætter
sig som følge af centrifugering mellem blodceller og plasma og danner et stabilt skillelag under transport, opbevaring og analyse.
EDTA-plasma anvendes som prøvemateriale til molekylær virusdiagnostik.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af EDTA.

SARSTEDT S-Monovette® Fluorid EDTA FE/Fluorid Heparin FH/Fluorid Citrat EDTA FC med glykolyseinhibitorer
S-Monovette® Fluorid EDTA FE indeholder antikoagulanten EDTA (1,2 mg/ml blod) samt fluorid (1,0 mg/ml blod) til glykolysehæmning og anvendes til udvinding af plasma**. Fluorid EDTA foreligger i sprøjtedoseret form.
S-Monovette® Fluorid Heparin FH indeholder antikoagulanten heparin (16 I.E. heparin/ml blod) samt fluorid (1,0 mg/ml blod) til glykolysehæmning og anvendes til udvinding af plasma**. Fluorid-heparin foreligger i
sprøjtedoseret form.
Glukosehæmningen alene som følge af fluorid begynder ca. 2 timer efter fyldning af blodprøvetagningsbeholderen og viser sin fulde virkning efter ca. 4 timer. Glukose opsamles derefter i mellemblod op til 6 % efter fåtimer og op til 10-15 % efter 24 timer i fuldblod.
S-Monovette® GlucoEXACT FC indeholder antikoagulanten EDTA samt citrat og fluorid til øjeblikkelig glykolysehæmning og anvendes til udvinding af plasma**. EDTA, Citrat og Fluorid foreligger som opløsninger.
Beregningen af glukosekoncentrationen kræver multiplikation med 1,16 på grund af fortyndingen.
S-Monovette® GlucoEXACT FC opfylder retningslinjerne for gestationsdiabetes fra det tyske diabetesselskab (Deutschen Diabetes Gesellschaft – DDG) og de nationale forsyningsretningslinjer (NVL) for diabetes type 2.
Den øjeblikkelige stabilisering af glukosekoncentrationen opretholdes i op til 96 timer ved rumtemperatur (se også SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / "Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours").
Fluorid-EDTA-(Citrat)plasma anvendes som prøvemateriale til glukosebestemmelse.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af EDTA.
%(0m5.)OXRULGNDQIRUÎUVDJHHQIRUĉJHOVHDIKÑPRO\VH'HUıQGHVĲHUHRSO\VQLQJHURPVXEVWDQVHUGHUNDQKDYHHQIRUVW\UUHQGHYLUNQLQJLGHQUHOHYDQWHEUXJVDQYLVQLQJIUDSURGXFHQWHQDI
testreagensen.
Læs BEMÆRK-meddelelser under prøvetagning og håndtering ved kombinationen S-Monovette® GlucoEXACT og vingekanyle.

SARSTEDT S-Monovette® CPDA
S-Monovette® CPDA indeholder antikoagulanten trinatriumcitrat samt citronsyre, natriumfosfat, dextrose og adenin og anvendes til udvinding af fuldblod og plasma**. CPDA findes som opløsningsmiddel.
Blandingsforholdet mellem CPDA og blod er 1:6 – 1 volumenandel citrat og 6 volumenandele blod. Korrekt fyldning er absolut nødvendigt for analysen.
CPDA fuldblod/plasma anvendes som prøvemateriale til blodgruppeserologi i transfusionsmedicin, til toleranceundersøgelser (krydsprøver) ved transfusioner. S-Monovette® CPDA egner sig konkret til
blodgruppebestemmelse (AB0) inklusive Kell og rhesusformel, test til søgning efter antistoffer for unormale blodgruppeantistoffer, polyspecifik direkte Coombs-test (til dag 10), tolerancetest (krydsprøve) med
blodgruppekompatibelt patientserum/-plasma (Major Test).
Transportvarigheden frem til opbevaring er valideret til maksimalt 4 timer ved 2-21 °C. Til sedimentering af celler skal prøverne først opbevares stående opret i mindst 16 timer i køleskab. Derefter kan de ovennævnte
analytter bestemmes analogt med den sædvanlige konserveringstid for stabiliseret blod efter lagring i køleskab (2-6 °C) i op til 35 dage (bortset fra direkte Coombs-test 10 dage). Egnet til søjleagglutinationsprocesser,
f.eks. på Vision Max fra Ortho Clinical Diagnostics. Prøvematerialet må ikke nedfryses.
Det er brugerens ansvar at validere egnetheden af prøvematerialet til disse undersøgelser ved hjælp af andre metoder/testreagenser/analyseapparater inkl. opbevaringsbetingelser, og denne skal selv udføre valideringen.
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af citrat.
Læs BEMÆRK-meddelelser under prøvetagning og håndtering ved kombinationen S-Monovette® CPDA og vingekanyle.

SARSTEDT S-Monovette® ThromboExact
S-Monovette® ThromboExact indeholder en magnesiumsalt som antikoagulant og anvendes til udvinding af fuldblod**. Magnesiumsaltet foreligger i sprøjtedoseret form.
Fuldblodet fra S-Monovette® ThromboExact anvendes som prøvemateriale til udelukkelse af falske lave trombocyttal på grund af en manglende tolerance for antikoagulationsmidler (f.eks. EDTA, citrat, heparin); ogsåkaldet pseudotromocytopeni. Dannelsen af trombocytaggregater forhindres, og bestemmelsen af det faktiske trombocyttal op til 12 timer efter blodtagning muliggøres.
Koagulationshæmning sker via magnesium-ionerne ved, at trombocytær Thromboxan A2 i magnesium-ionerne samt den aggregering af trombocytter, der sker gennem ADP og arachidonsyre, hæmmes.

SARSTEDT S-Monovette® Hirudin
S-Monovette® Hirudin indeholder antikoagulanten hirudin og anvendes til indvinding af fuldblod**. Hirudin foreligger i sprøjtedoseret form.
Hirudin-fuldblod anvendes til bestemmelse af trombocytfunktionen på Multiplate®-apparatet (analysator af flere blodpladefunktioner) fra ROCHE Diagnostics og er valideret hertil. Produktet anvendes til
behandlingsovervågning af blodpladehæmmende lægemidler samt til påvisning eller udelukkelse af forstyrrelser i trombocytfunktioner.
S-Monovette® Hirudin blev udviklet specielt til bestemmelse af trombocytfunktionen sammen med virksomheden Verum Diagnostica, i dag ROCHE Diagnostics, på Multiplate®-apparatet.
Koagulationshæmningen sker via Hirudin gennem direkte trombinhæmmelse og muliggør dermed diagnostik af trombocytfunktion i lokal tilstand.

SARSTEDT S-Monovette® Homocystein HCY-Z-gel / HCY-C
S-Monovette® Homocystein HCY-Z-gel indeholder ud over et plastikgranulat, der er belagt med en koagulationsaktivator (silikat), en special stabilisator samt en polymerbaseret gel og bruges til udvinding af serum**.
Gelen sætter sig som følge af centrifugering mellem blodkage og serum og danner et stabilt skillelag under transport, opbevaring og analyse. Præpareringen foreligger i sprøjtebaseret form.
Homocystein stabiliseres i op til 8 timer i fuldblod ved rumtemperatur. Hvis centrifugeringen sker inden for de første 8 timer med korrekt dannet skillelag mellem blodkage og serum, stabiliseres homocystein i op til 96
timer.
Serummet fra S-Monovette® Homocystein HCY-Z-gel anvendes som prøvemateriale til bestemmelse af homocystein. S-Monovette® Homocystein HCY-C indeholder en sur citrat (pH 4,3) som antikoagulant og anvendes
til udvinding af plasma**. Der findes citrat som opløsningsmiddel. Beregningen af homocysteinkoncentrationen kræver multiplikation med 1,11 på grund af fortyndingen.
Homocystein stabiliseres i op til 6 timer ved rumtemperatur og ved 4 °C op til 48 timer i fuldblod.
Plasmaet fra S-Monovette® Homocystein HCY-C anvendes som prøvemateriale til bestemmelse af homocystein.
Koagulationshæmning i S-Monovette® Homocystein HCY-C sker gennem kompleksdannelse af calcium-ionerne ved hjælp af citrat.
Læs BEMÆRK-meddelelser under prøvetagning og håndtering ved kombinationen S-Monovette® HCY-C og vingekanyle.

SARSTEDT S-Monovette® DNA Exact
S-Monovette® DNA Exact indeholder en antikoagulant på EDTA-basis og anvendes til udvinding af fuldblod**. Fluorid EDTA foreligger i sprøjtedoseret form.
EDTA-fuldblod anvendes som prøvemateriale til stabilisering af gDNA. Stabiliseringsydelsen for gDNA er valideret over fem dage ved 35 °C, 14 dage ved rumtemperatur (22 °C), 28 dage ved køling (4 °C) og mindst 1 år
ved -20 °C. De stabiliserede prøver kan desuden holde til 5 frysnings- og optøningscyklusser uden kvalitetsreduktion. Se også SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature/"SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis".
Koagulationshæmning sker gennem kompleksdannelse af calcium-ionerne ved hjælp af EDTA.

3UĉYHPDWHULDOHWVHJQHWKHGDIKÑQJHUDIDQDO\WWHQRJWHVWUHDJHQVHQDQDO\VHDSSDUDWHW6SHFLıNDWLRQHUQHIUDSURGXFHQWHQDIDSSDUDWHWVNDORYHUKROGHV

40

DA
Sikkerhedsanvisninger/fareanvisninger
1.

Generelle forholdsregler: Brug handsker og andet generelt personligt værnemiddel til at beskytte dig mod blod og mulig eksponering for sygdomsfremkaldende organismer.

2.

Håndter alle biologiske prøver og skarpe/spidse blodopsamlingsredskaber (kanyler) i henhold til din institutions politikker og procedurer. I tilfælde af en direkte kontakt med biologiske prøver eller en stikskade,
VNDOGHUVĉJHVOÑJHGD+,9+&9+%9HOOHUDQGUHLQIHNWLRQVV\JGRPPHNDQRYHUIĉUHV%UXJVLNNHUKHGVNDQ\OHU6DIHW\0XOWLĲ\®-kanyler med indbygget nålebeskyttelse. Organisationens sikkerhedspolitikker og-procedurer skal følges.

3.

Gælder for enkeltpakkede sterile produkter: Kontrollér hver enkelt emballage for beskadigelse inden brug, og brug ikke indholdet, hvis emballagen er beskadiget.

4.

3URGXNWHWHUEHUHJQHWWLOHQJDQJVEUXJ%RUWVNDIDOOHVNDUSHVSLGVHJHQVWDQGH NDQ\OHUDGDSWHUH WLOEORGSUĉYHWDJQLQJLHJQHGHDĳDOGVEHKROGHUHWLOELRORJLVNIDUOLJHVWRĳHU

5.

Hvis der udtages blod via en intravenøs (IV) adgang, skal sikres, at adgangen skylles korrekt i henhold til institutionens anvisninger (=rengøres for IV-opløsning), før blodtagningen startes. Korrekt skylning af
adgangen forebygger forkerte analyseresultater.

6.

En underfyldning af S-Monovette® fører til et forkert forhold mellem blod til præparering/additiv og kan føre til forkerte analyseresultater.

7.

Det blod, der er udtaget og behandlet ved hjælp af S-Monovette®, er ikke beregnet til geninjicering i den menneskelige krop.

8.

Produktet må ikke anvendes efter udløbsdatoen. Holdbarheden slutter den sidste dag i den angivne måned og det angivne år.

Opbevaring
Produktet skal opbevares ved stuetemperatur frem til anvendelsen.

Begrænsninger
1.

Opbevaringstid og -temperatur for en fyldt S-Monovette® afhænger af holdbarheden af de analytter, der skal undersøges. Vurderingen foretages af laboratoriet, eller oplysningerne fremgår af brugsanvisningerne fra
producenten af testreagenserne/analyseenhederne.

2.

Også når plasma eller serum adskilles via centrifugering af S-Monovette®SURGXNWHURJHOOHUGHUIRUHıQGHVHQEDUULHUHDGVNLOOHVLNNHQĉGYHQGLJYLVDOOHFHOOHUIXOGVWÑQGLJW5HVWHUHQGHVWRIVNLIWHHOOHUQDWXUOLJ
nedbrydning kan påvirke koncentrationen af analytter. Analyttens stabilitet skal vurderes i forhold til opbevaringsbeholderen og betingelserne på det pågældende laboratorium.

3.

I forbindelse med terapeutiske lægemidler skal prøvematerialets egnethed kontrolleres iht. brugsanvisningerne fra producenten af testreagenserne/analyseenheden.

4.

Analyser af sporelementer/metaller skal gennemføres med systemet S-Monovette®-metalanalyse + (sikkerheds)kanyle til metalanalyse.

Prøvetagning og håndteringLÆS HELE DOKUMENTET OMHYGGELIGT IGENNEM, INDEN DU PÅBEGYNDER BLODPRØVETAGNINGEN FRA VENE.
Arbejdsmateriale, der kræves til prøvetagning
1.

Alle påkrævede S-Monovette® blodprøvetagningssystemer.

2.

6LNNHUKHGV NDQ\OHUHOOHU0XOWLĲ\®(sikkerheds-)kanyler.

3.

Handsker, kittel, øjenværn eller anden passende beskyttelsesbeklædning til beskyttelse mod blodbårne sygdomsfremkaldende organismer eller potentielt smitsomme materialer.

4.

(WLNHWWHUWLOSDWLHQWLGHQWLıNDWLRQ5.

Desinfektionsmateriale til rengøring af prøveudtagningsstedet (følg anordningens retningslinjer for klargøring af stedet til prøveudtagningen). Brug ikke alkoholbaserede rengøringsmidler, hvis prøverne skal bruges til
test af blodalkohol.

6.

Tørre, aseptiske engangsservietter.

7.

Tourniquet.

8.

Plaster eller forbinding.

9.

%RUWVNDĳHOVHVEHKROGHUWLOVNDUSHVSLGVHJHQVWDQGHWLOVLNNHUERUWVNDĳHOVHDIEUXJWPDWHULDOH

Anbefalet udtagningsrækkefølge:1.

%ORGNXOWXUĲDVNHU

2.

Beholdere med citrat eller koagulationsaktivator (med/uden Gel Serum CAT/Serumgel CAT)

3.

Beholdere med koagulationsaktivator eller citrat

4.

Beholdere med heparin med/uden gel

5.

Beholdere med EDTA med/uden gel

6.

Beholdere med glykolyseinhibitorer

7.

Beholdere med andre additiverBEMÆRK: Hvis udtagning af en citratbeholder eller en anden beholder med en væskepræparation såsom PFA, CTAD, CPDA, HCY-C eller GlucoEXACT startes i kombination med en vingekanyle (f.eks.
PHG0XOWLĲ\®-(sikkerheds-)kanyle, anbefales forudgående udtagning af en tombeholder (f.eks. S-Monovette® Neutral Z) for at undgå underfyldning af beholderen under fyldning af slangenpå vingekanylen.
Derved sikres korrekt fyldning af beholderen og dermed et korrekt blandingsforhold (væske i forhold til blod).
BEMÆRK: Følg udtagningsrækkefølgen i forskrifterne fra din institution.

Forebyggelse af tilbageløb
De fleste S-Monovetterindeholder kemiske additiver. Tilbageløb forhindres ved at overholde følgende anvisninger:
1. Brug udelukkende de materialer, der er anbefalet i brugsanvisningen.
2.

Placeér patienten, så der er let adgang til venen, og armen eller et andet punktionsområde på patienten vender nedad.

3.

Hold S-Monovette®PHGVNUXHOÎJHWRSDGRJYHGDQYHQGHOVHQDIHQ0XOWLĲ\®-(sikkerheds)kanyle desuden under armniveau/punktionsområde.

4.

Der skal sikres, at indholdet af S-Monovette® ved venepunktur ikke berører hverken skruehætten eller enden af kanylen.

5.

/ĉVQWRXUQLTXHWHQPHQVEORGHWĲ\GHULQGL60RQRYHWWH®.

41

DA
Nedfrysning/optøning
I henhold til anbefalingerne fra Verdenssundhedsorganisationen (WHO/DIL/Lab/99.1 Rev.02) anbefales, at serum/plasma adskilles før frysning af blodceller.
For S-Monovette® gælder følgende anbefalinger for frysning:
Nedfryses under 0 °C•

Anvendelse i minustemperaturområdet skal grundlæggende set testes under virkelige betingelser, fordi belastningen af beholderen kan være meget forskellig alt efter det medium, der skal fryses, og
rutinebetingelserne (se kapitlet Materialeegenskaber i SARSTEDT-kataloget).

•Som udgangspunkt reduceres fasthedsværdierne for plast i temperaturområdet under 0 °C. Mekaniske belastninger skal derfor generelt undgås.

•Frysningsbetingelserne skal vælges, så indholdet af S-Monovette® fryses enten regelmæssigt eller nedefra og op. S-Monovette® skal have nok plads i holderen eller opbevaringspakken til, at den kan udvide sig.
Holdere af styropor eller metal er ikke egnede, fordi de kan føre til udvidelsesrevner.

Frysning ved -20 °C – Kontrollér før frysning:•

Interferenser: Kontrollér, om frysningen har forstyrrende påvirkninger af blodprøven eller analysen (f.eks. hæmolyse, stabilitet af analytter).

•

Centrifugering: Kan kræves i forhold til den planlagte analyse. Centrifugeringsbetingelser (se dette dokument under "Centrifugering", eller følg https://www.sarstedt.com/en/service/centrifugation/ på SARSTEDTwebstedet, samt gennemfør visuelle prøvekontroller).

•Hæmolyse: Fuldblod hæmolyserer ved frysning: Det kan undgås ved enten at anvende S-Monovette®-gelen eller efter centrifugeringen Seraplas®YHQWLOıOWHUHOOHUYHGDWDISLSHWWHUHSUĉYHQWLOHQVHNXQGÑUEHKROGHU

Frysning ved -20 °C – Gennemførelse:•

Nedkøling: Afkøl S-Monovette® stående opret over en periode på 45-60 min. fra rumtemperatur til +4 °C, før de kan fryses ved -20 °C.

•

Optøning: Lad optø stående opret i mindst 45 min. ved rumtemperatur. Også her skal mekaniske belastninger undgås. En for hurtig optøning kan have negativ virkning på analyseresultaterne.

Frysning og dybfrysning under -20 °C•

Dybfrysning ved en temperatur under -20 °C blev ikke godkendt af producenten. På grund af de mange mulige påvirkninger anbefales at gennemføre frysningstest under laboratorierutinebetingelser.

Frysning af S-Monovette®-gel:•

Frysningen sker som under punktet Frysning ved -20 °C – Gennemførelse.

•

Det er kendt, at gellaget kan blive forandret som følge af frysningsprocessen.

•På grund af de mange mulige påvirkninger anbefales at gennemføre frysningstest under laboratorierutinebetingelser.

•

Optøning: Lad prøven optø stående opret. Overfør prøvematerialet efter optøning via afpipettering (ikke dekantering) til ca. 2 mm over gellaget fra den primære beholder til en sekundær beholder. Bortskaf resten.
BEMÆRK: For analytternes stabilitet skal der følges producenternes brugsanvisninger for testreagenser/analyseenheder.

42

DA
Blodprøvetagning
Teknikker til blodprøvetagning
Der skelnes mellem to blodprøveteknikker: aspirationsteknik og vakuumteknik.
Et kontrolleret træk i stempelstangen under aspirationen muliggør skånende blodprøvetagning med en kontinuerlig, langsom blodstrøm. På den måde kan blodstrømmen umiddelbart tilpasses alle veneforhold og
situationer, samt reducere hæmolyse.
Vakuumteknikken muliggør blodprøvetagning med en forud tømt beholder i henhold til undertryksprincippet med en kontinuerlig og hurtig blodstrøm. Derfor er denne teknik ideel egnet til gode veneforhold og simple
udtagningsbetingelser.
Håndtering til blodindtagelse: Se også håndteringsvideoen til S-Monovette® i aspirationsteknikken eller vakuumteknikken med sikkerhedskanylen eller Multifly®-sikkerhedskanylen:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
TIL MINIMERING AF EKSPONERINGSRISIKO UNDER BLODPRØVETAGNINGEN SKAL DER BRUGES HANDSKER.
1. Vælg en egnet S-Monovette® til den påkrævede prøve.
2.

Vælg stedet til venepunktur. Følg institutionens retningslinjer for forberedelse af venepunkturstedet.

Blodprøvetagning med aspirationsteknikken
Advarsel! Anvend udelukkende S-Monovette® til blodprøvetagning og ikke til injektion.
Må kun anvendes med disse kanyler (S-Monovette®-(sikkerheds-)kanyler, eller Multifly®-(sikkerheds-)kanyler/adapter til S-Monovette®).
Her vises anvendelsen med sikkerhedskanyle:klik

Umiddelbart før venepunktionen skubbes S-Monovette® ind i den integrerede holder på sikkerhedskanylenog fastgøres gennem let drejning i urets retning .
Anlæg tourniquet ved behov (maks. 1 minut). Forbered punkturstedet med et egnet desinfektionsmiddel. Berør ikke længere venepunkturstedet efter desinfektion. Placeér patienten, så der er let
adgang til venen, og armen eller et andet punktionsområde på patienten vender nedad.
Aftag nålebeskyttelsen. Punktér venen, træk langsomt stempelstangen tilbage, og løsn tourniqueten, mens blodet flyder ind i S-Monovette®-produktet
Vent, indtil blodstrømmen stopper, for at muliggøre korrekt fyldning.

.

Bevæg S-Monovette® gennem let drejning mod urets retning , og træk det derefter ud af sikkerhedskanylen (frakobling) . Sikkerhedskanylen forbliver i venen.
I tilfælde af flere tilbagetrækninger, som beskrevet ovenfor, skal følgende S-Monovetterforbindes med sikkerhedskanylen, og yderligere prøver udtages.
Gennemførelse af blodprøvetagningen: Frakobl først S-Monovette®
+ , og træk derefter sikkerhedskanylen ud af venen. Aktivér nålebeskyttelsen med enhåndsteknik enten på stabilt, jævnt underlag (indtil
kanylen går i indgreb (aktiveres) i nålebeskyttelsen med et mærk- og hørbart "klik"), eller ved at trykke pegefingeren mod den nederste ende af nålbeskyttelsen. Se også brugsanvisningen til S-Monovette®(sikkerheds-)kanyle eller Multifly®-(sikkerheds-)kanyle.
Vend hver S-Monovette® én gang på hovedet umiddelbart efter frakobling af sikkerhedskanylen, og vend forsigtigt alle prøver med antikoagulationsmiddel flere gange på hovedet efter fuldførelse af
blodudtagningen.
Træk stempelstangen hørbart ind i stemplets
indgrebsposition (stemplet går i indgreb med S-Monovette®-bunden) til transport og centrifugering, og knæk stempelstangen af.
1.

Tryk på punkturstedet med en tør og steril vatrondel, indtil blødningen ophører.

2.

Så snart blodkoagulation er indtrådt, anlægges forbinding, hvis det ønskes.

3.

%RUWVNDIVLNNHUKHGVNDQ\OHQLHQHJQHWERUWVNDĳHOVHVEHKROGHUWLOELRORJLVNIDUOLJHVWRĳHU

43

DA
Blodprøvetagning med vakuumteknikken
Advarsel! Anvend udelukkende S-Monovette® til blodprøvetagning og ikke til injektion.
Må kun anvendes med disse kanyler (S-Monovette®-(sikkerheds-)kanyler, eller Multifly®-(sikkerheds-)kanyler/adapter til S-Monovette®).
Her vises anvendelsen med sikkerhedskanyle:klik

Til skånende start på blodprøvetagningen anbefaler SARSTEDT, at den første S-Monovette® tages ud ved hjælp af aspirationsteknik (se VENEPUNKTURTEKNIK aspirationsteknik
Fortsæt derefter med vakuumteknikken.
Før blodprøvetagningen trækkes stemplet ved hjælp af stempelstangen til S-Monovette®-bunden, og lades gå hørbart i indgreb . Derefter knækkes stempelstangen af .
Skub denne forberedte S-Monovette® ind i den integrerede holder på S-Monovette®-sikkerhedskanylen, og fastgør den gennem let drejning i urets retning

+

–

).

.

Vent, indtil blodstrømmen stopper, for at muliggøre korrekt fyldning.

Bevæg S-Monovette® gennem let drejning mod urets retning , og træk det derefter ud af sikkerhedskanylen (frakobling) . Sikkerhedskanylen forbliver i venen.
I tilfælde af flere tilbagetrækninger, som beskrevet ovenfor, skal følgende S-Monovetterførst forbindes med sikkerhedskanylen, og yderligere prøver udtages.
Gennemførelse af blodprøvetagningen:Frakobl S-Monovette® + , og træk derefter sikkerhedskanylen ud af venen. Aktivér nålebeskyttelsen med enhåndsteknik enten på stabilt, jævnt underlag (indtil kanylen går i indgreb (aktiveres) inålebeskyttelsen med et mærk- og hørbart "klik"), eller aktivér nålebeskyttelsen ved at trykke pegefingeren mod den nederste ende af nålbeskyttelsen.
Vend hver S-Monovette® én gang på hovedet umiddelbart efter frakobling af sikkerhedskanylen, og vend forsigtigt alle prøver med antikoagulationsmiddel flere gange på hovedet efter fuldførelse af
blodudtagningen.
1.

Tryk på punkturstedet med en tør og steril vatrondel, indtil blødningen ophører.

2.

Så snart blodkoagulation er indtrådt, anlægges forbinding, hvis det ønskes.

3.

%RUWVNDIVLNNHUKHGVNDQ\OHQLHQHJQHWERUWVNDĳHOVHVEHKROGHUWLOELRORJLVNIDUOLJHVWRĳHU

44

DACentrifugering
PAS PÅ! SARSTEDT S-Monovetterer beregnet til 4000 x g. Undtagelsen er S-Monovettermed Ø 8 mm (S-Monovette® Pædiatri), der aktuelt er valideret til 2500 x g. Der må kun anvendes passende bærerør ellerindsatser. Centrifugeringen af S-Monovettermed revner eller centrifugering ved for høj centrifugalacceleration kan føre til brud på S-Monovetterne, hvorved potentielt infektiøst materiale kan frigives.
Vælg centrifugeindsatser i forhold til størrelse af de anvendte S-Monovetter. Den relative centrifugalacceleration er relateret til det indstillede antal omdrejninger/min.:
RCA = 11,2 x r x (o/min./1000)2,"RCA": "Relativ centrifugalkraft" og kaldet "g-kraft"", (engelsk: RCF "relative centrifugal force"),"O/min.": "Omdrejninger pr. minut" (o/min.) eller: n = "omdrejningstal pr. minut" (engelsk: RPM "revolutions per minute"),"r": "Centrifugeringsradius fra midten af centrifugen til bunden af S-Monovette®", (cm).
S-Monovetteruden gel kan centrifugeres i centrifuger med fastvinkel- eller drejningsrotor.
S-Monovettermed gel er udelukkende beregnet til centrifuger med drejningsrotor. Centrifugering i centrifuger med fastvinkelrotor er ikke valideret af SARSTEDT og anbefales ikke.
S-Monovette-rskal centrifugeres i henhold til de nedenfor angivne centrifugeringsbetingelser. Hvis der skal anvendes andre betingelser, skal brugeren selv validere disse.
Der skal sikres, at S-Monovetterpasser korrekt i centrifugeindsatserne. S-Monovette-produkter, der rager ud over indsatserne, kan sidde fast i centrifugehovedet og knække. Centrifugen skal fyldes jævnt. Følg herved
brugsanvisningen til centrifugen.
ADVARSEL! Knækkede S-Monovette-produkter må ikke fjernes med hånden.
$QYLVQLQJHU WLO GHVLQıFHULQJ DI FHQWULIXJHQ ıQGHV L EUXJVDQYLVQLQJHQ WLO FHQWULIXJHQ

Relativ centrifugalacceleration (g)I henhold til
BS 4851+ (EU- DIN EN ISO 6710
kode)

–

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*Serum

10 min10 min

6 min

4 min

4 min

Serumgel15 min10 min

4 min

4 min

4 min

Serum Express Gel

15 min10 min

4 min

i.v.

i.v.

Litiumheparin

10 min10 min

7 min

7 min

7 min

Litiumheparingel

15 min15 min10 min

7 min

7 min

Litiumheparingel+

8 min

7 min

5 min

4 min

4 min

EDTA

i.v.

i.v.

7 min

6 min

5 min

EDTA-gel15 min10 min10 min

7 min

7 min

Citrat

9 min

8 min

7 min

6 min

5 min

('7$ĲXRULGKHSDULQ

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Citrat PBM 1,8 ml
Centrifugeradius > 17 cm

9 min

8 min

7 min

6 min

5 min

Citrat PBM 1,8 ml&HQWULIXJHUDGLXV!WLOƉFP

i.v.

i.v.

10 mini.v.

i.v.

i.v. = ikke valideret* Gælder for alle S-Monovettermed undtagelse af Ø 8 mm (S-Monovette Pædiatri)Centrifugering ved 20 ºC+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry; trukket tilbage.

Oplysninger om skillemateriale
Skillematerialets (gel) flydeegenskaber er temperaturafhængige. Hvis S-Monovetterkøles før eller under centrifugeringen, kan et gennemgående lag skillegel ikke længere garanteres.
S-Monovettermå ikke centrifugeres igen.

%RUWVNDĳHOVH
1.

'HJHQHUHOOHK\JLHMQHUHWQLQJVOLQMHUVDPWGHORYPÑVVLJHEHVWHPPHOVHUIRUNRUUHNWERUWVNDĳHOVHDILQIHNWLĉVHPDWHULDOHUVNDOIĉOJHVRJRYHUKROGHV2.

Engangshandsker formindsker risikoen for infektion.

3.

.RQWDPLQHUHGHHOOHUI\OGWHEORGWDJQLQJVV\VWHPHUVNDOERUWVNDĳHVLHJQHGHERUWVNDĳHOVHVEHKROGHUHWLOELRORJLVNIDUOLJHVWRĳHUVRPHIWHUIĉOJHQGHNDQDXWRNODYHUHVRJEUÑQGHV4.

%RUWVNDĳHOVHQVNDOVNHLHWHJQHWIRUEUÑQGLQJVDQOÑJHOOHUYHGKMÑOSDIDXWRNODYHULQJ GDPSVWHULOLVHULQJ 

45

DA
3URGXNWVSHFLıNNHQRUPHURJUHWQLQJVOLQMHULGHQWLOHQKYHUWLGJÑOGHQGHXGJDYH
CLSI* GP39 "Tubes and Additives for Venous and Capillary Blood Specimen Collection", Approved Standard.
CLSI* GP41 "Collection of Diagnostic Venous Blood Specimens", Approved Standard.
CLSI* GP44 "Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests", Approved Guideline.
CLSI* H21 "Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays", Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 "WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002".

Standarder for beholdere til venøs blodprøvetagning:
DIN EN ISO 6710: Beholdere til engangsbrug til venøs blodprøvetagning hos mennesker*CLSI (Clinical and Laboratory Standards Institute)

6\PERORJLGHQWLıFHULQJVNRGHU

Varenummer

Desuden gælder for enkeltpakkede sterile produkter:

Batchnummer

Anvendes ikke, hvis emballagen er beskadiget

Mindst holdbar til

Enkelt sterilt barrieresystem med beskyttende udvendig emballage

CE-mærke

Sterilisering ved bestråling

In-vitro-diagnostik

Følg brugervejledningen

Ved genanvendelse: Fare for kontaminering

Opbevares beskyttet mod sollys

Opbevares tørt

ProducentFremstillingsland

Steril væskebaneMå ikke gensteriliseres

Tekniske ændringer forbeholdes.
Alle alvorlige hændelser, der er opstået i forbindelse med dette produkt, skal meddeles producenten og den kompetente nationale myndighed.

462ǳǶǲǮǴǿȄǾǭȀǴȆǿşǣȊȀȁǶƑǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH® SARSTEDTEL

ǕǸǰin-vitroǳǸǰǲǻȆȀȁǸǹǭȄǾǭȀǶ
ǡǾǽǽǾǸǵȉƑǴǻǶȄǾǭȀǶ
ǤǰȀȂȀȁǭƑǰȁǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH®ǽǸǱǴǺȉǻǴǿǹǰǸǽǸȂƒǽǳǽȄǴǮǿȄǾǶȀǸƑǽƒǽǸǽȊǻȁǰǸƑǰǵǮȆǿȀȊȀȁǶƑǰǲǸǰȁǶȀȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻȃǺǴǱǸǹǽȊǰǮƑǰȁǽǿǤǰȀȂȀȁǭƑǰȁǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH®ȄǾǶȀǸƑǽƒǽǸǽȊǻȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭȁǶƑǴȁǰȃǽǾǫȁǶǻǴƒǴǼǴǾǲǰȀǮǰǹǰǸȁǶǻǰƒǽǷǭǹǴȂȀǶǳǴǸǲƑǫȁȆǻǰǮƑǰȁǽǿǲǸǰǳǸǰǲǻȆȀȁǸǹǽȊǿƒǾǽȀǳǸǽǾǸȀƑǽȊǿin vitroǰƒȉǽǾȉƒǺǫȀƑǰǭǽǺǸǹȉǰǮƑǰȀȁǽǹǺǸǻǸǹȉǴǾǲǰȀȁǭǾǸǽǤǽƒǾǽȇȉǻƒǾǽǽǾǮǵǴȁǰǸǲǸǰȁǶǻǴȃǰǾƑǽǲǭȀǴǴƒǰǲǲǴǺƑǰȁǸǹȉƒǴǾǸǱǫǺǺǽǻǹǰǸǲǸǰȄǾǭȀǶǰƒȉǹǰȁǰǾȁǸȀƑǬǻǽǸǰȁǾǸǹȉǹǰǸǴǾǲǰȀȁǶǾǸǰǹȉƒǾǽȀȆƒǸǹȉǡǴǾǸǲǾǰȃǭƒǾǽȇȉǻȁǽǿ
ǤǰȀȂȀȁǭƑǰȁǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH®ǰƒǽȁǴǺǽȊǻȁǰǸǰƒȉǬǻǰƒǺǰȀȁǸǹȉȀȆǺǶǻǫǾǸǽǬǻǰǬƑǱǽǺǽǬǻǰǱǫǹȁǾǽǴƑǱȉǺǽȂǹǰǸǬǻǰƒǺǰȀȁǸǹȉǱǸǳȆȁȉƒȋƑǰƑǴȄǾȆƑǰȁǸǹǭǹȆǳǸǹǽƒǽǮǶȀǶǹǰǸǴǻȀȆƑǰȁȆƑǬǻǶƑǴƑǱǾǫǻǶȁǽǽƒǽǮǽȀȄǴǳǸǫȀȁǶǹǴǴǸǳǸǹǫǲǸǰȁǶȀȊǻǳǴȀǶƑǴƑǸǰǱǴǺȉǻǰ ǰȀȃǰǺǴǮǰǿ 60RQRYHWWH®ǭƑǸǰǱǴǺȉǻǰ ǰȀȃǰǺǴǮǰǿ 0XOWLIO\®ǹǰǷȋǿǹǰǸǳǸǫȃǽǾǰƒǾȉȀǷǴȁǰ ƒǰǾǰȀǹǴȂǫȀƑǰȁǰ ƍǸǰȁǮǷǴȁǰǸǴƒǮȀǶǿǬǻǰ60RQRYHWWH®ǳǮȄȆǿƒǾȉȀǷǴȁǰǣȂȀȁǭƑǰȁǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH®ƑǴȁǰƒǾȉȀǷǴȁǰǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿƑǴǲǬǺǶǶƒǰǾǮǻǶǺǸǷǮǽȂǶƒǰǾǮǻǶǺǸǷǮǽȂƑǴǲǬǺǶǶƒǰǾǮǻǶǻǰȁǾǮǽȂǹǸȁǾǸǹȉǫǺǰǿ('7$ȃǷȉǾǸǽƑǴ('7$
ȃǷȉǾǸǽƑǴǶƒǰǾǮǻǶȃǷȉǾǸǽƑǴǹǸȁǾǸǹȉǫǺǰǿ&3'$ǹǰǷȋǿǹǰǸȄȆǾǮǿƒǾȉȀǷǴȁǽȁȆǻǽƒǽǮȆǻǽǸȀȂǲǹǴǻȁǾȋȀǴǸǿƒǾǽȀǷǬȁȆǻǽȉǲǹǽǿȁȆǻȂǲǾȋǻƒǾǽȀǷǬȁȆǻǹǰǸȁǰǴƒǸȁǾǴƒȉƑǴǻǰȉǾǸǰǰǻǽȄǭǿȁǽȂǿǹǰǷȋǿǹǰǸǶǰǻǰǺǽǲǮǰǰǮƑǰȁǽǿƒǾǽǿȁǽƒǾȉȀǷǴȁǽƒǺǶǾǽȊǻȁǸǿǰƒǰǸȁǭȀǴǸǿǹǰǸȁǸǿȀȂȀȁǫȀǴǸǿȁǽȂǳǸǴǷǻǽȊǿƒǾǽȁȊƒǽȂ',1(1,62ŝ6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŞǹǰǸȁȆǻ&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, ǘǴƒǸǺǽǲǭȁǽȂƒǾȉȀǷǴȁǽȂǴǼǰǾȁǫȁǰǸǰƒȉȁǶǻǰǻǰǺȂȁǸǹǭƑǬǷǽǳǽǳǽǹǸƑǭǿǛǰǷǽǾǮǵǴȁǰǸǰƒȉȁǽǻǹǰȁǰȀǹǴȂǰȀȁǭȁȆǻǰǻȁǸǳǾǰȀȁǶǾǮȆǻǴǼǬȁǰȀǶǿǭǹǰǸȁǽȂǰǻǰǺȂȁǭƑǴȁǽǻǽƒǽǮǽƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸǶǴǼǬȁǰȀǶǤǽȀȊȀȁǶƑǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH®ǳǸǰȁǮǷǴȁǰǸǰƒǽȀȁǴǸǾȆƑǬǻǽǴȀȆȁǴǾǸǹǫǭǰȁǽƑǸǹǫȀȂȀǹǴȂǰȀƑǬǻǽǰƒǽȀȁǴǸǾȆƑǬǻǽǴȀȆȁǴǾǸǹǫǹǰǸǴǼȆȁǴǾǸǹǫǧǾȆƑǰȁǸǹǽǮǹȆǳǸǹǽǮȁǽȂǱǸǳȆȁǽȊƒȋƑǰȁǽǿȁǽȂ60RQRYHWWH®*:ǡǾȉȀǷǴȁǽ

ǛȆǳǸǹȉǿǲǾǰƑƑǫȁȆǻ

ǧǾȋƑǰƒȋƑǰȁǽǿ',1(1
ISO 6710

ǧǾȋƑǰƒȋƑǰȁǽǿƑǴǱǫȀǶȁǽ%6+

Z

ǺǴȂǹȉ

ǺǴȂǹȉ

ǦǸǰǺǮǳǸǽǳǮȄȆǿƒǰǾǰȀǹǴȊǰȀƑǰ
S-Monovette® Neutral ZǦǸǰǺǮǳǸǽǽǾǽȊ
S-Monovette®ǽǾǽȊ&$7ƑǴǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿ

CATǹȉǹǹǸǻǽ

ǺǴȂǹȉS-Monovette®ǽǾǽȊƑǴǲǬǺǶ&$7ƑǴǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿǹǰǸǲǬǺǶCATȀǹǽȊǾǽǹǮȁǾǸǻǽ

ȀǹǽȊǾǽǹǮȁǾǸǻǽ

S-Monovette®ǽǾǽȊƑǴǲǬǺǶ([SUHVV&$7ƑǴǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿǷǾǽƑǱǮǻǶǹǰǸǲǬǺǶCATƒǽǾȁǽǹǰǺǮ

-S-Monovette®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ/+ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ

LHƒǾǫȀǸǻǽ

ƒǽǾȁǽǹǰǺǮ

S-Monovette®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂǾǴȂȀȁǭ/+ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ

LHƒǾǫȀǸǻǽ

ƒǽǾȁǽǹǰǺǮ

S-Monovette®ǶƒǰǾǮǻǶǿǺǸǷǮǽȂƑǴǲǬǺǶ/+ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂǹǰǸǲǬǺǶ

LHƒǾǫȀǸǻǽ

ƒǽǾȁǽǹǰǺǮ

S-Monovette®ǶƒǰǾǮǻǶǿǺǸǷǮǽȂƑǴǲǬǺǶ+/+ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂǹǰǸȁǰȄǴǮǰǲǬǺǶ

LHƒǾǫȀǸǻǽ

ƒǽǾȁǽǹǰǺǮ

S-Monovette®ƑǴǶƒǰǾǮǻǶǻǰȁǾǮǽȂ1+ƑǴǶƒǰǾǮǻǶǻǰȁǾǮǽȂ

NH

ǹǰȃǬ

ƒǾǫȀǸǻǽ

S-Monovette®ƑǴǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂ$+ƑǴǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂ

ǳǽ

ƑƒǺǴ

ƑƒǺǴ

S-Monovette®ǹǸȁǾǸǹȉ1&ǹǸȁǾǸǹȉǻǫȁǾǸǽ

9NC

ƑƒǺǴ

ƒǾǫȀǸǻǽ

S-Monovette 3)$ǹǸȁǾǸǹȉ1&ǹǸȁǾǸǹȉǻǫȁǾǸǽǾȂǷƑǸȀȁǸǹȉ

9NC

ǲǰǺǫǵǸǽ

-S-Monovette®.('7$.(ƑǴǹǫǺǸǽ('7$

K3E

ƑȆǱ

ǹȉǹǹǸǻǽ

S-Monovette®.('7$.(ƑǴǹǫǺǸǽ('7$

K2E

ƑȆǱ

ǹȉǹǹǸǻǽ

S-Monovette®.ƑǴǲǬǺǶ('7$.(ƑǴǹǫǺǸǽ('7$ǹǰǸǲǬǺǶ

K2E

ƑȆǱ

ǹȉǹǹǸǻǽ

S-Monovette®ƑǴȃǷȉǾǸǽ('7$)(ƑǴȃǷȉǾǸǽǹǰǸ('7$

FE

ǲǹǾǸ

ǹǮȁǾǸǻǽ

S-Monovette®ƑǴȃǷȉǾǸǽƑǴǶƒǰǾǮǻǶ)+ƑǴȃǷȉǾǸǽǹǰǸǶƒǰǾǮǻǶ

FH-

ǹǮȁǾǸǻǽ

S-Monovette®ƑǴ*OXFR(;$&7)&ƑǴȃǷȉǾǸǽǹǸȁǾǸǹȉǹǰǸ('7$

FC

Ǿǽǵ

ǲǹǾǸ

LH

ȀǹǽȊǾǽƑƒǺǴƒǽǾȁǽǹǰǺǮ

S-Monovette®7KURPER([DFWƑǴȀȊǻǳǴȀǶƑǰǲǻǶȀǮǽȂǳǽǳǽȄǾȋƑǰȁǰƑǽȊǾǽȂ

ǳǽȄǾȋƑǰȁǰƑǽȊǾǽȂ

S-Monovette® CTADǳǽǳǽƑƒǺǴǳǽƒǾǫȀǸǻǽ

S-Monovette® ACD

ACDǹǮȁǾǸǻǽ

ǹǮȁǾǸǻǽ

S-Monovette® CPDA

CPDAǹǮȁǾǸǻǽ

ǹǮȁǾǸǻǽ

S-Monovette®ƑǴǸǾǽȂǳǮǻǶǳǽǳǽǺǰǳǮ

ǳǽǺǰǳǮ

S-Monovette®ǽƑǽǹȂȀȁǴȇǻǶǿƑǴǲǬǺǶ+&<=ƑǴǲǬǺǶǹǰǸȀȁǰǷǴǾǽƒǽǸǶȁǭǳǽǳǽǲǹǾǸǳǽǲǹǾǸ

S-Monovette®ƑǴǽƑǽǹȂȀȁǴǒǻǶ+&<&ƑǴǾȂǷƑǸȀȁǸǹȉǹǸȁǾǸǹǽȊǳǽǳǽƑȆǱǳǽƑȆǱ

S-Monovette® DNA ExactǳǽǳǽƑƒǺǴǳǽƑƒǺǴǦǸǰǺǮǳǸǽǶƒǰǾǮǻǶǿ

ǦǸǰǺǮǳǸǽǹǸȁǾǸǹǽȊ

®

ǦǸǰǺǮǳǸǽ('7$ǦǸǰǺǮǳǸǽƑǴǰǻǰȀȁǽǺǴǮǿǲǺȂǹȉǺȂȀǶǿ

ǦǸǰǺǮǳǸǽǲǸǰǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻ
S-Monovette®ǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻ/+ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ

ǜǽǸƒǫȃǸǰǺǮǳǸǰǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ

ǡǴǾǸȀȀȉȁǴǾǰȄǾȋƑǰȁǰǱǸǳȆȁǽȊƒȋƑǰȁǽǿǳǸǰǷǬȀǸƑǰǳǽǳǴǻǽǾǮǵǴȁǰǸ
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistryǰǻǰǹǺǭǷǶǹǴ47

EL
SARSTEDT S-Monovette®ƑǴǽǾȉ&$7ǲǬǺǶǽǾǽȊ&$7
Ǥǽ60RQRYHWWH®ƑǴǽǾȉ&$7ƒǴǾǸǬȄǴǸǬǻǰƒǺǰȀȁǸǹȉǹǽǹǹǮǽǴƒǸǹǰǺȂƑƑǬǻǽƑǴǬǻǰǻǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿ ƒȂǾǸȁǸǹȉ ǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǺǭȅǶǽǾǽȊ ǤǽƒǺǰȀȁǸǹȉǹǽǹǹǮǽǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁǽȂǷǾȉƑǱǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂǽǾǽȊǖǹȁȉǿǰƒȉȁǽƒǺǰȀȁǸǹȉǹǽǹǹǮǽƒǽȂǴǮǻǰǸǴƒǸǹǰǺȂƑƑǬǻǽƑǴǬǻǰǻǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿ ƒȂǾǸȁǸǹȉ ȁǽ60RQRYHWWH®ƑǴǲǬǺǶǽǾǽȊ&$7ƒǴǾǸǬȄǴǸƑǸǰǲǬǺǶƑǴǱǫȀǶȁǽƒǽǺȂƑǴǾǬǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǺǭȅǶǽǾǽȊ ǘǲǬǺǶǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁǽȂǷǾȉƑǱǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂǽǾǽȊǹǰǸȀȄǶƑǰȁǮǵǴǸǬǻǰȀȁǰǷǴǾȉǳǸǰȄȆǾǸȀȁǸǹȉȀȁǾȋƑǰǹǰȁǫȁǶƑǴȁǰȃǽǾǫȁǶǻǰƒǽǷǭǹǴȂȀǶǹǰǸȁǶǻǰǻǫǺȂȀǶǠǽǾȉǿȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰȀǴǹǺǸǻǸǹǬǿȄǶƑǸǹǬǿǹǰǸǰǻǽȀǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǹǰǷȋǿǹǰǸȀǴǽǾǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǝǴȁǫǰƒȉȁǶǻǰǸƑǽǺǶȅǮǰǰȃǭȀȁǴȁǽǰǮƑǰǻǰƒǭǼǴǸȀǴȉǾǷǸǰǷǬȀǶǲǸǰǺǴƒȁǫȀȁǽ60RQRYHWWH®ƑǴǽǾȉ&$7ǲǬǺǶǽǾǽȊ&$7ƒǾǽǹǴǸƑǬǻǽȂǻǰǳǸǰȀȃǰǺǮȀǴȁǴȁǽȀȄǶƑǰȁǸȀƑȉǴǻȉǿǽǾǸǵȉǻȁǸǽȂǳǸǰȄȆǾǸȀȁǸǹǽȊȀȁǾȋƑǰȁǽǿƑǴȁǫǰƒȉȁǶȃȂǲǽǹǬǻȁǾǸȀǶǠȀȂǻǸȀȁȋƑǴǻǽǿȄǾȉǻǽǿǱǰȀǮǵǴȁǰǸȀǴƑǸǰǰǹǬǾǰǸǰǳǸǰǳǸǹǰȀǮǰƒǭǼǶǿǤǽǰǮƑǰǰȀǷǴǻȋǻƑǴǳǸǰȁǰǾǰȄǬǿȁǶǿƒǭǼǶǿƒǽȂȀȄǴȁǮǵǽǻȁǰǸƑǴǻǽȀǭƑǰȁǰǭƒǽȂǱǾǮȀǹǽǻȁǰǸȂƒȉǰǻȁǸƒǶǹȁǸǹǬǿǷǴǾǰƒǴǮǴǿǴǻǳǬȄǴȁǰǸǻǰǰƒǰǸȁǴǮƒǴǾǸȀȀȉȁǴǾǽȄǾȉǻǽǲǸǰȁǶǻƒǺǭǾǶƒǭǼǶ

SARSTEDT S-Monovette®ǽǾǽȊƑǴǲǬǺǶ([SUHVV&$7ǖǹȁȉǿǰƒȉȁǽƒǺǰȀȁǸǹȉǹǽǹǹǮǽƒǽȂǴǮǻǰǸǴƒǸǹǰǺȂƑƑǬǻǽƑǴǬǻǰǻǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿ ǷǾǽƑǱǮǻǶ ȁǽ60RQRYHWWH®ƑǴǲǬǺǶǽǾǽȊ([SUHVV&$7ƒǴǾǸǬȄǴǸƑǸǰǲǬǺǶƑǴǱǫȀǶȁǽƒǽǺȂƑǴǾǬǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǾǽȊ ǘǲǬǺǶǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁǽȂǷǾȉƑǱǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂǽǾǽȊǹǰǸȀȄǶƑǰȁǮǵǴǸǬǻǰȀȁǰǷǴǾȉǳǸǰȄȆǾǸȀȁǸǹȉȀȁǾȋƑǰǹǰȁǫȁǶƑǴȁǰȃǽǾǫȁǶǻǰƒǽǷǭǹǴȂȀǶǹǰǸȁǶǻǰǻǫǺȂȀǶǝǴȁǫǰƒȉȁǶǻǰǸƑǽǺǶȅǮǰǰȃǭȀȁǴȁǽǰǮƑǰǻǰƒǭǼǴǸȀǴȉǾǷǸǰǷǬȀǶǲǸǰǺǴƒȁǫȀȁǽ60RQRYHWWH®ƑǴǲǬǺǶǽǾǽȊ([SUHVVƒǾǽǹǴǸƑǬǻǽȂǻǰǳǸǰȀȃǰǺǮȀǴȁǴȁǽȀȄǶƑǰȁǸȀƑȉǴǻȉǿǽǾǸǵȉǻȁǸǽȂǳǸǰȄȆǾǸȀȁǸǹǽȊȀȁǾȋƑǰȁǽǿƑǴȁǫǰƒȉȁǶȃȂǲǽǹǬǻȁǾǸȀǶǠȀȂǻǸȀȁȋƑǴǻǽǿȄǾȉǻǽǿǱǰȀǮǵǴȁǰǸȀǴƑǸǰǰǻǴƒǶǾǬǰȀȁǶǳǸǰǳǸǹǰȀǮǰƒǭǼǶǿǰǹȉƑǶǹǰǸǲǸǰȁǽǰǮƑǰǶƒǰǾǶǻǸȀƑǬǻȆǻǰȀǷǴǻȋǻǤǽǰǮƑǰǰȀǷǴǻȋǻƑǴǳǸǰȁǰǾǰȄǬǿȁǶǿƒǭǼǶǿƒǽȂȀȄǴȁǮǵǽǻȁǰǸƑǴǻǽȀǭƑǰȁǰǭƒǽȂǱǾǮȀǹǽǻȁǰǸȂƒȉǰǻȁǸƒǶǹȁǸǹǬǿǷǴǾǰƒǴǮǴǿƑǴȂȅǶǺǬǿǳȉȀǴǸǿǶƒǰǾǮǻǶǿǰƒǰǸȁǴǮƒǴǾǸȀȀȉȁǴǾǽȄǾȉǻǽǲǸǰȁǶǻƒǺǭǾǶƒǭǼǶǠǽǾȉǿȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰȀǴǹǺǸǻǸǹǬǿȄǶƑǸǹǬǿǹǰǸǰǻǽȀǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǹǰǷȋǿǹǰǸȀǴǽǾǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿ

SARSTEDT S-Monovette® Neutral ZǤǽ60RQRYHWWH®1HXWUDO=ǳǴǻƒǴǾǸǬȄǴǸƒǰǾǰȀǹǴȊǰȀƑǰȁǽǽƒǽǮǽǰǻȁǸȀȁǽǸȄǴǮȀǴȃȂȀǸǹǭƒǭǼǶȁǽȂǳǴǮǲƑǰȁǽǿǰǮƑǰȁǽǿȄȆǾǮǿǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǺǭȅǶǽǾǽȊ ǝǬȀȆȁǶǿȃȂǲǽǹǬǻȁǾǸȀǶǿǴƒǸȁȂǲȄǫǻǴȁǰǸǽǳǸǰȄȆǾǸȀƑȉǿǷǾȉƑǱǽȂǹǰǸǽǾǽȊǠǽǾȉǿȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰǴǼǴȁǫȀǴǸǿƒǽȂǰȃǽǾǽȊǻȀȂǲǹǴǹǾǸƑǬǻǽȂǿȄǾǭȀȁǴǿǖƒǸƒǺǬǽǻȁǽ60RQRYHWWH®1HXWUDO=ƑƒǽǾǴǮǴƒǮȀǶǿǻǰȄǾǶȀǸƑǽƒǽǸǶǷǴǮȆǿǹǴǻȉȃǸǰǺǮǳǸǽȆǿǴǼǭǿǴǫǻǶǰǸƑǽǺǶȅǮǰƒǾȉǹǴǸȁǰǸǻǰǼǴǹǸǻǭȀǴǸƑǴǬǻǰ60RQRYHWWH®ƑǴǹǸȁǾǸǹȉȀǴȀȂǻǳȂǰȀƑȉƑǴƑǸǰǱǴǺȉǻǰ ǰȀȃǫǺǴǸǰǿ 
Multifly® ƒǴȁǰǺǽȊǳǰ ȁǽ60RQRYHWWH®1HXWUDO=ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿȁǽƒǾȋȁǽȃǸǰǺǮǳǸǽ ǹǴǻȉȃǸǰǺǮǳǸǽ ǲǸǰȁǶǻƒǺǭǾȆȀǶȁǽȂȀȆǺǭǻǰȁǶǿǱǴǺȉǻǰǿ ǰȀȃǫǺǴǸǰǿ 0XOWLIO\®.

SARSTEDT S-Monovette®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ/+ǶƒǰǾǮǻǶǿǺǸǷǮǽȂƑǴǲǬǺǶ/+ǶƒǰǾǮǻǶǿǺǸǷǮǽȂƑǴǲǬǺǶ/+ǶƒǰǾǮǻǶǻǰȁǾǮǽȂ1+ǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂ$+Ǥǽ60RQRYHWWH®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ/+ǶƒǰǾǮǻǶǻǰȁǾǮǽȂ1+ǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂ$+ƒǴǾǸǬȄǴǸǬǻǰƒǺǰȀȁǸǹȉǹǽǹǹǮǽƒǽȂǴǮǻǰǸǴƒǸǹǰǺȂƑƑǬǻǽƑǴȁǽǻǰǻǰȀȁǽǺǬǰƒǭǼǶǿ ǰǻȁǸƒǶǹȁǸǹȉ ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂǶƒǰǾǮǻǶǻǰȁǾǮǽȂǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂ ȀȂǻǭǷȆǿ,8ǶƒǰǾǮǻǶǿPOǰǮƑǰȁǽǿ ǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ ǤǽƒǺǰȀȁǸǹȉǹǽǹǹǮǽǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁȆǻǹȂȁȁǫǾȆǻȁǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂƒǺǫȀƑǰȁǽǿǣȁǶǻƒǴǾǮƒȁȆȀǶǴǻȉǿ60RQRYHWWH®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ/+ȄȆǾǮǿƒǺǰȀȁǸǹȉǹǽǹǹǮǽȁǽǰǻȁǸƒǶǹȁǸǹȉǶƒǰǾǮǻǶǿǺǸǷǮǽȂȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊ ȀȂǻǭǷȆǿ,8ǶƒǰǾǮǻǶǿPOǰǮƑǰȁǽǿ Ǥǽ60RQRYHWWH®ƑǴǲǬǺǶǶƒǰǾǮǻǶǿǺǸǷǮǽȂ/+ƒǴǾǸǬȄǴǸǴǹȁȉǿȁǽƒǺǰȀȁǸǹȉǹǽǹǹǮǽƑǴǴƒǸǹǫǺȂȅǶǰǻȁǸƒǶǹȁǸǹǽȊǶƒǰǾǮǻǶǿǺǸǷǮǽȂ ȀȂǻǭǷȆǿ,8ǶƒǰǾǮǻǶǿPOǰǮƑǰȁǽǿ ǹǰǸƑǸǰǲǬǺǶƑǴǱǫȀǶȁǽƒǽǺȂƑǴǾǬǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǺǭȅǶƒǺǫȀƑǰȁǽǿ ǘǲǬǺǶǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁȆǻǹȂȁȁǫǾȆǻȁǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂƒǺǫȀƑǰȁǽǿǹǰǸȀȄǶƑǰȁǮǵǴǸǬǻǰȀȁǰǷǴǾȉǳǸǰȄȆǾǸȀȁǸǹȉȀȁǾȋƑǰǹǰȁǫȁǶƑǴȁǰȃǽǾǫȁǶǻǰƒǽǷǭǹǴȂȀǶǹǰǸȁǶǻǰǻǫǺȂȀǶǤǽ60RQRYHWWH®ǶƒǰǾǮǻǶǿǺǸǷǮǽȂƑǴǲǬǺǶ+/+ƒǴǾǸǬȄǴǸǴƒǮȀǶǿƑǸǰǲǬǺǶƑǴǱǫȀǶȁǽƒǽǺȂƑǴǾǬǿƒǽȂǴƒǸȁǾǬƒǴǸȁǶƑǴǮȆȀǶȁǽȂȄǾȉǻǽȂȃȂǲǽǹǬǻȁǾǸȀǶǿǹǰȁǫƒǴǾǮƒǽȂȀǴȀȊǲǹǾǸȀǶƑǴȁǽ60RQRYHWWH®ǶƒǰǾǮǻǶǿǺǸǷǮǽȂƑǴǲǬǺǶǤǽƒǺǫȀƑǰǶƒǰǾǮǻǶǿȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰȀǴǹǺǸǻǸǹǬǿȄǶƑǸǹǬǿǹǰǸǰǻǽȀǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǤǽǽǺǸǹȉǰǮƑǰǶƒǰǾǮǻǶǿȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰȀǴǰǻǽȀǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǹǰǸȀǴǽǾǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƑǴǶƒǰǾǮǻǶǴƒǸȁȂǲȄǫǻǴȁǰǸƑǴȁǶǻǴǻǴǾǲǽƒǽǮǶȀǶȁǶǿǰǻȁǸǷǾǽƑǱǮǻǶǿǥǡǠƍǖǚǟǘƍǴǻǴƒǸȁǾǬƒǽǻȁǰǸƒǾǽȀǳǸǽǾǸȀƑǽǮǺǸǷǮǽȂǰƒȉȁǽ60RQRYHWWH®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂ/+ǲǬǺǶǶƒǰǾǮǻǶǿǺǸǷǮǽȂǲǬǺǶ+/+ƒǾǽȀǳǸǽǾǸȀƑǽǮǻǰȁǾǮǽȂǰƒȉȁǽ60RQRYHWWH®ƑǴǶƒǰǾǮǻǶǻǰȁǾǮǽȂ1+ǹǰǸƒǾǽȀǳǸǽǾǸȀƑǽǮǰƑƑȆǻǮǽȂǰƒȉȁǽ60RQRYHWWH®ƑǴǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂ$+ǌǻǰ60RQRYHWWH®ƑǴǶƒǰǾǮǻǶǺǸǷǮǽȂǲǬǺǶǶƒǰǾǮǻǶǿǺǸǷǮǽȂǲǬǺǶ+ǶƒǰǾǮǻǶǻǰȁǾǮǽȂǶƒǰǾǮǻǶǰƑƑȆǻǮǽȂƒǽȂǬȄǴǸƒǺǶǾȆǷǴǮƑǴȃǺǴǱǸǹȉǰǮƑǰǳǴǻǴǮǻǰǸǹǰȁǫǺǺǶǺǽǲǸǰǰǻǫǺȂȀǶǰǴǾǮȆǻǰǮƑǰȁǽǿ

SARSTEDT S-Monovette®ǲǸǰǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻ
Ǥǽ60RQRYHWWH®ǲǸǰǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǶƒǰǾǮǻǶǿǺǸǷǮǽȂǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ ǘǶƒǰǾǮǻǶǺǸǷǮǽȂȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊ ,8ǶƒǰǾǮǻǶǿPOǰǮƑǰȁǽǿ ǤǽǽǺǸǹȉǰǮƑǰǶƒǰǾǮǻǶǿǭȁǽƒǺǫȀƑǰǶƒǰǾǮǻǶǿȁǽȂ60RQRYHWWH®ǲǸǰȁǶǻǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻȀǴȀȂǻǳȂǰȀƑȉƑǴȁǶǻǴǸǳǸǹǭǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿ*[Ź ǹȆǳƒǾ ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǸǿǴǼǴȁǫȀǴǸǿǸȄǻǽȀȁǽǸȄǴǮȆǻƑǴȁǫǺǺȆǻǤǰǸȄǻǽȀȁǽǸȄǴǮǰƑǬȁǰǺǺǰǴƒǸǹȂǾȋǷǶǹǰǻƑǴȃǰȀƑǰȁǽƑǴȁǾǮǰǰȁǽƑǸǹǭǿǰƒǽǾǾȉȃǶȀǶǿ $$6 ǕǸǰȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǹǰǸȁǽ60RQRYHWWH®ǲǸǰȁǶǻǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻƒǾǽǹȊƒȁǽȂǻǽǸǰǹȉǺǽȂǷǴǿƑǬǲǸȀȁǴǿȁǸƑǬǿƑǫǾȁȂǾǰȀǴQJȀȊȀȁǶƑǰǲǸǰǰȂȁǫȁǰǸȄǻǽȀȁǽǸȄǴǮǰǣȁǽǸȄǴǮǽ

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

QJǣȊȀȁǶƑǰ

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

ǠǸƑǬǲǸȀȁǴǿȁǸƑǬǿƑǫǾȁȂǾǰǰǻǰǲǾǫȃǽǻȁǰǸǲǸǰǹǫǷǴȀȁǽǸȄǴǮǽȀȁǶǻǴȁǸǹǬȁǰȁǽȂ60RQRYHWWH .
®

ǠǸƒǾǽȀǳǸǽǾǸȀƑǽǮǸȄǻǽȀȁǽǸȄǴǮȆǻƒǾǰǲƑǰȁǽƒǽǸǽȊǻȁǰǸǰƒȉǽǺǸǹȉǰǮƑǰǶƒǰǾǮǻǶǿǭƒǺǫȀƑǰǶƒǰǾǮǻǶǿǰǻǫǺǽǲǰƑǴȁǶǻǰǻǰǺȂȁǸǹǭƑǬǷǽǳǽǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƑǴǶƒǰǾǮǻǶǴƒǸȁȂǲȄǫǻǴȁǰǸƑǴȁǶǻǴǻǴǾǲǽƒǽǮǶȀǶȁǶǿǰǻȁǸǷǾǽƑǱǮǻǶǿ

SARSTEDT S-Monovette®ƑǴǹǸȁǾǸǹȉ1&Ǥǽ60RQRYHWWH®ƑǴǹǸȁǾǸǹȉ1&ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǹǸȁǾǸǹȉǻǫȁǾǸǽǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ ǤǽǹǸȁǾǸǹȉǻǫȁǾǸǽȂƒǫǾȄǴǸȆǿƑǽǾǸǰǹȉǳǸǫǺȂƑǰ ǳǸǫǺȂƑǰǹǸȁǾǸǹǽȊǻǰȁǾǮǽȂȀȂȄǻǫȀȁǾǽǲǲȂǺǽƒǽǸǶƑǬǻǽȀȁǽ ǹǰǸǴǮǻǰǸȁǽȁǽȂǽǻǽƑǰȀȁǸǹǽȊȉǲǹǽȂǴǻȉǿ60RQRYHWWH®ƑǴǹǸȁǾǸǹȉǘǰǻǰǺǽǲǮǰǰǻǫƑǸǼǶǿȁǽȂǹǸȁǾǸǹǽȊƑǴȁǽǰǮƑǰǴǮǻǰǸşǹǺǫȀƑǰȉǲǹǽȂǹǸȁǾǸǹǽȊǹǰǸǹǺǫȀƑǰȁǰȉǲǹǽȂǰǮƑǰȁǽǿǘȀȆȀȁǭƒǺǭǾȆȀǶǴǮǻǰǸȂƒǽȄǾǴȆȁǸǹǭǲǸǰȁǶǻǰǻǫǺȂȀǶǤǽǹǸȁǾǸǹȉƒǺǫȀƑǰȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰȀǴǰǸƑǽȀȁǰȀǸǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴǹǸȁǾǸǹȉǤǶǾǴǮȁǴȁǸǿǠƍǘǕǚǖǣȁǶǿǴǻȉȁǶȁǰǿǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸȄǴǸǾǸȀƑȉǿǲǸǰȁǽȀȂǻǳȂǰȀƑȉȁǽȂ60RQRYHWWH®ƑǴǹǸȁǾǸǹȉǹǰǸȁȆǻƒǴȁǰǺǽȊǳȆǻ

SARSTEDT S-Monovette® PFA 9NC
Ǥǽ60RQRYHWWH®ƑǴ3)$1&ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǹǸȁǾǸǹȉǻǫȁǾǸǽǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ ǤǽǹǸȁǾǸǹȉǻǫȁǾǸǽȂƒǫǾȄǴǸȆǿƑǽǾǸǰǹȉǾȂǷƑǸȀȁǸǹȉǳǸǫǺȂƑǰ ǾȂǷƑǸȀȁǸǹȉS+ ǹǰǸǴǮǻǰǸȁǽȁǽȂǽǻǽƑǰȀȁǸǹǽȊȉǲǹǽȂǴǻȉǿ60RQRYHWWH®ƑǴ3)$ǘǰǻǰǺǽǲǮǰǰǻǫƑǸǼǶǿȁǽȂǹǸȁǾǸǹǽȊƑǴȁǽǰǮƑǰǴǮǻǰǸşǹǺǫȀƑǰȉǲǹǽȂǹǸȁǾǸǹǽȊǹǰǸǹǺǫȀƑǰȁǰȉǲǹǽȂǰǮƑǰȁǽǿǘȀȆȀȁǭƒǺǭǾȆȀǶǴǮǻǰǸȂƒǽȄǾǴȆȁǸǹǭǲǸǰȁǶǻǰǻǫǺȂȀǶǤǽǽǺǸǹȉǰǮƑǰȁǽȂ60RQRYHWWH®ƑǴ3)$1&ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǺǴǸȁǽȂǾǲǮǰǿȁȆǻǰǸƑǽƒǴȁǰǺǮȆǻƑǴȁǽǻǰǻǰǺȂȁǭ3)$ȁǶǿ6,(0(16+HDOWKLQHHUVǹǰǸǬȄǴǸǴƒǸǹȂǾȆǷǴǮǲǸǰȁǽǻȀǹǽƒȉǰȂȁȉǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴǹǸȁǾǸǹȉǤǶǾǴǮȁǴȁǸǿǠƍǘǕǚǖǣȁǶǿǴǻȉȁǶȁǰǿǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸȄǴǸǾǸȀƑȉǿǲǸǰȁǽȀȂǻǳȂǰȀƑȉȁǽȂ60RQRYHWWH®ƑǴ3)$ǹǰǸȁȆǻƒǴȁǰǺǽȊǳȆǻ

SARSTEDT S-Monovette® CTAD
Ǥǽ60RQRYHWWH®&7$'ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǹǸȁǾǸǹȉǻǫȁǾǸǽǹǰǷȋǿǹǰǸǷǴǽȃȂǺǺǮǻǶǰǳǴǻǽȀǮǻǶǹǰǸǳǸƒȂǾǸǳǰƑȉǺǶǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ Ǥǽ&7$'ȂƒǫǾȄǴǸȆǿǳǸǫǺȂƑǰǹǰǸǴǮǻǰǸȁǽȁǽȂǽǻǽƑǰȀȁǸǹǽȊȉǲǹǽȂǴǻȉǿ60RQRYHWWH®ƑǴ&7$'ǘǰǻǰǺǽǲǮǰǰǻǫƑǸǼǶǿȁǽȂ&7$'ƑǴȁǽǰǮƑǰǴǮǻǰǸşǹǺǫȀƑǰȉǲǹǽȂ&7$'ǹǰǸǹǺǫȀƑǰȁǰȉǲǹǽȂǰǮƑǰȁǽǿǘȀȆȀȁǭƒǺǭǾȆȀǶǴǮǻǰǸȂƒǽȄǾǴȆȁǸǹǭǲǸǰȁǶǻǰǻǫǺȂȀǶǤǽƒǺǫȀƑǰ&7$'ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǽȂǰǸƑǽƒǴȁǰǺǸǰǹǽȊƒǰǾǫǲǽǻȁǰ 3) ȁǶǿǱǷǾǽƑǱǽȀȃǰǸǾǮǻǶǿ Ǳ7* ǹǰǸȁǽȂǰǻǰȀȁǽǺǬǰȁǽȂǴǻǴǾǲǽƒǽǸǶȁǭȁǽȂƒǺǰȀƑǸǻǽǲȉǻǽȂ 3$, ǹǰǸǲǸǰǰǸƑǽȀȁǰȀǸǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǘǴǻǴǾǲǽƒǽǮǶȀǶȁȆǻǰǸƑǽƒǴȁǰǺǮȆǻǰǻǰȀȁǬǺǺǴȁǰǸǲǸǰȄǾǽǻǸǹȉǳǸǫȀȁǶƑǰȁǽȂǺǫȄǸȀȁǽǻȆǾȋǻǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǻƒǰǾǰǹǽǺǽȊǷǶȀǶȁȆǻǷǴǾǰƒǴǸȋǻƑǴǶƒǰǾǮǻǶǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴǹǸȁǾǸǹȉǤǶǾǴǮȁǴȁǸǿǠƍǘǕǚǖǣȁǶǿǴǻȉȁǶȁǰǿǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸȄǴǸǾǸȀƑȉǿǲǸǰȁǽȀȂǻǳȂǰȀƑȉȁǽȂ60RQRYHWWH®ƑǴ&7$'ǹǰǸȁȆǻƒǴȁǰǺǽȊǳȆǻǥǡǠƍǖǚǟǘǤǽ&7$'ǴǮǻǰǸǹǮȁǾǸǻǽǤǽ60RQRYHWWH®ƑǴ&7$'ƒǾǬƒǴǸǻǰƒǾǽȀȁǰȁǴȊǴȁǰǸǰƒȉȁǴȄǻǶȁȉǹǰǸȃȂȀǸǹȉȃȆǿǹǰȁǫȁǶǳǸǫǾǹǴǸǰȁǶǿǰƒǽǷǭǹǴȂȀǶǿǘǸȀȄȂǾǭǬǹǷǴȀǶȀȁǽȃȆǿǲǸǰƒǴǾǸȀȀȉȁǴǾǴǿǰƒȉȋǾǴǿƑƒǽǾǴǮǻǰǽǳǶǲǭȀǴǸȀǴǰǳǾǰǻǽƒǽǮǶȀǶȁȆǻƒǾǽȀǷǬȁȆǻ48

EL
SARSTEDT S-Monovette® EDTA K2E / K3E
Ǥǽ60RQRYHWWH® EDTA K2E / S-Monovette®('7$.(ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉ.('7$ǭ.('7$ǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿ Ǥǽ.('7$ǭ.('7$ȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊ PJ
('7$POǰǮƑǰȁǽǿ ǤǽǽǺǸǹȉǰǮƑǰ('7$ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰǰǸƑǰȁǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǤǰǴƒǸȄǾǮȀƑǰȁǰǰǮƑǰȁǽǿƒǾǬƒǴǸǻǰƒǰǾǰȄǷǽȊǻǴǻȁȉǿȁǴȀȀǫǾȆǻȆǾȋǻǰƒȉȁǶǻǰǸƑǽǺǶȅǮǰǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴ('7$ǤǽǰǮƑǰǰƒȉȁǽ60RQRYHWWH®('7$.(.(ƑƒǽǾǴǮǴƒǮȀǶǿǻǰȄǾǶȀǸƑǽƒǽǸǶǷǴǮǲǸǰǰǻǽȀǽǰǸƑǰȁǽǺǽǲǸǹǬǿǴǼǴȁǫȀǴǸǿǾǽȂȁǮǻǰǿǹǰǸǴǼǴȁǫȀǴǸǿǺǽǸƑȆǳȋǻǻǽȀǶƑǫȁȆǻǘǹǰȁǰǺǺǶǺȉȁǶȁǰȁǽȂǳǴǮǲƑǰȁǽǿǲǸǰǰȂȁǬǿȁǸǿǴǼǴȁǫȀǴǸǿȂƒȉǹǴǸȁǰǸȀȁǶǻǴȂǷȊǻǶȁǽȂȄǾǭȀȁǶƑǴȁǰǰǻȁǮȀȁǽǸȄǰǰǻȁǸǳǾǰȀȁǭǾǸǰǰǻǰǺȂȁǬǿȀȂƑƒǴǾǸǺǰƑǱǰǻǽƑǬǻȆǻȁȆǻȀȂǻǷǶǹȋǻǰƒǽǷǭǹǴȂȀǶǿ

SARSTEDT S-Monovette®ƑǴǲǬǺǶ('7$.(Ǥǽ60RQRYHWWH®ƑǴǲǬǺǶ('7$.(ƒǴǾǸǬȄǴǸǴǹȁȉǿǰƒȉȁǽǰǻȁǸƒǶǹȁǸǹȉ.('7$ƑǸǰǲǬǺǶƑǴǱǫȀǶȁǽƒǽǺȂƑǴǾǬǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǺǭȅǶǽǾǽȊ Ǥǽ.('7$ȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊ PJ('7$POǰǮƑǰȁǽǿ ǘǲǬǺǶǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁȆǻǹȂȁȁǫǾȆǻȁǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂƒǺǫȀƑǰȁǽǿǹǰǸȀȄǶƑǰȁǮǵǴǸǬǻǰȀȁǰǷǴǾȉǳǸǰȄȆǾǸȀȁǸǹȉȀȁǾȋƑǰǹǰȁǫȁǶƑǴȁǰȃǽǾǫȁǶǻǰƒǽǷǭǹǴȂȀǶǹǰǸȁǶǻǰǻǫǺȂȀǶǤǽƒǺǫȀƑǰ('7$ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǶƑǽǾǸǰǹǭǳǸǫǲǻȆȀǶǸȋǻǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴ('7$

SARSTEDT S-Monovette®ƑǴȃǷȉǾǸǽƑǴ('7$)(ȃǷȉǾǸǽƑǴǶƒǰǾǮǻǶ)+ȃǷȉǾǸǽƑǴǹǸȁǾǸǹȉǫǺǰǿ('7$)&ƑǴǰǻǰȀȁǽǺǴǮǿǲǺȂǹȉǺȂȀǶǿ
Ǥǽ60RQRYHWWH®ƑǴȃǷȉǾǸǽƑǴ('7$)(ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉ('7$ PJPOǰǮƑǰ ǹǰǸȃǷȉǾǸǽ PJPOǰǮƑǰ ǲǸǰȁǶǻǰǻǰȀȁǽǺǭȁǶǿǲǺȂǹȉǺȂȀǶǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭƒǺǫȀƑǰȁǽǿ ǤǽȃǷȉǾǸǽƑǴ
('7$ȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊǤǽ60RQRYHWWH®ƑǴȃǷȉǾǸǽƑǴǶƒǰǾǮǻǶ)+ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǶƒǰǾǮǻǶ ,8ǶƒǰǾǮǻǶǿPOǰǮƑǰȁǽǿ ǹǰǸȃǷȉǾǸǽ PJPOǰǮƑǰȁǽǿ ǲǸǰȁǶǻǰǻǰȀȁǽǺǭȁǶǿǲǺȂǹȉǺȂȀǶǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭƒǺǫȀƑǰȁǽǿ ǤǽȃǷȉǾǸǽƑǴǶƒǰǾǮǻǶȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊǘǰǻǰȀȁǽǺǭȁǶǿǲǺȂǹȉǺȂȀǶǿƑȉǻǽƑǴȃǷȉǾǸǽǼǴǹǸǻǫƒǴǾǮƒǽȂȋǾǴǿƑǴȁǫȁǶǻƒǺǭǾȆȀǶȁǽȂȃǸǰǺǸǳǮǽȂǰǸƑǽǺǶȅǮǰǿǹǰǸǳǾǰƒǺǭǾȆǿƑǴȁǫǰƒȉƒǴǾǮƒǽȂȋǾǴǿǖƒǽƑǬǻȆǿǶǲǺȂǹȉǵǶǳǸǰȀƒǫȁǰǸǹǰȁǫƑǬȀǽȉǾǽǬȆǿƑǴȁǫǰƒȉǺǮǲǴǿȋǾǴǿǹǰǸǬȆǿƑǴȁǫǰƒȉȋǾǴǿȀȁǽǽǺǸǹȉǰǮƑǰǤǽ60RQRYHWWH®*OXFR(;$&7)(ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉ('7$ǹǸȁǾǸǹȉǹǰǸȃǷȉǾǸǽǲǸǰȁǶǻǫƑǴȀǶǰǻǰȀȁǽǺǭȁǶǿǲǺȂǹȉǺȂȀǶǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭƒǺǫȀƑǰȁǽǿ Ǥǽ('7$ȁǽǹǸȁǾǸǹȉǹǰǸȁǽȃǷȉǾǸǽȂƒǫǾȄǽȂǻȆǿǳǸǫǺȂƑǰǠȂƒǽǺǽǲǸȀƑȉǿȁǶǿȀȂǲǹǬǻȁǾȆȀǶǿǲǺȂǹȉǵǶǿǰƒǰǸȁǴǮƒǽǺǺǰƒǺǰȀǸǰȀƑȉǴƒǮǺȉǲȆȁǶǿǰǾǰǮȆȀǶǿǤǽ60RQRYHWWH® GlucoEXACT)&ȀȂƑƑǽǾȃȋǻǴȁǰǸƑǴȁǶǻǹǰȁǴȂǷȂǻȁǭǾǸǰǲǾǰƑƑǭǲǸǰȁǽǻǳǸǰǱǭȁǶǹȊǶȀǶǿȁǶǿǕǴǾƑǰǻǸǹǭǿǖȁǰǸǾǴǮǰǿƍǸǰǱǭȁǶ ''* ǹǰǸȁǶǻǴǷǻǸǹǭǹǰȁǴȂǷȂǻȁǭǾǸǰǲǾǰƑƑǭǲǸǰȁǶǳǸǰȄǴǮǾǸȀǶǰȀǷǴǻǴǸȋǻ 19/ ǲǸǰȁǽǻǳǸǰǱǭȁǶȁȊƒǽȂǘǫƑǴȀǶȀȁǰǷǴǾǽƒǽǮǶȀǶȁǶǿȀȂǲǹǬǻȁǾȆȀǶǿȁǶǿǲǺȂǹȉǵǶǿǴǼǰȀȃǰǺǮǵǴȁǰǸǲǸǰǬȆǿǹǰǸȋǾǴǿȀǴǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂȀȁǽǽǺǸǹȉǰǮƑǰǱǺǴƒǮȀǶǿ6$567('7:KLWH3DSHUhttps://www.sarstedt.
com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
ǤǽƒǺǫȀƑǰȃǷǽǾǮǽȂ('7$ ǹǸȁǾǸǹǽȊ ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǲǺȂǹȉǵǶǿǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴ('7$
ǥǡǠƍǖǚǟǘǤǽȃǷȉǾǸǽƑƒǽǾǴǮǻǰƒǾǽǹǰǺǬȀǴǸǰȊǼǶȀǶȁǶǿǰǸƑȉǺȂȀǶǿǕǸǰƒǴǾǸȀȀȉȁǴǾǴǿƒǺǶǾǽȃǽǾǮǴǿȀȄǴȁǸǹǫƑǴǽȂȀǮǴǿƒǽȂƑƒǽǾǴǮǻǰǬȄǽȂǻǳǸǰȀƒǰȀȁǸǹǭǴƒǮǳǾǰȀǶǰǻǰȁǾǬǼȁǴȀȁǸǿǰǻȁǮȀȁǽǸȄǴǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿȁǽȂǹǰȁǰȀǹǴȂǰȀȁǭȁȆǻǰǻȁǸǳǾǰȀȁǶǾǮȆǻǰǻǫǺȂȀǶǿǤǶǾǴǮȁǴȁǸǿǠƍǘǕǚǖǣȁǶǿǴǻȉȁǶȁǰǿǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸȄǴǸǾǸȀƑȉǿǲǸǰȁǽȀȂǻǳȂǰȀƑȉȁǽȂ60RQRYHWWH®ƑǴ*OXFR(;$&7ǹǰǸȁȆǻƒǴȁǰǺǽȊǳȆǻ

SARSTEDT S-Monovette® CPDAǤǽ60RQRYHWWH®&3'$ƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǹǸȁǾǸǹȉǻǫȁǾǸǽǹǰǷȋǿǹǰǸǹǸȁǾǸǹȉǽǼȊȃȆȀȃǽǾǸǹȉǻǫȁǾǸǽǳǴǼȁǾȉǵǶǹǰǸǰǳǴǻǮǻǶǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰǸƒǺǫȀƑǰȁǽǿ Ǥǽ&3'$ȂƒǫǾȄǴǸȆǿǳǸǫǺȂƑǰǘǰǻǰǺǽǲǮǰǰǻǫƑǸǼǶǿȁǽȂ&3'$ƑǴȁǽǰǮƑǰǴǮǻǰǸǹǺǫȀƑǰȉǲǹǽȂ&3'$ǹǰǸǹǺǫȀƑǰȁǰȉǲǹǽȂǰǮƑǰȁǽǿǘȀȆȀȁǭƒǺǭǾȆȀǶǴǮǻǰǸȂƒǽȄǾǴȆȁǸǹǭǲǸǰȁǶǻǰǻǫǺȂȀǶǤǽǽǺǸǹȉǰǮƑǰƒǺǫȀƑǰ&3'$ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰǽǾǽǺǽǲǸǹǭǴǼǬȁǰȀǶǽƑǫǳȆǻǰǮƑǰȁǽǿȀȁǶǻǸǰȁǾǸǹǭƑǴȁǰǲǲǮȀǴȆǻǲǸǰǴǼǴȁǫȀǴǸǿȀȂƑǱǰȁȉȁǶȁǰǿ ǳǸǰȀȁǰȂǾǽȊƑǴǻǰǳǴǮǲƑǰȁǰ ȀǴƑǴȁǰǲǲǮȀǴǸǿǣȂǲǹǴǹǾǸƑǬǻǰȁǽS-Monovette®&3'$ǴǮǻǰǸǹǰȁǫǺǺǶǺǽǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǽƑǫǳǰǿǰǮƑǰȁǽǿ $% ȀȂƑƒǴǾǸǺǰƑǱǰǻǽƑǬǻȆǻȁȆǻȁȊƒȆǻ.HOOǹǰǸ5KHVXVȁǶǿǴǼǬȁǰȀǶǿǰǻǮȄǻǴȂȀǶǿǰǻȁǸȀȆƑǫȁȆǻǲǸǰǰǹǰǻȉǻǸȀȁǰǰǻȁǸȀȋƑǰȁǰǽƑǫǳǰǿǰǮƑǰȁǽǿȁǶǿǳǽǹǸƑǰȀǮǰǿ&RRPEVƒǽǺǺǰƒǺȋǻǴǸǳǸǹȋǻǫƑǴȀȆǻȀȂǲǹǴǻȁǾȋȀǴȆǻ ǬȆǿȁǶǻǶƑǬǾǰ ȁǶǿǳǽǹǸƑǭǿȀȂƑǱǰȁȉȁǶȁǰǿ ǳǸǰȀȁǰȂǾǽȊƑǴǻǽǳǴǮǲƑǰ ƑǴǽǾȉƒǺǫȀƑǰǰȀǷǴǻǽȊǿȀȂƑǱǰȁȉƑǴȁǶǻǽƑǫǳǰǰǮƑǰȁǽǿƑǴǮǵȆǻǳǽǹǸƑǰȀǮǰ ǠȄǾȉǻǽǿƑǴȁǰȃǽǾǫǿǬȆǿȁǶǻǰƒǽǷǭǹǴȂȀǶǬȄǴǸǴƒǸǹȂǾȆǷǴǮǲǸǰȋǾǴǿǹǰȁŖǰǻȋȁǰȁǽȉǾǸǽȀǴǷǴǾƑǽǹǾǰȀǮǰƓ&ǕǸǰȁǶǻǹǰǷǮǵǶȀǶȁȆǻǹȂȁȁǫǾȆǻȁǰǳǴǮǲƑǰȁǰƒǾǬƒǴǸƒǾȋȁǰǻǰȃȂǺǫȀȀǽǻȁǰǸȀǴȉǾǷǸǰǷǬȀǶȀȁǽȅȂǲǴǮǽǲǸǰȁǽȂǺǫȄǸȀȁǽǻȋǾǴǿǠǸƒǾǽǰǻǰȃǴǾȉƑǴǻǴǿǰǻǰǺȊȀǴǸǿƑƒǽǾǽȊǻȀȁǶȀȂǻǬȄǴǸǰǻǰƒǾǽȀǳǸǽǾǸȀȁǽȊǻǲǸǰǳǸǫȀȁǶƑǰǬȆǿǶƑǴǾȋǻǹǰȁŖǰǻǰǺǽǲǮǰƒǾǽǿȁǽǻȀȂǻǭǷǶȄǾȉǻǽȀȂǻȁǭǾǶȀǶǿȁǽȂǰǮƑǰȁǽǿƑǴȁǫȁǶǻǰƒǽǷǭǹǴȂȀǶȀǴȅȂǲǴǮǽ Ɠ&  ƑǴǴǼǰǮǾǴȀǶȁǶǻǫƑǴȀǶǳǽǹǸƑǰȀǮǰ&RRPEVǲǸǰǶƑǬǾǴǿ ǛǰȁǫǺǺǶǺǽǲǸǰǳǸǰǳǸǹǰȀǮǴǿȀȂǲǹȉǺǺǶȀǶǿȀȁǶǺȋǻƒȄȀȁǽ9LVLRQ0D[ȁǶǿ2UWKR&OLQLFDO'LDJQRVWLFVǓƒǰǲǽǾǴȊǴȁǰǸǶȅȊǼǶȁǽȂǳǴǮǲƑǰȁǽǿǘǹǰȁǰǺǺǶǺȉȁǶȁǰȁǽȂǳǴǮǲƑǰȁǽǿǲǸǰǰȂȁǬǿȁǸǿǴǼǴȁǫȀǴǸǿƑǴǫǺǺǴǿƑǴǷȉǳǽȂǿǰǻȁǸǳǾǰȀȁǭǾǸǰǰǻǫǺȂȀǶǿȀȂȀǹǴȂǬǿǰǻǫǺȂȀǶǿȀȂƑƒǴǾǸǺǰƑǱǰǻǽƑǬǻȆǻȁȆǻȀȂǻǷǶǹȋǻǰƒǽǷǭǹǴȂȀǶǿǰƒǽȁǴǺǽȊǻǴȂǷȊǻǶȁǽȂȄǾǭȀȁǶǹǰǸƒǾǬƒǴǸǻǰǴƒǸǹȂǾȋǻǽǻȁǰǸǰƒȉǰȂȁȉǻǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴǹǸȁǾǸǹȉǤǶǾǴǮȁǴȁǸǿǠƍǘǕǚǖǣȁǶǿǴǻȉȁǶȁǰǿǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸȄǴǸǾǸȀƑȉǿǲǸǰȁǽȀȂǻǳȂǰȀƑȉȁǽȂ60RQRYHWWH®ƑǴ&3'$ǹǰǸȁȆǻƒǴȁǰǺǽȊǳȆǻ

SARSTEDT S-Monovette® ThromboExactǤǽ60RQRYHWWH®7KURPER([DFWƒǴǾǸǬȄǴǸǬǻǰǫǺǰǿƑǰǲǻǶȀǮǽȂȆǿǰǻȁǸƒǶǹȁǸǹȉǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿ ǤǽǫǺǰǿƑǰǲǻǶȀǮǽȂȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊǤǽǽǺǸǹȉǰǮƑǰȁǽȂ60RQRYHWWH®7KURPER([DFWȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻǰƒǽǹǺǴǸȀƑȉȅǴȂǳȋǿȄǰƑǶǺȋǻǰǾǸǷƑȋǻǰǸƑǽƒǴȁǰǺǮȆǻǺȉǲȆǰǻȁǸƒǶǹȁǸǹǭǿǳȂȀǰǻǴǼǮǰǿ ȉƒȆǿ('7$ǹǸȁǾǸǹȉǶƒǰǾǮǻǶ ƒǽȂǽǻǽƑǫǵǴȁǰǸǴƒǮȀǶǿȅǴȂǳǽǷǾǽƑǱǽƒǴǻǮǰǘȀȂȀȀȋǾǴȂȀǶǰǸƑǽƒǴȁǰǺǮȆǻǰƒǽȁǾǬƒǴȁǰǸǹǰǸǽƒǾǽȀǳǸǽǾǸȀƑȉǿȁǽȂƒǾǰǲƑǰȁǸǹǽȊǰǾǸǷƑǽȊǰǸƑǽƒǴȁǰǺǮȆǻǴǮǻǰǸǳȂǻǰȁȉǿǬȆǿǹǰǸȋǾǴǿƑǴȁǫȁǶǻǰǸƑǽǺǶȅǮǰǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǬȀȆȁȆǻǸȉǻȁȆǻƑǰǲǻǶȀǮǽȂȁǰǽƒǽǮǰǰǻǰȀȁǬǺǺǽȂǻȁǶǷǾǽƑǱǽǹȂȁȁǰǾǸǹǭǷǾǽƑǱǽǼǫǻǶǓǹǰǸȁǶȀȂȀȀȋǾǴȂȀǶȁȆǻǷǾǽƑǱǽǹȂȁȁǫǾȆǻƑǴȁǶƑǴȀǽǺǫǱǶȀǶȁǽȂ$'3ǹǰǸȁǽȂǰǾǰȄǸǳǽǻǸǹǽȊǽǼǬǽǿ

SARSTEDT S-Monovette®ƑǴǸǾǽȂǳǮǻǶ
Ǥǽ60RQRYHWWH®ƑǴǸǾǽȂǳǮǻǶƒǴǾǸǬȄǴǸȁǽǰǻȁǸƒǶǹȁǸǹȉǸǾǽȂǳǮǻǶǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿ ǘǸǾǽȂǳǮǻǶȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊǤǽǽǺǸǹȉǰǮƑǰǸǾǽȂǳǮǻǶǿȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǺǴǸȁǽȂǾǲǮǰǿȁȆǻǰǸƑǽƒǴȁǰǺǮȆǻȀȁǶȀȂȀǹǴȂǭ0XOWLSODWH® PXOWLSOHSODWHOHWIXQFWLRQDQDO\VHU ȁǶǿ52&+(ǹǰǸǬȄǴǸǴƒǸǹȂǾȆǷǴǮǲǸǰȁǽȀǹǽƒȉǰȂȁȉǧǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶǻƒǰǾǰǹǽǺǽȊǷǶȀǶȁǶǿǷǴǾǰƒǴǮǰǿȁȆǻȃǰǾƑǫǹȆǻƒǽȂǰǻǰȀȁǬǺǺǽȂǻȁǰǰǸƑǽƒǴȁǫǺǸǰǹǰǸǲǸǰȁǶǻǰǻǮȄǻǴȂȀǶǭȁǽǻǰƒǽǹǺǴǸȀƑȉȁǶǿǳȂȀǺǴǸȁǽȂǾǲǮǰǿȁȆǻǰǸƑǽƒǴȁǰǺǮȆǻǤǽ60RQRYHWWH®ƑǴǸǾǽȂǳǮǻǶǰǻǰƒȁȊȄǷǶǹǴǴǸǳǸǹǫǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǺǴǸȁǽȂǾǲǮǰǿȁȆǻǰǸƑǽƒǴȁǰǺǮȆǻƑǰǵǮƑǴȁǶǻǴȁǰǸǾǴǮǰ9HUXP'LDJQRVWLFDȀǭƑǴǾǰ52&+('LDJQRVWLFVȀȁǶȀȂȀǹǴȂǭ0XOWLSODWH®.
ǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǬȀȆȁǶǿǸǾǽȂǳǮǻǶǿƑǴǫƑǴȀǶǰǻǰȀȁǽǺǭȁǶǿǷǾǽƑǱǮǻǶǿǹǰǸǬȁȀǸǴƒǸȁǾǬƒǴǸȁǶǳǸǫǲǻȆȀǶȁǶǿǺǴǸȁǽȂǾǲǮǰǿȁȆǻǰǸƑǽƒǴȁǰǺǮȆǻȀȁǶȃȂȀǸǹǭǹǰȁǫȀȁǰȀǶ

SARSTEDT S-Monovette®ǽƑǽǹȂȀȁǴǒǻǶǿƑǴǲǬǺǶ+&<=+&<&Ǥǽ60RQRYHWWH®ǽƑǽǹȂȀȁǴǒǻǶǿƑǴǲǬǺǶ+&<=ƒǴǾǸǬȄǴǸǴǹȁȉǿǰƒȉȁǽƒǺǰȀȁǸǹȉǹǽǹǹǮǽƒǽȂǴǮǻǰǸǴƒǸǹǰǺȂƑƑǬǻǽƑǴǬǻǰǻǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿ ƒȂǾǸȁǸǹȉ ǬǻǰǻǴǸǳǸǹȉȀȁǰǷǴǾǽƒǽǸǶȁǭǹǰǸƑǸǰǲǬǺǶƑǴǱǫȀǶȁǽƒǽǺȂƑǴǾǬǿǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǾǽȊ ǘǲǬǺǶǴǻǰƒǽȁǮǷǴȁǰǸƑǴȃȂǲǽǹǬǻȁǾǸȀǶƑǴȁǰǼȊȁǽȂǷǾȉƑǱǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂǽǾǽȊǹǰǸȀȄǶƑǰȁǮǵǴǸǬǻǰȀȁǰǷǴǾȉǳǸǰȄȆǾǸȀȁǸǹȉȀȁǾȋƑǰǹǰȁǫȁǶƑǴȁǰȃǽǾǫȁǶǻǰƒǽǷǭǹǴȂȀǶǹǰǸȁǶǻǰǻǫǺȂȀǶǤǽƒǰǾǰȀǹǴȊǰȀƑǰȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊǘǽƑǽǹȂȀȁǴǒǻǶȀȁǰǷǴǾǽƒǽǸǴǮȁǰǸǲǸǰǬȆǿǹǰǸȋǾǴǿȀǴǽǺǸǹȉǰǮƑǰȀǴǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂǖǫǻǶȃȂǲǽǹǬǻȁǾǸȀǶƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸǴǻȁȉǿȁȆǻƒǾȋȁȆǻȆǾȋǻƑǴǬǻǰȀȆȀȁǫȀȄǶƑǰȁǸȀƑǬǻǽȀȁǾȋƑǰǳǸǰȄȆǾǸȀƑǽȊƑǴȁǰǼȊȁǽȂǷǾȉƑǱǽȂǰǮƑǰȁǽǿǹǰǸȁǽȂǽǾǽȊǶǽƑǽǹȂȀȁǴǒǻǶȀȁǰǷǴǾǽƒǽǸǴǮȁǰǸǲǸǰǬȆǿǹǰǸȋǾǴǿǠǽǾȉǿȁǽȂ60RQRYHWWH®ƑǴǲǬǺǶǽƑǽǹȂȀȁǴǒǻǶǿ+&<=ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǽƑǽǹȂȀȁǴǒǻǶǿǤǽ60RQRYHWWH®ƑǴǽƑǽǹȂȀȁǴǒǻǶ+&<&ƒǴǾǸǬȄǴǸȉǼǸǻǽǹǸȁǾǸǹȉǫǺǰǿ S+ ȆǿǰǻȁǸƒǶǹȁǸǹȉǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭƒǺǫȀƑǰȁǽǿ ǤǽǹǸȁǾǸǹȉǫǺǰǿȂƒǫǾȄǴǸȆǿǳǸǫǺȂƑǰǠȂƒǽǺǽǲǸȀƑȉǿȁǶǿȀȂǲǹǬǻȁǾȆȀǶǿǽƑǽǹȂȀȁǴǒǻǶǿǰƒǰǸȁǴǮƒǽǺǺǰƒǺǰȀǸǰȀƑȉǴƒǮǺȉǲȆȁǶǿǰǾǰǮȆȀǶǿǘǽƑǽǹȂȀȁǴǒǻǶȀȁǰǷǴǾǽƒǽǸǴǮȁǰǸȀȁǽǽǺǸǹȉǰǮƑǰȀǴǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂǲǸǰǬȆǿȋǾǴǿǹǰǸȀȁǽȂǿƓ&ǲǸǰǬȆǿǹǰǸȋǾǴǿǤǽƒǺǫȀƑǰȁǽȂ60RQRYHWWH®ƑǴǽƑǽǹȂȀȁǴǒǻǶ+&<&ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǽǻƒǾǽȀǳǸǽǾǸȀƑȉȁǶǿǽƑǽǹȂȀȁǴǒǻǶǿǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿȀȁǽ60RQRYHWWH®ƑǴǽƑǽǹȂȀȁǴǒǻǶ+&<&ƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴǹǸȁǾǸǹȉǤǶǾǴǮȁǴȁǸǿǠƍǘǕǚǖǣȁǶǿǴǻȉȁǶȁǰǿǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸȄǴǸǾǸȀƑȉǿǲǸǰȁǽȀȂǻǳȂǰȀƑȉȁǽȂ60RQRYHWWH®ƑǴ+&<&ǹǰǸȁȆǻƒǴȁǰǺǽȊǳȆǻ

SARSTEDT S-Monovette® DNA ExactǤǽ60RQRYHWWH®'1$([DFWƒǴǾǸǬȄǴǸǬǻǰǰǻȁǸƒǶǹȁǸǹȉƑǴǱǫȀǶ('7$ǹǰǸȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸǲǸǰȁǶȀȂǺǺǽǲǭǽǺǸǹǽȊǰǮƑǰȁǽǿ Ǥǽ('7$ȂƒǫǾȄǴǸȀǴƑǽǾȃǭȅǴǹǰȀƑǽȊǤǽǽǺǸǹȉǰǮƑǰ('7$ȄǾǶȀǸƑǽƒǽǸǴǮȁǰǸȆǿǳǴǮǲƑǰǲǸǰȁǶȀȁǰǷǴǾǽƒǽǮǶȀǶȁǽȂJ'1$ǘǴƒǮǳǽȀǶȀȁǰǷǴǾǽƒǽǮǶȀǶǿǲǸǰȁǽJ'1$ǴƒǸǹȂǾȋǻǴȁǰǸǲǸǰǶƑǬǾǴǿȀȁǽȂǿƓ&ǶƑǬǾǴǿȀǴǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂ Ɠ& 
ǶƑǬǾǴǿƑǴȅȊǼǶ Ɠ& ǹǰǸȁǽȂǺǬȁǽǿȀȁǽȂǿƓ&ǖƒǸƒǺǬǽǻȁǰȀȁǰǷǴǾǽƒǽǸǶƑǬǻǰǳǴǮǲƑǰȁǰǴƒǸǱǸȋǻǽȂǻȀǴǹȊǹǺǽȂǿȅȊǼǶǿǹǰǸǰƒȉȅȂǼǶǿȄȆǾǮǿǰƒȋǺǴǸǰƒǽǸȉȁǶȁǰǿǱǺǴƒǮȀǶǿ6$567('7:KLWH3DSHUhttps://www.
sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole
Blood for Genomic DNA Analysis.”.
ǘǰǻǰȀȁǽǺǭȁǶǿƒǭǼǶǿƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸƑǴȁǶȀȂƑƒǺǽǹǽƒǽǮǶȀǶȁȆǻǸȉǻȁȆǻǰȀǱǴȀȁǮǽȂƑǴ('7$ǘǹǰȁǰǺǺǶǺȉȁǶȁǰȁǽȂǳǴǮǲƑǰȁǽǿǴǼǰǾȁǫȁǰǸǰƒȉȁǽǻǰǻǰǺȂȁǭǹǰǸȁǽǰǻȁǸǳǾǰȀȁǭǾǸǽȁǶȀȂȀǹǴȂǭǰǻǫǺȂȀǶǿȁǶǿǴǼǬȁǰȀǶǿǡǾǬƒǴǸǻǰǺǰƑǱǫǻǽǻȁǰǸȂƒȉȅǶǽǸǰǻȁǮȀȁǽǸȄǴǿȀȂȀȁǫȀǴǸǿȁǽȂǹǰȁǰȀǹǴȂǰȀȁǭ49

ELǥƒǽǳǴǮǼǴǸǿǰȀȃǰǺǴǮǰǿƒǾǽǴǸǳǽƒǽǸǭȀǴǸǿ
1.

ǕǴǻǸǹǬǿƒǾǽȃȂǺǫǼǴǸǿǧǾǶȀǸƑǽƒǽǸǴǮȁǴǲǫǻȁǸǰǹǰǸǫǺǺǽǲǴǻǸǹȉǰȁǽƑǸǹȉƒǾǽȀȁǰȁǴȂȁǸǹȉǴǼǽƒǺǸȀƑȉǲǸǰȁǶǻƒǾǽȀȁǰȀǮǰȀǰǿǰƒȉȁǽǰǮƑǰǹǰǸǰƒȉȁǶǻƒǸǷǰǻǭǬǹǷǴȀǶȀǴǺǽǸƑȋǳǶȂǺǸǹǫǳǴǮǲƑǰȁǽǿǹǰǸƑǴȁǰǳǸǳȉƑǴǻǽȂǿƒǰǷǽǲȉǻǽȂǿƑǸǹǾǽǽǾǲǰǻǸȀƑǽȊǿ

2.

ǧǴǸǾǮǵǴȀȁǴȉǺǰȁǰǱǸǽǺǽǲǸǹǫǳǴǮǲƑǰȁǰǹǰǸȁǰǰǸȄƑǶǾǫƑȂȁǴǾǫǰǻȁǸǹǴǮƑǴǻǰȀȂǺǺǽǲǭǿǰǮƑǰȁǽǿ ǱǴǺȉǻǴǿȂƒǽǳǽȄǴǮǿ ȀȊƑȃȆǻǰƑǴȁǸǿǽǳǶǲǮǴǿǹǰǸȁǸǿǳǸǰǳǸǹǰȀǮǴǿȁǽȂǸǳǾȊƑǰȁȉǿȀǰǿǣȁǶǻƒǴǾǮƒȁȆȀǶǫƑǴȀǶǿǴƒǰȃǭǿƑǴǱǸǽǺǽǲǸǹǫǳǴǮǲƑǰȁǰǭǰȁȂȄǭƑǰȁǽǿȁǾǰȂƑǰȁǸȀƑǽȊǰƒȉǱǴǺȉǻǰǴƒǸȀǹǴȃȁǴǮȁǴǬǻǰǻǲǸǰȁǾȉǹǰǷȋǿȂƒǫǾȄǴǸƒǸǷǰǻȉȁǶȁǰƑǴȁǫǳǽȀǶǿȁǽȂǸǽȊǰǻǷǾȋƒǸǻǶǿǰǻǽȀǽǰǻǴƒǫǾǹǴǸǰǿ +,9 ǶƒǰȁǮȁǸǳǰǿ& +&9 ǶƒǰȁǮȁǸǳǰǿ% +%9 ǹǰǸǫǺǺȆǻǺǽǸƑȆǳȋǻǻȉȀȆǻǧǾǶȀǸƑǽƒǽǸǴǮȁǴǱǴǺȉǻǴǿǰȀȃǰǺǴǮǰǿǱǴǺȉǻǴǿǰȀȃǰǺǴǮǰǿ0XOWLĲ\®ƑǴǴǻȀȆƑǰȁȆƑǬǻǽƒǾǽȀȁǰȁǴȂȁǸǹȉǱǴǺȉǻǰǿǠǸƒǽǺǸȁǸǹǬǿǹǰǸǽǸǳǸǰǳǸǹǰȀǮǴǿǰȀȃǰǺǴǮǰǿȁǽȂǸǳǾȊƑǰȁȉǿȀǰǿƒǾǬƒǴǸǻǰȁǶǾǽȊǻȁǰǸ

3.

ǚȀȄȊǴǸǲǸǰǰȁǽƑǸǹǫǰƒǽȀȁǴǸǾȆƑǬǻǰȀȂȀǹǴȂǰȀƑǬǻǰƒǾǽȇȉǻȁǰǖǺǬǲȄǴȁǴȁǶǻǰǹǴǾǰǸȉȁǶȁǰǹǫǷǴǰȁǽƑǸǹǭǿȀȂȀǹǴȂǰȀǮǰǿƒǾǸǻǰƒȉȁǶȄǾǭȀǶǖǫǻƑǸǰȀȂȀǹǴȂǰȀǮǰǬȄǴǸȂƒǽȀȁǴǮȃǷǽǾǫƑǶǻȄǾǶȀǸƑǽƒǽǸǭȀǴȁǴȁǽƒǾǽȇȉǻ4.

ǤǽƒǾǽȇȉǻƒǾǽǽǾǮǵǴȁǰǸǲǸǰƑǮǰƑȉǻǽȄǾǭȀǶǓƒǽǾǾǮƒȁǴȁǴȉǺǰȁǰǰǸȄƑǶǾǫƑȂȁǴǾǫǰǻȁǸǹǴǮƑǴǻǰ ǱǴǺȉǻǴǿƒǾǽȀǰǾƑǽǲǴǮǿ ƒǽȂȄǾǶȀǸƑǽƒǽǸǽȊǻȁǰǸȀȁǶǻǰǸƑǽǺǶȅǮǰȀǴǹǰȁǫǺǺǶǺǽȂǿǹǫǳǽȂǿǰƒȉǾǾǸȅǶǿǲǸǰǴƒǸǹǮǻǳȂǻǰǱǸǽǺǽǲǸǹǫȂǺǸǹǫ5.

ǖǫǻƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸȀȂǺǺǽǲǭǰǮƑǰȁǽǿƑǬȀȆǴǻǳǽȃǺǬǱǸǽȂ ,9 ǹǰǷǴȁǭǾǰƒǾǬƒǴǸǻǰǳǸǰȀȃǰǺǮǵǴȁǰǸȉȁǸǽǹǰǷǴȁǭǾǰǿǼǴƒǺǬǻǴȁǰǸȀȆȀȁǫ ǹǰǷǰǾǮǵǴȁǰǸǰƒȉȁǽǳǸǫǺȂƑǰ,9 ȀȊƑȃȆǻǰƑǴȁǽǮǳǾȂƑǰƒǾǸǻǼǴǹǸǻǭȀǴǸǶǰǸƑǽǺǶȅǮǰǘȀȆȀȁǭǬǹƒǺȂȀǶȁǽȂǹǰǷǴȁǭǾǰǰƒǽȁǾǬƒǴǸǴȀȃǰǺƑǬǻǰǰƒǽȁǴǺǬȀƑǰȁǰǰǻǰǺȊȀǴȆǻ6.

ǘǴǺǺǸƒǭǿƒǺǭǾȆȀǶȁǽȂ60RQRYHWWH®ǽǳǶǲǴǮȀǴǴȀȃǰǺƑǬǻǶǰǻǰǺǽǲǮǰǰǮƑǰȁǽǿƒǾǽǿƒǰǾǰȀǹǴȊǰȀƑǰƒǾȉȀǷǴȁǽǹǰǸƑƒǽǾǴǮǻǰǽǳǶǲǭȀǴǸȀǴǺǰǻǷǰȀƑǬǻǰǰƒǽȁǴǺǬȀƑǰȁǰǰǻǫǺȂȀǶǿ7.

ǤǽǰǮƑǰƒǽȂȀȂǺǺǬǲǴȁǰǸǹǰǸȂƒǽǱǫǺǺǴȁǰǸȀǴǴƒǴǼǴǾǲǰȀǮǰƑǴȁǽ60RQRYHWWH®ǳǴǻƒǾǽǽǾǮǵǴȁǰǸǲǸǰǴƒǰǻǬǲȄȂȀǶȀȁǽǰǻǷǾȋƒǸǻǽȀȋƑǰ8.

ǓƒǰǲǽǾǴȊǴȁǰǸǶȄǾǭȀǶȁǽȂƒǾǽȇȉǻȁǽǿƑǴȁǫȁǽƒǬǾǰǿȁǶǿǶƑǴǾǽƑǶǻǮǰǿǺǭǼǶǿǘǳǸǰȁǶǾǶȀǸƑȉȁǶȁǰǺǭǲǴǸȁǶǻȁǴǺǴȂȁǰǮǰǶƑǬǾǰȁǽȂǰǻǰǲǾǰȃȉƑǴǻǽȂƑǭǻǰǹǰǸǬȁǽȂǿǦȊǺǰǼǶ
ǦȂǺǫȀȀǴȁǴȁǽƒǾǽȇȉǻǬȆǿȁǶȄǾǭȀǶȀǴǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂǡǴǾǸǽǾǸȀƑǽǮ
1.

ǘǳǸǫǾǹǴǸǰǹǰǸǶǷǴǾƑǽǹǾǰȀǮǰȃȊǺǰǼǶǿǴǻȉǿƒǺǶǾȆƑǬǻǽȂ60RQRYHWWH®ǴǼǰǾȁȋǻȁǰǸǰƒȉȁǶǳǸǰȁǶǾǶȀǸƑȉȁǶȁǰȁȆǻǰǻǰǺȂȋƑǴǻȆǻǽȂȀǸȋǻƒǽȂƒǾǬƒǴǸǻǰǴǼǴȁǰȀȁǽȊǻǘǰǼǸǽǺȉǲǶȀǶǳǸǴǻǴǾǲǴǮȁǰǸǰƒȉȁǽǴǾǲǰȀȁǭǾǸǽǭǽǸƒǺǶǾǽȃǽǾǮǴǿǺǰƑǱǫǻǽǻȁǰǸǰƒȉȁǸǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿȁǽȂǹǰȁǰȀǹǴȂǰȀȁǭȁȆǻǰǻȁǸǳǾǰȀȁǶǾǮȆǻȁǶǿǴǼǬȁǰȀǶǿȁǶǿȀȂȀǹǴȂǭǿǰǻǫǺȂȀǶǿ

2.

ǓǹȉƑǶǹǰǸǰǻȁǽƒǺǫȀƑǰǭǽǽǾȉǿǳǸǰȄȆǾǮǵǴȁǰǸǰƒȉȁǽ60RQRYHWWH®ƑǴȃȂǲǽǹǬǻȁǾǸȀǶǭǹǰǸȂƒǫǾȄǴǸȃǾǰǲƑȉǿǳǴǻǴǮǻǰǸǰƒǰǾǰǮȁǶȁǽȉȁǸǷǰǳǸǰȄȆǾǸȀȁǽȊǻƒǺǭǾȆǿȉǺǰȁǰǹȊȁȁǰǾǰǠȂƒǽǺǴǸƒȉƑǴǻǽǿƑǴȁǰǱǽǺǸȀƑȉǿǭǶȃȂȀǸǹǭǰƒǽǳȉƑǶȀǶƑƒǽǾǽȊǻǻǰǴƒǶǾǴǫȀǽȂǻȁǸǿȀȂǲǹǴǻȁǾȋȀǴǸǿȁȆǻǰǻǰǺȂȁȋǻǘȀȁǰǷǴǾȉȁǶȁǰȁȆǻǰǻǰǺȂȋƑǴǻȆǻǽȂȀǸȋǻǷǰƒǾǬƒǴǸǻǰǰǼǸǽǺǽǲǴǮȁǰǸȀǴȀȄǬȀǶƑǴȁǰȃǸǰǺǮǳǸǰȃȊǺǰǼǶǿǹǰǸȁǸǿȀȂǻǷǭǹǴǿȁǽȂǰǻȁǮȀȁǽǸȄǽȂǴǾǲǰȀȁǶǾǮǽȂ

3.

ǣȁǶǻƒǴǾǮƒȁȆȀǶǷǴǾǰƒǴȂȁǸǹȋǻȃǰǾƑǫǹȆǻǶǹǰȁǰǺǺǶǺȉȁǶȁǰȁǽȂȂǺǸǹǽȊȁǽȂǳǴǮǲƑǰȁǽǿǷǰƒǾǬƒǴǸǻǰǴƒǰǺǶǷǴȊǴȁǰǸȀȁǸǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿȁǽȂǹǰȁǰȀǹǴȂǰȀȁǭȁȆǻǰǻȁǸǳǾǰȀȁǶǾǮȆǻȁǶǿǴǼǬȁǰȀǶǿȁǶǿȀȂȀǹǴȂǭǿǰǻǫǺȂȀǶǿ4.

ǠǸǰǻǰǺȊȀǴǸǿǲǸǰǸȄǻǽȀȁǽǸȄǴǮǰƑǬȁǰǺǺǰƒǾǬƒǴǸǻǰƒǾǰǲƑǰȁǽƒǽǸǽȊǻȁǰǸƑǴȁǽȀȊȀȁǶƑǰ60RQRYHWWH®ǲǸǰȁǶǻǰǻǫǺȂȀǶȁȆǻƑǴȁǫǺǺȆǻǱǴǺȉǻǴǿǰȀȃǰǺǴǮǰǿǲǸǰȁǶǻǰǻǫǺȂȀǶƑǴȁǫǺǺȆǻǣȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻǹǰǸǽǳǶǲǮǴǿȄǾǭȀǶǿ
ƍǚǓǔǓǣǤǖǡǜǘǢƏǣǤǠǡǓǢǠǞǖǕǕǢǓǦǠǡǢǠǤǠǥǟǖǛǚǞǘǣǖǤǖǤǘǣǥǜǜǠǕǘƍǖǚǕǝǓǤƏǞǦǜǖǔǚǛǠǥǓǚǝǓǤǠǣǓƒǰǸȁǽȊƑǴǻǽǿǱǽǶǷǶȁǸǹȉǿǴǼǽƒǺǸȀƑȉǿǲǸǰȁǶȀȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻ
1.

ǏǺǰȁǰǰƒǰǸȁǽȊƑǴǻǰȀȂȀȁǭƑǰȁǰǰǸƑǽǺǶȅǮǰǿ60RQRYHWWH®.

2.

ǔǴǺȉǻǴǿ ǰȀȃǰǺǴǮǰǿ ǭƒǴȁǰǺǽȊǳǴǿ ǰȀȃǰǺǴǮǰǿ 0XOWLĲ\®.

3.

ǕǫǻȁǸǰǾȉƑƒǰƒǾǽȀȁǰȁǴȂȁǸǹǫǲȂǰǺǸǫǭǫǺǺǶǹǰȁǫǺǺǶǺǶƒǾǽȀȁǰȁǴȂȁǸǹǭǴǻǳȂƑǰȀǮǰǲǸǰȁǶǻƒǾǽȀȁǰȀǮǰȀǰǿǰƒȉƒǰǷǽǲȉǻǽȂǿƑǸǹǾǽǽǾǲǰǻǸȀƑǽȊǿƒǽȂƑǴȁǰǳǮǳǽǻȁǰǸƑǬȀȆȁǽȂǰǮƑǰȁǽǿǭȁȂȄȉǻƑǽǺȂȀƑǰȁǸǹȋǻȂǺǸǹȋǻ

4.

ǖȁǸǹǬȁǴǿǰǻǰǲǾǰȃǭǿȀȁǽǸȄǴǮȆǻ

5.

ǓǻȁǸȀǶƒȁǸǹȉǲǸǰȁǽǻǹǰǷǰǾǸȀƑȉȁǽȂȀǶƑǴǮǽȂȀȂǺǺǽǲǭǿǰǮƑǰȁǽǿ ǲǸǰȁǶǻƒǾǽǴȁǽǸƑǰȀǮǰȁǽȂǰƒǽȀȁǴǸǾȆƑǬǻǽȂȀǶƑǴǮǽȂȀȂǺǺǽǲǭǿǰǹǽǺǽȂǷǴǮȁǴȁǸǿǽǳǶǲǮǴǿȁǽȂǸǳǾȊƑǰȁȉǿȀǰǿȀȄǴȁǸǹǫƑǴȁǶȀȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻ ǝǶǻȄǾǶȀǸƑǽƒǽǸǴǮȁǴƒǾǽȇȉǻȁǰǹǰǷǰǾǸȀƑǽȊƒǽȂǬȄǽȂǻȆǿǱǫȀǶȁǶǻǰǺǹǽȉǺǶǴǫǻȁǰǳǴǮǲƑǰȁǰƒǾȉǹǴǸȁǰǸǻǰȄǾǶȀǸƑǽƒǽǸǶǷǽȊǻǲǸǰǴǼǴȁǫȀǴǸǿȀȂǲǹǬǻȁǾȆȀǶǿǰǺǹǽȉǺȀȁǽǰǮƑǰ

6.

ǣȁǴǲǻȉǫȀǶƒȁǽǴƒǮǷǴƑǰƑǮǰǿȄǾǭȀǶǿ7.

ǓǸƑǽȀȁǰȁǸǹȉǺǫȀȁǸȄǽ8.

ǓȂȁǽǹȉǺǺǶȁǽǴƒǮǷǴƑǰ

9.

ƍǽȄǴǮǽǰƒȉǾǾǸȅǶǿǲǸǰǰǸȄƑǶǾǫǰǻȁǸǹǴǮƑǴǻǰǲǸǰȁǶǻǰȀȃǰǺǭǰƒȉǾǾǸȅǶȁȆǻȄǾǶȀǸƑǽƒǽǸǶƑǬǻȆǻȂǺǸǹȋǻǡǾǽȁǴǸǻȉƑǴǻǶȀǴǸǾǫǺǭȅǶǿ1.

ǦǸǰǺǮǳǸǰǹǰǺǺǸǬǾǲǴǸǰǿǰǮƑǰȁǽǿ

2.

ǦǸǰǺǮǳǸǰƑǴǹǸȁǾǸǹȉǭǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿ ƑǴȄȆǾǮǿǲǬǺǶǽǾǽȊ&$7ǲǬǺǶǽǾǽȊ&$7 

3.

ǦǸǰǺǮǳǸǰƑǴǴǻǴǾǲǽƒǽǸǶȁǭƒǭǼǶǿǭǹǸȁǾǸǹȉ

4.

ǦǸǰǺǮǳǸǰƑǴǶƒǰǾǮǻǶƑǴȄȆǾǮǿǲǬǺǶ

5.

ǦǸǰǺǮǳǸǰƑǴ('7$ƑǴȄȆǾǮǿǲǬǺǶ

6.

ǦǸǰǺǮǳǸǰƑǴǰǻǰȀȁǽǺǴǮǿǲǺȂǹȉǺȂȀǶǿ

7.

ǦǸǰǺǮǳǸǰƑǴǫǺǺǰƒǾȉȀǷǴȁǰ
ǣǘǝǖǚƏǣǘǖǫǻǼǴǹǸǻǭȀǴȁǴȁǶǻǰȃǰǮǾǴȀǶǴǻȉǿȃǸǰǺǸǳǮǽȂƑǴǹǸȁǾǸǹȉǭǫǺǺǽȂȃǸǰǺǸǳǮǽȂƑǴȂǲǾȉƒǰǾǰȀǹǴȊǰȀƑǰȉƒȆǿƒȄ3)$&7$'&3'$+&<&ǭ*OXFR(;$&7ȀǴȀȂǻǳȂǰȀƑȉƑǴƑǸǰƒǴȁǰǺǽȊǳǰ ƒȄǱǴǺȉǻǰ ǰȀȃǰǺǴǮǰǿ 0XOWLĲ\® ȀȂǻǸȀȁǫȁǰǸǶǴǹȁȆǻƒǾǽȁǬǾȆǻǰȃǰǮǾǴȀǶǴǻȉǿǫǳǴǸǽȂȃǸǰǺǸǳǮǽȂ ƒȄ60RQRYHWWH®1HXWUDO= ƒǾǽǹǴǸƑǬǻǽȂǻǰǰƒǽȃǴȂȄǷǴǮǶȂƒǽƒǺǭǾȆȀǶȁǽȂȃǸǰǺǸǳǮǽȂǰƒȉȁǶǻƒǺǭǾȆȀǶȁǽȂȀȆǺǭǻǰȁǶǿƒǴȁǰǺǽȊǳǰǿǝǴǰȂȁȉǻȁǽǻȁǾȉƒǽƑƒǽǾǴǮǻǰǳǸǰȀȃǰǺǸȀȁǴǮǶȀȆȀȁǭƒǺǭǾȆȀǶȁǽȂȃǸǰǺǸǳǮǽȂǹǰǸȆǿǴǹȁǽȊȁǽȂǶȀȆȀȁǭǰǻǰǺǽǲǮǰǰǻǫƑǸǼǶǿ ȂǲǾȉƒǾǽǿǰǮƑǰ ǡǢǠǣǠǧǘǕǸǰȁǶȀǴǸǾǫǺǭȅǶǿǷǰƒǾǬƒǴǸǻǰȁǶǾǴǮȁǴȁǽȂǿǹǰǻȉǻǴǿȁǽȂǸǳǾȊƑǰȁȉǿȀǰǿǓƒǽȃȊǲǴȁǴȁǶǻǴƒǰǻǴǸȀǾǽǭ
ǤǰƒǴǾǸȀȀȉȁǴǾǰ60RQRYHWWHƒǴǾǸǬȄǽȂǻȄǶƑǸǹǫƒǾȉȀǷǴȁǰǕǸǰǻǰǰƒǽȃȊǲǴȁǴȁǶǻǴƒǰǻǴǸȀǾǽǭǰǹǽǺǽȂǷǭȀȁǴȁǸǿƒǰǾǰǹǫȁȆǽǳǶǲǮǴǿ
1. ǧǾǶȀǸƑǽƒǽǸǴǮȁǴƑȉǻǽȁǰȂǺǸǹǫƒǽȂȀȂǻǸȀȁȋǻȁǰǸȀȁǸǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿ
2.

ǛǾǰȁǫȁǴȁǽȄǬǾǸȁǽȂǰȀǷǴǻǽȊǿȀǴǷǬȀǶƒǽȂǻǰǹǰǷǸȀȁǫǴȂǹǽǺȉȁǴǾǶȁǶǻƒǾȉȀǱǰȀǶȀȁǶǻǰǾȁǶǾǮǰǭȁǶȃǺǬǱǰǹǰǸȀȁǾǬȅȁǴȁǽȄǬǾǸȁǽȂǰȀǷǴǻǽȊǿǭǫǺǺǶƒǴǾǸǽȄǭƒǰǾǰǹǬǻȁǶȀǶǿȉȀǽȁǽǻǳȂǻǰȁȉǻƒǾǽǿȁǰǹǫȁȆ

3.

ǖƒǸƒǺǬǽǻǹǾǰȁǭȀȁǴȁǽ60RQRYHWWH®ƑǴȁǽǱǸǳȆȁȉƒȋƑǰȀȁǾǰƑƑǬǻǽƒǾǽǿȁǰƒǫǻȆǹǰǸȄǾǶȀǸƑǽƒǽǸȋǻȁǰǿƑǸǰǱǴǺȉǻǰ ǰȀȃǰǺǴǮǰǿ 0XOWLĲ\®ǴƒǸƒǺǬǽǻǹǫȁȆǰƒȉȁǽȊȅǽǿȁǽȂǱǾǰȄǮǽǻǰȁǽȀǶƑǴǮǽƒǰǾǰǹǬǻȁǶȀǶǿ

4.

ǡǾǬƒǴǸǻǰǳǸǰȀȃǰǺǮǵǴȁǰǸȉȁǸȁǽƒǴǾǸǴȄȉƑǴǻǽȁǶǿ60RQRYHWWH®ǳǴǻǬǾȄǴȁǰǸȀǴǴƒǰȃǭƑǴȁǽǱǸǳȆȁȉǹǰƒǫǹǸǭȁǽǫǹǾǽȁǶǿǱǴǺȉǻǰǿǹǰȁǫȁǶǳǸǫǾǹǴǸǰȁǶǿȃǺǴǱǸǹǭǿƒǰǾǰǹǬǻȁǶȀǶǿ

5.

ǧǰǺǰǾȋȀȁǴȁǽǰǸƑǽȀȁǰȁǸǹȉǺǫȀȁǸȄǽǴǻȋǾǬǴǸǰǮƑǰƑǬȀǰȀȁǽ60RQRYHWWH®.

50

ELǛǰȁǫȅȂǼǶǰƒȉȅȂǼǶ
ǣȊƑȃȆǻǰƑǴȁǸǿȀȂȀȁǫȀǴǸǿȁǽȂǡǠǥ :+2'LO/DEǓǻǰǷ ȀȂǻǸȀȁǫȁǰǸǽǳǸǰȄȆǾǸȀƑȉǿǽǾǽȊƒǺǫȀƑǰȁǽǿƒǾǸǻǰƒȉȁǶǻǹǰȁǫȅȂǼǶȁȆǻǰǸƑǽȀȃǰǸǾǮȆǻǕǸǰȁǰ60RQRYHWWH®ǸȀȄȊǽȂǻǽǸǰǹȉǺǽȂǷǴǿȀȂȀȁǫȀǴǸǿǹǰȁǫȅȂǼǶǿǛǰȁǫȅȂǼǶȀǴǷǴǾƑǽǹǾǰȀǮǰǹǫȁȆǰƒȉbƓ&•ǘȄǾǭȀǶȀǴǴȊǾǽǿǷǴǾƑǽǹǾǰȀǸȋǻȂƒȉȁǽȂƑǶǳǴǻȉǿƒǾǬƒǴǸƒǫǻȁǰǻǰǴǺǬǲȄǴȁǰǸȂƒȉƒǾǰǲƑǰȁǸǹǬǿȀȂǻǷǭǹǴǿǳǴǳǽƑǬǻǽȂȉȁǸȁǽȃǽǾȁǮǽȀȁǰȃǸǰǺǮǳǸǰƑƒǽǾǴǮǻǰƒǽǸǹǮǺǺǴǸȀǶƑǰǻȁǸǹǫǰǻǫǺǽǲǰƑǴȁǽƑǬȀǽƒǽȂƒǾȉǹǴǸȁǰǸǻǰǹǰȁǰȅȂȄǷǴǮǹǰǸȁǸǿȀȂǻǭǷǴǸǿȀȂǻǷǭǹǴǿ ǔǺǛǴȃǫǺǰǸǽǚǳǸȉȁǶȁǴǿȂǺǸǹȋǻǹǰȁǫǺǽǲǽǿ6$567('7 •ǠȂȀǸǰȀȁǸǹǫǽǸȁǸƑǬǿǰǻȁǽȄǭǿȁȆǻƒǺǰȀȁǸǹȋǻƑǴǸȋǻǽǻȁǰǸȀȁǽǴȊǾǽǿǷǴǾƑǽǹǾǰȀǮǰǿǹǫȁȆǰƒȉbƓ&ǖƒǽƑǬǻȆǿǽǸƑǶȄǰǻǸǹǬǿǹǰȁǰƒǽǻǭȀǴǸǿƒǾǬƒǴǸǲǴǻǸǹǫǻǰǰƒǽȃǴȊǲǽǻȁǰǸ•ǠǸȀȂǻǷǭǹǴǿǹǰȁǫȅȂǼǶǿƒǾǬƒǴǸǻǰǴƒǸǺǬǲǽǻȁǰǸƑǴȁǬȁǽǸǽȁǾȉƒǽȋȀȁǴȁǽƒǴǾǸǴȄȉƑǴǻǽǴǻȉǿ60RQRYHWWH®ǻǰƒǰǲȋǻǴǸǽƑǽǸȉƑǽǾȃǰǭǰƒȉǹǫȁȆƒǾǽǿȁǰƒǫǻȆǤǽ60RQRYHWWH®ǷǰƒǾǬƒǴǸǻǰǬȄǴǸǰǾǹǴȁȉǳǸǫǹǴǻǽȀǴǬǻǰȀȁǰȁȉǭǹǽȂȁǮǰƒǽǷǭǹǴȂȀǶǿȋȀȁǴǻǰƑƒǽǾǴǮǻǰǳǸǰȀȁǰǺǴǮǤǰȀȁǰȁȉǰƒȉƒǽǺȂȀȁȂǾǬǻǸǽǭƑǬȁǰǺǺǽǴǮǻǰǸǰǹǰȁǫǺǺǶǺǰǹǰǷȋǿƑƒǽǾǴǮǻǰǽǳǶǲǭȀǽȂǻȀǴǾȆǲƑǬǿǺȉǲȆǳǸǰȀȁǽǺǭǿǛǰȁǫȅȂǼǶȀȁǽȂǿƓ&şǖǺǬǲǼȁǴƒǾǸǻǰƒȉȁǶǻǹǰȁǫȅȂǼǶ•ǡǰǾǴƑǱǽǺǬǿǖǺǬǲǼȁǴǴǫǻǶǹǰȁǫȅȂǼǶǴƒǸǳǾǫǰǾǻǶȁǸǹǫȀȁǽǳǴǮǲƑǰǰǮƑǰȁǽǿǭȀȁǸǿǰǻǰǺȊȀǴǸǿǰǮƑǰȁǽǿ ƒȄǰǸƑȉǺȂȀǶȀȁǰǷǴǾȉȁǶȁǰȁȆǻǰǻǰǺȂȉƑǴǻȆǻǽȂȀǸȋǻ •ǦȂǲǽǹǬǻȁǾǸȀǶǓƒǰǸȁǴǮȁǰǸǰǻǫǺǽǲǰƑǴȁǶǻƒǾǽǲǾǰƑƑǰȁǸȀƑǬǻǶǰǻǫǺȂȀǶǕǸǰȁǸǿȀȂǻǷǭǹǴǿȃȂǲǽǹǬǻȁǾǸȀǶǿǰǻǰȁǾǬǼȁǴȀǴǰȂȁȉȁǽǬǲǲǾǰȃǽȀȁǶǻǴǻȉȁǶȁǰŝǦȂǲǽǹǬǻȁǾǸȀǶŞǭȀȁǽǻǸȀȁȉȁǽƒǽȁǶǿ6$567('7https://www.sarstedt.com/en/service/centrifugation/ǹǰǸǳǸǴǻǴǾǲǭȀȁǴǽƒȁǸǹȉǬǺǴǲȄǽȁǽȂǳǴǮǲƑǰȁǽǿ•ǓǸƑȉǺȂȀǶǓǸƑȉǺȂȀǶǽǺǸǹǽȊǰǮƑǰȁǽǿǹǰȁǫȁǶǻǹǰȁǫȅȂǼǶǕǸǰǻǰǰƒǽȃǴȂȄǷǴǮǹǫȁǸȁǬȁǽǸǽǴǮȁǴǷǰƒǾǬƒǴǸǻǰȄǾǶȀǸƑǽƒǽǸǶǷǴǮȁǽ60RQRYHWWH®ƑǴǲǬǺǶǴǮȁǴƑǴȁǫȁǶȃȂǲǽǹǬǻȁǾǸȀǶȁǽȃǮǺȁǾǽǱǰǺǱǮǳȆǻ6HUDSODV®ǭǻǰȁǽƒǽǷǴȁǶǷǴǮȁǽǳǴǮǲƑǰȀǴǬǻǰǳǴȂȁǴǾǴȊǽǻȃǸǰǺǮǳǸǽǛǰȁǫȅȂǼǶȀȁǽȂǿƓ&şƍǸǰǳǸǹǰȀǮǰ•ǨȊǼǶǨȊǼȁǴȁǽ60RQRYHWWH®ȀǴǹǰȁǰǹȉǾȂȃǶǷǬȀǶǲǸǰȄǾǽǻǸǹȉǳǸǫȀȁǶƑǰşǺǴƒȁȋǻǰƒȉȁǶǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂȀǴǷǴǾƑǽǹǾǰȀǮǰbƓ&ƒǾǽȁǽȊƑƒǽǾǬȀǴǸǻǰǹǰȁǰȅȂȄǷǴǮȀǴǷǴǾƑǽǹǾǰȀǮǰbƓ&•ǓƒȉȅȂǼǶǓȃǭȀȁǴȁǽǻǰǰƒǽȅȂȄǷǴǮȀǴǹǰȁǰǹȉǾȂȃǶǷǬȀǶǲǸǰȁǽȂǺǫȄǸȀȁǽǻǺǴƒȁǫȀǴǷǴǾƑǽǹǾǰȀǮǰǳȆƑǰȁǮǽȂǛǰǸȀǴǰȂȁǭǻȁǶǻƒǴǾǮƒȁȆȀǶƒǾǬƒǴǸǻǰǰƒǽȃǴȊǲǽǻȁǰǸǽǸƑǶȄǰǻǸǹǬǿǹǰȁǰƒǽǻǭȀǴǸǿǘƒǽǺȊǲǾǭǲǽǾǶǰƒȉȅȂǼǶƑƒǽǾǴǮǻǰǴƒǶǾǴǫȀǴǸȁǰǰƒǽȁǴǺǬȀƑǰȁǰȁǶǿǰǻǫǺȂȀǶǿǛǰȁǫȅȂǼǶǹǰǸǱǰǷǸǫǹǰȁǫȅȂǼǶȀǴǷǴǾƑǽǹǾǰȀǮǰǹǫȁȆǰƒȉbƓ&•ǘǱǰǷǸǫǹǰȁǫȅȂǼǶȀǴǷǴǾƑǽǹǾǰȀǮǰǹǫȁȆǰƒȉbƓ&ǳǴǻǬȄǴǸǴǺǴǲȄǷǴǮǰƒȉȁǽǻǹǰȁǰȀǹǴȂǰȀȁǭǜȉǲȆȁǽȂƑǴǲǫǺǽȂǰǾǸǷƑǽȊƒǸǷǰǻȋǻƒǰǾǰǲȉǻȁȆǻǴƒǸǾǾǽǭǿȀȂǻǸȀȁǫȁǰǸǶǳǸǴǻǬǾǲǴǸǰǳǽǹǸƑȋǻǹǰȁǫȅȂǼǶǿȂƒȉȀȂǻǭǷǴǸǿǴǾǲǰȀȁǶǾǸǰǹǬǿȀȂǻǷǭǹǴǿǛǰȁǫȅȂǼǶȁǽȂ60RQRYHWWH®ƑǴǲǬǺǶ•ǘǹǰȁǫȅȂǼǶƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸȉƒȆǿȀȁǽȀǶƑǴǮǽǹǰȁǫȅȂǼǶǿȀȁǽȂǿƓ&şƍǸǰǳǸǹǰȀǮǰ•ǖǮǻǰǸǲǻȆȀȁȉȉȁǸȁǽȀȁǾȋƑǰǲǬǺǶǿƑƒǽǾǴǮǻǰǰǺǺǫǼǴǸȆǿǰƒǽȁǬǺǴȀƑǰȁǶǿǳǸǰǳǸǹǰȀǮǰǿǹǰȁǫȅȂǼǶǿ•ǜȉǲȆȁǽȂƑǴǲǫǺǽȂǰǾǸǷƑǽȊƒǸǷǰǻȋǻƒǰǾǰǲȉǻȁȆǻǴƒǸǾǾǽǭǿȀȂǻǸȀȁǫȁǰǸǶǳǸǴǻǬǾǲǴǸǰǳǽǹǸƑȋǻǹǰȁǫȅȂǼǶǿȂƒȉȀȂǻǭǷǴǸǿǴǾǲǰȀȁǶǾǸǰǹǬǿȀȂǻǷǭǹǴǿ•ǓƒȉȅȂǼǶǓȃǭȀȁǴȁǽǳǴǮǲƑǰǻǰǰƒǽȅȂȄǷǴǮȀǴǹǰȁǰǹȉǾȂȃǶǷǬȀǶǝǴȁǫȁǶǻǰƒȉȅȂǼǶƑǴȁǰȃǬǾǴȁǴȁǽǳǴǮǲƑǰƑǴƒǸƒǴȁǫǾǸȀƑǰ ȉȄǸǬǹȄȂȀǶ ǬȆǿƒǴǾPPƒǫǻȆǰƒȉȁǽȀȁǾȋƑǰȁǶǿǲǬǺǶǿǰƒȉȁǽǹȊǾǸǽȃǸǰǺǮǳǸǽȀǴǬǻǰǳǴȂȁǴǾǽǲǴǻǬǿȃǸǰǺǮǳǸǽǓƒǽǾǾǮȅȁǴȁǽȂƒȉǺǽǸƒǽǥǡǠƍǖǚǟǘǕǸǰȁǶȀȁǰǷǴǾȉȁǶȁǰȁȆǻǰǻǰǺȂȋƑǴǻȆǻǽȂȀǸȋǻǰƒǰǸȁǴǮȁǰǸǶȀȂƑƑȉǾȃȆȀǶƑǴȁǸǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿȁȆǻǰǻȁǸǳǾǰȀȁǶǾǮȆǻȁǶǿǴǼǬȁǰȀǶǿȁȆǻǹǰȁǰȀǹǴȂǰȀȁȋǻǰǻǰǺȂȁȋǻ51

ELǓǸƑǽǺǶȅǮǰ
ǤǴȄǻǸǹǬǿȀȂǺǺǽǲǭǿƍǸǰǹǾǮǻǽǻȁǰǸǳȊǽȁǴȄǻǸǹǬǿȀȂǺǺǽǲǭǿǶȁǴȄǻǸǹǭǰǻǰǾǾȉȃǶȀǶǿǹǰǸǶȁǴȄǻǸǹǭǹǴǻǽȊǘȁǴȄǻǸǹǭǰǻǰǾǾȉȃǶȀǶǿǴƒǸȁǾǬƒǴǸƑǬȀȆȁǽȂǴǺǴǲȄȉƑǴǻǽȂȁǾǰǱǭǲƑǰȁǽǿȁǽȂǱǫǹȁǾǽȂȁǽȂǴƑǱȉǺǽȂȁǶǻǰƒǰǺǭǰǸƑǽǺǶȅǮǰƑǴȀȂǻǴȄǭǹǰǸǰǾǲǭǾǽǭǰǮƑǰȁǽǿǝǴǰȂȁȉǻȁǽǻȁǾȉƒǽǶǾǽǭǰǮƑǰȁǽǿƑƒǽǾǴǮǻǰƒǾǽȀǰǾƑǽȀȁǴǮǫƑǴȀǰȀǴȉǺǴǿȁǸǿȃǺǴǱǸǹǬǿȀȂǻǷǭǹǴǿǹǰǸƒǴǾǸƒȁȋȀǴǸǿǹǰǸǶǰǸƑȉǺȂȀǶƑƒǽǾǴǮǻǰƑǴǸȆǷǴǮǝǬȀȆǴǻȉǿȃǸǰǺǸǳǮǽȂƒǽȂǬȄǴǸǴǹǹǴǻȆǷǴǮǴǹȁȆǻƒǾǽȁǬǾȆǻǶȁǴȄǻǸǹǭǹǴǻǽȊǴƒǸȁǾǬƒǴǸȁǶǻǰǸƑǽǺǶȅǮǰȀȊƑȃȆǻǰȁǶǿǰǾȄǭȁǶǿȂƒǽƒǮǴȀǶǿƑǴȀȂǻǴȄǭȁǰȄǴǮǰǾǽǭǰǮƑǰȁǽǿƏǿǴǹȁǽȊȁǽȂǰȂȁǭǶȁǴȄǻǸǹǭǴǮǻǰǸǸǳǰǻǸǹǭǲǸǰǹǰǺǬǿȃǺǴǱǸǹǬǿȀȂǻǷǭǹǴǿǹǰǸǰƒǺǬǿȀȂǻǷǭǹǴǿȀȂǺǺǽǲǭǿǧǴǸǾǸȀƑȉǿǹǰȁǫȁǶǻǰǸƑǽǺǶȅǮǰǡǰǾǰǹǽǺǽȂǷǭȀȁǴǴƒǮȀǶǿȁǽǱǮǻȁǴǽȄǴǸǾǸȀƑǽȊȁǽȂ60RQRYHWWH®ȀȁǶǻȁǴȄǻǸǹǭǰǻǰǾǾȉȃǶȀǶǿǭȁǶǻȁǴȄǻǸǹǭǹǴǻǽȊƑǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿ0XOWLIO\®:
www.sarstedt.com/en/download/videos/Diagnostics/Venous bloodǕǚǓǤǘǞǖǜǓǧǚǣǤǠǡǠǚǘǣǘǤǠǥǛǚǞƍǥǞǠǥǖǛǙǖǣǘǣǛǓǤǓǤǘƍǚǓǢǛǖǚǓǤǘǣǣǥǜǜǠǕǘǣǓǚǝǓǤǠǣǦǠǢǓǤǖǕǓǞǤǚǓ
1. ǖƒǸǺǬǼȁǴȁǽǹǰȁǫǺǺǶǺǽ60RQRYHWWH®ǲǸǰȁǽǳǴǮǲƑǰȉƒȆǿǰƒǰǸȁǴǮȁǰǸ
2.

ǖƒǸǺǬǼȁǴȁǽȀǶƑǴǮǽǲǸǰȁǶȃǺǴǱǽǹǬǻȁǶȀǶǕǸǰȁǶǻƒǾǽǴȁǽǸƑǰȀǮǰȁǽȂȀǶƑǴǮǽȂȃǺǴǱǽǹǬǻȁǶȀǶǿǺǫǱǴȁǴȂƒȉȅǶȁǸǿǹǰȁǴȂǷȂǻȁǭǾǸǴǿǲǾǰƑƑǬǿȁǽȂǸǳǾȊƑǰȁǽǿǓǸƑǽǺǶȅǮǰƑǴȁǶǻȁǴȄǻǸǹǭǰǻǰǾǾȉȃǶȀǶǿǡǾǽȀǽȄǭǧǾǶȀǸƑǽƒǽǸǴǮȁǴȁǽ60RQRYHWWH®ƑȉǻǽǲǸǰȁǶǻǰǸƑǽǺǶȅǮǰǹǰǸȉȄǸǲǸǰǴǻǬȀǴǸǿǧǾǶȀǸƑǽƒǽǸǴǮȁǰǸƑȉǻǽƑǴǰȂȁǬǿȁǸǿǱǴǺȉǻǴǿ ǱǴǺȉǻǴǿ ǰȀȃǰǺǴǮǰǿ 60RQRYHWWH®ǭƒǴȁǰǺǽȊǳǴǿȂƒǽǳǽȄǴǮǿ ǰȀȃǰǺǴǮǰǿ 0XOWLIO\®ǲǸǰȁǽ60RQRYHWWH®).
ǖǳȋǴƑȃǰǻǮǵǴȁǰǸǶȄǾǭȀǶƑǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǹǺǸǹǓǹǾǸǱȋǿƒǾǸǻǰƒȉȁǶȃǺǴǱǽǹǬǻȁǶȀǶȆǷǭȀȁǴȁǽ60RQRYHWWH®ȀȁǶǻǴǻȀȆƑǰȁȆƑǬǻǶǱǫȀǶȁǶǿǱǴǺȉǻǰǿǰȀȃǰǺǴǮǰǿ ǹǰǸǰȀȃǰǺǮȀȁǴȁǽƒǴǾǸȀȁǾǬȃǽǻȁǫǿȁǽǴǺǰȃǾȋǿǳǴǼǸȉȀȁǾǽȃǰ .
ǖǫǻǴǮǻǰǸǰƒǰǾǰǮȁǶȁǽȁǽƒǽǷǴȁǭȀȁǴǰǸƑǽȀȁǰȁǸǹȉǺǫȀȁǸȄǽ ǬȆǿǺǴƒȁȉ ǡǾǽǴȁǽǸƑǫȀȁǴȁǽȀǶƑǴǮǽƒǰǾǰǹǬǻȁǶȀǶǿƑǴȁǽǹǰȁǫǺǺǶǺǽǰƒǽǺȂƑǰǻȁǸǹȉǝǶǻǰǲǲǮǵǴȁǴȁǽȀǶƑǴǮǽȁǶǿȃǺǴǱǽǹǬǻȁǶȀǶǿƑǴȁǫȁǶǻǰƒǽǺȊƑǰǻȀǶǛǾǰȁǫȁǴȁǽȄǬǾǸȁǽȂǰȀǷǴǻǽȊǿȀǴǷǬȀǶƒǽȂǻǰǹǰǷǸȀȁǫǴȂǹǽǺȉȁǴǾǶȁǶǻƒǾȉȀǱǰȀǶȀȁǶǻǰǾȁǶǾǮǰǭȁǶȃǺǬǱǰǹǰǸȀȁǾǬȅȁǴȁǽȄǬǾǸȁǽȂǰȀǷǴǻǽȊǿǭǫǺǺǶƒǴǾǸǽȄǭƒǰǾǰǹǬǻȁǶȀǶǿȉȀǽȁǽǳȂǻǰȁȉǻƒǾǽǿȁǰǹǫȁȆǓȃǰǸǾǬȀȁǴȁǽƒǾǽȀȁǰȁǴȂȁǸǹȉȁǶǿǱǴǺȉǻǰǿǤǾȂƒǭȀȁǴȁǶȃǺǬǱǰȁǾǰǱǭǼȁǴƑǴǰǾǲǬǿǹǸǻǭȀǴǸǿȁǽǱǫǹȁǾǽȁǽȂǴƑǱȉǺǽȂǹǰǸȄǰǺǰǾȋȀȁǴȁǽǰǸƑǽȀȁǰȁǸǹȉǺǫȀȁǸȄǽǴǻȋǾǬǴǸǰǮƑǰƑǬȀǰȀȁǽ60RQRYHWWH®
ǡǴǾǸƑǬǻǴȁǴǬȆǿȉȁǽȂȀȁǰƑǰȁǭȀǴǸǶǾǽǭȁǽȂǰǮƑǰȁǽǿǲǸǰǻǰǴƒǸȁǾǬȅǴȁǴȁǶȀȆȀȁǭƒǺǭǾȆȀǶ.

ǝǴȁǰǹǸǻǭȀȁǴȁǽ60RQRYHWWH®ƒǴǾǸȀȁǾǬȃǽǻȁǫǿȁǽǴǺǰȃǾȋǿǰǾǸȀȁǴǾȉȀȁǾǽȃǰ ǹǰǸȀȁǶȀȂǻǬȄǴǸǰȁǾǰǱǭǼȁǴȁǽǬǼȆǰƒȉȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿ ǰƒǽȀȊǻǳǴȀǶ  ǘǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿƒǰǾǰƑǬǻǴǸȀȁǶȃǺǬǱǰǣȁǶǻƒǴǾǮƒȁȆȀǶƒǽǺǺǰƒǺȋǻȀȂǺǺǽǲȋǻǰǮƑǰȁǽǿȀȂǻǳǬȀȁǴȉƒȆǿƒǴǾǸǲǾǫȃǴȁǰǸƒǰǾǰƒǫǻȆȁǰǴƒȉƑǴǻǰ60RQRYHWWHƑǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǹǰǸǺǫǱǴȁǴƒǴǾǸȀȀȉȁǴǾǰǳǴǮǲƑǰȁǰǠǺǽǹǺǭǾȆȀǶǰǸƑǽǺǶȅǮǰǿǡǾȋȁǰǰƒǽȀȂǻǳǬȀȁǴȁǽ60RQRYHWWH®
+ ǹǰǸȀȁǶȀȂǻǬȄǴǸǰȁǾǰǱǭǼȁǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǬǼȆǰƒȉȁǶȃǺǬǱǰǧǾǶȀǸƑǽƒǽǸȋǻȁǰǿȁǶǻȁǴȄǻǸǹǭȁǽȂǴǻȉǿȄǴǾǸǽȊǴǻǴǾǲǽƒǽǸǭȀȁǴȁǽƒǾǽȀȁǰȁǴȂȁǸǹȉǱǴǺȉǻǰǿǴǮȁǴȀǴƑǸǰȀȁǰǷǴǾǭǴƒǮƒǴǳǶǴƒǸȃǫǻǴǸǰǬȆǿȉȁǽȂǶǱǴǺȉǻǰǰȀȃǰǺǮȀǴǸƑǴǬǻǰŝǹǺǸǹŞȀȁǽƒǾǽȀȁǰȁǴȂȁǸǹȉǱǴǺȉǻǰǿ ǴǻǴǾǲǽƒǽǮǶȀǶ ǴǮȁǴƒǸǬǵǽǻȁǰǿȁǽǳǴǮǹȁǶȀȁǽǹǫȁȆǫǹǾǽȁǽȂƒǾǽȀȁǰȁǴȂȁǸǹǽȊȁǶǿǱǴǺȉǻǰǿǱǺǴƒǮȀǶǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿǲǸǰȁǶǱǴǺȉǻǰ ǰȀȃǰǺǴǮǰǿ 60RQRYHWWH®ǭȁǶǱǴǺȉǻǰ ǰȀȃǰǺǴǮǰǿ 0XOWLIO\®.
ǓǻǰǹǸǻǭȀȁǴǹǫǷǴ60RQRYHWWH®ǰƑǬȀȆǿƑǴȁǫȁǶǻǰƒǽȀȊǻǳǴȀǭȁǽȂǰƒȉȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿƑǮǰȃǽǾǫǹǰǸƑǴȁǫȁǶǻǽǺǽǹǺǭǾȆȀǶȁǶǿǰǸƑǽǺǶȅǮǰǿǰǻǰǹǸǻǭȀȁǴƑǴƒǾǽȀǽȄǭȉǺǰȁǰǳǴǮǲƑǰȁǰƑǴǰǻȁǸƒǶǹȁǸǹǫǰǾǹǴȁǬǿȃǽǾǬǿǕǸǰƑǴȁǰȃǽǾǫǹǰǸȃȂǲǽǹǬǻȁǾǸȀǶȁǾǰǱǭǼȁǴȁǽǱǫǹȁǾǽȁǽȂǴƑǱȉǺǽȂȀȁǶǷǬȀǶǰȀȃǫǺǸȀǶǿȁǽȂǴƑǱȉǺǽȂ  ȁǽǬƑǱǽǺǽǰȀȃǰǺǮǵǴǸȀȁǽǻƒȂǷƑǬǻǰȁǽȂ60RQRYHWWH® ǹǰǸȀƒǫȀȁǴȁǽǱǫǹȁǾǽȁǽȂǴƑǱȉǺǽȂ .
1.

ǡǸǬȀȁǴȁǽȀǶƑǴǮǽƒǰǾǰǹǬǻȁǶȀǶǿƑǴǬǻǰȀȁǴǲǻȉǫȀǶƒȁǽǴƒǮǷǴƑǰǬȆǿȉȁǽȂȀȁǰƑǰȁǭȀǴǸǶǰǸƑǽǾǾǰǲǮǰ

2.

ǏȁǰǻǰǾȄǮȀǴǸǻǰƒǭǵǴǸȁǽǰǮƑǰȁǽƒǽǷǴȁǭȀȁǴǬǻǰǰȂȁǽǹȉǺǺǶȁǽǴƒǮǷǴƑǰǴǫǻȁǽǴƒǸǷȂƑǴǮȁǴ

3.

ǓƒǽǾǾǮȅȁǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿȀǴǬǻǰǹǰȁǫǺǺǶǺǽǳǽȄǴǮǽǰƒȉǾǾǸȅǶǿǲǸǰǴƒǸǹǮǻǳȂǻǰǱǸǽǺǽǲǸǹǫȂǺǸǹǫ52

ELǓǸƑǽǺǶȅǮǰƑǴȁǶǻȁǴȄǻǸǹǭǹǴǻǽȊǡǾǽȀǽȄǭǧǾǶȀǸƑǽƒǽǸǴǮȁǴȁǽ60RQRYHWWH®ƑȉǻǽǲǸǰȁǶǻǰǸƑǽǺǶȅǮǰǹǰǸȉȄǸǲǸǰǴǻǬȀǴǸǿǧǾǶȀǸƑǽƒǽǸǴǮȁǰǸƑȉǻǽƑǴǰȂȁǬǿȁǸǿǱǴǺȉǻǴǿ ǱǴǺȉǻǴǿ ǰȀȃǰǺǴǮǰǿ 60RQRYHWWH®ǭǱǴǺȉǻǴǿƒǾǽȀǰǾƑǽǲǴǮǿ ǰȀȃǰǺǴǮǰǿ 0XOWLIO\®ǲǸǰȁǽ60RQRYHWWH®).
ǖǳȋǴƑȃǰǻǮǵǴȁǰǸǶȄǾǭȀǶƑǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǹǺǸǹǕǸǰǻǫǼǴǹǸǻǭȀǴȁǴǽƑǰǺǫȁǶǻǰǸƑǽǺǶȅǮǰǶ6$567('7ȀȂǻǸȀȁǫȁǶȄǾǭȀǶȁǽȂƒǾȋȁǽȂ60RQRYHWWH®ƑǴȁǶǻȁǴȄǻǸǹǭȁǶǿǰǻǰǾǾȉȃǶȀǶǿǱǺǤǖǧǞǚǛǘǦǜǖǔǠǛǖǞǤǘǣǘǣ – .
ǣȁǶȀȂǻǬȄǴǸǰȀȂǻǴȄǮȀȁǴƑǴȁǶǻȁǴȄǻǸǹǭǹǴǻǽȊǡǾǸǻǰƒȉȁǶǻǰǸƑǽǺǶȅǮǰȁǾǰǱǭǼȁǴȁǽǱǫǹȁǾǽȁǽȂǴƑǱȉǺǽȂǬȆǿȁǽǻƒȂǷƑǬǻǰȁǽȂ60RQRYHWWH®ǬȆǿȉȁǽȂǰȀȃǰǺǮȀǴǸƑǴȁǽǻȄǰǾǰǹȁǶǾǸȀȁǸǹȉ ǭȄǽǣȁǶȀȂǻǬȄǴǸǰǰȃǰǸǾǬȀȁǴȁǽǱǫǹȁǾǽȁǽȂǴƑǱȉǺǽȂ .
ƏǷǭȀȁǴȁǽ60RQRYHWWH®ƒǽȂƒǾǽǴȁǽǸƑǫȀǰȁǴȀȁǶǻǴǻȀȆƑǰȁȆƑǬǻǶǱǫȀǶȁǶǿǱǴǺȉǻǰǿǰȀȃǰǺǴǮǰǿȁǽȂ60RQRYHWWH®ǹǰǸǰȀȃǰǺǮȀȁǴȁǽƒǴǾǸȀȁǾǬȃǽǻȁǫǿȁǽǴǺǰȃǾȋǿǳǴǼǸȉȀȁǾǽȃǰ

+.

ǡǴǾǸƑǬǻǴȁǴǬȆǿȉȁǽȂȀȁǰƑǰȁǭȀǴǸǶǾǽǭȁǽȂǰǮƑǰȁǽǿǲǸǰǻǰǴƒǸȁǾǬȅǴȁǴȁǶȀȆȀȁǭƒǺǭǾȆȀǶǝǴȁǰǹǸǻǭȀȁǴȁǽ60RQRYHWWH®ƒǴǾǸȀȁǾǬȃǽǻȁǫǿȁǽǴǺǰȃǾȋǿǰǾǸȀȁǴǾȉȀȁǾǽȃǰ ǹǰǸȀȁǶȀȂǻǬȄǴǸǰȁǾǰǱǭǼȁǴȁǽǬǼȆǰƒȉȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿ ǰƒǽȀȊǻǳǴȀǶ  ǘǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿƒǰǾǰƑǬǻǴǸȀȁǶȃǺǬǱǰǣȁǶǻƒǴǾǮƒȁȆȀǶƒǽǺǺǰƒǺȋǻȀȂǺǺǽǲȋǻǰǮƑǰȁǽǿȀȂǻǳǬȀȁǴƒǾȋȁǰȉƒȆǿƒǴǾǸǲǾǫȃǴȁǰǸƒǰǾǰƒǫǻȆȁǰǴƒȉƑǴǻǰ60RQRYHWWHƑǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǹǰǸǺǫǱǴȁǴƒǴǾǸȀȀȉȁǴǾǰǳǴǮǲƑǰȁǰǠǺǽǹǺǭǾȆȀǶǰǸƑǽǺǶȅǮǰǿǓƒǽȀȂǻǳǬȀȁǴȁǽ60RQRYHWWH®
+ ǹǰǸȀȁǶȀȂǻǬȄǴǸǰȁǾǰǱǭǼȁǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿǬǼȆǰƒȉȁǶȃǺǬǱǰǧǾǶȀǸƑǽƒǽǸȋǻȁǰǿȁǶǻȁǴȄǻǸǹǭȁǽȂǴǻȉǿȄǴǾǸǽȊǴǻǴǾǲǽƒǽǸǭȀȁǴȁǽƒǾǽȀȁǰȁǴȂȁǸǹȉǱǴǺȉǻǰǿǴǮȁǴȀǴƑǸǰȀȁǰǷǴǾǭǴƒǮƒǴǳǶǴƒǸȃǫǻǴǸǰǬȆǿȉȁǽȂǶǱǴǺȉǻǰǰȀȃǰǺǮȀǴǸƑǴǬǻǰŝǹǺǸǹŞȀȁǽƒǾǽȀȁǰȁǴȂȁǸǹȉǱǴǺȉǻǰǿ ǴǻǴǾǲǽƒǽǮǶȀǶ ǴǮȁǴƒǸǬǵǽǻȁǰǿȁǽǳǴǮǹȁǶȀȁǽǹǫȁȆǫǹǾǽȁǽȂƒǾǽȀȁǰȁǴȂȁǸǹǽȊȁǶǿǱǴǺȉǻǰǿǓǻǰǹǸǻǭȀȁǴǹǫǷǴ60RQRYHWWH®ǰƑǬȀȆǿƑǴȁǫȁǶǻǰƒǽȀȊǻǳǴȀǭȁǽȂǰƒȉȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿƑǮǰȃǽǾǫǹǰǸƑǴȁǫȁǶǻǽǺǽǹǺǭǾȆȀǶȁǶǿǰǸƑǽǺǶȅǮǰǿǰǻǰǹǸǻǭȀȁǴƑǴƒǾǽȀǽȄǭȉǺǰȁǰǳǴǮǲƑǰȁǰƑǴǰǻȁǸƒǶǹȁǸǹǫǰǾǹǴȁǬǿȃǽǾǬǿ1.

ǡǸǬȀȁǴȁǽȀǶƑǴǮǽƒǰǾǰǹǬǻȁǶȀǶǿƑǴǬǻǰȀȁǴǲǻȉǫȀǶƒȁǽǴƒǮǷǴƑǰǬȆǿȉȁǽȂȀȁǰƑǰȁǭȀǴǸǶǰǸƑǽǾǾǰǲǮǰ

2.

ǏȁǰǻǰǾȄǮȀǴǸǻǰƒǭǵǴǸȁǽǰǮƑǰȁǽƒǽǷǴȁǭȀȁǴǬǻǰǰȂȁǽǹȉǺǺǶȁǽǴƒǮǷǴƑǰǴǫǻȁǽǴƒǸǷȂƑǴǮȁǴ

3.

ǓƒǽǾǾǮȅȁǴȁǶǱǴǺȉǻǰǰȀȃǰǺǴǮǰǿȀǴǬǻǰǹǰȁǫǺǺǶǺǽǳǽȄǴǮǽǰƒȉǾǾǸȅǶǿǲǸǰǴƒǸǹǮǻǳȂǻǰǱǸǽǺǽǲǸǹǫȂǺǸǹǫ53

ELǦȂǲǽǹǬǻȁǾǸȀǶ
ǡǢǠǣǠǧǘǤǰ60RQRYHWWHȁǶǿ6$567('7ǬȄǽȂǻȀȄǴǳǸǰȀȁǴǮǲǸǰ[JǖǼǰǸǾǽȊǻȁǰǸȁǰ60RQRYHWWHƑǴǳǸǫƑǴȁǾǽPP 60RQRYHWWH®ǲǸǰƒǰǸǳǸǫ ȁǰǽƒǽǮǰǴƒǮȁǽȂƒǰǾȉǻȁǽǿǬȄǽȂǻǴƒǸǹȂǾȆǷǴǮǲǸǰ[JǡǾǬƒǴǸǻǰȄǾǶȀǸƑǽƒǽǸǽȊǻȁǰǸƑȉǻǽǹǰȁǫǺǺǶǺǰȀȆǺǶǻǫǾǸǰȀȁǭǾǸǼǶǿǭǬǻǷǴȁǰǣȁǶǻƒǴǾǮƒȁȆȀǶȃȂǲǽǹǬǻȁǾǸȀǶǿ60RQRYHWWHƒǽȂȃǬǾǽȂǻǾȆǲƑǬǿǭǴǫǻǶȃȂǲǽǹǴǻȁǾǸǹǭǴƒǸȁǫȄȂǻȀǶǴǮǻǰǸƒǽǺȊȂȅǶǺǭƑƒǽǾǴǮǻǰƒǾǽǹǺǶǷǴǮǷǾǰȊȀǶȁȆǻ60RQRYHWWHǰƒǴǺǴȂǷǴǾȋǻǽǻȁǰǿǳȂǻǶȁǸǹǫƑǽǺȂȀƑǰȁǸǹǫȂǺǸǹǫǤǰǬǻǷǴȁǰȃȂǲǽǹǬǻȁǾǸȀǶǿƒǾǬƒǴǸǻǰǴƒǸǺǬǲǽǻȁǰǸǰǻǫǺǽǲǰƑǴȁǽƑǬǲǴǷǽǿȁȆǻ60RQRYHWWHƒǽȂȄǾǶȀǸƑǽƒǽǸǽȊǻȁǰǸǘȀȄǴȁǸǹǭȃȂǲȉǹǴǻȁǾǽǿǳȊǻǰƑǶȀȄǴȁǮǵǴȁǰǸƑǴȁǽǻǹǰǷǽǾǸȀƑǬǻǽǰǾǸǷƑȉȀȁǾǽȃȋǻǺǴƒȁȉȆǿǴǼǭǿǣǦƍ [U[ ȀǰǺ 2,ǣǦƍŝǣȄǴȁǸǹǭȃȂǲȉǹǴǻȁǾǽǿǳȊǻǰƑǶǭŝƍȊǻǰƑǶJŞŞ ǓǲǲǺǸǹǫ5&)ŝUHODWLYHFHQWULIXJDOIRUFHŞ ŝȀǰǺŞŝȀȁǾǽȃǬǿǰǻǫǺǴƒȁȉŞ ȀǰǺ ǭQ ŝǰǾǸǷƑȉǿȀȁǾǽȃȋǻǰǻǫǺǴƒȁȉŞ ǓǲǲǺǸǹǫ530ŝUHYROXWLRQVSHUPLQXWHŞ ŝUŞŝǓǹȁǮǻǰȃȂǲǽǹǬǻȁǾǸȀǶǿǰƒȉȁǽǹǬǻȁǾǽȁǶǿȃȂǲǽǹǬǻȁǾǽȂǬȆǿȁǽǻƒȂǷƑǬǻǰȁǽȂ60RQRYHWWH®Ş FP Ǥǰ60RQRYHWWHȄȆǾǮǿǲǬǺǶƑƒǽǾǽȊǻǻǰȃȂǲǽǹǴǻȁǾǶǷǽȊǻȀǴȀȂȀǹǴȂǬǿȃȂǲǽǹǬǻȁǾǸȀǶǿƑǴȀȁǰǷǴǾǭǲȆǻǮǰǭƒǴǾǸȀȁǾǴȃȉƑǴǻǽǾȉȁǽǾǰǤǰ60RQRYHWWHƑǴǲǬǺǶǴǮǻǰǸȀȄǴǳǸǰȀƑǬǻǰǰƒǽǹǺǴǸȀȁǸǹǫǲǸǰȀȂȀǹǴȂǬǿȃȂǲǽǹǬǻȁǾǸȀǶǿƑǴƒǴǾǸȀȁǾǴȃȉƑǴǻǽǾȉȁǽǾǰǘȃȂǲǽǹǬǻȁǾǸȀǶȀǴȀȂȀǹǴȂǬǿȃȂǲǽǹǬǻȁǾǸȀǶǿƑǴǾȉȁǽǾǰȀȁǰǷǴǾǭǿǲȆǻǮǰǿǳǴǻǬȄǴǸǴƒǸǹȂǾȆǷǴǮǰƒȉȁǶ6$567('7ǹǰǸǳǴǻȀȂǻǸȀȁǫȁǰǸǤǰ60RQRYHWWHƒǾǬƒǴǸǻǰȃȂǲǽǹǴǻȁǾǮǵǽǻȁǰǸȀȊƑȃȆǻǰƑǴȁǸǿȀȂǻǷǭǹǴǿȃȂǲǽǹǬǻȁǾǸȀǶǿƒǽȂǰǻǰȃǬǾǽǻȁǰǸƒǰǾǰǹǫȁȆǖǫǻȄǾǶȀǸƑǽƒǽǸǽȊǻȁǰǸǫǺǺǴǿȀȂǻǷǭǹǴǿǰȂȁǬǿƒǾǬƒǴǸǻǰǴƒǸǹȂǾȆǷǽȊǻǰƒȉȁǽǻǮǳǸǽȁǽǻȄǾǭȀȁǶǡǾǬƒǴǸǻǰǳǸǰȀȃǰǺǮǵǴȁǰǸȉȁǸȁǰ60RQRYHWWHǴȃǰǾƑȉǵǽȂǻȀȆȀȁǫȀȁǰǬǻǷǴȁǰȃȂǲǽǹǬǻȁǾǸȀǶǿǤǰ60RQRYHWWHƒǽȂƒǾǽǴǼǬȄǽȂǻǰƒȉȁǽǬǻǷǴȁǽƑƒǽǾǽȊǻǻǰƒǰǲǸǳǴȂȁǽȊǻȀȁǶǻǹǴȃǰǺǭȁǶǿȃȂǲǽǹǬǻȁǾǽȂǹǰǸǻǰȀƒǫȀǽȂǻǘȃȂǲȉǹǴǻȁǾǽǿƒǾǬƒǴǸǻǰǲǴƑǮǵǴǸǽƑǽǸȉƑǽǾȃǰǤǶǾǴǮȁǴȁǸǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿȁǶǿȃȂǲǽǹǬǻȁǾǽȂǡǢǠǣǠǧǘ ǝǶǻ ǰȃǰǸǾǴǮȁǴ ƑǴ ȁǽ ȄǬǾǸ ȁǰ ȀƒǰȀƑǬǻǰ 60RQRYHWWH
ǠǳǶǲǮǴǿ ǲǸǰ ȁǶǻ ǰƒǽǺȊƑǰǻȀǶ ȁǶǿ ȃȂǲǽǹǬǻȁǾǽȂ ƑƒǽǾǴǮȁǴ ǻǰ ǱǾǴǮȁǴ ȀȁǸǿ ǠǳǶǲǮǴǿ ȄǾǭȀǴȆǿ ȁǶǿ ȃȂǲǽǹǬǻȁǾǽȂǡǾǽȀǰǻǰȁǽǺǸȀƑǬǻǽȀȁǽ%6+ǹȆǳǸǹȉǿǖǖ–ǣȄǴȁǸǹǭȃȂǲȉǹǴǻȁǾǽǿǳȊǻǰƑǶ J

DIN EN ISO
6710

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*ǠǾȉǿǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫǺǴƒȁǫ

ǺǴƒȁǫ

ǠǾǽȊƑǴǲǬǺǶǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǠǾǽȊƑǴǲǬǺǶ([SUHVVǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǳȄ

ǳȄ

ǘƒǰǾǮǻǶǺǸǷǮǽȂ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǜǸǷǮǽȂǶƒǰǾǮǻǶǿƑǴǲǬǺǶǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǸǷǮǽȂǶƒǰǾǮǻǶǿƑǴǲǬǺǶǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǳȄ

ǳȄ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

('7$ƑǴǲǬǺǶǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǛǸȁǾǸǹȉ

bǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

('7$ȃǷȉǾǸǽƑǴǶƒǰǾǮǻǶ

bǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

GlucoEXACTbǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǛǸȁǾǸǹȉ3%0POǓǹȁǮǻǰȃȂǲǽǹǬǻȁǾǸȀǶǿ!FP

bǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǺǴƒȁǫ

ǳȄ

ǳȄ

ǺǴƒȁǫ

ǳȄ

ǳȄ

EDTA

ǛǸȁǾǸǹȉ3%0POǓǹȁǮǻǰȃȂǲǽǹǬǻȁǾǸȀǶǿ!ǬȆǿƉFPǳȄ ǳǴǻǬȄǴǸǴƒǸǹȂǾȆǷǴǮǚȀȄȊǴǸǲǸǰȉǺǰȁǰ60RQRYHWWHǴǹȁȉǿǰƒȉǴǹǴǮǻǰƑǴǳǸǫƑǴȁǾǽPP 60RQRYHWWHǲǸǰƒǰǸǳǸǫ ǦȂǲǽǹǬǻȁǾǸȀǶȀȁǽȂǿƓ&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry,ǰǻǰǹǺǭǷǶǹǴǡǺǶǾǽȃǽǾǮǴǿȀȄǴȁǸǹǫƑǴȁǽǳǸǰȄȆǾǸȀȁǸǹȉȂǺǸǹȉ
ǠǸǸǳǸȉȁǶȁǴǿǾǽǭǿȁǽȂǳǸǰȄȆǾǸȀȁǸǹǽȊȂǺǸǹǽȊ ǲǬǺǶ ǴǼǰǾȁȋǻȁǰǸǰƒȉȁǶǷǴǾƑǽǹǾǰȀǮǰǖǫǻȁǰ60RQRYHWWHȅȂȄǷǽȊǻƒǾǸǻǭǹǰȁǫȁǶǳǸǫǾǹǴǸǰȁǶǿȃȂǲǽǹǬǻȁǾǸȀǶǿǳǴǻǳǸǰȀȃǰǺǮǵǴȁǰǸƒǺǬǽǻǬǻǰȀȂǻǴȄǬǿȀȁǾȋƑǰȁǶǿǲǬǺǶǿǳǸǰȄȆǾǸȀƑǽȊƍǴǻǴƒǸȁǾǬƒǴȁǰǸǶǴǹǻǬǽȂȃȂǲǽǹǬǻȁǾǸȀǶȁȆǻ60RQRYHWWH

ǓƒȉǾǾǸȅǶ
1.

ǡǾǬƒǴǸǻǰǺǰƑǱǫǻǽǻȁǰǸȂƒȉȅǶǹǰǸǻǰȁǶǾǽȊǻȁǰǸǽǸǲǴǻǸǹǬǿǽǳǶǲǮǴǿȂǲǸǴǸǻǭǿǹǰǷȋǿǹǰǸǽǸǻǽƑǸǹǬǿǳǸǰȁǫǼǴǸǿǲǸǰȁǶǻǽǾǷǭǰƒȉǾǾǸȅǶƑǽǺȂȀƑǰȁǸǹȋǻȂǺǸǹȋǻ2.

ǤǰǲǫǻȁǸǰƑǮǰǿȄǾǭȀǶǿǰƒǽȁǾǬƒǽȂǻȁǽǻǹǮǻǳȂǻǽƑȉǺȂǻȀǶǿ3.

ǤǰƑǽǺȂȀƑǬǻǰǭǲǴƑǫȁǰȀȂȀȁǭƑǰȁǰȀȂǺǺǽǲǭǿǰǮƑǰȁǽǿƒǾǬƒǴǸǻǰǰƒǽǾǾǮƒȁǽǻȁǰǸȀǴǹǰȁǫǺǺǶǺǰǳǽȄǴǮǰǰƒȉǾǾǸȅǶǿǴƒǸǹǮǻǳȂǻȆǻǱǸǽǺǽǲǸǹȋǻȂǺǸǹȋǻȁǰǽƒǽǮǰƑƒǽǾǽȊǻȀȁǶȀȂǻǬȄǴǸǰǻǰȂƒǽǱǺǶǷǽȊǻȀǴǴƒǴǼǴǾǲǰȀǮǰȀǴǰȂȁȉǹǰȂȀȁǽǭǻǰǰƒǽȁǴȃǾȆǷǽȊǻ4.

ǘǰƒȉǾǾǸȅǶƒǾǬƒǴǸǻǰƒǾǰǲƑǰȁǽƒǽǸǴǮȁǰǸȀǴǹǰȁǫǺǺǶǺǶƑǽǻǫǳǰǰƒǽȁǬȃǾȆȀǶǿǭƑǬȀȆǴƒǴǼǴǾǲǰȀǮǰǿȀǴǰȂȁȉǹǰȂȀȁǽ ǰƒǽȀȁǴǮǾȆȀǶƑǴǰȁƑȉ 

54

ELǖǸǳǸǹǫƒǾȉȁȂƒǰǹǰǸǹǰȁǴȂǷȂǻȁǭǾǸǴǿǲǾǰƑƑǬǿǲǸǰȁǽƒǾǽȇȉǻȉƒȆǿǬȄǽȂǻȁǾǽƒǽƒǽǸǶǷǴǮǴƒǸǹǰǸǾǽƒǽǸǶǷǴǮCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

ǡǾȉȁȂƒǰǲǸǰȃǸǰǺǮǳǸǰǲǸǰȁǶȀȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻȃǺǴǱǸǹǽȊǰǮƑǰȁǽǿ',1(1,62ǦǸǰǺǮǳǸǰƑǮǰǿȄǾǭȀǶǿǲǸǰȀȂǺǺǽǲǭǳǴǸǲƑǫȁȆǻȃǺǴǱǸǹǽȊǰǮƑǰȁǽǿǰƒȉǰǻǷǾȋƒǽȂǿ*CLSI (Clinical and Laboratory Standards Institute)ǥƒȉƑǻǶƑǰȀȂƑǱȉǺȆǻǹǰǸǴƒǸȀǶƑǫǻȀǴȆǻǓǾǸǷƑȉǿƒǾǽȇȉǻȁǽǿ

ǚȀȄȊǴǸǴƒǸƒǺǬǽǻǲǸǰǰȁǽƑǸǹǫǰƒǽȀȁǴǸǾȆƑǬǻǰȀȂȀǹǴȂǰȀƑǬǻǰƒǾǽȇȉǻȁǰ

ǓǾǸǷƑȉǿƒǰǾȁǮǳǰǿ

ǓƒǽȃȊǲǴȁǴȁǶȄǾǭȀǶǴǫǻǶȀȂȀǹǴȂǰȀǮǰǬȄǴǸȂƒǽȀȁǴǮȃǷǽǾǫ

ǧǾǭȀǶǬȆǿǓƒǺȉȀȊȀȁǶƑǰȀȁǴǮǾǽȂȃǾǫǲƑǰȁǽǿƑǴǴǼȆȁǴǾǸǹǭƒǾǽȀȁǰȁǴȂȁǸǹǭȀȂȀǹǴȂǰȀǮǰ

ǣȊƑǱǽǺǽ&(ǓƒǽȀȁǴǮǾȆȀǶƑǴǰǹȁǸǻǽǱǽǺǮǰ

In vitroǳǸǰǲǻȆȀȁǸǹȉǸǰȁǾǽȁǴȄǻǽǺǽǲǸǹȉƒǾǽȇȉǻ

ǤǶǾǴǮȁǴȁǸǿǽǳǶǲǮǴǿȄǾǭȀǴȆǿ

ǣǴƒǴǾǮƒȁȆȀǶǴƒǰǻǰȄǾǶȀǸƑǽƒǽǮǶȀǶǿǛǮǻǳȂǻǽǿƑǽǺȊǻȀǴȆǻ

ǦȊǺǰǼǶȀǴȀǶƑǴǮǽƒǽȂǱǾǮȀǹǴȁǰǸƑǰǹǾǸǫǰƒȉȁǶǻǶǺǸǰǹǭǰǹȁǸǻǽǱǽǺǮǰ

ǦȊǺǰǼǶȀǴǼǶǾȉƑǬǾǽǿ

ǛǰȁǰȀǹǴȂǰȀȁǭǿ

ǧȋǾǰǹǰȁǰȀǹǴȂǭǿ

ǣȁǴǮǾǰǳǮǽǳǽǿȂǲǾȋǻ

ǞǰƑǶǻǰƒǽȀȁǴǸǾȋǻǴȁǰǸǴǹǻǬǽȂǥƒȉȁǶǻǴƒǸȃȊǺǰǼǶȁǴȄǻǸǹȋǻȁǾǽƒǽƒǽǸǭȀǴȆǻǏǺǰȁǰȀǽǱǰǾǫƒǴǾǸȀȁǰȁǸǹǫƒǽȂǰȃǽǾǽȊǻȁǽƒǾǽȇȉǻǹǽǸǻǽƒǽǸǽȊǻȁǰǸȀȁǽǻǹǰȁǰȀǹǴȂǰȀȁǭǹǰǸȀȁǶǻǰǾƑȉǳǸǰǴǷǻǸǹǭǰǾȄǭ55

ES
Para el uso en el diagnóstico in vitro
Uso previsto
Los sistemas de extracción de sangre S-Monovette®, las agujas y los adaptadores se utilizan juntos como un sistema para la extracción de sangre venosa. Los sistemas de extracción de sangre S-Monovette® están
destinados para la extracción, el transporte, el procesamiento y el almacenamiento de muestras de sangre para diagnósticos analíticos in-vitro en suero, plasma o sangre total en laboratorios clínicos. El producto está
destinado para la aplicación en el ámbito profesional y el uso por parte de personal sanitario y personal de laboratorio.

Descripción del producto
Los sistemas de extracción de sangre S-Monovette® constan de un tubo de plástico, un émbolo, un vástago de émbolo y un tapón roscado de plástico codificado por colores con membrana integrada, especialmentediseñado para su conexión a una aguja de seguridad S-Monovette® o a una aguja de seguridad Multifly®, así como de diversos aditivos (preparados). La S-Monovette® también está disponible sin aditivo. Los sistemas
de extracción de sangre S-Monovette® con los aditivos activadores de la coagulación, el activador de la coagulación con gel, la heparina de litio, la heparina de litio con gel, la heparina de sodio, el citrato, el EDTA,
el fluoruro con EDTA, el fluoruro con heparina, el fluoruro con citrato, la CPDA, así como sin aditivo, las concentraciones de los aditivos, el volumen de los aditivos líquidos y las tolerancias permitidas, así como la
SURSRUFLĂQHQWUHODVDQJUH\HODGLWLYRVHDMXVWDQDORVUHTXLVLWRV\UHFRPHQGDFLRQHVGHODQRUPDLQWHUQDFLRQDO81((1,62ŝ5HFLSLHQWHVGHXQVRORXVRSDUDODUHFRJLGDGHPXHVWUDVGHVDQJUHYHQRVDŞ\DODVnormas aprobadas del Instituto de Estándares Clínicos y de Laboratorio (CLSI). La elección del aditivo depende del método analítico. Lo establece el fabricante de los reactivos de ensayo o del analizador en el que selleva a cabo el análisis. El sistema de extracción de sangre S-Monovette® está disponible en la versión interior estéril o en envase individual con interior y exterior estéril.

Códigos de colores de los tapones de rosca de la S-Monovette®*:Aditivo

Código alfabético

Color del tapón según
UNE-EN ISO 6710

Color del tapón según BS
4851+

Z

blancoblancoRecipiente sin preparación
S-Monovette® Neutro Z
Recipiente con suero
S-Monovette® Suero CAT, con activador de la coagulación

CAT

rojo

blancoS-Monovette® Gel de suero CAT, con activador de la coagulación y gelCATamarillo oscuro

amarillo oscuro

S-Monovette® Gel de suero exprés CAT, con activador de la coagulación trombina y gelCATnaranja-

S-Monovette® Heparina de litio LH, con heparina de litio

LH

verde

naranja

S-Monovette® Heparina de litio líquida LH, con heparina de litio

LH

verde

naranja

S-Monovette® Gel de heparina de litio LH, con heparina de litio y gel

LH

verde

naranja

S-Monovette® Gel de heparina de litio+ LH, con heparina de litio y gel rápido

LH

verde

naranja

S-Monovette® Heparina de sodio NH, con heparina de sodio

NHmarrónverde

S-Monovette® Heparina de amonio AH, con heparina de amonio

n. d.

azul

azul

S-Monovette®&LWUDWR1&FRQFLWUDWRGHVRGLRDOb

9NC

azul

verde

S-Monovette 3)$FLWUDWR1&FRQFLWUDWRGHVRGLRDObWDPSRQDGR

9NC

azul claro-

S-Monovette®.b('7$.(FRQ('7$GHSRWDVLR

K3E

violetarojo

S-Monovette®.b('7$.(FRQ('7$GHSRWDVLR

K2E

violetarojo

S-Monovette®JHOGH.b('7$.(FRQ('7$GHSRWDVLR\JHO

K2E

violetarojo

S-Monovette®)OXRUXUR('7$)(FRQĲXRUXUR\('7$

FE

gris

amarillo

S-Monovette®)OXRUXURKHSDULQD)+FRQĲXRUXUR\KHSDULQD

FH-amarillo

S-Monovette®*OXFR(;$&7b)&FRQĲXRUXURFLWUDWR\('7$

FC

rosa

gris

LH

azul oscuronaranja

S-Monovette® ThromboExact, con un compuesto de magnesio

n. d.

n. d., morado

n. d., morado

S-Monovette® CTADn. d.

n. d., azul

n. d., verde

S-Monovette® ACD

ACD

amarillo

amarillo

S-Monovette® CPDA

CPDA

amarillo

amarillo

S-Monovette® Hirudina

n. d.

n. d., verde oliva

n. d., verde oliva

Recipiente con heparina

Recipiente con citrato®

Recipiente con EDTA

Recipiente con inhibidores de la glucólisis

5HFLSLHQWHSDUDHODQÈOLVLVGHPHWDOHVS-Monovette® Análisis de metales LH, con heparina de litio0ÈVUHFLSLHQWHVSDUDVDQJUHWRWDO\SODVPD

S-Monovette® Homocisteína HCY-Z-Gel, con gel y estabilizador

n. d.

n. d., grisn. d., gris

S-Monovette® Homocisteína HCY-C, con tampón de citrato

n. d.

n. d., violeta

n. d., violeta

S-Monovette®'1$b([DFWn. d.

n. d., azul

n. d., azul

*Los tapones rosacados están disponibles en otros colores.
n. d.: no definido+

British Standard BS4851:(VSHFLILFDFLĂQSDUDUHFLSLHQWHVHWLTXHWDGRVGHXQVRORXVRSDUDPXHVWUDVPÜGLFDVSDUDKHPDWRORJìD\ELRTXìPLFD, anulado.

56

ES
SARSTEDT S-Monovette® Suero CAT/suero gel CAT
La S-Monovette® Suero CAT contiene un granulado de plástico recubierto con un activador de la coagulación (silicato) y se utiliza para la obtención de suero**. El granulado de plástico se deposita entre el coágulo desangre y el suero por centrifugación.
La S-Monovette® de suero gel CAT contiene un gel a base de polímeros además del granulado de plástico recubierto con un activador de la coagulación (silicato) y se utiliza para la obtención de suero**. El gel sedeposita entre el coágulo de sangre y el suero por centrifugación y forma una capa de separación estable durante el transporte, el almacenamiento y el análisis.
El suero se utiliza como material de muestra en los análisis rutinarios de química clínica e inmunología, así como en la serología.
Después de la extracción, la sangre debe dejarse coagular en la S-Monovette®6XHUR&$7VXHURJHO&$7HQSRVLFLĂQYHUWLFDOGXUDQWHbPLQXWRVSDUDDVHJXUDUODIRUPDFLĂQGHXQDFDSDGHVHSDUDFLĂQKRUL]RQWDOFODUD
después de la centrifugación. El tiempo recomendado se basa en un proceso de coagulación sin alteraciones. La coagulación completa de la sangre de pacientes con trastornos de la coagulación o bajo tratamiento
anticoagulante puede requerir más tiempo.

SARSTEDT S-Monovette® Suero gel rápido CAT
La S-Monovette® suero gel rápido CAT contiene un gel a base de polímeros además del granulado de plástico recubierto con un activador de la coagulación (trombina) y se utiliza para la obtención de suero**. El gel sedeposita entre el coágulo de sangre y el suero por centrifugación y forma una capa de separación estable durante el transporte, el almacenamiento y el análisis.
Después de la extracción, la sangre debe dejarse coagular en la S-Monovette®FRQVXHURJHOUÈSLGRHQSRVLFLĂQYHUWLFDOGXUDQWHbPLQXWRVSDUDDVHJXUDUODIRUPDFLĂQGHXQDFDSDGHVHSDUDFLĂQKRUL]RQWDOFODUD
después de la centrifugación. El tiempo recomendado se basa en un proceso de coagulación sin alteraciones, también para la sangre de pacientes heparinizados. La coagulación completa de la sangre de pacientes
con trastornos de la coagulación o bajo tratamiento anticoagulante, incluidas dosis altas de heparina, requiere más tiempo.
El suero se utiliza como material de muestra en los análisis rutinarios de química clínica e inmunología, así como en la serología.

SARSTEDT S-Monovette® Neutra Z
La S-Monovette® Neutra Z no contiene ninguna preparación, lo que corresponde a la coagulación natural de la muestra de sangre sin activador de la coagulación, y se utiliza para la obtención de suero**. La
centrifugación permite separar el coágulo de sangre del suero.
El suero obtenido se utiliza como material de muestra para análisis específicos del usuario.
Además, la S-Monovette® Neutra Z también puede utilizarse como recipiente vacío en los siguientes casos: si la extracción de sangre debe iniciarse con una S-Monovette® Citrato en combinación con una aguja deseguridad Multifly® (palomilla), la S-Monovette® Neutra Z se utiliza como primer recipiente (vacío) para llenar el tubo de la aguja de seguridad Multifly®.

SARSTEDT S-Monovette® Heparina de litio LH/heparina de litio gel LH/heparina de litio gel+ LH, heparina de sodio NH, heparina de amonio AH
La S-Monovette® Heparina de litio LH/heparina de sodio NH/heparina de amonio AH contiene un granulado de plástico recubierto con el inhibidor de la coagulación (anticoagulante) heparina de litio/heparina de sodio/
KHSDULQDGHDPRQLR SRUORJHQHUDOb8,GHKHSDULQDSRUPOGHVDQJUH \VHXWLOL]DSDUDODREWHQFLĂQGHVDQJUHWRWDO\SODVPD (OJUDQXODGRGHSOÈVWLFRVHGHSRVLWDHQWUHORVJOĂEXORVVDQJXìQHRV\HOSODVPDSRU
centrifugación.
En la S-Monovette®+HSDULQDGHOLWLR/+VLQJUDQXODGRGHSOÈVWLFRHODQWLFRDJXODQWHKHSDULQDGHOLWLRHVWÈSUHVHQWHHQIRUPDGHDHURVRO SRUORJHQHUDOb8,GHKHSDULQDSRUPOGHVDQJUH 
La S-Monovette®KHSDULQDGHOLWLRJHO/+FRQWLHQHXQJHODEDVHGHSROìPHURVDGHPÈVGHOJUDQXODGRGHSOÈVWLFRUHFXELHUWRFRQHODQWLFRDJXODQWHKHSDULQDGHOLWLR SRUORJHQHUDOb8,GHKHSDULQDSRUPOGHVDQJUH \
se utiliza para la obtención de plasma**. El gel se deposita entre los glóbulos sanguíneos y el plasma por centrifugación y forma una capa de separación estable durante el transporte, el almacenamiento y el análisis.
La S-Monovette® heparina de litio gel+/+WDPELÜQFRQWLHQHXQJHODEDVHGHSROìPHURVTXHSHUPLWHUHGXFLUHOWLHPSRGHFHQWULIXJDFLĂQHQDSUR[LPDGDPHQWHXQbHQFRPSDUDFLĂQFRQOD60RQRYHWWH® heparina delitio gel.
El plasma de heparina se utiliza como material de muestra en los análisis rutinarios de química clínica e inmunología. La sangre total con heparina se utiliza como material de muestra en los análisis inmunológicos
rutinarios y en la serología.
La anticoagulación con heparina se produce mediante la activación de la antitrombina.
NOTA: La S-Monovette® Heparina de litio LH/heparina de litio gel/heparina de litio gel+/+QRVHSXHGHXWLOL]DUSDUDUHDOL]DUDQÈOLVLVGHOLWLROD60RQRYHWWH® heparina de sodio NH no se puede utilizar
SDUDUHDOL]DUDQÈOLVLVGHVRGLR\OD60RQRYHWWH®KHSDULQDGHDPRQLR$+QRVHSXHGHXWLOL]DUSDUDUHDOL]DUDQÈOLVLVGHDPRQLR8QD60RQRYHWWH® heparina de litio/gel de heparina de litio/gel deheparina de litio+KHSDULQDGHVRGLRKHSDULQDGHDPRQLROOHQDGHVDQJUHYHQRVDQRHVDGHFXDGRSDUDJDVRPHWUìDV

SARSTEDT S-Monovette® Análisis de metales
La S-Monovette®$QÈOLVLVGHPHWDOHVFRQWLHQHHODQWLFRDJXODQWHKHSDULQDGHOLWLR\VHXWLOL]DSDUDODREWHQFLĂQGHVDQJUHWRWDO\SODVPD /DKHSDULQDGHOLWLRHVWÈSUHVHQWHHQIRUPDGHDHURVRO b8,GHKHSDULQDSRUPO
de sangre).
La sangre total o el plasma de heparina de la S-Monovette® Análisis de metales en combinación con la aguja de seguridad especial 21G x 1 ½" (n.º art. 85.1162.600) se utiliza como material de muestra para los análisis
de oligoelementos/metales. Los oligoelementos/metales han sido validados por medio de la espectrometría de absorción atómica (AAS). Para el sistema de aguja de seguridad y S-Monovette® Análisis de metales, se
han obtenido los siguientes valores máximos en blanco en ng/sistema para los oligoelementos que se detallan a continuación:

Elemento
ng/sistema

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

/RVPÈ[LPRVYDORUHVHQEODQFRSDUDFDGDHOHPHQWRVHLQGLFDQHQODHWLTXHWDGHOD60RQRYHWWH®.
Las determinaciones de oligoelementos se realizan a partir de sangre total o plasma de heparina, en función del método analítico utilizado.
La anticoagulación con heparina se produce mediante la activación de la antitrombina.

SARSTEDT S-Monovette® Citrato 9NC
La S-Monovette®&LWUDWR1&FRQWLHQHHODQWLFRDJXODQWHFLWUDWRWULVĂGLFR\VHXWLOL]DSDUDODREWHQFLĂQGHVDQJUHWRWDO\SODVPD (OFLWUDWRWULVĂGLFRHVWÈSUHVHQWHHQIRUPDGHVROXFLĂQGHbPRO VROXFLĂQGHFLWUDWR
WULVĂGLFRDObDPHQXGRVHUHGRQGHDDOb \HTXLYDOHDObGHOYROXPHQQRPLQDOGHXQD60RQRYHWWH® Citrato. La proporción de mezcla entre el citrato y la sangre es de 1:9; es decir, 1 parte de volumen de
FLWUDWR\SDUWHVGHYROXPHQGHVDQJUH3DUDHODQÈOLVLVHVLPSUHVFLQGLEOHTXHHOOOHQDGRVHHIHFWěHFRUUHFWDPHQWH
El plasma de citrato se utiliza como material de muestra en los análisis rutinarios de hemostasia.
La anticoagulación se produce por la formación de complejos de iones de calcio por el citrato.
7HQJDHQFXHQWDODV127$6HQHODSDUWDGRŝ([WUDFFLĂQGHODPXHVWUD\PDQLSXODFLĂQŞSDUDODFRPELQDFLĂQGH60RQRYHWWH® Citrato y palomillas.

SARSTEDT S-Monovette®3)$b1&
La S-Monovette®3)$b1&FRQWLHQHHODQWLFRDJXODQWHFLWUDWRWULVĂGLFRSDUDODREWHQFLĂQGHVDQJUHWRWDO\SODVPD (OFLWUDWRWULVĂGLFRHVWÈSUHVHQWHHQIRUPDGHVROXFLĂQWDPSĂQGHbPRO VROXFLĂQWDPSĂQDO
bS+ \HTXLYDOHDObGHOYROXPHQQRPLQDOGHXQD60RQRYHWWH® PFA. La proporción de mezcla entre el citrato y la sangre es de 1:9; es decir, 1 parte de volumen de citrato y 9 partes de volumen de
VDQJUH3DUDHODQÈOLVLVHVLPSUHVFLQGLEOHTXHHOOOHQDGRVHHIHFWěHFRUUHFWDPHQWH
La sangre total obtenida con la S-Monovette®3)$b1&VHXWLOL]DFRPRPDWHULDOGHPXHVWUDSDUDGHWHUPLQDUODIXQFLĂQSODTXHWDULDFRQHODQDOL]DGRU3)$GH6,(0(16+HDOWKLQHHUV\KDVLGRYDOLGDGDSDUDHVWHILQ
La anticoagulación se produce por la formación de complejos de iones de calcio por el citrato.
7HQJDHQFXHQWDODV127$6HQHODSDUWDGRŝ([WUDFFLĂQGHODPXHVWUD\PDQLSXODFLĂQŞSDUDODFRPELQDFLĂQGH60RQRYHWWH® PFA y palomilla.

SARSTEDT S-Monovette® CTAD
La S-Monovette® CTAD contiene el anticoagulante citrato trisódico, así como teofilina, adenosina y dipiridamol, y se utiliza para la obtención de sangre total y plasma**. El CTAD está presente en forma de solución yHTXLYDOHDObGHOYROXPHQQRPLQDOGHXQD60RQRYHWWH® CTAD. La proporción de mezcla entre el CTAD y la sangre es de 1:9; es decir, 1 parte de volumen de CTAD y 9 partes de volumen de sangre. Para el análisis
HVLPSUHVFLQGLEOHTXHHOOOHQDGRVHHIHFWěHFRUUHFWDPHQWH
El plasma CTAD se utiliza como material de muestra para determinar el factor plaquetario 4 (PF4), la beta(ß)-tromboglobulina (ßTG) y el inhibidor del activador del plasminógeno (PAI-1), así como para los análisis
hemostáticos rutinarios.
/DDFWLYDFLĂQSODTXHWDULDVHLQKLEHGXUDQWHXQSHULRGRGHDOPHQRVbKRUDV\VHHPSOHDSDUDFRQWURODUHOWUDWDPLHQWRFRQKHSDULQD
La anticoagulación se produce por la formación de complejos de iones de calcio por el citrato.
7HQJDHQFXHQWDODV127$6HQHODSDUWDGRŝ([WUDFFLĂQGHODPXHVWUD\PDQLSXODFLĂQŞSDUDODFRPELQDFLĂQGH60RQRYHWWH® CTAD y palomillas.
NOTA: El CTAD es de color amarillo. La S-Monovette®&7$'GHEHDOPDFHQDUVHSURWHJLGRGHODOX]DUWLıFLDO\QDWXUDO/DH[SRVLFLĂQDXQDOX]LQWHQVDGXUDQWHPÈVGHbKRUDVSXHGHSURYRFDUOD
LQDFWLYDFLĂQGHORVDGLWLYRV57

ES
SARSTEDT S-Monovette® EDTA K2E/K3E
La S-Monovette® EDTA K2E/S-Monovette®('7$.(FRQWLHQHHODQWLFRDJXODQWH.b('7$R.b('7$\VHXWLOL]DSDUDODREWHQFLĂQGHVDQJUHWRWDO (O.b('7$R.b('7$HVWÈSUHVHQWHHQIRUPDGHDHURVRO bPJ
de EDTA por ml de sangre).
La sangre total de EDTA se utiliza como material de muestra para los análisis hematológicos. Los frotis de sangre deben prepararse dentro de las cuatro horas siguientes a la extracción de sangre.
La anticoagulación se produce por la formación de complejos de iones de calcio por el EDTA.
La sangre obtenida con la S-Monovette® EDTA K2E/K3E también puede utilizarse para los análisis inmunohematológicos rutinarios y las pruebas de enfermedades infecciosas. Es responsabilidad del usuario validar laidoneidad del material de la muestra para estas pruebas con los reactivos de ensayo o analizadores adecuados, incluidas las condiciones de almacenamiento.

SARSTEDT S-Monovette® EDTA gel K2E
La S-Monovette®('7$JHO.(FRQWLHQHXQJHODEDVHGHSROìPHURVDGHPÈVGHODQWLFRDJXODQWH.b('7$\VHXWLOL]DSDUDODREWHQFLĂQGHSODVPD (O.b('7$HVWÈSUHVHQWHHQIRUPDGHDHURVRO bPJGHEDTA por ml de sangre). El gel se deposita entre los glóbulos sanguíneos y el plasma por centrifugación y forma una capa de separación estable durante el transporte, el almacenamiento y el análisis.
El plasma EDTA se utiliza como material de muestra para el diagnóstico molecular de virus.
La anticoagulación se produce por la formación de complejos de iones de calcio por el EDTA.

SARSTEDT S-Monovette®)OXRUXUR('7$)(ĲXRUXURKHSDULQD)+ĲXRUXURFLWUDWR('7$)&FRQ,QKLELGRUHVGHJOXFĂOLVLVLa S-Monovette®)OXRUXUR('7$)(FRQWLHQHHODQWLFRDJXODQWH('7$ bPJSRUPOGHVDQJUH DVìFRPRIOXRUXUR bPJSRUPOGHVDQJUH SDUDODLQKLELFLĂQGHODJOXFĂOLVLV\VHXWLOL]DSDUDODREWHQFLĂQGHSODVPD (O
fluoruro EDTA está presente en forma de aerosol.
La S-Monovette®)OXRUXURKHSDULQD)+FRQWLHQHHODQWLFRDJXODQWHKHSDULQD b8,GHKHSDULQDSRUPOGHVDQJUH DVìFRPRIOXRUXUR bPJSRUPOGHVDQJUH SDUDODLQKLELFLĂQGHODJOXFĂOLVLV\VHXWLOL]DSDUDODREWHQFLĂQde plasma**. El fluoruro heparina está presente en forma de aerosol.
/DLQKLELFLĂQGHODJOXFĂOLVLVVRORSRUHOIOXRUXURFRPLHQ]DDSUR[LPDGDPHQWHbKRUDVGHVSXÜVGHOOHQDUHOUHFLSLHQWHGHH[WUDFFLĂQGHVDQJUH\HOHIHFWRFRPSOHWRVHREWLHQHGHVSXÜVGHXQDVbKRUDV3RUFRQVLJXLHQWHODJOXFRVDVHGHJUDGDKDVWDXQbHQSURPHGLRGHVSXÜVGHXQDVKRUDV\KDVWDHQWUHXQb\XQbGHVSXÜVGHbKRUDVHQODVDQJUHWRWDOLa S-Monovette®*OXFR(;$&7b)&FRQWLHQHHODQWLFRDJXODQWH('7$DVìFRPRFLWUDWR\IOXRUXURSDUDODLQKLELFLĂQLQPHGLDWDGHODJOXFĂOLVLV\VHXWLOL]DSDUDODREWHQFLĂQGHSODVPD (O('7$HOFLWUDWR\HOIOXRUXURHVWÈQ
presentes en forma de solución. Debido a la dilución, para calcular la concentración de glucosa es necesario multiplicar por 1,16.
La S-Monovette®*OXFR(;$&7b)&FXPSOHFRQODGLUHFWUL]GHGLDEHWHVJHVWDFLRQDOGHOD6RFLHGDG$OHPDQDGH'LDEHWHV ''* \FRQOD'LUHFWUL]1DFLRQDOGH$WHQFLĂQ 19/ SDUDODGLDEHWHVGHWLSRb/DHVWDELOL]DFLĂQ
LQPHGLDWDGHODFRQFHQWUDFLĂQGHJOXFRVDVHJDUDQWL]DGXUDQWHKDVWDbKRUDVDWHPSHUDWXUDDPELHQWHHQVDQJUHWRWDOYÜDVHWDPELÜQHOOLEUREODQFRGH6$567('7https://www.sarstedt.com/en/products/diagnostic/
venous-blood/s-monovetter//LWHUDWXUDŝ6DUVWHGW60RQRYHWWH®*OXFR(;$&7$EORRGFROOHFWLRQGHYLFHIRUVWDELOL]LQJJOXFRVHOHYHOVIRUKRXUVŞEl plasma de fluoruro-EDTA (citrato) se utiliza como material de muestra para el análisis de glucosa.
La anticoagulación se produce por la formación de complejos de iones de calcio por el EDTA.
127$(OĲXRUXURSXHGHSURYRFDUXQDXPHQWRGHODKHPĂOLVLV3DUDPÈVLQIRUPDFLĂQVREUHODVVXVWDQFLDVTXHSXHGHQLQWHUIHULUFRQVXOWHODVUHVSHFWLYDVLQVWUXFFLRQHVGHXVRGHOIDEULFDQWHGHORV
reactivos de ensayo.
7HQJDHQFXHQWDODV127$6HQHODSDUWDGRŝ([WUDFFLĂQGHODPXHVWUD\PDQLSXODFLĂQŞSDUDODFRPELQDFLĂQGH60RQRYHWWH® GlucoEXACT y palomilla.

SARSTEDT S-Monovette® CPDA
La S-Monovette® CPDA contiene el anticoagulante citrato de sodio, así como ácido cítrico, fosfato de sodio, dextrosa y adenina y se utiliza para la obtención de sangre total y plasma**. El CPDA está presente en
IRUPDGHVROXFLĂQ/DSURSRUFLĂQGHPH]FODHQWUHHO&3'$\ODVDQJUHHVGHHVGHFLUSDUWHGHYROXPHQGH&3'$\SDUWHVGHYROXPHQGHVDQJUH3DUDHODQÈOLVLVHVLPSUHVFLQGLEOHTXHHOOOHQDGRVHHIHFWěHcorrectamente.
La sangre total/el plasma de CPDA se utiliza como material de muestra para la serología del grupo sanguíneo en la medicina transfusional para las pruebas de compatibilidad (pruebas cruzadas) en las transfusiones. La
S-Monovette® CPDA es adecuada, en concreto, para la determinación del grupo sanguíneo (AB0), incluidas las fórmulas Kell y Rhesus, la prueba de detección de anticuerpos irregulares del grupo sanguíneo, la prueba
de Coombs directa poliespecífica (hasta el día 10), la prueba de compatibilidad (prueba cruzada) con suero/plasma de un paciente compatible con el grupo sanguíneo (prueba principal).
(OWLHPSRGHWUDQVSRUWHKDVWDHODOPDFHQDPLHQWRVHKDYDOLGDGRSDUDXQPÈ[LPRGHbKRUDVHQWUHbƓ&\bƓ&3DUDODVHGLPHQWDFLĂQGHODVFÜOXODVODVPXHVWUDVGHEHQDOPDFHQDUVHSUHYLDPHQWHHQSRVLFLĂQYHUWLFDOHQHOIULJRUìILFRGXUDQWHDOPHQRVbKRUDV3RVWHULRUPHQWHORVDQDOLWRVPHQFLRQDGRVSXHGHQGHWHUPLQDUVHKDVWDbGìDVGHVSXÜVGHVXFRQVHUYDFLĂQHQHOIULJRUìILFR bƓ&DbƓ&  H[FHSWRODSUXHEDGLUHFWDGH
&RRPEVbGìDV GHPDQHUDDQÈORJDDOWLHPSRKDELWXDOGHDOPDFHQDPLHQWRGHODVDQJUH$GHFXDGRSDUDHOSURFHGLPLHQWRGHDJOXWLQDFLĂQHQFROXPQDSRUHMHPSORHQHO9LVLRQ0D[GH2UWKR&OLQLFDO'LDJQRVWLFV(O
material de la muestra no se debe congelar.
Es responsabilidad del usuario validar la idoneidad del material de la muestra para estas pruebas con otros métodos, reactivos de ensayo o analizadores, incluidas las condiciones de almacenamiento.
La anticoagulación se produce por la formación de complejos de iones de calcio por el citrato.
7HQJDHQFXHQWDODV127$6HQHODSDUWDGRŝ([WUDFFLĂQGHODPXHVWUD\PDQLSXODFLĂQŞSDUDODFRPELQDFLĂQGH60RQRYHWWH® CPDA y apalomillas.

SARSTEDT S-Monovette® ThromboExact
La S-Monovette® ThromboExact contiene una sal de magnesio como anticoagulante y se utiliza para la obtención de sangre total**. El sal de magnesio está presente en forma de aerosol.
La sangre total obtenida con la S-Monovette® ThromboExact se utiliza como material de muestra para excluir recuentos plaquetarios erróneamente bajos debido a la incompatibilidad con el anticoagulante (como EDTA,FLWUDWRKHSDULQD WDPELÜQOODPDGDSVHXGRWURPERFLWRSHQLD6HHYLWDODIRUPDFLĂQGHDJUHJDGRVSODTXHWDULRV\SHUPLWHGHWHUPLQDUHOUHFXHQWRUHDOGHSODTXHWDVKDVWDbKRUDVGHVSXÜVGHODH[WUDFFLĂQGHVDQJUHLa anticoagulación se produce gracias a que los iones de magnesio inhiben el tromboxano A2 plaquetario y a la agregación plaquetaria que se produce por el ADP y el ácido araquidónico.

SARSTEDT S-Monovette® Hirudina
La S-Monovette® Hirudina contiene el anticoagulante hirudina y se utiliza para la obtención de sangre total**. La hirudina está presente en forma de aerosol.
La sangre total con hirudina se utiliza como material de muestra para el análisis de la función plaquetaria en el analizador Multiplate® (multiple platelet function analyser) de ROCHE Diagnostics y está validado para estefin. Se utiliza para controlar la respuesta del paciente a los fármacos antiplaquetarios y para detectar o excluir una disfunciones plaquetarias.
La S-Monovette® Hirudina se desarrolló específicamente junto con la empresa Verum Diagnostica, ahora ROCHE Diagnostics, para determinar la función plaquetaria en el analizador Multiplate®.
La anticoagulación se produce gracias a la hirudina por inhibición directa de la trombina, lo que permite diagnosticar la función plaquetaria en estado nativo.

SARSTEDT S-Monovette® Homocisteína HCY-Z-Gel/HCY-C
La S-Monovette® Homocisteína HCY-Z-Gel contiene un estabilizador especial y un gel a base de polímeros además del granulado de plástico recubierto con un activador de la coagulación (silicato) y se utiliza parala obtención de suero**. El gel se deposita entre el coágulo de sangre y el suero por centrifugación y forma una capa de separación estable durante el transporte, el almacenamiento y el análisis. El preparado estápresente en forma de aerosol.
/DKRPRFLVWHìQDVHHVWDELOL]DHQODVDQJUHWRWDODWHPSHUDWXUDDPELHQWHGXUDQWHXQPÈ[LPRGHbKRUDV6LODFHQWULIXJDFLĂQVHUHDOL]DGHQWURGHODVSULPHUDVbKRUDVFRQXQDFDSDGHVHSDUDFLĂQFRUUHFWDPHQWHIRUPDGDHQWUHHOFRÈJXORGHVDQJUH\HOVXHURODKRPRFLVWHìQDVHHVWDELOL]DGXUDQWHKDVWDbKRUDVEl suero obtenido con la S-Monovette® Homocisteína HCY-Z-Gel se utiliza como material de muestra para el análisis de la homocisteína. La S-Monovette® Homocisteína HCY-C contiene citrato ácido (pH 4,3) comoanticoagulante y se utiliza para la obtención de plasma**. El citrato está presente en forma de solución. Debido a la dilución, para calcular la concentración de homocisteína es necesario multiplicar por 1,11.
/DKRPRFLVWHìQDVHHVWDELOL]DHQODVDQJUHWRWDODWHPSHUDWXUDDPELHQWHGXUDQWHKDVWDbKRUDV\DbƓ&KDVWDbKRUDVEl plasma obtenido con la S-Monovette® Homocisteína HCY-C se utiliza como material de muestra para el análisis de la homocisteína.
En la S-Monovette® Homocisteína HCY-C, la anticoagulación se produce por la formación de complejos de iones de calcio por el citrato.
7HQJDHQFXHQWDODV127$6HQHODSDUWDGRŝ([WUDFFLĂQGHODPXHVWUD\PDQLSXODFLĂQŞSDUDODFRPELQDFLĂQGH60RQRYHWWH® HCY-C y palomilla.

SARSTEDT S-Monovette®'1$b([DFW
La S-Monovette®'1$b([DFWFRQWLHQHXQDQWLFRDJXODQWHDEDVHGH('7$\VHXWLOL]DSDUDODREWHQFLĂQGHVDQJUHWRWDO (O('7$HVWÈSUHVHQWHHQIRUPDGHDHURVRO
/DVDQJUHWRWDOGH('7$VHXWLOL]DFRPRPDWHULDOGHPXHVWUDSDUDODHVWDELOL]DFLĂQGHO$'1J/DFDSDFLGDGGHHVWDELOL]DFLĂQGHO$'1JVHKDYDOLGDGRSDUDbGìDVDbƓ&SDUDbGìDVDWHPSHUDWXUDDPELHQWH bƓ& 
SDUDbGìDVHQUHIULJHUDFLĂQ bƓ& \SDUDDOPHQRVbDþRDşbƓ&$GHPÈVODVPXHVWUDVHVWDELOL]DGDVVREUHYLYHQDbFLFORVGHFRQJHODFLĂQ\GHVFRQJHODFLĂQVLQSHUGHUFDOLGDGYÜDVHDOUHVSHFWRHOLQIRUPHWÜFQLFRde SARSTEDT https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter//LWHUDWXUDŝ6$567('760RQRYHWWH®'1$b([DFWş$1HZ,9'&HUWLILHG%ORRG&ROOHFWLRQ7XEHIRU&ROOHFWLRQ7UDQVSRUWDQG6WDELOL]DWLRQRI:KROH%ORRGIRU*HQRPLF'1$$QDO\VLVŞLa anticoagulación se produce por la formación de complejos de iones de calcio por el EDTA.

**La idoneidad del material de la muestra depende del analito y del reactivo de ensayo/analizador. Se deben observar las recomendaciones de los respectivos fabricantes.

58

ES
Indicaciones de seguridad y advertencias
1.

Medidas generales de precaución: Utilice guantes y un equipo de protección individual para protegerse de la sangre y de una posible exposición a material de muestra potencialmente infeccioso y a agentes
patógenos transmisibles por las muestras.

2.

Manipule las muestras biológicas y los utensilios punzocortantes para la extracción de sangre (agujas y adaptadores) conforme a las directrices y procedimientos de su centro médico. Acuda a un médico en caso
GHFRQWDFWRGLUHFWRFRQODVPXHVWUDVELROĂJLFDVRGHXQDKHULGDSXQ]DQWH\DTXHH[LVWHHOULHVJRGHWUDQVPLVLĂQGH9,+9+&9+%XRWUDVHQIHUPHGDGHVLQIHFFLRVDV8WLOLFHODVDJXMDVGHVHJXULGDGR0XOWLĲ\® deseguridad con protector incorporado. Observe las directrices y procedimientos de seguridad de su centro médico.

3.

Aplicable a productos estériles en envases individuales: Antes del uso, compruebe que el envase individual no presenta daños. Si presenta daños, no utilice el producto.

4.

El producto ha sido concebido para un solo uso. Elimine todos los objetos punzocortantes (agujas y adaptadores) para la extracción de sangre en un contenedor adecuado para la eliminación de materiales
biológicos peligrosos.

5.

6LODVDQJUHVHH[WUDHDWUDYÜVGHXQDYìDLQWUDYHQRVD ,9 DVHJěUHVHGHTXHODYìDVHODYHDGHFXDGDPHQWH HVGHFLUVHODYHGHODVROXFLĂQ,9 GHDFXHUGRFRQODVQRUPDVGHOFHQWURPÜGLFRDQWHVGHLQLFLDUOD
extracción de sangre. El lavado adecuado de la vía evita resultados de análisis erróneos.

6.

(OOOHQDGRLQVXıFLHQWHGHOD60RQRYHWWH® da lugar a una relación incorrecta entre la sangre y la preparación/el aditivo y puede generar resultados de análisis incorrectos.

7.

La sangre extraída y procesada con la S-Monovette® no es apta para la reinyección en el cuerpo humano.

8.

1RXVHHOSURGXFWRGHVSXÜVGHODIHFKDGHFDGXFLGDG/DIHFKDGHFDGXFLGDGVHUHıHUHDOěOWLPRGìDGHOPHV\DþRLQGLFDGRV

Almacenamiento
El producto debe almacenarse a temperatura ambiente hasta su uso.

Limitaciones
1.

El tiempo y la temperatura de conservación de la S-Monovette® llena dependen de la estabilidad de los analitos que se van a analizar. La evaluación la realiza el laboratorio o la información se consulta en las
instrucciones de uso del fabricante del reactivo de ensayo/analizador.

2.

Incluso si el plasma o el suero se separa por centrifugación en una S-Monovette® o se forma una barrera, no todas las células se separan necesariamente por completo. El metabolismo residual o la degradación
QDWXUDOSXHGHQLQĲXLUHQODVFRQFHQWUDFLRQHVGHORVDQDOLWRV/DHVWDELOLGDGGHORVDQDOLWRVGHEHHYDOXDUVHFRQUHVSHFWRDORVUHFLSLHQWHVGHDOPDFHQDPLHQWR\ODVFRQGLFLRQHVGHOUHVSHFWLYRODERUDWRULR

3.

En el caso de medicamentos terapéuticos, compruebe la idoneidad del material de la muestra en las instrucciones de uso del fabricante del reactivo de ensayo/analizador.

4.

Los análisis de oligoelementos o metales deben realizarse con el sistema S-Monovette® Análisis de metales y con aguja de seguridad de análisis de metales.

Extracción de la muestra y manipulación
LEA COMPLETAMENTE ESTE DOCUMENTO ANTES DE INICIAR LA EXTRACCIÓN DE SANGRE VENOSA.
Material de trabajo necesario para la recogida de la muestra
1.

Todos los sistemas de extracción de sangre S-Monovette® necesarios.

2.

$JXMDVGHVHJXULGDGR0XOWLĲ\® de seguridad.

3.

Guantes, bata, protección ocular u otra prenda de protección adecuada para protegerse de los patógenos de transmisión sanguínea o de materiales potencialmente infecciosos.

4.

(WLTXHWDVSDUDODLGHQWLıFDFLĂQGHOSDFLHQWH

5.

Material de desinfección para la limpieza del lugar de extracción (observe las normas del establecimiento relativas a la preparación del lugar de extracción para la recogida de muestras estériles). Si las muestras
deben emplearse para medir la tasa de alcoholemia, no utilice materiales de limpieza a base de alcohol.

6.

Hisopo desechable seco y aséptico.

7.

Torniquete.

8.

Apósito o vendaje.

9.

Recipiente de eliminación de objetos punzocortantes para desechar de forma segura el material usado.

Secuencia de recogida recomendada:
1.

Frascos de hemocultivo

2.

Recipientes con citrato o activador de la coagulación (con/sin gel suero CAT/gel de suero CAT)

3.

Recipientes con activador de la coagulación o citrato

4.

Recipientes con heparina con/sin gel

5.

Recipientes con EDTA con/sin gel

6.

Recipientes con inhibidores de la glucólisis

7.

Recipientes con otros aditivos
127$

6LVHFRPLHQ]DFRQODH[WUDFFLĂQGHXQUHFLSLHQWHGHFLWUDWRXRWURUHFLSLHQWHFRQXQDSUHSDUDFLĂQOìTXLGDFRPR3)$&7$'&3'$+&<&R*OXFR(;$&7HQFRPELQDFLĂQFRQXQDSDORPLOOD
SbHMODDJXMD0XOWLĲ\®GHVHJXULGDG VHUHFRPLHQGDFRPHQ]DUFRQXQHQYDVHYDFìR SbHM60RQRYHWWH®1HXWUD= SDUDHYLWDUHOOOHQDGRLQVXıFLHQWHGHOUHFLSLHQWHGHELGRDOOOHQDGRGHO
tubo de la aguja de la palomilla.
(VWRJDUDQWL]DHOFRUUHFWROOHQDGRGHOUHFLSLHQWH\SRUWDQWRODUHODFLĂQFRUUHFWDGHODPH]FOD OìTXLGR\VDQJUH 

127$

2EVHUYHODVQRUPDVGHVXFHQWURPÜGLFRHQFXDQWRDODVHFXHQFLDGHH[WUDFFLĂQEvitar el retroceso
La mayoría de las S-Monovette® contienen aditivos químicos. Para evitar el retroceso, deben observarse las siguientes indicaciones:
1. 8WLOLFHěQLFDPHQWHORVPDWHULDOHVUHFRPHQGDGRVHQODVLQVWUXFFLRQHVGHXVR
2.

Coloque al paciente de modo que pueda acceder fácilmente a la vena y dirija el brazo u otra zona de punción del paciente hacia abajo.

3.

Sostenga la S-Monovette®FRQHOWDSĂQGHURVFDKDFLDDUULED\FXDQGRXWLOLFHXQDDJXD0XOWXĲ\® de seguridad, también bajo el nivel del brazo/la zona de punción.

4.

Cerciórese de que el contenido de la S-Monovette® no entre en contacto con el tapón de rosca ni con el extremo de la aguja durante la punción venosa.

5.

$ĲRMHHOWRUQLTXHWHPLHQWUDVODVDQJUHĲX\HHQOD60RQRYHWWH®.

59

ES
Congelación/descongelación6HJěQODVUHFRPHQGDFLRQHVGHOD206 :+2',//DE5HY HVUHFRPHQGDEOHVHSDUDUHOVXHURSODVPDGHORVJOĂEXORVVDQJXìQHRVDQWHVGHODFRQJHODFLĂQ
Deben tenerse en cuenta las siguientes recomendaciones de congelación para la S-Monovette®:&RQJHODFLĂQSRUGHEDMRGHbƓ&•

La aplicación en el intervalo de temperaturas mínimas debe probarse siempre en condiciones reales, ya que la carga de los recipientes puede variar mucho en función del medio que se va a congelar y de las
FRQGLFLRQHVUXWLQDULDV YÜDVHHOFDSìWXORŝ3URSLHGDGHVGHOPDWHULDOŞHQHOFDWÈORJRGH6$567('7 •(QSULQFLSLRORVYDORUHVGHUHVLVWHQFLDGHORVSOÈVWLFRVVHUHGXFHQHQHOLQWHUYDORGHWHPSHUDWXUDVSRUGHEDMRGHbƓ&3RUHVRSRUORJHQHUDOGHEHQHYLWDUVHODVWHQVLRQHVPHFÈQLFDV•

Las condiciones de congelación deben elegirse de manera que el contenido de la S-Monovette® se congele de manera uniforme o de abajo a arriba. La S-Monovette®GHEHWHQHUVXıFLHQWHKROJXUDHQHOVRSRUWHR
en la caja de almacenamiento para permitir su expansión. Los soportes de poliestireno o metal no son adecuados, ya que pueden dar lugar a grietas de dilatación.

&RQJHODFLĂQDbƓ&&RPSUREDFLRQHVDQWHVGHODFRQJHODFLĂQ•,QWHUIHUHQFLDVFRPSUXHEHVLODFRQJHODFLĂQWLHQHDOJěQHIHFWRTXHLQWHUıHUDHQODPXHVWUDGHVDQJUHRHQHODQÈOLVLV SbHMKHPĂOLVLVHVWDELOLGDGGHORVDQDOLWRV •&HQWULIXJDFLĂQHVQHFHVDULRHQIXQFLĂQGHODQÈOLVLVSUHYLVWR2EVHUYHODVFRQGLFLRQHVGHFHQWULIXJDFLĂQYÜDVHDOUHVSHFWRHOGRFXPHQWRGLVSRQLEOHHQŝ&HQWULIXJDFLĂQŞRHQODSÈJLQDZHEGH6$567('7https://www.sarstedt.com/en/service/centrifugation/ y realice un control visual de la muestra.

•

Hemólisis: la sangre total se hemoliza durante la congelación. Para evitarlo, utilice la S-Monovette®JHORHOıOWURGHYÈOYXOD6HUDSODV® después de la centrifugación, o pipetee la muestra en un recipiente secundario.

&RQJHODFLĂQDbƓ&3URFHGLPLHQWR•Enfriamiento: enfríe la S-Monovette®HQSRVLFLĂQYHUWLFDOGXUDQWHDbPLQGHVGHODWHPSHUDWXUDDPELHQWHDbƓ&DQWHVGHFRQJHODUORDbƓ&

•'HVFRQJHODFLĂQGHMHTXHVHGHVFRQJHOHHQSRVLFLĂQYHUWLFDODWHPSHUDWXUDDPELHQWHGXUDQWHDOPHQRVbPLQXWRV'HQXHYRVHGHEHQHYLWDUODVWHQVLRQHVPHFÈQLFDV8QDGHVFRQJHODFLĂQGHPDVLDGRUÈSLGD
puede alterar los resultados del análisis.

(QIULDPLHQWR\FRQJHODFLĂQSRUGHEDMRGHbƓ&•(OIDEULFDQWHQRKDUHDOL]DGRSUXHEDVGHFRQJHODFLĂQSRUGHEDMRGHbƓ&'HELGRDOJUDQQěPHURGHSRVLEOHVIDFWRUHVTXHSXHGHQLQĲXLUVHUHFRPLHQGDUHDOL]DUSUXHEDVGHFRQJHODFLĂQHQFRQGLFLRQHVGH
laboratorio rutinarias.

Congelación de la S-Monovette® gel:•

/DFRQJHODFLĂQVHUHDOL]DFRPRVHGHVFULEHHQŝ&RQJHODFLĂQDşbƓ&3URFHGLPLHQWRŞ•Se sabe que la capa de gel puede cambiar debido al proceso de congelación.

•'HELGRDOJUDQQěPHURGHSRVLEOHVIDFWRUHVTXHSXHGHQLQĲXLUVHUHFRPLHQGDUHDOL]DUSUXHEDVGHFRQJHODFLĂQHQFRQGLFLRQHVGHODERUDWRULRUXWLQDULDV•Descongelación:'HMHTXHODPXHVWUDVHGHVFRQJHOHHQSRVLFLĂQYHUWLFDO7UDQVıHUDHOPDWHULDOGHODPXHVWUDGHVSXÜVGHODGHVFRQJHODFLĂQSLSHWHÈQGROR QRGHFDQWÈQGROR KDVWDDSUR[LPDGDPHQWHbPPSRU
encima de la capa de gel del recipiente primario a un recipiente secundario. Deseche el resto.
NOTA: Para conocer la estabilidad de los analitos, consulte las instrucciones de uso de los fabricantes de los reactivos de ensayo/analizadores.

60

ES
Extracción de sangre
Técnicas de extracción
Se distinguen dos técnicas de extracción: la técnica de aspiración y la técnica de vacío.
La técnica de aspiración extrae la sangre de forma suave con un flujo de sangre continuo y lento mediante la tracción controlada del vástago del émbolo. De este modo, el flujo de sangre puede adaptarse fácilmente a
todas las condiciones y circunstancias de las venas y se puede reducir la hemólisis.
/DWÜFQLFDGHYDFìRH[WUDHODVDQJUHVHJěQHOSULQFLSLRGHSUHVLĂQQHJDWLYDFRQXQIOXMRVDQJUHUÈSLGR\FRQWLQXRSRUPHGLRGHXQUHFLSLHQWHSUHSDUDGRFRQYDFìR(VWDWÜFQLFDHVLGHDOFXDQGRODVFRQGLFLRQHVYHQRVDV
son buenas y las condiciones de extracción sencillas.
Manipulación para la extracción de sangre: véase también el vídeo sobre la manipulación de la S-Monovette® con la técnica de aspiración o de vacío con la aguja aguja de seguridad o Multifly® de seguridad.:www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
87,/,&(*8$17(63$5$5('8&,5$/01,02(/5,(6*2'((;326,&,1'85$17(/$(;75$&&,1'(6$1*5(1. Seleccione la S-Monovette® adecuada para la muestra necesaria.
2.

Determine la zona de la punción venosa. Observe las directrices de su centro médico en cuanto a la preparación la zona de punción.

Extracción de sangre con la técnica de aspiración¡Atención! La S-Monovette® únicamente debe utilizarse para la extracción de sangre, no para la inyección.
Utilícela solo con estas agujas (agujas de seguridad o Multifly® de seguridad S-Monovette®/adaptador para S-Monovette®).
A continuación se detalla la aplicación con la aguja de seguridad:

clic

Inmediatamente antes de la punción venosa, introduzca el S-Monovette® en la el cabezal de la aguja de seguridad
y fíjela JLUÈQGRODGHVSDFLRHQVHQWLGRKRUDULR .
6LHVQHFHVDULRDSOLTXHXQWRUQLTXHWH PÈ[bPLQXWR 3UHSDUHOD]RQDGHODSXQFLĂQFRQXQGHVLQIHFWDQWHDGHFXDGR8QDYH]GHVLQIHFWDGDQRWRTXHOD]RQDGHODSXQFLĂQYHQRVD&RORTXHDO
SDFLHQWHGHPRGRTXHSXHGDDFFHGHUIÈFLOPHQWHDODYHQD\GLULMDHOEUD]RXRWUD]RQDGHSXQFLĂQGHOSDFLHQWHKDFLDDEDMR
Retire el protector de la aguja. Puncione la vena, tire despacio del vástago del émbolo y afloje el torniquete mientras la sangre fluye en la S-Monovette®
Espere hasta que el flujo de sangre se detenga para permitir el llenado correcto.

.

Mueva la S-Monovette® JLUÈQGROROLJHUDPHQWHHQVHQWLGRDQWLKRUDULRy extráigalo de la aguja de seguridad (desconéctelo) . La aguja de seguridad permanece en la vena.
Si se van a realizar varias extracciones, conecte las siguientes S-Monovette® a la aguja de seguridad de la manera descrita anteriormente y extraiga más muestras.
Finalización de la extracción de sangre: Primero desconecte la S-Monovette®
+ , después extraiga la aguja de seguridad de la vena. Active el protector de la aguja con la técnica de una sola mano,ya sea sobre una superficie plana y estable hasta que la aguja encaje en el protector con un ŝFOLFŞSHUFHSWLEOH\DXGLEOH, o presionando contra el extremo inferior del protector con el dedo índice, véanse
también las instrucciones de uso de la aguja de seguridad o Multifly® de seguridad S-Monovette®.
Voltee las S-Monovette® una vez inmediatamente después de la desconexión de la aguja de seguridad y, una vez terminada la extracción de sangre, voltee varias veces con suavidad todas las muestras con
anticoagulantes.
Para el transporte y la centrifugación, tire del vástago del émbolo de forma audible hasta que el émbolo
encaje en su posición (el émbolo encaja en la base de la S-Monovette®) y rompa el vástago delémbolo .
1.

Presione el lugar de la punción con un hisopo seco y aséptico hasta que se detenga el sangrado.

2.

Cuando se haya producido la coagulación, puede aplicar un apósito.

3.

Elimine la aguja de seguridad en un contenedor adecuado para la eliminación de materiales biológicos peligrosos.

61

ES
Extracción de sangre con la técnica de vacío¡Atención! La S-Monovette® únicamente debe utilizarse para la extracción de sangre, no para la inyección.
Utilícela solo con estas agujas (agujas de seguridad o Multifly® de seguridad/adaptador para S-Monovette®).
A continuación se detalla la aplicación con la aguja de seguridad:

clic

Para iniciar la extracción de sangre con suavidad, SARSTEDT recomienda utilizar la primera S-Monovette®PHGLDQWHODWÜFQLFDGHDVSLUDFLĂQYÜDVHOD7x&1,&$'(9(12381&,17ÜFQLFDGHDVSLUDFLĂQ.
'HVSXÜVFRQWLQěHFRQODWÜFQLFDGHYDFìR
Antes de extraer la sangre con el vástago del émbolo, tire del émbolo hasta la base de la S-Monovette® y encájelo de forma audible . Después, rompa el vástago del émbolo .
Introduzca la S-Monovette® preparada en el cabezal de la aguja de seguridad S-Monovette® y fíjelo JLUÈQGRORGHVSDFLRHQVHQWLGRKRUDULR+.

Espere hasta que el flujo de sangre se detenga para permitir el llenado correcto.

Mueva la S-Monovette® JLUÈQGROROLJHUDPHQWHHQVHQWLGRDQWLKRUDULRy extráigalo de la aguja de seguridad (desconéctelo) . La aguja de seguridad permanece en la vena.
Si se van a realizar varias extracciones, conecte primero las siguientes S-Monovette® a la aguja de seguridad de la manera descrita anteriormente y extraiga más muestras.
Finalización de la extracción de sangre: Desconecte la S-Monovette® + ; después, extraiga la aguja de seguridad de la vena. Active el protector de la aguja con la técnica de una sola mano, ya sea sobre
una superficie plana y estable hasta que la aguja encaje en el protector con un ŝFOLFŞSHUFHSWLEOH\DXGLEOH, o presionando el protector contra el extremo inferior del protector con el dedo índice.
Voltee las S-Monovette® una vez inmediatamente después de la desconexión de la aguja de seguridad y, una vez terminada la extracción de sangre, voltee varias veces con suavidad todas las muestras con
anticoagulantes.
1.

Presione el lugar de la punción con un hisopo seco y aséptico hasta que se detenga el sangrado.

2.

Cuando se haya producido la coagulación, puede aplicar un apósito.

3.

Elimine la aguja Safety en un contenedor adecuado para la eliminación de materiales biológicos peligrosos.

62

a

ES
Centrifugaciónœ$7(1&,1/DV60RQRYHWWH®GH6$567('7HVWÈQGLVHþDGDVSDUDƅJ([FHSWRODV60RQRYHWWH®GHbPPĉ 60RQRYHWWH®SHGLDWUìD TXHHVWÈQYDOLGDGDVDFWXDOPHQWHSDUDKDVWDƅJ(PSOHH
ěQLFDPHQWHWXERVGHVRSRUWHRLQVHUWRVDGHFXDGRV/DFHQWULIXJDFLĂQGH60RQRYHWWHDJULHWDGDVRFRQXQDDFHOHUDFLĂQFHQWUìIXJDGHPDVLDGRHOHYDGDSXHGHQGDUOXJDUDODURWXUDGHODV60RQRYHWWH® y a la posible
liberación de material infeccioso.
Los insertos de la centrífuga deben seleccionarse en función del tamaño de las S-Monovette® empleadas. La aceleración centrífuga relativa presenta la siguiente relación respecto a las revoluciones por minuto
ajustadas:
FCR = 11,2 x r x (rpm/1.000)2)&5ŝIXHU]DFHQWUìIXJDUHODWLYDŞWDPELÜQFRQRFLGDFRPRŝIXHU]DJŞ LQJOÜV5&)ŝUHODWLYHFHQWULIXJDOIRUFHŞ
ŝUSPŞŝUHYROXFLRQHVSRUPLQXWRŞ USP RQ ŝQěPHURGHUHYROXFLRQHVSRUPLQXWRŞ LQJOÜV530ŝUHYROXWLRQVSHUPLQXWHŞ
ŝUŞŝUDGLRGHJLURŞGHVGHHOFHQWURGHODFHQWUìIXJDKDVWDODEDVHGHOD60RQRYHWWH®, (cm)Las S-Monovette® sin gel pueden centrifugarse en centrífugas con rotor de ángulo fijo o basculante.
Las S-Monovette® con gel están diseñadas exclusivamente para centrífugas con rotor basculante. La centrifugación en centrífugas con rotores de ángulo fijo no ha sido validada por SARSTEDT y no se recomienda.
Las S-Monovette®GHEHQFHQWULIXJDUVHVHJěQODVFRQGLFLRQHVGHFHQWULIXJDGRLQGLFDGDVPÈVDGHODQWH6LVHDSOLFDQXQDVFRQGLFLRQHVGLVWLQWDVHVWDVGHEHUÈQYDOLGDUVHSRUSDUWHGHOSURSLRXVXDULR
Cerciórese de que las S-Monovette® encajan correctamente en el inserto de la centrífuga. Las S-Monovette® que sobresalen del inserto pueden quedar atrapados en el cabezal de la centrífuga y romperse. La centrífuga
debe cargarse de forma homogénea. Para ello, siga las instrucciones de uso de la centrífuga.
¡PRECAUCIÓN! No retire con la mano las S-Monovette® rotos.
/DV LQVWUXFFLRQHV SDUD OD GHVLQIHFFLĂQ GH OD FHQWUìIXJD VH HQFXHQWUDQ HQ ODV LQVWUXFFLRQHV GH XVR GH HVWD

De
conformidad
con laHVSHFLıFDFLĂQBS 4851+ (dela UE)–

Fuerza centrífuga relativa (g)UNE-EN ISO
6710

S-Monovette®
2.000 x g

2.500 x g

3.000 x g*

3.500 x g*

4.000 x g*

Suero

10 min10 min

6 min

4 min

4 min

Suero gel15 min10 min

4 min

4 min

4 min

6XHURJHOUÈSLGR

15 min10 min

4 min

n. v.

n. v.

Heparina de litio

10 min10 min

7 min

7 min

7 min

Heparina de litio gel

15 min15 min10 min

7 min

7 min

Heparina de litio+ gel

8 min

7 min

5 min

4 min

4 min

EDTA

n. v.

n. v.

7 min

6 min

5 min

EDTA gel15 min10 min10 min

7 min

7 min

Citrato

9 min

8 min

7 min

6 min

5 min

('7$ĲXRUXURKHSDULQD

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Citrato PBM 1,8 ml
Radio de centrifugación >17 cm

9 min

8 min

7 min

6 min

5 min

Citrato PBM 1,8 ml
Radio de centrifugación de >9 cm aƉFP

n. v.

n. v.

10 min

n. v.

n. v.

n. v. = no validado* Válido para todas las S-Monovette®H[FHSWRODVGHbPPĉ 60RQRYHWWHSHGLDWUìD 

Centrifugación a 20 ºC+

British Standard BS4851:(VSHFLILFDFLĂQSDUDUHFLSLHQWHVHWLTXHWDGRVGHXQVRORXVRSDUDPXHVWUDVPÜGLFDVSDUDKHPDWRORJìD\ELRTXìPLFD, anulado.

Información sobre el material de separación
Las propiedades de flujo del material de separación (gel) dependen de la temperatura. Si las S-Monovette® se enfrían antes o durante la centrifugación, ya no es posible garantizar que la capa del gel de separación sea
continua.
Las S-Monovette® no deben volver a centrifugarse/recentrifugarse.

Eliminación
1.

Se deben observar y cumplir las directivas sobre higiene general y las disposiciones legales para la eliminación correcta de material infeccioso.

2.

El uso de guantes desechables evita el riesgo de infección.

3.

Los sistemas de extracción de sangre llenos o contaminados deben eliminarse en contenedores adecuados para la eliminación de materiales biológicos peligrosos que admitan un posterior procesamiento en
autoclave e incineración.

4.

La eliminación debe llevarse a cabo en una planta incineradora adecuada o a través de un proceso de autoclave (esterilización por vapor).

63

ES
1RUPDV\GLUHFWULFHVHVSHFìıFDVGHOSURGXFWRHQODUHVSHFWLYDYHUVLĂQYÈOLGDCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Norma para los recipientes de extracción de sangre venosa:
UNE-EN ISO 6710: Recipientes de un solo uso para la recogida de muestras de sangre venosa humana*CLSI (Clinical and Laboratory Standards Institute)Leyendas de símbolos y marcas:

1ěPHURGHDUWìFXOR

Aplicable también a productos estériles en envases individuales

Código de loteNo utilizar en caso de daños en el envase

Fecha de caducidad

Sistema de barrera estéril simple con envase protector exterior

Marcado CE

Esterilización por radiación

Diagnóstico in vitro&RQVěOWHQVHODVLQVWUXFFLRQHVGHXVR

En caso de reutilización: peligro de contaminación

Manténgase alejado de la luz solar

Manténgase seco

FabricantePaís de fabricación&LUFXLWRGHĲXLGRVHVWÜULO

No reesterilizar

Reservado el derecho a realizar modificaciones técnicas.
Cualquier incidente grave relacionado con el producto debe ser notificado al fabricante y a la autoridad nacional competente.

64Kasutusjuhend – SARSTEDTI verevõtusüsteem S-Monovette®

ET

Kasutamiseks in vitro diagnostikas
Kasutusotstarve
Verevõtusüsteeme, kanüüle ja adaptereid S-Monovette® kasutatakse veenivere proovi võtmiseks. Verevõtusüsteemid S-Monovette® on mõeldud vereproovide võtmiseks, transportimiseks, töötlemiseks ja säilitamiseks invitro diagnostilistel eesmärkidel seerumist, plasmast või täisverest kliinilises laboris. Toode on ette nähtud professionaalses keskkonnas ning erialasele meditsiini- ja laboripersonalile kasutamiseks.

7RRWHNLUMHOGXV
Verevõtusüsteemid S-Monovette® koosnevad plastnõust, kolvist, kolvivardast ja värvikoodiga plastist keermekorgist koos integreeritud membraaniga, mis on välja töötatud spetsiaalselt süsteemi S-Monovette® (Safety)
kanüüli või (Safety-)Multifly® kanüüli külge ühendamiseks, ning mitmesugustest lisanditest (preparaatidest). Saadaval on samuti süsteem S-Monovette® ilma lisandita. Verevõtusüsteemid S-Monovette®, mille lisanditeks
on hüübimisaktivaator, hüübimisaktivaator koos geeliga, liitiumhepariin, liitiumhepariin koos geeliga, naatriumhepariin, tsitraat, EDTA, fluoriid-EDTA, fluoriidhepariin, fluoriid-tsitraat ja CPDA ning ilma lisandita, mille lisandite
kontsentratsioonid, vedelate lisandite maht ja nende lubatud tolerantsid ning vere vahekord lisaaine suhtes vastavad nõuetele ja soovitustele, mis sisalduvad rahvusvahelises standardis DIN EN ISO 6710 „Single-use
containers for venous blood specimen collection“ ning Kliiniliste ja Laboratoorsete Standardite Instituudi (CLSI, Clinical and Laboratory Standards Institute) heakskiidetud standardites. Lisandi valik oleneb analüütilisest
testimismeetodist. Selle, mille peal test tehakse, määrab testreaktiivide ja/või analüüsiseadme tootja. Verevõtusüsteem S-Monovette® on saadaval kas sisemiselt steriilsena või üksikult pakituna sisemiselt ja väliselt
steriilsena.

Süsteemi S-Monovette® keermekorkide* värvikoodid

LisandTähtkood

Korgi värv standardi DIN
EN ISO 6710 kohaselt

Korgi värv standardi BS
4851+ kohaselt

Z

valge

valge

Preparaadita katsuti
S-Monovette® Neutral Z
Seerumi katsuti
S-Monovette® seerum CAT, hüübimisaktivaatoriga

CATpunanevalge

S-Monovette® seerum-geel CAT, hüübimisaktivaatori ja geeligaCATtumekollane

tumekollane

S-Monovette® seerumi ekspressgeel CAT, hüübimisaktivaatori trombiini ja geeliga

CAT

RUDQĭ

-

S-Monovette® liitiumhepariin LH, liitiumhepariiniga

LH

rohelineRUDQĭ

S-Monovette® liitiumhepariin LH, vedel, liitiumhepariiniga

LH

rohelineRUDQĭ

S-Monovette® liitiumhepariin-geel LH, liitiumhepariini ja geeliga

LHrohelineRUDQĭ

S-Monovette® liitiumhepariin-geel+ LH, liitiumhepariini ja kiire geeliga

LHrohelineRUDQĭ

S-Monovette® naatriumhepariin NH, naatriumhepariiniga

NH

pruun

roheline

Määramatasininesinine9NC

sinineroheline

9NC

helesinine-

S-Monovette® K3 EDTA K3E, koos kaalium-EDTA-ga

K3E

violetne

punaneS-Monovette® K2 EDTA K2E, koos kaalium-EDTA-ga

K2E

violetne

punaneS-Monovette® K2 EDTA-geel K2E, koos kaalium-EDTA- ja geeliga

K2E

violetne

punaneS-Monovette®ĲXRULLG('7$)(NRRVĲXRULLGLMD('7$JDJD

FE

hall

kollaneS-Monovette®ĲXRULLGKHSDULLQ)+NRRVĲXRULLGLMDKHSDULLQLJD

FH-kollaneS-Monovette®*OXFR(;$&7)&NRRVĲXRULLGLWVLWUDDGLMD('7$JD

FC

roosa

hall

LH

tumesinine

RUDQĭ

S-Monovette® ThromboExact, koos magneesiumiga

määramatamääramata, murakapunane

määramata, murakapunane

S-Monovette® CTAD

määramatamääramata, sinine

määramata, roheline

S-Monovette® ACD

ACD

kollanekollaneS-Monovette® CPDA

CPDA

kollanekollaneS-Monovette® hirudiin

määramatamääramata, oliivrohelinemääramata, oliivroheline

S-Monovette® homotsüsteiin HCY-Z geel, koos geeli ja stabilisaatoriga

määramatamääramata, hall

määramata, hall

S-Monovette® homotsüsteiin HCY-C, koos tsitraadi puhvriga

määramatamääramata, violetne

määramata, violetne

S-Monovette® DNA Exact

määramatamääramata, sinine

määramata, sinine

Hepariiniga katsuti

S-Monovette® ammooniumhepariin AH, koos ammooniumhepariiniga
Tsitraadiga katsuti
S-Monovette® tsitraat 9NC, naatriumtsitraati 3,13%®

S-Monovette PFA, tsitraat 9NC, naatriumtsitraati 3,8%, puhverdatud
EDTA-ga katsuti

Glükolüüsi inhibiitoritega katsuti

Katsuti metallide uuringuks
S-Monovette® metallide uuring LH, koos liitiumhepariiniga

Täisvere ja plasma lisakatsutid* Saadaval on ka teisi keermekorkide värve.
n.d.: määramata+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, tagasi võetud.

65

ET
SARSTEDT S-Monovette® seerum CAT / seerum-geel CAT
Süsteem S-Monovette® seerum CAT sisaldab hüübimisaktivaatori (silikaadi) kihiga kaetud plastgraanuleid ja on kasutusel seerumi saamiseks**. Plastgraanulid settivad tsentrifuugimise teel verekämbu ja seerumi vahele.
Süsteem S-Monovette® seerum-geel CAT sisaldab hüübimisaktivaatori (silikaadi) kihiga kaetud plastgraanulitele lisaks polümeeripõhist geeli ja on kasutusel seerumi saamiseks**. Geel settib tsentrifuugimise teelverekämbu ja seerumi vahele ning moodustab transportimise, säilitamise ja analüüsi ajal stabiilse eralduskihi.
Seerumit kasutatakse proovimaterjalina kliinilise keemia ja immunoloogia rutiinseteks uuringuteks ning seroloogias.
Pärast vereproovi võtmist peab veri süsteemis S-Monovette® seerum CAT / seerum-geel CAT hüübima 30 minutit püstises asendis, selleks et tagada pärast tsentrifuugimist hästi moodustunud horisontaalne eralduskiht.
Soovitatud aeg tugineb intaktsele hüübimisprotsessile. Haigusest tingitud hüübimishäiretega või hüübimist pärssivate teraapiate mõju all olevate patsientide veri vajab vajaduse korral täielikuks hüübimiseks rohkem aega.

SARSTEDT S-Monovette® seerumi ekspressgeel CAT
Süsteem S-Monovette® seerumi ekspressgeel CAT sisaldab hüübimisaktivaatori (trombiini) kihiga kaetud plastgraanulitele lisaks polümeeripõhist geeli ja on kasutusel seerumi saamiseks**. Geel settib tsentrifuugimise teelverekämbu ja seerumi vahele ning moodustab transportimise, säilitamise ja analüüsi ajal stabiilse eralduskihi.
Pärast vereproovi võtmist peab veri süsteemis S-Monovette® seerumi ekspressgeel hüübima 5 minutit püstises asendis, selleks et tagada pärast tsentrifuugimist hästi moodustunud horisontaalne eralduskiht. Soovitatud
aeg tugineb intaktsele hüübimisprotsessile, ka hepariniseeritud patsientide vere puhul. Haigusest tingitud hüübimishäiretega või hüübimist pärssivate teraapiate, kaasa arvatud suure annusega hepariini mõju all olevatepatsientide veri vajab täielikuks hüübimiseks rohkem aega.
Seerumit kasutatakse proovimaterjalina kliinilise keemia ja immunoloogia rutiinseteks uuringuteks ning seroloogias.

SARSTEDT S-Monovette® Neutral Z
Süsteem S-Monovette® Neutral Z ei sisalda ühtki preparaati, mis vastab vereproovi loomulikule hüübimisele ilma hüübimisaktivaatorita, ja on kasutusel seerumi saamiseks**. Tsentrifuugimise teel toimub eraldamine
verekämbuks ja seerumiks.
Seerumit kasutatakse proovimaterjalina kasutajapõhisteks uuringuteks.
Süsteemi S-Monovette® Neutral Z saab kasutada ka tühja nõuna: kui vereproovi võtmist tuleb alustada süsteemiga S-Monovette® tsitraat kombinatsioonis (Safety-)Multifly® kanüüliga (tiibadega kanüüliga), siis
kasutatakse süsteemi S-Monovette® Neutral Z esimese nõuna (tühja nõuna) (Safety-)Multifly® kanüüli vooliku täitmiseks.

SARSTEDT S-Monovette® liitiumhepariin LH / liitiumhepariin-geel LH / liitiumhepariin-geel+ LH, naatriumhepariin NH, ammooniumhepariin AH
Süsteem S-Monovette® liitiumhepariin LH / naatriumhepariin NH / ammooniumhepariin AH sisaldab hüübimist pärssiva aine (antikoagulandi) liitiumhepariini / naatriumhepariini / ammooniumhepariini (üldjuhul 16 RÜ
hepariini / ml vere kohta) kattekihiga kaetud plastgraanuleid ning see on kasutusel täisvere ja plasma saamiseks**. Plastgraanulid settivad tsentrifuugimise teel vererakkude ja plasma vahele.
Ilma plastgraanuliteta süsteemi S-Monovette® liitiumhepariin LH puhul on antikoagulant liitiumhepariin olemas pihustuspurkide kujul (üldjuhul 19 RÜ hepariini / ml vere kohta).
Süsteem S-Monovette® liitiumhepariin-geel LH sisaldab antikoagulandi liitiumhepariini (üldjuhul 25 RÜ hepariini / ml vere kohta) kihiga kaetud plastgraanulitele polümeeripõhist geeli ja on kasutusel plasma saamiseks**.
Geel settib tsentrifuugimise teel vererakkude ja plasma vahele ning moodustab transportimise, säilitamise ja analüüsi ajal stabiilse eralduskihi.
Süsteem S-Monovette® liitiumhepariin-geel+ LH sisaldab samuti polümeeripõhist geeli, mis võimaldab saada võrreldes süsteemiga S-Monovette® liitiumhepariin-geel ca 50% võrra vähendatud tsentrifuugimisaja.
Hepariini plasmat kasutatakse proovimaterjalina kliinilise keemia ja immunoloogia rutiinseteks uuringuteks. Hepariini täisverd kasutatakse proovimaterjalina immunoloogia rutiinseteks uuringuteks ning seroloogias.
Hüübimise pärssimine hepariiniga toimub antitrombiini aktiveerimise teel.
JUHIS. Süsteemidest S-Monovette® liitiumhepariin LH, liitiumhepariin-geel / geel+ LH ei tohi teha liitiumi määramisi, süsteemist S-Monovette® naatriumhepariin NH ei tohi teha naatriumi
määramisi ja süsteemist S-Monovette® ammooniumhepariin AH ei tohi teha ammooniumi määramisi. Veeniverega täidetud süsteemid S-Monovette® liitiumhepariin / liitiumhepariin-geel /geel+ / naatriumhepariin / ammooniumhepariin ei sobi veregaaside analüüsi jaoks.

SARSTEDT S-Monovette® metallide uuring
Süsteem S-Monovette® metallide uuring sisaldab antikoagulanti liitiumhepariini ning on kasutusel täisvere ja plasma saamiseks**. Liitiumhepariin on olemas pihustuspurkide kujul (19 RÜ hepariini / ml vere kohta).
Süsteemi S-Monovette®PHWDOOLGHXXULQJKHSDULLQLWËLVYHUGYĄLKHSDULLQLSODVPDWNRPELQDWVLRRQLVNRRVVSHWVLDDOVH6DIHW\NDQĞĞOLJD*ƅŹ DUWLNOLQU NDVXWDWDNVHSURRYLPDWHUMDOLQDPLNURHOHPHQWLGH
metallide uuringuteks. Mikroelemendid/metallid valideeriti aatomabsorptsioonspektromeetria (AAS) abil. Safety kanüüli ja süsteemi S-Monovette® metallide uuring süsteemi jaoks saadakse nende mikroelementide kohta
ng/süsteemis järgmised maksimaalsed tühiväärtused.

Element

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/süsteem

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

Maksimaalsed tühiväärtused on iga elemendi kohta süsteemi S-Monovette® etiketil ära toodud.
Olenevalt analüüsimeetodist tehakse mikroelementide määramised hepariini täisverest või hepariini plasmast.
Hüübimise pärssimine hepariiniga toimub antitrombiini aktiveerimise teel.

SARSTEDT S-Monovette® tsitraat 9NC
Süsteem S-Monovette® tsitraat 9NC sisaldab antikoagulant trinaatriumtsitraati ning on kasutusel täisvere ja plasma saamiseks**. Trinaatriumtsitraat on olemas 0,106 molaarse lahuse kujul (3,13% trinaatriumtsitraadi
lahus; sageli ümardatud 3,2% peale) ja moodustab 10% süsteemi S-Monovette® tsitraat nimimahust. Tsitraadi seguvahekorraks vere suhtes on 1:9 – 1 mahuosa tsitraati ja 9 mahuosa verd. Korrektne täitmine onanalüütika jaoks tingimata nõutav.
Tsitraadi plasmat kasutatakse proovimaterjalina hemostaseoloogia alasteks rutiinseteks uuringuteks.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel tsitraadi tõttu.
Palun järgige proovivõtmise ja käitlemise JUHISEID süsteemi S-Monovette® tsitraat ja tiibadega kanüüli kombinatsiooni kohta.

SARSTEDT S-Monovette® PFA 9NC
Süsteem S-Monovette® PFA 9NC sisaldab täisvere ja plasma saamiseks antikoagulanti trinaatriumtsitraati**. Trinaatriumtsitraat on olemas 0,129 molaarse puhverdatud lahuse kujul (3,8% puhverdatud; pH 5,5) ja
moodustab 10% süsteemi S-Monovette® PFA nimimahust. Tsitraadi seguvahekorraks vere suhtes on 1:9 – 1 mahuosa tsitraati ja 9 mahuosa verd. Korrektne täitmine on analüütika jaoks tingimata nõutav.
Süsteemi S-Monovette® PFA 9NC täisverd kasutatakse proovimaterjalina trombotsüütide funktsiooni määramiseks ettevõtte SIEMENS Healthineers analüüsiseadme PFA abil ja see on selleks valideeritud.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel tsitraadi tõttu.
Palun järgige proovivõtmise ja käitlemise JUHISEID süsteemi S-Monovette® PFA ja tiibadega kanüüli kombinatsiooni kohta.

SARSTEDT S-Monovette® CTAD
Süsteem S-Monovette® CTAD sisaldab antikoagulanti trinaatriumtsitraati ning teofülliini, adenosiini ja dipüramidooli ning on kasutusel täisvere ja plasma saamiseks**. CTAD on olemas lahuse kujul ja moodustab 10%
süsteemi S-Monovette® CTAD nimimahust. CTAD seguvahekorraks vere suhtes on 1:9 – 1 mahuosa ainet CTAD ja 9 mahuosa verd. Korrektne täitmine on analüütika jaoks tingimata nõutav.
CTAD plasmat kasutatakse proovimaterjalina trombotsüütide faktori 4 (PF4), beeta(ß)-tromboglobuliini (ßTG) ja plasminogeeni aktivaatori inhibiitori (PAI-1) määramiseks ning hemostaseoloogia rutiinseteks uuringuteks.
Trombotsüütide aktiveerimine inhibeeritakse vähemalt 4 tunni pikkuseks ajavahemikuks ja see on kasutusel hepariini teraapiate järelevalveks.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel tsitraadi tõttu.
Palun järgige proovivõtmise ja käitlemise JUHISEID süsteemi S-Monovette® CTAD ja tiibadega kanüüli kombinatsiooni kohta.
JUHIS: CTAD on kollane. Süsteemi S-Monovette® CTAD peab hoiustamise ajal kunstliku ja loomuliku valguse eest kaitsma. Enam kui 12 tunni pikkune tugev valguse toime võib esile kutsuda lisandite
inaktiveerumise.

66

ET
SARSTEDT S-Monovette® EDTA K2E / K3E
Süsteem S-Monovette® EDTA K2E / S-Monovette® EDTA K3E sisaldab antikoagulanti K2 EDTA või K3 EDTA ja on kasutusel täisvere ja plasma saamiseks**. K2 EDTA või K3 EDTA on olemas pihustuspurkide kujul (1,6
mg ainet EDTA / ml vere kohta).
EDTA täisverd kasutatakse proovimaterjalina hematoloogilisteks uuringuteks. Vereäigepreparaadid tuleb valmistada nelja tunni jooksul pärast vereproovi võtmist.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel EDTA tõttu.
Süsteemist S-Monovette® EDTA K2E / K3E pärinevat verd saab samuti kasutada rutiinseteks immuunhematoloogilisteks uuringuteks ja nakkushaiguste testideks. Kasutajal vastutab proovimaterjali sobivuse valideerimiseeest nendeks uuringuteks vastavate testreaktiivide/analüüsiseadmete abil, k.a säilitamistingimuste eest.

SARSTEDT S-Monovette® EDTA-geel K2E
Süsteem S-Monovette® EDTA-geel K2E sisaldab antikoagulandile lisaks K2 EDTA polümeeripõhist geeli ja on kasutusel plasma saamiseks**. K2 EDTA on olemas pihustuspurkide kujul (1,6 mg ainet EDTA / ml vere kohta).
Geel settib tsentrifuugimise teel vererakkude ja plasma vahele ning moodustab transportimise, säilitamise ja analüüsi ajal stabiilse eralduskihi.
EDTA plasmat kasutatakse proovimaterjalina molekulaarseks viirusdiagnostikaks.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel EDTA tõttu.

SARSTEDT S-Monovette®ĲXRULLG('7$)(ĲXRULLGKHSDULLQ)+ĲXRULLGWVLWUDDW('7$)&NRRVJOĞNROĞĞVLLQKLELLWRULWHJD
Süsteem S-Monovette® fluoriid EDTA FE sisaldab antikoagulanti EDTA (1,2 mg / ml vere kohta) ning fluoriidi (1,0 mg / ml vere kohta) glükolüüsi inhibeerimiseks ja on kasutusel plasma saamiseks**. Fluoriidi EDTA onolemas pihustuspurkide kujul.
Süsteem S-Monovette® fluoriidhepariin FH sisaldab antikoagulanti hepariini (16 RÜ hepariini / ml vere kohta) ning fluoriidi (1,0 mg / ml vere kohta) glükolüüsi inhibeerimiseks ja on kasutusel plasma saamiseks**.
Fluoriidhepariin on olemas pihustuspurkide kujul.
Glükolüüsi inhibeerimine üksnes fluoriidi abil algab ca 2 tundi pärast vereproovi võtmise katsuti täitmist ja see näitab oma täielikku mõju ca 4 tunni pärast. Seetõttu laguneb glükoos täisveres mõne tunni pärast keskmiselt
kuni 6% ja 24 tunni pärast kuni 10–15%.
Süsteem S-Monovette® GlucoEXACT FC sisaldab antikoagulanti EDTA-d ning tsitraati ja fluoriidi glükolüüsi koheseks inhibeerimiseks ja on kasutusel plasma saamiseks**. EDTA, tsitraat ja fluoriid on olemas lahuse kujul.
Glükoosi kontsentratsiooni arvutamisel on lahjendamise tõttu nõutav korrutamine arvuga 1,16.
Süsteem S-Monovette® GlucoEXACT FC täidab nõuded, mis sisalduvad Saksamaa Diabeediühingu (DDG, Deutsche Diabetes Gesellschaft) rasedusdiabeedi suunistes ja riiklikes tervishoiusuunistes (NVL) 2. tüüpi
diabeedi kohta. Glükoosi kontsentratsiooni kohene stabiliseerumine täisveres tagatakse toatemperatuuril kuni 96 tunniks, vaata ka: SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venousblood/s-monovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
Fluoriidi EDTA-(tsitraadi) plasmat kasutatakse proovimaterjalina glükoosi määramiseks.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel EDTA tõttu.
JUHIS. Fluoriid võib põhjustada hemolüüsi tõusu. Lisainfot ainete kohta, mis võivad olla segava toimega, võib leida testreaktiivide tootja kasutusjuhendist.
Palun järgige proovivõtmise ja käitlemise JUHISEID, mis on süsteemi S-Monovette® GlucoEXACT ja tiibadega kanüüli kombinatsiooni kohta.

SARSTEDT S-Monovette® CPDA
Süsteem S-Monovette® CPDA sisaldab antikoagulanti naatriumtsitraati, sidrunhapet, naatriumfosfaati, dekstroosi ja adeniini ning on kasutusel täisvere ja plasma saamiseks**. CPDA on olemas lahuse kujul. CPDA
seguvahekorraks vere suhtes on 1:6 – 1 mahuosa ainet CPDA ja 6 mahuosa verd. Korrektne täitmine on analüütika tõttu tingimata nõutav.
CPDA täisverd/plasmat kasutatakse veregruppide veregrupi seroloogia proovimaterjalina vereülekannete meditsiinis ja ühilduvuse uuringuteks (ristsobivuse proovideks) vereülekannete korral. Konkreetselt sobib
S-Monovette® CPDA veregrupi määramiseks (AB0), kaasa arvatud Kell-süsteem ja reesuse fenotüüp, ebaregulaarsete veregrupi antikehade otsingu testiks, polüspetsiifiliseks otseseks Coombsi testiks (kuni 10. päevani),ühilduvuse testiks (ristsobivuse prooviks) veregrupiga ühilduva patsiendi seerumi/plasmaga (major test).
Transportimise kestus kuni säilitamiseni on valideeritud maksimaalselt 4 tunniks temperatuuril 2–21 °C. Rakkude settimiseks peab proovid vähemalt 16 tunniks püstises asendis külmikusse panema. Seejärel saabülalpool nimetatud analüüte kuni 35 päeva analoogselt tavapäraste verekonservide säilitusajaga pärast külmkapis säilitamist (2–6 °C) määrata (välja arvatud otsene Coombsi test 10 päeva). Sobib samba aglutinatsiooni
meetodi jaoks, nt Vision Max ettevõttelt Ortho Clinical Diagnostics. Proovimaterjali ei tohi külmutada.
Kasutaja vastutab proovimaterjali sobivuse eest nendeks uuringuteks teiste meetodite / testreaktiivide / analüüsiseadmete abil, k.a ladustamistingimuste eest, ja see tuleb temal endal valideerida.
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel tsitraadi tõttu.
Palun järgige proovivõtmise ja käitlemise JUHISEID süsteemi S-Monovette® CPDA ja tiibadega kanüüli kombinatsiooni kohta.

SARSTEDT S-Monovette® ThromboExact
Süsteem S-Monovette® ThromboExact sisaldab antikoagulandina üht magneesiumisoola ja on kasutusel täisvere saamiseks**. Magneesiumisool on olemas pihustuspurkide kujul.
Süsteemi S-Monovette® ThromboExact kasutatakse proovimaterjalina trombotsüütide valede väikeste arvude välistamiseks antikoagulantide talumatuse tõttu (nagu näiteks EDTA, tsitraat, hepariin), mida nimetatakse ka
pseudotrombotsütopeeniaks. Trombotsüütide agregaatide tekkimist takistatakse ja trombotsüütide tegeliku arvu määramine on võimalik kuni 12 tundi pärast vereproovi võtmist.
Hüübimise pärssimine toimub magneesiumi ioonide kaudu, mille käigus magneesiumi ioonid inhibeerivad trombotsüütilist tromboksaani A2 ning ADP ja arahhidoonhappe vahendatud trombotsüütide agregatsiooni.

SARSTEDT S-Monovette® hirudiin
Süsteem S-Monovette® hirudiin sisaldab antikoagulanti hirudiini ja on kasutusel täisvere saamiseks**. Hirudiin on olemas pihustuspurkide kujul.
Hirudiini täisverd kasutatakse proovimaterjalina trombotsüütide funktsiooni määramiseks ettevõtte ROCHE Diagnostics seadme Multiplate® (multiple platelet function analyser, trombotsüütide mitmete funktsioonide
analüsaatori) abil ja see on selleks valideeritud. Seda kasutatakse trombotsüüte pärssivate ravimite teraapia järelevalveks ning trombotsüütide funktsiooni häirete tõendamiseks või välistamiseks.
Süsteem S-Monovette® hirudiin töötati välja spetsiaalselt trombotsüütide funktsiooni määramiseks seadmel Multiplate® koos firmaga Verum Diagnostica, mis on tänapäeval ROCHE Diagnostics.
Hüübimise pärssimine hirudiini abil toimub trombiini otsese pärssimise teel ja see võimaldab selliselt trombotsüütide funktsiooni diagnostikat natiivses seisundis.

SARSTEDT S-Monovette® homotsüsteiin HCY-Z-Gel / HCY-C
Süsteem S-Monovette® homotsüsteiin HCY-Z-Gel sisaldab hüübimisaktivaatori (silikaadi) kattekihiga kaetud plastgraanulitele lisaks spetsiaalset stabilisaatorit ning polümeeripõhist geeli ja on kasutusel seerumi
saamiseks**. Geel settib tsentrifuugimise teel verekämbu ja seerumi vahele ning moodustab transportimise, säilitamise ja analüüsi ajal stabiilse eralduskihi. Preparaat on olemas pihustuspurkide kujul.
Homotsüsteiin stabiliseerub täisveres toatemperatuuril kuni 8 tundi. Kui tsentrifuugimine toimub esimese 8 tunni jooksul korrektselt moodustunud eralduskihiga verekämbu ja seerumi vahel, siis stabiliseeritakse
homotsüsteiin kuni 96 tunniks.
Süsteemi S-Monovette® homotsüsteiin HCY-Z-geel seerumit kasutatakse proovimaterjalina homotsüsteiini määramiseks. Süsteem S-Monovette® homotsüsteiin HCY-C sisaldab antikoagulandina happelist tsitraati (pH4,3) ja on kasutusel plasma saamiseks**. Tsitraat on olemas lahuse kujul. Homotsüsteiini kontsentratsiooni arvutamisel on lahjendamise tõttu nõutav korrutamine arvuga 1,11.
Homotsüsteiin stabiliseerub täisveres toatemperatuuril kuni 6 tundi ja temperatuuril 4 °C kuni 48 tundi.
Süsteemi S-Monovette® homotsüsteiin HCY-C plasmat kasutatakse proovimaterjalina homotsüsteiini määramiseks.
Hüübimise pärssimine süsteemis S-Monovette® homotsüsteiin HCY-C toimub kaltsiumi ioonide komplekseerumise teel tsitraadi tõttu.
Palun järgige proovivõtmise ja käitlemise JUHISEID süsteemi S-Monovette® HCY-C ja tiibadega kanüüli kombinatsiooni kohta.

SARSTEDT S-Monovette® DNA Exact
Süsteem S-Monovette® DNA Exact sisaldab EDTA põhist antikoagulanti ja on kasutusel täisvere saamiseks**. EDTA on olemas pihustuspurkide kujul.
EDTA täisverd kasutatakse proovimaterjalina gDNA stabiliseerimiseks. Stabiliseerumisvõime on gDNA kohta valideeritud üle 5 päeva temperatuuril 35 °C, 14 päeva toatemperatuuril (22 °C), 28 päeva jahutamise korralƓ& MDYËKHPDOWDDVWDWHPSHUDWXXULOƃƓ&6WDELOLVHHULWXGSURRYLGSHDYDGLOPDNYDOLWHHGLNDKDQHPLVHWDYDVWXNĞOPXWDPLVMDĞOHVVXODWDPLVWVĞNOLWYDDWDND6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/
products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic
DNA Analysis.”
Hüübimise pärssimine toimub kaltsiumi ioonide komplekseerumise teel EDTA tõttu.

3URRYLPDWHUMDOLVRELYXVVĄOWXEDQDOĞĞGLVWMDWHVWUHDNWLLYLVWDQDOĞĞVLVHDGPHVW-ËUJLGDWXOHEWRRWMDWHVRRYLWXVL

67

ET
Ohutus-/hoiatusjuhised1.

Üldised ettevaatusabinõud: kasutage kindaid ja teisi üldisi isikukaitsevahendeid, et kaitsta ennast vere ning võimaliku kokkupuute eest potentsiaalselt nakkusliku proovimaterjali ja ülekantavate haigustekitajatega.

2.

Käidelge kõiki bioloogilisi proove ning teravaid/teravaotsalisi vereproovi võtmise vahendeid (kanüüle, adaptereid) meditsiiniasutuse suuniste ja protseduuride kohaselt. Bioloogiliste proovidega otsese kokkupuute või
WRUNHYLJDVWXVHNRUUDOSąąUGXJHDUVWLSRROHNXQDVHHOËELYĄLYDG+,9+&9+%9YĄLWHLVHGQDNNXVKDLJXVHGĞOHNDQGXGD.DVXWDJHVLVVHHKLWDWXGQĄHODNDLWVPHJD6DIHW\NDQĞĞOH6DIHW\0XOWLĲ\® kanüüle. Järgima
peab meditsiiniasutuse ohutussuuniseid ja -protseduure.

3.

Kehtib üksikult steriilselt pakitud toodete kohta: enne kasutamist kontrollige iga üksikpakend üle, kas esineb kahjustusi, ja ärge seda kahjustuste korral kasutage.

4.

Toode on ette nähtud ühekordseks kasutamiseks. Visake kõik teravad/teravaotsalised vahendid (kanüülid, adapterid) ohtlike bioloogiliste materjalide jaoks mõeldud kogumismahutitesse.

5.

Kui vereproov võetakse intravenoosse (IV) juurdepääsu kaudu, siis peab tagama, et juurdepääs oleks enne vereproovi võtmist meditsiiniasutuse nõuete kohaselt loputatud (= IV lahusest puhastatud). Juurdepääsunõuetekohase loputamisega välditakse vigaseid analüüsitulemusi.

6.

Süsteemi S-Monovette® alatäitmine põhjustab vere vale vahekorra preparaadi/lisandi suhtes ja võib anda valesid analüüsitulemusi.

7.

Süsteemiga S-Monovette® prooviks võetud ja töödeldud veri ei ole ette nähtud taassüstimiseks inimese kehasse.

8.

Toodet ei tohi pärast säilivusaja lõppemist enam kasutada. Säilivusaeg lõpeb äratoodud kuu ja aasta viimasel päeval.

Hoiustamine
Toodet tuleb kuni kasutamiseni hoiustada toatemperatuuril.

Piirangud
1.

Täidetud süsteemi S-Monovette® hoiustamiskestus ja -temperatuur sõltub uuritavate analüütide säilivusest. Hindamise teeb labor või infot vaadatakse testikomplektide/analüüsiseadmete tootja kasutusjuhendist.

2.

Isegi kui plasma või seerum tsentrifuugimise teel süsteemist S-Monovette® eraldatakse ja/või barjäär on olemas, siis ei eraldata tingimata kõiki rakke täielikult. Jääkainevahetus või loomulik lagunemine võivad
mõjutada analüütide kontsentratsioone. Analüütide stabiilsust tuleks hinnata säilitamisnõusid ja labori tingimusi arvesse võttes.

3.

Terapeutiliste ravimite puhul tuleb proovimaterjali sobivus kontrollida üle testikomplektide/analüüsiseadmete tootja kasutusjuhendist.

4.

Mikroelementide/metallide analüüsid tuleb teha süsteemiga S-Monovette® metallide uuring + (Safety) kanüül metallide uuring.

3URRYLYĄWPLQHMDNËLWOHPLQH
ENNE KUI TE VEENIVERE PROOVI VÕTMIST ALUSTATE, LUGEGE SEE DOKUMENT TÄIELIKULT LÄBI.
Proovivõtmiseks vajatav töömaterjal
1.

Kõik vajatavad verevõtusüsteemid S-Monovette®.

2.

6DIHW\ NDQĞĞOLGYĄL 6DIHW\ 0XOWLĲ\® kanüülid.

3.

Kindad, kittel, silmakaitse või muu sobiv kaitseriietus kaitseks vere kaudu ülekantavate patogeenide või potentsiaalselt nakkuslike materjalide eest.

4.

(WLNHWLGSDWVLHQGLLGHQWLıWVHHULPLVHNV5.

'HVLQıWVHHULPLVPDWHUMDOSURRYLYĄWXNRKDSXKDVWXVHNV VWHULLOVHNVSURRYLYĄWPLVHNVMËUJLJHPHGLWVLLQLDVXWXVHVXXQLVHLGSURRYLYĄWXNRKDHWWHYDOPLVWDPLVHNRKWD gUJHNDVXWDJHDONRKROLSĄKLVHLGSXKDVWXVYDKHQGHLGNXL
proove tuleb kasutada vere alkoholitestide tegemiseks.

6.

Kuivad mikroobivaesed ühekordselt kasutatavad tampoonid.

7.

Veenisulgur.

8.

Plaaster või side.

9.

Teravate/teravaotsaliste esemete jaoks mõeldud kogumismahuti kasutatud materjali turvaliseks kõrvaldamiseks.

Soovitatud proovivõtmise järjekord
1.

Verekultuuri pudelid

2.

Tsitraadi või hüübimisaktivaatoriga katsutid (koos geeliga / ilma geelita, seerum CAT / seerum-geel CAT)3.

Hüübimisaktivaatori või tsitraadiga katsutid

4.

Hepariiniga katsutid geeliga/geelita

5.

EDTA-ga katsutid geeliga/geelita

6.

Glükolüüsi inhibiitoritega katsutid

7.

Teiste lisanditega katsutid
JUHIS:

kui proovi võtmist alustatakse tsitraadi või mõne teise vedela preparaadiga katsutiga, nagu nt PFA, CTAD, CPDA, HCY-C või GlucoEXACT, kombinatsioonis tiibadega kanüüliga (nt (Safety-)
0XOWLĲ\® kanüüliga), siis soovitatakse võtta proov tühja katsutiga (nt süsteemiga S-Monovette® Neutral Z), selleks et vältida katsuti alatäitmist tiibadega kanüülide vooliku täitmise tõttu.
Seeläbi saab tagada katsuti korrektse täitmise ja seega korrektse seguvahekorra (vedelik vere suhtes).

JUHIS:

järgige proovivõtmise järjekorra teada saamiseks meditsiiniasutuse eeskirju.

Tagasivoolu vältimine
Enamik süsteeme S-Monovette sisaldavad keemilisi lisandeid. Tagasivoolu takistamiseks tuleb järgida järgmisi juhiseid.
1. Kasutage eranditult kasutusjuhendis soovitatud materjale.
2.

Paigutage patsient selliselt, et oleks lihtne juurdepääs veeni juurde, ja asetage patsiendi käsivars või mõni teine punktsiooni piirkond allapoole.

3.

Hoidke süsteemi S-Monovette®NHHUPHNRUJLJDĞOHVSRROHMD 6DIHW\ 0XOWLĲ\® kanüüli kasutamisel allpool käsivarre tasapinda / punktsiooni piirkonda.

4.

Süsteemi S-Monovette® sisu ei tohi puudutada veeni punktsiooni ajal ei keermekorki ega kanüüli otsa.

5.

Sel ajal kui veri voolab süsteemi S-Monovette®, päästke veenisulgur lahti.

68

ET
Külmutamine/ülessulatamine
WHO soovituste (WHO/DIL/Lab/99.1 Rev.02) kohaselt soovitatakse seerum/plasma eraldada enne vererakkude külmutamist.
Süsteemi S-Monovette® kohta kehtivad külmutamisel järgmised soovitused.
Külmutamine temperatuuril alla 0 °C•

Miinustemperatuuride vahemikus kasutamist peab põhimõtteliselt reaalsetes tingimustes testima, kuna katsutite koormus võib olenevalt külmutatavast meediumist ja rutiinsetest tingimustest olla väga erinev. (Vaata
materjali omaduste peatükki, ettevõtte SARSTEDT kataloog.)•

Plastide tugevusväärtused vähenevad temperatuurivahemikus alla 0 °C. Mehaanilisi koormusi tuleb seetõttu üldiselt vältida.

•

Külmutamistingimused peavad olema valitud nii, et süsteemi S-Monovette® sisu külmuks ühtlaselt või altpoolt ülespoole. Süsteemil S-Monovette® peaks olema tugiposti või säilitamiskarbi sees piisavalt ruumi, et see
saaks paisuda. Stüropoorist või metallist tugipostid ei ole sobivad, kuna need võivad põhjustada paisumismõrade tekke.

.ĞOPXWDPLQHWHPSHUDWXXULOHƃƓ&şHQQHNĞOPXWDPLVWNRQWUROOLJHMËUJPLVW
•

Häiringud: kontrollige, kas külmutamisel on häirivaid mõjusid vereproovile või analüüsile (nt hemolüüsile, analüütide stabiilsusele).

•

Tsentrifuugimine: nõutav olenevalt kavandatud analüüsist. Järgige tsentrifuugimistingimusi, vaata dokumendi jaotisest „Tsentrifuugimine“ või SARSTEDTI veebilehte https://www.sarstedt.com/en/service/centrifugation/, ning tehke proovi visuaalne kontroll.

•

Hemolüüs: külmutamisel hemolüüsitud täisveri. Selle vältimiseks tuleks kasutada kas süsteemi S-Monovette®JHHOYĄLSËUDVWWVHQWULIXXJLPLVWNODSLıOWULW6HUDSODV® või pipettida proov sekundaarsesse katsutisse.

.ĞOPXWDPLQHWHPSHUDWXXULOHƃƓ&•

Mahajahutamine Jahutage süsteem S-Monovette®SĞVWLVHVDVHQGLVşPLQXWLSLNNXVHDMDYDKHPLNXNHVWHOWRDWHPSHUDWXXULOWWHPSHUDWXXULOHƓ&PDKDHQQHNXLVHOOHVDDEWHPSHUDWXXULOƃƓ&NĞOPXWDGD

•Ülessulatamine: laske vähemalt 45 minutit toatemperatuuril püstises asendis üles sulada. Siinkohal tuleb vältida mehaanilisi koormusi. Liiga kiire ülessulatamine võib kaasa tuua analüüsitulemuste muutumise.

.ĞOPXWDPLQHMDVĞJDYNĞOPXWDPLQHWHPSHUDWXXULOHDOODƃƓ&•

6ĞJDYNĞOPXWDPLVWWHPSHUDWXXULOHDOODƃƓ&HLROHWRRWMDNRQWUROOLQXG9ĄLPDOLNHPĄMXWHJXULWHWĄWWXVRRYLWDWDNVHNĞOPXWDPLVWHVWLGWHKDWDYDOLVWHVODERULWLQJLPXVWHV

Süsteemi S-Monovette® geel külmutamine•.ĞOPXWDWDNVHQLLQDJXRQNLUMHOGDWXGSXQNWLVNĞOPXWDPLQHWHPSHUDWXXULOHƃƓ&

•

Geelikiht võib külmutamise tõttu muutuda.

•Võimalike mõjutegurite tõttu soovitatakse külmutamistestid teha tavalistes laboritingimustes.

•Ülessulatamine: laske proovil püstises asendis üles sulada. Viige proovimaterjal pärast ülessulatamist pipeti abil (mitte dekanteerimise teel) primaarsest nõust sekundaarsesse nõusse üle, kuni seda on geelikihi
kohale jäänud u 2 mm. Visake ülejääk minema.
JUHIS: analüütide stabiilsuse tagamiseks tuleb järgida testreaktiivide/analüüsiseadmete tootjate kasutusjuhendeid.

69

ET
Vereproovi võtmine
Proovivõtmise tehnikad
Eristatakse kahte proovivõtmise tehnikat: aspiratsiooni- ja vaakumtehnikat.
Aspiratsioonitehnika võimaldab tänu kolvivarda kontrollitud tõmbamisele säästlikku vereproovi võtmist pideva aeglase verevooluga. Sel viisil saab verevoolu kõigi veeniseisundite ja asjaoludega vahetult kohandada ning
hemolüüsi vähendada.
Vaakumtehnika võimaldab võtta vereproovi evakueeritud katsuti abil alarõhu põhimõtte järgi pideva kiire verevooluga. See tehnika sobib ideaalselt heade veeniseisundite ja lihtsate proovivõtmise tingimuste korral.
Vereproovi võtmine: vt videot süsteemi S-Monovette® kasutamise kohta aspiratsiooni- või vaakumtehnikaga koos Safety kanüüli või Safety-Multifly® kanüüliga:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
KOKKUPUUTERISKI MINIMEERIMISEKS VEREPROOVI VÕTMISE AJAL KANDKE KINDAID.
1. Valige nõutava proovi jaoks sobiv süsteem S-Monovette®.
2.

Valige koht veeni punktsiooni jaoks. Veeni punktsioonikoha ettevalmistamiseks järgige meditsiiniasutuse suuniseid.

Vereproovi võtmine aspiratsioonitehnikaga
Tähelepanu! Kasutage süsteemi S-Monovette® ainult vereproovi võtmiseks, mitte süstimiseks.
Kasutage ainult koos nende kanüülidega (süsteemi S-Monovette® (Safety) kanüülid või (Safety-)Multifly® kanüülid/adapterid süsteemi S-Monovette® jaoks).
Siin näidatakse kasutamist koos Safety kanüüliga.

klõps

Lükake süsteem S-Monovette® vahetult enne veeni punktsiooni Safety kanüüli integreeritud hoidiku sisse
ja kinnitage see kergelt kellaosuti suunas pöörates .
Vajaduse korral pange peale veenisulgur (maksimaalselt 1 minutiks). Valmistage punktsioonikoht sobiva desinfitseerimisvahendiga ette. Ärge puudutage pärast desinfitseerimist enam veeni
punktsioonikohta. Paigutage patsient selliselt, et oleks lihtne juurdepääs veeni juurde, ja asetage patsiendi käsivars või mõni teine punktsiooni piirkond allapoole.
Eemaldage nõelakaitse. Sel ajal kui veri voolab süsteemi S-Monovette® sisse
Oodake, kuni verevool peatub, et korrektset täitmist võimaldada.

, punkteerige veen, tõmmake kolvivarras aeglaselt tagasi ja päästke veenisulgur lahti.

Liigutage süsteemi S-Monovette® kergelt kellaosuti vastassuunas pöörates
ja tõmmake see seejärel Safety kanüülist välja (ühendage lahti) . Safety kanüül jääb veeni sisse.
Mitme proovivõtu korral ühendage järgnevad süsteemid S-Monovette Safety kanüüliga, nagu ülalpool kirjeldatud, ja võtke edasised proovid.
Vereproovi võtmise lõpetamine: kõigepealt ühendage süsteem S-Monovette®
+
lahti, seejärel tõmmake Safety kanüül veenist välja. Aktiveerige nõelakaitse ühe käega kas stabiilsel tasasel pinnal – kuni
kanüül tuntava ja kuuldava klõpsuga nõelakaitsmesse fikseerub (aktiveerumine) – või nimetissõrmega nõelakaitsme alumise otsa vastu surumise teel, vt ka süsteemi S-Monovette® (Safety) kanüüli või(Safety-)Multifly® kanüüli kasutusjuhendit.
Pöörake igat süsteemi S-Monovette® vahetult pärast Safety kanüüli lahtiühendamist 1 kord tagurpidi ja pärast vereproovi võtmise lõpetamist pöörake kõiki antikoagulantidega proove mitu korda hoolikalt
tagurpidi.
Transportimiseks ja tsentrifuugimiseks tõmmake kolvivarras kuuldavalt kolvi fikseerumisasendisse(kolb fikseerub süsteemi S-Monovette® põhja) ja murdke kolvivarras
ära.
1.

Vajutage kuiva mikroobivaba tampooniga punktsioonikohale, kuni verevool lakkab.

2.

Niipea kui vere hüübimine on alanud, pange soovi korral side peale.

3.

Visake Safety kanüül ohtlike bioloogiliste materjalide jaoks mõeldud kogumismahutisse.

70

ET
Vereproovi võtmine vaakumtehnikaga
Tähelepanu! Kasutage süsteemi S-Monovette® ainult vereproovi võtmiseks, mitte süstimiseks.
Kasutage ainult koos nende kanüülidega (süsteemi S-Monovette® (Safety) kanüülid või (Safety-)Multifly® kanüülid/adapterid süsteemi S-Monovette® jaoks).
Siin näidatakse kasutamist koos Safety kanüüliga.

klõpsSelleks et vereproovi säästvalt võtta, soovitab SARSTEDT võtta esimene süsteem S-Monovette® ära aspiratsioonitehnikaga, vaata VEENIDE PUNKTSIOONITEHNIKA aspiratsioonitehnika
Seejärel jätkake vaakumtehnikaga.
Enne vereproovi võtmist tõmmake kolb kolvivarda abil kuni süsteemi S-Monovette® põhjani ja laske sellel kuuldavalt fikseeruda . Seejärel murtakse kolvivarras ära .
Lükake ettevalmistatud süsteem S-Monovette® süsteemi S-Monovette® Safety kanüüli integreeritud hoidiku sisse ja kinnitage see kergelt kellaosuti suunas pöörates

+

–

.

.

Oodake, kuni verevool peatub, et korrektset täitmist võimaldada.

Liigutage süsteemi S-Monovette® kergelt kellaosuti vastassuunas pöörates
ja tõmmake see seejärel Safety kanüülist välja (ühendage lahti) . Safety kanüül jääb veeni sisse.
Mitme proovivõtu korral ühendage järgnevad süsteemid S-Monovette Safety kanüüliga, nagu ülalpool kirjeldatud, ja võtke edasised proovid.
Vereproovi võtmise lõpetamineÜhendage süsteem S-Monovette® lahti + , seejärel tõmmake Safety kanüül veenist välja. Aktiveerige nõelakaitse ühe käega kas stabiilsel tasasel pinnal – kuni kanüül tuntava ja kuuldava klõpsuganõelakaitsmesse fikseerub (aktiveerumine) – või aktiveerige nõelakaitse nimetissõrmega nõelakaitsme alumise otsa vastu surumise teel.
Pöörake igat süsteemi S-Monovette® vahetult pärast Safety kanüüli lahtiühendamist 1 kord tagurpidi ja pärast vereproovi võtmise lõpetamist pöörake kõiki antikoagulantidega proove mitu korda hoolikalt
tagurpidi.
1.

Vajutage kuiva mikroobivaba tampooniga punktsioonikohale, kuni verevool lakkab.

2.

Niipea kui vere hüübimine on alanud, pange soovi korral side peale.

3.

Visake Safety kanüül ohtlike bioloogiliste materjalide jaoks mõeldud kogumismahutisse.

71

ET
Tsentrifuugimine
7g+(/(3$186$567('7,VĞVWHHPLG60RQRYHWWHRQNDYDQGDWXGbƅJMDRNV6ĞVWHHPLG60RQRYHWWHPLOOHORQ¢PP SHGLDDWULDVĞVWHHP60RQRYHWWH® RQYDOLGHHULWXGNXQLbƅJMDRNV.DVXWDGDWXOHE
ainult sobivaid kandureid või hoidikuid. Mõradega süsteemide S-Monovette tsentrifuugimine või liiga suure tsentrifugaalkiirendusega tsentrifuugimine võib põhjustada süsteemide S-Monovette murdumise, kusjuurespotentsiaalselt nakkuslik materjal võib välja pääseda.
Tsentrifuugide kandurid tuleb valida kasutatavate süsteemide S-Monovette suuruse järgi. Suhteline tsentrifugaalkiirendus on järgmises seoses seadistatud pöörete arvuga/minutis:
5=% ƅUƅ 8S0 2;
RZB: „Relative Zentrifugalbeschleunigung“, suhteline tsentrifugaalkiirendus, nimetatakse ka „g-Kraft“, g-jõud (inglise keeles: „RCF“: „relative centrifugal force“);„UpM“: „Umdrehung pro Minute“ (U/min), pööret minutis, või: n = „pöörete arv minutis“ (inglise keeles: RPM, „revolutions per minute“);„r“: „Tsentrifuugimisraadius alates tsentrifuugi keskkohast kuni süsteemi S-Monovette® põhjani“ (cm).
Geelita süsteeme S-Monovette võib tsentrifuugida fikseeritud või muudetava nurgaga rootoriga tsentrifuugides.
Geeliga süsteemid S-Monovette on mõeldud eranditult muudetava nurgaga rootoriga tsentrifuugide jaoks. SARSTEDT ei ole valideerinud tsentrifuugimist fikseeritud nurgaga rootoriga tsentrifuugides ja seda ei soovitata.
Süsteeme S-Monovette peaks tsentrifuugima allpool loetletud tsentrifuugimistingimustel. Kui peaks kasutatama teisi tingimusi, siis tuleb need kasutajal endal valideerida.
Süsteemid S-Monovette peavad istuma tsentrifuugi kandurites hästi. Süsteemid S-Monovette, mis üle kandurite ulatuvad, võivad tsentrifuugi pea külge takerduda ja puruneda. Tsentrifuug peab olema ühtlaselt täidetud.
Järgige kindlasti tsentrifuugi kasutusjuhendit.
ETTEVAATUST! Ärge eemaldage purunenud süsteeme S-Monovette käega.
-XKLVHG WVHQWULIXXJL GHVLQıWVHHULPLVH NRKWD OHLDWH WVHQWULIXXJL NDVXWXVMXKHQGLVWStandardi BS
4851+ kohane(EL-i kood)

Suhteline tsentrifugaalkiirendus (g)S-Monovette®

DIN EN ISO 6710–

ƅJƅJƅJƅJƅJ

Seerum

10 min10 min

6 min

4 min

4 min

Seerum-geel

15 min10 min

4 min

4 min

4 min

Seerumi ekspressgeel

15 min10 min4 min

Valideerimata

Valideerimata

Liitiumhepariin

10 min10 min

7 min

7 min

7 min

Liitiumhepariin ja geel

15 min15 min10 min

7 min

7 min

Liitiumhepariin ja geel+

8 min

7 min

5 min

4 min

4 min

Valideerimata

Valideerimata

7 min

6 min

5 min

EDTA-geel

15 min10 min10 min

7 min

7 min

Tsitraat

9 min

8 min

7 min

6 min

5 min

('7$ĲXRULLGKHSDULLQ

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Tsitraat PBM, 1,8 ml
Tsentrifuugi raadius > 17 cm

9 min

8 min

7 min

6 min

5 min

Valideerimata

Valideerimata

10 minValideerimata

Valideerimata

EDTA

Tsitraat PBM, 1,8 ml
7VHQWULIXXJLUDDGLXV!NXQLƉFPn.v. = valideerimata* Kehtib kõigi süsteemide S-Monovette kohta, välja arvatud Ø 8 mm (pediaatriasüsteemid
S-Monovette).
+

Tsentrifuugimine temperatuuril 20 °C

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, tagasi võetud.

,QIRHUDOGXVPDWHUMDOLNRKWD
Eraldusmaterjali (geeli) voolavusomadused olenevad temperatuurist. Kui süsteeme S-Monovette enne tsentrifuugimist või selle ajal jahutatakse, siis ei ole eraldusgeeli läbiulatuv kiht enam tagatud.
Süsteeme S-Monovette ei tohi uuesti tsentrifuugida / retsentrifuugida.

Jäätmekäitlus
1.

Järgida tuleb üldisi hügieenisuuniseid ning õigusaktide sätteid nakkusliku materjali nõuetekohase jäätmekäitluse kohta ja neist tuleb kinni pidada.

2.

Ühekordselt kasutatavad kindad vähendavad nakatumisriski.

3.

Saastunud või täidetud verevõtusüsteemide jäätmekäitluse peab korraldama ohtlike bioloogiliste materjalide jaoks mõeldud sobivates jäätmekäitlusmahutites, mida saab seejärel autoklaavida ja ära põletada.

4.

Jäätmekäitlus peab toimuma sobivas põletusrajatises või autoklaavimise (aursteriliseerimise) teel.

72

ET
Tootepõhiste standardite ja suuniste kehtivad versioonid
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 “Collection of Diagnostic Venous Blood Specimens“, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 “Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays“, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Standard veenivere proovi võtmiseks mõeldud katsutite kohta:
DIN EN ISO 6710: Ühekordselt kasutatavad katsutid veenivere proovide võtmiseks inimestelt*CLSI (Clinical and Laboratory Standards Institute)Sümbolite ja märgistuste võtiArtikli number

Kehtib üksikult steriilselt pakitud toodete kohta

Partii number

Kahjustatud pakendi korral ärge kasutageKõlblik kuni

Lihtne steriilne barjäärisüsteem välise kaitsepakendiga

CE-märgis

Steriliseerimine kiiritamise teel

In vitro diagnostikavahend

Järgige kasutusjuhendit

Taaskasutamise korral: saastumisoht

Hoidke päikesevalguse eest kaitstult

Hoiustage kuivas kohas

TootjaTootjariik

Steriilne vedelikuteeÄrge resteriliseerige

Tehnilised muudatused on võimalikud.
Kõigist tootega seotud ohujuhtumitest tuleb teavitada tootjat ja pädevat riiklikku asutust.

73

Mode d‘emploi – Système de prélèvement sanguin S-Monovette® SARSTEDTFR

Pour des applications de diagnostic in vitro
Emploi prévu
Les systèmes de prélèvement sanguin S-Monovette®, y compris les aiguilles et adaptateurs, sont utilisés comme système de prélèvement sanguin veineux. Les systèmes de prélèvement sanguin S-Monovette® servent
au prélèvement, au transport, au traitement et au stockage d’échantillons sanguins à des fins de déterminations diagnostiques in vitro à partir du sérum, du plasma ou du sang total en laboratoire clinique. Le produit est
conçu pour une utilisation dans un environnement professionnel et l’application par un personnel médical qualifié.

Description du produit
Les systèmes de prélèvement sanguin S-Monovette® se composent d’un tube en plastique, d’un piston, d’une tige de piston, d’un bouchon à vis en plastique avec codage couleur et membrane intégrée, spécialement
développé pour être raccordé à une aiguille (de sécurité) S-Monovette® ou aiguille (de sécurité) Multifly®, ainsi que de différents additifs (préparations). La S-Monovette® est également disponible sans additif. Les
systèmes de prélèvement sanguin S-Monovette® avec additif (activateur de coagulation, activateur de coagulation avec gel, héparine de lithium, héparine de lithium avec gel, héparine de sodium, citrate, EDTA, fluorure/
EDTA, fluorure/héparine, fluorure/citrate, CPDA) et sans additif, ainsi que leurs concentrations en additif, le volume des additifs liquides, leurs tolérances admissibles et le rapport sang/additif correspondent aux
H[LJHQFHVHWDX[UHFRPPDQGDWLRQVGHODQRUPHLQWHUQDWLRQDOH',1(1,62ŝb5ÜFLSLHQWVÇXVDJHXQLTXHSRXUSUÜOÛYHPHQWVGHVDQJYHLQHX[KXPDLQbŞ 6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQ et aux normes approuvées du CLSI (Clinical and Laboratory Standards Institute). Le choix de l’additif dépend de la méthode d’analyse. Cette dernière est spécifiée par le fabricant des réactifs d’essai et/ou de l’appareild’analyse destiné au test. Le système de prélèvement sanguin S-Monovette®HVWGLVSRQLEOHGDQVOHVYHUVLRQVVXLYDQWHVbLQWÜULHXUVWÜULOHRXHPEDOODJHLQGLYLGXHOLQWÜULHXUHWH[WÜULHXUVWÜULOHV

Codes couleur des bouchons à vis S-Monovette® b

Additif

Code lettres

Couleur du bouchon selon
DIN EN ISO 6710

Couleur du bouchon selon%6b+

Z

blanc

blanc

Tube sans préparation
S-Monovette® Neutral Z
Tube avec sérum
S-Monovette® Sérum CAT, avec activateur de coagulation

CAT

rouge

blanc

S-Monovette® Sérum-Gel CAT, avec activateur de coagulation et gelCATjaune foncé

jaune foncé

S-Monovette® Sérum Express Gel CAT, avec activateur de coagulation sous forme dethrombine et gelCATorange-S-Monovette® Héparine de lithium LH, avec héparine de lithium

LH

vert

orangeS-Monovette® Héparine de lithium liquide LH, avec héparine de lithium

LH

vert

orangeS-Monovette® Héparine de lithium gel LH, avec héparine de lithium et gel

LH

vert

orangeS-Monovette® Héparine de lithium gel+ LH, avec héparine de lithium et gel rapide

LH

vert

orangeS-Monovette® Héparine de sodium NH, avec héparine de sodiumNHmarronvert

S-Monovette® Héparine d’ammonium AH, avec héparine d’ammonium

n.d.

bleu

bleu

Tube avec héparine

Tube avec citrate
S-Monovette®&LWUDWH1&FLWUDWHGHVRGLXPÇb

9NC

bleu

vert

S-Monovette®3)$&LWUDWH1&FLWUDWHGHVRGLXPÇbWDPSRQQÜ

9NC

bleu clair-

K3E

violetrouge

S-Monovette EDTA K2 K2E, avec potassium EDTA

K2E

violetrouge

S-Monovette® EDTA K2 Gel K2E, avec potassium EDTA et gel

K2E

violetrouge

S-Monovette®)OXRUXUH('7$)(DYHFĲXRUXUHHW('7$

FE

gris

jaune

S-Monovette®)OXRUXUHKÜSDULQH)+DYHFĲXRUXUHHWKÜSDULQH

FH

-

jaune

S-Monovette®*OXFR(;$&7)&DYHFĲXRUXUHFLWUDWHHW('7$

FC

rose

gris

LH

bleu foncéorangeTube avec EDTA
S-Monovette® EDTA K3 K3E, avec potassium EDTA®

Tube avec inhibiteurs de glycolyse

Récipient pour analyse des métaux
S-Monovette® Analyse de métaux LH, avec héparine de lithium

Autres récipients pour sang total et plasma
S-Monovette® ThromboExact, avec composé de magnésium

n.d.

n.d., violet foncén.d., violet foncé

S-Monovette® CTADn.d.

n.d., bleun.d., vert

S-Monovette® ACD

ACD

jaune

jaune

®

S-Monovette CPDA

CPDA

jaune

jaune

S-Monovette® Hirudine

n.d.

n.d., vert olive

n.d., vert olive

S-Monovette® Gel homocystéine HCY-Z, avec gel et stabilisateurn.d.

n.d., grisn.d., gris

S-Monovette® Homocystéine HCY-C avec tampon de citraten.d.

n.d., violet

n.d., violet

S-Monovette® DNA Exactn.d.

n.d., bleun.d., bleu

* D’autres couleurs de bouchons sont disponibles.
QGbQRQGÜILQL
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, retirée.

74

FR
S-Monovette® Sérum CAT/Sérum-Gel CAT SARSTEDTLa S-Monovette® Sérum CAT contient un granulat en plastique enrobé d’un activateur de coagulation (silicate). Elle s’utilise pour l'obtention de sérum**. Lors de la centrifugation, le granulat en plastique se place entre lesang coagulé et le sérum.
Outre le granulat en plastique enrobé d’un activateur de coagulation (silicate), la S-Monovette® Sérum-Gel CAT contient un gel à base de polymère. Elle s’utilise pour le prélèvement de sérum**. Lors de la centrifugation,le gel se place entre le sang coagulé et le sérum et forme une couche de séparation stable pendant le transport, le stockage et l’analyse.
Le sérum sert d’échantillon dans les examens de routine cliniques chimiques et immunologiques, ainsi qu’en sérologie.
$SUÛVOHSUÜOÛYHPHQWVDQJXLQODLVVH]OHVDQJFRDJXOHUHQSRVLWLRQYHUWLFDOHSHQGDQWbPLQXWHVGDQVOD60RQRYHWWH® Sérum CAT/Sérum-Gel CAT afin de garantir une couche de séparation horizontale bien forméeaprès la centrifugation. La durée recommandée est basée sur un processus de coagulation intact. Le sang de patients présentant des troubles de la coagulation dus à une maladie ou à un traitement anticoagulant
nécessite éventuellement plus de temps pour une coagulation complète.

S-Monovette® Sérum Express Gel CAT SARSTEDT
Outre le granulat en plastique enrobé d’un activateur de coagulation (thrombine), la S-Monovette® Sérum Express Gel CAT contient un gel à base de polymère. Elle s’utilise pour l'obtention de sérum**. Lors de lacentrifugation, le gel se place entre le sang coagulé et le sérum et forme une couche de séparation stable pendant le transport, le stockage et l’analyse.
$SUÛVOHSUÜOÛYHPHQWVDQJXLQODLVVH]OHVDQJFRDJXOHUHQSRVLWLRQYHUWLFDOHSHQGDQWbPLQXWHVGDQVOD60RQRYHWWH® Sérum Express Gel afin de garantir une couche de séparation horizontale bien formée après lacentrifugation. La durée recommandée est basée sur un processus de coagulation intact, également dans le cas du sang des patients héparinés. Le sang de patients présentant des troubles de la coagulation dus à
une maladie ou à un traitement anticoagulant avec héparine à haute dose nécessite plus de temps pour une coagulation complète.
Le sérum sert d’échantillon dans les examens de routine cliniques chimiques et immunologiques, ainsi qu’en sérologie.

S-Monovette® Neutral Z SARSTEDTLa S-Monovette® Neutral Z ne contient aucune préparation, ce qui correspond à une coagulation naturelle de l’échantillon sanguin sans activateur de coagulation. Elle s’utilise pour l'obtention de sérum**. La
centrifugation entraîne la séparation du sang coagulé et du sérum.
Le sérum sert d’échantillon pour les analyses spécifiques aux besoins de l’utilisateur.
De plus, la S-Monovette®1HXWUDO=YLGHSHXWVŖXWLOLVHUGHODPDQLÛUHVXLYDQWHbORUVTXHOHSUÜOÛYHPHQWVDQJXLQHVWHIIHFWXÜÇOŖDLGHGŖXQH60RQRYHWWH® Citrate combinée à une aiguille (de sécurité) Multifly® (aiguille àailettes), la S-Monovette®1HXWUDO=SHXWVHUYLUGHSUHPLHUbUÜFLSLHQW UÜFLSLHQWYLGH SRXUUHPSOLUOHWX\DXGHOŖDLJXLOOH GHVÜFXULWÜ 0XOWLIO\®.

S-Monovette® Héparine de lithium LH / Héparine de lithium gel LH/Héparine de lithium gel+ LH, Héparine de sodium NH, Héparine d’ammonium AH
SARSTEDTLa S-Monovette® Héparine de lithium LH/Héparine de sodium NH/Héparine d’ammonium AH contient un granulat en plastique enrobé d’un inhibiteur de coagulation (anticoagulant) à base d’héparine de lithium/GŖKÜSDULQHGHVRGLXPGŖKÜSDULQHGŖDPPRQLXP JÜQÜUDOHPHQWb8,GŖKÜSDULQHPOGHVDQJ (OOHVŖXWLOLVHSRXUOHSUÜOÛYHPHQWGHVDQJWRWDOHWGHSODVPD /RUVGHODFHQWULIXJDWLRQOHJUDQXODWHQSODVWLTXHVHSODFH
entre les cellules sanguines et le plasma.
Dans le cas de la S-Monovette®+ÜSDULQHGHOLWKLXP/+VDQVJUDQXODWHQSODVWLTXHOŖDQWLFRDJXODQWÇEDVHGŖKÜSDULQHGHOLWKLXPHVWVRXVIRUPHYDSRULVÜH JÜQÜUDOHPHQWb8,GŖKÜSDULQHPOGHVDQJ 
2XWUHOHJUDQXODWHQSODVWLTXHHQUREÜGŖDQWLFRDJXODQWÇEDVHGŖKÜSDULQHGHOLWKLXP JÜQÜUDOHPHQWb8,GŖKÜSDULQHPOGHVDQJ OD60RQRYHWWH® Héparine de lithium gel LH contient un gel à base de polymère. Elles’utilise pour le prélèvement de plasma**. Lors de la centrifugation, le gel se place entre les cellules sanguines et le plasma et forme une couche de séparation stable pendant le transport, le stockage et l’analyse.
La S-Monovette® Héparine de lithium gel+/+FRQWLHQWÜJDOHPHQWXQJHOÇEDVHGHSRO\PÛUHUÜGXLVDQWGŖHQYLURQbODGXUÜHGHFHQWULIXJDWLRQSDUUDSSRUWÇOD60RQRYHWWH® Héparine de lithium gel.
Le plasma hépariné sert d’échantillon dans les examens de routine cliniques chimiques et immunologiques. Le sang total hépariné sert d’échantillon dans les examens de routine immunologiques, ainsi qu’en sérologie.
L’anticoagulation à l’aide de l’héparine se fait par activation de l’antithrombine.
5(0$548(b/HV60RQRYHWWH®+ÜSDULQHGHOLWKLXP/+HW+ÜSDULQHGHOLWKLXPJHOJHO+/+QHGRLYHQWSDVÝWUHXWLOLVÜHVSRXUPHVXUHUOHOLWKLXPOD60RQRYHWWH®+ÜSDULQHGHVRGLXP1+QHGRLWSDVÝWUHXWLOLVÜHSRXUPHVXUHUOHVRGLXPHWOD60RQRYHWWH®+ÜSDULQHGŖDPPRQLXP$+QHGRLWSDVÝWUHXWLOLVÜHSRXUPHVXUHUOŖDPPRQLXP/HV60RQRYHWWH®+ÜSDULQHGHOLWKLXP+ÜSDULQHGHOLWKLXPJHO
gel++ÜSDULQHGHVRGLXP+ÜSDULQHGŖDPPRQLXPUHPSOLHVGHVDQJYHLQHX[QHFRQYLHQQHQWSDVÇOŖDQDO\VHGHVJD]GXVDQJ

S-Monovette® Analyse de métaux SARSTEDTLa S-Monovette® Analyse de métaux contient un anticoagulant à base d’héparine de lithium. Elle s’utilise pour le prélèvement de sang total et de plasma**. L’héparine de lithium est sous forme vaporisée (généralementb8,GŖKÜSDULQHPOGHVDQJ 
Le sang total et le plasma héparinés de la S-Monovette®$QDO\VHGHPÜWDX[XWLOLVÜVHQFRPELQDLVRQDYHFOŖDLJXLOOHGHVÜFXULWÜVSÜFLDOH*[Ź UÜIb VHUYHQWGŖÜFKDQWLOORQVSRXUOHVDQDO\VHVGHVROLJRéléments/métaux. Les oligo-éléments/métaux ont été validés à l’aide de la spectrométrie d’absorption atomique (SAA). Pour l’aiguille de sécurité du système et la S-Monovette® Analyse de métaux, les valeurs témoins
PD[LPDOHVHQQJV\VWÛPHSRXUFHVROLJRÜOÜPHQWVVRQWOHVVXLYDQWHVb

Élément

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/système

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

®

Les valeurs témoins maximales sont indiquées sur l’étiquette de la S-Monovette pour chaque élément.
Les mesures des oligo-éléments dépendent du procédé d’analyse à partir du sang total ou du plasma héparinés.
L’anticoagulation à l’aide de l’héparine se fait par activation de l’antithrombine.

S-Monovette® Citrate 9NC SARSTEDTLa S-Monovette® Citrate 9NC contient un anticoagulant à base de citrate trisodique. Elle s’utilise pour le prélèvement de sang total et de plasma**. Le citrate trisodique est présent sous forme de solution 0,106 molaire
VROXWLRQGHFLWUDWHWULVRGLTXHÇbbVRXYHQWDUURQGLHÇb HWUHSUÜVHQWHbGXYROXPHQRPLQDOGHOD60RQRYHWWH®&LWUDWH/HUDSSRUWGHPÜODQJHFLWUDWHVDQJHVWGHVRLWbIUDFWLRQGHYROXPHGHFLWUDWH
SRXUbIUDFWLRQVGHYROXPHGHVDQJ3RXUOŖDQDO\VHLOHVWLQGLVSHQVDEOHTXHOHUHPSOLVVDJHVRLWFRUUHFWLe plasma citraté sert d’échantillon dans les analyses de routine de la coagulation.
L’anticoagulation se fait par la complexation des ions calcium par le citrate.
Veuillez tenir compte des REMARQUES sous Prélèvement d’échantillon et manipulation de la combinaison S-Monovette® Citrate/aiguille à ailettes.

S-Monovette® PFA 9NC SARSTEDTLa S-Monovette® PFA 9NC contient un anticoagulant à base de citrate trisodique. Elle s’utilise pour le prélèvement de sang total et de plasma**. Le citrate trisodique est présent sous forme de solution 0,129 molaire
WDPSRQQÜH WDPSRQÇbbS+ HWUHSUÜVHQWHbGXYROXPHQRPLQDOGHOD60RQRYHWWH®3)$/HUDSSRUWGHPÜODQJHFLWUDWHVDQJHVWGHVRLWbIUDFWLRQGHYROXPHGHFLWUDWHSRXUbIUDFWLRQVGHYROXPHGH
sang. Pour l’analyse, il est indispensable que le remplissage soit correct.
Le sang total de la S-Monovette® PFA 9NC sert d’échantillon pour la mesure de la fonction plaquettaire à l’aide de l’appareil d’analyse PFA SIEMENS Healthineers et est validé à cet effet.
L’anticoagulation se fait par la complexation des ions calcium par le citrate.
Veuillez tenir compte des REMARQUES sous Prélèvement d’échantillon et manipulation de la combinaison S-Monovette® PFA/aiguille à ailettes.

S-Monovette® CTAD SARSTEDTLa S-Monovette® CTAD contient un anticoagulant à base de citrate trisodique, de théophylline, d’adénosine et de dipyridamole. Elle s’utilise pour le prélèvement de sang total et de plasma**. Le CTAD est présent sous
IRUPHGHVROXWLRQHWUHSUÜVHQWHbGXYROXPHQRPLQDOGHOD60RQRYHWWH®&7$'/HUDSSRUWGHPÜODQJH&7$'VDQJHVWGHVRLWbIUDFWLRQGHYROXPHGH&7$'SRXUbIUDFWLRQVGHYROXPHGHVDQJ3RXUOŖDQDO\VH
il est indispensable que le remplissage soit correct.
/HSODVPDSUÜSDUÜDYHFGX&7$'VHUWGŖÜFKDQWLOORQSRXUODPHVXUHGXIDFWHXUSODTXHWWDLUHb )3 GHODWKURPERJOREXOLQHEÝWD Ĕ  Ĕ7* HWGHOŖLQKLELWHXUGHOŖDFWLYDWHXUGXSODVPLQRJÛQH 3$, DLQVLTXHSRXUOHV
analyses de routine de la coagulation.
/ŖDFWLYDWLRQGHVWKURPERF\WHVHVWLQKLEÜHSHQGDQWXQHGXUÜHGŖDXPRLQVbKHXUHVHWVHUWÇODVXUYHLOODQFHGHVWUDLWHPHQWVSDUKÜSDULQH
L’anticoagulation se fait par la complexation des ions calcium par le citrate.
Veuillez tenir compte des REMARQUES sous Prélèvement d’échantillon et manipulation de la combinaison S-Monovette® CTAD/aiguille à ailettes.
5(0$548(b/H&7$'HVWMDXQH3HQGDQWOHVWRFNDJHOD60RQRYHWWH®&7$'GRLWÝWUHSURWÜJÜHGHODOXPLÛUHQDWXUHOOHHWDUWLıFLHOOH8QHIRUWHH[SRVLWLRQÇODOXPLÛUHSHQGDQWSOXVGHbKHXUHVSHXWHQWUDîQHUOŖLQDFWLYDWLRQGHVDGGLWLIV

75

FR
S-Monovette® EDTA K2E/K3E SARSTEDTLa S-Monovette® EDTA K2E/S-Monovette®('7$.(FRQWLHQWGHVDQWLFRDJXODQWV('7$.RX('7$.HWVHUWDXSUÜOÛYHPHQWGHVDQJWRWDO /Ŗ('7$.('7$.HVWVRXVIRUPHYDSRULVÜH bPJGŖ('7$POGHsang).
/HVDQJWRWDOSUÜSDUÜDYHFGHOŖ('7$VHUWGŖÜFKDQWLOORQSRXUOHVDQDO\VHVKÜPDWRORJLTXHV/HVIURWWLVVDQJXLQVGRLYHQWÝWUHSUÜSDUÜVGDQVXQGÜODLGHTXDWUHbKHXUHVVXLYDQWOHSUÜOÛYHPHQWVDQJXLQ
L’anticoagulation se fait par la complexation des ions calcium par l’EDTA.
Le sang dans la S-Monovette® EDTA K2E/K3E peut également être utilisé pour les analyses immunohématologiques de routine et les tests de maladies infectieuses. Il incombe à l’utilisateur de valider l’aptitude del’échantillon pour ces analyses avec les réactifs d’essai/les appareils d’analyse correspondants, y compris les conditions de stockage.

S-Monovette® EDTA Gel K2E SARSTEDT
Outre l’anticoagulant EDTA K2, la S-Monovette®('7$*HO.(FRQWLHQWXQJHOÇEDVHGHSRO\PÛUH(OOHVŖXWLOLVHSRXUOHSUÜOÛYHPHQWGHSODVPD /Ŗ('7$.HVWVRXVIRUPHYDSRULVÜH bPJGŖ('7$POGHVDQJ /RUVde la centrifugation, le gel se place entre les cellules sanguines et le plasma et forme une couche de séparation stable pendant le transport, le stockage et l’analyse.
Le plasma préparé avec l’EDTA sert d’échantillon pour le diagnostic moléculaire des virus.
L’anticoagulation se fait par la complexation des ions calcium par l’EDTA.

S-Monovette®)OXRUXUH('7$)()OXRUXUHKÜSDULQH)+FLWUDWHGHĲXRUXUH('7$)&DYHFLQKLELWHXUVGHJO\FRO\VH6$567('7La S-Monovette®)OXRUXUH('7$)(FRQWLHQWXQDQWLFRDJXODQWÇEDVHGŖ('7$ bPJPOGHVDQJ HWGXIOXRUXUH bPJPOGHVDQJ SRXUOŖLQKLELWLRQGHODJO\FRO\VH(OOHVŖXWLOLVHSRXUOHSUÜOÛYHPHQWGXSODVPD /H
fluorure EDTA est sous forme vaporisée.
La S-Monovette®)OXRUXUHKÜSDULQH)+FRQWLHQWXQDQWLFRDJXODQWÇEDVHGŖKÜSDULQH b8,GŖKÜSDULQHPOGHVDQJ HWGHIOXRUXUH bPJPOGHVDQJ SRXUOŖLQKLELWLRQGHODJO\FRO\VH(OOHVŖXWLOLVHSRXUOHSUÜOÛYHPHQWGX
plasma**. Le fluorure/héparine est sous forme vaporisée.
/ŖLQKLELWLRQGHODJO\FRO\VHJUÉFHDXIOXRUXUHVHXOFRPPHQFHHQYLURQbKHXUHVDSUÛVOHUHPSOLVVDJHGXUÜFLSLHQWGHSUÜOÛYHPHQWVDQJXLQ&HGHUQLHUHVWSDUIDLWHPHQWHIILFDFHDSUÛVHQYLURQbKHXUHV/HJOXFRVHSUÜVHQWGDQVOHVDQJWRWDOVHGÜJUDGHGRQFHQPR\HQQHMXVTXŖÇbDSUÛVVHXOHPHQWTXHOTXHVKHXUHVHWMXVTXŖÇÇbDSUÛVbKHXUHVLa S-Monovette® GlucoEXACT FC contient un anticoagulant à base d’EDTA, de citrate et de fluorure pour l’inhibition immédiate de la glycolyse. Elle s’utilise pour l'obtention de plasma**. L’EDTA, le citrate et le fluoruresont sous forme de solution. En raison de la dilution, pour calculer la concentration de glucose, il faut multiplier par 1,16.
La S-Monovette® GlucoEXACT FC est conforme à la ligne directrice relative au diabète gestationnel de la DDG (Deutsche Diabetes Gesellschaft, Société allemande sur le diabète) et aux recommandationsWKÜUDSHXWLTXHVQDWLRQDOHV 1DWLRQDOH9HUVRUJXQJV/HLWOLQLH19/ SRXUOHVGLDEÛWHVGHW\SHb/DVWDELOLVDWLRQLPPÜGLDWHGHODFRQFHQWUDWLRQGHJOXFRVHGDQVOHVDQJWRWDOHVWJDUDQWLHSHQGDQWMXVTXŖÇbKHXUHVÇ
température ambiante, voir également le livre blanc de SARSTEDT https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/%LEOLRJUDSKLHbŝb6DUVWHGW60RQRYHWWH® GlucoEXACT A blood
FROOHFWLRQGHYLFHIRUVWDELOL]LQJJOXFRVHOHYHOVIRUKRXUVbŞLe plasma préparé avec le fluorure, l’EDTA (et le citrate) sert d’échantillon pour la détermination de la glycémie.
L’anticoagulation se fait par la complexation des ions calcium par l’EDTA.
5(0$548(b/HĲXRUXUHSHXWSURYRTXHUXQHDXJPHQWDWLRQGHOŖKÜPRO\VH3RXUGHSOXVDPSOHVLQIRUPDWLRQVVXUOHVVXEVWDQFHVSRXYDQWDYRLUXQLPSDFWQÜJDWLIFRQVXOWHUOHPRGHGŖHPSORLFRUUHVSRQGDQWGXIDEULFDQWGHVUÜDFWLIVGŖHVVDL
Veuillez tenir compte des REMARQUES sous Prélèvement d’échantillon et manipulation de la combinaison S-Monovette® GlucoEXACT/aiguille à ailettes.

S-Monovette® CPDA SARSTEDTLa S-Monovette® CPDA contient un anticoagulant à base de citrate de sodium, d’acide citrique, de phosphate de sodium, de dextrose et d’adénine. Elle s’utilise pour le prélèvement de sang total et de plasma**. Le&3'$HVWVRXVIRUPHGHVROXWLRQ/HUDSSRUWGHPÜODQJH&3'$VDQJHVWGHVRLWbIUDFWLRQGHYROXPHGH&3'$SRXUbIUDFWLRQVGHYROXPHGHVDQJ3RXUOŖDQDO\VHLOHVWLQGLVSHQVDEOHTXHOHUHPSOLVVDJHVRLW
correct.
Le sang total/plasma préparé avec du CPDA sert d’échantillon pour la sérologie des groupes sanguins en médecine transfusionnelle, afin de réaliser des études de tolérance (échantillons croisés) lors des transfusions.
Concrètement, la S-Monovette® CPDA convient pour la détermination des groupes sanguins (AB0), y compris le facteur Kell et le système Rhésus, les tests de détection des anticorps de groupes sanguins irréguliers, le
WHVWGH&RRPEVSRO\VSÜFLILTXHGLUHFW MXVTXŖDXMRXUb HWOHVÜWXGHVGHWROÜUDQFH ÜFKDQWLOORQVFURLVÜV DYHFGXVÜUXPSODVPDGXSDWLHQWFRPSDWLEOHDYHFOHJURXSHVDQJXLQ WHVWPDMHXU /DGXUÜHGHWUDQVSRUWPD[LPDOHYDOLGÜHÇXQHWHPSÜUDWXUHFRPSULVHHQWUHHWbƓ&MXVTXŖDXVWRFNDJHHVWGHbKHXUHV3RXUSHUPHWWUHODVÜGLPHQWDWLRQGHVFHOOXOHVOHVÜFKDQWLOORQVGRLYHQWÝWUHVWRFNÜVDXSUÜDODEOH
GDQVXQUÜIULJÜUDWHXUHQSRVLWLRQYHUWLFDOHSHQGDQWXQHGXUÜHGŖDXPRLQVbKHXUHV/HVDQDO\WHVVXVPHQWLRQQÜVSHXYHQWHQVXLWHÝWUHDQDO\VÜVSHQGDQWXQHGXUÜHDOODQWMXVTXŖÇbMRXUVVLPLODLUHÇODGXUÜHGHYLH
KDELWXHOOHGHODSRFKHGHVDQJDSUÛVVWRFNDJHDXUÜIULJÜUDWHXU HQWUHHWbƓ&  H[FHSWÜGDQVOHFDVGXWHVWGH&RRPEVGLUHFWÇbMRXUV &RQYLHQWDXSURFÜGÜGŖDJJOXWLQDWLRQGHFRORQQHSDUbH[DYHFOHV\VWÛPH
Vision Max d’Ortho Clinical Diagnostics. L’échantillon ne doit pas être congelé.
Il incombe à l’utilisateur de valider lui-même l’aptitude de l’échantillon pour ces analyses avec d’autres méthodes/réactifs d’essai/appareils d’analyse, y compris les conditions de stockage.
L’anticoagulation se fait par la complexation des ions calcium par le citrate.
Veuillez tenir compte des REMARQUES sous Prélèvement d’échantillon et manipulation de la combinaison S-Monovette® CPDA/aiguille à ailettes.

S-Monovette® ThromboExact SARSTEDTLa S-Monovette® ThromboExact contient un anticoagulant à base de sel de magnésium. Elle s’utilise pour le prélèvement de sang total**. Le sel de magnésium est sous forme vaporisée.
Le sang total dans la S-Monovette® ThromboExact sert d’échantillon pour exclure les numérations plaquettaires faussement faibles, pseudothrombocytopénies, dues à une intolérance aux anticoagulants (tels queOŖ('7$OHFLWUDWHOŖKÜSDULQH /DIRUPDWLRQGŖDJUÜJDWVSODTXHWWDLUHVHVWHPSÝFKÜHSHUPHWWDQWDLQVLODGÜWHUPLQDWLRQGHODQXPÜUDWLRQSODTXHWWDLUHUÜHOOHMXVTXŖÇbKHXUHVDSUÛVOHSUÜOÛYHPHQWVDQJXLQ/ŖDQWLFRDJXODWLRQVHIDLWJUÉFHDX[LRQVPDJQÜVLXPbFHVGHUQLHUVLQKLEHQWOH7KURPER[DQH$SURGXLWSDUOHVWKURPERF\WHVHWODIRUPDWLRQGŖDJUÜJDWVSODTXHWWDLUHVLQGXLWHSDUOŖ$'3HWOŖDFLGHDUDFKLGRQLTXH

S-Monovette® Hirudine SARSTEDTLa S-Monovette® Hirudine contient un anticoagulant à base d’hirudine. Elle s’utilise pour le prélèvement de sang total**. L’hirudine est sous forme vaporisée.
Le sang total préparé avec de l’hirudine sert d’échantillon pour la mesure de la fonction plaquettaire sur l’appareil Multiplate® (multiple platelet function analyser) de ROCHE Diagnostics et est validé à cette fin. Il est utilisé
pour la surveillance des traitements avec des médicaments à effet inhibiteur de plaquettes et pour la détection ou l’exclusion de perturbations de la fonction plaquettaire.
La S-Monovette® Hirudine a été spécialement développée en collaboration avec la société Verum Diagnostica, aujourd’hui ROCHE Diagnostics, pour mesurer la fonction plaquettaire sur l’appareil Multiplate®.
L’anticoagulation se fait par action de l’hirudine en induisant une inhibition directe de la thrombine, permettant ainsi un diagnostic de la fonction plaquettaire à l’état natif.

S-Monovette® Gel homocystéine HCY-Z/HCY-C SARSTEDT
Outre le granulat en plastique enrobé d’un activateur de coagulation (silicate), la S-Monovette® Gel homocystéine HCY-Z contient un stabilisateur spécial et un gel à base de polymère. Elle s’utilise pour le prélèvement desérum**. Lors de la centrifugation, le gel se place entre le sang coagulé et le sérum et forme une couche de séparation stable pendant le transport, le stockage et l’analyse. La préparation est sous forme vaporisée.
cWHPSÜUDWXUHDPELDQWHOŖKRPRF\VWÜLQHHVWVWDELOLVÜHGDQVOHVDQJWRWDOSHQGDQWXQHGXUÜHDOODQWMXVTXŖÇbKHXUHV6LODFHQWULIXJDWLRQDOLHXDXFRXUVGHVbSUHPLÛUHVKHXUHVDYHFXQHFRXFKHGHVÜSDUDWLRQFRUUHFWHPHQWIRUPÜHHQWUHOHVDQJFRDJXOÜHWOHVÜUXPOŖKRPRF\VWÜLQHHVWDORUVVWDELOLVÜHSHQGDQWXQHGXUÜHPD[LPDOHGHbKHXUHVLe sérum dans la S-Monovette® Gel homocystéine HCY-Z sert d’échantillon pour mesurer l’homocystéine. La S-Monovette®+RPRF\VWÜLQH+&<&FRQWLHQWXQDQWLFRDJXODQWÇEDVHGŖDFLGHFLWULTXH S+b (OOHVŖXWLOLVH
pour le prélèvement de plasma**. Le citrate est sous forme de solution. En raison de la dilution, pour calculer la concentration en homocystéine, il faut multiplier par 1,11.
cWHPSÜUDWXUHDPELDQWHOŖKRPRF\VWÜLQHHVWVWDELOLVÜHGDQVOHVDQJWRWDOSHQGDQWXQHGXUÜHDOODQWMXVTXŖÇbKHXUHVHWMXVTXŖÇbKHXUHVÇXQHWHPSÜUDWXUHGHbƓ&
Le plasma dans la S-Monovette® Homocystéine HCY-C sert d’échantillon pour mesurer l’homocystéine.
L’anticoagulation dans la S-Monovette® Homocystéine HCY-C se fait par la complexation des ions calcium par le citrate.
Veuillez tenir compte des REMARQUES sous Prélèvement d’échantillon et manipulation de la combinaison S-Monovette® HCY-C/aiguille à ailettes.

S-Monovette® DNA Exact SARSTEDTLa S-Monovette® DNA Exact contient un anticoagulant à base d’EDTA. Elle s’utilise pour le prélèvement de sang total**. L’EDTA est sous forme vaporisée.
/HVDQJWRWDOSUÜSDUÜÇOŖ('7$HVWXWLOLVÜFRPPHÜFKDQWLOORQSRXUVWDELOLVHUOŖ$'1J/HSRXYRLUGHVWDELOLVDWLRQSRXUOŖ$'1JHVWYDOLGÜSHQGDQWbMRXUVÇbƓ&bMRXUVÇWHPSÜUDWXUHDPELDQWH bƓ& bMRXUVHQFDV
GHUÜIULJÜUDWLRQ bƓ& HWDXPRLQVbDQÇbƓ&'HSOXVOHVÜFKDQWLOORQVVWDELOLVÜVUÜVLVWHQWÇbF\FOHVGHFRQJÜODWLRQGÜFRQJÜODWLRQVDQVTXHOHXUTXDOLWÜHQVRLWDOWÜUÜH9RLUÜJDOHPHQWOHOLYUHEODQF6$567('7https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/%LEOLRJUDSKLHŝb6$567('760RQRYHWWH® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of:KROH%ORRGIRU*HQRPLF'1$$QDO\VLVbŞ
L’anticoagulation se fait par la complexation des ions calcium par l’EDTA.

/ŖDSWLWXGHGHOŖÜFKDQWLOORQGÜSHQGGHOŖDQDO\WHHWGXUÜDFWLIGŖHVVDLGHOŖDSSDUHLOGŖDQDO\VH/HVUHFRPPDQGDWLRQVFRUUHVSRQGDQWHVGXIDEULFDQWGRLYHQWÝWUHUHVSHFWÜHV

76

FRConsignes de sécurité/avertissements
1.

3UÜFDXWLRQVJÜQÜUDOHVb8WLOLVH]GHVJDQWVHWXQDXWUHÜTXLSHPHQWGHSURWHFWLRQLQGLYLGXHOOHSRXUYRXVSURWÜJHUGXVDQJHWGŖXQHÜYHQWXHOOHH[SRVLWLRQÇGHVÜFKDQWLOORQVSRWHQWLHOOHPHQWLQIHFWLHX[HWÇGHVDJHQWV
pathogènes transmissibles.

2.

Traitez tous les échantillons biologiques et les accessoires de prélèvement sanguin tranchants/pointus (aiguilles, adaptateurs) conformément aux prescriptions et aux procédures en vigueur au sein de votreÜWDEOLVVHPHQW(QFDVGHFRQWDFWGLUHFWDYHFGHVÜFKDQWLOORQVELRORJLTXHVRXGHEOHVVXUHSDUSLTĜUHFRQVXOWH]XQPÜGHFLQSRXUYRXVDVVXUHUGHQHSDVÝWUHLQIHFWÜ H SbH[SDUOH9+%9+&9,+RXWRXWHDXWUHPDODGLHLQIHFWLHXVH8WLOLVH]GHVDLJXLOOHVGHVÜFXULWÜDLJXLOOHVGHVÜFXULWÜ0XOWLĲ\® avec protecteur d’aiguille intégré. Veuillez vous conformer aux directives et procédures de sécurité en vigueur au sein de votreétablissement.

3.

9DODEOHSRXUOHVSURGXLWVVRXVHPEDOODJHLQGLYLGXHOVWÜULOHb Avant l’utilisation, contrôlez le parfait état de chacun des emballages individuels. Renoncez à toute utilisation en présence de dommages sur ces derniers.

4.

Le produit est un dispositif à usage unique. Éliminez tous les objets tranchants/pointus (aiguilles, adaptateurs) nécessaires au prélèvement sanguin dans des conteneurs à déchets appropriés pour les substances
biologiques dangereuses.

5.

Si le sang est prélevé par voie intraveineuse (IV), veuillez vous assurer que la ligne d’accès est correctement purgée (= nettoyée avec une solution IV) conformément au protocole de l’établissement avant decommencer le prélèvement sanguin. Une purge appropriée de l’accès permet d’éviter des résultats d’analyse erronés.

6.

8QUHPSOLVVDJHLQVXĴVDQWGHOD60RQRYHWWH® a pour conséquence un rapport incorrect entre le sang et la préparation/l’additif, entraînant ainsi des résultats d’analyse incorrects.

7.

Le sang prélevé et traité avec la S-Monovette® n’est pas destiné à être réinjecté dans le corps humain.

8.

1ŖXWLOLVH]MDPDLVOHSURGXLWDSUÛVOŖH[SLUDWLRQGHVDGDWHOLPLWHGŖXWLOLVDWLRQ/DGXUÜHGHFRQVHUYDWLRQSUHQGıQOHGHUQLHUMRXUGXPRLVHWGHOŖDQQÜHLQGLTXÜV

Stockage
Le produit doit être stocké à température ambiante jusqu’à son utilisation.

Restrictions
1.

La durée et la température de stockage de la S-Monovette® remplie dépendent de la durée de conservation des analytes à examiner. Il incombe au laboratoire d’évaluer ces paramètres. Se reporter au moded’emploi du fabricant du réactif d’essai/de l’appareil d’analyse pour consulter ces informations.

2.

Même lorsque le plasma ou le sérum de la S-Monovette® est séparé par procédé de centrifugation et/ou en présence d’une barrière, il est possible que toutes les cellules ne soient pas entièrement séparées. Le
métabolisme résiduel ou le processus de dégradation naturel peuvent impacter les concentrations des substances à analyser. La stabilité des substances à analyser doit être évaluée en fonction du récipient destockage et des conditions dans le laboratoire concerné.

3.

(QSUÜVHQFHGHPÜGLFDPHQWVWKÜUDSHXWLTXHVOŖDSWLWXGHGHOŖÜFKDQWLOORQSRXUOŖDQDO\VHGRLWÝWUHYÜULıÜHGDQVOHPRGHGŖHPSORLGXIDEULFDQWGXUÜDFWLIGŖHVVDLGXGLVSRVLWLIGŖDQDO\VH

4.

Les analyses des oligo-éléments/métaux doivent être réalisées avec le système composé de la S-Monovette® Analyse de métaux et de l’aiguille de sécurité destinée à l’analyse des métaux.

Prélèvement d’échantillon et manipulation
AVANT DE COMMENCER LE PRÉLÈVEMENT DE SANG VEINEUX, VEUILLEZ LIRE LE PRÉSENT DOCUMENT DANS SON INTÉGRALITÉ.
Matériel de travail nécessaire pour le prélèvement d’échantillon
1.

Toutes les systèmes de prélèvement sanguin S-Monovette® nécessaires.

2.

$LJXLOOHV GHVÜFXULWÜ RXDLJXLOOHV GHVÜFXULWÜ 0XOWLĲ\®.

3.

Des gants, une blouse, des lunettes de protection ou tout autre vêtement de protection approprié pour vous protéger des agents pathogènes transmissibles par le sang ou des matières potentiellement infectieuses.

4.

xWLTXHWWHVSRXUOŖLGHQWLıFDWLRQGXSDWLHQW

5.

Matériel de désinfection pour le nettoyage de la zone de prélèvement (respectez les directives de l’établissement pour la préparation de la zone de prélèvement pour le prélèvement stérile de l’échantillon). N’utilisez
pas de matériel de nettoyage à base d’alcool si les échantillons sont destinés à être utilisés pour un test d’alcoolémie sanguin.

6.

Compresses sèches à faible charge microbiologique à usage unique.

7.

Garrot.

8.

Pansement ou bandage.

9.

Collecteur de déchets destiné aux objets tranchants/pointus dans le cadre d’une élimination sûre du matériel utilisé.

6ÜTXHQFHGHSUÜOÛYHPHQWUHFRPPDQGÜHb1.

Flacons d’hémoculture2.

Tubes avec citrate ou activateur de coagulation (avec/sans gel, Sérum CAT/Sérum-Gel CAT)

3.

Tubes avec activateur de coagulation ou citrate4.

Tubes avec héparine avec/sans gel

5.

Tubes avec EDTA avec/sans gel

6.

Tubes avec inhibiteurs de glycolyse

7.

Tubes avec d’autres additifs
5(0$548(b(QFDVGHSUÜOÛYHPHQWGDQVXQWXEHDYHFGXFLWUDWHRXXQDXWUHWXEHDYHFXQHSUÜSDUDWLRQOLTXLGHFRPPH3)$&7$'&3'$+&<&RX*OXFR(;$&7SDUH[HPSOHHQ
FRPELQDLVRQDYHFXQHDLJXLOOHÇDLOHWWHV SDUbH[XQHDLJXLOOH GHVÜFXULWÜ 0XOWLĲ\® LOHVWUHFRPPDQGÜGHFRPPHQFHUSDUSUHQGUHXQWXEHQHXWUH SDUbH[60RQRYHWWH® Neutral= SRXUUHPSOLUOHWX\DXGHOŖDLJXLOOHÇDLOHWWHVDıQGŖÜYLWHUOHUHPSOLVVDJHLQVXĴVDQWGXWXEH
,OHVWDLQVLSRVVLEOHGHJDUDQWLUOHUHPSOLVVDJHFRUUHFWGXWXEHHWGRQFXQUDSSRUWGHPÜODQJHFRUUHFW OLTXLGHVDQJ 

5(0$548(b

6XLYH]OHVLQVWUXFWLRQVGHYRWUHÜWDEOLVVHPHQWSRXUOŖRUGUHGHSUÜOÛYHPHQW

xYLWHUOHUHĲX[/DSOXSDUWGHV60RQRYHWWHFRQWLHQQHQWXQDGGLWLIFKLPLTXH$ILQGŖHPSÝFKHUXQUHIOX[OHVLQVWUXFWLRQVVXLYDQWHVGRLYHQWÝWUHUHVSHFWÜHVb
1. N’utilisez que les matériaux recommandés dans le mode d’emploi.
2.

Installer le patient de manière à pouvoir accéder facilement à la veine et orienter le bras ou autre point de ponction du patient vers le bas.

3.

Maintenir la S-Monovette®DYHFOHERXFKRQÇYLVRULHQWÜYHUVOHKDXWHWHQFDVGŖXWLOLVDWLRQGŖXQHDLJXLOOH GHVÜFXULWÜ 0XOWLĲ\®, en dessous du niveau du bras/du point de ponction.

4.

Veiller impérativement à ce que le contenu de la S-Monovette® ne touche ni le bouchon à vis ni l’extrémité de l’aiguille lors de la ponction de la veine.

5.

Desserrer le garrot pendant que le sang coule dans la S-Monovette®.

77

FR
Congélation/décongélation/Ŗ206 :+2',//DEUÜYb UHFRPPDQGHGHVÜSDUHUOHVÜUXPSODVPDGHVFHOOXOHVVDQJXLQHVDYDQWODFRQJÜODWLRQPour les S-Monovette®OHVUHFRPPDQGDWLRQVVXLYDQWHVFRQFHUQDQWODFRQJÜODWLRQVŖDSSOLTXHQWb
&RQJÜODWLRQÇXQHWHPSÜUDWXUHLQIÜULHXUHÇbƓ&•/DFRQJÜODWLRQÇGHVWHPSÜUDWXUHVLQIÜULHXUHVÇbƓ&GRLWÝWUHSDUSULQFLSHWHVWÜHGDQVGHVFRQGLWLRQVUÜHOOHV(QHĳHWODVROOLFLWDWLRQGHVWXEHVSHXWIRUWHPHQWYDULHUHQIRQFWLRQGXPLOLHXÇFRQJHOHUHWGHV
conditions de routine (voir le chapitre Propriétés des matériaux du catalogue SARSTEDT).

•(QSULQFLSHOHVYDOHXUVGHUÜVLVWDQFHGHVSODVWLTXHVVRQWUÜGXLWHVORUVTXHFHX[FLVRQWVRXPLVÇXQHWHPSÜUDWXUHLQIÜULHXUHÇbƓ&,OFRQYLHQWGRQFGŖÜYLWHUV\VWÜPDWLTXHPHQWWRXWHVROOLFLWDWLRQPÜFDQLTXH

•Les conditions de congélation doivent être choisies de manière à garantir une congélation homogène ou du bas vers le haut du contenu de la S-Monovette®. La S-Monovette®GRLWGLVSRVHUGHVXĴVDPPHQWGHMHXGDQVOHSRUWRLURXFDUWRQGHVWRFNDJHSRXUSHUPHWWUHVRQH[SDQVLRQ/HVSRUWRLUVHQSRO\VW\UÛQHRXHQPÜWDOQHVRQWSDVDSSURSULÜVFDULOVHQWUDîQHQWXQULVTXHGHıVVXUHVVRXVOŖHĳHWGHOŖH[SDQVLRQ&RQJÜODWLRQÇXQHWHPSÜUDWXUHLQIÜULHXUHÇbƓ&3RLQWVÇFRQWUăOHUDYDQWODFRQJÜODWLRQb
•,QWHUIÜUHQFHVb9ÜULıHUVLODFRQJÜODWLRQSHXWLPSDFWHUQÜJDWLYHPHQWOŖÜFKDQWLOORQGHVDQJRXOŖDQDO\VH SDUbH[KÜPRO\VHVWDELOLWÜGHVDQDO\WHV •&HQWULIXJDWLRQb1ÜFHVVDLUHHQIRQFWLRQGHOŖDQDO\VHSUÜYXH3RXUFRQQDîWUHOHVFRQGLWLRQVGHFHQWULIXJDWLRQYRLUOHFKDSLWUHŝb&HQWULIXJDWLRQbŞGXSUÜVHQWGRFXPHQWRXVHUHSRUWHUDXVLWH,QWHUQHW6$567('7https://www.sarstedt.com/en/service/centrifugation/ et contrôler l’échantillon visuellement.

•+ÜPRO\VHb6DQJWRWDOKÜPRO\VÜSRXUODFRQJÜODWLRQb3RXUSUÜYHQLUOHULVTXHGŖKÜPRO\VHXWLOLVHUOD60RQRYHWWH®*HORXOHıOWUHÇVRXSDSH6HUDSODV® après la centrifugation ou pipeter l’échantillon dans un tube
secondaire.

&RQJÜODWLRQÇXQHWHPSÜUDWXUHGHbƓ&3URFÜGXUHb
•5HIURLGLVVHPHQWb/DLVVHUUHIURLGLUOD60RQRYHWWH®HQSRVLWLRQYHUWLFDOHVXUXQHGXUÜHGHÇbPLQSRXUOŖDEDLVVHUGHODWHPSÜUDWXUHDPELDQWHÇbƓ&DYDQWGHODFRQJHOHUÇbƓ&•'ÜFRQJÜODWLRQb/DLVVHUGÜFRQJHOHUHQSRVLWLRQYHUWLFDOHSHQGDQWDXPRLQVbPLQÇWHPSÜUDWXUHDPELDQWH,OFRQYLHQWLFLÜJDOHPHQWGŖÜYLWHUWRXWHVROOLFLWDWLRQPÜFDQLTXH8QHGÜFRQJÜODWLRQWURSUDSLGHULVTXH
d’impacter les résultats des analyses.

&RQJÜODWLRQHWVXUJÜODWLRQÇXQHWHPSÜUDWXUHLQIÜULHXUHÇbƓ&•/DVXUJÜODWLRQÇXQHWHPSÜUDWXUHLQIÜULHXUHÇbƓ&QŖDSDVÜWÜYÜULıÜHSDUOHIDEULFDQW'HQRPEUHX[IDFWHXUVÜWDQWVXVFHSWLEOHVGŖLQĲXHULOHVWUHFRPPDQGÜGHSURFÜGHUÇGHVWHVWVGHFRQJÜODWLRQGDQVOHV
conditions de routine du laboratoire.

Congélation de la S-Monovette®*HOb
•

3RXUODFRQJÜODWLRQSURFÜGHUFRPPHDXSRLQWŝb&RQJÜODWLRQÇXQHWHPSÜUDWXUHGHbƓ&3URFÜGXUHbŞ•,OHVWUHFRQQXTXHODFRXFKHGHJHOSHXWÝWUHPRGLıÜHSDUOHSURFHVVXVGHFRQJÜODWLRQ•'HQRPEUHX[IDFWHXUVÜWDQWVXVFHSWLEOHVGŖLQĲXHULOHVWUHFRPPDQGÜGHSURFÜGHUÇGHVWHVWVGHFRQJÜODWLRQGDQVOHVFRQGLWLRQVGHURXWLQHGXODERUDWRLUH

•'ÜFRQJÜODWLRQb/DLVVHUGÜFRQJHOHUOŖÜFKDQWLOORQHQSRVLWLRQYHUWLFDOH$SUÛVODGÜFRQJÜODWLRQSLSHWHUOŖÜFKDQWLOORQ QHSDVODLVVHUGÜFDQWHU GXWXEHSULPDLUHDXWXEHVHFRQGDLUHMXVTXŖÇHQYLURQbPPDXGHVVXVGH
la couche de gel. Jeter le reste.
5(0$548(b3RXUJDUDQWLUODVWDELOLWÜGHVDQDO\WHVUHVSHFWH]OHVPRGHVGŖHPSORLGHVIDEULFDQWVGHVUÜDFWLIVGŖHVVDLGLVSRVLWLIVGŖDQDO\VH

78

FR
Prélèvement sanguin
Techniques de prélèvement,OH[LVWHGHX[bWHFKQLTXHVGHSUÜOÛYHPHQWbODWHFKQLTXHGŖDVSLUDWLRQHWODWHFKQLTXHGHYLGH
La technique d’aspiration, par la manipulation controlée de la tige de piston, permet un prélèvement en douceur du sang. Elle provoque un débit sanguin lent et continu. Cette méthode permet d’adapter directement ledébit sanguin à tous les types de veines et à toutes les conditions tout en réduisant le risque d’hémolyse.
/DWHFKQLTXHGHYLGHFRQVLVWHÇSUÜOHYHUOHVDQJVHORQOHSULQFLSHGHGÜSUHVVLRQJUÉFHÇXQWXEHSUÜDODEOHPHQWPLVVRXVYLGH(OOHSURYRTXHXQGÜELWVDQJXLQUDSLGHHWFRQWLQX&ŖHVWSRXUTXRLFHWWHWHFKQLTXHHVWLGÜDOHpour les veines faciles à piquer. Elle est indiquée lorsque le prélèvement peut se faire dans des conditions simples.
0DQLSXODWLRQGXSUÜOÛYHPHQWVDQJXLQbYRLUÜJDOHPHQWODYLGÜRUHODWLYHÇODPDQLSXODWLRQGHOD60RQRYHWWH® en cas d’utilisation de la technique d’aspiration ou de vide avec une aiguille de sécurité ou l’aiguille de sécurité
Multifly®b
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
POUR MINIMISER LE RISQUE D’EXPOSITION PENDANT LE PRÉLÈVEMENT SANGUIN, PORTER DES GANTS.
1. Sélectionner une S-Monovette® adaptée pour l’échantillon nécessaire.
2.

Sélectionnez la zone de la ponction veineuse. Pour la préparation de la zone de ponction veineuse, respecter les directives de l’établissement.

Prélèvement sanguin avec la technique d’aspiration$WWHQWLRQb8WLOLVHUOD60RQRYHWWH® uniquement pour le prélèvement sanguin, jamais pour une injection.
Utiliser exclusivement ces aiguilles (aiguilles (de sécurité) S-Monovette® ou aiguilles (de sécurité) Multifly®/adaptateur pour la S-Monovette®).
/DPÜWKRGHLOOXVWUÜHLFLHVWFHOOHFRQVLVWDQWÇHPSOR\HUXQHDLJXLOOHGHVÜFXULWÜb

clic

Insérer la S-Monovette® dans le support intégré de l’aiguille de sécurité,
puis la fixer en la tournant légèrement dans le sens des aiguilles d’une montre .
$XEHVRLQSRVHUXQJDUURW SHQGDQWbPLQXWHPD[ 3UÜSDUHUOD]RQHGHSRQFWLRQDYHFXQSURGXLWGHGÜVLQIHFWLRQDSSURSULÜ$SUÛVODGÜVLQIHFWLRQQHSOXVWRXFKHUOD]RQHGHSRQFWLRQ
veineuse. Installer le patient de manière à pouvoir accéder facilement à la veine et orienter le bras ou autre point de ponction du patient vers le bas.
Retirer le protecteur d’aiguille. Ponctionner la veine, tirer lentement sur la tige du piston et desserrer le garrot pendant que le sang coule dans la S-Monovette®
Pour permettre un remplissage correct, attendre que le débit sanguin s’arrête.

.

Déconnecter la S-Monovette® en la tournant légèrement dans le sens inverse des aiguilles d’une montre
puis la retirer de l’aiguille de sécurité (la déconnecter) . L’aiguille de sécurité reste dans laveine.
En cas de prélèvements multiples, connecter les S-Monovette suivantes à l’aiguille de sécurité et prélever les échantillons suivants comme décrit ci-dessus.
)LQGXSUÜOÛYHPHQWVDQJXLQb&RPPHQFHUSDUGÜFRQQHFWHUOD60RQRYHWWH®
+ , puis retirer l’aiguille de sécurité de la veine. D’une main, mettre en place le protecteur d’aiguille, soit en le poussant sur
une surface plane et stable jusqu’à ce que l’aiguille s’enclenche (s’active) dans le protecteur d’aiguille d’un ŝbFOLFbŞSHUFHSWLEOHHWDXGLEOH, soit en appuyant avec l’index sur l’extrémité inférieure du protecteurd’aiguille, voir également le mode d’emploi de l’aiguille (de sécurité) S-Monovette® ou de l’aiguille (de sécurité) Multifly®.
Agiter la S-Monovette® en la retournant 1x directement après l’avoir déconnectée de l’aiguille de sécurité et, une fois le prélèvement sanguin terminé, agiter délicatement plusieurs fois tous les échantillons
avec des anticoagulants.
Pour le transport et la centrifugation, tirer sur la tige du piston jusqu’à ce qu’elle s’enclenche de manière audible dans la position d’encliquetage du piston(le piston s’encliquette dans le fond de la
S-Monovette®), puis rompre la tige du piston .
1.

Appuyer sur la zone de ponction avec une compresse sèche à faible charge microbiologique, jusqu’à l’arrêt du saignement.

2.

Au besoin, appliquer un bandage dès apparition de la coagulation.

3.

Éliminer l’aiguille de sécurité dans un conteneur à déchets approprié pour substances biologiques dangereuses.

79

FR
Prélèvement sanguin avec la technique de vide.
$WWHQWLRQb8WLOLVHUOD60RQRYHWWH® uniquement pour le prélèvement sanguin, jamais pour une injection.
Utiliser exclusivement ces aiguilles (aiguilles (de sécurité) S-Monovette® ou aiguilles (de sécurité) Multifly®/adaptateur pour la S-Monovette®).
/DPÜWKRGHLOOXVWUÜHLFLHVWFHOOHFRQVLVWDQWÇHPSOR\HUXQHDLJXLOOHGHVÜFXULWÜbclic

Pour commencer le prélèvement sanguin en douceur, SARSTEDT recommande de prélever la première S-Monovette® avec la technique d’aspiration, voir TECHNIQUE DE PONCTION, Technique d’aspiration– .
Poursuivre ensuite avec la technique de vide.
Avant le prélèvement sanguin, tirer le piston jusqu’au fond de la S-Monovette® à l’aide de la tige du piston et la laisser s’encliqueter de manière audible . Rompre ensuite la tige du piston .
Insérer cette S-Monovette® préparée dans le support intégré de l’aiguille de sécurité S-Monovette®, puis la fixer en la tournant légèrement dans le sens des aiguilles d’une montre+.

Pour permettre un remplissage correct, attendre que le débit sanguin s’arrête.

Déconnecter la S-Monovette® en la tournant légèrement dans le sens inverse des aiguilles d’une montre
puis la retirer de l’aiguille de sécurité (la déconnecter) . L’aiguille de sécurité reste dans laveine.
En cas de prélèvements multiples, commencer par connecter les S-Monovette suivantes à l’aiguille de sécurité, puis prélever les échantillons suivants comme décrit ci-dessus.
)LQGXSUÜOÛYHPHQWVDQJXLQb
Déconnecter la S-Monovette® + , puis retirer l’aiguille de sécurité de la veine. D’une main, mettre en place le protecteur d’aiguille, soit en le poussant sur une surface plane et stable jusqu’à ce que l’aiguilles’enclenche (s’active) dans le protecteur d’aiguille d’un ŝbFOLFbŞSHUFHSWLEOHHWDXGLEOH, soit en appuyant avec l’index sur l’extrémité inférieure du protecteur d’aiguille.
Agiter la S-Monovette® en la retournant 1x directement après l’avoir déconnectée de l’aiguille de sécurité et, une fois le prélèvement sanguin terminé, agiter délicatement plusieurs fois tous les échantillons
avec des anticoagulants.
1.

Appuyer sur la zone de ponction avec une compresse sèche à faible charge microbiologique, jusqu’à l’arrêt du saignement.

2.

Au besoin, appliquer un bandage dès apparition de la coagulation.

3.

Éliminer l’aiguille de sécurité dans un conteneur à déchets approprié pour substances biologiques dangereuses.

80

FR
Centrifugation$77(17,21b/HV60RQRYHWWHGH6$567('7VRQWFRQ×XHVSRXUXQHFHQWULIXJDWLRQÇb[JcOŖH[FHSWLRQGHV60RQRYHWWHGH¢bbPP 60RQRYHWWH® Pédiatrie), actuellement validées pour une centrifugationÇb[J8WLOLVHUXQLTXHPHQWGHVWXEHVSRUWHXUVRXGHVLQVHUWVDGDSWÜV/DFHQWULIXJDWLRQGHV60RQRYHWWHDYHFGHVILVVXUHVRXODFHQWULIXJDWLRQORUVTXHOŖDFFÜOÜUDWLRQFHQWULIXJHHVWWURSÜOHYÜHSHXWFDVVHUOHVS-Monovette, libérant du matériel potentiellement infectieux.
/HVLQVHUWVGHFHQWULIXJHXVHGRLYHQWÝWUHVÜOHFWLRQQÜVHQIRQFWLRQGHODWDLOOHGHV60RQRYHWWHXWLOLVÜHV/ŖDFFÜOÜUDWLRQFHQWULIXJHUHODWLYH $&5 VHUDSSRUWHDXQRPEUHGHWRXUVSDUPLQXWHGÜILQLFRPPHVXLWb$&5 [U[ WUSPb 2,$&5bŝbIRUFHFHQWULIXJHUHODWLYHbŞRXŝbIRUFHJbŞ HQDQJODLV5&)ŝbUHODWLYHFHQWULIXJDOIRUFHbŞ ŝbWUSPbŞbŝbWRXUSDUPLQXWHbŞ WUPLQ RXQ ŝbWRXUSDUPLQXWHbŞ HQDQJODLV530ŝbUHYROXWLRQVSHUPLQXWHbŞ ŝbUbŞbŝb5D\RQGHURWDWLRQbŞGXFHQWUHGHODFHQWULIXJHXVHDXIRQGGHOD60RQRYHWWH®bŞ FP 
La centrifugation des S-Monovette sans gel peut se faire dans des centrifugeuses à angle fixe ou à rotor libre.
Les S-Monovette avec gel sont exclusivement conçues pour les centrifugeuses à rotor libre. La centrifugation dans des centrifugeuses dotées d’un rotor à angle fixe n’est ni validée par SARSTEDT, ni recommandée.
Les S-Monovette doivent être centrifugées selon les conditions de centrifugation répertoriées ci-dessous. Si d’autres conditions sont utilisées, celles-ci doivent être validées par l’utilisateur lui-même.
Il faut s’assurer que les S-Monovette sont placées correctement dans les inserts de la centrifugeuse. Une S-Monovette qui dépasse de l’insert peut se coincer dans la tête de la centrifugeuse et se briser. La
centrifugeuse doit être remplie de manière uniforme. Pour ce faire, observer le mode d’emploi de la centrifugeuse.
$77(17,21b 1H UHWLUH] SDV XQH 60RQRYHWWH EULVÜH Ç OD PDLQ/HV LQVWUXFWLRQV UHODWLYHV Ç OD GÜVLQIHFWLRQ GH OD FHQWULIXJHXVH ıJXUHQW GDQV OH PRGH GŖHPSORL GH OD FHQWULIXJHXVH

Selon BS
4851+ (CodeCE)–

Accélération centrifuge relative (g)S-Monovette®

DIN EN ISO 6710

b[Jb[Jb[Jb[Jb[JSérumbPLQbPLQbPLQ

bPLQ

bPLQ

Sérum-Gel

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Sérum Express Gel

bPLQbPLQ

bPLQ

n.v.

n.v.

Héparine de lithium

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Héparine de lithium gel

bPLQbPLQbPLQ

bPLQ

bPLQ

Héparine de lithium gel+

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA

n.v.

n.v.

bPLQ

bPLQ

bPLQ

EDTA gelbPLQbPLQbPLQ

bPLQ

bPLQ

Citrate

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA, Fluorure/héparine

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

GlucoEXACT

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDWH3%0bPO
5D\RQGHFHQWULIXJDWLRQ!bFP

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDWH3%0bPO
5D\RQGHFHQWULIXJDWLRQ!ÇƉbFP

n.v.

n.v.

bPLQn.v.

n.v.

n.v. = non validée
9DODEOHSRXUWRXWHVOHV60RQRYHWWHÇOŖH[FHSWLRQGHODYDULDQWH¢bbPP 60RQRYHWWH
Pédiatrie).

&HQWULIXJDWLRQÇbƓ&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, retiré.

Information relative au matériau de séparation
La fluidité du matériau de séparation (gel) dépend de la température. Si les S-Monovette sont refroidies avant ou après la centrifugation, la couche continue du gel de séparation n’est plus garantie.
Les S-Monovette ne doivent pas être de nouveau centrifugées/recentrifugées.

Élimination
1.

Les directives générales d’hygiène et les dispositions légales relatives à l’élimination conforme de matières infectieuses doivent être respectées.

2.

Les gants à usage unique limitent le risque d’infection.

3.

Les systèmes de prélèvement sanguin contaminés ou remplis doivent être mis au rebut dans un récipient d’élimination pour substances biologiques dangereuses, qui peut ensuite être placé en autoclave etincinéré.

4.

L’élimination doit être réalisée dans un incinérateur adapté ou par autoclavage (stérilisation à la vapeur).

81

FR
1RUPHVHWGLUHFWLYHVVSÜFLıTXHVDXSURGXLWGDQVOHXUYHUVLRQHQYLJXHXU
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
:+2',//$%5ÜYbŘ:25/'+($/7+25*$1,=$7,21HWDO8VHRIDQWLFRDJXODQWVLQGLDJQRVWLFODERUDWRU\LQYHVWLJDWLRQV*HQHYD:RUOG+HDOWK2UJDQL]DWLRQŘ

1RUPHUHODWLYHDX[UÜFLSLHQWVGHVWLQÜVDXSUÜOÛYHPHQWGHVDQJYHLQHX[b',1(1,62b5ÜFLSLHQWVÇXVDJHXQLTXHSRXUOHSUÜOÛYHPHQWGHVDQJYHLQHX[KXPDLQ*CLSI (Clinical and Laboratory Standards Institute)&OÜVGHV\PEROHHWGŖLGHQWLıFDWLRQb

Référence

Valable en outre pour les produits sous emballage individuel stérile

Désignation du lot

Ne pas utiliser si l’emballage est endommagé

Utilisable jusqu’auSystème de barrière stérile simple avec emballage de protection extérieur

Marque CE

Stérilisation par irradiation

Diagnostic in vitro

Respecter le mode d’emploi(QFDVGHUÜXWLOLVDWLRQb5LVTXHGHFRQWDPLQDWLRQConserver à l’abri du soleil

Stocker dans un endroit sec

FabricantPays de fabrication

9RLHGHĲXLGHVWÜULOH

Ne pas restériliser

Sous réserve de modifications techniques.
Tous les incidents sérieux liés au produit doivent être notifiés au fabricant et à l’autorité nationale compétente.

82Uputa za upotrebu – SARSTEDT S-Monovette® – sustav za prikupljanje krvi

HR

Za in vitroGLMDJQRVWLÕNXXSRUDEX
1DPMHQD
Sustav za uzorkovanje krvi S-Monovette®, igle i adapter koriste se zajedno kao sustav za uzorkovanje venske krvi. Sustavi za prikupljanje krvi S-Monovette®VOXĭH]DX]RUNRYDQMHWUDQVSRUWREUDGXLVNODGLđWHQMHX]RUDND
krvi za in vitroGLMDJQRVWLÕNHSUHWUDJHVHUXPDSOD]PHLOLSXQHNUYLXNOLQLÕNRPODERUDWRULMX3URL]YRGMHQDPLMHQMHQPHGLFLQVNRPVWUXÕQRPRVREOMXLODERUDWRULMVNRPRVREOMX]DSULPMHQXXSURIHVLRQDOQRPRNUXĭHQMX

Opis proizvoda
Sustavi za uzorkovanje krvi S-Monovette®VDVWRMHVHRGSODVWLÕQHHSUXYHWHNOLSDGUđNDNOLSDLQDYRMQRJSODVWLÕQRJÕHSDNRGLUDQRJERMRPVXJUDÙHQRPPHPEUDQRPNRMLMHSRVHEQRSULODJRÙHQ]DSULNOMXÕDNQD
S-Monovette® (Safety) Iglu ili (Safety) Multifly® Iglu, kao i od raznih aditiva (preparacija). S-Monovette®GRVWXSQHVXWDNRÙHULEH]DGLWLYD6XVWDYL]DX]RUNRYDQMHNUYL60RQRYHWWH® s aktivatorom koagulacije, aktivatorom
koagulacije s gelom, litij-heparinom, litij-heparin s gelom, natrij-heparinom, citratom, EDTA, fluoridom i EDTA, fluoridom i heparinom, fluoridom i citratom ili CPDA, kao i oni bez aditiva, koncentracijom aditiva, volumenomWHNXÓLKDGLWLYDLQMLKRYLPGRSXđWHQLPRGVWXSDQMLPDNDRLRPMHURPNUYLLDGLWLYDLVSXQMDYDMX]DKWMHYHLSUHSRUXNHPHÙXQDURGQHQRUPH',1(1,62Ś6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŗL
RGREUHQHQRUPH&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, 2GDELUDGLWLYDRYLVLRDQDOLWLÕNRMPHWRGLLVSLWLYDQMDNRMXRGUHÙXMXSURL]YRÙDÕWHVWDLLOLXUHÙDMD]DDQDOL]XNRMLPVHWHVWL]YRGL
Sustav za uzorkovanje krvi S-Monovette®GRVWXSDQMHXL]YHGEDPDVDVWHULOQRPXQXWUDđQMRđÓXLOLXSRMHGLQDÕQLPSDNLUDQMLPDVWHULOQLPL]QXWUDLL]YDQD

=QDÕHQMDERMDQDYRMQLKÕHSRYDHSUXYHWD60RQRYHWWH®*:

Aditiv

Oznaka%RMDÕHSDSUHPDQRUPLDIN EN ISO 6710

%RMDÕHSDSUHPDQRUPL%6
4851+

Z

bijelabijelaEpruveta bez preparacije
S-Monovette® Neutral Z
Epruveta s aktivatorom koagulacije
S-Monovette® Serum CAT, s aktivatorom koagulacijeCAT

crvenabijelaS-Monovette® Serum-Gel CAT, s aktivatorom koagulacije i gelom

CAT

WDPQRĭXWDWDPQRĭXWD

S-Monovette® Serum Express Gel CAT s aktivatorom koagulacije trombinom i gelom

CAT

QDUDQÕDVWD

-Epruveta s heparinom
S-Monovette® Litij-Heparin LH, s litij-heparinom

LHzelenaQDUDQÕDVWD

S-Monovette®/LWLM+HSDULQ/+VWHNXÓLPOLWLMKHSDULQRP

LH

zelenaQDUDQÕDVWD

S-Monovette® Litij-Heparin Gel LH, s litij-heparinom i gelom

LHzelenaQDUDQÕDVWD

S-Monovette® Litij-Heparin Gel+ LH, s litij-heparinom i gelom za brzo centrifugiranje

LHzelenaQDUDQÕDVWD

S-Monovette® Natrij-Heparin NH, s natrij-heparinom

NH

VPHÙD

zelenaS-Monovette® Amonij-Heparin AH, s amonijevim heparinom

n.d.

plava

plava

9NC

plava

zelena9NC

svijetloplava-

S-Monovette® K3 EDTA K3E, s kalijevim EDTA

K3E

OMXELÕDVWD

crvenaS-Monovette® K2 EDTA K2E, s kalijevim EDTAK2E

OMXELÕDVWD

crvenaS-Monovette® K2 EDTA Gel K2E, s kalijevim EDTA i gelom

K2E

OMXELÕDVWD

crvenaEpruveta s citratom
S-Monovette® Citrat 9NC, s natrijevim citratom, 3,13 %®

S-Monovette PFA, Citrat 9NC, s natrijevim citratom, 3,8 %, puferirano
Epruveta s EDTA-om

Epruveta s inhibitorima glikolize
S-Monovette®)OXRULG('7$)(VĲXRULGRPL('7$

FE

siva

ĭXWD

S-Monovette®)OXRULG+HSDULQ)+VĲXRULGRPLKHSDULQRP

FH

siva

ĭXWD

S-Monovette®*OXFR(;$&7)&VĲXRULGRPFLWUDWRPL('7$RPFCUXĭLÕDVWD

siva

LH

tamnoplava

QDUDQÕDVWD

S-Monovette® ThromboExact, s magnezijevim spojem

n.d.

n.d., boja kupine

n.d., boja kupine

S-Monovette® CTADn.d.

n.d., plava

n.d., zelena

S-Monovette® ACD

ACD

ĭXWD

ĭXWD

S-Monovette® CPDA

CPDA

ĭXWD

ĭXWD

S-Monovette® Hirudinn.d.

n.d., maslinasto zelenan.d., maslinasto zelena

Epruveta za analizu metala
S-Monovette® Za analizu metala LH, s litij-heparinom

Druge epruvete za punu krv i plazmu

S-Monovette® Homocistein-Gel HCY-Z, s gelom i stabilizatorom homocisteinan.d.

n.d., siva

n.d., siva

S-Monovette® Homocistein HCY-C s citratnim puferomn.d.

QGOMXELÕDVWD

QGOMXELÕDVWD

S-Monovette® DNA Exactn.d.

n.d., plava

n.d., plava

GRVWXSQLVXLQDYRMQLÕHSRYLXGUXJLPERMDPD
n.d.: nije definirano+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistrySRYXÕHQDQRUPD

83

HR
SARSTEDT S-Monovette® Serum CAT/Serum-Gel CAT
S-Monovette®6HUXP&$7VDGUĭLSODVWLÕQLJUDQXODWREORĭHQDNWLYDWRURPNRDJXODFLMH VLOLNDWRP DVOXĭL]DGRELYDQMHVHUXPD &HQWULIXJLUDQMHPVHSODVWLÕQLJUDQXODWUDVSRUHÙXMHL]PHÙXNUYQRJXJUXđNDLVHUXPD
S-Monovette®6HUXP*HO&$7X]SODVWLÕQLJUDQXODWREORĭHQDNWLYDWRURPNRDJXODFLMH VLOLNDWRP VDGUĭLLJHOQDRVQRYLSROLPHUDDVOXĭL]DGRELYDQMHVHUXPD .DRUH]XOWDWFHQWULIXJLUDQMDJHOVHUDVSRUHÙXMHL]PHÙXNUYQRJ
ugruška i seruma i stvara stabilan sloj razdvajanja prilikom transporta, skladištenja i analize.
6HUXPVHXSRWUHEOMDYDNDRX]RUNRYDQLPDWHULMDOXNOLQLÕNLPNHPLMVNLPSUHWUDJDPDNDRLXVHURORJLML
Nakon uzorkovanja krvi ostavite da se krv zgruša u epruveti S-Monovette®6HUXP&$76HUXP*HO&$7PLQXWDXXVSUDYQRPSRORĭDMXNDNRELVHRVLJXUDRMDVDQYRGRUDYQLUD]GYDMDMXÓLVORMQDNRQFHQWULIXJLUDQMD3UHSRUXÕHQRYULMHPHWHPHOMLVHQDLQWDNWQRPSURFHVX]JUXđDYDQMD=DSRWSXQR]JUXđDYDQMHNUYLSDFLMHQDWDVSRUHPHÓDMLPD]JUXđDYDQMDXYMHWRYDQLPDEROHđÓXLOLSDFLMHQDWDNRMLX]LPDMXDQWLNRDJXODQWQXWHUDSLMXPRĭHELWL
potrebno više vremen.

SARSTEDT S-Monovette® Serum Express Gel CAT
S-Monovette®6HUXP([SUHVV*HO&$7X]SODVWLÕQLJUDQXODWREORĭHQDNWLYDWRURPNRDJXODFLMH WURPELQ VDGUĭLLJHOQDRVQRYLSROLPHUDDVOXĭL]DGRELYDQMHVHUXPD .DRUH]XOWDWFHQWULIXJLUDQMDJHOVHUDVSRUHÙXMHL]PHÙX
krvnog ugruška i seruma i stvara stabilan sloj razdvajanja prilikom transporta, skladištenja i analize.
Nakon uzimanja krvi ostavite da se krv zgruša u S-Monovette®6HUXP([SUHVV*HOPLQXWDXXVSUDYQRPSRORĭDMXNDNRELVHRVLJXUDRMDVDQYRGRUDYQLUD]GYDMDMXÓLVORMQDNRQFHQWULIXJLUDQMD3UHSRUXÕHQRYULMHPHWHPHOML
VHQDLQWDNWQRPSURFHVX]JUXđDYDQMDÕDNLNDGMHULMHÕRNUYLKHSDULQL]LUDQLKSDFLMHQDWD.UYLSDFLMHQDWDVSRUHPHÓDMLPD]JUXđDYDQMDXYMHWRYDQLPDEROHđÓXLOLSDFLMHQDWDNRMLX]LPDMXDQWLNRDJXODQWQXWHUDSLMXXNOMXÕXMXÓL
visoke doze heparina treba više vremena za potpuno koaguliranje.
6HUXPVHXSRWUHEOMDYDNDRX]RUNRYDQLPDWHULMDOXNOLQLÕNLPNHPLMVNLPSUHWUDJDPDNDRLXVHURORJLMLSARSTEDT S-Monovette® Neutral Z
Epruveta S-Monovette®1HXWUDO=QHVDGUĭLDGLWLYHđWRRGJRYDUDSULURGQRP]JUXđDYDQMXX]RUNDNUYLEH]DNWLYDWRUDNRDJXODFLMHDVOXĭL]DGRELYDQMHVHUXPD &HQWULIXJLUDQMHPVHSRVWLĭHRGYDMDQMHXJUXđNDLVHUXPD
6HUXPVHXSRWUHEOMDYDNDRX]RUNRYDQLPDWHULMDO]DSUHWUDJHVSHFLILÕQH]DNRULVQLND
7DNRÙHU60RQRYHWWH®1HXWUDO=PRĭHVHNRULVWLWLNDRSUD]QDHSUXYHWDQDVOMHGHÓLQDÕLQDNRVHYDÙHQMHNUYL]DSRÕLQMHNRPELQDFLMRP60RQRYHWWH® Citrat i (Safety) Multifly®,JOH LJOHVOHSWLULÓHP 60RQRYHWWH® Neutral ZVOXĭLNDRSUYDHSUXYHWD SUD]QDHSUXYHWD ]DSXQMHQMHFMHYÕLFH 6DIHW\ 0XOWLIO\® Igle.

SARSTEDT S-Monovette®/LWLM+HSDULQ/+/LWLM+HSDULQ*HO/+/LWLM+HSDULQ*HO+/+1DWULM+HSDULQ1+$PRQLM+HSDULQ$+S-Monovette®/LWLM+HSDULQ/+1DWULM+HSDULQ1+$PRQLM+HSDULQ$+VDGUĭLSODVWLÕQLJUDQXODWREORĭHQLQKLELWRURPNRDJXODFLMH DQWLNRDJXODQVRP OLWLMKHSDULQQDWULMKHSDULQDPRQLMKHSDULQ RELÕQR,-KHSDULQDPONUYL DVOXĭL]DGRELYDQMHSXQHNUYLLSOD]PH &HQWULIXJLUDQMHPVHSODVWLÕQLJUDQXODWUDVSRUHÙXMHL]PHÙXNUYQLKVWDQLFDLVHUXPDZa S-Monovette®/LWLM+HSDULQ/+EH]SODVWLÕQRJJUDQXODWDVDGUĭLDQWLNRDJXODQVOLWLMKHSDULQQDQHVHQXREOLNXVSUHMD RELÕQR,-KHSDULQDPONUYL 
S-Monovette®/LWLM+HSDULQ*HO/+X]SODVWLÕQLJUDQXODWREORĭHQDNWLYDWRURPNRDJXODFLMH/LWLM+HSDULQ RELÕQR,-KHSDULQDPONUYL VDGUĭLLSROLPHUQLJHODVOXĭL]DGRELYDQMHSOD]PH .DRUH]XOWDWFHQWULIXJLUDQMDJHOVHUDVSRUHÙXMHL]PHÙXNUYQLKVWDQLFDLVHUXPDLVWYDUDVWDELODQVORMUD]GYDMDQMDSULOLNRPWUDQVSRUWDVNODGLđWHQMDLDQDOL]HS-Monovette® Litij-Heparin Gel+/+WDNRÙHUVDGUĭHSROLPHUQLJHONRMLRPRJXÓDYDNUDÓHWUDMDQMHFHQWULIXJLUDQMHXXVSRUHGELVDVWDQGDUGQRP60RQRYHWWH® Litij-Heparin Gel.
+HSDULQSOD]PDXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDOXNOLQLÕNLPNHPLMVNLPLLPXQRORđNLPSUHWUDJDPD+HSDULQSXQDNUYXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDOXLPXQRORđNLPSUHWUDJDPDNDRLXVHURORJLML,QKLELFLMDNRDJXODFLMHSRVWLĭHVHDNWLYLUDQMHPDQWLWURPELQD
NAPOMENA: Iz epruveta S-Monovette® Litij-Heparin LH, Litij-Heparin Gel / Gel+/+QHVPLMHVHRGUHÙLYDWLOLWLML]HSUXYHWD60RQRYHWWH®1DWULM+HSDULQ1+QHVPLMHVHRGUHÙLYDWLQDWULMDL]HSUXYHWD
S-Monovette®$PRQLM+HSDULQ$+QHVPLMHVHRGUHÙLYDWLDPRQLMDN9HQVNDNUYX]RUNRYDQDSRPRÓX60RQRYHWWH® Litij-Heparin/Lithium-Heparin-Gel/Gel+ / Natrij-Heparin / Amonij-Heparin nije prikladnaza analizu plinova u krvi.

SARSTEDT S-Monovette® Za analizu metala
S-Monovette®=DDQDOL]XPHWDODVDGUĭLDQWLNRDJXODQVOLWLMKHSDULQLVOXĭL]DGRELYDQMHSXQHNUYLLSOD]PH /LWLMKHSDULQQDQHVHQMHXREOLNXVSUHMD RELÕQR,-KHSDULQDPONUYL +HSDULQSXQDNUYRGQRVQRKHSDULQSOD]PDX]RUNRYDQDSRPRÓX60RQRYHWWH® Za analizu metala u kombinaciji s posebnom Safety Iglom 21G x 1 ½“ (br. art. 85.1162.600) upotrebljava se kao uzorkovani materijal za
pretrage elemenata u tragovima / metala. Elementi u tragovima / metali validiraju se atomskom apsorpcijskom spektrometrijom (AAS). Za sustav Safety Igla i S-Monovette®=DDQDOL]XPHWDODYULMHGHVOMHGHÓHPDNVLPDOQHSR]DGLQVNHYULMHGQRVWLL]UDĭHQHMHGLQLFRPQJVXVWDY]DVLMHGHÓHHOHPHQWHXWUDJRYLPD

Kemijski element

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/sustav

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

Maksimalne pozadinske vrijednosti navedene su za svaki element na naljepnici S-Monovette®.
2YLVQRRDQDOLWLÕNRPSRVWXSNXHOHPHQWLXWUDJRYLPDRGUHÙXMXVHL]KHSDULQSXQHNUYLLOLKHSDULQSOD]PH,QKLELFLMDNRDJXODFLMHSRVWLĭHVHDNWLYLUDQMHPDQWLWURPELQDSARSTEDT S-Monovette® Citrat 9NC
S-Monovette®&LWUDW1&VDGUĭLDQWLNRDJXODQVWULQDWULMFLWUDWLVOXĭL]DGRELYDQMHSXQHNUYLLSOD]PH 7ULQDWULMFLWUDWGRVWXSDQMHNDRPRODUQDRWRSLQD RWRSLQHWULQDWULMFLWUDWDÕHVWR]DRNUXĭHQRQD LÕLQL
10 % nazivnog volumena epruvete S-Monovette® Citrat. Omjer mješavine citrata i krvi iznosi 1 : 9, odnosno 1 volumni dio citrata i 9 volumnih dijelova krvi. Za analizu obavezno je potrebno ispravno punjenje.
Citrat-plazma upotrebljava se kao uzorkovani materijal u pretragama za hemostazu.
Citrat inhibira koagulaciju kompleksiranjem iona kalcija.
Pogledajte NAPOMENE pod Uzorkovanje i rukovanje za kombiniranu uporabu S-Monovette®&LWUDWLLJOHVOHSWLULÓHP

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&VDGUĭLDQWLNRDJXODQVWULQDWULMFLWUDWLVOXĭL]DGRELYDQMHSXQHNUYLLSOD]PH 7ULQDWULMFLWUDWGRVWXSDQMHNDRPRODUQDSXIHULUDQDRWRSLQD SXIHULUDQDS+ LÕLQLQD]LYQRJYROXPHQD
epruvete S-Monovette® PFA. Omjer mješavine citrata i krvi iznosi 1 : 9, odnosno 1 volumni dio citrata i 9 volumnih dijelova krvi. Za analizu obavezno je potrebno ispravno punjenje.
Puna krv epruvete S-Monovette®3)$1&XSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DRGUHÙLYDQMHIXQNFLMHWURPERFLWDDQDOL]DWRURP6,(0(16+HDOWKLQHHUV$QDOL]DWRU3)$L]DWDMSRVWXSDNMHYDOLGLUDQD
Citrat inhibira koagulaciju kompleksiranjem iona kalcija.
Pogledajte NAPOMENE pod Uzorkovanje i rukovanje za kombiniranu uporabu epruvete S-Monovette®3)$LLJOHVOHSWLULÓHP

SARSTEDT S-Monovette® CTAD
S-Monovette®&7$'VDGUĭLDQWLNRDJXODQVWULQDWULMFLWUDWNDRLWHRILOLQDGHQR]LQLGLSLULGDPRODVOXĭL]DGRELYDQMHSXQHNUYLLSOD]PH &7$'MHGRVWXSDQNDRRWRSLQDLÕLQLQD]LYQRJYROXPHQDHSUXYHWH60RQRYHWWH®
CTAD. Omjer mješavine CTAD i krvi iznosi 1 : 9, odnosno 1 volumni dio CTDA i 9 volumnih dijelova krvi. Za analizu obavezno je potrebno ispravno punjenje.
CTAD-plazma upotrebljava se kao uzorkovani materijal za trombocitni faktor 4 (PF4), beta (ß) globulin (ßTG) i inhibitor aktivatora plazminogena (PAI-1), kao i za dijagnostiku hemostaze.
$NWLYDFLMDWURPERFLWDLQKLELUDQDMHQDMPDQMHVDWDLVOXĭL]DQDG]RUKHSDULQVNHWHUDSLMH
Citrat inhibira koagulaciju kompleksiranjem iona kalcija.
Pogledajte NAPOMENE pod Uzorkovanje i rukovanje za kombiniranu uporabu epruvete S-Monovette®&7$'LLJOHVOHSWLULÓHP
1$320(1$&7$'MHĭXW(SUXYHWX60RQRYHWWH®&7$'SRWUHEQRMHÕXYDWLGDOMHRGL]YRUDXPMHWQHLOLSULURGQHVYMHWORVWLSULOLNRPVNODGLđWHQMD,]ORĭHQRVWMDNRMVYMHWORVWLGXOMHRGVDWLPRĭHL]D]YDWLinaktiviranje aditiva.

SARSTEDT S-Monovette® EDTA K2E / K3E
S-Monovette® EDTA K2E / S-Monovette®('7$.(VDGUĭLDQWLNRDJXODQV.('7$RGQRVQR.('7$LVOXĭL]DGRELYDQMHSXQHNUYL .('7$RGQRVQR.('7$QDQHVHQLVXXREOLNXVSUHMD PJ('7$PONUYL 
3XQDNUYV('7$XSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DKHPDWRORđNHSUHWUDJH.UYQHUD]PD]HSRWUHEQRMHXÕLQLWLXURNXRGÕHWLULVDWDRGX]LPDQMDX]RUNDNUYLEDTA inhibira koagulaciju kompleksiranjem iona kalcija.
Krv iz epruvete S-Monovette®('7$.(.(PRĭHVHXSRWUHEOMDYDWL]DLPXQRKHPDWRORđNHSUHWUDJHLWHVWRYHQD]DUD]QHEROHVWL2GJRYRUQRVWMHNRULVQLNDYDOLGLUDWLSULNODGQRVWX]RUNRYDQRJPDWHULMDOD]DRYHSUHWUDJHVRGJRYDUDMXÓLPUHDJHQVLPDDQDOL]DWRULPDXNOMXÕXMXÓLXYMHWHVNODGLđWHQMD

84

HRSARSTEDT S-Monovette® EDTA Gel K2E
S-Monovette®('7$*HO.(X]DQWLNRDJXODQV.('7$VDGUĭLLSROLPHUQLJHODVOXĭL]DGRELYDQMHSOD]PH .('7$QDQHVHQMHXREOLNXVSUHMD PJ('7$PONUYL .DRUH]XOWDWFHQWULIXJLUDQMDJHOVHUDVSRUHÙXMHL]PHÙXNUYQLKVWDQLFDLVHUXPDLVWYDUDVWDELODQVORMUD]GYDMDQMDSULOLNRPWUDQVSRUWDVNODGLđWHQMDLDQDOL]HEDTA-plazma upotrebljava se za molekularnu virusnu dijagnostiku.
('7$VSUHÕDYDNRDJXODFLMXNRPSOHNVLUDQMHPLRQDNDOFLMD

SARSTEDT S-Monovette® Fluorid EDTA FE / Fluorid-Heparin FH / Fluorid-Citrat EDTA FC s inhibitorima glikolize
S-Monovette®)OXRULG('7$)(VDGUĭLDQWLNRDJXODQV('7$ PJPONUYL NDRLIOXRULG PJPONUYL ]DLQKLELUDQMHJOLNROL]HDVOXĭL]DGRELYDQMHSOD]PH )OXRULG('7$QDQHVHQMHXREOLNXVSUHMDS-Monovette®)OXRULG+HSDULQ)+VDGUĭLDQWLNRDJXODQVKHSDULQ ,-KHSDULQDPONUYL NDRLIOXRULG PJPONUYL ]DLQKLELUDQMHJOLNROL]HDVOXĭL]DGRELYDQMHSOD]PH )OXRULGKHSDULQQDQHVHQMHXREOLNXVSUHMD,QKLELUDQMHJOLNROL]HVDPRIOXRULGRP]DSRÕLQMHRNRVDWDQDNRQX]RUNRYDQMDNUYLLLVND]XMHVYRMHSXQRGMHORYDQMHQDNRQRWSULOLNHVDWD8SURVMHNXVHQDWDMQDÕLQXSXQRMNUYLUD]JUDGLGRJOXNR]HQDNRQQHNROLNRVDWL
i do 10 % – 15 % nakon 24 sata.
S-Monovette®*OXFR(;$&7)&VDGUĭLDQWLNRDJXODQV('7$NDRLFLWUDWLIOXRULG]DWUHQXWDÕQRLQKLELUDQMHJOLNROL]HDVOXĭL]DGRELYDQMHSOD]PH('7$FLWUDWLIOXRULGQDOD]HVHXREOLNXRWRSLQH=ERJUD]ULMHÙHQMD]DL]UDÕXQkoncentracije glukoze potrebna je multiplikacija s 1,16.
S-Monovette®*OXFR(;$&7)&]DGRYROMDYDVPMHUQLFHRJHVWDFLMVNRPGLMDEHWHVX1MHPDÕNRJGLMDEHWRORđNRJGUXđWYD ''* LQMHPDÕNH1DFLRQDOQHVPMHUQLFH 19/ ]DGLMDEHWHVWLS7UHQXWDÕQDVWDELOQRVWNRQFHQWUDFLMHJOXNR]HXSXQRMNUYL]DMDPÕHQDMHGRVDWLQDVREQRMWHPSHUDWXUL3RJOHGDMWHWDNRÙHU6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt
S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
)OXRULG('7$ FLWUDW SOD]PDXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DRGUHÙLYDQMHJOXNR]H
('7$VSUHÕDYDNRDJXODFLMXNRPSOHNVLUDQMHPLRQDNDOFLMD
1$320(1$)OXRULGPRĭHSRYHÓDWLKHPROL]X'DOMQMHLQIRUPDFLMHRWYDULPDLQMLKRYLPQHJDWLYQLPXÕLQFLPDGRVWXSQHVXXXSXWDPD]DXSRUDEXSURL]YRÙDÕDSUHGPHWQRJUHDJHQVD
Pogledajte NAPOMENE pod Uzorkovanje i rukovanje za kombiniranu uporabu epruvete S-Monovette®*OXFR(;$&7LLJOHVOHSWLULÓHP

SARSTEDT S-Monovette® CPDA
S-Monovette®&3'$VDGUĭLDQWLNRDJXODQVQDWULMHYFLWUDWNDRLOLPXQVNXNLVHOLQXQDWULMHYIRVIDWGHNVWUR]XLDGHQLQDVOXĭL]DGRELYDQMHSXQHNUYLLSOD]PH &3'$QDOD]LVHXREOLNXRWRSLQH2PMHUPMHđDYLQH&3'$LNUYL
iznosi 1 : 6, odnosno 1 volumni dio CPDA i 6 volumnih dijelova krvi. Za analizu obavezno je potrebno ispravno punjenje.
&3'$SXQDNUYSOD]PDXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DVHURORJLMXNUYQLKJUXSDXWUDQVIX]LMVNRMPHGLFLQLL]DLVSLWLYDQMHSRGQRđOMLYRVWL NULĭQHUHDNFLMH NRGWUDQVIX]LMHNUYL60RQRYHWWH® CPDA prikladna je zaRGUHÙLYDQMHNUYQHJUXSH $% XNOMXÕXMXÓL.HOOL5KVXVWDYNUYQLKJUXSDWHVWLUHJXODUQDSURWXWLMHODQDNUYQHJUXSHSROLVSHFLILÕQLGLUHNWQL&RRPEVRYWHVW GRGDQD WHVWSRGQRđOMLYRVWL NULĭQHUHDNFLMH VSDFLMHQWRYLP
serumom/plazmom kompatibilnima s krvnim grupama („Major Test“).
7UDMDQMHWUDQVSRUWDGRVNODGLđWHQMDYDOLGLUDQRMHQDPDNVLPDOQRVDWDSULWHPSHUDWXULRGƓ&şƓ&=DRGUHÙLYDQMHVHGLPHQWDFLMHVWDQLFDX]RUFLSUHWKRGQRPRUDMXELWLXVNODGLđWHQLXKODGQMDNXXXVSUDYQRPSRORĭDMX
QDMPDQMHVDWL*RUHQDYHGHQLDQDOLWLPRJXVHRGUHGLWLGRGDQDDQDORJQRXRELÕDMHQRPWUDMDQMXNRQ]HUYLUDQHNUYLQDNRQVNODGLđWHQMDXKODGQMDNX Ɠ&şƓ&  L]X]HWDNMHGDQD]DGLUHNWQL&RRPEVRYWHVW 
3ULNODGQR]DSRVWXSDNDJOXWLQDFLMHXVWXSFXQSUQDXUHÙDMX9LVLRQ0D[SURL]YRÙDÕD2UWKR&OLQLFDO'LDJQRVWLFV8]RUNRYDQLPDWHULMDOQHVPLMHVH]DPU]DYDWL3ULNODGQRVWX]RUNRYDQRJPDWHULMDOD]DRYHSUHWUDJHGUXJLPPHWRGDPDUHDJHQVLPDDQDOL]DWRULPDXNOMXÕXMXÓLXYMHWHVNODGLđWHQMDRGJRYRUQRVWMHNRULVQLNDLRQLKPRUDVDPYDOLGLUDWL
Citrat inhibira koagulaciju kompleksiranjem iona kalcija.
Pogledajte NAPOMENE pod Uzorkovanje i rukovanje za kombiniranu uporabu epruvete S-Monovette®&3'$LLJOHVOHSWLULÓHP

SARSTEDT S-Monovette® ThromboExact
S-Monovette®7KURPER([DFWVDGUĭLNDRDQWLNRDJXODQVPDJQH]LMHYXVRODVOXĭL]DGRELYDQMHSXQHNUYL 0DJQH]LMHYDVROQDQHVHQDMHXREOLNXVSUHMD
3XQDNUYX]RUNRYDQDSRPRÓX60RQRYHWWH®7KURPER([DFWXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DLVNOMXÕLYDQMHODĭQRVQLĭHQRJEURMDWURPERFLWD]ERJDQWLNRDJXODFLMVNHQHSRGQRđOMLYRVWL ('7$FLWUDWKHSDULQ 
SR]QDWRJLNDRSVHXGRWURPERFLWRSHQLMD6SULMHÕDYDVHVWYDUDQMHQDNXSLQDWURPERFLWDLRPRJXÓDYDRGUHÙLYDQMHVWYDUQRJEURMDWURPERFLWDGRVDWLQDNRQX]LPDQMDX]RUNDNUYL.RDJXODFLMXLQKLELUDMXLRQLPDJQH]LMDQDQDÕLQGDLQKLELUDMXWURPERFLWQLWURPERNVDQ$NDRLDJUHJLUDQMHWURPERFLWDSRVUHGRYDQR$'3RPLDUDKLGRQVNRPNLVHOLQRPSARSTEDT S-Monovette® Hirudin
S-Monovette®KLUXGLQVDGUĭLDQWLNRDJXODQVKLUXGLQLVOXĭL]DGRELYDQMHSXQHNUYL +LUXGLQMHQDQHVHQXREOLNXVSUHMD+LUXGLQSXQDNUYXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DXWYUÙLYDQMHIXQNFLMHWURPERFLWDQDXUHÙDMX0XOWLSODWH® DQDOL]DWRUXYLđHVWUXNLKIXQNFLMDWURPERFLWD SURL]YRÙDÕD52&+('LDJQRVWLFVL]DWDMMHSRVWXSDNYDOLGLUDQ8SRWUHEOMDYDVH]DSUDÓHQMHOLMHÕHQMDDQWLNRDJXODQWQLPOLMHNRYLPDNDRL]DGHWHNWLUDQMHLOLLVNOMXÕLYDQMHGLVIXQNFLMHWURPERFLWD
Epruveta S-Monovette®KLUXGLQUD]YLMHQDMH]DXWYUÙLYDQMHIXQNFLMHWURPERFLWDXVXUDGQMLVWYUWNRP9HUXP'LDJQRVWLFDGDQDVWYUWND5RFKH'LDJQRVWLFVQDXUHÙDMX0XOWLSODWH®.
+LUXGLQGMHOXMHNDRLQKLELWRUNRDJXODFLMHL]UDYQLPLQKLELUDQMHPWURPELQDLWLPHRPRJXÓXMHGLMDJQRVWLNXIXQNFLMHWURPERFLWDXQDWLYQRPVWDQMXSARSTEDT S-Monovette® Homocistein Gel HCY-Z / HCY-C
S-Monovette®+RPRFLVWHLQ+&<=*HOX]SODVWLÕQLJUDQXODWREORĭHQDNWLYDWRURPNRDJXODFLMH VLOLNDWRP VDGUĭLSRVHEDQVWDELOL]DWRUNDRLJHOQDRVQRYLSROLPHUDDVOXĭL]DGRELYDQMHVHUXPD .DRUH]XOWDWFHQWULIXJLUDQMD
JHOVHUDVSRUHÙXMHL]PHÙXNUYQRJXJUXđNDLVHUXPDLVWYDUDVWDELODQVORMUD]GYDMDQMDSULOLNRPWUDQVSRUWDVNODGLđWHQMDLDQDOL]H3ULSUDYDNMHQDQHVHQXREOLNXVSUHMD+RPRFLVWHLQVHXSXQRMNUYLSULVREQRMWHPSHUDWXULVWDELOL]LUDQDGRVDWL$NRVHFHQWULIXJLUDQMHREDYLXQXWDUSUYLKVDWLX]SUDYLOQRIRUPLUDQUD]GMHOQLVORML]PHÙXNUYQRJXJUXđNDLVHUXPDKRPRFLVWHLQMHVWDELODQGRsati.
6HUXPX]RUNRYDQSRPRÓX60RQRYHWWH®+RPRFLVWHLQ+&<=*HOXSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DRGUHÙLYDQMHKRPRFLVWHLQD60RQRYHWWH®+RPRFLVWHLQ+&<&VDGUĭLNDRDQWLNRDJXODQVNLVHOLFLWUDW S+ 
DVOXĭL]DGRELYDQMHSOD]PH &LWUDWVHQDOD]LXREOLNXRWRSLQH,]UDÕXQNRQFHQWUDFLMHKRPRFLVWHLQDGRELMHVH]ERJUD]UMHÙLYDQMDPXOWLSOLNDFLMRPV
Homocistein je u punoj krvi pri sobnoj temperaturi stabilan do 6 sati, a pri temperaturi od 4 °C do 48 sati.
3OD]PDX]RUNRYDQDSRPRÓX60RQRYHWWH®+RPRFLVWHLQ+&<&XSRWUHEOMDYDVHNDRX]RUNRYDQLPDWHULMDO]DRGUHÙLYDQMHKRPRFLVWHLQD
Citrat inhibira koagulaciju u epruveti S-Monovette® homocistein HCY-C kompleksiranjem iona kalcija.
Pogledajte NAPOMENE pod Uzorkovanje i rukovanje za kombiniranu uporabu epruvete S-Monovette®+&<&LLJOHVOHSWLULÓHP

SARSTEDT S-Monovette® DNA Exact
S-Monovette®'1$([DFWVDGUĭLDQWLNRDJXODQVQDRVQRYL('7$DVOXĭL]DGRELYDQMHSXQHNUYL ('7$MHQDQHVHQXREOLNXVSUHMD.DRX]RUNRYDQLPDWHULMDO]DVWDELOL]LUDQMHJ'1$XSRWUHEOMDYDVHSXQDNUYV('7$9DOLGLUDQLXÕLQDNVWDELOL]DFLMHJ'1$YL]QRVLGDQDQDƓ&GDQDQDVREQRMWHPSHUDWXUL Ɠ& GDQDX]KODÙHQMH Ɠ& LQDMPDQMHJRGLQXQDƓ&8]WRVWDELOL]LUDQLX]RUFLSRGQRVHSHWFLNOXVDVPU]DYDQMDLRGPU]DYDQMDEH]JXELWNDNYDOLWHWH3RJOHGDMWHWDNRÙHU6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venousblood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
('7$VSUHÕDYDNRDJXODFLMXNRPSOHNVLUDQMHPLRQDNDOFLMD

3ULNODGQRVWX]RUNRYDQRJPDWHULMDODRYLVLRDQDOLWXLUHDJHQVXDQDOL]DWRUX3RWUHEQRMHSULGUĭDYDWLVHRGJRYDUDMXÓLKSUHSRUXNDSURL]YRÙDÕD85

HR
Sigurnosne upute / upozorenja
1.

2SÓHPMHUHRSUH]D8SRWUHEOMDYDMWHUXNDYLFHLGUXJXXRELÕDMHQXRVREQX]DđWLWQXRSUHPXNDNRELVWHVH]DđWLWLOLRGNUYLLL]ORĭHQRVWLSRWHQFLMDOQR]DUD]QRPX]RUNRYDQRPPDWHULMDOXLSUHQRVLYLPSDWRJHQLPD

2.

5XNXMWHVYLPELRORđNLPX]RUFLPDLRđWULPđLOMDVWLPSULERURP]DYDÙHQMHNUYL LJODPDDGDSWHULPD XVNODGXVDVPMHUQLFDPDLSRVWXSFLPDYDđHXVWDQRYH8VOXÕDMXL]UDYQRJGRGLUDVELRORđNLPX]RUFLPDLOLR]OMHGHLJORPSRWUDĭLWHOLMHÕQLÕNXSRPRÓMHUPRĭHGRÓLGRSULMHQRVDYLUXVD+,9D+&9D+%9DLOLGUXJLK]DUD]QLKEROHVWL8SRWUHEOMDYDMWHLJOH6DIHW\6DIHW\0XOWLĲ\®VXJUDÙHQLPđWLWQLNRP]DLJOX2EDYH]QRVHSULGUĭDYDMWH
sigurnosnih smjernica i postupaka vaše ustanove.

3.

9ULMHGL]DSRMHGLQDÕQRSDNLUDQHVWHULOQHSURL]YRGH3ULMHXSRUDEHSURYMHULWHMHVXOLSRMHGLQDÕQDSDNLUDQMDRđWHÓHQDLXWRPVOXÕDMXLKQHPRMWHXSRWUHEOMDYDWL

4.

2YDMMHSURL]YRGQDPLMHQMHQ]DMHGQRNUDWQXXSRUDEX2GORĭLWHVYHRđWUHđLOMDVWHSUHGPHWH LJOHDGDSWHUH ]DYDÙHQMHNUYLXSULNODGQHVSUHPQLNH]DRGODJDQMHELRORđNLRSDVQRJRWSDGD

5.

$NRVHNUYX]LPDSXWHPLQWUDYHQVNRJ ,9 SULVWXSDSULMHYDÙHQMDNUYLPRUDVHRVLJXUDWLGDVHSULVWXSSUDYLOQRLVSHUH RÕLVWLRG,9RWRSLQH XVNODGXVDVPMHUQLFDPDXVWDQRYH,VSUDYQLPLVSLUDQMHPSULVWXSDVSUHÕDYDMXVHQHWRÕQLUH]XOWDWLDQDOL]H6.

Nedovoljno punjenje S-Monovette®GRYRGLGRSRJUHđQRJRPMHUDNUYLXRGQRVXQDSUHSDUDFLMXDGLWLYLPRĭHSURX]URÕLWLQHWRÕQHUH]XOWDWHDQDOL]H7.

.UYX]HWDLREUDÙHQDSRPRÓX60RQRYHWWH® nije namijenjena ponovnom ubrizgavanju u ljudsko tijelo.

8.

1DNRQLVWHNDURNDWUDMDQMDSURL]YRGVHYLđHQHVPLMHXSRWULMHELWL5RNWUDMDQMDSURL]YRGDLVWMHÕH]DGQMHJGDQDQDYHGHQRJPMHVHFDLJRGLQH

6NODGLđWHQMH
Proizvod do uporabe treba skladištiti na sobnoj temperaturi.

2JUDQLÕHQMD
1.

Trajanje i temperatura skladištenja S-Monovette® s uzorkom krvi ovise o trajnosti analita koji se ispituju. Stabilnost analita treba procijeniti laboratorij ili informaciju o tome treba preuzeti iz uputa za uporabu
SURL]YRÙDÕDUHDJHQVDDQDOL]DWRUD

2.

qDNLDNRVHSOD]PDLOLVHUXPL]GYRMHFHQWULIXJLUDQMHPX60RQRYHWWH®LLOLMHVWYRUHQDEDULMHUDQLVXVYHVWDQLFHQXĭQRSRWSXQRRGYRMHQH0HWDEROL]DP]DRVWDOLKWYDULLOLSULURGQDUD]JUDGQMDPRJXXWMHFDWLQD
NRQFHQWUDFLMHDQDOLWD6WDELOQRVWDQDOLWDWUHEDSURFLMHQLWLXRGQRVXQDVSUHPQLN]DVNODGLđWHQMHLXYMHWHRGJRYDUDMXÓHJODERUDWRULMD

3.

8VOXÕDMXSULPMHQHWHUDSLMVNLKOLMHNRYDSULNODGQRVWX]RUNRYDQRJPDWHULMDODPRUDVHSURYMHULWLXXSXWDPD]DXSRUDEXSURL]YRÙDÕDUHDJHQVDDQDOL]DWRUD

4.

Analize elemenata u tragovima / metala treba obaviti sustavom S-Monovette®=DDQDOL]XPHWDODL 6DIHW\ 0XOWLĲ\® Iglom za analizu metala.

8]RUNRYDQMHLUXNRYDQMH
35,-(32q(7.$8=25.29$1-$9(16.(.59,8&,-(/267,352q,7$-7(29$-'2.80(17Materijal potreban za uzimanje uzoraka
1.

Sve potrebne S-Monovette®.

2.

6DIHW\ ,JOHLOL 6DIHW\ 0XOWLĲ\® Igle.

3.

5XNDYLFHRJUWDÕ]DđWLWD]DRÕLLOLGUXJDSULNODGQD]DđWLWQDRGMHÓD]D]DđWLWXRGSDWRJHQDNRMLVHSUHQRVHNUYOMXLOLSRWHQFLMDOQRLQIHNWLYQRJPDWHULMDOD

4.

1DOMHSQLFH]DLGHQWLıNDFLMXSDFLMHQDWD

5.

'H]LQIHNFLMVNDVUHGVWYD]DÕLđÓHQMHPMHVWDYDÙHQMDNUYL SULOLNRPSULSUHPHPMHVWDX]RUNRYDQMDVOLMHGLWHVPMHUQLFHXVWDQRYH]DVWHULOQRX]RUNRYDQMH 1HPRMWHXSRWUHEOMDYDWLVUHGVWYD]DÕLđÓHQMHQDED]LDONRKRODDNR
uzorkovanje provodite zbog mjerenja razine alkohola u krvi.

6.

6XKLDVHSWLÕQLMHGQRNUDWQLMDVWXÕLÓL

7.

Poveska.

8.

Flaster ili zavoj.

9.

Spremnik za odlaganje oštrih/šiljastih predmeta za sigurno zbrinjavanje iskorištenih materijala.

3UHSRUXÕHQLUHGRVOLMHGX]RUNRYDQMD
1.

%RÕLFH]DNUYQXNXOWXUX

2.

Epruvete s citratom ili aktivatorom koagulacije (s gelom CAT / bez gel seruma CAT / serum gel CAT)

3.

Epruvete s aktivatorom koagulacije ili citratom

4.

Epruvete s heparinom s gelom / bez gela

5.

Epruvete s EDTA s gelom / bez gela

6.

Epruvete s inhibitorima glikolize

7.

Epruvete s ostalim aditivima
1$320(1$$NRVH]DSRÕQHVX]RUNRYDQMHPHSUXYHWRPVFLWUDWRPLOLQHNRPGUXJRPHSUXYHWRPVWHNXÓLPSULSUDYNRPNDRđWRMH3)$&7$'&3'$+&<&LOL*OXFR(;$&7XNRPELQDFLMLVLJORPVOHSWLULÓHP QSU 6DIHW\ 0XOWLĲ\®LJORP SUHSRUXÕXMHVHSUHWKRGQRX]RUNRYDQMHSUD]QRPHSUXYHWRP QSU60RQRYHWWH®1HXWUDO= NDNRELVHVSULMHÕLORQHGRVWDWQR
SXQMHQMHHSUXYHWH]ERJSXQMHQMDFMHYÕLFHLJOHVOHSWLULÓHP
7LPHVHRVLJXUDYDSUDYLOQRSXQMHQMHHSUXYHWHWHXMHGQRLLVSUDYDQRPMHUPMHđDYLQH FLWUDWNUY 

1$320(1$=DUHGRVOLMHGX]RUNRYDQMDVOLMHGLWHVPMHUQLFHYDđHXVWDQRYH

Izbjegavajte povratni tok
9HÓLQDHSUXYHWD60RQRYHWWH®VDGUĭHNHPLMVNHDGLWLYH5DGLVSUHÕDYDQMDSRYUDWQRJWRNDSULGUĭDYDMWHVHVOMHGHÓLKQDSXWDND
1. 8SRWUHEOMDYDMWHLVNOMXÕLYRPDWHULMDOHSUHSRUXÕHQHXXSXWDPD]DXSRUDEX
2.

3DFLMHQWDSRVWDYLWHXSRORĭDMXNRMHPMHYHQDODNRGRVWXSQDDUXNXLOLGUXJRPMHVWRXERGDXVPMHULWHSUHPDGROMH

3.

'UĭLWHHSUXYHWX60RQRYHWWH®VQDYRMQLPÕHSRPRNUHQXWLPSUHPDJRUHDXVOXÕDMXNRULđWHQMD 6DIHW\ ,JOH 6DIHW\ 0XOWLĲ\® Igle dodatno i ispod razine ruke/mjesta uboda.

4.

0RUDWHRVLJXUDWLGDVDGUĭDMHSUXYHWH60RQRYHWWH®SULOLNRPYHQHSXQNFLMHQHGRGLUXMHQDYRMQLÕHSQLWLNUDMLJOH

5.

Otpustite povesku dok se epruveta S-Monovette® puni krvlju.

86

HR
Zamrzavanje/odmrzavanje
8VNODGXVSUHSRUXNDPD6=2 :+2',//DE5HY SUHSRUXÕXMHVHRGYDMDQMHVHUXPDSOD]PHRGNUYQLKVWDQLFDSULMH]DPU]DYDQMD
Za S-Monovette®YULMHGHVOMHGHÓHSUHSRUXNH]D]DPU]DYDQMH
Zamrzavanje ispod 0 °C•

8SRUDEDXWHPSHUDWXUQRPSRGUXÕMXLVSRGQXOHPRUDVHXSUDYLOXWHVWLUDWLXVWYDUQLPXYMHWLPDMHURSWHUHÓHQMHSRVXGDPRĭHXYHOLNHYDULUDWLRYLVQRRPHGLMXNRMLVHVPU]DYDLRVWDOLPXYMHWLPD 3RJOHGDMWHSRJODYOMH
Svojstva materijala u katalogu SARSTEDT).

•

8SUDYLOXVHÕYUVWRÓDSODVWLÕQLKPDWHULMDODVPDQMXMHXWHPSHUDWXUQRPSRGUXÕMXLVSRGƓ&0HKDQLÕNDRSWHUHÓHQMDVWRJDRSÓHQLWRWUHEDL]EMHJDYDWL

•

8YMHWL]DPU]DYDQMDPRUDMXVHRGDEUDWLWDNRGDVHVDGUĭDMHSUXYHWH60RQRYHWWH® zamrzava ravnomjerno, odnosno odozdo prema gore. Epruveta S-Monovette® mora imati dovoljno prostora na stalku ili u kutiji za
SRKUDQXNDNRELVHPRJODđLULWL6WDOFLRGVWLURSRUDLOLPHWDODQHSULNODGQLVXMHUPRJXSURX]URÕLWLSXFDQMHHSUXYHWH]ERJđLUHQMD

Zamrzavanje pri -20 °C – Prije zamrzavanja provjerite:•

6PHWQMH3URYMHULWHLPDOL]DPU]DYDQMHQHJDWLYQHXÕLQNHQDX]RUDNNUYLLOLDQDOL]X QSUKHPROL]XVWDELOQRVWDQDOLWD •

Centrifugiranje: potrebno je ovisno o planiranoj analizi. Za uvjete centrifugiranja pogledajte odjeljak „Centrifugiranje“ u ovom dokumentu ili web-stranici SARSTEDT https://www.sarstedt.com/en/service/centrifugation/, a obavite i vizualne provjere uzoraka.

•

Hemoliza: Puna krv hemolizira prilikom zamrzavanja: Kako bi se to izbjeglo, potrebno je upotrijebiti ili epruvetu S-Monovette® Gel, ili nakon centrifugiranja postaviti Seraplas® Filter s ventilom ili uzorak treba pipetirati u
sekundarni spremnik.

Zamrzavanje pri -20 °C – Postupak:•

5DVKODÙLYDQMH60RQRYHWWH®XXVSUDYQRPSRORĭDMXWLMHNRPşPLQXWDUDVKODGLWHVDVREQHWHPSHUDWXUHQDƓ&SULMHQHJRđWRVHRQDPRĭHVWDYLWLQD]DPU]DYDQMHQDƓ&

•2GPU]DYDQMH2GPU]DYDMWHXXVSUDYQRPSRORĭDMXQDVREQRMWHPSHUDWXULQDMPDQMHPLQ,RYGMHWUHEDL]EMHJDYDWLPHKDQLÕNDRSWHUHÓHQMD3UHEU]RRGPU]DYDQMHPRĭHQHJDWLYQRXWMHFDWLQDUH]XOWDWHDQDOL]HZamrzavanje i duboko zamrzavanje ispod -20 °C•

3URL]YRÙDÕQLMHLVSLWLYDR]DPU]DYDQMHQDWHPSHUDWXUHLVSRGƓ&=ERJYHOLNRJEURMDPRJXÓLKXWMHFDMDSUHSRUXÕXMHVHSURYRÙHQMHWHVWRYD]DPU]DYDQMDXUXWLQVNLPODERUDWRULMVNLPXYMHWLPD

Zamrzavanje epruveta S-Monovette® Gel:•

=DPU]DYDQMHVHREDYOMDNDRđWRMHRSLVDQRSRGWRÕNRP=DPU]DYDQMHQDƓ&ş3RVWXSDN

•3R]QDWRMHGDQDVORMXJHODPRĭHGRÓLGRSURPMHQDXYMHWRYDQLKSURFHVRP]DPU]DYDQMD

•=ERJYHOLNRJEURMDPRJXÓLKXWMHFDMDSUHSRUXÕXMHVHSURYRÙHQMHWHVWRYD]DPU]DYDQMDXUXWLQVNLPODERUDWRULMVNLPXYMHWLPD

•Odmrzavanje:2GPU]DYDMWHX]RUDNXXVSUDYQRPSRORĭDMX1DNRQRGPU]DYDQMDSUHQHVLWHPDWHULMDOX]RUNDL]SULPDUQRJVSUHPQLNDXVHNXQGDUQLVSUHPQLNSLSHWLUDQMHP QHGHNDQWLUDQMHP GRSULEOLĭQRPPL]QDG
sloja gela. Ostatak odbacite.
1$320(1$=DVWDELOQRVWDQDOLWDSRJOHGDMWHXSXWH]DXSRUDEXSURL]YRÙDÕDWHVWDXUHÙDMD]DDQDOL]X87

HR
Uzorkovanje krvi
7HKQLNHX]RUNRYDQMDNUYLPostoje dvije tehnike uzorkovanja krvi: aspiracijska tehnika i vakuumska tehnika.
$VSLUDFLMVNDWHKQLNDNRQWUROLUDQLPSRYODÕHQMHPNOLSDRPRJXÓXMHYDÙHQMHNUYLX]NRQWLQXLUDQLSRODJDQLSURWRNNUYL7DNRVHSURWRNNUYLPRĭHQHSRVUHGQRSULODJRGLWLVWDQMXYHQDLVYLPRVWDOLPRNROQRVWLPDWHVHPRĭH
smanjiti hemoliza.
9DNXXPVNDWHKQLNDSRPRÓXSUHWKRGQRHYDNXLUDQHHSUXYHWHRPRJXÓXMHX]LPDQMHNUYLSRPRÓXSRGWODNDX]NRQWLQXLUDQLEU]LSURWRN6WRJDMHWDWHKQLNDSRJRGQD]DYHQHNRMHVXXGREURPVWDQMXL]DMHGQRVWDYQH
RNROQRVWLYDÙHQMDNUYLPostupak uzorkovanja krvi: pogledajte i videozapis o rukovanju epruvetom S-Monovette® kod aspiracijske ili vakuumske tehnike sa Safety Iglom ili Safety-Multifly® Iglom:www.sarstedt.com/en/download/videos/Diagnostics/Venous blood.$.2%,67(35,/,.208=25.29$1-$.59,5,=,.,1)(.&,-(69(/,1$1$-0$1-802*8o80-(58126,7(58.$9,&(1. 2GDEHULWHRGJRYDUDMXÓX60RQRYHWWH® za potreban uzorak.
2.

Odaberite mjesto za venepunkciju. Za pripremu mjesta za venepunkciju slijedite smjernice ustanove.

Uzorkovanje krvi aspiracijskom tehnikom
Pozor! Upotrebljavajte S-Monovette®LVNOMXÕLYR]DX]RUNRYDQMHNUYLDQHL]DLQMHNFLMH
Upotrebljavajte samo sa S-Monovette® (Safety) Iglama ili (Safety) Multifly® Iglama ili Adapterom za S-Monovette®).
Prikaz primjene sa Safety Iglom:

klik

Neposredno prije venepunkcije, umetnite S-Monovette®XXJUDÙHQLGUĭDÕ6DIHW\,JOH LXÕYUVWLWHlaganim okretanjem u smjeru kretanja kazaljke na satu .
Prema potrebi postavite povesku (maks. 1 minutu). Dezinficirajte mjesto uboda prikladnim dezinficijensom. Više ne dodirujte mjesto venepunkcije nakon dezinficiranja. Pacijenta postavite uSRORĭDMXNRMHPMHYHQDODNRGRVWXSQDDUXNXLOLGUXJRPMHVWRXERGDXVPMHULWHSUHPDGROMH
8NORQLWHđWLWQLN]DLJOX8ERGLWHYHQXSRODNRL]YXFLWHNOLSLRODEDYLWHSRYHVNXGRNNUYWHÕHX60RQRYHWWH® .
3ULÕHNDMWHGRNVHWRNNUYLQH]DXVWDYLNDNRELVWHRPRJXÓLOLSUDYLOQRSXQMHQMH

S-Monovette® otpustite laganim zakretanjem u smjeru suprotnom od kretanja kazaljke na satu , a zatim ju izvucite iz Safety Igle (odspojite) . Safety Igla ostaje u veni.
8VOXÕDMXYLđHVWUXNRJX]RUNRYDQMDNDRđWRMHRSLVDQRVYHVOMHGHÓH60RQRYHWWHVSDMDMXVHX6DIHW\,JOXLGDOMHVHSULNXSOMDMXX]RUFL
Završetak uzorkovanja krvi: Prvo odvojite S-Monovette®
+ D]DWLPL]YXFLWH6DIHW\,JOXL]YHQHªWLWQLNLJOHDNWLYLUDVHQDVWDELOQRMUDYQRMSRYUđLQLWDNRGDLJODGRVMHGQHXđWLWQLNLJOHX]SULPMHWQLLÕXMQL„klik"
LOLSULWLVNRPNDĭLSUVWRPQDGRQMLGLRđWLWQLNDLJOH3RJOHGDMWHLXSXWH]DXSRUDEX]D60RQRYHWWH® (Safety) Iglu ili (Safety) Multifly® Iglu.
Svaku S-Monovette® odmah nakon odspajanja od Safety Igle promiješajte preokretanjem 1 x, a po potpunom završetku uzorkovanja krvi sve uzorke s antikoagulansima oprezno više puta promiješajte
preokretanjem!
=DWUDQVSRUWLFHQWULIXJLUDQMHSRYXFLWHNOLSXSRORĭDM]DNOMXÕDYDQMDNOLSD (klip dosjeda u dno epruvete S-Monovette®) i odlomite GUĭDNNOLSD
1.

3ULWLVQLWHPMHVWRXERGDVXKLPDVHSWLÕQLPMDVWXÕLÓHPGRNNUYDUHQMHQHSUHVWDQH

2.

qLPVHNUY]JUXđDSRSRWUHELVWDYLWH]DYRM

3.

6DIHW\,JOX]EULQLWHXRGJRYDUDMXÓLVSUHPQLN]DRGODJDQMHELRORđNLRSDVQRJRWSDGD

88

HR
Uzorkovanje krvi vakuumskom tehnikom
Pozor! Upotrebljavajte S-Monovette®LVNOMXÕLYR]DX]RUNRYDQMHNUYLDQHL]DLQMHNFLMH
Upotrebljavajte samo sa S-Monovette® (Safety) Iglama ili (Safety) Multifly® Iglama ili Adapterom za S-Monovette®).
Ovdje je prikazana primjena s Safety Iglom:klik=DđWREROMLXÕLQDNSURL]YRÙDÕ6$567('7SUHSRUXÕXMHX]RUNRYDQMHSUYRP60RQRYHWWH® aspiracijskom tehnikom, pogledajte TEHNIKA VENEPUNKCIJE Aspiracijska tehnika
Zatim nastavite s vakuumskom tehnikom.
3ULMHYDÙHQMDNUYLSRYXFLWHNOLSGRGQD60RQRYHWWH®GRNÕXMQRGRVMHGQHXSRORĭDM]D]DNOMXÕDYDQMHNOLSD =DWLPRGORPLWHGUĭDNNOLSD .
Ovako pripremljenu epruvetu S-Monovette®XPHWQLWHXXJUDÙHQLGUĭDÕ60RQRYHWWH® Safety Igle i osigurajte laganim okretanjem u smjeru kretanja kazaljke na satu

+

–

.

.

3ULÕHNDMWHGRNVHWRNNUYLQH]DXVWDYLNDNRELVWHRPRJXÓLOLSUDYLOQRSXQMHQMH

S-Monovette® otpustite laganim zakretanjem u smjeru suprotnom od kretanja kazaljke na satu , a zatim ju izvucite iz Safety Igle (odspojite) . Safety Igla ostaje u veni.
8VOXÕDMXYLđHVWUXNRJX]RUNRYDQMDNDRđWRMHJRUHRSLVDQRVYHVOMHGHÓH60RQRYHWWHVSDMDMXVHX6DIHW\,JOXLGDOMHVHSULNXSOMDMXX]RUFL
=DYUđHWDNYDÙHQMDNUYL
Odspojite S-Monovette® + D]DWLPL]YXFLWH6DIHW\,JOXL]YHQHªWLWQLNLJOHDNWLYLUDVHQDVWDELOQRMUDYQRMSRYUđLQLWDNRGDLJODGRVMHGQHXđWLWQLNLJOHX]SULPMHWQLLÕXMQL„klik"LOLSULWLVNRPNDĭLSUVWRPQDGRQML
dio štitnika igle.
Svaku S-Monovette®RGPDKQDNRQRGVSDMDQMDRG6DIHW\,JOHSURPLMHđDMWHSUHRNUHWDQMHP[DSRSRWSXQRP]DYUđHWNXYDÙHQMDNUYLVYHX]RUNHVDQWLNRDJXODQVLPDRSUH]QRYLđHSXWDSURPLMHđDMWH
preokretanjem!
1.

3ULWLVQLWHPMHVWRXERGDVXKLPDVHSWLÕQLPMDVWXÕLÓHPVYHGRNNUYDUHQMHQHSUHVWDQH

2.

qLPVHNUY]JUXđDSRSRWUHELVWDYLWH]DYRM

3.

6DIHW\,JOX]EULQLWHXRGJRYDUDMXÓLVSUHPQLN]DRGODJDQMHELRORđNLRSDVQRJRWSDGD

89

HRCentrifugiranje
POZOR! SARSTEDT S-Monovette®SUHGYLÙHQHVX]D[J,]X]HWDNVX60RQRYHWWH® promjera 8 mm (S-Monovette®3HGLDWULF NRMHVXWUHQXWDÕQRYDOLGLUDQHGR[J6PLMXVHXSRWUHEOMDYDWLVDPRSULNODGQLVWDOFL
LOLXPHWFL&HQWULIXJLUDQMHXRđWHÓHQLP60RQRYHWWH®LOLFHQWULIXJLUDQMHSULSUHYLVRNRPFHQWULIXJDOQRPXEU]DQMXPRĭHL]D]YDWLORP60RQRYHWWH®X]SRWHQFLMDOQRRVOREDÙDQMHRSDVQLKWYDUL
2GMHOMNHXPHWNHFHQWULIXJHWUHEDRGDEUDWLXVNODGXVYHOLÕLQRPXSRWULMHEOMHQLK60RQRYHWWH®5HODWLYQDFHQWULIXJDOQDVLODXVOMHGHÓHPMHRGQRVXSUHPDSRVWDYOMHQLPRNUHWDMLPDPLQ
RCF = 11,2 x r x (o/min/1000)2„RCF“: engl.: relativna centrifugalna sila, RCF „relative centrifugal force”, naziva se i g-silom„o/min“: „okretaji u minuti“ (o/min), ili: n = „broj okretaja u minuti“ (engl.: RPM „revolutions per minute“),„r“: „polumjer vrtnje od središta centrifuge do dna epruvete S-Monovette®“, (cm).
S-Monovette®EH]JHODPRJXVHFHQWULIXJLUDWLXFHQWULIXJDPDVURWRULPDVXWRULPDSRGILNVQLPNXWRPLOLQMLđXÓLPURWRULPD
S-Monovette®VJHORPSUHGYLÙHQHVXLVNOMXÕLYR]DFHQWULIXJHVQMLđXÓLPURWRULPD&HQWULIXJLUDQMHXFHQWULIXJDPDVURWRULPDVXWRULPDSRGILNVQLPNXWRPQLMHYDOLGLUDRSURL]YRÙDÕ6$567('7LRQRVHQHSUHSRUXÕXMH
S-Monovette® treba centrifugirati u skladu s dolje navedenim uvjetima centrifugiranja. Ako se primjenjuju drugi uvjeti, korisnik ih mora sam validirati.
3RWUHEQRMHYRGLWLUDÕXQDRWRPHGDVX60RQRYHWWH® pravilno postavljene u odjeljke centrifuge. S-Monovette®NRMHYLUHL]RGMHOMNDQRVDÕDPRJX]DKYDWLWLJODYXFHQWULIXJHLVORPLWLVH&HQWULIXJDVHPRUDSXQLWL
ravnomjerno. Pogledajte upute za uporabu centrifuge.
OPREZ! Slomljene S-Monovette® nemojte uklanjati rukama.
8SXWH ]D GH]LQIHNFLMX FHQWULIXJH QDÓL ÓHWH X XSXWDPD ]D XSRUDEX FHQWULIXJHPrema BS
4851+ (EUCode)Relativna centrifugalna sila (g)S-Monovette®

DIN EN ISO 6710–

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*Serum

10 min10 min

6 min

4 min

4 min

Serum gel15 min10 min

4 min

4 min

4 min

Serum Express Gel

15 min10 min4 min

n.v. (nije validirano)n.v. (nije validirano)

Litij-heparin

10 min10 min

7 min

7 min

7 min

Litij-heparin gel

15 min15 min10 min

7 min

7 min

Litij-heparin gel+

8 min

7 min

5 min

4 min

4 min

n.v. (nije validirano)n.v. (nije validirano)

7 min

6 min

5 min

EDTA gel15 min10 min10 min

7 min

7 min

Citrat

9 min

8 min

7 min

6 min

5 min

('7$ĲXRULGKHSDULQ

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Citrat PBM 1,8 ml
Polumjer centrifuge > 17 cm

9 min

8 min

7 min

6 min

5 min

n.v. (nije validirano)n.v. (nije validirano)

10 minn.v. (nije validirano)n.v. (nije validirano)

EDTA

Citrat PBM 1,8 ml
3ROXPMHUFHQWULIXJH!GRƉFPn.v. = nije validirano*Vrijedi za sve S-Monovette®, s izuzetkom onih promjera 8 mm (pedijatrijske
S-Monovette®)

Centrifugiranje pri temperaturi od 20 °C+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry,QRUPDSRYXÕHQD,QIRUPDFLMHRPDWHULMDOX]DUD]GYDMDQMH
Viskoznost materijala za odvajanje (gela) ovisi o temperaturi. Ako se S-Monovette®KODGHSULMHLOL]DYULMHPHFHQWULIXJLUDQMDNRQWLQXLUDQRVWVORMDJHOD]DRGYDMDQMHYLđHQLMH]DMDPÕHQD
S-Monovette® ne smiju se ponovno centrifugirati/recentrifugirati.

Zbrinjavanje u otpad
1.

3RWUHEQRMHYSULGUĭDYDWLVHRSÓLKKLJLMHQVNLKVPMHUQLFDL]DNRQVNLKRGUHGELRSUDYLOQRP]EULQMDYDQMX]DUD]QRJPDWHULMDOD

2.

Jednokratne rukavice smanjuju rizik od infekcije.

3.

.RQWDPLQLUDQLLOLNRULđWHQLVXVWDYL]DSULNXSOMDQMHNUYLPRUDMXVHRGORĭLWLXRGJRYDUDMXÓHVSUHPQLNH]DRGODJDQMHELRORđNLRSDVQRJRWSDGDNRMLVHSRWRPPRĭHDXWRNODYLUDWLLOLVSDOLWL

4.

Zbrinjavanje se mora obaviti u prikladnoj spalionici ili postupkom autoklaviranja (sterilizacije parom).

90

HR
1RUPHLGLUHNWLYHVSHFLıÕQH]DSURL]YRGXDNWXDOQRMYHU]LMLCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

1RUPH]DVSUHPQLNH]DX]RUNRYDQMHYHQVNHNUYLDIN EN ISO 6710: Spremnici za jednokratnu uporabu za uzorkovanje venske krvi u ljudi*CLSI (Clinical and Laboratory Standards Institute)Objašnjenja simbola i oznaka:

Broj artikla'RGDWQRYULMHGL]DSRMHGLQDÕQRSDNLUDQHVWHULOQHSURL]YRGH

Broj serije

1HXSRWUHEOMDYDMWHDNRMHSDNLUDQMHRđWHÓHQR

Upotrijebiti do

Sustav jednostruke sterilne barijere s vanjskim zaštitnim pakiranjem

Oznaka CE

6WHULOL]LUDQR]UDÕHQMHP

In vitroGLMDJQRVWLÕNLSURL]YRG

Pogledati upute za uporabu

Kod ponovne uporabe: rizik od kontaminacije

qXYDWL]DđWLÓHQRRGVXQÕHYHVYMHWORVWL

qXYDWLQDVXKRPPMHVWX

3URL]YRÙDÕ

Zemlja proizvodnje

6WHULOQLSXWWHNXÓLQH

Ne ponovno sterilizirati

3UDYRQDWHKQLÕNHL]PMHQHSULGUĭDQR
6YHR]ELOMQHLQFLGHQWHVRYLPSURL]YRGRPWUHEDSULMDYLWLSURL]YRÙDÕXLQDGOHĭQRMQDFLRQDOQRMXVWDQRYL

91

+DV]QÈODWLXWDVìWÈVş6$567('760RQRYHWWH® vérvételi rendszer

HU

In vitro diagnosztikai használatra$IHOKDV]QÈOÈVFÜOMDAz S-Monovette® vérvételi rendszereket, kanülöket és adaptereket együtt rendszerként a vénás vérvételhez használják. Az S-Monovette® vérvételi rendszer vérminták vételére, szállítására, feldolgozására és tárolásáraV]ROJÈONOLQLNDLODERUDWĂULXPEDQV]ÜUXPEĂOSOD]PÈEĂOYDJ\WHOMHVYÜUEĈOWąUWÜQĈin vitroGLDJQRV]WLNDLPHJKDWÈUR]ÈVRNKR]$WHUPÜNHWSURIHVV]LRQÈOLVNąUQ\H]HWEHQHJÜV]VÜJĞJ\LNÜS]HWWVÜJJHOUHQGHONH]ĈV]DNHPEHUHNés laboratóriumi szakdolgozók használhatják.

Termékleírás
Az S-Monovette®YÜUYÜWHOLUHQGV]HUHJ\PĢDQ\DJHGÜQ\EĈOHJ\GXJDWW\ěEĂOHJ\GXJDWW\ěUěGEĂOÜVHJ\EHÜSìWHWWPHPEUÈQRVV]ìQNĂGGDOHOOÈWRWWPĢDQ\DJFVDYDURVNXSDNEĂOÈOODPHO\HWVSHFLÈOLVDQHJ\
S-Monovette® (biztonsági) kanül vagy (biztonsági) Multifly®NDQĞOFVDWODNR]WDWÈVÈKR]IHMOHV]WHWWHNNLYDODPLQWNĞOąQEą]ĈDGDOÜNDQ\DJRN SUHSDUÈWXPRN WDUWR]QDNPÜJKR]]È$]60RQRYHWWH® adalékanyag nélkül
is kapható. Az S-Monovette® vérvételi rendszerek koagulációs aktivátor, géles koagulációs aktivátor, lítium-heparin, géles lítium-heparin, nátrium-heparin, citrát, EDTA, fluoridos EDTA, fluorid-heparin, fluorid-citrát,&3'$DGDOÜNDQ\DJRNNDOYDODPLQWDGDOÜNDQ\DJRNQÜONĞOD]RNDGDOÜNDQ\DJNRQFHQWUÈFLĂLDIRO\ÜNRQ\DGDOÜNDQ\DJRNPHQQ\LVÜJHD]RNPHJHQJHGHWWWĢUÜVKDWÈUDLYDODPLQWDYÜUQHND]DGDOÜNDQ\DJKR]YDOĂDUÈQ\Dmegfelelnek a DIN EN ISO 6710 „Single-use containers for venous blood specimen collection“ és a Clinical and Laboratory Standards Institute (CLSI) jóváhagyott szabványainak. Az adalékanyag kiválasztása az elemzési
WHV]WPĂGV]HUWĈOIĞJJ$]DGDOÜNRNDWDWHV]WUHDJHQVHNÜVYDJ\D]RQHOHP]ĈNÜV]ĞOÜNHNJ\ÈUWĂMDDGMDPHJDPHO\HQDWHV]WHWHOYÜJ]LN$]60RQRYHWWH® vérvételi rendszer belül steril vagy egyenként csomagolt belül és
kívül steril kivitelben kapható.

Az S-Monovette®FVąYHNFVDYDURVNXSDNMDLQDNV]ìQNĂGMDL

Adalékanyag%HWĢNĂG

Kupak színe DIN EN ISO
6710

Kupak színe a BS 4851+
szerint

Z

fehér

fehér

&VĈSUHSDUÈWXPQÜONĞO
S-Monovette® Neutral Z6]ÜUXPFVĈS-Monovette® szérum CAT, koagulációs aktivátorral

CAT

piros

fehér

S-Monovette® szérum-gél CAT, koagulációs aktivátorral és géllel

CAT

sötétsárga

sötétsárga

S-Monovette® szérum Express gél CAT, koagulációs aktivátorral, thrombinnal és géllel

CAT

narancssárga-

S-Monovette® lítium-heparin LH, lítium-heparinnal

LH

zöld

narancssárga

S-Monovette® lítium-heparin, folyékony LH, lítium-heparinnal

LH

zöld

narancssárga

S-Monovette® lítium-heparin gél LH, lítium-heparinnal és géllel

LH

zöld

narancssárga+HSDULQFVĈS-Monovette® lítium-heparin gél+ LH, lítium-heparinnal és gyorsgéllel

LH

zöld

narancssárga

S-Monovette® nátrium-heparin NH, nátrium-heparinnal

NH

barna

zöld

S-Monovette® ammónium-heparin AH, ammónium-heparinnal

n.d.

kék

kék

S-Monovette® citrát 9NC, nátrium-citrát 3,13%

9NC

kék

zöld

S-Monovette 3)$FLWUÈW1&QÈWULXPFLWUÈWSXĳHUROW

9NC

világoskék-

S-Monovette® K3 EDTA K3E, kálium EDTA-val

K3E

lila

piros

S-Monovette® K2 EDTA K2E, kálium EDTA-val

K2E

lila

piros

S-Monovette® K2 EDTA-gél K2E, kálium EDTA-val és géllel

K2E

lila

piros

S-Monovette®ĲXRULG('7$)(ĲXRULGGDOÜV('7$YDO

FE

szürkesárga

S-Monovette®ĲXRULGKHSDULQ)+ĲXRULGGDOÜVKHSDULQQDO

FH

-

sárga

S-Monovette®*OXFR(;$&7)&ĲXRULGGDOFLWUÈWWDOÜV('7$YDO

FC

rózsaszín

szürkeLH

sötétkéknarancssárga

S-Monovette® ThromboExact, magnézium kötéssel

n.d.

QGV]HGHUV]ìQĢ

QGV]HGHUV]ìQĢ

S-Monovette® CTADn.d.

n.d., kékn.d., zöld

S-Monovette® ACD

ACD

sárga

sárga

S-Monovette® CPDA

CPDA

sárga

sárga

S-Monovette® Hirudinn.d.

n.d., olajzöld

n.d., olajzöld

S-Monovette® homocisztein HCY-Z gél, géllel és stabilizátorraln.d.

n.d., szürken.d., szürke

S-Monovette®KRPRFLV]WHLQ+&<&FLWUÈWSXĳHUUHO

n.d.

n.d., lila

n.d., lila

S-Monovette® DNA Exactn.d.

n.d., kékn.d., kék&LWUÈWFVĈ

®

('7$FVĈ

&VĈJOLNROì]LVJÈWOĂV]HUUHO&VĈIÜPDQDOLWLNÈKR]S-Monovette® fémanalitika LH, lítium-heparinnal

7RYÈEELWHOMHVYÜUÜVSOD]PDFVąYHN

* További csavaros kupak színek is kaphatók
n.d.: nem definiált+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, visszavonva.

92

HU
SARSTEDT S-Monovette® szérum CAT, szérum-gél CAT
Az S-Monovette®V]ÜUXP&$7FVĈNRDJXOÈFLĂVDNWLYÈWRUUDO V]LOLNÈW EHYRQWPĢDQ\DJJUDQXOÈWXPRWWDUWDOPD]ÜVV]ÜUXPNLQ\HUÜVÜUH V]ROJÈO$PĢDQ\DJJUDQXOÈWXPDFHQWULIXJÈOÈVKDWÈVÈUDYÜUOHSÜQ\UHÜVV]ÜUXPUD
választ szét.
Az S-Monovette®V]ÜUXPJÜO&$7FVĈDNRDJXOÈFLĂVDNWLYÈWRUUDO V]LOLNÈW EHYRQWPĢDQ\DJJUDQXOÈWXPPHOOHWWSROLPHUDODSěJÜOWLVWDUWDOPD]ÜVV]ÜUXPNLQ\HUÜVÜUH V]ROJÈO$JÜODFHQWULIXJÈOÈVKDWÈVÈUDYÜUOHSÜQ\UHÜV
szérumra választ szét, és stabil elválasztó réteget képez a szállítás, tárolás és elemzés közben.
A szérumot klinikai-kémiai és immunológiai rutinvizsgálatokban, valamint a szerológiában mintaanyagként használják.
Vérvétel után az S-Monovette®V]ÜUXP&$7V]ÜUXPJÜO&$7FVąYHWPÈVRGSHUFLJIĞJJĈOHJHVKHO\]HWEHQKDJ\QLNHOOPHJDOYDGQLKRJ\DFHQWULIXJÈOÈVXWÈQPHJIHOHOĈYì]V]LQWHVHOYÈODV]WĂUÜWHJHWEL]WRVìWVRQ$]
DMÈQORWWLGĈLQWDNWDOYDGÈVLIRO\DPDWRQDODSXO%HWHJVÜJWĈOIĞJJĈYÜUDOYDGÈVL]DYDURNEDQV]HQYHGĈYDJ\YÜUDOYDGÈVWJÈWOĂWHUÈSLÈNDODWWÈOOĂEHWHJHNYÜUHHVHWÜQDGRWWHVHWEHQWąEELGĈV]ĞNVÜJHVDWHOMHVYÜUDOYDGÈVKR]

SARSTEDT S-Monovette® szérum Express gél CAT
Az S-Monovette®V]ÜUXP([SUHVVJÜO&$7FVĈDNRDJXOÈFLĂVDNWLYÈWRUUDO WKURPELQ EHYRQWPĢDQ\DJJUDQXOÈWXPPHOOHWWSROLPHUDODSěJÜOWLVWDUWDOPD]ÜVV]ÜUXPNLQ\HUÜVÜUH V]ROJÈO$JÜODFHQWULIXJÈOÈVKDWÈVÈUD
vérlepényre és szérumra választ szét, és stabil elválasztó réteget képez a szállítás, tárolás és elemzés közben.
Vérvétel után az S-Monovette®V]ÜUXP([SUHVVJÜOFVąYHWSHUFLJIĞJJĈOHJHVKHO\]HWEHQKDJ\QLNHOOPHJDOYDGQLKRJ\DFHQWULIXJÈOÈVXWÈQPHJIHOHOĈYì]V]LQWHVHOYÈODV]WĂUÜWHJHWEL]WRVìWVRQ$]DMÈQORWWLGĈLQWDNWDOYDGÈVLIRO\DPDWRQDODSXODKHSDULQQDONH]HOWEHWHJHNYÜUHHVHWÜQLV%HWHJVÜJWĈOIĞJJĈYÜUDOYDGÈVL]DYDURNEDQV]HQYHGĈYDJ\YÜUDOYDGÈVWJÈWOĂWHUÈSLÈNDODWWÈOOĂEHWHJHNYÜUHHVHWÜQEHOHÜUWYHDQDJ\GĂ]LVEDQDGRWWKHSDULQWLVWąEELGĈV]ĞNVÜJHVDWHOMHVYÜUDOYDGÈVKR]
A szérumot klinikai-kémiai és immunológiai rutinvizsgálatokban, valamint a szerológiában mintaanyagként használják.

SARSTEDT S-Monovette® Neutral Z
Az S-Monovette®1HXWUDO=FVĈQHPWDUWDOPD]SUHSDUÈWXPRWDPHO\PHJIHOHOĈDYÜUPLQWÈNNRDJXOÈFLĂVDNWLYÈWRUQÜONĞOLWHUPÜV]HWHVDOYDGÈVÈKR]ÜVV]ÜUXPNLQ\HUÜVÜUH V]ROJÈO$FHQWULIXJÈOÈVVRUÈQDYÜUOHSÜQ\ÜVD
szérum szétválaszt.
$V]ÜUXPRWPLQWDDQ\DJNÜQWIHOKDV]QÈOĂWĂOIĞJJĈYL]VJÈODWRNKR]KDV]QÈOMÈN
Ezenkívül az S-Monovette® Neutral Z csövet üres edényként is lehet használni az alábbiak szerint: ha a vérvételt S-Monovette®FLWUÈWFVĈYHONH]GL EL]WRQVÈJL 0XOWLIO\® kanüllel (szárnyas kanül) kombinálva, az
S-Monovette®1HXWUDO=FVąYHWHOVĈGOHJHVHGÜQ\NÜQW ĞUHVHGÜQ\ D EL]WRQVÈJL 0XOWLIO\®NDQĞOWąPOĈMÜQHNPHJWąOWÜVÜUHKDV]QÈOKDWMD

SARSTEDT S-Monovette® lítium-heparin LH / lítium-heparin gél LH / lítium-heparin gél+ LH, nátrium-heparin NH, ammónium-heparin AH
Az S-Monovette®OìWLXPKHSDULQ/+QÈWULXPKHSDULQ1+DPPĂQLXPKHSDULQ$+NRDJXOÈFLĂJÈWOĂYDOHOOÈWRWWOìWLXPKHSDULQQÈWULXPKHSDULQDPPĂQLXPKHSDULQ UHQGV]HULQW,(KHSDULQPOYÜU EHYRQDWě
PĢDQ\DJJUDQXOÈWXPRWWDUWDOPD]ÜVWHOMHVYÜUÜVSOD]PD NLQ\HUÜVÜUHV]ROJÈO$PĢDQ\DJJUDQXOÈWXPDFHQWULIXJÈOÈVKDWÈVÈUDYÜUVHMWUHÜVSOD]PÈUDYÈODV]WV]ÜW0ĢDQ\DJJUDQXOÈWXPQÜONĞOL60RQRYHWWH®OìWLXPKHSDULQ/+FVĈHVHWÜQDOìWLXPKHSDULQNRDJXOÈFLĂJÈWOĂDQ\DJSHUPHWDGDJROWIRUPÈEDQYDQMHOHQ UHQGV]HULQW,(KHSDULQPOYÜU 
Az S-Monovette®OìWLXPKHSDULQJÜO/+FVĈDOìWLXPKHSDULQNRDJXOÈFLĂJÈWOĂYDO UHQGV]HULQW,(KHSDULQPOYÜU EHYRQWPĢDQ\DJJUDQXOÈWXPPHOOHWWSROLPHUDODSěJÜOWLVWDUWDOPD]ÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO$
gél a centrifugálás hatására vérsejtre és plazmára választ szét, és stabil elválasztó réteget képez a szállítás, tárolás és elemzés közben.
Az S-Monovette® lítium-heparin gél+/+V]LQWÜQRO\DQSROLPHUDODSěJÜOWWDUWDOPD]DPHO\NENDOFVąNNHQWHWWFHQWULIXJÈOÈVLLGĈWWHV]OHKHWĈYÜD]60RQRYHWWH®OìWLXPKHSDULQJÜOHVFVĈYHOV]HPEHQ
A heparinos plazmát klinikai-kémiai és immunológiai rutinvizsgálatokban mintaanyagként használják. A heparinos teljes vért mintaanyagként az immunológiai rutinvizsgálatokban és a szerológiában használják.
Az heparinos véralvadás-gátlás antithrombin aktiválásával történik.
87$67d660RQRYHWWH®OìWLXPKHSDULQ/+OìWLXPKHSDULQJÜOJÜO+/+FVąYHNEĈOQHPV]DEDGOìWLXPPHJKDWÈUR]ÈVRNDW60RQRYHWWH®QÈWULXPKHSDULQ1+FVĈEĈOQHPV]DEDGQÈWULXPPHJKDWÈUR]ÈVRNDWÜV60RQRYHWWH®DOXPìQLXPKHSDULQ$+FVĈEĈOSHGLJQHPV]DEDGDPPĂQLXPPHJKDWÈUR]ÈVRNDWYÜJH]QL$YÜQÈVYÜUUHOWąOWąWW60RQRYHWWH®OìWLXPKHSDULQOìWLXPKHSDULQJÜO
JÜO+QÈWULXPKHSDULQDPPĂQLXPKHSDULQFVąYHNQHPPHJIHOHOĈHNYÜUJÈ]HOHP]ÜVKH]

SARSTEDT S-Monovette® fémanalitika
Az S-Monovette®IÜPDQDOLWLNDFVĈOìWLXPKHSDULQYÜUDOYDGÈVJÈWOĂWWDUWDOPD]ÜVWHOMHVYÜUÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO$OìWLXPKHSDULQSHUPHWDGDJROWIRUPÈEDQ ,(KHSDULQPOYÜU YDQMHOHQ
A heparin teljes vér, ill. heparin plazma S-Monovette® fémanalitika csövet a speciális 21G x 1 ½“ (cikksz. 85.1162.600) biztonsági kanüllel kombinálva mintaanyagként nyomelemek /fémek vizsgálatára használják. A
Q\RPHOHPHNHWIÜPHNHWDWRPDEV]RUSFLĂVVSHNWURPHWULD $66 VHJìWVÜJÜYHOYDOLGÈOMÈN$EL]WRQVÈJLNDQĞOEĈOÜV60RQRYHWWH®IÜPDQDOLWLNDLFVĈEĈOÈOOĂUHQGV]HUUHDNąYHWNH]ĈPD[LPÈOLVĞUHVÜUWÜNHNYRQDWNR]QDNQJ
rendszer esetén ezekre a nyomelemekre:Elemng/rendszer

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

$PD[LPÈOLVĞUHVÜUWÜNHNPLQGHQHOHPUHYRQDWNR]ĂDQD]60RQRYHWWH®FVĈFìPNÜMÜQYDQPHJDGYD$Q\RPHOHPPHJKDWÈUR]ÈVRND]DQDOLWLNDLHOMÈUÈVWĂOIĞJJĈHQKHSDULQRVWHOMHVYÜUEĈOYDJ\KHSDULQRVSOD]PÈEĂOWąUWÜQQHNAz heparinos véralvadás-gátlás antithrombin aktiválásával történik.

SARSTEDT S-Monovette® citrát 9NC
Az S-Monovette®FLWUÈW1&FVĈWULQÈWULXPFLWUÈWYÜUDOYDGÈVJÈWOĂWWDUWDOPD]ÜVWHOMHVYÜUÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO$WULQÈWULXPFLWUÈWPĂORVROGDWNÜQW WULQÈWULXPFLWUÈWJ\DNUDQUD
felkerekítve) van jelen, és egy S-Monovette®FLWUÈWFVĈQÜYOHJHVĢUWDUWDOPÈQDNÈWWHV]LNL$FLWUÈWNHYHUÜVLDUÈQ\DDYÜUKH]şHJ\VÜJQ\LWÜUIRJDWěFLWUÈWÜVHJ\VÜJQ\LWÜUIRJDWěYÜU$KHO\HVWąOWÜVD]DQDOLWLND
V]HPSRQWMÈEĂONąWHOH]ĈHQV]ĞNVÜJHVA citrát plazmát mintaanyagként hemosztazeológiai rutinvizsgálatokban használják.
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik a citrát által.
Kérjük, hogy a mintavétel és kezelés alatt tartsa be az S-Monovette®FLWUÈWFVĈYHOÜVV]ÈUQ\DVNDQĞOOHOYDOĂNRPELQÈFLĂUDYRQDWNR]Ă87$67d62.$7

SARSTEDT S-Monovette® PFA 9NC
Az S-Monovette®3)$1&FVĈWULQÈWULXPFLWUÈWYÜUDOYDGÈVJÈWOĂWWDUWDOPD]DWHOMHVYÜUÜVSOD]PDNLQ\HUÜVÜKH] $WULQÈWULXPFLWUÈWPĂORVSXIIHUROWROGDWNÜQW SXIIHUROWS+ YDQMHOHQÜVHJ\
S-Monovette®3)$FVĈQÜYOHJHVĢUWDUWDOPÈQDNÈWWHV]LNL$FLWUÈWNHYHUÜVLDUÈQ\DDYÜUKH]şHJ\VÜJQ\LWÜUIRJDWěFLWUÈWÜVHJ\VÜJQ\LWÜUIRJDWěYÜU$KHO\HVWąOWÜVD]DQDOLWLNDV]HPSRQWMÈEĂONąWHOH]ĈHQszükséges.
Az S-Monovette®3)$1&FVĈEHQOÜYĈWHOMHVYÜUWPLQWDDQ\DJNÜQW6,(0(16+HDOWKLQHHUV3)$HOHP]ĈNÜV]ĞOÜNVHJìWVÜJÜYHOWURPERFLWDIXQNFLĂPHJKDWÈUR]ÈVÈUDKDV]QÈOMÈNÜVHKKH]YDQYDOLGÈOYD
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik a citrát által.
Kérjük, hogy a mintavétel és kezelés alatt tartsa be az S-Monovette®3)$FVĈYHOÜVV]ÈUQ\DVNDQĞOOHOYDOĂNRPELQÈFLĂUDYRQDWNR]Ă87$67d62.$7

SARSTEDT S-Monovette® CTAD
Az S-Monovette®&7$'FVĈWULQÈWULXPFLWUÈWYÜUDOYDGÈVJÈWOĂWYDODPLQWWHRILOOLQWDGHQR]LQWÜVGLSLULGDPROWWDUWDOPD]ÜVWHOMHVYÜUÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO$&7$'ROGDWNÜQWYDQMHOHQÜVHJ\60RQRYHWWH® CTAD
FVĈQÜYOHJHVĢUWDUWDOPÈQDNÈWWHV]LNL$&7$'NHYHUÜVLDUÈQ\DDYÜUKH]şHJ\VÜJQ\LWÜUIRJDWě&7$'ÜVHJ\VÜJQ\LWÜUIRJDWěYÜU$KHO\HVWąOWÜVD]DQDOLWLNDV]HPSRQWMÈEĂONąWHOH]ĈHQV]ĞNVÜJHVA CTAD plazmát mintaanyagként a vérlemezke faktor 4 (PF4), béta(ß)-tromboglobulin (ßTG) és plazminogén-aktivátor gátlószer (PAI-1) meghatározására, valamint hemosztazeológiai vizsgálatokhoz használják.
$WURPERFLWDDNWLYLWÈVWOHJDOÈEEĂUÈVLGĈWDUWDPUDJÈWROMDÜVDKHSDULQRVWHUÈSLÈNIHOĞJ\HOHWÜUHV]ROJÈO
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik a citrát által.
Kérjük, hogy a mintavétel és kezelés alatt tartsa be az S-Monovette®&7$'FVĈYHOÜVV]ÈUQ\DVNDQĞOOHOYDOĂNRPELQÈFLĂUDYRQDWNR]Ă87$67d62.$7
87$67d6$&7$'VÈUJD$]60RQRYHWWH®&7$'FVąYHWWÈUROÈVNą]EHQYÜGHQLNHOODPHVWHUVÜJHVÜVWHUPÜV]HWHVIÜQ\WĈO7ąEEPLQWĂUÈVHUĈVIÜQ\KDWÈVD]DGDOÜNDQ\DJRNLQDNWLYLWÈVÈKR]YH]HWKHWSARSTEDT S-Monovette® EDTA K2E / K3E
Az S-Monovette® EDTA K2E / S-Monovette® EDTA K3E csövek K2 EDTA, ill. K3 EDTA koaguláció-gátlót tartalmaznak és a teljes vér kinyerésére** szolgálnak. A K2 EDTA, ill. K3 EDTA permetadagolt formában (1,6 mg
EDTA / ml vér) van jelen.
$]('7$WHOMHVYÜUWPLQWDDQ\DJNÜQWKHPDWROĂJLDLYL]VJÈODWRNKR]KDV]QÈOMÈN9ÜUNHQHWHWDYÜUYÜWHOWĈOV]ÈPìWRWWQÜJ\ĂUÈQEHOĞONHOONÜV]ìWHQL
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik az EDTA által.
Az S-Monovette®('7$.(.(FVĈEĈOV]ÈUPD]ĂYÜUWLVOHKHWLPPXQKHPDWROĂJLDLUXWLQYL]VJÈODWRNKR]ÜVIHUWĈ]ĈEHWHJVÜJHNWHV]WMHLKH]KDV]QÈOQL$IHOKDV]QÈOĂIHOHOĈVVÜJHPHJIHOHOĈWHV]WUHDJHQVHNNHOHOHP]Ĉkészülékekkel, valamint raktári feltételekkel validálni, hogy a mintaanyag ezen vizsgálatokhoz alkalmas legyen.

93

HU
SARSTEDT S-Monovette® EDTA-gél K2E
Az S-Monovette®('7$JÜO.(FVĈ.('7$DNRDJXOÈFLĂJÈWOĂPHOOHWWSROLPHUDODSěJÜOWLVWDUWDOPD]ÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO$.('7$SHUPHWDGDJROWIRUPÈEDQ PJ('7$POYÜU YDQMHOHQ$JÜOD
centrifugálás hatására vérsejtre és plazmára választ szét, és stabil elválasztó réteget képez a szállítás, tárolás és elemzés közben.
Az EDTA plazmát mintaanyagként a molekuláris vírusdiagnosztikához használják.
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik az EDTA által.

SARSTEDT S-Monovette®ĲXRULG('7$)(ĲXRULGKHSDULQ)+ĲXRULGFLWUÈW('7$)&JOLNROì]LVJÈWOĂNNDOAz S-Monovette® fluorid EDTA FE EDTA koaguláció-gátlót (1,2 mg / ml vér), valamint fluoridot (1,0 mg / ml vér) tartalmaz a glikolízis gátlásához, és plazma kinyerésére** szolgál. A fluoridos EDTA permetadagolt formában
van jelen.
Az S-Monovette®IOXRULGKHSDULQ)+FVĈKHSDULQNRDJXOÈFLĂJÈWOĂW ,(KHSDULQPOYÜU YDODPLQWIOXRULGRW PJPOYÜU WDUWDOPD]DJOLNROì]LVJÈWOÈVÈKR]ÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO$IOXRULGKHSDULQ
permetadagolt formában van jelen.
$IOXRULGÈOWDOLJOLNROì]LVJÈWOÈVDYÜUYÜWHOLFVĈPHJWąOWÜVHXWÈQNEĂUÈYDONH]GĈGLNÜVDWHOMHVKDWÈVÈWNEĂUDPěOYDIHMWLNL$JOĞNĂ]DV]HUYH]HWEHQQÜKÈQ\ĂUDHOWHOWÜYHOPD[LJĂUDHOWHOWÜYHOSHGLJLJ
bomlik le a teljes vérben.
Az S-Monovette® GlucoEXACT FC EDTA koaguláció-gátlót, valamint citrátot és fluoridot tartalmaz az azonnali glikolízis gátláshoz, és plazma kinyerésére** szolgál. Az EDTA, citrát és fluorid oldatként vannak jelen. A
glükóz koncentráció kiszámításához a hígítás miatt 1,16-tal való szorzást kell használni.
Az S-Monovette®*OXFR(;$&7)&HOHJHWWHV]D1ÜPHW'LDEÜWHV]7ÈUVDVÈJ ''* WHUKHVVÜJLFXNRUEHWHJVÜJUHYRQDWNR]ĂLUÈQ\HOYHLQHNÜVDHVWìSXVěFXNRUEHWHJHNRUV]ÈJRVHOOÈWÈVLLUÈQ\HOYÜQHN 19/ $JOĞNĂ]
NRQFHQWUÈFLĂD]RQQDOLVWDELOLWÈVDV]REDKĈPÜUVÜNOHWHQDWHOMHVYÜUEHQDNÈUĂUÈLJEL]WRVìWRWWOÈVGD6$567('7:KLWH3DSHUGRNXPHQWXPÈWhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/smonovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
A fluoridos EDTA (citrát) plazmát mintaanyagként a glükóz meghatározásához használják.
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik az EDTA által.
87$67d6$ĲXRULGDYÜUVHMWROGĂGÈVQąYHNHGÜVÜWRNR]KDWMD7RYÈEELLQIRUPÈFLĂNDWD]DYDUWRNR]KDWĂDQ\DJRNUĂODWHV]WUHDJHQVJ\ÈUWĂMÈQDNDGRWWKDV]QÈODWLXWDVìWÈVÈEDQWDOÈO
Kérjük, hogy a mintavétel és kezelés alatt tartsa be az S-Monovette®*OXFR(;$&7FVĈYHOÜVV]ÈUQ\DVNDQĞOOHOYDOĂNRPELQÈFLĂUDYRQDWNR]Ă87$67d62.$7

SARSTEDT S-Monovette® CPDA
Az S-Monovette®&3'$FVĈQÈWULXPFLWUÈWYÜUDOYDGÈVJÈWOĂWYDODPLQWFLWURPVDYDWQÈWULXPIRV]IÈWRWGH[WUĂ]WÜVDGHQLQWWDUWDOPD]ÜVWHOMHVYÜUÜVSOD]PDNLQ\HUÜVÜUH V]ROJÈO&3'$ROGDWNÜQWYDQMHOHQ$&3'$
NHYHUÜVLDUÈQ\DDYÜUKH]şHJ\VÜJQ\LWÜUIRJDWě&3'$ÜVHJ\VÜJQ\LWÜUIRJDWěYÜU$KHO\HVWąOWÜVD]DQDOLWLNDPLDWWNąWHOH]ĈHQV]ĞNVÜJHV$&3'$WHOMHVYÜUWSOD]PÈWPLQWDDQ\DJNÜQWKDV]QÈOMÈNDYÜUFVRSRUWV]HUROĂJLÈKR]DWUDQV]Iě]LĂVJ\ĂJ\ÈV]DWEDQLOOąVV]HIÜUKHWĈVÜJLYL]VJÈODWRNKR] NHUHV]WSUĂEÈN DWUDQV]Iě]LĂNHVHWÜQ$]60RQRYHWWH®&3'$FVĈ
NRQNUÜWDQYÜUFVRSRUWPHJKDWÈUR]ÈVKR] $% EHOHÜUWYHD.HOOÜV5KHXVIDNWRUWLUUHJXOÈULVYÜUFVRSRUWDQWLWHVWHNHQDQWLWHVWV]ĢUĈYL]VJÈODWRNKR]SROLVSHFLILNXVNą]YHWOHQ&RRPEVWHV]WHNKH] QDSLJ DYÜUFVRSRUWWDONRPSDWLELOLVEHWHJV]ÜUXPSOD]PÈYDOYDOĂ 0DMRUWHV]W ąVV]HIÜUKHWĈVÜJLYL]VJÈODWRNKR] NHUHV]WSUĂEÈN PHJIHOHOĈ$V]ÈOOìWÈVLGĈWDUWDPDDWÈUROÈVLJƓ&RQPD[LPXPĂUÈUDYDQYDOLGÈOYD$VHMWHNĞOHSìWÜVÜKH]DPLQWÈNDWHOĈ]ĈOHJOHJDOÈEEĂUÈLJIĞJJĈOHJHVHQIHOÈOOìWYDKĢWĈV]HNUÜQ\EHQNHOOWÈUROQL(]XWÈQDIHQWLDQDOLWRNDWDV]RNÈVRVYÜUVĢUìWPÜQ\HNOHMÈUDWLLGHMÜKH]KDVRQOĂDQPD[LPXPQDSLJOHKHWPHJKDWÈUR]QLKĢWĈV]HNUÜQ\EHQ Ɠ& YDOĂWÈUROÈVXWÈQ NLYÜYHDNą]YHWOHQ&RRPEVWHV]WHNHWDPHO\KH]QDSLJIHOKDV]QÈOKDWĂ 
0HJIHOHOĈRV]ORSDJJOXWLQÈFLĂVHOMÈUÈVRNKR]SOD]2UWKR&OLQLFDO'LDJQRVWLFV9LVLRQ0D[YL]VJÈODWHVHWÜQ$PLQWDDQ\DJRWQHPV]DEDGOHIDJ\DV]WDQL$IHOKDV]QÈOĂIHOHOĈVVÜJHKRJ\DPLQWDDQ\DJH]HQYL]VJÈODWRNKR]PÈVPĂGV]HUHNNHOWHV]WUHDJHQVHNNHODQDOLWLNDLHV]Ną]ąNNHOLOOPHJIHOHOĈWÈUROÈVLIHOWÜWHOHNPHOOHWWDONDOPDVOHJ\HQÜVQHNLNHOOH]WYDOLGÈOQLD
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik a citrát által.
Kérjük, hogy a mintavétel és kezelés alatt tartsa be az S-Monovette®&3'$FVĈYHOÜVV]ÈUQ\DVNDQĞOOHOYDOĂNRPELQÈFLĂUDYRQDWNR]Ă87$67d62.$7

SARSTEDT S-Monovette® ThromboExact
Az S-Monovette® ThromboExact véralvadás-gátlóként magnézium sót tartalmaz, és teljes vér kinyerésére** szolgál. A magnézium só permetadagolt formában van jelen.
Az S-Monovette®7KURPER([DFWFVĈEHQOÜYĈWHOMHVYÜUWPLQWDDQ\DJNÜQWYÜUDOYDGÈVJÈWOĂNNDOYDOĂąVV]HIÜUKHWHWOHQVÜJPLDWWL PLQW('7$FLWUÈWKHSDULQ DKDPLVPĂGRQDODFVRQ\WURPERFLWDV]ÈPNL]ÈUÈVÈUDKDV]QÈOMÈN
DPHO\HWSV]HXGRWURPERFLWRSÜQLÈQDNLVQHYH]QHN*ÈWROMDDWURPERFLWDKDOPD]RNNÜS]ĈGÜVÜWÜVDWÜQ\OHJHVWURPERFLWDV]ÈPPHJKDWÈUR]ÈVDDYÜUYÜWHOXWÈQPD[ĂUÈLJOHKHWVÜJHV$NRDJXOÈFLĂJÈWOÈVPDJQÜ]LXPLRQRNVHJìWVÜJÜYHOWąUWÜQLNDPHO\VRUÈQDYÜUOHPH]NHV]HUĢ7KURPER[DQ$PDJQÜ]LXPLRQMDLWYDODPLQWD]$'3ÜVDUDFKLGRQVDYÈOWDONą]YHWìWHWWWURPERFLWDKDOPD]RNDWJÈWROMÈN

SARSTEDT S-Monovette® Hirudin
Az S-Monovette®+LUXGLQFVĈKLUXGLQYÜUDOYDGÈVJÈWOĂWWDUWDOPD]ÜVWHOMHVYÜUNLQ\HUÜVÜUH V]ROJÈO$KLUXGLQSHUPHWDGDJROWIRUPÈEDQYDQMHOHQ
A hirudin teljes vért mintaanyagként a ROCHE Diagnostics Multiplate® készülékeinél (multiple platelet function analyser) a trombocita funkciók meghatározásához használják, és ehhez validálták. A vérlemezke gátló
gyógyszerek terápiás felügyeletére, valamint a trombocita funkciós zavarok igazolására vagy kizárására használják.
Az S-Monovette® Hirudin csövet speciálisan a trombocita funkciók meghatározására fejlesztették ki a Multiplate® készülékekhez a Verum Diagnostica, ma ROCHE Diagnostics céggel közösen.
$NRDJXOÈFLĂJÈWOÈVKLUXGLQRQNHUHV]WĞOWąUWÜQLNDNą]YHWOHQWKURPELQJÈWOÈVUÜYÜQÜVìJ\DWURPERFLWDIXQNFLĂNGLDJQRV]WLNÈMÈWQDWìYÈOODSRWEDQWHV]LOHKHWĈYÜ

SARSTEDT S-Monovette® homocisztein HCY-Z-gél / HCY-C
Az S-Monovette®KRPRFLV]WHLQ+&<=JÜOFVĈDNRDJXOÈFLĂVDNWLYÈWRUUDO V]LOLNÈW EHYRQWPĢDQ\DJJUDQXOÈWXPPHOOHWWVSHFLÈOLVVWDELOL]ÈWRUWYDODPLQWSROLPHUDODSěJÜOWLVWDUWDOPD]ÜVV]ÜUXPNLQ\HUÜVÜUH V]ROJÈO$JÜOa centrifugálás hatására vérlepényre és szérumra választ szét, és stabil elválasztó réteget képez a szállítás, tárolás és elemzés közben. A preparátum permetadagolt formában van jelen.
$KRPRFLV]WHLQWDNÈUĂUÈQÈWVWDELOL]ÈOMDV]REDKĈPÜUVÜNOHWHQDWHOMHVYÜUEHQ+DDFHQWULIXJÈOÈVD]HOVĈĂUÈQEHOĞOWąUWÜQLNDYÜUOHSÜQ\ÜVDV]ÜUXPNą]ąWWLKHO\HVHQNÜS]ĈGąWWHOYÈODV]WĂUÜWHJJHODKRPRFLV]WHLQDNÈU96 órán át stabilizálva lesz.
Az S-Monovette®KRPRFLV]WHLQ+&<=JÜOFVĈV]ÜUXPÈWPLQWDDQ\DJNÜQWKRPRFLV]WHLQPHJKDWÈUR]ÈVÈUDKDV]QÈOMÈN$]60RQRYHWWH®KRPRFLV]WHLQ+&<&FVĈYÜUDOYDGÈVJÈWOĂNÜQWVDYDVFLWUÈWRW S+ WDUWDOPD]ÜV
plazma kinyerésére** szolgál. A citrát oldatként van jelen. A homocisztein koncentráció kiszámításához a hígítás miatt 1,11-tal való szorzást kell használni.
$KRPRFLV]WHLQWV]REDKĈPÜUVÜNOHWHQPD[ĂUÈLJƓ&RQSHGLJDNÈUĂUÈQÈWVWDELOL]ÈOMDDWHOMHVYÜUEHQ
Az S-Monovette®KRPRFLV]WHLQ+&<&FVĈSOD]PÈMÈWPLQWDDQ\DJNÜQWKRPRFLV]WHLQPHJKDWÈUR]ÈVÈUDKDV]QÈOMÈNAz S-Monovette®+RPRF\VWHLQ+&<&FVĈEHQDYÜUDOYDGÈVJÈWOÈVDNDOFLXPLRQRNNRPSOH[ÈOÈVDVHJìWVÜJÜYHOWąUWÜQLNDFLWUÈWÈOWDO
Kérjük, hogy a mintavétel és kezelés alatt tartsa be az S-Monovette®+&<&FVĈYHOÜVV]ÈUQ\DVNDQĞOOHOYDOĂNRPELQÈFLĂUDYRQDWNR]Ă87$67d62.$7

SARSTEDT S-Monovette® DNA Exact
Az S-Monovette®'1$([DFWFVĈ('7$EÈ]LVěNRDJXOÈFLĂJÈWOĂWWDUWDOPD]ÜVWHOMHVYÜUNLQ\HUÜVÜUH V]ROJÈO$]('7$SHUPHWDGDJROWIRUPÈEDQYDQMHOHQ
$]('7$WHMHVYÜUWPLQWDDQ\DJNÜQWDJ'1$VWDELOL]ÈOÈVÈUDKDV]QÈOMÈN$J'1$VWDELOL]ÈFLĂVWHOMHVìWPÜQ\HƓ&RQQDSUDV]REDKĈPÜUVÜNOHWHQ Ɠ& QDSUDKĢWÜVHVHWÜQ Ɠ& QDSUDÜVƓ&RQOHJDOÈEEÜYUHYDQYDOLGÈOYD(]HQNìYĞODVWDELOL]ÈOWPLQWÈNIDJ\DV]WÈVLÜVIHOROYDV]WÈVLFLNOXVWÈOOQDNNLPLQĈVÜJLNÈURVRGÈVQÜONĞOOÈVGD6$567('7:KLWH3DSHUGRNXPHQWXPÈWLVhttps://www.sarstedt.com/en/products/
diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA
Analysis.”.
A véralvadás-gátlás a kalcium ionok komplexálása segítségével történik az EDTA által.

$PLQWDDQ\DJPHJIHOHOĈVÜJHD]DQDOLWWĂOÜVDWHV]WUHDJHQVWĈOHOHP]ĈNÜV]ĞOÜNWĈOIĞJJ$J\ÈUWĂPHJIHOHOĈDMÈQOÈVDLWıJ\HOHPEHNHOOYHQQL

94

HU%L]WRQVÈJLXWDVìWÈVRNıJ\HOPH]WHWĈXWDVìWÈVRN1.

dOWDOÈQRVĂYLQWÜ]NHGÜVHN+DV]QÈOMRQNHV]W\ĢWÜVÈOWDOÈQRVHJ\ÜQLYÜGĈHV]Ną]ąNHWKRJ\YÜUWĈOYDODPLQWHVHWOHJHVHQHJ\IHUWĈ]ĈPLQWDDQ\DJJDOV]HPEHQYDOĂNLWHWWVÜJWĈOÜVYÜUěWMÈQWHUMHGĈNĂURNR]ĂWĂOPHJYÜGMH
magát.

2.

Minden biológiai mintát és az éles/hegyes vérvételi eszközöket (kanülöket, adaptereket) az Ön intézményében érvényes irányelvek és eljárások szerint kezelje. Forduljon orvoshoz, ha biológiai mintákkal közvetlenülÜULQWNH]HWWYDJ\KDWĢV]ěUÈVRVVÜUĞOÜVHYDQPLYHOH]ÈOWDO+,9+&9+%9IHUWĈ]ÜVWYDJ\PÈVIHUWĈ]ĈEHWHJVÜJHNHWNDSKDWHO$EL]WRQVÈJLNDQĞOąNHWEL]WRQVÈJL0XOWLĲ\®NDQĞOąNHWEHÜSìWHWWWĢYÜGĈYHOKDV]QÈOMDTartsa be az Ön intézményében érvényes irányelveket és eljárásokat.

3.

A külön steril csomagolással ellátott termékekre érvényes:+DV]QÈODWHOĈWWHOOHQĈUL]]HQPLQGHQHJ\HGLFVRPDJROÈVWKRJ\QHPNÈURVRGRWWHÜVNÈURVRGÈVHVHWÜQQHKDV]QÈOMD4.

$WHUPÜNHJ\V]HULKDV]QÈODWUDV]ROJÈO$YÜUYÜWHOKH]KDV]QÈOWÜOHVKHJ\HVWÈUJ\DNDW NDQĞOąNHWDGDSWHUHNHW PHJIHOHOĈYHV]ÜO\HVELROĂJLDLDQ\DJRNV]ÈPÈUDIHQQWDUWRWWWDUWÈO\EDGREMDNL

5.

+DDYÜUWLQWUDYÜQÈV ,9 NDWÜWHUHQNHUHV]WĞOYHV]LEL]WRVìWDQLNHOOKRJ\DEHPHQHWDUHQGHONH]ÜVQHNPHJIHOHOĈHQUHQGHVHQHOOHJ\HQąEOìWYH D,9ROGDWWĂOPHJOHJ\HQWLV]WìWYD PLHOĈWWDYÜUYÜWHOWHONH]GL$NDWÜWHU
UHQGHVHOąEOìWÜVÜYHOHONHUĞOKHWĈNDKLEÈVHOHP]ÜVLHUHGPÜQ\HN

6.

Az S-Monovette®FVĈDOXOWąOWÜVHDYÜUÜVDSUHSDUÈWXPDGDOÜNDQ\DJKDPLVDUÈQ\ÈKR]YH]HWKHWÜVKLEÈVHOHP]ÜVLHUHGPÜQ\HNHWDGKDW7.

Az S-Monovette®FVĈYHOYHWWÜVIHOGROJR]RWWYÜUQHPDONDOPDVHPEHULWHVWEHYDOĂYLVV]DLQMHNFLĂ]ÈVÈUD8.

$WHUPÜNHWDOHMÈUDWLLGĈQWěOPÈUQHPV]DEDGIHOKDV]QÈOQL$WHUPÜNV]DYDWRVVÈJDDPHJDGRWWÜYÜVKĂQDSXWROVĂQDSMÈQMÈUOH

Tárolás$WHUPÜNHNHWIHOKDV]QÈOÈVLJV]REDKĈPÜUVÜNOHWHQNHOOWÈUROQL

Korlátozások
1.

Egy megtöltött S-Monovette®FVĈWÈUROÈVLLGĈWDUWDPDÜVKĈPÜUVÜNOHWHDYL]VJÈODQGĂDQDOLWRNWDUWĂVVÈJÈWĂOIĞJJ(QQHNPHJìWÜOÜVÜWDODERUDWĂULXPYÜJ]LLOOıJ\HOHPEHNHOOYHQQLDWHV]WUHDJHQVHNHOHP]ĈNÜV]ĞOÜNHNgyártójának használati utasításában található információkat.

2.

Ha a plazma vagy a szérum egy S-Monovette®FVĈFHQWULIXJÈOÈVDVRUÈQV]ÜWLVYÈOLNÜVYDJ\DNDGÈO\YDQMHOHQQHPIHOWÜWOHQĞONHUĞOWPLQGHQVHMWWHOMHVHQHONĞOąQìWÜVUH$PDUDGÜNDQ\DJRNPHWDEROL]PXVDYDJ\D
természetes bomlás befolyásolhatják az analitok koncentrációját. Az analitok stabilitását a tárolótartály és az adott laboratórium körülményei szerint kell megítélni.

3.

7HUÈSLÈVJ\ĂJ\V]HUHNHVHWÜEHQDPLQWDDQ\DJPHJIHOHOĈVÜJÜWDWHV]WUHDJHQVHNHOHP]ĈNÜV]ĞOÜNHNJ\ÈUWĂMÈQDNKDV]QÈODWLXWDVìWÈVÈEDQNHOOHOOHQĈUL]QL

4.

A nyomelemek / fémek elemzéseit az S-Monovette® fémanalitikai + biztonsági kanül fémanalitikai rendszer segítségével kell elvégezni.

Mintavétel és kezelés
2/9$66$(/9x*,*(=7$'2.80(1780270,(/¡77(/.(=',$9x1d69x59x7(/7A mintavételhez szükséges eszközök
1.

Minden szükséges S-Monovette ® vérvételi rendszer.

2.

%L]WRQVÈJL NDQĞOąNYDJ\ EL]WRQVÈJL 0XOWLĲ\® kanülök.

3.

.HV]W\ĢNąSHQ\YÜGĈV]HPĞYHJYDJ\PÈVYÜGĈUXKÈ]DWKRJ\PHJYÜGMHPDJÈWDYÜUÈOWDOWHUMHV]WHWWNĂURNR]ĂNWĂOYDJ\HVHWOHJHVHQIHUWĈ]ĈDQ\DJRNWĂO

4.

Címkék a beteg azonosításához.

5.

)HUWĈWOHQìWĈDQ\DJDYÜUYÜWHOLKHO\WLV]WìWÈVÈKR] 7DUWVDEHD]LQWÜ]PÜQ\ÜEHQV]RNÈVRVPLQWDYÜWHOLKHO\HOĈNÜV]ìWÜVÜUHYRQDWNR]ĂVWHULOPLQWDYÜWHOLUÈQ\HOYÜW 1HKDV]QÈOMRQDONRKROWDUWDOPěWLV]WìWĂDQ\DJRNDWKDD
mintát véralkohol-teszthez használják fel.

6.

Száraz, steril, egyszer használatos vattacsomó.

7.

Vénaleszorító.

8.

Ragtapasz vagy kötszer.

9.

xOHVKHJ\HVWÈUJ\DNNLGREÈVÈUDV]ROJÈOĂKXOODGÜNJ\ĢMWĈHGÜQ\DKDV]QÈOWDQ\DJRNÈUWDOPDWODQìWÈVÈKR]

$MÈQORWWPLQWDYÜWHOLVRUUHQG
1.

9ÜUNXOWěUDSDODFNRN

2.

Csövek citráttal vagy koaguláció aktivátorral (gél szérum CAT-tel / gél szérum CAT nélkül)

3.

Csövek koaguláció aktivátorral vagy citráttal

4.

Csövek heparinnal géllel / gél nélkül

5.

Csövek EDTA-val géllel / gél nélkül

6.

&VĈJOLNROì]LVJÈWOĂV]HUUHO

7.

Csövek más adalékanyagokkal
87$67d6+DDYÜUYÜWHOWV]ÈUQ\DVNDQĞOOHO SO EL]WRQVÈJL 0XOWLĲ\®NDQĞOąNNHO NRPELQÈOYDHJ\FLWUÈWRWWDUWDOPD]ĂHGÜQQ\HOYDJ\PÈVRO\DQHGÜQ\HNNHONH]GLDPHO\HNIRO\ÜNRQ\SUHSDUÈWXPRNDW
PLQWSO3)$&7$'&3'$+&<&YDJ\*OXFR(;$&7DQ\DJRNDWWDUWDOPD]QDNHOĈV]ąUDMÈQORWWHJ\ĞUHVHGÜQ\EH SO60RQRYHWWH®1HXWUDO= YDOĂOHYÜWHODQQDNÜUGHNÜEHQKRJ\HONHUĞOMHD]
HGÜQ\QHPHOHJHQGĈWąOWąWWVÜJLV]LQWMÜWDV]ÈUQ\DVNDQĞOWąPOĈMÜYHOYDOĂÈWWąOWÜVHPLDWW
(]ÈOWDOEL]WRVìWKDWĂD]HGÜQ\KHO\HVPHJWąOWÜVHÜVDPHJIHOHOĈNHYHUÜVLDUÈQ\ IRO\DGÜNDYÜUKH]NÜSHVW 
87$67d67DUWVDEHDYÜUYÜWHOLVRUUHQGUHYRQDWNR]ĂHOĈìUÈVRNDWD]LQWÜ]PÜQ\ÜEHQ

9LVV]DIRO\ÈVHONHUĞOÜVH$OHJWąEE60RQRYHWWHFVĈWDUWDOPD]NÜPLDLDGDOÜNDQ\DJRW$YLVV]DIRO\ÈVHONHUĞOÜVHÜUGHNÜEHQDNąYHWNH]ĈXWDVìWÈVRNDWNHOOEHWDUWDQL
1. Kizárólag a használati utasításban ajánlott anyagokat használja.
2.

$EHWHJHWěJ\IHNWHVVHOHKRJ\NąQQ\HQKR]]ÈIÜUMHQDYÜQÈMÈKR]ÜVDEHWHJNDUMDYDJ\PÈVSXQNFLĂVWHUĞOHWOHIHOÜQÜ]]HQ

3.

Tartsa a csavaros fedéllel ellátott S-Monovette®FVąYHWIHOIHOÜÜV EL]WRQVÈJL 0XOWLĲ\® kanülök használata esetén a kar szintje / punkciós terület alá.

4.

Biztosítani kell, hogy az S-Monovette®FVĈWDUWDOPDDYÜQÈVSXQNFLĂVRUÈQQHÜULQWNH]]HQVHDFVDYDURVIHGÜOOHOVHDNDQĞOYÜJÜYHO

5.

Lazítsa meg a vénás érszorítót, miközben a vér az S-Monovette®FVĈEHIRO\LN

95

HU/HIDJ\DV]WÈVIHOROYDV]WÈV
$:+2DMÈQOÈVDV]HULQW :+2',//DE5HY DV]ÜUXPRWSOD]PÈWIDJ\DV]WÈVHOĈWWV]ÜWNHOOYÈODV]WDQLDYÜUVHMWHNWĈOAz S-Monovette®FVąYHNHVHWÜEHQDNąYHWNH]ĈDMÈQOÈVRNÜUYÜQ\HVHNDOHIDJ\DV]WÈVUDYRQDWNR]ĂDQ)DJ\DV]WÈVƓ&DODWW•)DJ\SRQWDODWWLKĈPÜUVÜNOHWLWDUWRPÈQ\EDQYDOĂKDV]QÈODWRWDODSYHWĈHQYDOĂVIHOWÜWHOHNPHOOHWWNHOOWHV]WHOQLPLYHOD]FVąYHNWHUKHOÜVHDOHIDJ\DV]WDQGĂNą]HJWĈOÜVDUXWLQIHOWÜWHOHNWĈOIĞJJĈHQQDJ\RQNĞOąQEą]Ĉ
lehet (lásd az Anyagtulajdonságok c. fejezetet a SARSTEDT katalógusban).

•$ODSYHWĈHQDPĢDQ\DJRNV]LOÈUGVÈJLÜUWÜNHLƓ&DODWWLKĈPÜUVÜNOHWLWDUWRPÈQ\EDQFVąNNHQQHN(]ÜUWÈOWDOÈQRVVÈJEDQNHUĞOQLNHOODPHFKDQLNXVWHUKHOÜVHNHW•$OHIDJ\DV]WÈVLNąUĞOPÜQ\HNHWěJ\NHOOPHJYÈODV]WDQLKRJ\HJ\60RQRYHWWH®FVĈWDUWDOPDHJ\HQOHWHVHQLOOOHQWUĈOIHOIHOHIDJ\MRQPHJ$]60RQRYHWWH®FVĈQHNHJ\ÈOOYÈQ\EDQYDJ\HJ\WÈUROĂGRER]EDQHOHJHQGĈ
KHO\QHNNHOOOHQQLHDKKR]KRJ\NLWXGMRQWÈJXOQL+XQJDURFHOOYDJ\IÜPÈOOYÈQ\RNQHPPHJIHOHOĈHNPLYHOD]RNRQWÈJXOÈVLUHSHGÜVHNMHOHQWNH]KHWQHNƓ&UDYDOĂOHIDJ\DV]WÈVş/HIDJ\DV]WÈVHOĈWWHOOHQĈUL]QLNHOO•,QWHUIHUHQFLÈN(OOHQĈUL]]HKRJ\DOHIDJ\DV]WÈVQDNYDQH]DYDUĂKDWÈVDDYÜUPLQWÈUDYDJ\D]HOHP]ÜVUH KHPROì]LVDQDOLWRNVWDELOLWÈVD •&HQWULIXJÈOÈV$WHUYH]HWWHOHP]ÜVHNWĈOIĞJJĈHQV]ĞNVÜJHV$FHQWULIXJÈOÈVLIHOWÜWHOHNHWYHJ\HıJ\HOHPEHH]HQGRNXPHQWXPŚ&HQWULIXJÈOÈVŘFIHMH]HWÜEHQYDJ\D6$567('7https://www.sarstedt.com/en/service/centrifugation/ZHEROGDOÈQPHJDGRWWDNV]HULQWYDODPLQWYÜJH]]HQV]HPUHYÜWHOH]ÜVHVHOOHQĈU]ÜVW•

Hemolízis: Teljes vér hemolízise lefagyasztás esetén: Ennek elkerülése érdekében vagy géles S-Monovette® csövet, ill. a centrifugálás után Seraplas®V]HOHSHVV]ĢUĈWNHOOKDV]QÈOQLYDJ\DPLQWÈWHJ\PÈVRGODJRV
edénybe kell átpipettázni.

Ɠ&UDYDOĂOHIDJ\DV]WÈVş9ÜJUHKDMWÈV•/HKĢWÜV$]60RQRYHWWH®FVąYHWIĞJJĈOHJHVKHO\]HWEHQKĢWVHOHşSHUFHVLGĈWDUWDPDODWWƓ&UDPLHOĈWWƓ&RQOHIDJ\DV]WDQÈ•)HOROYDV]WÈV)ĞJJĈOHJHVKHO\]HWEHQOHJDOÈEESHUFLJKDJ\MDV]REDKĈPÜUVÜNOHWHQIHOROYDGQL,WWLVNHUĞOMHDPHFKDQLNXVWHUKHOÜVHNHW$WěOJ\RUVIHOROYDV]WÈVD]HOHP]ÜVLHUHGPÜQ\HNHWKÈWUÈQ\RVDQEHIRO\ÈVROKDWMD

/HIDJ\DV]WÈVÜVPÜO\IDJ\DV]WÈVƓ&DOÈ•$Ɠ&DODWWLPÜO\IDJ\DV]WÈVWDJ\ÈUWĂQHPYL]VJÈOWD$VRNOHKHWVÜJHVEHIRO\ÈVROĂWÜQ\H]ĈPLDWWMDYDVROMXNKRJ\YÜJH]]HQODERUDWĂULXPLUXWLQIHOWÜWHOHNPHOOHWWIDJ\DV]WÈVLWHV]WHWAz S-Monovette®JÜOHVFVĈOHIDJ\DV]WÈVD•A -20 °C-ra való lefagyasztás a lefagyasztás pont alatt megadottak szerint történik – Végrehajtás:•

Ismeretes, hogy a gélréteg a lefagyasztási folyamattól változhat.

•$VRNOHKHWVÜJHVEHIRO\ÈVROĂWÜQ\H]ĈPLDWWMDYDVROMXNKRJ\YÜJH]]HQODERUDWĂULXPLUXWLQIHOWÜWHOHNPHOOHWWIDJ\DV]WÈVLWHV]WHW•)HOROYDV]WÈV$PLQWÈWIĞJJĈOHJHVKHO\]HWEHQKDJ\MDIHOROYDGQL$PLQWDDQ\DJRWIHOROYDGÈVXWÈQSLSHWWÈ]]DÈW QHGHNDQWÈOMDÈW D]HOVĈGOHJHVHGÜQ\EĈOHJ\PÈVRGODJRVHGÜQ\EHKRJ\D]DQ\DJNEPPUHOHJ\HQa gélréteg felett. A maradékot dobja ki.
87$67d6$]DQDOLWRNVWDELOLWÈVÈKR]YHJ\HıJ\HOHPEHDWHV]WUHDJHQVHNHOHP]ĈNÜV]ĞOÜNHNJ\ÈUWĂMÈQDNKDV]QÈODWLXWDVìWÈVDLW

96

HU
Vérvétel
Vérvételi technikák$NąYHWNH]ĈYÜUYÜWHOLWHFKQLNÈNDWNĞOąQEą]WHWMĞNPHJDVSLUÈFLĂVWHFKQLNDÜVYÈNXXPWHFKQLND
$]DVSLUÈFLĂVWHFKQLNDDGXJDWW\ěUěGHOOHQĈU]ąWWKě]ÈVÈYDONìPÜOHWHVYÜUYÜWHOWWHV]OHKHWĈYÜIRO\DPDWRVODVVěYÜUÈUDPOÈVVDOJ\DYÜUÈUDPOÈVWNą]YHWOHQĞODYÜQÈVYLV]RQ\RNKR]ÜVDGRWWVÈJRNKR]OHKHWLJD]ìWDQL
valamint csökkenteni lehet a hemolízist.
$YÈNXXPWHFKQLNDD]HOĈYÈNXXPR]RWWHGÜQ\HNVHJìWVÜJÜYHODYÈNXXPHOYV]HULQWLYÜUYÜWHOWWHV]OHKHWĈYÜIRO\DPDWRVDQJ\RUVYÜUÈUDPOÈVVDOxSSHQH]ÜUWH]DWHFKQLNDLGHÈOLVMĂYÜQÈVYLV]RQ\RNÜVHJ\V]HUĢPLQWDYÜWHOL
feltételek esetén.
Alkalmazás vérvételhez: lásd az S-Monovette® csövek és a biztonsági kanülök, ill. biztonsági Multifly®NDQĞOąNNH]HOÜVÜUĈOV]ĂOĂYLGHĂWD]DVSLUÈFLĂVWHFKQLNDLOOYÈNXXPWHFKQLNDHVHWÜEHQLWW
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood$.2&.d=$72.&6..(17x6(x5'(.x%(1$9x59x7(/625d19,6(/-(1.(6=7<º7
1. 9ÈODVV]DNLDPHJIHOHOĈ60RQRYHWWH® csövet a szükséges mintához.
2.

9ÈODVV]DNLDYÜQÈVSXQNFLĂKHO\ÜW$YÜQÈVSXQNFLĂKHO\ÜQHNHOĈNÜV]ìWÜVÜUHNÜUMĞNWDUWVDEHD]LQWÜ]PÜQ\LUÈQ\HOYHLW

9ÜUYÜWHODVSLUÈFLĂVWHFKQLNÈYDO
Figyelem! Az S-Monovette®FVąYHWFVDNYÜUYÜWHOKH]V]DEDGKDV]QÈOQLGHLQMHNFLĂ]ÈVKR]QHP
Csak ezekkel a kanülökkel (S-Monovette® (biztonsági) kanülök vagy (biztonsági) Multifly® kanülök / S-Monovette®FVĈKą]YDOĂDGDSWHU KDV]QÈOMDItt mutatjuk be a biztonsági kanülök használatát:

katt.ą]YHWOHQĞODYÜQÈVSXQNFLĂHOĈWWWROMDEHD]60RQRYHWWH® csövet a biztonsági kanül beépített tartójába
és NLVVÜD]ĂUDPXWDWĂMÈUÈVÈYDOPHJHJ\H]ĈLUÈQ\EDIRUGìWYD biztosítsa .
6]ĞNVÜJV]HULQWKHO\H]]HQIHOYÜQDOHV]RUìWĂW PD[SHUF $SXQNFLĂKHO\ÜWNÜV]ìWVHHOĈPHJIHOHOĈIHUWĈWOHQìWĈV]HUUHO$IHUWĈWOHQìWÜVXWÈQPÈUQHÜULQWVHPHJDYÜQDSXQNFLĂKHO\ÜW$EHWHJHWěJ\
IHNWHVVHOHKRJ\NąQQ\HQKR]]ÈIÜUMHQDYÜQÈMÈKR]ÜVDEHWHJNDUMDYDJ\PÈVSXQNFLĂVWHUĞOHWOHIHOÜQÜ]]HQ
7ÈYROìWVDHODWĢYÜGĈW6]ěUMDPHJDYÜQÈWODVVDQKě]]DKÈWUDDGXJDWW\ěUXGDWÜVOD]ìWVDPHJDYÜQÈVÜUV]RUìWĂWPLNą]EHQDYÜUD]60RQRYHWWH®FVĈEHIRO\LN
9ÈUMRQDPìJDYÜUÈUDPOÈVPHJÈOOKRJ\ìJ\PHJIHOHOĈWąOWÜVWWHJ\HQOHKHWĈYÜFordítsa kissé az S-Monovette® csövet D]ĂUDPXWDWĂMÈUÈVÈYDOHOOHQWÜWHVLUÈQ\ED ÜVKě]]DNLDEL]WRQVÈJLNDQĞOEĈO . A biztonsági kanül a vénában marad.
7ąEEV]ąULYÜUYÜWHOHVHWÜQDIHQWOHìUWDNV]HULQWDNąYHWNH]Ĉ60RQRYHWWHHJ\VÜJHWNHOODEL]WRQVÈJLNDQĞOKą]FVDWODNR]WDWQLÜVWRYÈEELPLQWÈNDWYHQQL$YÜUYÜWHOEHIHMH]ÜVH(OĈV]ąUKě]]DNLD]60RQRYHWWH®
+ FVąYHWPDMGKě]]DNLDYÜQÈEĂODEL]WRQVÈJLNDQĞOW(J\NH]HVWHFKQLNÈYDODNWLYÈOMDDWĢYÜGĈWYDJ\HJ\VWDELOHJ\HQHVIHOĞOHWHQDPìJDNDQĞOegy MĂOÜUH]KHWĈÜVKDOOKDWĂŚNDWWDQÈVVDOŘDWĢYÜGĈEHQEHQHPNDWWDQ DNWLYÈOĂGLN YDJ\Q\RPMDDPXWDWĂXMMÈYDODWĢYÜGĈDOVĂYÜJHIHOÜOÈVGD]60RQRYHWWH®FVĈ EL]WRQVÈJL NDQĞOMHLUHYDJ\ EL]WRQVÈJL 
Multifly® kanüljeire vonatkozó használati utasítást is.
Minden S-Monovette®FVąYHWIRUGìWVRQHJ\V]HUIHMUHDEL]WRQVÈJLNDQĞOEĈOYDOĂNLKě]ÈVXWÈQÜVDWHOMHVYÜUYÜWHOEHIHMH]ÜVHXWÈQPLQGHQNRDJXOÈFLĂJÈWOĂWWDUWDOPD]ĂPLQWÈWĂYDWRVDQWąEEV]ąUIRUGìWVRQIHMUH
$V]ÈOOìWÈVKR]ÜVFHQWULIXJÈOÈVKR]Kě]]DDGXJDWW\ěVUXGDWKDOOKDWĂDQDGXJDWW\ě EHNDWWDQÈVLKHO\]HWÜEH DGXJDWW\ěEHNDWWDQD]60RQRYHWWH® FVĈDOMÈEDQ ÜVWąUMHOHDGXJDWW\ěVUXGDW .
1.

$SXQNFLĂKHO\ÜUHQ\RPMRQUÈHJ\V]ÈUD]IHUWĈWOHQìWHWWYDWWDFVRPĂWDPìJDYÜU]ÜVHOÈOO2.

Ha a véralvadás bekövetkezik, helyezzen rá kötést, ha szükséges.

3.

'REMDNLDEL]WRQVÈJLNDQĞOWHJ\PHJIHOHOĈELROĂJLDLYHV]ÜO\HVDQ\DJRNNLGREÈVÈUDV]ROJÈOĂKXOODGÜNJ\ĢMWĈHGÜQ\EH

97HU9ÜUYÜWHOYÈNXXPWHFKQLNÈYDO
Figyelem! Az S-Monovette®FVąYHWFVDNYÜUYÜWHOKH]V]DEDGKDV]QÈOQLGHLQMHNFLĂ]ÈVKR]QHPCsak ezekkel a kanülökkel (S-Monovette® (biztonsági) kanülök vagy (biztonsági) Multifly® kanülök / S-Monovette®FVĈKą]YDOĂDGDSWHU KDV]QÈOMDItt mutatjuk be a biztonsági kanülök használatát:katt$YÜUYÜWHONìPÜOHWHVHONH]GÜVÜKH]6$567('7D]WMDYDVROMDKRJ\D]HOVĈ60RQRYHWWH®FVĈEHDVSLUÈFLĂVWHFKQLNÈYDOYHJ\HQYÜUWOÈVGD9x1d6381.&,7(&+1,.$UÜV]WD]DVSLUÈFLĂVWHFKQLNÈEDQ
Ezután folytassa vákuumtechnikával.
9ÜUYÜWHOHOĈWWKě]]DNLDGXJDWW\ěUěGGDODGXJDWW\ěWD]60RQRYHWWH® aljáig, és hagyja hallhatóan bekattanni. (]XWÈQWąUMHOHDGXJDWW\ěUXGDW7ROMDEHH]WD]HOĈNÜV]ìWHWW60RQRYHWWH® csövet az S-Monovette® biztonsági kanül beépített tartójába és NLVVÜD]ĂUDPXWDWĂMÈUÈVÈYDOPHJHJ\H]ĈLUÈQ\EDIRUGìWYD biztosítsa

+

–

.

9ÈUMRQDPìJDYÜUÈUDPOÈVPHJÈOOKRJ\ìJ\PHJIHOHOĈWąOWÜVWWHJ\HQOHKHWĈYÜFordítsa kissé az S-Monovette® csövet D]ĂUDPXWDWĂMÈUÈVÈYDOHOOHQWÜWHVLUÈQ\ED ÜVKě]]DNLDEL]WRQVÈJLNDQĞOEĈO . A biztonsági kanül a vénában marad.
7ąEEV]ąULYÜUYÜWHOHVHWÜQDIHQWOHìUWDNV]HULQWHOĈV]ąUDNąYHWNH]Ĉ60RQRYHWWHHJ\VÜJHWNHOODEL]WRQVÈJLNDQĞOKą]FVDWODNR]WDWQLÜVWRYÈEELPLQWÈNDWYHQQL
A vérvétel befejezése:+ě]]DNLD]60RQRYHWWH® csövet + PDMGKě]]DNLDYÜQÈEĂODEL]WRQVÈJLNDQĞOW(J\NH]HVWHFKQLNÈYDODNWLYÈOMDDWĢYÜGĈWYDJ\HJ\VWDELOHJ\HQHVIHOĞOHWHQDPìJDNDQĞOHJ\MĂOÜUH]KHWĈÜVKDOOKDWĂŚNDWWDQÈVVDOŘDWĢYÜGĈEHQEHQHPNDWWDQ DNWLYÈOĂGLN YDJ\Q\RPMDDWĢYÜGĈWDPXWDWĂXMMÈYDODWĢYÜGĈDOVĂYÜJHIHOÜ
Minden S-Monovette®FVąYHWIRUGìWVRQHJ\V]HUIHMUHDEL]WRQVÈJLNDQĞOEĈOYDOĂNLKě]ÈVXWÈQÜVDWHOMHVYÜUYÜWHOEHIHMH]ÜVHXWÈQPLQGHQNRDJXOÈFLĂJÈWOĂWWDUWDOPD]ĂPLQWÈWĂYDWRVDQWąEEV]ąUIRUGìWVRQIHMUH
1.

$SXQNFLĂKHO\ÜUHQ\RPMRQUÈHJ\V]ÈUD]IHUWĈWOHQìWHWWYDWWDFVRPĂWDPìJDYÜU]ÜVHOÈOO2.

Ha a véralvadás bekövetkezik, helyezzen rá kötést, ha szükséges.

3.

'REMDNLDEL]WRQVÈJLNDQĞOWHJ\PHJIHOHOĈELROĂJLDLYHV]ÜO\HVDQ\DJRNNLGREÈVÈUDV]ROJÈOĂKXOODGÜNJ\ĢMWĈHGÜQ\EH

98

.

HU
&HQWULIXJÈOÈV
),*<(/(0$6$567('760RQRYHWWHFVąYHNHW[JÜUWÜNUHWHUYH]WÜN.LYÜWHOWNÜSH]QHN¢PPÈWPÜUĈMĢ60RQRYHWWHFVąYHN 60RQRYHWWH® gyermekgyógyászat), amelyek aktuálisan 2.500 x g értékig vannak
YDOLGÈOYD.L]ÈUĂODJDUUDDONDOPDVWDUWĂFVąYHNLOOEHWÜWHNKDV]QÈOKDWĂN$PHQQ\LEHQPHJUHSHGW60RQRYHWWHFVąYHWFHQWULIXJÈOYDJ\DFHQWULIXJÈOLVJ\RUVXOÈVWěOQDJ\D]60RQRYHWWHFVĈHOWąUKHWÜVHVHWOHJHVHQ
veszélyes anyagokat bocsáthat ki.
$FHQWULIXJÈOĂEHWÜWHNHWDKDV]QÈOWD]60RQRYHWWHFVąYHNPÜUHWÜQHNPHJIHOHOĈHQNHOONLYÈODV]WDQL$UHODWìYFHQWULIXJÈOLVJ\RUVXOÈVDNąYHWNH]ĈUHOÈFLĂEDQÈOODEHÈOOìWRWWIRUGXODWV]ÈPSHUFÜUWÜNKH]
RCF = 11,2 x r x (RPM/1000)2,
Ś5&)ŗŚ5HODWìYFHQWULIXJÈOLVJ\RUVXOÈVJHUĈQHNLVQHYH]]ĞNŘ DQJROXOUHODWLYHFHQWULIXJDOIRUFHŘ „RPM“: „Fordulat per perc“ (1/min), vagy: n = percenkénti fordulatszám“ angolul „revolutions per minute“),ŚUŗŚ*\RUVXOÈVLVXJÈUDFHQWULIXJDNą]HSÜWĈOD]60RQRYHWWH®FVĈDOMÈLJ FP $]60RQRYHWWHFVąYHNHWFHQWULIXJÈNEDQUąJ]ìWHWWV]ąJĢURWRUUDOYDJ\NLOHQJĈURWRUUDOOHKHWFHQWULIXJÈOQL$]60RQRYHWWHFVąYHNNL]ÈUĂODJNLOHQJĈURWRURVFHQWULIXJÈNKR]YDOĂN$UąJ]ìWHWWV]ąJĢURWRUUDOUHQGHONH]ĈFHQWULIXJÈNEDQWąUWÜQĈFHQWULIXJÈOÈVW6$567('7QHPYDOLGÈOWDÜVQHPDMÈQOMD$]60RQRYHWWHFVąYHNHWD]DOÈEELFHQWULIXJÈOÈVLNąUĞOPÜQ\HNNą]ąWWNHOOFHQWULIXJÈOQL$PHQQ\LEHQHWWĈOHOWÜUĈNąUĞOPÜQ\HNNą]ąWWDONDOPD]]ÈND]RNDWDIHOKDV]QÈOĂQDNPDJÈQDNNHOOYDOLGÈOQLD
0HJNHOOJ\Ĉ]ĈGQLUĂODKRJ\D]60RQRYHWWHFVąYHNPHJIHOHOĈHQLOOHV]NHGQHNDFHQWULIXJDEHWÜWEH$]RND]60RQRYHWWHFVąYHNDPHO\HNNLOĂJQDNDEHWÜWEĈOHODNDGKDWQDNDFHQWULIXJDIHMÜEHQÜVHOWąUKHWQHN$
centrifugát egyenletesen kell feltölteni. Erre vonatkozóan, kérjük, vegye figyelembe a centrifuga használati utasítását.
),*<(/(0 $ WąUąWW 60RQRYHWWH FVąYHW QH NÜ]]HO WÈYROìWVD HO
$ IHUWĈWOHQìWÜVUH YRQDWNR]Ă WXGQLYDOĂNDW D FHQWULIXJD KDV]QÈODWL XWDVìWÈVÈEDQ WDOÈOMDBS 4851+
szerint (EUkód)

5HODWìYFHQWULIXJÈOLVHUĈ J
S-Monovette®

DIN EN ISO 6710–

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Szérum10 perc

10 perc

6 perc4 perc4 percSzérum gél

15 perc

10 perc

4 perc4 perc4 percSzérum Express gél

15 perc

10 perc

4 percn.v.

n.v.

Lítium-heparin

10 perc

10 perc

7 perc7 perc7 percLítium-heparin gél

15 perc

15 perc

10 perc

7 perc7 percLítium-heparin gél+

8 perc7 perc5 perc4 perc4 perc

EDTA

n.v.

n.v.

7 perc6 perc5 percEDTA gél

15 perc

10 perc

10 perc

7 perc7 perc&LWUÈW

9 perc8 perc7 perc6 perc5 perc('7$ĲXRULGKHSDULQ

9 perc8 perc7 perc6 perc5 percGlucoEXACT

9 perc8 perc7 perc6 perc5 perc&LWUÈW3%0PO&HQWULIěJDVXJÈU!FP

9 perc8 perc7 perc6 perc5 perc&LWUÈW3%0PO&HQWULIěJDVXJÈU!FPGHƉFP

n.v.

n.v.

10 perc

n.v.

n.v.

n.v. = nem validált
60RQRYHWWHFVąYHNUHYRQDWNR]LND¢PPÈWPÜUĈNLYÜWHOÜYHO 60RQRYHWWH
gyermekgyógyászat).

Centrifugálás 20°C-on+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, visszavonva.

Információ az elválasztó anyagról$]HOYÈODV]WĂDQ\DJ JÜO IRO\ÈVLWXODMGRQVÈJDLDKĈPÜUVÜNOHWWĈOIĞJJHQHN+DD]60RQRYHWWHFVąYHNHWDFHQWULIXJÈOÈVHOĈWWYDJ\DODWWKĢWLNPÈUQHPEL]WRVìWRWWKRJ\D]HOYÈODV]WĂJÜOPHJV]DNìWÈVQÜONĞOLUÜWHJHW
képezzen.
$]60RQRYHWWHFVąYHNHWQHPV]DEDGěMUDFHQWULIXJÈOQLdUWDOPDWODQìWÈV
1.

$]ÈOWDOÈQRVKLJLÜQLDLLUÈQ\HOYHNHWYDODPLQWDIHUWĈ]ĈDQ\DJRNV]DEÈO\V]HUĢÈUWDOPDWODQìWÈVÈUDYRQDWNR]ĂWąUYÜQ\LUHQGHONH]ÜVHNHWıJ\HOHPEHNHOOYHQQLÜVEHNHOOWDUWDQL

2.

$]HOGREKDWĂNHV]W\ĢNPHJDNDGÈO\R]]ÈNDIHUWĈ]ÜVNRFNÈ]DWÈW3.

$IHUWĈ]ĈYDJ\PHJWąOWąWWYÜUYÜWHOLUHQGV]HUHNHWELROĂJLDLODJYHV]ÜO\HVDQ\DJRNÈUWDOPDWODQìWÈVÈUDKDV]QÈOWPHJIHOHOĈWDUWÈO\RNEDNHOONLGREQLDPHO\HNHWD]WNąYHWĈHQDXWRNOÈYYDOIHUWĈWOHQìWHQLOHKHWYDJ\HOOHKHW
égetni.

4.

$]ÈUWDOPDWODQìWÈVWPHJIHOHOĈKXOODGÜNÜJHWĈEHQYDJ\DXWRNOÈYYDO JĈ]VWHULOL]ÈOÈVVDO NHOOHOYÜJH]QL

99

HU7HUPÜNUHYRQDWNR]ĂV]DEYÈQ\RNÜVLUÈQ\HOYHNÜUYÜQ\HVYÈOWR]DWD
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Szabvány a vénás vérvételi edényekre:',1(1,62(J\V]HUKDV]QÈODWRVWDUWÈO\RNHPEHULYÜQÈVYÜUPLQWÈNJ\ĢMWÜVÜUH*CLSI (Clinical and Laboratory Standards Institute)6]LPEĂOXPRNÜVMHOąOÜVHNPDJ\DUÈ]DWD

Cikkszám(]HQNìYĞODNĞOąQVWHULOFVRPDJROÈVVDOHOOÈWRWWWHUPÜNHNUHÜUYÜQ\HV

Gyártási tételszám

Ne használja, ha a csomagolás sérült

Lejárat napja:(J\V]HUĢVWHULOYÜGHOPLUHQGV]HUNĞOVĈYÜGĈFVRPDJROÈVVDO

CE-jelölés

Sterilizálás besugárzás révén

In-vitro diagnosztikai orvostechnikai eszköz

Olvassa el a használati utasítást!

³MEĂOLIHOKDV]QÈOÈVHVHWÜQ)HUWĈ]ÜVYHV]ÜO\1DSIÜQ\WĈOYÜGYHWÈURODQGĂ

Száraz helyen tartandó

Gyártó

Gyártási ország

Steril folyadékpálya

1HVWHULOL]ÈOMDěMUD0ĢV]DNLYÈOWR]ÈVRNMRJÈWIHQQWDUWMXN
0LQGHQDWHUPÜNNHONDSFVRODWRVDQEHNąYHWNH]HWWVěO\RVHVHPÜQ\WD]LOOHWÜNHVQHP]HWLKDWĂVÈJKR]KLYDWDOKR]MHOHQWHQLNHOO

100

Istruzioni d‘uso – Sistema di prelievo ematico S-Microvette® SARSTEDTIT

Per uso diagnostico in-vitro
Destinazione d'uso
I sistemi di prelievo ematico S-Microvette®, gli aghi e gli adattatori sono utilizzati insieme come un sistema per i prelievi ematici venosi. Il sistema di prelievo ematico S-Monovette® serve a raccogliere, trasportare,manipolare e conservare i campioni ematici per le analisi diagnostiche in vitro da siero, plasma o sangue intero. Il prodotto è destinato all'uso in un ambiente professionale, da parte di personale medico e di laboratorio
preparato.

Descrizione del prodotto
I sistemi di prelievo ematico S-Monovette® sono costituiti da un contenitore in plastica, uno stantuffo, un pistone e un tappo a vite di plastica con codifica a colori con membrana integrata, sviluppata appositamente
per il collegamento a un ago (Safety-) o ago (Safety-) Multifly®, nonché da diversi additivi (preparazioni). Inoltre è disponibile una S-Monovette® senza additivi. Sistemi di prelievo ematico S-Monovette® con additivi
attivatore della coagulazione, attivatore della coagulazione con gel, litio eparina, litio eparina con gel, sodio eparina, citrato, EDTA, fluoruro EDTA, fluoruro eparina, fluoruro citrato, CPDA così come senza additivi, la
cui concentrazione di additivi, il volume dell’additivo liquido e la relativa tolleranza consentita così come il rapporto tra sangue e additivo rispettano i requisiti e le raccomandazione della norma internazionale DIN EN
ISO 6710 ”Single-use containers for venous blood specimen collection” e i Clinical and Laboratory Standards Institute’s Approved Standards (CLSI). La scelta dell'additivo dipende dal metodo di esame analitico.
Viene indicata dal produttore dei reagenti e/o dei dispositivi di analisi su cui viene condotto il test. Il sistema di prelievo ematico S-Monovette® è disponibile nelle seguenti versioni: sterile internamente, oppure imballato
singolarmente e sterile esternamente.

Codici colore dei tappi a vite S-Monovette®:

Additivo

Codice in lettere

Colore del tappo DIN EN
ISO 6710

Colore del tappo secondo
BS 4851+

Z

BiancoBiancoContenitore senza preparazione
S-Monovette® neutra Z
Contenitore con siero
S-Monovette® Siero CAT, con attivatore della coagulazione

CAT

Rosso

BiancoS-Monovette® Siero Gel CAT, con attivatore della coagulazione e gel

CAT

Giallo scuro

Giallo scuro

S-Monovette® Siero Express Gel CAT, con attivatore della coagulazione trombina e gel

CAT

Arancione-

S-Monovette® Litio-eparina LH, con litio eparina

LH

Verde

Arancione

S-Monovette® Litio-eparina liquida, con litio eparina

LH

Verde

Arancione

S-Monovette® Litio-eparina-Gel LH, con litio eparina e gel

LH

Verde

Arancione

S-Monovette® Litio-Eparina-Gel+ LH, con litio eparina e gel rapido

LH

Verde

Arancione

S-Monovette® Sodio-eparina NH, con sodio eparina

NH

MarroneVerde

S-Monovette® Ammonio-eparina AH, con ammonio eparina

n.d.

Blu

Blu

9NC

Blu

Verde

9NC

Azzurro-S-Monovette® K3 EDTA K3E, con potassio EDTA

K3E

Viola

Rosso

S-Monovette® K2 EDTA K2E, con potassio EDTA

K2E

Viola

Rosso

S-Monovette® K2 EDTA-gel K2E, con potassio EDTA e Gel

K2E

Viola

Rosso

S-Monovette®)OXRUXUR('7$)(FRQĲXRUXURHG('7$FE

GrigioGialloS-Monovette®)OXRUXURHSDULQD)+FRQĲXRUXURHGHSDULQD

FH-GialloS-Monovette®*OXFR(;$&7)&FRQĲXRUXURFLWUDWRHG('7$

FC

Rosa

GrigioLH

Blu scuro

Arancione

S-Monovette® ThromboExact, in combinazione con magnesio

n.d.

n.d., rosso scuron.d., rosso scuro

S-Monovette® CTADn.d.

n.d., blun.d., verde

S-Monovette® ACD

ACD

GialloGialloS-Monovette® CPDA

CPDA

GialloGialloS-Monovette® irudina

n.d.

n.d., verde oliva

n.d., verde oliva

S-Monovette® omocisteina HCY-Z gel, con gel e stabilizzatore

n.d.

n.d., grigio

n.d., grigio

S-Monovette® omocisteina HCY-C con tampone al citrato

n.d.

n.d., violan.d., viola

S-Monovette® DNA Exactn.d.

n.d., blun.d., bluContenitore eparina

Contenitore con citrato
S-Monovette® Citrato 9NC, citrato di sodio 3,13%®

S-Monovette PFA, Citrato 9NC, citrato di sodio 3,8%, con soluzione tampone
Contenitore con EDTA

Contenitore con inibitori della glicolisi

Contenitore per analisi metalli
S-Monovette® Analisi metalli LH, con litio eparina

Altri contenitori per sangue intero e plasma* Sono disponibili altri colori per tappi a vite.
n.d.: non definito+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, ritirato.

101

IT
SARSTEDT S-Monovette® Siero CAT / Siero gel CAT
La S-Monovette® Siero CAT contiene un granulato in plastica ricoperto da un attivatore della coagulazione (silicato) e serve per il prelievo di siero**. Il granulato in plastica si posiziona tramite centrifugazione tra sangue
coagulato e siero.
La S-Monovette® Siero gel CAT contiene, oltre al granulato in plastica ricoperto dall’attivatore della coagulazione (silicato), un gel a base polimerica e serve al prelievo di siero**. Il gel, tramite centrifugazione, si pone trasangue coagulato e siero e forma uno strato di separazione stabile durante il trasporto, la conservazione e l’analisi.
Il siero viene utilizzato come campione negli esami di routine clinico-chimici e immunologici così come in sierologia.
Una volta eseguito il prelievo ematico, il sangue deve coagulare per 30 minuti nella S-Monovette® Siero CAT / Siero gel CAT in posizione verticale per assicurare uno strato di separazione orizzontale ben formato dopo
la centrifugazione. Le tempistiche consigliate si basano su un processo di coagulazione intatto. Il sangue di pazienti con problemi di coagulazione dovuti a malattia o che assumono terapie anticoagulanti necessita
eventualmente di più tempo per la completa coagulazione.

S-Monovette® siero Express gel CAT SARSTEDTLa S-Monovette® Siero Express gel CAT contiene, oltre al granulato in plastica ricoperto dall’attivatore della coagulazione (trombina), un gel a base polimerica e serve al prelievo di siero**. Il gel, tramite centrifugazione, si
pone tra sangue coagulato e siero e forma uno strato di separazione stabile durante il trasporto, la conservazione e l’analisi.
Una volta eseguito il prelievo ematico, il sangue deve coagulare per 5 minuti nella S-Monovette® Siero Express gel in posizione verticale per assicurare uno strato di separazione orizzontale ben formato dopo lacentrifugazione. Le tempistiche consigliate si basano su un processo di coagulazione intatto, anche per il sangue di pazienti che ricevono eparina. Il sangue di pazienti con problemi di coagulazione dovuti a malattia oche assumono terapie anticoagulanti, inclusa eparina ad alte dosi, necessita di più tempo per la completa coagulazione.
Il siero viene utilizzato come campione negli esami di routine clinico-chimici e immunologici così come in sierologia.

S-Monovette® neutra Z SARSTEDTLa S-Monovette® neutrale Z non contiene alcuna preparazione, il che corrisponde a una coagulazione naturale del campione di sangue senza attivatore della coagulazione, e serve al prelievo di siero**. La centrifugazione
determina la separazione tra sangue coagulato e siero.
Il siero viene utilizzato come campione per analisi specifiche dell'operatore.
La S-Monovette® neutra Z, inoltre, può essere utilizzata come contenitore vuoto nei seguenti casi: se il prelievo ematico viene iniziato con una S-Monovette® Citrato in combinazione con un ago (Safety-)Multifly® (ago afarfalla), la S-Monovette® neutra Z sarà utilizzata come primo contenitore (contenitore vuoto) per il riempimento del tubo dell’ago (Safety-)Multifly®.

S-Monovette® Litio-eparina LH /Llitio-eparina-gel LH / Litio-eparina-Ggel+ LH, Sodio eparina NH, Ammonio eparina AH SARSTEDTLa S-Monovette® Litio-eparina LH / Sodio-eparina NH / Ammonio-eparina AH contiene un granulato in plastica ricoperto da un inibitore della coagulazione (anticoagulante) litio eparina / sodio eparina / ammonio eparina(solitamente 16 I.E. eparina/ ml sangue) e serve al prelievo di sangue intero e di plasma**. Il granulato in plastica si posiziona tramite centrifugazione tra cellule ematiche e plasma.
In caso di S-Monovette® Litio-eparina LH senza granulato in plastica, l’anticoagulante litio eparina è presente in forma dosata a spruzzo (solitamente 19 I.E. eparina/ ml sangue).
La S-Monovette® Litio-eparina-Gel LH contiene, oltre al granulato in plastica ricoperto dall’anticoagulante litio eparina (solitamente 25 I.E. eparina/ ml sangue), un gel a base polimerica e serve al prelievo di plasma**. Il
gel, tramite centrifugazione, si pone tra cellule ematiche e plasma e forma uno strato di separazione stabile durante il trasporto, la conservazione e l’analisi.
La S-Monovette® Litio-eparina-Gel+ LH contiene anche un gel a base polimerica che consente un periodo di centrifugazione ridotto di circa il 50% rispetto alla S-Monovette® Litio-eparina-Gel.
Il plasma eparinato viene utilizzato come campione negli esami di routine clinico-chimici e immunologici. Il sangue intero eparinato viene utilizzato come campione negli esami di routine immunologici così come insierologia.
L’inibizione della coagulazione con eparina avviene grazie all’attivazione dell’antitrombina.
NOTA: Dalla S-Monovette® Litio-eparina LH e Litio-eparinaGel/gel+ LH non possono essere eseguite determinazioni del litio, dalla S-Monovette® Sodio-eparina NH del sodio e dalla S-Monovette®
$PPRQLRHSDULQD$+GHOOŖDPPRQLR/D60RQRYHWWH® Litio-eparina/Litio-eparina-Gel/Gel+6RGLRHSDULQD$PPRQLRHSDULQDULHPSLWDGLVDQJXHYHQRVRQRQÛDGDWWDDGDQDOLVLHPDWLFKH

S-Monovette® Analisi metalli SARSTEDTLa S-Monovette® Analisi metalli contiene l’anticoagulante litio eparina e serve a prelievi di sangue intero e plasma**. La litio eparina è disponibile in forma dosata a spruzzo (19 I.E. eparina / ml sangue).
Il sangue intero o il plasma eparinato della S-Monovette® per l'analisi dei metalli, in combinazione con lo speciale ago di sicurezza 21G x 1 ½" (Art.-No. 85.1162.600), viene utilizzato come campione per gli esami sugli
oligoelementi/metalli. Gli oligoelementi / metalli sono stati validati tramite spettrometria di assorbimento atomico. Per il sistema ago Safety e S-Monovette® Analisi metalli risultano i seguenti valori massimi dei bianchi nel
sistema ng per questi oligoelementi:

Elemento

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/sistema

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

®

I valori massimi dei bianchi per questo elemento sono indicati sull’etichetta della S-Monovette .
La determinazione degli oligoelementi avviene a seconda del procedimento di analisi da sangue intero eparinato o da plasma eparinato.
L’inibizione della coagulazione con eparina avviene grazie all’attivazione dell’antitrombina.

SARSTEDT S-Monovette® Citrato 9NC
La S-Monovette® Citrato 9NC contiene l’anticoagulante citrato trisodico e serve al prelievo di sangue interno e di plasma**. Il citrato trisodico è presente come soluzione molare 0,106 (3,13% soluzione di citrato trisodico;
arrotondato spesso al 3,2%) e corrisponde al 10% del volume nominale di una S-Monovette® Citrato. Il rapporto di miscela tra citrato e sangue corrisponde a 1:9 – 1 parte di volume di citrato e 9 parti di volume disangue. Il corretto riempimento è indispensabile per le analisi.
Il plasma citrato viene utilizzato come campione nelle analisi di routine emostaseologiche.
L’inibizione della coagulazione avviene tramite complessazione degli ione calcio tramite il citrato.
Rispettare gli AVVISI su prelievo e manipolazione nella combinazione S-Monovette® Citrato e ago a farfalla.

S-Monovette® PFA 9NC SARSTEDTLa S-Monovette® PFA 9NC contiene l’anticoagulante citrato trisodico e serve al prelievo di sangue interno e di plasma**. Il citrato trisodico è presente come soluzione tamponata molare 0,129 (3,8% tamponata; pH 5,5)e corrisponde al 10% del volume nominale di una S-Monovette® PFA. Il rapporto di miscela tra citrato e sangue corrisponde a 1:9 – 1 parte di volume di citrato e 9 parti di volume di sangue. Il corretto riempimento è
indispensabile per le analisi.
Il sangue intero della S-Monovette® PFA 9NC viene utilizzato come campione per la determinazione della funzione dei trombociti con il dispositivo di analisi SIEMENS Healthineers PFA ed è validato a tal fine.
L’inibizione della coagulazione avviene tramite complessazione degli ione calcio tramite il citrato.
Rispettare gli AVVISI su prelievo e manipolazione nella combinazione S-Monovette® PFA e ago a farfalla.

S-Monovette® CTAD SARSTEDTLa S-Monovette® CTAD contiene l’anticoagulante citrato trisodico così come teofillina, adenosina e dipiridamolo e serve al prelievo di sangue interno e di plasma**. CTAD è presente come soluzione e corrisponde al 10%
del volume nominale di una S-Monovette® CTAD. Il rapporto di miscela tra CTAD e sangue corrisponde a 1:9 – 1 parte di CTAD e 9 parti di volume di sangue. Il corretto riempimento è indispensabile per le analisi.
Il plasma CTAD viene utilizzato come campione per la determinazione del fattore piastrinico 4 (PF4), della beta(ß) tromboglobulina (ßTG) e dell’inibitore dell’attivatore del plasminogeno (PAI-1) così come per esami diroutine emostaseologici.
L’attivazione di trombociti viene inibita per un periodo di almeno 4 ore e serve al controllo delle terapie con eparina.
L’inibizione della coagulazione avviene tramite complessazione degli ione calcio tramite il citrato.
Rispettare gli AVVISI su prelievo e manipolazione nella combinazione S-Monovette® CTAD e ago a farfalla.
127$&7$'ÛJLDOOR/D60RQRYHWWH®&7$'GXUDQWHOŖLPPDJD]]LQDJJLRGHYHHVVHUHSURWHWWDGDOODOXFHQDWXUDOHHDUWLıFLDOH8QDIRUWHD]LRQHGHOODOXFHSHUSLĚGLRUHSXāGHWHUPLQDUHOŖDWWLYD]LRQH
degli additivi.

102

IT
S-Monovette® SARSTEDT EDTA K2E / K3E
La S-Monovette® EDTA K2E / S-Monovette® EDTA K3E contiene l’anticoagulante K2 EDTA o K3 EDTA e serve al prelievo di sangue interno**. K2 EDTA e K3 EDTA sono disponibili in forma dosata a spruzzo (1,6 mg
EDTA / ml sangue).
Il sangue intero EDTA viene utilizzato come campione per esami ematologici. Gli strisci di sangue devono essere eseguiti entro quattro ore dopo il prelievo di sangue.
L’inibizione della coagulazione avviene tramite complessazione degli ione calcio tramite EDTA.
Il sangue dalla S-Monovette® EDTA K2E / K3E può essere utilizzato anche per indagini immunoematologiche di routine e test su malattie infettive. L’operatore è responsabile sia della validazione dell’idoneità delcampione per questi esami utilizzando i reagenti e i dispositivi di analisi sia delle condizioni di conservazione.

S-Monovette® EDTA gel K2E SARSTEDTLa S-Monovette® EDTA gel K2E contiene, oltre all’anticoagulante K2 EDTA, un gel a base polimerica e serve al prelievo di plasma**. K2 EDTA è disponibile in forma dosata a spruzzo (1,6 mg EDTA / ml sangue). Il gel,tramite centrifugazione, si pone tra cellule ematiche e plasma e forma uno strato di separazione stabile durante il trasporto, la conservazione e l’analisi.
Il plasma EDTA viene utilizzato come campione per la diagnostica virale molecolare.
L’inibizione della coagulazione avviene tramite complessazione degli ioni calcio tramite EDTA.

S-Monovette®)OXRUXUR('7$)(ĲXRUXURHSDULQD)+ĲXRUXURFLWUDWR('7$)&FRQLQLELWRULGHOODJORFROLVL6$567('7La S-Monovette® Fluoruro EDTA FE contiene l’anticoagulante EDTA (1,2 mg / ml sangue) così come fluoruro (1,0 mg / ml sangue) per l’inibizione della glicolìsi e serve al prelievo di plasma**. Fluoruro EDTA è disponibile informa dosata a spruzzo.
La S-Monovette® Fluoruro-eparina FH contiene l’anticoagulante eparina (16 I.E. eparina / ml sangue) così come fluoruro (1,0 mg / ml sangue) per l’inibizione della glicolìsi e serve al prelievo di plasma**. Fluoruro eparina èdisponibile in forma dosata a spruzzo.
L’inibizione della glicolisi dovuta solamente al fluoruro inizia circa 2 ore dopo il riempimento del contenitore del prelievo di sangue e mostra tutti i suoi effetti dopo circa 4 ore. Il glucosio, pertanto, degrada nel processo
fino al 6% dopo poche ore e fino al 10-15% dopo 24 ore nel sangue intero.
La S-Monovette® GlucoEXACT FC contiene l’anticoagulante EDTA così come citrato e fluoruro per l’immediata inibizione della glicolìsi e serve al prelievo di plasma**. EDTA, citato e fluoruro sono disponibili comesoluzione. Il calcolo della concentrazione di glucosio richiede, a causa della diluizione, la moltiplicazione con 1,16.
La S-Monovette® GlucoEXACT FC rispetta la linea guida sul diabete gestazionale della Deutsche Diabetes Gesellschaft (DDG) e la Nationale VersorgungsLeitlinie (NVL) per il diabete di tipo 2. La stabilizzazione immediatadella concentrazione di glucosio viene garantita fino a 96 a temperatura ambiente nel sangue intero (si veda anche il WhitePaper di SARSTEDT https://www.sarstedt.com/en/products/diagnostic/venous-blood/smonovetter/Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“).
Il plasma (citrato) fluoruro EDTA viene utilizzato come campione per la determinazione del glucosio.
L’inibizione della coagulazione avviene tramite complessazione degli ione calcio tramite EDTA.
127$,OĲXRUXURSXāSURYRFDUHXQDXPHQWRGHOO HPROLVL8OWHULRULLQIRUPD]LRQLVXOOHVRVWDQ]HFKHSRVVRQRLQWHUIHULUHGHYRQRHVVHUHYHULıFDWHQHOOHULVSHWWLYHLVWUX]LRQLG XVRGHOSURGXWWRUHGHL
reagenti.
Rispettare gli AVVISI su prelievo e manipolazione nella combinazione S-Monovette® GlucoEXACT e ago a farfalla.

S-Monovette® CPDA SARSTEDTLa S-Monovette® CPDA contiene l’anticoagulante citrato di sodio così come acido citrico, fosfato di sodio, destrosio e adenina e serve al prelievo di sangue interno e di plasma**. CPDA è disponibile come soluzione. Il
rapporto di miscela tra CPDA e sangue corrisponde a 1:6 – 1 parte di CPDA e 6 parti di volume di sangue. Il corretto riempimento, a causa dell’analisi, è assolutamente necessario.
Il CPDA sangue intero / plasma viene utilizzato come campione per la sierologia del gruppo sanguigno nella medicina trasfusionale, per ricerche sulla compatibilità (prove incrociate) nelle trasfusioni. La S-Monovette®
CPDA, concretamente, è adatta alla determinazione dei gruppi sanguigni (AB0), inclusi Kell e formula di Rhesus, test diagnostici su anticorpi irregolari dei gruppi sanguigni, test di Coombs diretti polispecifici (fino algiorno 10), test di compatibilità (prova incrociata) con siero/plasma del paziente compatibile per gruppo sanguigno (Major Test).
/DGXUDWDGHOWUDVSRUWRILQRDOORVWRFFDJJLRÛYDOLGDWDSHUXQPDVVLPRGLRUHDbƓ&3HUODVHGLPHQWD]LRQHGHOOHFHOOXOHLFDPSLRQLGHYRQRHVVHUHFRQVHUYDWLLQSUHFHGHQ]DSHUDOPHQRRUHLQSRVL]LRQHYHUWLFDOH
LQIULJRULIHUR*OLDQDOLWLVRSUDLQGLFDWLVXFFHVVLYDPHQWHSRWUDQQRHVVHUHGHWHUPLQDWLILQRDJLRUQLLQPRGRDQDORJRDOSHULRGRGLFRQVHUYD]LRQHGHOVDQJXHLQIULJRULIHUR bƓ& FRQHFFH]LRQHGHOWHVW&RRPEV
diretto, 10 giorni. Adatta per la procedura di agglutinazione su colonna ad es. sul Vision Max di Ortho Clinical Diagnostics. Il campione non può essere congelato.
L’operatore è responsabile sia della validazione dell’idoneità del campione per questi esami utilizzando altre metodologie/reagenti/dispositivi di analisi sia delle condizioni di conservazione.
L’inibizione della coagulazione avviene tramite complessazione degli ioni calcio tramite il citrato.
Rispettare gli AVVISI su prelievo e manipolazione nella combinazione S-Monovette® CPDA e ago a farfalla.

S-Monovette® ThromboExact SARSTEDTLa S-Monovette® ThromboExact contiene come anticoagulante un sale di magnesio e serve al prelievo di sangue intero**. Il sale di magnesio è disponibile in forma dosata a spruzzo.
Il sangue intero della S-Monovette® ThromboExact viene utilizzato come campione per escludere conteggi errati di bassi trombociti causati dall’intolleranza di anticoagulanti (ad es. EDTA, citrato, eparina), chiamata
anche pseudotrombocitopenia. La formazione di aggregati di trombociti è impedita e la determinazione del numero effettivo di trombociti è possibile fino a 12 ore dopo il prelievo di sangue.
L’inibizione della coagulazione avviene tramite ioni al magnesio che inibiscono il trombossano A2 trombocitario così come l’aggregazione di trombociti procurati tramite ADP e acido arachidonico.

S-Monovette® irudina SARSTEDTLa S-Monovette® irudina contiene l’anticoagulante irudina e serve a prelievi di sangue intero**. L’irudina è disponibile in forma dosata a spruzzo.
Il sangue intero (irudina) viene utilizzato come campione per la determinazione della funzione dei trombociti sul dispositivo Multiplate® (multiple platelet function analyser) di ROCHE Diagnostics ed è validato a tal scopo.
Viene utilizzato per il monitoraggio di terapie con medicinali inibitori delle piastrine così come per provare o escludere disturbi funzionali dei trombociti.
La S-Monovette® irudina è stata specificatamente sviluppata per la determinazione della funzione dei trombociti insieme alla società Verum Diagnostica, oggi ROCHE Diagnostics, sul dispositivo Multiplate®.
L’inibizione della coagulazione avviene tramite irudina con diretta inibizione della trombina e consente in questo modo una diagnosi funzionale dei trombociti nello stato naturale.

S-Monovette® omocisteina HCY-Z gel/HCY-C SARSTEDTLa S-Monovette® omocisteina HCY-Z gel contiene, oltre al granulato in plastica ricoperto dall’attivatore della coagulazione (silicato), uno speciale stabilizzatore e un gel a base polimerica e serve al prelievo di siero**. Il
gel, tramite centrifugazione, si pone tra sangue coagulato e siero e forma uno strato di separazione stabile durante il trasporto, la conservazione e l’analisi. La preparazione è disponibile in forma dosata a spruzzo.
L’omocisteina viene stabilizzata fino a 8 ore nel sangue intero a temperatura ambiente. Se la centrifugazione avviene entro le prime 8 ore con strato di separazione correttamente formatosi tra sangue coagulato e siero,l’omocisteina si stabilizza fino a 96 ore.
Il siero della S-Monovette® omocisteina HCY-Z-gel viene utilizzato come campione per la determinazione della omocisteina. La S-Monovette® omocisteina HCY-C contiene come anticoagulante citrato acido (pH 4,3) eserve al prelievo di plasma**. Il citrato è disponibile come soluzione. Il calcolo della concentrazione di omocisteina richiede, a causa della diluizione, la moltiplicazione con 1,11.
/ŖRPRFLVWHLQDYLHQHVWDELOL]]DWDDWHPSHUDWXUDDPELHQWHILQRDRUHHDbƓ&ILQRDRUHQHOVDQJXHLQWHUR
Il plasma della S-Monovette® omocisteina HCY-C viene utilizzato come campione per la determinazione della omocisteina.
L’inibizione della coagulazione nella S-Monovette® omocisteina HCY-C avviene tramite la complessazione degli ioni calcio tramite il citrato.
Rispettare gli AVVISI su prelievo e manipolazione nella combinazione S-Monovette® HCY-C e ago a farfalla.

S-Monovette® DNA Exact SARSTEDTLa S-Monovette® DNA Exact contiene un anticoagulante su base EDTA e serve al prelievo di sangue intero**. EDTA è disponibile in forma dosata a spruzzo.
,OVDQJXHLQWHUR('7$YLHQHXWLOL]]DWRFRPHFDPSLRQHSHUODVWDELOL]]D]LRQHGHOJ'1$/DFDSDFLWÇGLVWDELOL]]D]LRQHSHULOJ'1$ÛYDOLGDWDVXJLRUQLDbƓ&JLRUQLDWHPSHUDWXUDDPELHQWH bƓ& JLRUQLDOIUHGGRbƓ& HDOPHQRDQQRDbƓ&,FDPSLRQLVWDELOL]]DWLLQROWUHVRSUDYYLYRQRDFLFOLGLFRQJHODPHQWRHVFRQJHODPHQWRVHQ]DULGX]LRQLGHOODTXDOLWÇ VLYHGDDQFKHLO:KLWH3DSHUGL6$567('7https://www.sarstedt.
com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for
Genomic DNA Analysis.”).
L’inibizione della coagulazione avviene tramite complessazione degli ioni calcio tramite EDTA.

**L’idoneità del campione dipende dall’analita e dal reagente/dispositivo di analisi. Devono essere osservate le relative raccomandazioni del produttore.

103

IT
Istruzioni/avvertenze di sicurezza
1.

Precauzioni generali: Indossare guanti e altri dispositivi di protezione individuale generali per proteggersi dal sangue e dalla possibile esposizione a materiale del campione potenzialmente infettivi e a patogeni
trasmissibili.

2.

7UDWWDUHWXWWLLFDPSLRQLELRORJLFLHJOLVWUXPHQWLSHULOSUHOLHYRHPDWLFRDĴODWLDSSXQWLWL DJKLDGDWWDWRUL QHOULVSHWWRGHOOHGLUHWWLYHHGHOOHSURFHGXUHGHOSURSULRLVWLWXWR,QFDVRGLFRQWDWWRGLUHWWRFRQFDPSLRQLELRORJLFL
RGLSXQWXUDFRQVXOWDUHXQPHGLFRLQTXDQWRHVLVWHODSRVVLELOLWÇGLWUDVPLVVLRQHGL+,9+&9+%9RDOWUHPDODWWLHLQIHWWLYH8WLOL]]DUHDJKL6DIHW\6DIHW\0XOWLĲ\® con copriago incorporato. Attenersi alle direttive ealle procedure di sicurezza del proprio istituto.

3.

Si applica per prodotti confezionati sterili singolarmente Prima dell'uso, controllare ogni singola confezione per rilevare eventuali danni e, qualora ve ne fossero, non utilizzarla.

4.

,OSURGRWWRÛPRQRXVR6PDOWLUHWXWWLJOLRJJHWWLDĴODWLDSSXQWLWL DJKLDGDWWDWRUL SHULOSUHOLHYRGLVDQJXHLQXQFRQWHQLWRUHLGRQHRSHUPDWHULDOLDULVFKLRELRORJLFR5.

In caso di prelievo ematico mediante accesso endovenoso (EV), occorre assicurarsi che l’accesso venga risciacquato correttamente in base al presidio (ossia, che venga ripulito dalla soluzione endovenosa) prima diiniziare il prelievo di sangue. Il lavaggio corretto dell’accesso previene risultati delle analisi errate.

6.

,OULHPSLPHQWRLQVXĴFLHQWHGHOOD60RQRYHWWH® provoca una proporzione errata tra sangue e preparazione/additivo e può causare risultati di analisi errati.

7.

Il sangue prelevato e manipolato con la S-Monovette® non deve essere nuovamente iniettato nell'organismo umano.

8.

Non usare il prodotto dopo la data di scadenza. Il periodo di conservazione termina l’ultimo giorno del mese e dell’anno indicati.

Conservazione
Conservare il prodotto a temperatura ambiente fino all’utilizzo.

Limitazioni
1.

La durata e la temperatura di conservazione di una S-Monovette®SLHQDGLSHQGRQRGDOSHULRGRGLFRQVHUYD]LRQHGHJOLDQDOLWLGDHVDPLQDUH/DYDOXWD]LRQHÛHĳHWWXDWDGDOODERUDWRULRHOHLQIRUPD]LRQLVRQRSUHVH
dalle istruzioni d’uso del produttore del reagente/del dispositivo di analisi.

2.

Anche se il plasma o il siero viene separato tramite centrifugazione della S-Monovette® e/o è disponibile una barriera, non necessariamente sono separate tutte cellule. Il metabolismo residuo o il degrado naturale
SXāLQĲXHQ]DUHODFRQFHQWUD]LRQHGHJOLDQDOLWL2FFRUUHYHULıFDUHODVWDELOLWÇGHJOLDQDOLWLLQUHOD]LRQHDOFRQWHQLWRUHGLFRQVHUYD]LRQHHDOOHFRQGL]LRQLGHOUHODWLYRODERUDWRULR

3.

,QFDVRGLIDUPDFLWHUDSHXWLFLÛQHFHVVDULRYHULıFDUHO LGRQHLWÇGHOPDWHULDOHGHOFDPSLRQHQHOOHLVWUX]LRQLG XVRGHOSURGXWWRUHGHLUHDJHQWLGLVSRVLWLYRGLDQDOLVL

4.

Le analisi per gli oligoelementi/metalli devono essere condotti con il sistema S-Monovette® analisi dei metalli + ago Safety analisi dei metalli.

Prelievo e manipolazione del campione
PRIMA DI PROCEDERE AL PRELIEVO EMATICO VENOSO, LEGGERE FINO IN FONDO QUESTO DOCUMENTO.
Materiale di lavoro necessario per il prelievo del campione
1.

Tutti i sistemi di prelievo ematici S-Monovette® necessari.

2.

$JKL 6DIHW\ RDJKL 6DIHW\ 0XOWLĲ\®

3.

Guanti, camici, protezioni per gli occhi o altri indumenti protettivi appropriati per proteggersi da agenti patogeni trasmessi con il sangue o materiali potenzialmente infettivi.

4.

(WLFKHWWHSHUO LGHQWLıFD]LRQHGHOSD]LHQWH

5.

Materiale disinfettante per la pulizia del sito di prelievo (attenersi alle linee guida della struttura per la preparazione del sito di prelievo sterile del campione). Non utilizzare materiali di pulizia a base di alcol se i
campioni devono essere utilizzati per il test dell'alcolemia.

6.

Tamponi monouso asciutti e asettici.

7.

Laccio emostatico.

8.

Cerotto o bendaggio.

9.

&RQWHQLWRUHSHURJJHWWLDĴODWLDSSXQWLWLSHUORVPDOWLPHQWRVLFXURGHLPDWHULDOLXVDWL

Procedura di prelievo consigliata:1.

Bottiglie per emocoltura

2.

Contenitori con citrato o attivatore della coagulazione (con/senza gel siero CAT/siero gel CAT)

3.

Contenitori con attivatore della coagulazione o citrato

4.

Contenitori con eparina con/senza gel

5.

Contenitori con EDTA con/senza gel

6.

Contenitori con inibitori della glicolisi

7.

Contenitori con altri additivi
Avviso:se si inizia il prelievo di un contenitore di citrato o di un altro contenitore con preparazione di liquidi come ad es. PFA, CTAD, CPDA, HCY-C o GlucoEXACT in combinazione con un ago
DIDUIDOOD DGHVDJR 6DIHW\ 0XOWLĲ\®), si consiglia di anticipare il prelievo di un contenitore vuoto (ad es. S-Monovette®QHXWUD= SHUHYLWDUHLOULHPSLPHQWRLQVXĴFLHQWHGHOFRQWHQLWRUH
FDXVDWRGDOULHPSLPHQWRGHOWXERGHOOŖDJRDIDUIDOOD
,QTXHVWRPRGRÛSRVVLELOHJDUDQWLUHLOFRUUHWWRULHPSLPHQWRGHOFRQWHQLWRUHHTXLQGLLOFRUUHWWRUDSSRUWRGLPLVFHOD OLTXLGRVDQJXH 

Avviso:per la procedura di prelievo, attenersi alle norme del proprio istituto.

(YLWDUHULĲXVVL
La maggior parte delle S-Monovette contiene additivi chimici. Attenersi alle seguenti indicazioni per evitare il riflusso:
1. Utilizzare esclusivamente i materiali consigliati nelle istruzioni d’uso.
2.

Posizionare il paziente in modo da godere di un facile accesso alla vena e dirigere in basso il braccio o altra sede della puntura.

3.

Tenere la S-Monovette®FRQLOWDSSRDYLWHULYROWRYHUVROŖDOWRHLQFDVRGLXWLOL]]RGLXQDJR 6DIHW\ 0XOWLĲ\®, sotto il livello del braccio/sede della puntura.

4.

Occorre assicurarsi che, al momento della venipuntura, il contenuto della S-Monovette® non tocchi il tappo a vite o l’estremità dell’ago.

5.

$OOHQWDUHLOODFFLRHPRVWDWLFRPHQWUHLOVDQJXHĲXLVFHQHOOD60RQRYHWWH®.

104

IT
Congelamento/scongelamento
Si consiglia, a sensi delle raccomandazioni del WHO (WHO/DIL/Lab/99.1 Rev.02), di separare siero/plasma prima del congelamento di cellule ematiche.
Per la S-Monovette® valgono le seguenti indicazioni per il congelamento:&RQJHODPHQWRDPHQRGLbƓ&•/ŖXWLOL]]RLQLQWHUYDOOLGLWHPSHUDWXUDVRWWROR]HURGHYHHVVHUHQHFHVVDULDPHQWHWHVWDWRLQFRQGL]LRQLUHDOLSRLFKÜLOFDULFRGHLFRQWHQLWRULSXāHVVHUHPROWRGLĳHUHQWHDVHFRQGDGHOODVRVWDQ]DGDFRQJHODUHHGHOOH
condizioni routinarie (si veda il capitolo “Caratteristiche dei materiali”, catalogo SARSTEDT).

•,QOLQHDGLPDVVLPDLYDORULGLVWDELOLWÇGHOODSODVWLFDGLPLQXLVFRQRQHOO LQWHUYDOORGLWHPSHUDWXUDLQIHULRUHDbƓ&3HUWDQWRLQJHQHUDOHRFFRUUHHYLWDUHOHVROOHFLWD]LRQLPHFFDQLFKH

•

Occorre scegliere condizioni di congelamento tali da consentire che il contenuto della S-Monovette® venga congelato in modo omogeneo e dal basso verso l'alto. La S-Monovette®GHYHGLVSRUUHGLVSD]LRVXĴFLHQWH
LQXQSRUWDSURYHWWHRXQDVFDWRODGLVWRFFDJJLRDOıQHGLFRQVHQWLUQHO HVSDQVLRQH,SRUWDSURYHWWHLQSROLVWLURORRPHWDOORQRQVRQRLGRQHLLQTXDQWRSRVVRQRFDXVDUHLQFULQDWXUHDFDXVDGHOO HVSDQVLRQH

&RQJHODPHQWRDbƓ&3ULPDGHOFRQJHODPHQWRYHULıFDUHTXDQWRVHJXH•,QWHUIHUHQ]H9HULıFDUHVHLOFRQJHODPHQWRLQWHUIHULVFHFRQLOFDPSLRQHGLVDQJXHROHDQDOLVL DGHVHPROLVLVWDELOLWÇGHJOLDQDOLWL •&HQWULIXJD]LRQH1HFHVVDULRDVHFRQGDGHOOŖHVDPHSLDQLıFDWR3HUOHFRQGL]LRQLGLFHQWULIXJD]LRQHVLYHGDTXHVWRGRFXPHQWRDOSXQWRŗ&HQWULIXJD]LRQHŘVLFRQWUROOLLOVLWRZHEGL6$567('7https://www.sarstedt.
com/en/service/centrifugation/e si eseguano controlli visivi a campione.

•(PROLVL,OVDQJXHLQWHURHPROL]]DGXUDQWHLOFRQJHODPHQWRDOıQHGLHYLWDUORGRYUHEEHHVVHUHXWLOL]]DWDOD60RQRYHWWH®*HORGRSRODFHQWULIXJD]LRQHLOıOWURSHUYDOYROH6HUDSODV® ovvero il campione dovrebbe
essere travasato con pipetta in un contenitore secondario.

&RQJHODPHQWRDbƓ&(VHFX]LRQH
•5DĳUHGGDPHQWR5DĳUHGGDUHOD60RQRYHWWH®LQSRVL]LRQHGLULWWDFRQWHPSHUDWXUDDPELHQWHDbƓ&SHUXQSHULRGRGDDPLQSULPDGLFRQJHODUODDbƓ&

•Scongelamento: Lasciar scongelare in posizione diritta a temperatura ambiente per almeno 45 min. Anche in questo caso, occorre evitare sollecitazioni meccaniche. Uno scongelamento eccessivamente rapido può
alterare i risultati delle analisi.

&RQJHODPHQWRVRWWRLbƓ&•,OSURGXWWRUHQRQKDWHVWDWRLOFRQJHODPHQWRDWHPSHUDWXUHLQIHULRULDbƓ&$IURQWHGHOODPROWHSOLFLWÇGLSRVVLELOLIDWWRULG LQĲXHQ]DVLFRQVLJOLDGLHVHJXLUHWHVWGLFRQJHODPHQWRDOOHFRQGL]LRQLGLURXWLQHGHO
laboratorio.

Congelamento di S-Monovette® Gel:•,OFRQJHODPHQWRKDOXRJRFRPHLQGLFDWRQHOSXQWRŗ&RQJHODPHQWRDbƓ&ş(VHFX]LRQHŘ•Lo strato di gel, come noto, può cambiare a causa del processo di congelamento.

•$IURQWHGHOODPROWHSOLFLWÇGLSRVVLELOLIDWWRULG LQĲXHQ]DVLFRQVLJOLDGLHVHJXLUHWHVWGLFRQJHODPHQWRDOOHFRQGL]LRQLGLURXWLQHGHOODERUDWRULR

•Scongelamento:)DUVFRQJHODUHLQFDPSLRQHLQSRVL]LRQHYHUWLFDOH7UDVIHULUHLOFDPSLRQHGRSRORVFRQJHODPHQWRPHGLDQWHSLSHWWD VHQ]DGHFDQWD]LRQH ıQRDFLUFDPPVRSUDORVWUDWRGLJHOGDOFRQWHQLWRUH
primario in un contenitore secondario. Gettare il residuo.
127$3HUODVWDELOLWÇGHJOLDQDOLWLGHYRQRHVVHUHRVVHUYDWHOHLVWUX]LRQLGŖXVRGHOSURGXWWRUHGHOUHDJHQWHGHOGLVSRVLWLYRGLDQDOLVL

105

IT
Prelievo ematico
Tecniche di prelievo
Si differenzia tra due tecniche di prelievo: la tecnica di aspirazione e la tecnica sottovuoto.
La tecnica di aspirazione consente, grazie all’estrazione controllata dello stantuffo, un prelievo ematico atraumatico con flusso di sangue lento e continuo. Il flusso di sangue, in questo modo, si fa adattare direttamente a
tutte le situazioni e condizioni delle vene; l’emolisi si riduce.
La tecnica sottovuoto consente, grazie a un contenitore svuotato in precedenza, il prelievo ematico secondo il principio della depressione con un flusso di sangue continuo e rapido. Questa tecnica, pertanto, è ideale
per buone condizioni venose e semplici condizioni di prelievo.
Manipolazione per il prelievo di sangue: si veda anche il video sulla manipolazione della S-Monovette® nella tecnica di aspirazione e nella tecnica sottovuoto con l’ago Safety o con l’ago Safety-Multfly®:www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
PER RIDURRE AL MINIMO IL RISCHIO DI ESPOSIZIONE, DURANTE IL PRELIEVO DI SANGUE INDOSSARE I GUANTI.
1. Selezionare la S-Monovette® idonea per il campione richiesto.
2.

Selezionare il punto dove praticare la venipuntura. Per la preparazione del punto di incisione della venipuntura attenersi alle linee guida dell'istituto.

Prelievo ematico con tecnica di aspirazione
Attenzione! Utilizzare la S-Monovette® solo per il prelievo ematico e non a scopo di iniezione.
Utilizzare solo con aghi (aghi (Safety) S-Monovette® o aghi (Safety-)Multifly®/adattatore per la S-Monovette®).
Qui viene mostrato l’utilizzo dell’ago Safety:

clic

Immediatamente prima della venipuntura spingere la S-Monovette® nel supporto integrato dell’ago Safety
e fissarla ruotando leggermente in senso antiorario .
Applicare il laccio emostatico in caso di bisogno per massimo 1 minuto. Preparare il sito di iniezione con un disinfettante adeguato. Non toccare più la sede di venipuntura dopo la disinfezione.
Posizionare il paziente in modo da godere di un facile accesso alla vena e dirigere in basso il braccio o altra sede della puntura.
Togliere il copriago Pungere la vena, ritrarre lentamente lo stantuffo e allentare il laccio emostatico mentre il sangue fluisce nella S-Monovette®.
Attendere fino all’interruzione del flusso di sangue per consentire il corretto riempimento.

Muovere la S-Monovette®ruotando leggermente in senso antiorarioe toglierla (disconnetterla) dall’ago Safety . L’ago Safety rimane in vena.
In caso di prelievo multiplo, come sopra descritto, connettere le successive S-Monovette con l'ago Safety e prelevare ulteriori campioni.
Conclusione del prelievo di sangue: Disconnettere in primo luogo la S-Monovette®
+e quindi estrarre dalla vena l’ago Safety. Con tecnica a una mano attivare il copriago o su una superficie stabile e
piana - fino a quando l’ago scatta (si attiva) in posizione con un clic udibile e percettibile nel copriago - o premendo il copriago con il dito indice contro l’estremità inferiore dello stesso; si vedano anche leistruzioni d’uso per l’ago (Safety) S-Monovette® o l’ago (Safety-)Multifly®
Capovolgere ogni S-Monovette® direttamente dopo la disconnessione dall’ago Safety per 1 volta e, alla conclusione del prelievo ematico, capovolgere delicatamente più volte tutti i campioni con
anticoagulanti!
Per il trasporto e la centrifugazione tirare lo stantuffo fino a sentire lo scatto(lo stantuffo scatta nel corpo della S-Monovette®) e staccare il pistone .
1.

3UHPHUHODVHGHGHOODSXQWXUDFRQXQSDQQRDVFLXWWRHVHQ]DJHUPLıQRDTXDQGRLOVDQJXLQDPHQWRVLLQWHUURPSH2.

Una volta che il sangue si è coagulato applicare un bendaggio se si desidera.

3.

Smaltire l’ago Safety in un contenitore adatto per lo smaltimento di sostanze a rischio biologico.

106

IT
Prelievo ematico con tecnica sottovuoto.
Attenzione! Utilizzare la S-Monovette® solo per il prelievo ematico e non a scopo di iniezione.
Utilizzare solo con aghi (aghi (Safety) S-Monovette® o aghi (Safety-)Multifly®/adattatore per la S-Monovette®).
Qui viene mostrato l’utilizzo dell’ago Safety:

clic

Per iniziare il prelievo ematico in modo atraumatico, SARSTEDT consiglia di fare il primo prelievo con la S-Monovette® utilizzando la tecnica di aspirazione (si veda Tecnica di aspirazione per la TECNICA DI
VENIPUNTURA)- .
Quindi continuare con la tecnica sottovuoto.
Prima del prelievo ematico tirare con lo stantuffo il pistone fino al fondo della S-Monovette® e farlo scattare in modo udibile . Lo stantuffo viene quindi staccato .
Spingere la S-Monovette® preparata nel supporto integrato dell’ago Safety S-Monovette® e fissarlo ruotando leggermente in senso orario+.

Attendere fino all’interruzione del flusso di sangue per consentire il corretto riempimento.

Muovere la S-Monovette®ruotando leggermente in senso antiorarioe toglierla (disconnetterla) dall’ago Safety . L’ago Safety rimane in vena.
In caso di prelievo multiplo, come sopra descritto, connettere prima le successive S-Monovette con l'ago Safety e prelevare ulteriori campioni.
Conclusione del prelievo di sangue: Disconnettere la
S-Monovette® + e quindi togliere dalla vena l’ago Safety. Con tecnica a una mano attivare il copriago o su una superficie stabile e piana - fino a quando l’ago scatta (si attiva) in posizione con un clic
udibile e percettibile nel copriago - o premendo il copriago con il dito indice contro l’estremità inferiore dello stesso.
Capovolgere ogni S-Monovette® direttamente dopo la disconnessione dall’ago Safety per 1 volta e, alla conclusione del prelievo ematico, capovolgere delicatamente più volte tutti i campioni con
anticoagulanti!
1.

3UHPHUHODVHGHGHOODSXQWXUDFRQXQSDQQRDVFLXWWRHVHQ]DJHUPLıQRDTXDQGRLOVDQJXLQDPHQWRVLLQWHUURPSH2.

Una volta che il sangue si è coagulato applicare un bendaggio se si desidera.

3.

Smaltire l’ago Safety in un contenitore adatto per lo smaltimento di sostanze a rischio biologico.

107

IT
Centrifugazione
ATTENZIONE! Le S-Monovetten SARSTEDT sono concepite per 4.000 x g. Un’eccezione è rappresentata dalle S-Monovette con Ø 8 mm (S-Monovette® pediatria), validate attualmente fino a 2.500 x g. Utilizzare
esclusivamente provette per il trasporto e inserti idonei. La centrifugazione di S-Monovette che presentino incrinature o la centrifugazione a un'accelerazione eccessiva può causare la rottura di S-Monovette, coneventuale rilascio di materiali potenzialmente infettivi.
Gli inserti per centrifuga devono essere selezionati in base alle dimensioni delle S-Monovette utilizzate. L'accelerazione centrifuga relativa dipende dal numero di giri al minuto impostato:
RCF = 11,2 x r x (UpM/1000)2,
RCF: ''forza centrifuga relativa, chiamata anche ''forza g'''' (dall'inglese ''relative centrifugal force''),*LULPLQ  JLULDOPLQXWR  8PLQ RSSXUHQb b QXPHURGLJLULDOPLQXWR  LQLQJOHVHUSPb b UHYROXWLRQVSHUPLQXWH''r'': ''raggio della centrifuga' misurato dal centro della centrifuga al fondo di S Monovette®“, (cm).
È possibile centrifugare senza gel in centrifughe con rotore oscillante o ad angolo fisso.
Le soluzioni S-Monovette con gel sono concepite esclusivamente per centrifughe con rotore oscillante. La centrifugazione in centrifughe con rotore ad angolo fisso non è convalidata da SARSTEDT ed è sconsigliata.
La centrifugazione di S-Monovette deve avvenire secondo le condizioni di centrifugazione illustrate di seguito. Eventuali condizioni differenti devono essere convalidate autonomamente dall'utente.
Occorre verificare che le S-Monovette siano posizionate correttamente negli inserti per centrifuga. Le S-Monovette che sporgono dall'inserto possono restare intrappolate nella parte superiore della centrifuga e rompersi.
La centrifuga deve essere riempita in maniera omogenea. A tal proposito, attenersi alle istruzioni d'uso della centrifuga.
ATTENZIONE! Non rimuovere manualmente le S-Monovette rotte.
&RQVXOWDUH OH LVWUX]LRQL G XVR GHOOD FHQWULIXJD SHU LQGLFD]LRQL UHODWLYH DOOD GLVLQIH]LRQH

Accelerazione centrifuga relativa (g)Secondo BS
4851+ (codice DIN EN ISO 6710
UE)–

S-Monovette®
2000 x g

2500 x g

3000 x g

3500 x g

4000 x g

Siero

10 min10 min

6 min

4 min

4 min

Siero gelbPLQ

10 min

4 min

4 min

4 min

Siero Express gel

bPLQ

10 min

4 min

n.v.

n.v.

Litio eparina

10 min10 min

7 min

7 min

7 min

Litio eparina gel

bPLQbPLQ

10 min

7 min

7 min

Litio eparina gel+

8 min

7 min

bPLQ

4 min

4 min

EDTA

n.v.

n.v.

7 min

6 min

bPLQ

EDTA-Gel

bPLQ

10 min10 min

7 min

7 min

Citrato

9 min

8 min

7 min

6 min

bPLQ

('7$ĲXRUXURHSDULQD

9 min

8 min

7 min

6 min

bPLQ

GlucoEXACT

9 min

8 min

7 min

6 min

bPLQ

Citrato PBM 1,8 ml
Raggio centrifughe > 17 cm

9 min

8 min

7 min

6 min

bPLQ

Citrato PBM 1,8 ml
5DJJLRFHQWULIXJKH!FPıQRDƉ
17 cm

n.v.

n.v.

10 minn.v.

n.v.

n.v. = non validato* Si applica a tutte le S-Monovette ad eccezione di quelle di Ø 8 mm (S-Monovette pediatria).

Centrifugazione a 20°C+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, ritirato.

Informazioni sul materiale di separazione
La fluidità del materiale di separazione (gel) dipende dalle temperature. Se le S-Monovette sono raffreddate prima o durante la centrifugazione, non viene più assicurato lo strato continuo del gel di separazione.
Le S-Monovette non possono essere nuovamente centrifugate / ri-centrifugate.

Smaltimento1.

È necessario attenersi alle linee guida generali sull'igiene e alle disposizioni di legge per il corretto smaltimento del materiale infettivo.

2.

I guanti monouso prevengono il rischio di infezione.

3.

I sistemi di prelievo ematico contaminati o riempiti devono essere smaltiti in appositi contenitori per materiali a rischio biologico, che possono poi essere autoclavati e inceneriti.

4.

/RVPDOWLPHQWRGHYHHVVHUHHĳHWWXDWRLQXQLQFHQHULWRUHDGDWWRRFRQO DXWRFODYH VWHULOL]]D]LRQHDYDSRUH 

108

IT
1RUPHHOLQHHJXLGDVSHFLıFKHGHOSURGRWWRQHOODORURYHUVLRQHYDOLGDCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Norma sui contenitori per il prelievo ematico venoso:
DIN EN ISO 6710: Contenitori monouso per il prelievo di campioni ematici venosi negli esseri umani*CLSI (Clinical and Laboratory Standards Institute)

Legenda dei simboli e dei contrassegni:

Codice articolo

Si applica inoltre per prodotti confezionati sterili singolarmente

Designazione della partita

Se la confezione è danneggiata, non utilizzare

Usare entro

Sistema singolo di barriera sterile con imballaggio protettivo esterno

Marchio CE

Sterilizzazione per irradiazione

Diagnostica in vitro

Attenersi alle istruzioni d'uso

In caso di riutilizzo: rischio di contaminazione

Conservare al riparo dalla luce del sole

Conservare in un luogo asciutto

Produttore

Paese di fabbricazione

3HUFRUVRGHOĲXLGRVWHULOH

Non risterilizzare

Con riserva di modifiche tecniche.
Eventuali incidenti gravi relativi al prodotto devono essere notificati al produttore e all'autorità nazionale competente.

109

㌂㣿G㍺ⳛ㍲ – SARSTEDT S-Monovette® 㺚䡞 㔲㓺䎲KO㼊㣎G㰚┾㠦G㌂㣿
㣿☚zTt´G㺚䡞G㔲㓺䎲SG⹪⓮G⹥G㠊╧䎆⓪G㩫ⰻG㺚䡞㦚G㥚䟊G㔲㓺䎲㦒⪲G䞾℮G㌂㣿♿┞┺UGzTt´G㺚䡞G㔲㓺䎲㦖G㧚㌗G㔺䠮㔺㠦㍲G䡞㼃SG䡞㧻G⡦⓪G㩚䡞G㼊㣎G㰚┾㦚G㥚䟊G䡞㞷G㔲⬢⯒G㺚䀾SG㤊⹮SG㻮ⰂG⹥G⽊ὖ䞮₆G㥚䟊G㌂㣿♿┞┺UG㧊G㩲䛞㦖G㩚ⶎ㩗㧎G䢮ἓ㠦㍲G㦮䞯G㩚ⶎṖG⹥G㔺䠮㔺G㧎⩻Ⱒ㧊G㌂㣿䞮☚⪳G′㩫♲G₆₆㧛┞┺U

㩲䛞G㍺ⳛ
zTt´G㺚䡞G㔲㓺䎲㦖G䝢⧒㓺䕇G㣿₆SG䞒㓺䏺SG䞒㓺䏺G⪲✲G⹥G㌟㌗㦒⪲Gῂ⿚♲G䝢⧒㓺䕇G⋮㌂G䃷ὒGzTt´O㞞㩚PG⹪⓮G⡦⓪GO㞞㩚PGt ´G⹪⓮㠦G㡆ἆ䞮₆G㥚䟊G䔏⼚䧞GṲ⹲♲G䐋䞿GⲺぢ⩞㧎G⹥G┺㟧䞲G㻾Ṗ㩲O⺆䞿ⶒP⪲Gῂ㎇♿┞┺UG㻾Ṗ㩲G⹎䙂䞾GzTt´G㡃㔲G㩲Ὃ♿┞┺UG㦧ἶG㽟㰚㩲SG㩺㦚G䙂䞾䞲G㦧ἶG㽟㰚㩲SGⰂ䔂G䠺䕢ⰆSG㩺㦚G䙂䞾䞲GⰂ䔂G䠺䕢ⰆSG⋮䔎⮾G䠺䕢ⰆSGῂ㡆㌆㡒SGlk{hSG⿞㏢G
lk{hSG⿞㏢G䠺䕢ⰆSG⿞㏢Gῂ㡆㌆㡒SGjwkhG❇㦮G㻾Ṗ㩲⯒G䙂䞾䞮Ệ⋮G㻾Ṗ㩲⯒G䙂䞾䞮㰖G㞠㦖GzTt´G㺚䡞G㔲㓺䎲㦖G㻾Ṗ㩲G⏣☚SG㞷㼊G㻾Ṗ㩲㦮G⽒⮾G⹥G⁎G䠞㣿G㡺㹾SG䡞㞷G╖G㻾Ṗ㩲㦮G゚㥾ὒGὖ⩾䞮㡂Gῃ㩲G䚲㭖GkpuGluGpzvG]^XWGIzTGGGGGGGO㩫ⰻG䡞㞷G㌮䝢G㺚䀾⯒G㥚䞲G㧒䣢㣿G㣿₆PIG⹥GjGGs GzGp˅GhGzGOjszpSG㧚㌗G⹥G㔺䠮㔺G䚲㭖G㡆ῂ㏢㦮G㔏㧎G䚲㭖P㦚G➆⯛┞┺UG㻾Ṗ㩲G㍶䌳㦖G⿚㍳G䎢㓺䔎G⹿⻫㠦G➆⧒G╂⧒㰧┞┺UG㧊ộ㦖GỖ㌂㔲㟓G⹥V⡦⓪G䎢㓺䔎⯒G㔲䟟䞮⓪G⿚㍳G㧻䂮㦮G㩲㫆㠛㼊㠦G
㦮䟊G㰖㩫♿┞┺UGzTt´G㺚䡞G㔲㓺䎲㦖G⌊⿖GⳎ‶G⻚㩚G⡦⓪GṲ⼚G䙂㧻♲G⌊㣎⿖GⳎ‶G⻚㩚㦒⪲G㩲Ὃ♿┞┺U

zTt´G㓺䋂⮮G䃷QG㌟㌗G䆪✲a

㻾Ṗ㩲

ⶎ㧦G䆪✲

䃷G㌟㌗GkpuGluGpzvG]^XW

izG[_\XR㠦G➆⯎G䃷G㌟㌗



䧆㌟

䧆㌟

㩲㩲G⹎䙂䞾G㣿₆
zTt´GuG
䡞㼃G㣿₆zTt´GzGjh{SG㦧ἶG㽟㰚㩲G䙂䞾

jh{

ゾṚ㌟

䧆㌟

zTt´GzTnGjh{SG㦧ἶG㽟㰚㩲G⹥G㩺G䙂䞾jh{

㰯㦖G⏎⧖㌟

㰯㦖G⏎⧖㌟

zTt´GzGlGnGjh{SG㦧ἶG㽟㰚㩲G䔎⫂ゞG⹥G㩺G䙂䞾

jh{

㭒䢿㌟

T

zTt´GⰂ䔂G䠺䕢ⰆGsoSGⰂ䔂G䠺䕢ⰆG䙂䞾

so

⏏㌟

㭒䢿㌟

zTt´GⰂ䔂G䠺䕢ⰆG㞷㼊GsoSGⰂ䔂G䠺䕢ⰆG䙂䞾

so

⏏㌟

㭒䢿㌟

zTt´GⰂ䔂G䠺䕢ⰆG㩺GsoSGⰂ䔂G䠺䕢ⰆG⹥G㩺G䙂䞾

so

⏏㌟

㭒䢿㌟

zTt´GⰂ䔂G䠺䕢ⰆG㩺RGsoSGⰂ䔂G䠺䕢ⰆG⹥G㏣䣾㎇G㩺G䙂䞾

so

⏏㌟

㭒䢿㌟

zTt´G⋮䔎⮾G䠺䕢ⰆGuoSG⋮䔎⮾G䠺䕢ⰆG䙂䞾

uo

Ṟ㌟

⏏㌟

zTt´G㞪⳾ⓚG䠺䕢ⰆGhoSG㞪⳾ⓚG䠺䕢ⰆG䙂䞾

UU

䕢⧖㌟

䕢⧖㌟

zTt´Gῂ㡆㌆㡒G`ujSGῂ㡆㌆⋮䔎⮾GZUXZL

`uj

䕢⧖㌟

⏏㌟

zTt´GwmhSGῂ㡆㌆㡒G`ujSGῂ㡆㌆⋮䔎⮾GZU_LSG㢚㿿

`uj

䞮⓮㌟

T

zTt´GrZGlk{hGrZlSG䃒⮾Glk{hG䙂䞾

rZl

⽊⧒㌟

ゾṚ㌟

zTt´GrYGlk{hGrYlSG䃒⮾Glk{hG䙂䞾

rYl

⽊⧒㌟

ゾṚ㌟

zTt´GrYGlk{hG㩺GrYlSG䃒⮾Glk{hG⹥G㩺G䙂䞾

rYl

⽊⧒㌟

ゾṚ㌟

䠺䕢ⰆG㣿₆

ῂ㡆㌆㡒G㣿₆lk{hG㣿₆╏⿚䟊G㠋㩲㩲G䙂䞾G㣿₆
zTt´G⿞㏢Glk{hGmlSG⿞㏢G⹥Glk{hG䙂䞾

ml

䣢㌟

⏎⧖㌟

zTt´G⿞㏢G䠺䕢ⰆGmoSG⿞㏢G⹥G䠺䕢ⰆG䙂䞾

mo

T

⏎⧖㌟

zTt´Gnlhj{GmjSG⿞㏢SGῂ㡆㌆㡒G⹥Glk{hG䙂䞾

mj

⿚䢣㌟

䣢㌟

so

⋾㌟

㭒䢿㌟

⁞㏣G⿚㍳㣿G㣿₆
zTt´G⁞㏣G⿚㍳GsoSGⰂ䔂G䠺䕢ⰆG䙂䞾

₆䌖G㩚䡞G⹥G䡞㧻G㣿₆
zTt´G{lSGⰞ⁎⍺㓮G䢪䞿ⶒG䙂䞾

UU

UUSG㧦㭒㌟

UUSG㧦㭒㌟

zTt´Gj{hkG

UUUUSG䕢⧖㌟

UUSG⏏㌟

zTt´Ghjk

hjk

⏎⧖㌟

⏎⧖㌟

zTt´Gjwkh

jwkh

⏎⧖㌟

⏎⧖㌟

zTt´GoUU

UUSG㢂ⰂぢG⁎ⰆUUSG㢂ⰂぢG⁎ⰆzTt´G䢎⳾㔲㓺䎢㧎GojTG㩺SG㩺G⹥G㞞㩫㩲G䙂䞾

UU

UUSG䣢㌟

UUSG䣢㌟

zTt´G䢎⳾㔲㓺䎢㧎GojTjGῂ㡆㌆㡒G㢚㿿G䙂䞾

UU

UUSG⽊⧒㌟

UUSG⽊⧒㌟

zTt´GkuhGlUU

UUSG䕢⧖㌟

UUSG䕢⧖㌟

QG㿪Ṗ㩗㧎G㓺䋂⮮G䃷G㌟㌗G㡃㔲Gῂ㧛GṖ⓻U
UUaG㩫㦮♮㰖G㞠㦢
RiGzGiz[_\XaX`_YGzGGGGGGGGG GG SG㻶䣢♾U

XXW

KO
SARSTEDT S-Monovette® Serum CAT / Serum-Gel CAT
zTt´GzGjh{⓪G㦧ἶG㽟㰚㩲O′㌆㡒PṖG䆪䕛♲G䝢⧒㓺䕇GὒⰓ㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㼃G㺚䀾㠦G㌂㣿♿┞┺QQUG䝢⧒㓺䕇GὒⰓ㦖G㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞⼧ὒG䡞㼃G㌂㧊㠦G㥚䂮䞮ỢG♿┞┺U
zTt´GzTnGjh{⓪G㦧ἶG㽟㰚㩲O′㌆㡒PṖG䆪䕛♲G䝢⧒㓺䕇GὒⰓG㣎㠦☚G䙊ⰂⲎG₆⹮㦮G㩺㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㼃G㺚䀾㠦G㌂㣿♿┞┺QQUG㩺㦖G㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞⼧ὒG䡞㼃G㌂㧊㠦G㥚䂮䞮ỢG♮ⳆG㤊㏷SG⽊ὖG⹥G⿚㍳G㔲G㞞㩫㩗㧎G⿚Ⰲ䂋㦚G䡫㎇䞿┞┺UG
䡞㼃㦖G㧚㌗㣿G䢪䞯G㩫₆GỖ㌂SG㧒㌗㩗㧎GⳊ㡃GỖ㌂G⹥G䡞㼃G⹮㦧G䎢㓺䔎㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺U
㺚䡞G䤚㠦⓪GzTt´GzGjh{GVGzTnGjh{㦮G䡞㞷㦖GZW⿚G☯㞞G⡧⹪⪲G㎎㤊G㌗䌲⪲G㦧ἶ㔲䅲SG㤦㕂G⿚ⰂG䤚G㧮G䡫㎇♲G㑮䘟G⿚ⰂG䂋㦚G䢫⽊䞶G㑮G㧞☚⪳G䞿┞┺UGῢ㧻G㔲Ṛ㦖G㢚㩚䞲G㦧ἶGὒ㩫㦚G
₆㭖㦒⪲G䞿┞┺UG㰞⼧㦒⪲G㧎䞲G䡞㞷G㦧ἶG㧻㞶ṖG㧞Ệ⋮G䟃㦧ἶG䂮⬢⯒G⹱⓪G䢮㧦㦮G䡞㞷㦖Gἓ㤆㠦G➆⧒G㢚㩚䧞G㦧ἶ♮₆₢㰖G▪GⰤ㦖G㔲Ṛ㧊G㏢㣪♶G㑮G㧞㔋┞┺U

SARSTEDT S-Monovette® Serum Express Gel CAT
zTt´GzGlGnGjh{⓪G㦧ἶG㽟㰚㩲O䔎⫂ゞPṖG䆪䕛♲G䝢⧒㓺䕇GὒⰓG㣎㠦☚G䙊ⰂⲎG₆⹮㦮G㩺㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㼃G㺚䀾㠦G㌂㣿♿┞┺QQUG㩺㦖G㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞⼧ὒG䡞㼃G㌂㧊㠦G㥚䂮䞮ỢG♮ⳆG㤊㏷SG⽊ὖG⹥G⿚㍳G㔲G㞞㩫㩗㧎G⿚Ⰲ䂋㦚G䡫㎇䞿┞┺UG
㺚䡞G䤚㠦⓪GzTt´GzGlGn㦮G䡞㞷㦖G\⿚G☯㞞G⡧⹪⪲G㎎㤊G㌗䌲⪲G㦧ἶ㔲䅲SG㤦㕂G⿚ⰂG䤚G㧮G䡫㎇♲G㑮䘟G⿚ⰂG䂋㦚G䢫⽊䞶G㑮G㧞☚⪳G䞿┞┺UGῢ㧻G㔲Ṛ㦖G㢚㩚䞲G㦧ἶGὒ㩫㦚G₆㭖㦒⪲G
䞮ⳆSG䠺䕢ⰆG䂮⬢⯒G⹱㦖G䢮㧦㦮G䡞㞷G㡃㔲G☯㧒䞿┞┺UG㰞⼧㦒⪲G㧎䞲G䡞㞷G㦧ἶG㧻㞶ṖG㧞Ệ⋮Gἶ㣿⨟㦮G䠺䕢Ⰶ㦚G䙂䞾䞲G䟃㦧ἶG䂮⬢⯒G⹱⓪G䢮㧦㦮G䡞㞷㦖G㢚㩚䧞G㦧ἶ♮₆₢㰖G▪GⰤ㦖G㔲Ṛ㧊G㏢㣪♿┞┺U
䡞㼃㦖G㧚㌗㣿G䢪䞯G㩫₆GỖ㌂SG㧒㌗㩗㧎GⳊ㡃GỖ㌂G⹥G䡞㼃G⹮㦧G䎢㓺䔎㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺U

SARSTEDT S-Monovette® Neutral Z
zTt´GuG⓪G㩲㩲⯒G䙂䞾䞮㰖G㞠㞚SG㦧ἶG㽟㰚㩲G㠜㧊G䡞㞷G㔲⬢㦮G㧦㡆㓺⩂㤊G㦧ἶ⯒GṖ⓻䞮ỢG䞮ⳆG䡞㼃G㺚䀾㠦G㌂㣿♿┞┺QQUG㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞⼧ὒG䡞㼃㧊G⿚Ⰲ♿┞┺U
䡞㼃㦖G㌂㣿㧦G䔏㩫GỖ㌂⯒G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺U⡦䞲GzTt´GuG⓪GゞG㣿₆⪲☚G㌂㣿GṖ⓻䞿┞┺aGzTt´Gῂ㡆㌆㡒㦚GO㞞㩚Pt ´G⹪⓮O⋮゚⹪⓮PὒG䞾℮G㌂㣿䞮㡂G㺚䡞㦚G㔲㧧䞮ἶ㧦G䞮⓪Gἓ㤆SGzTt´GuG⯒GO㞞㩚Pt ´G⹪⓮㦮G㣿₆⪲G㺚㤆₆G㥚䞲G㼁G⻞㱎G㣿₆OゞG㣿₆P⪲G㌂㣿䞶G㑮G㧞㔋┞┺U

SARSTEDT S-Monovette® Ⰲ䔂 䠺䕢Ⰶ LH / Ⰲ䔂 䠺䕢Ⰶ 㩺 LH / Ⰲ䔂 䠺䕢Ⰶ 㩺+ LH, ⋮䔎⮾ 䠺䕢Ⰶ NH, 㞪⳾ⓚ 䠺䕢Ⰶ AH
kGzTt´GⰂ䔂G䠺䕢ⰆGsoGVG⋮䔎⮾G䠺䕢ⰆGuoGVG㞪⳾ⓚG䠺䕢ⰆGho⓪G㦧ἶG㠋㩲㩲O䟃㦧ἶ㩲PGⰂ䔂G䠺䕢ⰆGVG⋮䔎⮾G䠺䕢ⰆGVG㞪⳾ⓚG䠺䕢ⰆO㧒⹮㩗㦒⪲G䡞㞷GXG╏G䠺䕢ⰆGX]GpUlUP㦒⪲G䆪䕛♲G䝢⧒㓺䕇G
ὒⰓ㦚G䙂䞾䞮ⳆSG㩚䡞G⹥G䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUG䝢⧒㓺䕇GὒⰓ㦖G㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞㞷G㎎䙂㢖G䡞㧻G㌂㧊㠦G㥚䂮䞮ỢG♿┞┺UG
䝢⧒㓺䕇GὒⰓ㦚G䙂䞾䞮㰖G㞠㦖GzTt´GⰂ䔂G䠺䕢ⰆGso⯒Gἓ㤆SG䟃㦧ἶ㩲GⰂ䔂G䠺䕢ⰆO㧒⹮㩗㦒⪲G䡞㞷GXG╏G䠺䕢ⰆGX`GpUlUP㧊G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺U
zTt´GⰂ䔂G䠺䕢ⰆGso⓪G䟃㦧ἶ㩲GⰂ䔂G䠺䕢ⰆO㧒⹮㩗㦒⪲G䡞㞷GXG╏G䠺䕢ⰆGY\GpUlUP㦒⪲G䆪䕛♲G䝢⧒㓺䕇GὒⰓG㣎㠦☚G䙊ⰂⲎG₆⹮㦮G㩺㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUG㩺㦖G㤦㕂G
⿚Ⰲ⯒G䐋䟊G䡞㞷G㎎䙂㢖G䡞㧻G㌂㧊㠦G㥚䂮䞮ỢG♮ⳆG㤊㏷SG⽊ὖG⹥G⿚㍳G㔲G㞞㩫㩗㧎G⿚Ⰲ䂋㦚G䡫㎇䞿┞┺U
zTt´GⰂ䔂G䠺䕢ⰆG㩺RGsoG㡃㔲G䙊ⰂⲎG₆⹮㦮G㩺㧊G䙂䞾♮㠊G㧞㦒ⳆSG㧊⓪GzTt´GⰂ䔂G䠺䕢ⰆG㩺㠦G゚䟊G㤦㕂G⿚ⰂG㔲Ṛ㦚G㟓G\WLGṦ㏢㔲䌂G㑮G㧞㔋┞┺U
䠺䕢ⰆG䡞㧻㦖G㧚㌗㣿G䢪䞯G㩫₆GỖ㌂G⹥G㧒㌗㩗㧎GⳊ㡃GỖ㌂㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG䠺䕢ⰆG㩚䡞㦖G㧒㌗㩗㧎GⳊ㡃GỖ㌂G⹥G䡞㼃G⹮㦧G䎢㓺䔎㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺U
䠺䕢Ⰶ㦚G㌂㣿䞲G㦧ἶG㠋㩲⓪G䟃䔎⫂ゞ㦚G䢲㎇䢪䞮㡂G㧊⬾㠊㰧┞┺UG
㭒㦮aGzTt´GⰂ䔂G䠺䕢ⰆGsoSGⰂ䔂G䠺䕢ⰆG㩺V㩺RGso㦖GⰂ䔂G䁷㩫㦚G㥚䟊G㌂㣿䟊㍲⓪G㞞G♮ⳆSGzTt´G⋮䔎⮾G䠺䕢Ⰶ㦖GuoG⋮䔎⮾G䁷㩫SG⁎ⰂἶGzTt´G㞪⳾ⓚG䠺䕢ⰆGho㦖G㞪⳾ⓚG
䁷㩫㦚G㥚䟊G㌂㣿䟊㍲⓪G㞞G♿┞┺UG㩫ⰻ䡞㧊G㺚㤢㰚GzTt´GⰂ䔂G䠺䕢ⰆVⰂ䔂G䠺䕢ⰆG㩺V㩺RGVG⋮䔎⮾G䠺䕢ⰆGVG㞪⳾ⓚG䠺䕢Ⰶ㦖G䡞㞷GṖ㓺G⿚㍳㠦G㩗䞿䞮㰖G㞠㔋┞┺U

SARSTEDT S-Monovette® ⁞㏣ ⿚㍳
zTt´G⁞㏣G⿚㍳㠦⓪G䟃㦧ἶ㩲GⰂ䔂G䠺䕢Ⰶ㧊G䙂䞾♮㠊G㧞㦒ⳆG㩚䡞G⹥G䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUGⰂ䔂G䠺䕢Ⰶ㦖G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺O㧒⹮㩗㦒⪲G䡞㞷GXG╏G䠺䕢ⰆGX`GpUlUPU
zTt´G⁞㏣G⿚㍳㦮G䠺䕢ⰆG㩚䡞G⡦⓪G䠺䕢ⰆG䡞㧻㦖G䔏㑮G㞞㩚G⹪⓮GYXnGGXGÃˈO䛞⳿G⻞䢎G_\UXX]YU]WWP㢖G䞾℮G⹎⨟G㤦㏢V⁞㏣GỖ㌂⯒G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG⹎⨟G㤦㏢V⁞㏣㦖G㤦㧦G䦷㑮G
⿚ὧ⻫OhhzP㦚G㌂㣿䟊GỖ㯳♮㠞㔋┞┺UG㞞㩚G⹪⓮G⹥GzTt´G⁞㏣G⿚㍳㦮Gἓ㤆SG㧊⩂䞲G⹎⨟G㤦㏢㠦G╖䟊G┺㦢ὒGṯ㦖GὋ㔲䠮GṨ㦚G䢫㧎䞶G㑮G㧞㠞㔋┞┺OV㔲㓺䎲G┾㥚Pa

㎇⿚

{

j

V㔲㓺䎲

YU\

XU\

u

j

w

m

j



t

h

z

o

_UW

\UW

\

\W

^W

^W

XW

[W

XW

XW

ṗG㎇⿚㦮G㾲╖GὋ㔲䠮GṨ㦖GzTt´G⧒⻾㠦G䚲㔲♮㠊G㧞㔋┞┺U
⹎⨟G㤦㏢G䁷㩫㦖G䠺䕢ⰆG㩚䡞G⡦⓪G䠺䕢ⰆG䡞㧻㦮G⿚㍳G⹿⻫㠦G➆⧒G㧊⬾㠊㰧┞┺UG
䠺䕢Ⰶ㦚G㌂㣿䞲G㦧ἶG㠋㩲⓪G䟃䔎⫂ゞ㦚G䢲㎇䢪䞮㡂G㧊⬾㠊㰧┞┺U

SARSTEDT S-Monovette® ῂ㡆㌆㡒 9NC
zTt´Gῂ㡆㌆㡒G`uj㠦⓪G䟃㦧ἶ㩲Gῂ㡆㌆㌒⋮䔎⮾㧊G䙂䞾♮㠊G㧞㦒ⳆG㩚䡞G⹥G䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUGῂ㡆㌆㌒⋮䔎⮾㦖GWUXW]Gⴆ㦮G㣿㞷OZUXZLGῂ㡆㌆㌒⋮䔎⮾bG㫛㫛GZUYL⪲G⹮㢂Ⱂ♾P㦒⪲G㩲Ὃ♮ⳆSGzTt´Gῂ㡒㌆㡒GὋ䃃G㣿⨟㦮GXWL㧛┞┺UGῂ㡆㌆㡒G╖G䡞㞷㦮G䢒䞿゚⓪GXa`GTGῂ㡆㌆㡒G⿖䞒⿖GXὒG䡞㞷G⿖䞒⿖G`㧛┞┺UG⿚㍳㦚G㥚䟊㍲⓪G㩫䢫䞲G㿿㩚㧊G䞚㑮㩗㧛┞┺U
ῂ㡆㌆㡒G䡞㧻㦖G㧒㌗㩗㧎G㰖䡞GỖ㌂㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG
㦧ἶG㠋㩲⓪Gῂ㡆㌆㡒㦚G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG
zTt´Gῂ㡆㌆㡒ὒG⋮゚⹪⓮㦮G㫆䞿ὒGὖ⩾䞮㡂G㔲⬢G㺚䀾G⹥G䀾 㠦G╖䞲G㭒㦮G㌂䟃㠦G㥶㦮䞮㕃㔲㡺U

SARSTEDT S-Monovette® PFA 9NC
zTt´GwmhG`uj㠦⓪G㩚䡞G⹥G䡞㧻G㺚䀾⯒G㥚䟊G䟃㦧ἶ㩲Gῂ㡆㌆㌒⋮䔎⮾㧊G䙂䞾♮㠊G㧞㔋┞┺QQUGῂ㡆㌆㌒⋮䔎⮾㦖GWUXY`Gⴆ㦮G⹎㢚㿿G㣿㞷OZU_LG㢚㿿bGoG\U\P㦒⪲G㩲Ὃ♮ⳆGzTt´GwmhGὋ䃃G㣿⨟㦮GXWL㧛┞┺UGῂ㡆㌆㡒G╖G䡞㞷㦮G䢒䞿゚⓪GXa`GTGῂ㡆㌆㡒G⿖䞒⿖GXὒG䡞㞷G⿖䞒⿖G`㧛┞┺UG⿚㍳㦚G㥚䟊㍲⓪G㩫䢫䞲G㿿㩚㧊G䞚㑮㩗㧛┞┺U
zTt´GwmhG`uj㦮G㩚䡞㦖GzpltluzGoG⿚㍳G㧻䂮Gwmh⪲G䡞㏢䕦G₆⓻㦚G䁷㩫䞮₆G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♮ⳆG㧊⯒G㥚䟊GỖ㯳♮㠞㔋┞┺U
㦧ἶG㠋㩲⓪Gῂ㡆㌆㡒㦚G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG
zTt´Gwmh㢖G⋮゚⹪⓮㦮G㫆䞿ὒGὖ⩾䞮㡂G㔲⬢G㺚䀾G⹥G䀾 㠦G╖䞲G㭒㦮G㌂䟃㠦G㥶㦮䞮㕃㔲㡺U

SARSTEDT S-Monovette® CTAD
zTt´Gj{hk㠦⓪G䟃㦧ἶ㩲Gῂ㡆㌆㌒⋮䔎⮾ὒG䎢㡺䞚ⰆSG㞚◆⏎㔶G⹥G❪䞒Ⰲ┺ⴆ㧊G䙂䞾♮㠊G㧞㦒ⳆG㩚䡞G⹥G䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUGj{hk⓪G㣿㞷㦒⪲G㩲Ὃ♮ⳆGzTt´Gj{hkGὋ䃃G㣿⨟㦮GXWL㧛┞┺UGj{hkG╖G䡞㞷㦮G䢒䞿゚⓪GXa`GTGj{hkG⿖䞒⿖GXὒG䡞㞷G⿖䞒⿖G`㧛┞┺UG⿚㍳㦚G㥚䟊㍲⓪G㩫䢫䞲G㿿㩚㧊G䞚㑮㩗㧛┞┺Uj{hkG䡞㧻㦖G䡞㏢䕦G㧎㧦G[Owm[PSG⻶䌖OåPG䔎⫂⽊⁖⪲⿞ⰆOå{nPG⹥G䝢⧒㓺⹎⏎㩶G䢲㎇㩲G㠋㩲㩲OwhpTXPG䁷㩫G⹥G㧒㌗㩗㧎G㰖䡞GỖ㌂⯒G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG
䡞㏢䕦G䢲㎇䢪ṖG㾲㏢G[㔲ṚG☯㞞G㠋㩲♮ⳆSG䠺䕢ⰆG㣪⻫G⳾┞䎆Ⱇ㠦G㌂㣿♿┞┺U
㦧ἶG㠋㩲⓪Gῂ㡆㌆㡒㦚G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG
zTt´Gj{hk㢖G⋮゚⹪⓮㦮G㫆䞿ὒGὖ⩾䞮㡂G㔲⬢G㺚䀾G⹥G䀾 㠦G╖䞲G㭒㦮G㌂䟃㠦G㥶㦮䞮㕃㔲㡺U
㭒㦮aGj{hk⓪G⏎⧖㌟㧛┞┺UGzTt´Gj{hk⓪G⽊ὖG㭧G㧎ὋG㫆ⳛG⹥G㧦㡆ὧ㦒⪲⿖䎆G⽊䢎䟊㟒G䞿┞┺UG⹳㦖Gケ㠦GXY㔲ṚG㧊㌗G⏎㿲♮⓪Gἓ㤆SG㻾Ṗ㩲ṖG゚䢲㎇䢪♶G㑮G㧞㔋┞┺UG

SARSTEDT S-Monovette® EDTA K2E / K3E
zTt´Glk{hGrYlGVGzTt´Glk{hGrZl㠦⓪G䟃㦧ἶ㩲GrYGlk{hG⡦⓪GrZGlk{hṖG䙂䞾♮㠊G㧞㦒ⳆG㩚䡞G㺚䀾㠦G㌂㣿♿┞┺QQUGrYGlk{hG⡦⓪GrZGlk{h⓪G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺O䡞㞷G
XG╏Glk{hGXU]PUG
lk{hG㩚䡞㦖G䡞㞷GỖ㌂⯒G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG䡞㞷G☚ⰦG䚲⽎㦖G㺚䡞G䤚G[㔲ṚG㧊⌊㠦G㩲㧧♮㠊㟒G䞿┞┺U㦧ἶG㠋㩲⓪Glk{h⯒G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG
zTt´Glk{hGrYlGVGrZl㦮G䡞㞷㦖G㧒㌗㩗㧎GⳊ㡃G䡞㞷GỖ㌂G⹥GṦ㡒㎇G㰞䢮G䎢㓺䔎⯒G㥚䟊㍲☚G㌂㣿GṖ⓻䞿┞┺UG㌂㣿㧦⓪G⽊ὖG㫆Ị㦚G䙂䞾䟊G䟊╏G䎢㓺䔎G㔲㟓V⿚㍳G㧻䂮⯒G㌂㣿䞮㡂G㧊㢖Gṯ㦖G
Ỗ㌂㠦G㔲⬢Gⶒ㰞㧊G㩗䞿䞲㰖G㡂⿖⯒GỖ㯳䞶G㺛㧚㧊G㧞㔋┞┺UG

XXX

KO
SARSTEDT S-Monovette® EDTA 㩺 K2E
zTt´Glk{hG㩺GrYl㠦⓪G䟃㦧ἶ㩲GrYGlk{hG㣎㠦☚G䙊ⰂⲎG₆⹮㦮G㩺㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUGrYGlk{h⓪G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺O䡞㞷GXG╏Glk{hGXU]PUG㩺㦖G㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞㞷G㎎䙂㢖G䡞㧻G㌂㧊㠦G㥚䂮䞮ỢG♮ⳆG㤊㏷SG⽊ὖG⹥G⿚㍳G㔲G㞞㩫㩗㧎G⿚Ⰲ䂋㦚G䡫㎇䞿┞┺U
lk{hG䡞㧻㦖G⿚㧦G⹪㧊⩂㓺G㰚┾㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG
㦧ἶG㠋㩲⓪Glk{h⯒G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG

SARSTEDT S-Monovette® ⿞㏢ EDTA FE / ⿞㏢ 䠺䕢Ⰶ FH / ⿞㏢ ῂ㡆㌆㡒 EDTA FC, ╏⿚䟊 㠋㩲㩲 䙂䞾
zTt´G⿞㏢Glk{hGml㠦⓪G╏⿚䟊G㠋㩲⯒G㥚䟊G䟃㦧ἶ㩲Glk{hO䡞㞷GXG╏GXUYP㢖G⿞㏢O䡞㞷GXG╏GXUWPṖG䙂䞾♮㠊G㧞㦒ⳆG䡞㧻G㺚䀾⯒G㥚䟊G㌂㣿♿┞┺QQUG⿞㏢Glk{h⓪G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺UzTt´G⿞㏢G䠺䕢ⰆGmo㠦⓪G╏⿚䟊G㠋㩲⯒G㥚䟊G䟃㦧ἶ㩲G䠺䕢ⰆO䡞㞷GXG╏GX]GpUlUP㢖G⿞㏢O䡞㞷GXG╏GXUWPṖG䙂䞾♮㠊G㧞㦒ⳆG䡞㧻G㺚䀾⯒G㥚䟊G㌂㣿♿┞┺QQUG⿞㏢G䠺䕢Ⰶ㦖G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺U㡺㰗G⿞㏢G┾☛㦒⪲G㧊⬾㠊㰖⓪G╏⿚䟊G㠋㩲⓪G㺚䡞G㣿₆⯒G㺚㤆ἶG㟓GY㔲ṚG䤚㠦G㔲㧧♮ⳆG㟓G[㔲ṚG䤚㠦G㩚㼊G䣾⩻㦚G⽊㡂㭣┞┺UG➆⧒㍲G䙂☚╏㦖G㩚䡞㠦㍲GⳝG㔲ṚG䤚G䘟‶G㾲╖G]LSGY[㔲ṚG䤚G㾲╖G
XW¥X\L₢㰖G⿚䟊♿┞┺U
zTt´Gnlhj{Gmj㠦⓪G㯟ṗ㩗㧎G╏⿚䟊G㠋㩲⯒G㥚䟊Gῂ㡆㌆㡒G⹥G⿞㏢㢖G䟃㦧ἶ㩲㧎Glk{hṖG䙂䞾♮㠊G㧞㦒ⳆG䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUGlk{hSGῂ㡆㌆㡒G⹥G⿞㏢⓪G㣿㞷㦒⪲G㩲Ὃ♿┞┺UG
䧂㍳㦒⪲G㧎䟊G䙂☚╏G⏣☚⯒GἚ㌆䞮⩺ⳊGXUX]㦚G὇䟊㟒G䞿┞┺UG
zTt´Gnlhj{Gmj⓪G☛㧒G╏␾G䡧䣢OkGkGnSGkknP㦮G㧚㔶㎇G╏␾G㰖䂾G⹥G㩲Y䡫G╏␾㠦G╖䞲GῃṖG㰖䂾OuG}sSGu}sP㦚G㿿㫇㔲䌋┞┺UG
㩚䡞㦮Gἓ㤆G䙂☚╏G⏣☚㦮G㯟ṗ㩗㧎G㞞㩫㧊G㔺㡾㠦㍲G㾲╖G`]㔲ṚG☯㞞G⽊㧻♿┞┺UGzhyz{lk{G⺇㍲⯒G㺎㫆䞮㕃㔲㡺aGaVVUUVVVVTVTVGsGVGIzGzTt´Gnlhj{GhGGGGG¡GGGG`]GIU
⿞㏢Glk{hGOῂ㡆㌆㡒PG䡞㧻㦖G䙂☚╏G䁷㩫㠦㍲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG
㦧ἶG㠋㩲⓪Glk{h⯒G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG
㭒㦮aG⿞㏢⓪G㣿䡞G⹮㦧㦚G㯳Ṗ㔲䌂G㑮G㧞㔋┞┺UG⿖㩫㩗㧎G㡗䟻㦚G㭚G㑮G㧞⓪Gⶒ㰞ὒGὖ⩾♲G㿪Ṗ㩗㧎G㩫⽊⓪G䎢㓺䔎G㔲㟓G㩲㫆㠛㼊㦮G䟊╏G㌂㣿G㍺ⳛ㍲㠦㍲G䢫㧎䞮㔺G㑮G㧞㔋┞┺U
zTt´Gnlhj{㢖G⋮゚⹪⓮㦮G㫆䞿ὒGὖ⩾䞮㡂G㔲⬢G㺚䀾G⹥G䀾

㠦G╖䞲G㭒㦮G㌂䟃㠦G㥶㦮䞮㕃㔲㡺U

SARSTEDT S-Monovette® CPDA
zTt´Gjwkh㠦⓪G䟃㦧ἶ㩲㧎Gῂ㡆㌆㡒ὒGῂ㡆㌆SG㧎㌆G⋮䔎⮾SG◇㓺䔎⪲㓺G⹥G㞚◆┢㧊G䙂䞾♮㠊G㧞㦒ⳆG㩚䡞G⹥G䡞㧻G㺚䀾㠦G㌂㣿♿┞┺QQUGjwkh⓪G㣿㞷㦒⪲G㩲Ὃ♿┞┺UGjwkhG╖G䡞㞷㦮G䢒䞿゚⓪G
Xa]GTGjwkhG⿖䞒⿖GXὒG䡞㞷G⿖䞒⿖G]㧛┞┺UG⿚㍳㦚G㥚䟊㍲⓪G㩫䢫䞲G㿿㩚㧊G䞚㑮㩗㧛┞┺U
jwkhG㩚䡞V䡞㧻㦖G㑮䡞G㦮䞯㦮G䡞㞷䡫G䡞㼃G⹮㦧SG㑮䡞G㭧G㩗䞿㎇G䎢㓺䔎Oᾦ㹾G㧒䂮P⯒G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♶G㑮G㧞㔋┞┺UGῂ㼊㩗㦒⪲GzTt´Gjwkh⓪GrG⹥Gy⯒G䙂䞾䞲G䡞㞷䡫GỖ㌂OhiWPSG
⿞′䂯G䡞㞷G䟃㼊㠦G╖䞲G䟃㼊GỖ㌂G䎢㓺䔎SG┺䔏㧊㎇G㰗㩧G䉆㓺G䎢㓺䔎O㾲╖GXW㧒PSG䡞㞷䡫G䢎䢮㎇G䢮㧦G䡞㼃V䡞㧻O㭒G䎢㓺䔎P㦚G㌂㣿䞲G㩗䞿㎇G䎢㓺䔎Oᾦ㹾G㧒䂮P㠦G㩗䞿䞿┞┺UG
⽊ὖ₢㰖㦮G㤊㏷G₆Ṛ㦖GY¥YX¶j㠦㍲G㾲╖G[㔲Ṛ㦒⪲GỖ㯳♮㠞㔋┞┺UG㎎䙂G䂾ṫ㦚G㥚䟊G㔲⬢⯒GⲒ㩖G⌟㧻ἶ㠦㍲G㾲㏢GX]㔲ṚG☯㞞G⽊ὖ䟊㟒G䞿┞┺UG㧊䤚SG㌗₆㦮G⿚㍳Gⶒ㰞㦚G⌟㧻ἶ㠦G⽊ὖ䞲G䤚OY¥]¶jPSG
㧒⹮㩗㧎G䡞㞷G⽊ὖG₆ṚὒG㥶㌂䞮ỢG㾲╖GZ\㧒G☯㞞G䁷㩫䞶G㑮G㧞㔋┞┺O㰗㩧G䉆㓺G䎢㓺䔎㦮GXW㧒㦖G㡞㣎PUGvGjGk㦮G}GtG❇㦮G䃒⩒㦧㰧₆㑶㠦G㩗䞿䞿┞┺UG㔲⬢Gⶒ㰞㦚G⌟☯䟊㍲⓪G㞞G♿┞┺UG㌂㣿㧦⓪G⽊ὖG㫆Ị㦚G䙂䞾䟊G₆䌖G⹿㔳V䎢㓺䔎G㔲㟓V⿚㍳G㧻䂮⯒G㌂㣿䞮㡂G㧊㢖Gṯ㦖GỖ㌂㠦G㔲⬢Gⶒ㰞㧊G㩗䞿䞲㰖G㡂⿖⯒G䢫㧎䟊㟒G䞮ⳆSG㧊⓪G㌂㣿㧦ṖG㰗㩧GỖ㯳䟊㟒G䞿┞┺U㦧ἶG㠋㩲⓪Gῂ㡆㌆㡒㦚G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺UG
zTt´Gjwkh㢖G⋮゚⹪⓮㦮G㫆䞿ὒGὖ⩾䞮㡂G㔲⬢G㺚䀾G⹥G䀾 㠦G╖䞲G㭒㦮G㌂䟃㠦G㥶㦮䞮㕃㔲㡺U

SARSTEDT S-Monovette® ThromboExactzTt´G{l㠦⓪G䟃㦧ἶ㩲⪲GⰞ⁎⍺㓮㡒㧊G䙂䞾♮㠊G㧞㦒ⳆSG㩚䡞G㺚䀾㠦G㌂㣿♿┞┺QQUGⰞ⁎⍺㓮㡒㦖G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺UG
zTt´G{l㦮G㩚䡞㦖GṖ㎇G䡞㏢䕦GṦ㏢㯳㦒⪲☚G㞢⩺㰚G䟃㦧ἶ㩲G⿞⌊㎇O㡞aGlk{hSGῂ㡆㌆㡒SG䠺䕢ⰆP㦒⪲G㧎䞲G㧮ⴑ♲G䡞㏢䕦G㑮䂮⯒G⺆㩲䞮₆G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG䡞㏢䕦G㦧㰧㼊G䡫㎇㦚G⹿㰖䞮ἶSG㺚䡞G䤚G㾲╖GXY㔲ṚG☯㞞G㔺㩲G䡞㏢䕦G㑮⯒G䁷㩫䞶G㑮G㧞☚⪳G䞿┞┺U㦧ἶG㠋㩲⓪GⰞ⁎⍺㓮G㧊㡾㦚G䐋䟊G㧊⬾㠊㰧┞┺UG㧊➢GⰞ⁎⍺㓮G㧊㡾㦖G䡞㏢䕦G䔎⫂⽋㌆GhYG⹥Ghkw㢖G㞚Ⰲ䋺☞㌆㦒⪲GⰺṲ♮⓪G䡞㏢䕦G㦧㰧㦚G㠋㩲䞿┞┺U

SARSTEDT S-Monovette® Hirudin
zTt´Go㠦⓪G䟃㦧ἶ㩲G䧞⬾❮㧊G䙂䞾♮㠊G㧞㦒ⳆG㩚䡞G㺚䀾㠦G㌂㣿♿┞┺QQUG䧞⬾❮㦖G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺UG
䧞⬾❮G㩚䡞㦖GyvjolGk㦮Gt´G㧻䂮OGGG P㦮G䡞㏢䕦G₆⓻㦚G䁷㩫䞮₆G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♮ⳆG㧊⯒G㥚䟊GỖ㯳♮㠞㔋┞┺UG䡞㏢䕦G㠋㩲G㟓ⶒ㦚G㌂㣿䞲G䂮⬢G
⳾┞䎆ⰗG⹥G䡞㏢䕦G₆⓻G㧻㞶GṦ㰖G⡦⓪G⺆㩲⯒G㥚䟊G㌂㣿♿┞┺U
zTt´Go㦖Gt´G㧻䂮㠦㍲G䡚㨂GyvjolGk㦮G㩚㔶㧎G}Gk㢖GὋ☯㦒⪲G䡞㏢䕦G₆⓻G䁷㩫㦚G㥚䟊G䔏㑮GṲ⹲♮㠞㔋┞┺UG
䧞⬾❮㦚G䐋䞲G㦧ἶG㠋㩲⓪G㰗㩧㩗㧎G䔎⫂ゞG㠋㩲⯒G䐋䟊G⹎ṖὋG㌗䌲㠦㍲G䡞㏢䕦G₆⓻G㰚┾㦚GṖ⓻䞮ỢG䞿┞┺U

SARSTEDT S-Monovette® 䢎⳾㔲㓺䎢㧎 HCY-Z 㩺 / HCY-C
zTt´G䢎⳾㔲㓺䎢㧎GojTG㩺㦖G㦧ἶG㽟㰚㩲O′㌆㡒PṖG䆪䕛♲G䝢⧒㓺䕇GὒⰓG㣎㠦☚G䔏㑮G㞞㩫㩲㢖G䙊ⰂⲎG₆⹮㦮G㩺㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㼃G㺚䀾㠦G㌂㣿♿┞┺QQUG㩺㦖G㤦㕂G⿚Ⰲ⯒G䐋䟊G䡞⼧ὒG䡞㼃G㌂㧊㠦G㥚䂮䞮ỢG♮ⳆG㤊㏷SG⽊ὖG⹥G⿚㍳G㔲G㞞㩫㩗㧎G⿚Ⰲ䂋㦚G䡫㎇䞿┞┺UG㩲㩲⓪G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺U
䢎⳾㔲㓺䎢㧎㦖G㔺㡾㦮G㩚䡞㠦㍲G㾲╖G_㔲ṚG☯㞞G㞞㩫䢪♿┞┺UG㤦㕂G⿚ⰂṖG㾲㽞G_㔲ṚG⌊㠦G䡞⼧ὒG䡞㼃G㌂㧊㦮G⿚Ⰲ䂋㧊G㢂⹪⯊ỢG䡫㎇♲G㌗䌲㠦㍲G㧊⬾㠊㰖ⳊG䢎⳾㔲㓺䎢㧎㦖G㾲╖G`]㔲Ṛ₢㰖G㞞㩫䢪♿┞┺UzTt´G䢎⳾㔲㓺䎢㧎GojTG㩺㦮G䡞㼃㦖G䢎⳾㔲㓺䎢㧎G䁷㩫㦚G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UGzTt´G䢎⳾㔲㓺䎢㧎GojTj㠦⓪G䟃㦧ἶ㩲⪲G㌆㎇Gῂ㡆㌆㡒OoG[UZP㧊G䙂䞾♮㠊G㧞㦒ⳆG䡞㧻G
㺚䀾㠦G㌂㣿♿┞┺QQUGῂ㡆㌆㡒㦖G㣿㞷㦒⪲G㩲Ὃ♿┞┺UG䧂㍳㦒⪲G㧎䟊G䢎⳾㔲㓺䎢㧎G⏣☚⯒GἚ㌆䞮⩺ⳊGXUXX㦚G὇䟊㟒G䞿┞┺UG
䢎⳾㔲㓺䎢㧎㦖G㔺㡾㦮G㩚䡞㠦㍲G㾲╖G]㔲ṚSG⁎ⰂἶG[¶j㠦㍲G㾲╖G[_㔲ṚG☯㞞G㞞㩫䢪♿┞┺U
zTt´G䢎⳾㔲㓺䎢㧎GojTj㦮G䡞㧻㦖G䢎⳾㔲㓺䎢㧎G䁷㩫㦚G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UG
zTt´G䢎⳾㔲㓺䎢㧎GojTj㦮G㦧ἶG㠋㩲⓪Gῂ㡆㌆㡒㦚G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺U
zTt´GojTj㢖G⋮゚⹪⓮㦮G㫆䞿ὒGὖ⩾䞮㡂G㔲⬢G㺚䀾G⹥G䀾 㠦G╖䞲G㭒㦮G㌂䟃㠦G㥶㦮䞮㕃㔲㡺U

SARSTEDT S-Monovette® DNA ExactzTt´GkuhGl㠦⓪Glk{hG₆⹮㦮G䟃㦧ἶ㩲ṖG䙂䞾♮㠊G㧞㦒ⳆSG㩚䡞G㺚䀾㠦G㌂㣿♿┞┺QQUGlk{h⓪G㓺䝚⩞㧊G䡫䌲⪲G㩲Ὃ♿┞┺UG
lk{hG㩚䡞㦖GkuhG㞞㩫䢪⯒G㥚䞲G㔲⬢Gⶒ㰞⪲G㌂㣿♿┞┺UGkuh㦮G㞞㩫䢪G㎇⓻㦖GZ\¶j㠦㍲G\㧒SG㔺㡾OYY¶jP㠦㍲GX[㧒SG⌟ṗG㔲O[¶jPGY_㧒SGTYW¶j㠦㍲GX⎚G㧊㌗㧚㧊GỖ㯳♮㠞㔋┞┺UG⡦䞲G㞞㩫䢪♲G㔲⬢⓪G䛞㰞G㏦㌗G㠜㧊G\䣢㦮G☯ἆG⹥G䟊☯G㭒₆⯒Gἂ❲G㑮G㧞㔋┞┺UGzhyz{lk{G⺇㍲G㡃㔲G㺎㫆䞮㕃㔲㡺GaVVUUVVVVTVTVGsGVGIzhyz{lk{GzTt´GkuhGlGˀGhGuGp}kGjGiGjG{GGjSG{GGz¡GG~GiGGnGkuhGh UIU
㦧ἶG㠋㩲⓪Glk{h⯒G䐋䞲G䃒㓮ὒG㧊㡾㦮G㹿䢪⪲G㧊⬾㠊㰧┞┺U

QQ㔲⬢Gⶒ㰞㦮G㩗䞿㎇㦖G⿚㍳Gⶒ㰞ὒG䎢㓺䔎G㔲㟓V⿚㍳G㧻䂮㠦G➆⧒G╂⧒㰧┞┺UG㩲㫆㌂㦮Gῢ㧻G㌂䟃㦚G㭖㑮䟊㟒G䞿┞┺UG

XXY

KO
㞞㩚G㰖䂾GVGἓἶG㰖䂾XUG 㧒⹮㩗㧎G㡞⹿G㫆䂮aG㧻ṧG⹥G₆䌖G㧒⹮㩗㧎GṲ㧎⽊䢎㧻゚⯒G㹿㣿䞮㡂SG㧶㨂㩗㧎GṦ㡒G㔲⬢Gⶒ㰞ὒG㩚㡒♶G㑮G㧞⓪G⼧㤦㼊㠦G⏎㿲♶GṖ⓻㎇㦒⪲⿖䎆G㧦㔶㦚G⽊䢎䞮㕃㔲㡺U
YUG ⁒ⶊ䞮⓪G㫆㰗㦮G㰖䂾G⹥G㩞㹾㠦G➆⧒G⳾✶G㌳ⶒ䞯㩗G㔲⬢㢖G⋶䃊⪲㤊V㈆㫇䞲G㺚䡞G₆ῂO⹪⓮SG㠊╧䎆P⯒G㻮Ⰲ䞮㕃㔲㡺UG㌳ⶒ䞯㩗G㔲⬢㢖G㰗㩧G㩧㽟䞮㡖Ệ⋮G㧦㌗㦚G㧛㦖Gἓ㤆SG㧊⪲G㧎䟊Gop}SGoj}SGoi}G⡦⓪G₆䌖GṦ㡒⼧㠦G㩚㡒♶G㑮G㧞㦒⸖⪲G㦮㌂㦮G㰚㺆㦚G⹱㦒㕃㔲㡺UG⹪⓮G⽊䢎ῂṖG㧻㹿♲G㞞㩚G⹪⓮㞞㩚t͍ ´⯒G㌂㣿䞮㕃㔲㡺UG⁒ⶊ䞮⓪G㫆㰗㦮G㞞㩚G㰖䂾G⹥G㩞㹾⯒G㭖㑮䟊㟒G䞿┞┺UZUG Ṳ⼚GⳎ‶G䙂㧻♲G㩲䛞㠦G㩗㣿aG㌂㣿䞮₆G㩚GṗG䙂㧻㦮G㏦㌗G㡂⿖⯒GỖ㌂䞮ἶG㏦㌗♲Gἓ㤆SG㌂㣿䞮㰖GⰞ㕃㔲㡺U[UG 㧊G㩲䛞㦖G㧒䣢㣿㧛┞┺UG㺚䡞㦚G㥚䟊G㌂㣿䞲G⳾✶G⋶䃊⪲㤊V㈆㫇䞲Gⶒ㼊O⹪⓮SG㠊╧䎆P⯒G㌳ⶒ䞯㩗G㥚䠮ⶒ㰞㠦G㩗䞿䞲G䘦₆G㣿₆㠦G⍹㠊G䘦₆䞮㕃㔲㡺U\UG 㩫ⰻOp}P㦚G䐋䟊G㺚䡞䞮⓪Gἓ㤆SG㺚䡞㦚G㔲㧧䞮₆G㩚SG㫆㰗㦮G㰖䂾㠦G➆⧒G㩗䞿䞮ỢG㎎㻯♮㠞⓪㰖OdGp}G㣿㞷G㎎㻯PG䢫㧎䟊㟒G䞿┞┺UG㩧⁒⿖⯒G㢂⹪⯊ỢG㎎㻯䞮ⳊG㧮ⴑ♲G⿚㍳Gἆὒ⯒G㡞⹿䞶G㑮G㧞㔋┞┺U]UG zTt´⯒G⍞ⶊGὒ☚䞮ỢG㺚㤆⓪Gἓ㤆SG䡞㞷ὒG㩲㩲V㻾Ṗ㩲㦮G゚㥾㧊G㧮ⴑ♮㠊G⿚㍳GἆὒṖG㧮ⴑ♶G㑮G㧞㔋┞┺U^UG zTt´⪲G㺚䡞G⹥G㻮Ⰲ♲G䡞㞷㦖G㧎㼊㠦G㨂㭒㧛䞮₆㠦G㩗䞿䞮㰖G㞠㔋┞┺U_UG 㧊G㩲䛞㦖G㥶䣾G₆ṚGἓὒG䤚G㌂㣿䟊㍲⓪G㞞G♿┞┺UG㥶䣾G₆Ṛ㦖Gⳛ㔲♲G㡆☚㢖G╂㦮GⰞ㰖ⰟG⋶㰲㠦GⰢ⬢♿┞┺U⽊ὖ
㩲䛞㦖G㌂㣿G㩚₢㰖G㔺㡾㠦㍲G⽊ὖ䟊㟒G䞿┞┺UG㩲䞲XUG 㿿㩚G㌗䌲㦮GzTt´㦮G⽊ὖG㔲ṚὒG㡾☚⓪G⿚㍳Gⶒ㰞㦮G㥶䣾G₆Ṛ㠦G➆⧒G┺⯛┞┺UG䘟Ṗ⓪G㔺䠮㔺㠦㍲G㔺㔲䞮Ệ⋮G⡦⓪G䎢㓺䔎G㔲㟓V⿚㍳G㧻䂮G㩲㫆㌂㦮G㌂㣿G㍺ⳛ㍲㦮G㩫⽊⯒G䢫㧎䞿┞┺UG
YUG 㤦㕂G⿚Ⰲ㠦G㦮䟊G䡞㧻G⡦⓪G䡞㼃㧊GzTt´㠦㍲G⿚Ⰲ♮㠞Ệ⋮G㧻⼓㧊G㫊㨂䞮▪⧒☚SG⳾✶G㎎䙂ṖG㢚㩚䧞G⿚Ⰲ♮㰖G㞠㞮㦚G㑮G㧞㔋┞┺UG㧪⮮ⶒG⡦⓪G㧦㡆㩗㧎G⿚䟊ṖG⿚㍳Gⶒ㰞㦮G⏣☚㠦G㡗䟻㦚G㭚G
㑮G㧞㔋┞┺UG⿚㍳Gⶒ㰞㦮G㞞㩫㎇㦖G㩖㧻G㣿₆G⹥G䟊╏G㔺䠮㔺㦮G㫆Ị㦚Gἶ⩺䞮㡂G䘟Ṗ♮㠊㟒G䞿┞┺UZUG 䂮⬢G㟓ⶒ㦮Gἓ㤆SG䎢㓺䔎G㔲㟓V⿚㍳G㧻䂮G㩲㫆㠛㼊㦮G㌂㣿G㍺ⳛ㍲㠦㍲GỖ㼊Gⶒ㰞㦮G㩗䞿㎇㦚G䢫㧎䟊㟒G䞿┞┺U[UG ⹎⨟G㤦㏢V⁞㏣㠦G╖䞲G⿚㍳㦖GzTt´G⁞㏣G⿚㍳GRG㞞㩚G⹪⓮G⁞㏣G⿚㍳G㔲㓺䎲㦒⪲G㔺䟟䟊㟒G䞿┞┺U㔲⬢G㺚䀾G⹥G䀾㩫ⰻG㺚䡞㦚G㔲㧧䞮₆G㩚㠦G㧊Gⶎ㍲⯒Gザ㰦㠜㧊G㧓㦒㕃㔲㡺U
㔲⬢G㺚䀾㠦G䞚㣪䞲G㧧㠛G㨂⬢XUG 䞚㣪䞲G⳾✶GzTt´G㺚䡞G㔲㓺䎲UG
YUG O㞞㩚PG⹪⓮G⡦⓪GO㞞㩚Pt͍ ´G⹪⓮U
ZUG 䡞㞷㠦G㦮䟊G㩚㡒♮⓪G⼧㤦㼊⋮G㩚㡒㎇㧊G㧞⓪Gⶒ㰞⪲⿖䎆G㧦㔶㦚G⽊䢎䞮₆G㥚䞲G㧻ṧSGṖ㤊SG⽊㞞ἓG⡦⓪G₆䌖G㩗㩞䞲G⽊䢎⽋UG[UG 䢮㧦G㔳⼚㦚G㥚䞲G⧒⻾\UG 㺚䀾G㥚䂮⯒G┼㞚⌊₆G㥚䞲G㏢☛㩲O㺚䀾G㥚䂮⯒G㭖゚䞮⩺ⳊGⳎ‶GỖ㼊G㺚䀾⯒G㥚䟊SG⁒ⶊ䞮⓪G㫆㰗㦮G㰖䂾㦚G㭖㑮䞮㕃㔲㡺PUG㔲⬢⯒G䡞㭧G㞢䆪㢂G䎢㓺䔎㠦G㌂㣿䟊㟒G䞶Gἓ㤆SG㞢䆪㢂G₆⹮㦮G㎎㩫㩲⯒G㌂㣿䞮㰖GⰞ㕃㔲㡺UG]UG Ị㫆䞲Gⶊ‶G㧒䣢㣿G㓺㢧U^UG 㩫ⰻG㰖䡞╖UG_UG ⺊✲G⡦⓪G⿫╖U`UG ㌂㣿䞲G㨂⬢⯒G㞞㩚䞮ỢG䘦₆䞮₆G㥚䞲G⋶䃊⪲㤊V㈆㫇䞲Gⶒ㼊㣿G䘦₆G㣿₆U

ῢ㧻G㺚䀾G㑲㍲a
XUG 䡞㞷G⺆㟧G⽊䔖
YUG ῂ㡆㌆㡒G⡦⓪G㦧ἶG㽟㰚㩲⯒G䙂䞾䞲G㣿₆OnGzGjh{GVGzTnGjh{G䙂䞾V⹎䙂䞾PG
ZUG 㦧ἶG㽟㰚㩲G⡦⓪Gῂ㡆㌆㡒㦚G䙂䞾䞲G㣿₆G[UG 㩺㦚G䙂䞾V⹎䙂䞾䞲G䠺䕢ⰆG䙂䞾G㣿₆\UG 㩺㦚G䙂䞾V⹎䙂䞾䞲Glk{hG䙂䞾G㣿₆]UG ╏⿚䟊G㠋㩲㩲G䙂䞾G㣿₆^UG ₆䌖G㻾Ṗ㩲G䙂䞾G㣿₆
㭒㦮aG

Gῂ㡆㌆㡒G㣿₆G⡦⓪GwmhSGj{hkSGjwkhSGojTjG⡦⓪Gnlhj{㢖Gṯ㦖G㞷㼊G㩲㩲⯒G䙂䞾䞲G┺⯎G㣿₆⯒G⋮゚⹪⓮O㡞aGO㞞㩚Pt͍ ´G⹪⓮PὒG䞾℮G㌂㣿䞮㡂G㺚䀾⯒G㔲㧧䞮⓪Gἓ㤆SGゞG㣿₆O㡞aGzTt´GuGP⯒G㌂㩚㠦G㩲Ệ䞮㡂G⋶Ṳ⹪⓮㦮G䓲ぢ⯒G㺚㤢G㣿₆㦮G㭒㧛⨟㧊G⿖㫇䟊㰖⓪Gộ㦚G⹿㰖䞮⓪Gộ㧊G㫡㔋┞┺UGG
㧊⓪G㣿₆㦮G㢂⹪⯎G㿿㩚㦚G⽊㧻䞮㡂G㩫䢫䞲G䢒䞿゚O㣿㞷G╖G䡞㞷P⯒G╂㎇䞶G㑮G㧞☚⪳G䞿┞┺UG

㭒㦮aG

㺚䀾G㑲㍲⓪G㫆㰗㦮G′㩫㦚G➆⯊㕃㔲㡺U

㡃⮮G⹿㰖╖⿖⿚㦮GzTt㠦⓪G䢪䞯G㻾Ṗ㩲ṖG䙂䞾♮㠊G㧞㔋┞┺UG㡃⮮⯒G⹿㰖䞮₆G㥚䟊㍲⓪G┺㦢ὒGṯ㦖G㍺ⳛ㍲⯒G㭖㑮䟊㟒G䞿┞┺a
XUG ㌂㣿㍺ⳛ㍲㠦㍲Gῢ㧻䞮⓪G㨂⬢Ⱒ㦚G㌂㣿䞮㕃㔲㡺U
YUG 㩫ⰻ㠦G㓓ỢG㩧⁒䞶G㑮G㧞☚⪳G䢮㧦⯒G⑫䧞ἶG䕪G⡦⓪G₆䌖G㻲㧦G⿖㥚⯒G㞚⧮⪲G䟻䞮☚⪳G䞿┞┺UG
ZUG ⋮㌂G䃷㧊G㥚⯒G䟻䞮☚⪳GzTt´㦚G㧷ἶGO㞞㩚Pt͍ ´G⹪⓮㦚G㌂㣿䞶G➢☚G䕪G⏨㧊V㻲㧦G⿖㥚G㞚⧮⪲G㥶㰖䞿┞┺U[UG zTt´㦮G⌊㣿ⶒ㧊G㩫ⰻG㻲㧦G㭧G⋮㌂G䃷㧊⋮G⹪⓮㦮G⊳G⿖⿚㠦G╕㰖G㞠☚⪳G䟊㟒G䞿┞┺U\UG zTt´㦒⪲G䡞㞷㧊G㥶㧛♮⓪G☯㞞G㩫ⰻG㰖䡞╖⯒G䛟┞┺U

XXZ

KO
☯ἆV䟊☯
~ov㦮Gῢ㧻G㌂䟃O~ovVkpsVsV``UXGyUWYP㠦G➆⯊ⳊSG☯ἆG㩚㠦G䡞㞷G㎎䙂㠦㍲G䡞㼃V䡞㧻㦚G⿚Ⰲ䞮⓪Gộ㧊G㫡㔋┞┺UG
zTt´㠦⓪G┺㦢ὒGṯ㦖G☯ἆ㠦G╖䞲Gῢ㧻G㌂䟃㧊G㩗㣿♿┞┺aW¶jG㧊䞮G☯ἆ
ˍG

㡗䞮㦮G㡾☚㠦㍲G㌂㣿䞮⓪Gἓ㤆SG㣿₆㠦GṖ䟊㰖⓪G⿖䞮ṖG☯ἆ䞮ἶ㧦G䞮⓪Gⰺ㰞ὒG㧒㌗㩗㧎G㫆Ị㠦G➆⧒Gⰺ㤆G┺⯒G㑮G㧞₆G➢ⶎ㠦SG䟃㌗G㔺㩲G㫆Ị㠦㍲G䎢㓺䔎䟊㟒G䞿┞┺UGOzhyz{lk{G䃊䌞⪲⁎㦮G㨂⬢G
䔏㎇G㧻G㺎㫆P

ˍG

₆⽎㩗㦒⪲G䝢⧒㓺䕇㦮Gṫ☚GṨ㦖GW¶jG㧊䞮㠦㍲GṦ㏢䞿┞┺UG➆⧒㍲G㧒⹮㩗㦒⪲G₆Ἒ㩗G⿖䞮⯒G䞒䟊㟒G䞿┞┺U

ˍG

zTt´㦮G⌊㣿ⶒ㧊G‶㧒䞮ỢSG⡦⓪G㞚⧮㠦㍲G㥚⪲G☯ἆ䞮☚⪳G☯ἆG㫆Ị㦚G㍶䌳䟊㟒G䞿┞┺UGzTt´㦖G䢫㧻㧊GṖ⓻䞮☚⪳G㓺䌶✲G⡦⓪G⽊ὖG㌗㧦㠦G㿿⿚䞲GὋṚ㦚G䢫⽊䟊㟒G䞿┞┺UG
㓺䕆⪲䙒G⡦⓪G⁞㏣G㓺䌶✲⓪G䖓㺓㦒⪲G㧎䞲G‶㡊㧊G⹲㌳䞶G㑮G㧞㦒⸖⪲G⿖㩗䞿䞿┞┺U

TYW¶j₢㰖G☯ἆGˀG☯ἆG㩚㠦G┺㦢G㌂䟃㦚G㩦Ỗ䞮㕃㔲㡺aˍG

Ṛ㎃aG☯ἆ㧊G䡞㞷G㔲⬢G⡦⓪G⿚㍳㠦G⿖㩫㩗㧎G㡗䟻㦚G㭒⓪㰖G䢫㧎䞮㕃㔲㡺O㡞aG㣿䡞SG⿚㍳Gⶒ㰞G㞞㩫㎇PU

ˍG

㤦㕂G⿚ⰂaGἚ䣣䞲G⿚㍳㠦G➆⧒G䞚㣪䞿┞┺UG㤦㕂G⿚ⰂG㫆Ị㦖G⽎Gⶎ㍲㦮GI㤦㕂G⿚ⰂIG⡦⓪Gzhyz{lk{G㥏㌂㧊䔎GaVVUUVVVV⯒G䢫㧎䞮ἶG㔲ṗ㩗G㔲⬢GỖ㌂⯒G㔺㔲䞿┞┺U

ˍG

㣿䡞aG☯ἆG㔲G㩚䡞㦖G㣿䡞♿┞┺aG㧊⯒G⹿㰖䞮⩺ⳊSGzTt´G㩺G⡦⓪Gz´G⺎ぢG䞚䎆⯒G㤦㕂G⿚ⰂG䤚G㌂㣿䞮Ệ⋮SG㔲⬢⯒GY㹾G㣿₆㠦㍲G䞒䘁䕛䟊㟒G䞿┞┺U

TYW¶j⪲G☯ἆGˀG㩞㹾a
ˍG⌟ṗaGzTt´㦚G㔺㡾㠦㍲G[\¥]W⿚G☯㞞G⡧⹪⪲G㎎㤢G⌟ṗ㔲䋾G䤚SGTYW¶j⪲G☯ἆ㔲䋺₆G㩚SGR[¶j⪲G⌟ṗ㔲䌋┞┺U

ˍG

䟊☯aG㾲㏢䞲G[\⿚G㧊㌗G㔺㡾㠦㍲G⡧⹪⪲G㎎㤢G䟊☯䞿┞┺UG㧊➢☚SG₆Ἒ㩗G⿖䞮⯒G䞒䟊㟒G䞿┞┺UG⍞ⶊGザ⯊ỢG䟊☯♮⓪Gἓ㤆SG⿚㍳Gἆὒ㠦G㡗䟻㦚G㭚G㑮G㧞㔋┞┺U☯ἆG⹥GTYW¶jG㧊䞮㦮G
ˍG

TYW¶jG㧊䞮㦮G㏣G☯ἆ

㏣G☯ἆ㦖G㩲㫆㠛㼊㠦G㦮䟊G䎢㓺䔎♮㰖G㞠㞮㔋┞┺UG┺㟧䞲G㡗䟻G㣪㧎㧊G㫊㨂䞮₆G➢ⶎ㠦SG☯ἆG䎢㓺䔎⯒G㧒㌗㩗㧎G㔺䠮㔺G㫆Ị㠦㍲G㔺㔲䞶Gộ㦚Gῢ㧻䞿┞┺U

zTt´G㩺G☯ἆa
ˍG

TYW¶j⪲G☯ἆGˀG㩞㹾G䟃⳿㠦G㍺ⳛ♲Gộ㻮⩒G☯ἆ㔲䌋┞┺U

ˍG☯ἆGὒ㩫㦒⪲G㧎䟊SG㩺G䂋㧊G⼖䢪䞶G㑮G㧞┺⓪G㌂㔺㧊G㞢⩺㪎G㧞㔋┞┺U

ˍG┺㟧䞲G㡗䟻G㣪㧎㧊G㫊㨂䞮₆G➢ⶎ㠦SG☯ἆG䎢㓺䔎⯒G㧒㌗㩗㧎G㔺䠮㔺G㫆Ị㠦㍲G㔺㔲䞶Gộ㦚Gῢ㧻䞿┞┺U

ˍG

䟊☯aG㔲⬢⯒G⡧⹪⪲G㎎㤢G䟊☯䞿┞┺UG㔲⬢Gⶒ㰞㦖G䟊☯G䤚SGX㹾G㣿₆㠦㍲GY㹾G㣿₆⪲G㩺G䂋㦮G㟓GYG㥚₢㰖G䞒䘁䕛O⿖㠊G㢄₆㰖G㞠㦢P䞮㡂G㢄ₗ┞┺UG⋮Ⲏ㰖⓪G䘦₆䞿┞┺U
㭒㦮aG⿚㍳Gⶒ㰞㦮G㞞㩫㎇㦚G㥚䟊㍲⓪G䎢㓺䔎G㔲㟓V⿚㍳G㧻䂮G㩲㫆㠛㼊㦮G㌂㣿G㍺ⳛ㍲⯒G㭖㑮䞮㕃㔲㡺U

XX[

KO
㺚䡞
㺚䀾G₆㑶G䦷㧎G₆㑶ὒG㰚ὋG₆㑶㦮G⚦GṖ㰖G㺚䀾G₆㑶㧊G㧞㔋┞┺UG
䦷㧎G₆㑶㦖G䐋㩲♲G⹿㔳㦒⪲G䞒㓺䏺G⪲✲⯒G╏ỾG䡞㞷㧊G㰖㏣㩗㧊ⳆGⓦⰂỢG䦦⯊☚⪳G䞮㡂G⿖✲⩂㤊G㺚䡞㦚GṖ⓻䞮ỢG䞿┞┺UG㧊⩂䞲G⹿㔳㦖G䡞⮮ṖG⳾✶G㩫ⰻG㌗䌲㢖G㌗䢿㠦G㯟㔲G㩗㦧䞶G㑮G㧞☚⪳G䞮ⳆG㣿䡞㦚GṦ㏢㔲䌋┞┺U
㰚ὋG₆㑶㦖G㦢㞫G㤦Ⰲ㠦G➆⧒G䡞㞷㧊G㰖㏣㩗㧊ⳆGザ⯊ỢG䦦⯊☚⪳G䞮㡂G㌂㩚G㰚ὋG㻮Ⰲ♲G㣿₆㠦G䡞㞷㦚G㺚䀾䞶G㑮G㧞☚⪳G䞿┞┺UG➆⧒㍲G㧊G₆㑶㦖G㤦䢲䞲G㩫ⰻG㌗䌲㢖GṚ┾䞲G㺚䀾G㫆Ị㠦G㩗䞿䞿┞┺U
㺚䡞㦚G㥚䞲G䀾 G⹿⻫aG㞞㩚G⹪⓮G⡦⓪G㞞㩚t ´G⹪⓮㦚G㌂㣿䞲G䦷㧛G₆㑶G⡦⓪G㰚ὋG₆㑶㠦G╖䞲GzTt´G䀾 G゚❪㡺G㡃㔲G㺎㫆䞮㕃㔲㡺aG
UUVVVVkV}G
㺚䡞G㭧G⏎㿲G㥚䠮㦚G㾲㏢䢪䞮₆G㥚䟊G㧻ṧ㦚G㹿㣿䞮㕃㔲㡺UG
XU 䞚㣪䞲G㔲⬢㠦G㩗䞿䞲GzTt´㦚G㍶䌳䞿┞┺UG
YU

㩫ⰻG㻲㧦G⿖㥚⯒G㍶䌳䞿┞┺UG㩫ⰻG㻲㧦G⿖㥚⯒G㭖゚䞮₆G㥚䟊G㫆㰗㦮G㰖䂾㠦G㥶㦮䞮㕃㔲㡺U

䦷㧎G₆㑶㦚G㌂㣿䞲G㺚䡞G
㭒㦮HGzTt´㦖G㺚䡞㣿㦒⪲ⰢG㌂㣿䟊㟒G䞮ⳆG㭒㧛㣿㦒⪲G㌂㣿䟊㍲⓪G㞞G♿┞┺UG
㡺㰗G㧊G⹪⓮OzTt´GO㞞㩚PG⹪⓮SG⡦⓪O㞞㩚Pt ´G⹪⓮VzTt´㣿G㠊╧䎆PὒG䞾℮G㌂㣿䞮㕃㔲㡺UG
㞞㩚G⹪⓮㦚G㌂㣿䞮⓪G㩗㣿G⹿⻫㦖G┺㦢ὒGṯ㔋┞┺a➎₣㩫ⰻG㻲㧦G㰗㩚㠦GzTt´㦚G㞞㩚G⹪⓮㦮G⌊㧻G䢖▪㠦G G⹖㠊G⍹ἶG㔲ἚG⹿䟻㦒⪲G㌊㰳G☢⩺Gἶ㩫䞿┞┺ UG
䞚㣪㠦G➆⧒G㩫ⰻG㰖䡞╖⯒G㌂㣿䞿┞┺O㾲╖GX⿚PUG㩗㩞䞲G㏢☛㩲⯒G㌂㣿䞮㡂G㺚䡞G⿖㥚⯒G㩚㻮䂮䞮㕃㔲㡺UG㏢☛G䤚㠦⓪G㩫ⰻG㻲㧦G⿖㥚㢖G㩧㽟䞮㰖GⰞ㕃㔲㡺UG㩫ⰻ㠦G㓓ỢG㩧⁒䞶G㑮G㧞☚⪳G䢮㧦⯒G⑫䧞ἶG䕪G⡦⓪G₆䌖G㻲㧦G⿖㥚⯒G㞚⧮⪲G䟻䞮☚⪳G䞿┞┺U⹪⓮G⽊䢎ῂ⯒G㩲Ệ䞿┞┺UG㩫ⰻ㦚G㻲㧦䞮ἶSG䞒㓺䏺G⪲✲⯒G㻲㻲䧞G╏₆ⳆGzTt´㦒⪲G䡞㞷㧊G㥶㧛♮⓪G☯㞞G㩫ⰻG㰖䡞╖⯒G䛟┞┺ UG
㢂⹪⯊ỢG㺚㤢㰞G㑮G㧞☚⪳SG䡞⮮ṖGⲞ㿲G➢₢㰖G₆┺Ⱃ┞┺U

zTt´㦚G㔲ἚG⹮╖G⹿䟻㦒⪲G㌊㰳G☢⩺G 㞞㩚G⹪⓮㠦㍲Gヒ⌛┞┺O⿚ⰂP UG㞞㩚G⹪⓮㦖G㩫ⰻ㠦G⋾㞚G㧞㔋┞┺U
㡂⩂G⻞G㺚䡞䞮⓪Gἓ㤆㠦⓪SG┺㦢GzTt⯒G㞞㩚G⹪⓮㠦G㡆ἆ䞮ἶG㿪ṖG㔲⬢⯒G㺚䀾䞿┞┺U
㺚䡞G㢚⬢aGⲒ㩖GzTt´ R ⯒G⿚Ⰲ䞲G┺㦢G㞞㩚G⹪⓮㦚G㩫ⰻ㠦㍲Gヒ⌛┞┺UG䞲㏦G₆㑶㦚G㌂㣿䞮㡂G⹪⓮G⽊䢎ῂ⯒G㞞㩫㩗㧊ⳆG䘟䘟䞲G䚲Ⳋ㠦G⏩㔋┞┺UG⹪⓮G⽊䢎ῂ㠦G⹪⓮㧊GI➎₣I䞮⓪G
ộ㧊Gⓦ⅊㰖Ệ⋮G✺Ⰲ☚⪳Gἶ㩫O䢲㎇䢪PG㔲䋺Ệ⋮GỖ㰖⪲G⹪⓮G⽊䢎ῂG㞚⧮㴓G⊳㦚G③⩂G䢲㎇䢪䞿┞┺UGzTt´GO㞞㩚PG⹪⓮G⡦⓪GO㞞㩚Pt ´G⹪⓮㣿G㌂㣿G㍺ⳛ㍲G㡃㔲G㺎㫆䞮㕃㔲㡺U
⳾✶GzTt´㦖G㞞㩚G⹪⓮㠦㍲G⿚Ⰲ䞲G䤚SG㯟㔲GỆ∎⪲G⛺㰧㠊G䞲G⻞G䦪✺ἶG㩚㼊G㺚䡞G䤚㠦⓪G䟃㦧ἶ㩲ṖG㩚㼊G㔲⬢㠦G㧮G㍴㧊☚⪳G㔲⬢⯒G㡂⩂G⻞G⛺㰧㠊G⿖✲⩓ỢG䦪❃┞┺U
㤊⹮G⹥G㤦㕂G⿚Ⰲ⯒G㥚䟊G䞒㓺䏺G⪲✲⯒G䞒㓺䏺G㧶⁞G㥚䂮⪲G㏢ⰂṖG⋶G➢₢㰖 G╏₆ἶO䞒㓺䏺㧊GzTt´G⹪┻㠦Gⰴⶒ⩺Gἶ㩫♿┞┺PG䞒㓺䏺G⪲✲⯒G ⿖⩂䔎⩺G⿚Ⰲ䞿┞┺U
XU

㿲䡞㧊GⲞ㿲G➢₢㰖GỊ㫆䞲Gⶊ‶G㓺㢧㦒⪲G㻲㧦G⿖㥚⯒G⑚⯛┞┺UG

YU

㤦䞮⓪Gἓ㤆SG䡞㞷㧊G㦧ἶ♮ⳊG⿫╖⯒GṦ㔋┞┺UG

ZU

㞞㩚G⹪⓮㦚G㌳ⶒ䞯㩗G㥚䠮ⶒ㰞㣿G䘦₆G㣿₆㠦G䘦₆䞮㕃㔲㡺U

XX\

KO
㰚ὋG₆㑶㦚G㌂㣿䞲G㺚䡞G
㭒㦮HGzTt´㦖G㺚䡞㣿㦒⪲ⰢG㌂㣿䟊㟒G䞮ⳆG㭒㧛㣿㦒⪲G㌂㣿䟊㍲⓪G㞞G♿┞┺UG
㡺㰗G㧊G⹪⓮OzTt´GO㞞㩚PG⹪⓮SG⡦⓪O㞞㩚Pt ´G⹪⓮VzTt´㣿G㠊╧䎆PὒG䞾℮G㌂㣿䞮㕃㔲㡺UG
㞞㩚G⹪⓮㦚G㌂㣿䞮⓪G㩗㣿G⹿⻫㦖G┺㦢ὒGṯ㔋┞┺a➎₣㺚䡞㦚G㤦䢲䞮ỢG㔲㧧䞮₆G㥚䟊㍲SGzhyz{lk{⓪G䦷㧎G₆㑶㦚G㌂㣿䞮㡂G㼁G⻞㱎GzTt´⯒G㺚䀾䞶Gộ㦚Gῢ㧻䞿┞┺UG㩫ⰻG㻲㧦G₆㑶G䦷㧎G₆㑶㦚G㺎㫆䞮㕃㔲㡺 GˀG UG
㧊䤚G㰚ὋG₆㑶⪲GἚ㏣䞿┞┺U
䞒㓺䏺G⪲✲⯒G㌂㣿䞮㡂G㺚䡞䞮₆G㩚㠦SG䞒㓺䏺㦚GzTt´G⹪┻₢㰖G╏ỾG➎₣G㏢ⰂṖG⋮Ⳇ Gἶ㩫♮☚⪳G䞮㕃㔲㡺UG⁎⩂ⳊG䞒㓺䏺G⪲✲ṖG⿖⩂㪎G⿚Ⰲ♿┞┺ U㧊⩝ỢG㭖゚䞲GzTt´㦚GzTt´G㞞㩚G⹪⓮㦮G⌊㧻G䢖▪㠦G⹖㠊G⍹ἶG㔲ἚG⹿䟻㦒⪲G㟓ṚG☢⩺Gἶ㩫䞿┞┺ GRG U㢂⹪⯊ỢG㺚㤢㰞G㑮G㧞☚⪳SG䡞⮮ṖGⲞ㿲G➢₢㰖G₆┺Ⱃ┞┺U

zTt´㦚G㔲ἚG⹮╖G⹿䟻㦒⪲G㌊㰳G☢⩺G 㞞㩚G⹪⓮㠦㍲Gヒ⌛┞┺O⿚ⰂP UG㞞㩚G⹪⓮㦖G㩫ⰻ㠦G⋾㞚G㧞㔋┞┺U
㡂⩂G⻞G㺚䡞䞮⓪Gἓ㤆㠦⓪SGⲒ㩖G┺㦢GzTt⯒G㞞㩚G⹪⓮㠦G㡆ἆ䞮ἶG㿪ṖG㔲⬢⯒G㺚䀾䞿┞┺U
㺚䡞G㢚⬢aG
zTt´⯒G⿚Ⰲ䞲G┺㦢 R G㞞㩚G⹪⓮㦚G㩫ⰻ㠦㍲Gヒ⌛┞┺UG䞲㏦G₆㑶㦚G㌂㣿䞮㡂G⹪⓮G⽊䢎ῂ⯒G㞞㩫㩗㧊ⳆG䘟䘟䞲G䚲Ⳋ㠦G⏩㔋┞┺UG⹪⓮G⽊䢎ῂ㠦G⹪⓮㧊GI➎₣I䞮⓪Gộ㧊Gⓦ⅊㰖Ệ⋮G✺Ⰲ☚⪳Gἶ㩫O䢲㎇䢪PG㔲䋺Ệ⋮GỖ㰖⪲G⹪⓮G⽊䢎ῂG㞚⧮㴓G⊳㦚G③⩂G⹪⓮G⽊䢎ῂ⯒G䢲㎇䢪䞿┞┺U
⳾✶GzTt´㦖G㞞㩚G⹪⓮㠦㍲G⿚Ⰲ䞲G䤚SG㯟㔲GỆ∎⪲G⛺㰧㠊G䞲G⻞G䦪✺ἶG㩚㼊G㺚䡞G䤚㠦⓪G䟃㦧ἶ㩲ṖG㩚㼊G㔲⬢㠦G㧮G㍴㧊☚⪳G㔲⬢⯒G㡂⩂G⻞G⛺㰧㠊G⿖✲⩓ỢG䦪❃┞┺U
XU

㿲䡞㧊GⲞ㿲G➢₢㰖GỊ㫆䞲Gⶊ‶G㓺㢧㦒⪲G㻲㧦G⿖㥚⯒G⑚⯛┞┺UG

YU

㤦䞮⓪Gἓ㤆SG䡞㞷㧊G㦧ἶ♮ⳊG⿫╖⯒GṦ㔋┞┺UG

ZU

㞞㩚G⹪⓮㦚G㌳ⶒ䞯㩗G㥚䠮ⶒ㰞㣿G䘦₆G㣿₆㠦G䘦₆䞮㕃㔲㡺U

XX]

KO
㤦㕂G⿚Ⰲ
㭒㦮HGzhyz{lk{GzTt㦖G[SWWWGG㠦GⰴỢG㍺Ἒ♮㠞㔋┞┺UGÞG_㧎GzTtOzTt´G㏢㞚ὒ㣿P㦖G㡞㣎㧊ⳆSG䡚㨂G㾲╖GYS\WWGG₢㰖GỖ㯳♮㠞㔋┞┺UG㩗㩞䞲G䃦Ⰲ㠊G䓲ぢG⡦⓪G㧎㍲䔎Ⱒ㦚G㌂㣿䟊㟒G䞿┞┺UG‶㡊㧊G㧞⓪GzTt㦚G㤦㕂G⿚ⰂG㻮Ⰲ䞮Ệ⋮G⍞ⶊG⏨㦖G㤦㕂GṖ㏣☚⪲G㤦㕂G⿚Ⰲ䞮⓪Gἓ㤆SGzTt㧊G䕢㏦♮㠊G㧶㨂㩗㧎GṦ㡒Gⶒ㰞㧊G⹿㿲♶G㑮G㧞㔋┞┺U
㤦㕂G⿚Ⰲ₆G㧎㍲䔎⓪G㌂㣿䞮⓪GzTt㦮G䋂₆㠦G➆⧒G㍶䌳䟊㟒G䞿┞┺UG㌗╖G㤦㕂GṖ㏣☚⓪G㍺㩫♲G⿚╏G䣢㩚㑮㢖GὖἚṖG㧞㔋┞┺UG
yjmGdGXXUYGGGGOVXWWWPYS
yjmGaGI㌗╖G㤦㕂⩻SGITI⧒ἶ☚G䞾IO㡗㠊aGyjmGIGGIP
IIaGI⿚╏G䣢㩚IO|VPSG⡦⓪aGGdGI⿚╏G䣢㩚㑮IO㡗㠊aGywtGIGGIPS
IIaGI㤦㕂G⿚Ⰲ₆G㭧㕂㠦㍲GzTt´G⹪┻₢㰖㦮G䣢㩚G⹮ἓISGOPU
㩺G⹎䙂䞾GzTt㦖Gἶ㩫ṗG⡦⓪G㓺㥯G㞚㤙G⪲䎆ṖG㧞⓪G㤦㕂G⿚Ⰲ₆㠦㍲G㤦㕂G⿚Ⰲ䞶G㑮G㧞㔋┞┺UG
㩺㦚G䙂䞾䞲GzTt㦖G㓺㥯G㞚㤙G⪲䎆ṖG㧞⓪G㤦㕂G⿚Ⰲ₆G㩚㣿㦒⪲G㍺Ἒ♮㠞㔋┞┺UGἶ㩫ṗG⪲䎆ṖG㧞⓪G㤦㕂G⿚Ⰲ₆㠦㍲G㤦㕂G⿚ⰂG㻮Ⰲ䞮⓪Gộ㦖Gzhyz{lk{G䁷㠦㍲GỖ㯳♮㰖G㞠㞮㦒ⳆGῢ㧻♮㰖G
㞠㔋┞┺U
zTt㦖G䞮₆G㤦㕂G⿚ⰂG㫆Ị㠦G➆⧒G㤦㕂G⿚Ⰲ♮㠊㟒G䞿┞┺UG┺⯎G㫆Ị㦚G㌂㣿䞮⓪Gἓ㤆G㌂㣿㧦ṖG㰗㩧GỖ㯳䟊㟒G䞿┞┺U
zTt㧊G㤦㕂G⿚Ⰲ₆G㧎㍲䔎㠦G㢂⹪⯊ỢG㧻㹿♮㠞⓪㰖G䢫㧎䟊㟒G䞿┞┺UG㧎㍲䔎G⍞Ⲏ⪲G䓖㠊⋮㡾GzTt㦖G㤦㕂G⿚Ⰲ₆G䠺✲㠦GỎ⩺G䕢㏦♶G㑮G㧞㔋┞┺UG㤦㕂G⿚Ⰲ₆⓪Gἶ⯊ỢG㺚㤢㪎㟒G䞿┞┺UG
㧊⯒G㥚䟊㍲⓪G㤦㕂G⿚Ⰲ₆G㌂㣿G㍺ⳛ㍲⯒G㺎㫆䞮㕃㔲㡺UG
㭒㦮HG䕢㏦♲GzTt㦚G㏦㦒⪲G㩲Ệ䞮㰖GⰞ㕃㔲㡺U
㤦㕂G⿚Ⰲ₆G㏢☛ὒGὖ⩾♲G㭒㦮G㌂䟃㦖G㤦㕂G⿚Ⰲ₆G㌂㣿G㍺ⳛ㍲㠦㍲G䢫㧎䞶G㑮G㧞㔋┞┺U

izG[_\XR㠦G➆⯚Ol|G䆪✲P㌗╖G㤦㕂GṖ㏣☚OP

kpuGluGpzvG]^XWˀzTt´
YWWWGGY\WWGGZWWWGGQ

Z\WWGGQ[WWWGGQ

䡞㼃OzP

XW⿚

XW⿚

]⿚G

[⿚

[⿚

䡞㼃G㩺OzGnP

X\⿚

XW⿚

[⿚

[⿚

[⿚

䡞㼃GlG㩺GOzGlGnP

X\⿚

XW⿚

[⿚

UU

UU

Ⰲ䔂G䠺䕢Ⰶ

XW⿚

XW⿚

^⿚

^⿚

^⿚

Ⰲ䔂G䠺䕢ⰆG㩺

X\⿚

X\⿚

XW⿚

^⿚

^⿚

Ⰲ䔂G䠺䕢ⰆG㩺R

_⿚

^⿚

\⿚

[⿚

[⿚

lk{h

UU

UU

^⿚

]⿚

\⿚

lk{hG㩺

X\⿚

XW⿚

XW⿚

^⿚

^⿚

ῂ㡆㌆㡒

`⿚

_⿚

^⿚

]⿚

\⿚

lk{hSG⿞㏢G䠺䕢Ⰶ

`⿚

_⿚

^⿚

]⿚

\⿚

nlhj{

`⿚

_⿚

^⿚

]⿚

\⿚

ῂ㡆㌆㡒GwitGXU_G㤦㕂G⿚Ⰲ₆G⹮ἓGeGX^G

`⿚

_⿚

^⿚

]⿚

\⿚

ῂ㡆㌆㡒GwitGXU_G㤦㕂G⿚Ⰲ₆G⹮ἓGeG`G㾲╖G˺GX^

UU

UU

XW⿚

UU

UU

UUGdGỖ㯳♮㰖G㞠㦢
QG⳾✶GzTt㠦G㥶䣾SG┾GÞG_㦮Gἓ㤆G㡞㣎OzTtG㏢㞚ὒ㣿PU

YWÀj㠦㍲㦮G㤦㕂G⿚Ⰲ

R

iGzGiz[_\XaX`_YGzGGGGGGGGG GG SG㻶䣢♾U

⿚ⰂGⶒ㰞Gὖ⩾G㩫⽊
⿚ⰂGⶒ㰞O㩺P㦮G㥶☯ⶒ㎇㦖G㡾☚㠦G➆⧒G╂⧒㰧┞┺UGzTt㧊G㤦㕂G⿚ⰂG㩚G⡦⓪G☚㭧㠦G⌟ṗ♮ⳊSG⿚ⰂG㩺㦮G㡆㏣㩗㧎G䂋㦚G▪G㧊㌗G⽊㧻䞶G㑮G㠜㔋┞┺U
zTt㦚G┺㔲G㤦㕂G⿚ⰂV㨂㤦㕂G⿚Ⰲ䟊㍲⓪G㞞G♿┞┺U䘦₆XU㧒⹮㩗㧎G㥚㌳G′㩫G⹥GṦ㡒Gⶒ㰞㦮G㢂⹪⯎G䘦₆㠦G╖䞲G⻫㩗G′㩫㠦G㥶㦮䞮ἶG㧊⯒G㭖㑮䟊㟒G䞿┞┺U

YU

㧒䣢㣿G㧻ṧ㦖GṦ㡒G㥚䠮㦚G㡞⹿䞿┞┺U

ZU

㡺㡒♮㠞Ệ⋮G㭒㧛♲G䡞㞷G㺚䀾G㔲㓺䎲㦖Gἶ㞫G㯳₆⪲GⳎ‶䞮㡂G㏢ṗ㔲䌂G㑮G㧞⓪G㌳ⶒ䞯㩗G㥚䠮ⶒ㰞㠦G㩗䞿䞲G䘦₆G㣿₆㠦G⍹㠊G䘦₆䟊㟒G䞿┞┺U[U

䘦₆⓪G㩗㩞䞲G㏢ṗG㔲㓺䎲㧊⋮Gἶ㞫GⳎ‶O㯳₆GⳎ‶P㦒⪲G㔺㔲♮㠊㟒G䞿┞┺U

XX^

KO
㥶䣾䞲G⻚㩚㦮G㩲䛞⼚G䚲㭖ὒG㰖䂾
jszpQGnwZ`Gˉ{GGhGG}GGj GiGzGjˉSGhGzU
jszpQGnw[XGˉjGGkG}GiGzˉSGhGzU
jszpQGnw[[GˉwGGGoGGwGGiGzGGjGs G{ˉSGhGnU
jszpQGoYXGˉjSG{SGGwGGiGzGG{GwTiGjGh GGtGoGh ˉSGhGnU~ovVkpsVshiV``UXGyWYGˉ~vyskGolhs{oGvynhuph{pvuSGGUG|GGGGG GUGnaG~GoGv¡SGYWWYˉU㩫ⰻG㺚䡞㣿G㣿₆Gὖ⩾G䚲㭖a
kpuGluGpzvG]^XWaG㧎㼊㦮G㩫ⰻG㺚䡞㣿G㧒䣢㣿G㣿₆
QjszpGOjGGs GzGpP

₆䢎G⹥Gⳛ䃃G䋺a

䛞⳿G⻞䢎Ṳ⼚GⳎ‶G䙂㧻♲G㩲䛞㠦G㿪Ṗ⪲G㩗㣿

⺆䂮Gⳛ䃃

䙂㧻G㏦㌗G㔲G㌂㣿䞮㰖G㞠㦢

㥶䣾G₆Ṛ

㣎⿖G⽊䢎G䙂㧻㧊G㧞⓪G㧒䣢㣿GⳎ‶G㧻⼓G㔲㓺䎲jlGⰞ䋂⹿㌂㍶GⳎ‶

㼊㣎G㰚┾㌂㣿G㍺ⳛ㍲G㭖㑮㨂㌂㣿G㔲aG㡺㡒G㥚䠮㰗㌂ὧ㍶㧊G╕㰖G㞠ỢG⽊ὖ

Ị㫆G⽊ὖ

㩲㫆㌂

㩲㫆GῃṖ

Ⳏ‶G㥶㼊Gἓ⪲┺㔲GⳎ‶䞮㰖GⰞ㕃㔲㡺

₆㑶㩗㧎G⼖ἓG㥶⽊
㩲䛞Gὖ⩾♲G⳾✶G㭧╖䞲G㥚䟊㌂⪖⓪G⹮✲㔲G㩲㫆㤦G⹥Gὖ⩾G㩫⿖₆ὖ㠦G⽊ἶ䞲┺UGQ㡞aG䞲ῃTG㔳㟓㻮UXX_Naudojimo instrukcijos – SARSTEDT „S-Monovette®“ kraujo surinkimo sistemaLTin-vitro diagnostikai
1DXGRMLPRSDVNLUWLV„S-Monovette®ŗNUDXMRVXULQNLPRVLVWHPRVNDQLXOâVLUDGDSWHULDLNDUWXQDXGRMDPLNDLSYHQLQLRNUDXMRSDâPLPRVLVWHPD60RQRYHWWH®NUDXMRVXULQNLPRVLVWHPRVQDXGRMDPRVNUDXMRPâJLQLDPVVXULQNWLWUDQVSRUWXRWL
apdoroti ir laikyti in vitroGLDJQRVWLQLDPVW\ULPDPVLđVHUXPRSOD]PRVDUYLVRNUDXMRNOLQLNLQâMHODERUDWRULMRMH3URGXNWDVVNLUWDVQDXGRWLSURIHVLRQDOLRMHDSOLQNRMHLUVYHLNDWRVSULHĭLğURVVSHFLDOLVWDPVEHLODERUDWRULMRV
personalui.

Gaminio aprašymas„S-Monovette®ŗNUDXMRVXULQNLPRVLVWHPDVVXGDURSODVWLNLQLVPâJLQWXYâOLVVWğPRNOLVVWğPRNOLRVWU\SDVLUVSDOYRPLVXĭNRGXRWDVSODVWLNLQLVXĭVXNDPDVGDQJWHOLVVXLQWHJUXRWDPHPEUDQDNXULVEXYRVSHFLDOLDLVXNXUWDVprijungti prie „S-Monovette®ŗ VDXJRV NDQLXOâVDUED VDXJRV Ś0XOWLIO\®ŗNDQLXOâVWDLSSDWòYDLUğVSULHGDL SUHSDUDWDL 7DLSSDWJDOLPDòVLJ\WLŚ60RQRYHWWH®ŗEHSULHGģ60RQRYHWWH® kraujo surinkimo sistemos suNUHđâMLPRDNW\YDWRULDXVNUHđâMLPRDNW\YDWRULDXVVXJHOLXOLÕLRKHSDULQROLÕLRKHSDULQRVXJHOLXQDWULRKHSDULQRFLWUDWR('7$IOXRULGR('7$IOXRULGRKHSDULQRIOXRULGRFLWUDWR&3'$SULHGDLVWDLSSDWEHSULHGģMģ
SULHGģNRQFHQWUDFLMRVVN\VWģMģSULHGģWğULVLUMģOHLVWLQLQXRNU\SLDLEHLNUDXMRLUSULHGRVDQW\NLVDWLWLQNDWDUSWDXWLQLRVWDQGDUWR',1(1,626LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQLU&OLQLFDODQG
/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, SDWYLUWLQWģVWDQGDUWģUHLNDODYLPXVLUUHNRPHQGDFLMDV3ULHGRSDVLULQNLPDVSULNODXVRQXRDQDOLWLQLRW\ULPRPHWRGR-òQXURGRW\ULPRUHDJHQWģLU DUED DQDOL]âVaparato, su kuriuo atliekamas tyrimas, gamintojas. „S-Monovette®ŗNUDXMRVXULQNLPRVLVWHPDJDOLEğWLVWHULOLLđYLGDXVDUEDDWVNLUDLVXSDNXRWDLUVWHULOLLđYLGDXVLULđLđRUâV„S-Monovette®ŗXĭVXNDPģGDQJWHOLģ VSDOYģNRGDLPriedasRaidinis kodas

Dangtelio spalva pagal
DIN EN ISO 6710

Dangtelio spalva
RULHQWXRWDò%6+

Z

balta

balta

0âJLQWXYâOLVEHSUHSDUDWģ„S-Monovette® Neutral Z“
6HUXPRPâJLQWXYâOLV„S-Monovette®VHUXPDV&$7ŗVXNUHđâMLPRDNW\YDWRULXPLCAT

raudonabalta„S-Monovette®VHUXPDVJHOLV&$7ŗVXNUHđâMLPRDNW\YDWRULXPLLUJHOLX

CAT

tamsiai geltonas

tamsiai geltonas„S-Monovette®VHUXPDV([SUHVVJHOLV&$7ŗVXNUHđâMLPRDNW\YDWRULXPLWURPELQXLUJHOLXCATRUDQĭLQâ-+HSDULQRPâJLQWXYâOLV„S-Monovette®OLÕLRKHSDULQDV/+ŗVXOLÕLRKHSDULQX

LHĭDOLDVRUDQĭLQâ„S-Monovette®OLÕLRKHSDULQDVŗVN\VWDV/+VXOLÕLRKHSDULQX

LHĭDOLDVRUDQĭLQâ„S-Monovette®OLÕLRKHSDULQRJHOLV/+ŗVXOLÕLRKHSDULQXLUJHOLX

LHĭDOLDVRUDQĭLQâ„S-Monovette®OLÕLRKHSDULQRJHOLV+/+ŗVXOLÕLRKHSDULQXLUJUHLWDLYHLNLDQÕLXJHOLX

LHĭDOLDVRUDQĭLQâ„S-Monovette® natrio heparinas NH“, su natrio heparinu

NH

ruda

ĭDOLD

netaikoma

PâO\QDVPâO\QDV

9NC

PâO\QDV

ĭDOLD

9NC

đYLHVLDLPâO\QDV-„S-Monovette® K3 EDTA K3E“ su kalio EDTA

K3E

YLROHWLQâraudona„S-Monovette® K2 EDTA K2E“ su kalio EDTA

K2E

YLROHWLQâraudona„S-Monovette® K2 EDTA gelis K2E“ su kalio EDTA ir geliu

K2E

YLROHWLQâraudona„S-Monovette®ĲXRULGDV('7$)(ŗVXĲXRULGXLU('7$

FE

pilka

geltona„S-Monovette®ĲXRULGDVKHSDULQDV)+ŗVXĲXRULGXLUKHSDULQX

FH-geltona„S-Monovette®*OXFR(;$&7)&ŗVXĲXRULGXFLWUDWXLU('7$FC

rausvaspilka

LH

WDPVLDLPâO\QDVRUDQĭLQâ„S-Monovette® ThromboExact“ su magnio junginiu

netaikoma

QHWDLNRPDJHUYXRJLģVSDOYRVQHWDLNRPDJHUYXRJLģVSDOYRV„S-Monovette® CTAD“

netaikoma

QHWDLNRPDPâO\QDVQHWDLNRPDĭDOLDV„S-Monovette® ACD“ACD

geltonageltona„S-Monovette® CPDA“

CPDA

geltonageltona„S-Monovette® hirudinas“

netaikoma

1HWDLNRPDDO\YXRJLģĭDOLRVVSDOYRV

1HWDLNRPDDO\YXRJLģĭDOLRVVSDOYRV„S-Monovette® homocisteinas HCY-Z gelis“ su geliu ir stabilizatoriumi

netaikoma

netaikoma, pilkas

netaikoma, pilkas„S-Monovette® homocisteinas HCY-C“ su citratu, buferinis

netaikoma

netaikoma, violetinis

netaikoma, violetinis„S-Monovette® DNA Exact“

netaikoma

QHWDLNRPDPâO\QDVQHWDLNRPDPâO\QDV„S-Monovette® amonio heparinas AH“, su amonio heparinu&LWUDWRPâJLQWXYâOLV„S-Monovette® citratas 9NC“, natrio citratas 3,13 %®

„S-Monovette PFA, citratas 9NC“, natrio citratas 3,8 %, buferinis('7$PâJLQWXYâOLV0âJLQWXYâOLVVXJOLNROL]âVLQKLELWRULDLV

0âJLQWXYâOLVPHWDOģW\ULPXL„S-Monovette®0HWDO$QDO\VLV/+ŗVXOLÕLRKHSDULQX.LWLYLVRVVXGâWLHVNUDXMRLUSOD]PRVDQDOL]âVPâJLQWXYâOLDL

*DOLEğWLLUNLWģVSDOYģGDQJWHOLģQHWDLNRPDşQHDSLEUâĭWDV
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, atšauktas.

119

LT
SARSTEDT „S-Monovette® serumas CAT / Serumas-gelis CAT“
„S-Monovette®VHUXPDV&$7ŗVXGâW\MH\UDSODVWLNRJUDQXOLģSDGHQJWģNUHđâMLPRDNW\YDWRULXPL VLOLNDWX NXULRVQDXGRMDPRVVHUXPXLJDXWL 3ODVWLNRJUDQXOâVQXVâGDFHQWULIXJXRMDQWWDUSNUDXMRPDVâVLUVHUXPR%HSODVWLNLQLģJUDQXOLģSDGHQJWģNUHđâMLPRDNW\YDWRULXPL VLOLNDWX Ś60RQRYHWWH®VHUXPDVJHOLV&$7ŗVXGâW\MH\UDSROLPHURSDJULQGRJHOLRNXULVQDXGRMDPDVVHUXPXLJDXWL *HOLVQXVâGDFHQWULIXJXRMDQWWDUSNUDXMRPDVâVLUVHUXPRLUWUDQVSRUWDYLPRODLN\PRLUDQDOL]âVPHWXVXGDURVWDELOģDWVNLULDPÐMòVOXRNVQò
6HUXPDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDòSUDVWLQLXRVHNOLQLNLQLXRVHFKHPLQLXRVHLULPXQRORJLQLXRVHW\ULPXRVHWDLSSDWVHURORJLMRMH
3RNUDXMRSDâPLPRNUDXMDVWXULPLQXÕLģNUHđâWLŚ60RQRYHWWH®VHUXPDV&$7VHUXPDVJHOLV&$7ŗYHUWLNDOLRMHSDGâW\MHNDGSRFHQWULIXJDYLPRJHUDLVXVLIRUPXRWģKRUL]RQWDOXVDWVNLULDPDVLVVOXRNVQLV5HNRPHQGXRMDPDVODLNDVSULNODXVRQXRWLQNDPRNUHđâMLPRSURFHVR.UDXMXLLđSDFLHQWģNXULHPV\UDVXOLJDVXVLMXVLģNUHđâMLPRVXWULNLPģDUEDNXULHPVWDLNRPDVJ\G\PDVDQWLNRDJXOLDQWDLVNDUWDLVUHLNLDGDXJLDXODLNRSLOQDPVXNUHđâMLPXLSARSTEDT „S-Monovette® serumas Express gelis CAT“
%HSODVWLNLQLģJUDQXOLģSDGHQJWģNUHđâMLPRDNW\YDWRULXPL WURPELQX Ś60RQRYHWWH®VHUXPDV([SUHVVJHOLV&$7ŗVXGâW\MH\UDSROLPHURSDJULQGRJHOLRNXULVQDXGRMDPDVVHUXPXLJDXWL *HOLVQXVâGDFHQWULIXJXRMDQWWDUSNUDXMRPDVâVLUVHUXPRLUWUDQVSRUWDYLPRODLN\PRLUDQDOL]âVPHWXVXGDURVWDELOģDWVNLULDPÐMòVOXRNVQò
3RNUDXMRSDâPLPRNUDXMDVWXULPLQXWHVNUHđâWLŚ60RQRYHWWH®VHUXPDV([SUHVVJHOLVŗYHUWLNDOLRMHSDGâW\MHNDGSRFHQWULIXJDYLPREğWģXĭWLNULQWDVJHUDLVXVLIRUPXRWģKRUL]RQWDOXVDWVNLULDPDVLVVOXRNVQLV5HNRPHQGXRMDPDVODLNDVSULNODXVRQXRWLQNDPRNUHđâMLPRSURFHVRWDLJDOLRMDLUKHSDULQL]XRWģSDFLHQWģNUDXMXL.UDXMXLLđSDFLHQWģNXULHPV\UDVXOLJDVXVLMXVLģNUHđâMLPRVXWULNLPģDUEDNXULHPVWDLNRPDVJ\G\PDVDQWLNRDJXOLDQWDLVòVNDLWDQWGLGHOHVKHSDULQRGR]HVUHLNLDGDXJLDXODLNRSLOQDPNUHđâMLPXL6HUXPDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDòSUDVWLQLXRVHNOLQLNLQLXRVHFKHPLQLXRVHLULPXQRORJLQLXRVHW\ULPXRVHWDLSSDWVHURORJLMRMH

SARSTEDT „S-Monovette® Neutral Z“„S-Monovette®1HXWUDO=ŗVXGâW\MHQâUDSUHSDUDWRNXULVDWLWLQNDQDWğUDOģNUDXMRPâJLQLRNUHđâMLPÐEHNUHđâMLPRDNW\YDWRULDXVLU\UDQDXGRMDPDVVHUXPXLJDXWL &HQWULIXJXRMDQWDWVNLULDPRVNUDXMRQXRVâGRVLUVHUXPDV6HUXPDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDVSHFLILQLDPVQDXGRWRMRW\ULPDPVBe to, „S-Monovette®1HXWUDO=ŗWDLSSDWJDOLPDQDXGRWLNDLSWXđÕLÐPâJLQWXYâOòMHLNUDXMRPâJLQLģâPLPÐNHWLQDPDSUDGâWLVXŚ60RQRYHWWH® Citrat“ kartu su „(Safety) Multifly®ŗNDQLXOH VSDUQXRWÐMDNDQLXOH „S-Monovette®1HXWUDO=ŗQDXGRMDPDNDLSSLUPDVLVPâJLQWXYâOLV WXđÕLDV Ś 6DIHW\ 0XOWLIO\®ŗNDQLXOâVPâJLQWXYâOLXLXĭSLOG\WLSARSTEDT „S-Monovette®OLÕLRKHSDULQDV/+OLÕLRKHSDULQRJHOLV/+OLÕLRKHSDULQRJHOLV+ LH, natrio heparinas NH, amonio heparinas AH“„S-Monovette®OLÕLRKHSDULQDV/+QDWULRKHSDULQDV1+DPRQLRKHSDULQDV$+ŗVXGâW\MH\UDOLÕLRKHSDULQRQDWULRKHSDULQRDPRQLRKHSDULQR SDSUDVWDL79KHSDULQRPONUDXMR VXDQWLNRDJXOLDQWXMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMRLUSOD]PRVSDâPLPXL 3ODVWLNRJUDQXOâVQXVâGDFHQWULIXJXRMDQWWDUSNUDXMROÐVWHOLģLUSOD]PRVJei naudojamas „S-Monovette®OLÕLRKHSDULQDV/+ŗEHSODVWLNLQLģJUDQXOLģDQWLNRDJXOLDQWDVOLÕLRKHSDULQDV\UDSXUđNLDPRVIRUPRV SDSUDVWDL79KHSDULQRPONUDXMR „S-Monovette®OLÕLRKHSDULQRJHOLV/+ŗVXGâW\MH\UDDQWLNRDJXOLDQWROLÕLRKHSDULQR SDSUDVWDL79KHSDULQRPONUDXMR SROLPHURSDJULQGXSDJDPLQWRJHOLRQDXGRMDPRSOD]PDLJDXWL *HOLVQXVâGDFHQWULIXJXRMDQWWDUSNUDXMROÐVWHOLģLUSOD]PRVLUWUDQVSRUWDYLPRODLN\PRLUDQDOL]âVPHWXVXGDURVWDELOģDWVNLULDPÐMòVOXRNVQò„S-Monovette“®OLÕLRKHSDULQRJHOLV+/+ŗWDLSSDW\UDSROLPHURSDJULQGRJHOLVNXULVOHLGĭLDFHQWULIXJDYLPRODLNÐVXPDĭLQWLPDĭGDXJbSDO\JLQWLVXŚ60RQRYHWWH®OLÕLRKHSDULQRJHOLVŗ+HSDULQRSOD]PDQDXGRMDPDNDLSPâJLQLRPHGĭLDJDòSUDVWLQLXRVHNOLQLNLQLXRVHFKHPLQLXRVHLULPXQRORJLQLXRVHW\ULPXRVH+HSDULQDVYLVRVVXGâWLHVNUDXM\MHQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDòSUDVWLQLXRVH
imunologiniuose tyrimuose ir serologiniuose tyrimuose.
.UDXMRNUHđâMLPRVORSLQLPDVKHSDULQXY\NVWDDNW\YLQDQWDQWLWURPELQX
3$67$%$,đŚ60RQRYHWWH®OLÕLRKHSDULQDV/+OLÕLRKHSDULQRJHOLVJHOLV+/+ŗQHJDOLPDQXVWDW\WLOLÕLRNLHNLRLđŚ60RQRYHWWH®DPRQLRKHSDULQDV1+ŗQHJDOLPDQXVWDW\WLDPRQLRNLHNLRLULđŚ60RQRYHWWH®QDWULRKHSDULQDV1+ŗQHJDOLPDQXVWDW\WLQDWULRNLHNLRŚ60RQRYHWWH®OLÕLRKHSDULQDVOLÕLRKHSDULQRJHOLVJHOLVO+ / natrio heparinas / amonio heparinas“, pripildytas veninio kraujo,
QHWLQNDNUDXMRGXMģDQDOL]HLSARSTEDT „S-Monovette®PHWDOģDQDOL]HLŗ
„S-Monovette®PHWDOģDQDOL]HLŗ\UDDQWLNRDJXOLDQWROLÕLRKHSDULQRMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLLUSOD]PDLJDXWL /LÕLRKHSDULQDV\UDSXUđNLDPRVIRUPRV 79KHSDULQRPONUDXMR „S-Monovette®PHWDOģDQDOL]HLŗPâJLQWXYâO\MHHVDQWLVKHSDULQRYLVRVVXGâWLHVNUDXMDVDUEDKHSDULQRSOD]PDNDUWXVXVSHFLDOLDVDXJRVNDQLXOH*[ŹFRO SUHNâV1U QDXGRMDPDNDLSPâJLQLRPHGĭLDJDPLNURHOHPHQWDPVPHWDODPVWLUWL0LNURHOHPHQWDLPHWDODLEXYRSDWYLUWLQWLDWRPLQâVDEVRUEFLMRVVSHNWURPHWULMD $$6 1DXGRMDQWVLVWHPRVVDXJRVNDQLXOãLUŚ60RQRYHWWH®PHWDOģDQDOL]HLŗđLģPLNURHOHPHQWģGLGĭLDXVLRVWXđÕLRVLRVDQDOL]âVYHUWâVQJVLVWHPRMH\UDWRNLRV

Elementas

Tl

ng/Sistema

2,5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1,5

8,0

5,0

5

50

70

70

10

40

10

10

„S-Monovette®ŗHWLNHWâMHQXURG\WRVNLHNYLHQRHOHPHQWRGLGĭLDXVLRVWXđÕLRMRPâJLQLRYHUWâV
0LNURHOHPHQWģQXVWDW\PDVDWOLHNDPDVLđKHSDULQRYLVRVVXGâWLHVNUDXMRDUEDKHSDULQRSOD]PRVDWVLĭYHOJLDQWòDQDOL]âVPHWRGÐ.UDXMRNUHđâMLPRVORSLQLPDVKHSDULQXY\NVWDDNW\YLQDQWDQWLWURPELQXSARSTEDT „S-Monovette® citratas 9NC“
„S-Monovette®FLWUDWDV1&ŗ\UDDQWLNRDJXOLDQWRWULQDWULRFLWUDWRMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLLUSOD]PDLJDXWL 7ULQDWULRFLWUDWR\UDPROLQâVNRQFHQWUDFLMRVWLUSDOH WULQDWULRFLWUDWRWLUSDORGDĭQDL
suapvalinto iki 3,2 %) ir jis sudaro 10 % nominalaus „S-Monovette®FLWUDWDVŗWğULR&LWUDWRLUNUDXMRPDLđ\PRVDQW\NLV\UDWğULRFLWUDWRIUDNFLMDLUWğULRNUDXMRIUDNFLMRV7HLVLQJDVXĭSLOG\PDV\UDEğWLQDVDQDOL]HLDWOLNWL&LWUDWRSOD]PDQDXGRMDPDNDLSPâJLQLRPHGĭLDJDòSUDVWLQLXRVHKHPRVWD]LQLXRVHW\ULPXRVH
Koaguliacija slopinama kalcio jonus kompleksuojant su citratu.
/DLN\NLWâVŚ60RQRYHWWH®FLWUDWDVŗLUVSDUQXRWRVLRVNDQLXOâVPâJLQLģâPLPRLUQDXGRMLPR,16758.&,-»

SARSTEDT „S-Monovette® PFA 9NC“
„S-Monovette®3)$1&ŗ\UDDQWLNRDJXOLDQWRWULQDWULRFLWUDWRVNLUWRYLVRVVXGâWLHVNUDXMXLLUSOD]PDLJDXWL 7ULQDWULRFLWUDWR\UDPROLQâVNRQFHQWUDFLMRVEXIHULQLDPHWLUSDOH EXIHULQLVWLUSDODVS+ LUMLV
sudaro 10 % nominalaus „S-Monovette ®3)$ŗWğULR&LWUDWRLUNUDXMRPDLđ\PRVDQW\NLV\UDWğULRFLWUDWRIUDNFLMDLUWğULRNUDXMRIUDNFLMRV7HLVLQJDVXĭSLOG\PDV\UDEğWLQDVDQDOL]HLDWOLNWL
„S-Monovette®3)$1&ŗYLVRVVXGâWLHVNUDXMDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDWURPERFLWģIXQNFLMDLQXVWDW\WLŚ6,(0(16+HDOWKLQHHUV3)$ŗDQDOL]DWRULXMHLU\UDSDWYLUWLQWDVđLDPWLNVOXLKoaguliacija slopinama kalcio jonus kompleksuojant su citratu.
/DLN\NLWâVŚ60RQRYHWWH®3)$ŗLUVSDUQXRWRVLRVNDQLXOâVPâJLQLģâPLPRLUQDXGRMLPR,16758.&,-»

SARSTEDT „S-Monovette® CTAD“„S-Monovette®&7$'ŗVXGâW\MH\UDDQWLNRDJXOLDQWRWULQDWULRFLWUDWRWDLSSDWWHRILOLQRDGHQR]LQRLUGLSLULGDPROLRMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLLUSOD]PDLJDXWL &7$'WLUSDODVVXGDURQRPLQDODXV„S-Monovette ®&7$'ŗWğULR&7$'LUNUDXMRPDLđ\PRVDQW\NLV\UDWğULR&7$'IUDNFLMDLUWğULRNUDXMRIUDNFLMRV7HLVLQJDVXĭSLOG\PDV\UDEğWLQDVDQDOL]HLDWOLNWL
&7$'SOD]PDQDXGRMDPDNDLSPâJLQLRPHGĭLDJDQXVWDWDQWWURPERFLWģIDNWRULģ 3) EHWD Ǳ WURPERJOREXOLQÐ Ǳ7* LUSOD]PLQRJHQRDNW\YDWRULDXVLQKLELWRULģ 3$, EHLDWOLHNDQWòSUDVWXVKHPRVWD]LQLXVW\ULPXV7URPERFLWģDNW\YDFLMDVORSLQDPDQHWUXPSLDXNDLSYDODQGDVLUQDXGRMDPDKHSDULQRWHUDSLMRVVWHEâVHQDLKoaguliacija slopinama kalcio jonus kompleksuojant su citratu.
/DLN\NLWâVŚ60RQRYHWWH®&7$'ŗLUVSDUQXRWRVLRVNDQLXOâVPâJLQLģâPLPRLUQDXGRMLPR,16758.&,-»
3$67$%$&7$'\UDJHOWRQDVŚ60RQRYHWWH®&7$'ŗODLN\PRPHWXWXULEğWLDSVDXJRWDVQXRGLUEWLQâVLUQDWğUDOLRVđYLHVRV'âOVWLSUDXVđYLHVRVSRYHLNLRLOJLDXQHLYDODQGģSULHGDLJDOLEğWL
deaktyvuoti.

SARSTEDT „S-Monovette® EDTA K2E / K3E“„S-Monovette® EDTA K2E / S-Monovette®('7$.(ŗ\UDDQWLNRDJXOLDQWR.('7$DUED.('7$MLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLJDXWL .('7$DUED.('7$\UDSXUđNLDPRVIRUPRV PJ('7$PONUDXMR ('7$YLVRVVXGâWLHVNUDXMDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDKHPDWRORJLQLDPVW\ULPDPV.UDXMRWLWUDLEğWLSDJDPLQWLSHUNHWXULDVYDODQGDVQXRNUDXMRPâJLQLRSDâPLPR
Koaguliacija slopinama kalcio jonus kompleksuojant su EDTA.
.UDXMÐLđŚ60RQRYHWWH®('7$.(.(ŗWDLSSDWJDOLPDQDXGRWLòSUDVWLQLDPVLPXQRKHPDWRORJLQLDPVLULQIHNFLQLģOLJģW\ULPDPV8ĭPâJLQLRPHGĭLDJRVWLQNDPXPÐđLHPVW\ULPDPVDWVDNRQDXGRWRMDVQDXGRGDPDVDWLWLQNDPXVW\ULPRUHDJHQWXVDQDOL]DWRULXVòVNDLWDQWODLN\PRVÐO\JDV

120

LT
SARSTEDT „S-Monovette® EDTA gelis K2E“Be antikoagulianto K2 EDTA, S-Monovette®('7$JHOLV.(ŗ\UDSROLPHURSDJULQGRJHOLRNXULVQDXGRMDPDVSOD]PDLJDXWL .('7$\UDSXUđNLDPRVIRUPRV PJ('7$PONUDXMR *HOLVQXVâGDFHQWULIXJXRMDQWWDUSNUDXMROÐVWHOLģLUSOD]PRVLUWUDQVSRUWDYLPRODLN\PRLUDQDOL]âVPHWXVXGDURVWDELOģDWVNLULDPÐMòVOXRNVQò('7$SOD]PDQDXGRMDPDNDLSPâJLQLRPHGĭLDJDPROHNXOLQLģYLUXVģGLDJQRVWLNDL
Koaguliacija slopinama kalcio jonus kompleksuojant su EDTA.

SARSTEDT „S-Monovette®ĲXRULGDV('7$)(ĲXRULGRKHSDULQDV)+ĲXRULGRFLWUDWDV('7$)&ŗVXJOLNROL]âVLQKLELWRULDLV„S-Monovette®IOXRULGR('7$)(ŗVXGâW\MH\UDDQWLNRDJXOLDQWR('7$ PJPONUDXMR LUIOXRULGR PJPONUDXMR NXULHVORSLQDJOLNROL]ãMLVQDXGRMDPDVJDXWLSOD]PÐ )OXRULGR('7$\UDSXUđNLDPRVIRUPRV„S-Monovette®IOXRULGRKHSDULQDV)+ŗVXGâW\MH\UDDQWLNRDJXOLDQWRKHSDULQR 79KHSDULQDVPONUDXMR LUIOXRULGR PJPONUDXMR JOLNROL]âVVORSLQLPXLMLVQDXGRMDPDVJDXWLSOD]PÐ )OXRULGRKHSDULQDV\UD
purškiamos formos.
*OLNROL]âVVORSLQLPDVYLHQIOXRULGXSUDVLGHGDSUDâMXVPDĭGDXJYDODQGRPVSRNUDXMRâPLPRPâJLQWXYâOLRXĭSLOG\PRLUSDVLUHLđNLDYLVXSRYHLNLXPDĭGDXJSRYDODQGģ7RGâOYLVDPHNUDXM\MHJOLXNR]âSRNHOLģYDODQGģ
VX\UDYLGXWLQLđNDLLNLRSRYDODQGģşLNLş„S-Monovette®*OXFR(;$&7)&ŗVXGâW\MH\UDDQWLNRDJXOLDQWR('7$WDLSSDWFLWUDWRLUIOXRULGRNXULHLđNDUWRVORSLQDJOLNROL]ãLUSDGHGDJDXWLSOD]PÐ ('7$FLWUDWDVLUIOXRULGDVSDWHLNLDPLWLUSDORIRUPD1RULQWDSVNDLÕLXRWLJOLXNR]âVNRQFHQWUDFLMÐGâOSUDVNLHGLPRUHLNLDSDGDXJLQWLLđ„S-Monovette®*OXFR(;$&7)&ŗDWLWLQND9RNLHWLMRVGLDEHWRGUDXJLMRV ''* 1âđÕLģMģGLDEHWRJDLUHVLU1DFLRQDOLQHVWLSRGLDEHWRSULHĭLğURVJDLUHV 19/ 1HGHOVLDQWJOLXNR]âVNRQFHQWUDFLMDVWDELOL]XRMDPDLNLYDODQGģ
NDPEDULRWHPSHUDWğURMHYLVRVVXGâWLHVNUDXM\MHWDLSSDWĭU6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature/ „Sarstedt S-Monovette® GlucoEXACT A
blood collection device for Stabilizing glucose levels for 96 hours".
)OXRULGR('7$ FLWUDWR SOD]PDQDXGRMDPDNDLSPâJLQLRPHGĭLDJDJOLXNR]HLQXVWDW\WL
Koaguliacija slopinama kalcio jonus kompleksuojant su EDTA.
3$67$%$)OXRULGDVJDOLSDGLGLQWLKHPROL]ã'DXJLDXLQIRUPDFLMRVDSLHPHGĭLDJDVNXULRVJDOLWUXNG\WLJDOLPDUDVWLDWLWLQNDPRVHW\ULPRUHDJHQWRJDPLQWRMRQDXGRMLPRLQVWUXNFLMRVH/DLN\NLWâVŚ60RQRYHWWH®*OXFR(;$&7ŗLUVSDUQXRWRVLRVNDQLXOâVPâJLQLģâPLPRLUQDXGRMLPR,16758.&,-»

SARSTEDT „S-Monovette® CPDA“„S-Monovette®&3'$ŗVXGâW\MH\UDDQWLNRDJXOLDQWRQDWULRFLWUDWRWDLSSDWFLWULQģUğJđWLHVQDWULRIRVIDWRGHNVWUR]âVLUDGHQLQRMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLLUSOD]PDLJDXWL &3'$WLHNLDPDVWLUSDORIRUPD&3'$
LUNUDXMRPDLđ\PRVDQW\NLV\UDWğULR&3'$IUDNFLMDLUWğULRNUDXMRIUDNFLMRV$WOLHNDQWDQDOL]ãEğWLQDVWHLVLQJDVXĭSLOG\PDV&3'$YLVRVVXGâWLHVNUDXMDVSOD]PD\UDQDXGRMDPLNDLSPâJLQLRPHGĭLDJDNUDXMRJUXSâVVHURORJLQLģW\ULPģNUDXMRSHUS\OLPRPHGLFLQRMHWROHUDYLPRW\ULPģ NU\ĭPLQLģPâJLQLģ SHUS\OLPģPHWX.RQNUHÕLDL„S-Monovette®&3'$ŗWLQNDNUDXMRJUXSHLQXVWDW\WL $% òVNDLWDQW.HOOLU5KHVXVIRUPXOãDQWLNğQģQXVWDW\PRW\ULPÐQHòSUDVWLHPVNUDXMRJUXSâVDQWLNğQDPVSROLVSHFLILQòWLHVLRJLQò.XPEVRW\ULPÐ LNLGLHQRV 
WROHUDYLPRW\ULPÐ NU\ĭPLQòPâJLQò VXNUDXMRJUXSãDWLWLQNDQÕLXSDFLHQWRVHUXPXSOD]PD SDJULQGLQòW\ULPÐ 
3DWYLUWLQWDNDGJDEHQLPRòVDQGâOòODLNDVWXULEğWLQHLOJHVQLVNDLSYDODQGRVşƓ&WHPSHUDWğURMH1RULQWQXVRGLQWLOÐVWHOHVPâJLQLDLSLUPLDXVLDWXULEğWLODLNRPLđDOG\WXYHYHUWLNDOLRMHSDGâW\MHQHWUXPSLDXNDLSYDODQGDV3LUPLDXPLQâWDVDQDOLWHVJDOLPDQXVWDW\WLLNLGLHQģDQDORJLđNDLòSUDVWDLNUDXMRNRQVHUYDYLPRWUXNPHLSRODLN\PRđDOG\WXYH şƓ&  LđVN\UXVWLHVLRJLQò.XPEVRW\ULPÐGLHQģ 7LQNDVWXOSHOLģDJOLXWLQDFLMRVSURFHGğURPVSY]QDXGRMDQWŚ9LVLRQ0D[ŗLđŚ2UWKR&OLQLFDO'LDJQRVWLFVŗ0âJLQLRPHGĭLDJRVQHJDOLPDXĭđDOG\WL
0âJLQLRPHGĭLDJRVWLQNDPXPDVđLHPVW\ULPDPVVXNLWDLVPHWRGDLVW\ULPRUHDJHQWDLVDQDOL]âVSULHWDLVDLVòVNDLWDQWODLN\PRVÐO\JDVDWVDNRQDXGRWRMDVLUMLVWXULMDVSDWYLUWLQWL
Koaguliacija slopinama kalcio jonus kompleksuojant su citratu.
/DLN\NLWâVŚ60RQRYHWWH®&3'$ŗLUVSDUQXRWRVLRVNDQLXOâVPâJLQLģâPLPRLUQDXGRMLPR,16758.&,-»

SARSTEDT „S-Monovette® ThromboExact"„S-Monovette®7KURPER([DFWŗVXGâW\MH\UDPDJQLRGUXVNRVNDLSDQWLNRDJXOLDQWRLUMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMRW\ULPDPV 0DJQLRGUXVND\UDSXUđNLDPRVIRUPRV„S-Monovette®7KURPER([DFWŗYLVRVVXGâWLHVNUDXMDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDNODLGLQJDLPDĭDPWURPERFLWģVNDLÕLXLDWPHVWLGâODQWLNRDJXOLDQWģQHWROHUDYLPR SY]('7$FLWUDWRKHSDULQR GDUYDGLQDPRSVHXGRWURPERFLWRSHQLMD1HOHLGĭLDPDVXVLGDU\WLWURPERFLWģDJUHJDWDPVLUIDNWLQòWURPERFLWģVNDLÕLģJDOLPDQXVWDW\WLLNLYDODQGģSRNUDXMRPâJLQLRSDâPLPR.RDJXOLDFLMDVORSLQDPDSHUPDJQLRMRQXVQHVPDJQLRMRQDLVORSLQDWURPERFLWLQòWURPERNVDQÐ$LUWURPERFLWģDJUHJDFLMÐGDO\YDXMDQW$'3LUDUDFKLGRQRUğJđÕLDL

SARSTEDT „S-Monovette® hirudinas“„S-Monovette®KLUXGLQDVŗVXGâW\MH\UDDQWLNRDJXOLDQWRKLUXGLQRLUMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLJDXWL +LUXGLQDV\UDSXUđNLDPRVIRUPRV+LUXGLQRYLVRVVXGâWLHVNUDXMDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDWURPERFLWģIXQNFLMDLQXVWDW\WLŚ52&+('LDJQRVWLFVŗŚ0XOWLSODWH®“ prietaise („multiple platelet function analyser“) ir yra patvirtintas šiam tikslui. Jis
QDXGRMDPDVWURPERFLWXVVORSLQDQWLHPVYDLVWDPVVWHEâWLLUWURPERFLWģGLVIXQNFLMDLQXVWDW\WLDUEDSDđDOLQWL„S-Monovette®KLUXGLQDVŗEXYRVSHFLDOLDLVXNXUWDVWURPERFLWģIXQNFLMDLQXVWDW\WLNDUWXVXŚ9HUXP'LDJQRVWLFDŗđLDQGLHQşŚ52&+('LDJQRVWLFVŗQDXGRMDQWŚ0XOWLSODWH®ŗDQDOL]DWRULģ+LUXGLQDVYHLNLDWLHVLRJLDLVORSLQGDPDVWURPERFLWXVLUWDLSOHLGĭLDDWOLNWLWURPERFLWģIXQNFLMRVGLDJQRVWLNÐQDWğUDOLRMHEğVHQRMHSARSTEDT „S-Monovette® homocisteinas HCY-Z gelis / HCY-C“%HSODVWLNLQLģJUDQXOLģSDGHQJWģNUHđâMLPRDNW\YDWRULXPL VLOLNDWX Ś60RQRYHWWH®KRPRFLVWHLQDV+&<=JHOLVŗ\UDVSHFLDODXVVWDELOL]DWRULXVLUSROLPHURSDJULQGRJHOLRLUMLVQDXGRMDPDVVHUXPXLJDXWL *HOLVQXVâGD
FHQWULIXJXRMDQWWDUSNUDXMRPDVâVLUVHUXPRLUWUDQVSRUWDYLPRODLN\PRLUDQDOL]âVPHWXVXGDURVWDELOģDWVNLULDPÐMòVOXRNVQò3UHSDUDWDV\UDSXUđNLDPRVIRUPRV+RPRFLVWHLQDVVWDELOL]XRMDPDVLNLYDODQGģYLVRVVXGâWLHVNUDXM\MHNDPEDULRWHPSHUDWğURMH-HLFHQWULIXJXRMDPDSHUSLUPÐVLDVYDODQGDVVXWLQNDPDLVXIRUPXRWXNUDXMRPDVâVLUVHUXPRDWVNLULDPXRMXVOXRNVQLXKRPRFLVWHLQDVVWDELOL]XRMDPDVLNLYDODQGģ„S-Monovette®+RPRF\VWHLQ+&<=*HOŗVHUXPDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDKRPRFLVWHLQXLQXVWDW\WLŚ60RQRYHWWH®KRPRFLVWHLQDV+&<&ŗ\UDUğJđWLQLRFLWUDWR S+ NXULVYHLNLDNDLSDQWLNRDJXOLDQWDVLUMLVQDXGRMDPDVSOD]PDLJDXWL &LWUDWDVWLHNLDPDVWLUSDORIRUPD1RULQWDSVNDLÕLXRWLKRPRFLVWHLQRNRQFHQWUDFLMÐUHLNLDSDGDXJLQWLLđGâOSUDVNLHGLPR+RPRFLVWHLQDVVWDELOL]XRMDPDVYLVDPHNUDXM\MHNDPEDULRWHPSHUDWğURMHLNLYDODQGģLUƓ&WHPSHUDWğURMHLNLYDODQGģ„S-Monovette®KRPRFLVWHLQDV+&<&ŗSOD]PDQDXGRMDPDNDLSPâJLQLRPHGĭLDJDKRPRFLVWHLQXLQXVWDW\WL
Koaguliacijos slopinimas „S-Monovette® Homocystein HCY-C“ vyksta kalcio jonus kompleksuojant su citratu.
/DLN\NLWâVŚ60RQRYHWWH®+&<&ŗLUVSDUQXRWRVLRVNDQLXOâVPâJLQLģâPLPRLUQDXGRMLPR,16758.&,-»

SARSTEDT „S-Monovette® DNA Exact“„S-Monovette®'1$([DFWŗVXGâW\MH\UD('7$DQWLNRDJXOLDQWRLUMLVQDXGRMDPDVYLVRVVXGâWLHVNUDXMXLJDXWL ('75\UDSXUđNLDPRVIRUPRV('7$YLVRVVXGâWLHVNUDXMDVQDXGRMDPDVNDLSPâJLQLRPHGĭLDJDJ'15VWDELOL]XRWLJ'15VWDELOL]DYLPRYHLNVPLQJXPDVSDWYLUWLQWDVGLHQRPVƓ&WHPSHUDWğURMHGLHQģNDPEDULRWHPSHUDWğURMH Ɠ& GLHQRPVđDOG\PRWHPSHUDWğURMH Ɠ& LUEHQWPHWDPVƓ&WHPSHUDWğURMH%HWRVWDELOL]XRWLPâJLQLDLLđOLHNDXĭđDOG\PRLUDWđLOG\PRFLNOXVQHSUDUDQGDQWNRN\EâV7DLSSDWĭU6$567('7:KLWH3DSHUhttps://www.sarstedt.
com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for
Genomic DNA Analysis.”.
Koaguliacija slopinama kalcio jonus kompleksuojant su EDTA.

0âJLQLRPHGĭLDJRVWLQNDPXPDVSULNODXVRQXRDQDOLWâVLUW\ULPRUHDJHQWRDQDOL]DWRULDXV/DLN\NLWâVDWLWLQNDPģJDPLQWRMRQXURG\Pģ

121

LT
6DXJRVLQVWUXNFLMRVòVSâMLPDL
1.

%HQGURVLRVDWVDUJXPRSULHPRQâV0ğYâNLWHSLUđWLQHVLUQDXGRNLWHNLWDVEHQGUÐVLDVDVPHQVDSVDXJRVSULHPRQHVNDGDSVLVDXJRWXPâWHQXRNUDXMRLUJDOLPRVÐO\ÕLRVXSRWHQFLDOLDLXĭNUHÕLDPRPLVPâJLQLR
PHGĭLDJRPLVLUSHUQHđDPDLVSDWRJHQDLV2.

6XYLVDLVELRORJLQLDLVPâJLQLDLVLUDđWULDVPDLOLDNUDXMRVXULQNLPRòUDQJD NDQLXOâPLVDGDSWHULDLV HONLWâVODLN\GDPLHVLVDYRòVWDLJRVSROLWLNRVLUSURFHGğUģ7LHVLRJLQLRNRQWDNWRVXELRORJLQLDLVPâJLQLDLVDUEDGXUWLQâVĭDL]GRVDWYHMXNUHLSNLWâVòJ\G\WRMÐQHVJDOLPDXĭVLNUâVWLÅ,9+&9+%9DUNLWRPLVLQIHNFLQâPLVOLJRPLV1DXGRNLWHVDXJLDVNDQLXOHVVDXJLDVŚ0XOWLĲ\®ŗNDQLXOHVVXLQWHJUXRWDDGDWRVDSVDXJD7XULEğWLODLNRPDVLòVWDLJRVVDXJRVWDLV\NOLģLUSURFHGğUģ

3.

Taikoma atskirai steriliai supakuotiems gaminiams:3ULHđQDXGRMLPÐYLVDGDDSĭLğUâNLWHSDNXRWãDUMLQHSDĭHLVWD3DĭHLVWRVSDNXRWâVQHQDXGRNLWH

4.

*DPLQ\VVNLUWDVYLHQNDUWLQLDPQDXGRMLPXL,đPHVNLWHYLVXVDđWULXVVPDLOLXVGDLNWXV NDQLXOHVDGDSWHULXV NUDXMXLVXULQNWLòWLQNDPXVELRORJLđNDLSDYRMLQJģPHGĭLDJģLđPHWLPRNRQWHLQHULXV5.

-HLNUDXMDVLPDPDVLQWUDYHQLQLX ,9 EğGXSULHđSUDGHGDQWNUDXMRâPLPÐEğWLQDSDWLNULQWLDUâPLPRSULHPRQâVWLQNDPDLLđSODXWRV W\SDđDOLQWDV,9WLUSDODV SDJDOòVWDLJRVWDLV\NOHV7LQNDPDLLđSODXQDQWSULHLJÐLđYHQJLDPDQHWHLVLQJģDQDOL]âVUH]XOWDWģ

6.

1HSDNDQNDPDLSULSLOGĭLXVŚ60RQRYHWWH®ŗJDXQDPDVQHWHLVLQJDVNUDXMRLUSUHSDUDWRSULHGRVDQW\NLVWRGâOJDOLEğWLJDXWLQHWHLVLQJLDQDOL]âVUH]XOWDWDL7.

Kraujas, surinktas ir apdorotas naudojant „S-Monovette®ŗQâUDVNLUWDVSDNDUWRWLQDLđYLUNđWLòĭPRJDXVNğQÐ

8.

3DVLEDLJXVHWLNHWâMHQXURG\WDPJDOLRMLPRODLNXLJDPLQLRQDXGRWLQHJDOLPD*DOLRMLPRODLNDVEDLJLDVLSDVNXWLQãQXURG\WģPHWģLUPâQHVLRGLHQÐ

Laikymas*DPLQòLNLQDXGRMLPRUHLNLDODLN\WLNDPEDULRWHPSHUDWğURMH

$SULERMLPDL
1.

Pripildyto „S-Monovette ®ŗODLN\PRODLNDVLUWHPSHUDWğUDSULNODXVRQXRWLULDPģDQDOLÕLģJDOLRMLPRODLNR9HUWLQLPÐDWOLHNDODERUDWRULMDDUEDLQIRUPDFLMDJDXQDPDLđEDQGRPRMRUHDJHQWRDQDOLWLQLRLQVWUXPHQWRJDPLQWRMRQDXGRMLPRLQVWUXNFLMģ2.

Net jei plazma arba serumas atskiriami centrifuguojant „S-Monovettee®LU DUED \UDEDUMHUDVQHEğWLQDLYLVRVOÐVWHOâV\UDYLVLđNDLDWVNLULDPRV/LNXÕLģPHWDEROL]PDVDUEDQDWğUDOXVVNLOLPDVJDOLSDYHLNWLDQDOLWâV
NRQFHQWUDFLMDV$QDOLÕLģVWDELOXPDVWXUâWģEğWLYHUWLQDPDVDWVLĭYHOJLDQWòODLN\PRWDOS\NODVLUDWLWLQNDPRVODERUDWRULMRVVÐO\JDV3.

9DLVWģDWYHMXEDQGLQLRPHGĭLDJRVWLQNDPXPDVWXULEğWLSDWLNULQWDVĭUW\ULPRUHDJHQWģDQDOL]DWRULDXVJDPLQWRMRQDXGRMLPRLQVWUXNFLMDV4.

0LNURHOHPHQWģPHWDOģDQDOL]ãUHLNLDDWOLNWLQDXGRMDQWŚ60RQRYHWWH®PHWDOģDQDOL]HLŗVDXJRVNDQLXOâVPHWDOģDQDOL]âVVLVWHPÐ0âJLQLģâPLPDVLUWYDUN\PDV
35,(ª35$'~'$0,,07,9(1,1.5$8-l3(56.$,7<.,7(9,6lª'2.80(17l0âJLQLXLSDLPWLUHLNDOLQJRVGDUELQâVSULHPRQâV
1.

Visi reikalingi „S-Monovette®ŗNUDXMRVXULQNLPRVLVWHPRVPâJLQWXYâOLDL2.

6DXJRV NDQLXOâVDUED VDXJRV Ś0XOWLĲ\®ŗNDQLXOâV

3.

3LUđWLQâVFKDODWDLDNLģDSVDXJRVSULHPRQâVDUNLWLWLQNDPLDSVDXJLQLDLGUDEXĭLDLDSVDXJDQW\VQXRSHUNUDXMÐSOLQWDQÕLģSDWRJHQģDUSRWHQFLDOLDLLQIHNFLQLģPHGĭLDJģ

4.

3DFLHQWRLGHQWLıNDYLPRHWLNHWâV5.

'H]LQIHNDYLPRPHGĭLDJDPâJLQLRâPLPRYLHWDLYDO\WL UXRđGDPLPâJLQLRâPLPRYLHWÐYDGRYDXNLWâVòVWDLJRVWDLV\NOâPLVGâOVWHULODXVPâJLQLģâPLPR 1HQDXGRNLWHYDO\PRPHGĭLDJģDONRKROLRSDJULQGXMHLPâJLQLDLbus naudojami alkoholio kiekio kraujyje tyrimui.

6.

6DXVLYLHQNDUWLQLDLWDPSRQDLEHPLNUREģ

7.

9HQRVYDUĭÕLDL

8.

3OHLVWUDLDUEDWYDUVÕLDL

9.

,đPHWLPRNRQWHLQHULVDđWULHPVVPDLOLHPVGDLNWDPVVNLUWDVVDXJLDLLđPHVWLSDQDXGRWDVPHGĭLDJDV5HNRPHQGXRMDPDPâJLQLģâPLPRWYDUND
1.

.UDXMRSDVâOLģEXWHOLXNDL

2.

0âJLQWXYâOLDLVXFLWUDWXDUEDNUHđâMLPRDNW\YDWRULXPL VXDUEDEHŚ*HO6HUXP&$7ŗŚ6HUXP*HO&$7ŗ 

3.

0âJLQWXYâOLDLVXNUHđâMLPRDNW\YDWRULXPLDUEDFLWUDWX

4.

0âJLQWXYâOLDLNXULXRVH\UDKHSDULQRVXJHOLXDUEDEHMR

5.

0âJLQWXYâOLDLVX('7$VXJHOLXDUEDEHMR

6.

0âJLQWXYâOLDLVXJOLNROL]âVLQKLELWRULDLV

7.

0âJLQWXYâOLDLVXNLWDLVSULHGDLV
3$67$%$  HLFLWUDWRPâJLQWXYâOLVDUEDNLWDVPâJLQWXYâOLVVXVN\VWXSUHSDUDWXSY]3)$&7$'&3'$+&<&DUED*OXFR(;$&7SDđDOLQDPDVNDUWXVXVSDUQXRWÐMDNDQLXOH SY] VDXJRV Ś0XOWLĲ\®“NDQLXOH LđDQNVWRUHNRPHQGXRMDPDLđLPWLWXđÕLÐPâJLQWXYâOò SY]Ś60RQRYHWWH®1HXWUDO=ŗ NDGEğWģLđYHQJWDQHSDNDQNDPRPâJLQWXYâOLRSULSLOG\PRXĭSLOGDQWVSDUQXRWRVLRVNDQLXOâVYDP]GHOò
7DLSJDOLPDXĭWLNULQWLWLQNDPÐPâJLQWXYâOLRXĭSLOG\PÐLUWLQNDPÐPDLđ\PRVDQW\Nò VN\VÕLRLUNUDXMR 
3$67$%$ /DLN\NLWâVVDYRòVWDLJRVQXURG\PģGâOPâJLQLģâPLPRVHNRV

Venkite atgalinio srauto'DXJXPRMHŚ60RQRYHWWHŗ\UDFKHPLQLģSULHGģ6LHNLDQWLđYHQJWLDWJDOLQLRVUDXWRUHLNLDODLN\WLVđLģQXURG\Pģ
1. 1DXGRNLWHWLNQDXGRMLPRLQVWUXNFLMRVHUHNRPHQGXRMDPDVPHGĭLDJDV2.

/DLN\NLWHSDFLHQWÐWDLSNDGEğWģOHQJYDSDVLHNWLYHQÐRSDFLHQWRUDQNÐDUNLWÐSXQNFLMRVYLHWÐQXOHLVNLWHĭHP\Q

3.

Laikykite „S-Monovette®ŗXĭVXNDPXGDQJWHOLXòYLUđģLUSDSLOGRPDLĭHPLDXUDQNRVO\JLRSXQNFLMRVVULWLHVNDLQDXGRMDWH VDXJRV Ś0XOWLĲ\®ŗNDQLXOã

4.

5HLNLDXĭWLNULQWLNDGŚ60RQRYHWWH®ŗWXULQ\VQHOLHVWģXĭVXNDPRGDQJWHOLRDUEDNDQLXOâVJDORDWOLHNDQWYHQLQLRNUDXMRSXQNFLMÐ

5.

$WODLVYLQNLWHYHQģWXUQLNHWÐNRONUDXMDVWHNDòŚ60RQRYHWWH®“.

122

LT
8ĭđDOG\PDVDWđLOG\PDV
3DJDO362UHNRPHQGDFLMDV :+2',//DE5HY UHNRPHQGXRMDPDDWVNLUWLVHUXPÐSOD]PÐSULHđXĭđDOGDQWNUDXMROÐVWHOHV„S-Monovette®ŗWDLNRPRVđLRVXĭđDOG\PRUHNRPHQGDFLMRV
8ĭđDOG\PDVĭHPHVQâMHQHLƓ&WHPSHUDWğURMH
•1DXGRMLPDVPLQXVLQâVWHPSHUDWğURVLQWHUYDOHLđHVPâVWXULEğWLLđEDQG\WDVUHDOLRPLVVÐO\JRPLVQHVPâJLQWXYâOLģDSNURYDJDOLODEDLVNLUWLVSULNODXVRPDLQXRXĭđDOGRPRVWHUSâVLUòSUDVWģVÐO\Jģ ĭUVN\ULģŚ0HGĭLDJģVDY\EâVŗ6$567('7NDWDORJH •

3DSUDVWDLĭHPHVQâMHQHLƓ&WHPSHUDWğURMHSODVWLNģVWLSULVVXPDĭâMD7RGâOUHLNLDYHQJWLPHFKDQLQLģDSNURYģ•8ĭđDOG\PRVÐO\JRVWXULEğWLSDULQNWRVWDLSNDGŚ60RQRYHWWH®ŗWXULQ\VXĭđDOWģWRO\JLDLDUEDLđDSDÕLRVòYLUđģŚ60RQRYHWWH®ŗWXULEğWLSDNDQNDPDLODLVYRVYLHWRVVWRYHDUEDODLN\PRGâĭâMHNDGMLVJDOâWģLđVLSOâVWL3XWSODVÕLRDUEDPHWDOLQLDLVWRYDLQHWLQNDQHVMLHJDOLVXNHOWLòWUğNLPXVGâOSOâWLPRVL

8ĭđDOG\PDVLNLƓ&şSDWLNULQNLWHSULHđXĭđDOG\GDPL
•7UXNGĭLDL3DWLNULQNLWHDUXĭđDOG\PDVQHWXULQHLJLDPRSRYHLNLRNUDXMRPâJLQLXLDUEDDQDOL]HL SY]KHPROL]HLDQDOLÕLģVWDELOXPXL •&HQWULIXJDYLPDV5HLNDOLQJXPDVSULNODXVRQXRVXSODQXRWRVDQDOL]âV6WHEâNLWHFHQWULIXJDYLPRVÐO\JDVĭUđLRGRNXPHQWRVN\ULģŚ&HQWULIXJDYLPDVŗDUED6$567('7VYHWDLQãhttps://www.sarstedt.com/en/service/centrifugation/LUDWOLNLWHYL]XDOLQãPâJLQLRSDWLNUÐ•+HPROL]â8ĭđDOGDQWYLVRVVXGâWLHVNUDXMDVKHPROL]XRMDPDV1RULQWWRLđYHQJWLUHLNLDQDXGRWLŚ60RQRYHWWH® gelis“ arba po „Seraplas®ŗYRĭWXYRıOWURFHQWULIXJDYLPRDUEDPâJLQòSLSHWHòODđLQWLòDQWULQòPâJLQWXYâOò8ĭđDOG\PDVLNLƓ&şSURFHGğUD•$XđLQLPDV9âVLQNLWHŚ60RQRYHWWH®ŗYHUWLNDOLDLQXR57LNLƓ&PLQXÕLģSULHđXĭđDOG\GDPLƓ&WHPSHUDWğURMH

•$WđLOG\PDV$WđLOG\NLWHYHUWLNDOLDL57UHĭLPXEHQWPLQXWHVqLDWDLSSDWUHLNLDYHQJWLPHFKDQLQLģòWHPSLģ3HUJUHLWDVDWđLOG\PDVJDOLSDNHQNWLDQDOL]âVUH]XOWDWDPV

8ĭđDOG\PDVLUXĭđDOG\PDVĭHPHVQâMHQHLƓ&WHPSHUDWğURMH•*DPLQWRMDVQHLđEDQGâXĭđDOG\PRĭHPHVQâMHQHLƓ&WHPSHUDWğURMH'âOGLGHOLRJDOLPģYHLNVQLģVNDLÕLDXVUHNRPHQGXRMDPHDWOLNWLXĭđDOG\PREDQG\PXVòSUDVWRPLVODERUDWRULMRVVÐO\JRPLV„S-Monovette®JHOLVŗXĭđDOG\PDV•

8ĭđDOGRPDNDLSDSUDđ\WDSXQNWH8ĭđDOG\PDVLNLƓ&şSURFHGğUD•ÅLQRPDNDGGâOXĭđDOG\PRSURFHVRJHOLRVOXRNVQLVJDOLSDVLNHLVWL•'âOGLGHOLRJDOLPģYHLNVQLģVNDLÕLDXVUHNRPHQGXRMDPHDWOLNWLXĭđDOG\PREDQG\PXVòSUDVWRPLVODERUDWRULMRVVÐO\JRPLV

•

Atšildymas:0âJLQòDWđLOG\NLWHYHUWLNDOLDL$WđLOGĭLXVPâJLQLRPHGĭLDJDSHUNHOLDPDLđSLUPLQLRPâJLQLRòDQWULQòPâJLQòSLSHWH QHGHNDQWXRMDQW LNLPDĭGDXJPPYLUđJHOLRVOXRNVQLR/LNXVLXVLđPHVNLWH
3$67$%$.DGDQDOLWâVEğWģVWDELOLRVEğWLQDODLN\WLVW\ULPRUHDJHQWRDQDOL]DWRULDXVJDPLQWRMRSDWHLNWģQDXGRMLPRLQVWUXNFLMģ

123

LT
.UDXMRSDâPLPDV
3DâPLPREğGDL
6NLULDPLGXSDâPLPREğGDLDVSLUDFLMRVWHFKQLNDLUYDNXXPRWHFKQLND$VSLUDFLMRVWHFKQLNDOHLGĭLDđYHOQLDLLPWLNUDXMÐQXRODWLQHOâWDNUDXMRVURYHUHJXOLXRMDQWâPLPÐVWğPRNOLRVWU\SX7RNLXEğGXNUDXMRWâNPãJDOLPDSULWDLN\WLWLHVLRJLDLYLVRPVYHQģVÐO\JRPVLUDSOLQN\EâPVWDLSSDWJDOLPD
VXPDĭLQWLKHPROL]ã
1DXGRMDQWLđDQNVWRLđWXđWLQWÐPâJLQWXYâOòYDNXXPRWHFKQLNDOHLGĭLDSDLPWLNUDXMÐWDLNDQWQHLJLDPRVOâJLRSULQFLSÐHVDQWQHQXWUğNVWDPDPJUHLWDPNUDXMRVUDXWXL7RGâOđLPHWRGLNDLGHDOLDLWLQNDJHURPVYHQRPVLU
SDSUDVWRPVSDâPLPRVÐO\JRPV.UDXMRPâJLQLģâPLPDVWDLSSDWĭUYDL]GRòUDđÐDSLHŚ60RQRYHWWH®ŗDVSLUDFLMRVWHFKQRORJLMÐDUEDYDNXXPRWHFKQRORJLMÐVXDSVDXJLQHNDQLXOHDUEDVDXJRVŚ0XOWLIO\®“ kaniule:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood.$'680$Å,1780~7(6l/<q,25,=,.l.5$8-2~0,020(780·9~.,7(3,5ª7,1(6
1. 5HLNLDPDPPâJLQLXLSDVLULQNLWHWLQNDPÐŚ60RQRYHWWH®“.
2.

3DVLULQNLWHYHQRVSXQNFLMRVYLHWÐ1RUâGDPLSDUXRđWLYHQRVSXQNFLMRVYLHWÐODLN\NLWâVòVWDLJRVQXURG\Pģ.UDXMRSDâPLPDVDVSLUDFLMRVWHFKQLND
'âPHVLRŚ60RQRYHWWH®“ naudokite tik kraujui imti, o ne injekcijai.
1DXGRNLWHWLNVXđLRPLVNDQLXOâPLV Ś60RQRYHWWH®“ (saugos) kaniule, (saugos) „Multifly®“ kaniule / „S-Monovette®“ adapteriu).
1DXGRMLPDVVXDSVDXJLQHNDQLXOHSDYDL]GXRWDVÕLD

spragt3ULHđSDWYHQģSXQNFLMÐòNLđNLWH60RQRYHWWH®òLQWHJUXRWÐDSVDXJLQâVNDQLXOâVODLNLNOò LUXĭILNVXRNLWHMòOHQJYDLSDVXNGDPLSDJDOODLNURGĭLRURG\NOã .
-HLUHLNLDQDXGRNLWHYHQģWXUQLNHWÐ PDNVPLQXWâ 3DUXRđNLWHSXQNFLMRVYLHWÐWLQNDPDGH]LQIHNDYLPRSULHPRQH3RGH]LQIHNDYLPRQHOLHVNLWHYHQRVSXQNFLMRVYLHWRV/DLN\NLWHSDFLHQWÐWDLSNDGEğWģOHQJYDSDVLHNWLYHQÐRSDFLHQWRUDQNÐDUNLWÐSXQNFLMRVYLHWÐQXOHLVNLWHĭHP\Q
1XLPNLWHDGDWRVDSVDXJÐ3UDGXUNLWHYHQÐOâWDLLđWUDXNLWHVWğPRNOLRVWU\SÐLUDWODLVYLQNLWHYHQģWXUQLNHWÐNDLNUDXMDVWHNâWģòŚ60RQRYHWWH®
3DODXNLWHNRONUDXMRVUDXWDVVXVWRVNDGEğWģJDOLPDWLQNDPDLSULSLOG\WL

“.

Pajudinkite „S-Monovette®“ šiek tiek pasukdami SULHđODLNURGĭLRURG\NOã WDGDLđWUDXNLWH DWMXQNLWH LđVDXJRVNDQLXOâV 6DXJRVNDQLXOâOLHNDYHQRMH-HLPâJLQLDLLPDPLNHOLVNDUWXVNDLSDSUDđ\WDSLUPLDXSULMXQNLWHWROLDXQXURG\WXVŚ60RQRYHWWHŗSULHVDXJRVNDQLXOâVLUSDLPNLWHNLWXVPâJLQLXV.UDXMRPâJLQLģâPLPRQXWUDXNLPDV3LUPLDXVLDDWMXQNLWHŚ60RQRYHWWH®
+ ŗWDGDLđWUDXNLWHVDXJRVNDQLXOãLđYHQRV1DXGRGDPLYLHQRVUDQNRVPHWRGÐVXDNW\YLQNLWHDGDWRVDSVDXJÐDQWVWDELODXVO\JDXVSDYLUđLDXVNRONDQLXOâXĭVLILNVXRV VXDNW\YLQV DGDWRVDSVDXJÐMDXÕLDPXLUJLUGLPXVSUDJWHOâMLPXDUEDSDVSDXVGDPLURGRPÐMòSLUđWÐSULHDSDWLQLRDGDWRVDSVDXJRVJDOR7DLSSDWĭUŚ60RQRYHWWH® (saugos)
NDQLXOâDUED VDXJRV Ś0XOWLIO\®ŚNDQLXOâ$WMXQJãQXRDSVDXJLQâVNDQLXOâVNLHNYLHQÐŚ60RQRYHWWH®ŗYLHQÐNDUWÐDSYHUVNLWHRXĭEDLJãNUDXMRPâJLQLģâPLPÐNHOLVNDUWXVDWVDUJLDLDSYHUVNLWHYLVXVPâJLQWXYâOLXVVXDQWLNRDJXOLDQWDLV7UDQVSRUWXRMDQWLUFHQWULIXJXRMDQWUHLNLDSDWUDXNWLVWğPRNOLRVWU\SÐòVWğPRNOLRXĭILNVDYLPRSDGâWò  VWğPRNOLVXĭVLILNVXRMDŚ60RQRYHWWH®ŗDSDÕLRMH LUQXODXĭWLVWğPRNOLRVWU\SÐ .
1.

3XQNFLMRVYLHWÐVSDXVNLWHVDXVXđYDULXWDPSRQXNROQXVWRVNUDXMXRWL

2.

.DLòY\NVWDNRDJXOLDFLMDMHLUHLNLDXĭGâNLWHWYDUVWò

3.

,đPHVNLWHVDXJRVNDQLXOãòWLQNDPÐELRORJLđNDLSDYRMLQJģPHGĭLDJģđDOLQLPRNRQWHLQHUò

124

LT
.UDXMRSDâPLPDVYDNXXPRPHWRGX
'âPHVLRŚ60RQRYHWWH®“ naudokite tik kraujui imti, o ne injekcijai.
1DXGRNLWHWLNVXđLRPLVNDQLXOâPLV Ś60RQRYHWWH®“ (saugos) kaniule, (saugos) „Multifly®“ kaniule / „S-Monovette®“ adapteriu).
1DXGRMLPDVVXVDXJRVNDQLXOHSDYDL]GXRWDVÕLD

spragt1RULQWSUDGâWLDWVDUJLDLLPWLNUDXMÐ6$567('7UHNRPHQGXRMDQDXGRWLSLUPÐMòŚ60RQRYHWWH®ŗVXòVLXUELPRWHFKQLNDĭU9(126381.&,-267(&+1,.lDVSLUDFLMRVWHFKQLNÐ
3RWRWãVNLWHYDNXXPRWHFKQRORJLMÐ3ULHđSDLPGDPLNUDXMÐVWğPRNOLRVWU\SXSDWUDXNLWHVWğPRNOòSULHŚ60RQRYHWWH®ŗSDJULQGRLUOHLVNLWHMDPJLUGLPDLXĭVLILNVXRWL 7DGDQXODXĭNLWHVWğPRNOLRVWU\SÐ .
VWXPNLWHSDUXRđWÐŚ60RQRYHWWH®ŗòLQWHJUXRWÐŚ60RQRYHWWH®ŗVDXJRVNDQLXOâVODLNLNOòLUSULWYLUWLQNLWHlengvai pasukdami SDJDOODLNURGĭLRURG\NOã

+

-

.

.

3DODXNLWHNRONUDXMRVUDXWDVVXVWRVNDGEğWģJDOLPDWLQNDPDLSULSLOG\WL

Pajudinkite „S-Monovette®“ lengvai pasukdami SULHđODLNURGĭLRURG\NOã WDGDLđWUDXNLWH DWMXQNLWH LđVDXJRVNDQLXOâV 6DXJRVNDQLXOâOLHNDYHQRMH-HLPâJLQLDLLPDPLNHOLVNDUWXVNDLSDSUDđ\WDSLUPLDXLđSUDGĭLģSULMXQNLWHWROLDXQXURG\WXVŚ60RQRYHWWHŗSULHVDXJRVNDQLXOâVLUSDLPNLWHNLWXVPâJLQLXV.UDXMRPâJLQLģâPLPRQXWUDXNLPDVAtjunkite „S-Monovette®“ + WDGDLđWUDXNLWHVDXJRVNDQLXOãLđYHQRV1DXGRGDPLYLHQRVUDQNRVPHWRGÐVXDNW\YLQNLWHDGDWRVDSVDXJÐDQWVWDELODXVO\JDXVSDYLUđLDXVNRONDQLXOâXĭVLILNVXRV VXDNW\YLQV 
DGDWRVDSVDXJÐOMDXÕLDPXLUJLUGLPXVSUDJWHOâMLPXDUEDSDVSDXVGDPLSLUđWXDGDWRVDSVDXJÐSULHDSDWLQLRDGDWRVDSVDXJRVJDOR$WMXQJãQXRDSVDXJLQâVNDQLXOâVNLHNYLHQÐŚ60RQRYHWWH®ŗYLHQÐNDUWÐDSYHUVNLWHRXĭEDLJãNUDXMRPâJLQLģâPLPÐNHOLVNDUWXVDWVDUJLDLDSYHUVNLWHYLVXVPâJLQWXYâOLXVVXDQWLNRDJXOLDQWDLV1.

3XQNFLMRVYLHWÐVSDXVNLWHVDXVXđYDULXWDPSRQXNROQXVWRVNUDXMXRWL

2.

.DLòY\NVWDNRDJXOLDFLMDMHLUHLNLDXĭGâNLWHWYDUVWò

3.

,đPHVNLWHVDXJRVNDQLXOãòWLQNDPÐELRORJLđNDLSDYRMLQJģPHGĭLDJģđDOLQLPRNRQWHLQHUò

125

LT
Centrifugavimas'~0(6,26$567('7Ś60RQRYHWWHŗVNLUWL[JWğULXL,đVN\UXV¢PPŚ60RQRYHWWHŗ Ś60RQRYHWWH®SHGLDWULMDLŗ NXULHđLXRPHWXSDWYLUWLQWLLNL[JWğULXL*DOLPDQDXGRWLWLNWLQNDPXVODLN\PRPâJLQWXYâOLXVLU
òGâNOXV&HQWULIXJXRMDQWŚ60RQRYHWWHŗVXòWUğNLPDLVDUEDFHQWULIXJXRMDQWVXSHUGLGHOLXLđFHQWULQLXSDJUHLÕLXŚ60RQRYHWWHŗJDOLVXOğĭWLWRGâOJDOLLđVLVNLUWLSRWHQFLDOLDLXĭNUHÕLDPDPHGĭLDJD&HQWULIXJRVòGâNODLWXULEğWLSDUHQNDPLDWVLĭYHOJLDQWòQDXGRMDPģŚ60RQRYHWWHŗG\Gò6DQW\NLQâLđFHQWULQâMâJD\UDVXVLMXVLVXQXVWDW\WXVXNLPRVLGDĭQLXSHUPLQXWãWDLS
5=% [U[ VğNPLQ 2,
5=%Ś6DQW\NLQLVLđFHQWULQLVSDJUHLWLVŗGDUYDGLQDPDVŚJMâJDŗ DQJOŚUHODWLYHFHQWULIXJDOIRUFHŗ5&) 
DSVPLQŚ$SVXNRVSHUPLQXWãŗ DSVPLQ DUEDQ Ś6ğNLDLSHUPLQXWãŗ DQJO530şUHYROXWLRQVSHUPLQXWH 
r: išcentrinis spindulys nuo centrifugos centro iki „S-Monovette®“ dugno (cm),„S-Monovette“ be gelio galima centrifuguoti centrifugose su fiksuoto kampo rotoriais arba pasukamais rotoriais.
Ś60RQRYHWWHŗVXJHOLXVNLUWLWLNFHQWULIXJRPVVXEHVLVXNDQÕLDLVURWRULDLV&HQWULIXJDYLPRILNVXRWRNDPSRURWRULDXVFHQWULIXJRVH6$567('QHSDWYLUWLQRLUQHUHNRPHQGXRMD
Ś60RQRYHWWHŗWXULEğWLFHQWULIXJXRMDPLSDJDOWROLDXLđYDUG\WDVFHQWULIXJDYLPRVÐO\JDV-HL\UDNLWRVVÐO\JRVMDVWXULSDWYLUWLQWLSDWVQDXGRWRMDV
7XULEğWLXĭWLNULQWDNDGŚ60RQRYHWWHŗWYLUWDLSULJOXVWģSULHFHQWULIXJRVòGâNOģ8ĭòGâNORLđVLNLđãŚ60RQRYHWWHŗJDOLòVWULJWLFHQWULIXJRVJDOYXWâMHLUVXGXĭWL&HQWULIXJDWXULEğWLXĭSLOG\WDWRO\JLDL7DPODLN\NLWâVFHQWULIXJRVQDXGRMLPRLQVWUXNFLMģ$76$5*,$, 1HOLHVNLWH VXGXĭXVLģ Ś60RQRYHWWHŗ SOLNRPLV UDQNRPLV
Centrifugos dezinfekavimo nurodymai pateikti centrifugos naudojimo instrukcijoje.

2ULHQWXRWDò
BS 4851+ (ESkodas)

Santykinis išcentrinis pagreitis (g)„S-Monovette®“

DIN EN ISO 6710–

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Serumas10 min.

10 min.

6 min.

4 min.

4 min.

Serumas-gelis

15 min.

10 min.

4 min.

4 min.

4 min.

„Serumas Express gelis“

15 min.

10 min.

4 min.

QâUD

QâUD/LÕLRKHSDULQDV

10 min.

10 min.

7 min.

7 min.

7 min.

Ś/LÕLRKHSDULQRJHOLVŗ

15 min.

15 min.

10 min.

7 min.

7 min.

Ś/LÕLRKHSDULQRJHOLV+“

8 min.

7 min.

5 min.

4 min.

4 min.

EDTA

QâUD

QâUD

7 min.

6 min.

5 min.

EDTA gelis

15 min.

10 min.

10 min.

7 min.

7 min.

Citratas

9 min.

8 min.

7 min.

6 min.

5 min.

('7$ĲXRULGRKHSDULQDV

9 min.

8 min.

7 min.

6 min.

5 min.

„GlucoEXACT“

9 min.

8 min.

7 min.

6 min.

5 min.

Citrato PBM 1,8 ml
Centrifugos spindulys > 17 cm

9 min.

8 min.

7 min.

6 min.

5 min.

Citrato PBM 1,8 ml&HQWULIXJRVVSLQGXO\VQXR!LNLƉ
17 cm

QâUD

QâUD

10 min.

QâUD

QâUD

QâUD QHSDWYLUWLQWD
* Taikoma visiems „S-Monovette“, išskyrus Ø 8 mm („S-Monovette“ pediatrijai).

&HQWULIXJDYLPDV Ɠ&WHPSHUDWğURMH

+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, atšauktas.

,QIRUPDFLMDDSLHDWVN\ULPRPHGĭLDJÐ
$WVN\ULPRPHGĭLDJRV JHOLR VUDXWRVDY\EâVSULNODXVRQXRWHPSHUDWğURV-HLŚ60RQRYHWWHŗDWYâVLQDPLSULHđFHQWULIXJDYLPÐDUEDFHQWULIXJDYLPRPHWXQHEHJDUDQWXRMDPDVQXRODWLQLVVNLULDQÕLRMRJHOLRVOXRNVQLV„S-Monovette“ negalima pakartotinai centrifuguoti / recentrifuguoti.

Šalinimas
1.

5HLNLDODLN\WLVEHQGUģMģKLJLHQRVUHNRPHQGDFLMģLUòVWDW\PģQXRVWDWģGâOWLQNDPRLQIHNFLQLģPHGĭLDJģDWOLHNģđDOLQLPR

2.

9LHQNDUWLQâVSLUđWLQâVDSVDXJRQXRLQIHNFLMRVSDYRMDXV

3.

8ĭWHUđWÐDUEDSULSLOG\WÐNUDXMRVXULQNLPRVLVWHPÐUHLNLDđDOLQWLòWLQNDPDVELRORJLQLģSDYRMLQJģPHGĭLDJģđDOLQLPRWDOS\NODVNXULDVYâOLDXJDOLPDDXWRNODYXRWLLUVXGHJLQWL

4.

ªDOLQLPXLUHLNLDQDXGRWLWLQNDPÐGHJLQLPRNURVQòDUEDDXWRNODYÐ VWHULOL]DYLPÐJDUDLV 

126

LT
Šiuo metu gaminiui galiojantys standartai ir direktyvos
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 “WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

0âJLQWXYâOLģVNLUWģSDLPWLYHQLQòNUDXMÐVWDQGDUWDV
',1(1,620âJLQWXYâOLDLYLHQNDUWLQLDPQDXGRMLPXLVNLUWLSDLPWLĭPRJDXVNUDXMÐLđYHQRV*CLSI (Clinical and Laboratory Standards Institute)

6LPEROLģLUĭHQNOģSDDLđNLQLPDV

3UHNâVQXPHULV

Taip pat taikoma atskirai steriliai supakuotiems gaminiams

Partijos pavadinimas

1HQDXGRWLMHLJXSDNXRWâDSJDGLQWD

Tinka naudoti iki

Sterilaus barjero sistema su išorine apsaugine pakuote&(ĭHQNODVSterilizacija švitinantIn vitro diagnostikai

Laikytis naudojimo instrukcijos

1DXGRMDQWSDNDUWRWLQDLXĭWHUđLPRSDYRMXV/DLN\WLQXRVDXOâVđYLHVRVDSVDXJRWRMHYLHWRMH

Laikyti sausoje vietoje

Gamintojas

Pagaminimo šalis

6WHULOLVN\VÕLģYRQHOâNesterilizuoti pakartotinai

Galimi techniniai pakeitimai.
$SLHYLVXVULPWXVVXJDPLQLXVXVLMXVLXVòY\NLXVUHLNLDSUDQHđWLJDPLQWRMXLLUDWVDNLQJDLđDOLHVLQVWLWXFLMDL

127

/LHWRđDQDVQRUÌGHVş6$567('760RQRYHWWH®DVLQVSDÿHPđDQDVVLVWàPD

LVin vitro diagnostikas lietošanai
/LHWRđDQDVPàUõLV
S-Monovette®DVLQVSDÿHPđDQDVVLVWàPDNDQXODVXQDGDSWHULWLHNL]PDQWRWLNRSÌNÌYHQR]ÌDVLQVQRÿHPđDQDVVLVWàPD60RQRYHWWH®DVLQVSDÿHPđDQDVVLVWàPDVWLHNL]PDQWRWDVDVLQVSDUDXJXÿHPđDQDLWUDQVSRUWàđDQDLDSVWUÌGHLXQX]JODEÌđDQDLin vitroGLDJQRVWLNDVQRWHLNđDQDLQRVHUXPDSOD]PDVYDLSLOQÌPDVLQñPNOñQLVNDMÌODERUDWRULMÌ,]VWUÌGÌMXPVSDUHG]àWVOLHWRđDQDLSURIHVLRQÌOÌYLGàXQWRGUñNVWOLHWRWPHGLFñQDV
VSHFLÌOLVWLXQODERUDWRULMXSHUVRQÌOV,]VWUÌGÌMXPDDSUDNVWVS-Monovette®DVLQVSDÿHPđDQDVVLVWàPDVVDVWÌYQRSODVWPDVDVWUDXNDYLU]XùDYLU]XùDVWLHÿDXQDUNUÌVXNRGàWDVNUğYàMDPDSODVWPDVDVYÌFLÿDDULQWHJUàWXPHPEUÌQXNDVNDVñSDđLL]VWUÌGÌWDVDYLHQRMXPDPDU
S-Monovette ® GURđñEDV NDQXOXYDL GURđñEDV 0XOWLIO\®NDQXOXNÌDUñGDĭÌGÌPSLHGHYÌP SUHSDUÌWLHP ,USLHHMDPDDUñ60RQRYHWWH®EH]SLHGHYÌP60RQRYHWWH®DVLQVSDÿHPđDQDVVLVWàPDVDUSLHGHYÌPNRDJXOÌFLMDVDNWLYDWRUVNRDJXOÌFLMDVDNWLYDWRUVDUJHOXOLWLMDKHSDUñQVOLWLMDKHSDUñQVDUJHOXQÌWULMDKHSDUñQVFLWUÌWV('7$IOXRUñGV('7$IOXRUDKHSDUñQVIOXRUDFLWUÌWV&3'$XQEH]SLHGHYDVWÌVSLHGHYXNRQFHQWUÌFLMDVđõLGURSLHGHYXWLOSXPVXQWRSLHùDXMDPÌVSLHODLGHVNÌDUñDVLÿXDWWLHFñEDSUHWSLHGHYXDWELOVWVWDUSWDXWLVNÌVWDQGDUWD',1(1,629LHQUHL]àMÌVOLHWRđDQDVWUDXNLYHQR]RDVLÿXSDUDXJXVDYÌNđDQDLSUDVñEÌPXQLHWHLNXPLHP
XQ.OñQLVNRXQODERUDWRULMDVVWDQGDUWXLQVWLWğWDDSVWLSULQÌWLHPVWDQGDUWLHP &/6, 3LHGHYDVL]YàOHLUDWNDUñJDQRDQDOñWLVNÌVWHVWàđDQDVPHWRGHV7RQRVDNDWHVWDUHDçHQWXUDĭRWÌMVXQYDLWHVWDYHLNđDQDLL]PDQWRWDLVDQDOL]DWRUV$VLQVSDUDXJXSDÿHPđDQDVVLVWàPD60RQRYHWWH®LUSLHHMDPDPRGHùRVDUVWHULOXLHNđSXVLYDLDWVHYLđõÌLHSDNRMXPÌDUVWHULOXLHNđSXVLXQÌUSXVLS-Monovette®VNUğYàMDPRYÌFLÿXNUÌVXNRGL 

Piedeva

Burtu kods

9ÌFLÿDNUÌVD',1(1,62
6710

9ÌFLÿDNUÌVDSDPDWRMRWLHVuz BS 4851 +

Z

balts

balts

7UDXNVEH]SUHSDUÌWD
S-Monovette ® Neutral Z
Seruma trauks
S-Monovette®6HUXPV&$7DUNRDJXOÌFLMDVDNWLYDWRUX

CAT

sarkansbalts

S-Monovette®6HUXPVJHOV&$7DUNRDJXOÌFLMDVDNWLYDWRUXXQJHOX

CAT

tumši dzeltens

tumši dzeltens

S-Monovette®6HUXPV([SUHVVJHOV&$7DUNRDJXOÌFLMDVDNWLYDWRUXWURPEñQXXQJHOX

CATRUDQĭV-S-Monovette®/LWLMDKHSDUñQV/+DUOLWLMDKHSDUñQX

LH

]Dùđ

RUDQĭVS-Monovette®/LWLMDKHSDUñQDđõLGUXPV/+DUOLWLMDKHSDUñQX

LH

]Dùđ

RUDQĭVS-Monovette®/LWLMDKHSDUñQDJHOV/+DUOLWLMDKHSDUñQXXQJHOX

LH

]Dùđ

RUDQĭVS-Monovette®/LWLMDKHSDUñQDJHOV+/+DUOLWLMDKHSDUñQXXQÌWUXJHOX

LH

]Dùđ

RUDQĭVS-Monovette®1ÌWULMDKHSDUñQV1+DUQÌWULMDKHSDUñQX

NH

EUğQV

]Dùđ

S-Monovette®$PPRQLXP+HSDULQ$+DUDPRQLMDKHSDUñQX

n.d.

zils

zils

S-Monovette®&LWUÌWV1&QÌWULMDFLWUÌWV

9NC

zils

]Dùđ

S-Monovette 3)$&LWUÌWV1&QÌWULMDFLWUÌWVEXIHUđõñGXPV

9NC

gaiši zils-

S-Monovette®.('7$.(DUNÌOLMD('7$K3E

violetssarkans

S-Monovette®.('7$.(DUNÌOLMD('7$K2E

violetssarkans

S-Monovette®.('7$JHOV.(DUNÌOLMD('7$XQJHOX

K2E

violetssarkans

S-Monovette®)OXRUñGD('7$)(DUĲXRUñGXXQ('7$FE

SHOàNVdzeltens

S-Monovette®)OXRUñGDKHSDUñQV)+DUĲXRUñGXXQKHSDUñQX

FH-

dzeltens

S-Monovette®*OXFR(;$&7)&DUĲXRUñGXFLWUÌWXXQ('7$

FC

UR]Ì

SHOàNV

LH

tumši zilsRUDQĭVS-Monovette®7KURPER([DFWDUPDJQLMDPDLVñMXPX

n.d.

QGPHOOHQHVNUÌVÌ

QGPHOOHQHVNUÌVÌ

S-Monovette ® CTADn.d.

n.d., zils

QG]Dùđ

S-Monovette ® ACD

ACD

dzeltens

dzeltens

S-Monovette ® CPDA

CPDA

dzeltens

dzeltens

S-Monovette ®+LUXGñQVn.d.

QGROñYX]Dùđ

QGROñYX]Dùđ

S-Monovette®+RPRFLVWHñQD+&<=JHOVDUJHOXXQVWDELOL]DWRUXn.d.

QGSHOàNV

QGSHOàNV

S-Monovette®+RPRFLVWHñQD+&<&DUFLWUÌWDEXIHUYLHOX

n.d.

n.d., violets

n.d., violets

S-Monovette ® DNS Excact

n.d.

n.d., zilsn.d., zils

7UDXNVKHSDUñQDP

7UDXNVFLWUÌWDP®

EDTA trauks

Trauks ar glikozes inhibitoriem

7UDXNVPHWÌODDQDOñ]HLS-Monovette®0HWÌODDQDOñ]H/+DUOLWLMDKHSDUñQX

3LOQYàUWñJXDVLÿXXQSOD]PDVWUDXNV

3LHHMDPDVFLWDVVNUğYàMDPXYÌFLÿXNUÌVDVn.d.: nav noteikts+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, atsaukts.

128

LV
SARSTEDT S-Monovette® Seruma CAT / seruma gels CAT
S-Monovette®6HUXPD&$7VDWXUSODVWPDVDVJUDQXODVNDVSÌUNOÌWDVDUNRDJXOÌFLMDVDNWLYDWRUX VLOLNÌWX XQWLHNL]PDQWRWDVVHUXPDLHJğđDQDL 3ODVWPDVDVJUDQXOÌWXFHQWULIXJàVWDUSDVLQVUHFHNOLXQVHUXPX
3DSLOGXVSODVWPDVDVJUDQXOÌPNDVSÌUNOÌWDVDUNRDJXOÌFLMDVDNWLYDWRUX VLOLNÌWX 60RQRYHWWH®6HUXPDJHOV&$7VDWXUJHOXX]SROLPàUXEÌ]HVXQWLHNL]PDQWRWVVHUXPDLHJğđDQDL *HOVWLHNFHQWULIXJàWVVWDUSDVLQVUHFHNOLXQVHUXPXXQYHLGRVWDELOXDWGDORđRVOÌQLWUDQVSRUWàđDQDVX]JODEÌđDQDVXQDQDOñ]HVODLNÌ
6HUXPXL]PDQWRNÌSDUDXJXPDWHULÌOXNOñQLVNLõñPLVNDMRVXQLPXQRORçLVNDMRVUXWñQDVWHVWRVNÌDUñVHURORçLMÌ3àFDVLÿXÿHPđDQDVDVLQñPYDMDG]àWXVDUHFàW60RQRYHWWH®6HUXPD&$7VHUXPDJHOV&$7YHUWLNÌOÌVWÌYRNOñPLQğWHVODLSàFFHQWULIXJàđDQDVVDVQLHJWXODELDWWñVWñWXKRUL]RQWÌORDWGDORđRVOÌQL,HWHLFDPDLVODLNVLUEDOVWñWVX]QHVNDUWXNRDJXOÌFLMDVSURFHVX$VLQñPQRSDFLHQWLHPDUNRDJXOÌFLMDVWUDXFàMXPLHPNDVVDLVWñWLDUVOLPñEXYDLOLHWRMRWDQWLNRDJXODQWXWHUDSLMXLUQHSLHFLHđDPVYDLUÌNODLNDODLSLOQñEÌVDUHFàWXSARSTEDT S-Monovette® Seruma Express gels CAT
3DSLOGXVSODVWPDVDVJUDQXOÌPNDVSÌUNOÌWDVDUNRDJXOÌFLMDVDNWLYDWRUX WURPEñQX 60RQRYHWWH®6HUXPD([SUHVVJHOV&$7VDWXUJHOXX]SROLPàUXEÌ]HVXQWLHNL]PDQWRWVVHUXPDLHJğđDQDL *HOVWLHNFHQWULIXJàWVVWDUSDVLQVUHFHNOLXQVHUXPXXQYHLGRVWDELOXDWGDORđRVOÌQLWUDQVSRUWàđDQDVX]JODEÌđDQDVXQDQDOñ]HVODLNÌ3àFDVLÿXVDYÌNđDQDVDVLQñPYDMDG]àWXVDUHFàW60RQRYHWWH®6HUXPD([SUHVVJHOVPLQğWHVYHUWLNÌOÌVWÌYRNOñODLSàFFHQWULIXJàđDQDVQRGURđLQÌWXODELDWWñVWñWXKRUL]RQWÌORDWGDORđRVOÌQL,HWHLFDPDLVODLNVLUEDOVWñWVX]
QHVNDUWXNRDJXOÌFLMDVSURFHVXDUñDVLQñPQRKHSDULQL]àWLHPSDFLHQWLHP$VLQñPQRSDFLHQWLHPDUVOLPñEXVDLVWñWLHPNRDJXOÌFLMDVWUDXFàMXPLHPYDLDQWLNRDJXODQWXWHUDSLMXWRVWDUSOLHOXKHSDUñQDGHYXQHSLHFLHđDPVYDLUÌNODLNDSLOQñJDLUHFàđDQDL6HUXPXL]PDQWRNÌSDUDXJXPDWHULÌOXNOñQLVNLõñPLVNDMRVXQLPXQRORçLVNDMRVUXWñQDVWHVWRVNÌDUñVHURORçLMÌ

SARSTEDT S-Monovette® Neutral Z
S-Monovette®1HXWUDO=QHVDWXUQHNÌGXVSUHSDUÌWXVNDVDWELOVWGDELVNDLDVLQVSDUDXJDNRDJXOÌFLMDLEH]NRDJXOÌFLMDVDNWLYDWRUDXQWLHNL]PDQWRWVVHUXPDLHJğđDQDL &HQWULIXJàđDQDDWGDODDVLQVUHFHNùXVXQVHUXPX6HUXPVWLHNL]PDQWRWVNÌSDUDXJDPDWHULÌOVOLHWRWÌMDPVSHFLILVNLHPWHVWLHP7XUNOÌWđR60RQRYHWWH®1HXWUDO=YDUL]PDQWRWDUñNÌWXNđXWUDXNXMDDVLQLVWLHNÿHPWDVDU60RQRYHWWH®&LWUÌWX NRDJXOÌFLMDVWHVWL NRPELQÌFLMÌDU 'URđñEDV 0XOWLIO\®NDQXOX VSÌUQRWÌNDQXOD 60RQRYHWWH® Neutral Z
L]PDQWRNÌSLUPRWUDXNX WXNđRWUDXNX ODLDL]SLOGñWX 'URđñEDV 0XOWLIO\® kanulu.

SARSTEDT S-Monovette®OLWLMDKHSDUñQV/+OLWLMDKHSDUñQDJHOV/+OLWLMDKHSDUñQDJHOV+/+QÌWULMDKHSDUñQV1+DPRQLMDKHSDUñQV$+S-Monovette®/LWLMDKHSDUñQV/+1ÌWULMDKHSDUñQV1+$PRQLMDKHSDUñQV$+VDWXUDQWLNRDJXODQWX DQWLNRDJXODQWX OLWLMDKHSDUñQXQÌWULMDKHSDUñQXDPRQLMDKHSDUñQX SDUDVWL69KHSDUñQDPODVLÿX SÌUNOÌWDVSODVWPDVDVJUDQXODVXQL]PDQWRODLVDYÌNWXDVLQLVXQSOD]PX 3ODVWPDVDVJUDQXOÌWXFHQWULIXJàVWDUSDVLQVđğQÌPXQSOD]PXS-Monovette®/LWLMDKHSDUñQD/+EH]SODVWPDVDVJUDQXOÌPDQWLNRDJXODQWVOLWLMDKHSDUñQVLUL]VPLG]LQÌPÌYHLGÌ SDUDVWL69KHSDUñQDPODVLÿX 
3DSLOGXVSODVWPDVDVJUDQXOÌPNDVSÌUNOÌWDVDUDQWLNRDJXODQWXOLWLMDKHSDUñQX SDUDVWL69KHSDUñQDPODVLÿX 60RQRYHWWH®OLWLMDKHSDUñQDJHOV/+VDWXUJHOXX]SROLPàUDEÌ]HVXQWLHNL]PDQWRWVODLVDYÌNWXSOD]PX &HQWULIXJàMRWJHOVQRVàĭDVVWDUSDVLQVđğQÌPXQSOD]PXXQYHLGRVWDELOXDWGDORđRVOÌQLWUDQVSRUWàđDQDVX]JODEÌđDQDVXQDQDOñ]HVODLNÌ
S-Monovette®/LWLMDKHSDUñQDJHOV+/+VDWXUDUñJHOXX]SROLPàUXEÌ]HVNDVVDPD]LQDFHQWULIXJàđDQDVODLNXSDUDSWVDOñG]LQRWDU60RQRYHWWH®/LWLMDKHSDUñQDJHOX+HSDUñQDSOD]PXL]PDQWRNÌSDUDXJXPDWHULÌOXNOñQLVNLõñPLVNDMRVXQLPXQRORçLVNDMRVUXWñQDVSàWñMXPRV+HSDUñQDSLOQDVDVLQLVL]PDQWRNÌSDUDXJXPDWHULÌOXLNGLHQDVLPXQRORçLVNDMRVWHVWRVXQVHURORçLMÌ+HSDUñQVLQKLEàNRDJXOÌFLMXDNWLYL]àMRWDQWLWURPEñQX125h'-8061R60RQRYHWWH®/LWLMDKHSDUñQD/+OLWLMDKHSDUñQDJHODJHOD+ QHGUñNVWYHLNWOLWLMDQRWHLNđDQXQR60RQRYHWWH®1ÌWULMDKHSDUñQD1+QHGUñNVWYHLNWQÌWULMDQRWHLNđDQXXQQRS-Monovette ®$PRQLMDKHSDUñQD$+QHGUñNVWYHLNWDPRQLMDQRWHLNđDQX60RQRYHWWH®/LWLMDKHSDUñQD/LWLMDKHSDUñQDJHOVJHOV+1ÌWULMDKHSDUñQV$PRQLMDKHSDUñQVNDVSLOGñWVDUYHQR]DMÌPDVLQñPQDYSLHPàURWVDVLQVJÌ]XDQDOñ]HL

SARSTEDT S-Monovette®0HWÌODDQDOñ]HS-Monovette®PHWÌOXDQDOñ]HVDWXUDQWLNRDJXODQWXOLWLMDKHSDUñQXXQWRL]PDQWRDVLÿXXQSOD]PDVVDYÌNđDQDL /LWLMDKHSDUñQVLUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ 69KHSDUñQDPODVLÿX +HSDUñQDSLOQDVLQLVYDLKHSDUñQDSOD]PXQR60RQRYHWWH®PHWÌODDQDOñ]HVNRPELQÌFLMÌDUVSHFLÌORGURđñEDVNDQXOX*[Ź $UW1U L]PDQWRNÌSDUDXJXPDWHULÌOXPLNURHOHPHQWXPHWÌOXL]PHNOàMXPLHP
0LNURHOHPHQWLPHWÌOLWLNDDSVWLSULQÌWLL]PDQWRMRWDWRPXDEVRUEFLMDVVSHNWURPHWULMX $$6 6LVWàPDVGURđñEDVNDQXODLXQ60RQRYHWWH®PHWÌODDQDOñ]HLđLHPPLNURHOHPHQWLHPWLHNLHJğWDVđÌGDVPDNVLPÌOÌVWXNđÌV
YàUWñEDVQJVLVWàPÌElements

TI

Cd

Ni

Cr

Pb

Fe

Cu

QJVLVWàPD

2,5

1,5

8,0

5,0

5

50

70

Zn

Mn

Al

Se

Hg

70

10

40

10

10

0DNVLPÌOÌVWXNđÌVYàUWñEDVLUQRUÌGñWDVNDWUDP60RQRYHWWH HWLõHWHVHOHPHQWDP
®

0LNURHOHPHQWXSLHOÌJRđDQDWLHNYHLNWDDWNDUñEÌQRDQDOñ]HVPHWRGHVQRKHSDUñQDSLOQDVLQñPYDLKHSDUñQDSOD]PDV+HSDUñQVLQKLEàNRDJXOÌFLMXDNWLYL]àMRWDQWLWURPEñQXSARSTEDT S-Monovette®&LWUÌWV1&
S-Monovette®&LWUÌWD1&VDWXUDQWLNRDJXODQWXWULQÌWULMDFLWUÌWXXQWRL]PDQWRDVLÿXXQSOD]PDVVDYÌNđDQDL 7UñQÌWULMDFLWUÌWVLUSLHHMDPVNÌPROÌUDLVđõñGXPV WULQÌWULMDFLWUÌWDđõñGXPVELHĭLQRDSDùRWVOñG]
3,2%), un tas ir 10% no S-Monovette®&LWUDWQRPLQÌOÌWLOSXPD&LWUÌWDVDMDXNđDQDVDWWLHFñEDSUHWDVLQñPLUşWLOSXPDGDùDFLWUÌWDXQWLOSXPDGDùDVDVLÿX3DUHL]DSLOGñđDQDLUDEVROğWLQHSLHFLHđDPDDQDOñ]HL&LWUÌWDSOD]PDWLHNL]PDQWRWDNÌSDUDXJDPDWHULÌOVNÌUWàMRVKHPRVWÌ]HVL]PHNOàMXPRV.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDUFLWUÌWX/ğG]XÿHPLHWYàUÌ125h'-8086VDGDùÌSDUSDUDXJXÿHPđDQXXQDSVWUÌGL60RQRYHWWH®&LWUÌWDXQVSÌUQRWXNDQXOXNRPELQÌFLMDLSARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&VDWXUDQWLNRDJXODQWXWULQÌWULMDFLWUÌWXSLOQDVLÿXXQSOD]PDVVDYÌNđDQDL 7UñQÌWULMDFLWUÌWVLUSLHHMDPVNÌPROÌUXEXIHUđõñGXPV EXIHUàWVS+ XQWDVLUQR60RQRYHWWH® PFAQRPLQÌOÌWLOSXPD&LWUÌWDVDMDXNđDQDVDWWLHFñEDSUHWDVLQñPLUşWLOSXPDGDùDFLWUÌWDXQWLOSXPDGDùDVDVLÿX3DUHL]DSLOGñđDQDLUDEVROğWLQHSLHFLHđDPDDQDOñ]HL
Pilnasinis no S-Monovette®3)$1&WLHNL]PDQWRWDVNÌSDUDXJDPDWHULÌOVWURPERFñWXIXQNFLMDVQRWHLNđDQDLDU6,(0(16+HDOWKLQHHUV3)$DQDOL]DWRUXXQWDVLUDSVWLSULQÌWVđLPQROğNDP.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDUFLWUÌWX/ğG]XÿHPLHWYàUÌ125h'-8086VDGDùÌSDUSDUDXJXÿHPđDQXXQDSVWUÌGL60RQRYHWWH®3)$XQVSÌUQRWXNDQXOXNRPELQÌFLMDLSARSTEDT S-Monovette® CTAD
S-Monovette®&7$'VDWXUDQWLNRDJXODQWXWULQÌWULMDFLWUÌWXNÌDUñWHRILOñQXDGHQR]ñQXXQGLSLULGDPROXXQWRL]PDQWRDVLÿXXQSOD]PDVVDYÌNđDQDL &7$'LUSLHHMDPVNÌđõñGXPVXQWDVLUQR60RQRYHWWH® CTAD
QRPLQÌOÌWLOSXPD&7$'VDMDXNđDQDVDWWLHFñEDSUHWDVLQñPLUşWLOSXPDGDùD&7$'XQWLOSXPDGDùDVDVLÿX3DUHL]DSLOGñđDQDLUDEVROğWLQHSLHFLHđDPDDQDOñ]HL
&7$'SOD]PDWLHNL]PDQWRWDNÌSDUDXJDPDWHULÌOVWURPERFñWXIDNWRUD 3) EHWD Ĕ WURPERJOREXOñQD Ĕ7* XQSOD]PLQRJàQDDNWLYDWRUDLQKLELWRUD 3$, QRWHLNđDQDLNÌDUñNÌUWàMLHPKHPRVWÌ]HVL]PHNOàMXPLHP
7URPERFñWXDNWLYÌFLMDWLHNNDYàWDYLVPD]VWXQGDVXQWLHNL]PDQWRWDODLX]UDXG]ñWXKHSDUñQDWHUDSLMX.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDUFLWUÌWX/ğG]XÿHPLHWYàUÌ125h'-8086VDGDùÌSDUSDUDXJXÿHPđDQXXQDSVWUÌGL60RQRYHWWH®&7$'XQVSÌUQRWXNDQXOXNRPELQÌFLMDL
125h'-806&7$'LUG]HOWHQV60RQRYHWWH®&7$'X]JODEÌđDQDVODLNÌLUMÌDL]VDUJÌQRPÌNVOñJDVXQGDELVNDVJDLVPDV8]WXUàđDQDJDLVPÌLOJÌNSDUVWXQGÌPYDUGHDNWLYL]àWSLHGHYDVSARSTEDT S-Monovette® EDTA K2E / K3E
S-Monovette® EDTA K2E / S-Monovette®('7$.(VDWXUDQWLNRDJXODQWX.('7$YDL.('7$XQWRL]PDQWRSLOQDVLÿXVDYÌNđDQDL .('7$YDL.('7$LUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ PJ('7$PODVLÿX ('7$SLOQDVLQLVL]PDQWRNÌSDUDXJXPDWHULÌOXKHPDWRORçLVNDMLHPL]PHNOàMXPLHP$VLQVX]WULHSHVMÌQRÿHPÕHWUXVWXQGXODLNÌSàFDVLQVVDYÌNđDQDV.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDU('7$SDOñG]ñEXAsinis no S-Monovette®('7$.(.(YDUL]PDQWRWDUñNÌUWàMLHPLPğQKHPDWRORçLMDVXQLQIHNFLMDVVOLPñEXSÌUEDXGàP/LHWRWÌMVLUDWELOGñJVSDUSDUDXJDPDWHULÌODSLHPàURWñEDVDSVWLSULQÌđDQXđLHPWHVWLHPDUDWELOVWRđLHP
WHVWDUHDçHQWLHPDQDOñ]HVLHUñFàPWRVWDUSX]JODEÌđDQDVDSVWÌNùLHP

129

LV
SARSTEDT S-Monovette® EDTA gels K2E
Papildus antikoagulantam K2 EDTA S-Monovette®('7$JHOV.(VDWXUJHOXX]SROLPàUXEÌ]HVXQWLHNL]PDQWRWVSOD]PDVVDYÌNđDQDL .('7$LUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ PJ('7$PODVLÿX &HQWULIXJàMRWJHOVQRVàĭDVVWDUSDVLQVđğQÌPXQSOD]PXXQYHLGRVWDELOXDWGDORđRVOÌQLWUDQVSRUWàđDQDVX]JODEÌđDQDVXQDQDOñ]HVODLNÌ('7$SOD]PXL]PDQWRNÌSDUDXJXPDWHULÌOXPROHNXOÌUDLYñUXVXGLDJQRVWLNDL.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDU('7$SDOñG]ñEX

SARSTEDT S-Monovette®)OXRUñGD('7$)()OXRUñGDKHSDUñQV)+)OXRUñGDFLWUÌWV('7$)&DUJOLNROñ]HVLQKLELWRULHP
S-Monovette®)OXRULGH('7$)(VDWXUDQWLNRDJXODQWX('7$ PJPODVLÿX XQIOXRUX PJPODVLÿX ODLNDYàWXJOLNROñ]LXQWRL]PDQWRSOD]PDVVDYÌNđDQDL )OXRUñGV('7$LUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ
S-Monovette®)OXRUDKHSDUñQV)+VDWXUDQWLNRDJXODQWXKHSDUñQX 69KHSDUñQDPODVLÿX XQIOXRUX PJPODVLÿX ODLNDYàWXJOLNROñ]LXQWRL]PDQWRSOD]PDVVDYÌNđDQDL )OXRUñGVKHSDUñQVLUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ*OLNROñ]HVLQKLEñFLMDWLNDLDUIOXRUXVÌNDVDSWVWXQGDVSàFDVLQVVDYÌNđDQDVWUDXNDSLHSLOGñđDQDVXQSLOQñEÌLHGDUERMDVSàFDSWVWXQGÌP7ÌGàMÌGLJOLNR]HWLHNQRÌUGñWDYLGàMLOñG]SàFGDĭÌPVWXQGÌPXQOñG]
SàFVWXQGÌPSLOQDVLQñVS-Monovette®*OXFR(;$&7)&VDWXUDQWLNRDJXODQWX('7$NÌDUñFLWUÌWXXQIOXRUXWğOñWàMDLJOLNROñ]HVLQKLEÌFLMDLXQWRL]PDQWRSOD]PDVVDYÌNđDQDL ('7$FLWUÌWVXQIOXRUñGVLUSLHHMDPLNÌđõñGXPV/DLDSUàõLQÌWXJOLNR]HVNRQFHQWUÌFLMXDWđõDLGñđDQDVGàùWDVMÌUHL]LQDDU
S-Monovette®*OXFR(;$&7)&DWELOVW9ÌFLMDV'LDEàWDELHGUñEDV ''* JHVWÌFLMDVGLDEàWDYDGOñQLMÌPXQWLSDGLDEàWDYDOVWVSLHJÌGHVYDGOñQLMÌP 19/ 7ğOñWàMDJOLNR]HVNRQFHQWUÌFLMDVVWDELOL]ÌFLMDWLHNX]WXUàWDOñG]
VWXQGÌPSLOQDVLQñVLVWDEDVWHPSHUDWğUÌVNDWLHWDUñ6$567('7:KLWH3DSHU https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter//LWHUDWğUD6DUVWHGW60RQRYHWWH® GlucoEXACT A bloodcollection device for stabilizing glucose levels for 96 hours“.
)OXRUñGD('7$ FLWUÌWD SOD]PDWLHNL]PDQWRWDNÌSDUDXJDPDWHULÌOVJOLNR]HVQRWHLNđDQDL.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDU('7$SDOñG]ñEX125h'-806)OXRUñGVYDUL]UDLVñWKHPROñ]HVSDVWLSULQÌđDQRV3DSLOGXLQIRUPÌFLMDSDUYLHOÌPNXUÌPYDUEğWWUDXFàMRđDLHWHNPHSLHHMDPDDWWLHFñJDMÌWHVWDUHDçHQWXUDĭRWÌMDOLHWRđDQDVLQVWUXNFLMÌ/ğG]XÿHPLHWYàUÌ125h'-8086VDGDùÌSDUSDUDXJXÿHPđDQXXQDSVWUÌGL60RQRYHWWH®*OXFR(;$&7XQVSÌUQRWXNDQXOXNRPELQÌFLMDLSARSTEDT S-Monovette® CPDA
S-Monovette®&3'$VDWXUDQWLNRDJXODQWXQÌWULMDFLWUÌWXNÌDUñFLWURQVNÌELQÌWULMDIRVIÌWXGHNVWUR]LXQDGHQñQXXQWRL]PDQWRDVLÿXXQSOD]PDVVDYÌNđDQDL &3'$SLHHMDPVNÌđõñGXPV&3'$VDMDXNđDQDVDWWLHFñED
SUHWDVLQñPLUWLOSXPV&3'$XQWLOSXPDGDùDDVLÿX3DUHL]DSLHSLOGñđDQDLUDEVROğWLQHSLHFLHđDPDDQDOñ]HVGàù
&3'$SLOQDVLQLVSOD]PDWLHNL]PDQWRWDNÌSDUDXJDPDWHULÌOVDVLQVJUXSXVHURORçLMDLWUDQVIğ]LMXPHGLFñQÌVDGHUñEDVL]PHNOàMXPLHP VDYVWDUSàMÌVDWELOVWñEDV WUDQVIğ]LMXJDGñMXPÌ.RQNUàWL60RQRYHWWH® CPDA ir
SDUHG]àWVDVLQVJUXSXQRWHLNđDQDL $% WRVWDUS.HOOXQ5à]XVIRUPXODLDQWLYLHOXPHNOàđDQDVWHVWDPQHUHJXOÌUXDVLQVJUXSXDQWLYLHOXQRWHLNđDQDLSROLVSHFLILVNDPWLHđDP.XPEVDWHVWDP OñG]bGLHQDL VDGHUñEDV
WHVWDP VDNULWñED DUDVLQVJUXSXVDGHUñJXSDFLHQWDVHUXPXSOD]PX JDOYHQDLVWHVWV SLHPàURWV
7UDQVSRUWàđDQDVODLNVOñG]X]JODEÌđDQDLLUDSVWLSULQÌWVPDNVLPÌOLVWXQGDVƓ&WHPSHUDWğUÌªğQXVHGLPHQWÌFLMDLSDUDXJLYLVSLUPVMÌX]JODEÌVWÌYXVOHGXVVNDSñYLVPD]VWXQGDV,HSULHNđPLQàWRVDQDOñWXVSàFWDP
YDUQRWHLNWOñG]GLHQÌPWÌGÌSDđÌYHLGÌNÌSDUDVWDMÌDVLQVX]JODEÌđDQDVSHULRGÌSàFX]JODEÌđDQDVOHGXVVNDSñ şƓ&  L]ÿHPRWWLHđR.XPEVDWHVWXGLHQDV 3LHPàURWVNRORQQXDJOXWLQÌFLMDVPHWRGàPSLHPàUDP9LVLRQ0D[QR2UWKR&OLQLFDO'LDJQRVWLFV3DUDXJDPDWHULÌOVQHGUñNVWEğWVDVDOGàWV
3DUSDUDXJDPDWHULÌODSLHPàURWñEXđLHPWHVWLHPDUFLWÌPPHWRGàPWHVWDUHDçHQWLHPDQDOñ]HVLHUñFàPWRVWDUSX]JODEÌđDQDVDSVWÌNùLHPLUDWELOGñJVOLHWRWÌMVXQWDVLUMÌYDOLGàYLÿDPSDđDP.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDUFLWUÌWX/ğG]XÿHPLHWYàUÌ125h'-8086VDGDùÌSDUSDUDXJXÿHPđDQXXQDSVWUÌGL60RQRYHWWH®&3'$XQVSÌUQRWXNDQXOXNRPELQÌFLMDLSARSTEDT S-Monovette® ThromboExact
S-Monovette®7KURPER([DFWVDWXUPDJQLMDVÌOLNÌDQWLNRDJXODQWXXQWRL]PDQWRDVLÿXVDYÌNđDQDL 0DJQLMDVÌOVLUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ
S-Monovette®7KURPER([DFWSLOQDVLQLVWLHNL]PDQWRWDVNÌSDUDXJDPDWHULÌOVODLL]VOàJWXYLOWXV]HPXWURPERFñWXVNDLWXDQWLNRDJXODQWX SLHPàUDP('7$FLWUÌWDKHSDUñQD QHSDQHVñEDVGàùNRVDXFDUñSDU
SVHLGRWURPERFLWRSàQLMX7LHNQRYàUVWDWURPERFñWXDJUHJÌWXYHLGRđDQÌVXQIDNWLVNRWURPERFñWXVNDLWXYDUQRWHLNWOñG]VWXQGÌPSàFDVLQVVDYÌNđDQDV.RDJXOÌFLMDVNDYàđDQDQRWLHNFDXUPDJQLMDMRQLHPNXURVPDJQLMDMRQLLQKLEàWURPERFñWXWURPERNVÌQX$XQWURPERFñWXDJUHJÌFLMXNRPHGLà$'3XQDUDKLGRQVNÌEH

SARSTEDT S-Monovette®+LUXGñQVS-Monovette®+LUXGñQVVDWXUDQWLNRDJXODQWXKLUXGñQXXQWRL]PDQWRDVLÿXVDYÌNđDQD +LGXUñQVLUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ+LUXGñQDSLOQDVLQLVWLHNL]PDQWRWDVNÌSDUDXJDPDWHULÌOVWURPERFñWXIXQNFLMDVQRWHLNđDQDLLHUñFà52&+('LDJQRVWLFV0XOWLSODWH® YDLUÌNXWURPERFñWXIXQNFLMXDQDOL]DWRUV XQWDVLUDSVWLSULQÌWVđLPQROğNDP7ROLHWR
DQWLWURPERFñWX]ÌùXWHUDSLMDVNRQWUROHLXQWURPERFñWXGLVIXQNFLMDVQRWHLNđDQDLYDLL]VOàJđDQDLS-Monovette®+LUXGñQVWLNDñSDđLL]VWUÌGÌWVWURPERFñWXIXQNFLMDVQRWHLNđDQDLNRSÌDU9HUXP'LDJQRVWLFDWDJDG52&+('LDJQRVWLFV0XOWLSODWH®LHUñFà.RDJXOÌFLMDVLQKLEñFLMDQRWLHNDUKLUXGñQDVWDUSQLHFñEXWLHđLLQKLEàMRWWURPEñQXXQWÌGàMÌGLùDXMYHLNWWURPERFñWXIXQNFLMDVGLDJQRVWLNXVÌNRWQàMÌVWÌYRNOñSARSTEDT S-Monovette®+RPRFLVWHñQD+&<=JHOV+&<&
3DSLOGXVSODVWPDVDVJUDQXOÌPNDVSÌUNOÌWDVDUNRDJXOÌFLMDVDNWLYDWRUX VLOLNÌWX 60RQRYHWWH®+RPRFLVWHñQD+&<=JHOVVDWXUñSDđXVWDELOL]DWRUXXQJHOXX]SROLPàUDEÌ]HVXQWRL]PDQWRVHUXPDVDYÌNđDQDL *HOV
WLHNFHQWULIXJàWVVWDUSDVLQVUHFHNOLXQVHUXPXXQYHLGRVWDELOXDWGDORđRVOÌQLWUDQVSRUWàđDQDVX]JODEÌđDQDVXQDQDOñ]HVODLNÌ3UHSDUÌWVLUSLHHMDPVL]VPLG]LQÌPÌYHLGÌ+RPRFLVWHñQVVWDELOL]àMDVSLOQDVLQñVLVWDEDVWHPSHUDWğUÌOñG]VWXQGÌP-DFHQWULIXJàđDQDQRWLHNSLUPRVWXQGXODLNÌDUSDUHL]LL]YHLGRWXDWGDORđRVOÌQLVWDUSDVLQVUHFHNOLXQVHUXPXKRPRFLVWHñQVVWDELOL]àMDVOñG]
VWXQGÌP
Serums no S-Monovette®+RPRFLVWHñQD+&<=JHODWLHNL]PDQWRWVNÌSDUDXJDPDWHULÌOVKRPRFLVWHñQDQRWHLNđDQDL60RQRYHWWH®+RPRFLVWHñQV+&<&VDWXUVNÌEHVFLWUÌWX S+ NÌDQWLNRDJXODQWXXQWLHNL]PDQWRWVSOD]PDVVDYÌNđDQDL &LWUÌWVLUSLHHMDPVNÌđõñGXPV$WđõDLGñđDQDVGàùODLDSUàõLQÌWXKRPRFLVWHñQDNRQFHQWUÌFLMXMÌUHL]LQDDU+RPRFLVWHñQVVWDELOL]àMDVSLOQDVLQñVOñG]VWXQGÌPLVWDEDVWHPSHUDWğUÌXQOñG]VWXQGÌPƓ&WHPSHUDWğUÌ
S-Monovette®+RPRFLVWHñQD+&<&SOD]PDWLHNL]PDQWRWDNÌSDUDXJDPDWHULÌOVKRPRFLVWHñQDQRWHLNđDQDLS-Monovette®+RPRFLVWHñQD+&<&NRDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDUFLWUÌWX/ğG]XÿHPLHWYàUÌ125h'-8086VDGDùÌSDUSDUDXJXÿHPđDQXXQDSVWUÌGL60RQRYHWWH®+&<&XQVSÌUQRWXNDQXOXNRPELQÌFLMDLSARSTEDT S-Monovette® DNA Exact
S-Monovette®'1$([DFWVDWXUX]('7$EDOVWñWXDQWLNRDJXODQWXXQWRL]PDQWRDVLÿXVDYÌNđDQDL ('7$SLHHMDPVDHURVRODYHLGÌ('7$SLOQDVDVLQLVL]PDQWRNÌSDUDXJXPDWHULÌOXODLVWDELOL]àWXJ'16*'16VWDELOL]ÌFLMDVYHLNWVSàMDLUDSVWLSULQÌWDGLHQDVƓ&WHPSHUDWğUÌGLHQDVLVWDEDVWHPSHUDWğUÌ Ɠ& GLHQDVG]HVàđDQDVODLNÌ Ɠ& 
XQYLVPD]JDGVƓ&WHPSHUDWğUÌ7XUNOÌWVWDELOL]àWLHSDUDXJLL]WXUVDVDOGàđDQDVXQDWNDXVàđDQDVFLNOXVQH]DXGàMRWNYDOLWÌWLVNDWLHWDUñ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/
venous-blood/s -monovetter/<2 }/LWHUDWğUDŗ6$567('760RQRYHWWH® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
.RDJXOÌFLMDVNDYàđDQDQRWLHNNDOFLMDMRQXNRPSOHNVÌDU('7$SDOñG]ñEX

3DUDXJDPDWHULÌODSLHPàURWñEDLUDWNDUñJDQRDQDOL]àMDPÌVYLHODVXQWHVWDUHDçHQWDDQDOL]DWRUD-ÌLHYàURDWWLHFñJLHUDĭRWÌMDLHWHLNXPL

130

LV
'URđñEDVQRUÌGñMXPLEUñGLQÌMXPL
1.

9LVSÌUñJLHSLHVDUG]ñEDVSDVÌNXPL,]PDQWRMLHWFLPGXVXQFLWXVYLVSÌUñJXVLQGLYLGXÌORVDL]VDUG]ñEDVOñG]HNùXVODLDL]VDUJÌWXSUHWDVLQñPXQLHVSàMDPXVDVNDULDUSRWHQFLÌOLLQIHNFLR]LHPSDUDXJLHPXQLQIHNFLMDVL]UDLVñWÌMLHP2.

$UYLVLHPELRORçLVNDMLHPSDUDXJLHPXQDVLHPVPDLOLHPDVLQVSDUDXJXÿHPđDQDVSLHGHUXPLHP NDQXODVSÌUYHLGRWÌML UñNRMLHWLHVDWELOVWRđLNRQNUàWÌVLHVWÌGHVYDGOñQLMÌPXQSURFHGğUÌP7LHđLVDVNDURWLHVDUELRORçLVNLHPSDUDXJLHPYDLGXUWDVEUğFHVJDGñMXPÌYàUVLHWLHVSLHÌUVWDMRWÌYDUWLNWSÌUQHVWDV+,9+&9+%9YDLFLWDVLQIHNFLMDVVOLPñEDV,]PDQWRMLHWGURđñEDVNDQXODV6DIHW\0XOWLĲ\®NDQXODVDULHEğYàWXDGDWDVDL]VDUG]ñEX,HYàURMLHWMğVXLHVWÌGHVGURđñEDVYDGOñQLMDVXQPHWRGLNX

3.

$WWLHFDVX]DWVHYLđõLHPVWHULOLHPLHSDNRWLHPL]VWUÌGÌMXPLHP3LUPVOLHWRđDQDVSÌUEDXGLHWYDLNDWUDPDWVHYLđõDMDPLHSDNRMXPDPQDYERMÌMXPXXQQHOLHWRMLHWERMÌMXPXJDGñMXPÌ

4.

,]VWUÌGÌMXPVSDUHG]àWVYLHQUHL]àMDLOLHWRđDQDL,]PHWLHWYLVXVDVRVDVLQVVDYÌNđDQDVSULHNđPHWXV DGDWDVDGDSWHUXV DWELOVWRđRVELRORçLVNÌVEñVWDPñEDVDWNULWXPXNRQWHLQHURV

5.

-DDVLQLVWLHNÿHPWDVFDXULQWUDYHQR]X ,9 SLHHMXSLUPVDVLÿXÿHPđDQDVMÌQRGURđLQDNDSLHNùXYHLUSDUHL]LL]VNDORWD L]WñUñWDQR,9đõñGXPD DWELOVWRđLLHVWÌGHVYDGOñQLMÌP3DUHL]DSLHNùXYHVVNDORđDQDùDXML]YDLUñWLHVQRQHSDUHL]LHPDQDOñ]HVUH]XOWÌWLHP

6.

Nepietiekama S-Monovette®X]SLOGñđDQDL]UDLVDQHSDUHL]XDVLÿXDWWLHFñEXSUHWSUHSDUÌWXSLHGHYXXQYDUQRYHVWSLHQHSDUHL]LHPDQDOñ]HVUH]XOWÌWLHP7.

$VLQLVNDVÿHPWDVXQDSVWUÌGÌWDVDU60RQRYHWWH®QDYSDUHG]àWDVDWNÌUWRWDLLHYDGñđDQDLFLOYàNDõHUPHQñ

8.

,]VWUÌGÌMXPXQHGUñNVWOLHWRWSàFGHUñJXPDWHUPLÿDEHLJÌP'HUñJXPDWHUPLÿđEHLG]DVQRUÌGñWÌJDGDPàQHđDSàGàMÌGLHQÌ8]JODEÌđDQD
/ñG]OLHWRđDQDLL]VWUÌGÌMXPVMÌX]JODEÌLVWDEDVWHPSHUDWğUÌ,HUREHĭRMXPL
1.

8]SLOGñWÌV60RQRYHWWH®X]JODEÌđDQDVODLNVXQWHPSHUDWğUDLUDWNDUñJDQRSÌUEDXGÌPRDQDOñWXJODEÌđDQDVODLND1RYàUWàMXPXYHLFODERUDWRULMDYDLLQIRUPÌFLMDWLHNÿHPWDQRWHVWDUHDçHQWDDQDOñ]HVLHUñFHVUDĭRWÌMD
lietošanas instrukcijas.

2.

3DWMDSOD]PXYDLVHUXPXDWGDODFHQWULIXJàMRW60RQRYHWWH®XQYDLLUEDUMHUDQHYLVDVđğQDVLUREOLJÌWLSLOQñEÌDWGDOñWDV$WOLNXđDLVPHWDEROLVPVYDLGDELVNDQRÌUGñđDQÌVYDULHWHNPàWDQDOL]àMDPRYLHOXNRQFHQWUÌFLMX$QDOñWLVNRYLHOXVWDELOLWÌWHMÌQRYàUWàDWWLHFñEÌX]X]JODEÌđDQDVWYHUWQàPXQODERUDWRULMDVDSVWÌNùLHP

3.

7HUDSHLWLVNRPHGLNDPHQWXJDGñMXPÌSDUDXJDPDWHULÌODSLHPàURWñEDMÌSÌUEDXGDWHVWDUHDçHQWXDQDOñ]HVLHUñFHVUDĭRWÌMDOLHWRđDQDVLQVWUXNFLMÌ

4.

0LNURHOHPHQWXPHWÌOXDQDOñ]HVMÌYHLFDU60RQRYHWWH®PHWÌODDQDOñ]L 6DIHW\ NDQXOXPHWÌODDQDOñ]L3DUDXJXSDÿHPđDQDXQDSVWUÌGH
3,5069|18$6,83$(0ª$1$66h.ª$1$63,/1%h,=/$6,(7ª2'2.80(178
3DUDXJXSDÿHPđDQDLQHSLHFLHđDPLHPDWHULÌOL
1.

9LVDVQHSLHFLHđDPÌV60RQRYHWWH®DVLQVVDYÌNđDQDVVLVWàPDV

2.

'URđñEDV NDQXOÌPYDL 'URđñEDV 0XOWLĲ\®NDQXOÌP

3.

&LPGLKDOÌWLDFXDL]VDUG]ñEDVOñG]HNùLYDLFLWVSLHPàURWVDL]VDUJDSçàUEVDL]VDUG]ñEDLSUHWDVLQñVHVRđLHPSDWRJàQLHPYDLSRWHQFLÌOLLQIHNFLR]LHPPDWHULÌOLHP

4.

(WLõHWHVSDFLHQWDLGHQWLıNÌFLMDL

5.

'H]LQıFàMRđVPDWHULÌOVSDUDXJXSDÿHPđDQDVYLHWDVWñUñđDQDL VDJDWDYRMRWSDUDXJXSDÿHPđDQDVYLHWXLHYàURMLHWLHVWÌGHVQRUÌGñMXPXVSDUVWHULOXSDUDXJXÿHPđDQX 1HOLHWRMLHWVSLUWXVDWXURđXVWñUñđDQDVPDWHULÌOXVMDSDUDXJXVSDUHG]àWVL]PDQWRWDONRKRODSÌUEDXGHLDVLQñV6.

6DXVLYLHQUHL]àMÌVOLHWRđDQDVWDPSRQLDU]HPXEDNWàULMXVNDLWX

7.

ÅÿDXJV

8.

3OÌNVWHULVYDLSÌUVàMV

9.

$WNULWXPXWYHUWQHDVLHPVPDLOLHPSULHNđPHWLHPODLGURđLXWLOL]àWXL]OLHWRWRPDWHULÌOX,HWHLFDPÌSDUDXJXSDÿHPđDQDVVHFñED1.

$VLQVNXOWğUDVSXGHOHV

2.

7UDXNLDUFLWUÌWXYDLNRDJXOÌFLMDVDNWLYDWRUX DUEH]JHODVHUXPD&$7VHUXPDJHOD&$7 

3.

7UDXNLDUUHFHNùXDNWLYDWRUXYDLFLWUÌWX

4.

7UDXNLDUKHSDUñQXDUEH]JHOD

5.

Trauki ar EDTA ar/bez gela

6.

7UDXNLDUJOLNROñ]HVLQKLELWRULHP

7.

7UDXNLDUFLWÌPSLHGHYÌP
125h'-806

-DFLWUÌWDWUDXNXYDLFLWXWUDXNXDUđõLGUXSUHSDUÌWXSLHPàUDP3)$&7$'&3'$+&<&YDL*OXFR(;$&7OLHWRNRSÌDUVSÌUQRWXNDQXOX SLHPàUDP 6DIHW\ 0XOWLĲ\® kanulu),
LULHWHLFDPVLHSULHNđL]ÿHPWWXNđXWUDXNX SLHPàUDP60RQRYHWWH®1HXWUDO= ODLQHSLHùDXWXNDWUDXNVLUQHSLHWLHNDPLSLHSLOGñWVODLL]YDLUñWRVQRVSÌUQRWÌVNDQXODVFDXUXOHVSLHSLOGñđDQDV
7DVQRGURđLQDNDWUDXNVLUSDUHL]LSLHSLOGñWVXQVDMDXNđDQDVDWWLHFñED đõLGUXPVSUHWDVLQñP LUSDUHL]D

3,(=0( 3DUHL]DLL]ÿHPđDQDVNÌUWñEDLLHYàURMLHWLHVWÌGHVQRWHLNXPXV,]YDLULHWLHVQRSUHWSOğVPDV
/LHOÌNÌGDùD60RQRYHWWHVDWXUõñPLVNDVSLHGHYDV/DLQRYàUVWXDWWHFLMÌLHYàURđÌGLQRUÌGñMXPL
1. ,]PDQWRMLHWWLNDLWRVPDWHULÌOXVNDVLHWHLNWLOLHWRđDQDVLQVWUXNFLMÌV
2.

1RYLHWRMLHWSDFLHQWXWÌODLYDUàWXYLHQNÌUđLSLHNùğWYàQDLXQYàUVLHWSDFLHQWDURNXYDLFLWXSXQNFLMDV]RQXX]OHMX

3.

Turiet S-Monovette®DUVNUğYàMDPRYÌFLÿXX]DXJđXXQMDL]PDQWRMDW 6DIHW\ 0XOWLĲ\®NDQXOXWXULHWWRDUñ]HPURNDVOñPHÿDSXQNFLMDV]RQDV

4.

-ÌQRGURđLQDODL60RQRYHWWH®VDWXUVYHQLSXQNWğUDVODLNÌQHSLHVNDUWRVVNUğYHVYÌFLÿDPXQNDQXODVJDODP

5.

$WEUñYRMLHWĭÿDXJXNDPàUDVLQLVLHSOğVW60RQRYHWWH®.

131

LV
6DVDOGàđDQDDWNDXVàđDQD
6DVNDÿÌDU392LHWHLNXPLHP :+2',//DE5HY SLUPVVDVDOGàđDQDVLHWHLFDPVDWGDOñWVHUXPXSOD]PXQRDVLQVđğQÌPUz S-Monovette®DWWLHFDVđÌGLLHVDOGàđDQDVLHWHLNXPL
6DVDOGàđDQD]HPƓ&•/LHWRđDQDWHPSHUDWğUÌNDV]HPÌNDSDUQXOOLYLHQPàUMÌSÌUEDXGDUHÌORVDSVWÌNùRVMRWUDXNXVORG]HYDUEğWùRWLDWđõLUñJDDWNDUñEÌQRVDVDOGàđDQDVYLGHVXQLNGLHQDVDSVWÌNùLHP 6NDWLHWQRGDùXSDUPDWHULÌOXñSDđñEÌP
6$567('7NDWDORJÌ•%ğWñEÌSODVWPDVDVL]WXUñEDVYàUWñEDVWLHNVDPD]LQÌWDVWHPSHUDWğUDVGLDSD]RQÌ]HPbƓ&7ÌSàFSDUDVWLMÌL]YDLUÌVQRPHKÌQLVNÌPVORG]àP•

6DVDOđDQDVDSVWÌNùLMÌL]YàODVWÌODL60RQRYHWWH®VDWXUVYLHQPàUñJLVDVDOWXYDLVDVDOWXQRDSDNđDVX]DXJđX60RQRYHWWH®VWDWñYÌYDLJODEÌđDQDVNDVWàMÌEğWSLHWLHNDPLGDXG]EUñYDLYLHWDLODLWÌYDUàWXSDSODđLQÌWLHV3XWXSROLVWLURODYDLPHWÌODVWDWñYLQDYSLHPàURWLMRWLHYDUL]UDLVñWL]SOHđDQÌVSODLVDV6DVDOGàđDQDOñG]Ɠ&ş3LUPVVDVDOGàđDQDVSÌUEDXGLHW
•7UDXFàMXPL3ÌUEDXGLHWYDLVDVDOGàđDQDQHLHWHNPàDVLQVSDUDXJXYDLDQDOñ]L SLHPàUDPKHPROñ]LDQDOL]àMDPRYLHOXVWDELOLWÌWL •&HQWULIXJàđDQD1HSLHFLHđDPDDWNDUñEÌQRSOÌQRWÌVDQDOñ]HV,HYàURMLHWFHQWULIXJàđDQDVQRVDFñMXPXVVNDWLHWđRGRNXPHQWXVDGDùÌ&HQWULIXJàđDQDYDL6$567('7WñPHNùDYLHWQàhttps://www.sarstedt.com/en/
service/centrifugation/XQYHLFLHWYL]XÌOXSDUDXJDSÌUEDXGL•+HPROñ]H3LOQYàUWñJÌPDVLQñPQRWLHNKHPROñ]HNDGVDVDOXđDV/DLQRWÌVL]YDLUñWRVYDLQX60RQRYHWWH®JHOVYDLSàFFHQWULIXJàđDQDV6HUDSODV®YÌUVWDıOWUVYDLDUñSDUDXJVDUSLSHWLMÌLHYLHWRVHNXQGÌUDMÌWUDXNÌ

6DVDOGàđDQDOñG]Ɠ&3URFHGğUD•$WG]HVàđDQD$WG]HVàMLHW60RQRYHWWH®YHUWLNÌOLPLQğWHVQR57OñG]Ɠ&SLUPVWRYDUVDVDOGàWƓ&WHPSHUDWğUÌ•$WNDXVàđDQD$WNDXVàDWVWÌMRWLVWDEDVWHPSHUDWğUÌYLVPD]PLQğWHVªHLWMÌL]YDLUÌVDUñQRPHKÌQLVNÌPVORG]àP3ÌUÌNÌWUDDWNDXVàđDQDYDUSDVOLNWLQÌWDQDOñ]HVUH]XOWÌWXV

6DVDOGàđDQDXQG]LùDVDVDOGàđDQD]HPƓ&•5DĭRWÌMVQDYSÌUEDXGñMLVVDVDOGàđDQX]HPÌNÌWHPSHUDWğUÌSDUbƓ&'DXG]XLHVSàMDPRLHWHNPHVIDNWRUXGàùLHWHLFDPVYHLNWVDVDOGàđDQDVWHVWXVODERUDWRULMDVSDUDVWDMRVDSVWÌNùRV

S-Monovette ®JHODVDVDOGàđDQD•

6DVDOGàđDQXYHLFNÌDSUDNVWñWVVDGDùÌ6DVDOGàđDQDOñG]Ɠ&

•,U]LQÌPVNDVDVDOGàđDQDVSURFHVDUH]XOWÌWÌJHODVOÌQLVYDUPDLQñWLHV•'DXG]XLHVSàMDPRLHWHNPHVIDNWRUXGàùLHWHLFDPVYHLNWVDVDOGàđDQDVWHVWXVODERUDWRULMDVSDUDVWDMRVDSVWÌNùRV•$WNDXVàđDQD3DUDXJXDWNDXVàYHUWLNÌOÌVWÌYRNOñ3àFDWNDXVàđDQDVSDUDXJDPDWHULÌOXQRSULPÌUÌWUDXNDSÌUQHVVHNXQGÌUDMÌWUDXNÌSLSHWàMRW QHYLVGHNDQWàMRW OñG]DSWXYHQLPPYLUVJHODVOÌÿD3ÌUàMRL]PHVW
125h'-806/DLQRGURđLQÌWXDQDOñWXVWDELOLWÌWLMÌLHYàURWHVWDUHDçHQWDDQDOL]DWRUDUDĭRWÌMDOLHWRđDQDVLQVWUXNFLMDV

132

LV
$VLQVÿHPđDQD
3DUDXJXSDÿHPđDQDVPHWRGHV,UGLYDVSDÿHPđDQDVPHWRGHVDVSLUÌFLMDVWHKQLNDXQYDNXXPDWHKQLND$VSLUÌFLMDVWHKQLNDQRGURđLQDVDXG]ñJXDVLÿXVDYÌNđDQXDUQHSÌUWUDXNWXOàQXDVLQVSOğVPXNRQWUROàWLYHONRWYLU]XùDVWLHQL7ÌGÌYHLGÌDVLQVSOğVPXYDUQHNDYàMRWLHVSLHOÌJRWYLVLHPYàQXVWÌYRNùLHPXQDSVWÌNùLHPNÌDUñ
YDUVDPD]LQÌWKHPROñ]L9DNXXPDWHKQRORçLMDùDXMSDÿHPWDVLQLVQRLHSULHNđHYDNXàWDWUDXNDSàFQHJDWñYDVSLHGLHQDSULQFLSDDUQHSÌUWUDXNWXÌWUXDVLQVSOğVPX7ÌSàFđñPHWRGHLULGHÌOLSLHPàURWDODELHPYàQXVWÌYRNùLHPXQYLHQNÌUđLHP
SDUDXJXSDÿHPđDQDVDSVWÌNùLHP$VLQVÿHPđDQDVDSVWUÌGHVNDWLHWDUñ60RQRYHWWH®DSVWUÌGHVYLGHRNOLSXDVSLUÌFLMDVWHKQLNÌYDLYDNXXPDWHKQLNÌDUGURđñEDVNDQXOXYDL6DIHW\0XOWLIO\® kanulu:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood/$,6$0$=,1h78,('$5%%$65,6.8$6,163$5$8*83$(0ª$1$6/$,.h/,(72-,(7&,0'86
1. Nepieciešamajam paraugam atlasiet atbilstošo S-Monovette®.
2.

,]YàOLHWLHVYHQLSXQNWğUDVYLHWX6DJDWDYRMRWYàQXSXQNFLMDVYLHWXOğG]XLHYàURMLHWLHVWÌGHVQRUÌGñMXPXV$VLQVÿHPđDQDDUDVSLUÌFLMDVWHKQLNX
8]PDQñEX60RQRYHWWH®WLNDLDVLQVÿHPđDQDLQHYLVLQMHNFLMÌP/LHWRMLHWWLNDLDUđñPNDQXOÌP 60RQRYHWWH® GURđñEDV NDQXOÌPYDL GURđñEDV 0XOWLIO\®NDQXOÌPDGDSWHUL60RQRYHWWH®).
/LHWRđDQDDUGURđñEDVNDQXOXLUSDUÌGñWDđHLWNOLNđõLV

7LHđLSLUPVYHQLSXQNWğUDVLHEñGLHW60RQRYHWWH®GURđñEDVNDQXODVLQWHJUàWDMÌWXUàWÌMÌ un nostipriniet to, QHGDXG]SDJULHĭRWSXONVWHÿUÌGñWÌMDNXVWñEDVYLU]LHQÌ .
8]OLHFLHWĭÿDXJXSàFQHSLHFLHđDPñEDV QHYDLUÌNNÌPLQğWL 3XQNFLMDVYLHWXDSVWUÌGÌMLHWDUSLHPàURWXGH]LQIHNFLMDVOñG]HNOL3àFGH]LQIHNFLMDVYDLUÌNQHSLHVNDULHWLHVYàQDVSXQNFLMDVYLHWDL
1RYLHWRMLHWSDFLHQWXWÌODLYDUàWXYLHQNÌUđLSLHNùğWYàQDLXQYàUVLHWSDFLHQWDURNXYDLFLWXSXQNFLMDV]RQXX]OHMX
1RÿHPLHWDGDWDVDL]VDUJX,HGXULHWYàQXOàQÌPDWYHOFLHWYLU]XùDVWLHQLXQDWODLGLHWYHQR]RVDVWUàJXPXNDPàUDVLQLVLHSOğVW60RQRYHWWH® .
3DJDLGLHWOñG]DVLQVSOğVPDDSVWÌMDVSDUHL]DLX]SLOGHL

3ÌUYLHWRMLHW60RQRYHWWH®, nedaudz SDJULHĭRWSUHWàMLSXONVWHÿUÌGñWÌMDYLU]LHQDP XQSàFWDPL]YHONRWWRQRGURđñEDVNDQXODV DWYLHQRMRW  'URđñEDVNDQXODSDOLHNYàQÌ9DLUÌNXSDUDXJXÿHPđDQDVJDGñMXPÌNÌQRUÌGñWVLHSULHNđSLHYLHQRMLHWđÌGDV60RQRYHWWHGURđñEDVNDQXODLXQÿHPLHWSDSLOGXSDUDXJXV$VLQVÿHPđDQDVSDEHLJđDQD9LVSLUPVDWYLHQRMLHW60RQRYHWWH®
+ SàFWDPL]YHOFLHWGURđñEDVNDQXOXQRYàQDV,]PDQWRMRWYLHQDVURNDVWHKQLNXDGDWDVDL]VDUJVYDLQXX]VWDELODVOñG]HQDVYLUVPDVOñG]NDQXODLHVOàG]DVDGDWDVDL]VDUJÌ DNWLYL]àMDV DGDWDVDL]VDUJÌSDPDQÌPXXQG]LUGDPXNOLNđõLYDLDNWLYL]àMLHWQRVSLHĭRWDGDWDVDL]VDUJDDSDNđàMRJDOXDUUÌGñWÌMSLUNVWXVNDWLHWDUñQRUÌGñMXPXVSDU
S-Monovette® GURđñEDV NDQXOXYDL GURđñEDV 0XOWLIO\® kanulu.
7ğOñWSàFDWYLHQRđDQDVQRGURđñEDVNDQXODVYLHQXUHL]LDSJUHL]LHWNDWUX60RQRYHWWH®RWUÌGLXQSàFSLOQYàUWñJDVDVLÿXQRÿHPđDQDVYDLUÌNDVUHL]HVX]PDQñJLYLUSLQLHWYLVXVSDUDXJXVRWUÌGLDUDQWLNRDJXODQWLHP
3ÌUYDGÌđDQDLXQFHQWULIXJàđDQDLYLU]XùDVWLHQLG]LUGDPLLHYLHWRYLU]XùDEORõàđDQDV VWÌYRNOñ YLU]XOLVLHVOàG]DV60RQRYHWWH®SDPDWQà XQQRODXĭYLU]XùD stieni.
1.

1RVSLHGLHWSXQNFLMDVYLHWXDUVDXVXWDPSRQXNXUÌQDYGDXG]EDNWàULMXOñG]DVLÿRđDQDDSVWÌMDV

2.

.DGDVLQLVLUVDUHFàMXđDVX]OLHFLHWSÌUVàMXSàFL]YàOHV3.

,]PHWLHWGURđñEDVNDQXOXDWELOVWRđÌELRORçLVNÌVEñVWDPñEDVDWNULWXPXNRQWHLQHUÌ

133

LV
3DUDXJXÿHPđDQDDUYDNXXPDWHKQLNX
8]PDQñEX60RQRYHWWH®WLNDLDVLQVÿHPđDQDLQHYLVLQMHNFLMÌP/LHWRMLHWWLNDLDUđñPNDQXOÌP 60RQRYHWWH® GURđñEDV NDQXOÌPYDL GURđñEDV 0XOWLIO\®NDQXOÌPDGDSWHUL60RQRYHWWH®).
/LHWRđDQDDUGURđñEDVNDQXOXLUSDUÌGñWDđHLWNOLNđõLV

/DLVDXG]ñJLVÌNWXDVLQVVDYÌNđDQX6$567('7LHVDNDQRÿHPWSLUPR60RQRYHWWH®L]PDQWRMRWDVSLUÌFLMDVWHKQLNXVNDWLHW9(1,381.7·5$67(+1,.$DVSLUÌFLMDVWHKQLND
3àFWDPWXUSLQLHWDUYDNXXPDWHKQLNX3LUPVDVLÿXÿHPđDQDVDUYLU]XùDVWLHQLSDYHOFLHWYLU]XOLX]60RQRYHWWH®SDPDWQHVXQùDXMLHWWDPLHNOLNđõàW YLHWÌ7DGYLU]XùDVWLHQLVLUQRODX]WV .

–.

,HEñGLHWđRVDJDWDYRWR60RQRYHWWH®LHEğYàWDMÌ60RQRYHWWH®WXUàWÌMÌXQLHEñGLHWGURđñEDVNDQXOXXQQRVWLSULQLHWWRQHGDXG]SDJULHĭRWWRSXONVWHÿUÌGñWÌMDNXVWñEDVYLU]LHQÌ

+.

3DJDLGLHWOñG]DVLQVSOğVPDDSVWÌMDVSDUHL]DLX]SLOGHL

3ÌUYLHWRMLHW60RQRYHWWH®, nedaudz SDJULHĭRWSUHWàMLSXONVWHÿUÌGñWÌMDYLU]LHQDP XQSàFWDPL]YHONRWWRQRGURđñEDVNDQXODV DWYLHQRMRW  'URđñEDVNDQXODSDOLHNYàQÌ9DLUÌNXSDUDXJXÿHPđDQDVJDGñMXPÌNÌQRUÌGñWVLHSULHNđSLHYLHQRMLHWđÌGDV60RQRYHWWHGURđñEDVNDQXODLXQÿHPLHWSDSLOGXSDUDXJXV$VLQVÿHPđDQDVSDEHLJđDQD
Atvienojiet S-Monovette®
+ SàFWDPL]YHOFLHWGURđñEDVNDQXOXQRYàQDV,]PDQWRMRWYLHQDVURNDVWHKQLNXDGDWDVDL]VDUJVYDLQXX]VWDELODVOñG]HQDVYLUVPDVOñG]NDQXODLHVOàG]DVDGDWDVDL]VDUJÌ
DNWLYL]àMDV DGDWDVDL]VDUJÌSDPDQÌPXXQG]LUGDPXNOLNđõLYDLDNWLYL]àMLHWQRVSLHĭRWDGDWDVDL]VDUJDDSDNđàMRJDOXDUUÌGñWÌMSLUNVWX
7ğOñWSàFDWYLHQRđDQDVQRGURđñEDVNDQXODVYLHQXUHL]LDSJUHL]LHWNDWUX60RQRYHWWH®RWUÌGLXQSàFSLOQYàUWñJDVDVLÿXQRÿHPđDQDVYDLUÌNDVUHL]HVX]PDQñJLYLUSLQLHWYLVXVSDUDXJXVRWUÌGLDUDQWLNRDJXODQWLHP1.

1RVSLHGLHWSXQNFLMDVYLHWXDUVDXVXWDPSRQXNXUÌQDYGDXG]EDNWàULMXOñG]DVLÿRđDQDDSVWÌMDV

2.

.DGDVLQLVLUVDUHFàMXđDVX]OLHFLHWSÌUVàMXSàFL]YàOHV3.

,]PHWLHWGURđñEDVNDQXOXDWELOVWRđÌELRORçLVNÌVEñVWDPñEDVDWNULWXPXNRQWHLQHUÌ

134

LV
&HQWULIXJàđDQD
8=0$1%86$567('760RQRYHWWHVLUSDUHG]àWDV[J,]ÿàPXPVLU60RQRYHWWHDU¢bPP 60RQRYHWWH®SHGLDWULMÌ NXUDVSDđODLNLUDSVWLSULQÌWDVOñG]b[bJ,UMÌL]PDQWRWLNDLSLHPàURWDVQHVàMPàçHQHVYDLLHOLNWÿL&HQWULIXJàMRWVDSODLVÌMXđDV60RQRYHWWHYDLFHQWULIXJàMRWDUSÌUPàUñJXFHQWUEàG]HVVSàNX60RQRYHWWHYDUSOñVWL]GDORWSRWHQFLÌOLLQIHNFLR]XPDWHULÌOX&HQWULIğJDVLHOLNWÿLMÌL]YàODVDWELOVWRđLL]PDQWRWR60RQRYHWWHL]PàULHP5HODWñYDMDPFHQWUEàG]HVSDÌWULQÌMXPDPLUđÌGDDWWLHFñEDDULHVWDWñWDMLHPDSJULH]LHQLHPPLQğWà
RZB = 11,2 x r x (apgr./min./1000)2,
5=%5HODWñYDLVFHQWUEàG]HVSDÌWULQÌMXPVNRVDXFDUñSDUJIRUFH DQJùX5&)UHODWLYHFHQWULIXJDOIRUFH 
DSJUPLQDSJULH]LHQLPLQğWà PLQ YDLQ DSJULH]LHQXVNDLWVPLQğWà DQJùX530UHYROXWLRQVSHUPLQXWH ŚUŗ&HQWULIXJàđDQDVUÌGLXVVQRFHQWULIğJDVFHQWUDOñG]60RQRYHWWH® apakšai", (cm).
60RQRYHWWHEH]JHODYDUFHQWULIXJàWFHQWULIğJÌVDUILNVàWDOHÿõDYDLđğSRMRđDMLHPURWRULHP
60RQRYHWWHDUJHOXLUSDUHG]àWDVWLNDLFHQWULIğJÌPDUJUR]ÌPLHPURWRULHP6$567('7QDYDSVWLSULQÌMXVLFHQWULIXJàđDQXFHQWULIğJÌVDUILNVàWDOHÿõDURWRUXXQWÌQDYLHWHLFDPD
60RQRYHWWHMÌFHQWULIXJàVDVNDÿÌDUWXUSPÌNX]VNDLWñWDMLHPFHQWULIXJàđDQDVDSVWÌNùLHP-DWLHNL]PDQWRWLFLWLQRVDFñMXPLWLHMÌDSVWLSULQDSDđDPOLHWRWÌMDP-ÌQRGURđLQDODL60RQRYHWWHEğWXSDUHL]LLHYLHWRWDVFHQWULIğJDVLHOLNWÿRV60RQRYHWWHNDVLUL]YLU]ñWDVÌUSXVLHOLNWÿDYDUDL]õHUWLHVX]FHQWULIğJDVJDOYDVXQVDSOñVW&HQWULIğJDMÌDL]SLOGDYLHQPàUñJL/ğG]XVNDWLHWFHQWULIğJDVOLHWRđDQDVLQVWUXNFLMX
8=0$1%81HQRÿHPW VDODX]WÌV 60RQRYHWWH DU URNÌP1RUÌGHV SDU FHQWULIğJDV GH]LQIHNFLMX DWURGDPDV FHQWULIğJDV OLHWRđDQDV LQVWUXNFLMÌ

Pamatojoties
uz BS 4851+(ES-kods)

5HODWñYDLVFHQWUEàG]HVSDÌWULQÌMXPV J
S-Monovette ®

DIN EN ISO 6710–

2000 x g

2500 x g

3000 x g

3500 x g

4000 x g

Serums10 min10 min

6 min

4 min

4 min

Seruma gels

15 min10 min

4 min

4 min

4 min

Seruma Express gels

15 min10 min

4 min

n.v.

n.v.

/LWLMDKHSDUñQV

10 min10 min

7 min

7 min

7 min

/LWLMDKHSDUñQDJHOV

15 min15 min10 min

7 min

7 min

/LWLMDKHSDUñQDJHOV+

8 min

7 min

5 min

4 min

4 min

EDTA

n.v.

n.v.

7 min

6 min

5 min

EDTA gels

15 min10 min10 min

7 min

7 min

&LWUÌWV

9 min

8 min

7 min

6 min

5 min

('7$ĲXRUñGDKHSDUñQV

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

&LWUÌWV3%0PO&HQWULIğJDVUÌGLXVV!FP

9 min

8 min

7 min

6 min

5 min

&LWUÌWV3%0PO&HQWULIğJDVUÌGLXVV!OñG]ƉFP

n.v.

n.v.

10 minn.v.

n.v.

QD QDYDSVWLSULQÌWV $WWLHFDVX]YLVÌP60RQRYHWWHL]ÿHPRW¢PP 60RQRYHWWHSHGLDWULMD&HQWULIXJàđDQDų&WHPSHUDWğUÌ

+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, atsaukts.

,QIRUPÌFLMDSDUL]ODLđDQDVPDWHULÌOX$WGDORđÌPDWHULÌOD JHOD SOğVPDVñSDđñEDVLUDWNDUñJDVQRWHPSHUDWğUDV-D60RQRYHWWHDWG]HVàSLUPVFHQWULIXJàđDQDVYDLWÌVODLNÌDWGDOñđDQDVJHODQHSÌUWUDXNWVVOÌQLVYDLUVQHWLHNJDUDQWàWV
60RQRYHWWHQHGUñNVWFHQWULIXJàWDWNÌUWRWLFHQWULIXJàW

8WLOL]ÌFLMD
1.

HPLHWYàUÌXQLHYàURMLHWYLVSÌUñJÌVKLJLàQDVYDGOñQLMDVXQWLHVñEXQRUPDVSDULQIHNFLR]DPDWHULÌODSDUHL]XOLNYLGÌFLMX

2.

9LHQUHL]OLHWRMDPLHFLPGLQRYàUđLQIHNFLMDVULVNX

3.

3LHVÌUÿRWDVYDLX]SLOGñWDVDVLQVÿHPđDQDVVLVWàPDVMÌOLNYLGàSLHPàURWRVDWNULWXPXNRQWHLQHURVELRORçLVNLEñVWDPÌPYLHOÌPNRSàFWDPYDUDSVWUÌGÌWDXWRNOÌYRVXQVDGHG]LQÌW

4.

8WLOL]ÌFLMDMÌYHLFSLHPàURWÌVDGHG]LQÌđDQDVLHNÌUWÌYDLL]PDQWRMRWDXWRNOÌYX VWHULOL]ÌFLMDDUWYDLNX 

135

LV
6WDQGDUWLNDVDWWLHFDVX]NRQNUàWRL]VWUÌGÌMXPXXQYDGOñQLMDVDWWLHFñJLVSàNÌHVRđDMÌUHGDNFLMÌCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

6WDQGDUWVYàQXDVLÿXÿHPđDQDVWUDXNLHP
',1(1,629LHQUHL]àMDVOLHWRđDQDVWUDXNLYàQXDVLÿXÿHPđDQDLQRFLOYàNLHP*CLSI (Clinical and Laboratory Standards Institute)

6LPEROXXQDS]ñPàMXPXVNDLGURMXPVArtikula numurs

7DVDWWLHFDVDUñX]DWVHYLđõLVWHULOLLHSDNRWLHPSURGXNWLHP

Partijas nosaukums

1HOLHWRWMDLUERMÌWVLHSDNRMXPV,]OLHWRWOñG]

9LHQDVVWHULODVEDUMHUDVVLVWàPDDUÌUàMRDL]VDUJLHSDNRMXPX&(]ñPH

6WHULOL]ÌFLMDDSVWDURMRW

In vitro diagnostika,HYàURWOLHWRđDQDVLQVWUXNFLMX/LHWRMRWDWNÌUWRWL.RQWDPLQÌFLMDVULVNV8]JODEÌWSURPQRVDXOHVJDLVPDV8]JODEÌWVDXVÌYLHWÌ

5DĭRWÌMV

5DĭRWÌMYDOVWV

6WHULODđõLGUXPDWUDMHNWRULMD

1HVWHULOL]àWDWNÌUWRWL

6DJODEÌWDVWLHVñEDVYHLNWWHKQLVNDVL]PDLÿDV
3DUYLVLHPQRSLHWQLHPLQFLGHQWLHPNDVUDGXđLHVVDLVWñEÌDUL]VWUÌGÌMXPXMÌ]LÿRUDĭRWÌMDPXQDWWLHFñJDMDLYDOVWVLHVWÌGHL136

*HEUXLNVDDQZİ]LQJş6$567('760RQRYHWWH® bloedafnamesysteem

NL

Voor in-vitro diagnostiek gebruik
Gebruik
S-Monovette® bloedafnamesystemen, naalden en adapters worden samen gebruikt als systeem voor veneuze bloedafname. S-Monovette® bloedafnamesystemen worden gebruikt voor de afname, het transporteren,verwerken en opslaan van bloedmonsters voor in-vitro diagnostische doeleinden van serum, plasma of volbloed in het klinisch laboratorium. Het product is bestemd voor gebruik in een professionele omgeving en door
gespecialiseerd medisch personeel en laboratoriumpersoneel.

3URGXFWEHVFKUİYLQJ
S-Monovette® bloedafnamesystemen bestaan uit een kunststof buisje, een zuiger, een zuigerstang en een kleurgecodeerde kunststof schroefdop met geïntegreerd membraan, dat speciaal voor de aansluiting
op een S-Monovette® (Safety-) naald of (Safety-) Multifly® -naald werd ontwikkeld, alsook verschillende additieven (preparaten). Er is eveneens een S-Monovette® zonder additief te verkrijgen. S-Monovette®
bloedafnamesystemen met de additieven stollingsactivator, stollingsactivator met gel, lithiumheparine, lithiumheparine met gel, natriumheparine, citraat, EDTA, fluoride EDTA, fluoride heparine, fluoride citraat, CPDA,
alsook zonder additief, hun additiefconcentraties, het volume van de vloeibare additieven en hun toegestane toleranties, alsook de verhouding bloed tot additief komen overeen met de vereisten en aanbevelingen van deinternationale norm DIN EN ISO 6710 „Single-use containers for venous blood specimen collection“ en de Clinical and Laboratory Standards Institute’s Approved Standards (CLSI). De keuze van het additief hangt af vande analytische testmethode. Deze wordt gespecificeerd door de fabrikant van de testreagentia en/of het analyseapparaat waarop de test uitgevoerd wordt. Het S-Monovette® bloedafnamesysteem is verkrijgbaar in deuitvoeringen aan de binnenkant steriel of individueel verpakt aan de binnen- en buitenkant steriel.

Kleurcodes van de S-Monovette® schroefdoppen*:

Additief

Lettercode

Kleur van de dop DIN EN
ISO 6710

Kleur van de dop volgens
BS 4851+

Z

wit

wit

Buisje zonder preparaat
S-Monovette® Neutraal Z
Serumbuisje
S-Monovette® Serum CAT, met stollingsactivator

CAT

rood

wit

S-Monovette® Serumgel CAT, met stollingsactivator en gel

CATdonkergeel

donkergeel

S-Monovette® Serum Express Gel CAT, met stollingsactivator thrombine en gel

CAToranje-S-Monovette® lithiumheparine LH, met lithiumheparine

LH

groen

oranjeS-Monovette® lithiumheparine vloeibaar, met lithiumheparine

LH

groen

oranjeS-Monovette® Lithiumheparinegel LH, met lithiumheparine en gel

LH

groen

oranjeS-Monovette® Lithiumheparinegel+ LH, met lithiumheparine en snelle gel

LH

groen

oranjeS-Monovette® natriumheparine NH, met natriumheparine

NH

bruin

groen

S-Monovette® ammoniumheparine AH, met ammoniumheparine

n.b.

blauw

blauw

S-Monovette® citraat 9NC, natriumcitraat 3,13%

9NC

blauw

groen

S-Monovette 3)$FLWUDDW1&QDWULXPFLWUDDWJHEXĳHUG

9NC

lichtblauw-

S-Monovette® K3 EDTA K3E, met kalium EDTA

K3E

paars

rood

S-Monovette® K2 EDTA K2E, met kalium EDTA

K2E

paars

rood

S-Monovette® K2 EDTA-gel K2E, met kalium EDTA en gel

K2E

paars

rood

S-Monovette®ĲXRULGH('7$)(PHWĲXRULGHHQ('7$

FE

JUİV

geel

S-Monovette®ĲXRULGHKHSDULQH)+PHWĲXRULGHHQKHSDULQH

FH

-

geel

S-Monovette®*OXFR(;$&7)&PHWĲXRULGHFLWUDDWHQ('7$

FC

roze

JUİV

LH

donkerblauw

oranjeS-Monovette® ThromboExact, met magnesiumverbindingn.b.

n.b. framboos

n.b. framboos

S-Monovette® CTADn.b.

n.b., blauwn.b., groen

S-Monovette® ACD

ACD

geel

geel

S-Monovette® CPDA

CPDA

geel

geel

S-Monovette® Hirudinen.b.

QEROİIJURHQQEROİIJURHQ

Heparinebuisje

Citraatbuisje®

EDTA-buisje

Buisje met glycolyse-inhibitoren

Buisje voor metaalanalyse
S-Monovette® metaalanalyse LH, met lithiumheparine

Meer volbloed en plasmabuisjes

S-Monovette® Homocysteïne HCY-Z gel, met gel en stabilisatorn.b.

QEJUİV

QEJUİV

S-Monovette®+RPRF\VWHðQH+&<&PHWFLWUDDWEXĳHUn.b.

n.b., paars

n.b., paars

S-Monovette® DNA Exactn.b.

n.b., blauwn.b., blauw

0HHUVFKURHIGRSNOHXUHQWHYHUNUİJHQn.b.: niet bepaald+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, teruggetrokken.

137

NL
SARSTEDT S-Monovette® Serum CAT/Serumgel CAT
De S-Monovette® serum CAT bevat een met een stollingsactivator (silicaat) gecoate kunststofgranulaat en dient voor serumwinning**. Het kunststof-granulaat ontstaat door centrifugatie tussen bloedkoek en serum.
De S-Monovette® Serumgel CAT bevat naast het met de stollingsactivator (silicaat) gecoate kunststofgranulaat een gel op polymeerbasis en dient voor serumwinning**. De gel ontstaat door centrifugatie tussen
bloedkoek en serum en vormt een stabiele scheidingslaag tijdens transport, opslag en analyse.
Serum wordt als monstermateriaal in klinisch-chemische en immunologische routine-onderzoeken, alsook in de serologie gebruikt.
Na de bloedafname moet het bloed in de S-Monovette® Serum CAT/Serumgel CAT 30 minuten rechtop stollen om een goed gevormde horizontale scheidingslaag na centrifugatie te garanderen. De aanbevolen tijd isgebaseerd op een intact stollingsproces. Bloed van patiënten met ziektegerelateerde stollingsstoornissen of die een antistollingstherapie ondergaan, heeft eventueel meer tijd nodig voor volledige stolling.

SARSTEDT S-Monovette® Serum Express Gel CAT
De S-Monovette® Serum Express Gel CAT bevat naast het met de stollingsactivator (thrombine) gecoate kunststofgranulaat een gel op polymeerbasis en dient voor serumwinning**. De gel ontstaat door centrifugatie
tussen bloedkoek en serum en vormt een stabiele scheidingslaag tijdens transport, opslag en analyse.
Na de bloedafname moet het bloed in de S-Monovette® Serum Express Gel 5 minuten rechtop stollen om een goed gevormde horizontale scheidingslaag na centrifugatie te garanderen. De aanbevolen tijd is gebaseerd
op een intact stollingsproces, ook voor bloed van gehepariniseerde patiënten. Bloed van patiënten met ziektegerelateerde stollingsstoornissen of die een antistollingstherapie ondergaan, inclusief hoog gedoseerde
heparine, heeft meer tijd nodig voor volledige stolling.
Serum wordt als monstermateriaal in klinisch-chemische en immunologische routine-onderzoeken, alsook in de serologie gebruikt.

SARSTEDT S-Monovette® Neutraal Z
De S-Monovette® Neutraal Z bevat geen preparaat wat met een natuurlijke stolling van het bloedmonster zonder stollingsactivator overeenkomt, en dient voor serumwinning**. Door centrifugatie gebeurt een scheiding in
bloedkoek en serum.
Serum wordt als monstermateriaal voor gebruiksspecifieke onderzoeken gebruikt.
Bovendien kan de S-Monovette® Neutraal Z ook als wegwerp buisje als volgt worden gebruikt: moet de bloedafname met een S-Monovette® Citraat in combinatie met een (safety)Multifly®-naald (vleugelnaald) worden
begonnnen, dan wordt de S-Monovette® Neutraal Z als eerste buisje (wegwerp buisje) voor het vullen van de slang van de (safety)Multifly®-naald gebruikt.

SARSTEDT S-Monovette® lithiumheparine LH/lithiumheparinegel LH/Lithiumheparinegel+ LH, natriumheparine NH, ammoniumheparine AH
De S-Monovette® lithiumheparine LH/natriumheparine NH/ammoniumheparine AH bevat een met de stollingsremmer (anticoagulans) lithiumheparine/natriumheparine/ammoniumheparine (norm. 16 I.E. heparine/ml
bloed) gecoat kunststof -granulaat en dient voor volbloed- en plasmawinning**. Het kunststofgranulaat ontstaat door centrifugatie tussen bloedcellen en plasma.
Bij een S-Monovette® lithiumheparine LH zonder kunststofgranulaat is de anitocoagulans lithiumheparine in spuitgedoseerde vorm (norm. 19 I.E. heparine/ml bloed) beschikbaar.
De S-Monovette® lithiumheparine LH bevat naast het met de anticoagulans lithiumheparine (norm. 25 I.E. heparine/ml bloed) gecoate kunststof-granulaat een gel op polymeerbasis en dient voor plasmawinning**. De gel
ontstaat door centrifugatie tussen bloedcellen en plasma en vormt een stabiele scheidingslaag tijdens transport, opslag en analyse.
De S-Monovette® lithiumheparine gel+ LH bevat eveneens een gel op polymeerbasis, die een met ca. 50% gereduceerde centrifugatietijd in vergelijking met de S-Monovette® lithiumheparine gel mogelijk maakt.
Heparineplasma wordt als monstermateriaal in klinisch-chemische en immunologische routinematige onderzoeken gebruikt. Heparinevolbloed wordt als monstermateriaal in immunologische routinematige onderzoeken
en in de serologie gebruikt.
De stollingsremming met heparine gebeurt door een activering van antithrombine.
OPMERKING: Uit de S-Monovette® Lithiumheparine LH, lithiumheparinegel/gel+ LH mogen geen lithiumbepalingen, uit de S-Monovette® natriumheparine NH mogen geen natriumbepalingen en uit de
S-Monovette® ammoniumheparine AH mogen geen ammoniumbepalingen worden uitgevoerd. Een met veneus bloed gevulde S-Monovette® lithiumheparine/lithiumheparinegel/gel+ / natriumheparine/
DPPRQLXPKHSDULQH]İQQLHWJHVFKLNWYRRUGHEORHGJDVDQDO\VH

SARSTEDT S-Monovette® metaalanalyse
De S-Monovette® metaalanalyse bevat het anticoagulans lithiumheparine en dient voor de volbloed- en plasmawinning**. Lithiumheparine in spuitgedoseerde vorm (19 I.E. heparine/ml bloed) aanwezig.
Heparinevolbloed resp. heparineplasma van de S-Monovette® metaalanalyse in combinatie met de speciale safety-naald 21G x 1 ½“ (art.nr. 85.1162.600) wordt als monstermateriaal voor de onderzoeken vansporenelementen/metalen gebruikt. De sporenelementen/metalen werden door middel van de atoomabsorptiespectrometrie (ASS) gevalideerd. Voor het systeem Safety-naald en S-Monovette® metaalanalyse ontstaan
volgende maximale blanco's in ng/systeem voor deze sporenelementen:

Element

TI

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/systeem

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

'HPD[LPDOHEODQFRZDDUGHQ]İQYHUPHOGYRRUHONHOHPHQWRSKHWHWLNHWYDQGH60RQRYHWWH®.
Sporenelementenbepalingen gebeuren afhankelijk van het analyseproces uit heparinevolbloed of heparineplasma.
De stollingsremming met heparine gebeurt door een activering van antithrombine.

SARSTEDT S-Monovette® Citraat 9NC
De S-Monovette® Citraat 9NC bevat het anticoagulans trinatriumcitraat en dient voor volbloed- en plasmawinning**. Trinatriumcitraat is als 0,106 molaire oplossing (3,13% trinatriumcitraatoplossing; vaak naar 3,2%
afgrond) aanwezig en bedraagt 10% van het nominale volume van een S-Monovette® Citraat. De mengverhouding van citraat tot bloed bedraagt 1:9 - 1 volumedeel citraat en 9 volumedelen bloed. Een correcte vulling isabsoluut vereist voor de analyse.
Citraatplasma wordt als monstermateriaal in hemostaseologische routinematige onderzoeken gebruikt.
De stollingsremming gebeurt door de complexatie van de calciumionen door citraat.
AANWIJZINGEN onder monsterafname en behandeling voor de combinatie S-Monovette® Citraat en vleugelnaald in acht nemen.

SARSTEDT S-Monovette® PFA 9NC
De S-Monovette® PFA 9NC bevat het anticoagulans trinatriumcitraat voor volbloed- en plasmawinning**. Trinatriumcitraat is als 0,129 molaire gebufferde oplossing (3,8% gebufferd; pH 5,5) aanwezig en bedraagt 10%
van het nominale volume van een S-Monovette® PFA. De mengverhouding van citraat tot bloed bedraagt 1:9 - 1 volumedeel citraat en 9 volumedelen bloed. Een correcte vulling is absoluut vereist voor de analyse.
Het volbloed van de S-Monovette® PFA 9NC wordt als monstermateriaal voor de thrombocytenfunctiebepaling met het SIEMENS Healthineers analyseapparaat PFA gebruikt en is daarvoor gevalideerd.
De stollingsremming gebeurt door de complexatie van de calciumionen door citraat.
Aanwijzingen onder monsterafname en behandeling voor de combinatie S-Monovette® PFA en vleugelnaald in acht nemen.

SARSTEDT S-Monovette® CTAD
De S-Monovette® CTAD bevat het anticoagulans trinatriumcitraat, alsook theofylline, adenosine en dipyridamol en dient voor volbloed- en plasmawinning**. CTAD is als oplossing beschikbaar en bedraagt 10% van het
nominale volume van een S-Monovette® CTAD. De mengverhouding van CTAD tot bloed bedraagt 1:9 - 1 volumedeel CTAD en 9 volumedelen bloed. Een correcte vulling is absoluut vereist voor de analyse.
CTAD-plasma wordt als monstermateriaal voor de bepaling van plaatjesfactor 4 (PF4), beta(ß)-thromboglobuline (ßTG) en plasminogenactivator-inhibitor (PAI-1), alsook voor hemostaseologische routine-onderzoeken
gebruikt.
De thrombocytenactivering wordt gedurende ten minste 4 uur geremd en wordt gebruikt om heparinetherapieën te controleren.
De stollingsremming gebeurt door de complexatie van de calciumionen door citraat.
AANWIJZINGEN onder monsterafname en behandeling voor de combinatie S-Monovette® CTAD en vleugelnaald in acht nemen.
OPMERKING: CTAD is geel. De S-Monovette®&7$'PRHWWİGHQVGHRSVODJZRUGHQEHVFKHUPGWHJHQNXQVWOLFKWHQQDWXXUOİNOLFKW(HQVWHUNHOLFKWLQZHUNLQJYDQPHHUGDQXXUNDQOHLGHQWRWHHQ
inactivatie van de additieven.

138

NL
SARSTEDT S-Monovette® EDTA K2E / K3E
De S-Monovette® EDTA K2E/S-Monovette® EDTA K3E bevat het anticoagulans K2 EDTA resp. K3 EDTA en dient voor volbloedwinning**. K2 EDTA resp. K3 EDTA is beschikbaar in spuitgedoseerde vorm (1,6 mg EDTA/
ml bloed).
EDTA-volbloed wordt als monstermateriaal voor hematologische onderzoeken gebruikt. Bloeduitstrijkjes moeten binnen de vier uur na de bloedafname worden gemaakt.
De stollingsremming gebeurt door de complexatie van de calciumionen door EDTA.
Bloed uit de S-Monovette® EDTA K2E/K3E kan eveneens voor immuunhematologische routinematige onderzoeken en tests op infectieziekten worden gebruikt. De geschiktheid van het monstermateriaal voor deze
onderzoeken is de verantwoordelijkheid van de gebruiker en deze moet de overeenkomstige testreagentie/analyse-apparaten incl. opslagvoorwaarden valideren

SARSTEDT S-Monovette® EDTA-gel K2E
De S-Monovette® EDTA-gel K2E bevat naast de anticoagulans K2 EDTA een gel op polymeerbasis en dient voor plasmawinning**. K2 EDTA is beschikbaar in spuitgedoseerde vorm (1,6 mg EDTA/ml bloed). De gel
ontstaat door centrifugatie tussen bloedcellen en plasma en vormt een stabiele scheidingslaag tijdens transport, opslag en analyse.
EDTA-plasma wordt als monstermateriaal voor de moleculaire virusdiagnostiek gebruikt.
De stollingsremming gebeurt door de complexatie van de calciumionen door EDTA.

SARSTEDT S-Monovette®)OXRULGH('7$)()OXRULGHKHSDULQH)+)OXRULGH&LWUDDW('7$)&PHWJO\FRO\VHUHPPHUVDe S-Monovette® Fluoride EDTA FE bevat het anticoagulans EDTA (1,2 mg/ml bloed), alsook fluoride (1,0 mg/ml bloed) voor de glycolyseremming en dient voor plasmawinning**. Fluoride EDTA is beschikbaar inspuitgedoseerde vorm.
De S-Monovette® Fluoride Heparine FH bevat het anticoagulans heparine (16 I.E. heparine/ml bloed), alsook fluoride (1,0 mg/ml bloed) voor de glycolyseremming en dient voor plasmawinning**. Fluoride heparine isbeschikbaar in spuitgedoseerde vorm.
De glycolyseremming alleen door fluoride begint ca. 2 uur na het vullen van het bloedafnamebuisje en heeft zijn volledige werking bereikt na ca. 4 uur. Glucose breekt daarom gemiddeld tot max. 6% na enkele uren en
tot 10-15% na 24 uur in het volbloed af.
De S-Monovette® GlucoEXACT FC bevat het anticoagulans EDTA, alsook citraat en fluoride voor de onmiddellijke glycolyseremming en dient voor plasmawinning**. EDTA, citraat en fluoride zijn als oplossing
beschikbaar. De berekening van de glucoseconcentratie vereist op basis van de verdunning een vermenigvuldiging met 1,16.
De S-Monovette® GlucoEXACT FC vervult de richtlijn inzake zwangerschapsdiabetes van de Deutsche Diabetes Gesellschaft (DDG) en de Nationale VersorgungsLeitlinie (NVL) voor type-2 diabetes. De onmiddellijke
stabilisatie van de glucoseconcentratie wordt voor max. 96 uur bij kamertemperatuur in volbloed gegarandeerd, zie ook SARSTEDS WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/smonovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
Fluoride EDTA-(citraat)plasma wordt als monstermateriaal voor de glucosebepaling gebruikt.
De stollingsremming gebeurt door de complexatie van de calciumionen door EDTA.
230(5.,1*)OXRULGHNDQHHQWRHQDPHYDQKHPRO\VHYHURRU]DNHQ9RRUYHUGHUHLQIRUPDWLHRYHUVWRĳHQGLHNXQQHQLQWHUIHUHUHQUDDGSOHHJWXGHEHWUHĳHQGHJHEUXLNHUVKDQGOHLGLQJYDQGHIDEULNDQW
van de testreagentia.
Aanwijzingen onder monsterafname en behandeling voor de combinatie S-Monovette® GlucoEXACT en vleugelnaald in acht nemen.

SARSTEDT S-Monovette® CPDA
De S-Monovette® CPDA bevat het anticoagulans natriumcitraat, alsook citroenzuur, natriumfosfaat, dextrose en adenine en dient voor volbloed- en plasmawinning**. CPDA is als oplossing beschikbaar. De
mengverhouding van CPDA tot bloed bedraagt 1:6 - 1 volumedeel CPDA en 6 volumedelen bloed. Een correcte vulling is op basis van de analyse absoluut vereist.
CPDA volbloed/plasma wordt als monstermateriaal voor de bloedgroepserologie in de transfusiegeneeskunde, voor compatibiliteitsonderzoeken (kruisproeven) bij transfusies gebruikt. Concreet is de S-Monovette®
CPDA voor de bloedgroepbepaling (AB0) inclusief Kell en Rhesusfactor, antistofzoektest op irreguliere bloedgroepantistoffen, polyspecifieke directe Coombstest (tot dag 10), compatibiliteitstest (kruisproef) met
bloedgroepcompatibele patiëntenserum/-plasma (major test) geschikt.
De transportduur tot de opslag is gevalideerd voor maximaal 4 uur bij 2 - 21 °C. Voor de sedimentatie van de cellen moeten de monsters vooraf gedurende min. 16 uur rechtop in de koelkast worden bewaard.
Vervolgens kunnen de bovengenoemde analyten tot max. 35 dagen analoog met de gebruikelijke verlooptijd van de bloedzakjes na opslag in de koelkast (2-6 °C) worden bepaald (uitgezonderd directe Coombstest 10
dagen). Geschikt voor kolomagglutinatietest bijv. op de Vision Max van Ortho Clinical Diagnostics. Het monstermateriaal mag niet worden bevroren.
De geschiktheid van het monstermateriaal voor deze onderzoeken met andere methodes/testreagentia/analyse-apparaten incl. opslagvoorwaarden is de verantwoordelijkheid van de gebruiker en moet door hemzelf
worden gevalideerd.
De stollingsremming gebeurt door de complexatie van de calciumionen door citraat.
AANWIJZiNGEN onder monsterafname en behandeling voor de combinatie S-Monovette® CPDA en vleugelnaald in acht nemen.

SARSTEDT S-Monovette® ThromboExact
De S-Monovette® ThromboExact bevat als anticoagulans een magnesiumzout en dient voor de volbloedwinning**. Het magnesiumzout is beschikbaar in spuitgedoseerde vorm.
Het volbloed van de S-Monovette® ThromboExact wordt als monstermateriaal voor de uitsluiting van foutief lage thrombocytencijfers op basis van een anticoagulans-incompatibiliteit (zoals EDTA, citraat, heparine), ook
pseudothrombocytopenie omschreven, gebruikt. Het vormen van thrombocytenaggregaten worden verhinderd en het bepalen van het werkelijke thrombocytencijfer is max. 12 uur na bloedafname mogelijk.
De stollingsremming gebeurt via de magnesiumionen, waarin de magnesiumionen thrombocytair thromboxaan A2, alsook de door ADP en arachidonzuur gegeven thrombocytenaggregatie remt.

SARSTEDT S-Monovette® Hirudine
De S-Monovette® hirudine bevat het anticoagulans hirudine en dient voor de volbloedwinning**. Huridine is beschikbaar in spuitgedoseerde vorm.
Hirudine-volbloed wordt als monstermateriaal voor het bepalen van de thrombocytenfunctie op het Multiplate® toestel (multiple platelet function analyser) van ROCHE Diagnostics gebruikt en is hiervoor gevalideerd. Het
wordt gebruikt voor de therapiecontrole van plaatjesremmende medicijnen, alsook om thrombocytenfunctiestoringen te bewijzen of uit te sluiten.
De S-Monovette® Hirudine werd speciaal ontwikkeld voor het bepalen van de thrombocytenfunctie samen met de firma Verum Dianostica, vandaag ROCHE Diagnostics, op het Multiplate® toestel.
De stollingsremming gebeurt via hirudine door directe thrombineremming en zorgt zo voor een thrombocytenfunctiediagnostiek in native toestand.

SARSTEDT S-Monovette® Homocysteïne HCY-Z-gel/HCY-C
De S-Monovette® Homocysteïne HCY-Z-gel bevat naast het met de stollingsactivator (silicaat) gecoate kunststofgranulaat een speciale stabilisator, alsook een gel op polymeerbasis en dient voor serumwinning**. De gel
ontstaat door centrifugatie tussen bloedkoek en serum en vormt een stabiele scheidingslaag tijdens transport, opslag en analyse. Het preparaat is beschikbaar in spuitgedoseerde vorm.
Homocysteïne wordt tot max. 8 uur in het volbloed bij kamertemperatuur gestabiliseerd. Gebeurt de centrifugatie binnen de eerste 8 uur met correct gevormde scheidingslaag tussen bloedkoek en serum, dan wordt
homocysteïne tot max. 96 uur gestabiliseerd.
Het serum van de S-Monovette® Homocysteïne HCY-Z-gel wordt als monstermateriaal gebruikt om de homocysteïne te bepalen. De S-Monovette® Homocysteïne HCY-C bevat als anticoagulans een zuurcitraat (pH 4,3)
en dient voor de plasmawinning**. Citraat is als oplossing beschikbaar. De berekening van de homocysteïneconcentratie vereist op basis van de verdunning de multiplicatie met 1,11.
Homocysteïne wordt bij kamertemperatuur tot 6 uur en bij 4 °C tot max. 48 uur in het volbloed gestabiliseerd.
Het plasma van de S-Monovette® Homocysteïne HCY-C wordt als monstermateriaal gebruikt om de homocysteïne te bepalen.
De stollingsremming in de S-Monovette® Homocysteïne HCY-C gebeurt door de complexatie van de calciumionen door citraat.
AANWIJZINGEN onder monsterafname en behandeling voor de combinatie S-Monovette® HCY-C en vleugelnaald in acht nemen.

SARSTEDT S-Monovette® DNA Exact
De S-Monovette® DNA Exact bevat een anticoagulans op EDTA-basis en dient voor volbloedwinning**. EDTA is beschikbaar in spuitgedoseerde vorm.
EDTA-volbloed wordt als monstermateriaal gebruikt om gDNA te stabiliseren. Het stabiliseringsvermogen voor gDNA is gevalideerd gedurende 5 dagen bij 35 °C, 14 dagen bij kamertemperatuur (22 °C), 28 dagen bij
koeling (4 °C) en min. 1 jaar bij -20 °C. Bijkomend doorstaan de gestabiliseerde monsters 5 invries- en ontdooicycli zonder aan kwaliteit in te boeten, zie ook SARSTEDT White Paper https://www.sarstedt.com/en/
products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic
DNA Analysis.”.
De stollingsremming gebeurt door de complexatie van de calciumionen door EDTA.

'HJHVFKLNWKHLGYDQKHWPRQVWHUPDWHULDDOLVDIKDQNHOİNYDQKHWDQDO\WHQKHWWHVWUHDJHQWLXPDQDO\VHWRHVWHO2YHUHHQNRPVWLJHDDQEHYHOLQJHQYDQGHIDEULNDQWPRHWHQLQDFKWZRUGHQJHQRPHQ

139

NL
Veiligheidsinstructies/waarschuwingen
1.

$OJHPHQHYRRU]RUJVPDDWUHJHOHQ'UDDJKDQGVFKRHQHQHQDQGHUHDOJHPHQHSHUVRRQOİNHEHVFKHUPLQJVPLGGHOHQWHUEHVFKHUPLQJWHJHQEORHGHQHHQPRJHOİNHEORRWVWHOOLQJDDQSRWHQWLHHOLQIHFWLHXV
monstermateriaal en door bloed overgedragen pathogenen.

2.

Behandel alle biologische monsters en scherpe/puntige instrumenten voor bloedafname (naalden, adapters) volgens het beleid en de procedures van uw instelling. Zoek medische hulp in geval van direct contact
PHWELRORJLVFKHPRQVWHUVRIHHQSULNZRQGDDQJH]LHQKLHUGRRUKLY+&9+%9RIDQGHUHEHVPHWWHOİNH]LHNWHQRYHUJHEUDFKWNXQQHQZRUGHQ*HEUXLN6DIHW\QDDOGHQ6DIHW\0XOWLĲ\®naalden met ingebouwde
QDDOGEHVFKHUPLQJ'HYHLOLJKHLGVULFKWOİQHQHQSURFHGXUHVYDQXZLQVWHOOLQJPRHWHQDOWİGZRUGHQRSJHYROJG

3.

*HOGWYRRUDI]RQGHUOİNVWHULHOYHUSDNWHSURGXFWHQ Controleer elke individuele verpakking vóór gebruik op beschadigingen en gebruik het product niet in geval van beschadigingen.

4.

+HWSURGXFWLVEHGRHOGYRRUHHQPDOLJJHEUXLN*RRLDOOHVFKHUSHSXQWLJHYRRUZHUSHQ QDDOGHQDGDSWHUV YRRUEORHGDIQDPHZHJLQGHGDDUYRRUEHVWHPGHDIYDOFRQWDLQHUVYRRUELRORJLVFKJHYDDUOİNHVWRĳHQ

5.

$OVHUEORHGDIJHQRPHQZRUGWYLDHHQLQWUDYHQHX]H ,9 WRHJDQJPRHWHUYRRUZRUGHQJH]RUJGGDWGHWRHJDQJYROJHQVGHSODDWVHOİNHYRRUVFKULIWHQJHVSRHOGZRUGW JHUHLQLJGYDQ,9RSORVVLQJ YRRUGDWPHWGH
bloedafname begonnen wordt. Een spoeling van de toegang volgens de voorschriften voorkomt foutieve analyseresultaten.

6.

Ondervulling van de S-Monovette® leidt tot een onjuiste verhouding tussen bloed/additief en kan leiden tot onjuiste analyseresultaten.

7.

Bloed dat met de S-Monovette®DIJHQRPHQHQYHUZHUNWLVLVQLHWEHVWHPGYRRUKHULQMHFWLHLQKHWPHQVHOİNHOLFKDDP

8.

+HWSURGXFWPDJQLHWPHHUZRUGHQJHEUXLNWQDKHWYHUVWUİNHQYDQGHKRXGEDDUKHLGVGDWXP'HKRXGEDDUKHLGHLQGLJWRSGHODDWVWHGDJYDQGHDDQJHJHYHQPDDQGHQMDDU

BewarenHet product moet tot aan de toepassing bij kamertemperatuur worden bewaard.

Beperkingen
1.

'HEHZDDUWİGHQWHPSHUDWXXUYDQHHQJHYXOGH60RQRYHWWH®]İQDIKDQNHOİNYDQGHKRXGEDDUKHLGYDQGHWHRQGHU]RHNHQDQDO\WHQ'HEHRRUGHOLQJJHEHXUWGRRUKHWODERUDWRULXPUHVSLQIRUPDWLHYLQGWXLQGH
gebruikershandleiding van de fabrikant van de testreagentia/analysetoestellen.

2.

Ook indien plasma of serum door centrifugering van een S-Monovette®JHVFKHLGHQLVHQRIHHQEDUULÛUHDDQZH]LJLV]XOOHQQLHWQRRG]DNHOİNDOOHFHOOHQYROOHGLJZRUGHQJHVFKHLGHQ5HVWPHWDEROLVPHRIQDWXXUOİNH
DIEUDDNNXQQHQGHFRQFHQWUDWLHVYDQGHDQDO\WHQEHðQYORHGHQ'HVWDELOLWHLWYDQGHDQDO\WHQPRHWZRUGHQEHRRUGHHOGDDQGHKDQGYDQGHRSVODJUHFLSLßQWHQHQGHRPVWDQGLJKHGHQLQKHWGHVEHWUHĳHQGH
laboratorium.

3.

In het geval van therapeutische geneesmiddelen moet de geschiktheid van het monstermateriaal worden nagegaan in de gebruikershandleiding van de fabrikant van de testreagentia/analyseapparaten.

4.

Analysen voor sporenelementen/metalen moeten met het systeem S-Monovette® metaalanalyse + safety-naald metaalanalyse worden uitgevoerd.

Monsterafname en gebruik
LEES DIT DOCUMENT VOLLEDIG VOORDAT U MET DE VENEUZE BLOEDAFNAME BEGINT.
Benodigdheden voor de monsterafname
1.

$OOHQRRG]DNHOİNH60RQRYHWWH® bloedafnamesystemen.

2.

6DIHW\QDDOGHQRI 6DIHW\ 0XOWLĲ\®-naalden.

3.

+DQGVFKRHQHQMDVRRJEHVFKHUPLQJRIDQGHUHJHVFKLNWHYHLOLJKHLGVNOHGLQJWHUEHVFKHUPLQJWHJHQGRRUEORHGRYHUJHGUDJHQSDWKRJHQHQRIPRJHOİNLQIHFWLHXVPDWHULDDO

4.

(WLNHWWHQYRRULGHQWLıFDWLHYDQGHSDWLßQW

5.

2QWVPHWWLQJVPDWHULDDOYRRUGHRQWVPHWWLQJYDQKHWDIQDPHSXQW YROJGHULFKWOİQHQYDQGHLQVWHOOLQJYRRUHHQVWHULHOHPRQVWHUQDPHYRRUKHWYRRUEHUHLGHQYDQKHWDIQDPHSXQW *HEUXLNJHHQUHLQLJLQJVPDWHULDDORS
alcoholbasis als de monsters voor bloedalcoholtests gebruikt moeten worden.

6.

'URJHNLHPDUPHZDWWHQVFKİIMHV

7.

Stuwband.

8.

Pleister of verband.

9.

&RQWDLQHUYRRUVFKHUSHSXQWLJHYRRUZHUSHQYRRUGHYHLOLJHYHUZİGHULQJYDQKHWJHEUXLNWHPDWHULDDOAanbevolen afnamevolgorde:
1.

Flesjes bloedculturen

2.

Buisjes met citraat of stollingsactivator (met/zonder gel serum CAT/serumgel CAT)

3.

Buisjes met stollingsactivator of citraat

4.

Buisjes met heparine met/zonder gel

5.

Buisjes met EDTA met/zonder gel

6.

Buisjes met glycolyse-inhibitoren

7.

Buisjes met andere additieven$$1:į=,1*

:RUGWPHWGHDIQDPHYDQHHQFLWUDDWEXLVMHRIHHQDQGHUEXLVMHPHWHHQYORHLEDDUSUHSDUDDW]RDOVEİY3)$&7$'&3'$+&<&RI*OXFR(;$&7LQFRPELQDWLHPHWHHQ
YOHXJHOQDDOG EİY 6DIHW\ 0XOWLĲ\®QDDOG EHJRQQHQZRUGWGHDIQDPHYDQHHQZHJZHUSEXLVMH EİY60RQRYHWWH® Neutraal Z) vooraf aanbevolen om ondervulling van het buisje
GRRUKHWYXOOHQYDQGHVODQJYDQGHYOHXJHOQDDOGWHYHUPİGHQ
Daardoor kan een correcte vulling van het buisje en zo een correcte mengverhouding (vloeistof tot bloed) worden gegarandeerd.

$$1:į=,1*

9ROJGHLQVWUXFWLHVYDQXZLQVWHOOLQJYRRUGHYROJRUGHYDQDIQDPH

7HUXJVWURPLQJYHUPİGHQ
De meeste S-Monovetten bevatten chemische additieven. De volgende instructies moeten in acht worden genomen om terugstroming te voorkomen:
1. Gebruik alleen de in de gebruikershandleiding aanbevolen materialen.
2.

3ODDWVGHSDWLßQW]RGDWXJHPDNNHOİNEİGHDGHUNXQWNRPHQHQOHJGHDUPRIHHQDQGHUHSXQFWLH]RQHYDQGHSDWLßQWLQGLHQPRJHOİNQDDUEHQHGHQ

3.

Houd de S-Monovette®PHWGHVFKURHIVOXLWLQJQDDUERYHQHQEİJHEUXLNYDQHHQ 6DIHW\ 0XOWLĲ\®QDDOGEİNRPHQGRQGHUKHWDUPQLYHDXGHSXQFWLH]RQH

4.

Zorg ervoor dat de inhoud van de S-Monovette®WİGHQVKHWDDQSULNNHQYDQGHDGHUQLHWLQDDQUDNLQJNRPWPHWGHVFKURHIGRSRIKHWXLWHLQGHYDQGHQDDOG

5.

0DDNGHVWXZEDQGORVWHUZİOKHWEORHGLQGH60RQRYHWWH® stroomt.

140

NL
Invriezen/ontdooien
Conform de aanbevelingen van de WHO (WHO/DIL/Lab/99.1 Rev.02) wordt aanbevolen, serum/plasma voor het invriezen te scheiden van bloedcellen.
Voor de S-Monovette® gelden de volgende aanbevelingen voor het invriezen:,QYULH]HQRQGHUbƓ&•Het gebruik in minimumtemperatuurbereik moet in principe onder reële omstandigheden worden getest, aangezien de belasting van de buisjes naargelang het in te vriezen medium en de routinevoorwaarden zeer
YHUVFKLOOHQGNDQ]İQ ]LHKRRIGVWXN0DWHULDDOHLJHQVFKDSSHQ6$567('7FDWDORJXV •,QSULQFLSHQHPHQGHVWHUNWHZDDUGHQYDQNXQVWVWRĳHQDILQKHWWHPSHUDWXXUEHUHLNRQGHUbƓ&0HFKDQLVFKHEHODVWLQJPRHWGDDURPLQKHWDOJHPHHQZRUGHQYHUPHGHQ

•De invriesomstandigheden moeten zo worden gekozen dat de inhoud van een S-Monovette®JHOİNPDWLJRIYDQRQGHUHQQDDUERYHQEHYULHVW'H60RQRYHWWH® moet voldoende speling hebben in een houder of
RSEHUJNDUWRQRPXLW]HWWLQJPRJHOİNWHPDNHQ+RXGHUVYDQSRO\VW\UHHQRIPHWDDO]İQRQJHVFKLNWRPGDW]İWRWXLW]HWWLQJVVFKHXUHQNXQQHQOHLGHQ

Invriezen tot -20 °C - Voor het invriezen controleren:•,QWHUIHUHQWLHV&RQWUROHHURIKHWLQYULH]HQVWRUHQGHLQYORHGHQKHHIWRSKHWEORHGPRQVWHURIGHDQDO\VH EİYKHPRO\VHVWDELOLWHLWYDQGHDQDO\WHQ •&HQWULIXJDWLH$IKDQNHOİNYDQGHJHSODQGHDQDO\VHYHUHLVW&HQWULIXJDWLHRPVWDQGLJKHGHQ]LHGLWGRFXPHQWRQGHU &HQWULIXJDWLH RI6$567('7:HEVLWHhttps://www.sarstedt.com/en/service/centrifugation/ in acht
nemen en visuele monstercontrole uitvoeren.

•+HPRO\VH9ROEORHGJHKHPRO\VHHUGWİGHQVLQYULH]HQ2PWHYHUPİGHQPRHWRIZHOGH60RQRYHWWH® gel resp. na de centrifugatie het Seraplas®YHQWLHOıOWHUZRUGHQJHEUXLNWRIKHWPRQVWHULQHHQVHFXQGDLUEXLVMH
worden gepipetteerd.

Invriezen tot -20 °C - Uitvoering:•

Koelen: Koel de S-Monovette®UHFKWRSJHGXUHQGHHHQSHULRGHYDQPLQYDQNDPHUWHPSHUDWXXUWRWƓ&DIYRRUDOHHU]HEİbƓ&NDQZRUGHQLQJHYURUHQ•2QWGRRLHQ/DDWWHQPLQVWHPLQEİNDPHUWHPSHUDWXXUUHFKWRSRQWGRRLHQ2RNKLHUPRHWPHFKDQLVFKHEHODVWLQJZRUGHQYHUPHGHQ7HVQHOOHRQWGRRLLQJNDQOHLGHQWRWEHðQYORHGLQJYDQGHDQDO\VHUHVXOWDWHQ,QYULH]HQHQGLHSYULH]HQRQGHUbƓ&•'LHSYULH]HQWRWRQGHUbƓ&LVGRRUGHIDEULNDQWQLHWJHWHVW*H]LHQKHWJURWHDDQWDOPRJHOİNHEHðQYORHGHQGHIDFWRUHQZRUGWDDQEHYROHQLQYULHVWHVWVXLWWHYRHUHQRQGHUURXWLQHPDWLJHODERUDWRULXPRPVWDQGLJKHGHQ

Invriezen van de S-Monovette® gel:•Het invriezen gebeurt zoals beschreven onder punt invriezen op -20 °C - Uitvoering:•+HWLVEHNHQGGDWGHJHOODDJGRRUKHWLQYULHVSURFHVNDQZİ]LJHQ

•*H]LHQKHWJURWHDDQWDOPRJHOİNHEHðQYORHGHQGHIDFWRUHQZRUGWDDQEHYROHQLQYULHVWHVWVXLWWHYRHUHQRQGHUURXWLQHPDWLJHODERUDWRULXPRPVWDQGLJKHGHQ

•Ontdooien: Laat het monster rechtop ontdooien. Het monstermateriaal na het ontdooien door te pipetteren (niet decanteren) tot ca. 2 mm boven de gellaag uit het primaire buisje in een secundair buisje brengen.
Gooi de rest weg.
OPMERKING: Voor de stabiliteit van de analyten moeten de gebruikershandleidingen van de fabrikanten van de testreagentia/analyseapparaten worden opgevolgd.

141

NL
Bloedafname
Afnametechnieken
Men onderscheidt twee afnametechnieken: de aspiratietechniek en de vacuümtechniek.
De aspiratietechniek maakt door het gecontroleerd trekken van de zuigstang een zachte bloedafname mogelijk met een continue, langzame bloedstroom. Zo kan de bloedstroom onmiddellijk aan alle venenverhoudingenen omstandigheden worden aangepast en hemolyse verminderen.
De vacuümtechniek maakt door een voorgeëvacueerd buisje de bloedafname mogelijk volgens het onderdrukprincipe met een continue snelle bloedstroom. Daarom is deze techniek uitstekend geschikt voor goedeaderverhoudingen en eenvoudige afnameomstandigheden.
Gebruik voor bloedafname: zie ook de video over het gebruik van de S-Monovette® in de aspiratietechniek resp. vacuümtechniek met de Safety-naald resp. Safety-Multifly® naald:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
DRAAG HANDSCHOENEN TIJDENS DE BLOEDAFNAME OM HET BLOOTSTELLINGSRISICO TE BEPERKEN.
1. Kies de geschikte S-Monovette® voor de vereiste monstername.
2.

.LHVGHSODDWVYRRUKHWDDQSULNNHQYDQGHDGHU9ROJGHULFKWOİQHQYDQGHLQVWHOOLQJYRRUGHYRRUEHUHLGLQJYDQGHSULNSODDWVLQGHDGHU

Bloedafname met de aspiratietechniek
LET OP! S-Monovette® enkel gebruiken voor de bloedafname en niet voor injectie.
Gebruik enkel met deze naalden (S-Monovette® (Safety-)naalden of (Safety-)Multifly®-naalden/adapters voor de S-Monovette®).
Hier wordt de toepassing met de Safety-naald getoond:klik

Schuif onmiddellijk voor het aanprikken van de ader de S-Monovette® in de geïntegreerde houder van de Safety-naald
en vergrendel deze door lichtjes met de klok mee te draaien .
Plaats indien nodig de stuwband (max. 1 minuut). Bereid de prikplaats met geschikt desinfectiemiddel voor. Raak de prikplaats van de ader na de desinfectie niet meer aan. Plaats de patiënt zo
dat u gemakkelijk bij de ader kunt komen en leg de arm of een andere punctiezone van de patiënt indien mogelijk naar beneden.
Verwijder de naaldbescherming. Prik de ader aan, trek de zuigstang langzaam terug en maak de stuwband los terwijl het bloed in de S-Monovette® stroomt
Wacht tot de bloedstroom stopt om zo een correcte vulling mogelijk te maken.

.

Beweeg de S-Monovette® door lichtjes tegen de klok in te draaien
en trek deze dan uit de Safety-naald . Safety-naald blijft in de ader.
Koppel bij bloedafname met meerdere buisjes zoals hierboven beschreven de volgende S-Monovetten met de Safety-naald en neem verdere monsters af.
Beëindigen van de bloedafname: Ontkoppel eerst de S-Monovette®
+ , trek dan de Safety-naald uit de ader. Met de eenhandtechniek de naaldbescherming ofwel op een stevig, effen vlak - tot de naald
met een voel- en hoorbare 'klik' in de naaldbescherming klikt (activeren) - of door te drukken met de wijsvinger tegen het onderste uiteinde van de naaldbescherming activeren, zie ook gebruikershandleiding
voor de S-Monovette® (Safety-)naald of (Safety)Multifly®-naald.
Elke S-Monovette® direct na de ontkoppeling van de Safety-naald 1x ondersteboven draaien en na het beëindigen van de volledige bloedafname alle monsters met anticoagulans zorgvuldig meermaals
ondersteboven draaien!
Trek voor transport en centrifugatie de zuigerstang hoorbaar in de klikpositie van de zuiger(zuiger klikt in de S-Monovette®-bodem) en breek de zuigerstangaf.
1.

Druk met een droog, kiemarm watje op de prikplaats tot de bloeding stopt.

2.

Zodra de bloedstolling geactiveerd is, plaatst u een verband, indien gewenst.

3.

*RRLGH6DIHW\QDDOGLQHHQDIYDOFRQWDLQHUYRRUJHYDDUOİNELRORJLVFKDIYDO

142

NL
Bloedafname met de vacuümtechniek
Let op! S-Monovette® enkel gebruiken voor de bloedafname en niet voor injectie.
Gebruik enkel met deze naalden (S-Monovette® (Safety-)naalden of (Safety-)Multifly®-naalden/adapters voor de S-Monovette®).
Hier wordt de toepassing met de Safety-naald getoond:klik

Om de bloedafname zacht te beginnen, raadt SARSTEDT aan de eerste S-Monovette® met de aspiratietechniek af te nemen, zie Bloedafname met de aspiratietechniek
Ga daarna verder met de vacuümtechniek.
Trek voor de bloedafname de zuiger tot aan de S-Monovette®-bodem en laat deze hoorbaar
vastklikken. Dan wordt de zuigerstang afgebroken .
Schuif deze voorbereide S-Monovette® in de geïntegreerde houder van de S-Monovette® Safety-naald en vergrendel deze door lichtjes met de klok mee te draaien

–

+

.

.

Wacht tot de bloedstroom stopt om zo een correcte vulling mogelijk te maken.

Beweeg de S-Monovette® door lichtjes tegen de klok in te draaien en trek deze dan uit de Safety-naald . Safety-naald blijft in de ader.
Koppel bij bloedafname met meerdere buisjes zoals hierboven beschreven eerst volgende S-Monovetten met de Safety-naald en neem verdere monsters af.
Beëindigen van de bloedafname:
Ontkoppel de S-Monovette®
+ , trek dan de Safety-naald uit de ader. Met de eenhandtechniek de naaldbescherming ofwel op een stevig, effen vlak - tot de naald met een voel- en hoorbare 'klik' in denaaldbescherming klikt (activeren) - of de naaldbescherming door te drukken met de wijsvinger tegen het onderste uiteinde van de naaldbescherming activeren.
Elke S-Monovette® direct na de ontkoppeling van de Safety-naald 1x ondersteboven draaien en na het beëindigen van de volledige bloedafname alle monsters met anticoagulans zorgvuldig meermaals
ondersteboven draaien!
1.

Druk met een droog, kiemarm watje op de prikplaats tot de bloeding stopt.

2.

Zodra de bloedstolling geactiveerd is, plaatst u een verband, indien gewenst.

3.

*RRLGH6DIHW\QDDOGLQHHQDIYDOFRQWDLQHUYRRUJHYDDUOİNELRORJLVFKDIYDO

143

NL
Centrifugatie
LET OP! SARSTEDT S-Monovetten zijn ontworpen voor 4.000 x g. Uitgezonderd zijn S-Monovetten met Ø 8 mm (S-Monovette® pediatrie), die momenteel tot 2.500 x g zijn gevalideerd. Er mogen alleen geschiktedraagbuisjes of inzetstukken worden gebruikt. Het centrifugeren van microvetten met barsten of het centrifugeren met een te hoge centrifugale kracht kan de microvetten doen breken, waardoor potentieel gevaarlijke
stoffen kunnen vrijkomen.
Centrifuge-inzetstukken moeten worden gekozen op basis van de grootte van de gebruikte S-Monovetten. De relatieve centrifugale kracht is als volgt gerelateerd aan het ingestelde aantal omwentelingen/min:
RCK = 11,2 x r x (tmp/1000)2,
RCK: 'Relatieve centrifugale kracht ook 'g-kracht' genaamd', (Engels: RCF, relative centrifugal force”),'Tpm': 'Toeren per minuut' (U/min) of: n = 'toerental per minuut' (Engels: RPM 'revolutions per minute'),'r': 'Radius van het midden van de centrifuge tot de bodem van de S-Monovette®', (cm).
S-Monovetten zonder gel kunnen worden gecentrifugeerd in centrifuges met een rotor met vaste hoek of met een uitzwenkbare rotor.
S-Monovetten met gel zijn uitsluitend ontworpen voor centrifuges met uitzwenkbare rotor. Centrifugeren in centrifuges met een rotor met een vaste hoek is niet gevalideerd door SARSTEDT en wordt niet aanbevolen.
De S-Monovetten moeten worden gecentrifugeerd volgens de hieronder vermelde centrifugeervoorwaarden. Indien andere voorwaarden gehanteerd worden, dienen deze door de gebruiker zelf gevalideerd te worden.
Zorg ervoor dat de S-Monovetten goed in de centrifuge-inzetstukken passen. S-Monovetten die buiten het inzetstuk uitsteken, kunnen aan de centrifugekop vast komen te zitten en breken. De centrifuge moetgelijkmatig worden gevuld. Raadpleeg hiervoor de gebruikershandleiding van de centrifuge.
9225=,&+7,* 9HUZİGHU JHEURNHQ 60RQRYHWWHQ QLHW PHW GH KDQG
Instructies voor het desinfecteren van de centrifuge vindt u in de gebruikershandleiding van de centrifuge.

Volgens BS
4851+ (EUcode)–

Relatieve centrifugale kracht (g)S-Monovette®

DIN EN ISO 6710

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*Serum

10 min10 min

6 min

4 min

4 min

Serumgel15 min10 min

4 min

4 min

4 min

Serum Express Gel

15 min10 min

4 min

n.g.

n.g.

Lithiumheparine

10 min10 min

7 min

7 min

7 min

Lithiumheparinegel

15 min15 min10 min

7 min

7 min

Lithiumheparinegel+

8 min

7 min

5 min

4 min

4 min

EDTA

n.g.

n.g.

7 min

6 min

5 min

EDTA-gel15 min10 min10 min

7 min

7 min

Citraat

9 min

8 min

7 min

6 min

5 min

('7$ĲXRULGHKHSDULQH

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Citraat PBM 1,8 ml
Centrifugeerradius > 17 cm

9 min

8 min

7 min

6 min

5 min

Citraat PBM 1,8 ml&HQWULIXJHHUUDGLXV!WRWƉFP

n.g.

n.g.

10 minn.g.

n.g.

n.v. = niet gevalideerd* Geldt voor alle S-Monovetten met uitzonderingvan Ø 8 mm (S-Monovetten pediatrie).

&HQWULIXJDWLHEİų&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, teruggetrokken.

Informatie omtrent scheidingsmateriaal
Stroomeigenschappen van het scheidingsmateriaal (gel) zijn afhankelijk van de temperatuur. Worden S-Monovetten voor of tijdens de centrigutatie gekoeld, dan is een doorlopende laag van de scheidingsgel niet meer
gegarandeerd.
S-Monovetten mogen niet opnieuw worden gecentrifugeerd/gerecentrifugeerd.

9HUZİGHULQJ
1.

'HDOJHPHQHK\JLßQHULFKWOİQHQHQGHZHWWHOİNHEHSDOLQJHQYRRUGHFRUUHFWHYHUZİGHULQJYDQLQIHFWLHXVPDWHULDDOPRHWHQZRUGHQQDJHOHHIG

2.

Wegwerphandschoenen voorkomen het risico op infectie.

3.

*HFRQWDPLQHHUGHRIJHYXOGHEORHGDIQDPHV\VWHPHQPRHWHQZRUGHQYHUZİGHUGLQJHVFKLNWHFRQWDLQHUVYRRUJHYDDUOİNHELRORJLVFKHVWRĳHQGLHYHUYROJHQVNXQQHQZRUGHQJHDXWRFODYHHUGHQYHUEUDQG

4.

9HUZİGHULQJGLHQWSODDWVWHYLQGHQLQHHQJHVFKLNWHYHUEUDQGLQJVRYHQRIGRRUPLGGHOYDQDXWRFODYHUHQ VWRRPVWHULOLVDWLH 

144

NL
3URGXFWVSHFLıHNHQRUPHQHQULFKWOİQHQLQGHKXLGLJHJHOGLJHYHUVLHCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

1RUPEİEXLVMHVYRRUGHYHQHX]HEORHGDIQDPHDIN EN ISO 6710: Buisjes voor eenmalig gebruik voor veneuze bloedafname bij mensen*CLSI (Clinical and Laboratory Standards Institute)

Informatie over symbolen en markeringen:

Artikelnummer%İNRPHQGJHOGWYRRUDI]RQGHUOİNVWHULHOYHUSDNWHSURGXFWHQ

Lotnummer

Niet gebruiken als de verpakking is beschadigd

EXP

Enkelvoudig steriel barrièresysteem met beschermende buitenverpakking

CE-markering

Sterilisatie door bestraling

In-vitro diagnosticum

Gebruikershandleiding opvolgen%İKHUJHEUXLN5LVLFRRSEHVPHWWLQJ

Niet blootstellen aan zonlicht

Droog bewaren

FabrikantLand van productie

Steriele vloeistofbaan

Niet opnieuw steriliseren

Technische wijzigingen voorbehouden.
Alle ernstige incidenten met betrekking tot het product moeten worden gemeld aan de fabrikant en de bevoegde nationale instantie.

145

Bruksanvisning – SARSTEDT S-Monovette®-blodprøvetakingssystemNO

Til in vitro-diagnostisk bruk
Bruksformål
S-Monovette®-blodprøvetakingssystemer, kanyler og adaptere brukes sammen som et system til venøs blodprøvetaking. S-Monovette®-blodprøvetakingssystemer brukes til uttak, transport, bearbeiding og oppbevaring
av blodprøver til in vitro-diagnostiske bestemmelser av serum, plasma eller helblod i klinisk laboratorium. Produktet er ment brukt i profesjonelt miljø av medisinsk fagpersonale og laboratoriepersonale.

Produktbeskrivelse
S-Monovette®-blodprøvetakingssystemer består av en plastbeholder, et stempel, en stempelstang og fargekodet skrukork av plast med integrert membran, som er spesielt utviklet for tilkobling til en
S-Monovette® (Safety-)kanyle eller (Safety-) Multifly®-kanyle, samt forskjellige additiver (prepareringer). En S-Monovette® uten additiv er også tilgjengelig. S-Monovette®-blodprøvetakingssystemer med de additive
koaguleringsaktivatorene, koaguleringsaktivator med gel, litiumheparin, litiumheparin med gel, natriumheparin, citrat, EDTA, fluorid EDTA, fluoridheparin, fluoridcitrat, CPDA samt uten additiv, hvis additivkonsentrasjoner,
YROXPHWWLOGHIO\WHQGHDGGLWLYHQHRJGHUHVWLOODWWHWROHUDQVHVDPWIRUKROGHWPHOORPEORGRJDGGLWLYWLOVYDUHUNUDYHQHRJDQEHIDOLQJHQHLGHQLQWHUQDVMRQDOHVWDQGDUG',1(1,62ŝ6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŞVDPW&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHVLQHJRGNMHQWHVWDQGDUGHU &/6, +YLONHWDGGLWLYVRPYHOJHVDYKHQJHUDYGHQDQDO\WLVNHWHVWPHWRGHQ'HQQHEHVWHPPHVDYSURGXVHQWHQ
av prøvereagensene og/eller av produsenten av analyseutstyret som testen gjennomføres med. S-Monovette®-blodprøvetakingssystemer finnes i innvendig sterile utførelser eller i enkeltpakninger som er innvendig og
utvendig sterile.

Fargekodene til S-Monovette® skrukorkene*:

Additiv

Bokstavkode

Hettefarge DIN EN ISO
6710

Hettefarge etter BS 4851+

Z

hvit

hvit

Rør uten preparering
S-Monovette® nøytral Z
Serumrør
S-Monovette® serum CAT, med koaguleringsaktivator

CAT

rød

hvit

S-Monovette® serumgel CAT, med koaguleringsaktivator og gelCAT

mørkegulmørkegul

S-Monovette® serum express gel CAT, med koaguleringsaktivator trombin og gelCAToransje-Heparinrør
S-Monovette® litiumheparin LH, med litiumheparin

LH

grønn

oransje

S-Monovette®OLWLXPKHSDULQĲ\WHQGH/+PHGOLWLXPKHSDULQ

LH

grønn

oransje

S-Monovette® litiumheparin gel LH, med litiumheparin og gel

LH

grønn

oransje

S-Monovette® litiumheparin gel+ LH, med litiumheparin og hurtiggel

LH

grønn

oransje

S-Monovette® natriumheparin NH, med natriumheparin

NH

brun

grønn

S-Monovette® ammoniumheparin AH, med ammoniumheparin

i.d.

blå

blå

S-Monovette®FLWUDW1&QDWULXPFLWUDWb

9NC

blå

grønn

S-Monovette 3)$FLWUDW1&QDWULXPFLWUDWbEXIUHW

9NC

lyseblå

-S-Monovette® K3 EDTA K3E, med kalium EDTA

K3E

ıROHWW

rød

S-Monovette® K2 EDTA K2E, med kalium EDTA

K2E

ıROHWW

rød

S-Monovette® K2 EDTA-gel K2E, med kalium EDTA og gel

K2EıROHWW

rød

S-Monovette®ĲXRULG('7$)(PHGĲXRULGRJ('7$

FE

grå

gul

S-Monovette®ĲXRULGKHSDULQ)+PHGĲXRULGRJKHSDULQ

FH

-

gul

S-Monovette®*OXFR(;$&7)&PHGĲXRULGFLWUDWRJ('7$

FC

rosa

grå

LH

mørkeblå

oransje

S-Monovette® ThromboExact, med magnesiumforbindelse

i.d.

i.d., bringebærfargeti.d., bringebærfarget

S-Monovette® CTAD

i.d.

i.d., blåi.d., grønn

S-Monovette® ACD

ACD

gul

gul

S-Monovette® CPDA

CPDA

gul

gul

S-Monovette® hirudini.d.

i.d., olivengrønni.d., olivengrønn

S-Monovette® homocystein HCY-Z gel, med gel og stabilisatori.d.

i.d., gråi.d., gråS-Monovette®KRPRF\VWHLQ+&<&PHGFLWUDWEXĳHU

i.d.

LGıROHWW

LGıROHWW

S-Monovette® DNA Exacti.d.

i.d., blåi.d., blåCitratrør®

EDTA-rør

Rør med glykolysehemmer

Rør for metallanalyse
S-Monovette® metallanalyse LH, med litiumheparin

Ytterligere helblod- og plasmarø* Ytterligere skrukorkfarger er tilgjengelige.
i.d.: ikke definert+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, trukket tilbake.

146

NO
SARSTEDT S-Monovette® serum CAT / serumgel CAT
S-Monovette® serum CAT inneholder et plastgranulat som er belagt med en koaguleringsaktivator (silikat) og brukes til utvinning av serum**. Plastgranulatet setter seg mellom blodclot og serum gjennom sentrifugering.
S-Monovette® serumgel CAT inneholder, i tillegg til plastgranulatet som er belagt med en koaguleringsaktivator (silikat), også en polymerbasert gel og brukes til utvinning av serum**. Gelen setter seg mellom blodclot og
serum gjennom sentrifugering, og danner et stabilt skillelag under transport, oppbevaring og analyse.
Serum brukes som prøvemateriale i klinisk-kjemiske og immunologiske rutineundersøkelser samt innen serologi.
Etter bloduttaket skal blodet koagulere i S-Monovette®VHUXP&$7VHUXPJHO&$7LbPLQXWWHUPHQVGHQVWÎULORGGUHWWSRVLVMRQVOLNDWGHWVLNUHVDWGHWGDQQHUVHJHWW\GHOLJKRULVRQWDOWVNLOOHODJHWWHUVHQWULIXJHULQJHQDen anbefalte tiden baserer seg på en intakt koaguleringsprosess. Blod fra pasienter med sykdomsbetingede koagulasjonsforstyrrelser eller som behandles med koagulasjonshemmende legemidler, trenger eventuelt
lengre tid til fullstendig koagulering.

SARSTEDT S-Monovette® serum express gel CAT
S-Monovette® serum express gel CAT inneholder, i tillegg til plastgranulatet som er belagt med koaguleringsaktivatoren (trombin), også en polymerbasert gel og brukes til utvinning av serum**. Gelen setter seg mellom
blodclot og serum gjennom sentrifugering, og danner et stabilt skillelag under transport, oppbevaring og analyse.
Etter bloduttaket skal blodet koagulere i S-Monovette®VHUXPH[SUHVVJHO&$7LbPLQXWWHUPHQVGHQVWÎULORGGUHWWSRVLVMRQVOLNDWGHWVLNUHVDWGHWGDQQHUVHJHWW\GHOLJKRULVRQWDOWVNLOOHODJHWWHUVHQWULIXJHULQJHQDen anbefalte varigheten baserer seg på en intakt koaguleringsprosess, selv for blod fra hepariniserte pasienter. Blod fra pasienter med sykdomsbetingede koagulasjonsforstyrrelser eller som behandles med
koagulasjonshemmende legemidler inkludert høydosert heparin, trenger lengre tid til fullstendig gjennomkoagulering.
Serum brukes som prøvemateriale i klinisk-kjemiske og immunologiske rutineundersøkelser samt innen Serologi.

SARSTEDT S-Monovette® nøytral Z
S-Monovette® nøytral Z inneholder ingen preparering, noe som tilsvarer en naturlig koagulering av blodprøven uten koaguleringsaktivator, og den brukes til utvinning av serum**. Sentrifugeringen fører til en separering
mellom blodclot og serum.
Serum brukes som prøvemateriale for brukerspesifikke tom beholder.
Utover dette kan S-Monovette® nøytral Z også brukes som tombeholder på følgende måte: Hvis bloduttaket skal begynnes med en S-Monovette® citrat i kombinasjon med en (Safety-)Multifly®-kanyle(sommerfuglkanyle), så blir S-Monovetten® nøytral Z brukt som første beholder (tombeholder) til fylling av slangen til (Safety-)Multifly®-kanylen.

SARSTEDT S-Monovette® litiumheparin LH / litiumheparin-gel LH / litiumheparin-gel+ LH, natriumheparin NH, ammoniumheparin AH
S-Monovette® litiumheparin LH / natriumheparin NH / ammoniumheparin AH inneholder et plastgranulat som er belagt med koagulasjonhemmeren (antikoagulanten) litiumheparin / natriumheparin / ammoniumheparin(som regel 16 I.E. heparin / ml blod), og brukes til utvinning av helblod og plasma**. Plastgranulatet setter seg mellom blodcellene og plasma gjennom sentrifugering.
På en S-Monovette® litiumheparin LH uten plastgranulat, foreligger antikoagulanten litiumheparin i spraydosert form (som regel 19 I.E. heparin / ml blod).
S-Monovette® litiumheparin-gel LH inneholder, i tillegg til plastgranulatet som er belagt med antikoagulanten litiumheparin (som regel 25 I.E. heparin / ml blod), også en polymerbasert gel og brukes til utvinning av
plasma**. Gelen setter seg mellom blodcellene og plasmaet gjennom sentrifugering, og danner et stabilt skillelag under transport, oppbevaring og analyse.
S-Monovetter+ litiumheparin-gel+/+LQQHKROGHURJVÎHQSRO\PHUEDVHUWJHOVRPPXOLJJMĉUHQVHQWULIXJHULQJVWLGVRPUHGXVHUHVPHGFDbVDPPHQOLJQHWPHG60RQRYHWWH® litiumheparin-gel.
Heparinplasma brukes som prøvemateriale i klinisk-kjemiske og immunologiske rutineundersøkelser. Heparinhelblod brukes som prøvemateriale i immunologiske rutineundersøkelser samt innen serologi.
Koagulasjonshemmingen med heparin finner sted ved at antitrombin aktiveres.
MERKNAD: Det skal ikke utføres litiumsbestemmelser basert på S-Monovette® litiumheparin LH, litiumheparin gel/gel+ LH, det må ikke utføres natriumbestemmelser basert på S-Monovette®
natriumheparin NH og det må ikke utføres ammoniumsbestemmelser basert på S-Monovette® ammoniumheparin AH. En S-Monovette® litiumheparin/litiumheparin gel/gel+ natriumheparin/ammoniumheparin som er fylt med venøst blod, er ikke egnet for blodgassanalyse.

SARSTEDT S-Monovette® metallanalyse
S-Monovette® metallanalyse inneholder antikoagulanten litiumheparin, og brukes til utvinning av helblod og plasma**. Litiumheparin foreligger i spraydosert form (19 I.E. heparin / ml blod).
Heparinhelblod eller heparinplasma til S-Monovette® metallanalyse kombinert med den spesielle Safety-kanylen 21G x 1 ½" (art.nr. 85.1162.600) brukes som prøvemateriale til undersøkelsen av sporelementer.
Sporelementene ble validert ved hjelp av atomabsorpsjonsspektrometri (AAS). For systemet Safety-kanyle og S-Monovette® metallanalyse oppstår følgende maksimale blindverdier i ng/systemet for disse
sporelementene:

ElementTl

ng/system

2,5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1,5

8,0

5,0

5

50

70

70

10

40

10

10

De maksimale blindverdiene er angitt for hvert element på etiketten til S-Monovette®.
Bestemmelser av sporelementer finner sted basert på heparinhelblod eller heparinplasma, avhengig av analyseprosessen.
Koagulasjonshemmingen med heparin finner sted ved at antitrombin aktiveres.

SARSTEDT S-Monovette® citrat 9NC
S-Monovette®FLWUDW1&LQQHKROGHUDQWLNRDJXODQWHQWULQDWULXPFLWUDWRJEUXNHVWLOXWYLQQLQJDYKHOEORGRJSODVPD 7ULQDWULXPFLWUDWIRUHOLJJHUVRPPRODUOĉVQLQJ bWULQDWULXPFLWUDWOĉVQLQJRIWHDYUXQGHWWLO
b RJXWJMĉUbDYGHWQRPLQHOOHYROXPHWWLOHQ60RQRYHWWH® citrat. Blandingsforholdet mellom citrat og blod er 1:9 – 1 volumandel citrat og 9 volumandeler blod. Riktig fylling er absolutt nødvendig for analysen.
Citratplasma brukes som prøvemateriale i hemostaseologiske rutineundersøkelser.
Koagulasjonshemmingen finner sted gjennom komplekseringen av kalsiumionene vha. citrat.
Følg alltid MERKNADENEunder prøvetaking og håndtering ved sammenkobling av S-Monovette® citrat og sommerfuglkanylen.

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&LQQHKROGHUDQWLNRDJXODQWHQWULQDWULXPFLWUDWRJEUXNHVWLOXWYLQQLQJDYKHOEORGRJSODVPD 7ULQDWULXPFLWUDWIRUHOLJJHUVRPPRODUEXIUHWOĉVQLQJ bEXIUHWS+ RJXWJMĉUbDYGHW
nominelle volumet til en S-Monovette® PFA. Blandingsforholdet mellom citrat og blod er 1:9 – 1 volumandel citrat og 9 volumandeler blod. Riktig fylling er absolutt nødvendig for analysen.
Helblodet i S-Monovette® PFA 9NC brukes som prøvemateriale til bestemmelse av trombocyttfunksjonen med SIEMENS Healthineers-analyseutstyret PFA og er validert for dette.
Koagulasjonshemmingen finner sted gjennom komplekseringen av kalsiumionene vha. citrat.
Alltid Følg MERKNADENE under prøvetaking og håndtering ved sammenkobling av S-Monovette® PFA og sommerfuglkanylen.

SARSTEDT S-Monovette® CTAD
S-Monovette®&7$'LQQHKROGHUDQWLNRDJXODQWHQWULQDWULXPFLWUDWVDPWWHRI\OOLQDGHQRVLQRJGLS\ULGDPRORJEUXNHVWLOXWYLQQLQJDYKHOEORGRJSODVPD &7$'IRUHOLJJHUVRPOĉVQLQJRJXWJMĉUbDYGHWQRPLQHOOH
volumet til en S-Monovette® CTAD. Blandingsforholdet mellom CTAD og blod er 1:9 – 1 volumandel CTAD og 9 volumandeler blod. Riktig fylling er absolutt nødvendig for analysen.
CTAD-plasma brukes som prøvemateriale til bestemmelse av trombocyttfaktor 4 (PF4), beta(ß)-tromboglobulin (ßTG) og plasminogenaktivatorhemmer (PAI-1), samt til hemostaseologiske rutineundersøkelser.
7URPERF\WWDNWLYHULQJHQKHPPHVRYHUHWWLGVURPSÎPLQVWbWLPHURJEUXNHVWLORYHUYÎNLQJDYKHSDULQEHKDQGOLQJ
Koagulasjonshemmingen finner sted gjennom komplekseringen av kalsiumionene vha. citrat.
Følg alltid MERKNADENE under prøvetaking og håndtering ved sammenkobling av S-Monovette® CTAD og sommerfuglkanylen.
MERKNAD: CTAD er gul. S-Monovette®&7$'PÎEHVN\WWHVPRWNXQVWLJRJQDWXUOLJO\VXQGHURSSEHYDULQJHQ.UDIWLJO\VSÎYLUNQLQJRYHUPHUHQQbWLPHUNDQIĉUHWLODWDGGLWLYHQHEOLULQDNWLYH

SARSTEDT S-Monovette® EDTA K2E/K3E
S-Monovette® EDTA K2E / S-Monovette® EDTA K3E inneholder antikoagulanten K2 EDTA eller K3 EDTA og brukes til utvinning av helblod**. K2 EDTA og K3 EDTA er i spraydosert form (1,6 mg EDTA / ml blod).
EDTA-helblod brukes som prøvemateriale for hematologiske undersøkelser. Blodutstrykninger skal ferdiggjøres innen fire timer etter bloduttaket.
Koagulasjonshemmingen finner sted gjennom komplekseringen av kaliumionene vha. EDTA.
Blod fra S-Monovette® EDTA K2E/K3E kan også brukes til immunhematologiske rutineundersøkelser og tester av infeksjonssykdommer. Det er brukerens ansvar å validere prøvematerialets egnethet for disse testene
med passende testreagenser/analyseenheter inkludert lagringsforholdene.

147

NO
SARSTEDT S-Monovette® EDTA-gel K2E
S-Monovette® EDTA-gel K2E inneholder, i tillegg til antikoagulanten K2 EDTA, også en polymerbasert gel og brukes til utvinning av plasma**. K2 EDTA foreligger i spraydosert form (1,6 mg EDTA / ml blod). Gelen setterseg mellom blodcellene og plasmaet gjennom sentrifugering, og danner et stabilt skillelag under transport, oppbevaring og analyse.
EDTA-plasma brukes som prøvemateriale for molekylær virusdiagnostikk.
Koagulasjonshemmingen finner sted gjennom komplekseringen av Kaliumionene vha. EDTA.

SARSTEDT S-Monovette®ĲXRULG('7$)(ĲXRULGKHSDULQ)+ĲXRULGFLWUDW('7$)&PHGJO\NRO\VHKHPPHU
S-Monovette®IOXRULG('7$)(LQQHKROGHUDQWLNRDJXODQWHQ('7$ bPJPOEORG VDPWIOXRULG bPJPOEORG WLOJO\NRO\VHKHPPLQJRJEUXNHVWLOXWYLQQLQJDYSODVPD )OXRULG('7$IRUHOLJJHULVSUD\GRVHUWIRUP
S-Monovette®IOXRULGKHSDULQ)+LQQHKROGHUDQWLNRDJXODQWHQKHSDULQ bPJPOEORG VDPWIOXRULG bPJPOEORG WLOJO\NRO\VHKHPPLQJRJEUXNHVWLOXWYLQQLQJDYSODVPD )OXRULGKHSDULQIRUHOLJJHULVSUD\GRVHUWIRUP
*O\NRO\VHKHPPLQJHQIUDIOXRULGDOHQHEHJ\QQHUFDbWLPHUHWWHUI\OOLQJDYEORGXWWDNVEHKROGHUHQRJRSSQÎUVLQIXOOHYLUNQLQJHWWHUFDbWLPHU*OXNRVHQQHGEU\WHVGHUIRULKHOEORGHWJMHQQRPVQLWWOLJLQQWLObHWWHUQRHQIÎWLPHURJLQQWLOşbHWWHUbWLPHU
S-Monovette® GlucoEXACT FC inneholder antikoagulanten EDTA samt citrat og fluorid til øyeblikkelig glykolysehemming, og brukes til utvinning av plasma. EDTA, citrat og fluorid foreligger som løsning. På grunn av
fortynningen krever beregningen av glukosekonsentrasjonen multiplikasjon med 1,16.
S-Monovette® GlucoEXACT FC oppfyller retningslinjen for gestasjonsdiabetes fra Det tyske diabetesselskapet (Deutsche Diabetes Gesellschaft – DDG) og tysk nasjonal forsyningsretningslinje (National
9HUVRUJXQJV/HLWOLQLHş19/ IRUGLDEHWHVW\SH'HQĉ\HEOLNNHOLJHVWDELOLVHULQJHQDYJOXNRVHNRQVHQWUDVMRQHQJDUDQWHUHVLLQQWLObWLPHUYHGURPWHPSHUDWXUVHRJVÎ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/
en/products/diagnostic/venous-blood/s-monovetter//LWHUDWXUHŝ6DUVWHGW60RQRYHWWH®*OXFR(;$&7$EORRGFROOHFWLRQGHYLFHIRUVWDELOL]LQJJOXFRVHOHYHOVIRUKRXUVŞ
Fluorid-EDTA (citrat-)plasma brukes som prøvemateriale for glukosebestemmelse.
Koagulasjonshemmingen finner sted gjennom komplekseringen av kaliumionene vha. EDTA.
0(5.1$')OXRULGNDQIRUÎUVDNHHQĉNQLQJDYKHPRO\VH<WWHUOLJHUHLQIRUPDVMRQRPVWRĳHUVRPNDQYLUNHQHJDWLYWHUDQJLWWLGHQUHVSHNWLYHEUXNVDQYLVQLQJHQIUDSURGXVHQWHQDYSUĉYHUHDJHQVHQH
Overhold alltid MERKNADENE under prøvetaking og håndtering ved sammenkobling av S-Monovette® GlucoEXACT og sommerfuglkanylen.

SARSTEDT S-Monovette® CPDA
S-Monovette® CPDA inneholder antikoagulanten trinatriumcitrat, og brukes til utvinning av helblod og plasma**. CPDA foreligger som løsning. Blandingsforholdet mellom CPDA og blod er 1:6 – 1 volumandel CPDA og 6
volumandeler blod. Riktig fylling er absolutt nødvendig for analysen.
CPDA-helblod/-plasma brukes som prøvemateriale til blodgruppeserologi innen transfusjonsmedisin, til toleranseundersøkelser (kryssprøver) ved transfusjoner. Konkret er S-Monovette® CPDA egnet til
blodgruppebestemmelse (AB0) inkludert Kell og rhesusformel, antistoff-screening for irregulære blodgruppeantistoffer, polyspesifikk direkte Coombs’ test (inntil dag 10), toleransetest (kryssprøve) med
blodgruppekompatibelt pasientserum/-plasma (major-test).
7UDQVSRUWWLGHQWLOODJULQJHQHUYDOLGHUWWLOPDNVLPDOWbWLPHUYHGşbƓ&7LOVHGLPHQWHULQJDYFHOOHQHPÎSUĉYHQHIĉUVWODJUHVVWÎHQGHORGGUHWWLPLQVWbWLPHULNMĉOHVNDSHW'HUHWWHUNDQGHRYHQQHYQWHDQDO\WWHQH
EHVWHPPHVLQQWLObGDJHUDQDORJWPHGGHQYDQOLJHODJULQJVWLGHQIRUEORGHWWHUODJULQJLNMĉOHVNDSHW şbƓ&  XQQWDWWGLUHNWH&RRPEVŖWHVWGDJHU (JQHWIRUVĉ\OHDJJOXWLQDVMRQVPHWRGHQIHNVSÎ9LVLRQ0D[IUD
Ortho Clinical Diagnostics. Prøvematerialet skal ikke fryses.
Prøvematerialets egnethet til disse undersøkelsene med andre metoder/prøvereagenter/analyseutstyr inkludert lagringsbetingelser er det brukerens ansvar å verifisere.
Koagulasjonshemmingen finner sted gjennom komplekseringen av kalsiumionene vha. citrat.
Overhold alltid MERKNADENE under prøvetaking og håndtering ved sammenkobling av S-Monovette® CPDA og sommerfuglkanylen.

SARSTEDT S-Monovette® ThromboExact
S-Monovette® ThromboExact inneholder et magnesiumsalt som antikoagulant og brukes til utvinning av helblod**. Magnesiumsaltet foreligger i spraydosert form.
Helblodet i S-Monovette® ThromboExact brukes som prøvemateriale til å utelukke falskt lave trombocyttverdier på grunn av en intoleranse overfor antikoagulanter (som EDTA, citrat, heparin), også betegnet som
SVHXGRWURPERF\WRSHQL'DQQHOVHDYWURPERF\WWDJJUHJDWHUIRUKLQGUHVRJJMĉUGHWPXOLJÎEHVWHPPHGHQIDNWLVNHWURPERF\WWYHUGLHQLQQWLObWLPHUHWWHUEORGXWWDNHW
Koagulasjonshemmingen finner sted via magnesiumioner, hvor magnesiumionene hemmer blodplatederivert tromboksan A2 samt trombocyttaggregasjonen som formidles gjennom ADP og arakidonsyre.

SARSTEDT S-Monovette® hirudin
S-Monovette® hirudin inneholder antikoagulanten hirudin og brukes til utvinning av helblod**. Hirudin foreligger i spraydosert form.
Hirudinhelblod brukes som prøvemateriale til bestemmelse av trombocyttfunksjonen på Multiplate®-apparatet (multiple platelet function analyser) fra ROCHE Diagnostics og er validert for dette. Midlet brukes til
behandlingsovervåking av blodplatehemmende medikamenter samt som bevis for eller utelukkelse av trombocyttfunksjonsforstyrrelser.
S-Monovette® hirudin er spesielt utviklet for å bestemme trombocyttfunksjonen sammen med firmaet Verum Diagnostica, i dag ROCHE Diagnostics, på Multiplate®.
Koagulasjonshemmingen finner sted vha. hirudin gjennom hemming av trombin, og gjør det slik mulig å foreta en diagnose av trombocyttfunksjonen i nativ tilstand.

SARSTEDT S-Monovette® homocystein HCY-Z-gel / HCY-C
S-Monovette® homocystein HCY-Z gel inneholder, i tillegg til plastgranulatet som er belagt med en koaguleringsaktivator (silikat), også en spesiell stabilisator samt en polymerbasert gel og brukes til utvinning av serum**.
Gelen setter seg mellom blodclot og serum gjennom sentrifugering, og danner et stabilt skillelag under transport, oppbevaring og analyse. Preparatet foreligger i spraydosert form.
+RPRF\VWHLQVWDELOLVHUHVLQQWLObWLPHULKHOEORGHWYHGURPWHPSHUDWXU'HUVRPVHQWULIXJHULQJHQILQQHUVWHGLQQHQGHIĉUVWHbWLPHQHPHGNRUUHNWGDQQHWVNLOOHODJPHOORPEORGNDNHRJVHUXPVÎVWDELOLVHUHVKRPRF\VWHLQL
LQQWLObWLPHU
Serumet fra S-Monovette® homocystein HCY-Z-gel brukes som prøvemateriale til bestemmelse av homocystein. S-Monovette® homocystein HCY-C inneholder surt citrat (pH 4,3) som antikoagulant og brukes til
utvinning av plasma**. Sitrat foreligger som løsning. På grunn av fortynningen krever beregningen av homocysteinkonsentrasjonen multiplikasjon med 1,11.
+RPRF\VWHLQVWDELOLVHUHVLKHOEORGHWLLQQWLObWLPHUYHGURPWHPSHUDWXURJLLQQWLObWLPHUYHGbƓ&
Plasmaet fra S-Monovette® homocystein HCY-Z brukes som prøvemateriale til bestemmelse av homocystein.
Koagulasjonshemmingen i S-Monovette® homocystein HCY-C finner sted gjennom komplekseringen av kalsiumionene vha. citrat.
Følg alltid MERKNADENE under prøvetaking og håndtering ved sammenkobling av S-Monovette® HCY-C og sommerfuglkanylen.

SARSTEDT S-Monovette® DNA Exact
S-Monovette® DNA Exact inneholder en EDTA-basert antikoagulant og brukes til utvinning av helblod**. EDTA foreligger i spraydosert form.
('7$KHOEORGEUXNHVVRPSUĉYHPDWHULDOHWLOVWDELOLVHULQJDYJ'1$6WDELOLVHULQJVHIIHNWHQIRUJ'1$HUYDOLGHUWRYHUbGDJHUYHGbƓ&bGDJHUYHGURPWHPSHUDWXU bƓ& GDJHUYHGNMĉOLQJ bƓ& RJPLQVWÎU
YHGƃbƓ&,WLOOHJJWÎOHUGHVWDELOLVHUWHSUĉYHQHQHGIU\VLQJVRJRSSWLQLQJVV\NOXVHUXWHQDWNYDOLWHWHQIRUULQJHVVHRJVÎ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/smonovetter//LWHUDWXUHŝ6$567('760RQRYHWWH®'1$([DFWş$1HZ,9'&HUWLILHG%ORRG&ROOHFWLRQ7XEHIRU&ROOHFWLRQ7UDQVSRUWDQG6WDELOL]DWLRQRI:KROH%ORRGIRU*HQRPLF'1$$QDO\VLVŞ
Koagulasjonshemmingen finner sted gjennom komplekseringen av Kaliumionene vha. EDTA.

**Egnetheten til prøvematerialet er avhengig av analytten og prøvereagenten/analyseutstyret. Følg de relevante anbefalingene fra produsenten.

148

NO
Sikkerhetsmerknader/advarsler
1.

Generelle forsiktighetstiltak: Bruk hansker og annet generelt personlig verneutstyr for å beskytte deg mot blod og en mulig eksponering overfor potensielt infeksiøst prøvemateriale og sykdomsfremkallende
VPLWWHVWRĳHUVRPNDQRYHUIĉUHVYLDEORG

2.

Behandle alle biologiske prøver og skarpt/spisst utstyr til blodprøvetaking (kanyler, adaptere) i henhold til gjeldende retningslinjer og prosedyrer ved din helseinstitusjon. Ved direkte kontakt med biologiske prøver
HOOHUXWLOVLNWHWQÎOHVWLNNPÎGXNRQWDNWHOHJHHWWHUVRPGHWWHNDQIĉUHWLODW+,9+&9+%9HOOHUDQGUHVPLWWVRPPHV\NGRPPHURYHUIĉUHV%UXN6DIHW\NDQ\OHU6DIHW\0XOWLĲ\®-kanyler med innebygget nålehette.
Sikkerhetsretningslinjene og -prosessene til helseinstitusjonen din skal overholdes.

3.

Gjelder for enkeltvis sterilt emballerte produkter: Før bruk skal hver enkeltpakning kontrolleres for skader – produktet skal ikke brukes ved eventuelle skader.

4.

3URGXNWHWHUEHUHJQHWWLOHQJDQJVEUXN$OOHVNDUSHVSLVVHJMHQVWDQGHU NDQ\OHUDGDSWHUH WLOEORGXWWDNVNDONDVVHUHVLHJQHGHDYIDOOVEHKROGHUHIRUELRORJLVNHIDUHVWRĳHU

5.

Dersom blod tas ut via en intravenøs (IV) tilgang, må det sikres at tilgangen skylles på fagmessig måte i henhold til helseinstitusjonens retningslinjer (=rengjøres for IV-løsningen) før bloduttaket begynner. En
fagmessig utført skylling av tilgangen sørger for at feil analyseresultater unngås.

6.

En underfylling av S-Monovette® fører til et feilaktig forhold mellom blod og preparering/additiv, og kan føre til feil analyseresultater.

7.

Blodet som er tatt ut og bearbeidet med S-Monovette® er ikke ment for reinjeksjon i menneskekroppen.

8.

Produktet skal ikke brukes etter at holdbarhetsdatoen er utløpt. Holdbarhetsdatoen er den siste dagen i angitt måned og år.

Oppbevaring
Produktet skal oppbevares ved romtemperatur til det skal brukes.

Begrensninger
1.

Oppbevaringsvarigheten og -temperaturen til en påfylt S-Monovette® avhenger av holdbarheten til analyttene som skal undersøkes. Vurderingen utføres av laboratoriet eller informasjon hentes fra bruksanvisningen
fra produsenten av prøvereagentene/analyseutstyret.

2.

Selv om plasma eller serum separeres gjennom sentrifugeringen av en S-Monovette®RJHOOHUGHWIRUHOLJJHUHQEDUULHUHVÎEOLULNNHQĉGYHQGLJYLVDOOHFHOOHUIXOOVWHQGLJVHSDUHUW5HVWVWRĳVNLIWHHOOHUQDWXUOLJQHGEU\WLQJ
kan innvirke på konsentrasjonen av analytter. Analyttenes stabilitet skal vurderes med hensyn til oppbevaringsbeholderne og det respektive laboratoriets betingelser.

3.

I forbindelse med terapeutiske medikamenter skal det kontrolleres om prøvematerialet er egnet med utgangspunkt i bruksanvisningen fra produsenten av prøvetreagentene/analyseutstyret.

4.

Analyser for sporelementer/metaller skal gjennomføres med systemet S-Monovette® metallanalyse + Safety-kanyle metallanalyse.

Prøvetaking og håndtering
LES GJENNOM HELE DETTE DOKUMENTET FØR DU STARTER DET VENØSE BLODUTTAKET.
Arbeidsmateriale som behøves til prøvetakingen1.

Alle nødvendige S-Monovette®-systemer til blodprøvetaking.

2.

6DIHW\ NDQ\OHUHOOHU 6DIHW\ 0XOWLĲ\®-kanyler.

3.

Hansker, kittel, øyevern eller andre egnede verneklær som beskyttelse mot Blodoverførbare patogener eller potensielt infeksiøst materiale.

4.

(WLNHWWHUWLOSDVLHQWLGHQWLıNDVMRQ

5.

Desinfeksjonsmiddel til rengjøring av prøvetakingsstedet (følg helseinstitusjonens retningslinjer for steril prøvetaking ved forberedelse av prøvetakingsstedet). Ikke bruk alkoholbaserte rengjøringsmidler når prøven
skal benyttes til test av blodalkoholprosent.

6.

Tørre, sterile tupfere til engangsbruk.

7.

Stasebånd.

8.

Plaster eller gasbind.

9.

Avfallsbeholder for skarpe/spisse gjenstander til sikker kassering av brukte materialer.

Anbefalt uttaksrekkefølge:1.

%ORGNXOWXUĲDVNHU

2.

Rør med citrat eller koagulasjonsaktivator (med/uten gel serum CAT / serumgel CAT)3.

Rør med koagulasjonsaktivator eller citrat

4.

Rør med heparin med/uten gel

5.

Rør med EDTA med/uten gel

6.

Rør med glykolysehemmer

7.

Rør med andre additiver
MERKNAD:

Hvis det begynnes med uttak til en citratbeholder eller et annet rør med et væskepreparat som f.eks. PFA, CTAD, CPDA, HCY-C eller GlucoEXACT kombinert med en
VRPPHUIXJONDQ\OH IHNV 6DIHW\ 0XOWLĲ\®-kanyle), så anbefales det å ta ut en ett tomt rør (f.eks. S-Monovette® nøytral Z) på forhånd, for å unngå en underfylling av røret nårslangen til sommerfuglkanylen fylles.
Slik garanteres det en korrekt fylling av røret og dermed et korrekt blandingsforhold (væske til blod).

MERKNAD:

Følg forskriftene som gjelder i din helseinstitusjon for uttakets rekkefølge.

Unngå tilbakestrømning
De fleste S-Monovetter inneholder kjemiske additiver. For å forhindre tilbakestrømning, må de følgende instruksjonene overholdes:
1. Bruk utelukkende de materialene som anbefales i bruksanvisningen.
2.

Posisjoner pasienten slik at du får lett tilgang til en vene, og legg pasientens arm eller annet punksjonsområde i nedadrettet stilling.

3.

Hold S-Monovette®PHGVNUXNRUNHQUHWWHWRSSRJYHGEUXNDYHQ 6DIHW\ 0XOWLĲ\®-kanyle også under armnivået/punksjonsområdet.

4.

Det må sikres at innholdet i S-Monovette® hverken berører skrukorken eller kanyleenden under venepunksjonen.

5.

Løsne stasebåndet mens blodet strømmer inn i S-Monovette®.

149

NO
Frysing/tining
I samsvar med anbefalingene fra WHO (WHO/DIL/Lab/99.1 Rev.02) anbefales det å separere serum/plasma før blodceller nedfryses.
For S-Monovette® gjelder følgende anbefalinger for nedfrysing:
1HGIU\VLQJXQGHUbƓ&•

Bruk ved minustemperaturer må prinsipielt testes under reelle betingelser, da belastningen på beholderne kan være svært forskjellig, avhengig av mediet som skal fryses ned og rutinebetingelsene (se kapittel
Materialegenskaper i SARSTEDT-katalogen).

•

3ULQVLSLHOWUHGXVHUHVIDVWKHWVYHUGLHQHIRUSODVWPDWHULDOHULWHPSHUDWXURPUÎGHWXQGHUbƓ&0HNDQLVNHEHODVWQLQJHUPÎGHUIRUJHQHUHOWXQQJÎV•

Betingelsene for nedfrysing må velges slik at innholdet i S-Monovette® fryses jevnt og nedenfra og oppover. I et stativ eller en oppbevaringskartong bør S-Monovette® ha tilstrekkelig klaring, slik at den kan utvide
seg. Stativer av polystyren eller metall er uegnet, da de kan føre til ekspansjonssprekker.

1HGIU\VLQJWLOƃbƓ&şNRQWUROOHUIĉOJHQGHIĉUQHGIU\VLQJ•,QWHUIHUHQVHU.RQWUROOHURPQHGIU\VLQJHQKDUQHJDWLYLQQĲ\WHOVHSÎEORGSUĉYHQHOOHUDQDO\VHQ IHNVKHPRO\VHDQDO\WWHQHVVWDELOLWHW •

6HQWULIXJHULQJ1ĉGYHQGLJDYKHQJLJDYGHQSODQODJWHDQDO\VHQ2YHUKROGVHQWULIXJHULQJVEHWLQJHOVHQHGRNXPHQWHWıQQHVXQGHUŝ6HQWULIXJHULQJŞHOOHU6$567('7QHWWVWHGHWhttps://www.sarstedt.com/en/service/centrifugation/ og gjennomfør visuelle prøvekontroller.

•

Hemolyse: Helblod hemolyseres ved nedfrysing: For å unngå dette, skal det brukes enten S-Monovette® gel eller, etter sentrifugeringen, Seraplas®YHQWLOıOWHUHOOHUSUĉYHQVNDOSLSHWWHUHVWLOHQVHNXQGÑUEHKROGHU

1HGIU\VLQJWLOƃbƓ&şJMHQQRPIĉULQJ
•Nedkjøling: La S-Monovette®IÎNMĉOHVHJQHGRYHUHWWLGVURPSÎşPLQIUDURPWHPSHUDWXUWLObƓ&PHQVGHQVWÎUUHWWRSSIĉUGHQNDQIU\VHVQHGWLOƃbƓ&

•

Opptining: La tine opp i minst 45 min ved romtemperatur. Også her må mekaniske belastninger unngås. For rask opptining kan føre til negative innvirkninger på analyseresultatene.

1HGIU\VLQJRJG\SIU\VLQJXQGHUƃbƓ&•'\SIU\VLQJWLOXQGHUƃbƓ&KDULNNHEOLWWNRQWUROOHUWDYSURGXVHQWHQ3ÎJUXQQDYGHPDQJHPXOLJHLQQĲ\WHOVHVIDNWRUHQHDQEHIDOHVGHWÎJMHQQRPIĉUHQHGIU\VLQJVWHVWHUXQGHUUXWLQHEHWLQJHOVHUIRUODERUDWRULHU

Nedfrysing av S-Monovette® gel:•

1HGIU\VLQJHQıQQHUVWHGVRPDQJLWWXQGHUSXQNW1HGIU\VLQJWLOƃbƓ&şJMHQQRPIĉULQJ•Det er kjent at gelsjiktet kan forandre seg på grunn av nedfrysingsprosessen.

•3ÎJUXQQDYGHPDQJHPXOLJHLQQĲ\WHOVHVIDNWRUHQHDQEHIDOHVGHWÎJMHQQRPIĉUHQHGIU\VLQJVWHVWHUXQGHUUXWLQHEHWLQJHOVHUIRUODERUDWRULHU

•Opptining:/DSUĉYHQWLQHRSSPHQVGHQVWÎUORGGUHWW(WWHUDWGHWKDUWLQWRSSVNDOSUĉYHPDWHULDOHWRYHUIĉUHVIUDSULPÑUEHKROGHUHQWLOHQVHNXQGÑUEHKROGHUYHGDWGHWDYSLSHWWHUHV LNNHGHNDQWHUHV LQQWLObPP
over gelsjiktet. Resten skal kasseres.
MERKNAD: For å sikre analyttenes stabilitet, skal bruksanvisningene fra produsentene av prøvereagensene/analyseutstyret følges.

150

NO
Bloduttak
Teknikker til uttak
Man skiller mellom to teknikker til uttak: aspirasjonsteknikk og vakuumteknikk.
Gjennom den kontrollerte trekkingen i stempelstangen gjør aspirasjonsteknikken det mulig å foreta et skånsomt bloduttak med en kontinuerlig, langsom blodstrømning. På denne måten kan blodstrømningen tilpasses
umiddelbart til alle veneforhold og betingelser, og redusere hemolyse.
Vakuumteknikken gjør det mulig å foreta bloduttaket med en kontinuerlig, rask blodstrømning etter undertrykkprinsippet gjennom en beholder som er evakuert på forhånd. Derfor er denne teknikken ideell for gode
veneforhold og ukompliserte uttaksbetingelser.
Håndtering ved blodprøvetaking: Se også betjeningsvideoen for S-Monovette® med aspirasjonsteknikken eller vakuumteknikken med Safety-kanylen eller Safety-Multifly®-kanylen:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
BRUK HANSKER FOR Å MINIMERE FAREN FOR EKSPONERING UNDER BLODUTTAKET.
1. Velg en egnet S-Monovette® til den nødvendige prøven.
2.

Velg stedet der venepunksjonen skal foretas. Overhold retningslinjene for helseinstitusjonen ved forberedelsen av venepunksjonsstedet.

Blodprøvetaking med aspirasjonsteknikken
OBS! S-Monovette® skal bare brukes til blodprøvetaking, ikke til injeksjon.
Skal bare brukes med kanyler (S-Monovette® (Safety)-kanyler, eller (Safety-)Multifly®-kanyler / adapter for S-Monovette®).
Her vises anvendelsen med Safety-kanylen:

klikk

Umiddelbart før venepunksjonen skyves S-Monovetten® inn i den integrerte holderen til Safety-kanylenog sikres ved å vri den forsiktig med klokken .
Legg på stasebånd ved behov (maks. 1 minutt). Forbered punksjonsstedet med egnet desinfeksjonsmiddel. Ikke berør venepunksjonsstedet mer etter desinfeksjon. Posisjoner pasienten slik at
du får lett tilgang til en vene, og legg pasientens arm eller annet punksjonsområde i nedadrettet stilling.
Fjern nålehetten. Punkter venen, trekk stempelet langsomt tilbake og løsne stasebåndet mens blodet strømmer inn i S-Monovetten®
Vent til blodstrømmen stanser, slik at en korrekt fylling er mulig.

.

Beveg S-Monovetten® med en lett vridning mot klokken
og trekk den deretter ut av Safety-kanylen (frakobling) . Safety-kanylen blir værende igjen i venen.
Ved uttak av flere blodprøver skal etterfølgende S-Monovetter tilkobles Safety-kanylen, så tas ytterligere prøver.
Avslutning av bloduttaket: Koble først fra S-Monovette®
+ , og trekk deretter Safety-kanylen ut av venen. Med enhåndsteknikk settes nålehetten enten på en stabil, jevn flate – inntil kanylen smekker i lås
i nålehetten med et IĉOEDUWRJKĉUEDUWŝNOLNNŞ (aktivere) – eller aktiver ved å trykke med pekefingeren mot den nederste enden av nålehetten, se også bruksanvisningen for S-Monovette® (Safety-)kanyle eller(Safety-)Multifly®-kanyle.
Hver S-Monovette® skal svinges én gang opp-ned rett etter frakobling fra Safety-kanylen, og etter at det fullstendige bloduttaket er avsluttet, skal alle prøvene med antikoagulanter snus forsiktig opp-ned flere
ganger!
Til transport og sentrifugering skal stempelstangen trekkes inn i gripeposisjonen til stempelet(stempelet smekker i lås i bunnen av S-Monovette®) – stempelstangen knekkes så av .
1.

Trykk på punksjonsstedet med en tørr, steril tupfer inntil blødningen stanser.

2.

Så snart blodkoagulasjonen har begynt, legger du på et gassbind hvis ønsket.

3.

.DVVHU6DIHW\NDQ\OHQLHQHJQHWDYIDOOVEHKROGHUIRUELRORJLVNHIDUHVWRĳHU

151

NO
Blodprøvetaking med vakuumteknikken
OBS! S-Monovette® skal bare brukes til blodprøvetaking, ikke til injeksjon
Skal bare brukes med kanyler (S-Monovette® (Safety)-kanyler, eller (Safety-)Multifly®-kanyler / adapter for S-Monovette®).
Her vises anvendelsen med Safety-kanylen:klikk

For å begynne blodprøvetakingen skånsomt, anbefaler SARSTEDT å fylle den første S-Monovette® med aspirasjonsteknikk, se VENEPUNKSJONSTEKNIKK Aspirasjonsteknikk– .
Fortsett deretter med vakuumteknikken.
Før blodprøvetakingen begynner, må stempelet trekkes ned til bunnen av S-Monovette®med stempelstangen, og se til at det smekker hørbart i lås . Deretter brytes stempelstangen av
Skyv den klargjorte S-Monovette® inn i den integrerte holderen til S-Monovette® Safety-kanylen og sikre den ved å vri den forsiktig med klokken

+

.

.

Vent til blodstrømmen stanser, slik at en korrekt fylling er mulig.

Beveg S-Monovette® med en lett vridning mot klokken
og trekk den deretter ut av Safety-kanylen (frakobling) . Safety-kanylen blir værende igjen i venen.
Ved uttak av flere blodprøver skal etterfølgende S-Monovettertilkobles med Safety-kanylen, deretter tas det ytterligere prøver.
Avslutning av bloduttaket: Frakoble S-Monovette® + , trekk deretter Safety-kanylen ut av venen. Med enhåndsteknikk settes nålehetten enten på en stø, jevn flate – inntil kanylen smekker i lås i nålehetten
med et IĉOEDUWRJKĉUEDUWŝNOLNNŞ (aktivere) – eller aktiver nålehetten ved å trykke med pekefingeren mot den nederste enden av nålehetten.
Hver S-Monovette® skal svinges én gang opp-ned rett etter frakobling fra Safety-kanylen, og etter at det fullstendige bloduttaket er avsluttet, skal alle prøvene med antikoagulanter snus forsiktig opp-ned flere
ganger!
1.

Trykk på punksjonsstedet med en tørr, steril tupfer inntil blødningen stanser.

2.

Så snart blodkoagulasjonen har begynt, legger du på et gassbind hvis ønsket.

3.

.DVVHU6DIHW\NDQ\OHQLHQHJQHWDYIDOOVEHKROGHUIRUELRORJLVNHIDUHVWRĳHU

152

NO
Sentrifugering
2%66$567('760RQRYHWWHUHUPHQWIRU[J8QQWDWWIUDGHWWHHU60RQRYHWWHUPHG¢bPP 60RQRYHWWH® pediatri), som er validert til 2500 x g. Det skal bare brukes egnede bærerør eller innsatser.
Sentrifugering av S-Monovetter med sprekker eller sentrifugering ved for høy sentrifugalkraft kan føre til at S-Monovettene brekker, slik at potensielt smittsomt materiale kan frigjøres.
Sentrifugeinnsatser skal velges passende til størrelsen på S-Monovettene som anvendes. Den relative sentrifugalkraften står i følgende forhold til innstilt omdreining/min:
RZB = 11,2 x r x (o/min/1000)2,
5=%ŝUHODWLYVHQWULIXJDONUDIWŞRJVÎNDOWŝJNUDIWŞ HQJHOVN5&)ŝ5HODWLYH&HQWULIXJDO)RUFHŞ ŝRPLQŞŝRPGUHLQLQJSHUPLQXWWŞ RPLQ HOOHUQ ŝWXUWDOOSHUPLQXWWŞ HQJHOVN530ŝ5HYROXWLRQV3HU0LQXWHŞ ŝUŞŝVHQWULIXJHULQJVUDGLXVIUDPLGWHQDYVHQWULIXJHQWLOEXQQHQDY60RQRYHWWH®Ş FP 
S-Monovetter uten gel kan sentrifugeres i sentrifuger med fastvinkel- eller med utsvingrotor.
S-Monovetter med gel er utelukkende utlagt for sentrifuger med utsvingrotor. Sentrifugering i sentrifuger med fastvinkelrotor er ikke validert hos SARSTEDT og anbefales ikke.
S-Monovetter skal sentrifugeres i henhold til sentrifugeringsbetingelsene som er oppført nedenfor. Dersom andre betingelser skal anvendes, må de valideres av brukeren selv.
Det må sikres at S-Monovettene sitter ordentlig i sentrifugeinnsatsene. S-Monovetter som rager ut over innsatsen kan sette seg fast i sentrifugehodet og knuse. Sørg for at sentrifugen er jevnt fylt. Følg i denne
sammenhengen bruksanvisningen for sentrifugen.
ADVARSEL! Knuste S-Monovetter skal ikke fjernes med hånden.
,QVWUXNVMRQHU IRU GHVLQıVHULQJ DY VHQWULIXJHQ ıQQHU GX L EUXNVDQYLVQLQJHQ IRU VHQWULIXJHQ

Relativ sentrifugalkraft (g)Orientert etter
BS 4851+ (EU- DIN EN ISO 6710
kode)

–

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Serum

bPLQbPLQbPLQ

bPLQ

bPLQ

SerumgelbPLQbPLQ

bPLQ

bPLQ

bPLQ

*Serum express gel

bPLQbPLQ

bPLQ

i.v.

i.v.

Litiumheparin

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Litiumheparingel

bPLQbPLQbPLQ

bPLQ

bPLQ

Litiumheparingel+

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA

i.v.

i.v.

bPLQ

bPLQ

bPLQ

EDTA-gelbPLQbPLQbPLQ

bPLQ

bPLQ

Citrat

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

('7$ĲXRULGKHSDULQ

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

GlucoEXACT

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDW3%0bPO
6HQWULIXJHUDGLXV!bFP

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDW3%0bPO
6HQWULIXJHUDGLXV!WLOƉbFP

i.v.

i.v.

bPLQi.v.

i.v.

i.v. = ikke validert
*MHOGHUIRUDOOH60RQRYHWWHUXQQWDWW¢bPP 60RQRYHWWHSHGLDWUL 

6HQWULIXJHULQJYHGbƓ&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, trukket tilbake.

,QIRUPDVMRQVRPJMHOGHUVNLOOHPDWHULDOH
Skillematerialets (gel) flyteegenskaper er temperaturavhengig. Dersom S-Monovetter kjøles før eller under sentrifugeringen, kan et gjennomgående lag av skillegel ikke lenger garanteres.
S-Monovetten må ikke sentrifugeres på nytt/resentrifugeres.

Avfallshåndtering
1.

De generelle retningslinjene for hygiene samt de lovfestede bestemmelsene for forskriftsmessig destruksjon av infeksiøst materiale skal tas hensyn til og overholdes.

2.

Engangshansker forhindrer faren for infeksjon.

3.

.RQWDPLQHUWHHOOHUI\OWHEORGSUĉYHWDNLQJVV\VWHPHUPÎGHVWUXHUHVLHJQHGHDYIDOOVEHKROGHUHIRUELRORJLVNHIDUHVWRĳHUVRPNDQDXWRNODYHUHVRJIRUEUHQQHVHWWHUEUXNHQ4.

'HVWUXNVMRQHQPÎıQQHVWHGLHWHJQHWIRUEUHQQLQJVDQOHJJHOOHUYKDDXWRNODYHULQJ GDPSVWHULOLVHULQJ 

153

NO
3URGXNWVSHVLıNNHVWDQGDUGHURJUHWQLQJVOLQMHULWLOHQKYHUWLGJMHOGHQGHYHUVMRQCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Standard for beholdere til venøst bloduttak:
DIN EN ISO 6710: Beholdere til engangsbruk til venøst bloduttak på mennesker*CLSI (Clinical and Laboratory Standards Institute)

Forklaring av symboler og kjennetegn:

Artikkelnummer

I tillegg gjelder for enkeltvis sterilt emballerte produkter

Produksjonsnummer

Skal ikke brukes ved skadet emballasje

Brukes før

Enkelt sterilbarrieresystem med utvendig beskyttelsesemballasje

CE-merke

Sterilisering med bestråling

In vitro-diagnostisk utstyr

Overhold bruksanvisningen

Ved gjenbruk: kontaminasjonsfare

Oppbevares beskyttet mot sollys

Lagres tørt

Produsent

Produksjonsland

Steril væskebane

Skal ikke steriliseres på nytt

Med forbehold om tekniske endringer.
Alle alvorlige hendelser knyttet til produktet skal meldes fra om til produsenten og til ansvarlige nasjonale myndigheter.

154

PL
Do stosowania w diagnostyce in-vitro
Przeznaczenie
Systemy do pobierania krwi S-Monovette®LJú\LDGDSWHU\VWDQRZLÐúÐF]QLHV\VWHPGRSRELHUDQLDNUZLĮ\OQHM6\VWHP\GRSRELHUDQLDNUZL60RQRYHWWH®VúXĮÐGRSRELHUDQLDWUDQVSRUWXSU]HWZDU]DQLDLSU]HFKRZ\ZDQLD
SUĂEHNNUZLGRR]QDF]HüGLDJQRVW\F]Q\FKZZDUXQNDFKin-vitroSU]HSURZDG]DQ\FKZODERUDWRULDFKNOLQLF]Q\FK]VXURZLF\RVRF]DOXENUZLSHúQHM3URGXNWMHVWSU]H]QDF]RQ\GRVWRVRZDQLDZSURIHVMRQDOQ\PďURGRZLVNXSU]H]SHUVRQHOSRELHUDMÐF\LSHUVRQHOODERUDWRU\MQ\Opis produktu
Systemy do pobierania krwi S-Monovette®VNúDGDMÐVLã]QDF]\QLD]WZRU]\ZDV]WXF]QHJRWúRNDRUD]]NRGRZDQHMNRORU\VW\F]QLH]DNUãWNL]WZRU]\ZDV]WXF]QHJR]H]LQWHJURZDQÐPHPEUDQÐ=RVWDú\RSUDFRZDQH
VSHFMDOQLH]P\ďOÐRSRGúÐF]HQLXLJú\ EH]SLHF]QHM 60RQRYHWWH®OXELJú\ EH]SLHF]QHM 0XOWLIO\®LVÐGRVWãSQH]UĂĮQ\PLGRGDWNDPL SUHSDUDFMDPL 'RVWãSQHVÐWHĮSUREĂZNL60RQRYHWWH® bez dodatków. Systemy dopobierania krwi S-Monovette®GRVWãSQHVÐ]GRGDWNDPLZSRVWDFLDNW\ZDWRUDNU]HSQLãFLDDNW\ZDWRUDNU]HSQLãFLD]ĮHOHPKHSDU\Q\OLWRZHMKHSDU\Q\OLWRZHM]ĮHOHPKHSDU\Q\VRGRZHMF\WU\QLDQX('7$IOXRUNX('7$
IOXRUNXLKHSDU\Q\IOXRUNXLF\WU\QLDQX&3'$RUD]EH]GRGDWNĂZ6WãĮHQLDREMãWRďÓSú\QQ\FKGRGDWNĂZLLFKGRSXV]F]DOQHWROHUDQFMHRUD]VWRVXQHNNUZLGRGRGDWNXRGSRZLDGDMÐZ\PDJDQLRPL]DOHFHQLRP]JRGQ\P]PLãG]\QDURGRZÐQRUPÐ',1(1,62Ś6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŘRUD]VWDQGDUGDPL&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, :\EĂUGRGDWNX
]DOHĮ\RGZ\EUDQHMDQDOLW\F]QHMPHWRG\EDGDZF]HM:\EĂURNUHďORQ\MHVWSU]H]SURGXFHQWDRGF]\QQLNĂZWHVWRZ\FKLOXEXU]ÐG]HQLDDQDOLW\F]QHJRQDNWĂU\PSU]HSURZDG]DQHMHVWEDGDQLH6\VWHPGRSRELHUDQLDNUZLS-Monovette®MHVWGRVWãSQ\ZZHUVMLVWHU\OQHMZHZQÐWU]OXESDNRZDQHMSRMHG\QF]RVWHU\OQHM]DUĂZQRZHZQÐWU]MDNLQD]HZQÐWU]

.RG\NRORUĂZ]DNUãWHN 60RQRYHWWH®:

Dodatek

Kod literowy.RORU]DNUãWNL',1(1,62
6710.RORU]DNUãWNL]JRGQLH]
BS 4851+

Z

ELDú\

ELDú\

Naczynie bez preparatu
S-Monovette® Neutralny Z
1DF]\QLH]VXURZLFÐ
S-Monovette®6XURZLFD&$7]DNW\ZDWRUHPNU]HSQLãFLD

CAT

czerwony

ELDú\

S-Monovette®ÆHOVHSDUXMÐF\VXURZLFã&$7]DNW\ZDWRUHPNU]HSQLãFLDLĮHOHPCAT

FLHPQRĮĂúW\FLHPQRĮĂúW\S-Monovette®6XURZLFD([SUHVV]ĮHOHP&$7]WURPELQÐDNW\ZXMÐFÐNU]HSQLãFLHLĮHOHPCAT

SRPDUDüF]RZ\-

S-Monovette®+HSDU\QDOLWRZD/+]KHSDU\QÐOLWRZÐ

LH

zielony

SRPDUDüF]RZ\

S-Monovette®+HSDU\QDOLWRZD/+]KHSDU\QÐOLWRZÐZSRVWDFLSú\QQHM

LH

zielony

SRPDUDüF]RZ\

S-Monovette®+HSDU\QDOLWRZD]ĮHOHP/+]KHSDU\QÐOLWRZÐLĮHOHP

LH

zielony

SRPDUDüF]RZ\

S-Monovette®+HSDU\QDOLWRZD]ĮHOHP+/+]KHSDU\QÐOLWRZÐLĮHOHPRV]\ENLPG]LDúDQLX

LH

zielony

SRPDUDüF]RZ\

1DF]\QLH]KHSDU\QÐS-Monovette®+HSDU\QDVRGRZD1+]KHSDU\QÐVRGRZÐ

NHEUÐ]RZ\

zielony

S-Monovette®+HSDU\QDDPRQRZD$+]KHSDU\QÐDPRQRZÐ

b. d.

niebieski

niebieski

Naczynie z cytrynianem
S-Monovette® Cytrynian 9NC, cytrynian sodu 3,13%

9NC

niebieski

zielony

S-Monovette® PFA, Cytrynian 9NC, cytrynian sodu 3,8%, buforowany

9NC

jasnoniebieski-

K3EıROHWRZ\

czerwony

S-Monovette K2 EDTA K2E, z potasem EDTA

K2E

ıROHWRZ\

czerwony

S-Monovette®.('7$*HO.(]SRWDVHP('7$LĮHOHP

K2E

ıROHWRZ\

czerwony

S-Monovette®)OXRUHN('7$)(]ĲXRUNLHPL('7$

FE

szary

ĮĂúW\

S-Monovette®)OXRUHN+HSDU\QD)+]ĲXRUNLHPLKHSDU\QÐ

FH

-

ĮĂúW\

S-Monovette®*OXFR(;$&7)&]ĲXRUNLHPF\WU\QLDQHPL('7$FCUĂĮRZ\

szary

LH

granatowy

SRPDUDüF]RZ\

S-Monovette®7KURPER([DFW]H]ZLÐ]NLHPPDJQH]Xb. d.

b. d., malinowy

b. d., malinowy

S-Monovette® CTADb. d.

b. d., niebieski

b. d., zielony

S-Monovette® ACD

ACD

ĮĂúW\

ĮĂúW\

Naczynie EDTA
S-Monovette® K3 EDTA K3E, z potasem EDTA®

Naczynie z inhibitorami glikolizy

Naczynie do analizy metali
S-Monovette®GRDQDOL]\PHWDOL/+]KHSDU\QÐOLWRZÐ

,QQHQDF]\QLDQDNUHZSHúQÐLRVRF]HS-Monovette CPDA

CPDA

ĮĂúW\

ĮĂúW\

S-Monovette® Hirudyna

b. d.

b. d., oliwkowy

b. d., oliwkowy®

S-Monovette®+RPRF\VWHLQD]ĮHOHP+&<=]ĮHOHPLVWDELOL]DWRUHPb. d.

b. d., szary

b. d., szary

S-Monovette® Homocysteina HCY-C z buforem cytrynianowym

b. d.

EGıROHWRZ\

EGıROHWRZ\

S-Monovette® DNA Exactb. d.

b. d., niebieski

b. d., niebieski

'RVWãSQHVÐWHĮLQQHNRORU\]DNUãWHNb. d.: brak danych+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, wycofano.

155

PL
S-Monovette®6XURZLFD&$7ÆHOVHSDUXMÐF\VXURZLFã&$76$567('7System S-Monovette®6XURZLFD&$7]DZLHUDJUDQXONL]WZRU]\ZDV]WXF]QHJRSRNU\WHDNW\ZDWRUHPNU]HSQLãFLD NU]HPLDQHP LVúXĮ\GRSR]\VNLZDQLDVXURZLF\ :WUDNFLHZLURZDQLDJUDQXODW]WZRU]\ZDV]WXF]QHJRRVDG]DVLãPLãG]\VNU]HSHPNUZLDVXURZLFÐ
System S-Monovette®ÆHOVHSDUXMÐF\VXURZLFã&$7RSUĂF]JUDQXOHN]WZRU]\ZDV]WXF]QHJRSRNU\W\FKDNW\ZDWRUHPNU]HSQLãFLD NU]HPLDQHP ]DZLHUDUĂZQLHĮĮHOQDED]LHSROLPHUĂZLVúXĮ\GRSR]\VNLZDQLDVXURZLF\ :WUDNFLHZLURZDQLDĮHORVDG]DVLãPLãG]\VNU]HSHPNUZLDVXURZLFÐWZRU]ÐFVWDELOQÐZDUVWZãUR]G]LHODMÐFÐQDF]DVWUDQVSRUWXSU]HFKRZ\ZDQLDLDQDOL]\
6XURZLFDZ\NRU]\VW\ZDQDMHVWMDNRPDWHULDúSUĂENLZEDGDQLDFKFKHPLLNOLQLF]QHMRUD]ZUXW\QRZ\FKEDGDQLDFKLPPXQRORJLF]Q\FKDWDNĮHZSUĂEDFKVHURORJLF]Q\FK
3RSREUDQLXNUZLSUREĂZNã60RQRYHWWH®6XURZLFD&$7ÆHOVHSDUXMÐF\VXURZLFã&$7QDOHĮ\SR]RVWDZLÓZSR]\FMLSLRQRZHMQDPLQXWGRVNU]HSQLãFLDDE\SRRGZLURZDQLXXWZRU]\úDVLãZ\UDĬQDZDUVWZD
UR]G]LHODMÐFD=DOHFDQ\F]DVRSDUWRQDQLH]DNúĂFRQ\PSURFHVLHNU]HSQLãFLD.UHZSREUDQDRGSDFMHQWĂZ]]DEXU]HQLDPLNU]HSQLãFLDZ\ZRúDQ\PLFKRUREÐOXESRGGDZDQ\FKWHUDSLLSU]HFLZ]DNU]HSRZHMZQLHNWĂU\FK
SU]\SDGNDFKEãG]LHZ\PDJDúDZLãFHMF]DVXQDFDúNRZLWHVNU]HSQLãFLH

SARSTEDT S-Monovette®6XURZLFD(NVSUHV]ĮHOHP&$7
System S-Monovette®6XURZLFD([SUHVV]ĮHOHP&$7RSUĂF]JUDQXOHN]WZRU]\ZDV]WXF]QHJRSRNU\W\FKDNW\ZDWRUHPNU]HSQLãFLD WURPELQÐ ]DZLHUDUĂZQLHĮĮHOQDED]LHSROLPHUĂZLVúXĮ\GRSR]\VNLZDQLDVXURZLF\ :WUDNFLHZLURZDQLDĮHORVDG]DVLãPLãG]\VNU]HSHPNUZLDVXURZLFÐWZRU]ÐFVWDELOQÐZDUVWZãUR]G]LHODMÐFÐQDF]DVWUDQVSRUWXSU]HFKRZ\ZDQLDLDQDOL]\
3RSREUDQLXNUZLSUREĂZNã60RQRYHWWH®6XURZLFD([SUHVV]ĮHOHPQDOHĮ\SR]RVWDZLÓZSR]\FMLSLRQRZHMQDPLQXWGRVNU]HSQLãFLDDE\SRRGZLURZDQLXXWZRU]\úDVLãZ\UDĬQDZDUVWZDUR]G]LHODMÐFD=DOHFDQ\F]DVRSDUWRQDQLH]DNúĂFRQ\PSURFHVLHNU]HSQLãFLDUĂZQLHĮZSU]\SDGNXNUZLRGSDFMHQWĂZNWĂU\PSRGDQRKHSDU\Qã.UHZSREUDQDRGSDFMHQWĂZ]]DEXU]HQLDPLNU]HSQLãFLDZ\ZRúDQ\PLFKRUREÐOXESRGGDZDQ\FKWHUDSLLSU]HFLZ]DNU]HSRZHMZW\PRGSDFMHQWĂZNWĂU\PSRGDZDQHVÐZ\VRNLHGDZNLKHSDU\Q\EãG]LHZ\PDJDúDZLãFHMF]DVXQDFDúNRZLWHVNU]HSQLãFLH
6XURZLFDZ\NRU]\VW\ZDQDMHVWMDNRPDWHULDúSUĂENLZEDGDQLDFKFKHPLLNOLQLF]QHMRUD]ZUXW\QRZ\FKEDGDQLDFKLPPXQRORJLF]Q\FKDWDNĮHZSUĂEDFKVHURORJLF]Q\FKSARSTEDT S-Monovette® Neutralny Z
System S-Monovette®1HXWUDOQ\=QLH]DZLHUDĮDGQ\FKSUHSDUDWĂZFRXPRĮOLZLDQDWXUDOQ\SURFHVNU]HSQLãFLDSUĂENLNUZLEH]DNW\ZDWRUDNU]HSQLãFLDLVúXĮ\GRSR]\VNLZDQLDVXURZLF\ 3RGF]DVZLURZDQLDQDVWãSXMH
rozdzielenie skrzepu krwi i surowicy.
6HUXPVWDQRZLPDWHULDúSUĂENLGREDGDüVSHF\ILF]Q\FKGODGDQHJRXĮ\WNRZQLND
S-Monovette®1HXWUDOQ\=PRĮHUĂZQLHĮSRVúXĮ\ÓMDNRSXVWHQDF]\QLHGRQDSHúQLDQLDZUD]LHSRELHUDQLDNUZL]DSRPRFÐ60RQRYHWWH®&\WU\QLDQZSRúÐF]HQLX]LJúÐ EH]SLHF]QÐ 0XOWLIO\® LJúDPRW\ONRZD :WDNLP
przypadku S-Monovette®1HXWUDOQ\=PRĮQDXĮ\ÓMDNRSLHUZV]HJR SXVWHJR QDF]\QLDGRQDSHúQLHQLDLJú\ EH]SLHF]QHM 0XOWLIO\®.

SARSTEDT S-Monovette®+HSDU\QDOLWRZD/++HSDU\QDOLWRZD]ĮHOHP/++HSDU\QDOLWRZD]ĮHOHP+ LH, Heparyna sodowa NH, Heparyna amonowa AH
S-Monovette®+HSDU\QDOLWRZD/++HSDU\QDVRGRZD1++HSDU\QDDPRQRZD$+]DZLHUDMÐJUDQXONL]WZRU]\ZDV]WXF]QHJRSRNU\WHďURGNLHPSU]HFLZNU]HSQLãFLX DQW\NRDJXODQWHP ZSRVWDFLKHSDU\Q\OLWRZHMKHSDU\Q\VRGRZHMKHSDU\Q\DPRQRZHM ]Z\NOHMPKHSDU\Q\PONUZL LVúXĮÐGRSR]\VNLZDQLDNUZLSHúQHMLRVRF]D :WUDNFLHZLURZDQLDJUDQXODW]WZRU]\ZDV]WXF]QHJRRVDG]DVLãPLãG]\NUZLQNDPLLRVRF]HPW przypadku S-Monovette®+HSDU\QDOLWRZD/+EH]JUDQXOHN]WZRU]\ZDV]WXF]QHJRDQW\NRDJXODQWZSRVWDFLKHSDU\Q\OLWRZHMPDSRVWDÓUR]S\ODQÐ ]Z\NOHMPKHSDU\Q\PONUZL 
System S-Monovette®+HSDU\QDOLWRZD]ĮHOHP/+SR]DJUDQXONDPL]WZRU]\ZDV]WXF]QHJRSRZOHNDQ\PLDQW\NRDJXODQWHPZSRVWDFLKHSDU\Q\OLWRZHM ]Z\NOHMPKHSDU\Q\PONUZL ]DZLHUDUĂZQLHĮĮHOQDED]LHSROLPHUĂZLVúXĮ\GRSR]\VNLZDQLDRVRF]D :WUDNFLHZLURZDQLDĮHORVDG]DVLãPLãG]\NUZLQNDPLLRVRF]HPWZRU]ÐFVWDELOQÐZDUVWZãUR]G]LHODMÐFÐQDF]DVWUDQVSRUWXSU]HFKRZ\ZDQLDLDQDOL]\
System S-Monovette®+HSDU\QDOLWRZD]ĮHOHP+/+UĂZQLHĮ]DZLHUDĮHOQDED]LHSROLPHUĂZNWĂU\XPRĮOLZLDRNUĂWV]\F]DVZLURZDQLDQLĮPDWRPLHMVFHZSU]\SDGNXV\VWHPX60RQRYHWWH® Heparyna litowa zĮHOHP
2VRF]HZ\NRU]\VW\ZDQHMHVWMDNRPDWHULDúSUĂENLZEDGDQLDFKFKHPLLNOLQLF]QHMRUD]ZUXW\QRZ\FKEDGDQLDFKLPPXQRORJLF]Q\FK.UHZSHúQD]KHSDU\QÐZ\NRU]\VW\ZDQDMHVWMDNRPDWHULDúSUĂENLZUXW\QRZ\FKEDGDQLDFKLPPXQRORJLF]Q\FKDWDNĮHZSUĂEDFKVHURORJLF]Q\FK+HSDU\QDKDPXMHNU]HSQLãFLHSRSU]H]DNW\ZDFMãDQW\WURPELQ\:6.$=:.$=DSRPRFÐV\VWHPĂZ60RQRYHWWH®+HSDU\QDOLWRZD/++HSDU\QDOLWRZDLĮHOVHSDUXMÐF\ÆHO+/+QLHPRĮQDRNUHďODÓSR]LRPXOLWX]DSRPRFÐV\VWHPĂZ60RQRYHWWH®
+HSDU\QDVRGRZD1+QLHPRĮQDRNUHďODÓSR]LRPXVRGXD]DSRPRFÐV\VWHPĂZ60RQRYHWWH®+HSDU\QDDPRQRZD$+QLHPRĮQDR]QDF]DÓSR]LRPXDPRQX6\VWHPĂZ60RQRYHWWH® Heparyna
OLWRZDbb+HSDU\QDOLWRZD]ĮHOHPbbÆHO+bb+HSDU\QDVRGRZDbb+HSDU\QDDPRQRZDZ\SHúQLRQ\FKNUZLÐĮ\OQÐQLHPRĮQDVWRVRZDÓGRJD]RPHWULLNUZLSystem S-Monovette® do analizy metal SARSTEDT
System S-Monovette®GRDQDOL]\PHWDO]DZLHUDDQW\NRDJXODQWZSRVWDFLKHSDU\Q\OLWRZHMLVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHMRUD]RVRF]D +HSDU\QDOLWRZDPDSRVWDÓUR]S\ODQÐ ]Z\NOHMPKHSDU\Q\PONUZL .UHZSHúQD]KHSDU\QÐOXERVRF]H]KHSDU\QÐZV\VWHPDFK60RQRYHWWH®GRDQDOL]\PHWDOQDOHĮ\VWRVRZDÓZSRúÐF]HQLX]HVSHFMDOQ\PLLJúDPLEH]SLHF]Q\PL*[Źŗ QUDUW 6úXĮÐRQHMDNRPDWHULDúSUĂENLGREDGDüSLHUZLDVWNĂZďODGRZ\FKPHWDOL3LHUZLDVWNLďODGRZHbbPHWDOHSRGGDZDQHVÐZDOLGDFML]DSRPRFÐVSHNWURPHWULLDEVRUSFMLDWRPRZHM $$6 :SU]\SDGNXV\VWHPĂZLJú\EH]SLHF]QHMRUD]60RQRYHWWH®
GRDQDOL]\PHWDOX]\VNDQRQDVWãSXMÐFHPDNV\PDOQHZDUWRďFLRGF]\WXGODSLHUZLDVWNĂZďODGRZ\FKZQJ6\VWHP

Pierwiastek

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

ng/System

2,5

1,5

8,0

5,0

5

50

70

70

10

Al

Se

Hg

40

10

10

0DNV\PDOQHZDUWRďFLRGF]\WXSRGDQRGODNDĮGHJRHOHPHQWXQDHW\NLHFLH60RQRYHWWH .
®

2NUHďODQLHSLHUZLDVWNĂZďODGRZ\FKSU]HELHJD]DOHĮQLHRGSURFHVXDQDOL]\QDSRGVWDZLHNUZLSHúQHM]KHSDU\QÐOXERVRF]D]KHSDU\QÐ+HSDU\QDKDPXMHNU]HSQLãFLHSRSU]H]DNW\ZDFMãDQW\WURPELQ\S-Monovette® Cytrynian 9NC SARSTEDT
System S-Monovette®&\WU\QLDQ1&]DZLHUDDQW\NRDJXODQWZSRVWDFLF\WU\QLDQXWULVRGRZHJRLVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHMRUD]RVRF]D &\WU\QLDQWULVRGRZ\GRVWãSQ\MHVWZSRVWDFLUR]WZRUXPRORZHJR
UR]WZĂUF\WU\QLDQXWULVRGRZHJRZDUWRďÓF]ãVWR]DRNUÐJODQDMHVWGR LVWDQRZLQRPLQDOQHMREMãWRďFLSUREĂZNL60RQRYHWWH® Citrat. Stosunek mieszania cytrynianu do krwi wynosi 1:9, przy czym jest
WRF]ãďÓREMãWRďFLF\WU\QLDQXLF]ãďFLREMãWRďFLNUZL3UDZLGúRZHQDSHúQLHQLHSUREĂZNLMHVWQLH]EãGQHGRDQDOL]\
2VRF]H]F\WU\QLDQHPZ\NRU]\VW\ZDQHMHVWMDNRPDWHULDúSUĂENLZUXW\QRZ\FKEDGDQLDFKKHPRVWD]\+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]F\WU\QLDQ
1DOHĮ\]DSR]QDÓVLã]8:$*$0,GRW\F]ÐF\PLSRELHUDQLDSUĂEHNLVWRVRZDQLD60RQRYHWWH®&\WU\QLDQZSRúÐF]HQLX]LJúÐPRW\ONRZÐ

S-Monovette® PFA 9NC SARSTEDT
System S-Monovette®3)$1&]DZLHUDDQW\NRDJXODQWZSRVWDFLF\WU\QLDQXWULVRGRZHJRLVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHMRUD]RVRF]D &\WU\QLDQWULVRGRZ\GRVWãSQ\MHVWZSRVWDFLEXIRURZDQHJRUR]WZRUXPRORZHJR UR]WZĂUEXIRURZ\S+ LVWDQRZLQRPLQDOQHMREMãWRďFLSUREĂZNL60RQRYHWWH®3)$6WRVXQHNPLHV]DQLDF\WU\QLDQXGRNUZLZ\QRVLSU]\F]\PMHVWWRF]ãďÓREMãWRďFLF\WU\QLDQXLF]ãďFLREMãWRďFLNUZL3UDZLGúRZHQDSHúQLHQLHSUREĂZNLMHVWQLH]EãGQHGRDQDOL]\.UHZSHúQDZ60RQRYHWWH®3)$1&VWDQRZLPDWHULDúSUĂENLGRR]QDF]DQLDIXQNFMLWURPERF\WĂZZDQDOL]DWRUDFK6,(0(16+HDOWKLQHHUV3)$:\UĂE]RVWDú]DWZLHUG]RQ\SRGNÐWHPWHJR]DVWRVRZDQLD+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]F\WU\QLDQ
1DOHĮ\]DSR]QDÓVLã]8:$*$0,GRW\F]ÐF\PLSRELHUDQLDSUĂEHNLVWRVRZDQLD60RQRYHWWH®3)$ZSRúÐF]HQLX]LJúÐPRW\ONRZÐ

S-Monovette® CTAD SARSTEDT
Probówka S-Monovette®&7$']DZLHUDDQW\NRDJXODQWZSRVWDFLF\WU\QLDQXWULVRGRZHJRRUD]WHRILOLQãDGHQR]\QãLGLSLU\GDPROLMHVWSU]H]QDF]RQDGRSR]\VNLZDQLDNUZLSHúQHMLRVRF]D &7$'GRVWãSQHMHVWZIRUPLH
UR]WZRUXLVWDQRZLQRPLQDOQHMREMãWRďFLSUREĂZNL60RQRYHWWH®&7$'6WRVXQHNPLHV]DQLD&7$'GRNUZLZ\QRVLSU]\F]\PMHVWWRF]ãďÓREMãWRďFL&7$'LF]ãďFLREMãWRďFLNUZL3UDZLGúRZHQDSHúQLHQLH
SUREĂZNLMHVWQLH]EãGQHGRDQDOL]\
2VRF]H]&7$'VWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRR]QDF]DQLDF]\QQLNDSú\WNRZHJR 3) EHWD Ĕ WURPERJOREXOLQ\ Ĕ7* LLQKLELWRUDDNW\ZDWRUDSOD]PLQRJHQX 3$, RUD]GRUXW\QRZ\FKEDGDüKHPRVWD]\$NW\ZDFMDWURPERF\WĂZMHVWKDPRZDQDQDFRQDMPQLHMJRG]LQ\FRXPRĮOLZLDPRQLWRURZDQLHOHF]HQLD]Z\NRU]\VWDQLHPKHSDU\Q\+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]F\WU\QLDQ
1DOHĮ\]DSR]QDÓVLã]8:$*$0,GRW\F]ÐF\PLSRELHUDQLDSUĂEHNLVWRVRZDQLD60RQRYHWWH®&7$'ZSRúÐF]HQLX]LJúÐPRW\ONRZÐ:6.$=:.$&7$'PDNRORUĮĂúW\3RGF]DVSU]HFKRZ\ZDQLDSUREĂZNã60RQRYHWWH®&7$'QDOHĮ\FKURQLÓSU]HGQDUDĮHQLHPQDG]LDúDQLHďZLDWúDV]WXF]QHJRLQDWXUDOQHJR:\VWDZLHQLHQDG]LDúDQLH
VLOQHJRďZLDWúDSU]H]GúXĮHMQLĮJRG]LQPRĮHVSRZRGRZDÓGH]DNW\ZDFMãGRGDWNĂZ

156

PL
S-Monovette® EDTA K2E / K3E SARSTEDT
Probówka S-Monovette® EDTA K2E / S-Monovette®('7$.(]DZLHUDDQW\NRDJXODQWZSRVWDFL.('7$OXE.('7$LVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHM .('7$OXE.('7$VÐGRVWãSQHZSRVWDFLSU]H]QDF]RQHM
do rozpylania (1,6 mg EDTA / ml krwi).
.UHZSHúQD]('7$VWDQRZLPDWHULDúSUĂENLGREDGDüKHPDWRORJLF]Q\FK5R]PD]\NUZLQDOHĮ\VSUHSDURZDÓZFLÐJXF]WHUHFKJRG]LQRGSREUDQLDNUZL+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]('7$
Krew z probówek S-Monovette®('7$.(.(PRĮQDUĂZQLHĮVWRVRZDÓGRUXW\QRZ\FKEDGDüLPPXQRKHPDWRORJLF]Q\FKLWHVWĂZQDREHFQRďÓFKRUĂE]DNDĬQ\FK2GSRZLHG]LDOQRďFLÐXĮ\WNRZQLNDMHVWVSUDZG]HQLH
SU]\GDWQRďFLPDWHULDúXSUĂENLGRZ\NRQDQLDEDGDü]DSRPRFÐRGSRZLHGQ\FKRGF]\QQLNĂZWHVWRZ\FKDQDOL]DWRUĂZRUD]SRGNÐWHPZDUXQNĂZSU]HFKRZ\ZDQLDS-Monovette®('7$]ĮHOHP.(6$567('7Probówka S-Monovette®ÆHO('7$.(SR]DDQW\NRDJXODQWHPZSRVWDFL.('7$]DZLHUDUĂZQLHĮĮHOQDED]LHSROLPHUĂZLVúXĮ\GRSR]\VNLZDQLDRVRF]D .('7$MHVWGRVWãSQHZSRVWDFLSU]H]QDF]RQHMGRUR]S\ODQLD PJ('7$PONUZL :WUDNFLHZLURZDQLDĮHORVDG]DVLãPLãG]\NUZLQNDPLLRVRF]HPWZRU]ÐFVWDELOQÐZDUVWZãUR]G]LHODMÐFÐQDF]DVWUDQVSRUWXSU]HFKRZ\ZDQLDLDQDOL]\
2VRF]H]('7$VWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRPROHNXODUQHMGLDJQRVW\NLZLUXVĂZ+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]('7$

S-Monovette® Fluorek EDTA FE / Fluorek Heparyna FH / Fluorek Cytrynian EDTA FC z inhibitorami glikolizy SARSTEDT
Probówka S-Monovette®)OXRUHN('7$)(]DZLHUDDQW\NRDJXODQWZSRVWDFL('7$ PJPONUZL RUD]LQKLELWRUJOLNROL]\ZSRVWDFLIOXRUNX PJPONUZL LVúXĮ\GRSR]\VNLZDQLDRVRF]D )OXRUHN('7$MHVWGRVWãSQ\
w postaci przeznaczonej do rozpylania.
Probówka S-Monovette®)OXRUHN+HSDU\QD)+]DZLHUDDQW\NRDJXODQWZSRVWDFLKHSDU\Q\ PJPONUZL RUD]LQKLELWRUJOLNROL]\ZSRVWDFLIOXRUNX PJPONUZL LVúXĮ\GRSR]\VNLZDQLDRVRF]D )OXRUHN]KHSDU\QÐ
MHVWGRVWãSQ\ZSRVWDFLSU]H]QDF]RQHMGRUR]S\ODQLD+DPRZDQLHJOLNROL]\Z\ZRú\ZDQHSU]H]VDPIOXRUHN]DF]\QDVLãRNRúRJRG]LQ\SRQDSHúQLHQLXQDF]\QLDGRSRELHUDQLDSUĂEHNNUZLDSHúQHG]LDúDQLHPRĮQD]DREVHUZRZDÓSRRNJRG]LQDFK*OXNR]DZNUZLSHúQHM
MHVWGHJUDGRZDQDďUHGQLRGRSRNLONXJRG]LQDFKRUD]GRSRJRG]LQDFKProbówka S-Monovette®*OXFR(;$&7)&]DZLHUDDQW\NRDJXODQWZSRVWDFL('7$RUD]QDW\FKPLDVWRZHLQKLELWRU\JOLNROL]\ZSRVWDFLF\WU\QLDQXLIOXRUNXLVúXĮ\GRSR]\VNLZDQLDRVRF]D ('7$F\WU\QLDQLIOXRUHNPDMÐSRVWDÓUR]WZRUĂZ3RGF]DVREOLF]DQLDVWãĮHQLDJOXNR]\ZDUWRďÓQDOHĮ\SRPQRĮ\ÓSU]H]]XZDJLQDUR]FLHüF]HQLH
Probówka S-Monovette®*OXFR(;$&7)&MHVW]JRGQD]Z\W\F]Q\PL1LHPLHFNLHJR7RZDU]\VWZD'LDEHWRORJLF]QHJR ''* Z]DNUHVLHFXNU]\F\FLÐĮRZHMRUD]]NUDMRZ\PLZ\W\F]Q\PLZ]DNUHVLHOHF]HQLD 19/ FXNU]\F\
W\SX1DW\FKPLDVWRZÐVWDELOL]DFMãVWãĮHQLDJOXNR]\ZNUZLSHúQHMPRĮQD]DJZDUDQWRZDÓZSU]HFLÐJXJRG]LQZWHPSHUDWXU]HSRNRMRZHM=DSR]QDMVLãUĂZQLHĮ]6$567('7:KLWH3DSHUhttps://www.sarstedt.com/
en/products/diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours”.
2VRF]H]IOXRUNLHP('7$ F\WU\QLDQHP VWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRR]QDF]DQLDSR]LRPXJOXNR]\+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]('7$
:6.$=:.$)OXRUHNPRĮHSRZRGRZDÓZ]URVWKHPROL]\'DOV]HLQIRUPDFMHQDWHPDWVXEVWDQFMLSRWHQFMDOQLH]DNúĂFDMÐF\FKG]LDúDQLHPRĮQD]QDOHĬÓZLQVWUXNFMLREVúXJLSURGXFHQWDWHVWX
1DOHĮ\]DSR]QDÓVLã]8:$*$0,GRW\F]ÐF\PLSRELHUDQLDSUĂEHNLVWRVRZDQLD60RQRYHWWH®*OXFR(;$&7ZSRúÐF]HQLX]LJúÐPRW\ONRZÐ

S-Monovette® CPDA SARSTEDT
Probówka S-Monovette®&3'$]DZLHUDDQW\NRDJXODQWZSRVWDFLF\WU\QLDQXVRGXRUD]NZDVXF\WU\QRZHJRIRVIRUDQXVRGXGHNVWUR]\LDGHQLQ\LVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHMRUD]RVRF]D &3'$PDIRUPãUR]WZRUX6WRVXQHNPLHV]DQLD&3'$GRNUZLZ\QRVLSU]\F]\PMHVWWRF]ãďÓREMãWRďFL&3'$LF]ãďFLREMãWRďFLNUZL3UDZLGúRZHQDSHúQLHQLHSUREĂZNLMHVWQLH]EãGQHGODDQDOL]\.UHZSHúQDRVRF]H]&3'$VWDQRZLÐPDWHULDúSUĂENLGREDGDüVHURORJLF]Q\FKJUXSNUZLZWUDQVIX]MRORJLLRUD]GRWHVWĂZ]JRGQRďFL SUĂE\NU]\ĮRZH GRWUDQVIX]ML3UREĂZNL60RQRYHWWH®&3'$VúXĮÐ]ZúDV]F]D
GRR]QDF]DQLDJUXSNUZL $% ZW\PGRR]QDF]DQLDQDSRGVWDZLHXNúDGX.HOOL5KHVXVWHVWĂZZ\NU\ZDQLDSU]HFLZFLDúQDREHFQRďÓQLHUHJXODUQ\FKSU]HFLZFLDúJUXSNUZLGRZLHORVZRLVW\FKEH]SRďUHGQLFKWHVWĂZ&RRPEVD GRGQL WHVWĂZ]JRGQRďFL SUĂE\NU]\ĮRZH 1DOHĮ\VWRVRZDÓMH]VXURZLFÐRVRF]HPSDFMHQWDRGSRZLHGQLPLGODJUXS\NUZL 0DMRU7HVW =DWZLHUG]RQ\F]DVSU]HQLHVLHQLDGRSU]HFKRZ\ZDQLDZ\QRVLPDNVJRG]LQ\ZWHPSHUDWXU]HşƓ&:FHOXVHG\PHQWDFMLNRPĂUHNSUĂENãQDOHĮ\QDMSLHUZXPLHďFLÓZORGĂZFHZSR]\FMLSLRQRZHMQDFRQDMPQLHM
JRG]LQ:\PLHQLRQHZF]HďQLHMDQDOLW\PRĮQDQDVWãSQLHR]QDF]DÓQDMSĂĬQLHMGRGQLSRGREQLHMDNZSU]\SDGNX]Z\NúHJRSU]HFKRZ\ZDQLDNUZLZORGĂZFH şƓ&  ]Z\MÐWNLHPEH]SRďUHGQLHJRWHVWX&RRPEVDZ
W\PSU]\SDGNXMHVWWRGQL 3URGXNWMHVWRGSRZLHGQLGRDJOXW\QDFMLNROXPQRZHMQS9LVLRQ0D[ILUP\2UWKR&OLQLFDO'LDJQRVWLFV1LHZROQR]DPUDĮDÓPDWHULDúXSUĂENL
2GSRZLHG]LDOQRďFLÐXĮ\WNRZQLNDMHVWVSUDZG]HQLHSU]\GDWQRďFLPDWHULDúXSUĂENLGRZ\NRQDQLDEDGDü]DSRPRFÐLQQ\FKPHWRGRGF]\QQLNĂZWHVWRZ\FKDQDOL]DWRUĂZRUD]SRGNÐWHPZDUXQNĂZSU]HFKRZ\ZDQLD
8Į\WNRZQLNPXVL]ZHU\ILNRZDÓWHZDUXQNL+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]F\WU\QLDQ
1DOHĮ\]DSR]QDÓVLã]8:$*$0,GRW\F]ÐF\PLSRELHUDQLDSUĂEHNLVWRVRZDQLD60RQRYHWWH®&3'$ZSRúÐF]HQLX]LJúÐPRW\ONRZÐ

S-Monovette® ThromboExact SARSTEDT
S-Monovette®7KURPER([DFW]DZLHUDDQW\NRDJXODQWZSRVWDFLVROLPDJQH]RZHMLVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHM 6ĂOPDJQH]RZDMHVWGRVWãSQDZSRVWDFLSU]H]QDF]RQHMGRUR]S\ODQLD.UHZSHúQDZSUREĂZFH60RQRYHWWH®7KURPER([DFWVWDQRZLPDWHULDúSUĂENLVúXĮÐF\GRZ\NOXF]HQLDIDúV]\ZLHQLVNLHMOLF]E\WURPERF\WĂZZZ\QLNXQLHWROHUDQFMLDQW\NRDJXODQWĂZ WDNLFKMDN('7$F\WU\QLDQKHSDU\QD 
F]\OLWDN]ZDQHMSVHXGRWURPERF\WRSHQLL3URGXNW]DSRELHJDWZRU]HQLXVLãDJUHJDWĂZWURPERF\WĂZLXPRĮOLZLDRNUHďOHQLHU]HF]\ZLVWHMOLF]E\WURPERF\WĂZGRJRG]LQSRSREUDQLXNUZL-RQ\PDJQH]XSRZRGXMÐKDPRZDQLHNU]HSQLãFLD-RQ\PDJQH]XKDPXMÐWURPERF\WDUQ\WURPERNVDQ$RUD]DJUHJDFMãWURPERF\WĂZ]DSRďUHGQLFWZHP$'3LNZDVXDUDFKLGRQRZHJRS-Monovette®+LUXG\QDıUP\6$567('7Probówka S-Monovette®+LUXG\QD]DZLHUDDQW\NRDJXODQWZSRVWDFLKLUXG\Q\LVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHM +LUXG\QDMHVWGRVWãSQDZSRVWDFLSU]H]QDF]RQHMGRUR]S\ODQLD.UHZSHúQD]KLUXG\QÐVWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRRNUHďODQLDIXQNFMLWURPERF\WĂZZXU]ÐG]HQLDFK0XOWLSODWH® PXOWLSOHSODWHOHWIXQFWLRQDQDO\VHU ILUP\52&+('LDJQRVWLFV3URGXNW]RVWDú]DWZLHUG]RQ\GR
VWRVRZDQLDZW\PFHOX:\UĂESU]H]QDF]RQ\MHVWGRPRQLWRURZDQLDWHUDSLLSRGF]DVNWĂU\FKVWRVRZDQHVÐOHNLKDPXMÐFHSú\WNLRUD]GREDGDüPDMÐF\FKQDFHOXZ\NOXF]HQLHG\VIXQNFMLWURPERF\WĂZ
Probówka S-Monovette®+LUXG\QD]RVWDúDRSUDFRZDQDVSHFMDOQLH]P\ďOÐRRNUHďODQLXIXQNFMLWURPERF\WĂZZHZVSĂúSUDF\]ILUPÐ9HUXP'LDJQRVWLFDREHFQLH52&+('LDJQRVWLFVQDXU]ÐG]HQLDFK0XOWLSODWH®.
+LUXG\QDSRZRGXMHKDPRZDQLHNU]HSQLãFLDZZ\QLNXEH]SRďUHGQLHJRKDPRZDQLDWURPELQ\FRXPRĮOLZLDGLDJQRVW\NãIXQNFMLWURPERF\WĂZZLFKVWDQLHQDW\ZQ\P

S-Monovette®+RPRF\VWHLQD]ĮHOHP+&<=+&<&6$567('7System S-Monovette®+RPRF\VWHLQD]ĮHOHP+&<=RSUĂF]JUDQXOHN]WZRU]\ZDV]WXF]QHJRSRNU\W\FKDNW\ZDWRUHPNU]HSQLãFLD NU]HPLDQHP ]DZLHUDUĂZQLHĮVSHFMDOQ\VWDELOL]DWRUZSRVWDFLĮHOXQDED]LHSROLPHUĂZLVúXĮ\GRSR]\VNLZDQLDVXURZLF\ :WUDNFLHZLURZDQLDĮHORVDG]DVLãPLãG]\VNU]HSHPNUZLDVXURZLFÐWZRU]ÐFVWDELOQÐZDUVWZãUR]G]LHODMÐFÐQDF]DVWUDQVSRUWXSU]HFKRZ\ZDQLDLDQDOL]\3UHSDUDWMHVWGRVWãSQ\Z
postaci przeznaczonej do rozpylania.
+RPRF\VWHLQDZNUZLSHúQHMXOHJDVWDELOL]DFMLGRJRG]LQZWHPSHUDWXU]HSRNRMRZHM:SU]\SDGNXRGZLURZDQLDSUĂENLZFLÐJXJRG]LQSRSREUDQLXLSU]\SUDZLGúRZRXIRUPRZDQHMZDUVWZLHRGG]LHODMÐFHVNU]HSNUZLLVXURZLFãKRPRF\VWHLQDXOHJDVWDELOL]DFMLGRJRG]LQSurowica w probówce S-Monovette®+RPRF\VWHLQD]ĮHOHP+&<=VWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRR]QDF]DQLDKRPRF\VWHLQ\60RQRYHWWH® Homocysteina HCY-C zawiera antykoagulant w postaci cytrynianu
S+ LVúXĮ\GRSR]\VNLZDQLDRVRF]D &\WU\QLDQPDIRUPãUR]WZRUX3RGF]DVREOLF]DQLDVWãĮHQLDKRPRF\VWHLQ\ZDUWRďÓQDOHĮ\SRPQRĮ\ÓSU]H]]XZDJLQDUR]FLHüF]HQLH
+RPRF\VWHLQDZNUZLSHúQHMXOHJDVWDELOL]DFMLGRJRG]LQZWHPSHUDWXU]HSRNRMRZHMRUD]GRJRG]LQZWHPSHUDWXU]HƓ&
Osocze w probówce S-Monovette®+RPRF\VWHLQD+&<&VWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRR]QDF]DQLDKRPRF\VWHLQ\+DPRZDQLHNU]HSQLãFLDZSUREĂZFH60RQRYHWWH®+RPRF\VWHLQD+&<&QDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]F\WU\QLDQ
1DOHĮ\]DSR]QDÓVLã]8:$*$0,GRW\F]ÐF\PLSRELHUDQLDSUĂEHNLVWRVRZDQLD60RQRYHWWH®+&<&ZSRúÐF]HQLX]LJúÐPRW\ONRZÐ

S-Monovette® DNA Exact SARSTEDT
Probówka S-Monovette®'1$([DFW]DZLHUDDQW\NRDJXODQW\QDED]LH('7$LVúXĮ\GRSR]\VNLZDQLDNUZLSHúQHM ('7$MHVWGRVWãSQHZSRVWDFLSU]H]QDF]RQHMGRUR]S\ODQLD.UHZSHúQD]('7$VWDQRZLPDWHULDúSUĂENLSU]H]QDF]RQ\GRVWDELOL]DFMLJ'1$6NXWHF]QRďÓVWDELOL]DFMLJ'1$]RVWDúD]DWZLHUG]RQDGODGQLZWHPSƓ&GQLZWHPSHUDWXU]HSRNRMRZHM Ɠ& GQLZZDUXQNDFKFKúRG]HQLD Ɠ& LFRQDMPQLHMURNZZDUXQNDFK]DPURĮHQLDZWHPSƓ&3UĂENLVWDELOL]RZDQHPRJÐSRQDGWRZ\WU]\PDÓF\NOL]DPUDĮDQLDLUR]PUDĮDQLDEH]QHJDW\ZQ\FKVNXWNĂZGODMDNRďFL3DWU]UĂZQLHĮ
SARSTEDT White Paper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection,
Transport and Stabilization of Whole Blood for Genomic DNA Analysis”.
+DPRZDQLHNU]HSQLãFLDQDVWãSXMHZZ\QLNXNRPSOHNVRZDQLDMRQĂZZDSQLDSRSU]H]('7$

3U]\GDWQRďÓPDWHULDúXSUĂENL]DOHĮ\RGDQDOLWXRUD]RGF]\QQLNDWHVWRZHJRDQDOL]DWRUD1DOHĮ\SU]HVWU]HJDÓVSHF\ıNDFMLSURGXFHQWDZ\UREX

157

PL
:VND]ĂZNLEH]SLHF]HüVWZDRVWU]HĮHQLD
1.

2JĂOQHďURGNLRVWURĮQRďFL6WRVRZDÓUãNDZLFHLRJĂOQHďURGNLRFKURQ\LQG\ZLGXDOQHMZFHOXRFKURQ\SU]HGPRĮOLZ\PNRQWDNWHP]NUZLÐSRWHQFMDOQLH]DNDĬQ\PPDWHULDúHPSUĂENLLSU]HQRV]RQ\PLZNUZL
patogenami.

2.

2EFKRG]LÓVLã]HZV]\VWNLPLSUĂENDPLELRORJLF]Q\PLLRVWU\PLVSLF]DVW\PLSU]\ERUDPLGRSRELHUDQLDNUZL LJúDPLDGDSWHUDPL ]JRGQLH]Z\W\F]Q\PLLSURFHGXUDPLVZRMHMSODFĂZNL:SU]\SDGNXEH]SRďUHGQLHJR
NRQWDNWX]SUĂENDPLELRORJLF]Q\PLOXE]UDQLHQLDLJúÐ]ZUĂFLÓVLãRSRPRFOHNDUVNÐSRQLHZDĮLVWQLHMHU\]\NRSU]HQLHVLHQLDFKRUĂE]DNDĬQ\FKWDNLFKMDN+,9+&9+%9RUD]LQQ\FK8Į\ZDÓLJLHúEH]SLHF]QHMLJú\EH]SLHF]QHM0XOWLĲ\®]H]LQWHJURZDQÐQDVDGNÐRFKURQQÐ1DOHĮ\]DZV]HSU]HVWU]HJDÓ]DOHFHüLSURFHGXUEH]SLHF]HüVWZDVZRMHMSODFĂZNL3.

Dotyczy pojedynczych produktów pakowanych sterylnie:3U]HGXĮ\FLHPVSUDZG]LÓNDĮGHRSDNRZDQLHMHGQRVWNRZHSRGNÐWHPXV]NRG]HüDZSU]\SDGNXXV]NRG]HQLDQLHXĮ\ZDÓ

4.

:\URE\WHVÐSU]H]QDF]RQHGRMHGQRUD]RZHJRXĮ\WNX:V]\VWNLHRVWUHVSLF]DVWHSU]HGPLRW\ LJú\DGDSWHU\ GRSRELHUDQLDNUZLQDOHĮ\XW\OL]RZDÓZbSRMHPQLNDFKSU]H]QDF]RQ\FKGRXVXZDQLDPDWHULDúĂZ
niebezpiecznych biologicznie.

5.

-HďOLNUHZMHVWSRELHUDQD]DSRPRFÐGRVWãSXGRĮ\OQHJR ,9 SU]HGUR]SRF]ãFLHPSRELHUDQLDNUZLQDOHĮ\VLãXSHZQLÓĮHGRVWãSMHVWRGSRZLHGQLRSU]HSúXNDQ\ RF]\V]F]RQ\]UR]WZRUXGRĮ\OQHJR ]JRGQLH]
SURFHGXUDPLRERZLÐ]XMÐF\PLZSODFĂZFH3UDZLGúRZHSU]HSúXNDQLHGRVWãSXSR]ZROLXQLNQÐÓEúãGQ\FKZ\QLNĂZDQDOL]\

6.

1LHGRVWDWHF]QHQDSHúQLHQLH60RQRYHWWH®SURZDG]LGRQLHSUDZLGúRZHJRVWRVXQNXNUZLGRSUHSDUDWXGRGDWNXLPRĮHSURZDG]LÓGREúãGQ\FKZ\QLNĂZDQDOL]\7.

Krwi pobranej i przetworzonej w S-Monovette®QLHPRĮQDZSURZDG]DÓSRQRZQLHGRRUJDQL]PXOXG]NLHJR

8.

1LHQDOHĮ\XĮ\ZDÓSURGXNWXSRXSú\ZLHWHUPLQXZDĮQRďFL7HUPLQSU]\GDWQRďFLGRXĮ\FLDNRüF]\VLãRVWDWQLHJRGQLDZVND]DQHJRPLHVLÐFDLURNX

Przechowywanie'RPRPHQWX]DVWRVRZDQLDSURGXNWQDOHĮ\SU]HFKRZ\ZDÓZWHPSHUDWXU]HSRNRMRZHM

Ograniczenia
1.

&]DVLWHPSHUDWXUDSU]HFKRZ\ZDQLDQDSHúQLRQHMSUREĂZNL60RQRYHWWH®]DOHĮÐRGWUZDúRďFLEDGDQ\FKDQDOLWĂZ2FHQD]RVWDúDGRNRQDQDSU]H]ODERUDWRULXPOXELQIRUPDFMHSRFKRG]Ð]LQVWUXNFMLREVúXJL
dostarczonej przez producenta odczynnika testowego / analizatora.

2.

1DZHWMHďOLRVRF]HOXEVXURZLFD]RVWDQÐRGG]LHORQHSRSU]H]ZLURZDQLHQDF]\ü60RQRYHWWH®LOXEGRVWãSQDMHVWEDULHUDMHRGG]LHODMÐFDPRĮHVLã]GDU]\ÓĮHQLHZV]\VWNLHNRPĂUNLEãGÐZSHúQLRGG]LHORQH1DVWãĮHQLDDQDOLWĂZZSú\ZDÓPRĮHPHWDEROL]PUHV]WNRZ\OXEQDWXUDOQDGHJUDGDFMD6WDELOQRďÓDQDOLWĂZQDOHĮ\RFHQLÓXZ]JOãGQLDMÐFSRMHPQLNLGRSU]HFKRZ\ZDQLDLZDUXQNLODERUDWRU\MQH

3.

:SU]\SDGNXVWRVRZDQLDOHNĂZWHUDSHXW\F]Q\FKSU]\GDWQRďÓPDWHULDúXSUĂENLGRXĮ\FLDQDOHĮ\]ZHU\ıNRZDÓZLQVWUXNFMLREVúXJLSURGXFHQWDRGF]\QQLNDWHVWRZHJRDQDOL]DWRUD

4.

$QDOL]\SLHUZLDVWNĂZďODGRZ\FKPHWDOLQDOHĮ\SU]HSURZDG]DÓ]Z\NRU]\VWDQLHPV\VWHPX60RQRYHWWH®GRDQDOL]\PHWDOLLLJú\EH]SLHF]QHM

3RELHUDQLHSUĂEHNLREFKRG]HQLHVLã]QLPL'2.80(177(11$/(Æ<35=(&=<7$o:&$2¨&,35=('35=<67l3,(1,(0'232%,(5$1,$.5:,Æ</1(-0DWHULDúSRWU]HEQ\GRSREUDQLDSUĂEHN
1.

Wszystkie potrzebne systemy do pobierania krwi S-Monovette®.

2.

,Jú\ EH]SLHF]QH OXELJú\ EH]SLHF]QH 0XOWLĲ\®.

3.

5ãNDZLFHIDUWXFKRFKURQDRF]XOXELQQDRGSRZLHGQLDRG]LHĮRFKURQQDGR]DEH]SLHF]HQLDSU]HGSDWRJHQDPLSU]HQRV]RQ\PLSU]H]NUHZOXESRWHQFMDOQLH]DNDĬQ\PLPDWHULDúDPL4.

(W\NLHW\GRLGHQW\ıNDFMLSDFMHQWD

5.

¨URGHNGH]\QIHNXMÐF\GRRF]\V]F]HQLDPLHMVFDSRELHUDQLDSUĂEHN QDOHĮ\SRVWãSRZDÓ]JRGQLH]Z\W\F]Q\PLSODFĂZNLZ]DNUHVLHSU]\JRWRZDQLDPLHMVFDSRELHUDQLDSUĂEHN 1LHXĮ\ZDÓĮDGQ\FKPDWHULDúĂZGR
F]\V]F]HQLDQDED]LHDONRKROXJG\NRQLHF]QHMHVWXĮ\FLHSUĂEHNGRWHVWĂZDONRKRORZ\FK

6.

Suche, sterylne gaziki jednorazowe.

7.

2SDVNDXFLVNRZDGRĮ\ú

8.

3ODVWHUOXEEDQGDĮ

9.

3RMHPQLNQDRVWUHVSLF]DVWHSU]HGPLRW\GREH]SLHF]QHMXW\OL]DFML]XĮ\W\FKSU]\U]ÐGĂZ=DOHFDQDNROHMQRďÓSRELHUDQLD
1.

Buteleczki do posiewu krwi

2.

1DF]\QLD]F\WU\QLDQHPOXEDNW\ZDWRUHPNU]HSQLãFLD VXURZLFD&$7]ĮHOHPOXEEH]QLHJR]ĮHOHPVHSDUXMÐF\PVXURZLFã&$7 

3.

1DF]\QLD]DNW\ZDWRUHPNU]HSQLãFLDOXEF\WU\QLDQHP

4.

1DF]\QLD]KHSDU\QÐ]ĮHOHPEH]ĮHOX

5.

1DF]\QLD]('7$]ĮHOHPEH]ĮHOX

6.

Naczynia z inhibitorami glikolizy

7.

Naczynia z innymi dodatkami:6.$=:.$3RGF]DVSRELHUDQLDGRQDF]\QLD]F\WU\QLDQHPOXELQQHJRQDF]\QLD]Sú\QQ\PSUHSDUDWHPQS3)$&7$'&3'$+&<&OXE*OXFR(;$&7ZSRúÐF]HQLX]LJúÐPRW\ONRZÐ QSLJúÐ EH]SLHF]QÐ 0XOWLĲ\® ]DOHFDVLãZF]HďQLHMV]HSRELHUDQLH]SXVWHJRQDF]\QLDEH]SUHSDUDWX QS60RQRYHWWH®1HXWUDOQ\= DE\XQLNQÐÓQLHGRVWDWHF]QHJRQDSHúQLHQLD
QDF]\QLDZF]DVLHQDSHúQLDQLD]DSRPRFÐLJú\PRW\ONRZHM
:WHQVSRVĂEPRĮQD]DSHZQLÓSUDZLGúRZHQDSHúQLHQLHQDF]\QLDRUD]SUDZLGúRZ\VWRVXQHNPLHV]DQLD FLHF]\GRNUZL :6.$=:.$

3RGF]DVXW\OL]DFMLSRVWãSRZDÓ]JRGQLH]Z\W\F]Q\PLVZRMHMSODFĂZNL

8QLNDQLHSU]HSú\ZXZVWHF]QHJR:LãNV]RďÓZ\UREĂZ60RQRYHWWH]DZLHUDGRGDWNLFKHPLF]QH$E\]DSRELHFSU]HSú\ZRZLZVWHF]QHPXSU]HVWU]HJDÓQDVWãSXMÐF\FKZVND]ĂZHN
1. 8Į\ZDÓZ\úÐF]QLHPDWHULDúĂZ]DOHFDQ\FKZLQVWUXNFMLREVúXJL
2.

8úRĮ\ÓSDFMHQWDZVSRVĂEXúDWZLDMÐF\GRVWãSGRĮ\ú\WDNDE\UDPLãOXELQQHPLHMVFHZNúXFLDZPLDUãPRĮOLZRďFLE\úRVNLHURZDQHZGĂú

3.

7U]\PDÓSUREĂZNã60RQRYHWWH®]DNUãWNÐVNLHURZDQÐZJĂUã3RGF]DVVWRVRZDQLD EH]SLHF]QHM LJú\0XOWLĲ\®QDOHĮ\WU]\PDÓMÐWDNĮHSRQLĮHMUDPLHQLDREV]DUXZNúXFLD

4.

3RGF]DVQDNúXZDQLDQDOHĮ\GRSLOQRZDÓDE\]DZDUWRďÓ60RQRYHWWH®QLHPLDúDNRQWDNWX]]DNUãWNÐDQLNRüFĂZNÐLJú\5.

3ROX]RZDÓRSDVNãXFLVNRZÐJG\NUHZSU]HSú\ZDGR60RQRYHWWH®.

158

PL
=DPUDĮDQLHRGPUDĮDQLH
=JRGQLH]]DOHFHQLDPL:+2 :+2',//DE5HY SU]HG]DPURĮHQLHP]DOHFDVLãRGVHSDURZDQLHVXURZLF\RVRF]DRGNRPĂUHNNUZL2ERZLÐ]XMÐQDVWãSXMÐFH]DOHFHQLDGRW\F]ÐFH]DPUDĮDQLDSUREĂZHN60RQRYHWWH®:=DPUDĮDQLHSRQLĮHMƓ&•=DVWRVRZDQLHZWHPSHUDWXUDFKXMHPQ\FKQDOHĮ\]DZV]HSU]HWHVWRZDÓZZDUXQNDFKU]HF]\ZLVW\FKSRQLHZDĮREFLÐĮHQLHSUREĂZHNPRĮHVLã]QDF]QLHUĂĮQLÓ]DOHĮQLHRG]DPURĮRQHMSRĮ\ZNLLSDQXMÐF\FKZDUXQNĂZUXW\QRZ\FK SDWU]UR]G]LDúSRďZLãFRQ\ZúDďFLZRďFLRPPDWHULDúRZ\PZNDWDORJX6$567('7 •=DVDGQLF]RZ\WU]\PDúRďÓWZRU]\ZV]WXF]Q\FKVSDGDSU]\WHPSHUDWXU]HSRQLĮHMƓ&:]ZLÐ]NX]W\PQDRJĂúQDOHĮ\XQLNDÓREFLÐĮHüPHFKDQLF]Q\FK•

1DOHĮ\]DSHZQLÓWDNLHZDUXQNL]DPUDĮDQLDDE\]DZDUWRďÓSUREĂZNL60RQRYHWWH®]DPDU]DúDUĂZQRPLHUQLHOXERGGRúXGRJĂU\1DOHĮ\]DGEDÓRWRDE\SUREĂZND60RQRYHWWH®PLDúDQDW\OHGXĮRZROQHJRPLHMVFDZVWDW\ZLHOXESRMHPQLNXGRSU]HFKRZ\ZDQLDDE\PRĮOLZHE\úRMHMUR]V]HU]DQLH6WDW\Z\Z\NRQDQH]HVW\URSLDQXOXEPHWDOXVÐQLHRGSRZLHGQLHSRQLHZDĮPRJÐXOHFSãNQLãFLRPVSRZRGRZDQ\PUR]V]HU]DQLHPVLãPDWHULDúX=DPUDĮDQLHZƓ&şSU]HG]DPURĮHQLHPQDOHĮ\VSUDZG]LÓ•=DNúĂFHQLD1DOHĮ\VSUDZG]LÓF]\]DPURĮHQLHEãG]LHPLDúRMDNLNROZLHNZSú\ZQDSUĂENLNUZLOXEZ\QLNLDQDOL]\ QSQDKHPROL]ãVWDELOQRďÓDQDOLWĂZ •:LURZDQLH0RĮHE\ÓZ\PDJDQHZ]DOHĮQRďFLRGSODQRZDQHMDQDOL]\3U]HVWU]HJDÓZDUXQNĂZZLURZDQLDSRGDQ\FKZW\PGRNXPHQFLHZF]ãďFLŚ:LURZDQLHŘOXEQDVWURQLHLQWHUQHWRZHM6$567('7https://www.
sarstedt.com/en/service/centrifugation/DQDVWãSQLHSU]HSURZDG]LÓNRQWUROãZL]XDOQÐSUĂENL•+HPROL]D+HPROL]DNUZLSHúQHMSR]DPURĮHQLX$E\XQLNQÐÓKHPROL]\QDOHĮ\XĮ\ÓSUREĂZNL60RQRYHWWH®*HOOXESRRGZLURZDQLXıOWUDGR]DZRUX6HUDSODV®0RĮQDWHĮSU]HQLHďÓSUĂENãGRQDF]\QLDZWĂUQHJR]DSRPRFÐSLSHW\=DPUDĮDQLHZƓ&şSURFHGXUD
•6FKúDG]DQLH8PLHďFLÓSUREĂZNã60RQRYHWWH®ZSR]\FMLSLRQRZHMLFKúRG]LÓMÐRGWHPSHUDWXU\SRNRMRZHMGRƓ&SU]H]şPLQXW'RSLHURQDVWãSQLHPRĮQDMÐ]DPUR]LÓZWHPSHUDWXU]HƓ&

•5R]PUDĮDQLH3R]RVWDZLÓZSR]\FMLSLRQRZHMZWHPSHUDWXU]HSRNRMRZHMQDFRQDMPQLHMPLQXWDĮGRUR]PURĮHQLD5ĂZQLHĮLZW\PSU]\SDGNXQDOHĮ\XQLNDÓREFLÐĮHüPHFKDQLF]Q\FK=E\WV]\ENLHUR]PUDĮDQLH
PRĮHZSú\QÐÓQDZ\QLNLDQDOL]\=DPUDĮDQLHL]DPUDĮDQLHJúãERNLHSRQLĮHMƓ&•=DPUDĮDQLHSRQLĮHMƓ&QLH]RVWDúRVSUDZG]RQHSU]H]SURGXFHQWD=XZDJLQDGXĮÐOLF]EãSRWHQFMDOQ\FKF]\QQLNĂZPRJÐF\FKPLHÓQDWRZSú\Z]DOHFDVLãSU]HSURZDG]DQLHWHVWĂZ]DPUDĮDQLDZUXW\QRZ\FK
warunkach laboratoryjnych.

=DPUDĮDQLH60RQRYHWWH®ÆHO
•

3RGF]DV]DPUDĮDQLDSRVWãSRZDÓMDNRSLVDQRZSXQNFLHŚ=DPUDĮDQLHZƓ&şSURFHGXUDŘ•:Z\QLNX]DPUDĮDQLDZDUVWZDĮHORZDPRĮHXOHF]PLDQLH•=XZDJLQDGXĮÐOLF]EãSRWHQFMDOQ\FKF]\QQLNĂZPRJÐF\FKPLHÓQDWRZSú\Z]DOHFDVLãSU]HSURZDG]DQLHWHVWĂZ]DPUDĮDQLDZUXW\QRZ\FKZDUXQNDFKODERUDWRU\MQ\FK

•

5R]PUDĮDQLH3R]RVWDZLÓSUĂENãZSR]\FMLSLRQRZHMDĮGRUR]PURĮHQLD3RUR]PURĮHQLXSUĂENãQDOHĮ\SU]HQLHďÓ]QDF]\QLDSRGVWDZRZHJRGRZWĂUQHJR]DSRPRFÐSLSHW\ QLHGHNDQWRZDÓ 1DSHúQLÓGRRNPPSRZ\ĮHMZDUVWZ\ĮHOX5HV]WãZ\U]XFLÓ:6.$=:.$$E\]DSHZQLÓVWDELOQRďÓDQDOLWĂZQDOHĮ\SU]HVWU]HJDÓLQVWUXNFMLREVúXJLSU]HND]DQ\FKSU]H]SURGXFHQWDRGF]\QQLNDWHVWRZHJRDQDOL]DWRUD

159

PL
Pobieranie krwi
Technika pobierania'RVWãSQHVÐGZLHWHFKQLNLSRELHUDQLDWHFKQLNDDVSLUDF\MQDLWHFKQLNDSUĂĮQLRZD7HFKQLNDDVSLUDF\MQDSROHJDQDGHOLNDWQ\PSRELHUDQLXNUZLSU]\]DFKRZDQLXFLÐJúHJRSRZROQHJRSU]HSú\ZXSRSU]H]NRQWURORZDQHRGFLÐJDQLHWúRND:WHQVSRVĂESU]HSú\ZNUZLPRĮQDGRVWRVRZDÓGRGRZROQ\FKZDUXQNĂZLFHFKĮ\úRUD]]PQLHMV]\ÓU\]\NRKHPROL]\
7HFKQLNDSUĂĮQLRZDXPRĮOLZLDSRELHUDQLHNUZLGRQDF]\QLD]ZVWãSQLHZ\WZRU]RQÐSUĂĮQLÐ&LÐJúHSRGFLďQLHQLHVNXWNXMHV]\ENLPSU]HSú\ZHPNUZL:]ZLÐ]NX]W\PWHFKQLNDWDMHVWLGHDOQDZSU]\SDGNXNRU]\VWQHM
FKDUDNWHU\VW\NLĮ\úZúDWZ\FKZDUXQNDFKSRELHUDQLD
3RVWãSRZDQLHSU]\SRELHUDQLXNUZL]REDF]WHĮZLGHRGRW\F]ÐFHWHFKQLNLDVSLUDF\MQHMLSUĂĮQLRZHMSU]\Z\NRU]\VWDQLX60RQRYHWWH®ZUD]]LJúÐEH]SLHF]QÐOXELJúÐEH]SLHF]QÐ0XOWLIO\®:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood$%<=0,1,0$/,=2:$o5<=<.21$5$Æ(1,$1$.217$.7=.5:,l32'&=$632%,(5$1,$.5:,1$/(Æ<126,o5.$:,&(1. :\EUDÓZ\UĂE60RQRYHWWH® odpowiedni dla wymaganej próbki.
2.

:\EUDÓPLHMVFHZNúXFLDGRĮ\OQHJR:FHOXSU]\JRWRZDQLDPLHMVFDZNúXFLDGRĮ\OQHJRQDOHĮ\SRVWãSRZDÓ]JRGQLH]Z\W\F]Q\PLRERZLÐ]XMÐF\PLZSODFĂZFH

3RELHUDQLHNUZLWHFKQLNÐDVSLUDF\MQÐ
Uwaga! S-Monovette®VúXĮÐZ\úÐF]QLHGRSRELHUDQLDNUZLLQLHPRĮQDVWRVRZDÓLFKGRZVWU]\NLZDQLD6WRVRZDÓZ\úÐF]QLH]Z\PLHQLRQ\PLLJúDPL LJúD EH]SLHF]QD 60RQRYHWWH®OXELJúD EH]SLHF]QD 0XOWLIO\® / adapter do S-Monovette®).
6WRVRZDQLH]LJúÐEH]SLHF]QÐSRND]DQRWXWDMNOLNQLãFLH

%H]SRďUHGQLRSU]HGZNúXFLHPVLãZĮ\úãZVXQÐÓ60RQRYHWWH®GR]LQWHJURZDQHJRXFKZ\WXEH]SLHF]QHMLJú\ L]DEH]SLHF]\ÓMÐSRSU]H]delikatne obrócenie jej zgodnie z kierunkiem ruchu wskazówek
zegara .
:UD]LHSRWU]HE\]DúRĮ\ÓRSDVNãXFLVNRZÐ PDNVQDPLQXWã 3U]\JRWRZDÓPLHMVFHZNúXFLD]DSRPRFÐRGSRZLHGQLHJRďURGNDGH]\QIHNF\MQHJR1LHGRW\NDÓPLHMVFDZNúXFLDLJú\SR
GH]\QIHNFML8úRĮ\ÓSDFMHQWDZVSRVĂEXúDWZLDMÐF\GRVWãSGRĮ\ú\WDNDE\UDPLãOXELQQHPLHMVFHZNúXFLDZPLDUãPRĮOLZRďFLE\úRVNLHURZDQHZGĂú=GMÐÓRVúRQãLJú\:NúXÓVLãZĮ\úãSRZROLRGFLÐJQÐÓWúRNLSROX]RZDÓRSDVNãXFLVNRZÐJG\NUHZSU]HSú\ZDGR60RQRYHWWH®.
=DF]HNDÓDĮSU]HSú\ZNUZLXVWDQLHDE\]DSHZQLÓSUDZLGúRZHQDSHúQLHQLH

S-Monovette®QDOHĮ\GHOLNDWQLHREUĂFLÓZNLHUXQNXSU]HFLZQ\PGRUXFKXZVND]ĂZHN]HJDUD DQDVWãSQLHZ\FLÐJQÐÓMÐ]LJú\EH]SLHF]QHM RGúÐF]\Ó ,JúãEH]SLHF]QÐSR]RVWDZLÓZĮ\OH
3RGF]DVZLHORNURWQHJRSRELHUDQLDş]JRGQLH]SRZ\ĮV]\PRSLVHPşNROHMQHSUREĂZNL60RQRYHWWHQDOHĮ\SRGúÐF]DÓGRLJú\EH]SLHF]QHMLSRELHUDÓNROHMQHSUĂENL=DNRüF]HQLHSRELHUDQLDNUZL:SLHUZV]HMNROHMQRďFLRGúÐF]\Ó60RQRYHWWH®
+ DQDVWãSQLHZ\MÐÓLJúãEH]SLHF]QÐ]Į\ú\-HGQÐUãNÐ]GMÐÓRVúRQãLJú\LRGúRĮ\ÓMÐQDVWDELOQÐUĂZQÐSRZLHU]FKQLã,JúD]DWU]DďQLHVLãZRVúRQLHLJú\]HVú\V]DOQ\PLZ\F]XZDOQ\PNOLNQLãFLHP DNW\ZDFMD 0RĮQDWHĮQDFLVQÐÓGROQ\NRQLHFRVúRQ\LJú\SDOFHPZVND]XMÐF\P1DOHĮ\]DSR]QDÓVLã]LQVWUXNFMÐREVúXJLLJú\(bezpiecznej) S-Monovette®OXELJú\ EH]SLHF]QHM 0XOWLIO\®.
Wszystkie probówki S-Monovette®QDOHĮ\REUĂFLÓUD]GRJĂU\GQHPQDW\FKPLDVWSRRGúÐF]HQLXLFKRGLJú\EH]SLHF]QHM3R]DNRüF]HQLXSRELHUDQLDNUZLQDOHĮ\NLONDNURWQLHREUĂFLÓGRJĂUQ\GQHPZV]\VWNLH
SUĂENL]DZLHUDMÐFHDQW\NRDJXODQW\3U]HGWUDQVSRUWHPOXEZLURZDQLHPQDOHĮ\RGFLÐJQÐÓWúRNDĮ]DWU]DďQLHVLãZVú\V]DOQ\VSRVĂE  ]DWU]DďQLHVLãZGQLH60RQRYHWWH® 1DVWãSQLHQDOHĮ\RGúDPDÓNRüFĂZNãWúRND .
1.

0LHMVFHZNúXFLDQDOHĮ\XFLVNDÓVXFK\PZDFLNLHPZROQ\PRGGUREQRXVWURMĂZDĮGRXVWDQLDNUZDZLHQLD2.

*G\NUHZVNU]HSQLHZUD]LHSRWU]HE\PRĮQD]DúRĮ\ÓEDQGDĮ3.

:\U]XFLÓLJúãEH]SLHF]QÐGRSRMHPQLNDSU]H]QDF]RQHJRQDRGSDG\VWZDU]DMÐFH]DJURĮHQLHELRORJLF]QH

160

PL
3RELHUDQLHNUZLWHFKQLNÐSUĂĮQLRZÐ
Uwaga! S-Monovette®VúXĮÐZ\úÐF]QLHGRSRELHUDQLDNUZLLQLHPRĮQDVWRVRZDÓLFKGRZVWU]\NLZDQLD6WRVRZDÓZ\úÐF]QLH]Z\PLHQLRQ\PLLJúDPL LJúD EH]SLHF]QD 60RQRYHWWH®OXELJúD EH]SLHF]QD 0XOWLIO\® / adapter do S-Monovette®).
6WRVRZDQLH]LJúÐEH]SLHF]QÐSRND]DQRWXWDMNOLNQLãFLH

:FHOXUR]SRF]ãFLDGHOLNDWQHJRSRELHUDQLDNUZL6$567('7]DOHFDSREUDQLHNUZL]DSRPRFÐ60RQRYHWWH®SU]\Z\NRU]\VWDQLXWHFKQLNLDVSLUDF\MQHMSDWU]7(&+1,.$:.8o'2Æ</1<&+WHFKQLND
aspiracyjna– .
1DVWãSQLHSRELHUDÓNUHZWHFKQLNÐSUĂĮQLRZÐ3U]HGSU]\VWÐSLHQLHPGRSRELHUDQLDNUZLRGFLÐJQÐÓWúRN60RQRYHWWH®GRGQDQDF]\QLDDĮ]DWU]DďQLHVLãZVú\V]DOQ\VSRVĂE 1DVWãSQLHQDOHĮ\RGúDPDÓNRüFĂZNãWúRND .
:VXQÐÓSU]\JRWRZDQÐ60RQRYHWWH®GR]LQWHJURZDQHJRXFKZ\WXEH]SLHF]QHMLJú\60RQRYHWWH®L]DEH]SLHF]\ÓMÐSRSU]H]delikatne obrócenie jej zgodnie z kierunkiem ruchu wskazówek zegara.

+=DF]HNDÓDĮSU]HSú\ZNUZLXVWDQLHDE\]DSHZQLÓSUDZLGúRZHQDSHúQLHQLH

S-Monovette®QDOHĮ\GHOLNDWQLHREUĂFLÓZNLHUXQNXSU]HFLZQ\PGRUXFKXZVND]ĂZHN]HJDUD DQDVWãSQLHZ\FLÐJQÐÓMÐ]LJú\EH]SLHF]QHM RGúÐF]\Ó  ,JúãEH]SLHF]QÐSR]RVWDZLÓZĮ\OH
3RGF]DVZLHORNURWQHJRSRELHUDQLDş]JRGQLH]SRZ\ĮV]\PRSLVHPşNROHMQHSUREĂZNL60RQRYHWWHQDOHĮ\SRGúÐF]DÓGRLJú\EH]SLHF]QHMLSRELHUDÓNROHMQHSUĂENL=DNRüF]HQLHSRELHUDQLDNUZL
1DMSLHUZRGúÐF]\Ó60RQRYHWWH® + DQDVWãSQLHZ\MÐÓNDQLXOãEH]SLHF]QÐ]Į\ú\-HGQÐUãNÐ]GMÐÓRVúRQãLJú\LRGúRĮ\ÓMÐQDVWDELOQÐUĂZQÐSRZLHU]FKQLã.DQLXOD]DWU]DďQLHVLãZRVúRQLHLJú\ze
Vú\V]DOQ\PLZ\F]XZDOQ\PNOLNQLãFLHP DNW\ZDFMD 0RĮQDWHĮQDFLVQÐÓRVúRQãLJú\SDOFHPZVND]XMÐF\P
Wszystkie probówki S-Monovette®QDOHĮ\REUĂFLÓUD]GRJĂU\GQHPQDW\FKPLDVWSRRGúÐF]HQLXLFKRGLJú\EH]SLHF]QHM3R]DNRüF]HQLXSRELHUDQLDNUZLQDOHĮ\NLONDNURWQLHREUĂFLÓGRJĂUQ\GQHPZV]\VWNLH
SUĂENL]DZLHUDMÐFHDQW\NRDJXODQW\
1.

0LHMVFHZNúXFLDQDOHĮ\XFLVNDÓVXFK\PJD]LNLHPZROQ\PRGGUREQRXVWURMĂZDĮGRXVWDQLDNUZDZLHQLD2.

*G\NUHZVNU]HSQLHZUD]LHSRWU]HE\PRĮQD]DúRĮ\ÓEDQGDĮ3.

:\U]XFLÓLJúãEH]SLHF]QÐGRSRMHPQLNDSU]H]QDF]RQHJRQDRGSDG\VWZDU]DMÐFH]DJURĮHQLHELRORJLF]QH

161

,QVWUXNFMDREVúXJLş6\VWHPGRSRELHUDQLDNUZL60RQRYHWWH® SARSTEDT

PL

Wirowanie
8:$*$3UREĂZNL60RQRYHWWHILUP\6$567('7VÐSU]H]QDF]RQHGRZLURZDQLDSU]\[J:\MÐWNLHPVÐSUREĂZNL60RQRYHWWHR¢PP 60RQRYHWWH®SHGLDWU\F]QH NWĂUHREHFQLHVÐ]DWZLHUG]RQHGRZLURZDQLDSU]\[J1DOHĮ\XĮ\ZDÓZ\úÐF]QLHRGSRZLHGQLFKDGDSWHUĂZOXEZNúDGĂZ:LURZDQLHSãNQLãWHMSUREĂZNL60RQRYHWWHOXEZLURZDQLHJG\SU]\VSLHV]HQLHRGďURGNRZHMHVW]E\WGXĮHPRĮHVSRZRGRZDÓXV]NRG]HQLHSUREĂZNL60RQRYHWWHDZQDVWãSVWZLHXZROQLHQLHVXEVWDQFMLSRWHQFMDOQLHQLHEH]SLHF]Q\FK:NúDG\GRZLUĂZHNQDOHĮ\GRELHUDÓ]JRGQLH]UR]PLDUHPVWRVRZDQHMSUREĂZNL60RQRYHWWH:]JOãGQHSU]\VSLHV]HQLHRGďURGNRZHMHVW]ZLÐ]DQH]XVWDZLRQÐOLF]EÐREURWĂZQDPLQXWãZQDVWãSXMÐF\VSRVĂE
RCF = 11,2 x r x (obr./min/1000)2,
Ś5&)ŘŚZ]JOãGQHSU]\VSLHV]HQLHRGďURGNRZHŘQD]\ZDQHUĂZQLHĮŚVLúÐJŘ ]DQJLHOVNLHJR5&)ŚUHODWLYHFHQWULIXJDOIRUFHŘ ŚREUPLQŘŚREURW\QDPLQXWãŘ REUPLQ OXEQ ŚOLF]EDREURWĂZQDPLQXWãŘ ]DQJLHOVNLHJR530ŚUHYROXWLRQVSHUPLQXWHŘ ŚUŘŚSURPLHüZLURZDQLDRGďURGNDZLUĂZNLGRGQDSUREĂZNL60RQRYHWWH®”, (cm).
1DF]\QLD60RQRYHWWHEH]ĮHOXPRĮQDZLURZDÓZZLUĂZNDFK]ZLUQLNLHPNÐWRZ\POXEKRU\]RQWDOQ\P
1DF]\QLD60RQRYHWWH]ĮHOHPPRĮQDZLURZDÓZ\úÐF]QLHZZLUĂZNDFK]ZLUQLNDPLKRU\]RQWDOQ\PL:LURZDQLHZZLUĂZNDFK]ZLUQLNLHPNÐWRZ\PQLH]RVWDúR]DWZLHUG]RQHLQLHMHVW]DOHFDQHSU]H]6$567('7
3UREĂZNL60RQRYHWWHQDOHĮ\ZLURZDÓ]JRGQLH]RSLVDQ\PLSRQLĮHMZDUXQNDPL-HďOLVWRVRZDQHVÐLQQHZDUXQNLPXV]ÐRQH]RVWDÓ]DWZLHUG]RQHSU]H]VDPHJRXĮ\WNRZQLND
1DOHĮ\XSHZQLÓVLãĮHSUREĂZND60RQRYHWWHMHVWSUDZLGúRZRRVDG]RQDZHZNúDGDFKZLUĂZNL3UREĂZNL60RQRYHWWHZ\VWDMÐFHSR]DZNúDGPRJÐ]DF]HSLÓVLãRJúRZLFãZLUĂZNLLSãNQÐÓ:LUĂZNDPXVLE\ÓUĂZQRPLHUQLHZ\SHúQLRQD=DSR]QDÓVLã]LQVWUXNFMÐREVúXJLZLUĂZNL
8:$*$ 1LH QDOHĮ\ UãF]QLH XVXZDÓ XV]NRG]RQHM SUREĂZNL 60RQRYHWWH,QVWUXNFMH GRW\F]ÐFH GH]\QIHNFML ZLUĂZNL ]QDMGXMÐ VLã Z LQVWUXNFML REVúXJL ZLUĂZNL:]JOãGQHSU]\VSLHV]HQLHRGďURGNRZH J

Zgodnie z BS
DIN EN ISO 6710
4851+ (kod EU)–

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Surowica

10 min10 min

6 min

4 min

4 min

ÆHOVHSDUXMÐF\VXURZLFã

15 min10 min

4 min

4 min

4 min

6XURZLFD([SUHVV]ĮHOHP

15 min10 min

4 min

n. z.

n. z.

Heparyna litowa

10 min10 min

7 min

7 min

7 min

+HSDU\QDOLWRZDLĮHOVHSDUXMÐF\15 min15 min10 min

7 min

7 min

+HSDU\QDOLWRZDLĮHOVHSDUXMÐF\+

8 min

7 min

5 min

4 min

4 min

EDTA

n. z.

n. z.

7 min

6 min

5 min

ÆHO('7$

15 min10 min10 min

7 min

7 min

Cytrynian

9 min

8 min

7 min

6 min

5 min

('7$ĲXRUHNLKHSDU\QD

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

Cytrynian PBM 1,8 ml
3URPLHüZLUĂZNL!FP

9 min

8 min

7 min

6 min

5 min

Cytrynian PBM 1,8 ml
3URPLHüZLUĂZNL!GRƉFP

n. z.

n. z.

10 min

n. z.

n. z.

n. z. = nie zatwierdzono
'RW\F]\ZV]\VWNLFKSUREĂZHN60RQRYHWWH]Z\MÐWNLHP¢PP 60RQRYHWWHGR]DVWRVRZDüSHGLDWU\F]Q\FK 

Wirowanie w temp. 20°C+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, wycofano.

,QIRUPDFMHGRW\F]ÐFHPDWHULDúĂZVHSDUXMÐF\FK:úDďFLZRďFLSU]HSú\ZXPDWHULDúXVHSDUXMÐFHJR ĮHOX VÐ]DOHĮQHRGWHPSHUDWXU\:UD]LHFKúRG]HQLD60RQRYHWWHSU]HGZLURZDQLHPOXESRQLPQLHPRĮQD]DJZDUDQWRZDÓFLÐJúRďFLZDUVWZ\VHSDUXMÐFHM3UREĂZHN60RQRYHWWHQLHQDOHĮ\SRQRZQLHZLURZDÓ

Utylizacja
1.

1DOHĮ\SU]HVWU]HJDÓRJĂOQ\FKZ\W\F]Q\FKGRW\F]ÐF\FKKLJLHQ\RUD]SU]HSLVĂZSUDZQ\FKGRW\F]ÐF\FKSUDZLGúRZHJRXVXZDQLDPDWHULDúĂZ]DNDĬQ\FK2.

-HGQRUD]RZHUãNDZLFH]DSRELHJDMÐU\]\NXLQIHNFML

3.

6NDĮRQHOXEQDSHúQLRQHV\VWHP\GRSRELHUDQLDNUZLQDOHĮ\XVXZDÓGRRGSRZLHGQLFKSRMHPQLNĂZQDPDWHULDú\QLHEH]SLHF]QHELRORJLF]QLHNWĂUHQDVWãSQLHPRĮQDSRGGDÓREUĂEFHZDXWRNODZLHOXEVSDOLÓ

4.

8W\OL]DFMãQDOHĮ\SU]HSURZDG]DÓZRGSRZLHGQLHMVSDODUQLOXEZDXWRNODZLH VWHU\OL]DFMDSDUÐZRGQÐ 

162

PL
1RUP\LZ\W\F]QHVSHF\ıF]QHGODSURGXNWXZDNWXDOQLHRERZLÐ]XMÐFHMZHUVMLCLSI* GP39 „Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 „Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 „Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 „Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 „WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

1RUP\GRW\F]ÐFHQDF]\üGRSRELHUDQLDNUZLĮ\OQHM
',1(1,623RMHPQLNLMHGQRUD]RZHGRSRELHUDQLDSUĂEHNNUZLĮ\OQHMXOXG]L*CLSI (Clinical and Laboratory Standards Institute)2EMDďQLHQLHV\PEROLLR]QDF]Hü

1XPHUDUW\NXúX'RW\F]\UĂZQLHĮSRMHG\QF]\FKSURGXNWĂZSDNRZDQ\FKVWHU\OQLH

Oznaczenie partii

1LHXĮ\ZDÓZSU]\SDGNXXV]NRG]HQLDRSDNRZDQLD=XĮ\ÓGR

3RMHG\QF]\V\VWHPEDULHU\VWHU\OQHM]b]HZQãWU]Q\PRSDNRZDQLHPRFKURQQ\P

Znak CE

Sterylizacja przez napromieniowanie

Wyrób medyczny do diagnostyki in vitro

3U]HVWU]HJDÓLQVWUXNFMLXĮ\FLD:SU]\SDGNXSRQRZQHJRXĮ\FLDU\]\NRVNDĮHQLD

3U]HFKRZ\ZDÓ]GDODRGďZLDWúDVúRQHF]QHJR

3U]HFKRZ\ZDÓZVXFK\PPLHMVFX

ProducentKraj produkcji

6WHU\OQDďFLHĮNDSú\QX

1LHVWHU\OL]RZDÓSRQRZQLH=PLDQ\WHFKQLF]QH]DVWU]HĮRQH:V]HONLHSRZDĮQHLQF\GHQW\]ZLÐ]DQH]SURGXNWHPQDOHĮ\]JúDV]DÓSURGXFHQWRZLLZúDďFLZHPXRUJDQRZLNUDMRZHPX

163

Instruções de utilização – S-Monovette® Sistema de colheita de sangue SARSTEDTPT

Para utilização de diagnóstico in-vitro
Aplicações
Os sistemas de colheita de sangue S-Monovette®, as agulhas e os adaptadores são utilizados em conjunto como sistema para a colheita de sangue venoso. Os sistemas de colheita de sangue S-Monovette® servem
para a colheira, transporte, tratamento e armazenamento de amostras de sangue para determinação de diagnósticos in-vitro a partir de soro, plasma ou sangue total em laboratório clínico. O produto destina-se ao uso
em ambiente profissional e à aplicação por pessoal médico e técnico de laboratório especializados.

Descrição do produto
Os sistemas de colheita de sangue S-Monovette® são compostos por um recipiente de plástico, um êmbolo, uma haste do êmbolo e uma tampa roscada de plástico com código de cor, com membrana integrada,
projetada especificamente para ligar a uma agulha de segurança S-Monovette® ou a uma agulha de segurança Multifly®, bem como diversos aditivos (preparações). Também está disponível uma S-Monovette® sem
aditivo. Os sistemas de colheita de sangue S-Monovette® com os aditivos ativador de coagulação, ativador de coagulação com gel, heparina de lítio, heparina de lítio com gel, heparina sódica, citrato, EDTA, fluoreto('7$IOXRUHWRKHSDULQDIOXRUHWRFLWUDWR&3'$HVHPDGLWLYRDVVXDVFRQFHQWUD×ĄHVGHDGLWLYRRYROXPHGHDGLWLYRVOìTXLGRVHDVVXDVWROHUÉQFLDVSHUPLWLGDVEHPFRPRRFRPSRUWDPHQWRGRVDQJXHDRDGLWLYR
correspondem aos requisitos e recomendações da norma internacional DIN EN ISO 6710 „Single-use containers for venous blood specimen collection“ e do Clinical and Laboratory Standards Institute’s Approved
Standards (CLSI). A escolha do aditivo depende do método de teste analítico. Este é especificado pelo fabricante dos reagentes de teste e/ou do dispositivo de análises com o qual o teste é realizado. O sistema decolheita de sangue S-Monovette® está disponível nas versões estéril por dentro ou em embalagens individuais estéreis por dentro e por fora.

Códigos de cores das tampas de rosca S-Monovette®:

Aditivo

Código de letras

Cor da tampa DIN EN ISO
6710

Cor da tampa de acordo
com a BS 4851+

Z

brancobrancoRecipiente sem preparação
S-Monovette® Neutral Z
Recipiente de soro
S-Monovette® Soro CAT, com ativador de coagulação

CAT

vermelhobrancoS-Monovette® Gel de soro CAT, com ativador de coagulação e gelCATamarelo-escuro

amarelo-escuro

S-Monovette® Gel de soro Express CAT, com ativador de coagulação trombina e gelCATlaranja-

S-Monovette® Heparina de lítio LH, com heparina de lítio

HL

verde

laranja

S-Monovette® Heparina de lítio HL líquida, com heparina de lítio

HL

verde

laranja

S-Monovette® Gel de heparina de lítio LH, com heparina de lítio e gel

HL

verde

laranja

S-Monovette® Gel de heparina de lítio+ HL, com heparina de lítio e gel rápido

HL

verde

laranja

S-Monovette® heparina sódica NH, com heparina sódica

NH

castanho

verde

S-Monovette® Heparina de amónio AH, com heparina de amónia

n.d.

azul

azul

9NC

azul

verde

9NC

azul-claro-

S-Monovette® K3 EDTA K3E, com potássio EDTA

K3E

violetavermelho

S-Monovette® K2 EDTA K2E, com potássio EDTA

K2E

violetavermelho

S-Monovette® K2 Gel EDTA K2E, com potássio EDTA e gel

K2E

violetavermelho

S-Monovette®)OXRUHWR('7$)(FRPĲXRUHWRH('7$FE

cinzento

amarelo

S-Monovette®)OXRUHWRKHSDULQD)+FRPĲXRUHWRHKHSDULQD

FH-amarelo

S-Monovette®*OXFR(;$&7)&FRPĲXRUHWRFLWUDWRH('7$

FC

rosa

cinzento

HL

azul-escurolaranja

S-Monovette® ThromboExact, com composto de magnésio

n.d.

n.d., cores de amora

n.d., cores de amora

S-Monovette® CTADn.d.

n.d., azuln.d., verde

S-Monovette® ACD

ACD

amareloamarelo

S-Monovette® CPDA

CPDA

amareloamarelo

S-Monovette® hirudina

n.d.

n.d., verde azeitonan.d., verde azeitona

S-Monovette® Gel Homocisteína HCY-Z, com gel e estabilizador

n.d.

n.d., cinzenton.d., cinzento

S-Monovette® Homocisteína HCY-C com tampão de citrato

n.d.

n.d., violeta

n.d., violeta

S-Monovette® DNA Exactn.d.

n.d., azuln.d., azul

Recipiente de heparina

Recipiente de citrato
S-Monovette® Citrato 9NC, citrato de sódio 3,13%®

S-Monovette PFA, Citrato 9NC, citrato de sódio 3,8%, tamponado
Recipiente EDTA

Recipiente com inibidores de glicólise

5HFLSLHQWHSDUDDQÈOLVHGHPHWDLVS-Monovette® para análise de metais HL, com heparina de lítio

Outros recipientes de sangue total e de plasma

2XWUDVFRUHVGHWDPSDURVFDGDGLVSRQìYHLV
n.d.: não definido
Retirado de +British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, revogado.

164

PT
S-Monovette® Soro CAT/Gel de soro CAT
O S-Monovette® Soro CAT contém um granulado de material sintético revestidos com um ativador de coagulação (silicato) e serve para a colheita do soro**. O granulado de material sintético fixa-se por centrifugação
entre os coágulos de sangue e o soro.
O S-Monovette® Gel de soro CAT contém, além do granulado de material sintético revestido com um ativador de coagulação (silicato), um gel à base de polímero e serve para a colheita do soro**. O gel fixa-se por
centrifugação entre os coágulos de sangue e o soro e forma uma camada de separação estável durante o transporte, o armazenamento e a análise.
O soro é utilizado como material de amostra em exames de rotina clínico-químicos e imunológicos, bem como em sorologia.
Após a colheita de sangue, deixe os S-Monovette®6RUR*HOGHVRUR&$7FRDJXODUHPGXUDQWHbPLQXWRVHPSRVL×ÊRYHUWLFDOSDUDJDUDQWLUXPDFDPDGDGHVHSDUD×ÊRKRUL]RQWDOFODUDDSĂVDFHQWULIXJD×ÊR2WHPSRUHFRPHQGDGREDVHLDVHQXPSURFHVVRGHFRDJXOD×ÊRLQWDFWR2VDQJXHGHSDFLHQWHVFRPGLVWěUELRVGHFRDJXOD×ÊRDVVRFLDGRVDGRHQ×DRXHPWHUDSLDDQWLFRDJXODQWHUHTXHUHYHQWXDOPHQWHPDLVWHPSRSDUDXPD
coagulação completa.

S-Monovette® Gel de soro Express CAT
O S-Monovette® Gel de soro Express CAT contém, além do granulado de material sintético revestido com o ativador de coagulação (trombina), um gel à base de polímero e serve para a colheita do soro**. O gel fixa-se
por centrifugação entre os coágulos de sangue e o soro e forma uma camada de separação estável durante o transporte, o armazenamento e a análise.
Após a colheita de sangue, deixe os S-Monovette® Gel de soro Express coagularem durante 5 minutos em posição vertical, para garantir uma camada de separação horizontal clara após a centrifugação. O
WHPSRUHFRPHQGDGREDVHLDVHQXPSURFHVVRGHFRDJXOD×ÊRLQWDFWRPHVPRSDUDVDQJXHGHSDFLHQWHVKHSDULQL]DGRV2VDQJXHGHSDFLHQWHVFRPGLVWěUELRVGHFRDJXOD×ÊRDVVRFLDGRVDGRHQ×DRXHPWHUDSLD
anticoagulante, incluindo heparina em altas doses, requer mais tempo para uma coagulação completa.
O soro é utilizado como material de amostra em exames de rotina clínico-químicos e imunológicos, bem como em sorologia.

S-Monovette® Neutral Z SARSTEDTO S-Monovette® Neutral Z não contém nenhuma preparação, correspondendo à coagulação natural da amostra de sangue sem ativador de coagulação e serve para a colheita do soro**. Através da centrifugação,é feita a separação entre o coágulo de sangue e o soro.
O soro é utilizado como material de amostra para exames com aplicações específicas.
Além disso, o S-Monovette® Neutral Z também poderá ser utilizado como recipiente vazio da seguinte forma: se for iniciada uma colheita de sangue com um S-Monovette® citrato em conjunto com uma agulha desegurança Multifly® (agulha borboleta), o S-Monovette® Neutral Z é utilizado como primeiro recipiente (recipiente vazio) para encher a mangueira da agulha de segurança Multifly®.

S-Monovette® Heparina de lítio LH/Gel de heparina de lítio LH/Gel de heparina de lítio+ LH, Heparina de sódio NH, Heparina de amónio AH SARSTEDTO S-Monovette® Heparina de lítio LH/Heparina de sódio NH/Heparina de amónio AH contém um granulado de material sintético revestido com o anticoagulante heparina de lítio/heparina de sódio/heparina de amónio(geralmente 16 U.I. heparina/ml de sangue) e é utilizado para a colheita de sangue total e plasma**. O granulado de material sintético fixa-se por centrifugação entre as células de sangue e o plasma.
Num S-Monovette® Heparina de lítio LH sem granulado de material sintético, o anticoagulante heparina de lítio está presente em forma de spray (geralmente 19 U.I. heparina/ml de sangue).
O S-Monovette® Gel de heparina de lítio LH contém, além do granulado de material sintético revestido com o anticoagulante heparina de lítio (geralmente 25 U.I. heparina/ml de sangue), um gel à base de polímero eserve para a colheita do plasma**. O gel fixa-se por centrifugação entre as células de sangue e o plasma e forma uma camada de separação estável durante o transporte, o armazenamento e a análise.
O S-Monovette® Gel de Heparina de lítio+ HL também contém um gel à base de polímero, que permite um tempo de centrifugação 50% menor em comparação com o S-Monovette® Gel de Heparina de lítio.
O plasma com heparina é utilizado como material de amostra em exames de rotina química-clínica e imunológicos. A heparina de sangue total é utilizada como material de amostra em exames de rotina química-clínica
e imunológicos e em sorologia.
A anticoagulação com heparina é feita através de uma ativação de antitrombinas.
OBSERVAÇÃO: Com o S-Monovette®+HSDULQDGHOìWLR/+*HOGHKHSDULQDGHOìWLR*HO+/+QÊRÜSRVVìYHOID]HUGHWH×ĄHVGHOìWLRFRPR60RQRYHWWH®+HSDULQDGHVĂGLR1+QÊRÜSRVVìYHOID]HUGHWH×ĄHVGHVĂGLRHFRPR60RQRYHWWH®+HSDULQDGHDPĂQLR$+QÊRÜSRVVìYHOID]HUGHWH×ĄHVGHDPĂQLR60RQRYHWWH®+HSDULQDGHOìWLR+/*HOGH+HSDULQDGHOìWLR*HO+ / Heparina de
6ĂGLR+HSDULQDGH$PĂQLRFKHLRVFRPVDQJXHYHQRVRQÊRVÊRDGHTXDGRVSDUDHIHWXDUDQÈOLVHVVDQJXìQHDVS-Monovette® para análise de metais SARSTEDT
S-Monovette® para análise de metais contém o anticoagulante heparina de lítio e é utilizado para a colheita de sangue total e plasma**. A heparina de lítio está presente em forma de spray (geralmente 19 U.I. heparina/
ml de sangue).
O sangue total com heparina ou o plasma com heparina do S-Monovette® para análise de metais, em conjunto com a agulha de segurança especial 21G x 1 ½“ (n.º art. 85.1162.600) é utilizado como material deamostra para exames de oligoelementos/metais. Os oligoelementos/metais foram validados por meio da espectrometria de absorção atómica (AAS). Para o sistema de gulha de segurança e S-Monovette® para análise
de metais resultam os seguintes valores máximos em ng/sistema obtidos no ensaio em branco para estes oligoelementos:

Elemento

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Se

ng/Sistema

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

2VYDORUHVHPEUDQFRPÈ[LPRVHVWÊRLQGLFDGRVQDHWLTXHWDGR60RQRYHWWH para cada elemento.
®

As determinações de oligoelementos são feitas, dependendo de métodos de análise de sangue total com heparina ou plasma com heparina.
A anticoagulação com heparina é feita através de uma ativação de antitrombinas.

S-Monovette® Citrato 9NC SARSTEDT
S-Monovette® Citrato 9NC contém o anticoagulante citrato trissódico e é utilizado para a colheita de sangue total e plasma**. O citrato trissódico está presente como uma solução molar 0,106 (3,13% de solução
de citrato trissódico; frequentemente arredondado para 3,2%) e coresponde a 10% do valor nominal de um S-Monovette® Citrat. A proporção de mistura de citrato e sangue é de 1:9 – 1 percentagem de citrato e 9
percentagem de sangue. Para a análise, é absolutamente necessário um enchimento correto.
O plasma com citrato é utilizado como material de amostra em exames de rotina hemostaseológicos.
A anticoagulação é feita através da complexação com citrato dos iões de cálcio.
Observe os AVISOS em Colheita de amostras e manuseamento sobre a combinação S-Monovette® Citrato e agulha de borboleta.

S-Monovette® PFA 9NC SARSTEDTO S-Monovette® Citrato 9NC contém o anticoagulante citrato trissódico para a colheita de sangue total e plasma**. O citrato trissódico está presente como uma solução molar 0,129 (3,8% tamponado; pH 5,5) erepresenta 10% do volume nominal de um S-Monovette® PFA. A proporção de mistura de citrato e sangue é de 1:9 – 1 percentagem de citrato e 9 percentagem de sangue. Para a análise, é absolutamente necessário
um enchimento correto.
O sangue total do S-Monovette® PFA 9NC é utilizado como material de amostra, com o dispositivo de análises de PFA Healthineers da SIEMENS, para a determinação de função plaquetária.
A anticoagulação é feita através da complexação com citrato dos iões de cálcio.
Observe os AVISOS em Colheita de amostras e manuseamento sobre a combinação S-Monovette® PFA e agulhas de borboleta.

S-Monovette® CTAD SARSTEDT
S-Monovette® CTAD contém o anticoagulante citrato trissódico, bem como teofilina, adenosina e dipiridamol e é utilizado para a colheita de sangue total e plasma**. O citrato trissódico está presente como solução erepresenta 10% do volume nominal de um S-Monovette® PFA. A proporção de mistura de CTAD e sangue é de 1:9 – 1 percentagem de CTAD e 9 percentagem de sangue. Para a análise, é absolutamente necessário
um enchimento correto.
CTAD com plasma é utilizado como material de amostra para a determinação do fator plaquetário 4 (PF4), beta(ß)-tromboglobulina (ßTG) e inibidor do ativador do plasminogénio (PAI-1), bem como para estudos
hemostaseológicos de rotina.
A ativação de plaquetas é inibida por uma período de, pelo menos 4 horas e é usada na monitorização de terapias com heparina.
A anticoagulação é feita através da complexação com citrato dos iões de cálcio.
Observe os AVISOS em Colheita de amostras e manuseamento sobre a combinação S-Monovette® CTAD e agulhas de borboleta.
2%6(59$sf2&7$'ÜDPDUHOR'XUDQWHRDUPD]HQDPHQWRR60RQRYHWWH®&7$'GHYHUÈVHUSURWHJLGRFRQWUDDOX]DUWLıFLDOHQDWXUDO8PDIRUWHH[SRVL×ÊRÇOX]GHPDLVGHKRUDVSRGHUÈOHYDUÇ
LQDWLYD×ÊRGRDGLWLYR

165

PT
S-Monovette® EDTA K2E / K3E SARSTEDTO S-Monovette® EDTA K2E/S-Monovette® EDTA K3E contém o anticoagulante K2 EDTA ou K3 EDTA e é utilizado para a colheita de sangue total**. O K2 EDTA ou o K3 EDTA estão disponíveis em fómula de dosagem
em spray (1,6 mg EDTA/ml de sangue).
O sangue com EDTA é utilizado como material de amostra para exames hematológicos. Os esfregaços de sangue devem ser preparados dentro de quatro horas após a colheita de sangue.
A anticoagulação é feita através da complexação dos iões de cálcio com EDTA.
O sangue dos S-Monovette® EDTA K2E/K3EO também poderá ser utilizado para exames imuno-hematológicos de rotina e testes de doenças infeciosas. A adequação do material de amostra para estes exames é deresponsabilidade do utilizador com os reagentes de teste/dispositivos de análise apropriados incluindo validar as condições de armazenamento.

S-Monovette® com gel de EDTA K2E SARSTEDTO S-Monovette® com gel de EDTA K2E contém, além do anticoagulante K2 EDTA, um gel à base de polímero e serve para a colheita do plasma**. O K2 EDTA está disponível em spray (1,6 mg EDTA/ml de sangue). O
gel fixa-se por centrifugação entre as células de sangue e o plasma e forma uma camada de separação estável durante o transporte, o armazenamento e a análise.
O plasma com EDTA é utilizado como material de amostra para o diagnóstico molecular de vírus.
A anticoagulação é feita através da complexação dos iões de cálcio com EDTA.

S-Monovette® com Fluoreto EDTA FE/Fluoreto de heparina FH/Fluoreto Citrato EDTA FC com inibidores de glicóliseO S-Monovette® com fluoreto EDTA FE contém o anticoagulante EDTA (1,2 mg/ml de sangue), bem como fluoreto (1,0 mg/ml de sangue) para a inibição de glicólise e é usado para a colheita de plasma**. O fluoreto
EDTA está disponível em spray.
O S-Monovette® com fluoreto de heparina FH contém o anticoagulante heparina (16 heparina u.i./ml de sangue), bem como fluoreto (1,0 mg/ml de sangue) para a inibição de glicólise e é usado para a colheita deplasma**. O fluoreto de heparina está disponível em spray.
A inibição de glicólise apenas com o fluoreto começa aproximadamente 2 horas após o enchimento do tubo de colheita de sangue e mostra seu efeito total após aproximadamente 4 horas. A glicose, portanto,
decompõe-se no sangue em média até 6% após algumas horas e até 10-15% após 24 horas.
O S-Monovette® GlucoEXACT FC contém o anticoagulante EDTA, bem como citrato e fluoreto para a inibição imediata de glicólise e é usado para a colheita de plasma**. O EDTA, o citrato e o fluoreto estão disponíveis
como solução. O cálculo da concentração de glicose requer a multiplicação por 1,16 devido à diluição.
O S-Monovette® GlucoEXACT FC cumpre à Diretiva de diabetes gestacional da Sociedade Alemã de Diabetes (DDG) e à Diretiva Nacional de Alimentação (NVL) para a Diabetes tipo 2. A estabilização imediatada concentração de glicose é garantida no sangue por até 96 horas a temperatura ambiente, ver também SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
O plasma com fluoreto EDTA (citrato) é utilizado como material de amostra para a determinação da glicose.
A anticoagulação é feita através da complexação dos iões de cálcio com EDTA.
2%6(59$sf22ĲXRUHWRSRGHFDXVDUXPDXPHQWRGDKHPĂOLVH3DUDREWHUPDLVLQIRUPD×ĄHVVREUHVXEVWÉQFLDVTXHSRGHPLQWHUIHULUFRQVXOWHDVUHVSHWLYDVLQVWUX×ĄHVGHXWLOL]D×ÊRGRIDEULFDQWH
dos reagentes de teste.
Observe os AVISOS em Colheita de amostras e manuseamento sobre a combinação S-Monovette® GlucoEXACT e agulhas de borboleta.

S-Monovette® CPDA SARSTEDT
S-Monovette® CPDA contém o anticoagulante citrato de sódio, bem como ácido cítrico, fosfato de sódio, dextrose e adenina e é utilizado para a colheita de sangue total e plasma**. O CPDA está disponível comosolução. A proporção de mistura de CPDA e sangue é de 1:6 – 1 percentagem de CPDA e 6 percentagem de sangue. Para a análise, é absolutamente necessário um enchimento correto.
O CPDA sangue total/plasma é utilizado como material de amostra para a sorologia do grupo sanguíneo na medicina de transfusão, para testes de compatibilidade (ensaios cruzados) em transfusões. Concretamente,o S-Monovette® CPDA é usado para a determinação do grupo sanguíneo (AB0), incluindo as fórmulas Kell e Rhesus, teste de triagem de anticorpos para anticorpos de grupos sanguíneos irregulares, teste de Coombs
direto poliespecífico (até ao dia 10), teste de compatibilidade (ensaio cruzado) com soro/plasma de paciente compatível com grupo sanguíneo (Major Test).
A duração do transporte até o armazenamento é validada para um máximo de 4 horas a 2 - 21 °C. Para a sedimentação das células, as amostras devem primeiro ser armazenadas no frigorífico, na vertical por, pelo
menos, 16 horas. Em seguida, os analitos acima referidos podem ser determinados por até 35 dias após o armazenamento no frigorífico (2 - 6 °C), de forma análoga ao período usual de armazenamento de sangue (àexceção do teste direto de Coombs 10 dias). Usado para os métodos de aglutinação em colunas, por exemplo, no Vision Max da Ortho Clinical Diagnostics. O material de amostra não pode ser congelado.
A adequação do material de amostra para estes exames com outros métodos/reagentes de teste/dispositivos de análise, incluindo as condições de armazenamento, é de responsabilidade do utilizador e devem ser
validados pelo mesmo.
A anticoagulação é feita através da complexação com citrato dos iões de cálcio.
Observe os AVISOS em Colheita de amostras e manuseamento sobre a combinação S-Monovette® CPDA e agulhas de borboleta.

S-Monovette® ThromboExact SARSTEDTO S-Monovette® ThromboExact contém como anticoagulante um sal de magnésio e é usado para a colheita de sangue total**. O sal de magnésio está disponível no formato de dosagem em spray.
O sangue total do S-Monovette®7KURPER([DFWÜXWLOL]DGRFRPRPDWHULDOGHDPRVWUDSDUDDH[FOXVÊRGHQěPHURVEDL[RVGHSODTXHWDVLQFRUUHWRVGHYLGRDXPDLQWROHUÉQFLDDDQWLFRDJXODQWHV FRPR('7$FRWUDWRKHSDULQD WDPEÜPGHQRPLQDGDFRPRSVHXGRWURPERFLWRSHQLD$IRUPD×ÊRGHDJUHJDGRVSODTXHWÈULRVÜHYLWDGDHÜSRVVìYHOGHWHUPLQDURQěPHURUHDOGHSODTXHWDVDWÜKRUDVDSĂVDFROKHLWDGHVDQJXHA anticoagulação ocorre através dos iões de magnésio, em que o tromboxano A2 plaquetário dos iões de magnésio inibe a agregação de trombócitos transmitidos pelo ADP e pelo ácido araquidónico.

S-Monovette® Hirudina SARSTEDTO S-Monovette® Hirudina contém o anticoagulante hirudina e é utilizado para a colheita de sangue total**. A hirudina está disponível no formato de dosagem em spray.
O sangue total com hirudina é usado como material de amostra para a determinação da função plaquetária no dispositivo Multiplate® (multiple platelet function analyser) da ROCHE Diagnostics e é validado para essefim. É usado para a monitorização de terapias com medicação inibidora de plaquetas, bem como para a deteção ou exclusão de disfunções plaquetárias.
O S-Monovette® Hirudina foi especialmente desenvolvido em conjunto com a empresa Verum Diagnostica, hoje ROCHE Diagnostics, para a determinação da função plaquetária no dispositivo Multiplate®.
A anticoagulação ocorre por meio da hirudina, através da inibição direta de trombina e permite, assim, um diagnóstico da função plaquetária no estado nativo.

S-Monovette® Homocisteína Gel HCY-Z/HCY-C SARSTEDTO S-Monovette® Homocisteína Gel HCY-Z/HCY-C contém, além do granulado de material sintético revestido com um ativador de coagulação (silicato), um estabilizador especial, bem como um gel à base de polímero eserve para a colheita do soro**. O gel fixa-se por centrifugação entre os coágulos de sangue e o soro e forma uma camada de separação estável durante o transporte, o armazenamento e a análise. O preparado está
disponível em spray.
A homocisteína estabiliza até 8 horas no sangue total à temperatura ambiente. Se a centrifugação for feita nas primeiras 8 horas com uma camada de separação corretamente formada entre o coágulo sanguíneo e osoro, a homocisteína é estabilizada por até 96 horas.
O soro do S-Monovette® Homocisteína Gel HCY-Z é utilizado como material de amostra para a determinação de homocisteína. O S-Monovette® Homocisteína HCY-C contém como anticoagulante citrato ácido (pH 4,3)e é usado para a colheita de plasma**. O citrato está disponível como solução. O cálculo da concentração de homocisteína requer multiplicação por 1,11 devido à diluição.
A homocisteína estabiliza até 6 horas no sangue total à temperatura ambiente e a 4°C até 48 horas.
O plasma do S-Monovette® Homocisteína HCY-C é utilizado como material de amostra para a determinação de homocisteína.
A anticoagulação no S-Monovette® Homocisteína HCY-C é feita através da complexação com citrato dos iões de cálcio.
Observe os AVISOS em Colheita de amostras e manuseamento sobre a combinação S-Monovette® HCY-C e agulhas de borboleta.

S-Monovette® DNA Exact SARSTEDTO S-Monovette® DNA Exact contém um anticoagulante à base de EDTA e é usado para a colheita de sangue total**. O EDTA está disponível formato de dosagem em spray.
O sangue total com EDTA é utilizado como material de amostra na estabilização do gDNA. A capacidade de estabilização para gDNA é validada durante 5 dias a 35 °C, 14 dias à temperatura ambiente (22 °C), 28 dias
quando refrigerado (4 °C) e, pelo menos, 1 ano a -20 °C. Além disso, as amostras estabilizadas suportam 5 ciclos de congelamento e descongelamento sem perda de qualidade, veja também SARSTEDT White Paper
https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilizationof Whole Blood for Genomic DNA Analysis.”.
A anticoagulação é feita através da complexação dos iões de cálcio com EDTA.

$DGHTXD×ÊRGRPDWHULDOGHDPRVWUDGHSHQGHGDVXEVWÉQFLDDDQDOLVDUHGRUHDJHQWHGLVSRVLWLYRGHDQÈOLVH'HYHVHREVHUYDUDVUHVSHWLYDVHVSHFLıFD×ĄHVGRIDEULFDQWHGRGLVSRVLWLYR

166

PT
Instruções/avisos de segurança
1.

Precauções gerais: Use luvas e outro equipamento de proteção individual geral, para se proteger do sangue e de uma possível exposição a material de amostra potencialmente infecioso e agentes patogénicostransmissíveis.

2.

Trate todas as amostras biológicas e materiais de colheita de sangue perfurocortantes de colheita (agulhas, adaptadores) de acordo com as orientações e procedimentos da sua instituição. Em caso de contacto
direto com amostras biológicas ou de um ferimento por agulha, consulte um médico, dado que, em consequência, podem ser transmitidos os vírus HIV, VHC, VHB ou outras doenças infeciosas. Utilize agulhas de
VHJXUDQ×DDJXOKDV6DIHW\0XOWLĲ\® com proteção de agulha embutida. As diretrizes e os procedimentos de segurança da sua instituição devem ser seguidos.

3.

Aplica-se a produtos esterilizados e embalados individualmente:9HULıFDUGDQRVHPFDGDHPEDODJHPLQGLYLGXDODQWHVGRXVRHQÊRXWLOL]DUHPFDVRGHGDQRV

4.

2SURGXWRÜGHXWLOL]D×ÊRěQLFD(OLPLQHWRGRVRVREMHWRVDıDGRVSRQWLDJXGRV DJXOKDVDGDSWDGRUHV SDUDFROKHLWDGHVDQJXHHPUHFLSLHQWHVGHHOLPLQD×ÊRDGHTXDGRVSDUDVXEVWÉQFLDVELROĂJLFDVSHULJRVDV5.

Se o sangue for recolhido por meio de um acesso intravenoso (IV), deve-se garantir que o acesso seja devidamente enxaguado (= limpo da solução IV), de acordo com a instituição, antes do início da colheita desangue. A lavagem correta do acesso evitará resultados de análise incorretos.

6.

2HQFKLPHQWRLQVXıFLHQWHGR60RQRYHWWH® leva a uma proporção incorreta de sangue para preparação/aditivo e pode levar a resultados de análise incorretos.

7.

O sangue colhido e processado com o S-Monovette® não se destina a reinjeção no corpo humano.

8.

2SURGXWRQÊRSRGHVHUXVDGRDSĂVH[SLUDURSUD]RGHYDOLGDGH$YDOLGDGHWHUPLQDQRěOWLPRGLDGRPÝVHDQRLQGLFDGRVArmazenamento
O produto deve ser armazenado à temperatura ambiente até à sua aplicação.

Restrições
1.

O período e a temperatura de armazenamento de um S-Monovette® dependem do prazo de validade dos analitos a serem examinados. A avaliação é feita pelo laboratório ou as informações são consultadas nas
instruções de utilização fornecidas pelo fabricante do reagente de teste/dispositivo de análise.

2.

Mesmo que o plasma ou soro seja separado por centrifugação de um S-Monovette® e/ou esteja presente uma barreira, nem todas as células são necessariamente separadas na totalidade. O metabolismo residualRXDGHJUDGD×ÊRQDWXUDOSRGHPDIHWDUDVFRQFHQWUD×ĄHVGDVVXEVWÉQFLDVDQDOLVDGDV$HVWDELOLGDGHGDVVXEVWÉQFLDVDQDOLVDGDVGHYHVHUDYDOLDGDHPUHOD×ÊRDRVUHFLSLHQWHVGHDUPD]HQDPHQWRHFRQGL×ĄHVlaboratoriais.

3.

1RFDVRGHPHGLFDPHQWRVWHUDSÝXWLFRVDDGHTXD×ÊRGRPDWHULDOGDDPRVWUDGHYHVHUYHULıFDGDQDVLQVWUX×ĄHVGHXWLOL]D×ÊRGRIDEULFDQWHGRVUHDJHQWHVGHWHVWHGLVSRVLWLYRVGHDQÈOLVH

4.

As análises de oligoelementos/metais devem ser efetuadas com o sistema S-Monovette® para análise de metais + análise de metais com agulha de segurança.

Colheita de amostras e manuseamento
LEIA ESTE DOCUMENTO INTEGRALMENTE ANTES DE COMEÇAR A COLHEITA DE SENGUE VENOSO.
0DWHULDLVQHFHVVÈULRVSDUDDPRVWUDJHP
1.

Todos os sistemas de colheita de sangue S-Monovette®.

2.

$JXOKDV 6DIHW\ RXDJXOKDV0XOWLĲ\® (Safety).

3.

Luvas, batas, proteção para os olhos ou outro vestuário de proteção adequado para proteção contra agentes patogénicos transmitidos pelo sangue ou materiais potencialmente infeciosos.

4.

(WLTXHWDVSDUDLGHQWLıFD×ÊRGHSDFLHQWHV

5.

Material desinfetante para limpar o local de colheita (seguir as recomendações da instituição para preparar o local de amostragem). Não utilize materiais de limpeza à base de álcool se as amostras forem usadas
para testes quanto à presença de álcool no sangue.

6.

Zaragatoa descartável seca, com baixo teor de germes.

7.

Torniquete.

8.

Penso rápido ou bandagem.

9.

Recipiente para eliminação de objetos perfurocortantes, para a eliminação segura do material utilizado.

Ordem de colheita recomendada:
1.

Frasco de cultura de sangue

2.

Recipientes com citrato ou ativador de coagulação (com/sem gel soro CAT/soro gel CAT)

3.

Recipientes com ativador de coagulação ou citrato

4.

Recipientes com heparina com/sem gel

5.

Recipientes com EDTA com/sem gel

6.

Recipientes com inibidores da glicólise

7.

Recipientes com outros aditivos
127$

6HIRULQLFLDGDDUHPR×ÊRGHXPUHFLSLHQWHGHFLWUDWRRXGHXPRXWURUHFLSLHQWHFRPXPDSUHSDUD×ÊRFRPRSRUH[HPSOR3)$&7$'&3'$+&<&RX*OXFR(;$&7MXQWDPHQWHFRP
XPDDJXOKDGHERUEROHWD SRUH[HPSORDJXOKDV0XOWLĲ\® 6DIHW\ UHFRPHQGDVHDUHPR×ÊRSUÜYLDGHXPUHFLSLHQWHYD]LR SRUH[HPSOR60RQRYHWWH® Neutral Z), para evitar o enchimento
LQVXıFLHQWHGHXPUHFLSLHQWHGHYLGRDRHQFKLPHQWRGRWXERGDDJXOKDGHERUEROHWD$VVLPÜSRVVìYHOJDUDQWLURHQFKLPHQWRFRUUHWRGRUHFLSLHQWHHXPDSURSRU×ÊRGHPLVWXUDFRUUHWD OìTXLGRSDUDVDQJXH 

127$

6LJDDVHTXÝQFLDGHFROKHLWDGHDFRUGRFRPDVUHFRPHQGD×ĄHVGDVXDLQVWLWXL×ÊR(YLWDURUHĲX[RA maioria dos S-Monovettes contém aditivos químicos. Para evitar o refluxo, respeite as seguintes observações:1. Utilize exclusivamente os materiais recomendados nas instruções de utilização.
2.

Posicione o paciente de modo que haja um fácil acesso à veia e vire o braço ou outra área de punção para baixo.

3.

Segure o S-Monovette®FRPDWDPSDURVFDGDYLUDGDSDUDFLPDHVHXWLOL]DUXPDDJXOKD0XOWLĲ\® (Safety) segure-a também abaixo do nível do braço/área de punção.

4.

xQHFHVVÈULRJDUDQWLUTXHGXUDQWHDSXQ×ÊRYHQRVDRFRQWHěGRGR60RQRYHWWH® não entra em contacto nem com a tampa roscada nem com a extremidade da agulha.

5.

Solte o garrote enquanto o sangue entra para o S-Monovette®.

167

PT
Congelar/descongelar
De acordo com a OMS (WHO/DIL/Lab/99.1 Rev.02), recomendamos que separe o soro/plasma das células de sangue, antes da congelação.
Para a congelação do S-Monovette®, siga as seguintes recomendações gerais:
Congelar abaixo de 0 °C•

$XWLOL]D×ÊRQRLQWHUYDORGHWHPSHUDWXUDQHJDWLYDGHYHVHUVHPSUHWHVWDGDHPFRQGL×ĄHVUHDLVXPDYH]TXHDVREUHFDUJDGRVUHFLSLHQWHVSRGHYDULDUPXLWRGHSHQGHQGRGRĲXLGRDVHUFRQJHODGRHGDVFRQGL×ĄHVde rotina. (ver capítulo Propriedades do material, catálogo da SARSTEDT).

•

3RUQRUPDDVSURSULHGDGHVGHUHVLVWÝQFLDGRVPDWHULDLVVLQWÜWLFRVVÊRUHGX]LGDVDWHPSHUDWXUDVDEDL[RGHƓ&3RUHVVHPRWLYRHVIRU×RVPHFÉQLFRVVÊRJHUDOPHQWHGHHYLWDU•$VFRQGL×ĄHVGHFRQJHOD×ÊRWÝPGHVHUVHOHFLRQDGDVGHPRGRTXHRFRQWHěGRGHXP60RQRYHWWH®ıTXHFRQJHODGRXQLIRUPHPHQWHGHEDL[RSDUDFLPD260RQRYHWWH®GHYHWHUHVSD×RVXıFLHQWHQXPVXSRUWHRXQXPDFDL[DGHFDUWÊRSDUDSRGHUGLODWDU6XSRUWHVGHHVIHURYLWHRXPHWDOQÊRVÊRDGHTXDGRVXPDYH]TXHSRGHPFDXVDUıVVXUDVGHYLGRÇGLODWD×ÊRCongelar a -20 °C – Testar antes de congelar:•,QWHUIHUÝQFLDV9HULıFDUVHDFRQJHOD×ÊRLQĲXHQFLRXGHIRUPDQHJDWLYDDDPRVWUDGHVDQJXHRXDVDQÈOLVHV SH[KHPĂOLVHHVWDELOLGDGHGRVDQDOLWRV •

Centrifugação: Depende da análise planeada. Condições de centrifugação, ver este documento em “Centrifugação” ou consultar a página da SARSTEDT https://www.sarstedt.com/en/service/centrifugation/, bemcomo efetuar a controlo visual da amostra.

•

Hemólise: O sangue total hemolisa quando congelado: Para o evitar, deverá ser usado o S-Monovette®*HORXRıOWURGHYÈOYXOD6HUDSODV® após a centrifugação, ou a amostra poderá ser pipetada para um
recipiente secundário.

Congelar a -20 °C – Execução:•Arrefecer: Refrigerar S-Monovette® posicionado na vertical, durante um período entre 45 e 60 min., da temperatura ambiente a +4°C, antes de poder ser congelado a -20°C.

•'HVFRQJHODU'HL[DUGHVFRQJHODUQDYHUWLFDOGXUDQWHSHORPHQRVPLQÇWHPSHUDWXUDDPELHQWH7DPEÜPQHVWDVLWXD×ÊRVÊRGHHYLWDUHVIRU×RVPHFÉQLFRV8PDGHVFRQJHOD×ÊRGHPDVLDGRUÈSLGDSRGH
comprometer os resultados das análises.

Congelar e ultracongelar abaixo de -20 °C•$XOWUDFRQJHOD×ÊRDEDL[RGHƓ&QÊRIRLWHVWDGDSHORIDEULFDQWH'HYLGRÇYDULHGDGHGHSRVVìYHLVIDWRUHVGHLQĲXÝQFLDÜUHFRPHQGÈYHOUHDOL]DUWHVWHVGHFRQJHOD×ÊRHPFRQGL×ĄHVODERUDWRULDLVGHURWLQD

Congelação do S-Monovette® Gel:•

A congelação é feita como no ponto Congelar a -20 °C – Execução.

•xVDELGRTXHDFDPDGDGHJHOSRGHPRGLıFDUVHGHYLGRDRSURFHVVRGHFRQJHODPHQWR

•'HYLGRÇYDULHGDGHGHSRVVìYHLVIDWRUHVGHLQĲXÝQFLDÜUHFRPHQGÈYHOUHDOL]DUWHVWHVGHFRQJHOD×ÊRHPFRQGL×ĄHVODERUDWRULDLVGHURWLQD

•Descongelar: Deixar a amostra descongelar na vertical. Após o descongelamento, pipete o material da amostra do recipiente primário para um recipiente secundário (não decante) até aproximadamente 2 mmacima da camada de gel. Elimine o remanescente.
2%6(59$sf23DUDDHVWDELOLGDGHGRVDQDOLWRVFRQVXOWDUDVLQVWUX×ĄHVGHXWLOL]D×ÊRGRVIDEULFDQWHVGRVUHDJHQWHVGHWHVWHGLVSRVLWLYRGHDQÈOLVH

168

PT
Colheita de sangue
Técnicas de colheita
Existem duas técnicas de colheita distintas: a técnica de aspiração e a técnica de vácuo.
A técnica de aspiração permite uma colheita de sangue suave com um fluxo de sangue contínuo e lento, puxando a haste do pistão de maneira controlada. Desta forma, é possível ajustar imediatamente o fluxo de
VDQJXHDWRGDVDVFRQGL×ĄHVHFLUFXQVWÉQFLDVEHPFRPRUHGX]LUDKHPĂOLVH
A técnica de vácuo permite a colheita de sangue de acordo com o princípio da pressão negativa com um fluxo de sangue contínuo e rápido, através de um recipiente pré-evacuado. Portanto, esta técnica é ideal paraboas condições da veia e condições de colheita simples.
Manuseamento para a colheita de sangue: ver também o vídeo de manuseamento sobre o S-Monovette® com a técnica de aspiração ou com a técnica de vácuo com a agulha de segurança ou a agulha SafetyMultifly®:www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
PARA MINIMIZAR O RISCO DE EXPOSIÇÃO, USE LUVAS DURANTE A COLHEITA DE SANGUE.
1. Selecione o S-Monovette® apropriado para a amostra necessária.
2.

Escolha o local para a punção venosa. Respeite as orientações da instituição na preparação do local de punção venosa.

Colheita de sangue com a técnica de aspiração.
Atenção! Utilizar o S-Monovette® apenas para a colheita de sangue e não para injeção.
Utilizar apenas com agulhas (S-Monovette® com agulhas (Safety) ou agulhas Multifly® (Safety)/adaptador para S-Monovette®).
Aqui é mostrada a aplicação com a agulha de segurança:cliqueImediatamente antes da punção venosa, introduza o S-Monovette® no suporte integrado da gulha de segurança
e fixe-o rodando-o ligeiramente para a direita .
$SOLTXHRWRUQLTXHWHFRQIRUPHQHFHVVÈULR PÈ[PLQXWR 3UHSDUHRORFDOGHSXQ×ÊRFRPXPDJHQWHGHGHVLQIH×ÊRDGHTXDGR$SĂVDGHVLQIH×ÊRQÊRWRTXHPDLVQRORFDOGDSXQ×ÊRYHQRVD
3RVLFLRQHRSDFLHQWHGHPRGRTXHKDMDXPIÈFLODFHVVRÇYHLDHYLUHREUD×RRXRXWUDÈUHDGHSXQ×ÊRSDUDEDL[R
Remova a proteção da agulha. Pique a veia, puxe lentamente a haste do êmbolo para trás e solte o torniquete enquanto o sangue entra para o S-Monovette® .
Aguarde até que o fluxo de sangue pare, para permitir o enchimento correto.

Mova o S-Monovette® rodando-o ligeiramente para a direita
e puxe-o da gulha de segurança (desconectar) . A gulha de segurança permanece na veia.
1RFDVRGHFROKHLWDVPěOWLSODVFRQIRUPHDFLPDGHVFULWRFRQHFWHRVVHJXLQWHV60RQRYHWWHVÇDJXOKDGHVHJXUDQ×DHUHFROKDRXWUDVDPRVWUDV
Finalização da colheita de sangue: Primeiro, desconecte o S-Monovette®
+ , depois retire a agulha de segurança da veia. Com a técnica de uma mão, coloque a proteção da agulha numa superfícieplana e estável, até que a agulha encaixe na proteção da agulha FRPXPFOLTXHWÈWLOHDXGìYHO (ativar), ou ative-a pressionando a extremidade inferior da proteção da agulha com o indicador, ver também
as instruções de utilização da S-Monovette® gulha (Safety) ou da agulha Multifly® (Safety)
Diretamente após as desconexão da agulha de segurança, inverta cada S-Monovette® 1x e após a finalização da colheita completa de sangue, inverta cuidadosamente todas as amostras com
anticoagulantes várias vezes!
Para o transporte e centrifugação, puxe de forma audível a haste do êmbolo para a posição de encaixe(o êmbolo encaixa na base do S-Monovette®) e quebre a haste do êmbolo .
1.

Pressione o local da punção com uma compressa esterilizada e seca.

2.

Assim que o sangue estancar, aplique um penso, se o pretender.

3.

(OLPLQHDDJXOKDGHVHJXUDQ×DQXPUHFLSLHQWHGHHOLPLQD×ÊRSDUDVXEVWÉQFLDVELROĂJLFDVDGHTXDGR

169

PT
&ROKHLWDGHVDQJXHFRPDWÜFQLFDGHYÈFXRAtenção! Utilizar o S-Monovette® apenas para a colheita de sangue e não para injeção.
Utilizar apenas com agulhas (S-Monovette® com gulhas (Safety) ou gulhas Multifly® (Safety)/adaptador para S-Monovette®).
Aqui é mostrada a aplicação com a agulha de segurança:cliquePara iniciar suavemente a colheita de sangue, a SARSTEDT recomenda que remova o primeiro S-Monovette® com a técnica de aspiração, ver TÉCNICA DE PUNÇÃO VENOSA Técnica de aspiração
Depois prossiga com a técnica de vácuo.
Antes da colheita de sangue, use a haste do pistão para puxar o pistão até à base do S-Monovette®, encaixando-o de forma audível . Depois, a haste do êmbolo é quebrada .
Introduza este S-Monovette® preparado no suporte integrado da agulha de segurança do S-Monovette® e fixe-o rodando-o ligeiramente para a direita+.

Aguarde até que o fluxo de sangue pare, para permitir o enchimento correto.

Mova o S-Monovette® rodando-o ligeiramente para a direita e puxe-o da agulha de segurança (desconectar) . A agulha de segurança permanece na veia.
1RFDVRGHFROKHLWDVPěOWLSODVFRQIRUPHDFLPDGHVFULWRFRQHFWHSULPHLURRV60RQRYHWWHVVHJXLQWHVÇDJXOKDGHVHJXUDQ×DHUHFROKDRXWUDVDPRVWUDV
Finalização da colheita de sangue: Desconecte o
S-Monovette® + , depois retire a agulha de segurança da veia. Com a técnica de uma mão, coloque a proteção da agulha numa superfície plana e estável, até que a agulha encaixe na proteção daagulha FRPXPFOLTXHWÈWLOHDXGìYHO (ativar), ou ative proteção da agulha pressionando a extremidade inferior da proteção da agulha com o indicador.
Diretamente após as desconexão da agulha de segurança, inverta cada S-Monovette® 1x e após a finalização da colheita completa de sangue, inverta cuidadosamente todas as amostras com
anticoagulantes várias vezes!
1.

Pressione o local da punção com uma ompressa esterilizada e seca.

2.

Assim que o sangue estancar, aplique um penso, se o pretender.

3.

(OLPLQHDDJXOKDGHVHJXUDQ×DQXPUHFLSLHQWHGHHOLPLQD×ÊRSDUDVXEVWÉQFLDVELROĂJLFDVDGHTXDGR

170

–

.

PT
Centrifugação
ATENÇÃO! Os S-Monovettes SARSTEDT foram projetados para 4.000 x g. A exceção são os S-Monovettes com Ø 8 mm (S-Monovette® pediatria) que são atualmente validados até 2.500 x g. Utilizar apenas
tubos acoplados e acessórios adequados. A centrifugação de S-Monovettes com fissuras ou com uma aceleração centrífuga exageradamente elevada pode causar a rutura dos S-Monovettes, em que material
potencialmente infecioso pode ser libertado.
As pastilhas de centrifugação devem ser selecionadas de acordo com o tamanho dos S-Monovettes utilizados. A aceleração centrífuga relativa está relacionada com a rpm ajustada da seguinte forma:
RCF = 11,2 x r x (rpm/1000)2
RCF: “Força centrífuga relativa”, também designada como “força G” (inglês: RCF “relative centrigfugal force”),"rpm": “Rotação por minuto” (U/min), ou: n = “velocidade de rotação por minuto” (inglês: RPM “revolutions per minute”),“r”: "Raio de rotação do centro da centrífuga até ao fundo do S-Monovette®", (cm).
2V60RQRYHWWHVVHPJHOSRGHPVHUFHQWULIXJDGRVHPFHQWUìIXJDVGHÉQJXORIL[RRXGHURWRUHVRVFLODQWHV
2V60RQRYHWWHVFRPJHOVÊRSURMHWDGRVH[FOXVLYDPHQWHSDUDFHQWUìIXJDVFRPURWRUHVRVFLODQWHV$FHQWULIXJD×ÊRHPFHQWUìIXJDVFRPURWRUGHÉQJXORIL[RQÊRIRLYDOLGDGDSHOD6$567('7HQÊRÜUHFRPHQGDGDOs S-Monovettes devem ser centrifugados de acordo com as condições de centrifugação listadas abaixo. Caso sejam utilizadas outras condições, as mesmas devem ser validadas pelo próprio utilizador.
Certifique-se de que os S-Monovettes estão devidamente encaixados nos acessórios da centrífuga. Caso os S-Monovettes sobressaiam dos acessórios, podem ficar presos na cabeça da centrífuga e partir-se. Deveser garantido o enchimento homogéneo da centrífuga. Para isso, siga as instruções de utilização da centrífuga.
CUIDADO! Não remover manualmente S-Monovettes partidos.
$V LQVWUX×ĄHV GH GHVLQIH×ÊR GD FHQWUìIXJD SRGHP VHU FRQVXOWDGDV QDV LQVWUX×ĄHV GH XWLOL]D×ÊR GD FHQWUìIXJDDe acordo
com a BS
4851+ (código
da UE)–

Aceleração centrífuga relativa (g)S-Monovette®

DIN EN ISO 6710

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Soro

10 minutos

10 minutos

6 minutos

4 minutos

4 minutos

Gel de soro

15 minutos

10 minutos

4 minutos

4 minutos

4 minutos

Gel de soro Express

15 minutos

10 minutos

4 minutos

n.v.

n.v.

Heparina de lítio

10 minutos

10 minutos

7 minutos

7 minutos

7 minutos

Gel de heparina de lítio

15 minutos

15 minutos

10 minutos

7 minutos

7 minutos

Gel de heparina de lítio+8 minutos

7 minutos

5 minutos

4 minutos

4 minutos

n.v.

n.v.

7 minutos

6 minutos

5 minutos

Gel de EDTA

15 minutos

10 minutos

10 minutos

7 minutos

7 minutos

Citrato9 minutos

8 minutos

7 minutos

6 minutos

5 minutos('7$ĲXRUHWRKHSDULQD

9 minutos

8 minutos

7 minutos

6 minutos

5 minutos

GlucoEXACT

9 minutos

8 minutos

7 minutos

6 minutos

5 minutos

Citrato PBM 1,8 ml
Raio de centrifugação > 17 cm

9 minutos

8 minutos

7 minutos

6 minutos

5 minutos

n.v.

n.v.

10 minutos

n.v.

n.v.

EDTA

Citrato PBM 1,8 ml
5DLRGHFHQWULIXJD×ÊR!DƉFPn.v. = não validado* Aplica-se a todos os S-Monovettes à exceção dos de Ø 8 mm (S-Monovettes
pediatria).

Centrifugação a 20 ºC

Retirado de +British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, revogado.

Informação sobre o material de separação
As propriedades de fluxo do material de separação (gel) dependem da temperatura. Se os S-Monovettes forem refrigerados antes ou durante a centrifugação, já não poderá ser garantida a camada contínua do gel deseparação.
Os S-Monovettes não podem ser novamente centrifugados/recentrifugados.

Eliminação
1.

As diretivas gerais de higiene e as normas legais para a eliminação adequada dos materiais infeciosos devem ser observadas e cumpridas.

2.

Luvas descartáveis impedem o risco de infeção.

3.

2VVLVWHPDVGHFROKHLWDGHVDQJXHFRQWDPLQDGRVRXFKHLRVGHYHPVHUHOLPLQDGRVHPUHFLSLHQWHVGHHOLPLQD×ÊRDGHTXDGRVSDUDVXEVWÉQFLDVELROĂJLFDVSHULJRVDVTXHSRGHPHQWÊRVHUDXWRFODYDGRVH
incinerados de seguida.

4.

A eliminação deve ocorrer numa instalação de incineração adequada ou por meio de uma autoclave (esterilização a vapor).

171

PT
1RUPDVHGLUHWLYDVHVSHFìıFDVGRSURGXWRQDYHUVÊRDWXDOPHQWHYÈOLGDCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Norma sobre recipientes para colheita de sangue venoso:',1(1,625HFLSLHQWHVGHXVRěQLFRSDUDDFROKHLWDGHVDQJXHYHQRVRHPVHUHVKXPDQRV*CLSI (Clinical and Laboratory Standards Institute)

Lista de símbolos e sinais:

1ěPHURGRDUWLJR

Também se aplica a produtos esterilizados e embalados individualmente:1ěPHURGRORWH(PFDVRGHHPEDODJHPGDQLıFDGDQÊRXWLOL]HPrazo de validade

Sistema de barreira estéril simples com embalagem de proteção exterior

Marcação CE

Esterilização por meio de irradiação

Diagnóstico in vitro

Observar as instruções de utilização

Em caso de reutilização: Risco de contaminaçãoArmazenar protegido da luz do sol

Armazenar em local seco

FabricantePaís de fabrico&DPLQKRGHĲXLGRHVWÜULO

Não esterilizar novamente

Modificações técnicas reservadas.
Quaisquer incidentes graves relacionados com o produto devem ser comunicados ao fabricante e às autoridades nacionais competentes.

172

,QVWUXFėLXQLGHXWLOL]DUHş6LVWHPGHUHFROWDUHDVÉQJHOXL60RQRYHWWH® SARSTEDTRO

Utilizare pentru diagnostic in-vitro
6FRSXOXWLOL]ÍULL
6LVWHPHOHGHUHFROWDUHDVÉQJHOXL60RQRYHWWH®FDQXOHOHēLDGDSWRDUHOHVXQWXWLOL]DWHîPSUHXQÍIRUPÉQGXQVLVWHPSHQWUXSUHOHYDUHDGHVÉQJHYHQRV6LVWHPHOHGHUHFROWDUHDVÉQJHOXL60RQRYHWWH® servesc la
SUHOHYDUHDWUDQVSRUWXOSURFHVDUHDēLGHSR]LWDUHDSUREHORUGHVÉQJHSHQWUXGHWHUPLQÍULGLDJQRVWLFHin-vitroGLQVHUSODVPÍVDXVÉQJHWRWDOîQODERUDWRUXOFOLQLF3URGXVXOHVWHGHVWLQDWXWLOL]ÍULLîQWUXQPHGLXSURIHVLRQDOGHFÍWUHSHUVRQDOPHGLFDOLQVWUXLWîQDFHVWVFRSēLGHFÍWUHSHUVRQDOGHODERUDWRU

Descrierea produsului
6LVWHPHOHGHUHFROWDUHDVÉQJHOXL60RQRYHWWH®VHFRPSXQGLQWUXQWXEGLQSODVWLFXQSLVWRQRWLMÍGHSLVWRQēLXQFDSDFGLQSODVWLFFXILOHWFRGLILFDWSHFXORULFXPHPEUDQÍLQWHJUDWÍGH]YROWDWVSHFLDOSHQWUXFRQHFWDUHDODRFDQXOÍ 6DIHW\ SHQWUX60RQRYHWWH®VDXODRFDQXOÍ 6DIHW\ 0XOWLIO\®SUHFXPēLGLQGLYHUēLDGLWLYL VXEVWDQėHSUHSDUDWH 'HDVHPHQHDHVWHGLVSRQLELOēLXQ60RQRYHWWH®IÍUÍDGLWLY6LVWHPHOHGH
UHFROWDUHDVÉQJHOXL60RQRYHWWH®FXDGLWLYLLDFWLYDWRUGHFRDJXODUHDFWLYDWRUGHFRDJXODUHFXJHOKHSDULQÍēLOLWLXKHSDULQÍēLOLWLXFXJHOKHSDULQÍēLVRGLXFLWUDW('7$IOXRUXUÍ('7$IOXRUXUÍKHSDULQÍIOXRUXUÍFLWUDW&3'$SUHFXPēLIÍUÍDGLWLYFRQFHQWUDėLLOHGHDGLWLYLDOHDFHVWRUDYROXPXODGLWLYLORUOLFKL]LēLWROHUDQėHOHDGPLVHDOHDFHVWRUDSUHFXPēLUDSRUWXOGLQWUHFDQWLWDWHDGHVÉQJHēLFHDGHDGLWLYFRUHVSXQGFHULQėHORUēLUHFRPDQGÍULORUVWDQGDUGXOXLLQWHUQDėLRQDO',1(1,62Ś6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŘēL&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, $OHJHUHDDGLWLYXOXLGHSLQGHGHPHWRGDGHWHVWDUHDQDOLWLFÍ$FHDVWDHVWHLPSXVÍGHSURGXFÍWRUXODJHQėLORUUHDFWLYLSHQWUXWHVWDUHēLVDXGHSURGXFÍWRUXODSDUDWXOXLGHDQDOL]ÍSHFDUHVHHIHFWXHD]ÍWHVWXO6LVWHPXOGHUHFROWDUHDVÉQJHOXLS-Monovette®HVWHGLVSRQLELOîQYDULDQWHOHVWHULOîQLQWHULRUVDXDPEDODWLQGLYLGXDOVWHULOîQLQWHULRUēLH[WHULRU&RGXULOHGHFXORDUHDOHFDSDFHORUFXıOHW SHQWUX0RQRYHWWH6®:

aditiv

cod format din litere

Culoarea capacelor DIN
EN ISO 6710

Culoarea capacelor se
RULHQWHD]ÍGXSÍ%6+

Z

alb

alb

7XEIÍUÍVXEVWDQėHSUHSDUDWH
S-Monovette® neutru Z
Tub cu ser
S-Monovette® ser CAT, cu activator de coagulare

CAT

URēX

alb

S-Monovette®VHUJHO&$7FXDFWLYDWRUGHFRDJXODUHēLJHO

CAT

galben închis

galben închis

S-Monovette®VHUH[SUHV&$7FXDFWLYDWRUGHFRDJXODUHWURPELQÍēLJHO

CAT

portocaliu-

S-Monovette®KHSDULQÍFXOLWLX/+FXKHSDULQÍēLOLWLX

LH

verde

portocaliu

S-Monovette®KHSDULQÍēLOLWLXOLFKLG/+FXKHSDULQÍēLOLWLX

LH

verde

portocaliu

S-Monovette®KHSDULQÍFXOLWLXēLJHO/+FXKHSDULQÍFXOLWLXēLJHO

LH

verde

portocaliu

S-Monovette®KHSDULQÍFXOLWLXēLJHO+/+FXKHSDULQÍFXOLWLXēLJHOUDSLG

LH

verde

portocaliu

S-Monovette®KHSDULQÍFXVRGLX1+FXKHSDULQÍēLVRGLX

NH

maro

verde

S-Monovette®KHSDULQÍFXDPRQLX$+FXKHSDULQÍFXDPRQLX

n.d.

albastru

albastru

S-Monovette® citrat 9NC, citrat de sodiu 3,13%

9NC

albastru

verde

S-Monovette 3)$FLWUDW1&FLWUDWGHVRGLXFXHIHFWGHUHWHQėLH

9NC

albastru deschis-

S-Monovette® K3 EDTA K3E, cu EDTA de potasiu

K3E

violetURēX

S-Monovette® K2 EDTA K2E, cu EDTA cu potasiu

K2E

violetURēX

S-Monovette®.('7$JHO.(FX('7$GHSRWDVLXēLJHO

K2E

violetURēX

S-Monovette®ĲXRUXUÍ('7$)(FXĲXRUXUÍēL('7$

FE

gri

galbenS-Monovette®KHSDULQÍFXĲXRUXUÍ)+FXĲXRUXUÍēLKHSDULQÍ

FH-

galbenS-Monovette®*OXFR(;$&7)&FXĲXRUXUÍFLWUDWēL('7$FC

roz aprins

gri

LH

albastru închis

portocaliu

S-Monovette®7KURPER([DFWFXFRPSXēLGHPDJQH]LX

n.d.

n.d., culoarea zmeurei

n.d., culoarea zmeurei

S-Monovette® CTADn.d.

n.d., albastru

n.d., verde

S-Monovette® ACD

ACD

galbengalbenS-Monovette® CPDA

CPDA

galbengalbenS-Monovette®KLUXGLQÍ

n.d.

n.d., verde oliv

n.d., verde oliv

S-Monovette®KRPRFLVWHLQÍ+&<=JHOFXJHOēLVWDELOL]DWRU

n.d.

n.d., grin.d., griS-Monovette®KRPRFLVWHLQÍ+&<&FXFLWUDWFDDJHQWGHUHWHQėLH

n.d.

n.d., violet

n.d., violet

S-Monovette® DNA Exactn.d.

n.d., albastru

n.d., albastru

7XEFXKHSDULQÍ

Recipient pentru citrat®

Tub cu EDTA

7XEFXLQKLELWRULGHJOLFROL]Í

Recipient pentru analiza metalelor
S-Monovette®DQDOL]DPHWDOHORU/+FXKHSDULQÍēLOLWLX$OWHUHFLSLHQWHSHQWUXVÉQJHWRWDOēLSODVPÍ

6XQWGLVSRQLELOHēLFDSDFHıOHWDWHîQDOWHFXORUL
n.d.: nedefinit+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, retras.

173

RO
S-Monovette®VHU&$76$567('7FXVHU&$7VHUēLJHO&$7
S-Monovette®VHU&$7FRQėLQHXQJUDQXODWGLQSODVWLFDFRSHULWFXDFWLYDWRUGHFRDJXODUH VLOLFDW ēLHVWHXWLOL]DWSHQWUXFROHFWDUHDVHUXOXL *UDQXODWXOGLQSODVWLFVHSR]LėLRQHD]ÍSULQFHQWULIXJDUHîQWUHVÉQJHOHFRDJXODWēL
ser.
S-Monovette®VHUēLJHO&$7FRQėLQHSHOÉQJÍJUDQXODWXOGLQSODVWLFDFRSHULWFXDFWLYDWRUGHFRDJXODUH VLOLFDW XQJHOSROLPHULFēLHVWHXWLOL]DWSHQWUXFROHFWDUHDVHUXOXL 3ULQFHQWULIXJDUHJHOXOVHSR]LėLRQHD]ÍîQWUHFKHDJXOGHVÉQJHēLVHUēLIRUPHD]ÍXQVWUDWGHVHSDUDUHVWDELOîQWLPSXOWUDQVSRUWXOXLGHSR]LWÍULLēLDQDOL]HL
6HUXOHVWHXWLOL]DWFDPDWHULDOGHSUREÍîQDWÉWîQWHVWHFOLQLFRFKLPLFHēLLPXQRORJLFHGHUXWLQÍFÉWēLîQVHURORJLH
3HUPLWHėLFDGXSÍSUHOHYDUHVÉQJHOHVÍVHFRDJXOH]HîQ60RQRYHWWH®FXVHU&$7VHUēLJHO&$7WLPSGHPLQXWHîQSR]LėLHYHUWLFDOÍSHQWUXDDVLJXUDXQVWUDWVHSDUDWRURUL]RQWDOELQHGHILQLWGXSÍFHQWULIXJDUH7LPSXOUHFRPDQGDWVHED]HD]ÍSHXQSURFHVGHFRDJXODUHLQWDFW6ÉQJHOHSDFLHQėLORUFXWXOEXUÍULGHFRDJXODUHFRQGLėLRQDWHGHERDOÍVDXFDUHVXQWVXSXēLXQRUWHUDSLLFDUHLQKLEÍFRDJXODUHDHVWHSRVLELOVÍQHFHVLWHPDLPXOWWLPSSHQWUXFRDJXODUHDFRPSOHWÍ

S-Monovette®VHUH[SUHVēLJHO&$7
S-Monovette®VHUH[SUHVēLJHO&$7FRQėLQHSHOÉQJÍJUDQXODWXOGLQSODVWLFDFRSHULWFXDFWLYDWRUGHFRDJXODUH WURPELQÍ XQJHOSROLPHULFēLHVWHXWLOL]DWSHQWUXFROHFWDUHDVHUXOXL 3ULQFHQWULIXJDUHJHOXOVHSR]LėLRQHD]ÍîQWUHFKHDJXOGHVÉQJHēLVHUēLIRUPHD]ÍXQVWUDWGHVHSDUDUHVWDELOîQWLPSXOWUDQVSRUWXOXLGHSR]LWÍULLēLDQDOL]HL
3HUPLWHėLFDGXSÍSUHOHYDUHVÉQJHOHVÍVHFRDJXOH]HîQ60RQRYHWWH®VHUH[SUHVēLJHOWLPSGHPLQXWHîQSR]LėLHYHUWLFDOÍSHQWUXDDVLJXUDXQVWUDWVHSDUDWRURUL]RQWDOELQHGHILQLWGXSÍFHQWULIXJDUH7LPSXOUHFRPDQGDWVHED]HD]ÍSHXQSURFHVGHFRDJXODUHLQWDFWLQFOXVLYSHQWUXVÉQJHOHSDFLHQėLORUKHSDULQL]DėL6ÉQJHOHSDFLHQėLORUFXWXOEXUÍULGHFRDJXODUHFRQGLėLRQDWHGHERDOÍVDXFDUHVXQWVXSXēLXQRUWHUDSLLFDUHLQKLEÍFRDJXODUHDLQFOXVLYFXGR]ÍPDUHGHKHSDULQÍQHFHVLWÍPDLPXOWWLPSSHQWUXFRDJXODUHDFRPSOHWÍ
6HUXOHVWHXWLOL]DWFDPDWHULDOGHSUREÍîQDWÉWîQWHVWHFOLQLFRFKLPLFHēLLPXQRORJLFHGHUXWLQÍFÉWēLîQVHURORJLH

S-Monovette® neutru Z SARSTEDT
S-Monovette®QHXWUX=QXFRQėLQHQLFLRVXEVWDQėÍSUHSDUDWÍFHHDFHFRUHVSXQGHXQHLFRDJXOÍULQDWXUDOHDSUREHLGHVÉQJHIÍUÍDFWLYDWRUGHFRDJXODUHēLHVWHXWLOL]DWSHQWUXFROHFWDUHDVHUXOXL 6HSDUDUHDîQVÉQJHFRDJXODWēLVHUDUHORFSULQFHQWULIXJDUH
6HUXOHVWHXWLOL]DWFDPDWHULDOGHSUREÍSHQWUXLQYHVWLJDėLLVSHFLILFHXWLOL]DWRUXOXLÎn plus, Monovette S®QHXWUX=SRDWHILXWLOL]DWēLFDWXEJROGXSÍFXPXUPHD]ÍGDFÍUHFROWDUHDVÉQJHOXLXUPHD]ÍVÍîQFHDSÍFX60RQRYHWWH®FXFLWUDWîQFRPELQDėLHFXRFDQXOÍ 6DIHW\ 0XOWLIO\® FDQXOÍFXDULSLRDUH 
S-Monovette® neutru Z este folosit ca prim tub (tub gol) pentru umplerea furtunului canulei (Safety-)Multifly®.

S-Monovette®OLWLXKHSDULQÍ/+OLWLXKHSDULQÍJHO/+OLWLXKHSDULQÍJHO+/+6$567('7VRGLXKHSDULQÍ1+DPRQLXKHSDULQÍ$+
S-Monovette®OLWLXKHSDULQÍ/+VRGLXKHSDULQÍ1+DPRQLXKHSDULQÍ$+FRQėLQHXQJUDQXODWGLQSODVWLFDFRSHULWFXLQKLEDWRUGHFRDJXODUH DQWLFRDJXODQW OLWLXKHSDULQÍVRGLXKHSDULQÍDPRQLXKHSDULQÍ GHUHJXOÍ8,
KHSDULQÍPOVÉQJH ēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDOēLSODVPÍ *UDQXODWXOGLQSODVWLFVHSR]LėLRQHD]ÍSULQFHQWULIXJDUHîQWUHVÉQJHOHFRDJXODWēLSODVPÍ
La Monovette S®FXOLWLXKHSDULQÍ/+IÍUÍJUDQXODWGLQSODVWLFDQWLFRDJXODQWXOOLWLXKHSDULQÍHVWHSUH]HQWFDGR]DUHYDSRUL]DWÍ GHUHJXOÍ8,KHSDULQÍPOVÉQJH 
S-Monovette®FXOLWLXKHSDULQÍJHO/+FRQėLQHSHOÉQJÍJUDQXODWXOGLQSODVWLFDFRSHULWFXDFWLYDWRUGHFRDJXODUHOLWLXKHSDULQÍ GHUHJXOÍ8,KHSDULQÍPOVÉQJH XQJHOSROLPHULFēLHVWHXWLOL]DWSHQWUXFROHFWDUHDSODVPHL 3ULQFHQWULIXJDUHJHOXOVHSR]LėLRQHD]ÍîQWUHFHOXOHOHGHVÉQJHēLSODVPÍēLIRUPHD]ÍXQVWUDWGHVHSDUDUHVWDELOîQWLPSXOWUDQVSRUWXOXLGHSR]LWÍULLēLDQDOL]HLS-Monovette®FXOLWLXKHSDULQÍēLJHO+/+FRQėLQHGHDVHPHQHDXQJHOSROLPHULFFDUHSHUPLWHRGXUDWÍGHFHQWULIXJDUHUHGXVÍFXFFDFRPSDUDWLYFX60RQRYHWWH®FXOLWLXKHSDULQÍēLJHO3ODVPDFXKHSDULQÍHVWHXWLOL]DWÍFDPDWHULDOGHSUREÍîQWHVWHFOLQLFRFKLPLFHēLLPXQRORJLFHGHUXWLQÍ6ÉQJHOHWRWDOFXKHSDULQÍHVWHXWLOL]DWFDPDWHULDOGHSUREÍîQWHVWHLPXQRORJLFHGHUXWLQÍēLîQVHURORJLH,QKLEDUHDFXKHSDULQDDFRDJXOÍULLDUHORFSULQDFWLYDUHDDQWLWURPELQHL
,1',&$¯,('LQ60RQRYHWWH®FXOLWLXKHSDULQÍ/+OLWLXKHSDULQÍJHOJHO+/+QXHVWHSHUPLVÍHIHFWXDUHDGHGHWHUPLQÍULSHQWUXFRQėLQXWXOGHOLWLXGLQ60RQRYHWWH®FXVRGLXKHSDULQÍ1+QXHVWHSHUPLVÍHIHFWXDUHDGHGHWHUPLQÍULSHQWUXFRQėLQXWXOGHVRGLXēLGLQ60RQRYHWWH®FXDPRQLXKHSDULQÍQXHVWHSHUPLVÍHIHFWXDUHDGHGHWHUPLQÍULSHQWUXFRQėLQXWXOGHDPRQLX60RQRYHWWH® litiuKHSDULQÍOLWLXKHSDULQÍJHOJHO+VRGLXKHSDULQÍDPRQLXKHSDULQÍXPSOXWFXVÉQJHYHQRVQXHVWHLQGLFDWSHQWUXDQDOL]DJD]HORUVDQJXLQH

S-Monovette® SARSTEDT analiza metalelor
S-Monovette®SHQWUXDQDOL]DPHWDOHORUFRQėLQHDQWLFRDJXODQWXOOLWLXKHSDULQÍēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDOēLSODVPÍ $QWLFRDJXODQWXOOLWLXKHSDULQÍHVWHSUH]HQWFDGR]DUHYDSRUL]DWÍ GHUHJXOÍ8,
KHSDULQÍPOVÉQJH 
6ÉQJHOHWRWDOFXKHSDULQÍVDXSODVPDFXKHSDULQÍGLQ60RQRYHWWH®SHQWUXDQDOL]DPHWDOHORUîQFRPELQDėLFXFDQXOD6DIHW\VSHFLDOÍ*[Źŗ QUDUW VHXWLOL]HD]ÍFDPDWHULDOGHSUREÍSHQWUXWHVWHOH
GHROLJRHOHPHQWHPHWDOH2OLJRHOHPHQWHOHPHWDOHOHDXIRVWYDOLGDWHSULQVSHFWURPHWULHGHDEVRUEėLHDWRPLFÍ $$6 3HQWUXVLVWHPXOIRUPDWGLQFDQXOÍ6DIHW\ēL60RQRYHWWH®SHQWUXDQDOL]DPHWDOHORUUH]XOWÍXUPÍWRDUHOH
valori de vidare maxime pentru aceste oligoelemente, exprimate în ng/sistem:

Element

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

ng/sistem

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

9DORULOHGHYLGDUHPD[LPHVXQWLQGLFDWHSHQWUXıHFDUHHOHPHQWSHHWLFKHWD0RQRYHWWH6 .
®

7HVWHOHGHROLJRHOHPHQWHVHIDFGLQVÉQJHWRWDOFXKHSDULQÍVDXSODVPÍFXKHSDULQÍîQIXQFėLHGHPHWRGDGHDQDOL]Í,QKLEDUHDFXKHSDULQDDFRDJXOÍULLDUHORFSULQDFWLYDUHDDQWLWURPELQHLS-Monovette® citrat 9NC SARSTEDT
S-Monovette®FLWUDW1&FRQėLQHDQWLFRDJXODQWXOFLWUDWWULVRGLFēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDOēLSODVPÍ &LWUDWXOWULVRGLFHVWHGLVSRQLELOVXEIRUPÍGHVROXėLHPRODUÍGH VROXėLHGHFLWUDWWULVRGLF
DGHVHDURWXQMLWÍSÉQÍOD ēLHVWHGHGLQYROXPXOQRPLQDODOXQXL60RQRYHWWH®FXFLWUDW5DSRUWXOGHDPHVWHFDUHGHFLWUDWēLVÉQJHHVWHGHşSDUWHîQYROXPFLWUDWēLSÍUėLîQYROXPVÉQJH3HQWUXDQDOL]ÍHVWHDEVROXWQHFHVDUÍXPSOHUHDFRUHFWÍ&LWUDWXOSODVPÍHVWHXWLOL]DWFDPDWHULDOGHSUREÍîQLQYHVWLJDėLLOHGHKHPRVWD]HRORJLHGHUXWLQÍ,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUHFLWUDW
9ÍUXJÍPVÍUHVSHFWDėL,1',&$¯,,/(GLQVHFėLXQHDSULYLQGSUHOHYDUHDSUREHORUēLPDQLSXODUHDSHQWUXFRPELQDUHD60RQRYHWWH®FXFLWUDWēLDFDQXOHLFXDULSLRDUH

S-Monovette® PFA 9NC SARSTEDT
S-Monovette®3)$1&FRQėLQHDQWLFRDJXODQWXOFLWUDWWULVRGLFSHQWUXFROHFWDUHDGHVÉQJHWRWDOēLSODVPÍ &LWUDWXOWULVRGLFHVWHGLVSRQLELOVXEIRUPÍGHVROXėLHPRODUÍWDPSRQDWÍGH WDPSRQDWÍS+ ēLHVWHGHGLQYROXPXOQRPLQDODOXQXL60RQRYHWWH®3)$5DSRUWXOGHDPHVWHFDUHGHFLWUDWēLVÉQJHHVWHGHşSDUWHîQYROXPFLWUDWēLSÍUėLîQYROXPVÉQJH3HQWUXDQDOL]ÍHVWHDEVROXWQHFHVDUÍXPSOHUHDFRUHFWÍ
6ÉQJHOHWRWDOGLQ60RQRYHWWH®3)$1&HVWHXWLOL]DWFDPDWHULDOGHSUREÍSHQWUXGHWHUPLQDUHDIXQFėLHLWURPERFLWHORUFXDQDOL]RUXO6LHPHQV+HDOWKLQHHUV3)$ēLHVWHYDOLGDWîQDFHVWVFRS,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUHFLWUDW
9ÍUXJÍPVÍUHVSHFWDėL,1',&$¯,,/(GLQVHFėLXQHDSULYLQGSUHOHYDUHDSUREHORUēLPDQLSXODUHDSHQWUXFRPELQDUHD60RQRYHWWH®3)$ēLDFDQXOHLFXDULSLRDUH

S-Monovette® SARSTEDT CTAD
S-Monovette®&7$'FRQėLQHDQWLFRDJXODQWXOFLWUDWWULVRGLFSUHFXPēLWHRILOLQÍDGHQR]LQÍēLGLSLULGDPROēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDOēLSODVPÍ &7$'HVWHGLVSRQLELOVXEIRUPÍGHVROXėLHēLHVWHGH
10% din volumul nominal al unui S-Monovette®&7$'5DSRUWXOGHDPHVWHFDUHGH&7$'ēLVÉQJHHVWHGHşSDUWHîQYROXP&7$'ēLSÍUėLîQYROXPVÉQJH3HQWUXDQDOL]ÍHVWHDEVROXWQHFHVDUÍXPSOHUHDFRUHFWÍ
3ODVPDFX&7$'HVWHXWLOL]DWÍFDPDWHULDOGHSUREÍSHQWUXGHWHUPLQDUHDIDFWRUXOXLSODFKHWDU 3) DWURPERJOREXOLQHL Ĕ  Ĕ7* ēLDLQKLELWRUXOXLDFWLYDWRUXOXLSODVPLQRJHQXOXL 3$, SUHFXPēLSHQWUXLQYHVWLJDėLLOHGHKHPRVWD]HRORJLHGHUXWLQÍ$FWLYDUHDWURPERFLWHORUHVWHLQKLEDWÍSHQWUXRGXUDWÍGHPLQLPRUHēLHVWHXWLOL]DWÍSHQWUXPRQLWRUL]DUHDWHUDSLLORUFXKHSDULQÍ,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUHFLWUDW
9ÍUXJÍPVÍUHVSHFWDėL,1',&$¯,,/(GLQVHFėLXQHDSULYLQGSUHOHYDUHDSUREHORUēLPDQLSXODUHDSHQWUXFRPELQDUHD60RQRYHWWH®&7$'ēLDFDQXOHLFXDULSLRDUH
,1',&$¯,(&7$'HVWHJDOEHQ3HGXUDWDGHSR]LWÍULL60RQRYHWWH®&7$'WUHEXLHSURWHMDWÍGHOXPLQDDUWLıFLDOÍēLQDWXUDOÍ$FėLRQDUHDSXWHUQLFÍDOXPLQLLWLPSGHPDLPXOWGHRUHSRDWHGXFHOD
dezactivarea aditivilor.

174

RO
S-Monovette® EDTA K2E / K3E SARSTEDT
S-Monovette® EDTA K2E / S-Monovette®('7$.(FRQėLQHDQWLFRDJXODQWXO.('7$VDX.('7$ēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDO .('7$VDX.('7$HVWHSUH]HQWFDGR]DUHYDSRUL]DWÍ PJ
('7$POVÉQJH 
6ÉQJHOHWRWDOFX('7$HVWHXWLOL]DWFDPDWHULDOGHSUREÍSHQWUXLQYHVWLJDėLLGHKHPDWRORJLH)URWLXULOHGHVÉQJHWUHEXLHSUHSDUDWHîQWHUPHQGHSDWUXRUHGHODPRPHQWXOSUHOHYÍULLVÉQJHOXL,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUH('7$
6ÉQJHOHGLQ60RQRYHWWH®('7$.(.(SRDWHILIRORVLWGHDVHPHQHDSHQWUXLQYHVWLJDėLLLPXQRKHPDWRORJLFHGHUXWLQÍēLSHQWUXWHVWHGHEROLLQIHFėLRDVH$GHFYDUHDPDWHULDOXOXLGHSUREÍSHQWUXDFHVWHLQYHVWLJDėLLHVWHUHVSRQVDELOLWDWHDXWLOL]DWRUXOXLFXUHDFWLYLLGHWHVWDUHDQDOL]RDUHOHDGHFYDWHLQFOXVLYYDOLGDUHDFRQGLėLLORUGHGHSR]LWDUH

S-Monovette® EDTA-gel K2E SARSTEDT
S-Monovette®('7$JHO.(FRQėLQHSHOÉQJÍDQWLFRDJXODQWXO.('7$XQJHOSROLPHULFēLHVWHXWLOL]DWSHQWUXFROHFWDUHDSODVPHL .('7$HVWHSUH]HQWFDGR]DUHYDSRUL]DWÍ PJ('7$POVÉQJH 3ULQFHQWULIXJDUHJHOXOVHSR]LėLRQHD]ÍîQWUHFHOXOHOHGHVÉQJHēLSODVPÍēLIRUPHD]ÍXQVWUDWGHVHSDUDUHVWDELOîQWLPSXOWUDQVSRUWXOXLGHSR]LWÍULLēLDQDOL]HL3ODVPDFX('7$HVWHXWLOL]DWÍFDPDWHULDOGHSUREÍSHQWUXGLDJQRVWLFDUHDPROHFXODUÍDYLUXVXULORU,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUH('7$

S-Monovette®ĲXRUXUÍ('7$)(ĲXRUXUÍKHSDULQÍ)+ĲXRUXUÍFLWUDW('7$)&6$567('7FXLQKLEDWRULGHJOLFROL]Í
S-Monovette®IOXRUXUÍ('7$)(FRQėLQHDQWLFRDJXODQWXO('7$ PJPOVÉQJH SUHFXPēLIOXRUXUÍ PJPOVÉQJH SHQWUXLQKLEDUHDJOLFROL]HLēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHSODVPÍ ('7$FXIOXRUXUÍHVWH
SUH]HQWFDGR]DUHYDSRUL]DWÍS-Monovette®IOXRUXUÍKHSDULQÍ)+FRQėLQHDQWLFRDJXODQWXOKHSDULQÍ 8,KHSDULQÍPOVÉQJH SUHFXPēLIOXRUXUÍ PJPOVÉQJH SHQWUXLQKLEDUHDJOLFROL]HLēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHSODVPÍ +HSDULQDFXIOXRUXUÍHVWHSUH]HQWÍFDGR]DUHYDSRUL]DWÍ,QKLEDUHDJOLFROL]HLQXPDLFXIOXRUîQFHSHODFFDRUHGXSÍXPSOHUHDWXEXOXLGHFROHFWDUHDVÉQJHOXLēLSUH]LQWÍXQHIHFWFRPSOHWGXSÍFFDRUHQDFHVWWLPSJOXFR]DVHGHVFRPSXQHîQPHGLHGHSÉQÍODGXSÍFÉWHYDRUHēLGHSÉQÍODGXSÍGHRUHîQVÉQJHOHWRWDO
S-Monovette®*OXFR(;$&7)&FRQėLQHDQWLFRDJXODQWXO('7$SUHFXPēLFLWUDWēLIOXRUXUÍSHQWUXLQKLEDUHDLPHGLDWÍDJOLFROL]HLēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJH ('7$FLWUDWXOēLIOXRUXUDVXQWSUH]HQWHFDVROXėLH'LQFDX]DGLOXėLHLFDOFXOXOFRQFHQWUDėLHLGHJOXFR]ÍQHFHVLWÍPXOWLSOLFDUHDFX
S-Monovette®*OXFR(;$&7)&îQGHSOLQHēWH'LUHFWLYDSULYLQGGLDEHWXOJHVWDėLRQDOHPLVÍGH6RFLHWDWHDJHUPDQÍGHGLDEHWRORJLH ''* ēL'LUHFWLYDQDėLRQDOÍSULYLQGWUDWDPHQWXO 19/ GLDEHWXOXLGHWLS6WDELOL]DUHDLPHGLDWÍDFRQFHQWUDėLHLGHJOXFR]ÍHVWHDVLJXUDWÍODWHPSHUDWXUDFDPHUHLSHQWUXSÉQÍODRUHîQVÉQJHOHWRWDOFRQVXOWDėLGHDVHPHQHD&DUWD$OEÍ6$567('7https://www.sarstedt.com/en/products/diagnostic/
venous-blood/s-monovetter/ Bibliografie/„Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours”.
3ODVPDFX FLWUDW FX('7$ēLIOXRUXUÍHVWHXWLOL]DWÍFDPDWHULDOGHSUREÍSHQWUXWHVWXOGHJOXFR]Í,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUH('7$
,1',&$¯,()OXRUXUDSRDWHFDX]DRFUHēWHUHDKHPROL]HL*ÍVLėLLQIRUPDėLLVXSOLPHQWDUHSULYLQGVXEVWDQėHOHFDUHSRWDYHDHIHFWHGHUDQMDQWHîQLQVWUXFėLXQLOHGHXWLOL]DUHDIHUHQWHDOHSURGXFÍWRUXOXL
agentului de testare.
9ÍUXJÍPVÍUHVSHFWDėL,1',&$¯,,/(GLQVHFėLXQHDSULYLQGSUHOHYDUHDSUREHORUēLPDQLSXODUHDSHQWUXFRPELQDUHD60RQRYHWWH®*OXFR(;$&7ēLDFDQXOHLFXDULSLRDUH

S-Monovette® CPDA SARSTEDT
S-Monovette®&3'$FRQėLQHDQWLFRDJXODQWXOFLWUDWVRGLFSUHFXPēLDFLGFLWULFIRVIDWGHVRGLXGH[WUR]ÍēLDGHQLQÍēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDOēLSODVPÍ &3'$HVWHSUH]HQWFDVROXėLH5DSRUWXOGHDPHVWHFDUHGH&3'$ēLVÉQJHHVWHGHşSDUWHîQYROXP&3'$ēLSÍUėLîQYROXPVÉQJH3HQWUXDQDOL]ÍHVWHDEVROXWQHFHVDUÍXPSOHUHDFRUHFWÍ
6ÉQJHOHWRWDOSODVPDFX&3'$VHXWLOL]HD]ÍFDPDWHULDOGHSUREÍSHQWUXVHURORJLDJUXSHORUVDQJXLQHîQPHGLFLQDWUDQVIX]LRQDOÍSHQWUXVWXGLLGHFRPSDWLELOLWDWH SUREHîQFUXFLēDWH îQWUDQVIX]LLQPRGFRQFUHWS-Monovette®&3'$HVWHDGHFYDWSHQWUXGHWHUPLQDUHDJUXSHLVDQJXLQH $% LQFOXVLYIRUPXOD.HOOēL5KHVXVWHVWXOGHDQWLFRUSLSHQWUXDQWLFRUSLQHUHJXODėLDLJUXSHLVDQJXLQHWHVWXO&RRPEVGLUHFWSROLVSHFLILF SÉQÍîQ
]LXD WHVWXOGHFRPSDWLELOLWDWH SUREÍîQFUXFLēDWÍ FXVHUSODVPÍFRPSDWLELOÍFXJUXSDVDQJXLQÍDSDFLHQWXOXL WHVWXOPDMRU 'XUDWDGHWUDQVSRUWSÉQÍODGHSR]LWDUHHVWHYDOLGDWÍSHQWUXPD[LPXPRUHODƓ&3HQWUXVHGLPHQWDUHDFHOXOHORUSUREHOHWUHEXLHSÍVWUDWHDQWHULRUîQSR]LėLHYHUWLFDOÍîQIULJLGHUWLPSGHPLQRUH8OWHULRUVXEVWDQėHOHGHDQDOL]ÍPHQėLRQDWHPDLVXVSRWILGHWHUPLQDWHWLPSGHSÉQÍODGH]LOHîQPRGDQDORJFXSHULRDGDRELēQXLWÍGHFRQVHUYDUHDVÉQJHOXLGXSÍGHSR]LWDUHDîQIULJLGHU Ɠ&  FXH[FHSėLDWHVWXOXL&RRPEVGLUHFWGHSÉQÍOD]LOH $GHFYDWSHQWUXSURFHGXULOHGHDJOXWLQDUHSHFRORDQÍGHH[SH9LVLRQ0D[GHOD2UWKR&OLQLFDO'LDJQRVWLFV1XVHSHUPLWHFRQJHODUHDPDWHULDOXOXLGHSUREÍ$GHFYDUHDPDWHULDOXOXLGHSUREÍSHQWUXDFHVWHLQYHVWLJDėLLFXDOWHPHWRGHUHDFWLYLGHWHVWDUHDQDOL]RDUHLQFOXVLYFRQGLėLLOHGHGHSR]LWDUHVXQWUHVSRQVDELOLWDWHDXWLOL]DWRUXOXLēLWUHEXLHYDOLGDWHGHDFHVWDîQVXēL,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUHFLWUDW
9ÍUXJÍPVÍUHVSHFWDėL,1',&$¯,,/(GLQVHFėLXQHDSULYLQGSUHOHYDUHDSUREHORUēLPDQLSXODUHDSHQWUXFRPELQDUHD60RQRYHWWH®&3'$ēLDFDQXOHLFXDULSLRDUH

S-Monovette® ThromboExact SARSTEDT
S-Monovette®7KURPER([DFWFRQėLQHFDDQWLFRDJXODQWRVDUHGHPDJQH]LXēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDO 6DUHDGHPDJQH]LXHVWHSUH]HQWÍFDGR]DUHYDSRUL]DWÍ
S-Monovette®7KURPER([DFWHVWHXWLOL]DWFDPDWHULDOGHSUREÍODH[FOXGHUHDQXPÍUXOXLGHWURPERFLWHIDOVVFÍ]XWGLQFDX]DXQHLLQWROHUDQėHODDQWLFRDJXODQėL FXPDUIL('7$FLWUDWKHSDULQÍ GHQXPLWÍēL
SVHXGRWURPERFLWRSHQLH)RUPDUHDDJUHJDWHORUGHWURPERFLWHHVWHîPSLHGLFDWÍēLVHSHUPLWHGHWHUPLQDUHDQXPÍUXOXLHIHFWLYGHWURPERFLWHFKLDUēLSÉQÍODRUHGHODPRPHQWXOFROHFWÍULLVÉQJHOXL,QKLEDUHDFRDJXOÍULLDUHORFSULQLQWHUPHGLXOLRQLORUGHPDJQH]LXLRQLLGHPDJQH]LXLQKLEÉQGDWÉWWURPER[DQXOWURPERFLWDU$FÉWēLDJUHJDUHDWURPERFLWHORUPHGLDWÍGH$'3ēLDFLGXODUDKLGRQLF

S-Monovette®KLUXGLQÍ6$567('7S-Monovette®KLUXGLQÍFRQėLQHDQWLFRDJXODQWXOKLUXGLQÍēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDO +LUXGLQDHVWHSUH]HQWÍFDGR]DUHYDSRUL]DWÍ
6ÉQJHOHWRWDOFXKLUXGLQÍVHXWLOL]HD]ÍSHQWUXLQYHVWLJDUHDIXQFėLHLWURPERFLWHORUSHGLVSR]LWLYXO0XOWLSODWH® PXOWLSOHSODWHOHWIXQFWLRQDQDO\VHU GHOD52&+('LDJQRVWLFVēLHVWHYDOLGDWSHQWUXDFHDVWD6HIRORVHēWHODPRQLWRUL]DUHDWHUDSLHLFXPHGLFDPHQWHLQKLELWRDUHGHWURPERFLWHSUHFXPēLODGHPRQVWUDUHDSUH]HQėHLVDXODH[FOXGHUHDGLVIXQFėLLORUWURPERFLWHORU
S-Monovette®FXKLUXGLQÍDIRVWGH]YROWDWÍVSHFLDOSHQWUXGHWHUPLQDUHDIXQFėLHLWURPERFLWHORUîPSUHXQÍFXILUPD9HUXP'LDJQRVWLFDGHQXPLWÍîQSUH]HQW52&+('LDJQRVWLFVSHGLVSR]LWLYXO0XOWLSODWH®.
+LUXGLQDDFėLRQHD]ÍSULQLQKLEDUHDGLUHFWÍDWURPELQHLēLSHUPLWHDVWIHOGLDJQRVWLFDUHDIXQFėLHLWURPERFLWHORUîQVWDUHDQDWLYÍDDFHVWRUD

Monovette S®KRPRFLVWHLQÍ+&<=JHO+&<&6$567('7S-Monovette®KRPRFLVWHLQÍ+&<=JHOFRQėLQHSHOÉQJÍJUDQXODWXOGLQSODVWLFDFRSHULWFXDFWLYDWRUGHFRDJXODUH VLOLFDW XQVWDELOL]DWRUVSHFLDOēLXQJHOSROLPHULFēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVHU 3ULQFHQWULIXJDUHJHOXOVHSR]LėLRQHD]ÍîQWUHFKHDJXOGHVÉQJHēLVHUēLIRUPHD]ÍXQVWUDWGHVHSDUDUHVWDELOîQWLPSXOWUDQVSRUWXOXLGHSR]LWÍULLēLDQDOL]HL6XEVWDQėDSUHSDUDWÍHVWHSUH]HQWÍFDGR]DUHYDSRUL]DWÍ+RPRFLVWHLQDHVWHVWDELOL]DWÍîQVÉQJHOHWRWDOODWHPSHUDWXUDFDPHUHLWLPSGHSÉQÍODRUH'DFÍFHQWULIXJDUHDVHHIHFWXHD]ÍîQSULPHOHRUHFXXQVWUDWGHVHSDUDUHIRUPDWFRUHFWîQWUHVÉQJHOHFRDJXODWēLVHUKRPRFLVWHLQDHVWHVWDELOL]DWÍWLPSGHSÉQÍODGHRUH
Serul din S-Monovette®KRPRFLVWHLQÍ+&<=*HOVHXWLOL]HD]ÍFDPDWHULDOGHSUREÍSHQWUXGHWHUPLQDUHDKRPRFLVWHLQHL60RQRYHWWH®KRPRFLVWHLQÍ+&<&FRQėLQHDQWLFRDJXODQWXOFLWUDWDFLG S+ ēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHSODVPÍ &LWUDWXOHVWHSUH]HQWFDVROXėLH'LQFDX]DGLOXėLHLFDOFXOXOFRQFHQWUDėLHLGHKRPRFLVWHLQÍQHFHVLWÍPXOWLSOLFDUHDFX+RPRFLVWHLQDHVWHVWDELOL]DWÍîQVÉQJHOHWRWDOODWHPSHUDWXUDFDPHUHLWLPSGHSÉQÍODRUHēLODƓ&SÉQÍODGHRUH
Plasma din S-Monovette®KRPRFLVWHLQÍ+&<&VHXWLOL]HD]ÍFDPDWHULDOGHSUREÍSHQWUXGHWHUPLQDUHDKRPRFLVWHLQHL,QKLEDUHDFRDJXOÍULLîQ60RQRYHWWH®KRPRFLVWHLQÍ+&<&DUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUHFLWUDW
9ÍUXJÍPVÍUHVSHFWDėL,1',&$¯,,/(GLQVHFėLXQHDSULYLQGSUHOHYDUHDSUREHORUēLPDQLSXODUHDSHQWUXFRPELQDUHD60RQRYHWWH®+&<&ēLDFDQXOHLFXDULSLRDUH

S-Monovette® DNA Exact SARSTEDT
S-Monovette®'1$([DFWFRQėLQHXQDQWLFRDJXODQWSHED]ÍGH('7$ēLHVWHXWLOL]DWSHQWUXFROHFWDUHDGHVÉQJHWRWDO ('7$HVWHSUH]HQWFDGR]DUHYDSRUL]DWÍ
6ÉQJHOHWRWDOFX('7$HVWHXWLOL]DWFDPDWHULDOGHSUREÍSHQWUXVWDELOL]DUHDJ'1$3HUIRUPDQėDGHVWDELOL]DUHSHQWUXJ'1$HVWHYDOLGDWÍSHQWUX]LOHODƓ&]LOHODWHPSHUDWXUDFDPHUHL Ɠ& ]LOHîQPHGLXUHIULJHUDW Ɠ& ēLPLQLPDQODƓ&QSOXVSUREHOHVWDELOL]DWHUH]LVWÍODFLFOXULGHFRQJHODUHēLGHFRQJHODUHIÍUÍDILDIHFWDWÍFDOLWDWHDDFHVWRUDFRQVXOWDėLGHDVHPHQHD&DUWD$OEÍ6$567('7https://www.sarstedt.
com/en/products/diagnostic/venous-blood/s-monovetter/ Bibliografie/„SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for
Genomic DNA Analysis.”.
,QKLEDUHDFRDJXOÍULLDUHORFSULQFRPSOH[DUHDLRQLORUGHFDOFLXGHFÍWUH('7$

$GHFYDUHDPDWHULDOXOXLSUREHLGHSLQGHGHVXEVWDQėDGHDQDOL]ÍēLGHUHDFWLYXOGHWHVWDUHDQDOL]RU7UHEXLHOXDWHîQFRQVLGHUDUHUHFRPDQGÍULOHSURGXFÍWRUXOXL

175

RO
,QGLFDėLLSULYLQGVLJXUDQėDLQGLFDėLLGHDYHUWL]DUH
1.

3UHFDXėLLJHQHUDOH8WLOL]DėLPÍQXēLēLDOWHSLHVHGHHFKLSDPHQWLQGLYLGXDOGHSURWHFėLHSHQWUXDYÍSURWHMDGHVÉQJHēLGHRSRWHQėLDOÍH[SXQHUHODSUREHSRWHQėLDOLQIHFėLRDVHēLODDJHQėLSDWRJHQLWUDQVPLVLELOLSULQVÉQJH

2.

7UDWDėLWRDWHPRVWUHOHēLSUREHOHELRORJLFHēLXVWHQVLOHOHGHUHFROWDUHDVÉQJHOXLFXPXFKLLYÉUIXULDVFXėLWH FDQXOHDGDSWRDUH FRQIRUPGLUHFWLYHORUēLSURFHGXULORUXQLWÍėLLGYVQFD]XOXQHLH[SXQHULGLUHFWHODSUREH
ELRORJLFHVDXROH]LXQHGLQîPSXQJHUHFXDFXODSHODėLODXQPHGLFGHRDUHFHDVWIHOVHSRWWUDQVPLWH+,9+&9+%9VDXDOWHEROLLQIHFėLRDVH)RORVLėLFDQXOHGHVLJXUDQėÍ6DIHW\6DIHW\0XOWLĲ\®FXSURWHFėLHLQWHJUDWÍ
SHQWUXDF(VWHREOLJDWRULXVÍUHVSHFWDėLGLUHFWLYHOHēLSURFHGXULOHSULYLQGVLJXUDQėDYDODELOHîQLQVWLWXėLDGYV

3.

6HDSOLFÍSHQWUXSURGXVHOHDPEDODWHLQGLYLGXDOVWHULOQDLQWHGHXWLOL]DUHYHULıFDėLıHFDUHDPEDODMLQGLYLGXDOFXSULYLUHODGHWHULRUÍULLDUGDFÍDFHVWHDH[LVWÍQXIRORVLėLSURGXVXO

4.

3URGXVXOHVWHSUHYÍ]XWSHQWUXIRORVLQėÍXQLFÍ(OLPLQDėLFDGHēHXWRDWHRELHFWHOHFXPXFKLLYÉUIXULDVFXėLWH FDQXOHDGDSWRDUH SHQWUXSUHOHYDUHDVÉQJHOXLîQUHFLSLHQWHSHQWUXGHēHXULDGHFYDWHSHQWUXHOLPLQDUHDVXEVWDQėHORUELRORJLFHSHULFXORDVH

5.

'DFÍVHSUHOHYHD]ÍVÉQJHSULQWUXQDFFHVLQWUDYHQRV ,9 WUHEXLHDVLJXUDWIDSWXOFÍSXQFWXOGHDFFHVHVWHVSÍODW FXUÍėDWGHVROXėLD,9 FRUHVSXQ]ÍWRUVWDQGDUGHORUXQLWÍėLLPHGLFDOHîQDLQWHGHîQFHSHUHDSUHOHYÍULLVÉQJHOXL3ULQVSÍODUHDFRUHVSXQ]ÍWRDUHDSXQFWXOXLGHDFFHVVHHYLWÍREėLQHUHDGHUH]XOWDWHHURQDWHDOHDQDOL]HORU

6.

8PSOHUHDLQVXıFLHQWÍVDXH[FHVLYÍD60RQRYHWWH®GXFHODXQUDSRUWJUHēLWîQWUHVÉQJHēLVXEVWDQėDSUHSDUDWÍDGLWLYēLSRDWHGXFHODUH]XOWDWHHURQDWHDOHDQDOL]HORU

7.

6ÉQJHOHSUHOHYDWēLSURFHVDWîQ60RQRYHWWH® nu este destinat pentru reinjectarea în corpul uman.

8.

'XSÍH[SLUDUHDSHULRDGHLGHYDODELOLWDWHQXPDLHVWHSHUPLVÍXWLOL]DUHDSURGXVXOXL3HULRDGDGHYDODELOLWDWHVHîQFKHLHîQXOWLPD]LDOXQLLēLDDQXOXLVSHFLıFDWDepozitare3ÉQÍODXWLOL]DUHSURGXVXOVHYDGHSR]LWDODWHPSHUDWXUDFDPHUHL5HVWULFėLL
1.

'XUDWDēLWHPSHUDWXUDGHGHSR]LWDUHDXQXL60RQRYHWWH®XPSOXWGHSLQGGHGXUDWDGHYDODELOLWDWHDVXEVWDQėHORUGHDQDOL]Í(YDOXDUHDVHIDFHGHFÍWUHODERUDWRUVDXLQIRUPDėLLOHVXQWSUHOXDWHGLQLQVWUXFėLXQLOHGHXWLOL]DUHDOHSURGXFÍWRUXOXLUHDFWLYLORUGHWHVWDUHDQDOL]RUXOXL2.

&KLDUGDFÍSODVPDRULVHUXOVXQWVHSDUDWHSULQFHQWULIXJDUHDXQXL60RQRYHWWH®ēLVDXHVWHSUH]HQWÍREDULHUÍDFHDVWDQXîQVHDPQÍQHDSÍUDWFÍWRDWHFHOXOHOHVXQWVHSDUDWHFRPSOHW0HWDEROL]DUHDUH]LGXXULORUVDXGHJUDGDUHDQDWXUDOÍSRWLQĲXHQėDFRQFHQWUDėLLOHVXEVWDQėHORUGHDQDOL]Í6WDELOLWDWHDVXEVWDQėHORUGHDQDOL]ÍWUHEXLHHYDOXDWÍîQIXQFėLHGHUHFLSLHQWHOHGHGHSR]LWDUHēLGHFRQGLėLLOHGLQODERUDWRUXOUHVSHFWLY3.

QFD]XOPHGLFDPHQWHORUGHWHUDSLHWUHEXLHYHULıFDWÍDGHFYDUHDPDWHULDOXOXLSUREHLSULQFRQVXOWDUHDLQVWUXFėLXQLORUGHXWLOL]DUHHPLVHGHSURGXFÍWRUXOUHDFWLYLORUGHWHVWDUHDQDOL]RUXOXL

4.

Analizele pentru oligoelemente/metale se vor efectua cu sistemul S-Monovette® pentru analiza metalelor + canula Safety pentru analiza metalelor.

3UHOHYDUHDēLPDQLSXODUHDSUREHORU&,7,¯,$&(67'2&80(171175(*,0(1$,17('($1&(3(5(&2/7$5($'(6e1*(9(126
Material de lucru necesar pentru prelevarea probei
1.

7RDWHVLVWHPHOHGHUHFROWDUHDVÉQJHOXL60RQRYHWWH® necesare.

2.

&DQXOH 6DIHW\ VDXFDQXOH 6DIHW\ 0XOWLĲ\®.

3.

8WLOL]DėLPÍQXēLKDODWRFKHODULGHSURWHFėLHVDXDOWWLSGHîPEUÍFÍPLQWHGHSURWHFėLHDGHFYDWÍSHQWUXDYÍSURWHMDGHDJHQėLLSDWRJHQLWUDQVPLēLSULQVÉQJHVDXGHPDWHULDOHSRWHQėLDOLQIHFėLRDVH4.

(WLFKHWHSHQWUXLGHQWLıFDUHDSDFLHQWXOXL

5.

0DWHULDOGH]LQIHFWDQWSHQWUXFXUÍėDUHD]RQHLGHSUHOHYDUH VHYRUUHVSHFWDGLUHFWLYHOHXQLWÍėLLPHGLFDOHSHQWUXSUHOHYDUHDGHSUREHVWHULOHSHQWUXSUHJÍWLUHD]RQHLGHSUHOHYDUH 1XIRORVLėLPDWHULDOHGHFXUÍėDUHSHED]ÍGHDOFRROGDFÍSUREHOHXUPHD]ÍVÍıHXWLOL]DWHSHQWUXWHVWDUHDDOFRROHPLHL

6.

7DPSRDQHXVFDWHēLIÍUÍJHUPHQLGHXQLFÍIRORVLQėÍ

7.

8QJDURXSHQWUXEORFDUHDĲX[XOXLVDQJYLQGLQYHQÍ

8.

Un plasture sau tifon de pansare.

9.

5HFLSLHQWSHQWUXHOLPLQDUHDRELHFWHORUFXPXFKLLYÉUIXULDVFXėLWHSHQWUXHOLPLQDUHDîQFRQGLėLLGHVLJXUDQėÍDPDWHULDOHORUX]DWH

6XFFHVLXQHDGHSUHOHYDUHUHFRPDQGDWÍ1.

Flacoane pentru culturi sangvine

2.

7XEXULFXFLWUDWVDXDFWLYDWRUGHFRDJXODUH FXIÍUÍVHUēLJHO&$7VHUJHO&$7 

3.

Tuburi cu activator de coagulare sau citrat

4.

7XEXULFXKHSDULQÍFXIÍUÍJHO

5.

7XEXULFX('7$FXIÍUÍJHO

6.

7XEXULFXLQKLELWRULGHJOLFROL]Í

7.

7XEXULFXDOėLDGLWLYL,1',&$¯,('DFÍVHîQFHSHFXSUHOHYDUHDXQXLWXEFXFLWUDWVDXDXQXLDOWWXEFXRVXEVWDQėÍSUHSDUDWÍOLFKLGÍGHH[3)$&7$'&3'$+&<&VDX*OXFR(;$&7îQFRPELQDėLHFXRFDQXOÍFXDULSLRDUH GHH[FDQXOD 6DIHW\ 0XOWLĲ\® VHUHFRPDQGÍSUHOHYDUHDSUHDODELOÍDXQXLWXEJRO GHH[60RQRYHWWH®QHXWUX= SHQWUXDHYLWDXPSOHUHDLQVXıFLHQWÍDWXEXOXLGLQFDX]Dumplerii furtunului canulei cu aripioare.
$VWIHOVHSRDWHDVLJXUDXPSOHUHDFRUHFWÍDWXEXOXLēLDVWIHOXQUDSRUWGHDPHVWHFFRUHFW OLFKLGēLVÉQJH ,1',&$¯,(3HQWUXVXFFHVLXQHDGHSUHOHYDUHUHVSHFWDėLSUHYHGHULOHXQLWÍėLLGXPQHDYRDVWUÍPHGLFDOH

(YLWDUHDUHĲX[XOXL0DMRULWDWHDWXEXULORU60RQRYHWWHFRQėLQDGLWLYLFKLPLFL3HQWUXHYLWDUHDUHIOX[XOXLWUHEXLHUHVSHFWDWHLQGLFDėLLOHXUPÍWRDUH
1. )RORVLėLQXPDLPDWHULDOHOHUHFRPDQGDWHîQLQVWUXFėLXQLOHGHXWLOL]DUH
2.

$ēH]DėLSDFLHQWXODVWIHOîQFÉWVÍDYHėLDFFHVXēRUODYHQDDFHVWXLDēLRULHQWDėLEUDėXOVDXDOWH]RQHGHSXQFėLHDOHSDFLHQWXOXLîQMRV3.

¯LQHėL60RQRYHWWH®FXFDSDFXOıOHWDWRULHQWDWîQVXVLDUGDFÍIRORVLėLRFDQXOÍ 6DIHW\ 0XOWLĲ\®GHDVHPHQHDVXEQLYHOXOEUDėXOXL]RQHLGHSXQFėLH

4.

7UHEXLHVÍYÍDVLJXUDėLFÍFRQėLQXWXO60RQRYHWWH®QXDWLQJHQLFLFDSDFXOîQēXUXEDWQLFLFDSÍWXOFDQXOHLîQPRPHQWXOîPSXQJHULLYHQHL

5.

'HVIDFHėLJDURXOîQWLPSFHVÉQJHOHFXUJHîQWXEXO60RQRYHWWH®.

176

RO
Congelare/decongelare&RQIRUPUHFRPDQGÍULORU206 :+2',//DE5HY VHUHFRPDQGÍVHSDUDUHDVHUXOXLSODVPHLîQDLQWHGHFRQJHODUHDJOREXOHORUGLQVÉQJH
Pentru S-Monovette®VHDSOLFÍUHFRPDQGÍULOHXUPÍWRDUHSHQWUXFRQJHODUH
&RQJHODUHVXEbƓ&•

8WLOL]DUHDîQLQWHUYDOXOGHWHPSHUDWXUÍVXE]HURJUDGHWUHEXLHWHVWDWÍîQSULQFLSLXîQFRQGLėLLUHDOHGHRDUHFHîQFÍUFDUHDWXEXULORUSRDWHıIRDUWHGLIHULWÍîQIXQFėLHGHPHGLXOFDUHWUHEXLHFRQJHODWēLGHFRQGLėLLOHGHUXWLQÍ
FRQVXOWDėLFDSLWROXOSULYLQGSURSULHWÍėLOHPDWHULDOHORUGLQFDWDORJXO6$567('7•QSULQFLSLXYDORULOHGHVROLGLWDWHDOHPDWHULDOHORUGLQPDVHSODVWLFHVHUHGXFîQLQWHUYDOXOGHWHPSHUDWXUÍVXEbƓ&3ULQXUPDUHWUHEXLHHYLWDWHîQJHQHUDORULFHVROLFLWÍULPHFDQLFH•&RQGLėLLOHGHFRQJHODUHWUHEXLHDOHVHDVWIHOîQFÉWFRQėLQXWXO60RQRYHWWH®VÍîQJKHėHXQLIRUPUHVSHFWLYGHMRVîQVXV'DFÍVHDĲÍîQWUXQVXSRUWVDXFDUWRQGHGHSR]LWDUH60RQRYHWWH®WUHEXLHVÍDLEÍVXıFLHQWVSDėLXOLEHUîQMXUSHQWUXDVHSXWHDGLODWD6XSRUWXULOHGLQSROLVWLUHQVDXPHWDOQXVXQWDGHFYDWHGHRDUHFHSRWGXFHODıVXULGHGLODWDUH

&RQJHODUHODƓ&şYHULıFDėLîQDLQWHGHFRQJHODUH•,QWHUIHUHQėH9HULıFDėLGDFÍFRQJHODUHDDUHLQĲXHQėHGHUDQMDQWHDVXSUDSUREHLGHVÉQJHVDXDQDOL]HL GHH[KHPROL]ÍVWDELOLWDWHDVXEVWDQėHORUGHDQDOL]Í •&HQWULIXJDUH1HFHVDUîQIXQFėLHGHDQDOL]DSODQLıFDWÍ3HQWUXFRQGLėLLOHGHFHQWULIXJDUHFRQVXOWDėLDFHVWGRFXPHQWODŚ&HQWULIXJDUHŘVDXSHSDJLQDZHE6$567('7https://www.sarstedt.com/en/service/centrifugation/GDUHIHFWXDėLēLFRQWUROXOYL]XDODOSUREHORU

•+HPROL]Í6ÉQJHOHWRWDOKHPROL]HD]ÍODFRQJHODUH3HQWUXHYLWDUHWUHEXLHIRORVLWıHWXEXO60RQRYHWWH®FXJHOUHVSHFWLYGXSÍFHQWULIXJDUHıOWUXOFXVXSDSÍ6HUDSODV®VDXSUREDWUHEXLHVÍıHWUDQVIHUDWÍFXSLSHWDîntr-un recipient secundar.

Congelare la -20°C – efectuare:•5ÍFLUHSÉQÍODWHPSHUDWXUDGRULWÍ5ÍFLėL60RQRYHWWH®îQSR]LėLHYHUWLFDOÍWLPSGHşPLQXWHGHODWHPSHUDWXUDFDPHUHLODbƓ&îQDLQWHFDUHFLSLHQWXOVÍSRDWÍıFRQJHODWODbƓ&•'H]JKHėDUHOÍVDėLUHFLSLHQWXOVÍVHGH]JKHėHWLPSGHPLQLPPLQXWHODWHPSHUDWXUDFDPHUHLîQSR]LėLHYHUWLFDOÍ¬LDLFLWUHEXLHHYLWDWHRULFHVROLFLWÍULPHFDQLFH'HFRQJHODUHDSUHDUDSLGÍSRDWHGXFHODDIHFWDUHD
rezultatelor analizei.

&RQJHODUHēLFRQJHODUHSURIXQGÍODWHPSHUDWXULVXEbƓ&•&RQJHODUHDSURIXQGÍODWHPSHUDWXULVXEbƓ&QXDIRVWYHULıFDWÍGHFÍWUHSURGXFÍWRU'LQFDX]DPXOWLWXGLQLLGHIDFWRULGHLQĲXHQėDUHSRWHQėLDOLVHUHFRPDQGÍHIHFWXDUHDGHWHVWHGHFRQJHODUHîQFRQGLėLLGHODERUDWRUGHUXWLQÍCongelarea tuburilor S-Monovette® cu gel:•

3HQWUXFRQJHODUHVHSURFHGHD]ÍFDODSXQFWXO&RQJHODUHODbƓ&şHIHFWXDUH

•6HēWLHIDSWXOFÍVWUDWXOGHJHOVHSRDWHPRGLıFDîQIXQFėLHGHSURFHVXOGHFRQJHODUH

•'LQFDX]DPXOWLWXGLQLLGHIDFWRULGHLQĲXHQėDUHSRWHQėLDOLVHUHFRPDQGÍHIHFWXDUHDGHWHVWHGHFRQJHODUHîQFRQGLėLLGHODERUDWRUGHUXWLQÍ•'H]JKHėDUH/ÍVDėLSUREDVÍVHGH]JKHėHîQSR]LėLHYHUWLFDOÍ'XSÍGH]JKHėDUHWUDQVIHUDėLPDWHULDOXOSUREHLSULQSUHOHYDUHFXSLSHWD QXSULQGHFDQWDUH GLQUHFLSLHQWXOSULPDUîQWUXQUHFLSLHQWVHFXQGDUSÉQÍODFFD
PPGHDVXSUDVWUDWXOXLGHJHO$UXQFDėLUHVWXOGHPDWHULDO
,1',&$¯,(3HQWUXVWDELOLWDWHDVXEVWDQėHORUGHDQDOL]ÍWUHEXLHUHVSHFWDWHLQVWUXFėLXQLOHGHXWLOL]DUHDOHSURGXFÍWRULORUDJHQėLORUUHDFWLYLSHQWUXWHVWDUHDQDOL]RUXOXL

177

RO
3UHOHYDUHGHVÉQJH
Tehnici de prelevare
6HIDFHGLVWLQFėLHîQWUHGRXÍWHKQLFLGHSUHOHYDUHWHKQLFDSULQDVSLUDėLHēLWHKQLFDSULQYLG
7HKQLFDSULQDVSLUDėLHSHUPLWHRSUHOHYDUHXēRDUÍDVÉQJHOXLFXXQIOX[VDQJXLQFRQWLQXXēLOHQWSULQWUDJHUHDFRQWURODWÍDWLMHLSLVWRQXOXLQDFHVWPRGIOX[XOVDQJXLQSRDWHILDGDSWDWGLUHFWODWRDWHFRPSRUWDPHQWHOHēL
FRQGLėLLOHYHQRDVHLDUKHPROL]DSRDWHILUHGXVÍ
3ULQWUXQWXESUHYLGDWWHKQLFDSULQYLGSHUPLWHSUHOHYDUHDVÉQJHOXLSHED]DSULQFLSLXOXLSUHVLXQLLQHJDWLYHFXXQIOX[VDQJXLQFRQWLQXXēLUDSLG3ULQXUPDUHDFHDVWÍWHKQLFÍHVWHLGHDOÍSHQWUXFRPSRUWDPHQWHOHYHQRDVH
EXQHēLFRQGLėLLOHGHSUHOHYDUHXēRDUH
0DQLSXODUHSHQWUXSUHOHYDUHDGHVÉQJHFRQVXOWDėLGHDVHPHQHDPDWHULDOXOYLGHRSULYLQGPDQLSXODUHD60RQRYHWWH®SULQWHKQLFDSULQDVSLUDėLHVDXWHKQLFDSULQYLGFXFDQXOD6DIHW\UHVSFDQXOD6DIHW\0XOWLIO\®:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood
3857$¯,0i18¬,3(17580,1,0,=$5($5,6&8/8,'((;381(5(3('85$7$5(&2/7i5,,'(6e1*(1. $OHJHėLWXEXO60RQRYHWWH®DGHFYDWSHQWUXSUREDQHFHVDUÍ
2.

$OHJHėL]RQDSRWULYLWÍSHQWUXîPSXQJHUHDYHQHL3HQWUXSUHJÍWLUHD]RQHLGHîPSXQJHUHDYHQHLYÍUXJÍPUHVSHFWDėLGLUHFWLYHOHXQLWÍėLLGYVPHGLFDOH

3UHOHYDUHDGHVÉQJHSULQWHKQLFDSULQDVSLUDėLH$WHQėLH)RORVLėL60RQRYHWWH®QXPDLSHQWUXSUHOHYDUHDGHVÉQJHēLQXSHQWUXLQMHFWDUH
A se utiliza numai cu aceste canule (S-Monovette® canule (Safety) sau canule (Safety-)Multifly®/adaptoare pentru S-Monovette®).
$LFLVHSUH]LQWÍXWLOL]DUHDFXFDQXOD6DIHW\clic,PHGLDWîQDLQWHGHîPSXQJHUHDYHQHLîPSLQJHėL60RQRYHWWH® în suportul integrat al canulei Safety ēLEORFDėLWXEXOîQSR]LėLHSULQURWLUHXēRDUÍîQVHQVRUDU .
'DFÍHVWHQHFHVDUDSOLFDėLXQJDURXGHFRQVWULFėLHSHQWUXYHQÍ PD[PLQXW 3UHJÍWLėL]RQDGHîPSXQJHUHFXXQDJHQWGH]LQIHFWDQWDGHFYDW1XPDLDWLQJHėL]RQDGHîPSXQJHUHDYHQHLGXSÍGH]LQIHFWDUH$ēH]DėLSDFLHQWXODVWIHOîQFÉWVÍDYHėLDFFHVXēRUODYHQDDFHVWXLDēLRULHQWDėLEUDėXOVDXDOWH]RQHGHSXQFėLHDOHSDFLHQWXOXLîQMRV6FRDWHėLSURWHFėLDSHQWUXDFPSXQJHėLYHQDUHWUDJHėLOHQWEDUDSLVWRQXOXLēLGHVIDFHėLJDURXOîQWLPSFHVÉQJHOHFXUJHîQWXEXO60RQRYHWWH®
$ēWHSWDėLSÉQÍVHRSUHēWHIOX[XOVDQJYLQSHQWUXDSHUPLWHDVWIHORXPSOHUHFRUHFWÍ.

0LēFDėL60RQRYHWWH® prin URWLUHXēRDUÍîQVHQVRUDU ēLDSRLVFRDWHėL GHFRQHFWDėL UHFLSLHQWXOGLQFDQXOD6DIHW\ &DQXOD6DIHW\UÍPÉQHîQYHQÍ/DSUHOHYÍULPXOWLSOHVHFRQHFWHD]ÍDēDFXPHVWHGHVFULVPDLVXVSLHVHOH60RQRYHWWHXUPÍWRDUHFXFDQXOD6DIHW\ēLVHSUHOHYHD]ÍSUREHOHXUPÍWRDUH
)LQDOL]DUHDSUHOHYÍULLGHVÉQJH'HFRQHFWDėLPDLîQWÉL60RQRYHWWH®
+ DSRLVFRDWHėLFDQXOD6DIHW\GLQYHQÍ3ULQWHKQLFDIRORVLULLXQHLVLQJXUHPÉLQLDFWLYDėLSURWHFėLDSHQWUXDFILHSHRVXSUDIDėÍVWDELOÍSODQÍSÉQÍFÉQGFDQXODVHîQFOLFKHWHD]ÍîQSR]LėLHSULQWUXQŚFOLFŘSDOSDELOēLDXGLELOîQSURWHFėLDSHQWUXDF DFWLYDUH ILHSULQDSÍVDUHDFXGHJHWXODUÍWÍWRUSHFDSÍWXOGHMRVDOSURWHFėLHLDFXOXLFRQVXOWDėLGH
DVHPHQHDLQVWUXFėLXQLOHGHXWLOL]DUHSHQWUXFDQXOD 6DIHW\ 60RQRYHWWH® sau canula (Safety-)Multifly®.
Fiecare S-Monovette®WUHEXLHîQWRUVRGDWÍFXFDSXOîQMRVGLUHFWGXSÍGHFRQHFWDUHDGHODFDQXOD6DIHW\LDUGXSÍILQDOL]DUHDFRPSOHWÍDSUHOHYÍULLVÉQJHOXLWRDWHSUREHOHFXDQWLFRDJXODQėLWUHEXLHîQWRDUVHFXJULMÍFXFDSXOîQMRVGHPDLPXOWHRUL
3HQWUXWUDQVSRUWēLFHQWULIXJDUHWUDJHėLEDUDSLVWRQXOXLFXXQFOLFDXGLELOîQSR]LėLDGHîQFOLFKHWDUHDSLVWRQXOXL  SLVWRQXOVHEORFKHD]ÍîQSR]LėLHSHIXQGXOUHFLSLHQWXOXL60RQRYHWWH® ēLUXSHėLEDUDSLVWRQXOXL.
1.

7DPSRQDėL]RQDGHîPSXQJHUHFXXQWDPSRQXVFDWēLDVHSWLFSÉQÍFÉQGKHPRUDJLDVHRSUHēWH

2.

'HîQGDWÍFHVHFRDJXOHD]ÍVÉQJHOHDSOLFDėLXQSODVWXUHGDFÍSDFLHQWXOGRUHēWHDFHVWOXFUX3.

$UXQFDėLFDQXOD6DIHW\îQWUXQUHFLSLHQWDGHFYDWSHQWUXGHēHXULFXULVFELRORJLF

178

RO
3UHOHYDUHDGHVÉQJHSULQWHKQLFDSULQYLG
$WHQėLH)RORVLėL60RQRYHWWH®QXPDLSHQWUXSUHOHYDUHDGHVÉQJHēLQXSHQWUXLQMHFWDUH
A se utiliza numai cu aceste canule (S-Monovette® canule (Safety) sau canule (Safety-)Multifly®/adaptoare pentru S-Monovette®).
$LFLVHSUH]LQWÍXWLOL]DUHDFXFDQXOD6DIHW\clic

3HQWUXDîQFHSHUHFROWDUHDVÉQJHOXLîQWUXQPRGPHQDMDQW6$567('7UHFRPDQGÍSUHOHYDUHDSULPXOXLWXE60RQRYHWWH®SULQWHKQLFDGHDVSLUDUHFRQVXOWDėL7(+1,&$'(0381*(5($9(1(,7HKQLFDGH
aspirare– .
&RQWLQXDėLDSRLFXWHKQLFDSULQYLGQDLQWHGHUHFROWDUHDVÉQJHOXLWUDJHėLSLVWRQXOFXDMXWRUXOEDUHLSLVWRQXOXLSÉQÍODIXQGXOWXEXOXL60RQRYHWWH®ēLOÍVDėLSLVWRQXOVÍVHîQFOLFKHWH]HDXGLELO îQSR]LėLH$SRLUXSHėLEDUDSLVWRQXOXL .
PSLQJHėLDFHVWWXE60RQRYHWWH®SUHJÍWLWîQVXSRUWXOLQWHJUDWDOFDQXOHL6DIHW\SHQWUX60RQRYHWWH®ēLEORFDėLUHFLSLHQWXOîQSR]LėLHSULQURWLUHXēRDUÍîQVHQVRUDU+.

$ēWHSWDėLSÉQÍVHRSUHēWHIOX[XOVDQJYLQSHQWUXDSHUPLWHDVWIHORXPSOHUHFRUHFWÍ

0LēFDėL60RQRYHWWH® prin URWLUHXēRDUÍîQVHQVRUDU ēLDSRLVFRDWHėL GHFRQHFWDėL UHFLSLHQWXOGLQFDQXOD6DIHW\ &DQXOD6DIHW\UÍPÉQHîQYHQÍ/DSUHOHYÍULPXOWLSOHVHFRQHFWHD]ÍDēDFXPHVWHGHVFULVPDLVXVSLHVHOH0RQRYHWWH6XUPÍWRDUHFXFDQXOD6DIHW\ēLVHSUHOHYHD]ÍSUREHOHXUPÍWRDUH
)LQDOL]DUHDSUHOHYÍULLGHVÉQJH'HFRQHFWDėLPDLîQWÉL60RQRYHWWH® + DSRLVFRDWHėLFDQXOD6DIHW\GLQYHQÍ&XWHKQLFDIRORVLULLXQHLVLQJXUHPÉLQLDFWLYDėLSURWHFėLDSHQWUXDFILHSHRVXSUDIDėÍVWDELOÍSODQÍSÉQÍFÉQGFDQXODVHîQFOLFKHWHD]ÍîQSR]LėLHFXXQŚFOLFŗVHQVLELOēLDXGLELOîQSURWHFėLDSHQWUXDF DFWLYDUH VDXSULQDSÍVDUHDFXGHJHWXODUÍWÍWRUSHFDSÍWXOGHMRVDOSURWHFėLHLDFXOXLFiecare S-Monovette®WUHEXLHîQWRUVRGDWÍFXFDSXOîQMRVGLUHFWGXSÍGHFRQHFWDUHDGHODFDQXOD6DIHW\LDUGXSÍILQDOL]DUHDFRPSOHWÍDSUHOHYÍULLVÉQJHOXLWRDWHSUREHOHFXDQWLFRDJXODQėLWUHEXLHîQWRDUVHFXJULMÍFXFDSXOîQMRVGHPDLPXOWHRUL
1.

7DPSRQDėL]RQDGHîPSXQJHUHFXXQWDPSRQXVFDWēLDVHSWLFSÉQÍFÉQGKHPRUDJLDVHRSUHēWH

2.

'HîQGDWÍFHVHFRDJXOHD]ÍVÉQJHOHDSOLFDėLXQSODVWXUHGDFÍSDFLHQWXOGRUHēWHDFHVWOXFUX3.

$UXQFDėLFDQXOD6DIHW\îQWUXQUHFLSLHQWDGHFYDWSHQWUXGHēHXULFXULVFELRORJLF

179

RO
Centrifugare$7(1¯,(7XEXULOH60RQRYHWWH6$567('7VXQWFRQFHSXWHSHQWUX[J)DFH[FHSėLHWXEXULOH60RQRYHWWHFX¢PP 60RQRYHWWH®SHQWUXSHGLDWULH FDUHVXQWYDOLGDWHDFWXDOSÉQÍOD[J7UHEXLH
XWLOL]DWHQXPDLWXEXULGHVXSRUWVDXLQVHUėLLDGHFYDWH&HQWULIXJDUHDWXEXULORU60RQRYHWWHFXILVXULVDXFHQWULIXJDUHDODRDFFHOHUDėLHGHFHQWULIXJDUHSUHDPDUHSRDWHGXFHODVSDUJHUHDWXEXULORU60RQRYHWWHLDUDVWIHOOD
HOLEHUDUHDGHPDWHULDOSRWHQėLDOLQIHFėLRV/RFDēXULOHGHSR]LėLRQDUHGLQFHQWULIXJÍWUHEXLHDOHVHFRQIRUPPÍULPLLWXEXULORU60RQRYHWWH)RUėDFHQWULIXJÍUHODWLYÍVHDIOÍîQUDSRUWXOXUPÍWRUIDėÍGHQXPÍUXOUHJODWGHURWDėLLSHPLQXW
RCF = 11,2 x r x (rpm/1000)2,
5&)ŚIRUėDFHQWULIXJÍUHODWLYÍŘGHQXPLWÍēLŚIRUėDJŘ HQJOH]Í5&)ŚUHODWLYHFHQWULIXJDOIRUFHŘ 
Ś8S0ŘŚURWDėLHSHPLQXWŘ PLQ VDXQ ŚWXUDėLHSHPLQXWŘ HQJOH]Í530ŚUHYROXWLRQVSHUPLQXWHŘ ŚUŘŚUD]DGHFHQWULIXJDUHGHODPLMORFXOFHQWULIXJHLSÉQÍODIXQGXOWXEXOXL0RQRYHWWH6®”, (cm).
7XEXULOH60RQRYHWWHIÍUÍJHOSRWILFHQWULIXJDWHîQFHQWULIXJHFXURWRUFXXQJKLIL[VDXFXURWRUGHEDODQV
7XEXULOH60RQRYHWWHFXJHOVXQWFRQFHSXWHQXPDLSHQWUXFHQWULIXJHOHFXURWRUGHEDODQV&HQWULIXJDUHDîQFHQWULIXJHFXURWRUFXXQJKLIL[QXHVWHYDOLGDWÍGHFÍWUH6$567('7ēLQXHVWHUHFRPDQGDWÍ
7XEXULOH60RQRYHWWHWUHEXLHFHQWULIXJDWHFRQIRUPFRQGLėLLORUGHFHQWULIXJDUHHQXPHUDWHPDLMRV'DFÍVHXWLOL]HD]ÍDOWHFRQGLėLLDFHVWHDWUHEXLHYDOLGDWHGHFÍWUHXWLOL]DWRU
6HYDDVLJXUDSR]LėLDFRUHFWÍēLSRWULYLWÍDWXEXULORU60RQRYHWWHîQORFDēXULOHGHSR]LėLRQDUHDOHFHQWULIXJHL7XEXULOH60RQRYHWWHFDUHLHVîQDIDUDORFDēXOXLVHSRWDJÍėDGHFDSXOFHQWULIXJHLēLVHSRWVSDUJH6HYD
DVLJXUDXPSOHUHDXQLIRUPÍDFHQWULIXJHLQDFHVWVHQVYÍUXJÍPUHVSHFWDėLLQVWUXFėLXQLOHGHXWLOL]DUHDOHFHQWULIXJHL
$7(1¯,21$5( 1X VFRDWHėL FX PÉQD WXEXULOH VSDUWH 60RQRYHWWH
,QGLFDėLL SULYLQG GH]LQIHFWDUHD FHQWULIXJHL VH JÍVHVF îQ LQVWUXFėLXQLOH GH XWLOL]DUH DOH FHQWULIXJHL

Conform BS
4851+ (codulUE)

DFFHOHUDėLDFHQWULIXJÍUHODWLYÍ J
S-Monovette®

DIN EN ISO 6710–

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*ser

10 min10 min

6 min

4 min

4 min

ser-gel15 min10 min

4 min

4 min

4 min

6HUH[SUHVēLJHO

15 min10 min

4 min

n.v.

n.v.

OLWLXKHSDULQÍ

10 min10 min

7 min

7 min

7 min

OLWLXKHSDULQÍJHO

15 min15 min10 min

7 min

7 min

OLWLXKHSDULQÍJHO+

8 min

7 min

5 min

4 min

4 min

EDTA

n.v.

n.v.

7 min

6 min

5 min

('7$ēLJHO

15 min10 min10 min

7 min

7 min

citrat

9 min

8 min

7 min

6 min

5 min

('7$KHSDULQÍFXĲXRUXUÍ

9 min

8 min

7 min

6 min

5 min

GlucoEXACT

9 min

8 min

7 min

6 min

5 min

citrat PBM 1,8 ml
raza centrifugei > 17 cm

9 min

8 min

7 min

6 min

5 min

citrat PBM 1,8 ml
UD]DFHQWULIXJHL!GHODSÉQÍODƉ
17 cm

n.v.

n.v.

10 minn.v.

n.v.

n.v. = nevalidat
YDODELOSHQWUXWRDWHWXEXULOH60RQRYHWWHFXH[FHSėLD¢PP WXEXUL60RQRYHWWHSHQWUXSHGLDWULH

Centrifugare la 20 °C+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, retras.

,QIRUPDėLLGHVSUHPDWHULDOXOVHSDUDWRU
3URSULHWÍėLOHGHFXUJHUHDOHPDWHULDOXOXLVHSDUDWRU JHO VXQWîQIXQFėLHGHWHPSHUDWXUÍ'DFÍ60RQRYHWWHVXQWUÍFLWHîQDLQWHDVDXîQWLPSXOFHQWULIXJÍULLQXVHPDLDVLJXUÍXQVWUDWFRQWLQXXDOJHOXOXLVHSDUDWRU
1XHVWHSHUPLVÍUHSHWDUHDFHQWULIXJÍULLUHFHQWULIXJDUHDWXEXULORU60RQRYHWWH

(OLPLQDUHFDGHēHX
1.

7UHEXLHUHVSHFWDWHēLXUPDWHGLUHFWLYHOHJHQHUDOHGHLJLHQÍēLGLVSR]LėLLOHOHJDOHSULYLQGHOLPLQDUHDFRUHFWÍFDGHēHXULDPDWHULDOHORULQIHFėLRDVH

2.

0ÍQXēLOHGHXQLFÍIRORVLQėÍSUHYLQULVFXOGHLQIHFėLH

3.

6LVWHPHOHGHUHFROWDUHDVÉQJHOXLFRQWDPLQDWHVDXXPSOXWHWUHEXLHDUXQFDWHîQUHFLSLHQWHDGHFYDWHSHQWUXHOLPLQDUHDVXEVWDQėHORUELRORJLFHSHULFXORDVHFDUHSRWıXOWHULRUDXWRFODYL]DWHēLLQFLQHUDWH

4.

(OLPLQDUHDFDGHēHXWUHEXLHVÍDLEÍORFîQWUXQLQFLQHUDWRUDGHFYDWVDXîQDXWRFODYÍ VWHULOL]DUHFXDEXU 

180

RO
6WDQGDUGHēLGLUHFWLYHVSHFLıFHSURGXVXOXLîQYHUVLXQHDUHVSHFWLYÍYDODELOÍCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Standard privind recipientele pentru prelevarea de sânge din vene:',1(1,625HFLSLHQWHGHXQLFÍIRORVLQėÍSHQWUXSUHOHYDUHDGHVÉQJHYHQRVODRP*CLSI (Clinical and Laboratory Standards Institute)/HJHQGDVLPEROXULORUēLDPDUFDMHORU

1XPÍUDUWLFRO6XSOLPHQWDUSHQWUXSURGXVHOHDPEDODWHLQGLYLGXDOVWHULOVHDSOLFÍ

Denumire lot$QXVHIRORVLGDFÍDPEDODMXOHVWHGHWHULRUDW

8WLOL]DELOSÉQÍOD

6LVWHPFXEDULHUÍVWHULOÍXQLFÍFXDPEDODMGHSURWHFėLHH[WHULRUMarcaj CE

Sterilizare prin iradiere

Diagnostic in-vitro

5HVSHFWDėLLQVWUXFėLXQLOHGHXWLOL]DUH

La reutilizare: Pericol de contaminare$VHSÍVWUDIHULWGHOXPLQDVRDUHOXLA se depozita într-un loc uscat

3URGXFÍWRU

¯DUDGHIDEULFDėLH&LUFXLWVWHULOGHĲXLGHA nu se resteriliza

6XEUH]HUYDPRGLILFÍULORUWHKQLFH
7RDWHLQFLGHQWHOHJUDYHOHJDWHGHSURGXVWUHEXLHVÍILHDQXQėDWHDWÉWSURGXFÍWRUXOXLFÉWēLDXWRULWÍėLLQDėLRQDOHFRPSHWHQWH

181ȤɉɍɎɌɏɆɒɄɛɋɊɋɌɄɈɁɉɁɉɄɚşȭɄɍɎɁɈȼȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH® SARSTEDT

RUȠɇɛɄɍɋɊɇɘɃɊȾȼɉɄɛȾin vitroɀɄȼȿɉɊɍɎɄɆɁ
ȩȼɃɉȼɓɁɉɄɁ
ȭɄɍɎɁɈɗȾɃɛɎɄɛɆɌɊȾɄɄȿɇɗɄȼɀȼɋɎɁɌɗ60RQRYHWWH®ɄɍɋɊɇɘɃɏɚɎɍɛȾɆȼɓɁɍɎȾɁɆɊɈɋɊɉɁɉɎɊȾɍɄɍɎɁɈɗȾɃɛɎɄɛɋɌɊȽȾɁɉɊɃɉɊɅɆɌɊȾɄȭɄɍɎɁɈɗȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH®ɋɌɁɀɉȼɃɉȼɓɁɉɗɀɇɛȾɃɛɎɄɛ
ɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄɊȽɌȼȽɊɎɆɄɄɑɌȼɉɁɉɄɛɋɌɊȽɆɌɊȾɄɀɇɛin vitroɀɄȼȿɉɊɍɎɄɆɄɉȼɊɍɉɊȾɁɍɗȾɊɌɊɎɆɄɋɇȼɃɈɗɄɇɄɒɁɇɘɉɊɅɆɌɊȾɄȾɆɇɄɉɄɓɁɍɆɊɅɇȼȽɊɌȼɎɊɌɄɄȤɃɀɁɇɄɁɋɌɁɀɉȼɃɉȼɓɁɉɊɀɇɛɄɍɋɊɇɘɃɊȾȼɉɄɛȾ
ɋɌɊɐɁɍɍɄɊɉȼɇɘɉɊɅɍɌɁɀɁɆȾȼɇɄɐɄɒɄɌɊȾȼɉɉɗɈɄɍɊɎɌɏɀɉɄɆȼɈɄɈɁɀɄɒɄɉɍɆɄɑɄɇȼȽɊɌȼɎɊɌɉɗɑɏɓɌɁɂɀɁɉɄɅ

ȪɋɄɍȼɉɄɁɋɌɊɀɏɆɎȼ
ȭɄɍɎɁɈɗȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH®ȾɆɇɚɓȼɚɎȾɍɁȽɛɍɇɁɀɏɚɕɄɁɆɊɈɋɊɉɁɉɎɗɋɇȼɍɎɄɆɊȾȼɛɋɌɊȽɄɌɆȼɋɊɌɔɁɉɘɔɎɊɆɋɊɌɔɉɛɋɇȼɍɎɄɆɊȾȼɛɌɁɃɘȽɊȾȼɛɆɌɗɔɆȼɍɒȾɁɎɊȾɊɅɆɊɀɄɌɊȾɆɊɅɄȾɍɎɌɊɁɉɉɊɅ
ɈɁɈȽɌȼɉɊɅɌȼɃɌȼȽɊɎȼɉɉɊɅɍɋɁɒɄȼɇɘɉɊɀɇɛɍɊɁɀɄɉɁɉɄɛɍȽɁɃɊɋȼɍɉɊɅɄȿɇɊɅ60RQRYHWWH®ɄɇɄȽɁɃɊɋȼɍɉɊɅɄȿɇɊɅȽȼȽɊɓɆɊɅ0XOWLIO\®ȼɋɌɁɀɍɎȼȾɇɁɉɗɍɌȼɃɇɄɓɉɗɈɄɀɊȽȼȾɆȼɈɄȫɌɊȽɄɌɆȼ60RQRYHWWH®
ɎȼɆɂɁɀɊɍɎɏɋɉȼȽɁɃɀɊȽȼȾɊɆȦɊɉɒɁɉɎɌȼɒɄɄɀɊȽȼȾɊɆɊȽɖɁɈɂɄɀɆɊɅɀɊȽȼȾɆɄɄɄɑɀɊɋɏɍɎɄɈɗɁɊɎɆɇɊɉɁɉɄɛȾɍɄɍɎɁɈȼɑȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH®ɍɀɊȽȼȾɆȼɈɄ ȼɆɎɄȾȼɎɊɌɍȾɁɌɎɗȾȼɉɄɛȼɆɎɄȾȼɎɊɌ
ɍȾɁɌɎɗȾȼɉɄɛɄȿɁɇɘɇɄɎɄɅȿɁɋȼɌɄɉɇɄɎɄɅȿɁɋȼɌɄɉɄȿɁɇɘɉȼɎɌɄɅȿɁɋȼɌɄɉɒɄɎɌȼɎȹȠȮȜɐɎɊɌɄɀȹȠȮȜɐɎɊɌɄɀȿɁɋȼɌɄɉɐɎɊɌɄɀɒɄɎɌȼɎ&3'$ȼɎȼɆɂɁȽɁɃɀɊȽȼȾɊɆ ȼɎȼɆɂɁɍɊɊɎɉɊɔɁɉɄɁɆɌɊȾɄɄ
ɀɊȽȼȾɆɄɋɌɄɄɍɋɊɇɘɃɊȾȼɉɄɄɀȼɉɉɗɑɍɄɍɎɁɈȾɃɛɎɄɛɆɌɊȾɄɏɀɊȾɇɁɎȾɊɌɛɚɎɎɌɁȽɊȾȼɉɄɛɈɄɌɁɆɊɈɁɉɀȼɒɄɛɈɈɁɂɀɏɉȼɌɊɀɉɊȿɊɍɎȼɉɀȼɌɎȼ',1(1,626LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQȼɎȼɆɂɁɏɎȾɁɌɂɀɁɉɉɗɈɍɎȼɉɀȼɌɎȼɈȤɉɍɎɄɎɏɎȼɆɇɄɉɄɓɁɍɆɄɑɄɇȼȽɊɌȼɎɊɌɉɗɑɍɎȼɉɀȼɌɎɊȾ &/6, ȞɗȽɊɌɀɊȽȼȾɆɄɃȼȾɄɍɄɎɊɎɈɁɎɊɀȼȼɉȼɇɄɎɄɓɁɍɆɊȿɊɄɍɍɇɁɀɊȾȼɉɄɛȠȼɉɉɗɅɈɁɎɊɀɊɋɌɁɀɁɇɛɁɎɍɛ
ɋɌɊɄɃȾɊɀɄɎɁɇɁɈɎɁɍɎɊȾɊȿɊɌɁȼȿɁɉɎȼɄɄɇɄɋɌɄȽɊɌȼȼɉȼɇɄɃȼɎɊɌȼȾɆɊɎɊɌɊɈɋɌɊȾɊɀɄɎɍɛɎɁɍɎȭɄɍɎɁɈȼȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH®ɈɊɂɁɎɋɊɍɎȼȾɇɛɎɘɍɛɆȼɆȾȾɄɀɁɍɎɁɌɄɇɘɉɊȿɊȾɉɏɎɌɄɄɃɀɁɇɄɛɎȼɆɄȾ
ɄɉɀɄȾɄɀɏȼɇɘɉɊɅɏɋȼɆɊȾɆɁɀɇɛɍɊȽɇɚɀɁɉɄɛȾɉɁɔɉɁɅɄȾɉɏɎɌɁɉɉɁɅɍɎɁɌɄɇɘɉɊɍɎɄ

ȲȾɁɎɊȾɗɁɆɊɀɗɌɁɃɘȽɊȾɗɑɆɌɗɔɁɆ 60RQRYHWWH®:ȠɊȽȼȾɆȼ

ȝɏɆȾɁɉɉɗɅɆɊɀ

ȲȾɁɎɊȾȼɛɆɊɀɄɌɊȾɆȼ
ɆɌɗɔɁɆɍɊȿɇȼɍɉɊ
DIN EN ISO 6710

ȲȾɁɎɊȾȼɛɆɊɀɄɌɊȾɆȼ
ɆɌɗɔɁɆɍɊȿɇȼɍɉɊ
BS 4851+

Z

ȽɁɇɗɅ

ȽɁɇɗɅ

ȫɌɊȽɄɌɆȼȽɁɃɀɊȽȼȾɆɄ
S-Monovette®ɉɁɅɎɌȼɇɘɉȼɛ=ȫɌɊȽɄɌɆȼɍȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛ
S-Monovette®ȭɗȾɊɌɊɎɆȼ&$7ɍȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛ

CATɆɌȼɍɉɗɅ

ȽɁɇɗɅS-Monovette®ȭɗȾɊɌɊɎɆȼȿɁɇɘ&$7ɍȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛɄȿɁɇɁɈ

CATɎɁɈɉɊɂɁɇɎɗɅ

ɎɁɈɉɊɂɁɇɎɗɅ

S-Monovette®ȭɗȾɊɌɊɎɆȼəɆɍɋɌɁɍɍȿɁɇɘ&$7ɍȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛ ɎɌɊɈȽɄɉ ɄȿɁɇɁɈ

CATɊɌȼɉɂɁȾɗɅ

-S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉ/+ɍɇɄɎɄɅȿɁɋȼɌɄɉɊɈ

LHɃɁɇɁɉɗɅ

ɊɌȼɉɂɁȾɗɅ

S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉɂɄɀɆɄɅ/+ɍɂɄɀɆɄɈɇɄɎɄɅȿɁɋȼɌɄɉɊɈ

LHɃɁɇɁɉɗɅ

ɊɌȼɉɂɁȾɗɅ

S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ɍɇɄɎɄɅȿɁɋȼɌɄɉɊɈɄȿɁɇɁɈ

LHɃɁɇɁɉɗɅ

ɊɌȼɉɂɁȾɗɅ

S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ+/+ɍɇɄɎɄɅȿɁɋȼɌɄɉɊɈɄȿɁɇɁɈȽɗɍɎɌɊȿɊ
ɀɁɅɍɎȾɄɛ

LHɃɁɇɁɉɗɅ

ɊɌȼɉɂɁȾɗɅ

S-Monovette ȩȼɎɌɄɅȿɁɋȼɌɄɉ1+ɍɉȼɎɌɄɅȿɁɋȼɌɄɉɊɈ

NHɆɊɌɄɓɉɁȾɗɅ

ɃɁɇɁɉɗɅ

S-Monovette®ȜɈɈɊɉɄɅȿɁɋȼɌɄɉ$+ɍȼɈɈɊɉɄɅȿɁɋȼɌɄɉɊɈ

ɉɊ

ɍɄɉɄɅ

ɍɄɉɄɅ

ȫɌɊȽɄɌɆȼɍȿɁɋȼɌɄɉɊɈ

®

ȫɌɊȽɄɌɆȼɍɒɄɎɌȼɎɊɈ
S-Monovette®ȲɄɎɌȼɎ1&ɒɄɎɌȼɎɉȼɎɌɄɛ

9NC

ɍɄɉɄɅ

ɃɁɇɁɉɗɅ

S-Monovette®3)$ȲɄɎɌȼɎ1&ɒɄɎɌȼɎɉȼɎɌɄɛɃȼȽɏɐɁɌɁɉɉɗɅ

9NC

ȿɊɇɏȽɊɅ

-S-Monovette®.ȹȠȮȜ.(ɍȹȠȮȜ

K3E

ɐɄɊɇɁɎɊȾɗɅ

ɆɌȼɍɉɗɅ

S-Monovette®.ȹȠȮȜ.(ɍȹȠȮȜ

K2E

ɐɄɊɇɁɎɊȾɗɅ

ɆɌȼɍɉɗɅ

S-Monovette .ȹȠȮȜȿɁɇɘ.(ɍȹȠȮȜɄȿɁɇɁɈ

K2E

ɐɄɊɇɁɎɊȾɗɅ

ɆɌȼɍɉɗɅ

S-Monovette®ȰɎɊɌɄɀȹȠȮȜ)(ɍɐɎɊɌɄɀɊɈɄȹȠȮȜ

FE

ɍɁɌɗɅ

ɂɁɇɎɗɅ

S-Monovette®ȰɎɊɌɄɀȿɁɋȼɌɄɉ)+ɍɐɎɊɌɄɀɊɈɄȿɁɋȼɌɄɉɊɈ

FH-

ɂɁɇɎɗɅ

S-Monovette®*OXFR(;$&7)&ɍɐɎɊɌɄɀɊɈɒɄɎɌȼɎɊɈɄȹȠȮȜFCɌɊɃɊȾɗɅ

ɍɁɌɗɅ

LHɎɁɈɉɊɍɄɉɄɅ

ɊɌȼɉɂɁȾɗɅ

ȫɌɊȽɄɌɆȼɍȹȠȮȜ®

ȫɌɊȽɄɌɆȼɍɄɉȿɄȽɄɎɊɌȼɈɄȿɇɄɆɊɇɄɃȼ

ȫɌɊȽɄɌɆȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾ
S-Monovette®ɀɇɛɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾ/+ɍɇɄɎɄɅȿɁɋȼɌɄɉɊɈ

ȠɌɏȿɄɁɋɌɊȽɄɌɆɄɀɇɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ
S-Monovette®7KURPER([DFWɍ0JɍɊɀɁɌɂȼɕɁɅɀɊȽȼȾɆɊɅ

ɉɊɉɊɒȾɁɎȼɁɂɁȾɄɆɄ

ɉɊɒȾɁɎȼɁɂɁȾɄɆɄ

S-Monovette® CTAD

ɉɊɉɊɍɄɉɄɅ

ɉɊɃɁɇɁɉɗɅ

S-Monovette® ACDȜȲȠ ȼɉɎɄɆɊȼȿɏɇɛɉɎɒɄɎɌȼɎ
ɀɁɆɍɎɌɊɃȼ

ɂɁɇɎɗɅ

ɂɁɇɎɗɅ

S-Monovette® CPDAȲȰȠȜ ɒɄɎɌȼɎɐɊɍɐȼɎɀɁɆɍɎɌɊɃȼ
ȼɀɁɉɄɉ

ɂɁɇɎɗɅ

ɂɁɇɎɗɅ
ɉɊɊɇɄȾɆɊȾɊɃɁɇɁɉɗɅ

S-Monovette®ȟɄɌɏɀɄɉ

ɉɊɉɊɊɇɄȾɆɊȾɊɃɁɇɁɉɗɅ

S-Monovette®ȟɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɘɍȿɁɇɁɈɄɍɎȼȽɄɇɄɃȼɎɊɌɊɈ

ɉɊɉɊɍɁɌɗɅ

ɉɊɍɁɌɗɅ

S-Monovette®ȟɊɈɊɒɄɍɎɁɄɉ+&<&ɍɒɄɎɌȼɎɉɗɈȽɏɐɁɌɊɈ

ɉɊɉɊɐɄɊɇɁɎɊȾɗɅ

ɉɊɐɄɊɇɁɎɊȾɗɅ

S-Monovette® DNA ExactɉɊɉɊɍɄɉɄɅ

ɉɊɍɄɉɄɅ

ȬɁɃɘȽɊȾɗɁɆɌɗɔɆɄɎȼɆɂɁɀɊɍɎɏɋɉɗȾɀɌɏȿɄɑɒȾɁɎȼɑ
ɉɊ ɉɁɊɋɌɁɀɁɇɁɉ
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistryɊɎɊɃȾȼɉ

182

RU
SARSTEDT S-Monovette®ȭɗȾɊɌɊɎɆȼȭɗȾɊɌɊɎɆȼȿɁɇɘ&$7
S-Monovette®ȭɗȾɊɌɊɎɆȼ&$7ɍɊɀɁɌɂɄɎȿɌȼɉɏɇɗɍȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛ ɍɄɇɄɆȼɎ ɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɍɗȾɊɌɊɎɆɄ ȞɊȾɌɁɈɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛȿɌȼɉɏɇɗɊȽɌȼɃɏɚɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅ
ɍɇɊɅɈɁɂɀɏɍȿɏɍɎɆɊɈɆɌɊȾɄɄɍɗȾɊɌɊɎɆɊɅȞɀɊɋɊɇɉɁɉɄɁɆȿɌȼɉɏɇȼɈɋɊɆɌɗɎɗɈȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛ ɍɄɇɄɆȼɎ ɋɌɊȽɄɌɆȼȭɗȾɊɌɊɎɆȼȿɁɇɘɍɊɀɁɌɂɄɎɋɊɇɄȼɆɌɄɇɊȾɗɅȿɁɇɘɄɎȼɆɂɁɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛ
ɋɊɇɏɓɁɉɄɛɍɗȾɊɌɊɎɆɄ ȣȼɍɓɁɎɍȾɊɁɅɋɇɊɎɉɊɍɎɄȿɁɇɘɊȽɌȼɃɏɁɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅɍɇɊɅɈɁɂɀɏɍȿɏɍɎɆɊɈɆɌɊȾɄɄɍɗȾɊɌɊɎɆɊɅȾɊȾɌɁɈɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɄɀɁɅɍɎȾɏɁɎɆȼɆȽȼɌɘɁɌȾɊȾɌɁɈɛɑɌȼɉɁɉɄɛɄ
ɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄ
ȭɗȾɊɌɊɎɆȼɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼȾɆɇɄɉɄɆɊɑɄɈɄɓɁɍɆɄɑɄɄɈɈɏɉɊɇɊȿɄɓɁɍɆɄɑɌɏɎɄɉɉɗɑɄɍɍɇɁɀɊȾȼɉɄɛɑȼɎȼɆɂɁȾɍɁɌɊɇɊȿɄɄ
ȫɊɍɇɁȾɃɛɎɄɛɆɌɊȾɄɋɌɊȽɄɌɆɄȭɗȾɊɌɊɎɆȼȭɗȾɊɌɊɎɆȼȿɁɇɘɀɊɇɂɉɗɉȼɑɊɀɄɎɘɍɛȾȾɁɌɎɄɆȼɇɘɉɊɈɋɊɇɊɂɁɉɄɄȾɎɁɓɁɉɄɁɈɄɉɏɎɓɎɊȽɗɊȽɁɍɋɁɓɄɎɘɐɊɌɈɄɌɊȾȼɉɄɁɓɁɎɆɊȿɊɌȼɃɀɁɇɄɎɁɇɘɉɊȿɊɍɇɊɛɋɊɍɇɁ
ɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛ
ȬɁɆɊɈɁɉɀɏɁɈɗɁɃɉȼɓɁɉɄɛȾɌɁɈɁɉɄɌȼɍɍɓɄɎȼɉɗɉȼɋɌɊɒɁɍɍɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɉɁɉȼɌɏɔȼɁɈɗɅȾɉɁɔɉɄɈɄɐȼɆɎɊɌȼɈɄȠɇɛɋɊɇɉɊȿɊɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɋȼɒɄɁɉɎɊȾɄɈɁɚɕɄɑɊȽɏɍɇɊȾɇɁɉɉɗɁ
ɃȼȽɊɇɁȾȼɉɄɛɈɄɉȼɌɏɔɁɉɄɛɍȾɁɌɎɗȾȼɁɈɊɍɎɄɄɇɄɋɌɊɑɊɀɛɕɄɑȼɉɎɄɆɊȼȿɏɇɛɉɎɉɏɚɎɁɌȼɋɄɚɈɊɂɁɎɎɌɁȽɊȾȼɎɘɍɛȽɊɇɘɔɁȾɌɁɈɁɉɄ

S-Monovette®ȭɗȾɊɌɊɎɆȼəɆɍɋɌɁɍɍȿɁɇɘ&$7
ȞɀɊɋɊɇɉɁɉɄɁɆȿɌȼɉɏɇȼɈɋɊɆɌɗɎɗɈȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛ ɍɄɇɄɆȼɎ ɋɌɊȽɄɌɆȼ60RQRYHWWH®ȭɗȾɊɌɊɎɆȼəɆɍɋɌɁɍɍȿɁɇɘ&$7ɍɊɀɁɌɂɄɎɋɊɇɄȼɆɌɄɇɊȾɗɅȿɁɇɘɄɎȼɆɂɁɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛ
ɍɗȾɊɌɊɎɆɄ ȣȼɍɓɁɎɍȾɊɁɅɋɇɊɎɉɊɍɎɄȿɁɇɘɊȽɌȼɃɏɁɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅɍɇɊɅɈɁɂɀɏɍȿɏɍɎɆɊɈɆɌɊȾɄɄɍɗȾɊɌɊɎɆɊɅȾɊȾɌɁɈɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɄɀɁɅɍɎȾɏɁɎɆȼɆȽȼɌɘɁɌȾɊȾɌɁɈɛɑɌȼɉɁɉɄɛɄ
ɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄ
ȫɊɍɇɁȾɃɛɎɄɛɆɌɊȾɄɋɌɊȽɄɌɆɄ60RQRYHWWH®ȭɗȾɊɌɊɎɆȼəɆɍɋɌɁɍɍȿɁɇɘɀɊɇɂɉɗɉȼɑɊɀɄɎɘɍɛȾȾɁɌɎɄɆȼɇɘɉɊɈɋɊɇɊɂɁɉɄɄȾɎɁɓɁɉɄɁɈɄɉɏɎɓɎɊȽɗɊȽɁɍɋɁɓɄɎɘɐɊɌɈɄɌɊȾȼɉɄɁɓɁɎɆɊȿɊɌȼɃɀɁɇɄɎɁɇɘɉɊȿɊ
ɍɇɊɛɋɊɍɇɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛȬɁɆɊɈɁɉɀɏɁɈɗɁɃɉȼɓɁɉɄɛȾɌɁɈɁɉɄɌȼɍɍɓɄɎȼɉɗɉȼɋɌɊɒɁɍɍɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɉɁɉȼɌɏɔȼɁɈɗɅȾɉɁɔɉɄɈɄɐȼɆɎɊɌȼɈɄ ȾɎɊɈɓɄɍɇɁɀɇɛɆɌɊȾɄɋȼɒɄɁɉɎɊȾɋɌɄɉɄɈȼɚɕɄɑ
ȿɁɋȼɌɄɉ ȠɇɛɋɊɇɉɊȿɊɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɋȼɒɄɁɉɎɊȾɄɈɁɚɕɄɑɊȽɏɍɇɊȾɇɁɉɉɗɁɃȼȽɊɇɁȾȼɉɄɛɈɄɉȼɌɏɔɁɉɄɛɍȾɁɌɎɗȾȼɁɈɊɍɎɄɄɇɄɋɌɊɑɊɀɛɕɄɑȼɉɎɄɆɊȼȿɏɇɛɉɎɉɏɚɎɁɌȼɋɄɚȾɆɇɚɓȼɛȿɁɋȼɌɄɉȾȾɗɍɊɆɊɅ
ɀɊɃɄɌɊȾɆɁɎɌɁȽɏɁɎɍɛȽɊɇɘɔɁȾɌɁɈɁɉɄ
ȭɗȾɊɌɊɎɆȼɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼȾɆɇɄɉɄɆɊɑɄɈɄɓɁɍɆɄɑɄɄɈɈɏɉɊɇɊȿɄɓɁɍɆɄɑɌɏɎɄɉɉɗɑɄɍɍɇɁɀɊȾȼɉɄɛɑȼɎȼɆɂɁȾɍɁɌɊɇɊȿɄɄ

SARSTEDT S-Monovette®ɉɁɅɎɌȼɇɘɉȼɛ=S-Monovette®ɉɁɅɎɌȼɇɘɉȼɛ=ɉɁɍɊɀɁɌɂɄɎɀɊȽȼȾɊɆɓɎɊəɆȾɄȾȼɇɁɉɎɉɊɁɍɎɁɍɎȾɁɉɉɊɅɆɊȼȿɏɇɛɒɄɄɊȽɌȼɃɒȼɆɌɊȾɄȽɁɃȼɆɎɄȾȼɎɊɌȼɍȾɁɌɎɗȾȼɉɄɛɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɍɗȾɊɌɊɎɆɄ ȞɌɁɃɏɇɘɎȼɎɁ
ɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɋɌɊɄɍɑɊɀɄɎɌȼɃɀɁɇɁɉɄɁɍȿɏɍɎɆȼɆɌɊȾɄɄɍɗȾɊɌɊɎɆɄ
ȭɗȾɊɌɊɎɆȼɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɈȼɎɁɌɄȼɇȼɀɇɛȼɉȼɇɄɃɊȾɍɋɁɒɄɐɄɓɉɗɑɀɇɛɆɊɉɆɌɁɎɉɊȿɊɋɊɇɘɃɊȾȼɎɁɇɛ
ȦɌɊɈɁɎɊȿɊɋɌɊȽɄɌɆɏ60RQRYHWWH®ɉɁɅɎɌȼɇɘɉȼɛ=ɈɊɂɉɊɄɍɋɊɇɘɃɊȾȼɎɘȾɆȼɓɁɍɎȾɁɋɏɍɎɊɅɋɌɊȽɄɌɆɄɁɍɇɄɋɌɊɒɁɀɏɌȼȾɃɛɎɄɛɆɌɊȾɄɀɊɇɂɉȼɉȼɓɄɉȼɎɘɍɛɍɍɍɄɍɎɁɈɗ60RQRYHWWH®ȲɄɎɌȼɎȾɍɊɓɁɎȼɉɄɄɍ
ɄȿɇɊɅȽȼȽɊɓɆɊɅ 6DIHW\ 0XOWLIO\®ɎɊɋɌɊȽɄɌɆȼ60RQRYHWWH®ɉɁɅɎɌȼɇɘɉȼɛ=ɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɋɁɌȾɊɅ ɋɏɍɎɊɅ ɋɌɊȽɄɌɆɄɀɇɛɃȼɋɊɇɉɁɉɄɛɋɏɍɎɊȿɊɋɌɊɍɎɌȼɉɍɎȾȼɆȼɎɁɎɁɌȼɄȿɇɗȽȼȽɊɓɆɄ 6DIHW\ 0XOWLIO\®.

SARSTEDT S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉ/+ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ȩȼɎɌɄɅȿɁɋȼɌɄɉ1+ȜɈɈɊɉɄɅȿɁɋȼɌɄɉ$+S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ȩȼɎɌɄɅȿɁɋȼɌɄɉ1+ȜɈɈɊɉɄɅȿɁɋȼɌɄɉ$+ɍɊɀɁɌɂɄɎȿɌȼɉɏɇɗɋɊɆɌɗɎɗɁȼɉɎɄɆɊȼȿɏɇɛɉɎɊɈɇɄɎɄɅȿɁɋȼɌɄɉɊɈɉȼɎɌɄɅȿɁɋȼɌɄɉɊɈȼɈɈɊɉɄɅȿɁɋȼɌɄɉɊɈ
ɊȽɗɓɉɊȨȡɈɇɆɌɊȾɄ ɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ ȞɌɁɃɏɇɘɎȼɎɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛȿɌȼɉɏɇɗɊȽɌȼɃɏɚɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅɍɇɊɅɈɁɂɀɏɆɇɁɎɆȼɈɄɆɌɊȾɄɄɋɇȼɃɈɊɅ
Ȟ60RQRYHWWH®ȧɄɎɄɅȿɁɋȼɌɄɉɂɄɀɆɄɅ/+ȽɁɃȿɌȼɉɏɇȼɉɎɄɆɊȼȿɏɇɛɉɎɇɄɎɄɅȿɁɋȼɌɄɉɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈȾɆȼɋɁɇɘɉɊɈȾɄɀɁ ɆȼɆɋɌȼȾɄɇɊȨȡɈɇɆɌɊȾɄ ȞɀɊɋɊɇɉɁɉɄɁɆȿɌȼɉɏɇȼɈɋɊɆɌɗɎɗɈȼɉɎɄɆɊȼȿɏɇɛɉɎɊɈɇɄɎɄɅȿɁɋȼɌɄɉɊɈ ɆȼɆɋɌȼȾɄɇɊȨȡɈɇɆɌɊȾɄ 60RQRYHWWH®ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ɍɊɀɁɌɂɄɎɋɊɇɄȼɆɌɄɇɊȾɗɅȿɁɇɘɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛ
ɋɇȼɃɈɗ ȣȼɍɓɁɎɍȾɊɁɅɋɇɊɎɉɊɍɎɄȿɁɇɘɊȽɌȼɃɏɁɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅɍɇɊɅɈɁɂɀɏɆɇɁɎɆȼɈɄɆɌɊȾɄɄɋɇȼɃɈɊɅȾɊȾɌɁɈɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɄɀɁɅɍɎȾɏɁɎɆȼɆȽȼɌɘɁɌȾɊȾɌɁɈɛɑɌȼɉɁɉɄɛɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄɄ
ȼɉȼɇɄɃȼ
ȦɌɊɈɁɎɊȿɊȾɍɊɍɎȼȾ60RQRYHWWH®ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ȾɑɊɀɄɎɋɊɇɄȼɆɌɄɇɊȾɗɅȿɁɇɘɋɊɃȾɊɇɛɚɕɄɅɍɊɆɌȼɎɄɎɘȾɌɁɈɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɋɌɄȽɇɉȼɋɊɍɌȼȾɉɁɉɄɚɍ60RQRYHWWH®ȧɄɎɄɅȿɁɋȼɌɄɉ
ȿɁɇɘ/+ȫɇȼɃɈȼɍȿɁɋȼɌɄɉɊɈɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼȾɆɇɄɉɄɆɊɑɄɈɄɓɁɍɆɄɑɄɄɈɈɏɉɊɇɊȿɄɓɁɍɆɄɑɌɏɎɄɉɉɗɑɄɍɍɇɁɀɊȾȼɉɄɛɑȲɁɇɘɉȼɛɆɌɊȾɘɍȿɁɋȼɌɄɉɊɈɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼȾɆɇɄɉɄɆɊ
ɑɄɈɄɓɁɍɆɄɑɌɏɎɄɉɉɗɑɄɍɍɇɁɀɊȾȼɉɄɛɑȼɎȼɆɂɁȾɍɁɌɊɇɊȿɄɄ
ȟɁɋȼɌɄɉɋɊɀȼȾɇɛɁɎɍȾɁɌɎɗȾȼɉɄɁȼɆɎɄȾɄɌɏɛȼɉɎɄɎɌɊɈȽɄɉ
ȫȬȤȨȡȳȜȩȤȡɉɁɀɊɋɏɍɆȼɁɎɍɛɋɌɊȾɊɀɄɎɘɄɃɈɁɌɁɉɄɛɇɄɎɄɛɍɋɊɈɊɕɘɚ60RQRYHWWH®ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ/+ɉɁɀɊɋɏɍɆȼɁɎɍɛɋɌɊȾɊɀɄɎɘɄɃɈɁɌɁɉɄɛɉȼɎɌɄɛɍ
ɋɊɈɊɕɘɚ60RQRYHWWH®ȩȼɎɌɄɅȿɁɋȼɌɄɉ1+ɄɉɁɀɊɋɏɍɆȼɁɎɍɛɋɌɊȾɊɀɄɎɘɄɃɈɁɌɁɉɄɛȼɈɈɊɉɄɛɍɋɊɈɊɕɘɚ60RQRYHWWH®ȜɈɈɊɉɄɅȿɁɋȼɌɄɉ$+ȣȼɋɊɇɉɁɉɉɗɁȾɁɉɊɃɉɊɅɆɌɊȾɘɚɋɌɊȽɄɌɆɄ
S-Monovette®ȧɄɎɄɅȿɁɋȼɌɄɉȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘȩȼɎɌɄɅȿɁɋȼɌɄɉȜɈɈɊɉɄɅȿɁɋȼɌɄɉɉɁɋɌɄȿɊɀɉɗɀɇɛȼɉȼɇɄɃȼȿȼɃɊȾɆɌɊȾɄ

SARSTEDT S-Monovette®ɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾ
S-Monovette®ɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɇɄɎɄɅȿɁɋȼɌɄɉɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ ȧɄɎɄɅȿɁɋȼɌɄɉɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈȾɆȼɋɁɇɘɉɊɈȾɄɀɁ ɆȼɆɋɌȼȾɄɇɊȨȡɈɇɆɌɊȾɄ ȲɁɇɘɉȼɛɆɌɊȾɘɍȿɁɋȼɌɄɉɊɈɄɇɄɋɇȼɃɈȼɍȿɁɋȼɌɄɉɊɈɄɃ60RQRYHWWH®ɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾȾɍɊɓɁɎȼɉɄɄɍɊɍɋɁɒɄȼɇɘɉɊɅȽɁɃɊɋȼɍɉɊɅɄȿɇɊɅ*[Ź ȦȼɎǂ ɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁ
ɈȼɎɁɌɄȼɇȼɀɇɛɄɍɍɇɁɀɊȾȼɉɄɅɉȼɍɊɀɁɌɂȼɉɄɁɈɄɆɌɊəɇɁɈɁɉɎɊȾɈɁɎȼɇɇɊȾȭɊɀɁɌɂȼɉɄɁɈɄɆɌɊəɇɁɈɁɉɎɊȾɈɁɎȼɇɇɊȾɋɊɀɎȾɁɌɂɀȼɁɎɍɛɍɋɊɈɊɕɘɚȼɎɊɈɉɊȼȽɍɊɌȽɒɄɊɉɉɊɅɍɋɁɆɎɌɊɈɁɎɌɄɄ ȜȜȭ ȠɇɛɍɄɍɎɁɈɗ
ȽɁɃɊɋȼɍɉɗɑɄȿɇɄ60RQRYHWWH®ɀɇɛȼɉȼɇɄɃȼɉȼɍɊɀɁɌɂȼɉɄɁɈɁɎȼɇɇɊȾɏɍɎȼɉɊȾɇɁɉɗɍɇɁɀɏɚɕɄɁɈȼɆɍɄɈȼɇɘɉɗɁɃɉȼɓɁɉɄɛɑɊɇɊɍɎɊɅɋɌɊȽɗȾɉȿɍɄɍɎɁɈɏɀɇɛəɎɄɑɈɄɆɌɊəɇɁɈɁɉɎɊȾ

ȹɇɁɈɁɉɎ

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

ɉȿɍɄɍɎɁɈɏ

2,5

1,5

8,0

5,0

5

50

70

70

10

40

Se

Hg

10

10

ȨȼɆɍɄɈȼɇɘɉɗɁɃɉȼɓɁɉɄɛɑɊɇɊɍɎɊɅɋɌɊȽɗɀɇɛɆȼɂɀɊȿɊəɇɁɈɁɉɎȼɏɆȼɃȼɉɗɉȼəɎɄɆɁɎɆɁ60RQRYHWWH .
®

ȪɋɌɁɀɁɇɁɉɄɁɈɄɆɌɊəɇɁɈɁɉɎɊȾȾɗɋɊɇɉɛɁɎɍɛȾɒɁɇɘɉɊɅɆɌɊȾɄɍȿɁɋȼɌɄɉɊɈɄɇɄȾɋɇȼɃɈɁɍȿɁɋȼɌɄɉɊɈȾɃȼȾɄɍɄɈɊɍɎɄɊɎɈɁɎɊɀȼȼɉȼɇɄɃȼ
ȟɁɋȼɌɄɉɋɊɀȼȾɇɛɁɎɍȾɁɌɎɗȾȼɉɄɁȼɆɎɄȾɄɌɏɛȼɉɎɄɎɌɊɈȽɄɉ

SARSTEDT S-Monovette®ȲɄɎɌȼɎ1&
S-Monovette®ȲɄɎɌȼɎ1&ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɎɌɄɉȼɎɌɄɅɒɄɎɌȼɎɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ ȮɌɄɉȼɎɌɄɅɒɄɎɌȼɎɍɊɀɁɌɂɄɎɍɛȾȾɄɀɁɈɊɇɛɌɉɊȿɊɌȼɍɎȾɊɌȼ
ɍɊɊɎȾɁɎɍɎȾɏɁɎɉɊɈɏɌȼɍɎȾɊɌɏɎɌɄɉȼɎɌɄɛɒɄɎɌȼɎȼɓȼɍɎɊɊɆɌɏȿɇɛɁɎɍɛɀɊ ɓɎɊɍɊɍɎȼȾɇɛɁɎɊɎɉɊɈɄɉȼɇɘɉɊȿɊɊȽɖɁɈȼ60RQRYHWWH®ȲɄɎɌȼɎȭɊɊɎɉɊɔɁɉɄɁɍɈɁɔɄȾȼɉɄɛɒɄɎɌȼɎȼɄɆɌɊȾɄ
ɍɊɍɎȼȾɇɛɁɎŠɊȽɖɁɈɉȼɛɓȼɍɎɘɒɄɎɌȼɎȼɄɊȽɖɁɈɉɗɑɓȼɍɎɁɅɆɌɊȾɄȠɇɛɋɌɊȾɁɀɁɉɄɛȼɉȼɇɄɃȼɍɎɌɊȿɊɉɁɊȽɑɊɀɄɈɊɋɌȼȾɄɇɘɉɊɁɃȼɋɊɇɉɁɉɄɁ
ȫɇȼɃɈȼɍɒɄɎɌȼɎɊɈɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɋɌɄɌɏɎɄɉɉɗɑɄɍɍɇɁɀɊȾȼɉɄɛɑȿɁɈɊɍɎȼɃȼ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɍȾɁɌɎɗȾȼɉɄɛɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɒɄɎɌȼɎɊɈɄɊɉɊȾɆȼɇɘɒɄɛ
ȭɇɁɀɏɅɎɁȫȬȤȨȡȳȜȩȤȻȨȾɌȼɃɀɁɇɁŝȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽŞɋɌɄɌȼȽɊɎɁɍ60RQRYHWWH®ȲɄɎɌȼɎɄɄȿɇɊɅȽȼȽɊɓɆɊɅ

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɎɌɄɉȼɎɌɄɅɒɄɎɌȼɎɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ ȮɌɄɉȼɎɌɄɅɒɄɎɌȼɎɍɊɀɁɌɂɄɎɍɛȾȾɄɀɁɈɊɇɛɌɉɊȿɊȽɏɐɁɌɉɊȿɊɌȼɍɎȾɊɌȼ ȽɏɐɁɌɉɗɅ
ɌȼɍɎȾɊɌS+ ɓɎɊɍɊɍɎȼȾɇɛɁɎɊɎɉɊɈɄɉȼɇɘɉɊȿɊɊȽɖɁɈȼ60RQRYHWWH®3)$ȭɊɊɎɉɊɔɁɉɄɁɍɈɁɔɄȾȼɉɄɛɒɄɎɌȼɎȼɄɆɌɊȾɄɍɊɍɎȼȾɇɛɁɎŠɊȽɖɁɈɉȼɛɓȼɍɎɘɒɄɎɌȼɎȼɄɊȽɖɁɈɉɗɑɓȼɍɎɁɅɆɌɊȾɄȠɇɛɋɌɊȾɁɀɁɉɄɛȼɉȼɇɄɃȼɍɎɌɊȿɊɉɁɊȽɑɊɀɄɈɊɋɌȼȾɄɇɘɉɊɁɃȼɋɊɇɉɁɉɄɁ
ȲɁɇɘɉȼɛɆɌɊȾɘɄɃ60RQRYHWWH®3)$1&ɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛɐɏɉɆɒɄɄɎɌɊɈȽɊɒɄɎɊȾɍɋɊɈɊɕɘɚȼɉȼɇɄɃȼɎɊɌȼ6,(0(16+HDOWKLQHHUV3)$ɓɎɊɋɊɀɎȾɁɌɂɀɁɉɊɍɁɌɎɄɐɄɆȼɒɄɁɅ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɍȾɁɌɎɗȾȼɉɄɛɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɒɄɎɌȼɎɊɈɄɊɉɊȾɆȼɇɘɒɄɛ
ȭɇɁɀɏɅɎɁȫȬȤȨȡȳȜȩȤȻȨȾɌȼɃɀɁɇɁŝȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽŞɋɌɄɌȼȽɊɎɁɍ60RQRYHWWH®3)$ɄɄȿɇɊɅȽȼȽɊɓɆɊɅ

SARSTEDT S-Monovette® CTAD
ȫɌɊɀɏɆɎ60RQRYHWWH®&7$'ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɎɌɄɉȼɎɌɄɅɒɄɎɌȼɎȼɎȼɆɂɁɎɁɊɐɄɇɇɄɉȼɀɁɉɊɃɄɉɄɀɄɋɄɌɄɀȼɈɊɇɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ &7$'ɀɊɍɎɏɋɁɉȾȾɄɀɁ
ɌȼɍɎȾɊɌȼɄɍɊɍɎȼȾɇɛɁɎɊɎɉɊɈɄɉȼɇɘɉɊȿɊɊȽɖɁɈȼ60RQRYHWWH®&7$'ȭɊɊɎɉɊɔɁɉɄɁɍɈɁɔɄȾȼɉɄɛ&7$'ɄɆɌɊȾɄɍɊɍɎȼȾɇɛɁɎŠɊȽɖɁɈɉȼɛɓȼɍɎɘȲȮȜȠɄɊȽɖɁɈɉɗɑɓȼɍɎɁɅɆɌɊȾɄȠɇɛɋɌɊȾɁɀɁɉɄɛ
ȼɉȼɇɄɃȼɍɎɌɊȿɊɉɁɊȽɑɊɀɄɈɊɋɌȼȾɄɇɘɉɊɁɃȼɋɊɇɉɁɉɄɁ
&7$'ɍɋɇȼɃɈɊɅɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛɎɌɊɈȽɊɒɄɎȼɌɉɊȿɊɐȼɆɎɊɌȼ 3) ȽɁɎȼ Ǳ ɎɌɊɈȽɊȿɇɊȽɏɇɄɉȼ Ĕ7* ɄɄɉȿɄȽɄɎɊɌȼȼɆɎɄȾȼɎɊɌȼɋɇȼɃɈɄɉɊȿɁɉȼ 3$, ȼɎȼɆɂɁɀɇɛɌɏɎɄɉɉɗɑ
ɄɍɍɇɁɀɊȾȼɉɄɛɑȿɁɈɊɍɎȼɃȼ
ȜɆɎɄȾȼɒɄɛɎɌɊɈȽɊɒɄɎɊȾɋɊɀȼȾɇɛɁɎɍɛɉɁɈɁɉɁɁɓɁɈɉȼɓȼɍȼɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɆɊɉɎɌɊɇɛȿɁɋȼɌɄɉɊȾɊɅɎɁɌȼɋɄɄ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɍȾɁɌɎɗȾȼɉɄɛɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɒɄɎɌȼɎɊɈɄɊɉɊȾɆȼɇɘɒɄɛ
ȭɇɁɀɏɅɎɁȫȬȤȨȡȳȜȩȤȻȨȾɌȼɃɀɁɇɁŝȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽŞɋɌɄɌȼȽɊɎɁɍ60RQRYHWWH®&7$'ɄɄȿɇɊɅȽȼȽɊɓɆɊɅ
ȫȬȤȨȡȳȜȩȤȡ&7$'ɄɈɁɁɎɂɁɇɎɏɚɊɆɌȼɍɆɏȞɊȾɌɁɈɛɑɌȼɉɁɉɄɛ60RQRYHWWH®&7$'ɍɇɁɀɏɁɎɋɌɁɀɊɑɌȼɉɛɎɘɊɎ
ɄɍɆɏɍɍɎȾɁɉɉɊȿɊɄɁɍɎɁɍɎȾɁɉɉɊȿɊɊɍȾɁɕɁɉɄɛȞɊɃɀɁɅɍɎȾɄɁɍɄɇɘɉɊȿɊɍȾɁɎȼɉȼɋɌɊɎɛɂɁɉɄɄȽɊɇɁɁɓȼɍɊȾɈɊɂɁɎɋɌɄȾɁɍɎɄ
ɆɄɉȼɆɎɄȾȼɒɄɄɀɊȽȼȾɆɄ

183

RU
SARSTEDT S-Monovette®.(.(ȹȠȮȜ
S-Monovette®ȹȠȮȜ.(60RQRYHWWH®ȹȠȮȜ.(ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎ.ȹȠȮȜɄɇɄ.ȹȠȮȜɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄ .ȹȠȮȜɄɇɄ.ȹȠȮȜɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
ɈȿɈɇɆɌɊȾɄ ȲɁɇɘɉȼɛɆɌɊȾɘɍȹȠȮȜɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛȿɁɈȼɎɊɇɊȿɄɓɁɍɆɄɑɄɍɍɇɁɀɊȾȼɉɄɅȨȼɃɆɄɆɌɊȾɄɀɊɇɂɉɗȽɗɎɘɍɀɁɇȼɉɗȾɎɁɓɁɉɄɁɓɁɎɗɌɁɑɓȼɍɊȾɋɊɍɇɁȾɃɛɎɄɛɆɌɊȾɄ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɆɊȼȿɏɇɛɒɄɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɄɊɉɊȾɆȼɇɘɒɄɛɍɋɊɈɊɕɘɚȹȠȮȜȦɌɊɈɁɎɊȿɊɆɌɊȾɘɄɃɋɌɊȽɄɌɆɄ60RQRYHWWH®ȹȠȮȜ.(.(ɈɊɂɁɎɄɍɋɊɇɘɃɊȾȼɎɘɍɛɋɌɄɋɌɊȾɁɀɁɉɄɄɌɏɎɄɉɉɗɑɄɈɈɏɉɊȿɁɈȼɎɊɇɊȿɄɓɁɍɆɄɑɄɍɍɇɁɀɊȾȼɉɄɅɄɎɁɍɎɊȾɉȼɄɉɐɁɆɒɄɊɉɉɗɁɃȼȽɊɇɁȾȼɉɄɛ
ȫɊɇɘɃɊȾȼɎɁɇɘɉɁɍɁɎɊɎȾɁɎɍɎȾɁɉɉɊɍɎɄɃȼɋɌɊȾɁɌɆɏɋɌɄȿɊɀɉɊɍɎɄɈȼɎɁɌɄȼɇȼɊȽɌȼɃɒȼɀɇɛəɎɄɑɄɍɍɇɁɀɊȾȼɉɄɅɍɋɊɈɊɕɘɚɍɊɊɎȾɁɎɍɎȾɏɚɕɄɑɎɁɍɎɊȾɗɑɌɁȼȿɁɉɎɊȾɋɌɄȽɊɌɊȾȼɉȼɇɄɃȼɎɊɌɊȾȾɆɇɚɓȼɛɏɍɇɊȾɄɛ
ɑɌȼɉɁɉɄɛ

SARSTEDT S-Monovette®.ȹȠȮȜȿɁɇɘ
ȞɀɊɋɊɇɉɁɉɄɁɆȼɉɎɄɆɊȼȿɏɇɛɉɎɏ.ȹȠȮȜ60RQRYHWWH®.ȹȠȮȜȿɁɇɘɍɊɀɁɌɂɄɎɋɊɇɄȼɆɌɄɇɊȾɗɅȿɁɇɘɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɋɇȼɃɈɗ .ȹȠȮȜɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ ɈȿɈɇɆɌɊȾɄ ȞɌɁɃɏɇɘɎȼɎɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛȿɁɇɘɊȽɌȼɃɏɁɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅɍɇɊɅɈɁɂɀɏɆɇɁɎɆȼɈɄɆɌɊȾɄɄɋɇȼɃɈɊɅɄɀɁɅɍɎȾɏɁɎɆȼɆȽȼɌɘɁɌȾɊȾɌɁɈɛɑɌȼɉɁɉɄɛɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄɄȼɉȼɇɄɃȼ
ȫɇȼɃɈȼɍȹȠȮȜɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɈɊɇɁɆɏɇɛɌɉɊɅɀɄȼȿɉɊɍɎɄɆɄȾɄɌɏɍɊȾ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɆɊȼȿɏɇɛɒɄɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɄɊɉɊȾɆȼɇɘɒɄɛɍɋɊɈɊɕɘɚȹȠȮȜ

SARSTEDT S-Monovette®ȰɎɊɌɄɀȹȠȮȜ)(ȰɎɊɌɄɀȿɁɋȼɌɄɉ)+ȰɎɊɌɄɀɒɄɎɌȼɎȹȠȮȜ)&
S-Monovette®ȰɎɊɌɄɀȹȠȮȜ)(ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎȹȠȮȜ ɈȿɈɇɆɌɊȾɄ ɄɐɎɊɌɄɀ ɈȿɈɇɆɌɊȾɄ ɀɇɛɄɉȿɄȽɄɌɊȾȼɉɄɛȿɇɄɆɊɇɄɃȼɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɋɇȼɃɈɗ ȰɎɊɌɄɀȹȠȮȜɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
S-Monovette®ȰɎɊɌɄɀȿɁɋȼɌɄɉ)+ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎȿɁɋȼɌɄɉ ȨȡɈɇɆɌɊȾɄ ɄɐɎɊɌɄɀ ɈȿɈɇɆɌɊȾɄ ɀɇɛɄɉȿɄȽɄɌɊȾȼɉɄɛȿɇɄɆɊɇɄɃȼɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɋɇȼɃɈɗ ȰɎɊɌɄɀȿɁɋȼɌɄɉ
ɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
ȤɉȿɄȽɄɌɊȾȼɉɄɁȿɇɄɆɊɇɄɃȼɊɀɉɄɈɐɎɊɌɄɀɊɈɉȼɓɄɉȼɁɎɍɛɋɌɄɈɁɌɉɊɓɁɌɁɃɓȼɍȼɋɊɍɇɁɃȼɋɊɇɉɁɉɄɛɋɌɊȽɄɌɆɄɀɇɛȾɃɛɎɄɛɆɌɊȾɄɄɀɊɍɎɄȿȼɁɎɈȼɆɍɄɈɏɈȼɋɌɄɈɁɌɉɊɓɁɌɁɃɓȼɍȼȮȼɆɄɈɊȽɌȼɃɊɈȿɇɚɆɊɃȼ
ɌȼɍɋȼɀȼɁɎɍɛȾɒɁɇɘɉɊɅɆɌɊȾɄȾɍɌɁɀɉɁɈɀɊɓɁɌɁɃɉɁɍɆɊɇɘɆɊɓȼɍɊȾɄɀɊşɓɁɌɁɃɓȼɍȼ
S-Monovette®*OXFR(;$&7)&ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎȹȠȮȜȼɎȼɆɂɁɒɄɎɌȼɎɄɐɎɊɌɄɀɀɇɛɉɁɈɁɀɇɁɉɉɊȿɊɄɉȿɄȽɄɌɊȾȼɉɄɛȿɇɄɆɊɇɄɃȼɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɋɇȼɃɈɗ ȹȠȮȜɒɄɎɌȼɎɄɐɎɊɌɄɀ
ɀɊɃɄɌɏɚɎɍɛɌȼɍɋɗɇɁɉɄɁɈȞȾɄɀɏɌȼɃȽȼȾɇɁɉɄɛɋɌɄɌȼɍɓɁɎɁɆɊɉɒɁɉɎɌȼɒɄɄȿɇɚɆɊɃɗɍɊɊɎȾɁɎɍɎȾɏɚɕɄɁɃɉȼɓɁɉɄɛɉɁɊȽɑɊɀɄɈɊɏɈɉɊɂɄɎɘɉȼ
S-Monovette®*OXFR(;$&7)&ɍɊɊɎȾɁɎɍɎȾɏɁɎȠɄɌɁɆɎɄȾɁɋɊȿɁɍɎȼɒɄɊɉɉɊɈɏɀɄȼȽɁɎɏȩɁɈɁɒɆɊɅɀɄȼȽɁɎɄɓɁɍɆɊɅȼɍɍɊɒɄȼɒɄɄ ''* ȼɎȼɆɂɁȩȼɒɄɊɉȼɇɘɉɊɅɀɄɌɁɆɎɄȾɁɋɊɊɆȼɃȼɉɄɚɈɁɀɄɒɄɉɍɆɊɅɋɊɈɊɕɄɋɌɄ
ɀɄȼȽɁɎɁȿɊɎɄɋȼ 19/ ȩɁɈɁɀɇɁɉɉȼɛɍɎȼȽɄɇɄɃȼɒɄɛɆɊɉɒɁɉɎɌȼɒɄɄȿɇɚɆɊɃɗȾɒɁɇɘɉɊɅɆɌɊȾɄɋɊɀɀɁɌɂɄȾȼɁɎɍɛɀɊɓȼɍɊȾɋɌɄɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɁɍɈɎȼɆɂɁɄɉɐɊɌɈȼɒɄɊɉɉɗɅȽɏɆɇɁɎ6$567('7
https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
ȫɇȼɃɈȼɍɐɎɊɌɄɀȹȠȮȜ ɒɄɎɌȼɎɊɈ ɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛɏɌɊȾɉɛȿɇɚɆɊɃɗ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɆɊȼȿɏɇɛɒɄɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɄɊɉɊȾɆȼɇɘɒɄɛɍɋɊɈɊɕɘɚȹȠȮȜȫȬȤȨȡȳȜȩȤȡɐɎɊɌɄɀɈɊɂɁɎȾɗɃɗȾȼɎɘɏȾɁɇɄɓɁɉɄɁȿɁɈɊɇɄɃȼȠɊɋɊɇɉɄɎɁɇɘɉɏɚɄɉɐɊɌɈȼɒɄɚɊȾɁɕɁɍɎȾȼɑɍɋɊɍɊȽɉɗɑɋɊȾɇɄɛɎɘɉȼɌɁɃɏɇɘɎȼɎɗɄɍɍɇɁɀɊȾȼɉɄɛɈɊɂɉɊɉȼɅɎɄȾ
ɍɊɊɎȾɁɎɍɎȾɏɚɕɄɑɄɉɍɎɌɏɆɒɄɛɑɋɊɋɌɄɈɁɉɁɉɄɚɋɌɄȽɊɌȼȼɉȼɇɄɃȼɎɊɌȼ
ȭɇɁɀɏɅɎɁȫȬȤȨȡȳȜȩȤȻȨȾɌȼɃɀɁɇɁŝȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽŞɋɌɄɌȼȽɊɎɁɍ60RQRYHWWH®*OXFR(;$&7ɄɄȿɇɊɅȽȼȽɊɓɆɊɅ

SARSTEDT S-Monovette® CPDA
S-Monovette®&3'$ɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɒɄɎɌȼɎɉȼɎɌɄɛȼɎȼɆɂɁɇɄɈɊɉɉɏɚɆɄɍɇɊɎɏɐɊɍɐȼɎɉȼɎɌɄɛɀɁɆɍɎɌɊɃɏɄȼɀɁɉɄɉɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄɄɋɇȼɃɈɗ &3'$ɋɌɁɀɇȼȿȼɁɎɍɛȾ
ȾɄɀɁɌȼɍɎȾɊɌȼȭɊɊɎɉɊɔɁɉɄɁɍɈɁɔɄȾȼɉɄɛ&3'$ɄɆɌɊȾɄɍɊɍɎȼȾɇɛɁɎŠɊȽɖɁɈ&3'$ɄɊȽɖɁɈɊȾɆɌɊȾɄȠɇɛɋɌɊȾɁɀɁɉɄɛȼɉȼɇɄɃȼɍɎɌɊȿɊɉɁɊȽɑɊɀɄɈɊɋɌȼȾɄɇɘɉɊɁɃȼɋɊɇɉɁɉɄɁ
ȲɁɇɘɉȼɛɆɌɊȾɘɋɇȼɃɈȼɍ&3'$ɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɍɁɌɊɇɊȿɄɄȿɌɏɋɋɆɌɊȾɄȾɎɌȼɉɍɐɏɃɄɊɉɉɊɅɈɁɀɄɒɄɉɁɀɇɛɎɁɍɎɊȾɉȼɍɊȾɈɁɍɎɄɈɊɍɎɘ ɋɁɌɁɆɌɁɍɎɉɗɁɋɌɊȽɗ ɋɌɄɋɁɌɁɇɄȾȼɉɄɛɑȞɓȼɍɎɉɊɍɎɄ60RQRYHWWH®&3'$ɋɌɁɀɉȼɃɉȼɓɁɉɀɇɛɊɋɌɁɀɁɇɁɉɄɛȿɌɏɋɋɗɆɌɊȾɄ $% ȾɆɇɚɓȼɛȦɁɇɇɐȼɆɎɊɌɄɌɁɃɏɍɐɊɌɈɏɇɏɎɁɍɎɉȼȼɉɎɄɎɁɇȼɆɉɁɌɁȿɏɇɛɌɉɗɈȿɌɏɋɋȼɈɆɌɊȾɄɋɌɛɈɊɅɋɊɇɄɍɋɁɒɄɐɄɓɁɍɆɄɅ
ɎɁɍɎȦɏɈȽɍȼ ɀɊȿɊɀɉɛ ɎɁɍɎɉȼɍɊȾɈɁɍɎɄɈɊɍɎɘ ɋɁɌɁɆɌɁɍɎɉɏɚɋɌɊȽɏ ɍɋɊɀɑɊɀɛɕɁɅɍɗȾɊɌɊɎɆɊɅɋɇȼɃɈɊɅɋȼɒɄɁɉɎȼɋɊȿɌɏɋɋɁɆɌɊȾɄ ɊɍɉɊȾɉɊɅɎɁɍɎ ȫɌɊȾɁɌɁɉɉɊɁȾɌɁɈɛɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄɀɊɑɌȼɉɁɉɄɛɍɊɍɎȼȾɇɛɁɎɉɁȽɊɇɁɁɓȼɍɊȾɋɌɄɎɁɈɋɁɌȼɎɏɌɁşƓ&ȠɇɛɊɍȼɂɀɁɉɄɛɆɇɁɎɊɆɊȽɌȼɃɒɗɀɊɇɂɉɗɍɉȼɓȼɇȼɑɌȼɉɄɎɘɍɛȾȾɁɌɎɄɆȼɇɘɉɊɈɋɊɇɊɂɁɉɄɄȾ
ɑɊɇɊɀɄɇɘɉɄɆɁɉɁɈɁɉɁɁɓȼɍɊȾȣȼɎɁɈȾɗɔɁɏɋɊɈɛɉɏɎɗɁȼɉȼɇɄɎɗɈɊɂɉɊɑɌȼɉɄɎɘȾɑɊɇɊɀɄɇɘɉɄɆɁ ɋɌɄɎɁɈɋɁɌȼɎɏɌɁşƓȭ ɆȼɆɄɊȽɗɓɉɏɚɆɌɊȾɘɀɊɀɉɁɅ ɃȼɄɍɆɇɚɓɁɉɄɁɈɋɌɛɈɊɅɋɌɊȽɗȦɏɈȽɍȼ
ɆɊȿɀȼɍɌɊɆɑɌȼɉɁɉɄɛɍɊɍɎȼȾɇɛɁɎɀɉɁɅ ȫɊɀɑɊɀɄɎɀɇɛɈɁɎɊɀɄɆɄɆɊɇɊɉɊɓɉɊɅȼȿȿɇɚɎɄɉȼɒɄɄɉȼɋɌɄɈɁɌɉȼ9LVLRQ0D[ɊɎ2UWKR&OLQLFDO'LDJQRVWLFVȨȼɎɁɌɄȼɇɊȽɌȼɃɒȼɉɁɀɊɇɂɁɉɃȼɈɊɌȼɂɄȾȼɎɘɍɛ
ȫɊɇɘɃɊȾȼɎɁɇɘɊɎȾɁɓȼɁɎɃȼɋɌɄȿɊɀɉɊɍɎɘɊȽɌȼɃɒȼɀɇɛəɎɄɑɄɍɍɇɁɀɊȾȼɉɄɅɍɄɍɋɊɇɘɃɊȾȼɉɄɁɈɀɌɏȿɄɑɈɁɎɊɀɄɆɎɁɍɎɊȾɗɑɌɁȼȿɁɉɎɊȾɏɍɎɌɊɅɍɎȾȼɉȼɇɄɃȼɎɊɌɊȾȾɆɇɚɓȼɛɏɍɇɊȾɄɛɑɌȼɉɁɉɄɛɄɀɊɇɂɁɉ
ɍȼɈɊɍɎɊɛɎɁɇɘɉɊɋɌɊȾɁɌɄɎɘɁɁ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɍȾɁɌɎɗȾȼɉɄɛɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɒɄɎɌȼɎɊɈɄɊɉɊȾɆȼɇɘɒɄɛ
ȭɇɁɀɏɅɎɁȫȬȤȨȡȳȜȩȤȻȨȾɌȼɃɀɁɇɁŝȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽŞɋɌɄɌȼȽɊɎɁɍ60RQRYHWWH®&3'$ɄɄȿɇɊɅȽȼȽɊɓɆɊɅ

SARSTEDT S-Monovette® ThromboExact
S-Monovette®7KURPER([DFWɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɍɊɇɘɈȼȿɉɄɛɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄ ȭɊɇɘɈȼȿɉɄɛɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
ȲɁɇɘɉȼɛɆɌɊȾɘȾɋɌɊȽɄɌɆɁ60RQRYHWWH®7KURPER([DFWɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɄɍɆɇɚɓɁɉɄɛɉɁɀɊɍɎɊȾɁɌɉɊɉɄɃɆɊȿɊɓɄɍɇȼɎɌɊɈȽɊɒɄɎɊȾȾɍɇɏɓȼɁɉɁɍɊȾɈɁɍɎɄɈɊɍɎɄɍȼɉɎɄɆɊȼȿɏɇɛɉɎɊɈ
ɉȼɋɌɄɈɁɌȹȠȮȜɒɄɎɌȼɎɊɈȿɁɋȼɌɄɉɊɈ ɎȼɆɂɁɄɃȾɁɍɎɉɊȿɊɆȼɆŝɋɍɁȾɀɊɎɌɊɈȽɊɒɄɎɊɋɁɉɄɛŞȜȿɌɁȿȼɒɄɛɎɌɊɈȽɊɒɄɎɊȾɋɌɁɀɊɎȾɌȼɕȼɁɎɍɛɓɎɊɋɊɃȾɊɇɛɁɎɊɋɌɁɀɁɇɄɎɘɐȼɆɎɄɓɁɍɆɊɁɆɊɇɄɓɁɍɎȾɊɎɌɊɈȽɊɒɄɎɊȾȾ
ɎɁɓɁɉɄɁɋɁɌɄɊɀȼɀɊɓȼɍɊȾɋɊɍɇɁȾɃɛɎɄɛɆɌɊȾɄ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɆɊȼȿɏɇɛɒɄɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛȽɇȼȿɊɀȼɌɛɄɊɉȼɈɈȼȿɉɄɛɆɊɎɊɌɗɁɄɉȿɄȽɄɌɏɚɎɎɌɊɈȽɊɒɄɎȼɌɉɗɅɎɌɊɈȽɊɆɍȼɉȜȼɎȼɆɂɁȼȿɌɁȿȼɒɄɚɎɌɊɈȽɊɒɄɎɊȾɊɋɊɍɌɁɀɊȾȼɉɉɏɚȜȠȰɄȼɌȼɑɄɀɊɉɊȾɊɅɆɄɍɇɊɎɊɅ

SARSTEDT S-Monovette®ȟɄɌɏɀɄɉ
S-Monovette®ȟɄɌɏɀɄɉɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎȿɄɌɏɀɄɉɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄ ȟɄɌɏɀɄɉɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
ȲɁɇɘɉȼɛɆɌɊȾɘɍȿɄɌɏɀɄɉɊɈɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛɐɏɉɆɒɄɄɎɌɊɈȽɊɒɄɎɊȾɉȼɏɍɎɌɊɅɍɎȾɁ0XOWLSODWH® ɈɉɊɂɁɍɎȾɁɉɉɊɈȼɉȼɇɄɃȼɎɊɌɁɐɏɉɆɒɄɄɎɌɊɈȽɊɒɄɎɊȾ ɊɎ52&+('LDJQRVWLFVɓɎɊɋɊɀɎȾɁɌɂɀɁɉɊɍɊɊɎȾɁɎɍɎȾɏɚɕɄɈɍɁɌɎɄɐɄɆȼɎɊɈȪɉɋɌɄɈɁɉɛɁɎɍɛɀɇɛɆɊɉɎɌɊɇɛɎɁɌȼɋɄɄɍȾɛɃȼɉɉɊɅɍɋɌɄɁɈɊɈȼɉɎɄɎɌɊɈȽɊɒɄɎȼɌɉɗɑɋɌɁɋȼɌȼɎɊȾȼɎȼɆɂɁɀɇɛȾɗɛȾɇɁɉɄɛɇɄȽɊɄɍɆɇɚɓɁɉɄɛ
ɐɏɉɆɒɄɊɉȼɇɘɉɗɑɉȼɌɏɔɁɉɄɅɎɌɊɈȽɊɒɄɎɊȾ
S-Monovette®ȟɄɌɏɀɄɉȽɗɇɌȼɃɌȼȽɊɎȼɉɋɌɄɍɊɎɌɏɀɉɄɓɁɍɎȾɁɍɆɊɈɋȼɉɄɁɅ9HUXP'LDJQRVWLFD ȾɉȼɍɎɊɛɕɁɁȾɌɁɈɛȾɑɊɀɄɎȾɍɊɍɎȼȾ52&+('LDJQRVWLFV ɍɋɁɒɄȼɇɘɉɊɀɇɛɊɋɌɁɀɁɇɁɉɄɛɐɏɉɆɒɄɄɎɌɊɈȽɊɒɄɎɊȾɉȼ
ɋɌɄȽɊɌɁ0XOWLSODWH®.
ȮɊɌɈɊɂɁɉɄɁɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛȿɄɌɏɀɄɉɊɈɋɏɎɁɈɉɁɋɊɍɌɁɀɍɎȾɁɉɉɊȿɊɏȿɉɁɎɁɉɄɛɎɌɊɈȽɄɉȼɓɎɊɋɊɃȾɊɇɛɁɎɋɌɊȾɊɀɄɎɘɀɄȼȿɉɊɍɎɄɆɏɎɌɊɈȽɊɒɄɎȼɌɉɗɑɐɏɉɆɒɄɅȾɁɍɎɁɍɎȾɁɉɉɊɈɍɊɍɎɊɛɉɄɄ

SARSTEDT S-Monovette®ȟɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɘȟɊɈɊɒɄɍɎɁɄɉ+&<&ȫɊɈɄɈɊȿɌȼɉɏɇɋɊɆɌɗɎɗɑȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄ ɍɄɇɄɆȼɎɊɈ 60RQRYHWWH®ȟɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɘɍɊɀɁɌɂɄɎɍɋɁɒɄȼɇɘɉɗɅɍɎȼȽɄɇɄɃȼɎɊɌɄɋɊɇɄȼɆɌɄɇɊȾɗɅȿɁɇɘɄɍɇɏɂɄɎɀɇɛɋɊɇɏɓɁɉɄɛ
ɍɗȾɊɌɊɎɆɄ ȞɌɁɃɏɇɘɎȼɎɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛȿɁɇɘɊȽɌȼɃɏɁɎɌȼɃɀɁɇɄɎɁɇɘɉɗɅɍɇɊɅɈɁɂɀɏɍȿɏɍɎɆɊɈɆɌɊȾɄɄɍɗȾɊɌɊɎɆɊɅɄɀɁɅɍɎȾɏɁɎɆȼɆȽȼɌɘɁɌȾɊȾɌɁɈɛɑɌȼɉɁɉɄɛɎɌȼɉɍɋɊɌɎɄɌɊȾɆɄɄȼɉȼɇɄɃȼȠɊȽȼȾɆȼ
ɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
ȟɊɈɊɒɄɍɎɁɄɉɍɎȼȽɄɇɄɃɄɌɏɁɎɍɛȾɒɁɇɘɉɊɅɆɌɊȾɄɋɌɄɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɁɀɊɓȼɍɊȾȡɍɇɄɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁȾɗɋɊɇɉɛɁɎɍɛȾɎɁɓɁɉɄɁɋɁɌȾɗɑɓȼɍɊȾɍɋɌȼȾɄɇɘɉɊɍɐɊɌɈɄɌɊȾȼɉɉɗɈɌȼɃɀɁɇɄɎɁɇɘɉɗɈ
ɍɇɊɁɈɈɁɂɀɏɆɌɊȾɛɉɗɈɍȿɏɍɎɆɊɈɄɍɗȾɊɌɊɎɆɊɅȿɊɈɊɒɄɍɎɁɄɉɍɎȼȽɄɇɄɃɄɌɏɁɎɍɛɀɊɓȼɍɊȾ
ȭɗȾɊɌɊɎɆȼɄɃ60RQRYHWWH®ȟɊɈɊɒɄɍɎɁɄɉ+&<=ȿɁɇɘɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛȿɊɈɊɒɄɍɎɁɄɉȼ60RQRYHWWH®ȟɊɈɊɒɄɍɎɁɄɉ+&<&ɍɊɀɁɌɂɄɎɆɄɍɇɗɅɒɄɎɌȼɎ Ɍȩ ȾɆȼɓɁɍɎȾɁ
ȼɉɎɄɆɊȼȿɏɇɛɉɎȼɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɋɇȼɃɈɗ ȲɄɎɌȼɎɋɌɁɀɇȼȿȼɁɎɍɛȾɐɊɌɈɁɌȼɍɎȾɊɌȼȞȾɄɀɏɌȼɃȽȼȾɇɁɉɄɛɋɌɄɌȼɍɓɁɎɁɆɊɉɒɁɉɎɌȼɒɄɄȿɊɈɊɒɄɍɎɁɄɉȼɍɊɊɎȾɁɎɍɎȾɏɚɕɄɁɃɉȼɓɁɉɄɛɉɁɊȽɑɊɀɄɈɊ
ɏɈɉɊɂɄɎɘɉȼ
ȟɊɈɊɒɄɍɎɁɄɉɍɎȼȽɄɇɄɃɄɌɏɁɎɍɛȾɒɁɇɘɉɊɅɆɌɊȾɄɀɊɓȼɍɊȾɋɌɄɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɁɄɀɊɓȼɍɊȾɋɌɄƓȭȫɇȼɃɈȼɄɃ60RQRYHWWH®ȟɊɈɊɒɄɍɎɁɄɉ+&<&ɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɊɋɌɁɀɁɇɁɉɄɛȿɊɈɊɒɄɍɎɁɄɉȼ
ȤɉȿɄȽɄɌɊȾȼɉɄɁɆɊȼȿɏɇɛɒɄɄȾ60RQRYHWWH®ȟɊɈɊɒɄɍɎɁɄɉ+&<&ɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɒɄɎɌȼɎɊɈɄɊɉɊȾɆȼɇɘɒɄɛ
ȭɇɁɀɏɅɎɁȫȬȤȨȡȳȜȩȤȻȨȾɌȼɃɀɁɇɁŝȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽŞɋɌɄɌȼȽɊɎɁɍ60RQRYHWWH®ȟɊɈɊɒɄɍɎɁɄɉ+&<&ɄɄȿɇɊɅȽȼȽɊɓɆɊɅ

SARSTEDT S-Monovette® DNA Exact
S-Monovette®'1$([DFWɍɊɀɁɌɂɄɎȼɉɎɄɆɊȼȿɏɇɛɉɎɉȼɊɍɉɊȾɁȹȠȮȜɄɄɍɋɊɇɘɃɏɁɎɍɛɀɇɛɋɊɇɏɓɁɉɄɛɒɁɇɘɉɊɅɆɌɊȾɄ ȹȠȮȜɀɊɃɄɌɏɁɎɍɛɌȼɍɋɗɇɁɉɄɁɈ
ȲɁɇɘɉȼɛɆɌɊȾɘɍȹȠȮȜɄɍɋɊɇɘɃɏɁɎɍɛȾɆȼɓɁɍɎȾɁɊȽɌȼɃɒȼɀɇɛɍɎȼȽɄɇɄɃȼɒɄɄȿȠȩȦȭɎȼȽɄɇɄɃȼɒɄɛȿȠȩȦɋɊɀɎȾɁɌɂɀɁɉȼȾɎɁɓɁɉɄɁɀɉɁɅɋɌɄƓ&ȾɎɁɓɁɉɄɁɀɉɁɅɋɌɄɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɁ Ɠ& ȾɎɁɓɁɉɄɁɀɉɁɅɋɌɄɊɑɇȼɂɀɁɉɄɄ ɀɊƓ& ɄɉɁɈɁɉɁɁȿɊɀȼɋɌɄƓ&ȦɌɊɈɁɎɊȿɊɍɎȼȽɄɇɄɃɄɌɊȾȼɉɉɗɁɊȽɌȼɃɒɗȾɗɀɁɌɂɄȾȼɚɎɒɄɆɇɊȾɃȼɈɊɌȼɂɄȾȼɉɄɛɄɊɎɎȼɄȾȼɉɄɛȽɁɃɋɊɎɁɌɄɆȼɓɁɍɎȾȼɍɈɎȼɆɂɁ
ɎɁɑɉɄɓɁɍɆɊɁɊɋɄɍȼɉɄɁ6$567('7ɋɊȼɀɌɁɍɏhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection
Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis”.
ȤɉȿɄȽɄɌɊȾȼɉɄɁɆɊȼȿɏɇɛɒɄɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛɃȼɍɓɁɎɍȾɛɃɗȾȼɉɄɛɄɊɉɊȾɆȼɇɘɒɄɛɍɋɊɈɊɕɘɚȹȠȮȜȫɌɄȿɊɀɉɊɍɎɘɊȽɌȼɃɒȼɃȼȾɄɍɄɎɊɎȼɉȼɇɄɎȼɄɎɁɍɎɊȾɊȿɊɌɁȼȿɁɉɎȼɋɌɄȽɊɌȼȼɉȼɇɄɃȼɎɊɌȼ
ȩɁɊȽɑɊɀɄɈɊɍɊȽɇɚɀȼɎɘɍɊɊɎȾɁɎɍɎȾɏɚɕɄɁɌɁɆɊɈɁɉɀȼɒɄɄɋɌɊɄɃȾɊɀɄɎɁɇɛ

184

RU
ȨɁɌɗɋɌɁɀɊɍɎɊɌɊɂɉɊɍɎɄ
1.

ȪȽɕɄɁɈɁɌɗɋɌɁɀɊɍɎɊɌɊɂɉɊɍɎɄȾɊɄɃȽɁɂȼɉɄɁȾɊɃɈɊɂɉɊȿɊɆɊɉɎȼɆɎȼɍɆɌɊȾɘɚɄɋɁɌɁɀȼɚɕɄɈɄɍɛɍɆɌɊȾɘɚȾɊɃȽɏɀɄɎɁɇɛɈɄɃȼȽɊɇɁȾȼɉɄɅɄɍɋɊɇɘɃɏɅɎɁɃȼɕɄɎɉɗɁɋɁɌɓȼɎɆɄɄɊȽɕɄɁɍɌɁɀɍɎȾȼ
ɄɉɀɄȾɄɀɏȼɇɘɉɊɅɃȼɕɄɎɗ

2.

ȪȽɌȼɕȼɅɎɁɍɘɍɊȾɍɁɈɄȽɄɊɇɊȿɄɓɁɍɆɄɈɄɋɌɊȽȼɈɄɄɊɍɎɌɗɈɄɄɉɍɎɌɏɈɁɉɎȼɈɄɀɇɛȾɃɛɎɄɛɆɌɊȾɄ ɄȿɇȼɈɄȼɀȼɋɎɁɌȼɈɄ ȾɍɊɊɎȾɁɎɍɎȾɄɄɍɋɌȼȾɄɇȼɈɄɄɋɌɊɒɁɀɏɌȼɈɄɋɌɄɉɛɎɗɈɄȾȞȼɔɁɈɏɓɌɁɂɀɁɉɄɄ
ȞɍɇɏɓȼɁɋɌɛɈɊȿɊɆɊɉɎȼɆɎȼɍȽɄɊɇɊȿɄɓɁɍɆɄɈɄɋɌɊȽȼɈɄɄɇɄɋɊɇɏɓɁɉɄɛɎɌȼȾɈɗɊɎɏɆɊɇȼɄȿɇɊɅɉɁɊȽɑɊɀɄɈɊɊȽɌȼɎɄɎɘɍɛɃȼɋɊɈɊɕɘɚɆȾɌȼɓɏɋɊɍɆɊɇɘɆɏəɎɊɈɊɂɁɎɋɌɄȾɁɍɎɄɆɋɁɌɁɀȼɓɁȞȤȳȿɁɋȼɎɄɎȼ
&ȿɁɋȼɎɄɎȼ%ɄɋɌɊɓɄɑɄɉɐɁɆɒɄɊɉɉɗɑɃȼȽɊɇɁȾȼɉɄɅȤɍɋɊɇɘɃɏɅɎɁȽɁɃɊɋȼɍɉɗɁɄȿɇɗɄȿɇɗ6DIHW\0XOWLĲ\®ɍɊȾɍɎɌɊɁɉɉɗɈɃȼɕɄɎɉɗɈɆɊɇɋȼɓɆɊɈȬɏɆɊȾɊɀɍɎȾɏɅɎɁɍɘɋɌɁɀɋɄɍȼɉɄɛɈɄɀɁɅɍɎȾɏɚɕɄɈɄɀɇɛ
ȞȼɔɁȿɊɏɓɌɁɂɀɁɉɄɛ

3.

ȪɎɉɊɍɄɎɍɛɆɋɌɊɀɏɆɎȼɈȾɄɉɀɄȾɄɀɏȼɇɘɉɊɅɍɎɁɌɄɇɘɉɊɅɏɋȼɆɊȾɆɁȫɁɌɁɀɄɍɋɊɇɘɃɊȾȼɉɄɁɈɆȼɂɀɏɚɊɎɀɁɇɘɉɏɚɏɋȼɆɊȾɆɏɉɁɊȽɑɊɀɄɈɊɋɌɊȾɁɌɛɎɘɉȼɋɌɁɀɈɁɎɋɊȾɌɁɂɀɁɉɄɅɋɌɄɉȼɇɄɓɄɄɋɊȾɌɁɂɀɁɉɄɅ
ɋɌɊɀɏɆɎɄɍɋɊɇɘɃɊȾȼɎɘɉɁɇɘɃɛ

4.

ȤɃɀɁɇɄɁɋɌɁɀɉȼɃɉȼɓɁɉɊɀɇɛɊɀɉɊɌȼɃɊȾɊȿɊɋɌɄɈɁɉɁɉɄɛȯɎɄɇɄɃɄɌɏɅɎɁȾɍɁɊɍɎɌɗɁɄɉɍɎɌɏɈɁɉɎɗ ɄȿɇɗȼɀȼɋɎɁɌɗ ɄɍɋɊɇɘɃɏɁɈɗɁɀɇɛȾɃɛɎɄɛɆɌɊȾɄȾɍɊɊɎȾɁɎɍɎȾɏɚɕɄɁɆɊɉɎɁɅɉɁɌɗɀɇɛɏɎɄɇɄɃȼɒɄɄ
ɊɍɎɌɗɑɋɌɁɀɈɁɎɊȾ

5.

ȡɍɇɄɆɌɊȾɘɃȼȽɄɌȼɁɎɍɛɋɏɎɁɈȾɉɏɎɌɄȾɁɉɉɊȿɊɀɊɍɎɏɋȼɉɁɊȽɑɊɀɄɈɊɋɌɊɍɇɁɀɄɎɘɃȼɎɁɈɓɎɊȽɗɈɁɍɎɊȾȾɁɀɁɉɄɛɄȿɇɗȽɗɇɊɊȽɌȼȽɊɎȼɉɊɍɊȿɇȼɍɉɊɋɌȼȾɄɇȼɈɀɁɅɍɎȾɏɚɕɄɈȾȞȼɔɁɈɏɓɌɁɂɀɁɉɄɄ ɊɓɄɕɁɉɊ
ɊɎȾɉɏɎɌɄȾɁɉɉɊȿɊɌȼɍɎȾɊɌȼ ɋɁɌɁɀɉȼɓȼɇɊɈɋɌɊɒɁɀɏɌɗȾɃɛɎɄɛɆɌɊȾɄȩȼɀɇɁɂȼɕȼɛɊȽɌȼȽɊɎɆȼɈɁɍɎȼɀɊɍɎɏɋȼɋɊɈɊȿȼɁɎɋɌɁɀɊɎȾɌȼɎɄɎɘɄɍɆȼɂɁɉɄɁɌɁɃɏɇɘɎȼɎɊȾȼɉȼɇɄɃȼ

6.

ȩɁɀɊɍɎȼɎɊɓɉɊɁɃȼɋɊɇɉɁɉɄɁɍɄɍɎɁɈɗ60RQRYHWWH®ɋɌɄȾɊɀɄɎɆɉɁɋɌȼȾɄɇɘɉɊɈɏɍɊɊɎɉɊɔɁɉɄɚɀɊȽȼȾɆȼɆɌɊȾɘɄɈɊɂɁɎɍɎȼɎɘɋɌɄɓɄɉɊɅɉɁɀɊɍɎɊȾɁɌɉɗɑɌɁɃɏɇɘɎȼɎɊȾȼɉȼɇɄɃȼ

7.

ȦɌɊȾɘɆɊɎɊɌȼɛȽɗɇȼȾɃɛɎȼɄɊȽɌȼȽɊɎȼɉȼɍɋɊɈɊɕɘɚ60RQRYHWWH®ɉɁɋɌɁɀɉȼɃɉȼɓɁɉȼɀɇɛɋɊȾɎɊɌɉɊȿɊɄɉɖɁɒɄɌɊȾȼɉɄɛȾɊɌȿȼɉɄɃɈɓɁɇɊȾɁɆȼ

8.

ȩɁɄɍɋɊɇɘɃɏɅɎɁɋɌɊɀɏɆɎɋɊɍɇɁɄɍɎɁɓɁɉɄɛɁȿɊɍɌɊɆȼȿɊɀɉɊɍɎɄȭɌɊɆȿɊɀɉɊɍɎɄɋɌɊɀɏɆɎȼɍɊɊɎȾɁɎɍɎȾɏɁɎɋɊɍɇɁɀɉɁɈɏɀɉɚɏɆȼɃȼɉɉɊȿɊɈɁɍɛɒȼɄȿɊɀȼ

ȱɌȼɉɁɉɄɁ
ȫɁɌɁɀɄɍɋɊɇɘɃɊȾȼɉɄɁɈɋɌɊɀɏɆɎɍɇɁɀɏɁɎɑɌȼɉɄɎɘɋɌɄɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɁ

ȪȿɌȼɉɄɓɁɉɄɛ
1.

ȭɌɊɆɄɎɁɈɋɁɌȼɎɏɌȼɑɌȼɉɁɉɄɛɃȼɋɊɇɉɁɉɉɊɅɋɌɊȽɄɌɆɄ60RQRYHWWH®ɃȼȾɄɍɛɎɊɎɍɌɊɆȼɑɌȼɉɁɉɄɛɋɌɁɀɏɍɈɊɎɌɁɉɉɊȿɊɀɇɛɄɍɍɇɁɀɏɁɈɗɑȼɉȼɇɄɎɊȾȪɒɁɉɆȼɋɌɊȾɊɀɄɎɍɛɇȼȽɊɌȼɎɊɌɄɁɅɇɄȽɊɄɉɐɊɌɈȼɒɄɛ
ȽɁɌɁɎɍɛɄɃɄɉɍɎɌɏɆɒɄɄɋɊɋɌɄɈɁɉɁɉɄɚɊɎɋɌɊɄɃȾɊɀɄɎɁɇɛɎɁɍɎɊȾɊȿɊɌɁȼȿɁɉɎȼɏɍɎɌɊɅɍɎȾȼȼɉȼɇɄɃȼɎɊɌȼ

2.

ȠȼɂɁɁɍɇɄɋɇȼɃɈȼɄɇɄɍɗȾɊɌɊɎɆȼȾ60RQRYHWWH®ɌȼɃɀɁɇɛɚɎɍɛȾɍɇɁɀɍɎȾɄɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɄɄɇɄɈɁɂɀɏɉɄɈɄɋɌɄɍɏɎɍɎȾɏɁɎȽȼɌɘɁɌəɎɊɉɁɊɃɉȼɓȼɁɎɓɎɊȾɍɁɆɇɁɎɆɄȽɗɇɄɊɎɀɁɇɁɉɗɋɊɇɉɊɍɎɘɚ
ȫɌɊɒɁɍɍɗɊɍɎȼɎɊɓɉɊȿɊɊȽɈɁɉȼȾɁɕɁɍɎȾɄɇɄɁɍɎɁɍɎȾɁɉɉɊȿɊɌȼɍɋȼɀȼɈɊȿɏɎɊɆȼɃɗȾȼɎɘȾɇɄɛɉɄɁɉȼɆɊɉɒɁɉɎɌȼɒɄɄȼɉȼɇɄɎɊȾȭɎȼȽɄɇɘɉɊɍɎɘȼɉȼɇɄɎɊȾɀɊɇɂɉȼɏɍɎȼɉȼȾɇɄȾȼɎɘɍɛɍɏɓɁɎɊɈɍɋɁɒɄɐɄɆɄ
ɇȼȽɊɌȼɎɊɌɉɗɑɁɈɆɊɍɎɁɅɄɏɍɇɊȾɄɅɑɌȼɉɁɉɄɛȾɍɊɊɎȾɁɎɍɎȾɏɚɕɁɅɇȼȽɊɌȼɎɊɌɄɄ

3.

ȫɌɄɌȼȽɊɎɁɍɎɁɌȼɋɁȾɎɄɓɁɍɆɄɈɄɋɌɁɋȼɌȼɎȼɈɄɉɁɊȽɑɊɀɄɈɊɋɌɊȾɁɌɄɎɘɋɌɄȿɊɀɉɊɍɎɘɋɌɊȽɉɊȿɊɈȼɎɁɌɄȼɇȼȾɍɊɊɎȾɁɎɍɎȾɄɄɍɄɉɍɎɌɏɆɒɄɁɅɋɊɋɌɄɈɁɉɁɉɄɚɊɎɋɌɊɄɃȾɊɀɄɎɁɇɛɎɁɍɎɊȾɗɑɌɁȼȿɁɉɎɊȾɋɌɄȽɊɌȼ
ȼɉȼɇɄɃȼɎɊɌȼ

4.

ȮɁɍɎɗɉȼɍɊɀɁɌɂȼɉɄɁɈɄɆɌɊəɇɁɈɁɉɎɊȾɈɁɎȼɇɇɊȾɍɇɁɀɏɁɎɋɌɊȾɊɀɄɎɘɍɄɍɋɊɇɘɃɊȾȼɉɄɁɈɍɄɍɎɁɈɗ60RQRYHWWH®ɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾȽɁɃɊɋȼɍɉɗɑɄȿɇɀɇɛɊɋɌɁɀɁɇɁɉɄɛɈɁɎȼɇɇɊȾ

ȞɃɛɎɄɁɄɊȽɌȼȽɊɎɆȼɋɌɊȽ
ȫȪȧȩȪȭȮȸȺȫȬȪȳȤȮȜȥȮȡȩȜȭȮȪȻȵȤȥȠȪȦȯȨȡȩȮȫȡȬȡȠȩȜȳȜȧȪȨȫȬȪȲȡȠȯȬȷȞȣȻȮȤȻȞȡȩȪȣȩȪȥȦȬȪȞȤ
ȬɁɆɊɈɁɉɀɏɁɈɗɁɈȼɎɁɌɄȼɇɗɀɇɛȾɃɛɎɄɛɋɌɊȽ
1.

ȞɍɁɉɁɊȽɑɊɀɄɈɗɁɍɄɍɎɁɈɗȾɃɛɎɄɛɆɌɊȾɄ60RQRYHWWH®.

2.

ȝɁɃɊɋȼɍɉɗɁ ɄȿɇɗɄɇɄ 6DIHW\ 0XOWLĲ\®.

3.

ȪɀɉɊɌȼɃɊȾɗɁɋɁɌɓȼɎɆɄɈɁɀɄɒɄɉɍɆɄɅɑȼɇȼɎɃȼɕɄɎɉɗɁɊɓɆɄɄɇɄɀɌɏȿɄɁɋɊɀɑɊɀɛɕɄɁɍɌɁɀɍɎȾȼɄɉɀɄȾɄɀɏȼɇɘɉɊɅɃȼɕɄɎɗɀɇɛɋɌɁɀɊɎȾɌȼɕɁɉɄɛɆɊɉɎȼɆɎȼɍɋȼɎɊȿɁɉȼɈɄɄɇɄɋɊɎɁɉɒɄȼɇɘɉɊɄɉɐɁɆɒɄɊɉɉɗɈɄ
ɈȼɎɁɌɄȼɇȼɈɄɋɁɌɁɉɊɍɄɈɗɈɄɍɆɌɊȾɘɚ

4.

ȹɎɄɆɁɎɆɄɀɇɛɄɀɁɉɎɄɐɄɆȼɒɄɄɋȼɒɄɁɉɎɊȾ

5.

ȠɁɃɄɉɐɄɒɄɌɏɚɕɁɁɍɌɁɀɍɎȾɊɀɇɛɊȽɌȼȽɊɎɆɄɈɁɍɎȼɋɌɊɆɊɇȼ ɍɊȽɇɚɀȼɅɎɁɍȼɉɄɎȼɌɉɊȿɄȿɄɁɉɄɓɁɍɆɄɁɋɌȼȾɄɇȼɄɄɉɍɎɌɏɆɒɄɄɋɊɋɊɀȿɊɎɊȾɆɁɈɁɍɎȼɋɌɊɆɊɇȼɀɇɛȾɃɛɎɄɛɊȽɌȼɃɒɊȾɆɌɊȾɄɋɌɄɉɛɎɗɁȾȞȼɔɁɈ
ɏɓɌɁɂɀɁɉɄɄ ȩɁɄɍɋɊɇɘɃɏɅɎɁɀɁɃɄɉɐɄɒɄɌɏɚɕɄɁɍɌɁɀɍɎȾȼɍɊɀɁɌɂȼɕɄɁɍɋɄɌɎɁɍɇɄȾɃɛɎɗɁɋɌɊȽɗɋɌɁɀɉȼɃɉȼɓɁɉɗɀɇɛɎɁɍɎȼɉȼɍɊɀɁɌɂȼɉɄɁȼɇɆɊȿɊɇɛȾɆɌɊȾɄ

6.

ȭɎɁɌɄɇɘɉɗɁɍȼɇɐɁɎɆɄ

7.

ȞɁɉɊɃɉɗɅɂȿɏɎ

8.

ȫɇȼɍɎɗɌɘɄɇɄȽɄɉɎ

9.

ȦɊɉɎɁɅɉɁɌɀɇɛȽɁɃɊɋȼɍɉɊɅɏɎɄɇɄɃȼɒɄɄɄɍɋɊɇɘɃɊȾȼɉɉɊȿɊɈȼɎɁɌɄȼɇȼ

ȬɁɆɊɈɁɉɀɏɁɈɗɅɋɊɌɛɀɊɆȾɃɛɎɄɛɋɌɊȽȾɁɉɊɃɉɊɅɆɌɊȾɄ
1.

ȫɌɊȽɄɌɆɄ ɐɇȼɆɊɉ ɀɇɛȼɉȼɇɄɃȼɉȼɍɎɁɌɄɇɘɉɊɍɎɘ

2.

ȫɌɊȽɄɌɆɄɍɒɄɎɌȼɎɊɈɄɇɄȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄ ȭɗȾɊɌɊɎɆȼȭɗȾɊɌɊɎɆȼȿɁɇɘ 

3.

ȫɌɊȽɄɌɆɄɍȼɆɎɄȾȼɎɊɌɊɈɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɄɇɄɒɄɎɌȼɎɊɈ

4.

ȫɌɊȽɄɌɆɄɍȿɁɋȼɌɄɉɊɈɄȿɁɇɁɈ ɄɇɄȽɁɃȿɁɇɛ

5.

ȫɌɊȽɄɌɆɄɍȹȠȮȜɄȿɁɇɁɈ ɄɇɄȽɁɃȿɁɇɛ

6.

ȫɌɊȽɄɌɆɄɍɄɉȿɄȽɄɎɊɌȼɈɄȿɇɄɆɊɇɄɃȼ

7.

ȫɌɊȽɄɌɆɄɍɀɌɏȿɄɈɄɀɊȽȼȾɆȼɈɄ
ȫȬȤȨȡȳȜȩȤȡȡɍɇɄȾɃɛɎɄɁɆɌɊȾɄɊɍɏɕɁɍɎȾɇɛɁɎɍɛɋɌɄɋɊɈɊɕɄȽɁɃɊɋȼɍɉɊɅɄȿɇɗȽȼȽɊɓɆɄ6DIHW\0XOWLĲ\®ɄɋɌɊȽɄɌɆȼɍɒɄɎɌȼɎɊɈɄɇɄɀɌɏȿȼɛɋɌɊȽɄɌɆȼɍɂɄɀɆɊɅɀɊȽȼȾɆɊɅ ɉȼɋɌɄɈɁɌ
3)$&7$'&3'$+&<&ɄɇɄ*OXFR(;$&7 ɄɍɋɊɇɘɃɏɁɎɍɛɋɁɌȾɊɅɄɇɄɄɍɋɊɇɘɃɏɁɎɍɛɎɊɇɘɆɊɋɌɊȽɄɌɆȼɍɀɊȽȼȾɆɊɅɎɊɌɁɆɊɈɁɉɀɏɁɎɍɛɋɁɌȾɊɅɄɍɋɊɇɘɃɊȾȼɎɘɋɏɍɎɏɚ
ɋɌɊȽɄɌɆɏȽɁɃɀɊȽȼȾɆɄ ɉȼɋɌɄɈɁɌ60RQRYHWWH®ɉɁɅɎɌȼɇɘɉȼɛ= ɓɎɊȽɗɃȼɋɊɇɉɄɎɘɋɏɍɎɊɁɋɌɊɍɎɌȼɉɍɎȾɊɆȼɎɁɎɁɌȼɄȿɇɗȽȼȽɊɓɆɄɄɊȽɁɍɋɁɓɄɎɘɎɁɈɍȼɈɗɈɃȼɋɊɇɉɁɉɄɁ
ɍɇɁɀɏɚɕɁɅɋɌɊȽɄɌɆɄɍɀɊȽȼȾɆɊɅɀɊɉɏɂɉɊȿɊɏɌɊȾɉɛ

ȫȬȤȨȡȳȜȩȤȡȫɌɄȾɗȽɊɌɁɋɊɌɛɀɆȼȾɃɛɎɄɛɋɌɊȽɌɏɆɊȾɊɀɍɎȾɏɅɎɁɍɘɋɌɁɀɋɄɍȼɉɄɛɈɄɀɁɅɍɎȾɏɚɕɄɈɄȾȞȼɔɁɈɏɓɌɁɂɀɁɉɄɄ

ȩɁɀɊɋɏɍɆȼɅɎɁɊȽɌȼɎɉɊȿɊɊɎɎɊɆȼ
ȝɊɇɘɔɄɉɍɎȾɊɍɄɍɎɁɈ60RQRYHWWHɍɊɀɁɌɂȼɎɑɄɈɄɓɁɍɆɄɁɀɊȽȼȾɆɄȠɇɛɋɌɁɀɊɎȾɌȼɕɁɉɄɛɊȽɌȼɎɉɊȿɊɊɎɎɊɆȼɍɇɁɀɏɁɎɋɌɄɉɄɈȼɎɘɍɇɁɀɏɚɕɄɁɈɁɌɗ
1. ȫɌɄɈɁɉɛɅɎɁɄɍɆɇɚɓɄɎɁɇɘɉɊɈȼɎɁɌɄȼɇɗɏɆȼɃȼɉɉɗɁȾɄɉɍɎɌɏɆɒɄɄɋɊɋɌɄɈɁɉɁɉɄɚ
2.

ȬȼɍɋɊɇɊɂɄɎɁɋȼɒɄɁɉɎȼɎȼɆɓɎɊȽɗȽɗɇɊȽɁɍɋɁɓɁɉɏɀɊȽɉɗɅɀɊɍɎɏɋɆȾɁɉɁȼɌɏɆȼɄɇɄɀɌɏȿɊɁɈɁɍɎɊɋɏɉɆɒɄɄɋȼɒɄɁɉɎȼȽɗɇɊɉȼɋɌȼȾɇɁɉɊȾɉɄɃ

3.

ȯɀɁɌɂɄȾȼɅɎɁɋɌɊȽɄɌɆɏ60RQRYHWWH®ɌɁɃɘȽɊȾɊɅɆɌɗɔɆɊɅȾȾɁɌɑȼɋɌɄɄɍɋɊɇɘɃɊȾȼɉɄɄ ȽɁɃɊɋȼɍɉɊɅ ɄȿɇɗȽȼȽɊɓɆɄ 6DIHW\ 0XOWLĲ\®ɎȼɆɂɁɉɄɂɁɏɌɊȾɉɛɌɏɆɄɈɁɍɎȼɋɏɉɆɒɄɄ

4.

ȩɁɊȽɑɊɀɄɈɊɍɇɁɀɄɎɘɃȼɎɁɈɓɎɊȽɗɍɊɀɁɌɂɄɈɊɁ60RQRYHWWH®ɉɁɆȼɍȼɇɊɍɘɌɁɃɘȽɊȾɊɅɆɌɗɔɆɄɄɇɄɆɊɉɒȼɄȿɇɗȾɊȾɌɁɈɛɋɏɉɆɒɄɄȾɁɉɗ

5.

ȪɍɇȼȽɘɎɁɂȿɏɎɋɊɆȼɆɌɊȾɘɋɊɍɎɏɋȼɁɎȾ60RQRYHWWH®.

185

RU
ȣȼɈɊɌȼɂɄȾȼɉɄɁɌȼɃɈɊɌȼɂɄȾȼɉɄɁ
ȭɊȿɇȼɍɉɊɌɁɆɊɈɁɉɀȼɒɄɛɈȞȪȣ :+2',//DE5HY ɍɗȾɊɌɊɎɆɏɋɇȼɃɈɏɍɇɁɀɏɁɎɊɎɀɁɇɛɎɘɊɎɆɇɁɎɊɆɆɌɊȾɄɋɁɌɁɀɃȼɈɊɌȼɂɄȾȼɉɄɁɈ
ȫɌɄɃȼɈɊɌȼɂɄȾȼɉɄɄɋɌɊȽɄɌɊɆ60RQRYHWWH®ɌɁɆɊɈɁɉɀɏɁɎɍɛɋɌɄɀɁɌɂɄȾȼɎɘɍɛɍɇɁɀɏɚɕɄɑɋɌȼȾɄɇ
ȣȼɈɊɌȼɂɄȾȼɉɄɁɋɌɄɎɁɈɋɁɌȼɎɏɌɁɉɄɂɁƓ&•ȤɍɋɊɇɘɃɊȾȼɉɄɁɋɌɊȽɄɌɊɆȾɀɄȼɋȼɃɊɉɁɊɎɌɄɒȼɎɁɇɘɉɗɑɎɁɈɋɁɌȼɎɏɌɉɁɊȽɑɊɀɄɈɊɊɍɉɊȾȼɎɁɇɘɉɊɋɌɊɎɁɍɎɄɌɊȾȼɎɘȾɌɁȼɇɘɉɗɑɏɍɇɊȾɄɛɑɋɊɍɆɊɇɘɆɏɉȼȿɌɏɃɆȼɉȼɁɈɆɊɍɎɄɈɊɂɁɎɍɄɇɘɉɊɌȼɃɇɄɓȼɎɘɍɛȾ
ɃȼȾɄɍɄɈɊɍɎɄɊɎɃȼɈɊɌȼɂɄȾȼɁɈɊȿɊȾɁɕɁɍɎȾȼɄɌɏɎɄɉɉɗɑɏɍɇɊȾɄɅɋɌɄɈɁɉɁɉɄɛ ɍɈȿɇȼȾɏŝȭȾɊɅɍɎȾȼɈȼɎɁɌɄȼɇɊȾŞȾɆȼɎȼɇɊȿɁ6$567('7 •ȦȼɆɋɌȼȾɄɇɊɑȼɌȼɆɎɁɌɄɍɎɄɆɄɋɌɊɓɉɊɍɎɄɋɊɇɄɈɁɌɉɗɑɈȼɎɁɌɄȼɇɊȾɋɌɄɎɁɈɋɁɌȼɎɏɌɁɉɄɂɁƓ&ɍɉɄɂȼɚɎɍɛȫɊəɎɊɈɏɈɁɑȼɉɄɓɁɍɆɄɑɉȼȿɌɏɃɊɆɍɇɁɀɏɁɎȾɋɌɄɉɒɄɋɁɄɃȽɁȿȼɎɘ

•ȯɍɇɊȾɄɛɃȼɈɊɌȼɂɄȾȼɉɄɛɉɁɊȽɑɊɀɄɈɊȾɗȽɄɌȼɎɘɎȼɆɄɈɊȽɌȼɃɊɈɓɎɊȽɗɍɊɀɁɌɂɄɈɊɁɋɌɊȽɄɌɊɆ60RQRYHWWH®ɃȼɈɊɌȼɂɄȾȼɇɊɍɘɌȼȾɉɊɈɁɌɉɊɇɄȽɊɋɊɉȼɋɌȼȾɇɁɉɄɚɍɉɄɃɏȾȾɁɌɑȫɌɊȽɄɌɆȼ60RQRYHWWH®,ɋɊɈɁɕȼɁɈȼɛȾɔɎȼɎɄȾɄɇɄȽɊɆɍɀɇɛɑɌȼɉɁɉɄɛɀɊɇɂɉȼɄɈɁɎɘɀɊɍɎȼɎɊɓɉɊɍȾɊȽɊɀɉɊȿɊɋɌɊɍɎɌȼɉɍɎȾȼɉȼɍɇɏɓȼɅɌȼɍɔɄɌɁɉɄɛɁɁɊȽɖɁɈȼȠɁɌɂȼɎɁɇɄɄɃɋɁɉɊɋɇȼɍɎȼɄɇɄɈɁɎȼɇɇȼɉɁɋɊɀɑɊɀɛɎɀɇɛɀȼɉɉɊɅ
ɒɁɇɄɋɊɍɆɊɇɘɆɏɈɊȿɏɎȾɗɃɗȾȼɎɘɎɌɁɕɄɉɗɈȼɎɁɌɄȼɇȼɋɌɄɌȼɍɎɛɂɁɉɄɄ

ȣȼɈɊɌȼɂɄȾȼɉɄɁɀɊƓ&ŠɋɁɌɁɀɃȼɈɊɌȼɂɄȾȼɉɄɁɈɍɇɁɀɏɁɎɋɌɊȾɁɌɄɎɘ
•ȞɊɃɈɊɂɉɗɁɍɇɊɂɉɊɍɎɄɋɌɊȾɁɌɘɎɁɉɁɊɆȼɃɗȾȼɁɎɇɄɃȼɈɊɌȼɂɄȾȼɉɄɁɊɎɌɄɒȼɎɁɇɘɉɊȿɊȾɊɃɀɁɅɍɎȾɄɛɉȼɆȼɓɁɍɎȾɊɊȽɌȼɃɒȼɆɌɊȾɄɄɇɄȼɉȼɇɄɃȼ ɉȼɋɌɄɈɁɌȾɊɎɉɊɔɁɉɄɄȿɁɈɊɇɄɃȼɍɎȼȽɄɇɘɉɊɍɎɄȼɉȼɇɄɎɊȾ •ȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɎɌɁȽɏɁɎɍɛȾɃȼȾɄɍɄɈɊɍɎɄɊɎɋɇȼɉɄɌɏɁɈɊȿɊȼɉȼɇɄɃȼȭɊȽɇɚɀȼɅɎɁɏɍɇɊȾɄɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɍɈəɎɊɎɀɊɆɏɈɁɉɎȾɌȼɃɀɁɇɁŝȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁŞɄɇɄɋɊɍɁɎɄɎɁɍȼɅɎ6$567('7
https://www.sarstedt.com/en/service/centrifugation/ȼɎȼɆɂɁȾɗɋɊɇɉɄɎɁȾɄɃɏȼɇɘɉɗɅɆɊɉɎɌɊɇɘɊȽɌȼɃɒɊȾ

•ȟɁɈɊɇɄɃɋɌɄɃȼɈɊɌȼɂɄȾȼɉɄɄɒɁɇɘɉȼɛɆɌɊȾɘɍɎȼɉɊȾɄɎɍɛȿɁɈɊɇɄɃɄɌɊȾȼɉɉɊɅȠɇɛɋɌɁɀɊɎȾɌȼɕɁɉɄɛəɎɊȿɊɍɇɁɀɏɁɎɄɍɋɊɇɘɃɊȾȼɎɘɇɄȽɊɋɌɊȽɄɌɆɏ60RQRYHWWH®ɍȿɁɇɁɈɇɄȽɊɋɊɍɇɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛŠɆɇȼɋȼɉɉɗɅɐɄɇɘɎɌ6HUDSODV®ɇɄȽɊɋɁɌɁɇɄɎɘɊȽɌȼɃɁɒȾɊȾɎɊɌɄɓɉɏɚɋɌɊȽɄɌɆɏ

ȣȼɈɊɌȼɂɄȾȼɉɄɁɀɊƓ&ŠȾɗɋɊɇɉɁɉɄɁɋɌɊɒɁɀɏɌɗ
•ȣȼɈɊɌȼɂɄȾȼɉɄɁɊɑɇȼɀɄɎɁɋɌɊȽɄɌɆɏ60RQRYHWWH®ɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɗɉȼɑɊɀɛɕɏɚɍɛȾȾɁɌɎɄɆȼɇɘɉɊɈɋɊɇɊɂɁɉɄɄȾɎɁɓɁɉɄɁşɈɄɉɏɎɀɊƓ&ɋɌɁɂɀɁɓɁɈɋɊɀȾɁɌȿȼɎɘɁɁɃȼɈɊɌȼɂɄȾȼɉɄɚɀɊ
-20 °C.

•ȬȼɃɈɊɌȼɂɄȾȼɉɄɁɌȼɃɈɊɌȼɂɄȾȼɅɎɁɋɌɊȽɄɌɆɏȾȾɁɌɎɄɆȼɇɘɉɊɈɋɊɇɊɂɁɉɄɄɉȼɋɌɊɎɛɂɁɉɄɄɈɄɉɏɎɋɌɄɆɊɈɉȼɎɉɊɅɎɁɈɋɁɌȼɎɏɌɁȫɌɄəɎɊɈɍɇɁɀɏɁɎɎȼɆɂɁɄɃȽɁȿȼɎɘɈɁɑȼɉɄɓɁɍɆɄɑɉȼȿɌɏɃɊɆȭɇɄɔɆɊɈ
ȽɗɍɎɌɊɁɌȼɃɈɊɌȼɂɄȾȼɉɄɁɈɊɂɁɎɋɌɄȾɁɍɎɄɆɄɍɆȼɂɁɉɄɚɌɁɃɏɇɘɎȼɎɊȾȼɉȼɇɄɃȼ

ȣȼɈɊɌȼɂɄȾȼɉɄɁɄȿɇɏȽɊɆȼɛɃȼɈɊɌɊɃɆȼɋɌɄɎɁɈɋɁɌȼɎɏɌɁɉɄɂɁƓ&•ȟɇɏȽɊɆȼɛɃȼɈɊɌɊɃɆȼɀɊɎɁɈɋɁɌȼɎɏɌɉɄɂɁƓ&ɋɌɊɄɃȾɊɀɄɎɁɇɁɈɉɁɋɌɊȾɁɌɛɇȼɍɘȞɍȾɛɃɄɍȽɊɇɘɔɄɈɆɊɇɄɓɁɍɎȾɊɈȾɊɃɈɊɂɉɗɑɐȼɆɎɊɌɊȾȾɇɄɛɉɄɛɌɁɆɊɈɁɉɀɏɁɎɍɛɋɌɊȾɁɍɎɄɄɍɋɗɎȼɎɁɇɘɉɏɚɃȼɈɊɌɊɃɆɏȾ
ɌɏɎɄɉɉɗɑɏɍɇɊȾɄɛɑɆɊɉɆɌɁɎɉɊɅɇȼȽɊɌȼɎɊɌɄɄ

ȣȼɈɊɌȼɂɄȾȼɉɄɁɋɌɊȽɄɌɊɆ60RQRYHWWH®ɍȿɁɇɁɈ
•ȣȼɈɊɌȼɂɄȾȼɉɄɁɋɌɊȾɊɀɄɎɍɛɍɊȿɇȼɍɉɊɊɋɄɍȼɉɄɚȾɌȼɃɀɁɇɁŝȣȼɈɊɌȼɂɄȾȼɉɄɁɀɊƓ&ŠȾɗɋɊɇɉɁɉɄɁɋɌɊɒɁɀɏɌɗŞ•ȤɃȾɁɍɎɉɊɓɎɊȿɁɇɁȾɗɅɍɇɊɅɋɌɄɊɋɌɁɀɁɇɁɉɉɗɑɏɍɇɊȾɄɛɑɈɊɂɁɎɄɃɈɁɉɛɎɘɍɛɋɊɀȾɊɃɀɁɅɍɎȾɄɁɈɋɌɊɒɁɍɍȼɃȼɈɊɌɊɃɆɄ

•ȞɍȾɛɃɄɍȽɊɇɘɔɄɈɆɊɇɄɓɁɍɎȾɊɈȾɊɃɈɊɂɉɗɑɐȼɆɎɊɌɊȾȾɇɄɛɉɄɛɌɁɆɊɈɁɉɀɏɁɎɍɛɋɌɊȾɁɍɎɄɄɍɋɗɎȼɎɁɇɘɉɏɚɃȼɈɊɌɊɃɆɏȾɌɏɎɄɉɉɗɑɏɍɇɊȾɄɛɑɆɊɉɆɌɁɎɉɊɅɇȼȽɊɌȼɎɊɌɄɄ

•ȬȼɃɈɊɌȼɂɄȾȼɉɄɁɌȼɃɈɊɌȼɂɄȾȼɎɘɋɌɊȽɄɌɆɏɍɋɌɊȽɊɅɍɇɁɀɏɁɎȾȾɁɌɎɄɆȼɇɘɉɊɈɋɊɇɊɂɁɉɄɄȫɊɍɇɁɌȼɃɈɊɌȼɂɄȾȼɉɄɛɋɌɊȽɉɗɅɈȼɎɁɌɄȼɇɀɊɇɂɁɉȽɗɎɘɋɁɌɁɈɁɕɁɉɋɌɄɋɊɈɊɕɄɋɄɋɁɎɆɄ ɉɁɋɏɎɁɈ
ɋɁɌɁɇɄȾȼɉɄɛ ɄɃɋɁɌȾɄɓɉɊɅɋɌɊȽɄɌɆɄȾɊȾɎɊɌɄɓɉɏɚɎȼɆɓɎɊȽɗɉȼɀȿɁɇɁȾɗɈɍɇɊɁɈɊɍɎȼȾȼɇɊɍɘɋɌɄȽɇɈɈȪɍɎȼɎɊɆɈȼɎɁɌɄȼɇȼɈɊɂɉɊȾɗȽɌɊɍɄɎɘ
ȫȬȤȨȡȳȜȩȤȡɀɇɛɊȽɁɍɋɁɓɁɉɄɛɍɎȼȽɄɇɘɉɊɍɎɄȼɉȼɇɄɎɊȾɉɁɊȽɑɊɀɄɈɊɍɇɁɀɊȾȼɎɘɄɉɍɎɌɏɆɒɄɄɋɊɋɌɄɈɁɉɁɉɄɚɊɎɋɌɊɄɃȾɊɀɄɎɁɇɛɎɁɍɎɊȾɊȿɊɌɁȼȿɁɉɎȼɋɌɄȽɊɌȼȼɉȼɇɄɃȼɎɊɌȼ

186

RU
ȞɃɛɎɄɁɆɌɊȾɄ
ȨɁɎɊɀɄɆɄȾɃɛɎɄɛɋɌɊȽ
ȬȼɃɇɄɓȼɚɎɀȾɁɎɁɑɉɄɆɄȾɃɛɎɄɛɆɌɊȾɄŠȼɍɋɄɌȼɒɄɊɉɉɏɚɄȾȼɆɏɏɈɉɏɚ
ȝɇȼȿɊɀȼɌɛɆɊɉɎɌɊɇɄɌɏɁɈɊɈɏɊɎɎɛȿɄȾȼɉɄɚɔɎɊɆȼɋɊɌɔɉɛȼɍɋɄɌȼɒɄɊɉɉȼɛɎɁɑɉɄɆȼɊȽɁɍɋɁɓɄȾȼɁɎɕȼɀɛɕɁɁȾɃɛɎɄɁɆɌɊȾɄɍɉɁɋɌɁɌɗȾɉɗɈɄɈɁɀɇɁɉɉɗɈɆɌɊȾɊɎɊɆɊɈȹɎɊɋɊɃȾɊɇɛɁɎɉɁɈɁɀɇɁɉɉɊȼɀȼɋɎɄɌɊȾȼɎɘ
ɆɌɊȾɊɎɊɆɆɊȾɍɁɈȾɁɉɊɃɉɗɈɍɊɍɎɊɛɉɄɛɈɄɊȽɍɎɊɛɎɁɇɘɍɎȾȼɈȼɎȼɆɂɁɏɈɁɉɘɔɄɎɘȿɁɈɊɇɄɃ
ȞȼɆɏɏɈɉȼɛɎɁɑɉɄɆȼɋɊɃȾɊɇɛɁɎȽɌȼɎɘɆɌɊȾɘɄɃɋɌɁɀȾȼɌɄɎɁɇɘɉɊȾȼɆɏɏɈɄɌɊȾȼɉɉɊɅɋɌɊȽɄɌɆɄɋɊɋɌɄɉɒɄɋɏɊɎɌɄɒȼɎɁɇɘɉɊȿɊɀȼȾɇɁɉɄɛɍɉɁɋɌɁɌɗȾɉɗɈɄȽɗɍɎɌɗɈɋɊɎɊɆɊɈɆɌɊȾɄȮȼɆɄɈɊȽɌȼɃɊɈəɎɊɎɈɁɎɊɀ
ɄɀɁȼɇɁɉɀɇɛɌȼȽɊɎɗɍɋȼɒɄɁɉɎȼɈɄɍɑɊɌɊɔɄɈɍɊɍɎɊɛɉɄɁɈȾɁɉɄɉɁɃȼɎɌɏɀɉɁɉɉɗɑɏɍɇɊȾɄɅȾɃɛɎɄɛɋɌɊȽ
ȬɏɆɊȾɊɀɍɎȾɊɋɊȾɃɛɎɄɚɆɌɊȾɄɍɈɎȼɆɂɁȾɄɀɁɊɌɏɆɊȾɊɀɍɎȾɊɋɊɌȼȽɊɎɁɍɋɌɊȽɄɌɆȼɈɄ60RQRYHWWH®ɋɌɄɄɍɋɊɇɘɃɊȾȼɉɄɄȼɍɋɄɌȼɒɄɊɉɉɊɅɄɇɄȾȼɆɏɏɈɉɊɅɎɁɑɉɄɆɄɍȽɁɃɊɋȼɍɉɊɅɄȿɇɊɅɄɇɄɄȿɇɊɅȽȼȽɊɓɆɊɅ
Safety-Multifly®:www.sarstedt.com/en/download/videos/Diagnostics/Venous bloodȤȭȫȪȧȸȣȯȥȮȡȫȡȬȳȜȮȦȤȳȮȪȝȷȭȞȡȭȮȤȦȨȤȩȤȨȯȨȯȬȤȭȦȤȩȰȤȲȤȬȪȞȜȩȤȻȞȪȞȬȡȨȻȞȣȻȮȤȻȦȬȪȞȤ
1. ȞɗȽɁɌɄɎɁɋɊɀɑɊɀɛɕɄɁɍɄɍɎɁɈɗ60RQRYHWWH®ɀɇɛȾɃɛɎɄɛɉɁɊȽɑɊɀɄɈɊɅɋɌɊȽɗ
2.

ȪɋɌɁɀɁɇɄɎɁɈɁɍɎɊɋɌɊȾɁɀɁɉɄɛȾɁɉɁɋɏɉɆɒɄɄȫɌɄɋɊɀȿɊɎɊȾɆɁɏɓȼɍɎɆȼȾɁɉɁɋɏɉɆɒɄɄɍɇɁɀɏɅɎɁɋɌɁɀɋɄɍȼɉɄɛɈɀɁɅɍɎȾɏɚɕɄɈȾȞȼɔɁɈɏɓɌɁɂɀɁɉɄɄ

ȞɃɛɎɄɁɆɌɊȾɄɍɋɊɈɊɕɘɚȼɍɋɄɌȼɒɄɊɉɉɊɅɎɁɑɉɄɆɄ
ȞɉɄɈȼɉɄɁȫɌɊɀɏɆɎɗ60RQRYHWWH®ɋɌɁɀɉȼɃɉȼɓɁɉɗɎɊɇɘɆɊɀɇɛȾɃɛɎɄɛɆɌɊȾɄȼɉɁɀɇɛȾȾɁɀɁɉɄɛɄɉɖɁɆɒɄɅ
ȬȼȽɊɎȼɅɎɁɎɊɇɘɆɊɍəɎɄɈɄɄȿɇȼɈɄ ȽɁɃɊɋȼɍɉɗɁɄȿɇɗ60RQRYHWWH®ɄɇɄ ȽɁɃɊɋȼɍɉɗɁ ɄȿɇɗȽȼȽɊɓɆɄ 6DIHW\ 0XOWLIO\®  ȼɀȼɋɎɁɌɗɀɇɛ60RQRYHWWH®).
ȤɍɋɊɇɘɃɊȾȼɉɄɁɍȽɁɃɊɋȼɍɉɊɅɄȿɇɊɅɋɊɆȼɃȼɉɊɃɀɁɍɘ

ɕɁɇɓɊɆ

ȩɁɋɊɍɌɁɀɍɎȾɁɉɉɊɋɁɌɁɀȾɁɉɁɋɏɉɆɒɄɁɅȾɍɎȼȾɘɎɁɋɌɊȽɄɌɆɏ60RQRYHWWH®ȾɊȾɍɎɌɊɁɉɉɗɅɀɁɌɂȼɎɁɇɘȽɁɃɊɋȼɍɉɊɅɄȿɇɗ ɄɃȼɐɄɆɍɄɌɏɅɎɁɁɁɇɁȿɆɄɈɋɊȾɊɌɊɎɊɈɋɊɓȼɍɊȾɊɅɍɎɌɁɇɆɁ .
ȫɌɄɉɁɊȽɑɊɀɄɈɊɍɎɄɉȼɇɊɂɄɎɁȾɁɉɊɃɉɗɅɂȿɏɎ ɉɁȽɊɇɁɁɈɄɉɏɎɗ ȪȽɌȼȽɊɎȼɅɎɁɈɁɍɎɊɋɏɉɆɒɄɄɋɊɀɑɊɀɛɕɄɈɀɁɃɄɉɐɄɒɄɌɏɚɕɄɈɍɌɁɀɍɎȾɊɈȫɊɍɇɁɀɁɃɄɉɐɁɆɒɄɄȽɊɇɘɔɁɉɁ
ɋɌɄɆȼɍȼɅɎɁɍɘɆɈɁɍɎɏȾɁɉɁɋɏɉɆɒɄɄȬȼɍɋɊɇɊɂɄɎɁɋȼɒɄɁɉɎȼɎȼɆɓɎɊȽɗȽɗɇɊȽɁɍɋɁɓɁɉɏɀɊȽɉɗɅɀɊɍɎɏɋɆȾɁɉɁȼɌɏɆȼɄɇɄɀɌɏȿɊɁɈɁɍɎɊɋɏɉɆɒɄɄɋȼɒɄɁɉɎȼȽɗɇɊɉȼɋɌȼȾɇɁɉɊȾɉɄɃ
ȭɉɄɈɄɎɁɃȼɕɄɎɉɗɅɆɊɇɋȼɓɊɆɍɄȿɇɗȫɏɉɆɎɄɌɏɅɎɁȾɁɉɏɈɁɀɇɁɉɉɊɊɎɎɛɉɄɎɁɔɎɊɆɋɊɌɔɉɛɉȼɃȼɀȼɃȼɎɁɈɊɍɇȼȽɘɎɁȾɁɉɊɃɉɗɅɂȿɏɎɋɊɆȼɆɌɊȾɘȽɏɀɁɎɋɊɍɎɏɋȼɎɘȾɋɌɊȽɄɌɆɏ60RQRYHWWH®
ȠɊɂɀɄɎɁɍɘɋɌɁɆɌȼɕɁɉɄɛɎɊɆȼɆɌɊȾɄɓɎɊȽɗɊȽɁɍɋɁɓɄɎɘɋɌȼȾɄɇɘɉɊɁɃȼɋɊɇɉɁɉɄɁɋɌɊȽɄɌɆɄ

.

ȫɊɍɇɁəɎɊȿɊɋɌɊȽɄɌɆɏ60RQRYHWWH®ɍɇɁɀɏɁɎɍɇɁȿɆȼɋɊȾɁɌɉɏɎɘɋɌɊɎɄȾɓȼɍɊȾɊɅɍɎɌɁɇɆɄ ɄɄɃȾɇɁɓɘɁɁɄɃȽɁɃɊɋȼɍɉɊɅɄȿɇɗ ɊɎɍɊɁɀɄɉɁɉɄɁ  ȝɁɃɊɋȼɍɉȼɛɄȿɇȼɊɍɎȼɁɎɍɛȾȾɁɉɁ
ȫɌɄɈɉɊȿɊɆɌȼɎɉɊɈȾɃɛɎɄɄɋɌɊȽŠɆȼɆɊɋɄɍȼɉɊȾɗɔɁŠɋɊɍɇɁɀɏɚɕɄɁɋɌɊȽɄɌɆɄ60RQRYHWWH®ɋɊɀɍɊɁɀɄɉɛɚɎɍɛɆȽɁɃɊɋȼɍɉɊɅɄȿɇɁɄɆȼɂɀɗɅɌȼɃȽɁɌɁɎɍɛɀɊɋɊɇɉɄɎɁɇɘɉȼɛɋɌɊȽȼ
ȣȼȾɁɌɔɁɉɄɁɋɌɊɒɁɀɏɌɗȾɃɛɎɄɛɆɌɊȾɄɍɉȼɓȼɇȼɊɎɍɊɁɀɄɉɄɎɁɋɌɊȽɄɌɆɏ60RQRYHWWH®
+ ȼɃȼɎɁɈɄɃȾɇɁɆɄɎɁȽɁɃɊɋȼɍɉɏɚɄȿɇɏɄɃȾɁɉɗȞɗɈɊɂɁɎɁȼɆɎɄȾɄɌɊȾȼɎɘɃȼɕɄɎɉɗɅɆɊɇɋȼɓɊɆɊɀɉɊɅ
ɌɏɆɊɅɇɄȽɊɏɍɎȼɉɊȾɄɎɁɃȼɕɄɎɉɗɅɆɊɇɋȼɓɊɆɄȿɇɗɉȼɏɍɎɊɅɓɄȾɏɚɌɊȾɉɏɚɋɊȾɁɌɑɉɊɍɎɘɎȼɆɓɎɊȽɗɄȿɇȼɍɊɕɏɎɄɈɗɈɄɍɇɗɔɄɈɗɈŝɕɁɇɓɆɊɈŞɃȼɐɄɆɍɄɌɊȾȼɇȼɍɘȾɃȼɕɄɎɉɊɈɆɊɇɋȼɓɆɁ ȼɆɎɄȾȼɒɄɛ ɇɄȽɊɉȼɀȼȾɄɎɁɏɆȼɃȼɎɁɇɘɉɗɈɋȼɇɘɒɁɈɉȼɉɄɂɉɚɚɓȼɍɎɘɃȼɕɄɎɉɊȿɊɆɊɇɋȼɓɆȼȠɇɛȽɁɃɊɋȼɍɉɊɍɎɄɏȽɁɀɄɎɁɍɘɓɎɊɀȼȾɇɁɉɄɁɊɍɏɕɁɍɎȾɇɛɁɎɍɛɉȼɉɄɂɉɚɚɓȼɍɎɘɃȼɕɄɎɉɊȿɊɆɊɇɋȼɓɆȼȭɈɎȼɆɂɁ
ɄɉɍɎɌɏɆɒɄɚɋɊɋɌɄɈɁɉɁɉɄɚɀɇɛȽɁɃɊɋȼɍɉɗɑɄȿɇ60RQRYHWWH®ɄɇɄ 6DIHW\ 0XOWLIO\®.
ȭɌȼɃɏɋɊɍɇɁɊɎɍɊɁɀɄɉɁɉɄɛɊɎȽɁɃɊɋȼɍɉɊɅɄȿɇɗɋɌɊȽɄɌɆɏ60RQRYHWWH®ɍɇɁɀɏɁɎɌȼɃɋɁɌɁȾɁɌɉɏɎɘȾȾɁɌɑȾɉɄɃȼɋɊɍɇɁɊɆɊɉɓȼɎɁɇɘɉɊȿɊɃȼȾɁɌɔɁɉɄɛɋɌɊɒɁɀɏɌɗȾɃɛɎɄɛɆɌɊȾɄȾɍɁɋɌɊȽɗɍ
ȼɉɎɄɆɊȼȿɏɇɛɉɎȼɈɄɍɇɁɀɏɁɎɊɍɎɊɌɊɂɉɊɋɁɌɁȾɁɌɉɏɎɘȾȾɁɌɑɀɉɊɈɉɁɍɆɊɇɘɆɊɌȼɃ
ȫɁɌɁɀɎɌȼɉɍɋɊɌɎɄɌɊȾɆɊɅɄɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɈɉɁɊȽɑɊɀɄɈɊɊɎɎɛɉɏɎɘɔɎɊɆɋɊɌɔɉɛȾɉɄɃɀɊɁȿɊɐɄɆɍȼɒɄɄ  ɋɊɌɔɁɉɘɀɊɇɂɁɉɃȼɐɄɆɍɄɌɊȾȼɎɘɍɛɍɊɍɇɗɔɄɈɗɈɕɁɇɓɆɊɈȾɊɍɉɊȾȼɉɄɄɋɌɊȽɄɌɆɄ
S-Monovette® ȼɃȼɎɁɈɊɎɇɊɈɄɎɘɔɎɊɆɋɊɌɔɉɛ .
1.

ȫɌɄɇɊɂɄɎɁɆɈɁɍɎɏɋɏɉɆɒɄɄɍɏɑɏɚɍɎɁɌɄɇɘɉɏɚɍȼɇɐɁɎɆɏɄɀɊɂɀɄɎɁɍɘɋɊɇɉɊɅɊɍɎȼɉɊȾɆɄɆɌɊȾɊɎɊɆȼ

2.

ȦȼɆɎɊɇɘɆɊɉȼɓɉɁɎɍɛɋɌɊɒɁɍɍɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɉȼɇɊɂɄɎɁȽɄɉɎ ɋɊɂɁɇȼɉɄɚɋȼɒɄɁɉɎȼ 

3.

ȯɎɄɇɄɃɄɌɏɅɎɁȽɁɃɊɋȼɍɉɏɚɄȿɇɏȾɍɊɊɎȾɁɎɍɎȾɏɚɕɄɅɆɊɉɎɁɅɉɁɌɀɇɛɏɎɄɇɄɃȼɒɄɄȽɄɊɇɊȿɄɓɁɍɆɄɊɋȼɍɉɗɑɊɎɑɊɀɊȾ

187

RU
ȞɃɛɎɄɁɆɌɊȾɄȾȼɆɏɏɈɉɗɈɍɋɊɍɊȽɊɈ
ȞɉɄɈȼɉɄɁȫɌɊɀɏɆɎɗ60RQRYHWWH®ɋɌɁɀɉȼɃɉȼɓɁɉɗɎɊɇɘɆɊɀɇɛȾɃɛɎɄɛɆɌɊȾɄȼɉɁɀɇɛȾȾɁɀɁɉɄɛɄɉɖɁɆɒɄɅ
ȬȼȽɊɎȼɅɎɁɎɊɇɘɆɊɍəɎɄɈɄɄȿɇȼɈɄ ȽɁɃɊɋȼɍɉɗɁɄȿɇɗ60RQRYHWWH®ɄɇɄ ȽɁɃɊɋȼɍɉɗɁ ɄȿɇɗȽȼȽɊɓɆɄ 6DIHW\ 0XOWLIO\®  ȼɀȼɋɎɁɌɗɀɇɛ60RQRYHWWH®).
ȤɍɋɊɇɘɃɊȾȼɉɄɁɍȽɁɃɊɋȼɍɉɊɅɄȿɇɊɅɋɊɆȼɃȼɉɊɃɀɁɍɘ

ɕɁɇɓɊɆ

ȠɇɛɕȼɀɛɕɁȿɊɉȼɓȼɇȼȾɃɛɎɄɛɆɌɊȾɄ6$567('7ɌɁɆɊɈɁɉɀɏɁɎɋɌɄɌȼȽɊɎɁɍɋɁɌȾɊɅɋɌɊȽɄɌɆɊɅ60RQRYHWWH®ɄɍɋɊɇɘɃɊȾȼɎɘȼɍɋɄɌȼɒɄɊɉɉɏɚɎɁɑɉɄɆɏ ɍɈɌȼɃɀɁɇŝȮȡȱȩȤȦȜȞȡȩȡȫȯȩȦȲȤȤŞŝȜɍɋɄɌȼɒɄɊɉɉȼɛɎɁɑɉɄɆȼŞ  – .
ȠȼɇɁɁɈɊɂɉɊɋɌɊɀɊɇɂȼɎɘɌȼȽɊɎɏɍɋɊɈɊɕɘɚȾȼɆɏɏɈɉɊɅɎɁɑɉɄɆɄ
ȫɁɌɁɀȾɃɛɎɄɁɈɆɌɊȾɄɍɇɁɀɏɁɎɊɎɎɛɉɏɎɘɔɎɊɆɋɊɌɔɉɛɉȼɃȼɀɎȼɆɓɎɊȽɗɋɊɌɔɁɉɘɀɊɍɎɄȿɀɉȼɋɌɊȽɄɌɆɄ60RQRYHWWH®ɄɃȼɐɄɆɍɄɌɊȾȼɇɍɛȾɉɁɈɍɊɍɇɗɔɄɈɗɈ ɕɁɇɓɆɊɈȣȼɎɁɈɔɎɊɆɋɊɌɔɉɛ
ɉɁɊȽɑɊɀɄɈɊɊɎɇɊɈɄɎɘ .
ȞɍɎȼȾɘɎɁɋɊɀȿɊɎɊȾɇɁɉɉɏɚɎȼɆɄɈɊȽɌȼɃɊɈɋɌɊȽɄɌɆɏ60RQRYHWWH®ȾɊȾɍɎɌɊɁɉɉɗɅɀɁɌɂȼɎɁɇɘȽɁɃɊɋȼɍɉɊɅɄȿɇɗ60RQRYHWWH® ɄȿɇȼɏɂɁɏɍɎȼɉɊȾɇɁɉȼȾȾɁɉɁ ɄɃȼɐɄɆɍɄɌɏɅɎɁɁɁɇɁȿɆɄɈɋɊȾɊɌɊɎɊɈ+ .
ɋɊɓȼɍɊȾɊɅɍɎɌɁɇɆɁ

ȠɊɂɀɄɎɁɍɘɋɌɁɆɌȼɕɁɉɄɛɎɊɆȼɆɌɊȾɄɓɎɊȽɗɊȽɁɍɋɁɓɄɎɘɋɌȼȾɄɇɘɉɊɁɃȼɋɊɇɉɁɉɄɁɋɌɊȽɄɌɆɄ

ȫɊɍɇɁəɎɊȿɊɋɌɊȽɄɌɆɏ60RQRYHWWH®ɍɇɁɀɏɁɎɍɇɁȿɆȼɋɊȾɁɌɉɏɎɘɋɌɊɎɄȾɓȼɍɊȾɊɅɍɎɌɁɇɆɄ ɄɄɃȾɇɁɓɘɁɁɄɃȽɁɃɊɋȼɍɉɊɅɄȿɇɗ ɊɎɍɊɁɀɄɉɁɉɄɁ  ȝɁɃɊɋȼɍɉȼɛɄȿɇȼɊɍɎȼɁɎɍɛȾȾɁɉɁ
ȫɌɄɈɉɊȿɊɆɌȼɎɉɊɈȾɃɛɎɄɄɋɌɊȽŠɆȼɆɊɋɄɍȼɉɊȾɗɔɁŠɋɊɍɇɁɀɏɚɕɄɁɋɌɊȽɄɌɆɄ60RQRYHWWH®ɋɊɊɓɁɌɁɀɉɊɋɊɀɍɊɁɀɄɉɛɚɎɍɛɆȽɁɃɊɋȼɍɉɊɅɄȿɇɁɄɆȼɂɀɗɅɌȼɃȽɁɌɁɎɍɛɀɊɋɊɇɉɄɎɁɇɘɉȼɛɋɌɊȽȼ
ȣȼȾɁɌɔɁɉɄɁɋɌɊɒɁɀɏɌɗȾɃɛɎɄɛɆɌɊȾɄ
ȪɎɍɊɁɀɄɉɄɎɁɋɌɊȽɄɌɆɏ60RQRYHWWH® + ȼɃȼɎɁɈɄɃȾɇɁɆɄɎɁȽɁɃɊɋȼɍɉɏɚɄȿɇɏɄɃȾɁɉɗȞɗɈɊɂɁɎɁȼɆɎɄȾɄɌɊȾȼɎɘɃȼɕɄɎɉɗɅɆɊɇɋȼɓɊɆɊɀɉɊɅɌɏɆɊɅɇɄȽɊɏɍɎȼɉɊȾɄɎɁɃȼɕɄɎɉɗɅɆɊɇɋȼɓɊɆɄȿɇɗɉȼ
ɏɍɎɊɅɓɄȾɏɚɌɊȾɉɏɚɋɊȾɁɌɑɉɊɍɎɘɎȼɆɓɎɊȽɗɄȿɇȼɍɊɕɏɎɄɈɗɈɄɍɇɗɔɄɈɗɈŝɕɁɇɓɆɊɈŞɃȼɐɄɆɍɄɌɊȾȼɇȼɍɘȾɃȼɕɄɎɉɊɈɆɊɇɋȼɓɆɁ ȼɆɎɄȾȼɒɄɛ ɇɄȽɊɉȼɀȼȾɄɎɁɏɆȼɃȼɎɁɇɘɉɗɈɋȼɇɘɒɁɈɉȼɉɄɂɉɚɚ
ɓȼɍɎɘɃȼɕɄɎɉɊȿɊɆɊɇɋȼɓɆȼȠɇɛȽɁɃɊɋȼɍɉɊɍɎɄɏȽɁɀɄɎɁɍɘɓɎɊɀȼȾɇɁɉɄɁɊɍɏɕɁɍɎȾɇɛɁɎɍɛɉȼɉɄɂɉɚɚɓȼɍɎɘɃȼɕɄɎɉɊȿɊɆɊɇɋȼɓɆȼ
ȭɌȼɃɏɋɊɍɇɁɊɎɍɊɁɀɄɉɁɉɄɛɊɎȽɁɃɊɋȼɍɉɊɅɄȿɇɗɋɌɊȽɄɌɆɏ60RQRYHWWH®ɍɇɁɀɏɁɎɌȼɃɋɁɌɁȾɁɌɉɏɎɘȾȾɁɌɑȾɉɄɃȼɋɊɍɇɁɊɆɊɉɓȼɎɁɇɘɉɊȿɊɃȼȾɁɌɔɁɉɄɛɋɌɊɒɁɀɏɌɗȾɃɛɎɄɛɆɌɊȾɄȾɍɁɋɌɊȽɗɍ
ȼɉɎɄɆɊȼȿɏɇɛɉɎȼɈɄɍɇɁɀɏɁɎɊɍɎɊɌɊɂɉɊɋɁɌɁȾɁɌɉɏɎɘȾȾɁɌɑɀɉɊɈɉɁɍɆɊɇɘɆɊɌȼɃ
1.

ȫɌɄɇɊɂɄɎɁɆɈɁɍɎɏɋɏɉɆɒɄɄɍɏɑɏɚɍɎɁɌɄɇɘɉɏɚɍȼɇɐɁɎɆɏɄɀɊɂɀɄɎɁɍɘɋɊɇɉɊɅɊɍɎȼɉɊȾɆɄɆɌɊȾɊɎɊɆȼ

2.

ȦȼɆɎɊɇɘɆɊɉȼɓɉɁɎɍɛɋɌɊɒɁɍɍɍȾɁɌɎɗȾȼɉɄɛɆɌɊȾɄɉȼɇɊɂɄɎɁȽɄɉɎ ɋɊɂɁɇȼɉɄɚɋȼɒɄɁɉɎȼ 

3.

ȯɎɄɇɄɃɄɌɏɅɎɁȽɁɃɊɋȼɍɉɏɚɄȿɇɏȾɍɊɊɎȾɁɎɍɎȾɏɚɕɄɅɆɊɉɎɁɅɉɁɌɀɇɛɏɎɄɇɄɃȼɒɄɄȽɄɊɇɊȿɄɓɁɍɆɄɊɋȼɍɉɗɑɊɎɑɊɀɊȾ

188

RU
ȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁ
ȞȩȤȨȜȩȤȡȫɌɊȽɄɌɆɄ6$567('760RQRYHWWH®ɌȼɍɍɓɄɎȼɉɗɉȼɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɍɏɍɆɊɌɁɉɄɁɈ[JȤɍɆɇɚɓɁɉɄɁɈɛȾɇɛɚɎɍɛɋɌɊȽɄɌɆɄ60RQRYHWWH®ɀɄȼɈɁɎɌɊɈɈɈ 60RQRYHWWH®ɀɇɛɋɁɀɄȼɎɌɄɄ ɆɊɎɊɌɗɁȾɉȼɍɎɊɛɕɁɁȾɌɁɈɛȾȼɇɄɀɄɌɊȾȼɉɗɀɇɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɍɏɍɆɊɌɁɉɄɁɈɀɊ[JȤɍɋɊɇɘɃɏɅɎɁɎɊɇɘɆɊɋɊɀɑɊɀɛɕɄɁɉɁɍɏɕɄɁɋɌɊȽɄɌɆɄɄɇɄȾɆɇȼɀɆɄȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɋɌɊȽɄɌɊɆ
S-Monovette®ɍɎɌɁɕɄɉȼɈɄȼɎȼɆɂɁɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɍɊɍɇɄɔɆɊɈȾɗɍɊɆɄɈɊɎɉɊɍɄɎɁɇɘɉɗɈɒɁɉɎɌɊȽɁɂɉɗɈɏɍɆɊɌɁɉɄɁɈɈɊɂɁɎɋɌɄȾɁɍɎɄɆɋɊȾɌɁɂɀɁɉɄɚɋɌɊȽɄɌɊɆ60RQRYHWWH®ɓɎɊɈɊɂɁɎɋɊȾɇɁɓɘɃȼ
ɍɊȽɊɅȾɗɍȾɊȽɊɂɀɁɉɄɁɋɊɎɁɉɒɄȼɇɘɉɊɄɉɐɁɆɒɄɊɉɉɗɑɈȼɎɁɌɄȼɇɊȾ
ȞɍɎȼȾɆɄɀɇɛɒɁɉɎɌɄɐɏȿɄɍɇɁɀɏɁɎȾɗȽɄɌȼɎɘȾɍɊɊɎȾɁɎɍɎȾɄɄɍɌȼɃɈɁɌɊɈɄɍɋɊɇɘɃɏɁɈɗɑɋɌɊȽɄɌɊɆ60RQRYHWWH®ȪɎɉɊɍɄɎɁɇɘɉɊɁɒɁɉɎɌɊȽɁɂɉɊɁɏɍɆɊɌɁɉɄɁɉȼɑɊɀɄɎɍɛȾɍɇɁɀɏɚɕɁɈɍɊɊɎɉɊɔɁɉɄɄɍ
ɏɍɎȼɉɊȾɇɁɉɉɗɈɓɄɍɇɊɈɊȽɊɌɊɎɊȾȾɈɄɉɏɎɏ 530URWDWLRQSHUPLQXWH ȪȲȯ [U[ 530 2,ŝȪȲȯŞŝȪɎɉɊɍɄɎɁɇɘɉɊɁɒɁɉɎɌɊȽɁɂɉɊɁɏɍɆɊɌɁɉɄɁŞɎȼɆɂɁɉȼɃɗȾȼɁɈȼɛŝJɓɄɍɇɊɈŞ ȼɉȿɇ5&)ŝUHODWLYHFHQWULIXJDOIRUFHŞ 
ŝ530ŞŝȳɄɍɇɊɊȽɊɌɊɎɊȾȾɈɄɉɏɎɏŞ ɊȽɈɄɉ ɄɇɄQ ŝɓɄɍɇɊȾɌȼɕɁɉɄɅȾɈɄɉɏɎɏŞ ȼɉȿɇ530ŝUHYROXWLRQVSHUPLQXWHŞ ŝUŞ>ɍɈ@ŝȬȼɀɄɏɍȾɌȼɕɁɉɄɛɊɎɒɁɉɎɌȼɒɁɉɎɌɄɐɏȿɄɀɊɀɉȼɋɌɊȽɄɌɆɄ60RQRYHWWH®ŞȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɋɌɊȽɄɌɊɆ60RQRYHWWH®ɉɁɍɊɀɁɌɂȼɕɄɑȿɁɇɛɈɊɂɉɊȾɗɋɊɇɉɛɎɘȾɒɁɉɎɌɄɐɏȿȼɑɍɏȿɇɊȾɗɈɌɊɎɊɌɊɈɄɇɄɌɊɎɊɌɊɈɆɌɁɍɎɊȾɄɉɊɅ
ȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɋɌɊȽɄɌɊɆ60RQRYHWWH®ɍȿɁɇɁɈɀɊɇɂɉɊɊɍɏɕɁɍɎȾɇɛɎɘɍɛɄɍɆɇɚɓɄɎɁɇɘɉɊȾɒɁɉɎɌɄɐɏȿɁɍɌɊɎɊɌɊɈɆɌɁɍɎɊȾɄɉɊɅȤɑɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɋɌɄɋɊɈɊɕɄɒɁɉɎɌɄɐɏȿɍɏȿɇɊȾɗɈɌɊɎɊɌɊɈɉɁ
ɋɌɊɔɇɊȾȼɇɄɀȼɒɄɚɍɊɍɎɊɌɊɉɗ6$567('7ɄɋɊəɎɊɈɏɉɁɌɁɆɊɈɁɉɀɏɁɎɍɛ
ȫɌɄɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɄɋɌɊȽɄɌɊɆ60RQRYHWWH®ɉɁɊȽɑɊɀɄɈɊɍɊȽɇɚɀȼɎɘɏɍɇɊȾɄɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɋɌɄȾɁɀɁɉɉɗɁɉɄɂɁȞɍɇɏɓȼɁɋɌɄɈɁɉɁɉɄɛɀɌɏȿɄɑɏɍɇɊȾɄɅɌɁɃɏɇɘɎȼɎɗɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɀɊɇɂɉɗ
ȽɗɎɘȾȼɇɄɀɄɌɊȾȼɉɗɍȼɈɄɈɋɊɇɘɃɊȾȼɎɁɇɁɈ
ȭɇɁɀɏɁɎɏȽɁɀɄɎɘɍɛɓɎɊɋɌɊȽɄɌɆɄ60RQRYHWWH®ɍɊȾɋȼɀȼɚɎɋɊɌȼɃɈɁɌɏɍɛɓɁɅɆȼɈɄɒɁɉɎɌɄɐɏȿɄȫɌɊȽɄɌɆɄ60RQRYHWWH®ȾɗɍɎɏɋȼɚɕɄɁɄɃɛɓɁɅɆɄɈɊȿɏɎɍɎɊɇɆɉɏɎɘɍɛɍȾɌȼɕȼɚɕɁɅɍɛȿɊɇɊȾɆɊɅɒɁɉɎɌɄɐɏȿɄ
ɓɎɊɋɌɄȾɁɀɁɎɆɄɑɌȼɃȽɄȾȼɉɄɚȭɇɁɀɄɎɁɃȼɎɁɈɓɎɊȽɗɒɁɉɎɌɄɐɏȿȼȽɗɇȼɃȼɋɊɇɉɁɉȼɌȼȾɉɊɈɁɌɉɊȫɌɄəɎɊɈɌɏɆɊȾɊɀɍɎȾɏɅɎɁɍɘɄɉɍɎɌɏɆɒɄɁɅɋɊɋɌɄɈɁɉɁɉɄɚɒɁɉɎɌɄɐɏȿɄ
ȪȭȮȪȬȪȢȩȪ ȩɁ ȾɗɉɄɈȼɅɎɁ ɌȼɃȽɄɎɗɁ ɋɌɊȽɄɌɆɄ 60RQRYHWWH® ȾɌɏɓɉɏɚ
ȯɆȼɃȼɉɄɛ ɋɊ ɀɁɃɄɉɐɁɆɒɄɄ ɒɁɉɎɌɄɐɏȿɄ ɍɈ Ⱦ ɄɉɍɎɌɏɆɒɄɄ ɋɊ ɋɌɄɈɁɉɁɉɄɚ ɒɁɉɎɌɄɐɏȿɄ

ȭɊȿɇȼɍɉɊ
ɍɎȼɉɀȼɌɎɏ
BS 4851+ɆɊɀȡȭ

–ȪɎɉɊɍɄɎɁɇɘɉɊɁɒɁɉɎɌɊȽɁɂɉɊɁɏɍɆɊɌɁɉɄɁ J

ȭɊȿɇȼɍɉɊ
ɍɎȼɉɀȼɌɎɏ
ISO 6710

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*ȭɗȾɊɌɊɎɆȼ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȭɗȾɊɌɊɎɆȼȿɁɇɘ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȭɗȾɊɌɊɎɆȼəɆɍɋɌɁɍɍȿɁɇɘ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɉȾ

ɉȾ

ȧɄɎɄɅȿɁɋȼɌɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȧɄɎɄɅȿɁɋȼɌɄɉȿɁɇɘ+ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȹȠȮȜ

ɉȾ

ɉȾ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȹȠȮȜȿɁɇɘ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȲɄɎɌȼɎ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȹȠȮȜɐɎɊɌɄɀȿɁɋȼɌɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

GlucoEXACTɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȲɄɎɌȼɎ3%0Ɉɇ
ȲɁɉɎɌɊȽɁɂɉɗɅɌȼɀɄɏɍ!ɍɈ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ɈɄɉ

ȲɄɎɌȼɎ3%0Ɉɇ
ɍɈȲɁɉɎɌɊȽɁɂɉɗɅɌȼɀɄɏɍƉɍɈ

ɉȾ

ɉȾ

ɈɄɉ

ɉȾ

ɉȾ

ɉȾ ɉɁȾȼɇɄɀɄɌɊȾȼɉɊ
ȯɍɇɊȾɄɛɋɌɄɈɁɉɄɈɗɀɇɛȾɍɁɑɋɌɊȽɄɌɊɆ60RQRYHWWH®ɃȼɄɍɆɇɚɓɁɉɄɁɈ¢ɈɈ 60RQRYHWWH®ɀɇɛɋɁɀɄȼɎɌɄɄ

ȲɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɁɋɌɄ ų&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry,ɊɎɊɃȾȼɉ

ȤɉɐɊɌɈȼɒɄɛɊɍɁɋȼɌȼɒɄɊɉɉɊɈɈȼɎɁɌɄȼɇɁ
ȬɁɊɇɊȿɄɓɁɍɆɄɁɍȾɊɅɍɎȾȼɍɁɋȼɌȼɒɄɊɉɉɊȿɊɈȼɎɁɌɄȼɇȼ ȿɁɇɛ ɃȼȾɄɍɛɎɊɎɎɁɈɋɁɌȼɎɏɌɗȡɍɇɄɋɌɊȽɄɌɆɄ60RQRYHWWH®ɋɊɀȾɁɌȿȼɚɎɍɛɊɑɇȼɂɀɁɉɄɚɀɊɄɇɄȾɊȾɌɁɈɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɉɄɛɐɊɌɈɄɌɊȾȼɉɄɁ
ɍɋɇɊɔɉɊȿɊɍɇɊɛɍɁɋȼɌȼɒɄɊɉɉɊȿɊȿɁɇɛɉɁɈɊɂɁɎȽɗɎɘȿȼɌȼɉɎɄɌɊȾȼɉɊ
ȤɃɀɁɇɄɛ60RQRYHWWH®ɉɁɇɘɃɛɒɁɉɎɌɄɐɏȿɄɌɊȾȼɎɘɋɊȾɎɊɌɉɊɉɁɍɆɊɇɘɆɊɌȼɃ

ȯɎɄɇɄɃȼɒɄɛ
1.

ȭɊȽɇɚɀȼɅɎɁɍȼɉɄɎȼɌɉɊȿɄȿɄɁɉɄɓɁɍɆɄɁɋɌȼȾɄɇȼɄɋɌɁɀɋɄɍȼɉɄɛ

2.

ȠɇɛɍɉɄɂɁɉɄɛɌɄɍɆȼɄɉɐɄɒɄɌɊȾȼɉɄɛɄɍɋɊɇɘɃɏɅɎɁɊɀɉɊɌȼɃɊȾɗɁɋɁɌɓȼɎɆɄ

3.

ȣȼȿɌɛɃɉɁɉɉɗɁɄɇɄɃȼɋɊɇɉɁɉɉɗɁɍɄɍɎɁɈɗȾɃɛɎɄɛɆɌɊȾɄɍɇɁɀɏɁɎɏɎɄɇɄɃɄɌɊȾȼɎɘȾɍɊɊɎȾɁɎɍɎȾɏɚɕɄɁɆɊɉɎɁɅɉɁɌɗɀɇɛɏɎɄɇɄɃȼɒɄɄȽɄɊɇɊȿɄɓɁɍɆɄɊɋȼɍɉɗɑɊɎɑɊɀɊȾɍɄɑɋɊɍɇɁɀɏɚɕɁɅɍɎɁɌɄɇɄɃȼɒɄɁɅȾ
ȼȾɎɊɆɇȼȾɁɄɍɂɄȿȼɉɄɁɈ

4.

ȯɎɄɇɄɃȼɒɄɛɀɊɇɂɉȼɊɍɏɕɁɍɎȾɇɛɎɘɍɛȾɍɋɁɒɄȼɇɘɉɊɅɋɁɓɄɀɇɛɍɂɄȿȼɉɄɛɊɎɑɊɀɊȾɄɇɄɍɋɊɈɊɕɘɚȼȾɎɊɆɇȼȾȼ ɍɎɁɌɄɇɄɃȼɒɄɛɋȼɌɊɈ 

189

RU
ȪɎɌȼɍɇɁȾɗɁɍɎȼɉɀȼɌɎɗɄɌɁɆɊɈɁɉɀȼɒɄɄɀɇɛɆɊɉɆɌɁɎɉɗɑɋɌɊɀɏɆɎɊȾȾɀɁɅɍɎȾɏɚɕɁɅɌɁɀȼɆɒɄɄCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

ȭɎȼɉɀȼɌɎɀɇɛɍɄɍɎɁɈȾɃɛɎɄɛȾɁɉɊɃɉɊɅɆɌɊȾɄ
DIN EN ISO 6710: Single-use containers for human venous blood specimen collection*CLSI (Clinical and Laboratory Standards Institute)ȬȼɍɔɄɐɌɊȾɆȼɍɄɈȾɊɇɊȾɄɊȽɊɃɉȼɓɁɉɄɅ

ǂȼɌɎɄɆɏɇȼ

ȠɊɋɊɇɉɄɎɁɇɘɉɊɋɌɄɈɁɉɄɈɊɆɋɌɊɀɏɆɒɄɄȾɄɉɀɄȾɄɀɏȼɇɘɉɊɅ
ɍɎɁɌɄɇɘɉɊɅɏɋȼɆɊȾɆɁ

ȪȽɊɃɉȼɓɁɉɄɁɋȼɌɎɄɄ

ȩɁɄɍɋɊɇɘɃɊȾȼɎɘȾɍɇɏɓȼɁɋɊȾɌɁɂɀɁɉɄɛɏɋȼɆɊȾɆɄ

ȟɊɀɁɉɀɊ

ȪɀɄɉȼɌɉȼɛɍɎɁɌɄɇɘɉȼɛȽȼɌɘɁɌɉȼɛɍɄɍɎɁɈȼɍȾɉɁɔɉɁɅɋɌɁɀɊɑɌȼɉɄɎɁɇɘɉɊɅ
ɏɋȼɆɊȾɆɊɅ

ȣɉȼɆ&(

ȭɎɁɌɄɇɄɃȼɒɄɛɊȽɇɏɓɁɉɄɁɈ

ȧȼȽɊɌȼɎɊɌɉȼɛ ɀɄȼȿɉɊɍɎɄɆȼ

ȭɊȽɇɚɀȼɅɎɁɄɉɍɎɌɏɆɒɄɚɋɊɋɌɄɈɁɉɁɉɄɚ

ȫɌɄɋɊȾɎɊɌɉɊɈɄɍɋɊɇɘɃɊȾȼɉɄɄɊɋȼɍɉɊɍɎɘɃȼɌȼɂɁɉɄɛ

ȫɌɁɀɊɑɌȼɉɛɎɘɊɎȾɊɃɀɁɅɍɎȾɄɛɍɊɇɉɁɓɉɗɑɇɏɓɁɅ

ȱɌȼɉɄɎɘȾɍɏɑɊɈɈɁɍɎɁ

ȫɌɊɄɃȾɊɀɄɎɁɇɘ

ȭɎɌȼɉȼɄɃȿɊɎɊȾɇɁɉɄɛ

ȭɎɁɌɄɇɘɉȼɛɂɄɀɆɊɍɎɘȾɉɏɎɌɄɄɃɀɁɇɄɛ

ȩɁɋɊɀȾɁɌȿȼɎɘɋɊȾɎɊɌɉɊɅɍɎɁɌɄɇɄɃȼɒɄɄ

ȭɊɑɌȼɉɛɚɎɍɛɋɌȼȾȼɉȼɎɁɑɉɄɓɁɍɆɄɁɄɃɈɁɉɁɉɄɛ
ȪȽɊȾɍɁɑɍɁɌɘɁɃɉɗɑɄɉɒɄɀɁɉɎȼɑɍȾɛɃȼɉɉɗɑɍɋɌɊɀɏɆɎɊɈɋɌɄɁȿɊɋɌɄɈɁɉɁɉɄɄɍɇɁɀɏɁɎɏȾɁɀɊɈɇɛɎɘɋɌɊɄɃȾɊɀɄɎɁɇɛɄɏɋɊɇɉɊɈɊɓɁɉɉɗɅɉȼɒɄɊɉȼɇɘɉɗɅɊɌȿȼɉ

190

1ÈYRGQD3RXĭLWLHş6$567('760RQRYHWWH® systém na odber krvi

SK

1DGLDJQRVWLFNÜSRXĭLWLHin-vitro³ÕHOSRXĭLWLD
S-Monovette®V\VWÜP\QDRGEHUNUYLLKO\DbDGDSWÜU\VDVSRORÕQHSRXĭìYDMěDNRV\VWÜPQDRGEHUYHQĂ]QHMNUYL60RQRYHWWH®V\VWÜP\QDRGEHUNUYLVDSRXĭìYDMěQDRGEHUPDQXÈOQ\LQWHUQĨWUDQVSRUWDbVSUDFRYDQLH
vzoriek krvi na diagnostiku in-vitro]RVÜUDSOD]P\DOHERSOQHMNUYL9ĨURERNMHXUÕHQĨQDSRXĭLWLHYbSURIHVLRQÈOQRPSURVWUHGìDQDbDSOLNÈFLX]GUDYRWQìFN\PDbODERUDWĂUQ\PSHUVRQÈORP

2SLVYĨURENX
S-Monovette®V\VWÜP\QDRGEHUNUYLSR]RVWÈYDMě]bSODVWRYHMVNěPDYN\SLHVWDSLHVWRYHMW\ÕLQN\DbIDUHEQÜKRSODVWRYÜKRX]ÈYHUXVR]ÈYLWRPVbLQWHJURYDQRXPHPEUÈQRXNWRUĨEROđSHFLÈOQHY\YLQXWĨQDSULSRMHQLHNEH]SHÕQRVWQHM LKOH60RQRYHWWH®DOHER EH]SHÕQRVWQHM LKOH0XOWLIO\®. S-Monovette®VěNGLVSR]ìFLLVREVDKRPUă]Q\FKSUHSDUÈFLìDOHEREH]SUHSDUÈFLH60RQRYHWWH®V\VWÜP\QDRGEHUNUYLVbSUHSDUÈFLDPLDNWLYÈWRU]UÈĭDQLDDNWLYÈWRU]UÈĭDQLDVJÜORPOìWKLXPKHSDUìQOìWKLXPKHSDUìQVJÜORPVRGLXPKHSDUìQFLWUÈW('7$IOXRULG('7$IOXRULGKHSDUìQIOXRULGFLWUÈW&3'$DNRDMEH]SUHSDUÈFLHNWRUĨFKNRQFHQUÈFLDSUHSDUÈFLHREMHPWHNXWĨFKSUHSDUÈFLìDLFKSRYROHQÜWROHUDQFLH]RGSRYHGDMěSRPHUXNUYLDSUHSDUÈFLHDVěYVěODGHVSRĭLDGDYNDPLDRGSRUěÕDQLDPLPHG]LQÈURGQHMQRUP\',1(1,62Ś6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRG
VSHFLPHQFROOHFWLRQŗDb&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, 9ĨEHUDGLWìYD]ÈYLVìRGDQDO\WLFNHMWHVWRYDFHMPHWĂG\ªSHFLILNXMHKRYĨUREFDWHVWRYDFìFKUHDJHQFLìDDOHERDQDO\WLFNÜKR]DULDGHQLDNWRUĨPVDWHVWY\NRQÈYD60RQRYHWWH®V\VWÜPQDRGEHUNUYLMHNbGLVSR]ìFLLYRY\KRWRYHQìVbYQěWRUQRXVWHULOL]ÈFLRXDOHERMHGQRWOLYREDOHQĨVbYQěWRUQRXDbYRQNDMđRXVWHULOL]ÈFLRX

Farebné kódovanie* uzáveru so závitom S-Monovette®:

3UHSDUÈFLD

Písmenový kód)DUEDX]ÈYHURY',1(1
ISO 6710)DUEDX]ÈYHUXSRGøD%6
4851+

Z

biela

biela

6NěPDYNDEH]SUHSDUÈFLH
S-Monovette® neutrálna Z
Skúmavka sérum
S-Monovette®VÜUXP&$7VbDNWLYÈWRURP]UÈĭDQLD

CATÕHUYHQÈ

biela

S-Monovette®VÜUXPJÜO&$7VbDNWLYÈWRURP]UÈĭDQLDDbJÜORPCAT

WPDYRĭOWÈWPDYRĭOWÈ

S-Monovette®VÜUXP([SUHVVJÜO&$7VbDNWLYÈWRURP]UÈĭDQLDWURPEìQRPDbJÜORP

CATRUDQĭRYÈ

-6NěPDYNDVbKHSDUìQRP
S-Monovette® líthium heparín LH, s líthium heparínom

LH

zelená

RUDQĭRYÈ

S-Monovette®OìWKLXPKHSDUìQWHNXWĨ/+VWHNXWĨPOìWKLXPKHSDUìQRP

LH

zelená

RUDQĭRYÈ

S-Monovette® líthium heparín gél LH, s líthium heparínom a gélom

LH

zelená

RUDQĭRYÈ

S-Monovette® líthium heparín gél+/+VbOìWKLXPKHSDUìQRPDbUĨFKO\PJÜORP

LH

zelená

RUDQĭRYÈ

S-Monovette®KHSDUìQVRGQĨ1+VbKHSDUìQRPVRGQĨP

NH

hnedá

zelená

QHGHıQ

modrá

modrá

S-Monovette®FLWUÈW1&FLWUÈWWULVRGQĨb

9NC

modrá

zelená

S-Monovette 3)$FLWUÈW1&FLWUÈWWULVRGQĨbSXIURYDQĨ

9NC

svetlomodrá-

S-Monovette®.('7$.(VbNDOLXP('7$K3EıDORYÈ

ÕHUYHQÈ

S-Monovette®.('7$.(VbNDOLXP('7$K2EıDORYÈ

ÕHUYHQÈ

S-Monovette®.('7$JÜO.(VbNDOLXP('7$DJÜORP

K2E

ıDORYÈ

ÕHUYHQÈ

S-Monovette®ĲXRULG('7$)(VbĲXRULGRPDb('7$

FE

sivá

ĭOWÈ

S-Monovette®ĲXRULGKHSDUìQ)+VbĲXRULGRPDbKHSDUìQRP

FH

-

ĭOWÈ

S-Monovette®*OXFR(;$&7)&VbĲXRULGRPFLWUÈWRPDb('7$FCUXĭRYÈ

sivá

LH

tmavomodráRUDQĭRYÈ

S-Monovette®7URPER([DFWVbPDJQÜ]LRYRX]OěÕHQLQRXQHGHıQ

QHGHıQRVWUXĭLQRYÈ

QHGHıQRVWUXĭLQRYÈ

S-Monovette® CTAD

QHGHıQ

QHGHıQPRGUÈ

QHGHıQ]HOHQÈ

S-Monovette® ACD

ACD

ĭOWÈ

ĭOWÈ

S-Monovette® CPDA

CPDA

ĭOWÈ

ĭOWÈ

S-Monovette® hirudín

QHGHıQ

QHGHıQROLYRYR]HOHQÈ

QHGHıQROLYRYR]HOHQÈ

S-Monovette®KRPRF\VWHìQ+&<=JÜOVbJÜORPDbVWDELOL]ÈWRURP

QHGHıQ

QHGHıQVLYÈ

QHGHıQVLYÈ

S-Monovette®KRPRF\VWHìQ+&<&VbFLWUÈWRPDbSXIURP

QHGHıQ

QHGHıQıDORYÈ

QHGHıQıDORYÈ

S-Monovette® DNA Exact

QHGHıQ

QHGHıQPRGUÈ

QHGHıQPRGUÈ

S-Monovette®KHSDUìQDPĂQQ\$+VbKHSDUìQRPDPĂQQ\P6NěPDYNDVbFLWUÈWRP

®

6NěPDYNDVb('7$6NěPDYNDVbLQKLEìWRUPLJO\NROĨ]\Skúmavka na analýzu kovov
S-Monovette®DQDOĨ]DNRYRY/+VbOìWKLXPKHSDUìQRP

tDOđLHVNěPDYN\QDSOQěNUYDbSOD]PX

.bGLVSR]ìFLLVěØDOđLHIDUE\X]ÈYHURY
nedefin.: nedefinovaná+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, stiahnutá.

191

SK
SARSTEDT S-Monovette® sérum CAT//sérum gél CAT
S-Monovette®VÜUXP&$7REVDKXMHSODVWRYĨJUDQXOÈWSRWLDKQXWĨDNWLYÈWRURP]UÈĭDQLD VLOLNÈWRP DbSRXĭìYDVDQD]ìVNDQLHVÜUD 3ODVWRYĨJUDQXOÈWSULFHQWULIXJÈFLLXORĭìPHG]LNUYQĨNROÈÕDbVÜUXP
S-Monovette®VÜUXPJÜO&$7REVDKXMHRNUHPSODVWRYÜKRJUDQXOÈWXSRWLDKQXWÜKRDNWLYÈWRURP]UÈĭDQLD VLOLNÈWRP DMJÜOQDEÈ]HSRO\PÜUXDbSRXĭìYDVDQD]ìVNDQLHVÜUD *ÜOVDFHQWULIXJÈFLRXXORĭìPHG]LNUYQĨNROÈÕDbVÜUXPDbSRÕDVSUHSUDY\VNODGRYDQLDDbDQDOĨ]\WYRUìVWDELOQěVHSDUDÕQěYUVWYX
6ÜUXPVDSRXĭìYDDNRY]RUNDQDNOLQLFNRELRFKHPLFNÜDbLPXQRORJLFNÜUXWLQQÜY\đHWUHQLDDbDMYbVÜUROĂJLL
3RRGEHUHE\VDPDODNUY]UÈĭDĕYb60RQRYHWWH®VÜUXP&$7VÜUXPJÜO&$7YR]YLVOHMSRORKHPLQěWDE\SRFHQWULIXJÈFLLY]QLNOD]UHWHøQÈKRUL]RQWÈOQDVHSDUDÕQÈYUVWYD2GSRUěÕDQĨÕDVMH]DORĭHQĨQDQHQDUXđHQRPSURFHVHNRDJXOÈFLH.UYSDFLHQWRYVbSRUXFKDPL]UÈĭDQOLYRVWLNUYLVěYLVLDFLPLVbRFKRUHQìPDOHERVbDQWLNRDJXODÕQRXOLHÕERXPăĭHSRWUHERYDĕYLDFÕDVXQDěSOQěNRDJXOÈFLX

SARSTEDT S-Monovette® sérum expres gél CAT
S-Monovette®VÜUXPH[SUHVJÜO&$7REVDKXMHRNUHPSODVWRYÜKRJUDQXOÈWXSRWLDKQXWÜKRDNWLYÈWRURP]UÈĭDQLD WURPEìQRP DMJÜOQDEÈ]HSRO\PÜUXDbSRXĭìYDVDQD]ìVNDQLHVÜUD *ÜOVDFHQWULIXJÈFLRXXORĭìPHG]LNUYQĨNROÈÕDbVÜUXPDbSRÕDVSUHSUDY\VNODGRYDQLDDbDQDOĨ]\WYRUìVWDELOQěVHSDUDÕQěYUVWYX
3RRGEHUHE\VDPDODNUY]UÈĭDĕYb60RQRYHWWH®VÜUXPH[SUHVJÜOYR]YLVOHMSRORKHPLQěWDE\SRFHQWULIXJÈFLLY]QLNODGREUHY\WYRUHQÈKRUL]RQWÈOQDVHSDUDÕQÈYUVWYD2GSRUěÕDQĨÕDVMH]DORĭHQĨQDQHQDUXđHQRPSURFHVHNRDJXOÈFLHDMDNLGHRbNUYKHSDULQL]RYDQĨFKSDFLHQWRY.UYSDFLHQWRYVbSRUXFKDPL]UÈĭDQOLYRVWLNUYLVěYLVLDFLPLVbRFKRUHQìPDOHERVbDQWLNRDJXODÕQRXOLHÕERXYUÈWDQHY\VRNĨFKGÈYRNKHSDUìQXSRWUHEXMHYLDF
ÕDVXQDěSOQěNRDJXOÈFLX
6ÜUXPVDSRXĭìYDDNRY]RUNDQDNOLQLFNRELRFKHPLFNÜDbLPXQRORJLFNÜUXWLQQÜY\đHWUHQLDDbDMYbVÜUROĂJLL

SARSTEDT S-Monovette® neutrálna Z
6NěPDYND60RQRYHWWH®QHXWUÈOQD=bQHREVDKXMHSUHSDUÈFLXÕRRGSRYHGÈSULURG]HQHMNRDJXOÈFLLY]RUN\NUYLEH]DNWLYÈWRUD]UÈĭDQLDDbSRXĭìYDVDQD]ìVNDQLHVÜUD &HQWULIXJÈFLRXVDGRVLDKQHRGGHOHQLHNUYQÜKRNROÈÕDod séra.
6ÜUXPVDSRXĭìYDDNRY]RUNDQDđSHFLILFNÜY\đHWUHQLDSDFLHQWD
2NUHPWRKRVDVNěPDYND60RQRYHWWH®QHXWUÈOQD=bPăĭHSRXĭLĕDNRSUÈ]GQDVNěPDYNDWDNWRDNVDPÈRGEHUNUYL]DÕDĕVb60RQRYHWWH®FLWUÈWYbNRPELQÈFLLVb EH]SHÕQRVWQRX LKORX0XOWLIO\® LKODVbNUìGHONDPL SRWRPsa S-Monovette®QHXWUÈOQD=bSRXĭLMHDNRSUYÈVNěPDYND SUÈ]GQD QDQDSOQHQLHKDGLÕN\ EH]SHÕQRVWQHM LKO\0XOWLIO\®.

SARSTEDT S-Monovette® líthium heparín LH/ líthium heparín gél LH/ líthium heparín gél+/+KHSDUìQVRGQĨ1+KHSDUìQDPĂQQ\$+
S-Monovette®OìWKLXPKHSDUìQ/+KHSDUìQVRGQĨ1+KHSDUìQDPĂQQ\$+REVDKXMHSODVWRYĨJUDQXOÈWSRWLDKQXWĨLQKLEìWRURP]UÈĭDQLD DQWLNRDJXODQW OìWKLXPKHSDUìQKHSDUìQVRGQĨKHSDUìQDPĂQQ\VSUDYLGOD,8KHSDUìQXPONUYL DbVOěĭLQDRGEHUSOQHMNUYLDOHER]ìVNDQLHSOD]P\ 3ODVWRYĨJUDQXOÈWVDFHQWULIXJÈFLRXXORĭìPHG]LNUYQÜEXQN\DbSOD]PX
9bVNěPDYNH60RQRYHWWH® líthium heparín LH bez plastového granulátu je antikoagulant líthium heparín vo forme aerosólu (spravidla 19 I.U. heparínu/ml krvi).
S-Monovette®OìWKLXPKHSDUìQJÜO/+REVDKXMHRNUHPSODVWRYÜKRJUDQXOÈWXSRWLDKQXWÜKRDQWLNRDJXODQWRPOìWKLXPKHSDUìQRP VSUDYLGOD,8KHSDUìQXPONUYL DMJÜOQDEÈ]HSRO\PÜUXDbSRXĭìYDVDQDRGEHUSOD]P\ *ÜOVDFHQWULIXJÈFLRXXORĭìPHG]LNUYQÜEXQN\DbSOD]PXDbSRÕDVSUHSUDY\VNODGRYDQLDDbDQDOĨ]\WYRUìVWDELOQěVHSDUDÕQěYUVWYX
S-Monovette® líthium heparín gél+/+REVDKXMHWLHĭJÜOQDEÈ]HSRO\PÜUXNWRUĨXPRĭýXMHFFDRbbNUDWđìÕDVFHQWULIXJÈFLHYbSRURYQDQìVb60RQRYHWWH® líthium heparín gél.
+HSDUìQRYÈSOD]PDVDSRXĭìYDDNRY]RUNDQDNOLQLFNRELRFKHPLFNÜDbLPXQRORJLFNÜUXWLQQÜY\đHWUHQLD3OQÈNUYVKHSDUìQRPVDSRXĭìYDDNRY]RUNDQDUXWLQQÜLPXQRORJLFNÜY\đHWUHQLDDbDMYbVÜUROĂJLL.bDQWLNRDJXOÈFLLVbKHSDUìQRPGRFKÈG]DDNWLYÈFLRXDQWLWURPEìQXUPOZORNENIE: Zo skúmavky S-Monovette®OìWKLXPKHSDUìQ/+OìWKLXPKHSDUìQJÜOJÜO+/+VDQHVPLHVWDQRYRYDĕOìWLXP]RVNěPDYN\60RQRYHWWH®KHSDUìQVRGQĨ1+VDQHVPěY\NRQÈYDĕDQDOĨ]\VRGìNDDb]RVNěPDYN\60RQRYHWWH®KHSDUìQDPĂQQ\$+VDQHVPLHVWDQRYRYDĕDPĂQLXP6NěPDYN\60RQRYHWWH®OìWKLXPKHSDUìQOìWKLXPKHSDUìQJÜOJÜO+KHSDUìQVRGQĨKHSDUìQDPĂQQ\QDSOQHQÜYHQĂ]QRXNUYRXQLHVěYKRGQÜQDDQDOĨ]XNUYQĨFKSO\QRYSARSTEDT S-Monovette®DQDOĨ]DNRYRY
S-Monovette®DQDOĨ]DNRYRYREVDKXMHDQWLNRDJXODQWOìWKLXPKHSDUìQDSRXĭìYDVDQDRGEHUSOQHMNUYLDbSOD]P\ /ìWKLXPKHSDUìQMHYRIRUPHDHURVĂOX ,8KHSDUìQXPONUYL 
3OQÈNUYDOHERSOD]PDVKHSDUìQRPY60RQRYHWWHŪDQDOĨ]DNRYRYYNRPELQÈFLLVRđSHFLÈOQRXEH]SHÕQRVWQRXLKORX*[ NDWDOĂJRYÜÕ VDSRXĭìYDDNRY]RUNDQDY\đHWUHQLHVWRSRYĨFKSUYNRYNRYRY6WRSRYÜSUYN\NRY\EROLYDOLGRYDQÜDWĂPRYRXDEVRUSÕQRXVSHNWURPHWULRX $$6 3UHV\VWÜPRYěEH]SHÕQRVWQěNDQ\OXDb60RQRYHWWH®DQDOĨ]DNRYRYY\SOĨYDMěQDVOHGXMěFHPD[LPÈOQHKRGQRW\VOHSÜKRSRNXVXYbQJV\VWÜPSUHWLHWRVWRSRYÜSUYN\

Prvok

Tl

ng/systém

2,5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1,5

8,0

5,0

5

50

70

70

10

40

10

10

0D[LPÈOQHSUÈ]GQHKRGQRW\VěSUHNDĭGĨSUYRNXYHGHQÜQDđWìWNX60RQRYHWWH®.
6WDQRYHQLHVWRSRYĨFKSUYNRYVDUREì]SOQHMNUYLVKHSDUìQRPDOHER]SOD]P\VKHSDUìQRPYb]ÈYLVORVWLRGDQDO\WLFNHMPHWĂG\K antikoagulácii heparínom dochádza aktiváciou antitrombínu.

SARSTEDT S-Monovette® citrát 9NC
S-Monovette®FLWUÈW1&REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDbSRXĭìYDVDQDRGEHUSOQHMNUYLDbSOD]P\ &LWUÈWWULVRGQĨMHNbGLVSR]ìFLLDNRPROÈUQ\bUR]WRN bUR]WRNFLWUÈWXWULVRGQÜKRÕDVWR]DRNUěKOHQĨQDb DbSUHGVWDYXMHbPHQRYLWÜKRREMHPXVNěPDYN\60RQRYHWWH®FLWUÈW=PLHđDYDFìSRPHUFLWUÈWXDbNUYLMHşREMHPRYĨGLHOFLWUÈWXDbREMHPRYĨFKGLHORYNUYL3UHDQDOĨ]XMHDEVROěWQHQHY\KQXWQÜGRGUĭDĕsprávny objem naplnenia.
&LWUÈWRYÈSOD]PDVDSRXĭìYDDNRY]RUNDQDUXWLQQÜY\đHWUHQLHKRPHRVWÈ]\$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVbFLWUÈWRP
'RGUĭLDYDMWH32.<1<YÕDVWL2GEHUY]RULHNDPDQLSXOÈFLDSULNRPELQÈFLL60RQRYHWWH® citrát a ihly s krídelkami.

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDbSRXĭìYDVDQDRGEHUSOQHMNUYLDbSOD]P\ &LWUÈWWULVRGQĨMHNbGLVSR]ìFLLDNRPROÈUQ\bUR]WRN bSXIURYDQĨS+ DbSUHGVWDYXMHb
PHQRYLWÜKRREMHPXVNěPDYN\60RQRYHWWH®3)$=PLHđDYDFìSRPHUFLWUÈWXDbNUYLMHşREMHPRYĨGLHOFLWUÈWXDbREMHPRYĨFKGLHORYNUYL3UHDQDOĨ]XMHDEVROěWQHQHY\KQXWQÜGRGUĭDĕVSUÈYQ\REMHPQDSOQHQLD
3OQÈNUYVNěPDYN\60RQRYHWWH®3)$1&VDSRXĭìYDDNRY]RUNDQDDQDOĨ]XIXQNFLHWURPERF\WRYSRPRFRXDQDO\]DÕQÜKR]DULDGHQLD6,(0(16+HDOWKLQHHUV3)$DbMHQDWHQWRSRVWXSYDOLGRYDQÈ$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVbFLWUÈWRP
'RGUĭLDYDMWH32.<1<YÕDVWL2GEHUY]RULHNDPDQLSXOÈFLDSULNRPELQÈFLL60RQRYHWWH® PFA a ihly s krídelkami.

SARSTEDT S-Monovette® CTAD
S-Monovette®&7$'REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDNRDMWHRI\OìQDGHQR]ìQDbGLS\ULGDPRODbSRXĭìYDVDQDRGEHUSOQHMNUYLDbSOD]P\ &7$'MHNbGLVSR]ìFLLDNRUR]WRNDbSUHGVWDYXMHbPHQRYLWÜKRREMHPX
VNěPDYN\60RQRYHWWH®&7$'=PLHđDYDFìSRPHU&7$'DbNUYLMHşREMHPRYĨGLHO&7$'DbREMHPRYĨFKGLHORYNUYL3UHDQDOĨ]XMHDEVROěWQHQHY\KQXWQÜGRGUĭDĕVSUÈYQ\REMHPQDSOQHQLD
3OD]PD&7$'VDSRXĭìYDDNRY]RUNDQDVWDQRYHQLHGRđWLÕNRYÜKRIDNWRUD 3) EHWD Ĕ WURPERJOREXOìQX Ĕ7* DbLQKLEìWRUDDNWLYÈWRUDSOD]PLQRJÜQX 3$, DNRDMQDUXWLQQÜY\đHWUHQLDKHPRVWÈ]\$NWLYÈFLDWURPERF\WRYMHLQKLERYDQÈQDMPHQHMQDKRGLQ\DbSRXĭìYDVDQDPRQLWRURYDQLHKHSDUìQRYHMWHUDSLH$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVbFLWUÈWRP
'RGUĭLDYDMWH32.<1<YÕDVWL2GEHUY]RULHNDPDQLSXOÈFLDSULNRPELQÈFLL60RQRYHWWH® CTAD a ihly s krídelkami.
832=251(1,(&7$'MHĭOWHMIDUE\60RQRYHWWH®&7$'PXVìE\ĕSRÕDVVNODGRYDQLDFKUÈQHQÈSUHGXPHOĨPDbSULURG]HQĨPVYHWORP9\VWDYHQLHVLOQÜPXVYHWOXQDYLDFDNRbKRGìQPăĭHYLHVĕ
NbGHDNWLYÈFLLDGLWìY

192

SK
SARSTEDT S-Monovette® EDTA K2E/K3E
S-Monovette® EDTA K2E/S-Monovette®('7$.(REVDKXMHDQWLNRDJXODQW.('7$SUìS.('7$DbSRXĭìYDVDQDRGEHUSOQHMNUYL .('7$SUìS.('7$VěNbGLVSR]ìFLLYRIRUPHDHURVĂOX bPJ('7$PONUYL 
3OQÈNUYVb('7$VDSRXĭìYDDNRY]RUNDQDKHPDWRORJLFNÜY\đHWUHQLD.UYQÜQÈWHU\E\VDPDOLY\KRWRYLĕGRđW\URFKKRGìQSRRGEHUHNUYL$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVb('7$
.UY]b60RQRYHWWH®('7$.(.(PRĭQRSRXĭLĕWDNWLHĭQDUXWLQQÜLPXQRKHPDWROLFNÜY\đHWUHQLDDbWHVW\LQIHNÕQĨFKFKRUăE3RXĭìYDWHø]RGSRYHGÈ]DYDOLGRYDQLHYKRGQRVWLY]RUN\QDWLHWRY\đHWUHQLDVbSUìVOXđQĨPL
WHVWRYDFìPLUHDJHQFLDPLDQDO\WLFNĨPL]DULDGHQLDPLYUÈWDQHSRGPLHQRNVNODGRYDQLDSARSTEDT S-Monovette® EDTA gél K2E
S-Monovette®('7$JÜO.(REVDKXMHRNUHPDQWLNRDJXODQWX.('7$DMJÜOQDEÈ]HSRO\PÜUXDbSRXĭìYDVDQDRGEHUSOD]P\ .('7$MHNbGLVSR]ìFLLYRIRUPHDHURVĂOX bPJ('7$PONUYL *ÜOVDFHQWULIXJÈFLRXXORĭìPHG]LNUYQÜEXQN\DbSOD]PXDbSRÕDVSUHSUDY\VNODGRYDQLDDbDQDOĨ]\WYRUìVWDELOQěVHSDUDÕQěYUVWYX
3OD]PDVb('7$VDSRXĭìYDDNRY]RUNDQDPROHNXOÈUQXGLDJQRVWLNXYìUXVRY$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVb('7$

SARSTEDT S-Monovette®ĲXRULG('7$)(ĲXRULGKHSDUìQ)+ĲXRULGFLWUÈW('7$)&VbLQKLEìWRUPLJO\NROĨ]\S-Monovette®IOXRULG('7$)(REVDKXMHDQWLNRDJXODQW('7$ PJPONUYL DIOXRULG PJPONUYL QDLQKLEìFLXJO\NROĨ]\DbSRXĭìYDVDQDRGEHUSOD]P\ )OXRULG('7$MHYRIRUPHDHURVĂOX
S-Monovette®IOXRULGKHSDUìQ)+REVDKXMHDQWLNRDJXODQWKHSDUìQ ,8KHSDUìQXPONUYL DNRDMIOXRULG PJPONUYL QDLQKLEìFLXJO\NROĨ]\DbSRXĭìYDVDQDRGEHUSOD]P\ )OXRULGKHSDUìQMHYRIRUPHDHURVĂOX,QKLEìFLDJO\NROĨ]\VDPRWQĨPIOXRULGRPVD]DÕìQDFFDbKRGLQ\SRRGEHUHNUYLGRVNěPDYN\DbSOQĨěÕLQRNQDVWDQHSRFFDbKRGLQÈFK*OXNĂ]DVDSUHWRYSOQHMNUYLRGEěUDYDSRQLHNRøNĨFKKRGLQÈFKYSULHPHUHRDDĭRbşbSRKRGLQÈFK
S-Monovette®*OXFR(;$&7)&REVDKXMHDQWLNRDJXODQW('7$DNRDMFLWUÈWDbIOXRULGQDRNDPĭLWěLQKLEìFLXJO\NROĨ]\DbSRXĭìYDVDQDRGEHUSOD]P\ ('7$FLWUÈWDbIOXRULGVěNbGLVSR]ìFLLDNRUR]WRN3ULYĨSRÕWH
NRQFHQWUÈFLHJOXNĂ]\VD]bGăYRGXULHGHQLDYĨVOHGRNY\QÈVREìÕìVORP
S-Monovette®*OXFR(;$&7)&VS÷ýDVPHUQLFX1HPHFNHMGLDEHWLFNHMVSRORÕQRVWL ''* SUHJHVWDÕQĨGLDEHWHVDbQÈURGQÜPHGLFìQVNHXVPHUQHQLH 1DWLRQDOH9HUVRUJXQJV/HLWOLQLHş19/ SUHGLDEHWHVW\SX
2NDPĭLWÈVWDELOL]ÈFLDNRQFHQWUÈFLHJOXNĂ]\YbSOQHMNUYLMH]DUXÕHQÈGRbKRGìQSULL]ERYHMWHSORWHSR]ULWLHĭ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / „Sarstedt S-Monovette®*OXFR(;$&7$bEORRGFROOHFWLRQGHYLFHIRUVWDELOL]LQJJOXFRVHOHYHOVIRUKRXUVŗ
3OD]PDIOXRULG('7$ FLWUÈW VDSRXĭìYDDNRY]RUNDQDVWDQRYHQLHJOXNĂ]\$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVb('7$
8SR]RUQHQLH)OXRULGPăĭHVSăVRELĕ]YĨđHQLHKHPROĨ]\9LDFLQIRUPÈFLìRbLQWHUIHUXMěFLFKOÈWNDFKQÈMGHWHYbSUìVOXđQRPQÈYRGHQDSRXĭLWLHYĨUREFXWHVWRYDFìFKUHDJHQFLì'RGUĭLDYDMWH32.<1<YÕDVWL2GEHUY]RULHNDPDQLSXOÈFLDSULNRPELQÈFLL60RQRYHWWH® GlucoEXACT a ihly s krídelkami.

SARSTEDT S-Monovette® CPDA
S-Monovette®&3'$REVDKXMHDQWLNRDJXODQWFLWUÈWWULVRGQĨDNRDMN\VHOLQXFLWUĂQRYěIRVIÈWWULVRGQĨGH[WUĂ]XDbDGHQìQDbSRXĭìYDVDQDRGEHUSOQHMNUYLDbSOD]P\ &3'$MHNbGLVSR]ìFLLDNRUR]WRN=PLHđDYDFìSRPHU
&3'$DbNUYLMHşREMHPRYĨGLHO&3'$DbREMHPRYĨFKGLHORYNUYL3UHVSUÈYQRVĕDQDOĨ]\MHDEVROěWQHQHY\KQXWQÜGRGUĭDĕVSUÈYQ\REMHPQDSOQHQLD
3OQÈNUYSOD]PDVb&3'$VDSRXĭìYDDNRY]RUNDQDVÜUROĂJLXNUYQĨFKVNXSìQYbWUDQVIě]QHMPHGLFìQHQDWHVW\NRPSDWLELOLW\ NUìĭRYÜVNěđN\ SULWUDQVIě]LÈFK.RQNUÜWQHMHVNěPDYND60RQRYHWWH®&3'$XUÕHQÈ
QDVWDQRYHQLHNUYQĨFKVNXSìQ $% YUÈWDQH.HOORYKRDb5KIDNWRUDWHVWQDGHWHNFLXSURWLOÈWRN]ULHGNDYĨFKNUYQĨFKVNXSìQSRO\đSHFLILFNĨSULDP\&RRPEVRYWHVW GRGýD WHVWNRPSDWLELOLW\ NUìĭRYÈVNěđND 
VbNRPSDWLELOQĨP SRGøDNUYQHMVNXSLQ\ NUYQĨPVÜURPSOD]PRXSDFLHQWD KODYQĨWHVW 'REDWUDQVSRUWXDĭGRXVNODGQHQLDMHYDOLGRYDQÈQDPD[LPÈOQHbKRGLQ\SULWHSORWHşbƓ&1DVHGLPHQWÈFLXEXQLHNMHSRWUHEQÜY]RUN\QDMVNăUVNODGRYDĕYR]YLVOHMSRORKHYbFKODGQLÕNHPLQbKRGìQ1ÈVOHGQHVDPăĭXY\đđLHXYHGHQÜDQDO\W\VWDQRYLĕGRbGQìDQDORJLFN\SRGøD]Y\ÕDMQHMGRE\VNODGRYDQLDNUYQĨFKNRQ]HUYSRVNODGRYDQìYbFKODGQLÕNH şbƓ&  VYĨQLPNRXSULDPHKR&RRPEVRYKRWHVWXbGQì 9KRGQÜSUH
PHWĂGXVW÷SFRYHMDJOXWLQÈFLHQDSUìNODGQD]DULDGHQì9LVLRQ0D[RG2UWKR&OLQLFDO'LDJQRVWLFV9]RUNDVDQHVPLH]PUD]Lĕ
3RXĭìYDWHø]RGSRYHGÈ]DYKRGQRVĕY]RUN\QDWLHWRY\đHWUHQLDVbLQĨPLPHWĂGDPLWHVWRYDFìPLUHDJHQFLDPLDQDO\WLFNĨPL]DULDGHQLDPLYUÈWDQHSRGPLHQRNVNODGRYDQLDDbVÈPLFKPXVìYDOLGRYDĕ$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVbFLWUÈWRP
'RGUĭLDYDMWH32.<1<YÕDVWL2GEHUY]RULHNDPDQLSXOÈFLDSULNRPELQÈFLL60RQRYHWWHŪ&3'$DLKO\VNUìGHONDPLSARSTEDT S-Monovette® TromboExact
S-Monovette®7URPER([DFWREVDKXMHDQWLNRDJXODQWPDJQÜ]LRYěVRøDbSRXĭìYDVDQDRGEHUSOQHMNUYL 0DJQÜ]LRYÈVRøMHNbGLVSR]ìFLLYRIRUPHDHURVĂOX&HOÈNUY]RVNěPDYN\60RQRYHWWH®7URPER([DFWVDSRXĭìYDDNRY]RUNDQDY\OěÕHQLHIDORđQHQì]NHKRSRÕWXWURPERF\WRYYbGăVOHGNXLQWROHUDQFLHDQWLNRDJXODQWRY DNRMH('7$FLWUÈWKHSDUìQ NWRUÈVDWLHĭR]QDÕXMHDNR
SVHXGRWURPERF\WRSÜQLD=DEUÈQLVDWYRUEHDJUHJÈWRYWURPERF\WRYDbVNXWRÕQĨSRÕHWWURPERF\WRYVDGÈXUÕLĕGRbKRGìQSRRGEHUHNUYL$QWLNRDJXOÈFLDVDXVNXWRÕýXMHSURVWUHGQìFWYRPKRUÕìNRYĨFKLĂQRYSULÕRPLĂQ\KRUÕìNDEORNXMěWURPERF\WRYĨWURPER[DQ$DbDJUHJÈFLXWURPERF\WRYVSURVWUHGNRYDQě$'3DbN\VHOLQRXDUDFKLGRQRYRXSARSTEDT S-Monovette® Hirudin
S-Monovette®+LUXGLQREVDKXMHDQWLNRDJXODQWKLUXGìQDbSRXĭìYDVDQDRGEHUSOQHMNUYL +LUXGìQMHNbGLVSR]ìFLLYRIRUPHDHURVĂOX
3OQÈNUYVbKLUXGìQRPVDSRXĭìYDDNRY]RUNDQDVWDQRYHQLHIXQNFLHWURPERF\WRYQD]DULDGHQì0XOWLSODWH® PXOWLSOHSODWHOHWIXQFWLRQDQDO\VHU RG52&+('LDJQRVWLFVDbMHQDWHQWRěÕHOYDOLGRYDQÈ3RXĭìYDVDQDPRQLWRURYDQLHěÕLQQRVWLDQWLNRDJXODÕQHMOLHÕE\DbQD]LVWHQLHDOHERY\OěÕHQLHG\VIXQNFLHWURPERF\WRY
6NěPDYND60RQRYHWWH®+LUXGLQERODY\YLQXWÈđSHFLÈOQHQDVWDQRYHQLHIXQNFLHWURPERF\WRYYbVSROXSUÈFLVbILUPRX9HUXP'LDJQRVWLFDGQHV52&+('LDJQRVWLFVQD]DULDGHQì0XOWLSODWH®.
$QWLNRDJXOÈFLDVDXVNXWRÕýXMHSURVWUHGQìFWYRPKLUXGìQXSULDPRXLQKLEìFLRXWURPEìQXDbXPRĭýXMHWDNGLDJQRVWLNXIXQNFLHWURPERF\WRYYbQDWìYQRPVWDYH

SARSTEDT S-Monovette® Homocystein HCY-Z gél/HCY-C
S-Monovette®+RPRF\VWHLQ+&<=JÜOREVDKXMHRNUHPSODVWRYÜKRJUDQXOÈWXSRWLDKQXWÜKRDNWLYÈWRURP]UÈĭDQLD VLOLNÈWRP DMđSHFLÈOQ\VWDELOL]ÈWRUDbJÜOQDEÈ]HSRO\PÜUXDbSRXĭìYDVDQD]ìVNDQLHVÜUD *ÜOVD
FHQWULIXJÈFLRXXORĭìPHG]LNUYQĨNROÈÕDbVÜUXPDbSRÕDVSUHSUDY\VNODGRYDQLDDbDQDOĨ]\WYRUìVWDELOQěVHSDUDÕQěYUVWYX3UHSDUÈFLDMHYVNěPDYNHYRIRUPHDHURVĂOX+RPRF\VWHìQVDVWDELOL]XMHYbSOQHMNUYLSULL]ERYHMWHSORWHGRbKRGìQ$NFHQWULIXJÈFLDSUHEHKQHSRÕDVSUYĨFKbKRGìQVRVSUÈYQHY\WYRUHQRXVHSDUDÕQRXYUVWYRXPHG]LNUYQĨPNROÈÕRPDbVÜURPKRPRF\VWHìQVD
VWDELOL]XMHGRbKRGìQ
6ÜUXP]RVNěPDYN\60RQRYHWWH®+RPRF\VWHLQ+&<=JÜOVDSRXĭìYDDNRY]RUNDQDVWDQRYHQLHKRPRF\VWHìQX60RQRYHWWH®+RPRF\VWHLQ+&<&REVDKXMHDNRDQWLNRDJXODQWN\VOĨFLWUÈW S+ DbSRXĭìYDVDQD
RGEHUSOD]P\ &LWUÈWMHNbGLVSR]ìFLLDNRUR]WRN3ULYĨSRÕWHNRQFHQWUÈFLHKRPHRF\VWÜìQXVD]bGăYRGXULHGHQLDYĨVOHGRNY\QÈVREìÕìVORP+RPRF\VWHìQVDVWDELOL]XMHYbSOQHMNUYLSULL]ERYHMWHSORWHGRbKRGìQSULWHSORWHbƓ&GRbKRGìQ
3OD]PD]RVNěPDYN\60RQRYHWWH®+RPRF\VWHLQ+&<<VDSRXĭìYDDNRY]RUNDQDVWDQRYHQLHKRPRF\VWHìQX$QWLNRDJXOÈFLDYb60RQRYHWWH®+RPRF\VWHLQ+&<<QDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVbFLWUÈWRP'RGUĭLDYDMWH32.<1<YÕDVWL2GEHUY]RULHNDPDQLSXOÈFLDSULNRPELQÈFLL60RQRYHWWH® HCY-Y a ihly s krídelkami.

SARSTEDT S-Monovette® DNA Exact
S-Monovette®'1$([DFWREVDKXMHDQWLNRDJXODQWQDEÈ]H('7$DbSRXĭìYDVDQDRGEHUSOQHMNUYL ('7$MHYVNěPDYNHYRIRUPHDHURVĂOX
3OQÈNUYVb('7$VDSRXĭìYDDNRY]RUNDQDVWDELOL]ÈFLXJ'1$³ÕLQQRVĕVWDELOL]ÈFLHSUHJ'1$MHYDOLGRYDQÈbGQìSULWHSORWHbƓ&bGQìSULL]ERYHMWHSORWH bƓ& bGQìYFKODGH bƓ& DbPLQbURNSULWHSORWHbƓ&
2NUHPWRKRVWDELOL]RYDQÜY]RUN\Y\GUĭLDbF\NORY]PUD]RYDQLDDbUR]PUD]RYDQLDEH]VWUDW\NYDOLW\SR]ULWLHĭ6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / „SARSTEDT S-Monovette®'1$([DFWş$b1HZ,9'&HUWLILHG%ORRG&ROOHFWLRQ7XEHIRU&ROOHFWLRQ7UDQVSRUWDQG6WDELOL]DWLRQRI:KROH%ORRGIRU*HQRPLF'1$$QDO\VLVŘ$QWLNRDJXOÈFLDQDVWÈYDY\WYÈUDQìPNRPSOH[RYYÈSHQDWĨFKLĂQRYVb('7$

9KRGQRVĕY]RUN\]ÈYLVìRGDQDO\WXDbWHVWRYDFìFKUHDJHQFLìDQDO\WLFNÜKR]DULDGHQLD'RGUĭLDYDMWHSUìVOXđQÜRGSRUěÕDQLDYĨUREFX

193

SK
%H]SHÕQRVWQÜSRN\Q\DGăOHĭLWÜXSR]RUQHQLD
1.

9đHREHFQÜSUHYHQWìYQHRSDWUHQLD3RXĭìYDMWHUXNDYLFHDbØDOđLHYđHREHFQÜRVREQÜRFKUDQQÜSURVWULHGN\DE\VWHVDFKUÈQLOLSUHGPRĭQĨPY\VWDYHQìPSRWHQFLÈOQHLQIHNÕQÜPXPDWHULÈOXY]RULHNDbSUHQRVQĨPpatogénom.

2.

6RYđHWNĨPLELRORJLFNĨPLY]RUNDPLDbRVWUĨPLđSLFDWĨPLSRPăFNDPLQDRGEHU LKODPLDGDSWÜUPL ]DREFKÈG]DMWHSRGøDVPHUQìFDbSRVWXSRYVWDQRYHQĨFKYDđìP]DULDGHQìP9bSUìSDGHSULDPHKRNRQWDNWXVbELRORJLFNĨPLY]RUNDPLDOHERSULSRUDQHQìLKORXY\KøDGDMWHOHNÈUVNXSRPRFSUHWRĭHPăĭHGăMVĕNbSUHQRVX+,9+&9+%9DOHERLQĨFKLQIHNÕQĨFKFKRUăE3RXĭìYDMWHEH]SHÕQRVWQÜLKO\EH]SHÕQRVWQÜLKO\0XOWLĲ\® so]DEXGRYDQĨPRFKUDQQĨPNU\WRPLKO\'RGUĭLDYDMWHEH]SHÕQRVWQÜVPHUQLFHDbSRVWXS\SODWQÜYRYDđRP]DULDGHQì

3.

Platí pre jednotlivo sterilne balené pomôcky:3UHGSRXĭLWìPVNRQWUROXMWHNDĭGÜMHGQRWOLYÜEDOHQLHÕLQLHMHSRđNRGHQÜ$NMHEDOHQLHSRđNRGHQÜSRPăFNXQHSRXĭìYDMWH

4.

9ĨURERNMHXUÕHQĨQDMHGQRUD]RYÜSRXĭLWLH2VWUÜđSLFDWÜSUHGPHW\ LKO\DGDSWÜU\ QDRGEHUNUYL]OLNYLGXMWHYRYKRGQĨFKQÈGREÈFKQDOLNYLGÈFLXQHEH]SHÕQÜKRELRORJLFNÜKRRGSDGX

5.

$NVDNUYRGREHUÈFH]LQWUDYHQĂ]Q\ ,9 NDWÜWHUPXVìVD]DEH]SHÕLĕDE\ERONDWÜWHUSUHG]DÕDWìPRGEHUXNUYLULDGQHSUHSOÈFKQXWĨ Y\ÕLVWHQĨRGLQWUDYHQĂ]QHKRUR]WRNX SRGøDSRVWXSRYSODWQĨFKYbGDQRP
]DULDGHQì6SUÈYQ\PSUHSOÈFKQXWìPNDWÜWUDVDY\KQHWHQHVSUÈYQ\PODERUDWĂUQ\PYĨVOHGNRP

6.

1HGRVWDWRÕQÜQDSOQHQLH60RQRYHWWH®YHGLHNbQHVSUÈYQHPXSRPHUXNUYLDbSUHSDUÈFLHDGLWìYDDbPăĭHYLHVĕNbQHVSUÈYQ\PYĨVOHGNRPDQDOĨ]\

7.

.UYRGREUDWÈDbVSUDFRYDQÈSRPRFRX60RQRYHWWH®QLHMHXUÕHQÈQDRSËWRYQÜSRGDQLHGRøXGVNÜKRWHOD

8.

3RXSO\QXWìGRE\SRXĭLWHøQRVWLVDYĨURERNXĭQHVPLHSRXĭìYDĕ'REDSRXĭLWHøQRVWLNRQÕìYbSRVOHGQĨGHýXYHGHQÜKRPHVLDFDDbURND

Skladovanie
9ĨURERNDĭGRSRXĭLWLDVNODGXMWHSULL]ERYHMWHSORWH

Obmedzenia
1.

'REDVNODGRYDQLDDbWHSORWDSULVNODGRYDQìQDSOQHQHM60RQRYHWWH®]ÈYLVLDRGGRE\SRXĭLWHøQRVWLDQDO\WRYXUÕHQĨFKQDGLDJQRVWLNX3RVěGLWRODERUDWĂULXPDOHERVDLQIRUPÈFLH]LVWLD]bQÈYRGXQDSRXĭLWLHYĨUREFX
testovacích reagencií/analytického zariadenia.

2.

$MNHØVDSOD]PDDOHERVÜUXPFHQWULIXJÈFLRX60RQRYHWWH®RGGHOìDDOHERMHSUìWRPQÈEDULÜUDQLHYđHWN\EXQN\VěEH]SRGPLHQHÕQHěSOQHRGGHOHQÜ=Y\đNRYÈOÈWNRYÈSUHPHQDDOHERSULURG]HQÜRGEěUDYDQLHPăĭX
RYSO\YQLĕNRQFHQWUÈFLHDQDO\WRY6WDELOLWDDQDO\WRYE\VDPDODSRVěGLĕY]KøDGRPQDVNODGRYDFLHQÈGRE\DbGDQÜODERUDWĂUQHSRGPLHQN\

3.

9bSUìSDGHWHUDSHXWLFNĨFKOLHÕLYMHSRWUHEQÜSUHYHULĕYKRGQRVĕY]RUN\YbQÈYRGHQDSRXĭLWLHRGYĨUREFXWHVWRYDFìFKUHDJHQFLìDQDO\WLFNÜKR]DULDGHQLD

4.

$QDOĨ]\QDVWDQRYHQLHVWRSRYĨFKSUYNRYNRYRYMHSRWUHEQÜY\NRQÈYDĕV\VWÜPRP60RQRYHWWH®DQDOĨ]DNRYRYEH]SHÕQRVWQÈLKODQDDQDOĨ]XNRYRY

2GEHUY]RULHNDbPDQLSXOÈFLD
35('2'%(5209(1=1(-.59,6,'./$'1(35(q7$-7(&(/À7(172'2.80(17
3UDFRYQĨPDWHULÈOSRWUHEQĨQDRGEHUY]RUN\
1.

Všetky potrebné systémy na odber krvi S-Monovette®.

2.

%H]SHÕQRVWQÜ LKO\DOHER EH]SHÕQRVWQÜ LKO\0XOWLĲ\®.

3.

5XNDYLFHSOÈđĕRFKUDQDRÕìDOHERLQĨYKRGQĨRFKUDQQĨRGHYQDRFKUDQXSUHGSDWRJÜQPLSUHQÈđDQĨPLNUYRXDOHERSRWHQFLÈOQHLQIHNÕQĨPLPDWHULÈOPL

4.

ªWìWN\QDLGHQWLıNÈFLXSDFLHQWD

5.

'H]LQIHNÕQĨSURVWULHGRNQDY\ÕLVWHQLHPLHVWDRGEHUX SRVWXSXMWHSRGøDVPHUQìF]DULDGHQLDWĨNDMěFLFKVDSUìSUDY\PLHVWDVWHULOQÜKRRGEHUXY]RUN\ 1HSRXĭìYDMWHGH]LQIHNÕQĨSURVWULHGRNQDEÈ]HDONRKROXDNVDPDMěY]RUN\SRXĭLĕQDWHVWRYDQLHDONRKROXYbNUYL

6.

6XFKÜVWHULOQÜWDPSĂQ\QDMHGQRUD]RYÜSRXĭLWLH

7.

Škrtidlo.

8.

1ÈSODVĕDOHERREYË]

9.

1ÈGREDQDRGKDG]RYDQLHRVWUĨFKđSLFDWĨFKSUHGPHWRYQDEH]SHÕQěOLNYLGÈFLXSRXĭLWÜKRPDWHULÈOX

2GSRUěÕDQÜSRUDGLHSULRGEHUH
1.

+HPRNXOWLYDÕQÜIøDđWLÕN\2.

6NěPDYN\VbFLWUÈWRPDbDNWLYÈWRURP]UÈĭDQLD VJÜORPEH]JÜOXVÜUXP&$7VÜURYĨJÜO&$7 

3.

6NěPDYN\VbDNWLYÈWRURP]UÈĭDQLDDOHERFLWUÈWRP

4.

6NěPDYN\VbKHSDUìQRPVbJÜORPEH]JÜOX

5.

6NěPDYN\Vb('7$VbJÜORPEH]JÜOX

6.

6NěPDYN\VbLQKLEìWRUPLJO\NROĨ]\7.

6NěPDYN\VbLQĨPLSUHSDUÈFLDPL
832=251(1,($NVD]DÕQHRGEHURPVNěPDYNRXVbFLWUÈWRPDOHERLQRXVNěPDYNRXVbWHNXWRXSUHSDUÈFLRXDNRMHQDSU3)$&7$'&3'$+&<&DOHER*OXFR(;$&7YbNRPELQÈFLLVbLKORX
VbNUìGHONDPL QDSU EH]SHÕQRVWQRX LKORX0XOWLĲ\® RGSRUěÕDVDSUHGWĨPRGEHUSUÈ]GQRXVNěPDYNRX QDSU60RQRYHWWH®QHXWUÈOQD= DE\VDSUHGLđORQHGRVWDWRÕQÜPXQDSOQHQLXVNěPDYN\QDSOQHQìPKDGLÕN\NUìGHONRYHMLKO\7ĨPVD]DLVWìVSUÈYQHQDSOQHQLHVNěPDYN\DbVSUÈYQ\SRPHUPLHđDQLD SUHSDUÈFLHDbNUYL 

832=251(1,(

3ULRGEHUHSRVWXSXMWHSRGøDSRUDGLDXUÕHQÜKRYbSUHGSLVRFKYÈđKR]DULDGHQLD

=DEUÈQHQLHVSËWQÜPXWRNX
9ËÕđLQDVNěPDYLHN60RQRYHWWHREVDKXMHFKHPLFNÜDGLWìYD$E\VWH]DEUÈQLOLVSËWQÜPXWRNXGRGUĭLDYDMWHQDVOHGXMěFHSRN\Q\
1. 3RXĭìYDMWHLEDPDWHULÈO\RGSRUěÕDQÜYbQÈYRGHQDSRXĭLWLH
2.

8PLHVWQLWHSDFLHQWDWDNDE\ERO]DEH]SHÕHQĨøDKNĨSUìVWXSNbĭLOHDbDNMHWRPRĭQÜQDVPHUXMWHKRUQěNRQÕDWLQXSDFLHQWDDOHERLQěREODVĕYSLFKXVPHURPQDGRO

3.

'UĭWH60RQRYHWWH®VNUXWNRYDFìPX]ÈYHURPQDKRUDbSULSRXĭLWì EH]SHÕQRVWQHM LKO\0XOWLĲ\®RNUHPWRKRDMSRGěURYýRXKRUQHMNRQÕDWLQ\REODVWLYSLFKX

4.

=DEH]SHÕWHDE\VDREVDKVNěPDYN\60RQRYHWWH®SULYSLFKXGRĭLO\ĭLO\QHGRWĨNDOVNUXWNRYDFLHKRX]ÈYHUXDQLNRQFDLKO\

5.

8YRøQLWHđNUWLGORNĨPNUYSUěGLGRVNěPDYN\60RQRYHWWH®.

194

SK
Zmrazenie/rozmrazenie
3RGøDRGSRUěÕDQì:+2 :+2',//DE5HY VDRGSRUěÕDSUHG]PUD]HQìPRGGHOLĕVÜUXPSOD]PXRGNUYQĨFKEXQLHN
Pre zmrazovanie S-Monovette®SODWLDQDVOHGXMěFHRGSRUěÕDQLD
=PUD]HQLHSRGbƓ&•3RXĭLWLHYbUR]VDKXWHSOăWSRGQXORXVDPXVìYĭG\WHVWRYDĕYbUHÈOQ\FKSRGPLHQNDFKSUHWRĭH]DĕDĭHQLHVNěPDYLHNVDPăĭHYĨUD]QHOìđLĕYb]ÈYLVORVWLRGPÜGLDNWRUÜVDPÈ]PUD]LĕDbRGEHĭQĨFKSRGPLHQRN SR]ULkapitolu Vlastnosti materiálu, katalóg SARSTEDT).

•+RGQRW\SHYQRVWLSODVWRYVD]ÈVDGQH]QLĭXMěYbWHSORWQRPUR]VDKXSRGbƓ&0HFKDQLFNÜPX]DĕDĭHQLXE\VWHVDSUHWRPDOLYRYđHREHFQRVWLY\KĨEDĕ•

3RGPLHQN\]PUD]RYDQLDVDPXVLD]YROLĕWDNDE\VDREVDKVNěPDYN\60RQRYHWWH®]PUD]LOURYQRPHUQHUHVSRGVSRGXQDKRU6NěPDYND60RQRYHWWH®E\PDODPDĕYbVWRMDQHDOHERYběORĭQRPNDUWĂQHGRVWDWRÕQěYăøXDE\VDPRKODUR]SìQDĕ6WRMDQ\]bSRO\VW\UÜQXDOHERNRYXQLHVěYKRGQÜSUHWRĭHPăĭXVSăVRELĕGLODWDÕQÜWUKOLQ\=PUD]HQLHQDbƓ&şSUHG]PUD]HQìPVNRQWUROXMWH•,QWHUIHUHQFLH6NRQWUROXMWHÕL]PUD]HQLHQHPÈUXđLYÜYSO\Y\QDY]RUNXNUYLDOHERDQDOĨ]X KHPROĨ]DVWDELOLWDDQDO\WRY •&HQWULIXJÈFLD9b]ÈYLVORVWLRGSOÈQRYDQHMDQDOĨ]\MHSRWUHEQÈ'RGUĭLDYDMWHSRGPLHQN\FHQWULIXJÈFLHSR]ULWHQWRGRNXPHQWÕDVĕŚ&HQWULIXJÈFLDŗSUìSQDZHERYHMVWUÈQNH6$567('7https://www.sarstedt.com/en/
service/centrifugation/DbY\NRQDMWHYL]XÈOQXNRQWUROXY]RUN\•+HPROĨ]D3OQÈNUYKHPRO\]XMHSUL]PUD]HQì$E\VDWRPXSUHGLđORPDODE\VDSRXĭLĕEXØ60RQRYHWWH®JÜOSUìSSRFHQWULIXJÈFLLYHQWLORYĨıOWHU6HUDSODV®DOHERE\VDPDODY]RUNDRGSLSHWRYDĕGRVHNXQGÈUQHM
VNěPDYN\=PUD]HQLHQDbƓ&şSRVWXS•Ochladenie: S- Monovette®YR]YLVOHMSRORKHRFKODØWH]bL]ERYHMWHSORW\QDbƓ&SRÕDVşbPLQVNăUDNRMXGÈWH]PUD]LĕQDbƓ&

•5R]PUD]HQLH1HFKDMWHUR]PUD]LĕYR]YLVOHMSRORKHSULL]ERYHMWHSORWHDVSRýbPLQěW$MWXVDWUHEDY\KQěĕPHFKDQLFNÜPXQDPÈKDQLX3UìOLđUĨFKOHUR]PUD]RYDQLHPăĭHYLHVĕNb]KRUđHQLXYĨVOHGNRYDQDOĨ]\=PUD]HQLHDbKOERNÜ]PUD]HQLHSRGbƓ&•+OERNÜ]PUD]HQLHQDWHSORWXQLĭđLXDNRbƓ&QHERORYĨUREFRPWHVWRYDQÜ9]KøDGRPQDYHøNĨSRÕHWPRĭQĨFKRYSO\YýXMěFLFKIDNWRURYVDRGSRUěÕDY\NRQDĕWHVW]PUD]HQLDYbEHĭQĨFKODERUDWĂUQ\FKSRGPLHQNDFKZmrazenie S-Monovette® gél:•

=PUD]HQLHVDY\NRQÈSRGøDRSLVX=PUD]HQLHQDbƓ&şSRVWXS•-H]QÈPHĭHYUVWYDJÜOXVDPăĭHPHQLĕYbGăVOHGNXSURFHVX]PUD]RYDQLD

•9]KøDGRPQDYHøNĨSRÕHWPRĭQĨFKRYSO\YýXMěFLFKIDNWRURYVDRGSRUěÕDY\NRQDĕWHVW]PUD]HQLDYbEHĭQĨFKODERUDWĂUQ\FKSRGPLHQNDFK•Rozmrazenie:1HFKDMWHY]RUNXUR]PUD]LĕYR]YLVOHMSRORKH3RUR]PUD]HQìSUHQHVWHY]RUNX]bSULPÈUQHMVNěPDYN\GRVHNXQGÈUQHMVNěPDYN\RGSLSHWRYDQìP QHGHNDQWXMWH GRFFDbPPQDGYUVWYRXJÜOX=Y\đRN
Y\KRØWH
832=251(1,(3RNLDøLGHRbVWDELOLWXSDUDPHWURYGRGUĭLDYDMWHQÈYRGQDSRXĭLWLHRGYĨUREFRYWHVWRYDFìFKUHDJHQFLìDQDO\WLFNÜKR]DULDGHQLD

195

SK
Odber krvi
Odberové techniky([LVWXMěGYHRGEHURYÜWHFKQLN\DVSLUDÕQÈDbYÈNXRYÈ$VSLUDÕQÈWHFKQLNDXPRĭýXMHđHWUQĨRGEHUNUYLVbNRQWLQXÈOQ\PSRPDOĨPSULHWRNRPNUYLNRQWURORYDQĨPĕDKDQìP]DWLDKORSLHVWX7ĨPWRVSăVRERPMHPRĭQÜRNDPĭLWHSULVSăVRELĕSULHWRNNUYLYđHWNĨPVWDYRPĭìO
DbRNROQRVWLDPDb]UHGXNRYDĕKHPROĨ]X
9ÈNXRYÈWHFKQLNDXPRĭýXMHRGEHUNUYL]bYRSUHGYÈNXRYDQHMVNěPDYN\QDSULQFìSHSRGWODNXVbQHSUHWUĭLWĨPUĨFKO\PSULHWRNRPNUYL3UHWRMHWÈWRWHFKQLNDLGHÈOQDYbSUìSDGHSULD]QLYÜKRVWDYXĭìODbMHGQRGXFKĨFK
podmienok odberu vzoriek.
0DQLSXOÈFLDQDRGEHUNUYLSR]ULWHVLYLGHRRbPDQLSXOÈFLLVb60RQRYHWWH®SULDVSLUDÕQHMSUìSYÈNXRYHMWHFKQLNHVbEH]SHÕQRVWQRXLKRXSUìSEH]SHÕQRVWQRXLKORX0XOWLIO\®:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood328Å9$-7(58.$9,&($%<67(0,1,0$/,=29$/,5,=,.2.217$0,1d&,(32q$62'%(58.59,
1. =YRøWHYKRGQěVNěPDYNX60RQRYHWWH®SUHSRĭDGRYDQěY]RUNX
2.

9\EHUWHPLHVWRYSLFKX3ULSUìSUDYHPLHVWDYSLFKXGRĭLO\SRVWXSXMWHSRGøDVPHUQìF]DULDGHQLD2GEHUNUYLDVSLUDÕQRXWHFKQLNRX
Pozor! S-Monovette®SRXĭìYDMWHOHQQDRGEHUNUYLQLHQDLQMHNFLX
3RXĭìYDMWHOHQVbWĨPLWR EH]SHÕQRVWQĨPL LKODPL60RQRYHWWH®DOHER EH]SHÕQRVWQĨPL LKODPL0XOWLIO\®/adaptérom pre S-Monovette®.
7XMH]REUD]HQÈDSOLNÈFLDVEH]SHÕQRVWQRXLKORX

klik%H]SURVWUHGQHSUHGYSLFKRPGRĭLO\]DVXýWH60RQRYHWWH®GRLQWHJURYDQÜKRGUĭLDNDEH]SHÕQRVWQHMLKO\ Db]DLVWLWHMXPLHUQ\PRWRÕHQìPYbVPHUHKRGLQRYĨFKUXÕLÕLHN .
9bSUìSDGHSRWUHE\SRXĭLWHđNUWLGOR PD[bPLQěWX 2đHWULWHPLHVWRYSLFKXYKRGQĨPGH]LQIHNÕQĨPSURVWULHGNRP3RGH]LQIHNFLLVDXĭQHGRWĨNDMWHPLHVWDYSLFKXGRĭLO\8PLHVWQLWHSDFLHQWDWDNDE\ERO]DEH]SHÕHQĨøDKNĨSUìVWXSNbĭLOHDbDNMHWRPRĭQÜQDVPHUXMWHKRUQěNRQÕDWLQXSDFLHQWDDOHERLQěREODVĕYSLFKXVPHURPQDGRO2GVWUÈýWHRFKUDQQĨNU\WLKO\9\NRQDMWHYSLFKGRĭLO\WLDKORSLHVWXSRPDO\ĕDKDMWHDbXYRøQLWHđNUWLGORNĨPNUYSUěGLGRVNěPDYN\60RQRYHWWH®
3RÕNDMWHNĨPVDWRNNUYL]DVWDYìDE\VDXPRĭQLORVSUÈYQHQDSOQHQLH

.

8YRøQLWH60RQRYHWWH® øDKNĨPRWRÕHQìPSURWLVPHUXKRGLQRYĨFKUXÕLÕLHN DbSRWRPMXY\WLDKQLWH]bEH]SHÕQRVWQHMLKO\ RGSRMWH  %H]SHÕQRVWQÈLKOD]RVWDQHYbĭLOH9bSUìSDGHYLDFQÈVREQÜKRRGEHUXVDQDVOHGXMěFH60RQRYHWWHŪSULSRMDNEH]SHÕQRVWQHMLKOHSRGøDSRSLVXY\đđLHDRGREHUěVDØDOđLHY]RUN\
8NRQÕHQLHRGEHUXNUYL1DMSUYRGSRMWH60RQRYHWWH®
+ SRWRPY\WLDKQLWHEH]SHÕQRVWQěLKOX]RĭLO\3ULMHGQRUXÕQHMWHFKQLNHEXØSRORĭWHFKUÈQLÕLKO\QDVWDELOQěURYQěSORFKXşNĨPLKODQH]DSDGQH
do ochranného krytu ihly FLWHøQĨPDbSRÕXWHøQĨPŚNOLNQXWìPŗ DNWLYÈFLD DOHERRFKUDQQĨNU\WLKO\DNWLYXMWH]DWODÕHQìPXND]RYÈNRPQDVSRGQĨNRQLHFRFKUDQQÜKRNU\WXLKO\SR]ULWLHĭQÈYRGQDSRXĭLWLH
S-Monovette® EH]SHÕQRVWQHM LKO\DOHER EH]SHÕQRVWQHM LKO\0XOWLIO\®.
.DĭGěVNěPDYNX60RQRYHWWH®LKQHØSRRGSRMHQìRGEH]SHÕQRVWQHMLKO\[REUÈĕWHKRUHGQRPDbSRVNRQÕHQìFHOÜKRRGEHUXNUYLSRRWÈÕDMWHRSDWUQHQLHNRøNRNUÈWYđHWN\Y]RUN\VbDQWLNRDJXODQWPLKRUHGQRP3ULWUDQVSRUWHDbFHQWULIXJÈFLLSRWLDKQLWHWLDKORSLHVWXSRÕXWHøQHGRDUHWDÕQHMSRORK\SLHVWD (piest zapadne do dna S-Monovette® DbWLDKORSLHVWX odlomte.
1.

3ULWODÕWHPLHVWRYSLFKXVXFKĨPVWHULOQĨPWDPSĂQRPNĨPVDNUYÈFDQLHQH]DVWDYì

2.

/HQÕRVDNUY]DÕQH]UÈĭDĕDSOLNXMWHQÈSODVĕDNMHWRSRWUHEQÜ3.

=OLNYLGXMWHEH]SHÕQRVWQěLKOXYQÈGREHQDOLNYLGÈFLXQHEH]SHÕQÜKRELRORJLFNÜKRRGSDGX

196

SK
2GEHUNUYLYÈNXRYRXWHFKQLNRX
Pozor! S-Monovette®SRXĭìYDMWHOHQQDRGEHUNUYLQLHQDLQMHNFLX
3RXĭìYDMWHOHQVbWĨPLWR EH]SHÕQRVWQĨPL LKODPL60RQRYHWWH®DOHER EH]SHÕQRVWQĨPL LKODPL0XOWLIO\®/adaptérom pre S-Monovette®.
7XMH]REUD]HQÈDSOLNÈFLDVEH]SHÕQRVWQRXLKORX

klik$E\VWHPRKOLđHWUQH]DÕDĕVbRGEHURPNUYLVSRORÕQRVĕ6$567('7RGSRUěÕDXURELĕRGEHUGRSUYHMVNěPDYN\60RQRYHWWH®DVSLUDÕQRXWHFKQLNRXSR]UL7(&+1,.$381.&,(Å,/<DVSLUDÕQÈWHFKQLND
3RWRPSRNUDÕXMHYÈNXRYRXWHFKQLNRX
3UHGRGEHURPNUYLSRWLDKQLWHWLDKORSLHVWXDĭNbGQX60RQRYHWWH®DbQHFKDMWHKRSRÕXWHøQH]DSDGQěĕ . Potom tiahlo piestu odlomte .
3ULSUDYHQě60RQRYHWWH®]DVXýWHGRLQWHJURYDQÜKRGUĭLDND60RQRYHWWH®EH]SHÕQRVWQHMLKO\Db]DLVWLWHMXPLHUQ\PRWRÕHQìPYbVPHUHKRGLQRYĨFKUXÕLÕLHN

+

–

.

3RÕNDMWHNĨPVDWRNNUYL]DVWDYìDE\VDXPRĭQLORVSUÈYQHQDSOQHQLH

8YRøQLWH60RQRYHWWH® øDKNĨPRWRÕHQìPSURWLVPHUXKRGLQRYĨFKUXÕLÕLHN DbSRWRPMXY\WLDKQLWH]bEH]SHÕQRVWQHMLKO\ RGSRMWH  %H]SHÕQRVWQÈLKOD]RVWDQHYbĭLOH9bSUìSDGHYLDFQÈVREQÜKRRGEHUXVDQDVOHGXMěFH60RQRYHWWH®SULSRMDNEH]SHÕQRVWQHMLKOHSRGøDSRSLVXY\đđLHDRGREHUěVDØDOđLHY]RUN\
8NRQÕHQLHRGEHUXNUYL
Odpojte S-Monovette® + SRWRPY\WLDKQLWHEH]SHÕQRVWQěLKOX]RĭLO\3ULMHGQRUXÕQHMWHFKQLNHEXØSRORĭWHFKUÈQLÕLKO\QDVWDELOQěURYQěSORFKXşNĨPLKODQH]DSDGQHGRRFKUDQQÜKRNU\WXLKO\FLWHøQĨPDbSRÕXWHøQĨPŚNOLNQXWìPŗ DNWLYÈFLD DOHERRFKUDQQĨNU\WLKO\DNWLYXMWH]DWODÕHQìPXND]RYÈNRPQDVSRGQĨNRQLHFRFKUDQQÜKRNU\WXLKO\.DĭGěVNěPDYNX60RQRYHWWH®LKQHØSRRGSRMHQìRGEH]SHÕQRVWQHMLKO\[REUÈĕWHKRUHGQRPDbSRVNRQÕHQìFHOÜKRRGEHUXNUYLSRRWÈÕDMWHRSDWUQHQLHNRøNRNUÈWYđHWN\Y]RUN\VbDQWLNRDJXODQWPLKRUHGQRP
1.

3ULWODÕWHPLHVWRYSLFKXVXFKĨPVWHULOQĨPWDPSĂQRPNĨPVDNUYÈFDQLHQH]DVWDYì

2.

/HQÕRNUYVDNUY]DÕQH]UÈĭDĕDSOLNXMWHQÈSODVĕDNMHWRSRWUHEQÜ3.

=OLNYLGXMWHEH]SHÕQRVWQěLKOXYQÈGREHQDOLNYLGÈFLXQHEH]SHÕQÜKRELRORJLFNÜKRRGSDGX

197

.

SK
&HQWULIXJÈFLD
32=256NěPDYN\6$567('760RQRYHWWHVěGLPHQ]RYDQÜQDPD[LPÈOQH[bJ9ĨQLPNRXVě60RQRYHWWHVb¢PP 60RQRYHWWH®SHGLDWULD NWRUÜVěDNWXÈOQHYDOLGRYDQÜGR[bJ3RXĭìYDMWHOHQYKRGQÜYRQNDMđLHVNěPDYN\UHVSDGDSWÜU\3ULFHQWULIXJÈFLLSRSUDVNDQĨFKVNěPDYLHN60RQRYHWWHDOHERSULFHQWULIXJÈFLLVbQDGPHUQRXRGVWUHGLYRXVLORXPăĭHGăMVĕNbSUDVNQXWLXVNěPDYLHN60RQRYHWWHDbXYRøQHQLXSRWHQFLÈOQHQHEH]SHÕQĨFKOÈWRN$GDSWÜU\FHQWULIěJ\E\VDPDOLY\EHUDĕSRGøDYHøNRVWLSRXĭLWĨFKVNěPDYLHN60RQRYHWWH5HODWìYQDFHQWULIXJDÕQÈVLOD]ÈYLVìRGQDVWDYHQĨFKRWÈÕRNWDNWR
5&) [bU[b RWPLQ 2,Ś5&)ŗŚ5HODWìYQDFHQWULIXJDÕQÈVLODŗQD]ĨYDQÈDMVLODJ DQJOLFN\5&)ŚUHODWLYHFHQWULIXJDOIRUFHŘ ŚRWPLQŗŚ2WÈÕN\]DPLQěWXŗ PLQ DOHERQb ŚSRÕHWRWÈÕRN]DPLQěWXŗ DQJOLFN\530ŚUHYROXWLRQVSHUPLQXWHŗ ŚUŗŚSRORPHUFHQWULIěJ\RGMHMVWUHGXSRGQRVNěPDYN\60RQRYHWWH®“, (cm).
6NěPDYN\60RQRYHWWHEH]JÜOXMHPRĭQÜFHQWULIXJRYDĕYbFHQWULIěJDFKVbURWRURPVbSHYQĨPXKORPDOHERVbYĨN\YQĨPURWRURP
6NěPDYN\60RQRYHWWHVbJÜORPVěXUÕHQÜYĨKUDGQHSUHFHQWULIěJ\VbYĨN\YQĨPURWRURP&HQWULIXJÈFLDYbFHQWULIěJDFKVbURWRURPVbSHYQĨPXKORPQHERODYDOLGRYDQÈVSRORÕQRVĕRX6$567('7DbQHRGSRUěÕDVD
6NěPDYN\60RQRYHWWHE\VDPDOLFHQWULIXJRYDĕSRGøDSRGPLHQRNFHQWULIXJÈFLHXYHGHQĨFKØDOHMYbWH[WH9bSUìSDGHLQĨFKSRGPLHQRNMHSRWUHEQÜDE\LFKSRXĭìYDWHøVÈPYDOLGRYDO
=DEH]SHÕWHDE\VNěPDYN\60RQRYHWWHVSUÈYQHGRVDGOLGRDGDSWÜUDFHQWULIěJ\6NěPDYN\60RQRYHWWHNWRUÜY\ÕQLHYDMěFH]DGDSWÜUVDPăĭX]DFK\WLĕRKODYXFHQWULIěJ\D]ORPLĕVD8LVWLWHVDĭHMHFHQWULIěJDQDSOQHQÈURYQRPHUQH'RGUĭLDYDMWHQÈYRGQDSRXĭLWLHFHQWULIěJ\
32=25 5R]ELWÜ VNěPDYN\ 60RQRYHWWH QHRGVWUDýXMWH UXNRX3RN\Q\ QD GH]LQIHNFLX FHQWULIěJ\ QÈMGHWH YbSUìVOXđQRP QÈYRGH QD SRXĭLWLH FHQWULIěJ\

5HODWìYQDFHQWULIXJDÕQÈVLOD J

3RGøD%6
DIN EN ISO 6710
4851+ (kód EU)–

S-Monovette®
[bJ[bJ[bJ[bJ[bJSérum

bPLQbPLQbPLQ

bPLQ

bPLQ

Sérum gélbPLQbPLQ

bPLQ

bPLQ

bPLQ

Sérum expres gél

bPLQbPLQbPLQ

nevalid.

nevalid.

Líthium heparín

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Líthium heparín gél

bPLQbPLQbPLQ

bPLQ

bPLQ

Líthium heparín gél+

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA

nevalid.

nevalid.

bPLQ

bPLQ

bPLQ

EDTA gélbPLQbPLQbPLQ

bPLQ

bPLQ

&LWUÈW

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

Fluorid heparín

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

GlucoEXACT

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUÈW3%0PO
3RORPHUFHQWULIěJ\!bFP

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUÈW3%0PO
3RORPHUFHQWULIěJ\!DĭƉbFP

nevalid.

nevalid.

bPLQnevalid.

nevalid.

nevalid. = nevalidované
3ODWìSUHVNěPDYN\60RQRYHWWHVbYĨQLPNRX¢bbPP VNěPDYN\60RQRYHWWHSHGLDWULD &HQWULIXJÈFLDSULbƓ&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, stiahnutá.

,QIRUPÈFLHRbVHSDUDÕQRPPDWHULÈOL
.RQ]LVWHQFLDVHSDUDÕQÜKRPDWHULÈOX JÜOX MH]ÈYLVOÈRGWHSORW\$NVDVNěPDYN\60RQRYHWWHSUHGDOHERSRÕDVFHQWULIXJÈFLHRFKODGLDVěYLVOÈYUVWYDVHSDUDÕQÜKRJÜOXXĭQLHMHJDUDQWRYDQÈ
6NěPDYN\60RQRYHWWHVDQHVPěRSDNRYDQHFHQWULIXJRYDĕUHFHQWULIXJRYDĕ/LNYLGÈFLD
1.

5HđSHNWXMWHDbGRGUĭLDYDMWHYđHREHFQÜK\JLHQLFNÜ]ÈVDG\DSODWQÜQDULDGHQLDRbVSUÈYQHMOLNYLGÈFLLLQIHNÕQÜKRPDWHULÈOX

2.

3RXĭìYDQLHMHGQRUD]RYĨFKUXNDYìF]DPHG]XMHUL]LNXLQIHNFLH

3.

.RQWDPLQRYDQÜDOHERQDSOQHQÜV\VWÜP\QDRGEHUNUYLVDPXVLD]OLNYLGRYDĕYRYKRGQĨFKQÈGREÈFKQDOLNYLGÈFLXQHEH]SHÕQÜKRELRORJLFNÜKRRGSDGXNWRUÜVDSRWRPPăĭXDXWRNOÈYRYDĕDbVSÈOLĕ

4.

/LNYLGÈFLDVDPXVìY\NRQDĕYRYKRGQRPVSDøRYDFRP]DULDGHQìDOHERDXWRNOÈYRYDQìP VWHULOL]ÈFLDSDURX 

198

SK
1RUP\DbVPHUQLFHđSHFLıFNÜSUHSURGXNWYbSODWQRP]QHQì
CLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

1RUPDSUHVNěPDYN\QDRGEHUYHQĂ]QHMNUYL
',1(1,62-HGQRUD]RYÜVNěPDYN\QDRGEHUøXGVNHMNUYL]RĭLO\*CLSI (Clinical and Laboratory Standards Institute)/HJHQGDV\PERORYDbR]QDÕHQì.DWDOĂJRYÜÕìVOR

3ODWìSUHMHGQRWOLYRVWHULOQHEDOHQÜSRPăFN\Kód dávky

1HSRXĭìYDMWHDNMHREDOSRđNRGHQĨ

3RXĭLWHøQÜGR-HGQRGXFKĨV\VWÜPVWHULOQHMEDULÜU\VbYRQNDMđìPRFKUDQQĨPREDORP=QDÕND&(

6WHULOL]RYDQÜĭLDUHQìP

Diagnostická zdravotnícka pomôcka in-vitro

3RVWXSXMWHSRGøDQÈYRGXQDSRXĭLWLH

3ULRSDNRYDQRPSRXĭLWì1HEH]SHÕHQVWYRNRQWDPLQÈFLH

&KUÈQLĕSUHGVOQNRP

8FKRYÈYDĕYbVXFKX

9ĨUREFD

Krajina pôvodu

Sterilná dráha tekutiny

Zákaz opakovanej sterilizácie

Technické zmeny vyhradené.
9đHWN\]ÈYDĭQÜXGDORVWLWĨNDMěFHVDYĨURENXPXVLDE\ĕR]QÈPHQÜYĨUREFRYLDbSUìVOXđQÜPXđWÈWQHPXRUJÈQX

199

Navodila za uporabo – Sistem za odvzem krvi S-Monovette® SARSTEDTSL=DGLDJQRVWLÕQRXSRUDERin-vitro
Namen uporabe
Sistemi za odvzem krvi S-Monovette®, kanile in adapterji se uporabljajo skupaj kot sistem za venozni odvzem krvi. Sistemi za odvzem krvi S-Monovette® se uporabljajo za odvzem, prevoz, obdelavo in shranjevanje
Y]RUFHYNUYL]DGLDJQRVWLÕQHSUHLVNDYHin-vitroL]VHUXPDSOD]PHDOLSROQHNUYLYNOLQLÕQHPODERUDWRULMX,]GHOHNODKNRYSURIHVLRQDOQHPRNROMXXSRUDEOMDMRVWURNRYQL]GUDYVWYHQLGHODYFLLQVWURNRYQMDNLYODERUDWRULMXOpis izdelka
Sisteme za odvzem krvi S-Monovette®VHVWDYOMDMRSODVWLÕQDHSUXYHWDEDWEDWQLFDLQEDUYQRNRGLUDQSODVWLÕQLQDYRMQLSRNURYÕHN]YJUDMHQRPHPEUDQRNLMHELOL]GHODQSRVHEHM]DSULNOMXÕHNQD YDUQRVWQR NDQLORS-Monovette® ali na (varnostno) kanilo Multifly®WHUUD]OLÕQLGRGDWNL SULSUDYNL 1DYROMRMHWXGLHSUXYHWD60RQRYHWWH® brez dodatka. Sistemi za odvzem krvi S-Monovette® z dodatki, kot sokoagolacijski aktivator,
koagulacijski aktivator z gelom, litijev heparin, litijev heparin z gelom, natrijev heparin, citrat, EDTA, fluorid EDTA, fluorid-heparin, fluorid-citrat, CPDA in brez dodatkov, pri katerih koncentracije dodatkov, prostorninaWHNRÕLKGRGDWNRYLQQMLKRYHGRYROMHQHWROHUDQFHWHUUD]PHUMHNUYLLQGRGDWNDXVWUH]DMR]DKWHYDPLQSULSRURÕLORPPHGQDURGQLKVWDQGDUGRY',1b(1b,62bŚ6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŗ
LQ&OLQLFDODQG/DERUDWRU\6WDQGDUGV,QVWLWXWHŖV$SSURYHG6WDQGDUGV &/6, ,]ELUDGRGDWNDMHRGYLVQDRGDQDOLWLÕQHPHWRGHWHVWD'RORÕLMRSURL]YDMDOHFUHDJHQWDWHVWLUDQMDLQDOLDSDUDWD]DDQDOL]RQDNDWHUHPERWHVWLUDQMH
izvedeno. Sistem za odvzem krvi S-Monovette®MHQDYROMRY]QRWUDMVWHULOQLKL]YHGEDKDOLYSRVDPLÕQLKSDNLUDQMLKNLVRVWHULOQD]QRWUDMLQ]XQDM%DUYQHNRGHQDYRMQLKSRNURYÕNRY60RQRYHWWH®*:

DodatekqUNRYQDNRGD%DUYDSRNURYÕND',1b(1b,62b

%DUYDSRNURYÕNDQDSRGODJL%6b+

Z

bela

bela

Epruveta brez pripravka
S-Monovette® Neutral Z
Epruveta s serumom
S-Monovette® Serum CAT, s koagulacijskim aktivatorjem

CAT

UGHÕD

bela

S-Monovette® Serum-Gel CAT, s koagulacijskim aktivatorjem in gelomCATtemno rumena

temno rumena

S-Monovette® Serum Express Gel CAT, s koagulacijskim aktivatorjem trombinom in gelomCATRUDQĭQD-

Epruveta s heparinom
S-Monovette® Lithium-Heparin LH, z litijevim heparinom

LHzelenaRUDQĭQD

S-Monovette®/LWKLXP+HSDULQĲĞVVLJ/+]OLWLMHYLPKHSDULQRP

LH

zelenaRUDQĭQD

S-Monovette® Lithium-Heparin-Gel LH, z litijevim heparinom in gelom

LHzelenaRUDQĭQD

S-Monovette® Lithium-Heparin-Gel+ LH, z litijevim heparinom in hitrim gelom

LHzelenaRUDQĭQD

S-Monovette® Natrium-Heparin NH, z natrijevim heparinom

NH

rjava

zelenaS-Monovette® Ammonium-Heparin AH, z amonijevim heparinom

n.d.

modra

modra

S-Monovette®&LWUDW1&QDWULMHYFLWUDWb

9NC

modra

zelenaS-Monovette 3)$&LWUDW1&QDWULMHYFLWUDWbSXIHULUDQ

9NC

svetlo modra-

S-Monovette® K3 EDTA K3E, s kalijem EDTA

K3E

YLMROLÕQD

UGHÕDS-Monovette® K2 EDTA K2E, s kalijem EDTA

K2E

YLMROLÕQD

UGHÕDS-Monovette® K2 EDTA gel K2E, s kalijem EDTA in z gelom

K2E

YLMROLÕQD

UGHÕDS-Monovette®)OXRULG('7$)(VĲXRULGRPLQ('7$

FE

siva

rumenaS-Monovette®)OXRULG+HSDULQ)+VĲXRULGRPLQKHSDULQRP

FH-

rumenaS-Monovette®*OXFR(;$&7)&VĲXRULGRPFLWUDWRPLQ('7$

FC

roza

siva

LH

temno modraRUDQĭQD

S-Monovette® ThromboExact, z magnezijevo spojino

n.d.

n.d., barva robide

n.d., barva robide

S-Monovette® CTADn.d.

n.d., modra

n.d., zelena

S-Monovette® ACD

ACD

rumenarumenaS-Monovette® CPDA

CPDA

rumenarumenaS-Monovette® Hirudinn.d.

n.d., olivno zelenan.d., olivno zelena

Epruveta s citratom®

Epruveta EDTA

Epruveta z inhibitorji glikolize

Epruveta za analizo kovin
S-Monovette® analiza kovin LH, z litijevim heparinom

Druge epruvete za polno kri in plazmo

S-Monovette® Homocystein HCY-Z Gel, z gelom in stabilizatorjem

n.d.

n.d., siva

n.d., siva

S-Monovette® Homocystein HCY-C s citratnim pufromn.d.

QGYLMROLÕQD

QGYLMROLÕQD

S-Monovette® DNA Exactn.d.

n.d., modra

n.d., modra

1DYROMRVRđHGUXJHEDUYHQDYRMQLKSRNURYÕNRY
QGQLGRORÕHQR
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, umaknjen.

200

SL
Epruveta S-Monovette® Serum CAT/ erum-Gel CAT SARSTEDT
Epruveta S-Monovette®6HUXP&$7YVHEXMHSODVWLÕQLJUDQXODWVSODVWMRDNWLYDWRUMDNRDJXODFLMH VLOLNDW LQVHXSRUDEOMD]DSULGRELYDQMHVHUXPD 3ODVWLÕQLJUDQXODWVHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQRSRJDÕRLQVHUXP
Epruveta S-Monovette®6HUXP*HO&$7YVHEXMHSROHJSODVWLÕQHJDJUDQXODWDVSODVWMRDNWLYDWRUMDNRDJXODFLMH VLOLNDWRP WXGLJHOQDRVQRYLSROLPHURYLQVHXSRUDEOMD]DSULGRELYDQMHVHUXPD *HOVHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQRSRJDÕRLQVHUXPWHUWYRULORÕHYDOQRSUHJUDGRPHGSUHYR]RPVNODGLđÕHQMHPLQDQDOL]R6HUXPVHXSRUDEOMDNRWY]RUÕQLPDWHULDOYNOLQLÕQRNHPLÕQLKLQLPXQRORđNLKUXWLQVNLKSUHLVNDYDKWHUYVHULRORJLMLPo odvzemu kri pustite, da se strjuje v epruveti S-Monovette®6HUXP&$76HUXP*HO&$7bPLQXWYSRNRQÕQHPSRORĭDMXGDERSRFHQWULIXJLUDQMX]DJRWRYOMHQDGREURL]UDĭHQDYRGRUDYQDORÕHYDOQDSUHJUDGD
3ULSRURÕHQÕDVWHPHOMLQDLQWDNWQHPSRVWRSNXNRDJXODFLMH.ULEROQLNRY]EROH]HQVNLPLPRWQMDPLVWUMHYDQMDNUYLDOLYSULPHUXWHUDSLMSURWLVWUMHYDQMXNUYLPRUGDSRWUHEXMH]DSRSROQRVWUGLWHYGDOMÕDVD

S-Monovette® Serum Express Gel CAT SARSTEDT
Epruveta S-Monovette®6HUXP([SUHVV*HO&$7YVHEXMHSROHJSODVWLÕQHJDJUDQXODWDVSODVWMRDNWLYDWRUMDNRDJXODFLMH WURPELQ WXGLJHOQDRVQRYLSROLPHURYLQVHXSRUDEOMD]DSULGRELYDQMHVHUXPD *HOVHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQRSRJDÕRLQVHUXPWHUWYRULVWDELOQRORÕHYDOQRSUHJUDGRPHGSUHYR]RPVNODGLđÕHQMHPLQDQDOL]RPo odvzemu kri pustite, da se strjuje v epruveti S-Monovette®6HUXP([SUHVV*HObPLQXWYSRNRQÕQHPSRORĭDMXGDERSRFHQWULIXJLUDQMX]DJRWRYOMHQDGREURL]UDĭHQDYRGRUDYQDORÕHYDOQDSUHJUDGD3ULSRURÕHQÕDV
WHPHOMLQDLQWDNWQHPSRVWRSNXNRDJXODFLMHWXGL]DNULEROQLNRYQDKHSDULQVNLWHUDSLML.ULEROQLNRY]EROH]HQVNLPLPRWQMDPLVWUMHYDQMDNUYLDOLYSULPHUXWHUDSLMSURWLVWUMHYDQMXNUYLYNOMXÕQR]YLVRNLPRGPHUNRPKHSDULQD
SRWUHEXMH]DSRSROQRVWUGLWHYGDOMÕDVD
6HUXPVHXSRUDEOMDNRWY]RUÕQLPDWHULDOYNOLQLÕQRNHPLÕQLKLQLPXQRORđNLKUXWLQVNLKSUHLVNDYDKWHUYVHULRORJLMLS-Monovette® Neutral Z SARSTEDT
Epruveta S-Monovette® Neutral Z ne vsebuje pripravka, kar pomeni naravno strjevanje vzorca krvi brez aktivatorja koagulanta in se uporablja za pridobivanje seruma**. S centrifugiranjem se vzpostavi pregrada med
NUYQRSRJDÕRLQVHUXPRP
6HUXPVHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DVSHFLILÕQHSUHLVNDYHXSRUDEQLND
Zato se lahko epruveta S-Monovette®1HXWUDO=XSRUDEOMDWXGLNRWSUD]QDHSUXYHWDÕHVHRGY]HPNUYL]DÕQH]HSUXYHWR60RQRYHWWH® Citrat v kombinaciji z (varno) kanilo Safety-Multifly® (kanila s krilci), se lahko epruveta
S-Monovette® Neutral Z uporabi kot prva epruveta (prazna epruveta) za polnjenje cevi (varnostne) kanile Multifly®.

S-Monovette® Lithium-Heparin LH / Lithium-Heparin-Gel LH / Lithium-Heparin-Gel+ LH, Natrium-Heparin NH, Ammonium-Heparin AH SARSTEDT
Epruveta S-Monovette®/LWKLXP+HSDULQ/+1DWULXP+HSDULQ1+$PPRQLXP+HSDULQ$+YVHEXMHSODVWLÕQLJUDQXODWVSODVWMR]DYLUDOFDVWUMHYDQMDNUYL DQWLNRDJXODQWD OLWLMHYHJDKHSDULQDQDWULMHYHJDKHSDULQDDPRQLMHYHJDKHSDULQD SUDYLORPD,(KHSDULQDPONUYL LQVHXSRUDEOMD]DSULGRELYDQMHSROQHNUYLLQSOD]PH 3ODVWLÕQLJUDQXODWVHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQHFHOLFHLQSOD]PRPri S-Monovette®/LWKLXP+HSDULQ/+EUH]SODVWLÕQHJDJUDQXODWDMHDQWLNRDJXODQWOLWLMHYKHSDULQRGPHUMHQYUD]SUđLOX SUDYLORPD,(KHSDULQDPONUYL 
Epruveta S-Monovette®/LWKLXP+HSDULQ*HO/+YVHEXMHSROHJSODVWLÕQHJDJUDQXODWDVSODVWMRDQWLNRDJXODQWDOLWLMHYHJDKHSDULQD SUDYLORPD,(KHSDULQDPONUYL WXGLJHOQDRVQRYLSROLPHURYLQVHXSRUDEOMD]D
SULGRELYDQMHSOD]PH *HOVHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQHFHOLFHLQSOD]PRWHUWYRULORÕHYDOQRSUHJUDGRPHGSUHYR]RPVNODGLđÕHQMHPLQDQDOL]R
Epruveta S-Monovette® Lithium-Heparin Gel+/+YVHEXMHWXGLJHOQDRVQRYLSROLPHURYNLRPRJRÕD]DSULEOLĭQRbNUDMđLÕDVFHQWULIXJLUDQMDYSULPHUMDYL]HSUXYHWR60RQRYHWWH® Lithium-Heparin Gel.
+HSDULQVNDSOD]PDVHXSRUDEOMDNRWY]RUÕQLPDWHULDOYNOLQLÕQRNHPLÕQLKLQLPXQRORđNLKUXWLQVNLKSUHLVNDYDK+HSDULQVNDSROQDNULVHXSRUDEOMDNRWY]RUÕQLPDWHULDOYLPXQRORđNLKUXWLQVNLKSUHLVNDYDKWHUYVHULRORJLML
3UHSUHÕHYDQMHVWUMHYDQMDVKHSDULQRPMH]DJRWRYOMHQR]DUDGLDNWLYLUDQMDDQWLWURPELQDOBVESTILO: Iz epruvete S-Monovette® Lithium-Heparin LH, Lithium-Heparin-Gel/Gel+/+QLGRYROMHQRL]YDMDQMHGRORÕDQMDUDYQLOLWLMDL]HSUXYHWH60RQRYHWWH® Natrium-Heparin NH ni dovoljeno
L]YDMDQMHGRORÕDQMDUDYQLQDWULMDLQL]HSUXYHWH60RQRYHWWH®$PPRQLXP+HSDULQ$+QLGRYROMHQRL]YDMDQMHGRORÕDQMDUDYQLDPRQLMD=YHQR]QRNUYMRQDSROQMHQHHSUXYHWH60RQRYHWWH® LithiumHeparin/Lithium-Heparin-Gel/Gel+ / Natrium-Heparin/Ammonium-Heparin niso primerne za plinsko analizo krvi.

Epruveta za analizo kovin S-Monovette® SARSTEDT
Epruveta za analizo kovin S-Monovette® vsebuje antikoagulant litijev heparin in se uporablja za pridobivanje polne krvi in plazme**. Litijev heparin je na voljo v obliki razpršila (19 I.E. heparina/ml krvi).
Heparinska polna kri oz. heparinska plazma epruvete za analizo kovin S-Monovette®VHYNRPELQDFLMLVVSHFLDOQRYDUQRVWQRNDQLOR*[Źŗ đWDUW XSRUDEOMDNRWY]RUÕQLPDWHULDO]DSUHLVNDYHHOHPHQWRY
v sledeh/kovin. Elemente v sledovih/kovine potrdimo z uporabo atomske absorbcijske spektometrije (AAS). Za sistem za analizo kovin varnostne kanile in epruvete S-Monovette®REVWDMDMRQDVOHGQMHQDMYHÕMHDEVRUSFLMHY
ng/sistem za te elemente v sledeh:

Element
ng/sistem

Tl

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

2,5

1,5

8,0

5,0

5

50

70

70

10

40

10

10

Najvišje vrednosti slepega vzorca so za vsak element navedene na nalepki epruvete S-Monovette®.
GRORÕDQMHHOHPHQWRYYVOHGHKSRWHNDRGYLVQRRGSRVWRSNDDQDOL]HL]KHSDULQVNHSROQHNUYLDOLKHSDULQVNHSOD]PH
3UHSUHÕHYDQMHVWUMHYDQMDVKHSDULQRPMH]DJRWRYOMHQR]DUDGLDNWLYLUDQMDDQWLWURPELQD

S-Monovette® Citrat 9NC SARSTEDT
Epruveta S-Monovette®&LWUDW1&YVHEXMHDQWLNRDJXODQWWULQDWULMHYFLWUDWLQVHXSRUDEOMD]DSULGRELYDQMHSROQHNUYLLQSOD]PH 7ULQDWULMHYFLWUDWMHYREOLNLPRODUQHUD]WRSLQH bUD]WRSLQDWULQDWULMHYHJDFLWUDWDSRJRVWR]DRNURĭHQRQDb LQ]QDđDbQD]LYQHSURVWRUQLQHHSUXYHWH60RQRYHWWH® Citrat. Razmerje mešanja citrata in krvi znaša 1:9 – 1 del prostornine citrata in 9 delov prostornine krvi. Za analizo je pravilna
napolnjenost nujno potrebna.
&LWUDWQDSOD]PDVHXSRUDEOMDNRWY]RUÕQLPDWHULDOYKHPRVWD]HRORđNLKUXWLQVNLKSUHLVNDYDKZaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.
Prosimo, upoštevajte OPOZORILA pod odvzemom vzorca in postopek za kombinacijo epruvete S-Monovette® Citrat in kanile s krilci.

S-Monovette® PFA 9NC SARSTEDT
Epruveta S-Monovette®3)$1&YVHEXMHDQWLNRDJXODQWWULQDWULMHYFLWUDW]DSULGRELYDQMHSROQHNUYLLQSOD]PH 7ULQDWULMHYFLWUDWMHQDYROMRNRWPRODUQDSXIHULUDQDUD]WRSLQD bSXIHULUDQDS+ LQ]QDđDbnazivne prostornine epruvete S-Monovette® PFA. Razmerje mešanja citrata in krvi znaša 1:9 – 1 del prostornine citrata in 9 delov prostornine krvi. Za analizo je pravilna napolnjenost nujno potrebna.
Polna kri epruvete S-Monovette®3)$1&VHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DGRORÕDQMHIXQNFLMWURPERFLWRY]DSDUDWRP]DDQDOL]R6,(0(16+HDOWKLQHHUV3)$LQMH]DWRWXGLSRWUMHQD
Zaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.
Prosimo, upoštevajte OPOZORILA pod odvzemom vzorca in ravnanjem za kombinacijo epruvete S-Monovette® PFA in kanile s krilci.

Epruveta S-Monovette® CTAD SARSTEDT
Epruveta S-Monovette®&7$'YVHEXMHDQWLNRDJXODQWWULQDWULMHYFLWUDWLQWHRILOLQDGHQR]LQLQGLSLULGDPROWHUVHXSRUDEOMD]DSULGRELYDQMHSROQHNUYLLQSOD]PH &7$'MHQDYROMRNRWUD]WRSLQDLQ]QDđDbQD]LYQH
prostornine epruvete S-Monovette® CTAD. Razmerje mešanja CTAD in krvi znaša 1:9 – 1 del prostornine CTAD in 9 delov prostornine krvi. Za analizo je pravilna napolnjenost nujno potrebna.
3OD]PD&7$'VHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DGRORÕDQMHIDNWRUMDSORđÕLF 3) EHWD Ĕ WURPERJOREXOLQD Ĕ7* LQSOD]PLQRJHQDNWLYDWRUMDLQKLELWRUMD 3$, NRWWXGL]DKHPRVWD]LRORđNHUXWLQVNHSUHLVNDYH
$NWLYLUDQMHWURPERFLWRYVHSUHSUHÕL]DREGREMHQDMPDQMđWLULKXULQVHXSRUDEOMD]DQDG]RUKHSDULQVNLKWHUDSLM
Zaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.
Prosimo, upoštevajte OPOZORILA pod odvzemom vzorca in postopanjem za kombinacijo epruvete S-Monovette® CTAD in kanile s krilci.
OBVESTILO: CTAD je rumene barve. Epruveta S-Monovette®&7$'PRUDELWLPHGVNODGLđÕHQMHP]DđÕLWHQDSUHGXPHWQRLQQDUDYQRVYHWORER2VYHWOLWHY]PRÕQRVYHWORER]DYHÕNRWXUODKNR
SRY]URÕLLQDNWLYLUDQMHGRGDWNRY

201

SL
Epruveta S-Monovette® EDTA K2E/K3E
Epruveta S-Monovette® EDTA K2E / S-Monovette®('7$.(YVHEXMHDQWLNRDJXODQW.('7$R].('7$LQVHXSRUDEOMD]DSULGRELYDQMHSROQHNUYL .('7$R].('7$MHQDYROMRYREOLNLUD]SUđLOD bPJ('7$POkrvi).
3ROQRNUL('7$VHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DKHPDWRORđNHSUHLVNDYH.UYQLUD]PD]MHWUHEDSULSUDYLWLYURNXđWLULKXUSRRGY]HPXNUYL
Zaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.
Kri iz epruvete S-Monovette®('7$.(.(VHODKNRXSRUDELWXGL]DLPXQRKHPDWRORđNHUXWLQVNHSUHLVNDYHLQWHVWHLQIHNFLMVNLKEROH]QL3ULPHUQRVWY]RUÕQHJDPDWHULDOD]DWRSUHLVNDYRMHXSRUDEQLNGROĭDQSUHYHULWL]
XVWUH]QLPLWHVWQLPLUHDJHQWLDSDUDWL]DDQDOL]RYNOMXÕQRVSRJRMLVNODGLđÕHQMD

Epruveta S-Monovette® EDTA-Gel K2E SARSTEDT
Epruveta S-Monovette®('7$*HO.(SROHJDQWLNRDJXODQWD.('7$YVHEXMHJHOQDRVQRYLSROLPHURYLQVHXSRUDEOMD]DSULGRELYDQMHSOD]PH .('7$MHQDYROMRYREOLNLUD]SUđLOD bPJ('7$PONUYL *HOVHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQHFHOLFHLQSOD]PRWHUWYRULORÕHYDOQRSUHJUDGRPHGSUHYR]RPVNODGLđÕHQMHPLQDQDOL]R
3OD]PD('7$VHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DPROHNXODUQRYLUXVQRGLDJQRVWLNR
Zaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.

S-Monovette®)OXRULG('7$)()OXRULG+HSDULQ)+)OXRULG&LWUDW('7$)&6$567('7]LQKLELWRUMLJOLNROL]H
Epruveta S-Monovette®)OXRULG('7$)(YVHEXMHDQWLNRDJXODQW('7$ bPJPONUYL LQIOXRULG bPJPONUYL ]D]DYLUDQMHJOLNROL]HWHUVHXSRUDEOMD]DSULGRELYDQMHSOD]PH )OXRULG('7$MHQDYROMRYREOLNLUD]SUđLOD
Epruveta S-Monovette® Fluorid Heparin FH vsebuje antikoagulant heparin (16 I.E. heparina/ml krvi) in fluorid (1,0 mg/ml krvi) za zaviranje glikolize in se uporablja za pridobivanje plazme**. Fluorid heparin je na voljo v
obliki razpršila.
=DYLUDQMHJOLNROL]HVH]DÕQHVDPRVIOXRULGRPSULEOGYHXULSRQDSROQLWYLHSUXYHWH]DRGY]HPNUYLSROQRSDGHOXMHSRSULEOđWLULKXUDK*OXNR]DVHYSROQLNUYLYSRYSUHÕMXUD]JUDGLGRbSRQHNDMXUDKLQGRşbSR
24 urah.
Epruveta S-Monovette® GlucoEXACT FC vsebuje antikoagulant EDTA kot tudi citrat in fluorid za takojšnje zaviranje glikolize in se uporablja za pridobivanje plazme**. EDTA, citrat in fluorid so na voljo v obliki raztopine. Za
L]UDÕXQNRQFHQWUDFLMHJOXNR]HMH]DUDGLUD]UHGÕHQMDSRWUHEQRPQRĭHQMH]
Epruveta S-Monovette®*OXFR(;$&7)&L]SROQMXMH]DKWHYHQRVHÕQLđNHJDGLDEHWHVDQHPđNHGUXĭEH]DGLDEHWHV ''* LQGUĭDYQRVPHUQLFR]DRVNUER 19/ ]DGLDEHWHVWLS7DNRMđQMDVWDELOL]DFLMDNRQFHQWUDFLMHJOXNR]Hje pri sobni temperaturi zagotovljena za do 96 ur, glejte tudi belo knjigo SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literaturo/ „Sarstedt S-Monovette®
GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours“.
)OXRULG('7$ FLWUDW SOD]PDVHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DGRORÕDQMHJOXNR]HZaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.
2%9(67,/2ĲXRULGODKNRSRY]URÕLSRYLđDQMHKHPROL]H9HÕLQIRUPDFLMRVQRYHKNLODKNRSRY]URÕDMRPRWQMHVRQDYROMRYQDYRGLOLK]DXSRUDERNLMLKMHSULSUDYLOSURL]YDMDOHFWHVWQLKUHDJHQWRY$VVD\Prosimo, da upoštevate OPOZORILA pod odvzemom vzorca in postopanje pri kombinaciji S-Monovette® GlucoEXACT in kanile s krilci.

S-Monovette® CPDA SARSTEDT
Epruveta S-Monovette® CPDA vsebuje antikoagulant natrijev citrat in citronsko kislino, natrijev fosfat, dekstrozo in adenin ter se uporablja za pridobivanje polne krvi in plazme**. CPDA je na voljo v obliki raztopine.
Razmerje mešanja CPDA in krvi znaša 1:6 – 1 del prostornine CPDA in 6 delov polne krvi. Za analizo je pravilna napolnjenost nujno potrebna.
3ROQDNUL&3'$SOD]PDVHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DVHULRORJLMRNUYQLKVNXSLQYWUDQVIX]QLPHGLFLQL]DSUHLVNDYHR]GUXĭOMLYRVWL NULĭQLWHVWL SULWUDQVIX]LML.RQNUHWQRMHHSUXYHWD60RQRYHWWH® CPDA primerna zaGRORÕDQMHNUYQLKVNXSLQ $% YNOMXÕQRVVLVWHPRP.HOOLQ5+]DLVNDQMHSURWLWHOHV]DUDGLQHSUDYLOQLKSURWLWHOHVNUYQHVNXSLQHSROLVSHFLILÕQLQHSRVUHGQL&RRPEVRYWHVW GRGQH WHVW]GUXĭOMLYRVWL NULĭQLSUHL]NXV V
serumom ali plazmo bolnika, ki je kompatibilen s krvno skupino (major test).
qDVSUHYR]DGRVKUDQMHYDQMDMHSRWUMHQ]DQDMYHÕđWLULXUHSULşbƓ&=DVHGLPHQWDFLMRFHOLFMHWUHEDY]RUFHSUHGWHP]DQDMPDQMXUSRVWDYLWLSRNRQÕQRYKODGLOQLN3RWHPODKNR]JRUDMQDYHGHQHDQDOLWHGRORÕDPR
GRGQLDQDORJQR]RELÕDMQLPÕDVRPNRQ]HUYLUDQHNUYLSRVKUDQMHYDQMXYKODGLOQLNX şbƓ&  L]NOMXÕHQMHQHSRVUHGQL&RPEVRYWHVWGQL 3ULPHUQR]DSRVWRSHNNRORQVNHDJOXQLWDFLMHQSUSULYL]LMLPDNVRUWRNOLQLÕQHGLDJQRVWLNH9]RUÕQHJDPDWHULDODQHVPHWH]DPU]QLWL
=DSULPHUQRVWY]RUÕQHJDPDWHULDOD]DWHSUHLVNDYH]GUXJLPLPHWRGDPLWHVWQLPLUHDJHQWLDSDUDWL]DDQDOL]HYNOMXÕQRVSRJRMLVKUDQMHYDQMDMHGROĭDQSRVNUEHWLXSRUDEQLNNLMLKPRUDWXGLVDPSRWUGLWL
Zaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.
Upoštevajte OPOZORILA pod odvzemom vzorca in postopanjem za kombinacijo epruvete S-Monovette® CPDA in kanile s krilci.

S-Monovette® ThromboExact SARSTEDT
Epruveta S-Monovette® ThromboExact vsebuje kot antikoagulant magnezijevo sol in se uporablja za pridobivanje polne krvi**. Magnezijeva sol je na voljo v obliki razpršila.
Polna kri epruvete S-Monovette®7KURPER([DFWVHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DL]NOMXÕLWHYQDSDÕQRQL]NLKđWHYLONWURPERFLWRY]DUDGLQH]GUXĭOMLYRVWLDQWLNRDJXODQWRY NRWVR('7$FLWUDWKHSDULQ NLMRR]QDÕXMHPRWXGLNRWSVHYGRWURPERFLWRSHQLMD7YRUEDWURPERFLWQLKDJUHJDWRYVHSUHSUHÕLLQGRORÕDQMHGHMDQVNHJDđWHYLODWURPERFLWRYMHPRJRÕHGRXUSRRGY]HPXNUYL
Magnezijevi ioni zavirajo strjevanje, tako da magnezijevi ioni zavirajo trombocitni tromboksan A2 kot tudi z ADP in arahidonsko kislino posredovano agregacijo trombocitov.

S-Monovette® Hirudin SARSTEDT
Epruveta S-Monovette® Hirudin vsebuje antikoagulant Hirudin in se uporablja za pridobivanje polne krvi**. Hirudin je na voljo v obliki razpršila.
3ROQDNULKLUXGLQDVHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DGRORÕDQMHIXQNFLMHWURPERFLWRYQDQDSUDYL0XOWLSODWH® (multiple platelet function analyser) proizvajalca ROCHE Diagnostics in je za to tudi potrjena. Uporablja se za
QDG]RUWHUDSLMH]]GUDYLOLNL]DYLUDMRDJUHJDFLMRWURPERFLWRYNRWWXGL]DGRND]RYDQMHDOLL]NOMXÕLWHYPRWHQMIXQNFLMHWURPERFLWRY
Epruveta S-Monovette®+LUXGLQMHELODL]GHODQDSRVHEHM]DGRORÕDQMHIXQNFLMHWURPERFLWRYVNXSDM]GUXĭER9HUXP'LDJQRVWLFDGDQHV52&+('LDJQRVWLFVQDQDSUDYL0XOWLSODWH®.
+LUXGLQ]DYLUDVWUMHYDQMH]QHSRVUHGQLP]DYLUDQMHPWURPELQDLQRPRJRÕDGLDJQRVWLNRIXQNFLMHWURPERFLWRYYQDWLYQHPVWDQMXS-Monovette® Homocystein HCY-Z-Gel/HCY-C SARSTEDT
Epruveta S-Monovette®+RPRF\VWHLQ+&<=*HOYVHEXMHSROHJSODVWLÕQHJDJUDQXODWDVSODVWMRDNWLYDWRUMDVWUMHYDQMD VLOLNDWD SRVHEHQVWDELOL]DWRULQJHOQDRVQRYLSROLPHURYWHUVHXSRUDEOMD]DSULGRELYDQMHVHUXPD *HO
VHVFHQWULIXJLUDQMHPSRVWDYLPHGNUYQRSRJDÕRLQVHUXPWHUWYRULVWDELOQRORÕHYDOQRSUHJUDGRPHGSUHYR]RPVNODGLđÕHQMHPLQDQDOL]R3ULSUDYHNMHQDYROMRYREOLNLUD]SUđLOD+RPRFLVWHLQVHSULVREQLWHPSHUDWXULYSROQLNUYLVWDELOL]LUDGRRVHPXUqHMHFHQWULIXJLUDQMHYURNXSUYLKRVPLKXUVSUDYLOQRORÕHYDOQRSUHJUDGRPHGNUYQRSRJDÕRLQVHUXPRPVHKRPRFLVWHLQVWDELOL]LUDGRXU
Serum epruvete S-Monovette®+RPRF\VWHLQ+&<=*HOVHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DGRORÕDQMHKRPRFLVWHLQD(SUXYHWD60RQRYHWWH® Homocystein HCY-C vsebuje kot antikoagulant kisli citrat (pH 4,3) in se
XSRUDEOMD]DSULGRELYDQMHSOD]PH &LWUDWMHQDYROMRYREOLNLUD]WRSLQH=DL]UDÕXQNRQFHQWUDFLMHKRPRFLVWHLQDMH]DUDGLUHGÕHQMDSRWUHEQRPQRĭHQMH]+RPRFLVWHLQVHSULVREQLWHPSHUDWXULYSROQLNUYLVWDELOLUDGRđHVWXULQSULbƓ&GRbXU
Plazma epruvete S-Monovette®+RPRF\VWHLQ+&<&VHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DGRORÕDQMHKRPRFLVWHLQD
Zaviranje strjevanja v epruveti S-Monovette® Homocystein HCY-C poteka tako, da citrat kompleksira kalcijeve ione.
Upoštevajte OPOZORILA pod odvzemom vzorca in postopanjem za kombiniranje epruvete S-Monovette® HCY-C in kanile s krilci.

S-Monovette® DNA Exact SARSTEDT
Epruveta S-Monovette® DNA Exact vsebuje antikoagulant na osnovi EDTA in se uporablja za pridobivanje polne krvi**. EDTA je na voljo v obliki razpršila.
3ROQDNUL('7$VHXSRUDEOMDNRWY]RUÕQLPDWHULDO]DVWDELOL]LUDQMHJ'1$6WDELOL]LUDQMH]DJ'1$MHSRWUMHQRYSHWLKGQHKSULbƓ&GQHKSULVREQLWHPSHUDWXUL bƓ& GQHKSULKODMHQMX bƓ& LQQDMPDQMYHQHPOHWX
SULşbƓ&'RGDWQRSUHVWDQHMRVWDELOL]LUDQLY]RUFLSHWFLNORY]DPU]RYDQMDLQRGPU]RYDQMDEUH]SRVODEđDQMDNDNRYRVWLJOHMWHWXGLEHORNQMLJR6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/
venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
Zaviranje strjevanja poteka s kompleksiranjem kalcijevih ionov s citratom.

3ULPHUQRVWY]RUÕQHJDPDWHULDODMHRGYLVQDRGDQDOLWRYLQWHVWQLKUHDJHQWRYDSDUDWD]DDQDOL]R8SRđWHYDWLMHWUHEDSULSRURÕLODSURL]YDMDOFD

202

SL
Varnostna opozorila/opozorila
1.

6SORđQLSUHYLGQRVWQLXNUHSLXSRUDEOMDMWHURNDYLFHLQGUXJRVSORđQRRVHEQRYDURYDOQRRSUHPRGDVH]DđÕLWLWHSUHGNUYMRLQSUHGPRUHELWQRL]SRVWDYOMHQRVWMRSRWHQFLDOQHPXLQIHNWLYQHPXPDWHULDOXLQSUHQRVOMLYLP
patogenim organizmom.

2.

=YVHPLELRORđNLPLY]RUFLLQRVWULPNRQLÕDVWLPSULERURP]DRGY]HPNUYL NDQLOHDGDSWHUML UDYQDMWHYVNODGXVVPHUQLFDPLLQSRVWRSNLNLVRYYHOMDYLYYDđLXVWDQRYL3ULQHSRVUHGQHPVWLNX]ELRORđNLPY]RUFHPDOLYSULPHUXSRđNRGEH]DUDGLYERGDSRLđÕLWH]GUDYQLđNRSRPRÕNHUVHQDWDQDÕLQODKNRSUHQDđDMR+,9+&9+%9DOLGUXJHLQIHNFLMVNHEROH]QL9DUQRVWQHNDQLOH6DIHW\6DIHW\0XOWLĲ\®XSRUDEOMDMWHVDPRÕHMHQDPHđÕHQD]DđÕLWDLJOH8SRđWHYDWLPRUDWHYDUQRVWQHVPHUQLFHLQSRVWRSNHNLYHOMDMRYYDđLXVWDQRYL

3.

9HOMD]DSRVDPLÕQRVWHULOQRSDNLUDQHL]GHONH3UHGXSRUDERSUHJOHMWHYVDNRSRVDPH]QRSDNLUDQMHLQVHSUHSULÕDMWHGDQLSRđNRGRYDQRqHHPEDODĭDQLEUH]KLEQDL]GHONDQHXSRUDEOMDMWH

4.

,]GHOHNMHSUHGYLGHQ]DHQNUDWQRXSRUDER9VHRVWUHNRQLÕDVWHSUHGPHWH NDQLOHDGDSWHUMH ]DRGY]HPNUYLRGORĭLWHYXVWUH]QHSRVRGH]DRGODJDQMHQHYDUQLKELRORđNLKVQRYL5.

qHNULRGY]DPHWH]LQWUDYHQR]QHJD ,9 PHVWDPRUDWHPHVWR]DJRWRYRRÕLVWLWL ]UD]WRSLQR,9 YVNODGXVSUHGSLVLYDđHXVWDQRYHSUHGHQERVWH]DÕHOL]RGY]HPRPNUYL3UDYLOQRRÕLđÕHQRPHVWRRGY]HPDMHSRJRM
za pravilne izvide.

6.

Premalo napolnjena epruveta S-Monovette®SRPHQLQDSDÕQRUD]PHUMHPHGNUYMRLQSULSUDYNRPGRGDWNRPWHUMHODKNRY]URNQDSDÕQLKUH]XOWDWRYDQDOL]H7.

Kri, odvzeta in obdelana z epruveto S-Monovette®QLSULPHUQD]DSRQRYQRYEUL]JDQMHYÕORYHđNRWHOR

8.

,]GHONDSRSUHWHNXXSRUDEQRVWLQHVPHWHYHÕXSRUDEOMDWL8SRUDEQRVWSRWHÕH]DGQMLGDQQDYHGHQHJDPHVHFDLQOHWD

6KUDQMHYDQMH
Izdelek do uporabe hranite pri sobni temperaturi.

2PHMLWYH
1.

qDVLQWHPSHUDWXUDVKUDQMHYDQMDQDSROQMHQHHSUXYHWH60RQRYHWWH® sta odvisna od uporabnosti analitov preiskave. Oceno opravi laboratorij oz. preverite informacije v navodilih za uporabo reagentov testiranja/
aparata za analizo, ki jih je pripravil proizvajalec.

2.

7XGLÕHVHSOD]PDDOLVHUXPVFHQWULIXJLUDQMHPHSUXYHWH60RQRYHWWH®ORÕLLQDOLMHQDYROMRSUHJUDGDQLQXMQRGDVHYVHFHOLFHYFHORWLORÕLMR3UHVQRYDRVWDQNRYDOLQDUDYQDUD]JUDGQMDODKNRYSOLYDWDQDNRQFHQWUDFLMHDQDOLWRY6WDELOQRVWDQDOLWRYMHWUHEDSUHYHULWL]DYVDNRSRVDPH]QRSRVRGR]DVNODGLđÕHQMHLQ]DSRJRMHSRVDPH]QHJDODERUDWRULMD

3.

V primeru terapije z zdravili je treba preveriti primernost vzorca v navodilih za uporabo, ki jih je pripravil proizvajalec Assay/aparata za analizo.

4.

Analize za elemente v sledovih/kovine je treba izvesti s sistemom za analizo kovin S-Monovette® + (varnostno) kanilo za analizo kovin.

2GY]HPY]RUFDLQURNRYDQMHPRED ODVZEMOM VENOZNE KRVI V CELOTI PREBERITE TA DOKUMENT.
Material, potreben za odvzem vzorca.
1.

Vsi potrebni sistemi za odvzem krvi S-Monovette®.

2.

(Varnostne) kanile ali (varnostne) kanile® s krilci.

3.

5RNDYLFHKDOMD]DđÕLWD]DRÕLDOLGUXJDXVWUH]QD]DđÕLWQDREODÕLOD]D]DđÕLWRSUHGSDWRJHQLNLVHSUHQDđDMRVNUYMRDOL]D]DđÕLWRSUHGSRWHQFLDOQRLQIHNWLYQLPPDWHULDORP

4.

1DOHSNH]DLGHQWLıNDFLMRSDFLHQWD

5.

0DWHULDO]DUD]NXĭHYDQMH]DÕLđÕHQMHPHVWDRGY]HPD XSRđWHYDMWHVPHUQLFHXVWDQRYH]DVWHULOQLRGY]HPY]RUFD]DSULSUDYRPHVWDRGY]HPD 1HXSRUDEOMDMWHÕLVWLOQDRVQRYLDONRKRODÕHERGRY]RUFLY]HWL]DWHVW
alkohola v krvi.

6.

6XKHVWHULOQHSDOÕNH]DHQNUDWQRXSRUDER

7.

Venska preveza.

8.

2EOLĭDOLSUHYH]D9.

=ELUDOQLN]DRGODJDQMHRVWULKNRQLÕDVWLKSUHGPHWRY]DYDUQRRGODJDQMHUDEOMHQHJDPDWHULDOD3ULSRURÕHQYUVWQLUHGSRVWRSDQMDSULRGY]HPX
1.

6WHNOHQLÕNHNUYQHNXOWXUH

2.

Epruvete s citratom ali aktivatorjem strjevanja (z/brez gela seruma CAT/seruma v gelu CAT)

3.

Epruvete z aktivatorjem strjevanja ali citratom

4.

Epruvete s heparinom z/brez gela

5.

Epruvete z EDTA z/brez gela

6.

Epruvete z zaviralci glikolize

7.

Epruvete z drugimi dodatki
232=25,/2

32=25

qHVH]DÕQHRGY]HPHSUXYHWHFLWUDWDDOLGUXJHHSUXYHWHVWHNRÕLPSULSUDYNRPNRWQDSULPHU3)$&7$'&3'$+&<&DOL*OXFR(;$&7YNRPELQDFLMLVNDQLORVNULOFL QSUYDUQRVWQRNDQLOR0XOWLĲ\® SULSRURÕDPRSUHGWHPRGY]HPSUD]QHHSUXYHWH QSU60RQRYHWWH®1HXWUDO= GDQHELSULđORGRSUHPDMKQHQDSROQMHQRVWLVSROQMHQMHPFHYNHNDQLOH
s krilci.
7DNRODKNR]DJRWRYLWHSUDYLOQRQDSROQMHQRVWHSUXYHWHLQSRVOHGLÕQRWXGLSUDYLOQRUD]PHUMHVQRYL WHNRÕLQDLQNUL XSRđWHYDMWHSUHGSLVHYDđHXVWDQRYHRYUVWQHPUHGXSULRGY]HPX3UHSUHÕLWHSRYUDWQLSUHWRN
9HÕLQDHSUXYHW60RQRYHWWHYVHEXMHNHPLÕQHGRGDWNH3RYUDWQLSUHWRNSUHSUHÕLWHNRWMHRSLVDQRYQDGDOMHYDQMX
1. XSRUDEOMDMWHL]NOMXÕQRVDPRYQDYRGLOLK]DXSRUDERSULSRURÕHQHPDWHULDOH
2.

%ROQLNQDMVHQDPHVWLWDNRGDMHPRJRÕQHRYLUDQGRVWRSGRYHQHLQURNRDOLGUXJSUHGHO]DYERGEROQLNDXVPHULWHQDY]GRO

3.

'UĭLWHHSUXYHWR60RQRYHWWH®]QDYRMQLPSRNURYÕNRPQDY]JRULQSULXSRUDELYDUQRVWQHNDQLOH 6DIHW\ 0XOWLĲ\®tudi pod nivojem roke/mesta vboda.

4.

3UHSULÕDMWHVHGDVHYVHELQDNDQLOH60RQRYHWWH®SULYERGXYYHQRQHERGRWDNQLODQLWLSRNURYÕND]QDYRMHPQLWLNRQFDNDQLOH

5.

6SURVWLWHYHQVNRSUHYH]RNRNULWHÕHYHSUXYHWR60RQRYHWWH®.

203

SL
Zamrzovanje/odmrzovanje
9VNODGXVSULSRURÕLOL6YHWRYQH]GUDYVWYHQHRUJDQL]DFLMH:+2 :+2',//DE5HY SULSRURÕDPRGDVHUXPSOD]PRSUHG]DPU]RYDQMHPNUYQLKFHOLFORÕLWH
Za epruveto S-Monovette®YHOMDMRSUL]DPU]RYDQMXQDVOHGQMDSULSRURÕLOD=DPU]RYDQMHSRGbƓ&•=DKWHYDQRWHPSHUDWXUQRREPRÕMHSRGQLÕORMHWUHEDQDWDQÕQRSUHYHULWLYGHMDQVNLKSRJRMLKNHUVHREUHPHQLWHYHSUXYHWODKNR]HORUD]OLNXMH]DUDGLPHGLMDNLJD]DPU]XMHWHLQ]DUDGLUXWLQVNLKSRJRMHY JOHMWHSRJODYMH
Katalog lastnosti materialov SARSTEDT)•

1DÕHORPDVH]PDQMđDVWRSQMDWUGQRVWLSODVWLÕQLKPDVSULWHPSHUDWXUDKSRGbƓ&=DWRMHQDVSORđQRWUHEDSUHSUHÕLWLPHKDQVNHREUHPHQLWYH

•Treba je izbrati pogoje za zamrzovanje, v katerih vsebina epruvete S-Monovette® zamrzuje enakomerno oz. od spodaj navzgor. Epruveta S-Monovette® mora imeti v stojalu ali v škatli za shranjevanje dovolj prostora,
GDVHODKNRUD]WH]D6WRMDODL]VWLURSRUDDOLNRYLQHVRQHSULPHUQDNHUODKNRSRY]URÕLMRUD]SRNH]DUDGLUD]WH]DQMD

=DPU]RYDQMHQDWHPSHUDWXURşbƓ&ş3UHG]DPU]RYDQMHPSUHYHULWH
•6NODGQRVW3UHYHULWHDOLER]DPU]RYDQMHPRWHÕHYSOLYDORQDY]RUHFNUYLDOLQDDQDOL]R QSUKHPROL]RVWDELOQRVWDQDOLWRY •&HQWULIXJLUDQMHRGYLVQRRGQDÕUWRYDQHDQDOL]H=DSRJRMHFHQWULIXJLUDMDVLRJOHMWHGRNXPHQWSRGWRÕNR&HQWULIXJDR]VSOHWQRVWUDQ6$567('7https://www.sarstedt.com/en/service/centrifugation/, izvajajte tudivizualne preglede vzorcev.

•+HPROL]D3ROQDNULSUL]DPU]RYDQMXKHPROL]LUDWRSUHSUHÕLWHWDNRGDXSRUDELWHDOLHSUXYHWR60RQRYHWWH®JHOR]SRFHQWULIXJLUDQMXıOWHUYHQWLOD6HUDSODV® ali vzorec pipetirate v sekundarno epruveto.

=DPU]RYDQMHQDWHPSHUDWXURşbƓ&ş,]YHGED
•Ohladitev: epruveto S-Monovette®RKODMDMWHYSRNRQÕQHPSRORĭDMXşbPLQXWVVREQHWHPSHUDWXUHQDbƓ&SUHGHQMRERVWHODKNR]DPU]QLOLQDşbƓ&

•2GPU]RYDQMHQDMPDQMbPLQXWSXVWLWHYSRNRQÕQHPSRORĭDMXSULVREQLWHPSHUDWXULGDRGPU]QH7XGLYWHPWUHQXWNXQHVPHSULWLGRPHKDQVNLKREUHPHQLWHY3UHKLWURRGPU]RYDQMHODKNRYSOLYDQDUH]XOWDWHDQDOL]H=DPU]RYDQMHLQJORERNR]DPU]RYDQMHSRGşbƓ&•*ORERNHJD]DPU]RYDQMDQDPDQMNRWşbƓ&SURL]YDMDOHFQLSUHYHULO=DUDGLđWHYLOQLKPRĭQLKGHMDYQLNRYSULSRURÕDPRWHVW]DPU]RYDQMDYUXWLQVNLKODERUDWRULMVNLKSRJRMLK

Zamrzovanje epruvete S-Monovette® gel:•

=DPU]RYDQMHSRWHNDNRWMHRSLVDQRYWRÕNL]DPU]RYDQMHQDWHPSHUDWXURşbƓ&ş,]YHGED

•

Znano je, da se plast gela zaradi postopka zamrzovanja lahko spremeni.

•=DUDGLđWHYLOQLKPRĭQLKGHMDYQLNRYSULSRURÕDPRWHVW]DPU]RYDQMDYUXWLQVNLKODERUDWRULMVNLKSRJRMLK

•Odmrzovanje:Y]RUHFSXVWLWHGDRGPU]QHYSRNRQÕQHPSRORĭDMX0DWHULDOY]RUFDSRRGPU]QLWYLSLSHWLUDMWH QHGHNDQWLUDMWH GRSULEObPPÕH]SODVWJHODL]SULPDUQHHSUXYHWHYVHNXQGDUQR2VWDQHN]DYU]LWH
2%9(67,/2=DVWDELOQRVWDQDOLWRYMHWUHEDXSRđWHYDWLQDYRGLOD]DXSRUDERUHDJHQWRYWHVWDDSDUDWD]DDQDOL]RNLMLKMHSULSUDYLOSURL]YDMDOHF

204

SL
Odvzem krvi
Tehnike odvzema
Razlikujemo med dvema tehnikama odvzema: aspiracijska in vakuumska tehnika.
$VSLUDFLMVNDWHKQLNDSRPHQLQDWDQÕHQRGY]HPNUYL]QDG]RURYDQLPSRWHJRPEDWQLFH]QHSUHNLQMHQLPSRÕDVQLPWRNRPNUYL1DWDQDÕLQVHODKNRWRNNUYLQHSRVUHGQRSULODJRGLQDYVHUD]PHUHLQGDQRVWLYHQHLQ]PDQMđDse hemoliza.
9DNXXPVNDWHKQLNDVSULSUDYOMHQRHSUXYHWRRPRJRÕDRGY]HPNUYLSRSULQFLSXSRGWODND]QHSUHNLQMHQLPLQKLWULPWRNRPNUYL=DWRMHWDWHKQLNDLGHDOQDSULGREULKUD]PHUDKQDYHQDKLQ]DSUHSURVWHSRJRMHRGY]HPDPostopanje pri odvzemu krvi: oglejte si tudi video s postopkom ravnanja pri delu z epruveto S-Monovette® z aspiracijsko tehniko oz. vakuumsko tehniko z varnostno kanilo oz. varnostno kanilo s krilci Multifly®:www.sarstedt.com/en/download/videos/Diagnostics/Venous bloodZA ZMANJŠANJE NEVARNOSTI IZPOSTAVLJENOSTI MED ODVZEMOM KRVI NOSITE ROKAVICE.
1. Izberite ustrezno epruveto S-Monovette® za potreben vzorec.
2.

Izberite mesto za vbod v veno. Pri pripravi mesta vboda v veno upoštevajte smernice svoje ustanove.

Odvzem krvi z aspiracijsko tehniko
Previdno! Epruveto S-Monovette® uporabite samo za odvzem krvi in ne za injeciranje.
Uporabite samo te kanile (S-Monovette® (varnostne) kanile ali (varnostne) kanile Multifly®/adapter za epruveto S-Monovette®).
Tukaj je predstavljena uporaba z varnostno kanilo Safety:

klik

Neposredno pred vbodom v veno epruveto S-Monovette®SRWLVQLWHYYJUDMHQRGUĭDORNDQLOH6DIHW\ in jo fiksirajte z rahlim obratom v smeri urnega kazalca .
3RSRWUHELQDPHVWLWHYHQVNRSUHYH]R QDMYPLQXWR 0HVWRYERGDSULSUDYLWHVSULPHUQLPVUHGVWYRP]DUD]NXĭHYDQMH0HVWDYERGDYHQHVHSRUD]NXĭHYDQMXQHGRWLNDMWHYHÕ%ROQLNQDMVH
QDPHVWLWDNRGDMHPRJRÕQHRYLUDQGRVWRSGRYHQHLQURNRDOLGUXJHSUHGHO]DYERGEROQLNDXVPHULWHQDY]GRO2GVWUDQLWH]DđÕLWR]DLJOR3UHERGLWHYHQRSRÕDVLEDWSRYOHFLWHQD]DMLQVSURVWLWHYHQVNRSUHYH]RNRNULWHÕHYHSUXYHWR60RQRYHWWH®
3RÕDNDMWHGDVHSUHWRNNUYL]DXVWDYLGDERQDYROMR]DGRVWQDNROLÕLQD]DSROQMHQMH

.

Epruveto S-Monovette® z UDKOLPREUDÕDQMHPQDVSURWLXUQHPXND]DOFX VSURVWLWHLQQDWRL]YOHFLWH L]NOMXÕLWH L]YDUQRVWQHNDQLOH6DIHW\ . Varnostna kanila Safety ostane v veni.
3ULYHÕNUDWQLKRGY]HPLKNRWMHRSLVDQR]JRUDMSRYHĭLWHQDGDOMQMHHSUXYHWH60RQRYHWWHVNDQLOR6DIHW\LQQDGDOMXMWH]RGY]HPLY]RUFHY'RNRQÕDQMHRGY]HPDNUYL1DMSUHML]NOMXÕLWHHSUXYHWR60RQRYHWWH®
+ QDWRNDQLOR6DIHW\L]YOHFLWHL]YHQH=HQRURNRDNWLYLUDMWH]DđÕLWRLJOHDOLQDVWDELOQLUDYQLSRYUđLQLşGDNDQLODY]DđÕLWL]DLJOR]DVNRÕLV
slišnim in opaznim „klikom“şDOLVSULWLVNRPND]DOFDQDVSRGQMLGHO]DđÕLWH]DLJORJOHMWHWXGLQDYRGLOD]DXSRUDER]DHSUXYHWR60RQRYHWWH® (varnostna) kanila ali (varnostna) kanila Multifly®s krilci.
Vsako epruveto S-Monovette®WDNRMSRRGNORSXL]NDQLOH6DIHW\HQNUDWREUQLWHQDJODYRLQSR]DNOMXÕHQHPDOLGRNRQÕDQHPRGY]HPXYVHY]RUFH]DQWLNRDJXODQWLYHÕNUDWREUQLWHQDJODYR=DSUHYR]LQFHQWULIXJLUDQMHSRYOHFLWHEDWYSRORĭDMNMHUVHVOLđQR]DVNRÕL  EDWVH]DVNRÕLQDGQXHSUXYHWH60RQRYHWWH®) in batnico
odlomite.
1.

Na mesto vboda pritisnite suh in sterilen tampon, dokler se krvavenje ne ustavi.

2.

.RVH]DÕQHNULVWUMHYDWLODKNRSRĭHOMLQDPHVWLWHSUHYH]R3.

9DUQRVWQRNDQLORRGORĭLWHYXVWUH]QRSRVRGR]DRGODJDQMHQHYDUQLKELRORđNLKVQRYL

205

SL
Odvzem krvi z vakuumsko tehniko
Previdno! Epruveto S-Monovette® uporabite samo za odvzem krvi in ne za injeciranje.
Uporabite samo te kanile (S-Monovette® (varnostne) kanile ali (varnostne) kanile Multifly®/adapter za epruveto S-Monovette®).
Tukaj je predstavljena uporaba z varnostno kanilo Safety:

klik=DSUHYLGHQ]DÕHWHNRGY]HPDNUYL6$567('7SULSRURÕDGDSUYRHSUXYHWR60RQRYHWWH® odvzamete s tehniko aspiracije, glejte TEHNIKO VBODA V VENO tehnika aspiracije
Nato nadaljujte z vakuumskim odvzemom.
Pred odvzemom krvi z batnico bat povlecite do dna epruvete S-Monovette®, da se slišno ]DVNRÕL1DWREDWQLFRRGORPLWH .
Pripravljeno epruveto S-Monovette®SRWLVQLWHYYJUDMHQRGUĭDOR]DHSUXYHWR60RQRYHWWH® kanile Safety in jo fiksirajte z UDKOLPREUDÕDQMHPYVPHULXUQHJDND]DOFD

+

–

.

.

3RÕDNDMWHGDVHSUHWRNNUYL]DXVWDYLGDERQDYROMR]DGRVWQDNROLÕLQD]DSROQMHQMH

Epruveto S-Monovette® z UDKOLPREUDÕDQMHPQDVSURWLXUQHPXND]DOFX VSURVWLWHLQQDWRL]YOHFLWH L]NOMXÕLWH L]YDUQRVWQHNDQLOH6DIHW\ . Varnostna kanila Safety ostane v veni.
3ULYHÕNUDWQLKRGY]HPLKNRWMHRSLVDQR]JRUDMQDMSUHMSRYHĭLWHQDGDOMQMHHSUXYHWH60RQRYHWWHVNDQLOR6DIHW\LQQDGDOMXMWH]RGY]HPLY]RUFHY'RNRQÕDQMHRGY]HPDNUYLL]NOMXÕLWHHSUXYHWR
S-Monovette® + SRWHPYDUQRVWQRNDQLORSRYOHFLWHL]YHQH=HQRURNRDNWLYLUDMWH]DđÕLWRLJOHQDVWDELOQLUDYQLSRYUđLQLşGDVHNDQLOD]opaznim in slišnim klikom]DVNRÕLY]DđÕLWRLJOHşDOLSD]DđÕLWRLJOHDNWLYLUDMWHWDNRGDMRSULWLVQLWHVND]DOFHPSURWLVSRGQMHPNRQFX]DđÕLWHLJOH
Vsako epruveto S-Monovette®WDNRMSRRGNORSXL]NDQLOH6DIHW\HQNUDWREUQLWHQDJODYRLQSR]DNOMXÕHQHPDOLGRNRQÕDQHPRGY]HPXYVHY]RUFH]DQWLNRDJXODQWLYHÕNUDWREUQLWHQDJODYR1.

Na mesto vboda pritisnite suh in sterilen tampon, dokler se krvavenje ne ustavi.

2.

.RVH]DÕQHNULVWUMHYDWLODKNRSRĭHOMLQDPHVWLWHSUHYH]R3.

9DUQRVWQRNDQLORRGORĭLWHYXVWUH]QRSRVRGR]DRGODJDQMHQHYDUQLKELRORđNLKVQRYL

206

SL
Centrifugiranje
35(9,'12(SUXYHWH60RQRYHWWH6$567('7VRRSUHPOMHQH]Db[bJ,]Y]HWHVRHSUXYHWH60RQRYHWWHV¢bbPP 60RQRYHWWH®SHGLDWULÕQD NLVRWUHQXWQRSRWUMHQHGRb[bJ8SRUDEOMDWHODKNRVDPRSULPHUQHQRVLOFHR]QDVWDYNH]DHSUXYHWH&HQWULIXJLUDQMHHSUXYHW60RQRYHWWH]UD]SRNDPLR]FHQWULIXJLUDQMHSULYLVRNLFHQWULIXJDOQLVLOLODKNRSRY]URÕL]ORPHSUXYHW60RQRYHWWH]DUDGLÕHVDUVHODKNRVSURVWLSRWHQFLDOQR
nevaren material.
Nosilce centrifuge izberete glede na velikost uporabljenih epruvet S-Monovette. Relativna centrifugalna sila je v naslednjem razmerju z nastavljenimi vrtljaji/min:
5=% b[bUb[b 8S0 2,
RZB: „Relativna centrifugalna sila imenovana tudi „g-sila““, (angleško: RCF „relative centrifugal force“),„UpM“: „vrtljajev na minuto“ (vrtlj./min), ali: n = „število vrtljajev na minuto“ (angleško: RPM „revolutions per minute“),„r“: „Polmer centrifuge od sredine centrifuge do dna epruvete S-Monovette®“, (cm).
Epruvete S-Monovette brez gela lahko v centrifugah centrifugirate z rotorjem s fiksnim kotom ali z nagibnim rotorjem.
(SUXYHWH60RQRYHWWH]JHORPVRSULPHUQHL]NOMXÕQR]DFHQWULIXJLUDQMH]QDJLEQLPURWRUMHP6$567('7FHQWULIXJLUDQMDYFHQWULIXJDK]URWRUMHPVILNVQLPNRWRPQLRGREULOLQJD]DWRQHSULSRURÕDPR(SUXYHWH60RQRYHWWHMHWUHEDFHQWULIXJLUDWLVNODGQRVVSRGDMQDYHGHQLPLSRJRMLFHQWULIXJLUDQMDqHELELOLSRJRMLGUXJDÕQLPRUDXSRUDEQLNVDPSUHYHULWLQMLKRYR]DQHVOMLYRVW3UHSULÕDMWHVHGDVHHSUXYHWH60RQRYHWWHSULOHJDMRQRVLOFHPFHQWULIXJHLQVRVWDELOQH(SUXYHWH60RQRYHWWHNLVHJDMRÕH]QRVLOHFODKNRXGDULMRREJODYRFHQWULIXJHLQVH]ORPLMR&HQWULIXJDPRUDELWLHQDNRPHUQR
napolnjena. Upoštevajte navodila za uporabo centrifuge.
OPOZORILO! Razbitih epruvet S-Monovette ne odstranjujte z rokami.
1DYRGLOD ]D UD]NXĭHYDQMH FHQWULIXJH QDMGHWH Y QDYRGLOLK ]D XSRUDER FHQWULIXJH

Relativna centrifugalna sila (g)Usmerjeno na
BS 4851+ (koda ',1b(1b,62bEU)–

S-Monovette®
b[bJb[bJb[bJb[bJb[bJSerum

bPLQbPLQbPLQ

bPLQ

bPLQ

Serum-gelbPLQbPLQ

bPLQ

bPLQ

bPLQ

Serum Express Gel

bPLQbPLQ

bPLQ

n.v.

n.v.

Litijev heparin

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Litijev heparin v gelu

bPLQbPLQbPLQ

bPLQ

bPLQ

Litijev heparin v gelu+

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA

n.v.

n.v.

bPLQ

bPLQ

bPLQ

EDTA v gelu

bPLQbPLQbPLQ

bPLQ

bPLQ

Citrat

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA, Fluorid Heparin

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

GlucoEXACT

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDW3%0bPO
3ROPHUFHQWULIXJH!bFP

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDW3%0bPO
3ROPHUFHQWULIXJH!GRƉbFP

n.v.

n.v.

bPLQn.v.

n.v.

n.v. = ni validirano
9HOMD]DYVHHSUXYHWH60RQRYHWWH]L]MHPR¢bbPP 60RQRYHWWH]DSHGLDWULMR

Centrifugiranje pri 20 ºC+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, umaknjen.

,QIRUPDFLMHRPDWHULDOXORÕHYDQMD
7HNRÕQRVWPDWHULDODORÕHYDQMD JHO MHRGYLVQDRGWHPSHUDWXUHqHVHHSUXYHWH60RQRYHWWHSUHGDOLPHGFHQWULIXJLUDQMHPRKODGLMRQLPRJRÕH]DJRWRYLWLQHSUHNLQMHQHSODVWLJHOD]DORÕHYDQMH
(SUXYHW60RQRYHWWHVHQHVPHSRQRYQRYHÕNUDWFHQWULIXJLUDWL

Odlaganje med odpadke
1.

6SUHPOMDWLLQXSRđWHYDWLMHWUHEDVSORđQHVPHUQLFH]DKLJLHQRLQ]DNRQVNHGRORÕEHRSUDYLOQHPRGODJDQMXLQIHNWLYQHJDPDWHULDODPHGRGSDGNH

2.

5RNDYLFH]DHQNUDWQRXSRUDERSUHSUHÕXMHMRQHYDUQRVW]DRNXĭER

3.

2QHVQDĭHQHDOLQDSROQMHQHVLVWHPH]DRGY]HPNUYLMHWUHEDRGORĭLWLYSULPHUQHSRVRGH]DRGODJDQMHQHYDUQLKELRORđNLKVQRYLNLMLKMHPRJRÕHQDWRDYWRNODYLUDWLLQVHĭJDWL

4.

2GVWUDQMHYDQMHPRUDSRWHNDWLYXVWUH]QLVHĭLJDOQLFLDOL]DYWRNODYLUDQMHP VWHULOL]DFLMRVSDUR 

207

SL
=DL]GHOHNVSHFLıÕQLVWDQGDUGLLQVPHUQLFHYYVDNRNUDWQLXVWUH]QLYHOMDYQLUD]OLÕLFLCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

Standard o epruvetah za venozni odvzem krvi:',1b(1b,62b(SUXYHWH]DHQNUDWQRXSRUDER]DYHQR]QLRGY]HPNUYLSULOMXGHK*CLSI (Clinical and Laboratory Standards Institute)

6LPEROLLQR]QDÕHYDOQHNRGHŠtevilka izdelka'RGDWQRYHOMD]DSRVDPLÕQRVWHULOQRSDNLUDQHL]GHONH

Oznaka serije

1HXSRUDEOMDMWHÕHMHHPEDODĭDSRđNRGRYDQD

Uporabno do(QRMQLVLVWHPVWHULOQHSUHJUDGH]]XQDQMR]DđÕLWQRHPEDODĭR

Znak CE

Sterilizacija z obsevanjem

In-vitro diagnostika

Upoštevajte navodila za uporabo.

Pri ponovni uporabi: nevarnost kontaminacije+UDQLWH]DđÕLWHQRSUHGVRQÕQRVYHWORER

Hranite na suhem mestu.

Proizvajalec'UĭDYDYNDWHULMHELOL]GHOHNL]GHODQ

6WHULOQRGRYDMDQMHWHNRÕLQ

Ne sterilizirajte ponovno.

3ULGUĭXMHPRVLSUDYLFRGRWHKQLÕQLKVSUHPHPEO vseh resnih dogodkih v zvezi z izdelkom je treba obvestiti proizvajalca in pristojni nacionalni organ.

208

Bruksanvisning – SARSTEDT S-Monovette® system för blodprovstagningSV

För diagnostisk användning in-vitro
Användning
S-Monovette® system för blodprovtagning, kanyler och adaptrar används tillsammans som system för venblodprovtagning. S-Monovette® system för blodprovtagning används för provtagning, transport, bearbetningoch förvaring av blodprover för diagnostiska analyser in-vitro av serum, plasma eller helblod i ett kliniskt laboratorium. Produkten är avsedd för professionell användning av medicinskt utbildad personal ochlaboratoriepersonal.

Produktbeskrivning
S-Monovette® system för blodprovtagning består av ett plaströr, en kolv, en pistong och ett färgkodat skruvkork i plast med integrerat membran, som utvecklats speciellt för anslutning till en S-Monovette® (Safety-)kanyl eller (Safety-) Multifly®-kanyl, samt olika tillsatser (beredningar). S-Monovette® finns även utan tillsats. S-Monovette® system för blodprovtagning med tillsatserna koagulationsaktivator, koagulationsaktivator med
gel, litium-heparin, litium-heparin med gel, natrium-heparin, citrat, EDTA, fluorid heparin, fluorid citrat, CPDA samt utan tillsats. Tillsatskoncentrationerna volymen av tillsatser i vätskeformat och deras tillåtna toleranser
liksom förhållandet mellan blod och tillsats motsvarar kraven och rekommendationerna i den internationella standard DIN EN ISO 6710 "Single-use containers for venous blood specimen collection" och Clinical andLaboratory Standards Institute's Approved Standards (CLSI). Valet av tillsats är beroende av analysmetoden. Det anges av tillverkaren av testreagenserna och/eller det analysinstrument på vilken testet genomförs.
Blodprovtagningssystemet S-Monovette® finns som invändigt sterilt eller styckvis förpackat och sterilt invändigt och utvändigt.

Färgkoder för S-Monovette® skruvkork*:

Bokstavskod

Korkfärg DIN EN ISO 6710

Korkfärg enligt BS 4851+

Z

vit

vit

CAT

röd

vit

S-Monovette Serum-gel CAT, med koagulationsaktivator och gelCATmörkgulmörkgul

S-Monovette® Serum express gel CAT, med koagulationsaktivator trombin och gelCATorange-S-Monovette® Litium-heparin LH, med litium-heparin

LH

grön

orangeS-Monovette®/LWLXPKHSDULQĲ\WDQGH/+PHGOLWLXPKHSDULQ

LH

grön

orangeS-Monovette® Litium-heparin-gel LH, med litium-heparin och gel

LH

grön

orangeS-Monovette® Litium-heparin-gel+ LH, med litium-heparin och snabbgel

LH

grön

orangeS-Monovette® Natrium-heparin NH, med natrium-heparin

NH

brun

grön

S-Monovette® Ammonium-heparin AH, med ammonium-heparinej.def.

blåblå

Tillsats
Rör utan tillsats
S-Monovette® Neutral Z
Serumrör
S-Monovette® Serum CAT, med koagulationsaktivator®

Heparinrör

Citratrör
S-Monovette®&LWUDW1&QDWULXPFLWUDWb

9NC

blå

grön

S-Monovette®3)$&LWUDW1&QDWULXPFLWUDWbEXĳUDW

9NC

ljusblå

-

K3E

lila

röd

S-Monovette K2 EDTA K2E, med kalium-EDTA

K2E

lila

röd

S-Monovette® K2 EDTA-gel K2E, med kalium-EDTA och gel

K2E

lila

röd

S-Monovette®)OXRULG('7$)(PHGĲXRULGRFK('7$

FE

grå

gul

S-Monovette®)OXRULGKHSDULQ)+PHGĲXRULGRFKKHSDULQ

FH

-

gul

S-Monovette®*OXFR(;$&7)&PHGĲXRULGFLWUDWRFK('7$

FC

rosa

grå

LH

mörkblå

orangeS-Monovette® ThromboExact, med magnesiumförening

ej.def.

ej.def., blåsvart

ej.def., blåsvart

S-Monovette® CTAD

ej.def.

ej.def., blåej.def., grön

S-Monovette® ACD

ACD

gul

gul

EDTA-rör
S-Monovette® K3 EDTA K3E, med kalium-EDTA®

Rör med glykolyshämmare

Rör för metallanalys
S-Monovette® Metallanalys LH, med litium-heparin

Ytterligare rör för helblod och plasma®

S-Monovette CPDA

CPDA

gul

gul

S-Monovette® Hirudin

ej.def.

ej.def., olivgrön

ej.def., olivgrön

S-Monovette® Homocystein HCY-Z gel, med gel och stabilisator

ej.def.

ej.def., gråej.def., grå

S-Monovette®+RPRF\VWHLQ+&<&PHGFLWUDWEXĳHUWej.def.

ej.def., lila

ej.def., lila

S-Monovette® DNA Exact

ej.def.

ej.def., blåej.def., blå)OHUVNUXYNRUNIËUJHUıQQVDWWWLOOJÎ
ej.def.: ej definierat+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, återkallad.

209

SV
SARSTEDT S-Monovette® Serum CAT / Serum-gel CAT
S-Monovette® Serum CAT innehåller ett plastgranulat belagt med en koagulationsaktivator (silikat) och används för insamling av serum**. Plastgranulatet hamnar efter centrifugering mellan blodkoaglet och serumet.
S-Monovette® Serum-gel CAT innehåller förutom ett plastgranulat belagt med koagulationsaktivator (silikat) även en polymerbaserad gel och används för serumsamling**. Gelen hamnar efter centrifugering mellan
blodkoaglet och serumet och bildar ett stabilt separerande skikt under transport, förvaring och analys.
Serum används som provmaterial i klinisk-kemiska och immunologiska rutinundersökningar samt inom serologin.
Efter blodprovtagningen ska blodet i S-Monovette®6HUXP&$76HUXPJHO&$7NRDJXOHUDLXSSUËWWOËJHLbPLQXWHUIąUDWWJDUDQWHUDHWWW\GOLJWKRULVRQWHOOWVHSDUHUDQGHVNLNWHIWHUFHQWULIXJHULQJ'HQUHNRPPHQGHUDGH
tiden är baserad på en normal koagulationsprocess. Blod från patienter med sjukdomsbetingade koagulationsrubbningar eller patienter som får koagulationshämmande behandling kräver eventuellt längre tid för
fullständig koagulation.

SARSTEDT S-Monovette® Serum Express gel CAT
S-Monovette® Serum Express Gel CAT innehåller förutom ett plastgranulat belagt med koagulationsaktivator (trombin) även en polymerbaserad gel och används för insamling av serum**. Gelen hamnar efter
centrifugering mellan blodkoaglet och serumet och bildar ett stabilt separerande skikt under transport, förvaring och analys.
Efter blodprovtagningen ska blodet i S-Monovette® Serum Express gel koagulera i upprätt läge i 5 minuter, för att garantera ett tydligt horisontellt separerande skikt efter centrifugering. Den rekommenderade tiden är
baserad på en normal koagulationsprocess, även för blod från hepariniserade patienter. Blod från patienter med sjukdomsbetingade koagulationsrubbningar eller patienter som får koagulationshämmande behandlinginklusive hög dos heparin kräver längre tid för fullständig koagulation.
Serum används som provmaterial i klinisk-kemiska och immunologiska rutinundersökningar samt inom serologin.

SARSTEDT S-Monovette® Neutral Z
S-Monovette® Neutral Z innehåller ingen tillsats, vilket motsvarar en naturlig koagulation av blodprovet utan koagulationsaktivator och används för serumsamling**. Genom centrifugeringen separeras blodkoaglet ochserumet.
Serum används för användarspecifika undersökningar.
Dessutom kan S-Monovette® Neutral Z även användas som ett tomt rör: ska blodprovtagningen påbörjas med en S-Monovette® Citrat i kombination med en (Safety-)Multifly®-kanyl (vingkanyl), används S-Monovette®
Neutral Z som ett rör (slaskrör) för fyllning av slangen till (Safety-)Multifly®-kanylen.

SARSTEDT S-Monovette® Litium-heparin LH / Litium-heparin-gel LH / Litium-heparin-gel+ LH, Natrium-heparin NH, Ammonium-heparin AH
S-Monovette® Litium-heparin LH / Natrium-heparin NH / Ammonium-heparin AH innehåller ett plastgranulat belagt med koagulationshämmaren (antikoagulans) litium-heparin/natrium-heparin/ammonium-heparin (i regel
16 I.E. heparin/ml blod) och används för insamling av helblod och plasma**. Plastgranulatet hamnar efter centrifugering mellan blodkroppar och plasma.
Vid en S-Monovette®/LWLXPKHSDULQ/+XWDQSODVWJUDQXODWILQQVDQWLNRDJXODQVHQOLWLXPKHSDULQLVSUHMGRVHUDGIRUP LUHJHO,(KHSDULQPObEORG 
S-Monovette®/LWLXPKHSDULQJHO/+LQQHKÎOOHUIąUXWRPHWWSODVWJUDQXODWEHODJWPHGNRDJXODWLRQVDNWLYDWRUDQWLNRDJXODQVHQOLWLXPKHSDULQ LUHJHO,(KHSDULQPObEORG ËYHQHQSRO\PHUEDVHUDGJHORFKDQYËQGVIąU
plasmasamling**. Gelen hamnar efter centrifugering mellan blodkroppar och plasma och bildar ett stabilt separerande skikt under transport, förvaring och analys.
S-Monovette® Litium-heparin gel+ LH innehåller även en polymerbaserad gel, vilken reducerar centrifugeringstiden med ca. 50% jämfört med vanliga S-Monovette® Litium-heparin gel.
Heparin-plasma används som provmaterial i klinisk-kemiska och immunologiska rutinundersökningar. Heparin-helblod används som provmaterial i immunologiska rutinundersökningar samt inom serologin.
Koagulationshämningen med heparin sker genom en aktivering av antitrombin.
OBSERVERA: Från S-Monovette® Litium-heparin LH, Litium-heparin-gel/gel+ LH får inga litiumanalyser göras, från S-Monovette® Natrium-heparin får inga natriumanalyser göras och från S-Monovette®
Ammonium-heparin får inga ammoniumanalyser göras. En med venöst blod fylld S-Monovette® Lithium-heparin/Litium-heparin-gel/gel+ /Natrium-heparin/Ammonium-heparin gel är inte lämpad för
blodgasanalyser.

SARSTEDT S-Monovette® Metallanalys
S-Monovette®0HWDOODQDO\VLQQHKÎOOHUDQWLNRDJXODQVHQOLWLXPKHSDULQRFKDQYËQGVIąULQVDPOLQJDYKHOEORGRFKSODVPD /LWLXPKHSDULQËULVSUD\IRUP LUHJHO,(KHSDULQPObEORG 
Heparin-helblod resp. Heparin-plasma i S-Monovette® Metallanalys i kombination med den särskilda Safety-kanylen 21G x 1 ½“ (art.nr. 85.1162.600) används som provmaterial för undersökningar av spårämnen/
metaller. Spårämnena/metallerna valideras genom atomabsorptionsspektroskopi (AAS). För systemet Safety-kanyler och S-Monovette® Metallanalys gäller följande maximala blankvärden i ng/system för dessaspårämnen:

ElementTl

ng/system

2,5

Cd

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

1,5

8,0

5,0

5

50

70

70

10

40

10

10

De maximala blankvärdena för varje element anges på S-Monovette®:s etikett.
Spårämnesbestämningar utförs beroende på analysförfarande från heparin-helblod eller heparin-plasma.
Koagulationshämningen med heparin sker genom en aktivering av antitrombin.

SARSTEDT S-Monovette® Citrat 9NC
S-Monovette®&LWUDW1&LQQHKÎOOHUDQWLNRDJXODQVHQWULQDWULXPFLWUDWRFKDQYËQGVIąULQVDPOLQJDYKHOEORGRFKSODVPD 7ULQDWULXPFLWUDWIąUHOLJJHUVRPPROËUOąVQLQJ bWULQDWULXPFLWUDWOąVQLQJRIWDDYUXQGDWWLOOb RFKXWJąUbDYGHQQRPLQHOODYRO\PHQLHQ60RQRYHWWH® Citrat. Blandningsförhållandet för citrat och blod är 1:9 – 1 volymandel citrat och 9 volymandelar blod. En korrekt fyllning är absolut nödvändig för
analysen.
Citrat-plasma används som provmaterial i hemostasutredningar.
Koagulationshämningen sker genom ett kalciumjonkomplex inducerat av citrat.
Ta hänsyn till ANVISNINGAR under provtagning och handhavande av kombinationen S-Monovette® Citrat och vingkanyl.

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&LQQHKÎOOHUDQWLNRDJXODQVHQWULQDWULXPFLWUDWRFKDQYËQGVIąULQVDPOLQJDYKHOEORGRFKSODVPD 7ULQDWULXPFLWUDWIąUHOLJJHUVRPPROËUEXIIUDGOąVQLQJ bEXIIUDGS+ RFKXWJąUb
av den nominella volymen i en S-Monovette® PFA. Blandningsförhållandet för citrat och blod är 1:9 – 1 volymandel citrat och 9 volymandelar blod. En korrekt fyllning är absolut nödvändig för analysen.
Helblodet i S-Monovette® PFA 9NC används som provmaterial för bedömning av trombocytfunktion med SIEMENS Healthineers analysinstrument PFA och är validerat för detta.
Koagulationshämningen sker genom ett kalciumjonkomplex inducerat av citrat.
Ta hänsyn till ANVISNINGAR under provtagning och handhavande av kombinationen S-Monovette® PFA och vingkanyl.

SARSTEDT S-Monovette® CTAD
S-Monovette®&7$'LQQHKÎOOHUDQWLNRDJXODQVHQWULQDWULXPFLWUDWVDPWWHRI\OOLQDGHQRVLQRFKGLS\ULGDPRORFKDQYËQGVIąULQVDPOLQJDYKHOEORGRFKSODVPD &7$'IąUHOLJJHUVRPOąVQLQJRFKXWJąUbDYGHQQRPLQHOOD
volymen i en S-Monovette® CTAD. Blandningsförhållandet för CTAD och blod är 1:9 – 1 volymandel CTAD och 9 volymandelar blod. En korrekt fyllning är absolut nödvändig för analysen.
CTAD-plasma används som provmaterial för bestämning av trombocytfaktor 4 (PF4), betatromboglobulin (ßTG) och plasminogenaktivatorhämmare 1 (PAI-1), samt för hemostasutredningar.
Tromocytaktivering hämmas under minst 4 timmar och används för övervakning av heparinbehandling.
Koagulationshämningen sker genom ett kalciumjonkomplex inducerat av citrat.
Ta hänsyn till ANVISNINGAR under provtagning och handhavande av kombinationen S-Monovette® CTAD och vingkanyl.
OBSERVERA: CTAD är gul. S-Monovette®&7$'PÎVWHXQGHUIąUYDULQJVN\GGDVPRWDUWLıFLHOOWRFKQDWXUOLJWOMXV6WDUNOMXVSÎYHUNDQXQGHUOËQJUHWLGËQWLPPDUNDQOHGDWLOOLQDNWLYHULQJDYWLOOVDWVHUQD

SARSTEDT S-Monovette® EDTA K2E / K3E
S-Monovette® EDTA K2E / S-Monovette®('7$.(LQQHKÎOOHUDQWLNRDJXODQVHQ.('7$UHVS.('7$RFKDQYËQGVIąUVDPOLQJDYKHOEORG .('7$UHVS.('7$ËULVSUD\IRUP bPJ('7$PObEORG 
EDTA-helblod används som provmaterial för hematologiska undersökningar. Blodutstryk måste göras inom fyra timmar efter blodprovtagningen.
Koagulationshämningen sker genom ett kalciumjonkomplex inducerat av EDTA.
Blod från S-Monovette® EDTA K2E / K3E kan också användas för immunhematologiska rutinundersökningar och tester på infektionssjukdomar. Användaren är ansvarig för att validera provmaterialets lämplighet för dessa
undersökningar med de respektive testreagenserna/analysenheterna inkl. förvaringsvillkoren för proverna.

210

SV
SARSTEDT S-Monovette® EDTA-gel K2E
S-Monovette®('7$*HO.(LQQHKÎOOHUIąUXWRPDQWLNRDJXODQVHQ.('7$HQSRO\PHUEDVHUDGJHORFKDQYËQGVIąUSODVPDLQVDPOLQJ .('7$ILQQVLVSUHMGRVHUDGIRUP bPJ('7$PObEORG *HOHQKDPQDUHIWHU
centrifugering centrifugeringen mellan blodkroppar och plasma och bildar ett stabilt separerande skikt under transport, förvaring och analys.
EDTA-plasma används för molekylär virusdiagnostik.
Koagulationshämningen sker ett kalciumjonkomplex inducerat av EDTA.

SARSTEDT S-Monovette® Fluorid EDTA FE/Fluorid heparin FH/Fluorid citrat EDTA FC med glykolyshämmare
S-Monovette®)OXRULG('7$)(LQQHKÎOOHUDQWLNRDJXODQVHQ('7$ bPJPObEORG VDPWIOXRULG bPJPObEORG IąUJO\NRO\VKËPQLQJRFKDQYËQGVIąULQVDPOLQJDYSODVPD)OXRULG('7$ËULVSUD\IRUP
S-Monovette®)OXRULGKHSDULQ)+LQQHKÎOOHUDQWLNRDJXODQVHQKHSDULQ ,(KHSDULQPObEORG VDPWIOXRULG bPJPObEORG IąUJO\NRO\VKËPQLQJRFKDQYËQGVIąULQVDPOLQJDYSODVPD)OXRULGKHSDULQËULVSUD\IRUP
Glykolyshämningen börjar ca 2 timmar efter fyllning av provtagningsröret och uppvisar full effekt efter ca 4 timmar. Därefter minskar glukoshalten upp till 6 % efter ett par timmar och upp till 10-15% efter 24 timmar.
S-Monovette® GlucoEXACT FC innehåller antikoagulansen EDTA samt citrat och fluorid för omedelbar glykolyshämning och används för insamling av plasma. EDTA, citrat och fluorid är i lösning. På grund av
utspädningen behöver man multiplicera med 1,16 vid beräkningen av glukoskoncentrationen.
S-Monovette® GlucoEXACT FC överensstämmer med riktlinjerna för graviditetsdiabetes från Deutschen Diabetes Gesellschaft (DDG) och Nationale VersorgungsLeitlinie (NVL) für Typ-2-Diabetes. Den omedelbara
stabiliseringen av glukoskoncentrationen upprätthålls i rumstemperatur i upp till 96 timmar. Se även SARSTEDT WhitePaper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature/”Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing glucose levels for 96 hours”.
Fluorid-EDTA-(citrat-)plasma används som provmaterial för glukosbestämning.
Koagulationshämningen sker ett kalciumjonkomplex inducerat av EDTA.
2%6(59(5$)OXRULGNDQOHGDWLOOąNDGKHPRO\V<WWHUOLJDUHLQIRUPDWLRQRPVXEVWDQVHUVRPNDQYHUNDVWąUDQGHıQQVLGHQDNWXHOODEUXNVDQYLVQLQJHQIUÎQWLOOYHUNDUHQDYWHVWUHDJHQVHUQD
Ta hänsyn till ANVISNINGAR under provtagning och handhavande av kombinationen S-Monovette® GlucoEXACT och vingkanyl.

SARSTEDT S-Monovette® CPDA
S-Monovette® CPDA innehåller antikoagulansen natriumcitrat samt citronsyra, natriumfosfat, dextros och adenin och används för insamling av plasma och helblod**. CPDA är i lösning. Blandningsförhållandet för CPDA
och blod är 1:6 - 1 volymandel CPDA och 6 volymandelar blod. En korrekt fyllning är absolut nödvändig för analysen.
CPDA helblod/plasma används som provmaterial för blodgruppsserologi inom transfusionsmedicin, för korstester i samband med transfusioner. Konkret lämpar sig S-Monovette® CPDA för blodgruppsbestämning (AB0)inklusive Kell och Rhesustillhörighet, antikroppstest av irreguljära blodgruppsantikroppar, polyspecifikt direkt Coombstest (till dag 10), förenlighetstest (korstest) med blodgruppskompatibelt patientserum/-plasma (Major
Test).
7UDQVSRUWWLGHQWLOOIąUYDULQJËUYDOLGHUDGIąUPD[LPDOWWLPPDULbƓ&)ąUVHGLPHQWDWLRQDYFHOOHUQDPÎVWHSURYHQIąUVWIąUYDUDVXSSUËWWVWÎHQGHLN\OVNÎSLPLQVWWLPPDU6HGDQNDQGHRYDQQËPQGD
ËPQHQDVRPVNDDQDO\VHUDVEHVWËPPDVLXSSWLOOGDJDULOLNKHWPHGKÎOOEDUKHWHQIąUGHWEORGVRPVSDUDVLEORGEDQNHQHIWHUIąUYDULQJLN\OVNÎS bƓ&  XQGDQWDJHWGLUHNW&RRPEVWHVWGDJDU /ËPSOLJWIąUkolonnagglutinationsförfarande t.ex. på Vision Max från Ortho Clinical Diagnostics. Provmaterialet får inte frysas in.
Det åligger användaren att själv validera provmaterialets lämplighet för dessa undersökningar med andra metoder/testreagenser/analysenheter inkl. förvaringsvillkoren.
Koagulationshämningen sker ett kalciumjonkomplex inducerat av citrat.
Ta hansyn till ANVISNINGAR under provtagning och handhavande av kombinationen S-Monovette® CPDA och vingkanyl.

SARSTEDT S-Monovette® ThromboExact
S-Monovette® ThromboExact innehåller ett magnesiumsalt som antikoagulans och används för insamling av helblod. Magnesiumsaltet är i sprayform.
Helblodet i S-Monovette® ThromboExact används som provmaterial för att utesluta falskt låga trombocytantal orsakade av oförenlighet med antikoagulantia (såsom EDTA, citrat, heparin), även kallad
pseudotrombocytopeni. Bildandet av trombocytaggregat förhindras och bestämningen av verkligt trombocytantal är möjlig i upp till 12 timmar efter blodprovtagningen.
Koagulationshämningen sker via magnesiumjoner, där magnesiumjonerna hämmar trombocytrelaterad tromboxan A2 samt det genom ADP och arakidonsyra förmedlade trombocytaggregatet.

SARSTEDT S-Monovette® Hirudin
S-Monovette® Hirudin innehåller antikoagulansen hirudin och används för insamling av helblod. Hirudin är i sprayform.
Hirudin-helblod används som provmaterial för analys av trombocytfunktion på Multiplate®-enheten (multiple platelet function analyser) från ROCHE Diagnostics och är validerad för detta. Det används för kontroll av
behandling med trombocythämmande läkemedel liksom för påvisande eller uteslutande av rubbningar av trombocytfunktionen.
S-Monovette® Hirudin utvecklades särskilt för analys av trombocytfunktion tillsammans med företaget Verum Diagnostica, idag ROCHE Diagnostics, på Multiplate®-enheten.
Koagulationshämningen sker över hirudin genom direkt trombocythämning och möjliggör därmed en diagnostik av funktionen hos trombocyter i nativt tillstånd.

SARSTEDT S-Monovette® Homocystein HCY-Z-Gel / HCY-C
S-Monovette® Homocystein HCY-Z-gel innehåller förutom ett plastgranulat belagt med koagulationsaktivator (silikat) även en särskild stabilisator samt en polymerbaserad gel och används för insamling av serum. Gelen
hamnar efter centrifugering mellan blodkoaglet och serumet och bildar ett stabilt separerande skikt under transport, förvaring och analys. Beredningen är i sprayform.
Homocystein stabiliseras i upp till 8 timmar i rumstemperatur. Om centrifugeringen följer inom de första 8 timmarna med korrekt bildat separerande skikt mellan blodkoagel och serum stabiliseras homocystein i upp till
96 timmar.
Serumet i S-Monovette® Homocystein HCY-Z-gel används som provmaterial för homocysteinbestämning. S-Monovette® Homocystein HCY-C innehåller surt citrat (pH 4,3) som antikoagulans och används för insamling
av plasma. Citrat är i lösning. På grund av utspädningen behöver man multiplicera med 1,11 vid beräkningen av homocytkoncentrationen.
+RPRF\VWHLQVWDELOLVHUDVLXSSWLOOWLPPDULUXPVWHPSHUDWXURFKYLGbƓ&LXSSWLOOWLPPDULKHOEORG
Plasman i S-Monovette® Homocystein HCY-C används som provmaterial vid homocysteinbestämning.
Koagulationshämningen i S-Monovette® Homocystein HCY-C sker genom en sammansatt formation av kalciumjoner genom citrat.
Beakta ANVISNINGAR under provtagning och handhavande av kombinationen S-Monovette® HCY-C och vingkanyl.

SARSTEDT S-Monovette® DNA Exact
S-Monovette® DNA Exact innehåller en en EDTA-baserad antikoagulans och används för insamling av helblod. EDTA är i sprayform.
('7$KHOEORGDQYËQGVVRPSURYPDWHULDOIąUVWDELOLVHULQJDYJ'1$6WDELOLVHULQJVHIIHNWHQIąUJ'1$YDOLGHUDVWLOOGDJDUYLGbƓ&GDJDUYLGUXPVWHPSHUDWXU bƓ& GDJDULN\OD bƓ& RFKLPLQVWÎUYLGbƓ&
Dessutom klarar de stabiliserade proverna 5 infrysnings- och upptiningscykler utan försämrad kvalité. Se även SARSTEDT White Paper https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/
Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis.”.
Koagulationshämningen sker genom ett kalciumjonkomplex inducerat av EDTA.

**Provmaterialets lämplighet beror på ämnet som ska analyseras och testreagensen/analysenheten. Tillverkarens rekommendationer ska beaktas.

211

SV
Säkerhetsanvisningar/varningar
1.

Allmänna försiktighetsåtgärder: Använd handskar och annan vanlig personlig skyddsutrustning för skydd mot blod och möjlig exponering för potentiellt smittförande provmaterial och överförda patogener.

2.

Behandla alla biologiska prover och stickande/skärande tillbehör för blodprovtagning (kanyler, adaptrar) enligt klinikens riktlinjer och förfaranden. Uppsök läkare efter direktkontakt med biologiska prover ellerQÎOVWLFNVVNDGDHIWHUVRP+,9+&9+%9HOOHUDQGUDLQIHNWLRQVVMXNGRPDUNDQąYHUIąUDVSÎGHWWDVËWW$QYËQG6DIHW\NDQ\OHU6DIHW\0XOWLĲ\®-kanyler med inbyggt nålskydd. Klinikens säkerhetsriktlinjer och-förfaranden måste följas.

3.

Gäller för styckvis förpackade sterila produkter: Kontrollera före användning att varje separatförpackning är oskadad, och använd inte skadade förpackningar.

4.

Produkten är endast avsedd för engångsbruk. Kassera alla stickande/skärande föremål (kanyler, adaptrar) för blodprovtagning i lämpliga avfallsbehållare för biologiskt riskavfall.

5.

Om blodprov tas genom en intravenös (IV) infart, måste det säkerhetställas att denna spolas enligt klinikens regler (=rengörs från IV-lösningen), innan blodprovtagningen påbörjas. Genom regelrätt spolning av
infarten undviker man felaktiga analysresultat.

6.

Underfyllning av S-Monovette® leder till ett felaktigt förhållande mellan blod och preparat/tillsats och kan leda till felaktiga analysresultat.

7.

Det med S-Monovette® tagna och bearbetade blodprovet är inte avsett för återinjektion i människokroppen.

8.

Produkten får ej användas efter sista förbrukningsdag. Utgångsdatum är den sista dagen i angiven månad och år.

Förvaring
Produkten ska förvaras i rumstemperatur.

Viktigt1.

Lagringstid och temperatur för en fylld S-Monovette® beror på hållbarheten för de ämnen som ska analyseras. Detta bedöms av laboratoriet eller informationen inhämtas i bruksanvisningen från tillverkaren av
testreagenserna/analysinstrumentet.

2.

Även om plasma eller serum separeras från en S-Monovette®JHQRPFHQWULIXJHULQJRFKHOOHUGHWıQQVHQEDUULËUËUGHWLQWHVËNHUWDWWDOODFHOOHUVHSDUHUDUIXOOVWËQGLJW5HVWPHWDEROLVPHOOHUQDWXUOLJQHGEU\WQLQJNDQändra koncentrationen av de ämnen som ska analyseras. Analysämnenas stabilitet ska bedömas med avseende på förvaringsbehållarna och utifrån förhållandena i det aktuella laboratoriet.

3.

När det gäller läkemedelsbehandling ska provmaterialets lämplighet kontrolleras i bruksanvisningen från tillverkaren av testreagenserna/analysapparaturen.

4.

Analyser avseende spårelement/metaller ska göras med S-Monovette® Metallanalys + Safety-kanyl metallanalys.

Provtagning och hanteringLÄS DETTA DOKUMENT I SIN HELHET INNAN DU PÅBÖRJAR DEN VENÖSA BLODPROVTAGNINGEN.
Nödvändigt arbetsmaterial för provtagningen1.

Alla nödvändiga S-Monovette® system för blodprovtagning

2.

6DIHW\ NDQ\OHUHOOHU 6DIHW\ 0XOWLĲ\®-kanyler.

3.

Handskar, skyddsrock, ögonskydd eller andra lämpliga skyddskläder för skydd mot blodöverförda patogener eller potentiellt smittförande material.

4.

(WLNHWWHUIąUSDWLHQWLGHQWLıHULQJ

5.

Desinfektionsmaterial för rengöring av provtagningsstället (följ klinikens riktlinjer för steril provtagning angående förberedelse av provtagningsstället). Använd inte några alkoholbaserade rengöringsmedel när proverna
ska användas för blodalkoholtest.

6.

Torr engångssudd med låg bakteriehalt.

7.

Stasband.

8.

Plåster eller förband.

9.

Avfallsbehållare för stickande/skärande föremål för säker avfallshantering av använt material.

Rekommenderad ordningsföljd vid provtagning:
1.

%ORGRGOLQJVĲDVNRU

2.

Rör med citrat eller koagulationsaktivator (med/utan gel serum CAT/serum-gel CAT)3.

Rör med koagulationsaktivator eller citrat

4.

Rör med heparin med/utan gel

5.

Rör med EDTA med/utan gel

6.

Rör med glykolyshämmare

7.

Rör med andra tillsatser$19,61,1*

2PSURYWDJQLQJHQSÎEąUMDVPHGHWWFLWUDWUąUHOOHUDQQDWUąUPHGHQYËWVNHEHUHGQLQJVRPWH[3)$&7$'&3'$+&<&HOOHU*OXFR(;$&7LNRPELQDWLRQPHGHQYLQJNDQ\O
WH[ 6DIHW\ 0XOWLĲ\®NDQ\O UHNRPPHQGHUDVDQYËQGQLQJDYHWWWRPWUąU WH[60RQRYHWWH® Neutral Z) för att undvika underfyllning av röret genom fyllningen vingkanylens
slang.
På så sätt kan en korrekt fyllning av röret och därmed ett korrekt blandningsförhållande (vätska och blod) garanteras.

ANVISNING:

Följ klinikens föreskrifter när det gäller ordningsföljden i provtagningen.

8QGYLNÎWHUĲąGH
De flesta S-Monovetter innehåller kemiska tillsatser. För att förhindra återflöde ta hänsyn till följande råd:1. Använd endast i bruksanvisningen rekommenderade material.
2.

Placera patienten så att venen blir lättåtkomlig och armen eller annat provtagningsområde på patienten hålls nedåt.

3.

Håll S-Monovette®PHGVNUXYORFNHWXSSÎWRFKYLGDQYËQGQLQJDYHQ 6DIHW\ 0XOWLĲ\®-kanyl dessutom under armnivån/punktionsområdet.

4.

Kontrollera vid venpunktionen att innehållet i S-Monovette® inte vidrör vare sig skruvlocket eller kanyländen.

5.

/RVVDVWDVEDQGHWPHGDQEORGHWĲąGDULQL60RQRYHWWH®.

212

SV
Infrysning/upptining
Enligt rekommendationer från WHO (WHO/DIL/Lab/99.1 Rev.02) rekommenderas att serum/plasma separeras från blodkropparna före infrysning.
För S-Monovette® gäller följande rekommendationer för infrysning:
Infrysning under 0 °C•$QYËQGQLQJYLGWHPSHUDWXUHUXQGHUbƓ&PÎVWHDYSULQFLSWHVWDVXQGHUYHUNOLJDIąUKÎOODQGHGÎUąUHQVSÎYHUNDQDYPHGLXPHWVRPVNDIU\VDVVDPWUXWLQHUQDNDQYDUDP\FNHWROLND VHNDSLWOHW0DWHULDOHJHQVNDSHUSARSTEDT katalog)•

3ODVWHQVKÎOOIDVWKHWPLQVNDUYLGWHPSHUDWXUHUXQGHUbƓ&0HNDQLVNDEHODVWQLQJDUVNDGËUIąUJHQHUHOOWXQGYLNDV•Infrysningsförhållandena måste väljas så att innehållet i S-Monovette® fryser homogent resp. underifrån och uppåt. S-Monovette® ska ha tillräckligt med utrymme i ställ eller förvaringskartong för att kunna utvidgas.
Ställ av frigolit eller metall är olämpliga, då de kan leda till vidgningssprickor.

Infrysning till -20 °C – testa före infrysning:•

Störningar: Kontrollera om infrysningen inverkar negativt på blodprovet eller analysen (t.ex. hemolys, de analyserade ämnenas stabilitet).

•Centrifugering: Nödvändig beroende på planerad analys. Följ centrifugeringsförhållandena, se detta dokument under ”Centrifugering” resp. SARSTEDTs webbplats https://www.sarstedt.com/en/service/centrifugation/ och kontrollera proverna visuellt.

•

Hemolys: Helblod hemolyseras vid infrysning: För att undvika detta ska antingen S-Monovette® Gel resp. efter centrifugering Seraplas®9HQWLOıOWHUDQYËQGDVHOOHUSURYHWDYSLSHWWHUDVWLOOHWWVHNXQGËUNËUO,QIU\VQLQJWLOObƓ&şJHQRPIąUDQGH
•Nedkylning: Kyl S-Monovette®XSSUËWWVWÎHQGHXQGHUşbPLQIUÎQUXPVWHPSHUDWXUWLOOƓ&LQQDQGHQNDQIU\VDVQHGWLOObƓ&•

Upptining: Tina upprättstående vid rumstemperatur i minst 45 min. Även här måste mekaniska belastningar undvikas. En för snabb upptining kan påverka analysresultaten negativt.

Infrysning och djupfrysning till under -20 °C.
•

Djupfrysning till under -20 °C har ej testats av tillverkaren. På grund av de många tänkbara faktorer som kan påverka infrysningen rekommenderas att infrysningstester görs enligt laboratoriets arbetsrutiner.

Infrysning av S-Monovette® Gel:•

,QIU\VQLQJVNHUVRPXQGHUSXQNWHQ,QIU\VQLQJWLOObƓ&şJHQRPIąUDQGH•

Det är känt att gelskiktet kan förändras genom infrysningsprocessen.

•På grund av de många tänkbara faktorer som kan påverka infrysningen rekommenderas att infrysningstester görs enligt laboratoriets arbetsrutiner.

•

Upptining: Låt provet tina upprättstående. Efter upptining avpipetteras (häll ej) provmaterialet till cirka 2 mm över gelskiktet i primärkärlet och överförs till ett sekundärkärl. Resten kasseras.
OBSERVERA: Konsultera bruksanvisningarna från tillverkaren av testreagenserna/analysapparaturen för de analyserade ämnenas stabilitet.

213

SV
Blodprovstagning
Provtagning
Det finns två provtagningsätt: aspiration och vakuum.
Aspirationstekniken möjliggör en skonsam blodprovtagning med ett kontinuerligt, långsamt blodflöde tack vare den kontrollerade dragningen av pistongen. På detta sätt kan blodflödet anpassas till alla venförhållanden
och förutsättningar samt hemolys minskas.
Vakuumtekniken möjliggör blodprovtagning enligt undertrycksprincipen med ett kontinuerligt snabbt blodflöde tack vare ett förevakuerat kärl. Denna teknik är därför idealisk för goda venförhållanden och enkla
blodprovstagningsförutsättningar.
Hantering inför blodprovtagning: se även hanteringsvideo för S-Monovette® i Aspirationsteknik resp. Vakuumteknik med Safety-kanyl resp. Safety-Multifly®-kanyl:
https://www.sarstedt.com/en/download/videos/ Sök på diagnostic och venous bloodANVÄND HANDSKAR FÖR ATT MINIMERA RISKEN FÖR EXPONERING UNDER BLODPROVSTAGNINGEN.
1. Välj lämplig S-Monovette® för de prover som krävs.
2.

Välj stället för venpunktionen. Ta hansyn till klinikens riktlinjer vid förberedelse av punktionsstället.

Blodprovtagning med aspiration
Observera! Använd S-Monovette® endast för blodprovtagning och inte för injektion.
Använd endast med dessa kanyler (S-Monovette® (Safety-)kanyler, eller (Safety-)Multifly®-kanyler/adaptrar för S-Monovette®).
Här visas användning med Safety-kanyl:klick

För omedelbart före venpunktionen in S-Monovette® i Safety-kanylens integrerade hållare
och säkra den genom att försiktigt vrida den medurs .
Använd vid behov ett stasband (max. 1 minut). Förbered venpunktionsstället med lämpligt desinfektionsmedel. Vidrör inte venpunktionsstället efter desinficeringen. Placera patienten så att
venen blir lättåtkomlig och armen eller annat provtagningsområde på patienten hålls nedåt.
Ta bort nålskyddet. Punktera venen, dra långsamt ut pistongen och lossa stasbandet, medan blodet flödar in i S-Monovette®
Vänta tills blodflödet upphör för att möjliggöra en korrekt fyllning.

.

Lossa S-Monovette® genom att försiktigt vrida den moturs
och sedan dra ut den ur Safety-kanylen (koppla loss) . Safety-kanylen ligger kvar i venen.
Vid tagning av flera prover ansluts som ovan beskrivits följande S-Monovetter till Safety-kanylen och ytterligare prover tas.
Avslutande av blodprovtagningen: Koppla först loss S-Monovette®
+ , och dra sedan ut Safety-kanylen ur venen. Med enhandsteknik kan nålskyddet aktiveras antingen mot en stabil, jämn yta – tills
kanylen med ett känn- och hörbart "klick" snäpper in i nålskyddet (aktiveras) – eller aktiveras genom tryck med pekfingret mot nålskyddets undre ände. Se även bruksanvisning för S-Monovette® (Safety-)kanyl eller (Safety-)Multifly®-kanyl.
Vänd varje S-Monovette® en gång upp och ned direkt efter borttagandet från Safety-kanylen och alla prover med antikoagulantia flera gånger försiktigt upp och ned efter avslutande av hela blodprovtagningen!
Dra inför transport och centrifugering i pistongen, tills den hörbart snäpper i ytterlägetoch bryt av
pistongen.
1.

Tryck en torr sudd med låg bakteriehalt mot punktionsstället till dess att blödningen upphör.

2.

När blodet börjat koagulera sätts, om så önskas, på ett plåster.

3.

Kassera Safety-kanylen i en avfallsbehållare för biologiskt riskavfall.

214

SV
Blodprovtagning med vakuum.
Observera! Använd S-Monovette® endast för blodprovtagning och inte för injektion.
Använd endast med dessa kanyler (S-Monovette® (Safety-)kanyler, eller (Safety-)Multifly®-kanyler/adaptrar för S-Monovette®).
Här visas användning med Safety-kanyl:

klick

För en skonsam inledning av blodprovtagningen rekommenderar SARSTEDT att den första S-Monovette® fylls med aspirationsteknik; se VENPUNKTION Aspiration
Fortsätt därefter med vakuum.
Före blodprovtagningen dras kolven med pistongen till ändläget i S-Monovette®tills den hörbart
snäpper i läge. Sedan bryts pistongen av .
För in den förberedda S-Monovette® i S-Monovette® Safety-kanylens integrerade hållare och säkra den genom att försiktigt vrida den medurs

+

–

.

.

Vänta tills blodflödet upphör för att möjliggöra en korrekt fyllning.

Lossa S-Monovette® genom att försiktigt vrida den moturs
och sedan dra ut den ur Safety-kanylen (koppla loss) . Safety-kanylen ligger kvar i venen.
Vid tagning av flera prover ansluts som ovan beskrivits följande S-Monovetter till Safety-kanylen och ytterligare prover tas.
Avslutande av blodprovtagningen: Koppla loss
S-Monovette® och + dra sedan ut Safety-kanylen ur venen. Med enhandsteknik kan nålskyddet aktiveras antingen mot en stabil, jämn yta – tills kanylen med ett känn- och hörbart "klick" snäpper in inålskyddet (aktiveras) – eller aktiveras genom tryck med pekfingret mot nålskyddets undre ände.
Vänd varje S-Monovette® en gång upp och ned direkt efter borttagandet från Safety-kanylen och alla prover med antikoagulantia flera gånger försiktigt upp och ned efter avslutande av hela blodprovtagningen!
1.

Tryck en torr sudd med låg bakteriehalt mot punktionsstället till dess att blödningen upphör.

2.

När blodet börjat koagulera sätts, om så önskas, på ett plåster.

3.

Kassera Safety-kanylen i en avfallsbehållare för biologiskt riskavfall.

215

SV
Centrifugering
2%6(59(5$6$567('760RQRYHWWHUËUJMRUGDIąU[J8QGDQWDJQDKËULIUÎQËU60RQRYHWWHUPHG¢bPP 60RQRYHWWH®SHGLDWULN VRPIąUQËUYDUDQGHËUYDOLGHUDGHIąUXSSWLOOb[J$QYËQGHQGDVW
lämpliga rörhållare eller insatser. Centrifugering av S-Monovetter med sprickor resp. centrifugering med alltför stor centrifugalkraft kan göra att S-Monovetterna bryts sönder, varvid potentiellt smittförande material kan
komma att frisättas.
Centrifuginsatser ska väljas utifrån storleken på använda S-Monovetter. Den relativa centrifugalkraften har följande relation till inställt varvtal i varv/min:
RCF = 11,2 x r x (RPM/1000)2"RCF": ”Relative centrifugal force” (”relativ centrifugalkraft”), även kallad g-kraft,"RPM": ”Revolutions per minute” (”varv per minut”),"r": ”Centrifugradie från mitten av centrifugen till botten på S-Monovette®” (cm),S-Monovetter utan gel kan centrifugeras i centrifuger med fast vinkel eller utsvängande rotor.
S-Monovetter med gel är avsedda uteslutande för centrifuger med utsvängande rotor. Centrifugering i centrifuger med fast vinkelrotor är ej validerad av SARSTEDT och rekommenderas ej.
S-Monovetter ska centrifugeras under nedan angivna villkor för centrifugering. Om andra villkor gäller, måste dessa valideras av användaren själv.
Man måste kontrollera att S-Monovetterna passar i centrifuginsatserna. S-Monovetter som sticker upp över insatsen kan fastna i centrifughuvudet och brytas av. Centrifugen måste balanseras. Beakta centrifugens
bruksanvisning för detta.
FÖRSIKTIGHET! Avlägsna inte krossade S-Monovetter med händerna.
$QYLVQLQJDU JËOODQGH GHVLQıFHULQJ DY FHQWULIXJHQ ıQQV L GHVV EUXNVDQYLVQLQJ

Relativ centrifugalkraft (g)Efter BS 4851+
DIN EN ISO 6710
(EU-kod)–

S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Serum

bPLQbPLQbPLQ

bPLQ

bPLQ

Serum-gelbPLQbPLQ

bPLQ

bPLQ

bPLQ

Serum Express gel

bPLQbPLQbPLQ

ej.val.

ej.val.

Litium-heparin

bPLQbPLQ

bPLQ

bPLQ

bPLQ

Litium-heparin-gel

bPLQbPLQbPLQ

bPLQ

bPLQ

Litium-heparin-gel+

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

EDTA

ej.val.

ej.val.

bPLQ

bPLQ

bPLQ

EDTA-gelbPLQbPLQbPLQ

bPLQ

bPLQ

Citrat

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

('7$ĲXRULGKHSDULQ

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

GlucoEXACT

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDW3%0bPO&HQWULIXJUDGLH!bFP

bPLQ

bPLQ

bPLQ

bPLQ

bPLQ

&LWUDW3%0bPO&HQWULIXJUDGLH!WLOOƉbFP

ej.val.

ej.val.

bPLQej.val.

ej.val.

ej.val. = ej validerat*ËOOHUDOOD60RQRYHWWHUPHGXQGDQWDJIąU¢bPP 60RQRYHWWHUSHGLDWULN &HQWULIXJHULQJYLGbƓ&+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, återkallad.

Information om separerande material
Egenskaperna för det separerande materialet (gel) är temperaturberoende. Om S-Monovetter kyls före eller under centrifugeringen, kan ett genomgående skikt av separerande gel ej garanteras.
S-Monovetter får inte centrifugeras på nytt/omcentrifugeras.

Avfallshantering
1.

Ta hansyn och följ allmänna hygieniska riktlinjer och lagbestämmelser gällande korrekt avfallshantering av smittförande material.

2.

Engångshandskar minskar risken för infektion.

3.

Kontaminerade eller fyllda system för blodprovtagning måste placeras i lämpliga avfallsbehållare för biologiskt riskavfall som direkt kan autoklaveras och brännas.

4.

Avfallshanteringen måste ske i för ändamålet lämpliga förbränningsanläggningar eller genom autoklavering (ångsterilisering).

216

SV
3URGXNWVSHFLıNDVWDQGDUGHURFKULNWOLQMHULUHVSHNWLYHDNWXHOOYHUVLRQCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

5LNWOLQMHUIąUNËUOIąUYHQąVEORGSURYWDJQLQJDIN EN ISO 6710: Engångskärl för venös blodprovtagning på människa*CLSI (Clinical and Laboratory Standards Institute)

Förklaring av symboler och märkning:

Artikelnummer

Dessutom gäller för enskilda sterilt förpackade produkter:

Satsbeteckning

Använd ej om förpackningen är skadad

Användbar till och med

Enkelt sterilbarriärsystem med yttre skyddsförpackning

CE-märkning

Sterilisering genom bestrålning

In-vitro-diagnostik

Följ bruksanvisningen

Vid återanvändning: Risk för kontaminering

Förvaras skyddad mot solljus

Förvaras torrt

Tillverkare

Tillverkningsland

Steril vätskebana

Får ej omsteriliseras

Med reservation för tekniska ändringar.
Alla allvarliga händelser som rör produkten ska meddelas tillverkaren och ansvarig nationell myndighet.

217

TH

คําแนะนําในการใช้งาน – ระบบการเจาะเลือด S-Monovette® ของ SARSTEDTใช้สําหรับการตรวจวินิจฉัยในหลอดทดลอง
วัตถุประสงค์ในการใช้งาน

ระบบการเจาะเลือด S-Monovette® หัวเข็ม และตัวปรับทํางานร่วมกันเป็นระบบที่ใช้สําหรับเจาะเลือดจากเส้นเลือดดํา ระบบการเจาะเลือด S-Monovette® ใช้สําหรับการเก็บรวบรวม การขนส่ง การดําเนินการ และการเก็บรักษาตัวอย่างเลือดสําหรับการตรวจวินิจฉัย ในหลอดทดลอง เพื่อตรวจวัดปริมาณเซรุ่ม
พลาสมา หรือเลือดครบส่วนในห้องปฏิบัติการทางคลินิก ผลิตภัณฑ์มีไว้สําหรับการใช้งานในสถานพยาบาลโดยเฉพาะและต้องใช้งานโดยบุคลากรที่ได้รับการฝึกอบรมทางการแพทย์มาแล้วและบุคลากรในห้องปฏิบัติการเท่านั้น

คําอธิบายผลิตภัณฑ์
ระบบการเจาะเลือด S-Monovette® ประกอบด้วยหลอดพลาสติก ลูกสูบ ก้านสูบ และฝาเกลียวพลาสติกที่มีรหัสสีและมีเยื่อหุ้มในตัว ซึ่งออกแบบมาเป็นพิเศษเพื่อให้เชื่อมต่อกับหัวเข็ม (นิรภัย) S-Monovette® หรือหัวเข็ม (นิรภัย) Multifly® ได้โดยเฉพาะ รวมทั้งมีสารเติมแต่งต่างๆ (การจัดเตรียม) นอกจากนี้ยังมี
ระบบการเจาะเลือด S-Monovette® ที่ไม่มีสารเติมแต่งด้วย ระบบการเจาะเลือด S-Monovette® แบบที่เติมแต่งด้วยเป็นสารเร่งการแข็งตัวเป็นลิ่มของเลือด, สารเร่งการแข็งตัวเป็นลิ่มของเลือดที่มีเจล, ลิเทียม-เฮพาริน, ลิเทียม-เฮพารินที่มีเจล, โซเดียม-เฮพาริน, ซิเตรต, EDTA, ฟลูออไรด์ EDTA, ฟลูออไรด์-เฮพาริน, ฟลูออไรด์ซิเตรต, CPDA, และแบบที่ไม่มีสารเติมแต่ง จะมีความเข้มข้นของสารเติมแต่ง ปริมาตรของสารเติมแต่งที่เป็นของเหลว และความคลาดเคลื่อนยินยอมของปริมาตรดังกล่าว ตลอดจนอัตราส่วนระหว่างเลือดกับสารเติมแต่งตามข้อกําหนดและคําแนะนําของมาตรฐานสากล DIN EN ISO 6710
ว่าด้วย "Single-use containers for venous blood specimen collection" (ภาชนะแบบใช้ครั้งเดียวสําหรับการเก็บตัวอย่างเลือดจากเส้นเลือดดํา) และมาตรฐานที่ได้รับการอนุมัติจาก Clinical and Laboratory Standards Institute (CLSI) (สถาบันมาตรฐานด้านคลินิกและห้องปฏิบัติการ) ตัวเลือกของสารเติม
แต่งขึ้นอยู่กับวิธีการทดสอบวิเคราะห์ ซึ่งจะกําหนดโดยผู้ผลิตสารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบและ/หรือเครื่องมือวิเคราะห์ที่จะใช้ทําการทดสอบ ระบบการเจาะเลือด S-Monovette® มีจําหน่ายในแบบปลอดเชื้อด้านในและแบบบรรจุแยกชิ้นด้านในและปลอดเชื้อด้านนอก

รหัสสีบนฝาเกลียวของ S-Monovette®*:สารเติมแต่ง

รหัสตัวอักษร

สีฝาเป็นไปตามมาตรฐาน DIN EN
ISO 6710

สีฝาเป็นไปตามมาตรฐาน BS 4851+

Z

สีขาว

สีขาว

หลอดที่ไม่มีการจัดเตรียมด้วยสารเติมแต่ง
S-Monovette® เป็นกลาง Z
หลอดเซรุ่ม
S-Monovette® เซรุ่ม CAT ที่มีสารเร่งการแข็งตัวเป็นลิ่มของเลือด

CAT

สีแดง

สีขาว

S-Monovette® เซรุ่ม-เจล CAT ที่มีสารเร่งการแข็งตัวเป็นลิ่มของเลือดและเจล

CATสีเหลืองเข้ม

สีเหลืองเข้ม

S-Monovette® เซรุ่ม เอ็กซ์เพรส เจล CAT ที่มีเอนไซม์ทรอมบินเป็นสารเร่งการแข็งตัวเป็นลิ่มของเลือดและเจล

CAT

สีส้ม

-

หลอดเฮพาริน (สารป้องกันการแข็งตัวเป็นลิ่มของเลือด)S-Monovette® ลิเทียม-เฮพาริน LH ที่มีลิเทียม-เฮพาริน

LHสีเขียว

สีส้มS-Monovette® ลิเทียม-เฮพารินเหลว LH ที่มีลิเทียม-เฮพาริน

LHสีเขียว

สีส้มS-Monovette® ลิเทียม-เฮพาริน-เจล LH ที่มีลิเทียม-เฮพารินและเจล

LHสีเขียว

สีส้มS-Monovette® ลิเทียม-เฮพาริน-เจล+ LH ที่มีลิเทียม-เฮพารินและเจลออกฤทธิ์เร็ว

LHสีเขียว

สีส้มS-Monovette® โซเดียม-เฮพาริน NH ที่มีโซเดียม-เฮพาริน

NHสีน้ําตาล

สีเขียว

S-Monovette® แอมโมเนียม-เฮพาริน AH ที่มีแอมโมเนียม-เฮพาริน

ไม่ระบุ

สีฟ้า

สีฟ้า

หลอดซิเตรต
S-Monovette® ซิเตรต 9NC โซเดียมซิเตรต 3.13 %

9NC

สีฟ้า

สีเขียว

S-Monovette® PFA ซิเตรต 9NC โซเดียมซิเตรต 3.8 % มีสารบัฟเฟอร์

9NC

สีฟ้าอ่อน

-S-Monovette® K3 EDTA K3E ที่มีโพแทสเซียม EDTA

K3E

สีม่วง

สีแดงS-Monovette® K2 EDTA K2E ที่มีโพแทสเซียม EDTA

K2E

สีม่วง

สีแดงS-Monovette® K2 EDTA-เจล K2E ที่มีโพแทสเซียม EDTA และเจล

K2E

สีม่วง

สีแดงS-Monovette® ฟลูออไรด์ EDTA FE ที่มีฟลูออไรด์และ EDTA

FE

สีเทา

สีเหลือง

S-Monovette® ฟลูออไรด์-เฮพาริน FH ที่มีฟลูออไรด์และเฮพาริน

FH-

สีเหลือง

FCสีชมพู

สีเทา

LHสีน้ําเงินเข้ม

สีส้มไม่ระบุ

ไม่ระบุ สีม่วงเข้ม

ไม่ระบุ สีม่วงเข้ม

S-Monovette CTAD

ไม่ระบุ

ไม่ระบุ สีฟา้

ไม่ระบุ สีเขียว

S-Monovette® ACD

ACDสีเหลือง

สีเหลือง

S-Monovette® CPDA

CPDAสีเหลือง

สีเหลือง

S-Monovette® ฮีรูดีน

ไม่ระบุ

ไม่ระบุ สีเขียวมะกอก

ไม่ระบุ สีเขียวมะกอก

S-Monovette® โฮโมซิสทีน HCY-Z เจล ที่มีเจลและสารคงความเสถียร

ไม่ระบุ

ไม่ระบุ สีเทา

ไม่ระบุ สีเทา

S-Monovette® โฮโมซิสทีน HCY-C ที่มีสารบัฟเฟอร์ซิเตรต

ไม่ระบุ

ไม่ระบุ สีม่วง

ไม่ระบุ สีม่วง

S-Monovette® DNA Exactไม่ระบุ

ไม่ระบุ สีฟา้

ไม่ระบุ สีฟา้

หลอด EDTA (กรดเอทิลีนไดอามีนเตตราอาเซติก)หลอดที่มีสารยับยั้งปฏิกิริยาไกลโคไลซิส (การเปลี่ยนเป็นกลูโคส)®

S-Monovette GlucoEXACT FC ที่มีฟลูออไรด์ ซิเตรต และ EDTA
หลอดสําหรับการวิเคราะห์โลหะ
S-Monovette® การวิเคราะห์โลหะ LH ที่มีลิเทียม-เฮพาริน

หลอดแบบอื่นสําหรับการตรวจวิเคราะห์เลือดครบส่วนและพลาสมา
S-Monovette® ThromboExact ที่มีสารประกอบแมกนีเซียม
®

* มีฝาเกลียวสีอื่นๆ ด้วยไม่ระบุ: ไม่มีการระบุสี
+ข้อมูลจากมาตรฐานอังกฤษ BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, เพิกถอน.

218

TH
S-Monovette® เซรุ่ม CAT/เซรุ่ม-เจล CAT ของ SARSTEDT
S-Monovette® เซรุ่ม CAT มีเม็ดพลาสติกเคลือบสารเร่งการแข็งตัวเป็นลิ่มของเลือดและเจล (ซิลิเกต) และใช้สําหรับการสกัดเซรุ่ม** การหมุนเหวี่ยงจะทําให้เม็ดพลาสติกคั่นแยกก้อนเลือดและเซรุ่มออกจากกัน
S-Monovette® เซรุ่ม-เจล CAT มีทั้งเม็ดพลาสติกเคลือบสารเร่งการแข็งตัวเป็นลิ่มของเลือด (ซิลิเกต) และเจลโพลิเมอร์ และใช้สําหรับการสกัดเซรุ่ม** การหมุนเหวี่ยงจะทําให้เจลคั่นแยกก้อนเลือดและเซรุ่มออกจากกันและสร้างชั้นแยกที่เสถียรในระหว่างการขนส่ง การเก็บรักษา และการวิเคราะห์
เซรุ่มเป็นวัสดุตัวอย่างที่ใช้สําหรับการทดสอบเคมีทางคลินิก การวิเคราะห์ทางวิทยาภูมิคุ้มกันตามปกติ และการวิเคราะห์ทางวิทยาเซรุ่ม
หลังจากการเจาะเลือด ให้วาง S-Monovette® เซรุ่ม CAT/เซรุ่ม-เจล CAT ตั้งตรงนาน 30 นาที เพื่อให้เลือดแข็งตัวเป็นลิ่มและให้ได้การแยกชั้นในแนวนอนที่ชัดเจนหลังจากการหมุนเหวี่ยง เวลาที่แนะนําขึ้นอยู่กับกระบวนการแข็งตัวเป็นลิ่มของเลือดที่ทํางานเป็นปกติ เลือดจากผู้ป่วยที่มีความผิดปกติในการ
แข็งตัวเป็นลิ่มของเลือดเนื่องจากการเจ็บป่วยหรือจําเป็นต้องอยู่ภายใต้การบําบัดด้วยสารยับยั้งการแข็งตัวเป็นลิ่มของเลือดต้องใช้เวลานานนานกว่าในการทําให้เลือดครบส่วนแข็งตัวเป็นลิ่ม

S-Monovette® เซรุ่ม เอ็กซ์เพรส เจล CAT ของ SARSTEDT
S-Monovette® เซรุ่ม เอ็กซ์เพรส เจล CAT มีทั้งเม็ดพลาสติกเคลือบสารเร่งการแข็งตัวเป็นลิ่มของเลือด (เอนไซม์ทรอมบิน) และเจลโพลิเมอร์ และใช้สําหรับการสกัดเซรุ่ม** การหมุนเหวี่ยงจะทําให้เจลคั่นแยกก้อนเลือดและเซรุ่มออกจากกันและสร้างชั้นแยกที่เสถียรในระหว่างการขนส่ง การเก็บรักษา และการ
วิเคราะห์
หลังจากการเจาะเลือด ให้วาง S-Monovette® เซรุ่ม เอ็กซ์เพรส เจล ตั้งตรงนาน 5 นาที เพื่อให้เลือดแข็งตัวเป็นลิ่มและให้ได้การแยกชั้นในแนวนอนที่ชัดเจนหลังจากการหมุนเหวี่ยง เวลาที่แนะนําขึ้นอยู่กับกระบวนการแข็งตัวเป็นลิ่มของเลือดที่ทํางานเป็นปกติ รวมถึงเลือดจากผู้ป่วยที่ได้รับยาเฮพาริน เลือดจาก
ผู้ป่วยที่มีความผิดปกติในการแข็งตัวเป็นลิ่มของเลือดเนื่องจากการเจ็บป่วยหรืออยู่ภายใต้การบําบัดด้วยสารยับยั้งการแข็งตัวเป็นลิ่มของเลือดรวมทั้งผู้ป่วยที่ได้รับยาเฮพารินในปริมาณสูงต้องใช้เวลานานนานกว่าในการทําให้เลือดครบส่วนแข็งตัวเป็นลิ่ม
เซรุ่มเป็นวัสดุตัวอย่างที่ใช้สําหรับการทดสอบเคมีทางคลินิก การวิเคราะห์ทางวิทยาภูมิคุ้มกันตามปกติ และการวิเคราะห์ทางวิทยาเซรุ่ม

S-Monovette® เป็นกลาง Z ของ SARSTEDT
S-Monovette® เป็นกลาง Z ไม่มีการจัดเตรียมด้วยสารเติมแต่ง ซึ่งจะทําให้ตัวอย่างเลือดแข็งตัวเป็นลิ่มตามธรรมชาติโดยไม่ใช้สารเร่งการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเซรุ่ม** การหมุนเหวี่ยงจะทําให้ก้อนเลือดและเซรุ่มแยกออกจากกัน
เซรุ่มเป็นวัสดุตัวอย่างที่ใช้สําหรับการทดสอบที่ผู้ใช้กําหนด
นอกจากนี้ S-Monovette® เป็นกลาง Z ยังสามารถใช้เป็นหลอดเปล่าในกรณีต่อไปนี้ได้อีกด้วย: หากการเจาะเลือดเริ่มขึ้นโดยใช้ S-Monovette® ซิเตรต ร่วมกับหัวเข็ม (นิรภัย) Multifly® (หัวเข็มแบบมีปีก) S-Monovette® เป็นกลาง Z จะถูกใช้เป็นหลอดแรก (หลอดเปล่า) สําหรับเติมสารจากท่ออ่อนของหัวเข็ม
(นิรภัย) Multifly®

S-Monovette® ลิเทียม-เฮพาริน LH/ลิเทียม-เฮพาริน-เจล LH/ลิเทียม-เฮพาริน-เจล+ LH, โซเดียม-เฮพาริน NH, แอมโมเนียม-เฮพาริน AH
S-Monovette® ลิเทียม-เฮพาริน LH/โซเดียม-เฮพาริน NH/แอมโมเนียม-เฮพาริน AH มีเม็ดพลาสติกเคลือบลิเทียม-เฮพาริน/โซเดียม-เฮพาริน/แอมโมเนียม-เฮพารินเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด (Anticoagulant) (โดยปกติมีเฮพาริน 16 I.U./เลือด 1 มล.) และใช้สําหรับการสกัดเลือดครบส่วน
และพลาสมา** การหมุนเหวี่ยงจะทําให้เม็ดพลาสติกคั่นแยกเเซลล์เม็ดเลือดและเซรุ่มออกจากกัน
S-Monovette® ลิเทียม-เฮพาริน LH ไม่มีเม็ดพลาสติก แต่มีลิเทียม-เฮพารินเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือดในรูปของเหลวที่พ่นออกมา (โดยปกติมีเฮพาริน 19 I.U./เลือด 1 มล.)S-Monovette® ลิเทียม-เฮพาริน-เจล LH มีทั้งเม็ดพลาสติกที่เคลือบด้วยลิเทียม-เฮพารินเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด (ปกติมีเฮพาริน 25 I.U./เลือด 1 มล.) และเจลโพลิเมอร์ และใช้สําหรับการสกัดเซรุ่ม** การหมุนเหวี่ยงจะทําให้เจลคั่นแยกเซลล์เม็ดเลือดและพลาสมาออกจากกันและสร้างชั้น
แยกที่เสถียรในระหว่างการขนส่ง การเก็บรักษา และการวิเคราะห์
S-Monovette® ลิเทียม-เฮพาริน-เจล+ LH มีเจลโพลิเมอร์เช่นเดียวกัน ซึ่งจะช่วยลดเวลาการหมุนเหวี่ยงลงประมาณ 50 % เมื่อเทียบกับ S-Monovette® ลิเทียม-เฮพาริน-เจล แบบธรรมดา
พลาสมาผสมเฮพารินเป็นวัสดุตัวอย่างที่ใช้สําหรับการทดสอบเคมีทางคลินิกและการวิเคราะห์ทางวิทยาภูมิคุ้มกันตามปกติ เลือดครบส่วนผสมเฮพารินเป็นวัสดุตัวอย่างที่ใช้สําหรับการวิเคราะห์ทางวิทยาภูมิคุ้มกันตามปกติและการวิเคราะห์ทางวิทยาเซรุ่ม
เฮพารินจะกระตุ้นการทํางานของแอนติทรอมบินเพื่อยับยั้งการแข็งตัวเป็นลิ่มของเลือด
หมายเหตุ: อย่าใช้ S-Monovette® ลิเทียม-เฮพาริน LH, ลิเทียม-เฮพาริน-เจล/เจล+ LH เพื่อตรวจวัดปริมาณลิเทียม อย่าใช้ S-Monovette® โซเดียม-เฮพาริน NH เพื่อตรวจวัดปริมาณโซเดียม และอย่าใช้ S-Monovette® แอมโมเนียม-เฮพาริน AH เพื่อตรวจวัดปริมาณแอมโมเนียม S-Monovette® ลิเทียม-เฮพาริน/ลิเทียม-เฮพาริน-เจล/เจล+/โซเดียม-เฮพาริน/แอมโมเนียม-เฮพาริน ที่มีเลือดจากเส้นเลือดดําไม่เหมาะสําหรับการวิเคราะห์ก๊าซในเลือด

S-Monovette® การวิเคราะห์โลหะ ของ SARSTEDT
S-Monovette® การวิเคราะห์โลหะ มีลิเทียม-เฮพารินเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วนและพลาสมา** ลิเทียม-เฮพารินอยู่ในรูปของเหลวที่พ่นออกมา (โดยปกติมีเฮพาริน 19 I.U./เลือด 1 มล.)เลือดครบส่วนหรือพลาสมาผสมเฮพารินใน S-Monovette® การวิเคราะห์โลหะ ที่ใช้งานร่วมกับหัวเข็มนิรภัยพิเศษขนาด 21G x 1 ½" (รหัสสินค้า 85.1162.600) เป็นวัสดุตัวอย่างที่ใช้สําหรับการวิเคราะห์จุลธาตุ/โลหะ การตรวจวัดปริมาณจุลธาตุ/โลหะใช้เครื่องวัดการดูดกลืนแสงของอะตอม (Atomic Absorption
Spectrophotometry, AAS) ระบบของหัวเข็มนิรภัยและ S-Monovette® การวิเคราะห์โลหะ ให้คา่ ว่างเปล่าสูงสุดเป็นนาโนกรัม/ระบบของจุลธาตุดังต่อไปนี้:ธาตุแทลเลียม (Tl)แคดเมียม (Cd)นิกเกิล (Ni)โครเมียม (Cr)ตะกั่ว (Pb)เหล็ก (Fe)ทองแดง (Cu)นาโนกรัม/ระบบ

2.5

1.5

8.0

5.0

5

50

70

ค่าว่างเปล่าสูงสุดของแต่ละธาตุจะระบุไว้บนสติกเกอร์ของ S-Monovetteสังกะสี (Zn)แมงกานีส (Mn)อะลูมิเนียม (Al)ซีลีเนียม (Se)ปรอท (Hg)

70

10

40

10

10

®

การตรวจวัดปริมาณจุลธาตุขึ้นอยู่กับขั้นตอนการวิเคราะห์เลือดครบส่วนผสมเฮพารินหรือพลาสมาผสมเฮพาริน
เฮพารินจะกระตุ้นการทํางานของแอนติทรอมบินเพื่อยับยั้งการแข็งตัวเป็นลิ่มของเลือด

S-Monovette® ซิเตรต 9NC ของ SARSTEDT
S-Monovette® ซิเตรต 9NC มีไตรโซเดียมซิเตรตเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วนและพลาสมา** ไตรโซเดียมซิเตรตเป็นสารละลายที่มีความเข้มข้น 0.106 โมล (สารละลายไตรโซเดียมซิเตรต 3.13 % มักจะปัดเศษเป็น 3.2 %) และมีปริมาตร 10 % ของปริมาตรที่
กําหนดของ S-Monovette® ซิเตรต อัตราการผสมของซิเตรตกับเลือดเป็น 1:9 กล่าวคือ มีปริมาตรซิเตรต 1 ส่วน และมีปริมาตรเลือด 9 ส่วน ปริมาณเลือดที่ใช้ในการวิเคราะห์ต้องถูกต้อง
พลาสมาผสมซิเตรตเป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวิเคราะห์ทางโลหิตวิทยาด้านการแข็งตัวเป็นลิ่มของเลือดตามปกติ
ซิเตรตทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด
กรุณาดูหมายเหตุภายใต้หัวข้อ การเก็บตัวอย่างและการจัดการ สําหรับการใช้งาน S-Monovette® ซิเตรต ร่วมกับหัวเข็มแบบมีปีก

S-Monovette® PFA 9NC ของ SARSTEDT
S-Monovette® PFA 9NC มีไตรโซเดียมซิเตรตเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วนและพลาสมา** ไตรโซเดียมซิเตรตเป็นสารละลายบัฟเฟอร์ที่มีความเข้มข้น 0.129 โมล (บัฟเฟอร์ 3.8 % ค่าความเป็นกรด-เบส (pH) 5.5) และมีปริมาตร 10 % ของปริมาตรที่กําหนด
ของ S-Monovette® PFA อัตราการผสมของซิเตรตกับเลือดเป็น 1:9 กล่าวคือ มีปริมาตรซิเตรต 1 ส่วน และมีปริมาตรเลือด 9 ส่วน ปริมาณเลือดที่ใช้ในการวิเคราะห์ต้องถูกต้อง
เลือดครบส่วนใน S-Monovette® PFA 9NC เป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวัดการทํางานของเกล็ดเลือดด้วยระบบตรวจวัด Healthineers รุ่น PFA ของ SIEMENSซิเตรตทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด
กรุณาดูหมายเหตุภายใต้หัวข้อ การเก็บตัวอย่างและการจัดการ สําหรับการใช้งาน S-Monovette® PFA ร่วมกับหัวเข็มแบบมีปีก

S-Monovette® CTAD ของ SARSTEDT
S-Monovette® CTAD มีไตรโซเดียมซิเตรตเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด รวมทั้งธีโอฟิลลีน (ยาขยายหลอดลม) อะดีโนซีน (สารให้พลังงานแก่เซลล์) และไดไพริดาโมล (ยาต้านเกล็ดเลือด) และใช้สําหรับการสกัดเลือดครบส่วนและพลาสมา** CTAD เป็นสารละลายที่มีปริมาตร 10 % ของปริมาตรที่
กําหนดของ S-Monovette® CTAD อัตราการผสมของ CTAD กับเลือดเป็น 1:9 กล่าวคือ มีปริมาตร CTAD 1 ส่วน และมีปริมาตรเลือด 9 ส่วน ปริมาณเลือดที่ใช้ในการวิเคราะห์ต้องถูกต้อง
พลาสมาผสม CTAD เป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวัดปริมาณของปัจจัยในการแข็งตัวของเลือดชนิดที่ 4 (PF4) เบตาทรอมโบโกลบูลิน (ßTG) และตัวยับยั้งตัวกระตุ้นพลาสมิโนเจน (PAI-1) และใช้สําหรับการตรวจวิเคราะห์ทางโลหิตวิทยาด้านการแข็งตัวเป็นลิ่มของเลือดตามปกติ
การทํางานของเกล็ดเลือดจะถูกยับยั้งเป็นระยะเวลาอย่างน้อย 4 ชั่วโมง และใช้สําหรับการเฝ้าติดตามการรักษาด้วยยาเฮพาริน
ซิเตรตทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด
กรุณาดูหมายเหตุภายใต้หัวข้อ การเก็บตัวอย่างและการจัดการ สําหรับการใช้งาน S-Monovette® CTAD ร่วมกับหัวเข็มแบบมีปีก
หมายเหตุ: CTAD มีสีเหลือง ต้องเก็บรักษา S-Monovette® CTAD ให้พ้นจากทั้งแสงธรรมชาติและแสงไฟ การถูกแสงจ้าเป็นเวลานานกว่า 12 ชั่วโมงจะทําให้สารเติมแต่งเสื่อมสภาพ

S-Monovette® EDTA K2E/K3E ของ SARSTEDT
S-Monovette® EDTA K2E และ S-Monovette® EDTA K3E มี K2 EDTA หรือ K3 EDTA เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วน** K2 EDTA หรือ K3 EDTA อยู่ในรูปของเหลวที่พ่นออกมา (EDTA 1.6 มก./เลือด 1 มล.)เลือดครบส่วนผสม EDTA เป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวิเคราะห์ทางโลหิตวิทยา ควรเตรียมฟิล์มเลือดให้เสร็จภายใน 4 ชั่วโมงหลังจากการเจาะเลือดEDTA ทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด
เลือดจาก S-Monovette® EDTA K2E/K3E ใช้สําหรับการทดสอบอิมมูโนวิทยาทางโลหิตตามปกติและการทดสอบโรคติดเชื้อได้เช่นกัน ผู้ใช้ต้องรับผิดชอบต่อการใช้สารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบ เครื่องมือวิเคราะห์ และเงื่อนไขการจัดเก็บวัสดุตัวอย่าง เพื่อตรวจสอบความเหมาะสมของวัสดุตัวอย่าง
ที่ใช้ในการทดสอบเหล่านี้

219

TH
S-Monovette® EDTA-เจล K2E ของ SARSTEDT
S-Monovette® EDTA-เจล K2E มีทั้ง K2 EDTA เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และเจลโพลิเมอร์ และใช้สําหรับการสกัดพลาสมา** K2 EDTA อยู่ในรูปของเหลวที่พ่นออกมา (EDTA 1.6 มก./เลือด 1 มล.) การหมุนเหวี่ยงจะทําให้เจลคั่นแยกเซลล์เม็ดเลือดและพลาสมาออกจากกันและสร้างชั้น
แยกที่เสถียรในระหว่างการขนส่ง การเก็บรักษา และการวิเคราะห์
พลาสมาผสม EDTA เป็นวัสดุตัวอย่างที่ใช้สําหรับการวินิจฉัยไวรัสระดับโมเลกุลEDTA ทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด

S-Monovette® ฟลูออไรด์ EDTA FE/ฟลูออไรด์ เฮพาริน FH/ฟลูออไรด์ ซิเตรต EDTA FC ที่มีสารยับยั้งปฏิกิริยาไกลโคไลซิส ของ SARSTEDT
S-Monovette® ฟลูออไรด์ EDTA FE มี EDTA (1.2 มก./เลือด 1 มล.) เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และมีฟลูออไรด์ (1.0 มก./เลือด 1 มล.) เป็นสารยับยั้งปฏิกิริยาไกลโคไลซิส และใช้สําหรับการสกัดพลาสมา** ฟลูออไรด์ EDTA อยู่ในรูปของเหลวที่พ่นออกมา
S-Monovette® ฟลูออไรด์-เฮพาริน FH มีเฮพาริน (เฮพาริน 16 I.U./เลือด 1 มล.) เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และมีฟลูออไรด์ (1.0 มก./เลือด 1 มล.) เป็นสารยับยั้งปฏิกิริยาไกลโคไลซิส และใช้สําหรับการสกัดพลาสมา** ฟลูออไรด์-เฮพารินอยู่ในรูปของเหลวที่พ่นออกมา
การยับยั้งปฏิกิริยาไกลโคไลซิสด้วยฟลูออไรด์เพียงอย่างเดียวจะเริ่มขึ้นประมาณ 2 ชั่วโมงหลังจากการเติมเลือดลงไปในหลอดเก็บตัวอย่าง และจะแสดงให้เห็นผลอย่างเต็มที่หลังจากผ่านไปประมาณ 4 ชั่วโมง อัตราการสลายของกลูโคสในเลือดครบส่วนเฉลี่ยสูงถึง 6 % หลังจากไม่กี่ชั่วโมง และสูงถึง 10-15 % หลังจากผ่านไป 24 ชั่วโมง
S-Monovette® GlucoEXACT FC มี EDTA เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และมีฟลูออไรด์เป็นสารยับยั้งปฏิกิริยาไกลโคไลซิสทันที และใช้สําหรับการสกัดพลาสมา** EDTA ซิเตรต และฟลูออไรด์อยู่ในรูปของสารละลาย การคํานวณความเข้มข้นของกลูโคสต้องคูณด้วย 1.16 เพราะถูกเจือจางไปบ้าง
แล้วS-Monovette® GlucoEXACT FC เป็นไปตามแนวทางปฏิบัติสําหรับโรคเบาหวานขณะตั้งครรภ์ของสมาคมโรคเบาหวานแห่งเยอรมนี (DDG) และแนวทางปฏิบัติสําหรับสําหรับการดูแลสุขภาพแห่งชาติ (NVL) สําหรับโรคเบาหวานชนิดที่ 2 การทําให้ความเข้มข้นของกลูโคสเสถียรโดยทันทีช่วยรับประกันว่า
ตัวอย่างในเลือดครบส่วนจะคงสภาพไว้ได้นานถึง 96 ชั่วโมงที่อุณหภูมิห้อง ดูเอกสารแสดงข้อเท็จจริงของ SARSTEDT https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ บทความเรื่อง "Sarstedt S-Monovette® GlucoEXACT A blood collection device for stabilizing
glucose levels for 96 hours"พลาสมาผสมฟลูออไรด์-EDTA-(ซิเตรต) เป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวัดปริมาณกลูโคสEDTA ทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด
หมายเหตุ: ฟลูออไรด์อาจเป็นสาเหตุที่ทําให้เม็ดเลือดแดงแตกสลายมากขึ้น สําหรับข้อมูลเพิ่มเติมเกี่ยวกับสารต่างๆ ที่ส่งผลกระทบ กรุณาดูคําแนะนําในการใช้งานที่เกี่ยวข้องของผู้ผลิตสารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบ
กรุณาดูหมายเหตุภายใต้หัวข้อ การเก็บตัวอย่างและการจัดการ สําหรับการใช้งาน S-Monovette® GlucoEXACT ร่วมกับหัวเข็มแบบมีปีก

S-Monovette® CPDA ของ SARSTEDT
S-Monovette® CPDA มีโซเดียมซิเตรตเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด รวมทั้งกรดมะนาว โซเดียมฟอสเฟต น้ําตาลเด็กซ์โทรส และแอดีนีน และใช้สําหรับการสกัดเลือดครบส่วนและพลาสมา** CPDA อยู่ในรูปของสารละลาย อัตราการผสมของ CPDA กับเลือดเป็น 1:6 กล่าวคือ มีปริมาตร CPDA
1 ส่วน และมีปริมาตรเลือด 6 ส่วน ปริมาณเลือดที่ใช้ในการวิเคราะห์ต้องถูกต้อง
เลือดครบส่วน/พลาสมาผสม CPDA เป็นวัสดุตัวอย่างที่ใช้สําหรับวิทยาเซรุ่มในการตรวจหมู่โลหิตในเวชศาสตร์บริการโลหิต เพื่อทดสอบความเข้ากัน (ความเข้ากันได้ของเลือด) ในการบริการโลหิต S-Monovette® CPDA ใช้สําหร้บการระบุหมู่โลหิตระบบเอบีโอ (ABO) รวมถึงระบบ Kell และ Rhesus การตรวจคัด
กรองแอนติบอดีของหมู่โลหิตพิเศษ การทดสอบ Coombs โดยตรงแบบ Polyspecific (ถึงวันที่ 10) การทดสอบความเข้ากัน (ความเข้ากันได้ของเลือด) ด้วยเซรุ่ม/พลาสมาของผู้ป่วยในหมู่โลหิตที่เข้ากันได้ (Major Test) โดยเฉพาะ
ระยะเวลาสูงสุดในการขนส่งถึงการเก็บรักษาคือ 4 ชั่วโมงที่อุณหภูมิ 2 - 21 °C ต้องเก็บตัวอย่างโดยตั้งให้ตรงไว้ในตู้เย็นนานอย่างน้อย 16 ชั่วโมงเพื่อให้เซลล์ตกตะกอน หลังจากนั้น สามารถนําสารที่วิเคราะห์ข้างต้นไปตรวจวัดปริมาณได้นานถึง 35 วัน ซึ่งเท่ากับระยะเวลาการเก็บรักษาเลือดตามปกติในตู้เย็น (2 6 °C) (ยกเว้นการทดสอบ Coombs โดยตรงที่เก็บได้เพียง 10 วัน) เหมาะสําหรับการตรวจคัดกรองแอนติบอดีตอ่ แอนติเจนของเม็ดเลือดแดงด้วยวิธี Column Agglutination เช่น โดยใช้เครื่องอัตโนมัติ Vision Max ของ Ortho Clinical Diagnostics เป็นต้น ห้ามนําวัสดุตัวอย่างไปแช่แข็ง
ผู้ใช้ต้องรับผิดชอบและตรวจสอบความเหมาะสมของวัสดุตัวอย่างกับการตรวจวิเคราะห์เหล่านี้ด้วยวิธี สารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบ เครื่องมือวิเคราะห์ และเงื่อนไขการจัดเก็บวัสดุตัวอย่างอื่นๆ
ซิเตรตทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด
กรุณาดูหมายเหตุภายใต้หัวข้อ การเก็บตัวอย่างและการจัดการ สําหรับการใช้งาน S-Monovette® CPDA ร่วมกับหัวเข็มแบบมีปีก

S-Monovette® ThromboExact ของ SARSTEDT
S-Monovette® ThromboExact มีเกลือแมกนีเซียมเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วน** เกลือแมกนีเซียมอยู่ในรูปของเหลวที่พ่นออกมา
เลือดครบส่วนใน S-Monovette® ThromboExact เป็นวัสดุตัวอย่างที่ใช้สําหรับการไม่นับรวมจํานวนเกล็ดเลือดที่ต่ําเกินไปซึ่งเกิดจากการนับผิดเพราะเลือดไม่ทนต่อสารป้องกันการแข็งตัวเป็นลิ่มของเลือด (เช่น EDTA ซิเตรต เฮพาริน) หรือเรียกอีกอย่างว่า เครื่องนับถูกหลอก (pseudothrombocytopenia) การรวมตัวกันของเกล็ดเลือดจะถูกขัดขวางและทําให้สามารถนับจํานวนเกล็ดเลือดได้อย่างถูกต้องนานถึง 12 ชั่วโมงหลังจากการเจาะเลือด
ไอออนแมกนีเซียมยับยั้งการแข็งตัวเป็นลิ่มของเลือด โดยที่ไอออนแมกนีเซียมจะยับยั้งทรอมบอกเซน A2 ของเกล็ดเลือด รวมทั้งการเกาะกลุ่มของเกล็ดเลือดที่เกิดจาก ADP และกรดอะราคิโดนิกด้วย

S-Monovette® ฮีรูดีน ของ SARSTEDT
S-Monovette® ฮีรูดีน มีฮีรูดีนเป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วน** ฮีรูดีนอยู่ในรูปของเหลวที่พ่นออกมา
เลือดครบส่วนผสมฮีรูดีนเป็นวัสดุตัวอย่างที่ใช้สําหรับการวินิจฉัยและตรวจสอบการทํางานของเกล็ดเลือดโดยใช้เครื่องมือ Multiplate® (เครื่องวิเคราะห์การทํางานต่างๆ ของเกล็ดเลือด) ของบริษัท ROCHE Diagnostics ใช้สําหรับการสังเกตติดตามการรักษาด้วยยายับยั้งเกล็ดเลือดและเพื่อตรวจจับหรือคัดแยก
การทํางานผิดปกติของเกล็ดเลือด
S-Monovette® ฮีรูดีน ถูกพัฒนามาเป็นพิเศษเฉพาะสําหรับการตรวจวัดการทํางานของเกล็ดเลือดโดยใช้งานร่วมกับ Multiplate® ของบริษัท Verum Diagnostica ซึ่งเปลี่ยนชื่อมาเป็น ROCHE Diagnostics ในปัจจุบัน
ฮีรูดีนยับยั้งการแข็งตัวเป็นลิ่มของเลือดโดยการยับยั้งเอนไซม์ทรอมบินโดยตรงและทําให้การวินิจฉัยการทํางานของเกล็ดเลือดอยู่ในสถานะดั้งเดิม

S-Monovette® โฮโมซิสทีน HCY-Z-เจล/HCY-C ของ SARSTEDT
S-Monovette® โฮโมซิสทีน HCY-Z-เจล มีทั้งเม็ดพลาสติกเคลือบสารเร่งการแข็งตัวเป็นลิ่มของเลือด (ซิลิเกต) สารคงความเสถียรพิเศษ และเจลโพลิเมอร์ และใช้สําหรับการสกัดเซรุ่ม** การหมุนเหวี่ยงจะทําให้เจลคั่นแยกก้อนเลือดและเซรุ่มออกจากกันและสร้างชั้นแยกที่เสถียรในระหว่างการขนส่ง การเก็บ
รักษา และการวิเคราะห์ สารเติมแต่งที่จัดเตรียมอยู่ในรูปของเหลวที่พ่นออกมา
โฮโมซิสทีนจะคงความเสถียรได้นานถึง 8 ชั่วโมงในเลือดครบส่วนที่อุณหภูมิห้อง หากทําการหมุนเหวี่ยงภายใน 8 ชั่วโมงแรกและได้ชั้นแยกที่ชัดเจนระหว่างก้อนเลือดกับเซรุ่ม โฮโมซิสทีนจะคงความเสถียรได้นานถึง 96 ชั่วโมง
เซรุ่มใน S-Monovette® โฮโมซิสทีน HCY-Z-เจล เป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวัดปริมาณโฮโมซิสทีน S-Monovette® โฮโมซิสทีน HCY-C มีกรดซิเตรต (ค่าความเป็นกรดหรือเบส (pH) 4.3) เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดพลาสมา** ซิเตรตอยู่ในรูปของสารละลาย
การคํานวณความเข้มข้นของโฮโมซิสทีนต้องคูณด้วย 1.11 เพราะถูกเจือจางไปบ้างแล้ว
โฮโมซิสทีนในเลือดครบส่วนจะคงความเสถียรที่อุณหภูมิห้องได้นานถึง 6 ชั่วโมง และคงความเสถียรที่อุณหภูมิ 4 °C ได้นานถึง 48 ชั่วโมง
พลาสมาใน S-Monovette® โฮโมซิสทีน HCY-C เป็นวัสดุตัวอย่างที่ใช้สําหรับการตรวจวัดปริมาณโฮโมซิสทีน
ซิเตรตทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือดใน S-Monovette® โฮโมซิสทีน HCY-C
กรุณาดูหมายเหตุภายใต้หัวข้อ การเก็บตัวอย่างและการจัดการ สําหรับการใช้งาน S-Monovette® HCY-C ร่วมกับหัวเข็มแบบมีปีก

S-Monovette® DNA Exact ของ SARSTEDT
S-Monovette® DNA Exact มี EDTA เป็นสารป้องกันการแข็งตัวเป็นลิ่มของเลือด และใช้สําหรับการสกัดเลือดครบส่วน** EDTA อยู่ในรูปของเหลวที่พ่นออกมา
เลือดครบส่วนผสม EDTA เป็นวัสดุตัวอย่างที่ใช้สําหรับการคงความเสถียรของ gDNA ประสิทธิภาพในการคงความเสถียรของ gDNA ที่ตรวจวัดได้มีดังต่อไปนี้: 5 วันที่อุณหภูมิ 35 °C 14 วันที่อุณหภูมิห้อง (22 °C) 28 วันที่อุณหภูมิตู้เย็น (4 °C) และอย่างน้อง 1 ปีที่อุณหภูมิ -20 °C นอกจากนี้ตัวอย่างที่เสถียร
จะคงสภาพอยู่ได้ในการเก็บในอุณหภูมิสูงและต่ําสลับกัน 5 รอบโดยที่คุณภาพไม่ลดลง ดูเอกสารแสดงข้อเท็จจริงของ SARSTEDT https://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ บทความเรื่อง "SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood
Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic DNA Analysis"
EDTA ทําให้เกิดสารประกอบเชิงซ้อนของไอออนแคลเซียม ซึ่งจะยับยั้งการแข็งตัวเป็นลิ่มของเลือด

**ความเหมาะสมของวัสดุตัวอย่างขึ้นอยู่กับสารที่วิเคราะห์และตัวกระทําปฏิกิริยาหรือเครื่องมือวิเคราะห์ ต้องปฏิบัติตามคําแนะนําของผู้ผลิตที่เกี่ยวข้อง

220

TH
คําแนะนําด้านความปลอดภัย/คําเตือน
1.

ข้อควรระวังทั่วไป: สวมถุงมือและอุปกรณ์ป้องกันส่วนบุคคลทั่วไปอื่นๆ เพื่อจะป้องกันตนเองจากเลือดและการรับสัมผัสวัสดุตัวอย่างที่อาจแพร่เชื้อโรคได้และเชื้อโรคที่ติดต่อทางเลือด

2.

จัดการกับตัวอย่างทางชีวภาพสําหรับการส่งตรวจทั้งหมดและอุปกรณ์เจาะเลือดที่แหลมคม (หัวเข็ม ตัวปรับ) ตามระเบียบข้อบังคับและขั้นตอนของสถานพยาบาล หากได้รับสัมผัสกับตัวอย่างทางชีวภาพโดยตรงหรือได้รับบาดเจ็บจากการถูกเข็มทิ่ม ให้ไปพบแพทย์ เพราะอาจติดเชื้อ HIV, HCV, HBV หรือโรคติดต่ออื่นๆ ได้ ใช้หัวเข็มนิรภัย/หัวเข็ม Safety-Multifly® ร่วมกับตัวป้องกันเข็มที่ให้มาด้วย ต้องปฏิบัติตามระเบียบข้อบังคับและขั้นตอนด้านความปลอดภัยในสถานพยาบาลเสมอ

3.

ใช้กับผลิตภัณฑ์ปลอดเชื้อที่บรรจุแยกชิ้น: ก่อนการใช้งาน ให้ตรวจสอบความเสียหายของบรรจุภัณฑ์แต่ละชิ้นทุกครั้งและห้ามใช้งานในกรณีที่บรรจุภัณฑ์เสียหาย

4.

ผลิตภัณฑ์นี้มีไว้สําหรับการใช้งานครั้งเดียว ทิ้งวัตถุแหลมคมทั้งหมด (หัวเข็ม ตัวปรับ) ที่ใช้ในการเจาะเลือดลงในภาชนะสําหรับทิ้งสารชีวภาพอันตรายที่เหมาะสม

5.

หากเก็บตัวอย่างเลือดทางสายน้ําเกลือ (IV) ต้องตรวจสอบให้แน่ใจว่าได้ล้างทางเข้าเส้นเลือดเรียบร้อยดีแล้ว (=เอาน้ําเกลือออกให้หมด) อย่างถูกต้องตามข้อกําหนดของสถานพยาบาล ก่อนที่จะทําการเก็บตัวอย่างเลือด การล้างทางเข้าเส้นเลือดอย่างถูกต้องจะป้องกันไม่ให้ผลการวิเคราะห์ผิดพลาด

6.

การเติมเลือดลงใน Monovette® น้อยเกินไปจะทําให้อัตราส่วนของเลือดต่อสารเติมแต่งที่จัดเตรียมผิดพลาดและอาจทําให้ผลการวิเคราะห์ผิดพลาด

7.

ห้ามใช้เลือดที่เจาะและจัดเตรียมด้วย S-Monovette® ฉีดเข้าไปในร่างกายมนุษย์อีกครั้ง

8.

ห้ามใช้ผลิตภัณฑ์หลังจากวันหมดอายุ ผลิตภัณฑ์ใช้งานได้ถึงวันสุดท้ายของเดือนและปีที่ระบุ

การเก็บรักษา
เก็บรักษาผลิตภัณฑ์ไว้ที่อุณหภูมิห้องจนกว่าจะใช้งาน

ข้อจํากัด
1.

ระยะเวลาและอุณหภูมิสําหรับการเก็บรักษาของหลอดเก็บตัวอย่าง S-Monovette® ที่มีเลือดอยู่ขึ้นอยู่กับอายุการใช้งานของสารที่วิเคราะห์ เจ้าหน้าที่ห้องปฏิบัติการจะเป็นผู้ตัดสินหรือใช้ข้อมูลจากคําแนะนําในการใช้งานของผู้ผลิตสารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบ/เครื่องมือวิเคราะห์

2.

ถึงแม้วา่ พลาสมาหรือเซรุ่มจะถูกแยกออกจากเลือดด้วยการหมุนเหวี่ยง S-Monovette® และ/หรือมีตัวกั้น แต่เซลล์ทั้งหมดไม่จําเป็นต้องแยกออกจากกันโดยสมบูรณ์ กระบวนการเมแทบอลิซึมของสารตกค้างหรือการย่อยสลายตามธรรมชาติอาจมีผลต่อความเข้มข้นของสารที่วิเคราะห์ ควรประเมินความ
เสถียรของสารที่วิเคราะห์ตามภาชนะเก็บสารและเงื่อนไขของห้องปฏิบัติการที่ทําการวิเคราะห์

3.

ในกรณีของยารักษาโรค ให้ตรวจสอบความเหมาะสมของวัสดุตัวอย่างตามคําแนะนําในการใช้งานของผู้ผลิตสารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบ/เครื่องวิเคราะห์

4.

การวิเคราะห์จุลธาตุ/โลหะสามารถทําได้โดยใช้ระบบ S-Monovette® การวิเคราะห์โลหะ ร่วมกับหัวเข็มนิรภัย การวิเคราะห์โลหะ

การเก็บตัวอย่างและการจัดการ
กรุณาอ่านและทําความเข้าใจเอกสารนี้อย่างละเอียดก่อนเริ่มทําการเจาะเลือดจากเส้นเลือดดํา
วัสดุที่ต้องใช้ในการเจาะเลือด
1.

ระบบการเจาะเลือด S-Monovette® ทั้งหมดที่ต้องใช้

2.

หัวเข็ม (นิรภัย) หรือหัวเข็ม (นิรภัย) Multifly®

3.

สวมใส่ถุงมือ ผ้ากันเปื้อน อุปกรณ์ปกป้องดวงตา หรือชุดป้องกันอื่นๆ ที่เหมาะสมสําหรับการป้องกันเชื้อโรคที่แพร่กระจายทางเลือดหรือวัสดุที่อาจมีการติดเชื้อ

4.

สติกเกอร์สําหรับการระบุตัวผู้ป่วย

5.

อุปกรณ์ฆา่ เชื้อสําหรับทําความสะอาดตําแหน่งที่จะเจาะเลือด (การเตรียมตําแหน่งที่จะเจาะเลือด ให้ปฏิบัติตามระเบียบข้อบังคับด้านการฆ่าเชื้อในการเจาะเก็บตัวอย่างของสถานพยาบาล) ห้ามใช้สารทําความสะอาดที่มีแอลกอฮอล์ หากต้องการนําตัวอย่างไปใช้ในการทดสอบแอลกอฮอล์ในเลือด

6.

สําลีก้านแบบใช้แล้วทิ้งที่แห้งและปลอดเชื้อ

7.

สายรัด

8.

พลาสเตอร์หรือผ้าพันแผล

9.

ภาชนะสําหรับทิ้งวัตถุแหลมคมสําหรับการทิ้งวัสดุที่ใช้แล้วอย่างปลอดภัย

ลําดับขั้นตอนการเจาะเก็บตัวอย่างที่แนะนํา:1.

ขวดสําหรับการเพาะเชื้อจากเลือด

2.

หลอดที่มีซิเตรตหรือสารเร่งการแข็งตัวเป็นลิ่มของเลือด (มี/ไม่มีเจล เซรุ่ม CAT/เซรุ่ม-เจล CAT)

3.

หลอดที่มีสารเร่งการแข็งตัวเป็นลิ่มของเลือดหรือซิเตรต

4.

หลอดที่มีเฮพารินที่มีเจล/ไม่มีเจล

5.

หลอดที่มี EDTA ที่มีเจล/ไม่มีเจล

6.

หลอดที่มีสารยับยั้งปฏิกิริยาไกลโคไลซิส (การเปลี่ยนเป็นกลูโคส)7.

หลอดที่มีสารเติมแต่งอื่นๆ
หมายเหตุ:หากเริ่มทําการเจาะเลือดโดยใช้หลอดซิเตรตหรือหลอดแบบอื่นที่มีการจัดเตรียมด้วยสารเหลว เช่น PFA, CTAD, CPDA, HCY-C หรือ GlucoEXACT ร่วมกับหัวเข็มแบบมีปีก (เช่น หัวเข็ม (นิรภัย) Multifly®) ขอแนะนําให้เจาะเลือดใส่ในหลอดเปล่า (เช่น S-Monovette® เป็นกลาง Z)
ก่อน เพื่อหลีกเลี่ยงการเติมเลือดลงในหลอดน้อยเกินไปด้วยการเติมเลือดทางท่ออ่อนของหัวเข็มแบบมีปีก
ซึ่งจะรับรองความถูกต้องของปริมาณเลือดในหลอดและทําให้มีอัตราส่วนในการผสม (สารเหลวต่อเลือด) ที่ถูกต้อง

หมายเหตุ:ลําดับขั้นตอนการเจาะเก็บตัวอย่างให้ปฏิบัติตามข้อกําหนดของสถานพยาบาล

หลีกเลี่ยงการไหลย้อนกลับ
S-Monovette ส่วนใหญ่มีสารเติมแต่งทางเคมี เพื่อป้องกันการไหลย้อนกลับ ให้ปฏิบัติตามคําแนะนําต่อไปนี้:1. ใช้วัสดุตามที่คําแนะนําในการใช้งานนี้กําหนดไว้เท่านั้น
2.

จัดตําแหน่งผู้ป่วยให้สามารถมองเห็นทางเข้าเส้นเลือดได้งา่ ยและให้แขนหรือบริเวณที่จะเจาะเลือดของผู้ป่วยหันลงด้านล่าง

3.

จับ S-Monovette® ที่มีฝาเกลียวหันขึ้นด้านบน และเมื่อใช้หัวเข็ม (นิรภัย) Multifly® ร่วมด้วยให้จับหัวเข็มให้อยู่ต่ํากว่าระดับแขน/บริเวณที่จะเจาะเลือด

4.

ต้องตรวจสอบให้แน่ใจว่าส่วนประกอบของ S-Monovette® ไม่สัมผัสกับฝาเกลียวหรือปลายของหัวเข็มในขณะที่ทําการเจาะเลือด

5.

คลายสายรัดเมื่อเลือดไหลเข้าไปใน S-Monovette®

221

TH
การแช่แข็ง/การละลาย
ตามคําแนะนําขององค์การอนามัยโลก (WHO/DIL/Lab/99.1 Rev.02) ต้องแยกเซรุ่ม/พลาสมาออกจากเซลล์เม็ดเลือดก่อนที่จะนําไปแช่แข็ง
สําหรับการแช่แข็ง S-Monovette® ให้ปฏิบัติตามคําแนะนําต่อไปนี้:แช่แข็งที่อุณหภูมิต่ํากว่า 0 °C•ตามหลักการแล้ว ต้องทดสอบการใช้ช่วงอุณหภูมิติดลบภายใต้สภาพตามความเป็นจริง แรงที่กระทําต่อหลอดอาจแตกต่างกันมากตามสารที่จะแช่แข็งและเงื่อนไขตามปกติ (ดูหัวข้อ คุณสมบัติวัสดุ ในแคตตาล็อกของ SARSTEDT)•ตามหลักการแล้ว ค่าความแข็งแกร่งของพลาสติกจะลดลงเมื่อช่วงอุณหภูมิต่ํากว่า 0 °C ดังนั้นจึงควรหลีกเลี่ยงแรงกลต่างๆ

•ต้องเลือกสภาพการแช่แข็งในลักษณะที่สารใน S-Monovette® จะแข็งตัวสม่ําเสมอกันทั่วทั้งหลอดหรือแข็งตัวจากล่างขึ้นบน แท่นวางหรือกล่องเก็บ S-Monovette® ควรมีระยะเว้นว่างพอสมควรเพื่อเผื่อการขยายตัวของหลอด แท่นวางที่ทําจากโฟมหรือโลหะไม่เหมาะสม เพราะอาจทําให้หลอดขยายตัวจน
แตกได้

การแช่แข็งที่อุณหภูมิ -20 °C – ตรวจสอบก่อนทําการแช่แข็ง:•สิ่งรบกวน: ตรวจสอบว่าการแช่แข็งมีสิ่งรบกวนที่ส่งผลต่อตัวอย่างเลือดหรือการวิเคราะห์หรือไม่ (เช่น การแตกสลายของเม็ดเลือดแดง ความเสถียรของสารที่วิเคราะห์)•การหมุนเหวี่ยง: ขึ้นอยู่กับการวิเคราะห์ที่วางแผนว่าจะทํา สําหรับเงื่อนไขในการหมุนเหวี่ยง ให้ดูหัวข้อ "การหมุนเหวี่ยง" ในเอกสารนี้หรือเว็บไซต์ของ SARSTEDT https://www.sarstedt.com/en/service/centrifugation/ และทําการตรวจสอบตัวอย่างด้วยสายตา

•การแตกสลายของเม็ดเลือดแดง: เม็ดเลือดแดงในเลือดครบส่วนจะแตกสลายเมื่อแช่แข็ง: เพื่อหลีกเลี่ยงการแตกสลายของเม็ดเลือดแดง ควรใช้ S-Monovette® เจล หรือใช้ตัวกรองวาล์ว Seraplas® หลังจากการหมุนเหวี่ยง หรือใช้ปิเปตต์ดูดตัวอย่างออกไปใส่ไว้ในอีกหลอดหนึ่ง

การแช่แข็งที่อุณหภูมิ -20 °C – การดําเนินงาน:•การค่อยๆ ทําให้เย็นลง: ทําให้ S-Monovette® เย็นลง โดยตั้งหลอดให้ตรงไว้ที่อุณหภูมิห้องแล้วค่อยๆ ลดอุณหภูมิลงมาที่ +4 °C ในช่วงเวลา 45 - 60 นาที ก่อนที่จะนําไปแช่แข็งที่ -20 °C•

การละลาย: ตั้งหลอดให้ตรงไว้ที่อุณหภูมิห้องแล้วปล่อยให้ละลายประมาณ 45 นาที ต้องหลีกเลี่ยงแรงกลด้วยเช่นกัน การละลายที่เร็วเกินไปจะทําให้ผลการวิเคราะห์ผิดพลาด

การแช่แข็งและการแช่เยือกแข็งที่อุณหภูมิต่ํากว่า -20 °C•

ผู้ผลิตไม่ได้ทําการทดสอบการแช่เยือกแข็งที่อุณหภูมิต่ํากว่า -20 °C เนื่องจากมีหลายปัจจัยที่อาจส่งผลกระทบ ขอแนะนําให้ทําการทดสอบการแช่แข็งภายใต้สภาพของห้องปฏิบัติการตามปกติ

การแช่แข็ง S-Monovette® เจล:•การแช่แข็งเป็นไปตามหัวข้อ การแช่แข็งที่อุณหภูมิ -20 °C – การดําเนินงาน:•เป็นที่ทราบกันว่า ชั้นเจลอาจเปลี่ยนแปลงเนื่องจากกระบวนการแช่แข็ง

•เนื่องจากมีหลายปัจจัยที่อาจส่งผลกระทบ ขอแนะนําให้ทําการทดสอบการแช่แข็งภายใต้สภาพของห้องปฏิบัติการตามปกติ

•การละลาย: ตั้งหลอดเก็บตัวอย่างให้ตรงแล้วปล่อยให้ละลาย หลังจากละลายแล้ว ให้ถา่ ยวัสดุตัวอย่างออกจากหลอดหลักไปยังอีกหลอดหนึ่งโดยใช้ปิเปตต์ดูด (ไม่ใช้การเท) โดยให้ตัวอย่างอยู่สูงกว่าชั้นเจลประมาณ 2 มม. ทิ้งส่วนที่เหลือ
หมายเหตุ: เพื่อความเสถียรของสารที่วิเคราะห์ ให้ปฏิบัติตามคําแนะนําในการใช้งานของผู้ผลิตสารที่ใช้เป็นตัวกระทําปฏิกิริยาในการทดสอบ/เครื่องมือวิเคราะห์

222

TH
การเจาะเลือด
เทคนิคการเจาะเลือด
การเจาะเลือดมีเทคนิคที่แตกต่างกันอยู่สองแบบ ได้แก่ เทคนิคการดูดเลือด และเทคนิคสุญญากาศ
เทคนิคการดูดเลือดสามารถเก็บตัวอย่างเลือดได้อย่างนุ่มนวล ซึ่งเลือดจะไหลช้าๆ อย่างต่อเนื่องเข้าไปในหลอดโดยการค่อยๆ ดึงก้านสูบอย่างเบามือ วิธีสามารถปรับการไหลของเลือดให้สอดคล้องกับขนาดเส้นเลือดดําและสถานการณ์ได้ทันที และช่วยลดการแตกสลายของเม็ดเลือดแดง
เทคนิคสุญญากาศเก็บตัวอย่างเลือดโดยใช้หลอดที่ไล่อากาศออกหมดก่อนแล้วตามหลักการแรงดันลบ ซึ่งเลือดจะไหลอย่างรวดเร็วและต่อเนื่องเข้าไปในหลอด ดังนั้นเทคนิคนี้จึงเหมาะอย่างยิ่งกับเส้นเลือดดําขนาดใหญ่และสถานการณ์ท่เี จาะเลือดได้งา่ ยการจัดการกับการเจาะลือด: กรุณาดูวิดีโอสาธิตการจัดการกับ S-Monovette® ด้วยเทคนิคการดูดเลือดหรือเทคนิคสุญญากาศโดยใช้ร่วมกับหัวเข็มนิรภัยหรือหัวเข็ม Safety-Multifly®:www.sarstedt.com/en/download/videos/Diagnostics/Venous bloodสวมถุงมือเพื่อลดความเสี่ยงในการรับผัสในระหว่างการเจาะเลือดให้เหลือน้อยที่สุด
1. เลือกใช้ S-Monovette® ที่เหมาะสมกับตัวอย่างที่จะเก็บ
2.

เลือกตําแหน่งที่จะเจาะเลือด สําหรับการเตรียมตําแหน่งที่จะเจาะเลือด ให้ปฏิบัติตามระเบียบข้อบังคับของสถานพยาบาล

การเจาะเลือดด้วยเทคนิคการดูดเลือด
ระวัง! S-Monovette® ใช้สําหรับการเจาะเลือดเท่านั้น ไม่ใช้สําหรับการฉีด
ใช้ร่วมกับหัวเข็ม (หัวเข็ม (นิรภัย) S-Monovette® หรือหัวเข็ม (นิรภัย) Multifly®/ตัวปรับสําหรับ S-Monovette®) เท่านั้น
การใช้งานร่วมกับหัวเข็มนิรภัยแสดงไว้ที่นี่:คลิกทันทีก่อนการเจาะเลือด ให้เลื่อน S-Monovette® เข้าไปในส่วนยึดในตัวของหัวเข็มนิรภัย และยึดให้เรียบร้อยด้วย การหมุนเบาๆ ตามเข็มนาฬิกา
มัดสายรัดตามความต้องการ (ไม่เกิน 1 นาที) เตรียมตําแหน่งที่จะเจาะเลือดด้วยการใช้น้ํายาฆ่าเชื้อที่เหมาะสม ห้ามสัมผัสตําแหน่งที่จะทําการเจาะเลือดอีกต่อไปหลังจากการฆ่าเชื้อแล้ว จัดตําแหน่งผู้ป่วยให้สามารถมองเห็นทางเข้าเส้นเลือดได้งา่ ยและให้แขนหรือบริเวณที่จะเจาะเลือดของผู้ป่วย
หันลงด้านล่าง
เปิดตัวป้องกันเข็มออก แทงเข็มเข้าไปในเส้นเลือด ดึงก้านสูบไปด้านหลังช้าๆ แล้วคลายสายรัดเมื่อเลือดไหลเข้าไปใน S-Monovette®
รอจนกว่าเลือดจะหยุดไหลเพื่อให้ได้เลือดในปริมาณที่ถูกต้อง

ถอด S-Monovette® ออกด้วยการ หมุนเบาๆ ทวนเข็มนาฬิกา แล้วดึงออกจากหัวเข็มนิรภัย (ถอดการเชื่อมต่อ) หัวเข็มนิรภัยจะยังคงเสียบอยู่ในเส้นเลือด
ในการเจาะเลือดหลายครั้ง ให้เชื่อมต่อ S-Monovette อันถัดไปเข้ากับหัวเข็มนิรภัยตามคําอธิบายที่แสดงไว้ขา้ งต้น แล้วทําการเก็บตัวอย่างเลือดต่อไป
การสิ้นสุดการเจาะเลือด: ขั้นแรกให้ถอด S-Monovette® ออกก่อน + แล้วจากนั้นให้ดึงเข็มนิรภัยออกจากเส้นเลือด ใช้เทคนิคมือเดียวในการปิดตัวป้องกันเข็ม โดยยันกับพื้นผิวที่แน่นเรียบจนกว่าตัวป้องกันเข็มจะปิดเข็มมิดทั้งหมด (เปิดใช้งาน) ซึ่งจะ รู้สึกและได้ยินเสียง "คลิก" หรือเปิดใช้
งานตัวป้องกันเข็มโดยใช้นิ้วชี้กดลงไปที่ปลายด้านล่างของตัวป้องกันเข็ม ดูคําแนะนําในการใช้งานของหัวเข็ม (นิรภัย) S-Monovette® หรือหัวเข็ม (นิรภัย) Multifly® เพิ่มเติม
หมุน S-Monovette® กลับไปกลับมา 1 รอบทันทีที่ถอดออกจากหัวเข็มนิรภัย และหลังจากเจาะเลือดเสร็จแล้ว ให้หมุนตัวอย่างเลือดครบส่วนกลับไปกลับมาเบาๆ สามสี่รอบเพื่อให้ตัวอย่างเลือดผสมเข้ากับสารป้องกันการแข็งตัวเป็นลิ่มของเลือดอย่างทั่วถึง
สําหรับการขนส่งและการหมุนเหวี่ยง ให้ดึงก้านสูบเข้าไปในตําแหน่งล็อกของลูกสูบจนได้ยินเสียงคลิก (ลูกสูบล็อกอยู่ในฐานของ S-Monovette®) แล้วหักก้านสูบทิ้ง
1.

กดตําแหน่งที่เจาะเลือดไว้ด้วยสําลีที่แห้งและปลอดเชื้อจนกว่าเลือดจะหยุดไหล

2.

เมื่อเลือดเริ่มแข็งตัวเป็นลิ่มหรือแห้ง ให้ใช้พลาสเตอร์ปิดแผลตามต้องการ

3.

ทิ้งหัวเข็มนิรภัยลงในภาชนะสําหรับทิ้งสารชีวภาพอันตรายที่เหมาะสม

223

TH
การเจาะเลือดด้วยเทคนิคสุญญากาศ
ระวัง! S-Monovette® ใช้สําหรับการเจาะเลือดเท่านั้น ไม่ใช้สําหรับการฉีด
ใช้ร่วมกับหัวเข็ม (หัวเข็ม (นิรภัย) S-Monovette® หรือหัวเข็ม (นิรภัย) Multifly®/ตัวปรับสําหรับ S-Monovette®) เท่านั้น
การใช้งานร่วมกับหัวเข็มนิรภัยแสดงไว้ที่นี่:คลิกเพื่อเริ่มการเจาะเลือดอย่างนุ่มนวล SARSTEDT ขอแนะนําว่าให้เจาะเลือดใส่ไว้ใน S-Monovette® อันแรกโดยใช้เทคนิคการดูดเลือด ดูเทคนิคการเจาะเลือด เทคนิคการดูดเลือด
จากนั้นให้ดําเนินการต่อโดยใช้เทคนิคสุญญากาศ
ก่อนการเจาะเลือดด้วยก้านสูบ ให้ดึงลูกสูบให้ถึงฐานของ S-Monovette® จนกว่าจะได้ยินเสียงคลิก จากนั้นให้หักก้านสูบทิ้ง

เลื่อน S-Monovette® ที่เตรียมไว้แล้วเข้าไปในส่วนยึดในตัว S-Monovette® ของหัวเข็มนิรภัย และยึดให้เรียบร้อยด้วย การหมุนเบาๆ ตามเข็มนาฬิกา

-+รอจนกว่าเลือดจะหยุดไหลเพื่อให้ได้เลือดในปริมาณที่ถูกต้อง

ถอด S-Monovette® ออกด้วยการ หมุนเบาๆ ทวนเข็มนาฬิกา แล้วดึงออกจากหัวเข็มนิรภัย (ถอดการเชื่อมต่อ) หัวเข็มนิรภัยจะยังคงเสียบอยู่ในเส้นเลือด
ในการเจาะเลือดหลายครั้ง ให้เชื่อมต่อ S-Monovette อันถัดไปเข้ากับหัวเข็มนิรภัยก่อนตามคําอธิบายที่แสดงไว้ขา้ งต้น แล้วทําการเก็บตัวอย่างเลือดต่อไป
การสิ้นสุดการเจาะเลือด:ถอด S-Monovette® ออกก่อน + แล้วจากนั้นให้ดึงเข็มนิรภัยออกจากเส้นเลือดดํา ใช้เทคนิคมือเดียวในการปิดตัวป้องกันเข็ม โดยยันกับพื้นผิวที่แน่นเรียบจนกว่าตัวป้องกันเข็มจะปิดเข็มมิดทั้งหมด (เปิดใช้งาน) ซึ่งจะ รู้สึกและได้ยินเสียง "คลิก" หรือเปิดใช้งานตัวป้องกันเข็มโดยใช้นิ้วชี้กด
ลงไปที่ปลายด้านล่างของตัวป้องกันเข็ม
หมุน S-Monovette® กลับไปกลับมา 1 รอบทันทีที่ถอดออกจากหัวเข็มนิรภัย และหลังจากเจาะเลือดเสร็จแล้ว ให้หมุนตัวอย่างเลือดครบส่วนกลับไปกลับมาเบาๆ สามสี่รอบเพื่อให้ตัวอย่างเลือดผสมเข้ากับสารป้องกันการแข็งตัวเป็นลิ่มของเลือดอย่างทั่วถึง
1.

กดตําแหน่งที่เจาะเลือดไว้ด้วยสําลีที่แห้งและปลอดเชื้อจนกว่าเลือดจะหยุดไหล

2.

เมื่อเลือดเริ่มแข็งตัวเป็นลิ่มหรือแห้ง ให้ใช้พลาสเตอร์ปิดแผลตามต้องการ

3.

ทิ้งหัวเข็มนิรภัยลงในภาชนะสําหรับทิ้งสารชีวภาพอันตรายที่เหมาะสม

224

TH
การหมุนเหวี่ยง
ระวัง! S-Monovette ของ SARSTEDT ถูกออกแบบมาสําหรับการหมุนเหวี่ยงที่ 4,000 x g ยกเว้น S-Monovette ที่มีเส้นผ่าศูนย์กลาง 8 มม. (S-Monovette® กุมารเวชศาสตร์) ซึ่งหมุนเหวี่ยงได้ถึง 2,500 x g เท่านั้น ใช้หลอดรองรับหรือภาชนะที่เหมาะสมเท่านั้น การหมุนเหวี่ยงของ S-Monovette ที่มีรอยแตกร้าว
หรือการหมุนเหวี่ยงที่มีแรงหนีศูนย์กลางในการหมุนเหวี่ยงสูงเกินไปอาจทําให้ S-Monovette แตกและปล่อยสารที่อาจแพร่เชื้อโรคออกมา
ต้องเลือกภาชนะใส่หลอดสําหรับการหมุนเหวี่ยงตามขนาดของ S-Monovette ที่ใช้ แรงหนีศูนย์กลางสัมพัทธ์มีความสัมพันธ์ดังต่อไปนี้ คือเป็นรอบการหมุน/นาที:RCF = 11.2 x r x (RPM/1000)2"RCF": "แรงหนีศูนย์กลางสัมพัทธ์" หรือเรียกอีกอย่างว่า "แรง g" (ภาษาอังกฤษ: RCF หรือ "relative centrifugal force")"RPM": "รอบการหมุนต่อนาที" (รอบ/นาที) หรือ n = "จํานวนรอบต่อนาที" (ภาษาอังกฤษ: RPM หรือ "revolutions per minute")"r": "รัศมีในการหมุนจากจุดศูนย์กลางของเครื่องหมุนเหวี่ยงถึงส่วนล่างสุดของ S-Monovette®" (ซม.)
S-Monovette ที่ไม่มีเจล สามารถหมุนเหวี่ยงได้ในเครื่องหมุนเหวี่ยงที่มีตัวหมุนแบบมุมเอียงคงที่หรือมีตัวหมุนแบบเหวี่ยงออก
S-Monovette ที่มีเจล สามารถหมุนเหวี่ยงได้ในเครื่องหมุนเหวี่ยงที่มีตัวหมุนแบบเหวี่ยงออกเท่านั้น การหมุนเหวี่ยงในเครื่องหมุนเหวี่ยงที่มีตัวหมุนแบบมุมเอียงคงที่ ไม่ได้รับการตรวจสอบความถูกต้องจาก SARSTEDT และไม่แนะนําให้ทํา
ควรหมุนเหวี่ยง S-Monovette ตามเงื่อนไขการหมุนเหวี่ยงที่แสดงไว้ดา้ นล่าง หากใช้เงื่อนไขอื่น ผู้ใช้ต้องตรวจสอบความถูกต้องของเงื่อนไขนั้นๆ เองต้องตรวจสอบให้แน่ใจว่า S-Monovette ใส่ได้แน่นพอดีกับภาชนะใส่หลอดสําหรับการหมุนเหวี่ยง S-Monovette ที่ยื่นออกมาเกินภาชนะใส่หลอดอาจเข้าไปชนกับส่วนบนของเครื่องหมุนเหวี่ยงและแตกได้ ต้องใส่หลอดลงในเครื่องหมุนเหวี่ยงให้สมดุลเท่าๆ กัน ดังนั้นกรุณาปฏิบัติตามคําแนะนําในการใช้งานของ
เครื่องหมุนเหวี่ยง
ข้อควรระวัง! อย่าใช้มือหยิบ S-Monovette ที่แตกออก
ดูคําแนะนําในการฆ่าเชื้อโรคเครื่องหมุนเหวี่ยงได้ในคําแนะนําในการใช้งานของเครื่องหมุนเหวี่ยง

สีฝาเป็นไปตาม
มาตรฐาน BS 4851+(กฎหมายของสหภาพ
ยุโรป)–

ความเร่งในการหมุนเหวี่ยงสัมพัทธ์ (g)S-Monovette®

DIN EN ISO 6710

2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*เซรุ่ม

10 นาที

10 นาที

6 นาที

4 นาที

4 นาที

เซรุ่ม-เจล

15 นาที

10 นาที

4 นาที

4 นาที

4 นาที

เซรุ่ม เอ็กซ์เพรส เจล

15 นาที

10 นาที

4 นาที

ไม่ตรวจ

ไม่ตรวจ

ลิเทียม-เฮพาริน

10 นาที

10 นาที

7 นาที

7 นาที

7 นาที

ลิเทียม-เฮพาริน-เจล

15 นาที

15 นาที

10 นาที

7 นาที

7 นาที

ลิเทียม-เฮพาริน-เจล+

8 นาที

7 นาที

5 นาที

4 นาที

4 นาที

EDTA

ไม่ตรวจ

ไม่ตรวจ

7 นาที

6 นาที

5 นาที

EDTA-เจล

15 นาที

10 นาที

10 นาที

7 นาที

7 นาที

ซิเตรต

9 นาที

8 นาที

7 นาที

6 นาที

5 นาทีEDTA ฟลูออไรด์-เฮพาริน

9 นาที

8 นาที

7 นาที

6 นาที

5 นาที

GlucoEXACT

9 นาที

8 นาที

7 นาที

6 นาที

5 นาที

ซิเตรต PBM 1.8 มล.
รัศมีการหมุนเหวี่ยง > 17 ซม.

9 นาที

8 นาที

7 นาที

6 นาที

5 นาที

ซิเตรต PBM 1.8 มล.
รัศมีการหมุนเหวี่ยง > 9 ถึง ≤ 17 ซม.

ไม่ตรวจ

ไม่ตรวจ

10 นาที

ไม่ตรวจ

ไม่ตรวจ

ไม่ตรวจ = ไม่ได้ตรวจสอบความถูกต้อง
* ใช้สําหรับ S-Monovette ทั้งหมดที่ไม่ได้มีเส้นผ่าศูนย์กลาง 8 มม. (S-Monovette กุมารเวชศาสตร์)การหมุนเหวี่ยงที่ 20 °C+

ข้อมูลจากมาตรฐานอังกฤษ BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry, เพิกถอน.

ข้อมูลเกี่ยวกับวัสดุแยกสาร
คุณสมบัติการไหลของวัสดุแยกสาร (เจล) ขึ้นอยู่กับอุณหภูมิ หาก S-Monovette ถูกทําให้เย็นลงก่อนหรือระหว่างการหมุนเหวี่ยง จะไม่รับประกันชั้นที่ต่อเนื่องของเจลแยกสารอีกต่อไป
ห้ามนํา S-Monovette ไปหมุนเหวี่ยงใหม่/หมุนเหวี่ยงซ้ําอีกครั้ง

การทิ้ง
1.

ต้องศึกษาและปฏิบัติตามแนวทางปฏิบัติดา้ นสุขอนามัยทั่วไปและข้อกําหนดของกฎหมายสําหรับการทิ้งวัสดุติดเชื้ออย่างถูกต้อง

2.

การสวมถุงมือแบบใช้ครั้งเดียวจะช่วยป้องกันความเสี่ยงในการติดเชื้อ

3.

ต้องทิ้งระบบการเจาะเลือดที่มีการปนเปื้อนหรือใส่เลือดแล้วลงในภาชนะสําหรับทิ้งสารชีวภาพอันตรายที่เหมาะสมซึ่งสามารถนําไปอบฆ่าเชื้อและเผาทําลายในภายหลังได้

4.

ต้องทิ้งโดยใช้เตาเผาหรือใช้การอบฆ่าเชื้อ (การนึ่งฆ่าเชื้อ) ที่เหมาะสม

225

TH
มาตรฐานและระเบียบข้อบังคับเฉพาะสําหรับผลิตภัณฑ์ที่ใช้CLSI* GP39 "Tubes and Additives for Venous and Capillary Blood Specimen Collection", Approved Standard
CLSI* GP41 "Collection of Diagnostic Venous Blood Specimens", Approved Standard
CLSI* GP44 "Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests", Approved Guideline
CLSI* H21 "Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays", Approved Guideline
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002".

มาตรฐานของหลอดสําหรับการเจาะเลือดจากเส้นเลือดดํา:DIN EN ISO 6710: หลอดแบบใช้ครั้งเดียวสําหรับการเจาะเลือดจากเส้นเลือดดําของมนุษย์*CLSI (Clinical and Laboratory Standards Institute)สัญลักษณ์และรหัสระบุ:รหัสสินค้า

ใช้กับผลิตภัณฑ์ปลอดเชื้อที่บรรจุแยกชิ้นด้วย

หมายเลขรุ่นที่ผลิต

ห้ามนํามาใช้หากบรรจุภัณฑ์เสียหาย

ใช้ได้จนถึง

ระบบป้องกันปลอดเชื้อแบบชั้นเดียวที่มีบรรจุภัณฑ์ป้องกันด้านนอก

สัญลักษณ์ CEการฆ่าเชื้อด้วยการฉายรังสี

การตรวจวินิจฉัยในหลอดทดลอง

กรุณาดูคําแนะนําในการใช้งาน

ในกรณีการนํากลับมาใช้ซ้ํา: อันตรายจากการปนเปื้อน

เก็บให้พ้นแสงแดด

เก็บไว้ในที่แห้ง

ผู้ผลิต

ประเทศที่ผลิต

ภาชนะเก็บของเหลวปลอดเชื้อ

ห้ามทําให้ปลอดเชื้ออีกครั้ง

สงวนสิทธิ์ในการดัดแปลงทางเทคนิค
หากพบอุบัติการณ์ร้ายแรงใดๆ ที่เกี่ยวข้องกับผลิตภัณฑ์ จะต้องแจ้งให้ผู้ผลิตและผู้มีหน้าที่กํากับดูแลผลิตภัณฑ์ในประเทศของท่านทราบ

226

.XOODQêPL×LQWDOLPDWODUş6$567('760RQRYHWWH® Kan alma sistemi

TR

In vitroGLDJQRVWLNNXOODQêPL×LQGLU.XOODQêPDPDFê
S-Monovette®NDQDOPDVLVWHPOHULWRSODUGDPDUODUGDQNDQDOPDNL×LQLåQHOHUYHDGDSWąUOHUOHELUOLNWHNXOODQêOêU60RQRYHWWH® kan alma sistemleri klinik laboratuvarlarda in vitroVHUXPSOD]PDYH\DWDPNDQWDQêWHVWOHULQH
\ąQHOLNNDQąUQHNOHULQLDOPDNWDĒêPDNLĒOHPHNYHGHSRODPDNDPDFê\ODNXOODQêOêU%XĞUĞQVDåOêNPHVOHåLPHQVXSODUêYHODERUDWXYDUSHUVRQHOLWDUDIêQGDQSURIHV\RQHORUWDPGDNXOODQêOPDNĞ]HUHWDVDUODQPêĒWêU¶UĞQD×êNODPDVê
S-Monovette®NDQDOPDVLVWHPOHULSODVWLNELUDGHWNDS WĞS ELUSLVWRQELUSLVWRQ×XEXåXYH60RQRYHWWH® 6DIHW\ LåQH\HYH\D 6DIHW\ 0XOWLIO\®LåQH\HEDåODQPDVêL×LQą]HORODUDNJHOLĒWLULOPLĒHQWHJUHPHPEUDQDVDKLSUHQNNRGOXSODVWLNELUDGHWYLGDOêNDSDNYHD\UêFDPXKWHOLINDWNêPDGGHOHULQGHQ L×HULN PH\GDQDJHOPHNWHGLU+L×ELUNDWNêPDGGHVLL×HUPH\HQELU60RQRYHWWH® de mevcuttur. S-Monovette®SêKWêODĒPDDNWLYDWąUĞMHOOL
SêKWêODĒPDDNWLYDWąUĞOLW\XPKHSDULQMHOOLOLW\XPKHSDULQVRG\XPKHSDULQVLWUDW('7$IORUĞU('7$IORUĞUKHSDULQIORUĞUVLWUDWYH&3'$NDWNêPDGGHVLL×HUHQNDQDOPDVLVWHPOHULROGXåXJLELNDWNêPDGGHVLL×HUPH\HQNDQ
DOPDVLVWHPOHULGHNDWNêPDGGHVLNRQVDQWUDV\RQODUêVêYêNDWNêPDGGHOHULQLQKDFPLYHL]LQYHULOHQWROHUDQVODUêLOHNDQêQNDWNêPDGGHVLQHRUDQêEDNêPêQGDQ',1(1,62ŗ6LQJOHXVHFRQWDLQHUVIRUYHQRXVEORRGVSHFLPHQFROOHFWLRQŘXOXVODUDUDVêVWDQGDUGêQêQJHUHNOLOLNYHWDYVL\HOHULQHYH.OLQLNYH/DERUDWXYDU6WDQGDUWODUê(QVWLWĞVĞ2QD\Oê6WDQGDUWODUê QD &/6, X\JXQGXU.DWNêPDGGHVLVH×LPLDQDOLWLNWHVW\ąQWHPLQHEDåOêGêU%X\ąQWHPWHVWUHDNWLIOHULQLQYHYH\DWHVWLQJHU×HNOHĒWLULOGLåLDQDOL]FLKD]êQêQĞUHWLFLVLWDUDIêQGDQEHOLUOHQLU60RQRYHWWH®NDQDOPDVLVWHPLL×LVWHULOYH\DD\UêD\UêSDNHWOHQPLĒL×LYHGêĒêVWHULORODUDNWHPLQHGLOHELOLUS-Monovette®YLGDOêNDSDNODUêQUHQNNRGODUê.DWNêPDGGHVLHarf kodu

DIN EN ISO 6710 kapakrengi

BS 4851+VWDQGDUGêQêHVDValan kapak rengi

Z

beyaz

beyaz

.DWNêVê]'Ğ]7ĞS
S-Monovette® Düz Z
Serum Tüpü
S-Monovette®VHUXP&$73êKWêODĒPDDNWLYDWąUOĞ

CATNêUPê]ê

beyaz

S-Monovette®VHUXPMHO&$73êKWêODĒPDDNWLYDWąUOĞYHMHOOLCAT

NR\XVDUê

NR\XVDUê

S-Monovette®VHUXP([SUHVVMHO&$73êKWêODĒPDDNWLYDWąUOĞWURPELQYHMHOOL

CAT

turuncu-

S-Monovette® lityum heparin LH, Lityum heparinli

LH

\HĒLO

turuncu

S-Monovette®OLW\XPKHSDULQVêYê/+/LW\XPKHSDULQOL

LH

\HĒLO

turuncu

S-Monovette® lityum heparin jel LH, Lityum heparinli ve jelli

LH

\HĒLO

turuncu

S-Monovette® lityum heparin jel+/+/LW\XPKHSDULQOLYHKê]OêMHOOL

LH

\HĒLO

turuncu

S-Monovette® sodyum heparin NH, Sodyum heparinliNHkahverengi\HĒLOS-Monovette® amonyum heparin AH, Amonyum heparinli

t.d.

mavi

mavi

9NC

mavi

\HĒLO

9NC

D×êNPDYL-

S-Monovette®.('7$.(3RWDV\XP('7$ Oê

K3E

mor

NêUPê]ê

S-Monovette®.('7$.(3RWDV\XP('7$ Oê

K2E

mor

NêUPê]ê

S-Monovette® K2 EDTA jel K2E, Potasyum EDTA ve jelli

K2E

mor

NêUPê]ê

S-Monovette®ĲRUĞU('7$)()ORUĞUYH('7$ Oê

FE

gri

VDUê

S-Monovette®ĲRUĞU+HSDULQ)+)ORUĞUYHKHSDULQOL

FH

-

VDUê

S-Monovette®*OXFR(;$&7)&)ORUĞUVLWUDWYH('7$ Oê

FC

pembe

gri

LH

koyu mavituruncu

S-Monovette®7KURPER([DFW0DJQH]\XPELOHĒLNOL

t.d.

t.d., bordot.d., bordo

S-Monovette® CTADt.d.

t.d., mavi

WG\HĒLOS-Monovette® ACD

ACD

VDUê

VDUê

S-Monovette® CPDA

CPDA

VDUê

VDUê

S-Monovette® hirudint.d.

WG]H\WLQ\HĒLOL

WG]H\WLQ\HĒLOL

Heparin Tüpü

Sitrat Tüpü
S-Monovette® Cssitrat 9NC, Sodyum sitrat %3,13®

S-Monovette PFA, Cssitrat 9NC, Sodyum sitrat %3,8 tamponlu
EDTA Tüpü*OLNROL]QKLELWąUOĞ7ĞS

Metal Analizi Tüpü
S-Monovette® metal analizi LH, Lityum heparinli'LåHU7DP.DQYH3OD]PD7ĞSOHUL

S-Monovette® homosistein HCY-Z Jel, Jel ve stabilizatörlüt.d.

t.d., grit.d., griS-Monovette® homosistein HCY-C, Sitrat tamponlut.d.

t.d., mort.d., mor

S-Monovette® DNA Exactt.d.

t.d., mavit.d., mavi

%DĒNDYLGDNDSDåêUHQNOHULEXOXQPDNWDGêUWGWDQêPOêGHåLO
+British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistryJHUL×HNLOPLĒ

227

TR
SARSTEDT S-Monovette®VHUXP&$7VHUXPMHO&$7
S-Monovette®VHUXP&$7WĞSĞSêKWêODĒPDDNWLYDWąUĞ VLOLNDW LOHNDSODQPêĒSODVWLNWDQHFLNOHUL×HULUYHVHUXPXQHOGHHGLOPHVLQGHNXOODQêOêU 6DQWULIĞMOHPH\DSêOGêåêQGDVą]NRQXVXSODVWLNWDQHFLNOHUSêKWêODĒPêĒNDQLOHVHUXPDUDVêQGDNDOêU
S-Monovette®VHUXPMHO&$7WĞSĞSêKWêODĒPDDNWLYDWąUĞ VLOLNDW LOHNDSODQPêĒSODVWLNWDQHFLNOHULQ\DQêVêUDSROLPHUHVDVOêELUMHOL×HULUYHVHUXPXQHOGHHGLOPHVLQGHNXOODQêOêU 6DQWULIĞMOHPH\DSêOGêåêQGDVą]NRQXVXMHO
SêKWêODĒPêĒNDQLOHVHUXPDUDVêQGDNDODUDNWDĒêPDVDNODPDYHDQDOL]VêUDVêQGDVWDELOELUD\êUPDWDEDNDVêROXĒWXUXU6HUXPUXWLQNOLQLNNLP\DYHLPPĞQRORMLWHVWOHULLOHVHURORMLGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU.DQêDOGêNWDQVRQUDVDQWULIĞJDV\RQDPĞWHDNLSL\LEHOLUOHQPLĒ\DWD\ELUD\êUPDWDEDNDVêQêQROXĒPDVêQêVDåODPDNDPDFê\OD60RQRYHWWH® serum CAT / serum jel CAT tüp içindeki kan dik konumda 30 dakika süreyleSêKWêODĒPDOêGêU7DYVL\HHGLOHQVĞUHER]XOPDL×HUPH\HQELUSêKWêODĒPDVĞUHFLQHGD\DQPDNWDGêU+DVWDOêNODLOLĒNLOLSêKWêODĒPDER]XNOXNODUêRODQYH\DDQWLNRDJĞODQWHGDYLJąUHQKDVWDODUGDQDOêQDQNDQêQWDPDPHQSêKWêODĒPDVêdaha fazla zaman alabilir.

SARSTEDT S-Monovette®VHUXP([SUHVVMHO&$7
S-Monovette®VHUXP([SUHVVMHO&$7WĞSĞSêKWêODĒPDDNWLYDWąUĞ WURPELQ LOHNDSODQPêĒSODVWLNWDQHFLNOHULQ\DQêVêUDSROLPHUHVDVOêELUMHOL×HULUYHVHUXPXQHOGHHGLOPHVLQGHNXOODQêOêU 6DQWULIĞMOHPH\DSêOGêåêQGDVą]
NRQXVXMHOSêKWêODĒPêĒNDQLOHVHUXPDUDVêQGDNDODUDNWDĒêPDVDNODPDYHDQDOL]VêUDVêQGDVWDELOELUD\êUPDWDEDNDVêROXĒWXUXU
.DQêDOGêNWDQVRQUDVDQWULIĞJDV\RQDPĞWHDNLSL\LEHOLUOHQPLĒ\DWD\ELUD\êUPDWDEDNDVêQêQROXĒPDVêQêVDåODPDNDPDFê\OD60RQRYHWWH®VHUXP([SUHVVMHOWĞSL×LQGHNLNDQGLNNRQXPGDGDNLNDVĞUH\OHSêKWêODĒPDOêGêU
7DYVL\HHGLOHQVĞUHER]XOPDL×HUPH\HQELUSêKWêODĒPDVĞUHFLQHGD\DQPDNWDGêUYHKHSDULQYHULOPLĒKDVWDODUGDQDOêQDQNDQL×LQGHJH×HUOLGLU+DVWDOêNODLOLĒNLOLSêKWêODĒPDER]XNOXNODUêRODQYH\D\ĞNVHNGR]GDKHSDULQGDKLODQWLNRDJĞODQWHGDYLOHULJąUHQKDVWDODUGDQDOêQDQNDQêQWDPDPHQSêKWêODĒPDVêGDKDID]OD]DPDQDOêU
6HUXPUXWLQNOLQLNNLP\DYHLPPĞQRORMLWHVWOHULLOHVHURORMLGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU

SARSTEDT S-Monovette® düz Z
S-Monovette®GĞ]=WĞSL×LQGHELUL×HULNEXOXQPD]GROD\êVê\ODNDQąUQHåLKHUKDQJLELUSêKWêODĒPDDNWLYDWąUĞROPDNVê]êQGRåDORODUDNSêKWêODĒêUYHVHUXPHOGHHGLOPHVLQGHNXOODQêOêU 3êKWêODĒPêĒNDQYHVHUXPVDQWULIĞMOHPH
\ROX\ODELUELULQGHQD\UêOêU
6HUXPNXOODQêFêQêQEHOLUOHGLåLWHVWOHUGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU
Buna ek olarak, S-Monovette®GĞ]=WĞSĒXĒHNLOGHERĒNDSRODUDNGDNXOODQêODELOLUNDQDOPDELUJĞYHQOLNOL6DIHW\0XOWLIO\®LåQH NHOHEHNLåQH EDåODQPêĒELU60RQRYHWWH®VLWUDWWĞSĞ\OHEDĒODWêODFDNVD60RQRYHWWH® düz
Z tüp, (Safety) Multifly®LåQHKDWWêQêGROGXUPDNL×LQLONNDS ERĒNDS RODUDNNXOODQêOêU

SARSTEDT S-Monovette®OLW\XPKHSDULQ/+OLW\XPKHSDULQMHO/+OLW\XPKHSDULQ-HO+ LH, sodyum heparin NH, amonyum heparin AH
S-Monovette®OLW\XPKHSDULQ/+VRG\XPKHSDULQ1+DPRQ\XPKHSDULQ$+SêKWêąQOH\LFL DQWLNRDJĞODQ OLW\XPKHSDULQVRG\XPKHSDULQDPRQ\XPKHSDULQ RODåDQRODUDN,8KHSDULQPONDQ LOHNDSOêSODVWLNWDQHFLNOHU
L×HULUYHWDPNDQêQYHSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêOêU 6DQWULIĞMOHPH\DSêOGêåêQGDVą]NRQXVXSODVWLNWDQHFLNOHUNDQKĞFUHOHULLOHSOD]PDDUDVêQGDNDOêU
Plastik tanecik içermeyen bir S-Monovette®OLW\XPKHSDULQ/+WĞSĞQGHDQWLNRDJĞODQOLW\XPKHSDULQ RODåDQRODUDN,8KHSDULQPONDQ SĞVNĞUWĞOPĞĒEL×LPGHEXOXQXUS-Monovette®OLW\XPKHSDULQMHO/+WĞSĞDQWLNRDJĞODQOLW\XPKHSDULQ RODåDQRODUDN,8KHSDULQPONDQ LOHNDSODQPêĒSODVWLNWDQHFLNOHULQ\DQêVêUDSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêODQSROLPHUHVDVOêELUMHOL×HULU 
6DQWULIĞMOHPH\DSêOGêåêQGDVą]NRQXVXMHONDQKĞFUHOHULLOHSOD]PDDUDVêQGDNDODUDNWDĒêPDVDNODPDYHDQDOL]VêUDVêQGDVWDELOELUD\êUPDWDEDNDVêROXĒWXUXUS-Monovette® lityum heparin jel+/+WĞSĞD\UêFD60RQRYHWWH®OLW\XPKHSDULQMHOWĞSĞLOHNê\DVODQGêåêQGDVDQWULIĞMOHPHVĞUHVLQLQFLYDUêQGDD]DOPDVêQêPĞPNĞQNêODQSROLPHUHVDVOêELUMHOL×HULU
+HSDULQOLSOD]PDUXWLQNOLQLNNLP\DYHLPPĞQRORMLWHVWOHULQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU+HSDULQOLWDPNDQUXWLQLPPĞQRORMLWHVWOHULLOHVHURORMLGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU3êKWêODĒPDQêQKHSDULQLOHHQJHOOHQPHVLDQWLWURPELQDNWLYDV\RQX\ROX\ODROXU
%/*60RQRYHWWH® lityum heparin LH, lityum heparin jel/jel+ LH tüpleriyle lityum tespiti; S-Monovette® sodyum heparin NH tüpleriyle sodyum tespiti ve S-Monovette® amonyum heparin AH tüpleriyle
DPRQ\XPWHVSLWL\DSêOPDPDOêGêU9HQą]NDQLOHGROGXUXOPXĒ60RQRYHWWH® lityum heparin/lityum heparin-jel/jel+VRG\XPKHSDULQDPRQ\XPKHSDULQWĞSĞNDQJD]êDQDOL]LL×LQX\JXQGHåLOGLU

SARSTEDT S-Monovette® metal analizi
S-Monovette®PHWDODQDOL]LWĞSĞDQWLNRDJĞODQOLW\XPKHSDULQPDGGHVLL×HULUYHWDPNDQêQYHSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêOêU /LW\XPKHSDULQ RODåDQRODUDN,8KHSDULQPONDQ SĞVNĞUWĞOPĞĒEL×LPGHEXOXQXUS-Monovette®PHWDODQDOL]LWĞSĞKXVXVLJĞYHQOLNOL*[Źŗ ĞUĞQQR 6DIHW\LåQHELUOLNWHDOêQDQKHSDULQOLWDPNDQYH\DKHSDULQOLSOD]PDHVHUHOHPHQWOHULQPHWDOOHULQWHVWOHULL×LQąUQHNPDO]HPHVLRODUDNNXOODQêOêU(VHUHOHPHQWOHUPHWDOOHUDWRPLNDEVRUSVL\RQVSHNWURPHWUHVL $$6 NXOODQêODUDNGRåUXODQêU6DIHW\ *ĞYHQOLNOL LåQHYH60RQRYHWWH®PHWDODQDOL]LWĞSĞVLVWHPLĒXHVHUHOHPHQWOHUL×LQQJVLVWHPFLQVLQGHQDĒDåêGDNLNąUGHåHUOHULYHULU

Element

Tl

Cd

ng/Sistem

2,5

1,5

Ni

Cr

Pb

Fe

Cu

Zn

Mn

Al

Se

Hg

8,0

5,0

5

50

70

70

10

40

10

10

+HUHOHPHQWL×LQD]DPLNąUGHåHUOHU60RQRYHWWH®HWLNHWLQGHYHULOPLĒWLU(VHUHOHPHQWWD\LQOHULDQDOL]\ąQWHPLQHEDåOêRODUDNKHSDULQOLWDPNDQYH\DKHSDULQOLSOD]PDGDQ\DSêOêU3êKWêODĒPDQêQKHSDULQLOHHQJHOOHQPHVLDQWLWURPELQDNWLYDV\RQX\ROX\ODROXUSARSTEDT S-Monovette® Sitrat 9NC
S-Monovette®VLWUDW1&WĞSĞDQWLNRDJĞODQWULVRG\XPVLWUDWL×HULUYHWDPNDQêQYHSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêOêU 7ULVRG\XPVLWUDWPRODUOêN×ą]HOWLRODUDNEXOXQXU WULVRG\XPVLWUDW×ą]HOWLVLJHQHOGH
 \H\XYDUODQêU YH60RQRYHWWH®VLWUDWWĞSĞQĞQDQPDKDFPLQLQ XGXU6LWUDWNDQNDUêĒêPêRUDQêROXSKDFLPFHąO×ĞVLWUDWYHKDFLPFHąO×ĞNDQGêU$QDOL]L×LQGRåUXGROXPPXWODNRODUDNJHUHNOLGLU
6LWUDWOêSOD]PDUXWLQKHPRVWD]LWHVWOHULQGHWHVWPDO]HPHVLRODUDNNXOODQêOêU3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQVLWUDWODROXĒWXUGXåXNRPSOHNVOHUDUDFêOêåê\ODROXUS-Monovette®VLWUDWOêWĞSYHNHOHEHNLåQHQLQELUOLNWHNXOODQêPêQDGDLU%/*L×LQąUQHNDOêPêYHKD]êUODQPDVêEDĒOêåêDOWêQGDNLQRWODUDEDNêQ

SARSTEDT S-Monovette® PFA 9NC
S-Monovette®3)$1&WĞSĞDQWLNRDJĞODQWULVRG\XPVLWUDWL×HULUYHWDPNDQêQYHSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêOêU 7ULVRG\XPVLWUDWPRODUOêNWDPSRQOX×ą]HOWLRODUDNEXOXQXU WDPSRQOXS+ YHS-Monovette®3)$WĞSĞQĞQDQPDKDFPLQLQ XGXU6LWUDWNDQNDUêĒêPêRUDQêROXSKDFLPFHąO×ĞVLWUDWYHKDFLPFHąO×ĞNDQGêU$QDOL]L×LQGRåUXGROXPPXWODNRODUDNJHUHNOLGLU
S-Monovette®3)$1&WĞSĞ\OHHOGHHGLOHQWDPNDQ6,(0(16+HDOWKLQHHUV3)$DQDOL]FLKD]ê\ODWURPERVLWLĒOHYLWD\LQLQGHWHVWPDO]HPHVLRODUDNNXOODQêOêUYHEXDPD×ODGRåUXODPDVê\DSêOPêĒWêU3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQVLWUDWODROXĒWXUGXåXNRPSOHNVOHUDUDFêOêåê\ODROXUS-Monovette®3)$WĞSĞYHNHOHEHNLåQHQLQELUOLNWHNXOODQêPêQDGDLU%/*L×LQąUQHNDOêPêYHKD]êUODQPDVêEDĒOêåêDOWêQGDNLQRWODUDEDNêQ

SARSTEDT S-Monovette® CTAD
S-Monovette®&7$'WĞSĞDQWLNRDJĞODQWULVRG\XPVLWUDWêQ\DQêVêUDWHRILOLQDGHQR]LQYHGLSLULGDPROL×HULUYHWDPNDQêQYHSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêOêU &7$'×ą]HOWLRODUDNEXOXQXUYH60RQRYHWWH® CTAD
WĞSĞQĞQDQPDKDFPLQLQ XGXU&7$'NDQNDUêĒêPêRUDQêROXSKDFLPFHąO×Ğ&7$'YHKDFLPFHąO×ĞNDQGêU$QDOL]L×LQGRåUXGROXPPXWODNRODUDNJHUHNOLGLU
&7$' OêSOD]PDWURPERVLWIDNWąU 3) EHWD Ĕ WURPERJOREĞOLQ Ĕ7* YHSOD]PLQRMHQDNWLYDWąUĞLQKLELWąUĞ 3$, WD\LQLQLQ\DQêVêUDUXWLQKHPRVWD]LWHVWOHULQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU
7URPERVLWDNWLYDV\RQXHQD]VDDWVĞUH\OHLQKLEHHGLOLUYHKHSDULQWHGDYLVLQLQWDNLELQLQ\DSêOPDVêQêVDåODU3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQVLWUDWODROXĒWXUGXåXNRPSOHNVOHUDUDFêOêåê\ODROXUS-Monovette®&7$'WĞSĞYHNHOHEHNLåQHQLQELUOLNWHNXOODQêPêQDGDLU%/*L×LQąUQHNDOêPêYHKD]êUODQPDVêEDĒOêåêDOWêQGDNLQRWODUDEDNêQ%/*&7$'VDUêGêU60RQRYHWWH®&7$'VDNODPDVêUDVêQGDVXQLYHGRåDOêĒêNWDQNRUXQPDOêGêUVDDWWHQID]ODJĞ×OĞêĒêåDPDUX]NDOPDNNDWNêPDGGHOHULQLHWNLVL]KDOHJHWLUHELOLUSARSTEDT S-Monovette® EDTA K2E / K3E
S-Monovette® EDTA K2E / S-Monovette®('7$.(WĞSĞDQWLNRDJĞODQ.('7$YH\D.('7$PDGGHVLL×HULUYHWDPNDQHOGHHGLOPHVLQGHNXOODQêOêU .('7$YH\D.('7$SĞVNĞUWĞOPĞĒEL×LPGH PJ('7$POkan) bulunur.
('7$ OêWDPNDQKHPDWRORMLNWHVWOHUGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU.DQ\D\PDODUêNDQDOêQGêNWDQVRQUDNLGąUWVDDWL×LQGHKD]êUODQPDOêGêU3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQ('7$DUDFêOêåê\ODROXĒWXUGXåXNRPSOHNVOHUVD\HVLQGHROXUS-Monovette®('7$.(.(WĞSĞ\OHDOêQDQNDQUXWLQLPPĞQRKHPDWRORMLYHEXODĒêFêKDVWDOêNWHVWOHULL×LQGHNXOODQêODELOLU%XąUQHNPDO]HPHVLQLQVą]NRQXVXWHVWOHUL×LQX\JXQOXåXQXPXKDID]DNRĒXOODUêGDGDKLOROPDNĞ]HUHX\JXQWHVWUHDNWLIOHULYHDQDOL]FLKD]ODUê\ODGRåUXODPDNNXOODQêFêQêQVRUXPOXOXåXQGDGêU

228

TR
SARSTEDT S-Monovette®('7$MHO.(S-Monovette®('7$MHO.(WĞSĞDQWLNRDJĞODQ.('7$PDGGHVLQLQ\DQêVêUDSROLPHUHVDVOêELUMHOL×HULUYHSOD]PDHOGHHWPHNL×LQNXOODQêOêU .('7$SĞVNĞUWĞOPĞĒEL×LPGH PJ('7$PONDQ EXOXQXU6DQWULIĞMOHPH
\DSêOGêåêQGDVą]NRQXVXMHONDQKĞFUHOHULLOHSOD]PDDUDVêQGDNDODUDNWDĒêPDVDNODPDYHDQDOL]VêUDVêQGDVWDELOELUD\êUPDWDEDNDVêROXĒWXUXU
('7$ OêSOD]PDPROHNĞOHUYLUĞVWDQêWHVWOHULQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQ('7$DUDFêOêåê\ODROXĒWXUGXåXNRPSOHNVOHUVD\HVLQGHROXUSARSTEDT S-Monovette®ĲRUĞU('7$)(ĲRUĞU+HSDULQ)+ĲRUĞUVLWUDW('7$)&*OLNROL]LQKLELWąUOĞ
S-Monovette®IORUĞU('7$)(WĞSĞDQWLNRDJĞODQ('7$ PJPONDQ PDGGHVLQLQ\DQêVêUDJOLNROL]LLQKLEHHWPHNL×LQIORUĞU PJPONDQ L×HULUYHSOD]PDHOGHHWPHNL×LQNXOODQêOêU )ORUĞU('7$SĞVNĞUWĞOPĞĒEL×LPGH
bulunur.
S-Monovette®IORUĞUKHSDULQ)+WĞSĞDQWLNRDJĞODQKHSDULQ ,8KHSDULQPONDQ PDGGHVLQLQ\DQêVêUDJOLNROL]LLQKLEHHWPHNL×LQIORUĞU PJPONDQ L×HULUYHSOD]PDHOGHHWPHNL×LQNXOODQêOêU )ORUĞUKHSDULQSĞVNĞUWĞOPĞĒEL×LPGHEXOXQXU
6DGHFHIORUĞUWDUDIêQGDQJOLNROL]LQLQKLEHHGLOPHVLNDQDOPDWĞSĞGROGXUXOGXNWDQ\DNODĒêNVDDWVRQUDEDĒODUYHWDPHWNLVLQLVDDWNDGDUVRQUDJąVWHULU%XQDJąUHWDPNDQGDJOLNR]XQELUND×VDDWVRQUDRUWDODPD \DNDGDURODQYHVDDWVRQUD HNDGDURODQEąOĞPĞ\êNêPDXåUDU
S-Monovette®*OXFR(;$&7)&WĞSĞDQWLNRDJĞODQ('7$PDGGHVLQLQ\DQêVêUDJOLNROL]LDQLLQKLEHHWPHNL×LQVLWUDWYHIORUĞUL×HULUYHSOD]PDHOGHHWPHNL×LQNXOODQêOêU ('7$VLWUDWYHIORUĞU×ą]HOWLEL×LPLQGHEXOXQXU
6H\UHOWPHVHEHEL\OHJOLNR]NRQVDQWUDV\RQXQXQKHVDSODQPDVêL×LQLOH×DUSêOPDVêJHUHNLU
S-Monovette®*OXFR(;$&7)&WĞSOHU$OPDQ'L\DEHW'HUQHåL ''* *HEHOLN'L\DEHWL.êODYX]XYH7LS'L\DEHWL×LQ8OXVDO%DNêP.êODYX]XQD 19/ X\JXQGXU7DPNDQGDJOLNR]NRQVDQWUDV\RQXQXQDQLVWDELOL]DV\RQXRGD
VêFDNOêåêQGDVDDWHNDGDUVĞUHUD\UêFDEN]6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/products/diagnostic/venous-blood/s-monovetter/ Literature / „Sarstedt S-Monovette® GlucoEXACT A blood collection
device for stabilizing glucose levels for 96 hours“.
)ORUĞU('7$ VLWUDW OêSOD]PDJOLNR]WD\LQLL×LQąUQHNPDO]HPHVLRODUDNNXOODQêOêU3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQ('7$DUDFêOêåê\ODROXĒWXUGXåXNRPSOHNVOHUVD\HVLQGHROXU
%/*)ORUĞUKHPROL]GHDUWêĒDQHGHQRODELOLU*LULĒLPGHEXODQDELOHFHNPDGGHOHUKDNNêQGDGDKDID]ODELOJLWHVWUHDNWLILĞUHWLFLVLQLQLOJLOLNXOODQPDWDOLPDWODUêQGDEXOXQDELOLUS-Monovette®*OXFR(;$&7WĞSĞYHNHOHEHNLåQHQLQELUOLNWHNXOODQêPêQDGDLU%/*L×LQąUQHNDOêPêYHKD]êUODQPDVêEDĒOêåêDOWêQGDNLQRWODUDEDNêQ

SARSTEDT S-Monovette® CPDA
S-Monovette®&3'$DQWLNRDJĞODQVRG\XPVLWUDWPDGGGHVLQLQ\DQêVêUDVLWULNDVLWVRG\XPIRVIDWGHNVWUR]YHDGHQLQL×HULUYHWDPNDQêQYHSOD]PDQêQHOGHHGLOPHVLQGHNXOODQêOêU &3'$×ą]HOWLEL×LPLQGHEXOXQXU&3'$
NDQNDUêĒêPêRUDQêROXSKDFLPFHąO×Ğ&3'$YHKDFLPFHąO×ĞNDQGêU$QDOL]EDNêPêQGDQGRåUXGROXPPXWODNRODUDNJHUHNOLGLU
&3'$ OêWDPNDQSOD]PDWUDQVIĞ]\RQWêEEêQGDNDQJUXEXVHURORMLVLQGHQDNLOOHUGHNLX\XPOXOXN ×DSUD]NDUĒêODĒWêUPD WHVWOHULQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU60RQRYHWWH® CPDA tüpü bilhassa Kell ve Rhesus alt
JUXSODUêGDKLO $% NDQJUXEXWD\LQLQGHRODåDQGêĒêNDQJUXEXDQWLNRUODUêL×LQDQWLNRUWDUDPDWHVWOHULQGHSROLVSHVLILNGLUHNW&RRPEVWHVWL JĞQHNDGDU NDQJUXEXX\XPOXKDVWDVHUXPXSOD]PDVê PDMąUNDQJUXEX LOH
X\XPOXOXN ×DSUD]NDUĒêODĒWêUPD WHVWOHULL×LQX\JXQGXU
'HSRODPD\DNDGDUƓ& GHHQID]ODVDDWOLNWDĒêPDVĞUHVLGRåUXODQPêĒWêU+ĞFUHOHULQ×ąNHOWLOPHVLL×LQąUQHNOHUąQFHHQD]VDDWVĞUH\OHGLNNRQXPGDEX]GRODEêQGDEHNOHWLOPHOLGLU%X]GRODEêQGD Ɠ& 
EHNOHWLOGLNWHQVRQUD\XNDUêGDEHNOHWLOHQDQDOLWOHURODåDQNDQPXKDID]DVêVĞUHVL\OHD\QêĒHNLOGHHQID]ODJĞQHNDGDU LVWLVQDLRODUDNGLUHNW&RRPEVWHVWLQGHJĞQ WHVSLWHGLOHELOLU.RORQDJOĞWLQDV\RQ\ąQWHPOHULPHVHOD2UWKR&OLQLFDO'LDJQRVWLFVILUPDVêQêQ9LVLRQ0D[FLKD]êL×LQX\JXQGXUUQHNPDO]HPHVLGRQGXUXOPDPDOêGêU6ą]NRQXVXWHVWOHUL×LQEXąUQHNPDO]HPHVLQLQPXKDID]DNRĒXOODUêGDGDKLOROPDNĞ]HUHGLåHU\ąQWHPWHVWUHDNWLIOHULDQDOL]FLKD]ODUê\ODX\JXQOXåXNXOODQêFêQêQVRUXPOXOXåXQGDGêUYHNHQGLVLQLQGRåUXODPDVêJHUHNLU
3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQVLWUDWODROXĒWXUGXåXNRPSOHNVOHUDUDFêOêåê\ODROXUS-Monovette®&3'$WĞSĞYHNHOHEHNLåQHQLQELUOLNWHNXOODQêPêQDGDLU%/*L×LQąUQHNDOêPêYHKD]êUODQPDVêEDĒOêåêDOWêQGDNLQRWODUDEDNêQ

SARSTEDT S-Monovette® ThromboExact
S-Monovette®7KURPER([DFWWĞSĞDQWLNRDJĞODQRODUDNPDJQH]\XPWX]XL×HULUYHWDPNDQHOGHHWPHNL×LQNXOODQêOêU 0DJQH]\XPWX]XSĞVNĞUWĞOPĞĒEL×LPGHEXOXQXUS-Monovette®7KURPER([DFWWĞSĞ SVąGR WURPERVLWRSHQLRODUDNGDELOLQHQDQWLNRDJĞODQLQWROHUDQVê ('7$VLWUDWKHSDULQJLEL VHEHEL\OHKDWDOêRODUDNROGXåXQGDQGĞĒĞN×êNDQWURPERVLWVD\êODUêQêHNDUWHHWPHNL×LQ
NXOODQêOêU7URPERVLWDJUHJDWODUêQêQROXĒPDVêąQOHQLUYHNDQąUQHåLDOêQGêNWDQVRQUDVDDWHNDGDUVĞUH\OHJHU×HNWURPERVLWVD\êVêEHOLUOHQHELOLU
3êKWêODĒPDQêQąQOHQPHVLPDJQH]\XPL\RQODUêYDVêWDVê\ODJHU×HNOHĒLUĒą\OHNLPDJQH]\XPL\RQODUêWURPERNVDQ$ \LWURPERVLWLNNêODUYH$'3YHDUDĒLGRQLNDVLWDUDFêOêWURPERVLWDJUHJDWODUêROXĒXPXHQJHOOHQLUSARSTEDT S-Monovette® hirudin
S-Monovette®KLUXGLQWĞSĞDQWLNRDJĞODQKLUXGLQPDGGHVLL×HULUYHWDPNDQHOGHHGLOPHVLQGHNXOODQêOêU +LUXGLQSĞVNĞUWĞOPĞĒEL×LPGHEXOXQXU+LUXGLQOLWDPNDQ52&+('LDJQRVWLFVILUPDVêQêQ0XOWLSODWH® PXOWLSOHSODWHOHWIXQFWLRQDQDO\VHU×RNOXWURPERVLWIRQNVL\RQXDQDOL]FLKD]ê LOHWURPERVLWLĒOHYLQLQWHVSLWHGLOPHVLQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêUYHEX
DPD×L×LQGRåUXODQPêĒWêU%XWURPERVLWLQKLEHHGLFLLOD×ODUODWHGDYLQLQWDNLELYHWURPERVLWLĒOHYER]XNOXåXQXQWHVSLWLYH\DGêĒODQPDVêL×LQNXOODQêOêU
S-Monovette® hirudin, Multiplate®FLKD]êQGDWURPERVLWIRQNVL\RQXQXQEHOLUOHQPHVLL×LQą]HORODUDNEXJĞQNĞDGê\OD52&+('LDJQRVWLFVRODQ9HUXP'LDJQRVWLFDILUPDVê\ODLOHELUOLNWHJHOLĒWLULOPLĒWLU
3êKWêODĒPDQêQKLUXGLQĞ]HULQGHQLQKLEHHGLOPHVLGRåUXGDQWURPELQLQKLELV\RQX\ROX\ODPH\GDKDJHOLUYHEą\OHFHWURPERVLWLĒOHYLQLQGRåDOKDOL\OHWHĒKLVLQLPĞPNĞQNêODU

SARSTEDT S-Monovette® homosistein HCY-Z-Gel/HCY-C
S-Monovette®KRPRVLVWHLQ+&<=MHOWĞSĞSêKWêODĒPDDNWLYDWąUĞ VLOLNDW LOHNDSODQPêĒSODVWLNWDQHFLNOHULQ\DQêVêUDą]HOELUVWDELOL]DWąUYHSROLPHUHVDVOêELUMHOL×HULUYHVHUXPXQHOGHHGLOPHVLQGHNXOODQêOêU 6DQWULIĞMOHPH
\DSêOGêåêQGDVą]NRQXVXMHOSêKWêODĒPêĒNDQLOHVHUXPDUDVêQGDNDODUDNWDĒêPDVDNODPDYHDQDOL]VêUDVêQGDVWDELOELUD\êUPDWDEDNDVêROXĒWXUXU×HULNSĞVNĞUWĞOPĞĒEL×LPGHEXOXQXU+RPRVLVWHLQWDPNDQGDRGDVêFDNOêåêQGDVDDWHNDGDUVWDELONDOêU3êKWêODĒPêĒNDQYHVHUXPDUDVêQGDJHUHNWLåLJLELROXĒPXĒD\êUPDWDEDNDVêQDPĞWHDNLSLONVDDWL×LQGHVDQWULIĞMOHPH\DSêOêUVDKRPRVLVWHLQVDDWHNDGDUVWDELONDOêU
S-Monovette®KRPRVLVWHLQ+&<=MHOWĞSĞQGHNLVHUXPKRPRVLVWHLQWD\LQLQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU60RQRYHWWH® homosistein HCY-C tüpü, antikoagülan olarak sitrik asit (pH 4,3) içerir ve plazma elde etmek
L×LQNXOODQêOêU 6LWUDW×ą]HOWLEL×LPLQGHEXOXQXU6H\UHOWPHVHEHEL\OHKRPRVLVWHLQNRQVDQWUDV\RQXQXQKHVDSODQPDVêL×LQLOH×DUSêOPDVêJHUHNLU+RPRVLVWHLQWDPNDQGDRGDVêFDNOêåêQGDVDDWHNDGDUYHƓ& GHVDDWHNDGDUVWDELONDOêU
S-Monovette®KRPRVLVWHLQ+&<&WĞSĞQGHNLSOD]PDKRPRVLVWHLQWD\LQLQGHąUQHNPDO]HPHVLRODUDNNXOODQêOêU
S-Monovette®KRPRVLVWHLQ+&<&WĞSĞQGHSêKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQVLWUDWDUDFêOêåê\ODROXĒWXUGXåXNRPSOHNVOHUVD\HVLQGHROXU
S-Monovette®+&<&WĞSĞYHNHOHEHNLåQHQLQELUOLNWHNXOODQêPêQDGDLU%/*L×LQąUQHNDOêPêYHKD]êUODQPDVêEDĒOêåêDOWêQGDNLQRWODUDEDNêQ

SARSTEDT S-Monovette® DNA Exact
S-Monovette®'1$([DFWWĞSĞ('7$HVDVOêELUDQWLNRDJĞODQPDGGHL×HULUYHWDPNDQHOGHHGLOPHVLQGHNXOODQêOêU ('7$SĞVNĞUWĞOPĞĒEL×LPGHEXOXQXU
('7$ OêWDPNDQJ'1$VWDELOL]DV\RQXL×LQąUQHNPDO]HPHVLRODUDNNXOODQêOêUJ'1$ QêQƓ& GHJĞQRGDVêFDNOêåêQGD Ɠ& JĞQEX]GRODEêNRĒXOXQGD Ɠ& JĞQYHƓ& GHHQD]\êOOêNVWDELOL]DV\RQSHUIRUPDQVêGRåUXODQPêĒWêU%XQDHNRODUDNVWDELOL]HHGLOPLĒąUQHNOHUGRQGXUPDYH×ą]GĞUPHGąQJĞVĞER\XQFDNDOLWHND\EêROPDNVê]êQNDOêU$\UêFDEN]6$567('7:KLWH3DSHUhttps://www.sarstedt.com/en/
products/diagnostic/venous-blood/s-monovetter/ Literature / „SARSTEDT S-Monovette® DNA Exact – A New IVD Certified Blood Collection Tube for Collection, Transport and Stabilization of Whole Blood for Genomic
DNA Analysis.”.
3êKWêODĒPDQêQąQOHQPHVLNDOVL\XPL\RQODUêQêQ('7$DUDFêOêåê\ODROXĒWXUGXåXNRPSOHNVOHUVD\HVLQGHROXUUQHNPDO]HPHVLQLQX\JXQOXåXDQDOLWWHVWUHDNWLILDQDOL]FLKD]êQDEDåOêGêUPDODW×êQêQLOJLOLWDYVL\HOHULQHX\XOPDOêGêU

229

TR
*ĞYHQOLNYH8\DUê%LOJLOHUL
1.

*HQHOQOHPOHU.DQDYHSRWDQVL\HORODUDNHQIHNVL\RQ\DSDELOHFHNąUQHNPDO]HPHVLQHYHWDĒêQDELOLUSDWRMHQOHUHRODVêELUPDUX]NDOPDGXUXPXQDNDUĒêNRUXQPDNL×LQHOGLYHQYHJHQHORODUDNNLĒLVHONRUX\XFXGRQDQêPNXOODQêQ

2.

7ĞPEL\RORMLNQXPXQHOHUHYHNHVLFLGHOLFLNDQDOPDJHUH×OHULQH LåQHOHUDGDSWąUOHU NXUXPXQX]GDNLNêODYX]YHLONHOHUHJąUHPXDPHOHHGLQ%L\RORMLNąUQHNOHUOHGRåUXGDQWHPDVYH\DLåQHEDWPDVê\DUDODQPDVêGXUXPXQGD+,9+&9+%9YH\DGLåHUEXODĒêFêKDVWDOêNODUWDĒêQDELOHFHåLQGHQELUGRNWRUDEDĒYXUXQ6DIHW\ *ĞYHQOLNOL LåQHOHUL6DIHW\0XOWLĲ\®LåQHOHULL×LQGHYDURODQLåQHNRUX\XFXVX\ODNXOODQêQ.XUXPXQX]GDNLHPQL\HWNXUDOODUêYHLONHOHULQHX\XOPDVê]RUXQOXGXU

3.

Tekli steril ambalajdaki ürünler için:.XOODQPDGDQąQFHKHUELUWHNOLDPEDODMêKDVDUEDNêPêQGDQNRQWUROHGLQYHELUKDVDUROPDVêGXUXPXQGDNXOODQPD\êQ

4.

¶UĞQWHNNXOODQêPOêNWêU.DQDOêPêL×LQNXOODQêODQWĞPNHVLFLGHOLFLQHVQHOHUL LåQHOHUDGDSWąUOHU EL\RORMLNWHKOLNHEDNêPêQGDQX\JXQDWêNNDSODUêQDDWêQ

5.

.DQLQWUDYHQą] ,9 GDPDU\ROXQGDQDOêQDFDNVDNDQDOêPêQDEDĒODPDGDQąQFHGDPDU\ROXQXQPXKDNNDNNXUXPXQX]GDNLXVXOHX\JXQĒHNLOGH\êNDQPDVê \DQLVHUXP×ą]HOWLVLEêUDNPDGDQ JHUHNLU'DPDU\ROXQXQGRåUXĒHNLOGH\êNDQPDVêDQDOL]VRQX×ODUêQêQ\DQOêĒROPDVêQêąQOHU

6.

S-Monovette®WĞSĞQĞQJHUHåLQGHQD]GROGXUXOPDVêNDQL×HULN NDWNêPDGGHVL RUDQêQêQ\DQOêĒROPDVêQDYH\DQOêĒDQDOL]VRQX×ODUêQD\ROD×DU

7.

S-Monovette®LOHDOêQDQYHLĒOHQHQNDQLQVDQYĞFXGXQD\HQLGHQHQMHNWHHGLOPHNL×LQGHåLOGLU

8.

%XĞUĞQUDIąPUĞQĞQGROPDVêQGDQVRQUDDUWêNNXOODQêOPDPDOêGêU5DIąPUĞEHOLUWLOHQ\êOYHD\êQVRQJĞQĞQGHVRQDHUHU

Depolama¶UĞQNXOODQêOêQFD\DGHNRGDVêFDNOêåêQGDGHSRODQPDOêGêU

6êQêUODPDODU
1.

'ROGXUXOPXĒELU60RQRYHWWH®WĞSĞQVDNODPDVĞUHVLYHVêFDNOêåêLQFHOHQHFHNDQDOLWOHULQUDIąPUĞQHEDåOêGêU'HåHUOHQGLUPHODERUDWXYDUWDUDIêQGDQ\DSêOêUYH\DELOJLOHUWHVWUHDNWLILDQDOL]FLKD]êĞUHWLFLVLQLQNXOODQPD
WDOLPDWODUêQGDQDOêQPDOêGêU

2.

Plazma veya serum, santrifügasyon ile S-Monovette®WĞSOHUGHQD\UêOVDYHYH\DELUEDUL\HUPHYFXWVDELOHWĞPKĞFUHOHUWDPDPHQD\UêOê\RUGHPHNGHåLOGLU*HUL\HNDODQPHWDEROL]PDYH\DGRåDO\êNêPVĞUHFLDQDOLWOHULQNRQVDQWUDV\RQODUêQêHWNLOH\HELOLU$QDOLWVWDELOLWHVLVDNODPDNDEêQDYHLOJLOLODERUDWXYDUêQNRĒXOODUêQDJąUHGHåHUOHQGLULOPHOLGLU

3.

7HUDSąWLNLOD×ODUêQVą]NRQXVXROPDVêKDOLQGHąUQHNPDWHU\DOLQLQX\JXQOXåXWHVWUHDNWLILDQDOL]FLKD]êĞUHWLFLVLQLQNXOODQêPWDOLPDWODUêQGDNRQWUROHGLOPHOLGLU

4.

Eser elementlere/metallere yönelik analizler S-Monovette®PHWDODQDOL]LWĞSĞJĞYHQOLNOL*ĞYHQOLNOLPHWDODQDOL]LLåQHVLVWHPLLOH\DSêOPDOêGêU

UQHN$OêPêYH+D]êUODQPDVê
9(1=.$1$/,0,1$%$«/$0$'$11&(%8%(/*(117$0$0,1,2.8<81Örnek almak için gerekli malzemeler
1.

Gerekli tüm S-Monovette® kan alma sistemleri.

2.

*ĞYHQOLNOL 6DIHW\ LåQHOHUYH\D 6DIHW\ 0XOWLĲ\®LåQHOHU

3.

.DQLOHWDĒêQDQSDWRMHQOHUHYH\DSRWDQVL\HOHQIHNWHHGLFLPDGGHOHUHNDUĒêNRUXQPDNL×LQHOGLYHQąQOĞNNRUX\XFXJą]OĞNYH\DGLåHUX\JXQNRUX\XFXJL\VLOHU

4.

+DVWDQêQWDQêPODQPDVêL×LQHWLNHWOHU5.

UQHNDOêPEąOJHVLQLWHPL]OHPHNL×LQGH]HQIHNWDQPDO]HPH ąUQHNDOêPEąOJHVLQLQKD]êUODQPDVêQGDNXUXPXQX]XQVWHULOąUQHNDOêPêNêODYX]XQDX\XQ UQHNOHUNDQGDDONROWHVWOHULL×LQNXOODQêODFDNVDDONROED]OêWHPL]OLN
PDO]HPHOHULNXOODQPD\êQ

6.

6WHULONXUXWHNNXOODQêPOêNJD]OêEH]

7.

Damar turnikesi.

8.

)ODVWHUYH\DVDUJêEH]L9.

.XOODQêOPêĒPDO]HPHQLQJĞYHQOLELUĒHNLOGHEHUWDUDIHGLOPHVLL×LQNHVLFLGHOLFLDWêNNDEê

QHULOHQDOêPVêUDVê
1.

.DQNĞOWĞUĞĒLĒHOHUL

2.

6LWUDWOêYH\DSêKWêODĒPDDNWLYDWąUOĞWĞSOHU MHOVHUXP&$7L×HUHQYHL×HUPH\HQVHUXPMHO&$7 

3.

3êKWêODĒPDDNWLYDWąUOĞYH\DVLWUDWOêWĞSOHU

4.

Jelli/jelsiz heparin tüpleri

5.

Jelli/jelsiz EDTA tüpleri

6.

Glikoliz inhibitörlü tüpler

7.

'LåHUNDWNêPDGGHOLWĞSOHU
%/*

6LWUDWOêELUWĞSHYH\D3)$&7$'&3'$+&<&YH\D*OXFR(;$&7JLELVêYêL×HULåLEXOXQDQEDĒNDELUWĞSHNHOHEHNELULåQH\OH ąUQ 6DIHW\ 0XOWLĲ\®LåQH ELUOLNWHNDQDOêQPDVêQDEDĒODQDFDNVDNHOHEHNLåQHQLQKRUWXPVLVWHPLQLQGROPDVêVHEHEL\OHWĞSOHULQJHUHåLQGHQD]GROPDVêQêQąQĞQHJH×PHNDPDFê\ODąQFHVLQGHERĒELUWĞSH ąUQ60RQRYHWWH®=GĞ]WĞS DOêP\DSêOPDVêWDYVL\Hedilir.
%ą\OHFHVą]NRQXVXWĞSOHULQGROXPXQXQGRåUXYHGROD\êVê\ODNDUêĒêPRUDQêQêQ VêYêQêQNDQD GRåUXROPDVêWHPLQHGLOLU

%/*$OêPVêUDODPDVêL×LQNXUXPXQX]XQNXUDOODUêQDX\XQ*HULDNêĒêąQOH\LQ
60RQRYHWWHVLVWHPOHULQLQ×RåXNLP\DVDONDWNêPDGGHVLL×HULU*HULDNêĒêąQOHPHNL×LQDĒDåêGDNLWDOLPDWODUDX\XOPDOêGêU
1. <DOQê]FDNXOODQêPWDOLPDWODUêQGDąQHULOHQPDO]HPHOHULNXOODQêQ2.

+DVWD\êGDPDUDNROD\HULĒLPVDåOD\DFDNĒHNLOGHNRQXPODQGêUêQYHKDVWDQêQNROXQXYH\DEDĒNDELUSRQNVL\RQEąOJHVLQLDĒDåêEDNDFDNĒHNLOGH\ąQOHQGLULQ

3.

S-Monovette®WĞSĞYLGDOêNDSDåê\XNDUêGRåUXEDNDFDNĒHNLOGHWXWXQYHELU 6DIHW\ 0XOWLĲ\®LåQHNXOODQê\RUVDQê]D\Qê]DPDQGDNROVHYL\HVLQLQSRQNVL\RQEąOJHVLQLQDĒDåêVêQGDWXWXQ

4.

9HQą]SRQNVL\RQVêUDVêQGD60RQRYHWWH®WĞSĞQL×HULåLQLQYLGDOêNDSDåDYHLåQHQLQXFXQDWHPDVHWPHPHVLVDåODQPDOêGêU5.

Kan S-Monovette®WĞSHDNDUNHQWXUQLNH\LJHYĒHWLQ

230

TR
Dondurma/Çözdürme'6 QĞQ :+2',//DE5HY WDYVL\HOHULQHJąUHVHUXPSOD]PDQêQGRQPDGDQąQFHNDQKĞFUHOHULQGHQD\UêOPDVêąQHULOLU
S-Monovette®WĞSOHUL×LQDĒDåêGDNLGRQGXUPDąQHULOHULJH×HUOLGLUƓ& QLQDOWêQGDGRQGXUXQ•

6êIêUêQDOWêQGDNLVêFDNOêNDUDOêåêQGDNLNXOODQêPKHU]DPDQJHU×HNNRĒXOODUDOWêQGDWHVWHGLOPHOLGLU×ĞQNĞWĞSOHUGHNL\ĞNGRQGXUXODFDNRUWDPDYHUXWLQNRĒXOODUDEDåOêRODUDNEĞ\ĞNąO×ĞGHIDUNOêOêNJąVWHUHELOLU EN]
6$567('7NDWDORåXPDO]HPHą]HOOLNOHULEąOĞPĞ •

7HPHORODUDNƓ& QLQDOWêQGDNLVêFDNOêNDUDOêåêQGDSODVWLNOHULQPXNDYHPHWGHåHUOHULD]DOêU%XQHGHQOHPHNDQLN\ĞNOHUGHQJHQHORODUDNND×êQêOPDOêGêU•'RQGXUPDNRĒXOODUê60RQRYHWWH®WĞSL×HULåLQLQHĒLWĒHNLOGHYHDĒDåêGDQ\XNDUê\DGRQDFDåêĒHNLOGHVH×LOPHOLGLU60RQRYHWWH®WĞSOHULQVWDQWYH\DVDNODPDNXWXVXQGDJHQOHĒPH\HPĞVDDGHHGHFHNERĒOXNEXOXQPDOêGêU6WUDIRUYH\DPHWDOVWDQWODUJHQOHĒPH×DWODNODUêQDQHGHQRODELOHFHåLQGHQX\JXQGHåLOGLU

Ɠ& \HNDGDUGRQGXUPDGRQGXUPDGDQąQFHĒXQODUêNRQWUROHGLQ•*LULĒLPOHU'RQGXUPDLĒOHPLQLQNDQąUQHåLYH\DDQDOL]GHJLULĒLPGHEXOXQXSEXOXQPDGêåêQêNRQWUROHGLQ ąUQKHPROL]DQDOLWLQVWDELOLWHVL •

6DQWULIĞJDV\RQ3ODQODQDQDQDOL]HEDåOêRODUDNJHUHNOLGLU6DQWULIĞMOHPHNRĒXOODUêL×LQ6$567('7:HEVLWHVLQGHNLhttps://www.sarstedt.com/en/service/centrifugation/=HQWULIXJDWLRQEDĒOêåêDOWêQGDNLEHOJH\LGLNNDWHDOêQYHąUQHåLJąUVHOEDNêPGDQNRQWUROHGLQ•+HPROL]7DPNDQGRQDUNHQKHPROL]HXåUDU%XQXąQOHPHNL×LQ\D60RQRYHWWH® jel tüpte santrifügasyondan sonra Seraplas®YDOIILOWUHVLNXOODQêOPDOê\DGDąUQHNLNLQFLOELUWĞSHSLSHWOHQPHOLGLU

-20°C'ye kadar dondurma: Prosedür:•6RåXWPD60RQRYHWWH®WĞSOHULƓ& GHGRQGXUDELOPHNL×LQąQFHRGDVêFDNOêåêQGDQƓ& \HNDGDUGDNLNDOêNELUVĞUHER\XQFDGLNH\RODUDNVRåXWXQ•są]GĞUPH(QD]GDNLNDER\XQFDRGDVêFDNOêåêQGDGLNGXUXUKDOGH×ą]GĞUĞQ%XUDGDGDPHNDQLN\ĞNOHUGHQND×êQêOPDOêGêUsRNKê]Oê×ą]GĞUPH\DQOêĒDQDOL]VRQX×ODUêQDQHGHQRODELOLU

Ɠ& QLQDOWêQGDGRQGXUPDYHGHULQGRQGXUPD•

Ɠ& QLQDOWêQGDGRQGXUPDĞUHWLFLWDUDIêQGDQWHVWHGLOPHPLĒWLUsRNVD\êGDRODVêHWNLIDNWąUĞQHGHQL\OHGRQPDWHVWOHULQLQUXWLQODERUDWXYDUNRĒXOODUêQGD\DSêOPDVêWDYVL\HHGLOLUS-Monovette®MHOWĞSĞQGRQGXUXOPDVê•'RQGXUPDLĒOHPLDĒDåêGDNLƓ& \HNDGDUGRQGXUPD3URVHGĞUEDĒOêåêQGDWDULIHGLOGLåLĒHNLOGHJHU×HNOHĒWLULOLU•'RQGXUPDLĒOHPLVRQXFXQGDMHOWDEDNDVêQêQGHåLĒHELOHFHåLELOLQPHNWHGLU•sRNVD\êGDRODVêHWNLIDNWąUĞQHGHQL\OHGRQPDWHVWOHULQLQUXWLQODERUDWXYDUNRĒXOODUêQGD\DSêOPDVêWDYVL\HHGLOLU

•Çözdürme:UQHåLGLNSR]LV\RQGXUX\RUNHQ×ą]GĞUĞQsą]ĞOGĞNWHQVRQUDELULQFLOWĞSWHNLMHOWDEDNDVêQêQ\DNODĒêNPP\XNDUêVêQDNDGDURODQąUQHNPDO]HPHVLQLSLSHWOH\HUHNLNLQFLOELUNDEDDNWDUêQ GąNHUHN
ERĒDOWPD\êQ *HULVLQLDOPD\êQ%/*$QDOL]OHULQVWDELOLWHVLL×LQWHVWUHDNWLĲHULQLQDQDOL]FLKD]êĞUHWLFLOHULQLQNXOODQPDWDOLPDWODUêQDX\XOPDOêGêU

231

TR
.DQDOêPê
$OêPWHNQLåL
NLWĞUOĞDOêQWHNQLåLEXOXQPDNWDGêUDVSLUDV\RQWHNQLåLYHYDNXPWHNQLåL$VSLUDV\RQWHNQLåLQGHNDQêQQD]LNEL×LPGHDOêQPDVêPĞPNĞQGĞUSLVWRQXQNRQWUROOĞEL×LPGH×HNLOPHVL\OHNDQDNêĒêVĞUHNOLYH\DYDĒWêU%ą\OHOLNOHNDQDNêĒêWĞPGDPDUKDOYHNRĒXOODUêQDKHPHQX\DUODQDELOLUYHKHPROL]
D]DOWêODELOLU
9DNXPWHNQLåLLVHNDQêQąQFHGHQYDNXPX\JXODQPêĒELUWĞSL×LQHQHJDWLIEDVêQ×LONHVLQHX\JXQRODUDNVĞUHNOLYHKê]OêNDQDNêĒê\ODDOêQPDVêQêVDåODU'ROD\êVê\ODEXWHNQLNGDPDUNRĒXOODUêQêQL\LROGXåXYHNDQDOPD
NRĒXOODUêQêQEDVLWROGXåXGXUXPODUGDX\JXQGXU
.DQDOêPêX\JXODPDVêD\UêFDEN]JĞYHQOLNOL6DIHW\ *ĞYHQOLNOL LåQHYH\D6DIHW\0XOWLIO\®LåQHLOHDVSLUDV\RQWHNQLåLYH\DYDNXPWHNQLåLQGH60RQRYHWWH® uygulama videosu:
www.sarstedt.com/en/download/videos/Diagnostics/Venous blood.$1$/,0,6,5$6,1'$0$58=.$/0$56.1$=$/70$.s1(/'9(1*<1
1. Gerekli örnek için uygun S-Monovette® tüpü seçin.
2.

9HQą]SRQNVL\RQL×LQELUEąOJHVH×LQ9HQą]SRQNVL\RQ\HULQLQKD]êUODQPDVêL×LQOĞWIHQNXUXPXQX]XQNêODYX]XQDX\XQ$VSLUDV\RQWHNQLåLLOHNDQDOêPê
Dikkat! S-Monovette®WĞSOHULHQMHNVL\RQL×LQGHåLOVDGHFHNDQDOPDNL×LQNXOODQêQ
6DGHFHEXLåQHOHU 60RQRYHWWH®6DIHW\ *ĞYHQOLNOL LåQHOHU\DGD60RQRYHWWH® için (Safety) Multifly®LåQHOHUDGDSWąUOHU LOHELUOLNWHNXOODQêQ
6DIHW\ *ĞYHQOLNOL LåQHLOHX\JXODPDEXUDGDJąVWHULOPHNWHGLU

klik

Venöz ponksiyondan hemen önce, S-Monovette®WĞSĞ6DIHW\ *ĞYHQOLNOL LåQHHQWHJUHWXWXFXQXQL×LQHLWLQ ve hafifçe saat yönünde çevirerek sabitleyin .
*HUHNLUVHWXUQLNHX\JXOD\êQ HQID]ODGDNLND 3RQNVL\RQEąOJHVLQLX\JXQQLWHOLNWHELUGH]HQIHNWDQPDGGHLOHKD]êUOD\êQ'H]HQIHNVL\RQGDQVRQUDYHQą]SRQNVL\RQEąOJHVLQHGRNXQPD\êQ+DVWD\êGDPDUDNROD\HULĒLPVDåOD\DFDNĒHNLOGHNRQXPODQGêUêQYHKDVWDQêQNROXQXYH\DEDĒNDELUSRQNVL\RQEąOJHVLQLDĒDåêEDNDFDNĒHNLOGH\ąQOHQGLULQåQHNRUX\XFXVXQX×êNDUêQ9HQą]SRQNVL\RQX\DSêQSLVWRQ×XEXåXQX\DYDĒ×DJHUL×HNLQYHNDQ60RQRYHWWH®WĞSL×LQHDNDUNHQWXUQLNH\LJHYĒHWLQ .
'RåUXGROXPDL]LQYHUPHNL×LQNDQDNêĒêGXUDQDNDGDUEHNOH\LQ

S-Monovette® tüpü hafifçe saat yönünün tersine çevirerek \HULQGHQR\QDWêQYHDUGêQGDQ6DIHW\ *ĞYHQOLNOL LåQHGHQ×HNLQ D\êUêQ  6DIHW\ *ĞYHQOLNOL LåQHGDPDUGDNDOêU<XNDUêGDD×êNODQGêåêJLEL×RNOXDOêPGXUXPXQGDDĒDåêGDNL60RQRYHWWHWĞSOHUL6DIHW\ *ĞYHQOLNOL LåQH\HEDåOD\êQYHGLåHUąUQHNOHULDOêQ.DQDOêPêQêQWDPDPODQPDVêQFH60RQRYHWWH®
+ EDåODQWêVêQêD\êUêQDUGêQGDQ6DIHW\ *ĞYHQOLNOL LåQH\LGDPDUGDQGêĒDUê×HNLQ7HNHOWHNQLåLQLNXOODQDUDN\DVDELWGĞ]ELU\Ğ]H\Ğ]HULQGHLåQH\Ldokunsal
YHLĒLWVHOELUNOLN\DSDUDNLåQHNRUX\XFXVXQDRWXUXQFD\D HWNLQOHĒWLULQFH\H NDGDULåQHNRUX\XFXVXQD\HUOHĒWLULQ\DGDLĒDUHWSDUPDåêQê]ODLåQHNRUX\XFXVXQXQDOWXFXQDEDVDUDNHWNLQOHĒWLULQ$\UêFDEN]
S-Monovette® 6DIHW\ LåQHYH\D 6DIHW\ 0XOWLIO\®LåQHNXOODQPDNêODYX]XHer bir S-Monovette®WĞSĞ6DIHW\ *ĞYHQOLNOL LåQHGHQ×êNDUGêNWDQKHPHQVRQUDNH]WHSHVLĞVWĞ WHUV ×HYLULQYHWĞPNDQDOPDLĒOHPLVRQDHUGLNWHQVRQUDDQWLNRDJĞODQL×HUHQWĞPąUQHNOHULELUND×NH]\DYDĒ×D
WHUV×HYLUHUHNNDUêĒWêUêQ7DĒêPDYHVDQWULIĞJDV\RQL×LQSLVWRQ×XEXåXQXGX\XOXUĒHNLOGHSLVWRQXQNLOLWOHQPHNRQXPXQD çekin (piston, S-Monovette®WĞSĞQWDEDQêQGDNL\HULQHJLUHU YH×XEXåXSLVWRQGDQ D\êUêQ
1.

3RQNVL\RQEąOJHVLQHNDQDPDGXUXQFD\DNDGDUNXUXVWHULOELUJD]OêEH]EDVWêUêQ

2.

.DQSêKWêODĒWêNWDQVRQUDLVWHQLUVHELUVDUJêX\JXOD\êQ

3.

6DIHW\ *ĞYHQOLNOL LåQH\LEL\RORMLNWHKOLNHOLPDGGHOHUH\ąQHOLNELUDWêNNDEêQGDEHUWDUDIHGLQ

232

TR
9DNXPWHNQLåLLOHNDQDOêPê
Dikkat! S-Monovette®WĞSOHULHQMHNVL\RQL×LQGHåLOVDGHFHNDQDOPDNL×LQNXOODQêQ
6DGHFHEXLåQHOHU 60RQRYHWWH®6DIHW\ *ĞYHQOLNOL LåQHOHU\DGD60RQRYHWWH® için (Safety) Multifly®LåQHOHUDGDSWąUOHU LOHELUOLNWHNXOODQêQ
6DIHW\ *ĞYHQOLNOL LåQHOHULOHX\JXODPDEXUDGDJąVWHULOPHNWHGLU

klik

6$567('7NDQDOêPêQêQD]LN×HEDĒODWPDNL×LQLON60RQRYHWWH®WĞSĞQHDVSLUDV\RQWHNQLåLQLNXOODQDUDNNDQDOêQPDVêQêWDYVL\HHGHUEN]9(,1381&7,217(&+1,48($VSLUDV\RQ7HNQLåL –$UGêQGDQYDNXPWHNQLåL\OHGHYDPHGLQ.DQêDOPDGDQąQFH×XEXåXQXNXOODQDUDNSLVWRQX60RQRYHWWH®WĞSĞQĞQWDEDQêQDNDGDU×HNLQYHVHV×êNDUWDFDNĒHNLOGH\HULQHRWXUPDVêQê VDåOD\êQ$UGêQGDQ×XEXåXSLVWRQGDQD\êUêQ .
+D]êUODQDQEX60RQRYHWWH® tüpü, S-Monovette®6DIHW\ *ĞYHQOLNOL LåQHQLQHQWHJUHWXWXFXVXQDLWLQYHhafifçe saat yönünde çevirerek sabitleyin

+

.

.

'RåUXGROXPDL]LQYHUPHNL×LQNDQDNêĒêGXUDQDNDGDUEHNOH\LQ

S-Monovette® tüpü hafifçe saat yönünün tersine çevirerek \HULQGHQR\QDWêQYHDUGêQGDQ6DIHW\ *ĞYHQOLNOL LåQHGHQ×HNLQ D\êUêQ  6DIHW\ *ĞYHQOLNOL LåQHGDPDUGDNDOêU<XNDUêGDD×êNODQGêåêJLEL×RNOXDOêPGXUXPXQGDąQFHDĒDåêGDNL60RQRYHWWHWĞSOHUL6DIHW\ *ĞYHQOLNOL LåQH\HEDåOD\êQYHGLåHUąUQHNOHULDOêQ.DQDOêPêQêQWDPDPODQPDVêS-Monovette®EDåODQWêVêQêNHVLQ + DUGêQGDQ6DIHW\ *ĞYHQOLNOL LåQH\LGDPDUGDQGêĒDUê×HNLQ7HNHOWHNQLåLQLNXOODQDUDN\DVDELWGĞ]ELU\Ğ]H\Ğ]HULQGHLåQH\LGRNXQVDOYHLĒLWVHOELUNOLN\DSDUDNLåQH
NRUX\XFXVXQDRWXUXQFD\D HWNLQOHĒWLULQFH\H NDGDULåQHNRUX\XFXVXQD\HUOHĒWLULQ\DGDLĒDUHWSDUPDåêQê]ODLåQHNRUX\XFXVXQXQDOWXFXQDEDVDUDNHWNLQOHĒWLULQ
Her bir S-Monovette®WĞSĞ6DIHW\ *ĞYHQOLNOL LåQHGHQ×êNDUGêNWDQKHPHQVRQUDNH]WHSHVLĞVWĞ WHUV ×HYLULQYHWĞPNDQDOPDLĒOHPLVRQDHUGLNWHQVRQUDDQWLNRDJĞODQL×HUHQWĞPąUQHNOHULELUND×NH]\DYDĒ×D
WHUV×HYLUHUHNNDUêĒWêUêQ
1.

3RQNVL\RQEąOJHVLQHNDQDPDGXUXQFD\DNDGDUNXUXVWHULOELUJD]OêEH]EDVWêUêQ

2.

.DQSêKWêODĒWêNWDQVRQUDLVWHQLUVHELUVDUJêX\JXOD\êQ

3.

6DIHW\ *ĞYHQOLNOL LåQH\LEL\RORMLNWHKOLNHOLPDGGHOHUH\ąQHOLNELUDWêNNDEêQGDEHUWDUDIHGLQ

233

TR
Santrifügasyon'..$76$567('760RQRYHWWHWĞSOHUL[L×LQWDVDUODQPêĒWêUVWLVQDRODUDN¢PP×DSOê60RQRYHWWHWĞSOHU 60RQRYHWWH®SHGL\DWUL KDOLKD]êUGD[JKê]DNDGDUGRåUXODQPêĒWêU6DGHFHX\JXQWDĒê\êFêWĞSOHUYH\DWĞSWXWXFXODUNXOODQêOPDOêGêUsDWODPêĒ60RQRYHWWHWĞSOHULQVDQWULIĞMOHQPHVLYH\DDĒêUêVDQWULIĞMKê]êX\JXODQDUDNVDQWULIĞMOHPH\DSêOPDVê60RQRYHWWHWĞSOHULQLNêUDUDNSRWDQVL\HORODUDNWHKOLNHOLPDGGHOHULD×êåD×êNDUDELOLU
6DQWULIĞMNRYDODUêWĞSWXWXFXODUêNXOODQêODQ60RQRYHWWHWĞSOHULQER\XQDJąUHVH×LOPHOLGLU%DåêOVDQWULIĞMKê]êD\DUODQDQGHYLUGDNLNDLOHDĒDåêGDNLLOLĒNL\HVDKLSWLU
BSK = 11,2 x r x (DevDk/1000)2,%6.%DåêOVDQWULIĞMKê]êD\Qê]DPDQGDJNXYYHWLRODUDNGDDGODQGêUêOêU QJLOL]FH5&)UHODWLYHFHQWULIXJDOIRUFH 
'HY'N'DNLNDGDWXUVD\êVê WXUGN YH\DQ 'DNLNDGDNLGHYLUVD\êVê QJLOL]FH530UHYROXWLRQVSHUPLQXWH "r": "Santrifüjün merkezinden S-Monovette®WĞSĞQWDEDQêQDNDGDURODQGąQPH\DUê×DSê FPFLQVLQGHQ -HOVL]60RQRYHWWHWĞSOHUVDELWD×êOêYH\DVDOODQDQNRYDURWRUOXVDQWULIĞMOHUGHVDQWULIĞMOHQHELOLU
-HOOL60RQRYHWWHWĞSOHUą]HOOLNOHVDOODQDQNRYDURWRUOXVDQWULIĞMOHUL×LQWDVDUODQPêĒWêU%XQODUêQVDELWD×êOêURWRUOXVDQWULIĞMOHUGHVDQWULIĞMOHQPHVL6$567('7WDUDIêQGDQGRåUXODQPDPêĒWêUYHąQHULOPH]
60RQRYHWWHWĞSOHUDĒDåêGDVêUDODQDQVDQWULIĞMNRĒXOODUêQDJąUHVDQWULIĞMOHQPHOLGLU%XQODUGDQEDĒNDNRĒXOODUNXOODQêODFDNVDEXQODUNXOODQêFêQêQNHQGLVLWDUDIêQGDQGRåUXODQPDOêGêU
60RQRYHWWHWĞSOHULQVDQWULIĞMGHNLWĞSWXWXFXODUDX\JXQĒHNLOGHRWXUGXåXQGDQHPLQROXQPDOêGêU7ĞSWXWXFXGDQWDĒDQ60RQRYHWWHWĞSOHUVDQWULIĞMEDĒOêåêQDWDNêOêSNêUêODELOLU6DQWULIĞMHĒLWĒHNLOGHGROGXUXOPDOêGêU/ĞWIHQVDQWULIĞMĞQNXOODQPDWDOLPDWODUêQDEDNêQ'..$7 .êUêN 60RQRYHWWH WĞSOHUL HOOH ×êNDUPD\êQ
6DQWULIĞMĞQ GH]HQIHNWH HGLOPHVLQH \ąQHOLN ELOJLOHU VDQWULIĞMĞQ NXOODQPD WDOLPDWODUêQGD EXOXQDELOLU

Göreceli santrifüj ivmesi (g)BS 4851+ (ABKodeksi) esas DIN EN ISO 6710
DOêQêU–S-Monovette®
2000 x g

2500 x g

3000 x g*

3500 x g*

4000 x g*

Serum

10 dk

10 dk

6 dk

4 dk

4 dk

Serum jel

15 dk

10 dk

4 dk

4 dk

4 dk

Serum Express jel

15 dk

10 dk

4 dk

d.d.

d.d.

Lityum heparin

10 dk

10 dk

7 dk

7 dk

7 dk

Lityum heparin jel

15 dk

15 dk

10 dk

7 dk

7 dk

Lityum heparin jel+

8 dk

7 dk

5 dk

4 dk

4 dk

EDTA

d.d.

d.d.

7 dk

6 dk

5 dk

EDTA jel

15 dk

10 dk

10 dk

7 dk

7 dk

Sitrat

9 dk

8 dk

7 dk

6 dk

5 dk

('7$ĲRUĞUKHSDULQ

9 dk

8 dk

7 dk

6 dk

5 dk

GlucoEXACT

9 dk

8 dk

7 dk

6 dk

5 dk

Sitrat PBM 1,8 ml
6DQWULIĞM\DUê×DSê!FP

9 dk

8 dk

7 dk

6 dk

5 dk

Sitrat PBM 1,8 ml
6DQWULIĞM\DUê×DSê!LODƉFPDUDVê

d.d.

d.d.

10 dk

d.d.

d.d.

GG GRåUXODQPêĒGHåLOPP×DSOê 60RQRYHWWHSHGLDWULNWĞSOHU KDUL×60RQRYHWWHWĞSOHULQKHSVLL×LQJH×HUOLGLU

20ºC'de santrifüjleyin+

British Standard BS4851:1982 Specification for single use labelled medical specimen containers for haematology and biochemistry,JHUL×HNLOPLĒ$\êUPDPDWHU\DOLKDNNêQGDELOJL$\êUPDPDWHU\DOLQLQ MHO DNêĒą]HOOLNOHULVêFDNOêåDEDåOêGêU60RQRYHWWHWĞSOHUVDQWULIĞJDV\RQGDQąQFHYH\DVDQWULIĞJDV\RQVêUDVêQGDVRåXWXOXUVDVĞUHNOLELUD\êUPDMHOWDEDNDVêJDUDQWLHGLOPH]
S-Monovette tüpler yeniden/tekrar santifüjlenmemelidir.

Bertaraf
1.

%XODĒêFêPDWHU\DOOHULQX\JXQĒHNLOGHEHUWDUDIHGLOPHVLQH\ąQHOLNJHQHOKLM\HQNXUDOODUêYH\DVDOKĞNĞPOHUGLNNDWHDOêQPDOêYHEXQODUDX\XOPDOêGêU

2.

7HNNXOODQêPOêNHOGLYHQOHUHQIHNVL\RQULVNLQLąQOHU3.

.RQWDPLQHYH\DGROGXUXOPXĒNDQDOPDVLVWHPOHULGDKDVRQUDRWRNODYODQêS\DNêODELOHQEL\RORMLNWHKOLNHOLPDGGHOHUL×LQX\JXQEHUWDUDINDSODUêQGDEHUWDUDIHGLOPHOLGLU

4.

%HUWDUDILĒOHPLX\JXQELU\DNPDIêUêQêQGDYH\DRWRNODYODPD EXKDUVWHULOL]DV\RQX \ROX\ODJHU×HNOHĒWLULOPHOLGLU

234

TR
«XDQGDJH×HUOLVĞUĞPOHUL\OHĞUĞQHPDKVXVVWDQGDUWODUYHNêODYX]ODUCLSI* GP39 ”Tubes and Additives for Venous and Capillary Blood Specimen Collection”, Approved Standard.
CLSI* GP41 ”Collection of Diagnostic Venous Blood Specimens”, Approved Standard.
CLSI* GP44 ”Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests”, Approved Guideline.
CLSI* H21 ”Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays”, Approved Guideline.
WHO/DIL/LAB/99.1 Rev02 ”WORLD HEALTH ORGANIZATION, et al. Use of anticoagulants in diagnostic laboratory investigations. Geneva: World Health Organization, 2002”.

9HQą]NDQDOêPWĞSOHULQH\ąQHOLNVWDQGDUW
',1(1,62QVDQODUGDYHQą]NDQDOêPêL×LQWHNNXOODQêPOêNWĞSOHU*CLSI (Clinical and Laboratory Standards Institute)

6HPEROYHLĒDUHWOHPHGL]LQL¶UĞQQXPDUDVê

6DGHFHWHNOLVWHULODPEDODMOêĞUĞQOHUL×LQJH×HUOLGLU

3DUWLWDQêPODPDVê$PEDODMKDVDUOê\VDNXOODQPD\êQ

Son kullanma tarihi'êĒNRUXPDDPEDODMOêWHNLOVWHULOEDUL\HUVLVWHPL&(LĒDUHWL,ĒêQODPDLOHVWHULOL]DV\RQ

In vitroWDQêFLKD]ê

.XOODQPDWDOLPDWêQêGLNNDWHDOêQ<HQLGHQNXOODQêPGXUXPXQGD.RQWDPLQDV\RQWHKOLNHVL*ĞQHĒêĒêåêQGDQNRUXQPXĒRODUDNPXKDID]DHGLQ.XUX\HUGHGHSROD\êQÜreticiÜretim ülkesi

6WHULOVêYê\ROX

Yeniden sterilize etmeyin

7HNQLNGHåLĒLNOLNKDNNêVDNOêGêU¶UĞQOHLOJLOLWĞPFLGGLROD\ODULPDODW×ê\DYH\HWNLOLXOXVDORWRULWH\HELOGLULOPHOLGLU

235

἗䓀完㖦 – SARSTEDT S-Monovette® 埘㵊慟晞䲓乷;)䓀Ḧừ⢮孢㕅
ḿ⑙䓀徬
4.POPWFUUF煂埘㵊慟晞䲓乷ǃ搠⣌␤徚惥☀ᶘ崏Ỵ᷒曱傡慟埘䲓乷἗䓀Ǆ4.POPWFUUF煂埘㵊慟晞䲓乷䓀Ḧ慟晞ǃ彨弫ǃ⢜䎞␤ή⫰埘㟏ʼṽὗ⛀᷌⸢⬶樤⬼⮑埘㶝ǃ埘㳞ㆮ℀埘彳埤ừ⢮孢㕅Ǆ㛄ḿ⑙孖嬹䓀Ḧᶫᶲ栞❷⸎ᶬṝἳ⋓䔯ᶫᶲṒ⏰␤⬶樤⬼⵽ỴṒ⏰἗䓀Ǆḿ⑙ṣ乥
4.POPWFUUF煂埘㵊慟晞䲓乷⊝㊄ᶘ㟑⟩㔱䬹ǃᶘ᷂㳓⟶ǃᶘ᷂㳓⟶㛞␤ᶘ᷂慟䓀⼁刊亮䞙䘜⟩㔱坒㕣䙮ʸℝⳤ儴ʹǄᶫ斀孖嬹䓀Ḧ彶㌽4.POPWFUUF煂ʸ⬡℀ʹ搠⣌ㆮʸ⬡℀ʹ.VMUJGMZ煂圌圎搠ʼℏ㚡ᶥ⎤㶓∸⇚ʸ⇎⇚ʹǄ⎤㖎㍨ἳᶥ⏃㶓∸⇚䘜4.POPWFUUF煂Ǆ4.POPWFUUF煂埘㵊慟晞䲓乷㇘⏃㶓∸⇚⊝㊄ˊὛⅵ⇚ǃὛⅵ⇚⍢↞䥓傎ǃ倵䲸撚ǃ倵䲸撚⍢↞䥓傎ǃ倵䲸搸ǃ㝸㩄愐䙨ǃ&%5"ǃ㮷⊮䈁&%5"ǃ㮷⊮䈁倵䲸ǃ㮷⊮䈁㝸㩄愐䙨ǃ$1%"ʼ㫼⢮彰㍨ἳ㕸㶓∸⇚䬹Ǆ㶓∸⇚㳫⸾ǃ㵊ừ㶓∸⇚ừ䦇⍢ℎ子⎇℄ⶆṽ⍢埘㵊ᶦ㶓∸⇚䘜㭬ἣ䪾⎠⚕旝㞟⅞%*/&/*40ǉᶘ㪹⾿἗䓀曱傡埘㟏慟晞⭑☀Ǌṽ⍢伦⚕᷌⸢␤⬶樤⬼㞟⅞⋧Ẳ$-4* 㞟⅞䘜夙㯚␤⺒孆Ǆ㶓∸⇚䘜御㊁⍮⅋Ḧ↞㜨㡘㳣㕑㱭Ǆ䓉㡘㳣἗䓀䘜㡘㳣孭⇚␤ㆮ↞㜨Ẃ⇎徸ⓞ㊟⬲Ǆ4.POPWFUUF煂埘㵊慟晞䲓乷䘜奜㟔⊝㊄ℝ悀䀅卤ㆮ⋭᷂⊝塝ℝ悀䀅卤␤⢮悀䀅卤Ǆ

4.POPWFUUF煂坒㕣䙮栴刊亮䞙ˊ

㶓∸⇚

⫯㭥亮䞙

䬹ⷕ栴刊%*/&/*40

䬹ⷕ栴刊㟑㌆#4

;

䘕刊

䘕刊

$"5

为刊

䘕刊

4.POPWFUUF 埘㶝䬹$"5ʼ⏃Ὓⅵ⇚␤↞䥓傎

$"5

㶉湜刊

㶉湜刊

4.POPWFUUF煂&YQSFTT埘㶝↞䥓傎䬹$"5ʼ⏃Ὓⅵ⇚ǃⅵ埘愎␤↞䥓傎

$"5

㧱刊



4.POPWFUUF煂倵䲸撚䬹-)ʼ⏃倵䲸撚

-)

亗刊

㧱刊

4.POPWFUUF煂㵊ừ倵䲸撚䬹-)ʼ⏃倵䲸撚

-)

亗刊

㧱刊

4.POPWFUUF煂倵䲸撚↞䥓傎䬹-)ʼ⏃倵䲸撚␤↞䥓傎

-)

亗刊

㧱刊

4.POPWFUUF煂倵䲸撚↞䥓傎 䬹-)ʼ⏃倵䲸撚␤⾃德↞䥓傎

-)

亗刊

㧱刊

/)

㡭刊

亗刊

㛂⬲ᷡ

呵刊

呵刊

㕸㶓∸⇚䬹
4.POPWFUUF煂᷅⾿䬹;埘㶝䬹
4.POPWFUUF煂埘㶝䬹$"5ʼ⏃Ὓⅵ⇚煂倵䲸撚䬹

4.POPWFUUF煂倵䲸搸䬹/)ʼ⏃倵䲸搸
4.POPWFUUF煂倵䲸撍䙨䬹")ʼ⏃倵䲸撍䙨㝸㩄愐䙨䬹
4.POPWFUU煂㝸㩄愐䙨䬹/$ʼ㝸㩄愐搸

/$

呵刊

亗刊

4.POPWFUUF煂1'"㝸㩄愐䙨䬹/$ʼ㝸㩄愐搸ʼⶊ享⅊

/$

㳝呵刊



,&

䳃刊

为刊

&%5"䬹
4.POPWFUUF煂&%5",䬹,&ʼ⏃&%5"摖䙨煂

4.POPWFUUF &%5",䬹,&ʼ⏃&%5"摖䙨

,&

䳃刊

为刊

4.POPWFUUF煂&%5",↞䥓傎䬹,&ʼ⏃&%5"摖䙨␤↞䥓傎

,&

䳃刊

为刊

4.POPWFUUF煂㮷⊮䈁&%5"䬹'&ʼ⏃㮷⊮䈁␤&%5"

'&

䀈刊

湜刊

4.POPWFUUF煂㮷⊮䈁倵䲸䬹')ʼ⏃㮷⊮䈁␤倵䲸

')



湜刊

4.POPWFUUF煂(MVDP&9"$5䬹'$ʼ⏃㮷⊮䈁ǃ㝸㩄愐䙨␤&%5"

'$

䰡刊

䀈刊

-)

㶉呵刊

㧱刊

4.POPWFUUF煂5ISPNCP&YBDU䬹ʼ⏃擙⊮⎠䈁㛂⬲ᷡ㛂⬲ᷡʼ㳞㜴为刊

㛂⬲ᷡʼ㳞㜴为刊

4.POPWFUUF煂$5"%䬹㛂⬲ᷡ㛂⬲ᷡʼ呵刊㛂⬲ᷡʼ亗刊

4.POPWFUUF煂"$%䬹

"$%

湜刊

湜刊

䱮愍奻㈩⇎⇚䬹⽆慧慩⯶↞㜨䬹
4.POPWFUUF煂⽆慧慩⯶↞㜨䬹-)ʼ⏃倵䲸撚ℎṮ℀埘䬹␤埘㳞䬹煂

4.POPWFUUF $1%"䬹

$1%"

湜刊

湜刊

4.POPWFUUF煂㯌嚅䲸䬹㛂⬲ᷡ㛂⬲ᷡʼ㧜㤜亗刊

㛂⬲ᷡʼ㧜㤜亗刊

4.POPWFUUF煂⎤✣⋢傉㯀愐)$:;↞䥓傎䬹ʼ⏃↞䥓傎␤䧋⬲⇚㛂⬲ᷡ㛂⬲ᷡʼ䀈刊㛂⬲ᷡʼ䀈刊

4.POPWFUUF煂⎤✣⋢傉㯀愐)$:$䬹ʼ⏃㝸㩄愐䙨享⅊㵊㛂⬲ᷡ㛂⬲ᷡʼ䳃刊㛂⬲ᷡʼ䳃刊

4.POPWFUUF煂%/"&YBDU䬹㛂⬲ᷡ㛂⬲ᷡʼ呵刊㛂⬲ᷡʼ呵刊

⎇㍨ἳℎṮ䬹ⷕ栴刊Ǆ
OEˊ㛂⬲ᷡ劉⚕㞟⅞#4ˊ4QFDJGJDBUJPOGPSTJOHMFVTFMBCFMMFENFEJDBMTQFDJNFODPOUBJOFSTGPSIBFNBUPMPHZBOECJPDIFNJTUSZʼⶊ⍮㴠Ǆ



;)
4"345&%54.POPWFUUF煂埘㶝䬹$"5埘㶝↞䥓傎䬹$"5
4.POPWFUUF煂埘㶝䬹$"5⏃㚡㴚⶛Ὓⅵ⇚ʸ䟝愐䙨ʹ䘜⟩㔱⽆䰪ʼ䓀Ḧ㓎晞埘㶝 Ǆ䥓⽛⎦⟩㔱⽆䰪ṣḦ埘乞偶␤埘㶝ᷣ斌Ǆ
4.POPWFUUF煂埘㶝↞䥓傎䬹$"5旼Ḟ⏃㚡㴚⶛Ὓⅵ⇚ʸ䟝愐䙨ʹ䘜⟩㔱⽆䰪⢮ʼ彰⏃㚡俲⎠䈁ⅵ傎ʼ䓀Ḧ㓎晞埘㶝 Ǆ彳埤彨弫ǃ⁀⫰␤↞㜨㖎ʼ䥓⽛⎦ⅵ傎⛀埘乞偶␤埘㶝ᷣ斌⻺ㆨ䧋⬲䘜↞䥓⯚Ǆ埘㶝塃䓀Ỵⷐ奜᷌⸢⊮⫾␤⃥䕃⫾㡘㳣ṽ⍢埘㶝⫾㡘㳣䘜㟏㛄㛨㔱Ǆ慟埘⎦ʼ⮞4.POPWFUUF煂埘㶝䬹$"5埘㶝↞䥓傎䬹$"5ή㊙䩮䚌ụ伆↞搷彳埤ⅵ埘ʼṽ䠆ή䥓⽛⎦⻺ㆨ㖦㗖↞䥓⯚Ǆ⺒孆䘜㖎斌➒Ḧ㫻ⷐ䘜ⅵ埘彟䦣Ǆ♸䕖䕝侤⫰⛀ⅵ埘昴䠥ㆮ㌽⍯㈯ⅵ㱓䔯䘜〻依䘜埘㵊⎇傕暘夙㚌攗㖎斌㇥傕⬤℀ⅵ⚒Ǆ

4"345&%54.POPWFUUF煂&YQSFTT埘㶝↞䥓傎䬹$"5
4.POPWFUUF煂&YQSFTT埘㶝↞䥓傎䬹$"5旼Ḟ⏃㚡㴚⶛Ὓⅵ⇚ʸⅵ埘愎ʹ䘜⟩㔱⽆䰪⢮ʼ彰⏃㚡俲⎠䈁ⅵ傎ʼ䓀Ḧ㓎晞埘㶝 Ǆ彳埤彨弫ǃ⁀⫰␤↞㜨㖎ʼ䥓⽛⎦ⅵ傎⛀埘乞偶␤埘㶝ᷣ斌⻺ㆨ䧋⬲䘜↞䥓⯚Ǆ慟埘⎦ʼ⮞4.POPWFUUF煂&YQSFTT埘㶝↞䥓傎䬹ή㊙䩮䚌ụ伆↞搷彳埤ⅵ埘ʼṽ䠆ή䥓⽛⎦⻺ㆨ㖦㗖↞䥓⯚Ǆ⺒孆䘜㖎斌➒Ḧ㫻ⷐ䘜ⅵ埘彟䦣ʼ⎤㟏徚䓀Ḧ倵䲸⊮〻依䘜埘㵊Ǆ♸䕖䕝侤⫰⛀ⅵ埘昴䠥ㆮ㌽⍯㈯ⅵ
㱓䔯ʸ⏃⢿⇚慧倵䲸ʹ䘜〻依䘜埘㵊暘夙㚌攗㖎斌㇥傕⬤℀ⅵ⚒Ǆ埘㶝塃䓀Ỵⷐ奜᷌⸢⊮⫾␤⃥䕃⫾㡘㳣ṽ⍢埘㶝⫾㡘㳣䘜㟏㛄㛨㔱Ǆ

4"345&%54.POPWFUUF煂᷅⾿䬹;
4.POPWFUUF煂᷅⾿䬹;ᶥ⏃㶓∸⇚ʼ埘㟏⛀㕸Ὓⅵ⇚䘜そ⅍ᶣ冂䃎ⅵ⚒ʼ䓀Ḧ㓎晞埘㶝 Ǆ䥓⽛⎦⛀埘乞偶␤埘㶝ᷣ斌⻺ㆨ↞䥓⯚Ǆ埘㶝塃䓀Ỵ〻依䈑⬲㡘㳣䘜㟏㛄㛨㔱Ǆ㫼⢮ʼ4.POPWFUUF煂᷅⾿䬹;᷷⎇Ỵ᷒䨒䬹἗䓀ʼℏừ㕑㱭⤚ᶣˊ4.POPWFUUF煂㝸㩄愐䙨䬹ᶦ.VMUJGMZ煂ʸ⬡℀ʹ圌圎搠ʸ侔搠ʹ乫⎠἗䓀彳埤慟埘㖎ʼ4.POPWFUUF煂᷅⾿䬹;⎇Ỵ᷒䫄ᶘ㓇慟埘䬹ʸ䨒䬹ʹ䓀Ḧ栜⃝.VMUJGMZ煂ʸ⬡℀ʹ圌圎搠䘜⺎攗䬹Ǆ

4"345&%54.POPWFUUF煂倵䲸撚䬹-)倵䲸撚↞䥓傎䬹-)倵䲸撚↞䥓傎 䬹-)ǃ倵䲸搸䬹/)ǃ倵䲸撍䙨䬹")4"345&%54.POPWFUUF煂倵䲸撚䬹-)倵䲸搸䬹/)倵䲸撍䙨䬹")⏃㚡㴚⶛㈯ⅵ⇚倵䲸撚倵䲸搸倵䲸撍䙨ʸ徲ⷐ᷒*6倵䲸NM埘㵊ʹ䘜⟩㔱⽆䰪ʼ䓀Ḧ㓎晞℀埘␤埘㳞 Ǆ䥓⽛⎦⟩㔱⽆䰪ṣḦ埘乞偶␤埘㳞ᷣ斌Ǆ⛀ᶥ⏃⟩㔱⽆䰪䘜4.POPWFUUF煂倵䲸撚䬹-)᷅ʼ㈯ⅵ埘⇚倵䲸撚ṽ╏暖㴚⯚⻺⺧⫰⛀ʸ徲ⷐ᷒*6倵䲸NM埘㵊ʹǄ
4.POPWFUUF煂倵䲸撚↞䥓傎䬹-)旼Ḟ⏃㚡㴚⶛㈯ⅵ⇚倵䲸撚ʸ徲ⷐ᷒*6倵䲸NM埘㵊ʹ䘜⟩㔱⽆䰪⢮ʼ彰⏃㚡俲⎠䈁ⅵ傎ʼ䓀Ḧ㓎晞埘㳞 Ǆ彳埤彨弫ǃ⁀⫰␤↞㜨㖎ʼ䥓⽛⎦ⅵ傎⛀埘乞偶␤埘㳞ᷣ斌⻺ㆨ䧋⬲䘜↞䥓⯚Ǆ
4.POPWFUUF煂倵䲸撚↞䥓傎 䬹-)⎤㟏⏃㚡俲⎠䈁ⅵ傎Ǆᶦ4.POPWFUUF煂倵䲸撚↞䥓傎䬹䚐㭬ʼℎ䥓⽛㖎斌⎇仁䞅举Ǆ倵䲸埘㳞塃䓀Ỵⷐ奜᷌⸢⊮⫾␤⃥䕃⫾㡘㳣䘜㟏㛄㛨㔱Ǆ倵䲸℀埘塃䓀Ỵⷐ奜᷌⸢⊮⫾␤⃥䕃⫾㡘㳣ṽ⍢埘㶝⫾㡘㳣䘜㟏㛄㛨㔱Ǆ倵䲸徲彟㽘㳓㈯ⅵ埘愎崏⇈㈯ⅵỴ䓀Ǆ
㷁楀㍨䣒ˊ4.POPWFUUF煂倵䲸撚䬹-)ǃ倵䲸撚↞䥓傎䬹↞䥓傎 䬹-)ᶥ⼯䓀Ḧ撚㳣⬲ʼ4.POPWFUUF煂倵䲸搸䬹/)ᶥ⼯䓀Ḧ搸㳣⬲ʼ4.POPWFUUF煂倵䲸撍䙨䬹")ᶥ⼯䓀Ḧ撍䙨㳣⬲Ǆ⠃⃝曱傡埘䘜
4.POPWFUUF煂倵䲸撚䬹倵䲸撚↞䥓傎䬹↞䥓傎 䬹倵䲸搸䬹倵䲸撍䙨䬹ᶥ⬴䓀Ḧ埘㮬↞㜨Ǆ

4"345&%54.POPWFUUF煂⽆慧慩⯶↞㜨䬹
4.POPWFUUF煂⽆慧慩⯶↞㜨䬹⏃㚡㈯ⅵ⇚倵䲸撚ʼ䓀Ḧ㓎晞℀埘␤埘㳞 Ǆ倵䲸撚ṽ╏暖㴚⯚⻺⺧⫰⛀ʸ*6倵䲸NM埘㵊ʹǄ
4.POPWFUUF煂⽆慧慩⯶↞㜨䬹ᶦᶫ䓀⬡℀搠⣌(Y煌ʸḿ⑙亮⎏ʹ乫⎠἗䓀ʼ㓎晞䘜倵䲸℀埘ㆮ倵䲸埘㳞塃䓀Ỵ⽆慧⃛䲸慩⯶⃛䲸㡘㳣䘜㟏㛄㛨㔱Ǆ徲彟⌷⫨⏐㓎⃡寉↞㜨㱭 ""4 㳣⬲⽆慧⃛䲸慩⯶⃛䲸Ǆ搠⮑⬡℀搠⣌␤4.POPWFUUF煂⽆慧慩⯶↞㜨䬹ʼ⽆慧⃛䲸䘜㚘⢿䨒䘕῔ʸOH䲓乷ʹ⤚ᶣˊ

⃛䲸

摢

擡

擥

撄

OH䲓乷









摝

摙

摴

撤

擈

摵

䟪

㯶

















煂

4.POPWFUUF 䘜㞟䬖ᶢ㲀㖦Ḟ⎜⃛䲸䘜㚘⢿䨒䘕῔Ǆ⽆慧⃛䲸䘜㳣⬲⍮⅋Ḧ倵䲸℀埘ㆮ倵䲸埘㳞䘜↞㜨㕑㱭Ǆ倵䲸徲彟㽘㳓㈯ⅵ埘愎崏⇈㈯ⅵỴ䓀Ǆ

4"345&%54.POPWFUUF煂㝸㩄愐䙨䬹/$
4.POPWFUUF煂㝸㩄愐䙨䬹/$⏃㚡㈯ⅵ⇚㝸㩄愐ᶡ搸ʼ䓀Ḧ㓎晞℀埘␤埘㳞 Ǆ㝸㩄愐ᶡ搸ṽ㐁⮬㹎㵊⻺⺧⫰⛀ʸ㝸㩄愐ᶡ搸㹎㵊ˋ徲ⷐ♳冥Ḭ⃽᷒ʹʼ⋸4.POPWFUUF煂㝸㩄愐䙨䬹㞟䦈⭑慧䘜Ǆ㝸㩄愐䙨ᶦ埘㵊䘜㶏⎠㭬ἣ᷒ʼ⌋ẕ㝸㩄愐䙨␤ẕ埘㵊Ǆ㫻䠆⠃⃝⮑↞㜨冋ℋ慥夙Ǆ㝸㩄愐䙨埘㳞塃䓀Ỵⷐ奜㫺埘⫾㡘㳣䘜㟏㛄㛨㔱Ǆ㝸㩄愐䙨ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ宏㲀ェ4.POPWFUUF煂㝸㩄愐䙨䬹ᶦ圌圎搠乫⎠἗䓀彳埤慟㟏␤⢜䎞㖎䘜㲀ェḣ树Ǆ

4"345&%54.POPWFUUF煂1'"䬹/$
4.POPWFUUF煂1'"䬹/$⏃㚡㈯ⅵ⇚㝸㩄愐ᶡ搸ʼ䓀Ḧ㓎晞℀埘␤埘㳞 Ǆ㝸㩄愐ᶡ搸ṽ㐁⮬㹎㵊⻺⺧⫰⛀ʸⶊ享⅊ˋQ)ʹʼ⋸4.POPWFUUF煂1'"䬹㞟䦈⭑慧䘜Ǆ㝸㩄愐䙨ᶦ埘㵊䘜㶏⎠㭬ἣ᷒ʼ⌋ẕ㝸㩄愐䙨␤ẕ埘㵊Ǆ㫻䠆⠃⃝⮑↞㜨冋ℋ慥夙Ǆ
4.POPWFUUF煂1'"䬹/$䘜℀埘塃䓀Ỵ4*&.&/4)FBMUIJOFFST1'"↞㜨Ẃ㳣⬲埘⮧㜗∷傕䘜㟏㛄㛨㔱ʼ⸎᷒㫼彳埤Ḟ樤孙Ǆ㝸㩄愐䙨ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ宏㲀ェ4.POPWFUUF煂1'"䬹ᶦ圌圎搠乫⎠἗䓀彳埤慟㟏␤⢜䎞㖎䘜㲀ェḣ树Ǆ

4"345&%54.POPWFUUF煂$5"%䬹
4.POPWFUUF煂$5"%䬹⏃㚡㈯ⅵ⇚㝸㩄愐ᶡ搸ǃ勎䡉ǃ儒劏␤⍤▿彖千ʼ䓀Ḧ㓎晞℀埘␤埘㳞 Ǆ$5"%ṽ㹎㵊⻺⺧⫰⛀ʼ⋸4.POPWFUUF煂$5"%䬹㞟䦈⭑慧䘜Ǆ$5"%ᶦ埘㵊䘜㶏⎠㭬ἣ᷒ʼ⌋ẕ$5"%
␤ẕ埘㵊Ǆ㫻䠆⠃⃝⮑↞㜨冋ℋ慥夙Ǆ
$5"%埘㳞塃䓀Ỵ㳣⬲埘⮧㜗♸⫨ 1' ǃ¢埘⮧㜗䎛噣䘕 煭5( ␤丼㹎愎⌷㽘㳓䈁㈩⇎⇚ 1"* 䘜㟏㛄㛨㔱ʼṽ⍢䓀Ḧⷐ奜㫺埘㡘㳣Ǆ傕⢷㈩⇎埘⮧㜗㽘㳓冋⮩⮧㖎ʼ䓀Ḧ倵䲸㱓䔯䘜䙩㳣Ǆ㝸㩄愐䙨ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ宏㲀ェ4.POPWFUUF煂$5"%䬹ᶦ圌圎搠乫⎠἗䓀彳埤慟㟏␤⢜䎞㖎䘜㲀ェḣ树Ǆ
㷁楀㍨䣒ˊ$5"%㗇湜刊䘜Ǆ4.POPWFUUF煂$5"%䬹⽝栓怗⃡ʸṒ⵽⃡␤冂䃎⃡ʹή⫰Ǆ⛀⻒䁠⃡乗ᶣ㙌曊崝彟⮧㖎Ẳ⮔册㶓∸⇚⣉㳓Ǆ

4"345&%54.POPWFUUF煂&%5",&,&䬹
4.POPWFUUF煂&%5",&䬹4.POPWFUUF煂&%5",&䬹⏃㚡㈯ⅵ⇚&%5",ㆮ&%5",ʼ䓀Ḧ㓎晞℀埘 Ǆ&%5",ㆮ&%5",ṽ╏暖㴚⯚⻺⺧⫰⛀ʸNH&%5"NM埘㵊ʹǄ
&%5"℀埘塃䓀Ỵ埘㵊⫾㡘㳣䘜㟏㛄㛨㔱Ǆ⸬⛀慟埘⎦♳⮧㖎ℝ⇎Ỵ埘㴚䇟Ǆ&%5"ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ
4.POPWFUUF煂&%5",&,&埘㟏᷷⎇䓀Ḧ⃥䕃埘㵊⫾䘜ⷐ奜㡘㳣␤Ẹ㝫䕝㳣孭Ǆ䓀㇏岷岻慟䓀䚐⸬䘜㡘㳣孭⇚↞㜨孖⢟ʸ⊝㊄⁀⫰㛹Ẏʹ樤孙㟏㛄㛨㔱㗇⎾徚䓀Ḧ孽㡘㳣Ǆ

4"345&%54.POPWFUUF煂&%5"↞䥓傎䬹,&4.POPWFUUF煂&%5"↞䥓傎䬹,&旼⏃㚡㈯ⅵ⇚&%5",⢮ʼ彰⏃㚡俲⎠䈁ⅵ傎ʼ䓀Ḧ㓎晞埘㳞 Ǆ&%5",ṽ╏暖㴚⯚⻺⺧⫰⛀ʸNH&%5"NM埘㵊ʹǄ彳埤彨弫ǃ⁀⫰␤↞㜨㖎ʼ䥓⽛⎦ⅵ傎⛀埘乞偶␤埘㳞ᷣ斌⻺ㆨ䧋⬲䘜↞䥓⯚Ǆ&%5"埘㳞塃䓀Ỵ↞⫨䕝㭪孢㕅䘜㟏㛄㛨㔱Ǆ&%5"ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ



;)
4"345&%54.POPWFUUF煂㮷⊮䈁&%5"䬹'&ǃ㮷⊮䈁倵䲸䬹')ǃ㮷⊮䈁㝸㩄愐䙨&%5"䬹'$ʸ⏃䱮愍奻㈩⇎⇚ʹ
4.POPWFUUF煂㮷⊮䈁&%5"䬹'&⏃㚡㈯ⅵ埘⇚&%5"ʸNHNM埘㵊ʹ␤㈩⇎䱮愍奻䘜㮷⊮䈁ʸNHNM埘㵊ʹʼ䓀Ḧ埘㳞慟晞 Ǆ㮷⊮䈁␤&%5"ṽ╏暖㴚⯚⻺⺧⫰⛀Ǆ
4.POPWFUUF煂㮷⊮䈁倵䲸䬹')⏃㚡㈯ⅵ埘⇚倵䲸ʸ*6倵䲸NM埘㵊ʹ␤㈩⇎䱮愍奻䘜㮷⊮䈁ʸNHNM埘㵊ʹʼ䓀Ḧ埘㳞慟晞 Ǆ㮷⊮䈁␤倵䲸ṽ╏暖㴚⯚⻺⺧⫰⛀Ǆ㮷⊮䈁⮑䱮愍奻䘜㈩⇎Ỵ䓀⛀⠃⃝慟埘䬹⎦举⮧㖎⺘⥣崏㓠ʼ⛀举⮧㖎⎦⬤℀崏㓠Ǆ♸㫼ʼ℀埘᷅䘜叹厜䱮⛀ⅸ⮧㖎⎦⸋⛟↞奻ʼ⮧㖎⎦↞奻Ǆ
4.POPWFUUF煂(MVDP&9"$5䬹'$⏃㚡㈯ⅵ埘⇚&%5"ṽ⍢⎇䩣⌋㈩⇎䱮愍奻䘜㝸㩄愐䙨␤㮷⊮䈁ʼ䓀Ḧ埘㳞慟晞 Ǆ&%5"ǃ㝸㩄愐䙨␤㮷⊮䈁ṽ㹎㵊⻺⺧⫰⛀Ǆ䓉Ḧ䦘慢䘜⌷♸ʼ嬹䬯埘䱮㳫⸾㖎暘夙ᷰṽǄ
4.POPWFUUF煂(MVDP&9"$5䬹'$䪾⎠⽏⚕䱮⯗䕝⋧Ẳ %%( 䘜⤢⦸㚷䱮⯗䕝㊟⋯␤**✣䱮⯗䕝䘜⚕⭎ή´㊟⋯ /7- Ǆ⛀⬼㷁ᶣ䠆ή℀埘᷅䘜埘䱮㳫⸾⌋⇓䧋⬲ʼ㖎斌攗彖⮧㖎ʼ⍚奙4"345&%58IJUF1BQFSIUUQTXXXTBSTUFEUDPNFOQSPEVDUTEJBHOPTUJDWFOPVTCMPPETNPOPWFUUFS-JUFSBUVSF牙4BSTUFEU4.POPWFUUF煂(MVDP&9"$5"CMPPEDPMMFDUJPOEFWJDFGPSTUBCJMJ[JOHHMVDPTFMFWFMTGPSIPVSTÿǄ
㮷⊮䈁&%5"ʸ㝸㩄愐䙨ʹ埘㳞塃䓀Ỵ埘䱮㳣⬲䘜㟏㛄㛨㔱Ǆ&%5"ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ
㷁楀㍨䣒ˊ㮷⊮䈁⎇⺭崏㹎埘∸慥ǄℋḦ⎇傕ḿ䒷⸊㈈⾿Ỵ䓀䘜䈁峀䘜孾乞ό〇ʼ宏⍚奙㡘㳣孭⇚⇎徸ⓞ䘜䚐ℋ἗䓀完㖦Ǆ宏㲀ェ4.POPWFUUF煂(MVDP&9"$5䬹ᶦ圌圎搠乫⎠἗䓀彳埤慟㟏␤⢜䎞㖎䘜㲀ェḣ树Ǆ

4"345&%54.POPWFUUF煂$1%"䬹
4.POPWFUUF煂$1%"䬹⏃㚡㈯ⅵ⇚㝸㩄愐搸␤㝸㩄愐ǃ䢏愐搸ǃ⎋㕣䱮␤儒▤⏼ʼ䓀Ḧ㓎晞℀埘␤埘㳞 Ǆ$1%"ṽ㹎㵊⻺⺧⫰⛀Ǆ$1%"ᶦ埘㵊䘜㶏⎠㭬ἣ᷒ʼ⌋ẕ$1%"␤ẕ埘㵊Ǆ㫻䠆⠃⃝⮑↞㜨冋ℋ慥夙Ǆ
$1%"℀埘埘㳞⎇Ỵ᷒弫埘⫾䘜埘✣埘㶝⫾㟏㛄㛨㔱ʼ䓀Ḧ弫埘㖎䘜䚐⭑⾿㳣孭ʸḼ⍡惥埘ʹǄℏừ㛽完ʼ4.POPWFUUF煂$1%"徚䓀Ḧ⊝㊄,FMM␤3I埘✣⛀ℝ䘜埘✣戌⬲ "# ǃ埘✣ᶥ奜↱㈯ừ䫳㡘ǃ⢲䈑⺚⾿
䚌㌽㈯Ṓ䎛噣䘕孭樤ʸ冋䫄⣁ʹṽ⍢἗䓀埘✣䚐⭑䘜⍯埘依埘㶝埘㳞彳埤䘜䚐⭑⾿㳣孭ʸᷓἿḼ⍡惥埘ʹǄ⁀⫰⇥䘜彨弫㖎斌㚘攗᷒⮧㖎ʸd$ᶣʼⶊ樤孙ʹǄ᷒Ḟ἗乞偶㰡日ʼ⽝栓⃠⮞㟏⑙䚌䩣⫰㓖⛀ⅈ䭉᷅冋⮩⮧㖎Ǆ昧⎦ʼ⎇⁧㘆徲埘㵊⇎⑙ᶘ㟏ή⫰⛀ⅈ䭉 d$ ᷅ʼ⛀攗彖⣁ℝ⮑ᶢ很↞㜨䈁彳埤㡘㳣ʸỞ䚌㌽㈯Ṓ䎛噣䘕孭樤᷒⣁ʹǄ徚䓀Ḧ㞉ⅵ晞㱭ʼἣ⤚ˊ἗䓀0SUIP$MJOJDBM%JBHOPTUJDT℄⎐䘜7JTJPO.BY埘✣↞㜨ẂǄᶽ䤙⅏⅓㟏⑙㛨㔱Ǆ䓀㇏岷岻慟䓀䚐⸬䘜㡘㳣孭⇚↞㜨孖⢟ʸ⊝㊄⁀⫰㛹Ẏʹ樤孙㟏㛄㛨㔱㗇⎾徚䓀Ḧ孽㡘㳣Ǆ㝸㩄愐䙨ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ宏㲀ェ4.POPWFUUF煂$1%"䬹ᶦ圌圎搠乫⎠἗䓀彳埤慟㟏␤⢜䎞㖎䘜㲀ェḣ树Ǆ

4"345&%54.POPWFUUF煂5ISPNCP&YBDU䬹
4.POPWFUUF煂5ISPNCP&YBDU䬹⏃㚡Ỵ᷒㈯ⅵ⇚䘜擙䙨ʼ䓀Ḧ㓎晞℀埘 Ǆ擙䙨ṽ╏暖㴚⯚⻺⺧⫰⛀Ǆ
4.POPWFUUF煂5ISPNCP&YBDU䬹䘜℀埘Ỵ᷒㟏㛄㛨㔱ʼ䓀Ḧ㌪旼㈯ⅵ⇚ʸ⤚ˊ&%5"ǃ㝸㩄愐䙨ǃ倵䲸ʹ安⮔䘜埘⮧㜗῟⾿ῧỦ䘜䍈对ʼ᷷䦈᷒῟⾿埘⮧㜗Ⅷ⮩䕟Ǆ旓㫺⍩䒷埘⮧㜗俲晞ʼ⎇⛀慟埘⎦⮧㖎ℝ㳣⬲⬶旝埘⮧㜗㔈慧Ǆ擙䥓⫨徲彟㈩⇎埘㞫䲸"ṽ⍢䓉"%1␤剉䒷♳䂇愐ṣ⮔䘜埘⮧㜗俲晞侤崏⇈㈯ⅵ埘Ỵ䓀Ǆ

4"345&%54.POPWFUUF煂㯌嚅䲸䬹
4.POPWFUUF煂㯌嚅䲸䬹⏃㚡㈯ⅵ⇚㯌嚅䲸ʼ䓀Ḧ㓎晞℀埘 Ǆ㯌嚅䲸ṽ╏暖㴚⯚⻺⺧⫰⛀Ǆ
㯌嚅䲸℀埘Ỵ᷒㟏㛄㛨㔱ʼ䓀Ḧ⛀30$)&%JBHOPTUJDT℄⎐䘜.VMUJQMBUF煂Ẃ☀ʸ埘⮧㜗∷傕↞㜨Ẃʹᶢ㳣⬲埘⮧㜗∷傕ʼ⸎᷒㫼彳埤Ḟ樤孙Ǆ䓀Ḧ䙩㳣㈯埘⮧㜗匇䈁䘜䔯㓠ʼ⸎㡘㳣ㆮ䫳㝽埘⮧㜗∷傕昴䠥Ǆ
4.POPWFUUF煂㯌嚅䲸䬹㗇ᶦ7FSVN%JBHOPTUJDB℄⎐ʸ䍈30$)&%JBHOPTUJDT℄⎐ʹ㏒㇣⺘⍩䘜ʼ䈑⇃䓀Ḧ⛀.VMUJQMBUF煂Ẃ☀彳埤埘⮧㜗∷傕㡘㳣Ǆ㯌嚅䲸䚌㌽㈩⇎ⅵ埘愎侤崏⇈㈯ⅵ埘Ỵ䓀ʼ♸㫼⎇⛀冂䃎䉎⾙ᶣ彳埤埘⮧㜗∷傕㡘㳣Ǆ

4"345&%54.POPWFUUF煂⎤✣⋢傉㯀愐)$:;↞䥓傎䬹)$:$䬹
4.POPWFUUF煂⎤✣⋢傉㯀愐)$:;↞䥓傎䬹旼Ḟ⏃㚡㴚⶛Ὓⅵ⇚ʸ䟝愐䙨ʹ䘜⟩㔱⽆䰪⢮ʼ彰⏃㚡䈑㬢䧋⬲⇚␤俲⎠䈁ⅵ傎ʼ䓀Ḧ㓎晞埘㶝 Ǆ彳埤彨弫ǃ⁀⫰␤↞㜨㖎ʼ䥓⽛⎦ⅵ傎⛀埘乞偶␤埘㶝ᷣ斌⻺ㆨ䧋⬲䘜↞䥓⯚Ǆ㶓∸⇚ṽ╏暖㴚⯚⻺⺧⫰⛀Ǆ
℀埘᷅䘜⎤✣⋢傉㯀愐⛀⬼㷁ᶣ⎇䧋⬲攗彖⮧㖎Ǆ⤚㜴⛀⮧㖎ℝ彳埤䥓⽛ʼ⛀埘乞偶␤埘㶝ᷣ斌㫻䠆⻺ㆨ↞䥓⯚ʼ↱⎤✣⋢傉㯀愐⎇⛀攗彖⮧㖎ℝή㊙䧋⬲Ǆ
4.POPWFUUF煂⎤✣⋢傉㯀愐)$:;↞䥓傎䬹䘜埘㶝Ỵ᷒㟏⑙㛨㔱䓀Ḧ㳣⬲⎤✣⋢傉㯀愐Ǆ4.POPWFUUF煂⎤✣⋢傉㯀愐)$:$䬹⏃㚡Ỵ᷒㈯ⅵ⇚䘜愐⾿㝸㩄愐䙨 Q)  ʼ䓀Ḧ㓎晞埘㳞 Ǆ㝸㩄愐䙨ṽ㹎㵊⻺⺧⫰⛀Ǆ䓉Ḧ䦘慢䘜⌷♸ʼ嬹䬯⎤✣⋢傉㯀愐㳫⸾㖎暘夙ᷰṽǄ℀埘᷅䘜⎤✣⋢傉㯀愐⛀⬼㷁ᶣ⎇䧋⬲彖⮧㖎ʼ⛀d$ᶣ⎇䧋⬲彖⮧㖎Ǆ
4.POPWFUUF煂⎤✣⋢傉㯀愐)$:$䬹䘜埘㳞Ỵ᷒㟏⑙㛨㔱䓀Ḧ㳣⬲⎤✣⋢傉㯀愐Ǆ
4.POPWFUUF煂⎤✣⋢傉㯀愐)$:$䬹᷅䘜㝸㩄愐䙨ᶦ搱䥓⫨乴⎠ʼ崏⇈㈯ⅵỴ䓀Ǆ宏㲀ェ4.POPWFUUF煂)$:$䬹ᶦ圌圎搠乫⎠἗䓀彳埤慟㟏␤⢜䎞㖎䘜㲀ェḣ树Ǆ

4"345&%54.POPWFUUF煂%/"&YBDU䬹
4.POPWFUUF煂%/"&YBDU䬹⏃㚡➒Ḧ&%5"䘜㈯ⅵ⇚ʼ䓀Ḧ㓎晞℀埘 Ǆ&%5"ṽ╏暖㴚⯚⻺⺧⫰⛀Ǆ
&%5"℀埘㟏㛄᷅䘜H%/"⎇ή㊙䧋⬲ǄH%/"⎇⛀ćᶣ⣁ǃ⬼㷁 d$ ᶣ⣁ǃ⅏啧 d$ ᶣ⣁␤ćᶣ冋⮩⸌ή㊙䧋⬲ʸⶊ樤孙ʹǄ㫼⢮ʼ䧋⬲⊮㟏⑙⎇乧⍯㪹⅏⅓奻⅓⽂䍇侤㰹㚡峀慧㋷⣉ʼ⍚奙ˊ4"345&%5䘕䙆᷾IUUQTXXXTBSTUFEUDPNFOQSPEVDUTEJBHOPTUJDWFOPVTCMPPETNPOPWFUUFS-JUFSBUVSF牙4"345&%54.POPWFUUF煂%/"&YBDU̖"/FX*7%$FSUJGJFE#MPPE$PMMFDUJPO5VCFGPS
$PMMFDUJPO 5SBOTQPSUBOE4UBCJMJ[BUJPOPG8IPMF#MPPEGPS(FOPNJD%/""OBMZTJTĀǄ&%5"ᶦ搱䥓⫨乴⎠ʼ⍩㊽㈯ⅵỴ䓀Ǆ㟏⑙㛨㔱䘜徚䓀⾿⍮⅋Ḧ↞㜨䈁␤㡘㳣孭⇚↞㜨Ẃ☀Ǆ∹⽝㲀ェ⇎徸ⓞ䘜䚐ℋ⺒孆Ǆ



;)
⬡℀㲀ェḣ树嫾⏢㲀ェḣ树 ᶘ凄栜旊㍂㕕ˊ἗䓀㛄ḿ⑙㖎ʼ宏䨗㇌㇣⣯␤ℎṮᶘ凄᷂Ṓ旊㈼塝⢟ʼṽή㈼冂ⶉ⃥⍯㻴⛀Ẹ㝫⾿㟏㛄㛨㔱␤Ẹ㝫⾿䕝⌷ừὍ⭋Ǆ 怍䃿぀㇘⛀㛒㜜䘜⅞↱␤㑥Ỵ㳙䦣ʼ㫻䠆⢜䎞㇘㚡䒷䈁㟏㛄␤撣⇁⮮撨䘜慟埘䓀ℏʸ搠⣌ǃ徚惥☀ʹǄᶘ㕾䚌㌽㌽奾⇈䒷䈁㟏㛄ㆮ塃⇒Ẽʼ宏䩣⌋⯉⋓ʼṽ怗⃥シ㝫)*7ǃ)$7ǃ)#7ㆮℎṮẸ㝫䕖䕝Ǆ宏἗䓀ⶾ㚡ℝ伆搠⣌㈼⣯䘜⬡℀慟埘☀.VMUJ犕Z煂⬡℀圌圎搠Ǆ宏ᶽ㟔怍⬠぀㇘⛀㛒㜜䘜⬡℀㓗䫮␤䦣⸧奜⬲Ǆ 徚䓀Ḧ䊄䩣㕸卤⊝塝ḿ⑙ˊ἗䓀⇥宏∹⽝Ṭ乞㡘㝽⎜᷂⊝塝㗇⎾㋷⛧ʼ⤚㚡㋷⛧ʼ宏⊗἗䓀Ǆ 㛄ḿ⑙᷒ᶘ㪹⾿䓀⑙Ǆ⸬⮞䓀Ḧ慟埘䘜㇘㚡撣⇁⮮撨䈁ừʸ搠⣌ǃ徚惥☀ʹ㈭⃽⇈ᶫ斀⫰㓖䒷䈁⌉昁⑙䘜〈⻫⫰⁀⭑☀᷅彳埤⸷⺛⢜䎞Ǆ 慟䓀曱傡䓱伆搠慟埘㖎ʼ⽝栓⛀慟埘⇥䠆嬼ⶊ㊡䃿㛒㜜夙㯚⎠奜㶝㲯䓱伆搠ʸḾ⌋἗䓀*7㹎㵊㶝㲯ʹǄ⮑䓱伆搠彳埤⎠奜⅊㲯⎇怗⃥→䍈撱宇䘜⬶樤⬼乫㜴Ǆ
 4.POPWFUUF煂⠃⃝ᶥ嵋Ẳ⮔册埘㵊ᶦ⇎⇚㶓∸⇚㭬ἣ撱宇ʼ⎇傕徸ㆨ↞㜨乫㜴撱宇Ǆ 䓀4.POPWFUUF煂慟晞␤⢜䎞䘜埘㵊ᶥ傕䓀Ḧ慥㕈㲀⮜⇈Ṓừ᷅Ǆ 崝彟ή峀㚷⎦宏⊗乿亅἗䓀㛄ḿ⑙Ǆή峀㚷Ḧ㊟⬲⸌㚠䘜㚘⎦ᶘ⣁⇈㚷Ǆḿ⑙⁀⫰㛄ḿ⑙⸬ή⫰⛀⬼㷁ᶣǄ旨⇎ ⶊ⠃⃝䘜4.POPWFUUF煂䘜⁀⫰㚷旨␤㷁⸾⍮⅋Ḧ⼝↞㜨䈁䘜ή⫰㚷旨Ǆ䓉⬶樤⬼⮑㫼彳埤孜ỈʼㆮṦ㡘㳣孭⇚↞㜨孖⢟⇎徸ⓞ䘜἗䓀完㖦᷅协⍮ό〇Ǆ ⌋἗⮞4.POPWFUUF煂䥓⽛⎦↞䥓→埘㳞ㆮ埘㶝␤ㆮ䒷ㆨ昬䥓⯚ʼ᷷ᶥᶘ⬲堀䣒⬤℀↞䥓→㇘㚡乞偶Ǆ㬣ựṻ宺ㆮ冂䃎↞奻Ẳ⼉⑥↞㜨䈁䘜㳫⸾Ǆ⮑↞㜨䈁䘜䧋⬲⾿彳埤孜Ỉ㖎⸬供嗩⁀⫰⭑☀␤⎜⬶樤⬼䘜㛹ẎǄ ⤚㜴㗇㱓䔯⾿匇䈁ʼ宏⛀㡘㳣孭⇚↞㜨孖⢟⇎徸ⓞ䘜἗䓀完㖦᷅㝽䚣㟏⑙㛨㔱䘜徚䓀⾿Ǆ 彳埤⽆慧⃛䲸慩⯶䘜↞㜨㖎ʼ夙἗䓀4.POPWFUUF煂⽆慧慩⯶↞㜨䬹 ⽆慧慩⯶↞㜨⬡℀搠⣌Ǆ慟㟏⍢㑥Ỵ彳埤曱傡慟埘ᷣ⇥ʼ宏Ṭ乞⬤㔌斝宓㛄㔟Ǆ慟㟏㇘暘⵽Ỵ㛨㔱 嵋⢷㔈慧䘜4.POPWFUUF煂慟埘䓀⑙Ǆ ʸ⬡℀ʹ搠⣌ㆮ.VMUJ犕Z煂⬡℀圌圎搠Ǆ ㇣⣯ǃ⵽Ỵ㚥ǃ㈼䚆擴ṽ⍢ℎṮ⽝夙䘜旊㈼㚥ʼ栜旊埘㵊Ẹ㑅䕝⌷ừㆮ㻴⛀Ẹ㝫⾿䕖䕝Ὅ⭋Ǆ 〻依孞⇃㞟䬖Ǆ 䓀Ḧ㶝㲙慟埘ụ伆䘜㴠㭪㛨㔱ʸ⅞⢟慟埘ụ伆㖎⸬怍⬠㇘⛀㛒㜜䘜㕸卤慟埘㊟ṼʹǄ⤚㜴慟晞埘㵊彳埤埘㵊ℝ惪䱖⏃慧㳣孭ʼ↱⊗䓀惪䱖䰓㶝㲙⇚Ǆ ⸊䅽ǃ⮩卤䘜ᶘ㪹⾿㊅⫨Ǆ 㫺埘ⶾǄ ↳⎇峌␤亏ⶾǄ 䓀Ḧ⬡℀⸷⺛⢜䎞撣⇁⮮撨⸷⺛㛨㔱䘜⸷㔱⭑☀Ǆ⺒孆慟晞㳙䦣ˊ 埘➑ℓ䒎 ⏃㝸㩄愐䙨ㆮὛⅵ⇚䘜慟埘䬹ʸ⏃ᶥ⏃↞䥓傎䘜埘㶝䬹$"5埘㶝↞䥓傎䬹$"5ʹ ⏃Ὓⅵ⇚ㆮ㝸㩄愐䙨䘜慟埘䬹 倵䲸䬹倵䲸↞䥓傎䬹
 &%5"䬹&%5"↞䥓傎䬹 䱮愍奻㈩⇎⇚䬹 ℎṮ㶓∸⇚䬹
㷁楀㍨䣒ˊ㝸㩄愐䙨䬹ㆮ⏃ℎṮ㵊ừ㶓∸⇚ʸ⤚ˊ1'"ǃ$5"%ǃ$1%"ǃ)$:$ㆮ(MVDP&9"$5ʹ䘜慟埘䬹ᶦ圌圎搠ʸἣ⤚ˊ.VMUJ犕Z煂ʸ⬡℀ʹ圌圎搠ʹᶘ崏䓀Ḧ慟㟏㖎ʼ⺒孆栜⃝ᶘ᷂䨒䬹ʸἣ⤚ˊ4
.POPWFUUF煂᷅⾿䬹;ʹʼṽ怗⃥圌圎搠弇䬹⠃⃝ᶥ嵋Ǆ影㖀⛀䠆ή慟埘䬹㫻䠆⠃⃝ʼṽή孙ʸ㵊ừ␤埘㵊ʹ㶏⎠㭬ἣ㫻䠆Ǆ
㷁楀㍨䣒ˊ慟埘栒⸧⸬怍⽂぀㇘⛀㛒㜜䘜奜䩸Ǆ怗⃥♶㳙⢿悀↞4.POPWFUUF⏃㚡⊮⫾㶓∸⇚Ǆ᷒怗⃥♶㳙ʼ栓㲀ェṽᶣ㍨䣒ˊ ṝ἗䓀⛀἗䓀完㖦᷅㍀勨䘜㛨㔱Ǆ Ṽ〻依⢜Ḧ㖫Ḧ曱傡䨗⇒䘜ừụʼ⸎἗〻依㇣党ㆮℎṮ䨗⇒悀ụ⯕⎇傕㚵ᶣǄ ᶦ.VMUJ犕Z煂ʸ⬡℀ʹ圌圎搠ᶘ崏἗䓀㖎ʼ㍹ủ4.POPWFUUF煂ʼ坒㕣䙮㚵ᶢ伆Ḧʼ㇣党䨗⇒悀ụṽᶣǄ ⽝栓䠆ή⛀曱傡䨗⇒㖎4.POPWFUUF煂䘜ℝ⭑䈁ᶥẲ㌽奾⇈坒㕣䙮␤搠⣌㛃䪇Ǆ ⛀埘㵊㳙⃽4.POPWFUUF煂㚷斌㜖⺘㫺埘ⶾǄ



;)
⅏⅓奻⅓
㟑㌆ᶮ䓤⌃䒷乜也䘜⺒孆 8)0%*--BC3FW ʼ⺒孆⛀⅏⅓⇥⮞埘㶝埘㳞ᶦ埘乞偶↞䥓Ǆṽᶣ⅏⅓⺒孆徚䓀Ḧ4.POPWFUUF煂ˊ⛀d$ṽᶣ⅏⅓牜⛀暎ᶣ㷁⸾力⚌἗䓀㖎ʼ⌷↱ᶢ⽝栓⛀⬶旝㛹Ẏᶣ彳埤㳣孭Ǆ♸᷒慟埘䬹䘜岷匏♸⅏⅓ṣ峀␤ⷐ奜㛹Ẏ䘜ᶥ⎤侤ⶆ⺚ⶀ⢿ʸ⍚奙4"345&%5䚆⻭䘜㛨㔱䈑⾿䩸刚ʹǄ牜⌷↱ᶢʼ⛀ỦḦć䘜㷁⸾力⚌ℝʼ⟩㔱䘜⻒⸾῔Ẳ日ỦǄ♸㫼ʼᶘ凄そ⅍ᶣ夙怗⃥㛒㡈岷匏Ǆ牜

御㊁⅏⅓㛹Ẏ㖎ʼ夙䠆ή4.POPWFUUF煂ℝ⭑䈁⛟⊘⛈ㆮṦ⸭悀⇈栎悀⅓乫Ǆ4.POPWFUUF煂⛀䬹㝎ㆮ⁀⫰䭉᷅⸬㚡嵋⢷䘜兀偘䨒斌Ǆᶥ⬴἗䓀俲劇ᷱ䂇㱹㱃ㆮ慩⯶㛨峀䘜䬹㝎ʼ⎾↱⎇傕⮔册兀偘⺘塚Ǆ

⅏⅓冋d$û⅏⅓⇥㡘㝽ˊ牜

⸊㈈ˊ㡘㝽⅏⅓㗇⎾⮑埘㟏ㆮ↞㜨㚡ẓử⸊㈈⾿⼉⑥ʸἣ⤚ˊ㹎埘ǃ↞㜨䈁䘜䧋⬲⾿ʹǄ牜䥓⽛ˊ⍮⅋Ḧ㇘夙彳埤䘜↞㜨Ǆ䥓⽛㛹Ẏʼ⍚奙㛄㔟Ẏÿ䥓⽛Ā䩸刚ㆮ4"345&%5仩䩱IUUQTXXXTBSTUFEUDPNFOTFSWJDFDFOUSJGVHBUJPOʼ⸎⮑㟏⑙彳埤⢮奚㡘㝽Ǆ牜㹎埘ˊ℀埘⛀⅏⅓䉎⾙ᶣẲ→䍈㹎埘ˊ᷒怗⃥影䥥そ⅍ʼ⸬἗䓀4.POPWFUUF煂↞䥓傎䬹ㆮ⛀䥓⽛⎦἗䓀4FSBQMBT煂斘⺧彟㹼☀ʼㆮ⮞㟏⑙䦓⃽Ḥ丿⭑☀Ǆ

⅏⅓冋d$ûㇿ埤ˊ牜⅏⌌ˊ⮞4.POPWFUUF煂䚌䩣↞搷ʼṦ⬼㷁⅏⌌冋 ćʼ䃎⎦⛀ćᶣ⅏⅓Ǆ

牜

奻⅓ˊ⛀⬼㷁ᶣ䚌䩣奻⅓冋⮩↞搷Ǆ㫼㖎᷷⽝栓怗⃥㛒㡈岷匏Ǆ奻⅓彟⾃㚡⎇傕⮑↞㜨乫㜴徸ㆨ⼉⑥Ǆćṽᶣ⅏⅓␤㶉⸾⅏⅓牜⇎徸ⓞ⮲㛂⮑ćṽᶣ䘜㶉⸾⅏⅓彳埤㳣孭Ǆ䓉Ḧ⫰⛀⢿慧⎇傕䘜⼉⑥♸䲸ʼ⺒孆⛀ⷐ奜⬶樤⬼㛹Ẏᶣ彳埤⅏⅓㳣孭Ǆ

⅏⅓4.POPWFUUF煂↞䥓傎䬹ˊ牜㊡䃿ÿ⅏⅓冋d$ûㇿ埤Ā᷅㇘很彳埤Ǆ牜ⶊ䝽↞䥓傎⯚Ẳ♸⅏⅓彟䦣侤⍩䒷⍰⊮Ǆ牜䓉Ḧ⫰⛀⢿慧⎇傕䘜⼉⑥♸䲸ʼ⺒孆⛀ⷐ奜⬶樤⬼㛹Ẏᶣ彳埤⅏⅓㳣孭Ǆ牜

奻⅓ˊ䚌䩣奻⅓㟏⑙Ǆ䓀䦓㵊☀⮞奻⅓⎦䘜㟏⑙㛨㔱Ṧᶘ丿⭑☀弄䦓⇈Ḥ丿⭑☀᷅ʸᶥ㗇ῖᾪʹʼ䚌冋↞䥓傎⯚ᶢ㕑举NNǄᶺ⺛∁ự悀↞Ǆ
㷁楀㍨䣒ˊ⮑Ḧ↞㜨䈁䘜䧋⬲⾿ʼ⽝栓怍⬠㳣孭孭⇚↞㜨Ẃ⇎徸ⓞ䘜἗䓀完㖦Ǆ



;)
埘㵊慟晞
慟晞㕑⺧
慟晞㕑⺧↞ᶼ䥥ˊ㉕⏐⺧␤䚷䨒⺧Ǆ
㉕⏐⺧徲彟㌿⇎㳓⟶㛞䘜㉡≀そ⅍ʼṽ彶亅享ヺ䘜埘㳙彳埤㷁␤慟埘Ǆ慟䓀影䥥㕑⺧ʼ埘㳙⎇ṽ徚⸬⎜䥥曱傡㛹Ẏ␤そ⅍ʼ⸎⎇Ⅷ⮩㹎埘䍈对Ǆ䚷䨒⺧㟑㌆岷⌣⌷䎞彳埤慟埘ʼ徲彟栜伆䚷䨒⭑☀ṽ㊙亅⾃德䘜埘㳙彳埤慟埘Ǆ♸㫼ʼ孽㕑⺧䈑⇃徚䓀Ḧ曱傡㛹Ẏ切⤕␤慟埘⭑㖫䘜〻依Ǆ
ℋḦ埘㵊慟晞䘜㑥Ỵˊ⍚奙㉕⏐⺧⍢䚷䨒⺧4.POPWFUUF煂⍢⬡℀搠⣌␤.VMUJGMZ煂⬡℀圌圎搠䘜㑥Ỵ奞栩ˊ
XXXTBSTUFEUDPNFOEPXOMPBEWJEFPT%JBHOPTUJDT7FOPVTCMPPE
᷒Ḟ⯕慧Ⅷ⮩㙌曊桦昁ʼ⛀慟埘㖎⸬ἁ㇌㇣⣯Ǆ
 御㊁䓀Ḧ㇘暘埘㟏䘜徚⻫4.POPWFUUF煂Ǆ

御㊁曱傡䨗⇒悀ụǄ⅞⢟曱傡䨗⇒ụ伆㖎ʼ宏怍⬠㇘⛀㛒㜜䘜㊟ṼǄ

㉕⏐⺧慟埘
㲀ェʱ4.POPWFUUF煂ṝ䓀Ḧ慟埘ʼᶥ傕䓀Ḧ㲀⮜Ǆṝᶦ孽搠⣌ʸ4.POPWFUUF煂ʸ⬡℀ʹ搠⣌ʼㆮ.VMUJGMZ煂ʸ⬡℀ʹ圌圎搠4.POPWFUUF煂徚惥☀ʹᶘ崏἗䓀Ǆṽᶣ㗇⬡℀搠⣌䘜἗䓀㕑㱭ˊ䁑↓⛀曱傡䨗⇒⇥ʼ⮞4.POPWFUUF煂㍀⃽⬡℀搠⣌㊙搠☀᷅ʼ⸎ 栒㖎搠弓弓弄≀ṽ⮞ℎ⚒⬲ Ǆ㟑㌆暘夙἗䓀曱傡㫺埘ⶾʸ㚘攗↞搷ʹǄ⮑㉕埘悀ụ彳埤㴠㭪⢜䎞Ǆ㴠㭪⎦宏⊗奾㐐曱傡䨗⇒悀ụǄṼ〻依⢜Ḧ㖫Ḧ曱傡䨗⇒䘜ừụʼ⸎἗〻依㇣党ㆮℎṮ䨗⇒悀ụ⯕⎇傕㚵ᶣǄ

㏰ᶣ搠⣌㈼⣯Ǆ曱傡䨗⇒㖎ʼ享ヺ♶㉡㳓⟶㛞ʼ⸎⛀埘㵊㳙⃽4.POPWFUUF煂㚷斌㜖⺘㫺埘ⶾ Ǆ䫡⼝埘㳙ῴ㫺ʼṽ䠆ή㫻䠆⠃⃝Ǆ⮞4.POPWFUUF煂 從㖎搠弓弓弄≀ ʼṦ⬡℀搠⣌ᶢ㉬ᶣʸ奻旼彶㌽ʹ Ǆ⬡℀搠⣌䓱⛀曱傡᷅Ǆ⤚暘慟晞⢲䬹埘㟏ʼ⸬⤚ᶢ㇘很ʼἵ㪹⮞4.POPWFUUFT慟埘䬹彶㌽冋⬡℀搠⣌ʼ乿亅慟埘Ǆ慟埘⬤ㆨˊ⃠⍮ᶣ4.POPWFUUF煂   ʼ䃎⎦℥⮞⬡℀搠⣌Ṧ曱傡᷅㉬→Ǆ慟䓀⋭㇣㑥Ỵ㱭ʼ⛀ᶘ᷂䧋⚒⸋⛾䘜堀曺ᶢʼ䚌⇈搠⣌⛀搠⣌㈼⣯᷅⋹䲿ʸ㽘㳓ʹʼ⎇シ䝽⸎⏄⇈ÿ␬⑪Ā⢈᷒㫺ˋㆮ依䓀桷㊟⌣ủ搠⣌㈼⣯ᶣ䪇ṽ⋹䲿ʼ宏⍚奙4.POPWFUUF煂ʸ⬡℀ʹ搠⣌ㆮ.VMUJGMZ煂ʸ⬡℀ʹ圌圎搠䘜἗䓀完㖦Ǆ⛀㉬ᶣ⬡℀搠⣌⎦ʼ䩣⌋⮞⎜4.POPWFUUF煂ᾪ伆㗛≀ᶘ㪹Ǆ⛀⬤ㆨ℀悀慟埘⎦ʼ⮞㇘㚡ⶾ㈯ⅵ⇚䘜埘㟏ᾪ伆⮧⽛㗛≀㔈㪹ʱ搠⮑彨弫␤䥓⽛ˊ⮞㳓⟶㛞㉡⇈㳓⟶ 䘜⋹䲿ụ伆⸎⏄⇈⢈⑥ʸ㳓⟶⛀4.POPWFUUF煂⸭悀⋹䲿ʹʼ⸎㈰㕅㳓⟶㛞 Ǆ䓀⸊䅽䘜㕸卤㡡䬖㊡⌣䨗⇒悀ụʼ䚌⇈→埘ῴ㫺Ǆᶘ㕾→䍈ⅵ埘ʼ⤚㚡暘夙ʼ⎇ṽ彳埤⊝㇦Ǆ

⮞⬡℀搠⣌伆Ḧ䒷䈁⌉昁⑙⸷䈁⭑☀᷅⸷⺛⢜䎞Ǆ



;)
䚷䨒⺧慟埘
㲀ェʱ4.POPWFUUF煂ṝ䓀Ḧ慟埘ʼᶥ傕䓀Ḧ㲀⮜Ǆṝᶦ孽搠⣌ʸ4.POPWFUUF煂ʸ⬡℀ʹ搠⣌ʼㆮ.VMUJGMZ煂ʸ⬡℀ʹ圌圎搠4.POPWFUUF煂徚惥☀ʹᶘ崏἗䓀Ǆṽᶣ㗇⬡℀搠⣌䘜἗䓀㕑㱭ˊ䁑↓᷒Ḟ弓㝬⛈⺘⥣慟埘ʼ4"345&%5⺒孆⃠䓀㉕⏐⺧4NPOPWFUUF煂ʼ⍚奙曱傡䨗⇒㈘㛇㉕⏐⺧ ̖ Ǆ䃎⎦℥䓀䚷䨒⺧乿亅Ǆ慟埘ᷣ⇥ʼ⃠䓀㳓⟶㛞⮞㳓⟶㉡⇈4.POPWFUUF煂⸭悀⸎⏄⇈⋹䲿⢈ Ǆ䃎⎦㈰㕅㳓⟶㛞 Ǆ⮞影㓇⅞⢟⤕䘜4.POPWFUUF煂㍀⃽4.POPWFUUF煂⬡℀搠⣌㊙搠☀᷅ʼ⸎栒㖎搠弓弓弄≀ṽ⮞ℎ⚒⬲   Ǆ䫡⼝埘㳙ῴ㫺ʼṽ䠆ή㫻䠆⠃⃝Ǆ⮞4.POPWFUUF煂 從㖎搠弓弓弄≀ ʼṦ⬡℀搠⣌ᶢ㉬ᶣʸ奻旼彶㌽ʹ Ǆ⬡℀搠⣌䓱⛀曱傡᷅Ǆ⤚暘慟晞⢲䬹埘㟏ʼ⸬⤚ᶢ㇘很ʼἵ㪹⮞4.POPWFUUFT慟埘䬹彶㌽冋⬡℀搠⣌ʼ乿亅慟埘Ǆ慟埘⬤ㆨˊ⃠⍮ᶣ4.POPWFUUF煂
ʼ䃎⎦℥⮞⬡℀搠⣌Ṧ曱傡᷅㉬→Ǆ慟䓀⋭㇣㑥Ỵ㱭ʼ⛀ᶘ᷂䧋⚒⸋⛾䘜堀曺ᶢʼ䚌⇈搠⣌⛀搠⣌㈼⣯᷅⋹䲿ʸ㽘㳓ʹʼ⎇シ䝽⸎⏄⇈ÿ␬⑪Ā⢈᷒㫺ˋㆮ依䓀桷㊟⌣ủ搠⣌㈼⣯ᶣ䪇ṽ⋹䲿Ǆ⛀㉬ᶣ⬡℀搠⣌⎦ʼ䩣⌋⮞⎜4.POPWFUUF煂ᾪ伆㗛≀ᶘ㪹Ǆ⛀⬤ㆨ℀悀慟埘⎦ʼ⮞㇘㚡ⶾ㈯ⅵ⇚䘜埘㟏ᾪ伆⮧⽛㗛≀㔈㪹ʱ䓀⸊䅽䘜㕸卤㡡䬖㊡⌣䨗⇒悀ụʼ䚌⇈→埘ῴ㫺Ǆᶘ㕾→䍈ⅵ埘ʼ⤚㚡暘夙ʼ⎇ṽ彳埤⊝㇦Ǆ

⮞⬡℀搠⣌伆Ḧ䒷䈁⌉昁⑙⸷䈁⭑☀᷅⸷⺛⢜䎞Ǆ



;)
䥓⽛
㲀ェʱ4"345&%54.POPWFUUF䘜孖嬹䥓⽛∳᷒ YHǄ4.POPWFUUF煦NNʸ4.POPWFUUF煂⃗䥩ʹ旼⢮ʼℎ⻫⇥ⶊ樤孙䥓⽛∳⎇彖 YHǄṝ⎇἗䓀⎠徚䘜㓇㐩䬹ㆮ㓇㝎Ǆ⮑㚡塚乑䘜4.POPWFUUF彳埤䥓⽛ㆮ䥓⽛㖎䘜∸德⸾彟橰ʼ⎇傕Ẳ㋷⛧4.POPWFUUFʼṦ侤⮔册㻴⛀䘜Ẹ㝫⾿䈁峀㱜㺧Ǆ⸬㟑㌆㇘἗䓀䘜4.POPWFUUF⯒⮐御㊁䥓⽛㛒㓇㝎Ǆ䚐⮑䥓⽛∳ᶦ孖⬲䘜㭧↞搷弄㔈ℋ䲓⤚ᶣ㇘䣒ˊ
3$'YSY 31. 
3$'ˊÿ䚐⮑䥓⽛∳Āʼʸ劉㔟ˊ3$'SFMBUJWFDFOUSJGVHBMGPSDFʹʼÿ31.Āˊÿ㭧↞搷弄㔈Ā SNJO ʼㆮˊOÿ㭧↞搷弄德Āʸ劉㔟ˊ31.ÿSFWPMVUJPOTQFSNJOVUFĀʹʼÿSĀÿṦ䥓⽛㛒᷅⽛⇈4.POPWFUUF煂⸭悀 DN 䘜㕣弄⋢⼜Ǆᶥ⏃↞䥓傎䘜4.POPWFUUF⎇⛀⚒⬲奪⸾ㆮ㏞≀⺧弄⫨䥓⽛㛒᷅彳埤䥓⽛Ǆ⏃↞䥓傎䘜4.POPWFUUF⎂傕䓀㏞≀⺧弄⫨䥓⽛㛒彳埤䥓⽛Ǆ4"345&%5㛂⮑἗䓀⚒⬲奪⸾弄⫨䥓⽛㛒䥓⽛彳埤樤孙ʼ♸㫼ᶥ㍀勨἗䓀Ǆ
4.POPWFUUF⸬㟑㌆ᶣ㕑↯→䘜䥓⽛㛹Ẏ彳埤䥓⽛Ǆ⤚㜴慟䓀ℎṮ㛹Ẏʼ↱⽝栓䓉䓀㇏冂埤樤孙Ǆ
⽝栓䠆ή4.POPWFUUF㫻䠆㓖伆⛀䥓⽛㛒㓇㝎᷅ǄỐ→㓇㝎⢮䘜4.POPWFUUF⎇傕Ẳ⋹⛀䥓⽛㛒⣌ᶢ⸎㕅塚Ǆ⽝栓⛟⊘⠃⃝䥓⽛㛒Ǆ᷒㫼ʼ⸬∹⽝㲀ェ䥓⽛㛒䘜἗䓀完㖦Ǆ⮧⽛ʱ䤙㫺䓀㇣⍮→㕅塚䘜4.POPWFUUFǄ
䥓⽛㛒㴠㭪㲀ェḣ树⍚奙䥓⽛㛒἗䓀完㖦Ǆ

㟑㌆#4ʸ㪿䙷ṻ䞙ʹ

䚐⮑䥓⽛∸德⸾ H
4.POPWFUUF煂

%*/&/*40

̖YHYHYHYHYH

埘㶝䬹

↞搷

↞搷

↞搷

↞搷

↞搷

埘㶝↞䥓傎䬹

↞搷

↞搷

↞搷

↞搷

↞搷

&YQSFTT埘㶝↞䥓傎䬹

↞搷

↞搷

↞搷

㛂樤孙

㛂樤孙

倵䲸撚䬹

↞搷

↞搷

↞搷

↞搷

↞搷

倵䲸撚↞䥓傎䬹

↞搷

↞搷

↞搷

↞搷

↞搷

倵䲸撚↞䥓傎䬹

↞搷

↞搷

↞搷

↞搷

↞搷

&%5"䬹

㛂樤孙

㛂樤孙

↞搷

↞搷

↞搷

&%5"↞䥓傎䬹

↞搷

↞搷

↞搷

↞搷

↞搷

㝸㩄愐䙨䬹

↞搷

↞搷

↞搷

↞搷

↞搷

&%5"㮷⊮䈁䬹

↞搷

↞搷

↞搷

↞搷

↞搷

(MVDP&9"$5䬹

↞搷

↞搷

↞搷

↞搷

↞搷

㝸㩄愐䙨䬹1#.NM䥓⽛⋢⼜DN

↞搷

↞搷

↞搷

↞搷

↞搷

㝸㩄愐䙨䬹1#.NM䥓⽛⋢⼜DN冋İDN

㛂樤孙

㛂樤孙

↞搷

㛂樤孙

㛂樤孙

OW㛂樤孙徚䓀Ḧ㇘㚡4.POPWFUUFʼ煦NNʸ4.POPWFUUFO⃗䥩ʹ旼⢮Ǆ⛀d$㛹Ẏᶣ䥓⽛劉⚕㞟⅞#4ˊ4QFDJGJDBUJPOGPSTJOHMFVTFMBCFMMFENFEJDBMTQFDJNFODPOUBJOFSTGPSIBFNBUPMPHZBOECJPDIFNJTUSZʼⶊ⍮㴠Ǆ

ℋḦ↞䥓䈁峀䘜ό〇↞䥓䈁峀ʸ↞䥓傎ʹ䘜㳙≀䈑⾿⍮⅋Ḧ㷁⸾Ǆ⤚㜴⛀䥓⽛⇥ㆮ䥓⽛彟䦣᷅⮑4.POPWFUUF彳埤⅏⌌ʼ↱㕸㱭䠆ή↞䥓傎⯚彶亅Ǆᶽ䤙⮑4.POPWFUUF彳埤Ḥ㪹䥓⽛慥㕈䥓⽛Ǆ

⸷⺛⢜伆


⸬∹⽝怍⬠ᶘ凄⌃䒷⅞↱ṽ⍢〈⻫⢜䎞シ㝫⾿㛨㔱䘜㱭⼣奜䩸Ǆ䨗㇌ᶘ㪹⾿㇣⣯⎇怗⃥シ㝫桦昁Ǆ㯹㝫ㆮⶊ⠃㹹䘜埘㵊慟晞䲓乷⽝栓ᶺ⺛⛀⎠徚䘜䒷䈁⌉昁䈁峀⢜䎞⭑☀᷅ʼ䃎⎦⎇彳埤橰⌣䀅卤␤䂲䁿Ǆ⽝栓⛀〈⻫䘜䂲䁿☀᷅ㆮᾷ≁橰⌣慴ʸ呐㰕䀅卤ʹ彳埤⸷⺛⢜䎞Ǆ



;)
ḿ⑙䈑⬲㞟⅞␤㊟Ṽ䘜㚡㓠䇠㛄$-4* (1Ā5VCFTBOE"EEJUJWFTGPS7FOPVTBOE$BQJMMBSZ#MPPE4QFDJNFO$PMMFDUJPOĀ "QQSPWFE4UBOEBSE
$-4* (1Ā$PMMFDUJPOPG%JBHOPTUJD7FOPVT#MPPE4QFDJNFOTĀ "QQSPWFE4UBOEBSE
$-4* (1Ā1SPDFEVSFTGPSUIF)BOEMJOHBOE1SPDFTTJOHPG#MPPE4QFDJNFOTGPS$PNNPO-BCPSBUPSZ5FTUTĀ "QQSPWFE(VJEFMJOF
$-4* )Ā$PMMFDUJPO 5SBOTQPSU BOE1SPDFTTJOHPG#MPPE4QFDJNFOTGPS5FTUJOH1MBTNB#BTFE$PBHVMBUJPO"TTBZTBOE.PMFDVMBS)FNPTUBTJT"TTBZTĀ "QQSPWFE(VJEFMJOF
8)0%*--"#3FWĀ803-%)&"-5)03("/*;"5*0/ FUBM6TFPGBOUJDPBHVMBOUTJOEJBHOPTUJDMBCPSBUPSZJOWFTUJHBUJPOT(FOFWB8PSME)FBMUI0SHBOJ[BUJPO Ā

ℋḦ曱傡慟埘䓀⭑☀䘜㞟⅞ˊ
%*/&/*40䓀ḦṒừᶘ㪹⾿曱傡埘㟏慟晞䘜⭑☀$-4* $MJOJDBMBOE-BCPSBUPSZ4UBOEBSET*OTUJUVUF

䪾⎏␤孞⇃䞙ˊḿ⑙亮⎏⍾徚䓀Ḧ䊄䩣㕸卤⊝塝ḿ⑙ḿ⑙㈑⎏⤚㜴⊝塝㋷⛧ʼ宏⊗἗䓀⃙子἗䓀㚷旨ⶾ⢮ή㈼⊝塝䘜⋭ᶘ㕸卤⯧昴䲓乷

$&㞟孞

弨䃿䀅卤

ừ⢮孢㕅

㲀ェ἗䓀完㖦

慥⢥἗䓀㖎ˊ㯹㝫桦昁怗⃥旋⃡䚌⮜⫰㓖Ḧ⸊䅽⢜⇎徸ⓞ⇎徸⚕⭎⛈⋒

㕸卤㵊ừ徲快宏⊗慥㕈䀅卤

ή䓱㈘㛇⍰㚌㛛⇁Ǆ㇘㚡ᶦḿ⑙㚡ℋ䘜ᶽ慥ḣẎʼ⸬⍢㖎徲䝽⇎徸ⓞ⍢䚐⸬ᷓ䬹悀斀Ǆ